Citrus Sinensis ID: 044127
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 282 | 2.2.26 [Sep-21-2011] | |||||||
| Q6Z8C8 | 459 | Cyclin-dependent kinase F | no | no | 0.985 | 0.605 | 0.575 | 5e-95 | |
| Q84SN3 | 433 | Cyclin-dependent kinase F | no | no | 0.989 | 0.644 | 0.516 | 2e-84 | |
| Q04859 | 622 | Serine/threonine-protein | yes | no | 0.964 | 0.437 | 0.483 | 9e-82 | |
| P20793 | 622 | Serine/threonine-protein | yes | no | 0.964 | 0.437 | 0.48 | 1e-81 | |
| P20794 | 623 | Serine/threonine-protein | yes | no | 0.964 | 0.436 | 0.476 | 9e-81 | |
| Q9UPZ9 | 632 | Serine/threonine-protein | no | no | 0.975 | 0.435 | 0.467 | 1e-76 | |
| Q9JKV2 | 629 | Serine/threonine-protein | no | no | 0.975 | 0.437 | 0.478 | 2e-76 | |
| Q62726 | 629 | Serine/threonine-protein | no | no | 0.975 | 0.437 | 0.478 | 2e-76 | |
| P43294 | 443 | Serine/threonine-protein | no | no | 0.960 | 0.611 | 0.490 | 7e-76 | |
| Q55FJ6 | 507 | Probable serine/threonine | yes | no | 0.964 | 0.536 | 0.447 | 2e-72 |
| >sp|Q6Z8C8|CDKF4_ORYSJ Cyclin-dependent kinase F-4 OS=Oryza sativa subsp. japonica GN=CDKF-4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 347 bits (890), Expect = 5e-95, Method: Compositional matrix adjust.
Identities = 161/280 (57%), Positives = 213/280 (76%), Gaps = 2/280 (0%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V++A++K++GE VAVKK+K+K +S +E +L+EVK LR+MN HPNIVKL+ +++E
Sbjct: 13 GTFGSVWRAINKQNGEVVAVKKMKRKYYSFEECMSLREVKSLRRMN-HPNIVKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ + EYME +L +LMK+R + FSE EVRN CFQ+FQ L YMH++GYFHRDLKP N
Sbjct: 72 NDILYFIMEYMECNLYQLMKDRV-KPFSEAEVRNWCFQIFQALAYMHQRGYFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLVSK VIK+ D G+ +E+ S P T+YV+TRWYRAPEVLL S IY VDMWAMGAIM
Sbjct: 131 LLVSKDVIKLADFGLAREVTSVPPYTEYVSTRWYRAPEVLLQSSIYDSAVDMWAMGAIMA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+L+ LFPG + AD+I KIC VIGSP E SWP G+ LA + ++FPQ+ G L E+
Sbjct: 191 ELLTLHPLFPGTSEADEILKICNVIGSPDEQSWPQGLSLAETMKFQFPQVSGNQLAEVMT 250
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280
S S E++ LIS LCSW+P RP AAE L+H FF+ C FVP
Sbjct: 251 SVSSEAVDLISSLCSWDPCKRPKAAEVLQHTFFQGCTFVP 290
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3 |
| >sp|Q84SN3|CDKF3_ORYSJ Cyclin-dependent kinase F-3 OS=Oryza sativa subsp. japonica GN=CDKF-3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (799), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 145/281 (51%), Positives = 200/281 (71%), Gaps = 2/281 (0%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ G+VF+A + ++ E VAVKK+K+K F +E +L+EVK L+K+N HPNIVKL+ + E
Sbjct: 13 GTCGNVFRAYNTETNEIVAVKKMKRKFFQWEECISLREVKALQKLN-HPNIVKLKEVTME 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+ ++F +FE ME +L +++ER FSE+E+RN Q+ QGL YMH GYFHRDLKP N
Sbjct: 72 NHELFFIFENMECNLYDVIRERQAA-FSEEEIRNFMVQILQGLAYMHNNGYFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLV+ G +KI D G+ +E+ SS P TDYV+TRWYRAPEVLL S Y P +DMWA+GAI+
Sbjct: 131 LLVTDGTVKIADFGLAREVSSSPPYTDYVSTRWYRAPEVLLQSSAYTPAIDMWAVGAILA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+ + LFPG + DQ+YKIC V+G+P WP G+ L + + F Q+ NL EL P
Sbjct: 191 ELFTLSPLFPGGSETDQLYKICAVLGTPDHTVWPEGMNLPRSSSFNFFQIPPRNLWELIP 250
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPR 281
+A+ E+I LI +LCSW+P RPTA ++L+HPFF ++VPR
Sbjct: 251 NATLEAIDLIQQLCSWDPRRRPTAEQSLQHPFFNVGNWVPR 291
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q04859|MAK_MOUSE Serine/threonine-protein kinase MAK OS=Mus musculus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 303 bits (776), Expect = 9e-82, Method: Compositional matrix adjust.
Identities = 133/275 (48%), Positives = 206/275 (74%), Gaps = 3/275 (1%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V +SGE VA+K++K+K +S DE NL+EVK L+K+N H N++KL+ +++E
Sbjct: 13 GTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-HANVIKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ VFEYM+ +L +LMK+R + F E +RN+ +Q+ QGL ++H+ G+FHRD+KP N
Sbjct: 72 NDHLYFVFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPEN 130
Query: 121 LL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVLL S +Y +D+WA+G+IM
Sbjct: 131 LLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSPIDVWAVGSIM 190
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ +FR LFPG + D+I+KICQV+G+P + WP G QLAS+++++FPQ +NL+ L
Sbjct: 191 AELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQCIPINLKTLI 250
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P+AS E+I L++ + +W+P RPTA++AL+HP+F+
Sbjct: 251 PNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors. Could have an important function in sensory cells and in spermatogenesis. May participate in signaling pathways used in visual and olfactory sensory transduction. Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P20793|MAK_RAT Serine/threonine-protein kinase MAK OS=Rattus norvegicus GN=Mak PE=1 SV=2 | Back alignment and function description |
|---|
Score = 302 bits (774), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 132/275 (48%), Positives = 206/275 (74%), Gaps = 3/275 (1%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V +SGE VA+K++K+K +S DE NL+EVK L+K+N H N++KL+ +++E
Sbjct: 13 GTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-HANVIKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ +FEYM+ +L +LMK+R + F E +RN+ +Q+ QGL ++H+ G+FHRD+KP N
Sbjct: 72 NDHLYFIFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPEN 130
Query: 121 LL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVLL S +Y +D+WA+G+IM
Sbjct: 131 LLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSPIDVWAVGSIM 190
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ +FR LFPG + D+I+KICQV+G+P + WP G QLAS+++++FPQ +NL+ L
Sbjct: 191 AELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQCIPINLKTLI 250
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P+AS E+I L++ + +W+P RPTA++AL+HP+F+
Sbjct: 251 PNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Could play an important function in spermatogenesis. Phosphorylates FZR1 in a cell cycle-dependent manner (By similarity). Plays a role in the transcriptional coactivation of AR. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P20794|MAK_HUMAN Serine/threonine-protein kinase MAK OS=Homo sapiens GN=MAK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 300 bits (768), Expect = 9e-81, Method: Compositional matrix adjust.
Identities = 131/275 (47%), Positives = 204/275 (74%), Gaps = 3/275 (1%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V +SGE VA+K++K+K +S DE NL+EVK L+K+N H N++KL+ +++E
Sbjct: 13 GTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-HANVIKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ +FEYM+ +L +LMK+R + F E +RN+ +Q+ QGL ++H+ G+FHRD+KP N
Sbjct: 72 NDHLYFIFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPEN 130
Query: 121 LL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVLL S +Y +D+WA+G+IM
Sbjct: 131 LLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSPIDVWAVGSIM 190
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ R LFPG + D+I+KICQV+G+P + WP G QLAS+++++FPQ +NL+ L
Sbjct: 191 AELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQCVPINLKTLI 250
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P+AS E+I L++ + +W+P RPTA++AL+HP+F+
Sbjct: 251 PNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
Essential for the regulation of ciliary length and required for the long-term survival of photoreceptors (By similarity). Phosphorylates FZR1 in a cell cycle-dependent manner. Plays a role in the transcriptional coactivation of AR. Could play an important function in spermatogenesis. May play a role in chromosomal stability in prostate cancer cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9UPZ9|ICK_HUMAN Serine/threonine-protein kinase ICK OS=Homo sapiens GN=ICK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (732), Expect = 1e-76, Method: Compositional matrix adjust.
Identities = 130/278 (46%), Positives = 198/278 (71%), Gaps = 3/278 (1%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V +SGE +A+KK+K+K +S +E NL+EVK L+K+N H N+VKL+ +++E
Sbjct: 13 GTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLN-HANVVKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ +FEYM+ +L +L+KER + F E +RN+ +Q+ QGL ++H+ G+FHRDLKP N
Sbjct: 72 NDHLYFIFEYMKENLYQLIKER-NKLFPESAIRNIMYQILQGLAFIHKHGFFHRDLKPEN 130
Query: 121 LL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LL + ++KI D G+ +EI S P TDYV+TRWYRAPEVLL S Y +D+WA+G IM
Sbjct: 131 LLCMGPELVKIADFGLAREIRSKPPYTDYVSTRWYRAPEVLLRSTNYSSPIDVWAVGCIM 190
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ + R LFPG + D I+KICQV+G+P + WP G QL+S +++++PQ NL+ L
Sbjct: 191 AEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFRWPQCVPNNLKTLI 250
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
P+AS E++ L+ + W+P RPTA++AL +P+F+ H
Sbjct: 251 PNASSEAVQLLRDMLQWDPKKRPTASQALRYPYFQVGH 288
|
May play a key role in the development of multiple organ systems and particularly in cardiac development. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9JKV2|ICK_MOUSE Serine/threonine-protein kinase ICK OS=Mus musculus GN=Ick PE=2 SV=2 | Back alignment and function description |
|---|
Score = 286 bits (731), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 133/278 (47%), Positives = 197/278 (70%), Gaps = 3/278 (1%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V +SGE +A+KK+K+K +S +E NL+EVK L+K+N H NIVKL+ +++E
Sbjct: 13 GTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLN-HANIVKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ +FEYM+ +L +L+KER + F E +RN+ +Q+ QGL ++H+ G+FHRDLKP N
Sbjct: 72 NDHLYFIFEYMKENLYQLIKER-NKLFPESAIRNIMYQILQGLAFIHKHGFFHRDLKPEN 130
Query: 121 LL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LL + ++KI D G+ +EI S P TDYV+TRWYRAPEVLL S Y +D+WA+G IM
Sbjct: 131 LLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVLLRSTNYSSPIDIWAVGCIM 190
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ + R LFPG + D I+KICQV+G+P + WP G QL+S +++ +PQ NL+ L
Sbjct: 191 AEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFLWPQCIPNNLKTLI 250
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
P+AS E+I L+ L W+P RPTA++AL +P+F+ H
Sbjct: 251 PNASSEAIQLLRDLLQWDPKKRPTASQALRYPYFQIGH 288
|
May play a role in cardiac development. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q62726|ICK_RAT Serine/threonine-protein kinase ICK OS=Rattus norvegicus GN=Ick PE=1 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (730), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 133/278 (47%), Positives = 197/278 (70%), Gaps = 3/278 (1%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V +SGE +A+KK+K+K +S +E NL+EVK L+K+N H NIVKL+ +++E
Sbjct: 13 GTYGSVLLGRSIESGELIAIKKMKRKFYSWEECMNLREVKSLKKLN-HANIVKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ +FEYM+ +L +L+KER + F E +RN+ +Q+ QGL ++H+ G+FHRDLKP N
Sbjct: 72 NDHLYFIFEYMKENLYQLIKER-NKLFPESAIRNIMYQILQGLAFIHKHGFFHRDLKPEN 130
Query: 121 LL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LL + ++KI D G+ +EI S P TDYV+TRWYRAPEVLL S Y +D+WA+G IM
Sbjct: 131 LLCMGPELVKIADFGLAREIRSRPPYTDYVSTRWYRAPEVLLRSTNYSSPIDVWAVGCIM 190
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ + R LFPG + D I+KICQV+G+P + WP G QL+S +++ +PQ NL+ L
Sbjct: 191 AEVYTLRPLFPGASEIDTIFKICQVLGTPKKTDWPEGYQLSSAMNFIWPQCIPNNLKTLI 250
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
P+AS E+I L+ L W+P RPTA++AL +P+F+ H
Sbjct: 251 PNASSEAIQLLRDLLQWDPKKRPTASQALRYPYFQIGH 288
|
May play a role in cardiac development. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|P43294|MHK_ARATH Serine/threonine-protein kinase MHK OS=Arabidopsis thaliana GN=MHK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 283 bits (725), Expect = 7e-76, Method: Compositional matrix adjust.
Identities = 134/273 (49%), Positives = 194/273 (71%), Gaps = 2/273 (0%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ G V++A++ ++ E VAVKK+K+K + +E NL+EVK LRK+N HP+I+KL+ +V+E
Sbjct: 21 GTCGSVYKAVNLETYEVVAVKKMKRKFYYWEECVNLREVKALRKLN-HPHIIKLKEIVRE 79
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
H ++F +FE M+ +L +MKER + FSE E+R+ Q+ QGL +MH+ GYFHRDLKP N
Sbjct: 80 HNELFFIFECMDHNLYHIMKERE-RPFSEGEIRSFMSQMLQGLAHMHKNGYFHRDLKPEN 138
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLV+ ++KI D G+ +E+ S P T+YV+TRWYRAPEVLL S +Y P VDMWA+GAI+
Sbjct: 139 LLVTNNILKIADFGLAREVASMPPYTEYVSTRWYRAPEVLLQSSLYTPAVDMWAVGAILA 198
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+ + LFPG++ DQ+YKIC V+G P ++P ++ + + + +L P
Sbjct: 199 ELYALTPLFPGESEIDQLYKICCVLGKPDWTTFPEAKSISRIMSISHTEFPQTRIADLLP 258
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
+A+ E+I LI+RLCSW+P RPTA EAL HPFF
Sbjct: 259 NAAPEAIDLINRLCSWDPLKRPTADEALNHPFF 291
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q55FJ6|Y8078_DICDI Probable serine/threonine-protein kinase DDB_G0268078 OS=Dictyostelium discoideum GN=DDB_G0268078 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (695), Expect = 2e-72, Method: Compositional matrix adjust.
Identities = 124/277 (44%), Positives = 194/277 (70%), Gaps = 5/277 (1%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YGDV +A+D K+GE VA+K++KKK E L+E+K L+K+ HPNIVKL ++ E
Sbjct: 13 GAYGDVIKAIDVKTGEIVAIKRMKKKFSDWKECIQLREIKALKKLK-HPNIVKLLEIILE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+++F VFEY+E++L + +K+R + E +RN+ +Q+ Q LH+MH G+FHRDLKP N
Sbjct: 72 RDELFFVFEYLENNLYESIKDRT-KLLPETTIRNIIYQILQALHFMHTNGFFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
+++ +KI D G+ +EI+S P TDY++TRWYRAPEVLL Y +D+WA+GAIM
Sbjct: 131 IMLVGERLKIADFGLAREIESKPPFTDYISTRWYRAPEVLLRCTYYNAPIDIWAVGAIMA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS- 239
E+ S + +FPG + DQ++KIC ++GSPT +W GI+LA+++ + FP + ++ LS
Sbjct: 191 ELYSLKPMFPGSSEIDQLFKICTIMGSPTSATWIDGIKLANSMGFTFPNVQPPSINPLST 250
Query: 240 --PSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P+A++++I LI+ L ++P RPT +AL+H +F+
Sbjct: 251 LLPNANQDAIELITDLLQYDPLKRPTPLQALQHRYFK 287
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 282 | ||||||
| 357484657 | 449 | Serine/threonine protein kinase ICK [Med | 0.992 | 0.623 | 0.617 | 1e-101 | |
| 30684655 | 464 | putative serine/threonine protein kinase | 0.992 | 0.603 | 0.599 | 1e-100 | |
| 18422554 | 499 | conserved peptide upstream open reading | 0.992 | 0.561 | 0.602 | 1e-100 | |
| 15450860 | 499 | serine/threonine-protein kinase Mak (mal | 0.992 | 0.561 | 0.602 | 1e-100 | |
| 18415242 | 461 | putative serine/threonine protein kinase | 0.992 | 0.607 | 0.599 | 1e-100 | |
| 334188209 | 497 | conserved peptide upstream open reading | 0.992 | 0.563 | 0.602 | 1e-100 | |
| 297800140 | 460 | hypothetical protein ARALYDRAFT_492943 [ | 0.992 | 0.608 | 0.599 | 1e-100 | |
| 359474639 | 452 | PREDICTED: cyclin-dependent kinase F-4-l | 0.992 | 0.619 | 0.609 | 2e-99 | |
| 224074450 | 453 | predicted protein [Populus trichocarpa] | 0.992 | 0.618 | 0.606 | 2e-99 | |
| 255557681 | 455 | mak, putative [Ricinus communis] gi|2235 | 0.985 | 0.610 | 0.592 | 3e-99 |
| >gi|357484657|ref|XP_003612616.1| Serine/threonine protein kinase ICK [Medicago truncatula] gi|355513951|gb|AES95574.1| Serine/threonine protein kinase ICK [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 372 bits (955), Expect = e-101, Method: Compositional matrix adjust.
Identities = 174/282 (61%), Positives = 226/282 (80%), Gaps = 2/282 (0%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V++A+ K++GE VA+KK+KKK +S +E NL+EVK LRKMN HPNIVKL+ +++E
Sbjct: 13 GTFGSVWRAISKQTGEVVAIKKMKKKYYSWEECVNLREVKSLRKMN-HPNIVKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+ ++ VFEYME +L +LMK+R + FSE E+RN CFQVFQGL YMH++GYFHRDLKP N
Sbjct: 72 SDILYFVFEYMECNLYQLMKDRE-KLFSEGEIRNWCFQVFQGLAYMHQRGYFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLV+K VIKI D G+ +EI+S P T+YV+TRWYRAPEVLL S IY +VDMWAMGAIM
Sbjct: 131 LLVTKDVIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLLQSYIYSSKVDMWAMGAIMA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+ S R LFPG + AD+IYKIC VIG+PT DSW G++LA +++++FPQ+ GVNL L P
Sbjct: 191 ELFSLRPLFPGASEADEIYKICGVIGNPTTDSWADGLKLARDINYQFPQLAGVNLSALIP 250
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282
SAS +ISLI LCSW+P RPTA+EAL+HPFF+SC ++P S
Sbjct: 251 SASDHAISLIQSLCSWDPCKRPTASEALQHPFFQSCFYIPPS 292
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30684655|ref|NP_849407.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|332658742|gb|AEE84142.1| putative serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 371 bits (953), Expect = e-100, Method: Compositional matrix adjust.
Identities = 169/282 (59%), Positives = 230/282 (81%), Gaps = 2/282 (0%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V++A++K++GE VA+KK+KKK +S DE NL+EVK LR+MN HPNIVKL+ +++E
Sbjct: 13 GTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMN-HPNIVKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ VFEYME +L +LMK+R + F+E +++N CFQVFQGL YMH++GYFHRDLKP N
Sbjct: 72 NDILYFVFEYMECNLYQLMKDRQ-KLFAEADIKNWCFQVFQGLSYMHQRGYFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLVSK +IKI D G+ +E++SS P T+YV+TRWYRAPEVLL S +Y +VDMWAMGAIM
Sbjct: 131 LLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSKVDMWAMGAIMA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+LS R +FPG + AD+IYKIC VIG+PTE++W G+ LA+ ++++FPQ+ GV L L P
Sbjct: 191 ELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQLPGVPLSSLMP 250
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282
SAS ++I+LI RLCSW+P RPTAAE L+HPFF+SC +VP S
Sbjct: 251 SASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCFYVPPS 292
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18422554|ref|NP_568646.1| conserved peptide upstream open reading frame 24 [Arabidopsis thaliana] gi|24899765|gb|AAN65097.1| serine/threonine-protein kinase Mak (male germ cell-associated kinase)-like protein [Arabidopsis thaliana] gi|332007866|gb|AED95249.1| conserved peptide upstream open reading frame 24 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 371 bits (953), Expect = e-100, Method: Compositional matrix adjust.
Identities = 170/282 (60%), Positives = 231/282 (81%), Gaps = 2/282 (0%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G+V++A++K++ E VA+K++KKK FS +E NL+EVK L +MN HPNIVKL+ +++E
Sbjct: 13 GTFGNVWRAVNKQTNEVVAIKRMKKKYFSWEECVNLREVKSLSRMN-HPNIVKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ VFEYME +L +LMK+R ++F+E ++RN CFQVFQGL YMH++GYFHRDLKP N
Sbjct: 72 NDILYFVFEYMECNLYQLMKDRP-KHFAESDIRNWCFQVFQGLSYMHQRGYFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLVSK VIKI DLG+ +EIDSS P T+YV+TRWYRAPEVLL S +Y +VDMWAMGAIM
Sbjct: 131 LLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYVYTSKVDMWAMGAIMA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+LS R LFPG + AD+IYKIC VIGSPTE++W G+ LAS ++++FPQ GV+L + P
Sbjct: 191 ELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINYQFPQFPGVHLSSVMP 250
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282
AS ++++LI RLCSW+P RPT AEAL+HPFF+SC+++P S
Sbjct: 251 YASADAVNLIERLCSWDPCNRPTTAEALQHPFFQSCYYIPPS 292
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15450860|gb|AAK96701.1| serine/threonine-protein kinase Mak (male germ cell-associated kinase)-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 371 bits (952), Expect = e-100, Method: Compositional matrix adjust.
Identities = 170/282 (60%), Positives = 231/282 (81%), Gaps = 2/282 (0%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G+V++A++K++ E VA+K++KKK FS +E NL+EVK L +MN HPNIVKL+ +++E
Sbjct: 13 GTFGNVWRAVNKQTNEVVAIKRMKKKYFSWEECVNLREVKSLSRMN-HPNIVKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ VFEYME +L +LMK+R ++F+E ++RN CFQVFQGL YMH++GYFHRDLKP N
Sbjct: 72 NDILYFVFEYMECNLYQLMKDRP-KHFAESDIRNWCFQVFQGLSYMHQRGYFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLVSK VIKI DLG+ +EIDSS P T+YV+TRWYRAPEVLL S +Y +VDMWAMGAIM
Sbjct: 131 LLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYVYTSKVDMWAMGAIMA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+LS R LFPG + AD+IYKIC VIGSPTE++W G+ LAS ++++FPQ GV+L + P
Sbjct: 191 ELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINYQFPQFPGVHLSSVMP 250
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282
AS ++++LI RLCSW+P RPT AEAL+HPFF+SC+++P S
Sbjct: 251 YASADAVNLIERLCSWDPCNRPTTAEALQHPFFQSCYYIPPS 292
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18415242|ref|NP_567574.1| putative serine/threonine protein kinase [Arabidopsis thaliana] gi|13430556|gb|AAK25900.1|AF360190_1 putative kinase [Arabidopsis thaliana] gi|14532760|gb|AAK64081.1| putative kinase [Arabidopsis thaliana] gi|332658741|gb|AEE84141.1| putative serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 371 bits (952), Expect = e-100, Method: Compositional matrix adjust.
Identities = 169/282 (59%), Positives = 230/282 (81%), Gaps = 2/282 (0%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V++A++K++GE VA+KK+KKK +S DE NL+EVK LR+MN HPNIVKL+ +++E
Sbjct: 13 GTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMN-HPNIVKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ VFEYME +L +LMK+R + F+E +++N CFQVFQGL YMH++GYFHRDLKP N
Sbjct: 72 NDILYFVFEYMECNLYQLMKDRQ-KLFAEADIKNWCFQVFQGLSYMHQRGYFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLVSK +IKI D G+ +E++SS P T+YV+TRWYRAPEVLL S +Y +VDMWAMGAIM
Sbjct: 131 LLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSKVDMWAMGAIMA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+LS R +FPG + AD+IYKIC VIG+PTE++W G+ LA+ ++++FPQ+ GV L L P
Sbjct: 191 ELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQLPGVPLSSLMP 250
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282
SAS ++I+LI RLCSW+P RPTAAE L+HPFF+SC +VP S
Sbjct: 251 SASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCFYVPPS 292
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334188209|ref|NP_001190473.1| conserved peptide upstream open reading frame 24 [Arabidopsis thaliana] gi|332007867|gb|AED95250.1| conserved peptide upstream open reading frame 24 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 371 bits (952), Expect = e-100, Method: Compositional matrix adjust.
Identities = 170/282 (60%), Positives = 231/282 (81%), Gaps = 2/282 (0%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G+V++A++K++ E VA+K++KKK FS +E NL+EVK L +MN HPNIVKL+ +++E
Sbjct: 13 GTFGNVWRAVNKQTNEVVAIKRMKKKYFSWEECVNLREVKSLSRMN-HPNIVKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ VFEYME +L +LMK+R ++F+E ++RN CFQVFQGL YMH++GYFHRDLKP N
Sbjct: 72 NDILYFVFEYMECNLYQLMKDRP-KHFAESDIRNWCFQVFQGLSYMHQRGYFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLVSK VIKI DLG+ +EIDSS P T+YV+TRWYRAPEVLL S +Y +VDMWAMGAIM
Sbjct: 131 LLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYVYTSKVDMWAMGAIMA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+LS R LFPG + AD+IYKIC VIGSPTE++W G+ LAS ++++FPQ GV+L + P
Sbjct: 191 ELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINYQFPQFPGVHLSSVMP 250
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282
AS ++++LI RLCSW+P RPT AEAL+HPFF+SC+++P S
Sbjct: 251 YASADAVNLIERLCSWDPCNRPTTAEALQHPFFQSCYYIPPS 292
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297800140|ref|XP_002867954.1| hypothetical protein ARALYDRAFT_492943 [Arabidopsis lyrata subsp. lyrata] gi|297313790|gb|EFH44213.1| hypothetical protein ARALYDRAFT_492943 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 370 bits (951), Expect = e-100, Method: Compositional matrix adjust.
Identities = 169/282 (59%), Positives = 230/282 (81%), Gaps = 2/282 (0%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V++A++K++GE VA+KK+KKK +S DE NL+EVK LR+MN HPNIVKL+ +++E
Sbjct: 13 GTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMN-HPNIVKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ VFEYME +L +LMK+R + F+E +++N CFQVFQGL YMH++GYFHRDLKP N
Sbjct: 72 NDILYFVFEYMECNLYQLMKDRQ-KLFAEADIKNWCFQVFQGLSYMHQRGYFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLVSK +IKI D G+ +E++SS P T+YV+TRWYRAPEVLL S +Y +VDMWAMGAIM
Sbjct: 131 LLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSKVDMWAMGAIMA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+LS R +FPG + AD+IYKIC VIG+PTE++W G+ LA+ ++++FPQ+ GV L L P
Sbjct: 191 ELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQLPGVPLSSLMP 250
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282
SAS ++I+LI RLCSW+P RPTAAE L+HPFF+SC +VP S
Sbjct: 251 SASEDAINLIERLCSWDPCSRPTAAEVLQHPFFQSCFYVPPS 292
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474639|ref|XP_002265359.2| PREDICTED: cyclin-dependent kinase F-4-like [Vitis vinifera] gi|296088459|emb|CBI37450.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 368 bits (944), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 172/282 (60%), Positives = 225/282 (79%), Gaps = 2/282 (0%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V++A++K++GE VA+KK+K+K +S +E NL+EVK LRKMN HPNIVKLR + +E
Sbjct: 13 GTFGSVWRAINKQTGEVVAIKKMKRKYYSWEECLNLREVKSLRKMN-HPNIVKLREVFRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ VFEYME +L +LMK+R + FSE EVRN CFQVFQGL YMHR+GYFHRDLKP N
Sbjct: 72 NDILYFVFEYMECNLYQLMKDRL-KLFSETEVRNWCFQVFQGLAYMHRRGYFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLV+K VIKI D G+ +EI+S P T+YV+TRWYRAPEVLL S YG VDMWAMGAIM
Sbjct: 131 LLVTKDVIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLLQSSTYGSAVDMWAMGAIMA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+ + R LFPG + AD+IYKIC V+GSPT +SW G++LA+ ++++FPQ ++L L P
Sbjct: 191 ELFTLRPLFPGSSEADEIYKICSVMGSPTWNSWAEGLKLANAINYQFPQFSSIHLSVLIP 250
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282
SAS ++ISLI+ LCSW+P RPTA EAL+HPFF+SC +VP S
Sbjct: 251 SASEDAISLITSLCSWDPCKRPTALEALQHPFFQSCFYVPPS 292
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224074450|ref|XP_002304373.1| predicted protein [Populus trichocarpa] gi|222841805|gb|EEE79352.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 367 bits (943), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 171/282 (60%), Positives = 225/282 (79%), Gaps = 2/282 (0%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V++A++K+SGE VA+KK+KKK +S +E NL+EVK LRKMN HPNIVKLR +++E
Sbjct: 13 GTFGSVWRAINKQSGEVVAIKKMKKKYYSWEECVNLREVKSLRKMN-HPNIVKLREVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ VFEYME +L +L K+R + FSE EVRN CFQVFQGL YMH++GYFHRDLKP N
Sbjct: 72 NDILYFVFEYMECNLYQLTKDRE-KLFSEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLVSK +IKI D G+ +E++S P T+YV+TRWYRAPEVLL S +Y +VDMWAMGAIM
Sbjct: 131 LLVSKSIIKIADFGLAREVNSQPPYTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+ + R LFPG + AD+IYKIC VIGSPT D+W G+ LA ++++FPQ GV+L L P
Sbjct: 191 ELFTLRPLFPGTSEADEIYKICSVIGSPTTDTWADGLNLARAINYQFPQFAGVHLPTLIP 250
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282
SAS ++I+LI LCSW+P RP+AA+AL+HPFF+SC +VP S
Sbjct: 251 SASEDAINLIKSLCSWDPCTRPSAADALQHPFFQSCFYVPPS 292
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255557681|ref|XP_002519870.1| mak, putative [Ricinus communis] gi|223540916|gb|EEF42474.1| mak, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 367 bits (943), Expect = 3e-99, Method: Compositional matrix adjust.
Identities = 166/280 (59%), Positives = 225/280 (80%), Gaps = 2/280 (0%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V++A++K+SGE VA+KK+KKK ++ +E NL+EVK LR+MN HPNIVKL+ +++E
Sbjct: 13 GTFGSVWRAINKQSGEVVAIKKMKKKYYTWEECVNLREVKSLRRMN-HPNIVKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ VFEYM+ +L +L+K+R + F E EVRN CFQVFQGL YMH++GYFHRDLKP N
Sbjct: 72 NDILYFVFEYMDCNLYQLIKDRV-KLFPEAEVRNWCFQVFQGLAYMHQRGYFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLV+KG+IKI D G+ +EI+S P T+YV+TRWYRAPEVLL S +Y +VDMWAMGAIM
Sbjct: 131 LLVTKGIIKIADFGLAREINSQPPYTEYVSTRWYRAPEVLLQSYLYSSKVDMWAMGAIMA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+ + R LFPG + AD+IYKIC +IGSPT+DSW G+ LA ++++FPQ GGV L L P
Sbjct: 191 ELFTLRPLFPGTSEADEIYKICNIIGSPTKDSWADGLNLARAINYQFPQFGGVQLSALIP 250
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280
SAS ++++LI LCSW+P RP+A EAL+HPFF+SC +VP
Sbjct: 251 SASEDAVNLIKSLCSWDPSKRPSAGEALQHPFFQSCFYVP 290
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 282 | ||||||
| TAIR|locus:2134746 | 464 | AT4G19110 [Arabidopsis thalian | 0.992 | 0.603 | 0.599 | 1.6e-93 | |
| TAIR|locus:2163583 | 499 | AT5G45430 [Arabidopsis thalian | 0.992 | 0.561 | 0.602 | 2.7e-93 | |
| UNIPROTKB|F1RV90 | 624 | MAK "Uncharacterized protein" | 0.964 | 0.435 | 0.48 | 1.5e-76 | |
| MGI|MGI:96913 | 622 | Mak "male germ cell-associated | 0.964 | 0.437 | 0.483 | 1.9e-76 | |
| RGD|3036 | 622 | Mak "male germ cell-associated | 0.964 | 0.437 | 0.48 | 2.4e-76 | |
| UNIPROTKB|P20793 | 622 | Mak "Serine/threonine-protein | 0.964 | 0.437 | 0.48 | 2.4e-76 | |
| UNIPROTKB|P20794 | 623 | MAK "Serine/threonine-protein | 0.964 | 0.436 | 0.476 | 1e-75 | |
| UNIPROTKB|Q8IXN4 | 457 | MAK "MAK protein" [Homo sapien | 0.964 | 0.595 | 0.476 | 1e-75 | |
| UNIPROTKB|E1BDG4 | 623 | MAK "Uncharacterized protein" | 0.964 | 0.436 | 0.476 | 1.7e-75 | |
| UNIPROTKB|Q2YDJ7 | 382 | MAK "Uncharacterized protein" | 0.964 | 0.712 | 0.476 | 1.7e-75 |
| TAIR|locus:2134746 AT4G19110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 931 (332.8 bits), Expect = 1.6e-93, P = 1.6e-93
Identities = 169/282 (59%), Positives = 230/282 (81%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V++A++K++GE VA+KK+KKK +S DE NL+EVK LR+MN HPNIVKL+ +++E
Sbjct: 13 GTFGSVWRAINKQTGEVVAIKKMKKKYYSWDECINLREVKSLRRMN-HPNIVKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ VFEYME +L +LMK+R + F+E +++N CFQVFQGL YMH++GYFHRDLKP N
Sbjct: 72 NDILYFVFEYMECNLYQLMKDRQ-KLFAEADIKNWCFQVFQGLSYMHQRGYFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLVSK +IKI D G+ +E++SS P T+YV+TRWYRAPEVLL S +Y +VDMWAMGAIM
Sbjct: 131 LLVSKDIIKIADFGLAREVNSSPPFTEYVSTRWYRAPEVLLQSYVYTSKVDMWAMGAIMA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+LS R +FPG + AD+IYKIC VIG+PTE++W G+ LA+ ++++FPQ+ GV L L P
Sbjct: 191 ELLSLRPIFPGASEADEIYKICSVIGTPTEETWLEGLNLANTINYQFPQLPGVPLSSLMP 250
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282
SAS ++I+LI RLCSW+P RPTAAE L+HPFF+SC +VP S
Sbjct: 251 SASEDAINLIERLCSWDPSSRPTAAEVLQHPFFQSCFYVPPS 292
|
|
| TAIR|locus:2163583 AT5G45430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 929 (332.1 bits), Expect = 2.7e-93, P = 2.7e-93
Identities = 170/282 (60%), Positives = 231/282 (81%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G+V++A++K++ E VA+K++KKK FS +E NL+EVK L +MN HPNIVKL+ +++E
Sbjct: 13 GTFGNVWRAVNKQTNEVVAIKRMKKKYFSWEECVNLREVKSLSRMN-HPNIVKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ VFEYME +L +LMK+R ++F+E ++RN CFQVFQGL YMH++GYFHRDLKP N
Sbjct: 72 NDILYFVFEYMECNLYQLMKDRP-KHFAESDIRNWCFQVFQGLSYMHQRGYFHRDLKPEN 130
Query: 121 LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMF 180
LLVSK VIKI DLG+ +EIDSS P T+YV+TRWYRAPEVLL S +Y +VDMWAMGAIM
Sbjct: 131 LLVSKDVIKIADLGLAREIDSSPPYTEYVSTRWYRAPEVLLQSYVYTSKVDMWAMGAIMA 190
Query: 181 EMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
E+LS R LFPG + AD+IYKIC VIGSPTE++W G+ LAS ++++FPQ GV+L + P
Sbjct: 191 ELLSLRPLFPGASEADEIYKICSVIGSPTEETWLEGLNLASVINYQFPQFPGVHLSSVMP 250
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282
AS ++++LI RLCSW+P RPT AEAL+HPFF+SC+++P S
Sbjct: 251 YASADAVNLIERLCSWDPCNRPTTAEALQHPFFQSCYYIPPS 292
|
|
| UNIPROTKB|F1RV90 MAK "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 771 (276.5 bits), Expect = 1.5e-76, P = 1.5e-76
Identities = 132/275 (48%), Positives = 205/275 (74%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V +SGE VA+K++K+K +S DE NL+EVK L+K+N H N++KL+ +++E
Sbjct: 13 GTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-HANVIKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ +FEYM+ +L +LMK+R + F E +RN+ +Q+ QGL ++H+ G+FHRD+KP N
Sbjct: 72 NDHLYFIFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPEN 130
Query: 121 LL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVLL S +Y +D+WA+G+IM
Sbjct: 131 LLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSPIDVWAVGSIM 190
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ + R LFPG + D+I+KICQV+G+P + WP G QLAS+++++FPQ +NL+ L
Sbjct: 191 AELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQCAPINLKTLI 250
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P+AS E+I L++ + SW+P RPTA++AL+HP+F+
Sbjct: 251 PNASNEAIQLMTEMLSWDPKKRPTASQALKHPYFQ 285
|
|
| MGI|MGI:96913 Mak "male germ cell-associated kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 770 (276.1 bits), Expect = 1.9e-76, P = 1.9e-76
Identities = 133/275 (48%), Positives = 206/275 (74%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V +SGE VA+K++K+K +S DE NL+EVK L+K+N H N++KL+ +++E
Sbjct: 13 GTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-HANVIKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ VFEYM+ +L +LMK+R + F E +RN+ +Q+ QGL ++H+ G+FHRD+KP N
Sbjct: 72 NDHLYFVFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPEN 130
Query: 121 LL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVLL S +Y +D+WA+G+IM
Sbjct: 131 LLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSPIDVWAVGSIM 190
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ +FR LFPG + D+I+KICQV+G+P + WP G QLAS+++++FPQ +NL+ L
Sbjct: 191 AELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQCIPINLKTLI 250
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P+AS E+I L++ + +W+P RPTA++AL+HP+F+
Sbjct: 251 PNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
| RGD|3036 Mak "male germ cell-associated kinase" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 769 (275.8 bits), Expect = 2.4e-76, P = 2.4e-76
Identities = 132/275 (48%), Positives = 206/275 (74%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V +SGE VA+K++K+K +S DE NL+EVK L+K+N H N++KL+ +++E
Sbjct: 13 GTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-HANVIKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ +FEYM+ +L +LMK+R + F E +RN+ +Q+ QGL ++H+ G+FHRD+KP N
Sbjct: 72 NDHLYFIFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPEN 130
Query: 121 LL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVLL S +Y +D+WA+G+IM
Sbjct: 131 LLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSPIDVWAVGSIM 190
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ +FR LFPG + D+I+KICQV+G+P + WP G QLAS+++++FPQ +NL+ L
Sbjct: 191 AELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQCIPINLKTLI 250
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P+AS E+I L++ + +W+P RPTA++AL+HP+F+
Sbjct: 251 PNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
| UNIPROTKB|P20793 Mak "Serine/threonine-protein kinase MAK" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 769 (275.8 bits), Expect = 2.4e-76, P = 2.4e-76
Identities = 132/275 (48%), Positives = 206/275 (74%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V +SGE VA+K++K+K +S DE NL+EVK L+K+N H N++KL+ +++E
Sbjct: 13 GTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-HANVIKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ +FEYM+ +L +LMK+R + F E +RN+ +Q+ QGL ++H+ G+FHRD+KP N
Sbjct: 72 NDHLYFIFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPEN 130
Query: 121 LL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVLL S +Y +D+WA+G+IM
Sbjct: 131 LLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSPIDVWAVGSIM 190
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ +FR LFPG + D+I+KICQV+G+P + WP G QLAS+++++FPQ +NL+ L
Sbjct: 191 AELYTFRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQCIPINLKTLI 250
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P+AS E+I L++ + +W+P RPTA++AL+HP+F+
Sbjct: 251 PNASSEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
| UNIPROTKB|P20794 MAK "Serine/threonine-protein kinase MAK" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 763 (273.6 bits), Expect = 1.0e-75, P = 1.0e-75
Identities = 131/275 (47%), Positives = 204/275 (74%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V +SGE VA+K++K+K +S DE NL+EVK L+K+N H N++KL+ +++E
Sbjct: 13 GTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-HANVIKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ +FEYM+ +L +LMK+R + F E +RN+ +Q+ QGL ++H+ G+FHRD+KP N
Sbjct: 72 NDHLYFIFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPEN 130
Query: 121 LL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVLL S +Y +D+WA+G+IM
Sbjct: 131 LLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSPIDVWAVGSIM 190
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ R LFPG + D+I+KICQV+G+P + WP G QLAS+++++FPQ +NL+ L
Sbjct: 191 AELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQCVPINLKTLI 250
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P+AS E+I L++ + +W+P RPTA++AL+HP+F+
Sbjct: 251 PNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
| UNIPROTKB|Q8IXN4 MAK "MAK protein" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 763 (273.6 bits), Expect = 1.0e-75, P = 1.0e-75
Identities = 131/275 (47%), Positives = 204/275 (74%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V +SGE VA+K++K+K +S DE NL+EVK L+K+N H N++KL+ +++E
Sbjct: 13 GTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-HANVIKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ +FEYM+ +L +LMK+R + F E +RN+ +Q+ QGL ++H+ G+FHRD+KP N
Sbjct: 72 NDHLYFIFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPEN 130
Query: 121 LL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVLL S +Y +D+WA+G+IM
Sbjct: 131 LLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSVYSSPIDVWAVGSIM 190
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ R LFPG + D+I+KICQV+G+P + WP G QLAS+++++FPQ +NL+ L
Sbjct: 191 AELYMLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQCVPINLKTLI 250
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P+AS E+I L++ + +W+P RPTA++AL+HP+F+
Sbjct: 251 PNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
| UNIPROTKB|E1BDG4 MAK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 761 (272.9 bits), Expect = 1.7e-75, P = 1.7e-75
Identities = 131/275 (47%), Positives = 204/275 (74%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V +SGE VA+K++K+K +S DE NL+EVK L+K+N H N++KL+ +++E
Sbjct: 13 GTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-HANVIKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ +FEYM+ +L +LMK+R + F E +RN+ +Q+ QGL ++H+ G+FHRD+KP N
Sbjct: 72 NDHLYFIFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPEN 130
Query: 121 LL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVLL S Y +D+WA+G+IM
Sbjct: 131 LLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSAYSSPIDVWAVGSIM 190
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ + R LFPG + D+I+KICQV+G+P + WP G QLAS+++++FPQ +NL+ L
Sbjct: 191 AELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQCVPINLKTLI 250
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P+AS E+I L++ + +W+P RPTA++AL+HP+F+
Sbjct: 251 PNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
| UNIPROTKB|Q2YDJ7 MAK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 761 (272.9 bits), Expect = 1.7e-75, P = 1.7e-75
Identities = 131/275 (47%), Positives = 204/275 (74%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V +SGE VA+K++K+K +S DE NL+EVK L+K+N H N++KL+ +++E
Sbjct: 13 GTYGSVLMGKSNESGELVAIKRMKRKFYSWDECMNLREVKSLKKLN-HANVIKLKEVIRE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ +FEYM+ +L +LMK+R + F E +RN+ +Q+ QGL ++H+ G+FHRD+KP N
Sbjct: 72 NDHLYFIFEYMKENLYQLMKDR-NKLFPESVIRNIMYQILQGLAFIHKHGFFHRDMKPEN 130
Query: 121 LL-VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LL + ++KI D G+ +E+ S P TDYV+TRWYRAPEVLL S Y +D+WA+G+IM
Sbjct: 131 LLCMGPELVKIADFGLARELRSQPPYTDYVSTRWYRAPEVLLRSSAYSSPIDVWAVGSIM 190
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ + R LFPG + D+I+KICQV+G+P + WP G QLAS+++++FPQ +NL+ L
Sbjct: 191 AELYTLRPLFPGTSEVDEIFKICQVLGTPKKSDWPEGYQLASSMNFRFPQCVPINLKTLI 250
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P+AS E+I L++ + +W+P RPTA++AL+HP+F+
Sbjct: 251 PNASNEAIQLMTEMLNWDPKKRPTASQALKHPYFQ 285
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| AT4G19110 | protein kinase, putative; protein kinase, putative; FUNCTIONS IN- protein serine/threonine kinase activity, protein kinase activity, kinase activity, ATP binding; INVOLVED IN- protein amino acid phosphorylation; LOCATED IN- cellular_component unknown; EXPRESSED IN- sperm cell, male gametophyte, pollen tube; EXPRESSED DURING- L mature pollen stage, M germinated pollen stage; CONTAINS InterPro DOMAIN/s- Protein kinase, ATP binding site (InterPro-IPR017441), Protein kinase, core (InterPro-IPR000719), Serine/threonine protein kinase (InterPro-IPR002290), Serine/threonine protein kinase-rel [...] (464 aa) | ||||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
| AT1G27480 | lecithin-cholesterol acyltransferase family protein / LACT family protein; lecithin-cholesterol [...] (432 aa) | • | 0.508 | ||||||||
| AT3G18160 | peroxin-3 family protein; peroxin-3 family protein; FUNCTIONS IN- molecular_function unknown; I [...] (376 aa) | • | 0.417 | ||||||||
| AT5G06270 | unknown protein; unknown protein; FUNCTIONS IN- molecular_function unknown; INVOLVED IN- biolog [...] (122 aa) | • | 0.406 | ||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 282 | |||
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-143 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-103 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-102 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-92 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-92 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-88 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-87 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-86 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-84 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-81 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-79 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-79 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-76 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-73 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-73 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-71 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-71 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-69 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-68 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-66 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-66 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-66 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-65 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-64 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-63 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-62 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-61 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-61 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-60 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-59 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-59 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-58 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-57 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-56 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-55 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-55 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-54 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-53 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-53 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-52 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-52 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-52 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-51 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-51 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-51 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-50 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-50 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-49 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-49 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-46 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-45 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-44 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-44 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-42 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-42 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-40 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-40 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-37 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-36 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-35 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-34 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-34 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-34 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-33 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-32 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-32 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-31 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-31 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-30 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-29 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-29 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-28 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-27 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-27 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-26 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-26 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-26 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-25 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-24 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-24 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-24 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-23 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-23 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-23 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-23 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-23 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-23 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-22 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-22 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-22 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-22 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-22 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-21 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-21 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-20 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-20 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-20 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-19 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-19 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-18 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-18 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-17 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-17 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-16 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-16 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-15 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-15 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-15 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-14 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-14 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-13 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-11 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-08 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 1e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-04 | |
| TIGR01982 | 437 | TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase | 3e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-04 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 0.002 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 403 bits (1037), Expect = e-143
Identities = 145/274 (52%), Positives = 205/274 (74%), Gaps = 1/274 (0%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V+ A +K++GE VA+KK+KKK +S +E NL+EVK LRK+N HPNIVKL+ + +E
Sbjct: 10 GTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE 69
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+++++ VFEYME +L +LMK+R G+ FSE +R++ +Q+ QGL ++H+ G+FHRDLKP N
Sbjct: 70 NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPEN 129
Query: 121 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
LLVS V+KI D G+ +EI S P TDYV+TRWYRAPE+LL S Y VD+WA+G IM
Sbjct: 130 LLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIM 189
Query: 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239
E+ + R LFPG + DQ+YKIC V+G+PT+ WP G +LAS L ++FPQ +L +L
Sbjct: 190 AELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLI 249
Query: 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
P+AS E+I LI + W+P RPTA++AL+HP+F
Sbjct: 250 PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 300 bits (772), Expect = e-103
Identities = 111/283 (39%), Positives = 176/283 (62%), Gaps = 20/283 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN------LKEVKCLRKMNNHPNIVKL 54
G+YG V++A DKK+GE VA+KK++ LD L+E+ L+++ HPNIVKL
Sbjct: 10 GTYGVVYKARDKKTGEIVALKKIR-----LDNEEEGIPSTALREISLLKELK-HPNIVKL 63
Query: 55 RNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+++ +++VFEY + DL K + +R G S + ++++ +Q+ +GL Y H HR
Sbjct: 64 LDVIHTERKLYLVFEYCDMDLKKYLDKRPGP-LSPNLIKSIMYQLLRGLAYCHSHRILHR 122
Query: 115 DLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEIYGPEVDM 172
DLKP N+L+++ GV+K+ D G+ + L T V T WYRAPE+LL S+ Y VD+
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDI 182
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK--FPQM 230
W++G I EM++ + LFPG + DQ++KI Q++G+PTE+SWP + D+K FP+
Sbjct: 183 WSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP---GVTKLPDYKPTFPKF 239
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
+L ++ P E I L+S++ +NP R +A EAL+HP+F
Sbjct: 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 299 bits (768), Expect = e-102
Identities = 119/276 (43%), Positives = 184/276 (66%), Gaps = 5/276 (1%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G+YG V++A DK +GE VA+KK+K + S L+E+K L+++N HPNI+KL ++ +
Sbjct: 10 GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKLLDVFR 68
Query: 60 EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
D+++VFE+M++DL KL+K+R + E +++ +Q+ QGL + H G HRDLKP
Sbjct: 69 HKGDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPE 127
Query: 120 NLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
NLL++ GV+K+ D G+ + S P T YV TRWYRAPE+LL + Y VD+W++G
Sbjct: 128 NLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGC 187
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
I E+LS R LFPGK+ DQ++KI + +G+P + WP LA N + FP+ G+ L +
Sbjct: 188 IFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPK 247
Query: 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
L P+AS +++ L+S++ ++PH R TA +AL HP+F
Sbjct: 248 LFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 275 bits (705), Expect = 1e-92
Identities = 108/275 (39%), Positives = 179/275 (65%), Gaps = 4/275 (1%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV-- 58
G++ +V +A +K+G++ A+K +KK SL++ NL+E++ LR+++ HPNI++L ++
Sbjct: 10 GTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFD 69
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
++ + +VFE M+ +L +L+K R + E V++ +Q+ + L +MHR G FHRD+KP
Sbjct: 70 RKTGRLALVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKP 128
Query: 119 SNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAI 178
N+L+ ++K+ D G + I S P T+Y++TRWYRAPE LL YGP++D+WA+G +
Sbjct: 129 ENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCV 188
Query: 179 MFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238
FE+LS LFPG N DQI KI V+G+P + + ++++ FP G LR+L
Sbjct: 189 FFEILSLFPLFPGTNELDQIAKIHDVLGTPDA-EVLKKFRKSRHMNYNFPSKKGTGLRKL 247
Query: 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
P+AS E + L+ +L +++P R TA +AL HP+F
Sbjct: 248 LPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 275 bits (706), Expect = 3e-92
Identities = 108/294 (36%), Positives = 175/294 (59%), Gaps = 25/294 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G+YG V A+DK++G VA+KK+ +F +D R L+E+K LR + H NI+ L +++
Sbjct: 11 GAYGVVCSAVDKRTGRKVAIKKISN-VFDDLIDAKRILREIKLLRHLR-HENIIGLLDIL 68
Query: 59 K-----EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
+ + DV+IV E ME+DL K++K + Q ++D ++ +Q+ +GL Y+H H
Sbjct: 69 RPPSPEDFNDVYIVTELMETDLHKVIK--SPQPLTDDHIQYFLYQILRGLKYLHSANVIH 126
Query: 114 RDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPC----TDYVTTRWYRAPEVLLLSEIYGP 168
RDLKPSN+LV+ +KI D G+ + +D T+YV TRWYRAPE+LL S Y
Sbjct: 127 RDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTK 186
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK-- 226
+D+W++G I E+L+ + LFPG++ DQ+ I +V+G+P+E+ ++ ++ +
Sbjct: 187 AIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED----LKFITSEKARNY 242
Query: 227 ---FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
P+ L +L P AS E+I L+ ++ ++P R TA EAL HP+ H
Sbjct: 243 LKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 263 bits (675), Expect = 4e-88
Identities = 99/285 (34%), Positives = 168/285 (58%), Gaps = 19/285 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN------LKEVKCLRKMNNHPNIVKL 54
G+YG V++A +KK+GE VA+KK++ ++ + ++E+K L+K+ HPNIV+L
Sbjct: 10 GTYGQVYKARNKKTGELVALKKIR-----MENEKEGFPITAIREIKLLQKLR-HPNIVRL 63
Query: 55 RNLVKEHE--DVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ +V +++VFEYM+ DL L+ + F+E +++ Q+ +GL Y+H G
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLL-DSPEVKFTESQIKCYMKQLLEGLQYLHSNGIL 122
Query: 113 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDS--SLPCTDYVTTRWYRAPEVLLLSEIYGPE 169
HRD+K SN+L++ GV+K+ D G+ + S T+ V T WYR PE+LL + YGPE
Sbjct: 123 HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPE 182
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
VDMW++G I+ E+ + +F G +Q+ KI ++ GSPT+++WP +L + K +
Sbjct: 183 VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKK 242
Query: 230 MGGVNLRE-LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
LRE ++ L+ +L + +P R +A +AL+H +F
Sbjct: 243 PYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 261 bits (668), Expect = 5e-87
Identities = 113/285 (39%), Positives = 174/285 (61%), Gaps = 19/285 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESR------NLKEVKCLRKMNNHPNIVKL 54
G+YG V++A DKK+GE VA+KKLK +++ + +L+E+ L K+ HPNIV +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLK-----MEKEKEGFPITSLREINILLKLQ-HPNIVTV 69
Query: 55 RNLV--KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ +V + +++V EY+E DL LM E Q F + EV+ L Q+ G+ ++H
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQPFLQSEVKCLMLQLLSGVAHLHDNWIL 128
Query: 113 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEIYGPEV 170
HRDLK SNLL++ +G++KI D G+ +E S L P T V T WYRAPE+LL ++ Y +
Sbjct: 129 HRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAI 188
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
DMW++G I E+L+ + LFPGK+ DQ+ KI +++G+PTE WP +L F +
Sbjct: 189 DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKY 248
Query: 231 GGVNLRELSP--SASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
LR+ P S S L++RL +++P R +A +AL+HP+F
Sbjct: 249 PYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 258 bits (662), Expect = 1e-86
Identities = 103/275 (37%), Positives = 153/275 (55%), Gaps = 32/275 (11%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+G V+ A DKK+G+ VA+K +KKK D R L+E+K L+K+ HPNIV+L ++ ++
Sbjct: 10 GSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK-HPNIVRLYDVFED 68
Query: 61 HEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ +++V EY E DL L+K+R SEDE R Q+ L Y+H +G HRDLKP
Sbjct: 69 EDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPE 126
Query: 120 NLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAI 178
N+L+ G +K+ D G+ +++D T +V T Y APEV LL + YG VD+W++G I
Sbjct: 127 NILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEV-LLGKGYGKAVDIWSLGVI 185
Query: 179 MFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238
++E+L+ + FPG + +++K IG P P
Sbjct: 186 LYELLTGKPPFPGDDQLLELFKK---IGKPKPPFPP-----------------------P 219
Query: 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
S E+ LI +L +P R TA EAL+HPFF
Sbjct: 220 EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 255 bits (655), Expect = 2e-84
Identities = 116/293 (39%), Positives = 175/293 (59%), Gaps = 24/293 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-----SLDESRNLKEVKCLRKMNNHPNIVKLR 55
G+YG V++A+D+++ E VA+KK IF + D R +E+ L+++ +HPNIVKL
Sbjct: 18 GAYGIVWKAIDRRTKEVVALKK----IFDAFRNATDAQRTFREIMFLQELGDHPNIVKLL 73
Query: 56 NLVK--EHEDVFIVFEYMESDLLKLMKERAGQNFSED-EVRNLCFQVFQGLHYMHRQGYF 112
N++K +D+++VFEYME+DL +++ N ED R + +Q+ + L Y+H
Sbjct: 74 NVIKAENDKDIYLVFEYMETDLHAVIR----ANILEDVHKRYIMYQLLKALKYIHSGNVI 129
Query: 113 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC------TDYVTTRWYRAPEVLLLSEI 165
HRDLKPSN+L+ S +K+ D G+ + + TDYV TRWYRAPE+LL S
Sbjct: 130 HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTR 189
Query: 166 YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPT-EDSWPLGIQLASNLD 224
Y VDMW++G I+ EML + LFPG ++ +Q+ KI +VIG P+ ED + A+ +
Sbjct: 190 YTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATML 249
Query: 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
P L EL P AS +++ L+ +L +NP+ R TA EALEHP+ H
Sbjct: 250 DSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 245 bits (629), Expect = 5e-81
Identities = 105/288 (36%), Positives = 169/288 (58%), Gaps = 24/288 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDESRN---LKEVKCLRKMNNHPNIVKLRN 56
G+Y V++A DK++G VA+KK+K + + N L+E+K L+++ HPNI+ L
Sbjct: 11 GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLL- 68
Query: 57 LVKEHEDVF-------IVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ 109
DVF +VFE+ME+DL K++K+++ + ++++ +GL Y+H
Sbjct: 69 ------DVFGHKSNINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN 121
Query: 110 GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEIYG 167
HRDLKP+NLL++ GV+K+ D G+ + + T V TRWYRAPE+L + YG
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYG 181
Query: 168 PEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227
VDMW++G I E+L PG + DQ+ KI + +G+PTE++WP L +F
Sbjct: 182 VGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL--PDYVEF 239
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
L+++ P+AS +++ L+ RL + NP+ R TA +ALEHP+F +
Sbjct: 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 239 bits (613), Expect = 4e-79
Identities = 105/277 (37%), Positives = 156/277 (56%), Gaps = 30/277 (10%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
GS+G V++A K +G+ VAVK LKK S + +E++ LR+++ HPNIV+L + +
Sbjct: 10 GSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS-HPNIVRLIDAFE 68
Query: 60 EHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ + +++V EY E DL + G SEDE + + Q+ +GL Y+H G HRDLKP
Sbjct: 69 DKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKP 126
Query: 119 SN-LLVSKGVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N LL GV+KI D G+ K++ SS T +V T WY APEVLL YGP+VD+W++G
Sbjct: 127 ENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLG 186
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
I++E+L+ + F G+N DQ+ I +++G P E P
Sbjct: 187 VILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEP---------------------- 224
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
S S E+ LI + + +P RPTA E L+HP+F
Sbjct: 225 -KWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 240 bits (615), Expect = 5e-79
Identities = 105/280 (37%), Positives = 169/280 (60%), Gaps = 12/280 (4%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLK-KKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G VF+A D+++GE VA+KK+ +++ ++ L+E+K L+ HP +VKL ++
Sbjct: 11 GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFP 69
Query: 60 EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+V EYM SDL +++++ + E +V++ + +G+ YMH G HRDLKP+
Sbjct: 70 HGSGFVLVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPA 128
Query: 120 NLLVS-KGVIKIGDLGMVKEIDS--SLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
NLL+S GV+KI D G+ + + V TRWYRAPE+L + Y P VD+WA+G
Sbjct: 129 NLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVG 188
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW---KFPQMGGV 233
I E+L+ LFPG+N +Q+ + + +G+P E++WP L S D+ FP+ +
Sbjct: 189 CIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWP---GLTSLPDYNKITFPESKPI 245
Query: 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
L E+ P AS E++ L+ L ++P R +AAEAL HP+F
Sbjct: 246 PLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 233 bits (597), Expect = 3e-76
Identities = 101/286 (35%), Positives = 158/286 (55%), Gaps = 21/286 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDES----RNLKEVKCLRKMN--NHPNIVKL 54
G+YG V++A D +G FVA+KK++ L E L+E+ L+++ HPNIV+L
Sbjct: 10 GAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 55 RNLVKEHE-----DVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ 109
++ + +VFE+++ DL + + + +++L Q+ +G+ ++H
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH 126
Query: 110 GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGP 168
HRDLKP N+LV+ G +KI D G+ + + T V T WYRAPEVLL S Y
Sbjct: 127 RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS-YAT 185
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA-SNLDWKF 227
VDMW++G I E+ R LF G + ADQ+ KI VIG P+E+ WP + L S+ F
Sbjct: 186 PVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSS----F 241
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
P + + P E + L+ ++ ++NPH R +A EAL+HP+F
Sbjct: 242 PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 227 bits (582), Expect = 2e-73
Identities = 112/291 (38%), Positives = 168/291 (57%), Gaps = 19/291 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDES--RNLKEVKCLRKMNNHPNIVKLRNL- 57
G+YG V A+D +SG+ VA+KK+ F + R L+E+K LR H NI+ +R++
Sbjct: 16 GAYGVVCSAIDTRSGKKVAIKKIPH-AFDVPTLAKRTLRELKILRHFK-HDNIIAIRDIL 73
Query: 58 ---VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ +DV++V + MESDL ++ + Q +E+ +R +Q+ +GL Y+H HR
Sbjct: 74 RPPGADFKDVYVVMDLMESDLHHII--HSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHR 131
Query: 115 DLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP------CTDYVTTRWYRAPEVLLLSEIYG 167
DLKPSNLLV++ ++IGD GM + + SS P T+YV TRWYRAPE+LL Y
Sbjct: 132 DLKPSNLLVNEDCELRIGDFGMARGLSSS-PTEHKYFMTEYVATRWYRAPELLLSLPEYT 190
Query: 168 PEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSW-PLGIQLASNLDWK 226
+DMW++G I EML R LFPGKN Q+ I V+GSP+E+ +G
Sbjct: 191 TAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQN 250
Query: 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
P+ V ++ P AS E++ L+S++ ++P R T +AL+HPF H
Sbjct: 251 LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 3e-73
Identities = 100/280 (35%), Positives = 149/280 (53%), Gaps = 10/280 (3%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
G+YG V + +K +GE VA+KK K+ ++ + L+EVK LR++ H NIV L+
Sbjct: 12 GAYGVVLKCRNKATGEIVAIKKFKE-SEDDEDVKKTALREVKVLRQLR-HENIVNLKEAF 69
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ +++VFEY+E LL+L++ G D VR+ +Q+ Q + Y H HRD+KP
Sbjct: 70 RRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKP 128
Query: 119 SNLLVSK-GVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N+LVS+ GV+K+ D G + + + P TDYV TRWYRAPE+L+ YG VD+WA+
Sbjct: 129 ENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAI 188
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G IM E+L LFPG + DQ+Y I + +G L FP+
Sbjct: 189 GCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPES 248
Query: 236 RELSPSA--SRESISLISRLCSWNPHMRPTAAEALEHPFF 273
E S ++ + +P R T E L+HP+F
Sbjct: 249 LERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 3e-71
Identities = 109/291 (37%), Positives = 166/291 (57%), Gaps = 21/291 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL---KKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G+YG V A K +G VA+KK+ + + F R L+E+K LR+ H NI+ + ++
Sbjct: 16 GAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQ---RTLREIKILRRFK-HENIIGILDI 71
Query: 58 VK-----EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
++ DV+IV E ME+DL KL+K Q+ S D ++ +Q+ +GL Y+H
Sbjct: 72 IRPPSFESFNDVYIVQELMETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVL 128
Query: 113 HRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEIYG 167
HRDLKPSNLL++ +KI D G+ + D T+YV TRWYRAPE++L S+ Y
Sbjct: 129 HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYT 188
Query: 168 PEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGI-QLASNLDWK 226
+D+W++G I+ EMLS R LFPGK+ Q+ I V+G+P+++ I A N
Sbjct: 189 KAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKS 248
Query: 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
P V +L P+A +++ L+ ++ ++NPH R T EAL HP+ H
Sbjct: 249 LPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 219 bits (561), Expect = 6e-71
Identities = 101/280 (36%), Positives = 168/280 (60%), Gaps = 13/280 (4%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE---SRNLKEVKCLRKMNNHPNIVKLRNL 57
G+YG V++A DK +GE VA+KK++ + + DE S ++E+ L+++N HPNIV+L ++
Sbjct: 10 GTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAIREISLLKELN-HPNIVRLLDV 66
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
V +++VFE+++ DL K M +++ +Q+ QG+ Y H HRDLK
Sbjct: 67 VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLK 126
Query: 118 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEVDMW 173
P NLL+ + G +K+ D G+ + +P Y V T WYRAPE+LL S Y VD+W
Sbjct: 127 PQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIW 184
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
++G I EM++ R LFPG + DQ+++I + +G+P ED WP G+ + FP+
Sbjct: 185 SIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP-GVTSLPDYKPTFPKWARQ 243
Query: 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
+L ++ P+ + + L+S++ ++P R +A AL+HP+F
Sbjct: 244 DLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 1e-69
Identities = 104/287 (36%), Positives = 165/287 (57%), Gaps = 17/287 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNL-- 57
G+YG V A D K+G VA+KKL + S R +E++ L+ M+ H N++ L ++
Sbjct: 26 GAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD-HENVIGLLDVFT 84
Query: 58 ----VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
+++ +DV++V M +DL ++K Q S+D ++ L +Q+ +GL Y+H G H
Sbjct: 85 PASSLEDFQDVYLVTHLMGADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIH 141
Query: 114 RDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
RDLKPSN+ V++ +KI D G+ + D + T YV TRWYRAPE++L Y VD+
Sbjct: 142 RDLKPSNIAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDI 199
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQL--ASNLDWKFPQM 230
W++G IM E+L+ + LFPG + DQ+ +I ++G+P E+ I A N PQM
Sbjct: 200 WSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE-LLQKISSESARNYIQSLPQM 258
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+ +E+ A+ +I L+ ++ +P R TAAEAL HP+ H
Sbjct: 259 PKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 212 bits (543), Expect = 6e-68
Identities = 109/286 (38%), Positives = 161/286 (56%), Gaps = 21/286 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN------LKEVKCLRKMNNHPNIVKL 54
G+YG V++A D SGE VA+KK++ +D R+ L+E+ L + HPNIV+L
Sbjct: 18 GTYGIVYRARDTTSGEIVALKKVR-----MDNERDGIPISSLREITLLLNLR-HPNIVEL 71
Query: 55 RNLV--KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ +V K + +F+V EY E DL L+ + FSE +V+ L Q+ +GL Y+H
Sbjct: 72 KEVVVGKHLDSIFLVMEYCEQDLASLL-DNMPTPFSESQVKCLMLQLLRGLQYLHENFII 130
Query: 113 HRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGP 168
HRDLK SNLL++ KG +KI D G+ + LP V T WYRAPE+LL Y
Sbjct: 131 HRDLKVSNLLLTDKGCLKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228
+DMWA+G I+ E+L+ + L PGK+ +Q+ I Q++G+P E WP L + P
Sbjct: 189 AIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLP 248
Query: 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+ NL+ P S + L++ L ++P R TA EALE +F+
Sbjct: 249 KQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 1e-66
Identities = 108/292 (36%), Positives = 164/292 (56%), Gaps = 28/292 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE----SRNLKEVKCLRKMNNHPNIVKLRN 56
G+YG V++A DK +G+ VA LKK +DE L+E+ L+ ++ IV+L +
Sbjct: 12 GTYGKVYKARDKNTGKLVA---LKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 57 LVKEHED-----VFIVFEYMESDLLKLM---KERAGQNFSEDEVRNLCFQVFQGLHYMHR 108
+ E +++VFEY++SDL K M G+ +++ +Q+ +G+ + H+
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 109 QGYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLS 163
G HRDLKP NLLV KG++KI DLG+ + S+P Y + T WYRAPEVLL S
Sbjct: 129 HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF--SIPVKSYTHEIVTLWYRAPEVLLGS 186
Query: 164 EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL 223
Y VD+W++G I EM + LFPG + Q+ I +++G+PTE WP G+ S L
Sbjct: 187 THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP-GV---SKL 242
Query: 224 -DW-KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
DW +FPQ +L P S E + L+ ++ ++P R +A AL HP+F
Sbjct: 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 3e-66
Identities = 102/285 (35%), Positives = 162/285 (56%), Gaps = 23/285 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE------SRNLKEVKCLRKMNNHPNIVKL 54
G+YG V++A +K +GE VA+KK++ LD S ++E+ L+++N HPNIVKL
Sbjct: 11 GTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKELN-HPNIVKL 64
Query: 55 RNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+++ +++VFE++ DL K M +++ FQ+ QGL + H HR
Sbjct: 65 LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124
Query: 115 DLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEV 170
DLKP NLL++ G IK+ D G+ + +P Y V T WYRAPE+LL + Y V
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 182
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK--FP 228
D+W++G I EM++ R LFPG + DQ+++I + +G+P E WP L D+K FP
Sbjct: 183 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP---DYKPSFP 239
Query: 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
+ + ++ P + L+S++ ++P+ R +A AL HPFF
Sbjct: 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 9e-66
Identities = 99/278 (35%), Positives = 163/278 (58%), Gaps = 9/278 (3%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+Y V++ ++ +GE VA+K++ S ++E+ ++++ H NIV+L +++
Sbjct: 11 GTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK-HENIVRLHDVIHT 69
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQN-FSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ +VFEYM+ DL K M + + V++ +Q+ +G+ + H HRDLKP
Sbjct: 70 ENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQ 129
Query: 120 NLLVSK-GVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEVDMWAM 175
NLL++K G +K+ D G+ + +P + V T WYRAP+VLL S Y +D+W++
Sbjct: 130 NLLINKRGELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSV 187
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G IM EM++ R LFPG N+ DQ+ KI +++G+PTE +WP GI FP+ +L
Sbjct: 188 GCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP-GISQLPEYKPTFPRYPPQDL 246
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
++L P A I L+ RL NP +R +A +AL+HP+F
Sbjct: 247 QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 1e-65
Identities = 98/300 (32%), Positives = 161/300 (53%), Gaps = 34/300 (11%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL----KKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G++G+V++A K+G VA+KK+ +K F + L+E+K L+K+ HPN+V L +
Sbjct: 19 GTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA---LREIKILKKLK-HPNVVPLID 74
Query: 57 LVKEHED--------VFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHR 108
+ E D V++V YM+ DL L+ E +E +++ Q+ +G++Y+H
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-ENPSVKLTESQIKCYMLQLLEGINYLHE 133
Query: 109 QGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC------------TDYVTTRWYR 155
HRD+K +N+L+ +G++KI D G+ + D P T+ V TRWYR
Sbjct: 134 NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYR 193
Query: 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPL 215
PE+LL Y VD+W +G + EM + R + GK+ DQ++ I ++ G+PTE++WP
Sbjct: 194 PPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPG 253
Query: 216 GIQL--ASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
L + L E E + L+S+L S +P+ R TA++ALEHP+F
Sbjct: 254 WRSLPGCEGVHSFTNYPR--TLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 204 bits (522), Expect = 2e-64
Identities = 99/291 (34%), Positives = 162/291 (55%), Gaps = 22/291 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G+YG V A + ++ E VA+KK+ F +D R L+E+K LR ++ H N++ +++++
Sbjct: 16 GAYGIVCSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLD-HENVIAIKDIM 73
Query: 59 K-----EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
DV+IV+E M++DL +++ R+ Q S+D + +Q+ +GL Y+H H
Sbjct: 74 PPPHREAFNDVYIVYELMDTDLHQII--RSSQTLSDDHCQYFLYQLLRGLKYIHSANVLH 131
Query: 114 RDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEIYGPEVD 171
RDLKPSNLL+ + +KI D G+ + T+YV TRWYRAPE+LL Y +D
Sbjct: 132 RDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAID 191
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK----- 226
+W++G I E+L + LFPGK+ Q+ I +++GSP+E+ + N +
Sbjct: 192 VWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED----LGFIRNEKARRYIRS 247
Query: 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
P + L P A+ +I L+ ++ ++P R T EAL HP+ S H
Sbjct: 248 LPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 3e-63
Identities = 104/307 (33%), Positives = 166/307 (54%), Gaps = 35/307 (11%)
Query: 1 GSYGDVFQALDK--KSGEFVAVKKLK--KKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G+YG V++A K K G+ A+KK K K+ ++ +E+ LR++ H N+V L
Sbjct: 11 GTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVE 69
Query: 57 LVKEHED--VFIVFEYMESDLLKLMK---ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
+ EH D V+++F+Y E DL +++K + + V++L +Q+ G+HY+H
Sbjct: 70 VFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWV 129
Query: 112 FHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSSL-PCTD---YVTTRWYRAPEVLLL 162
HRDLKP+N+LV +GV+KIGDLG+ + ++ L P D V T WYRAPE+LL
Sbjct: 130 LHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG 189
Query: 163 SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS---------ADQIYKICQVIGSPTEDSW 213
+ Y +D+WA+G I E+L+ +F G+ + DQ+ +I +V+G+PTE W
Sbjct: 190 ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDW 249
Query: 214 PLGIQL----ASNLDWKFPQMGGVNLR---ELSPSASRESISLISRLCSWNPHMRPTAAE 266
P ++ D+K +L E + L+ +L ++P R TA E
Sbjct: 250 PDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE 309
Query: 267 ALEHPFF 273
ALEHP+F
Sbjct: 310 ALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 4e-62
Identities = 101/283 (35%), Positives = 172/283 (60%), Gaps = 18/283 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE---SRNLKEVKCLRKMNNHPNIVKLRNL 57
G+YG V++ +KK+G+ VA+KK++ + S +E S ++E+ L+++ HPNIV L+++
Sbjct: 11 GTYGVVYKGRNKKTGQIVAMKKIR--LESEEEGVPSTAIREISLLKELQ-HPNIVCLQDV 67
Query: 58 VKEHEDVFIVFEYMESDLLKLMKE-RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + ++++FE++ DL K + GQ + V++ +Q+ QG+ + H + HRDL
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDL 127
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEVDM 172
KP NLL+ +KGVIK+ D G+ + +P Y V T WYRAPEVLL S Y VD+
Sbjct: 128 KPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDI 185
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK--FPQM 230
W++G I EM + + LF G + DQ+++I +++G+PTED WP + S D+K FP+
Sbjct: 186 WSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWP---GVTSLPDYKNTFPKW 242
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
+LR + + + L+ ++ ++P R +A +AL HP+F
Sbjct: 243 KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 1e-61
Identities = 101/304 (33%), Positives = 170/304 (55%), Gaps = 34/304 (11%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-------------LKEVKCLRKMNN 47
G+YG V +A D +G+ VA+KK+K S D +++ L+E+K + ++
Sbjct: 20 GTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK- 78
Query: 48 HPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMH 107
H NI+ L ++ E + + +V + M SDL K++ + +E +V+ + Q+ GL+ +H
Sbjct: 79 HENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQILNGLNVLH 136
Query: 108 RQGYFHRDLKPSNLLV-SKGVIKIGDLGMV---------------KEIDSSLPCTDYVTT 151
+ + HRDL P+N+ + SKG+ KI D G+ + + T V T
Sbjct: 137 KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVT 196
Query: 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTED 211
WYRAPE+L+ +E Y VDMW++G I E+L+ + LFPG+N DQ+ +I +++G+P ED
Sbjct: 197 LWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNED 256
Query: 212 SWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHP 271
+WP +L L +F +L+ + P+AS ++I L+ L NP R +A EAL+H
Sbjct: 257 NWPQAKKLP--LYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314
Query: 272 FFRS 275
+F+S
Sbjct: 315 YFKS 318
|
Length = 335 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 2e-61
Identities = 111/289 (38%), Positives = 166/289 (57%), Gaps = 22/289 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK----KIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G+YG V A+DK++GE VA+KKL + +IF+ R +E+ L+ M H N++ L +
Sbjct: 26 GAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFA---KRAYRELTLLKHMQ-HENVIGLLD 81
Query: 57 L------VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG 110
+ E +D ++V YM++DL K+M G SED+V+ L +Q+ GL Y+H G
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG 137
Query: 111 YFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPE 169
HRDLKP NL V++ +KI D G+ + D+ + T YV TRWYRAPEV+L Y
Sbjct: 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVVTRWYRAPEVILNWMHYNQT 195
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSP-TEDSWPLGIQLASNLDWKFP 228
VD+W++G IM EML+ + LF GK+ DQ+ +I +V G P E L + A + P
Sbjct: 196 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLP 255
Query: 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+ + L P AS +++ L+ ++ + R TA EALEHP+F S
Sbjct: 256 KYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 1e-60
Identities = 96/290 (33%), Positives = 169/290 (58%), Gaps = 18/290 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE---SRNLKEVKCLRKMNNHPNIVKLRNL 57
G+YG V++A D+ + E +A+KK++ + DE S ++E+ L++M H NIV+L+++
Sbjct: 13 GTYGVVYKARDRVTNETIALKKIR--LEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDV 69
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDE--VRNLCFQVFQGLHYMHRQGYFHRD 115
V + +++VFEY++ DL K M + +F+++ ++ +Q+ +G+ Y H HRD
Sbjct: 70 VHSEKRLYLVFEYLDLDLKKHMD--SSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRD 127
Query: 116 LKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEV 170
LKP NLL+ +K+ D G+ + +P + V T WYRAPE+LL S Y V
Sbjct: 128 LKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPV 185
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
D+W++G I EM++ + LFPG + D+++KI +++G+P E++WP G+ + FP+
Sbjct: 186 DIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWP-GVTSLPDYKSAFPKW 244
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280
+L + P+ + L+S++ +P R TA ALEH +F+ P
Sbjct: 245 PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDAP 294
|
Length = 294 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 7e-60
Identities = 73/190 (38%), Positives = 111/190 (58%), Gaps = 6/190 (3%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G V+ A DKK+G+ VA+K +KK+ S L+E++ L+K+N HPNIVKL + ++
Sbjct: 4 GGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGVFED 62
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+++V EY E L L+KE SEDE+ + Q+ +GL Y+H G HRDLKP
Sbjct: 63 ENHLYLVMEYCEGGSLKDLLKEN-EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121
Query: 120 NLLVSK--GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+L+ G +K+ D G+ K + S V T Y APEVLL Y + D+W++G
Sbjct: 122 NILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLG 181
Query: 177 AIMFEMLSFR 186
I++E+ +
Sbjct: 182 VILYELPELK 191
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 1e-59
Identities = 102/291 (35%), Positives = 163/291 (56%), Gaps = 26/291 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN------LKEVKCLRKMNNHPNIVKL 54
G+YG V++A DK +GE VA+KK++ LD + ++E+K LR++N H NIV L
Sbjct: 18 GTYGQVYKARDKDTGELVALKKVR-----LDNEKEGFPITAIREIKILRQLN-HRNIVNL 71
Query: 55 RNLV----------KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLH 104
+ +V K+ ++VFEYM+ DL+ L+ E +FSED +++ Q+ +GL+
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-ESGLVHFSEDHIKSFMKQLLEGLN 130
Query: 105 YMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVK--EIDSSLPCTDYVTTRWYRAPEVLL 161
Y H++ + HRD+K SN+L++ KG IK+ D G+ + + S P T+ V T WYR PE+LL
Sbjct: 131 YCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLL 190
Query: 162 LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221
E YGP +D+W+ G I+ E+ + + +F Q+ I ++ GSP WP I+L
Sbjct: 191 GEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPY 250
Query: 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
K + LRE ++ L+ + + +P R TA EAL P+
Sbjct: 251 FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 8e-59
Identities = 100/285 (35%), Positives = 155/285 (54%), Gaps = 21/285 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-----LKEVKCLRKMNNHPNIVKLR 55
GSY V++ K +G+ VA+K++ L+ ++E L+ + H NIV L
Sbjct: 16 GSYATVYKGRSKLTGQLVALKEI-----RLEHEEGAPFTAIREASLLKDLK-HANIVTLH 69
Query: 56 NLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+++ + + +VFEY+++DL + M + G S VR FQ+ +GL Y H++ HRD
Sbjct: 70 DIIHTKKTLTLVFEYLDTDLKQYM-DDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRD 128
Query: 116 LKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEVD 171
LKP NLL+S +G +K+ D G+ + S+P Y V T WYR P+VLL S Y +D
Sbjct: 129 LKPQNLLISERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLD 186
Query: 172 MWAMGAIMFEMLSFRILFPG-KNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
MW +G I +EM + R LFPG + DQ++KI +V+G+PTE++WP + FP
Sbjct: 187 MWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFY 246
Query: 231 GGVNLRELSPSASR--ESISLISRLCSWNPHMRPTAAEALEHPFF 273
L +P R L + + P R +AAEA++HP+F
Sbjct: 247 PPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 6e-58
Identities = 108/286 (37%), Positives = 169/286 (59%), Gaps = 15/286 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNL-- 57
G+YG V ALD+++G VA+KKL + S L R +E++ L+ M H N++ L ++
Sbjct: 26 GAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK-HENVIGLLDVFT 84
Query: 58 ----VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
+ D ++V +M +DL KLMK + SED ++ L +Q+ +GL Y+H G H
Sbjct: 85 PDLSLDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIH 141
Query: 114 RDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
RDLKP NL V++ +KI D G+ ++ DS + T YV TRWYRAPEV+L Y VD+
Sbjct: 142 RDLKPGNLAVNEDCELKILDFGLARQTDSEM--TGYVVTRWYRAPEVILNWMHYTQTVDI 199
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTED-SWPLGIQLASNLDWKFPQMG 231
W++G IM EML+ + LF G + DQ+ +I +V G+P+++ L + A N K P+
Sbjct: 200 WSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFR 259
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+ R L P+A+ +++++ ++ + R TAAEAL HP+F H
Sbjct: 260 KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 5e-57
Identities = 99/281 (35%), Positives = 159/281 (56%), Gaps = 15/281 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE---SRNLKEVKCLRKMNNHPNIVKLRNL 57
G+YG VF+A ++++ E VA+K+++ + DE S L+E+ CL K H NIV+L ++
Sbjct: 11 GTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREI-CLLKELKHKNIVRLYDV 67
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ + + +VFEY + DL K G + V++ FQ+ +GL + H HRDLK
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSHNVLHRDLK 126
Query: 118 PSNLLVSK-GVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
P NLL++K G +K+ D G+ + + C + V T WYR P+VL +++Y +DMW+
Sbjct: 127 PQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA 186
Query: 176 GAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF--PQMGG 232
G I E+ + R LFPG + DQ+ +I +++G+PTE+SWP +L D+K
Sbjct: 187 GCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP---DYKPYPMYPAT 243
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
+L + P + L+ L NP R +A EAL+HP+F
Sbjct: 244 TSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 1e-56
Identities = 109/304 (35%), Positives = 172/304 (56%), Gaps = 36/304 (11%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
GSYG V A+D +GE VA+KK+ +F D +R L+E+K LR + HP+IV++++++
Sbjct: 11 GSYGVVCSAIDTHTGEKVAIKKIND-VFEHVSDATRILREIKLLRLLR-HPDIVEIKHIM 68
Query: 59 -----KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
+E +D+++VFE MESDL +++K A + + + + +Q+ + L Y+H FH
Sbjct: 69 LPPSRREFKDIYVVFELMESDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTANVFH 126
Query: 114 RDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC----TDYVTTRWYRAPEVL--LLSEIY 166
RDLKP N+L + +KI D G+ + + P TDYV TRWYRAPE+ S+ Y
Sbjct: 127 RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSK-Y 185
Query: 167 GPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN---- 222
P +D+W++G I E+L+ + LFPGKN Q+ I ++G+P+ P I N
Sbjct: 186 TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS----PETISRVRNEKAR 241
Query: 223 -----LDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+ K P V + P+A ++ L+ RL +++P RPTA EAL P+F+
Sbjct: 242 RYLSSMRKKQP----VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297
Query: 278 FVPR 281
V R
Sbjct: 298 KVER 301
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-55
Identities = 97/294 (32%), Positives = 164/294 (55%), Gaps = 22/294 (7%)
Query: 1 GSYGDVFQALDKKS--GEFVAVKKL----KKKIFSLDESRNLKEVKCLRKMNNHPNIVKL 54
G+YG V A + ++ E VA+KK+ KKI + R L+E+K LR H NI L
Sbjct: 11 GAYGIVCSARNAETSEEETVAIKKITNVFSKKILA---KRALRELKLLRHFRGHKNITCL 67
Query: 55 RNL----VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG 110
++ ++++ E ME+DL +++ R+GQ ++ ++ +Q+ GL Y+H
Sbjct: 68 YDMDIVFPGNFNELYLYEELMEADLHQII--RSGQPLTDAHFQSFIYQILCGLKYIHSAN 125
Query: 111 YFHRDLKPSNLLV-SKGVIKIGDLGMVKEI-----DSSLPCTDYVTTRWYRAPEVLLLSE 164
HRDLKP NLLV + +KI D G+ + +++ T+YV TRWYRAPE++L +
Sbjct: 126 VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ 185
Query: 165 IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP-LGIQLASNL 223
Y +D+W++G I+ E+L + +F GK+ DQ+ +I QV+G+P E++ +G A N
Sbjct: 186 SYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNY 245
Query: 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
P + + P+A+ ++ L+ +L +++P R + EALEHP+ H
Sbjct: 246 IRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 4e-55
Identities = 98/290 (33%), Positives = 158/290 (54%), Gaps = 32/290 (11%)
Query: 1 GSYGDVFQALDKKSGEFVAVKK--------LKKKIFSLDESRNLKEVKCLRKMNNHPNIV 52
GSYG VF+ ++++G+ VA+KK + KKI +L E R LK++K HPN+V
Sbjct: 12 GSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI-ALREIRMLKQLK-------HPNLV 63
Query: 53 KLRNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
L + + + +VFEY + +L + E+ + E ++ + +Q Q +++ H+
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNEL-EKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCI 122
Query: 113 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC---TDYVTTRWYRAPEVLLLSEIYGP 168
HRD+KP N+L++K G IK+ D G + + + P TDYV TRWYRAPE+L+ YGP
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATRWYRAPELLVGDTQYGP 180
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW--- 225
VD+WA+G + E+L+ + L+PGK+ DQ+Y I + +G D P Q+ S +
Sbjct: 181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG----DLIPRHQQIFSTNQFFKG 236
Query: 226 -KFPQMGGVN-LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
P+ L P+ S ++S + +P R + E LEHP+F
Sbjct: 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 177 bits (449), Expect = 3e-54
Identities = 101/283 (35%), Positives = 152/283 (53%), Gaps = 15/283 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMN--NHPNIVKLRN 56
G+YG V++A D SG FVA+K ++ + L S ++EV L+++ +HPNIV+L +
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLS-TVREVALLKRLEAFDHPNIVRLMD 69
Query: 57 L-----VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
+ V +VFE+++ DL + + + +++L Q +GL ++H
Sbjct: 70 VCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCI 129
Query: 112 FHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
HRDLKP N+LV S G +K+ D G+ + + T V T WYRAPEVLL S Y V
Sbjct: 130 VHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS-TYATPV 188
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
DMW++G I EM + LF G + ADQ+ KI +IG P ED WP + L F
Sbjct: 189 DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRG---AFSPR 245
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
G ++ + P L+ + ++NPH R +A AL+HPFF
Sbjct: 246 GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 1e-53
Identities = 103/293 (35%), Positives = 165/293 (56%), Gaps = 18/293 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+Y VF+ K + VA+K+++ + ++EV L+ + H NIV L ++V
Sbjct: 17 GTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIVHT 75
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+ + +VFEY++ DL + M + G S V+ +Q+ +GL Y HR+ HRDLKP N
Sbjct: 76 DKSLTLVFEYLDKDLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQN 134
Query: 121 LLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
LL++ +G +K+ D G+ + S+P Y V T WYR P+VLL S Y ++DMW +G
Sbjct: 135 LLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVG 192
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK---FPQMGGV 233
I FEM S R LFPG D+++ I +++G+PTE++WP ++SN ++K FP+
Sbjct: 193 CIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP---GISSNDEFKNYNFPKYKPQ 249
Query: 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS----CHFVPRS 282
L +P E I L+++ + R +A EA++H +FRS H +P S
Sbjct: 250 PLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPES 302
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 177 bits (449), Expect = 1e-53
Identities = 102/286 (35%), Positives = 161/286 (56%), Gaps = 15/286 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDES-RNLKEVKCLRKMNNHPNIVKLRNL-- 57
G+YG V A D K+G VAVKKL + S+ + R +E++ L+ M H N++ L ++
Sbjct: 28 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFT 86
Query: 58 ----VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
++E DV++V M +DL ++K Q ++D V+ L +Q+ +GL Y+H H
Sbjct: 87 PARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADIIH 143
Query: 114 RDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
RDLKPSNL V++ +KI D G+ + D + T YV TRWYRAPE++L Y VD+
Sbjct: 144 RDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRWYRAPEIMLNWMHYNQTVDI 201
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSP-TEDSWPLGIQLASNLDWKFPQMG 231
W++G IM E+L+ R LFPG + DQ+ I +++G+P E + + A N QM
Sbjct: 202 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMP 261
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+N + A+ ++ L+ ++ + R TAA+AL H +F H
Sbjct: 262 KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 7e-53
Identities = 97/280 (34%), Positives = 157/280 (56%), Gaps = 14/280 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+Y VF+ K + VA+K+++ + ++EV L+ + H NIV L +++
Sbjct: 16 GTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK-HANIVTLHDIIHT 74
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+ +VFEY++SDL + + + G S V+ FQ+ +GL Y H++ HRDLKP N
Sbjct: 75 ERCLTLVFEYLDSDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQN 133
Query: 121 LLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
LL++ KG +K+ D G+ + S+P Y V T WYR P+VLL S Y +DMW +G
Sbjct: 134 LLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVG 191
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK---FPQMGGV 233
I++EM + R +FPG ++++ I +++G+PTE++WP GI SN +++ FPQ
Sbjct: 192 CILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP-GI--TSNEEFRSYLFPQYRAQ 248
Query: 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
L +P + I L+S L + R +A AL H +F
Sbjct: 249 PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-52
Identities = 87/285 (30%), Positives = 131/285 (45%), Gaps = 47/285 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL-KEVKCLRKMNNHPNIVKLR--NL 57
GS+G V+ ALDK +GE +AVK ++ S +E L +E++ L + HPNIV+
Sbjct: 11 GSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSER 69
Query: 58 VKEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
+E + I EY+ S LLK E +R Q+ +GL Y+H G H
Sbjct: 70 DEEKNTLNIFLEYVSGGSLSSLLK-----KFGKLPEPVIRKYTRQILEGLAYLHSNGIVH 124
Query: 114 RDLKPSNLLV-SKGVIKIGDLG---MVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPE 169
RD+K +N+LV S GV+K+ D G + +I++ T ++ APEV+ E YG
Sbjct: 125 RDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR-GEEYGRA 183
Query: 170 VDMWAMGAIMFEMLSFRILFPG-KNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228
D+W++G + EM + + + N +YKI GS E P
Sbjct: 184 ADIWSLGCTVIEMATGKPPWSELGNPMAALYKI----GSSGEPPE-------------IP 226
Query: 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
+ LS A + + +P RPTA E L+HPF
Sbjct: 227 E-------HLSEEA----KDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 3e-52
Identities = 91/286 (31%), Positives = 155/286 (54%), Gaps = 24/286 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESR----NLKEVKCLRKMNNHPNIVKLRN 56
GSYG V + K++G+ VA+KK + S D+ ++E++ L+++ H N+V L
Sbjct: 12 GSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMREIRMLKQLR-HENLVNLIE 67
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + + +++VFE+++ +L + E+ E VR FQ+ +G+ + H HRD+
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL-EKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDI 126
Query: 117 KPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
KP N+LVS+ GV+K+ D G + + + TDYV TRWYRAPE+L+ YG VD+WA
Sbjct: 127 KPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWA 186
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTE------DSWPLGIQLASNLDWKFP 228
+G ++ EML+ LFPG + DQ+Y I + +G+ PL + + P
Sbjct: 187 VGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM------RLP 240
Query: 229 QMGGV-NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
++ + L + P S + L + +P RP++++ L H FF
Sbjct: 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 3e-52
Identities = 100/287 (34%), Positives = 163/287 (56%), Gaps = 22/287 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNL- 57
G++G V A D+ +G+ VA+KK+ K FS + R +E+K L+ + H NI+ L ++
Sbjct: 21 GAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKHLR-HENIISLSDIF 78
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDE-VRNLCFQVFQGLHYMHRQGYFHRDL 116
+ ED++ V E + +DL +L+ R E + ++ +Q+ +GL Y+H G HRDL
Sbjct: 79 ISPLEDIYFVTELLGTDLHRLLTSRP----LEKQFIQYFLYQILRGLKYVHSAGVVHRDL 134
Query: 117 KPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
KPSN+L+++ +KI D G+ + D + T YV+TR+YRAPE++L + Y EVD+W+
Sbjct: 135 KPSNILINENCDLKICDFGLARIQDPQM--TGYVSTRYYRAPEIMLTWQKYDVEVDIWSA 192
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQ-LASNLDWKF----PQM 230
G I EML + LFPGK+ +Q I ++G+P +D I + S +F P+
Sbjct: 193 GCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV----INTICSENTLRFVQSLPKR 248
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
V E +A +I L+ ++ ++P R +AAEAL HP+ H
Sbjct: 249 EPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-51
Identities = 89/279 (31%), Positives = 157/279 (56%), Gaps = 8/279 (2%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+Y V++ K + VA+K+++ + ++EV L+ + H NIV L +++
Sbjct: 17 GTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHT 75
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+ + +VFEY++ DL + + + G + + V+ FQ+ +GL+Y HR+ HRDLKP N
Sbjct: 76 EKSLTLVFEYLDKDLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQN 134
Query: 121 LLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
LL++ +G +K+ D G+ + S+P Y V T WYR P++LL S Y ++DMW +G
Sbjct: 135 LLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVG 192
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
I +EM + R LFPG +Q++ I +++G+PTE++WP + + +P+ L
Sbjct: 193 CIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLH 252
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
+P + L+S+L + R +A EA++HP+F
Sbjct: 253 NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 4e-51
Identities = 101/309 (32%), Positives = 159/309 (51%), Gaps = 42/309 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK----EVKCLRKMNNHPNIVK--- 53
GS G VF A+D + VAVKK+ L + +++K E+K +R+++ H NIVK
Sbjct: 16 GSNGLVFSAVDSDCDKRVAVKKI-----VLTDPQSVKHALREIKIIRRLD-HDNIVKVYE 69
Query: 54 ------------LRNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQ 101
+ +L E V+IV EYME+DL ++++ SE+ R +Q+ +
Sbjct: 70 VLGPSGSDLTEDVGSLT-ELNSVYIVQEYMETDLANVLEQ---GPLSEEHARLFMYQLLR 125
Query: 102 GLHYMHRQGYFHRDLKPSNLLVSKG--VIKIGDLGMVKEIDSSLPCTDY----VTTRWYR 155
GL Y+H HRDLKP+N+ ++ V+KIGD G+ + +D Y + T+WYR
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIG-SPTEDSWP 214
+P +LL Y +DMWA G I EML+ + LF G + +Q+ I + + ED
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNE 245
Query: 215 LGIQLASNLDWKFPQMGGVN--LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
L + S + G LR+L P + E++ + ++ ++NP R TA EAL HP+
Sbjct: 246 LLNVIPSFVR---NDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY 302
Query: 273 FRSCHFVPR 281
SC+ P
Sbjct: 303 M-SCYSCPF 310
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 8e-51
Identities = 97/286 (33%), Positives = 164/286 (57%), Gaps = 15/286 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESR-NLKEVKCLRKMNNHPNIVKLRNL-- 57
G+YG V A D + + VAVKKL + SL +R +E++ L+ M H N++ L ++
Sbjct: 26 GAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLLDVFT 84
Query: 58 ----VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
++ +V++V M +DL ++K Q S++ V+ L +Q+ +GL Y+H G H
Sbjct: 85 PATSIENFNEVYLVTNLMGADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSAGIIH 141
Query: 114 RDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
RDLKPSN+ V++ ++I D G+ ++ D + T YV TRWYRAPE++L Y VD+
Sbjct: 142 RDLKPSNVAVNEDCELRILDFGLARQADDEM--TGYVATRWYRAPEIMLNWMHYNQTVDI 199
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSW-PLGIQLASNLDWKFPQMG 231
W++G IM E+L + LFPG + DQ+ +I +V+G+P+ + + + A P M
Sbjct: 200 WSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMP 259
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+L+++ A+ +I L+ ++ + R +A+EAL HP+F H
Sbjct: 260 QQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-50
Identities = 101/283 (35%), Positives = 146/283 (51%), Gaps = 17/283 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GSY V++ + + +G+ VA+K + K ++E L+ + H NIV L +++
Sbjct: 16 GSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK-HANIVLLHDIIHT 74
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
E + VFEYM +DL + M + G VR FQ+ +GL Y+H Q HRDLKP N
Sbjct: 75 KETLTFVFEYMHTDLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQN 133
Query: 121 LLVSK-GVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
LL+S G +K+ D G+ + S+P Y V T WYR P+VLL + Y +D+W G
Sbjct: 134 LLISYLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAG 191
Query: 177 AIMFEMLSFRILFPGKNSA-DQIYKICQVIGSPTEDSWPLGIQLASNLD-----WKFPQM 230
I EML + FPG + +Q+ KI V+G PTED+WP G+ N PQ
Sbjct: 192 CIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP-GVSKLPNYKPEWFLPCKPQQ 250
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
V + LS E L S++ P R +A +AL HP+F
Sbjct: 251 LRVVWKRLSRPPKAE--DLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-50
Identities = 92/293 (31%), Positives = 149/293 (50%), Gaps = 25/293 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL----KKKIFSLDESRNLKEVKCLRKMNNHPNIVKL-- 54
G++G+VF+A KK+ + VA+KK+ +K+ F + L+E+K L+ + H N+V L
Sbjct: 23 GTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA---LREIKILQLLK-HENVVNLIE 78
Query: 55 --RNLVKEHE----DVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHR 108
R + ++VFE+ E DL L+ + + F+ E++ + + GL+Y+HR
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK-FTLSEIKKVMKMLLNGLYYIHR 137
Query: 109 QGYFHRDLKPSNLLVSK-GVIKIGDLGM-----VKEIDSSLPCTDYVTTRWYRAPEVLLL 162
HRD+K +N+L++K G++K+ D G+ + + T+ V T WYR PE+LL
Sbjct: 138 NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG 197
Query: 163 SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP--LGIQLA 220
YGP +DMW G IM EM + + G Q+ I Q+ GS T + WP ++L
Sbjct: 198 ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELF 257
Query: 221 SNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
++ Q V R ++ LI +L +P R A AL H FF
Sbjct: 258 KKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 3e-49
Identities = 96/285 (33%), Positives = 148/285 (51%), Gaps = 18/285 (6%)
Query: 1 GSYGDVFQALD-KKSGEFVAVKKLKKKIFSLDESRNL---KEVKCLRKMNN--HPNIVKL 54
G+YG VF+A D K G FVA+K+++ + + +E L +EV LR + HPN+V+L
Sbjct: 12 GAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHLETFEHPNVVRL 69
Query: 55 RNL-----VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ 109
++ + +VFE+++ DL + + + ++++ FQ+ +GL ++H
Sbjct: 70 FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH 129
Query: 110 GYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGP 168
HRDLKP N+LV S G IK+ D G+ + + T V T WYRAPEVLL S Y
Sbjct: 130 RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YAT 188
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228
VD+W++G I EM + LF G + DQ+ KI VIG P E+ WP + L F
Sbjct: 189 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ---AFH 245
Query: 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
+ + L+ + ++NP R +A AL HP+F
Sbjct: 246 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 3e-49
Identities = 80/279 (28%), Positives = 137/279 (49%), Gaps = 37/279 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
GS+G V+ K G+ +K++ S E + L EVK L+K+N HPNI+K +
Sbjct: 11 GSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFE 69
Query: 60 EHEDVFIVFEYMES-DLLKLMKER--AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
E + IV EY + DL + +K++ G+ F E+++ + Q+ L Y+H + HRD+
Sbjct: 70 EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDI 129
Query: 117 KPSN-LLVSKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
KP N L S G++K+GD G+ K + S++ V T +Y +PE L ++ Y + D+W+
Sbjct: 130 KPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE-LCQNKPYNYKSDIWS 188
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G +++E+ + + F G+N + KI + G
Sbjct: 189 LGCVLYELCTLKHPFEGENLLELALKILK--GQY-------------------------- 220
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
+ S E +L+S L +P RP+ A+ L+ PF
Sbjct: 221 -PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 8e-47
Identities = 96/285 (33%), Positives = 157/285 (55%), Gaps = 14/285 (4%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDES-RNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G V+ D + G+ VA+KK+ +L R +E+K L H N++ ++++
Sbjct: 11 GAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQ 69
Query: 60 E-----HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
E++++V E M+SDL K++ + Q S D V+ +Q+ +GL Y+H G HR
Sbjct: 70 PPHIDPFEEIYVVTELMQSDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 115 DLKPSNLLV-SKGVIKIGDLGM--VKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
D+KP NLLV S V+KI D G+ V+E D S T V T++YRAPE+L+ S Y VD
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVD 187
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN--LDWKFPQ 229
+W++G I E+L RILF ++ Q+ I ++G+P+ ++ + A L
Sbjct: 188 IWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKP 247
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
L LS A+ E++ L+ R+ ++P R +AA+AL HP+
Sbjct: 248 PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLD 292
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 158 bits (399), Expect = 6e-46
Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 41/296 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
GS+G+V+ A D+K VA+K L KK+ S + L+E++ L +N+ PNIVKL +
Sbjct: 11 GSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF 67
Query: 59 KEHEDVFIVFEYMESDLLK--LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
++ +++V EY++ L+ L K SE E + Q+ L Y+H +G HRD+
Sbjct: 68 QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDI 127
Query: 117 KPSNLLVSK--GVIKIGDLGMVKEIDSS-------LPCTDYVTTRWYRAPEVLLLSEI-- 165
KP N+L+ + V+K+ D G+ K + + V T Y APEVLL +
Sbjct: 128 KPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAY 187
Query: 166 YGPEVDMWAMGAIMFEMLSFRILFPGKNSA---DQIYKICQVIGSPTEDSWPLGIQLASN 222
D+W++G ++E+L+ F G+ ++ Q KI + +P LAS
Sbjct: 188 ASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---------SLASP 238
Query: 223 LDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278
L P S+ + L+ +L + +P R +++ L H
Sbjct: 239 LSPSNP-----------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL 283
|
Length = 384 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 8e-45
Identities = 97/280 (34%), Positives = 147/280 (52%), Gaps = 11/280 (3%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GSY V++ K +G+ VA+K ++ + ++E L+ + H NIV L +++
Sbjct: 16 GSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-HANIVLLHDIIHT 74
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
E + +VFEY+ +DL + M + G + V+ FQ+ +GL Y+H++ HRDLKP N
Sbjct: 75 KETLTLVFEYVHTDLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQN 133
Query: 121 LLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
LL+S G +K+ D G+ + S+P Y V T WYR P+VLL S Y +DMW +G
Sbjct: 134 LLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVG 191
Query: 177 AIMFEMLSFRILFPG-KNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
I EM+ FPG K+ DQ+ +I V+G+P ED+WP L +F NL
Sbjct: 192 CIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNL 251
Query: 236 RELSPSAS--RESISLISRLCSWNPHMRPTAAEALEHPFF 273
R+ S + L S+L P R +A AL H +F
Sbjct: 252 RQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 1e-44
Identities = 80/277 (28%), Positives = 144/277 (51%), Gaps = 37/277 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLVK 59
G++G V++ L+ ++G+FVA+K++ + + +++ E+ L+ + HPNIVK ++
Sbjct: 11 GAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSIE 69
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ ++I+ EY E+ L +++K + G F E V +QV QGL Y+H QG HRD+K
Sbjct: 70 TSDSLYIILEYAENGSLRQIIK-KFG-PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKA 127
Query: 119 SNLLVSK-GVIKIGDLGM-VKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
+N+L +K GV+K+ D G+ K D S V T ++ APEV+ +S D+W++G
Sbjct: 128 ANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA-STASDIWSLG 186
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+ E+L+ + N +++I Q +D PL P+ L+
Sbjct: 187 CTVIELLTGNPPYYDLNPMAALFRIVQ------DDHPPL------------PEGISPELK 228
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
+ L+ +P++RPTA + L+HP+
Sbjct: 229 DF----------LMQCFQK-DPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-44
Identities = 87/280 (31%), Positives = 127/280 (45%), Gaps = 40/280 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
GS+G V K +G+ A+K LKKK I E + + + NHP IVKL +
Sbjct: 4 GSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ 63
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
E +++V EY +L + + FSE+ R ++ L Y+H G +RDLKP
Sbjct: 64 TEEKLYLVLEYAPGGELFSHLSKEGR--FSEERARFYAAEIVLALEYLHSLGIIYRDLKP 121
Query: 119 SNLLV-SKGVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+L+ + G IK+ D G+ KE+ S + T Y APEVLL YG VD W++G
Sbjct: 122 ENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLG 180
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+++EML+ + F ++ + KI PL +FP
Sbjct: 181 VLLYEMLTGKPPFYAEDRKEIYEKI---------LKDPL----------RFP-------- 213
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALE---HPFF 273
S E+ LIS L +P R + A E HPFF
Sbjct: 214 ---EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 1e-42
Identities = 95/299 (31%), Positives = 160/299 (53%), Gaps = 35/299 (11%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDES-RNLKEVKCLRKMNNHPNIVKLRNL-- 57
G+ G V A D +G+ VA+KKL + ++ + R +E+ L K+ NH NI+ L N+
Sbjct: 27 GAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV-LMKLVNHKNIIGLLNVFT 85
Query: 58 ----VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
++E +DV++V E M+++L ++++ + + + L +Q+ G+ ++H G H
Sbjct: 86 PQKSLEEFQDVYLVMELMDANLCQVIQ----MDLDHERMSYLLYQMLCGIKHLHSAGIIH 141
Query: 114 RDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
RDLKPSN++V S +KI D G+ + +S T YV TR+YRAPEV+L Y VD+
Sbjct: 142 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GMGYKENVDI 200
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSW----PLGIQLASNL----- 223
W++G IM EM+ +LFPG + DQ KI + +G+P+++ P N
Sbjct: 201 WSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAG 260
Query: 224 --------DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
D FP + +L S +R+ L+S++ +P R + +AL+HP+
Sbjct: 261 YSFEELFPDVLFP-PDSESHNKLKASQARD---LLSKMLVIDPEKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-42
Identities = 72/277 (25%), Positives = 131/277 (47%), Gaps = 39/277 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V++A K++G+ VA+K +K + + + + E++ L+K HPNIVK +
Sbjct: 11 GGFGEVYKARHKRTGKEVAIKVIKLES-KEKKEKIINEIQILKKCK-HPNIVKYYGSYLK 68
Query: 61 HEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
++++IV E+ DLLK + +E ++ +C ++ +GL Y+H G HRD+
Sbjct: 69 KDELWIVMEFCSGGSLKDLLKSTNQT----LTESQIAYVCKELLKGLEYLHSNGIIHRDI 124
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
K +N+L+ S G +K+ D G+ ++ + V T ++ APEV+ + Y + D+W++
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYDYKADIWSL 183
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G E+ + + ++KI P P K+
Sbjct: 184 GITAIELAEGKPPYSELPPMKALFKI--ATNGPPGLRNP----------EKW-------- 223
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
S E + + NP RPTA + L+HPF
Sbjct: 224 -------SDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 3e-42
Identities = 94/288 (32%), Positives = 154/288 (53%), Gaps = 27/288 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G+YG V + K++ E VA+KK K + + + L+E+K LR + NIV+L+ +
Sbjct: 12 GAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE-NIVELKEAFR 70
Query: 60 EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+++VFEY+E ++L+L++E ++VR+ +Q+ + +H+ H+ HRD+KP
Sbjct: 71 RRGKLYLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPE 129
Query: 120 NLLVSKG-VIKIGDLGMVKEID--SSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
NLL+S V+K+ D G + + S+ T+YV TRWYR+PE LLL YG VDMW++G
Sbjct: 130 NLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE-LLLGAPYGKAVDMWSVG 188
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGS-PTEDSWPLGIQLASNLDWKFPQMGGVNL 235
I+ E+ + LFPG++ DQ++ I +V+G P E L + P+ G+
Sbjct: 189 CILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ---------MKLFYSNPRFHGLRF 239
Query: 236 RELSPSASRES----------ISLISRLCSWNPHMRPTAAEALEHPFF 273
++ S E + L+ L NP R + L HP F
Sbjct: 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 90/286 (31%), Positives = 156/286 (54%), Gaps = 21/286 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN---- 56
GS+G V++A+ + E VA+KK+ + D +E+ ++ +N H NI+ L++
Sbjct: 77 GSFGVVYEAICIDTSEKVAIKKVLQ-----DPQYKNRELLIMKNLN-HINIIFLKDYYYT 130
Query: 57 --LVKEHEDVF--IVFEYMESDLLKLMKERAGQNFSEDE--VRNLCFQVFQGLHYMHRQG 110
K +++F +V E++ + K MK A N + V+ +Q+ + L Y+H +
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF 190
Query: 111 YFHRDLKPSNLLVSKGV--IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGP 168
HRDLKP NLL+ +K+ D G K + + Y+ +R+YRAPE++L + Y
Sbjct: 191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTT 250
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228
+D+W++G I+ EM+ +F G++S DQ+ +I QV+G+PTED L + D KFP
Sbjct: 251 HIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ--LKEMNPNYADIKFP 308
Query: 229 QMGGVNLRELSPSAS-RESISLISRLCSWNPHMRPTAAEALEHPFF 273
+ +L+++ P + ++I+ IS+ + P R EAL PFF
Sbjct: 309 DVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-40
Identities = 89/291 (30%), Positives = 148/291 (50%), Gaps = 24/291 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL--- 57
G+ G V A D G VAVKKL + + ++ L K NH NI+ L N+
Sbjct: 32 GAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP 91
Query: 58 ---VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
++E +DV++V E M+++L +++ + + L +Q+ G+ ++H G HR
Sbjct: 92 QKSLEEFQDVYLVMELMDANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHR 147
Query: 115 DLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMW 173
DLKPSN++V S +KI D G+ + ++ T YV TR+YRAPEV+L Y VD+W
Sbjct: 148 DLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIW 206
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
++G IM E++ ++F G + DQ K+ + +G+P+ + N PQ G+
Sbjct: 207 SVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGI 266
Query: 234 NLRELSPS------------ASRESISLISRLCSWNPHMRPTAAEALEHPF 272
+ EL P + ++ L+S++ +P R + EAL HP+
Sbjct: 267 SFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 3e-39
Identities = 90/291 (30%), Positives = 151/291 (51%), Gaps = 24/291 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL--- 57
G+ G V A D VA+KKL + + ++ L K NH NI+ L N+
Sbjct: 28 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87
Query: 58 ---VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
++E +DV++V E M+++L ++++ + + L +Q+ G+ ++H G HR
Sbjct: 88 QKSLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHR 143
Query: 115 DLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMW 173
DLKPSN++V S +KI D G+ + +S T YV TR+YRAPEV+L Y VD+W
Sbjct: 144 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GMGYKENVDIW 202
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
++G IM EM+ +ILFPG++ DQ K+ + +G+P + N P+ G+
Sbjct: 203 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL 262
Query: 234 NLRELSPSA------------SRESISLISRLCSWNPHMRPTAAEALEHPF 272
+L P + + ++ L+S++ +P R + EAL+HP+
Sbjct: 263 TFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-38
Identities = 71/283 (25%), Positives = 126/283 (44%), Gaps = 50/283 (17%)
Query: 1 GSYGDVFQA----LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G++G+V++ VAVK LK+ L+E + +RK++ HPNIVKL
Sbjct: 10 GAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD-HPNIVKLLG 68
Query: 57 LVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+ E E + IV EYM DLL +++ + S ++ + Q+ +G+ Y+ + + HRD
Sbjct: 69 VCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRD 128
Query: 116 LKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYG 167
L N LV + V+KI D G+ +++ DY RW APE L +
Sbjct: 129 LAARNCLVGENLVVKISDFGLSRDLYD----DDYYKVKGGKLPIRWM-APESLKEG-KFT 182
Query: 168 PEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226
+ D+W+ G +++E+ + +PG ++A+ + +
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL------------------------- 217
Query: 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269
+ G P+ E L+ + + +P RPT +E +E
Sbjct: 218 --KKG--YRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-37
Identities = 71/283 (25%), Positives = 126/283 (44%), Gaps = 51/283 (18%)
Query: 1 GSYGDVFQA----LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G++G+V++ K VAVK LK+ L+E + +RK++ HPN+VKL
Sbjct: 10 GAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD-HPNVVKLLG 68
Query: 57 LVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+ E E ++IV EYME DLL +++ S ++ + Q+ +G+ Y+ + + HRD
Sbjct: 69 VCTEEEPLYIVMEYMEGGDLLSYLRKNRP-KLSLSDLLSFALQIARGMEYLESKNFIHRD 127
Query: 116 LKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYG 167
L N LV + V+KI D G+ +++ DY RW APE L +
Sbjct: 128 LAARNCLVGENLVVKISDFGLSRDLYD----DDYYRKRGGKLPIRWM-APESLKEG-KFT 181
Query: 168 PEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226
+ D+W+ G +++E+ + +PG ++ + + +
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL------------------------- 216
Query: 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269
G P+ E L+ + + +P RPT +E +E
Sbjct: 217 ---KNG-YRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-37
Identities = 80/284 (28%), Positives = 125/284 (44%), Gaps = 39/284 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS G V++ K +G+ A+KK+ + L+E+K LR P +VK +
Sbjct: 12 GSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESPYVVKCYGAFYK 70
Query: 61 HEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY-FHRD 115
++ IV EYM+ +DLLK + E + + Q+ +GL Y+H + + HRD
Sbjct: 71 EGEISIVLEYMDGGSLADLLKKVG-----KIPEPVLAYIARQILKGLDYLHTKRHIIHRD 125
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEIYGPEVDMW 173
+KPSNLL+ SKG +KI D G+ K ++++L C +V T Y +PE + E Y D+W
Sbjct: 126 IKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYSYAADIW 184
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
++G + E + F + + P S P
Sbjct: 185 SLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP-SLPAEE---------------- 227
Query: 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
S E IS +P RP+AAE L+HPF +
Sbjct: 228 --------FSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 1e-36
Identities = 90/292 (30%), Positives = 152/292 (52%), Gaps = 26/292 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL--- 57
G+ G V A D VA+KKL + + ++ L K NH NI+ L N+
Sbjct: 35 GAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTP 94
Query: 58 ---VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
++E +DV+IV E M+++L ++++ + + L +Q+ G+ ++H G HR
Sbjct: 95 QKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHR 150
Query: 115 DLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMW 173
DLKPSN++V S +KI D G+ + +S T YV TR+YRAPEV+L Y VD+W
Sbjct: 151 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL-GMGYKENVDIW 209
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSP-TEDSWPLGIQLASNLDWKFPQMGG 232
++G IM EM+ +LFPG + DQ K+ + +G+P E L + + ++ + P+ G
Sbjct: 210 SVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR-PKYAG 268
Query: 233 VNLRELSPSA------------SRESISLISRLCSWNPHMRPTAAEALEHPF 272
+ +L P + ++ L+S++ + R + EAL+HP+
Sbjct: 269 YSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-36
Identities = 82/309 (26%), Positives = 132/309 (42%), Gaps = 76/309 (24%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVK---------CLRKMNNHPNI 51
GS+ V A +K++ + A+K L K+ + +KE K L ++N HP I
Sbjct: 12 GSFSTVVLAKEKETNKEYAIKILDKR-------QLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 52 VKLRNLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG 110
+KL ++ E+++ V EY + +LL+ +++ + E R ++ L Y+H +G
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG 122
Query: 111 YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---------------------CTDY 148
HRDLKP N+L+ K IKI D G K +D + +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSP 208
V T Y +PE LL + G D+WA+G I+++ML+ + F G N Y Q I
Sbjct: 183 VGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YLTFQKI--- 234
Query: 209 TEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268
L++ FP P+ ++ LI +L +P R E
Sbjct: 235 ------------LKLEYSFP-----------PNFPPDAKDLIEKLLVLDPQDRLGVNEGY 271
Query: 269 E----HPFF 273
+ HPFF
Sbjct: 272 DELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-35
Identities = 72/285 (25%), Positives = 128/285 (44%), Gaps = 44/285 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL-KEVKCLRKMNNHPNIVKL--RNL 57
GS+G V + K G+ + K++ + E + L EV LR++ HPNIV+ R +
Sbjct: 11 GSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYYDRII 69
Query: 58 VKEHEDVFIVFEYMES-DLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGY--- 111
+ ++ ++IV EY E DL +L+++ + + E+ + + Q+ L+ H +
Sbjct: 70 DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN 129
Query: 112 --FHRDLKPSNL-LVSKGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEIYG 167
HRDLKP+N+ L + +K+GD G+ K + S YV T +Y +PE L Y
Sbjct: 130 TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLN-HMSYD 188
Query: 168 PEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227
+ D+W++G +++E+ + F +N KI +
Sbjct: 189 EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE------------------------ 224
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
G R + S E +I + + +P RP+ E L+ P
Sbjct: 225 ----G-KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-34
Identities = 82/280 (29%), Positives = 131/280 (46%), Gaps = 41/280 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK----EVKCLRKMNNHPNIVKLRN 56
GS+G V++ L+ G+F AVK++ +K E+ L K+ HPNIV+
Sbjct: 11 GSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLG 69
Query: 57 LVKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+E ++++I E + L KL+K+ +F E +R Q+ GL Y+H + HRD
Sbjct: 70 TEREEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
+K +N+LV + GV+K+ D GM K++ + + ++ APEV+ YG D+W+
Sbjct: 128 IKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWS 187
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQV--IGSPTEDSWPLGIQLASNLDWKFPQMGG 232
+G + EM + GK Q+ + V IG E
Sbjct: 188 LGCTVLEMAT------GKPPWSQLEGVAAVFKIGRSKE---------------------- 219
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
L + S E+ I + +P +RPTAAE LEHPF
Sbjct: 220 --LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 92/310 (29%), Positives = 156/310 (50%), Gaps = 41/310 (13%)
Query: 1 GSYGDVFQAL--DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G+YG V++A D K A+K+++ S+ R E+ LR++ HPN++ L+ +
Sbjct: 12 GTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR---EIALLRELK-HPNVISLQKVF 67
Query: 59 KEHED--VFIVFEYMESDLLKLMK-ERAGQ------NFSEDEVRNLCFQVFQGLHYMHRQ 109
H D V+++F+Y E DL ++K RA + V++L +Q+ G+HY+H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 110 GYFHRDLKPSNLLV-----SKGVIKIGDLGMVKEIDSSL-PCTDY---VTTRWYRAPEVL 160
HRDLKP+N+LV +G +KI D+G + +S L P D V T WYRAPE+L
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 161 LLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS---------ADQIYKICQVIGSPTED 211
L + Y +D+WA+G I E+L+ +F + DQ+ +I V+G P +
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK 247
Query: 212 SWPLGIQLA--SNLDWKFPQMGGVN------LRELSPSASRESISLISRLCSWNPHMRPT 263
W ++ S L F + N + + ++ L+ +L + +P R T
Sbjct: 248 DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 307
Query: 264 AAEALEHPFF 273
+ +A++ P+F
Sbjct: 308 SEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-34
Identities = 92/310 (29%), Positives = 155/310 (50%), Gaps = 41/310 (13%)
Query: 1 GSYGDVFQAL--DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G+YG V++A D K + A+K+++ S+ R E+ LR++ HPN++ L+ +
Sbjct: 12 GTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR---EIALLRELK-HPNVIALQKVF 67
Query: 59 KEHED--VFIVFEYMESDLLKLMK-ERAGQ------NFSEDEVRNLCFQVFQGLHYMHRQ 109
H D V+++F+Y E DL ++K RA + V++L +Q+ G+HY+H
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 110 GYFHRDLKPSNLLV-----SKGVIKIGDLGMVKEIDSSL-PCTDY---VTTRWYRAPEVL 160
HRDLKP+N+LV +G +KI D+G + +S L P D V T WYRAPE+L
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 161 LLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS---------ADQIYKICQVIGSPTED 211
L + Y +D+WA+G I E+L+ +F + DQ+ +I V+G P +
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADK 247
Query: 212 SWPLGIQLAS--NLDWKFPQMGGVN------LRELSPSASRESISLISRLCSWNPHMRPT 263
W ++ L F + N + + + L+ +L + +P R T
Sbjct: 248 DWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRIT 307
Query: 264 AAEALEHPFF 273
+ +AL+ P+F
Sbjct: 308 SEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 7e-33
Identities = 86/285 (30%), Positives = 135/285 (47%), Gaps = 38/285 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKK--LKKKIFSLDESRNLKEVKCLR------KMNNHPNIV 52
G+YG V+ AL+ +GE +AVK+ L I +SR VK LR K +H NIV
Sbjct: 12 GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIV 71
Query: 53 KLRNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ E + I EY+ + G+ F E VR QV +GL Y+H +G
Sbjct: 72 QYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-FEEQLVRFFTEQVLEGLAYLHSKGIL 130
Query: 113 HRDLKPSNLLVS-KGVIKIGDLGMVKEID---SSLPCTDYVTTRWYRAPEVL-LLSEIYG 167
HRDLK NLLV G+ KI D G+ K+ D + + ++ APEV+ S+ Y
Sbjct: 131 HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYS 190
Query: 168 PEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227
+VD+W++G ++ EM + R + + + ++K+ +P P+
Sbjct: 191 AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP-----PI------------ 233
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
P ++S + S ++ ++ + NP RPTA E L+HPF
Sbjct: 234 PP-------DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 7e-33
Identities = 79/290 (27%), Positives = 133/290 (45%), Gaps = 55/290 (18%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN-----NHPNIVKLR 55
G++G V+ A++ +GE +AVK+++ ++ + +KE+ +M HPN+VK
Sbjct: 11 GTFGKVYTAVNLDTGELMAVKEIR---IQDNDPKTIKEIA--DEMKVLELLKHPNLVKYY 65
Query: 56 NLVKEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
+ E V+I EY +LL+ G+ E +R Q+ +GL Y+H G
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHSHGI 120
Query: 112 FHRDLKPSN-LLVSKGVIKIGDLGMVKEI-DSSLPC----TDYVTTRWYRAPEVLLLSEI 165
HRD+KP+N L GVIK+GD G ++ +++ T Y APEV+ +
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 166 --YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQI-YKICQVIGSPTEDSWPLGIQLASN 222
+G D+W++G ++ EM + + + ++ QI + + P DS
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDS---------- 230
Query: 223 LDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
+LSP E + R +P RPTA+E L+HPF
Sbjct: 231 -------------LQLSP----EGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 73/281 (25%), Positives = 122/281 (43%), Gaps = 37/281 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G +G V K A+K +KK+ I + ++ K + + NHP IVKL K
Sbjct: 4 GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK 63
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ + ++++ EY +L ++++R F E R V Y+H +G +RDLKP
Sbjct: 64 DKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKP 121
Query: 119 SNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
NLL+ S G +K+ D G K++ S + T Y APE+ +L++ Y VD W++G
Sbjct: 122 ENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEI-ILNKGYDFSVDYWSLGI 180
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
+++E+L+ R F + +I I L N +FP
Sbjct: 181 LLYELLTGRPPFGE--DDEDPMEIYNDI-------------LKGNGKLEFPNY------- 218
Query: 238 LSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFF 273
+ + LI +L NP R + +H +F
Sbjct: 219 ----IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-32
Identities = 81/289 (28%), Positives = 123/289 (42%), Gaps = 48/289 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK--KIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G+YG VF A K +G+ A+K +KK I + L E L + + P +VKL
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKLYYSF 62
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ +++++V EY+ DL L++ + ED R ++ L Y+H G HRDLK
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 118 PSNLLVSK-GVIKIGDLG---------MVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYG 167
P N+L+ G +K+ D G + D V T Y APEV +L + +
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV-ILGQGHS 179
Query: 168 PEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227
VD W++G I++E L F G+ + I N ++
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL-------------------NGKIEW 220
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE---HPFF 273
P+ S E+I LIS+L +P R A E HPFF
Sbjct: 221 PE---------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 7e-32
Identities = 76/276 (27%), Positives = 128/276 (46%), Gaps = 37/276 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
GSYG V++ +F A+K++ S E + + E++ L +N HPNI+ +
Sbjct: 11 GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEAFL 69
Query: 60 EHEDVFIVFEYME-SDLLKLMKERAGQN--FSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + IV EY DL K + +R + E E+ + Q+ +GL +H Q HRDL
Sbjct: 70 DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDL 129
Query: 117 KPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
K +N LLV+ ++KIGDLG+ K + ++ T + T Y APEV Y + D+W++
Sbjct: 130 KSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPEV-WKGRPYSYKSDIWSL 187
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G +++EM +F F ++ D YK+ + K+P
Sbjct: 188 GCLLYEMATFAPPFEARSMQDLRYKVQRG---------------------KYPP------ 220
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHP 271
+ P S++ + I + P +RP + L P
Sbjct: 221 --IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 8e-32
Identities = 83/278 (29%), Positives = 138/278 (49%), Gaps = 36/278 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESR-NLKEVKCLRKMNNHPNIVKLRNLVK 59
GS+G ++ A K E +K++ + E + KEV L KM HPNIV +
Sbjct: 11 GSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVTFFASFQ 69
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
E+ +FIV EY + DL+K + + G FSED++ + Q+ GL ++H + HRD+K
Sbjct: 70 ENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKS 129
Query: 119 SNLLVSKG--VIKIGDLGMVKEIDSSLPCTDY-VTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N+ +SK V K+GD G+ ++++ S+ V T +Y +PE+ + Y + D+W++
Sbjct: 130 QNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI-CQNRPYNNKTDIWSL 188
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G +++E+ + + F G N + KICQ +P
Sbjct: 189 GCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP--------------------------- 221
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
+SP+ SR+ SLIS+L +P RP+ L+ PF
Sbjct: 222 --ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 25/204 (12%)
Query: 1 GSYGDVFQA-LDKKSGEF--VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G++G+V++ L K G+ VAVK LK+ + LKE + ++K+ HPN+V+L +
Sbjct: 6 GAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGV 64
Query: 58 VKEHEDVFIVFEYME-SDLLKLMKERA-------GQNFSEDEVRNLCFQVFQGLHYMHRQ 109
E E +++V EYME DLL +++ S ++ + Q+ +G+ Y+ +
Sbjct: 65 CTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK 124
Query: 110 GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLL 161
+ HRDL N LV + V+KI D G+ +++ Y RW APE L
Sbjct: 125 KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD---DYYRKKTGGKLPIRWM-APES-L 179
Query: 162 LSEIYGPEVDMWAMGAIMFEMLSF 185
I+ + D+W+ G +++E+ +
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-31
Identities = 84/290 (28%), Positives = 142/290 (48%), Gaps = 52/290 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLK-------EVKCLRKMNNHPNIV 52
GS+G V+ ++ SGE +AVK+++ S + R E+ L+++ H NIV
Sbjct: 11 GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIV 69
Query: 53 KL--RNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG 110
+ +L +H ++F+ EY+ + + G F E VRN Q+ +GL+Y+H +G
Sbjct: 70 QYLGSSLDADHLNIFL--EYVPGGSVAALLNNYGA-FEETLVRNFVRQILKGLNYLHNRG 126
Query: 111 YFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTR-------WYRAPEVLLL 162
HRD+K +N+LV +KG IKI D G+ K+++++ T R ++ APEV+
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186
Query: 163 SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN 222
+ Y + D+W++G ++ EML+ + FP I+KI + SP
Sbjct: 187 T-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA-SPE------------- 231
Query: 223 LDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
P + S E+I + + + + RPTAAE L+HPF
Sbjct: 232 ----IPS-----------NISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-31
Identities = 62/217 (28%), Positives = 115/217 (52%), Gaps = 25/217 (11%)
Query: 1 GSYGDVFQALDKKSGEF----VAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLR 55
G++G+V++ K GE VAVK LK+ S +E L+E ++K++ HPNIV+L
Sbjct: 10 GAFGEVYKGTLKGDGEGTETKVAVKTLKEG-ASEEEREEFLEEASIMKKLS-HPNIVRLL 67
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ + E ++IV EYM DLL +++ G+ + ++ + Q+ +G+ Y+ + + HR
Sbjct: 68 GVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLESKNFVHR 126
Query: 115 DLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRAPEVLLLSEI 165
DL N LV++ V+KI D G+ ++I DY +W APE L
Sbjct: 127 DLAARNCLVTENLVVKISDFGLSRDIYE----DDYYRKRGGGKLPIKWM-APESLKDG-K 180
Query: 166 YGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+ + D+W+ G +++E+ + +PG ++ + + +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217
|
Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-31
Identities = 58/185 (31%), Positives = 105/185 (56%), Gaps = 6/185 (3%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ G+V++A D+ +G+ VA+KK++ + ++ + E+ + K HPNIV +
Sbjct: 30 GASGEVYKATDRATGKEVAIKKMR--LRKQNKELIINEIL-IMKDCKHPNIVDYYDSYLV 86
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+++++V EYM+ L + + +E ++ +C +V QGL Y+H Q HRD+K N
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDN 146
Query: 121 LLVSK-GVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAI 178
+L+SK G +K+ D G ++ V T ++ APEV+ + YGP+VD+W++G +
Sbjct: 147 ILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIM 205
Query: 179 MFEML 183
EM
Sbjct: 206 CIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 9e-31
Identities = 84/312 (26%), Positives = 136/312 (43%), Gaps = 72/312 (23%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G+V+ DK +G+ A+K L+K + ++ +++ + + + P IVKL +
Sbjct: 12 GAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ E +++V EYM DL+ L+ + F E+ R ++ L +H+ G+ HRD+KP
Sbjct: 72 DEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKP 129
Query: 119 SNLLV-SKGVIKIGDLGMVKEIDSS------------LPCTDYVTTRW------------ 153
N+L+ + G IK+ D G+ K+++ + L D V R
Sbjct: 130 DNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANS 189
Query: 154 ------YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGS 207
Y APEV L YG E D W++G I++EML F + KI
Sbjct: 190 TVGTPDYIAPEV-LRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKI------ 242
Query: 208 PTEDSWPLGIQLASNLDWK----FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPT 263
++WK FP V S E+I LI RL +P R
Sbjct: 243 ---------------INWKESLRFPPDPPV---------SPEAIDLICRLLC-DPEDRLG 277
Query: 264 AAE-ALEHPFFR 274
+ E HPFF+
Sbjct: 278 SFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 86/290 (29%), Positives = 134/290 (46%), Gaps = 53/290 (18%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V A K + E AVK LKK + D+ + E + L HP + +L +
Sbjct: 6 GSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF 65
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ + +F V EY+ DL+ ++ F E R ++ GL ++H +G +RDLK
Sbjct: 66 QTKDRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLK 123
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------YRAPEVLLLSEIYGPEV 170
N+L+ S+G IKI D GM KE VTT Y APE+L + YGP V
Sbjct: 124 LDNVLLDSEGHIKIADFGMCKE-----GILGGVTTSTFCGTPDYIAPEILS-YQPYGPAV 177
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
D WA+G +++EML+ + F G + D+++ Q I + ++P+
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDE-DELF---QSI---------------LEDEVRYPR- 217
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMR----PTAAEAL-EHPFFRS 275
S+E+ S++ + NP R PT + + HPFFR
Sbjct: 218 ----------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-30
Identities = 76/295 (25%), Positives = 128/295 (43%), Gaps = 69/295 (23%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL----KEVKCLRKMNNHPNIVKLRN 56
G+YGDV++A D +GE VA+K + L+ + +E+ L++ HPNIV
Sbjct: 14 GTYGDVYKARDIATGELVAIK-----VIKLEPGDDFEIIQQEISMLKECR-HPNIVAYFG 67
Query: 57 LVKEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ ++IV EY D+ ++ + SE ++ +C + +GL Y+H G
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLHETGKI 123
Query: 113 HRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEI--YGP 168
HRD+K +N LL G +K+ D G+ ++ +++ ++ T ++ APEV + Y
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDG 183
Query: 169 EVDMWAMG--AI--------MFEMLSFRILFP-GKNSADQIYKICQVIGSPTEDSWPLGI 217
+ D+WA+G AI MF++ R LF K++ P
Sbjct: 184 KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP----------PPK-------- 225
Query: 218 QLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
L W S I + + +P RPTA + L+HPF
Sbjct: 226 -LKDKEKW-----------------SPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 6e-30
Identities = 83/291 (28%), Positives = 121/291 (41%), Gaps = 59/291 (20%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
GS+G V K SG++ A+K L K KI L + ++ K + + HP +V L +
Sbjct: 12 GSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71
Query: 60 EHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ ++++V EY+ +L + R F E R QV L Y+H +RDLKP
Sbjct: 72 DDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKP 129
Query: 119 SNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTR-W-------YRAPEVLLLSEIYGPE 169
NLL+ S G IKI D G K V R + Y APE+ +LS+ YG
Sbjct: 130 ENLLLDSDGYIKITDFGFAK----------RVKGRTYTLCGTPEYLAPEI-ILSKGYGKA 178
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
VD WA+G +++EML+ F D +I + I L + +FP
Sbjct: 179 VDWWALGILIYEMLAGYPPF----FDDNPIQIYEKI-------------LEGKV--RFP- 218
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRS 275
SP A LI L + R + HP+F
Sbjct: 219 ------SFFSPDA----KDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-29
Identities = 71/282 (25%), Positives = 135/282 (47%), Gaps = 48/282 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL--KKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
GSYG V++A+ K++G+ VA+K + ++ + + +KE+ L++ ++ P IVK
Sbjct: 14 GSYGSVYKAIHKETGQVVAIKVVPVEEDLQEI-----IKEISILKQCDS-PYIVKYYGSY 67
Query: 59 KEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
++ D++IV EY SD++K+ + +E+E+ + +Q +GL Y+H HR
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKT----LTEEEIAAILYQTLKGLEYLHSNKKIHR 123
Query: 115 DLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLLSEIYGPEVDM 172
D+K N+L++ +G K+ D G+ ++ ++ + + T ++ APEV+ Y + D+
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNNKADI 182
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
W++G EM + + + I+ I P P P
Sbjct: 183 WSLGITAIEMAEGKPPYSDIHPMRAIFMI------PN---KP-------------PP--- 217
Query: 233 VNLRELSPSA-SRESISLISRLCSWNPHMRPTAAEALEHPFF 273
L + P S E + + +P RP+A + L+HPF
Sbjct: 218 -TLSD--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-29
Identities = 79/280 (28%), Positives = 136/280 (48%), Gaps = 43/280 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVK-----KLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
GS+G K+ G+ +K K+ K +ESR KEV L M HPNIV+ +
Sbjct: 11 GSFGKAILVKSKEDGKQYVIKEINISKMSPK--EREESR--KEVAVLSNMK-HPNIVQYQ 65
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+E+ +++IV +Y E DL K + + G F ED++ + Q+ L ++H + HR
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHR 125
Query: 115 DLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDY-VTTRWYRAPEVLLLSEIYGPEVDM 172
D+K N+ ++K G IK+GD G+ + ++S++ + T +Y +PE+ + Y + D+
Sbjct: 126 DIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEI-CENRPYNNKSDI 184
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
WA+G +++EM + + F N + + KI + GS +P
Sbjct: 185 WALGCVLYEMCTLKHAFEAGNMKNLVLKI--IRGS-------------------YP---- 219
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
+S S + +L+S+L NP RP+ LE F
Sbjct: 220 ----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 83/293 (28%), Positives = 130/293 (44%), Gaps = 64/293 (21%)
Query: 1 GSYGDVFQALDKKSGEFVAVKK--LKKKIFSLDESRNL--KEVKCLRKMNNHPNIVKLRN 56
GS G V A DK +G VAVKK L+K+ + R L EV +R HPNIV++ +
Sbjct: 30 GSTGIVCIATDKSTGRQVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQ-HPNIVEMYS 83
Query: 57 LVKEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+++++V E++E +D++ +E+++ +C V + L ++H QG
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHT------RMNEEQIATVCLAVLKALSFLHAQGVI 137
Query: 113 HRDLKP-SNLLVSKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEIYGPEV 170
HRD+K S LL S G +K+ D G ++ +P V T ++ APEV + YG EV
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEV-ISRLPYGTEV 196
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
D+W++G ++ EM V G P + P P
Sbjct: 197 DIWSLGIMVIEM---------------------VDGEPPYFNEP-------------PLQ 222
Query: 231 GGVNLRELSPSASRESI-------SLISRLCSWNPHMRPTAAEALEHPFFRSC 276
+R+ P + S + R+ +P R TAAE L HPF
Sbjct: 223 AMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-29
Identities = 80/283 (28%), Positives = 133/283 (46%), Gaps = 46/283 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRN-L 57
GS+G V+ A D ++ E VA+KK+ +E +KEV+ L+++ HPN ++ +
Sbjct: 26 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCY 84
Query: 58 VKEHEDVFIVFEYM---ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
++EH ++V EY SD+L++ K + E E+ +C QGL Y+H HR
Sbjct: 85 LREHT-AWLVMEYCLGSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHERIHR 139
Query: 115 DLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE--IYGPEVD 171
D+K N+L+++ G +K+ D G + P +V T ++ APEV+L + Y +VD
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSASLVS---PANSFVGTPYWMAPEVILAMDEGQYDGKVD 196
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231
+W++G E+ + N+ +Y I Q SPT L+SN DW
Sbjct: 197 VWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPT---------LSSN-DW------ 239
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
S + + P RP++ E L+H F
Sbjct: 240 -----------SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-29
Identities = 80/279 (28%), Positives = 130/279 (46%), Gaps = 36/279 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ G V + L + +G+ +AVK ++ +I + + L+E+ L K N P IV
Sbjct: 12 GNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN-SPYIVGFYGAFYN 70
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPS 119
+ D+ I EYM+ L + + E + + V +GL Y+H + HRD+KPS
Sbjct: 71 NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPS 130
Query: 120 NLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAI 178
N+LV S+G IK+ D G+ ++ +SL T +V T Y APE + Y + D+W++G
Sbjct: 131 NILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPE-RIQGNDYSVKSDIWSLGLS 188
Query: 179 MFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGI--QLASNLDWKFPQMGGVNLR 236
+ E+ + R FP P E+ P GI L ++ P++
Sbjct: 189 LIELATGR--FP----------------YPPENDPPDGIFELLQYIVNEPPPRL------ 224
Query: 237 ELSPSA--SRESISLISRLCSWNPHMRPTAAEALEHPFF 273
PS S + ++ +P RP+ E LEHPF
Sbjct: 225 ---PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-28
Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 35/276 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
G++G+ + V K++ S E R+ L E+ L + HPNI+ N
Sbjct: 11 GAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPNIIAYYNHFM 69
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ + I EY L + + GQ F E+ V FQ+ + Y+H+ G HRD+K
Sbjct: 70 DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKT 129
Query: 119 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVT-TRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+ ++K G+IK+GD G+ K + S + V T +Y +PE L Y + D+WA+G
Sbjct: 130 LNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPE-LCQGVKYNFKSDIWALG 188
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+++E+L+ + F N + + KI Q +P +
Sbjct: 189 CVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY----------------------- 225
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
S E ISL+ L +P RPTA E L+ P
Sbjct: 226 ------SSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-28
Identities = 76/284 (26%), Positives = 129/284 (45%), Gaps = 43/284 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
G++G V+ A + +G++ A+K LKK + + ++ N+K E + P + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ + +++V EY+ D L+K G ED + +V G+ +H++G HRD+K
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124
Query: 118 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
P NLL+ + G +K+ D G+ + + L +V T Y APE +L D W++G
Sbjct: 125 PENLLIDQTGHLKLTDFGLSR---NGLENKKFVGTPDYLAPETIL-GVGDDKMSDWWSLG 180
Query: 177 AIMFEMLSFRILFPGKNSADQIYK--ICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
++FE L F + D ++ + + I WP
Sbjct: 181 CVIFEFLFGYPPFHA-ETPDAVFDNILSRRIN------WP-------------------- 213
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTA---AEALEHPFFRS 275
E+ S E++ LI+RL +P R A E HPFF+S
Sbjct: 214 -EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-28
Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 35/275 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLK-KKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
GS+G VF+ + K A+K++ K+ + + E + L K++ I++
Sbjct: 11 GSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYIIRYYESFL 69
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ + IV EY E+ DL KL+K + G+ ED+V Q+ GL ++H + HRD+K
Sbjct: 70 DKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKS 129
Query: 119 SNLLVSKGV-IKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
NL + +KIGDLG+ K + D++ V T +Y +PE L + Y + D+WA+G
Sbjct: 130 LNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LCEDKPYNEKSDVWALG 188
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+++E + + F N I KI + FP +
Sbjct: 189 VVLYECCTGKHPFDANNQGALILKI---------------------IRGVFPPVSQ---- 223
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHP 271
S++ LI + + + RP + L +P
Sbjct: 224 ----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-27
Identities = 76/291 (26%), Positives = 133/291 (45%), Gaps = 50/291 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL-----KEVKCLRKMNNHPNIVKLR 55
G++ +QA D K+G +AVK++ + E + KE++ + ++N HP+I+++
Sbjct: 11 GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRML 69
Query: 56 NLVKE--HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
E H ++F+ E+M + + + G F E + N Q+ +GL Y+H H
Sbjct: 70 GATCEDSHFNLFV--EWMAGGSVSHLLSKYGA-FKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 114 RDLKPSNLLV-SKG-VIKIGDLGMVKEIDSSLPCTD-----YVTTRWYRAPEVLLLSEIY 166
RD+K +NLL+ S G ++I D G + + + T + APEV L E Y
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV-LRGEQY 185
Query: 167 GPEVDMWAMGAIMFEMLSFRILFPGKNSADQ---IYKICQVIGSPTEDSWPLGIQLASNL 223
G D+W++G ++ EM + + + + ++ I+KI +P+ + +L
Sbjct: 186 GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS---------IPEHL 236
Query: 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P + V LR L E P RP + E L+HP FR
Sbjct: 237 S---PGLRDVTLRCL------EL----------QPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 88/286 (30%), Positives = 136/286 (47%), Gaps = 46/286 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDE-SRNLKEVKCLRKMNNHPNIVKLRNLV 58
G++G V +K +G++ A+K LKK+ I + DE + L E + L+ HP + L+
Sbjct: 6 GTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTALKYSF 64
Query: 59 KEHEDVFIVFEYMESDLL--KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ H+ + V EY L L +ER FSED R ++ L Y+H +RDL
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 117 KPSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
K NL++ K G IKI D G+ KE I + T Y APEVL ++ YG VD W
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWG 180
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G +M+EM+ R+ F ++ ++++++ + + +FP
Sbjct: 181 LGVVMYEMMCGRLPFYNQDH-EKLFELILM------------------EEIRFP------ 215
Query: 235 LRELSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRS 275
R LSP A SL++ L +P R A E +EH FF S
Sbjct: 216 -RTLSPEAK----SLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 37/279 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLV 58
G++G V + + + A+K + K+K RN L E + L+++N HP +V L
Sbjct: 11 GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSF 69
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
++ E++++V + + L+ + + FSE++V+ ++ L Y+H +G HRD+KP
Sbjct: 70 QDEENMYLVVDLLLGGDLRYHLSQKVK-FSEEQVKFWICEIVLALEYLHSKGIIHRDIKP 128
Query: 119 SNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
N+L+ +G + I D + ++ T T Y APEV L + Y VD W++G
Sbjct: 129 DNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEV-LCRQGYSVAVDWWSLGV 187
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
+E L + + G S T Q +
Sbjct: 188 TAYECLRGKRPYRGH--------------SRTIRDQIRAKQETA--------------DV 219
Query: 238 LSPSA-SRESISLISRLCSWNPHMR--PTAAEALEHPFF 273
L P+ S E+I I++L +P R + HP+F
Sbjct: 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 61/214 (28%), Positives = 116/214 (54%), Gaps = 15/214 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN----LKEVKCLRKMNNHPNIVKLRN 56
G + V++A+ G VA+KK++ IF + +++ LKE+ L++++ HPN++K
Sbjct: 13 GQFSVVYKAICLLDGRVVALKKVQ--IFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLA 69
Query: 57 LVKEHEDVFIVFEYMES-DLLKLMKERAGQN--FSEDEVRNLCFQVFQGLHYMHRQGYFH 113
E+ ++ IV E ++ DL +++K Q E + Q+ L +MH + H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMH 129
Query: 114 RDLKPSNLLVS-KGVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
RD+KP+N+ ++ GV+K+GDLG+ + S + V T +Y +PE + Y + D
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER-IHENGYNFKSD 188
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVI 205
+W++G +++EM + + F G +Y +C+ I
Sbjct: 189 IWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
G +G+V +K +G+ A+K +KK + E+ + +E + + ++N P I +L+ +
Sbjct: 12 GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ +++++V EY DLL L+ Q F ED + ++ +H +H+ GY HRD+KP
Sbjct: 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQMGYVHRDIKP 130
Query: 119 SNLLVSK-GVIKIGDLGMV------KEIDSSLPCTDYVTTRWYRAPEVLLL-----SEIY 166
N+L+ + G IK+ D G K ++S LP V T Y APEVL Y
Sbjct: 131 ENVLIDRTGHIKLADFGSAARLTANKMVNSKLP----VGTPDYIAPEVLTTMNGDGKGTY 186
Query: 167 GPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKI 201
G E D W++G I +EM+ R F SA I
Sbjct: 187 GVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 81/280 (28%), Positives = 136/280 (48%), Gaps = 39/280 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDESRNLK---EVKCLRKMNNHPNIVKLRN 56
GS+G V+ DKK+ +K LK+ + L+ + ++ E + L K++ HP IVK
Sbjct: 11 GSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHA 69
Query: 57 LVKEHEDVFIVFEYMES-DLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
E + I+ EY E DL ++E G+ SE++V Q+ G+HYMH++ H
Sbjct: 70 SFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILH 129
Query: 114 RDLKPSNLLVSKGVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
RDLK N+ + ++KIGD G+ + + S T + T +Y +PE L + Y + D+
Sbjct: 130 RDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA-LKHQGYDSKSDI 188
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
W++G I++EM F G+N + +I + PT
Sbjct: 189 WSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---GPTP---------------------- 223
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
L + SR+ S++ + + +P +RP+AAE L +PF
Sbjct: 224 ----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 35/275 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
G++G V K + V +K++ + + DE E + L+ ++ HPNI++
Sbjct: 11 GAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYENFL 69
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
E + + IV EY L + +++R ED + + Q+ LH++H + HRDLK
Sbjct: 70 EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKT 129
Query: 119 SNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+L+ K V+KIGD G+ K + S V T Y +PE L + Y + D+WA+G
Sbjct: 130 QNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE-LCEGKPYNQKSDIWALG 188
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+++E+ S + F N + KI +P D +
Sbjct: 189 CVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRY----------------------- 225
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHP 271
S + LI + + +P RP ++ + P
Sbjct: 226 ------SPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 68/211 (32%), Positives = 107/211 (50%), Gaps = 33/211 (15%)
Query: 1 GSYGDVFQA-----LDKKSGEF-VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKL 54
G++G+V++ L SG VAVK L+K ++ LKE + N HPNIVKL
Sbjct: 6 GAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN-HPNIVKL 64
Query: 55 RNLVKEHEDVFIVFEYMES-DLLKLMKERAGQNF-----SEDEVRNLCFQVFQGLHYMHR 108
+ +E +I+ E ME DLL +++ + F + E+ ++C V +G Y+ +
Sbjct: 65 LGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ 124
Query: 109 QGYFHRDLKPSNLLVSKG------VIKIGDLGMVKEIDSSLPCTDY--------VTTRWY 154
+ HRDL N LVS+ V+KIGD G+ ++I S DY + RW
Sbjct: 125 MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS----DYYRKEGEGLLPVRWM 180
Query: 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
APE LL + + D+W+ G +M+E+L+
Sbjct: 181 -APES-LLDGKFTTQSDVWSFGVLMWEILTL 209
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 83/285 (29%), Positives = 129/285 (45%), Gaps = 43/285 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V A K + E A+K LKK + D+ + + E + L HP + L
Sbjct: 6 GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF 65
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ + +F V EY+ L +R+ + F E R +V L ++HR G +RDLK
Sbjct: 66 QTKDRLFFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKL 124
Query: 119 SNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+L+ ++G K+ D GM KE I + + T + T Y APE+L E YGP VD WA+G
Sbjct: 125 DNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE-YGPSVDWWALG 183
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+M+EM++ + F N D I + D +P V L
Sbjct: 184 VLMYEMMAGQPPFEADNEDDLFESIL-------------------HDDVLYP----VWL- 219
Query: 237 ELSPSASRESISLISRLCSWNPHMR-------PTAAEALEHPFFR 274
S+E++S++ + NP+ R +HPFF+
Sbjct: 220 ------SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFK 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-26
Identities = 77/277 (27%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GSYG+V + G+ +KKL + S E + ++ L HPNIV R E
Sbjct: 11 GSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE-SWE 69
Query: 61 HED--VFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
ED ++IV + E DL +KE+ G+ E++V Q+ L Y+H + HRDLK
Sbjct: 70 GEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLK 129
Query: 118 PSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N+ +++ +IK+GDLG+ + +++ + + T +Y +PE L ++ Y + D+WA+
Sbjct: 130 TQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFSNKPYNYKSDVWAL 188
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G ++EM + + F K+ +Y+I ++ K P M
Sbjct: 189 GCCVYEMATLKHAFNAKDMNSLVYRI---------------------IEGKLPPMP---- 223
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
++ SP E LI+ + S P RP+ L P+
Sbjct: 224 KDYSP----ELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 82/294 (27%), Positives = 126/294 (42%), Gaps = 40/294 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G YG VF A K +GE VA+K++KK +F L+E R++ + + +VKL +
Sbjct: 12 GGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ E +++ EY+ D L+ SED R ++F+ + +H GY HRDLKP
Sbjct: 72 DDEYLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKP 129
Query: 119 SNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
N L+ + G IK+ D G+ K I + V + Y APEV L + Y VD W++G
Sbjct: 130 ENFLIDASGHIKLTDFGLSKGIVTY--ANSVVGSPDYMAPEV-LRGKGYDFTVDYWSLGC 186
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
+++E L G GS ++W L NL
Sbjct: 187 MLYEFLC------GFPPFS---------GSTPNETWENLKYWKETLQRPVYDDPRFNL-- 229
Query: 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH----------FVPR 281
S E+ LI++L + + + HPFF+ FVP
Sbjct: 230 -----SDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELRELKPPFVPE 278
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 76/258 (29%), Positives = 126/258 (48%), Gaps = 18/258 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+G S + A+K+++ S + KE L KM HPNIV + +
Sbjct: 11 GSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEA 69
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
++IV EY + DL++ +K + G+ F ED + Q+ G+ ++H + HRD+K
Sbjct: 70 DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSK 129
Query: 120 NL-LVSKGVIKIGDLGMVKEIDS--SLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+ L G +K+GD G + + S + CT YV T +Y PE+ + Y + D+W++G
Sbjct: 130 NIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPPEI-WENMPYNNKSDIWSLG 187
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
I++E+ + + F + + I K+CQ GS PL + L QM N R
Sbjct: 188 CILYELCTLKHPFQANSWKNLILKVCQ--GSYK----PLPSHYSYELRSLIKQMFKRNPR 241
Query: 237 ELSPSASRESISLISRLC 254
PSA+ +++SR
Sbjct: 242 S-RPSAT----TILSRGS 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 62/227 (27%), Positives = 112/227 (49%), Gaps = 18/227 (7%)
Query: 1 GSYGDVFQALDKKSGE-FVAVKK-------LKKKIFSLDESRN--LKEVKCLRKMNNHPN 50
G++G V++ K +G+ +A+K+ K D+S + EV +++ HPN
Sbjct: 11 GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPN 70
Query: 51 IVKLRNLVKEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYM 106
IV+ E++ ++IV + +E + +KE+ Q F+E+ + N+ Q+ L Y+
Sbjct: 71 IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYL 129
Query: 107 HRQGYF-HRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE 164
H++ HRDL P+N +L + I D G+ K+ T V T Y PE+ + +E
Sbjct: 130 HKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEI-VKNE 188
Query: 165 IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTED 211
YG + D+WA G I+++M + + F N KI + + P +
Sbjct: 189 PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE 235
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 69/202 (34%), Positives = 102/202 (50%), Gaps = 10/202 (4%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESR--NLKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V A K+SG AVK LKK + D+ + E + L NHP + +L
Sbjct: 6 GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF 65
Query: 59 KEHEDVFIVFEYMES-DLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + +F V E++ DL+ + K R F E R ++ L ++H +G +RDL
Sbjct: 66 QTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 117 KPSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
K N+L+ G K+ D GM KE I + + + T Y APE+L +YGP VD WA
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQ-EMLYGPSVDWWA 181
Query: 175 MGAIMFEMLSFRILFPGKNSAD 196
MG +++EML F +N D
Sbjct: 182 MGVLLYEMLCGHAPFEAENEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 4e-24
Identities = 76/281 (27%), Positives = 125/281 (44%), Gaps = 38/281 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKC---LRKMNNHPNIVKLRNL 57
G++G V+ D +G +AVK++ S + + + ++C L K H IV+
Sbjct: 13 GAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+++ E + I EYM +K + G +E R Q+ +G+ Y+H HRD+K
Sbjct: 73 LRDDETLSIFMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGVEYLHSNMIVHRDIK 131
Query: 118 PSNLLV-SKGVIKIGDLGMVKE---IDSSLPCTDYVT-TRWYRAPEVLLLSEIYGPEVDM 172
+N+L S G +K+GD G K I SS VT T ++ +PEV + E YG + D+
Sbjct: 132 GANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV-ISGEGYGRKADV 190
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
W++G + EML+ + P + + I ++ PT PQ
Sbjct: 191 WSVGCTVVEMLTEK---PPWAEFEAMAAIFKIATQPTN-----------------PQ--- 227
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
L S ++ + + R N RP+A E L H F
Sbjct: 228 -----LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 5e-24
Identities = 86/280 (30%), Positives = 136/280 (48%), Gaps = 44/280 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKK--LKKKIFSLDESRNL--KEVKCLRKMNNHPNIVKLRN 56
GS G V A K SG+ VAVKK L+K+ + R L EV +R H N+V++ N
Sbjct: 31 GSTGIVCIATVKSSGKLVAVKKMDLRKQ-----QRRELLFNEVVIMRDYQ-HENVVEMYN 84
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+++++V E++E L + N E+++ +C V + L +H QG HRD+
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMN--EEQIAAVCLAVLKALSVLHAQGVIHRDI 142
Query: 117 KPSNLLVS-KGVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLLLSEI-YGPEVDMW 173
K ++L++ G +K+ D G ++ +P V T ++ APE L+S + YGPEVD+W
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE--LISRLPYGPEVDIW 200
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
++G ++ EM V G P + P + D P++
Sbjct: 201 SLGIMVIEM---------------------VDGEPPYFNEPPLKAMKMIRDNLPPKLK-- 237
Query: 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
NL ++SPS + RL +P R TAAE L+HPF
Sbjct: 238 NLHKVSPSLK----GFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 6e-24
Identities = 72/299 (24%), Positives = 131/299 (43%), Gaps = 76/299 (25%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-----LKEVKCLRKMNNHPNIVKLR 55
GS+G+V++A+DK++ + VA+K + L+E+ + +E++ L + + P I K
Sbjct: 12 GSFGEVYKAIDKRTNQVVAIK-----VIDLEEAEDEIEDIQQEIQFLSQCRS-PYITKYY 65
Query: 56 NLVKEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
+ ++I+ EY DLLK K E + + +V GL Y+H +G
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGK------LDETYIAFILREVLLGLEYLHEEGK 119
Query: 112 FHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEIYGPE 169
HRD+K +N+L+S+ G +K+ D G+ ++ + +V T ++ APEV+ S Y +
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEK 178
Query: 170 VDMWAMGAIMFEML----------SFRILF--PGKNSADQIYKICQVIGSPTEDSWPLGI 217
D+W++G E+ R+LF P KN+ + + +
Sbjct: 179 ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSL----------EGNKF---- 223
Query: 218 QLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276
S ++ +SL +P RP+A E L+H F +
Sbjct: 224 ---------------------SKPF-KDFVSLCLNK---DPKERPSAKELLKHKFIKKA 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-23
Identities = 71/290 (24%), Positives = 123/290 (42%), Gaps = 44/290 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V + +G +AVK+++ + S ++ R L ++ + + P V +
Sbjct: 12 GAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71
Query: 61 HEDVFIVFEYMESDLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLK 117
DV+I E M++ L K K+ G ED + + + + L Y+H + HRD+K
Sbjct: 72 EGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVK 131
Query: 118 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL---LLSEIYGPEVDMW 173
PSN+L+++ G +K+ D G+ + S+ T + Y APE + L + Y + D+W
Sbjct: 132 PSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVW 191
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
++G M E+ + R FP + ++ QV+ P
Sbjct: 192 SLGITMIELATGR--FPYDSWKTPFQQLKQVVEEP------------------------- 224
Query: 234 NLRELSPSASRESISL-----ISRLCSWNPHMRPTAAEALEHPFFRSCHF 278
SP E S +++ N RP E L+HPFF
Sbjct: 225 -----SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-23
Identities = 89/294 (30%), Positives = 133/294 (45%), Gaps = 60/294 (20%)
Query: 1 GSYGDVFQA---LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNN------HPNI 51
G YG VFQ +G+ A+K LKK RN K+ + N HP I
Sbjct: 7 GGYGKVFQVRKVTGADTGKIFAMKVLKKATIV----RNQKDTAHTKAERNILEAVKHPFI 62
Query: 52 VKLRNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCF---QVFQGLHYMHR 108
V L + ++++ EY+ L + ER G F ED CF ++ L ++H+
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI-FMEDTA---CFYLSEISLALEHLHQ 118
Query: 109 QGYFHRDLKPSN-LLVSKGVIKIGDLGMVKE--IDSSLPCTDYVTTRWYRAPEVLLLSEI 165
QG +RDLKP N LL ++G +K+ D G+ KE + ++ T + T Y APE+L+ S
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEILMRSG- 176
Query: 166 YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225
+G VD W++GA+M++ML+ F +N I KI L L+
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI-----------------LKGKLN- 218
Query: 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMR----PTAAEALE-HPFFR 274
L P + E+ L+ +L NP R P A ++ HPFFR
Sbjct: 219 ------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-23
Identities = 67/214 (31%), Positives = 111/214 (51%), Gaps = 16/214 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL--KEVKCLRKMNNHPNIVKLRNLV 58
GSY V KK+ A+K +KK++ + DE + E +NHP +V L +
Sbjct: 6 GSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF 65
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ +F V E++ DL+ M+ + + E+ R ++ L+++H +G +RDLK
Sbjct: 66 QTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLK 123
Query: 118 PSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N+L+ ++G IK+ D GM KE I + + T Y APE+L E YG VD WA+
Sbjct: 124 LDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR-GEDYGFSVDWWAL 182
Query: 176 GAIMFEMLSFRILF--------PGKNSADQIYKI 201
G +MFEM++ R F P +N+ D ++++
Sbjct: 183 GVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV 216
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-23
Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 44/281 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
G+ G V++ + + +G A+K + D R +E++ LR +N HPN+VK ++
Sbjct: 85 GAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVN-HPNVVKCHDMF 141
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNF-SEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ ++ ++ E+M+ L+ G + E + ++ Q+ G+ Y+HR+ HRD+K
Sbjct: 142 DHNGEIQVLLEFMDGGSLE------GTHIADEQFLADVARQILSGIAYLHRRHIVHRDIK 195
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVL---LLSEIY-GPEVD 171
PSNLL+ S +KI D G+ + + ++ PC V T Y +PE + L Y G D
Sbjct: 196 PSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGD 255
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231
+W++G + E R F D +C + S
Sbjct: 256 IWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP--------------------- 294
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
E +ASRE IS P R +A + L+HPF
Sbjct: 295 -----EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 3e-23
Identities = 68/213 (31%), Positives = 109/213 (51%), Gaps = 14/213 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL--KEVKCLRKMNNHPNIVKLRNLV 58
GSY V KK+ A+K +KK++ + DE + E + +NHP +V L +
Sbjct: 6 GSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 65
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ +F V EY+ L +R + E+ R ++ L+Y+H +G +RDLK
Sbjct: 66 QTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKL 124
Query: 119 SNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+L+ S+G IK+ D GM KE + + + T Y APE+L E YG VD WA+G
Sbjct: 125 DNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR-GEDYGFSVDWWALG 183
Query: 177 AIMFEMLSFRILF--------PGKNSADQIYKI 201
+MFEM++ R F P +N+ D ++++
Sbjct: 184 VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 216
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 3e-23
Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 35/283 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V + L K SG +AVK+++ + ++ R L ++ + + ++ P IVK +
Sbjct: 15 GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR 74
Query: 61 HEDVFIVFEYMESDLLKLMK---ERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDL 116
D +I E M+ L K K E E+ + + + L+Y+ + HRD+
Sbjct: 75 EGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDV 134
Query: 117 KPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEV--DMW 173
KPSN+L+ G IK+ D G+ ++ S+ T R Y APE + S G +V D+W
Sbjct: 135 KPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVW 194
Query: 174 AMGAIMFEMLSFRILFPGKNSA-DQIYKICQVI-GSPTEDSWPLGIQLASNLDWKFPQMG 231
++G ++E+ + + +P NS DQ + QV+ G P P +
Sbjct: 195 SLGITLYEVATGKFPYPKWNSVFDQ---LTQVVKGDP-------------------PILS 232
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
RE SP ++ I+ + RP E LEHPF +
Sbjct: 233 NSEEREFSP----SFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-23
Identities = 90/289 (31%), Positives = 129/289 (44%), Gaps = 44/289 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNN---HPNIVKLRN 56
G +G V A KK+GE A+K LKK I + DE +L K + + N HP +V L
Sbjct: 10 GHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFA 69
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + V V EY LM FSE V GL Y+H +RDL
Sbjct: 70 CFQTEDHVCFVMEYAAGG--DLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDL 127
Query: 117 KPSNLLVS-KGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
K NLL+ +G +KI D G+ KE + + + T + APEVL Y VD W
Sbjct: 128 KLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT-ETSYTRAVDWWG 186
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G +++EML FPG + ++++ DS N + ++P
Sbjct: 187 LGVLIYEMLVGESPFPGDDE-EEVF-----------DS-------IVNDEVRYP------ 221
Query: 235 LRELSPSASRESISLISRLCSWNPHMR----PTAAEAL-EHPFFRSCHF 278
R L SRE+IS++ RL NP R AE + + PFFR ++
Sbjct: 222 -RFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-23
Identities = 69/212 (32%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVK-------CLRKMNNHPNIVK 53
GS+G V A K G+F AVK L+KK KE K L K HP +V
Sbjct: 6 GSFGKVLLAKHKADGKFYAVKVLQKKAI-----LKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 54 LRNLVKEHEDVFIVFEYMESDLL--KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
L + + ++ V +Y+ L L +ER +F E R ++ L Y+H
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLNI 117
Query: 112 FHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPE 169
+RDLKP N+L+ S+G + + D G+ KE I+ S + + T Y APEV L + Y
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV-LRKQPYDRT 176
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKI 201
VD W +GA+++EML F +++A+ I
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 8e-23
Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 16/211 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V+ A D ++ E VA+KK+ +E +KEV+ L+K+ HPN ++ R
Sbjct: 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCY 84
Query: 59 KEHEDVFIVFEYM---ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
++V EY SDLL++ K + E E+ + QGL Y+H HRD
Sbjct: 85 LREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 116 LKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE--IYGPEVDM 172
+K N+L+S+ G++K+GD G + P +V T ++ APEV+L + Y +VD+
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQ 203
W++G E+ + N+ +Y I Q
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-22
Identities = 82/284 (28%), Positives = 131/284 (46%), Gaps = 48/284 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V+ A + + E VAVKK+ +E +KEVK L+++ HPN ++ +
Sbjct: 32 GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCY 90
Query: 59 KEHEDVFIVFEYM---ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+ ++V EY SDLL++ K + E E+ + QGL Y+H HRD
Sbjct: 91 LKEHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 116 LKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE--IYGPEVDM 172
+K N+L+++ G +K+ D G + P +V T ++ APEV+L + Y +VD+
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDV 203
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
W++G E+ + N+ +Y I Q SPT L SN +W G
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSPT---------LQSN-EWTDSFRGF 252
Query: 233 VN--LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
V+ L+++ P RP +AE L H F R
Sbjct: 253 VDYCLQKI-------------------PQERPASAELLRHDFVR 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 84/286 (29%), Positives = 135/286 (47%), Gaps = 46/286 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDE-SRNLKEVKCLRKMNNHPNIVKLRNLV 58
G++G V +K +G + A+K L+K+ I + DE + + E + L+ HP + L+
Sbjct: 6 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALKYAF 64
Query: 59 KEHEDVFIVFEYMESDLL--KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ H+ + V EY L L +ER F+E+ R ++ L Y+H + +RD+
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 117 KPSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
K NL++ K G IKI D G+ KE I + T Y APEVL ++ YG VD W
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWG 180
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G +M+EM+ R+ F ++ ++++ +L + +FP
Sbjct: 181 LGVVMYEMMCGRLPFYNQDH-ERLF------------------ELILMEEIRFP------ 215
Query: 235 LRELSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRS 275
R LSP A SL++ L +P R A E +EH FF S
Sbjct: 216 -RTLSPEAK----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 2e-22
Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 45/287 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKK--LKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G+ V+ A+ + E VA+K+ L+K S+DE R KEV+ + NHPN+VK
Sbjct: 12 GATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELR--KEVQAM-SQCNHPNVVKYYTSF 68
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQN-FSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+++++V Y+ LL +MK + E + + +V +GL Y+H G HRD+
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDI 128
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCT-----DYVTTRWYRAPEVLLLSEIYGPEV 170
K N+L+ G +KI D G+ + T +V T + APEV+ Y +
Sbjct: 129 KAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKA 188
Query: 171 DMWAMGAIMFEMLS----FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226
D+W+ G E+ + + P K + Q P L + D+K
Sbjct: 189 DIWSFGITAIELATGAAPYSKYPPMK----VLMLTLQ--NDPP--------SLETGADYK 234
Query: 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
S+ +IS +P RPTA E L+H FF
Sbjct: 235 --------------KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-22
Identities = 90/284 (31%), Positives = 134/284 (47%), Gaps = 46/284 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDE-SRNLKEVKCLRKMNNHPNIVKLRNLV 58
G++G V +K SG++ A+K LKK+ I + DE + L E + L K HP + L+
Sbjct: 6 GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVL-KNTRHPFLTSLKYSF 64
Query: 59 KEHEDVFIVFEYMESDLL--KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + + V EY+ L L +ER FSED R ++ L Y+H +RDL
Sbjct: 65 QTKDRLCFVMEYVNGGELFFHLSRERV---FSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 117 KPSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
K NL++ K G IKI D G+ KE I + + T Y APEVL ++ YG VD W
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND-YGRAVDWWG 180
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G +M+EM+ R+ F ++ ++++ +L D KFP
Sbjct: 181 LGVVMYEMMCGRLPFYNQDH-EKLF------------------ELILMEDIKFP------ 215
Query: 235 LRELSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFF 273
R LS A SL+S L +P+ R A E + H FF
Sbjct: 216 -RTLSADAK----SLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-22
Identities = 65/189 (34%), Positives = 94/189 (49%), Gaps = 10/189 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V A K G F AVK L+KK I E + + E L K HP +V L
Sbjct: 6 GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF 65
Query: 59 KEHEDVFIVFEYMESD--LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ E ++ V +Y+ L +ER F E R +V + Y+H +RDL
Sbjct: 66 QTAEKLYFVLDYVNGGELFFHLQRERC---FLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 117 KPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
KP N+L+ S+G + + D G+ KE ++ + + T Y APEV L E Y VD W
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV-LRKEPYDRTVDWWC 181
Query: 175 MGAIMFEML 183
+GA+++EML
Sbjct: 182 LGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-22
Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 8/206 (3%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESR--NLKEVKCLRKMNNHPNIVKLRNLV 58
GS+G VF A K + +F A+K LKK + +D+ + E + L HP + L
Sbjct: 6 GSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF 65
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ E++F V EY+ L + ++ F ++ GL ++H +G +RDLK
Sbjct: 66 QTKENLFFVMEYLNGGDL-MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKL 124
Query: 119 SNLLVSK-GVIKIGDLGMVKE--IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N+L+ G IKI D GM KE + + CT + T Y APE+ LL + Y VD W+
Sbjct: 125 DNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEI-LLGQKYNTSVDWWSF 182
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKI 201
G +++EML + F G + + I
Sbjct: 183 GVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 5e-22
Identities = 75/287 (26%), Positives = 117/287 (40%), Gaps = 37/287 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD--ESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G +G+V K +G+ A KKL KK E L E K L K+++ IV L
Sbjct: 4 GGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLAYAF 62
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQN-FSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ +D+ +V M LK G+ F E Q+ GL ++H++ +RDLK
Sbjct: 63 ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLK 122
Query: 118 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
P N+L+ G ++I DLG+ E+ T Y APEV L E+Y VD +A+G
Sbjct: 123 PENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEV-LQGEVYDFSVDWFALG 181
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
++EM++ R F + + ++ +
Sbjct: 182 CTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV-------------------------- 215
Query: 237 ELSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRSCHF 278
E S E+ L L +P R +A E EHP F+ ++
Sbjct: 216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 6e-22
Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 68/299 (22%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVK------ 53
G+YG V++A KK+G+ VA+K + DE +K E LRK +NHPNI
Sbjct: 17 GTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73
Query: 54 LRNLVKEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ 109
+N + +++V E +DL+K ++++ G+ E+ + + + +GL Y+H
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHEN 132
Query: 110 GYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLLSE--- 164
HRD+K N LL +K+ D G+ ++DS+L + ++ T ++ APEV+ E
Sbjct: 133 KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPD 192
Query: 165 -IYGPEVDMWAMG--AI--------MFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSW 213
Y D+W++G AI + +M R LF ++ +P
Sbjct: 193 ASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF-------------KIPRNPPP--- 236
Query: 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
L S +W S++ IS N RP E LEHPF
Sbjct: 237 ----TLKSPENW-----------------SKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 8e-22
Identities = 88/287 (30%), Positives = 135/287 (47%), Gaps = 47/287 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDE-SRNLKEVKCLRKMNNHPNIVKLRNLV 58
G++G V +K +G + A+K LKK+ I + DE + L E + L+ + HP + L+
Sbjct: 6 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALKYSF 64
Query: 59 KEHEDVFIVFEYMESDLL--KLMKERAGQNFSEDEVRNLCFQVFQGLHYMH-RQGYFHRD 115
+ H+ + V EY L L +ER FSED R ++ L Y+H + +RD
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 116 LKPSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMW 173
LK NL++ K G IKI D G+ KE I + T Y APEVL ++ YG VD W
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWW 180
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
+G +M+EM+ R+ F ++ ++++ +L + +FP
Sbjct: 181 GLGVVMYEMMCGRLPFYNQDH-EKLF------------------ELILMEEIRFP----- 216
Query: 234 NLRELSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRS 275
R LSP A SL+S L +P R A E ++H FF
Sbjct: 217 --RTLSPEAK----SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 9e-22
Identities = 64/188 (34%), Positives = 103/188 (54%), Gaps = 13/188 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL--KEVKCLRKMNNHPNIVKLRNLV 58
GS G V A +K +G+ VAVKK+ + + R L EV +R + H N+V + N
Sbjct: 33 GSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYH-HENVVDMYNSY 88
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+++++V E++E L + N E+++ +C V + L Y+H QG HRD+K
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMN--EEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 119 -SNLLVSKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEI-YGPEVDMWAM 175
S LL S G IK+ D G ++ +P V T ++ APEV +S + YG EVD+W++
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEV--ISRLPYGTEVDIWSL 204
Query: 176 GAIMFEML 183
G ++ EM+
Sbjct: 205 GIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-21
Identities = 79/284 (27%), Positives = 126/284 (44%), Gaps = 39/284 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V A K + EF A+K LKK + D+ + E + L HP + L
Sbjct: 6 GSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF 65
Query: 59 KEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ E +F V EY+ DL+ ++ F E R ++ GL ++H++G +RDLK
Sbjct: 66 QTKEHLFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLK 123
Query: 118 PSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N+L+ K G IKI D GM KE ++ + + T Y APE+ L + Y VD W+
Sbjct: 124 LDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEI-LKGQKYNESVDWWSF 182
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G +++EML + F G++ + I + FP+
Sbjct: 183 GVLLYEMLIGQSPFHGEDEDELFDSILN------DRPH-------------FPR------ 217
Query: 236 RELSPSASRESISLISRLCSWNPHMR-PTAAEALEHPFFRSCHF 278
S+E+ +S+L +P R + +HPFFR +
Sbjct: 218 -----WISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-21
Identities = 78/284 (27%), Positives = 132/284 (46%), Gaps = 43/284 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V A K + E A+K LKK + D+ + E + L P + +L +
Sbjct: 11 GSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 70
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ + ++ V EY+ L ++ G+ F E ++ GL ++H +G +RDLK
Sbjct: 71 QTMDRLYFVMEYVNGGDLMYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKL 129
Query: 119 SNLLV-SKGVIKIGDLGMVKE--IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N+++ ++G IKI D GM KE T + T Y APE++ + YG VD WA
Sbjct: 130 DNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTPDYIAPEIIA-YQPYGKSVDWWAF 187
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G +++EML+ + F G++ D++++ S E + +P+
Sbjct: 188 GVLLYEMLAGQPPFDGEDE-DELFQ------SIMEHN------------VSYPK------ 222
Query: 236 RELSPSASRESISLISRLCSWNPHMR----PTAAEAL-EHPFFR 274
S S+E++S+ L + +P R PT + EH FFR
Sbjct: 223 -----SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-21
Identities = 75/278 (26%), Positives = 120/278 (43%), Gaps = 35/278 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V+ A D + +A+K++ ++ + L E L H NIV+ E
Sbjct: 19 GTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE 76
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQ-NFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ I E + L L++ + G +E + Q+ +GL Y+H HRD+K
Sbjct: 77 NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKG 136
Query: 119 SNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVT-TRWYRAPEVLLLSEI-YGPEVDMWA 174
N+LV+ GV+KI D G K + PCT+ T T Y APEV+ YG D+W+
Sbjct: 137 DNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWS 196
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G + EM + + F +G P + +G+ P
Sbjct: 197 LGCTIVEMATGKPPF-------------IELGEPQAAMFKVGMFK------IHP------ 231
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
E+ S S E+ + I R +P R +A + L+ PF
Sbjct: 232 --EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-21
Identities = 78/282 (27%), Positives = 133/282 (47%), Gaps = 42/282 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVK--KLKKKIFSLDESRNL--KEVKCLRKMNNHPNIVKLRN 56
GS G V A +K SG VAVK L+K+ + R L EV +R H N+V++
Sbjct: 32 GSTGIVCIAREKHSGRQVAVKMMDLRKQ-----QRRELLFNEVVIMRDYQ-HQNVVEMYK 85
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
E+++++ E+++ L + + +E+++ +C V Q L Y+H QG HRD+
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQGVIHRDI 143
Query: 117 KPSNLLVS-KGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
K ++L++ G +K+ D G +I +P V T ++ APEV+ + YG EVD+W+
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWS 202
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G ++ EM+ P S + + ++ SP P++ N
Sbjct: 203 LGIMVIEMVDGE---PPYFSDSPVQAMKRLRDSPP------------------PKLK--N 239
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276
++SP + R+ + P R TA E L+HPF
Sbjct: 240 AHKISPVLR----DFLERMLTREPQERATAQELLDHPFLLQT 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 6e-21
Identities = 51/173 (29%), Positives = 94/173 (54%), Gaps = 13/173 (7%)
Query: 18 VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD-LL 76
VA+K +++ S D+ ++E K + K++ HPN+V+L + + +FIV EYM + LL
Sbjct: 31 VAIKMIREGAMSEDDF--IEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87
Query: 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGM 135
++ER G+ + + ++C V + + Y+ G+ HRDL N LV V+K+ D G+
Sbjct: 88 NYLRERKGK-LGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGL 146
Query: 136 VKEI-DSSLPCTDYVTTRW---YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS 184
+ + D + T++ + PEV S + + D+W+ G +M+E+ S
Sbjct: 147 ARYVLDDQYTSS--QGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-21
Identities = 87/326 (26%), Positives = 134/326 (41%), Gaps = 89/326 (27%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKM---NNHPNIVKLRNL 57
G++G+V K +G A+KKL+K + E + V+ R + ++P +VKL
Sbjct: 12 GAFGEVRLVQKKDTGHIYAMKKLRKS--EMLEKEQVAHVRAERDILAEADNPWVVKLYYS 69
Query: 58 VKEHEDVFIVFEYMES-DLLK-LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
++ ++++ EY+ D++ LMK+ F+E+E R + + +H+ GY HRD
Sbjct: 70 FQDENYLYLIMEYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLGYIHRD 126
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDY-------------------------- 148
+KP NLL+ +KG IK+ D G+ + S Y
Sbjct: 127 IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAE 186
Query: 149 -------------VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSA 195
V T Y APEV L + Y E D W++G IM+EML + +P S
Sbjct: 187 TWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEML---VGYPPFCS- 241
Query: 196 DQIYKICQVIGSPTEDSWPLGIQLASNLDWK----FPQMGGVNLRELSPSASRESISLIS 251
D + + I ++WK FP V L S E+ LI
Sbjct: 242 DNPQETYRKI-----------------INWKETLQFPD--EVPL-------SPEAKDLIK 275
Query: 252 RLCSWNPHMR---PTAAEALEHPFFR 274
RLC R E HPFF+
Sbjct: 276 RLCC-EAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 9e-21
Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 1 GSYGDVFQAL----DKKSGEF-VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G+V++ L D + E VAVK L + DES L E + K N H NIV+L
Sbjct: 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN-HQNIVRLI 75
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKE---RAGQNFS--EDEVRNLCFQVFQGLHYMHRQ 109
+ E FI+ E M DL ++E R + S ++ V +G Y+
Sbjct: 76 GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN 135
Query: 110 GYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSSLPCTDY--------VTTRWYRAP 157
+ HRD+ N LL KG V KI D GM ++I + Y + +W P
Sbjct: 136 HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA----SYYRKGGRAMLPIKWM-PP 190
Query: 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGK 192
E L I+ + D+W+ G +++E+ S + +PG+
Sbjct: 191 EA-FLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 9e-21
Identities = 55/191 (28%), Positives = 96/191 (50%), Gaps = 11/191 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++GDV++ + K + E VAVK + + + + L+E + L K +HPNIVKL + +
Sbjct: 6 GNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIGVCVQ 63
Query: 61 HEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ ++IV E + LL ++++ + + ++ + G+ Y+ + HRDL
Sbjct: 64 KQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAAGMEYLESKNCIHRDLAAR 122
Query: 120 NLLVS-KGVIKIGDLGMVKE----IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
N LV V+KI D GM +E I + + +W APE L Y E D+W+
Sbjct: 123 NCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEALNYGR-YTSESDVWS 180
Query: 175 MGAIMFEMLSF 185
G +++E S
Sbjct: 181 YGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 66/209 (31%), Positives = 110/209 (52%), Gaps = 17/209 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESR--NLKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V A K + E A+K LKK + D+ + E + L + P + +L +
Sbjct: 11 GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF 70
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ + ++ V EY+ L ++ G+ F E + ++ GL ++HR+G +RDLK
Sbjct: 71 QTVDRLYFVMEYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKL 129
Query: 119 SNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------YRAPEVLLLSEIYGPEVD 171
N+++ S+G IKI D GM KE D VTTR Y APE++ + YG VD
Sbjct: 130 DNVMLDSEGHIKIADFGMCKE-----HMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVD 183
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYK 200
WA G +++EML+ + F G++ D++++
Sbjct: 184 WWAYGVLLYEMLAGQPPFDGEDE-DELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-20
Identities = 68/223 (30%), Positives = 111/223 (49%), Gaps = 23/223 (10%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-----LKEVKCLRKMNNHPNIVKLR 55
GS+G V+ A D ++ E VA+KK+ +S +S +KEVK L+++ HPN ++ +
Sbjct: 36 GSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYK 91
Query: 56 NLVKEHEDVFIVFEYM---ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
++V EY SDLL++ K + E E+ + QGL Y+H
Sbjct: 92 GCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 113 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE--IYGPE 169
HRD+K N+L+++ G +K+ D G P +V T ++ APEV+L + Y +
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSASIAS---PANSFVGTPYWMAPEVILAMDEGQYDGK 204
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDS 212
VD+W++G E+ + N+ +Y I Q SPT S
Sbjct: 205 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQS 246
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-20
Identities = 73/283 (25%), Positives = 128/283 (45%), Gaps = 39/283 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
G++G V++A +K++G A K ++ K S +E + + E++ L N HP IVKL
Sbjct: 23 GAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCN-HPYIVKLLGAFY 79
Query: 60 EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
++I+ E+ + + + +E +++ +C Q+ + L Y+H HRDLK
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAG 139
Query: 120 NLLVS-KGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLLSEI----YGPEVDMW 173
N+L++ G IK+ D G+ + +L D ++ T ++ APEV++ + Y + D+W
Sbjct: 140 NVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 199
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
++G + EM N + KI + S P +
Sbjct: 200 SLGITLIEMAQIEPPHHELNPMRVLLKIAK--------SEPPTL---------------- 235
Query: 234 NLRELSPSA-SRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
PS S E + +P RP+AA+ LEHPF S
Sbjct: 236 ----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-20
Identities = 87/292 (29%), Positives = 135/292 (46%), Gaps = 48/292 (16%)
Query: 1 GSYGDVF---QALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRN 56
GS+G VF + +G+ A+K LKK + D R E L ++N HP IVKL
Sbjct: 7 GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVKLHY 65
Query: 57 LVKEHEDVFIVFEYMES-DLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ ++++ +++ DL +L KE F+E++V+ ++ L ++H G +R
Sbjct: 66 AFQTEGKLYLILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLHSLGIIYR 122
Query: 115 DLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
DLKP N+L+ +G IK+ D G+ KE ID + T Y APEV + + D
Sbjct: 123 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV-VNRRGHTQSADW 181
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
W+ G +MFEML+ + F GK+ + + I + LG+ PQ
Sbjct: 182 WSFGVLMFEMLTGSLPFQGKDRKETMTMILKA---------KLGM----------PQF-- 220
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMR----PTAAEALE-HPFFRSCHFV 279
LSP A SL+ L NP R P E ++ HPFF + +
Sbjct: 221 -----LSPEAQ----SLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-20
Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 12/211 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL--KEVKCLRKMNNHPNIVKLRNLV 58
GSY V KK+ + A+K +KK++ DE + E + +++P +V L +
Sbjct: 6 GSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF 65
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ +F+V EY+ L +R + E+ R ++ L+++H +G +RDLK
Sbjct: 66 QTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKL 124
Query: 119 SNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+L+ G IK+ D GM KE + + + T Y APE+L E YG VD WA+G
Sbjct: 125 DNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR-GEEYGFSVDWWALG 183
Query: 177 AIMFEMLSFRILF------PGKNSADQIYKI 201
+MFEM++ R F P N+ D ++++
Sbjct: 184 VLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-20
Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 11/193 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +GDV + G+ VAVK LK + L E + + HPN+V+L +V +
Sbjct: 17 GEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAF--LAEASVMTTLR-HPNLVQLLGVVLQ 71
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
++IV EYM L+ ++ R + + V +G+ Y+ + + HRDL
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAAR 131
Query: 120 NLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAI 178
N+LVS+ V K+ D G+ KE + + +W APE L + + + D+W+ G +
Sbjct: 132 NVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVKW-TAPEALREKK-FSTKSDVWSFGIL 188
Query: 179 MFEMLSF-RILFP 190
++E+ SF R+ +P
Sbjct: 189 LWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-20
Identities = 64/189 (33%), Positives = 96/189 (50%), Gaps = 10/189 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V A K G+ AVK L+KKI ++ + E L K HP +V L
Sbjct: 6 GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF 65
Query: 59 KEHEDVFIVFEYMESDLL--KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ E ++ V +++ L L +ER+ F E R ++ L Y+H +RDL
Sbjct: 66 QTTEKLYFVLDFVNGGELFFHLQRERS---FPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 117 KPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
KP N+L+ S+G + + D G+ KE I S T + T Y APEV + + Y VD W
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV-IRKQPYDNTVDWWC 181
Query: 175 MGAIMFEML 183
+GA+++EML
Sbjct: 182 LGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-20
Identities = 74/289 (25%), Positives = 124/289 (42%), Gaps = 58/289 (20%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVK---CLRKMNNHPNIVKLRNL 57
G+YGDV++A + +GE A+K +K L+ + V+ + K H NIV
Sbjct: 20 GTYGDVYKARNVNTGELAAIKVIK-----LEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ ++I E+ L+ + G SE ++ + + QGL+Y+H +G HRD+K
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVTGP-LSESQIAYVSRETLQGLYYLHSKGKMHRDIK 133
Query: 118 PSNLLVS-KGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEI--YGPEVDMW 173
+N+L++ G +K+ D G+ +I +++ ++ T ++ APEV + Y D+W
Sbjct: 134 GANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIW 193
Query: 174 AMG--AI--------MFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL 223
A+G AI MF++ R LF S Q K L +
Sbjct: 194 AVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK------------------LKDKM 235
Query: 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
W S + + NP RPTA + L+HPF
Sbjct: 236 KW-----------------SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-20
Identities = 55/174 (31%), Positives = 98/174 (56%), Gaps = 15/174 (8%)
Query: 18 VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD-LL 76
VA+K + + ++ E ++E K + K++ HP +V+L + + + ++IV E+ME+ LL
Sbjct: 31 VAIKAINEG--AMSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87
Query: 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGM 135
+++R G+ S+D + ++C V +G+ Y+ R + HRDL N LVS GV+K+ D GM
Sbjct: 88 NYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGM 146
Query: 136 VK-----EIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS 184
+ E SS +W PEV S+ Y + D+W+ G +M+E+ +
Sbjct: 147 TRYVLDDEYTSS--SGAKFPVKW-SPPEVFNFSK-YSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-20
Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 41/282 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKC---LRKMNNHPNIVKLRNL 57
G++G+V+ D +G +AVK++ S + S+ + ++C L K H IV+
Sbjct: 13 GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72
Query: 58 VKEHED--VFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+++ E+ + I EYM +K + G +E+ R Q+ QG+ Y+H HRD
Sbjct: 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLHSNMIVHRD 131
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKEID----SSLPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
+K +N+L S G +K+GD G K I S T ++ +PEV + E YG +
Sbjct: 132 IKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV-ISGEGYGRKA 190
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
D+W++ + EML+ + + + I+KI PT+ P G+
Sbjct: 191 DVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTKPMLPDGVS------------ 235
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
A R+ + ++ RPTA L HPF
Sbjct: 236 ----------DACRD---FLKQIFVEE-KRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-20
Identities = 63/214 (29%), Positives = 115/214 (53%), Gaps = 15/214 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN----LKEVKCLRKMNNHPNIVKLRN 56
G + +V++A G VA+KK++ IF L +++ +KE+ L+++N HPN++K
Sbjct: 13 GQFSEVYRATCLLDGVPVALKKVQ--IFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYA 69
Query: 57 LVKEHEDVFIVFEYMES-DLLKLMKERAGQN--FSEDEVRNLCFQVFQGLHYMHRQGYFH 113
E ++ IV E ++ DL +++K Q E V Q+ L +MH + H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH 129
Query: 114 RDLKPSNLLVS-KGVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
RD+KP+N+ ++ GV+K+GDLG+ + S + V T +Y +PE + Y + D
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSD 188
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVI 205
+W++G +++EM + + F G +Y +C+ I
Sbjct: 189 IWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 8e-20
Identities = 83/316 (26%), Positives = 121/316 (38%), Gaps = 74/316 (23%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-----LKEVKCLRKMNNHPNIVKLR 55
G G VF K +G+ A+K L KK RN L E + L ++ HP + L
Sbjct: 12 GDVGRVFLVRLKGTGKLFALKVLDKK---EMIKRNKVKRVLTEQEILATLD-HPFLPTLY 67
Query: 56 NLVKEHEDVFIVFEY-MESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ + +V +Y +L +L++ + G+ SE+ R +V L Y+H G +R
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYR 127
Query: 115 DLKPSNLL------------------------VSKGVIKIGDLGMVKEI-------DSSL 143
DLKP N+L VSK + K V I + S
Sbjct: 128 DLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF 187
Query: 144 PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQ 203
+V T Y APEV + + +G VD W +G +++EML F G N + I
Sbjct: 188 RSNSFVGTEEYIAPEV-ISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNI-- 244
Query: 204 VIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMR-- 261
L + FP V S + LI +L +P R
Sbjct: 245 ---------------LKKEV--TFPGSPPV---------SSSARDLIRKLLVKDPSKRLG 278
Query: 262 --PTAAEALEHPFFRS 275
AAE +HPFFR
Sbjct: 279 SKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 8e-20
Identities = 72/283 (25%), Positives = 119/283 (42%), Gaps = 43/283 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK----EVKCLRKMNNHPNIVKLRN 56
G++G V++A K++G F A K I ++ L+ E+ L + HPNIV L
Sbjct: 16 GAFGKVYKAQHKETGLFAAAK-----IIQIESEEELEDFMVEIDILSECK-HPNIVGLYE 69
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
++I+ E+ + L + + +E ++R +C Q+ + L+++H HRDL
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDL 129
Query: 117 KPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLL----SEIYGPEV 170
K N LL G +K+ D G+ + S+L D ++ T ++ APEV+ Y +
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA 189
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
D+W++G + E+ N + KI PT L W
Sbjct: 190 DIWSLGITLIELAQMEPPHHELNPMRVLLKI-LKSEPPT---------LDQPSKW----- 234
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
S + +P RPTAAE L+HPF
Sbjct: 235 ------------SSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-19
Identities = 62/236 (26%), Positives = 118/236 (50%), Gaps = 20/236 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V+ S + VAVK LK S+ E L K H +V+L +V +
Sbjct: 17 GQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 61 HEDVFIVFEYM-ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E ++I+ EYM + LL +K G ++ + Q+ +G+ Y+ R+ Y HRDL+ +
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAA 132
Query: 120 NLLVSKGVI-KIGDLGMVKEIDSSLPCTDYVTTRW-------YRAPEVLLLSEIYGPEVD 171
N+LVS+ ++ KI D G+ + I+ + T R + APE + + + D
Sbjct: 133 NVLVSESLMCKIADFGLARVIED-----NEYTAREGAKFPIKWTAPEAINFGS-FTIKSD 186
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226
+W+ G +++E++++ +I +PG +++D + + + P ++ P + WK
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWK 242
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-19
Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 28/212 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V+ + + VAVK LK ++ L+E + ++K+ H +V+L + E
Sbjct: 17 GQFGEVWMGTWNGTTK-VAVKTLKPG--TMSPEAFLQEAQIMKKLR-HDKLVQLYAVCSE 72
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E ++IV EYM LL +K G+ ++ ++ Q+ +G+ Y+ + Y HRDL
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAAR 132
Query: 120 NLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTTR--------WYRAPEVLLLSEIYGP-- 168
N+LV + V KI D G+ + I+ D T R W APE YG
Sbjct: 133 NILVGENLVCKIADFGLARLIED-----DEYTAREGAKFPIKW-TAPEAAN----YGRFT 182
Query: 169 -EVDMWAMGAIMFEMLSF-RILFPGKNSADQI 198
+ D+W+ G ++ E++++ R+ +PG + + +
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVPYPGMTNREVL 214
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-19
Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 17/184 (9%)
Query: 13 KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHED--VFIVFEY 70
+GE VAVK LK + + KE++ LR + H NIVK + + E + ++ E+
Sbjct: 31 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEF 89
Query: 71 MESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIK 129
+ S LK R + + Q+ +G+ Y+ + Y HRDL N+LV S+ +K
Sbjct: 90 LPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK 149
Query: 130 IGDLGMVKEIDSSLPCTDYVTTR--------WYRAPEVLLLSEIYGPEVDMWAMGAIMFE 181
IGD G+ K I++ +Y T + WY APE L+ S+ Y D+W+ G ++E
Sbjct: 150 IGDFGLTKAIETD---KEYYTVKDDLDSPVFWY-APECLIQSKFYIAS-DVWSFGVTLYE 204
Query: 182 MLSF 185
+L++
Sbjct: 205 LLTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-19
Identities = 57/188 (30%), Positives = 97/188 (51%), Gaps = 7/188 (3%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE--SRNLKEVKCLRK--MNNHPNIVKLRN 56
G++G V+Q K + A+K L KK + + + E L + ++ P IV L+
Sbjct: 4 GTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKF 63
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ D+++V +YM L ++ G+ FSED + ++ L ++H+ +RDL
Sbjct: 64 SFQTDSDLYLVTDYMSGGELFWHLQKEGR-FSEDRAKFYIAELVLALEHLHKYDIVYRDL 122
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLLSEIYGPEVDMWA 174
KP N+L+ + G I + D G+ K + T+ + T Y APEVLL + Y VD W+
Sbjct: 123 KPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWS 182
Query: 175 MGAIMFEM 182
+G ++FEM
Sbjct: 183 LGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-19
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 17/196 (8%)
Query: 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +G+V + K G+ VA+K LK L E + + + HPNI++L +
Sbjct: 15 GEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPNIIRLEGV 73
Query: 58 VKEHEDVFIVFEYMESDLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
V + V I+ EYME+ L K ++E G+ F+ ++ + + G+ Y+ Y HRDL
Sbjct: 74 VTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLSEMNYVHRDL 132
Query: 117 KPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPEVLLLSEIYGPE 169
N+LV+ V K+ D G+ + ++ S Y T RW APE + +
Sbjct: 133 AARNILVNSNLVCKVSDFGLSRRLEDSEA--TYTTKGGKIPIRW-TAPEAIAY-RKFTSA 188
Query: 170 VDMWAMGAIMFEMLSF 185
D+W+ G +M+E++S+
Sbjct: 189 SDVWSFGIVMWEVMSY 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-19
Identities = 70/282 (24%), Positives = 126/282 (44%), Gaps = 46/282 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLK-----KKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G+ G V+ A+D +G+ VA+K++ KK ++E ++E N HPNIV
Sbjct: 30 GASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE-------NKHPNIVNYL 82
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ +++++V EY+ L ++ E E ++ +C + Q L ++H HR
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHR 139
Query: 115 DLKPSNLLVS-KGVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
D+K N+L+ G +K+ D G +I + V T ++ APEV+ YGP+VD+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDI 198
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
W++G + EM+ + +N +Y I A+N +
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLI------------------ATNGTPELQN--- 237
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
E + R+ ++R + R +A E L+HPF +
Sbjct: 238 ---PEKLSAIFRD---FLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-19
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLK-KKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G V D+ S + A+K + ++ L + +++ K + K +HP I++L
Sbjct: 12 GTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ ++++ EY+ +L + R FS ++ L Y+H + +RDLKP
Sbjct: 72 DQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKP 129
Query: 119 SNLLVSK-GVIKIGDLGMVKE-IDSSLP-CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N+L+ K G IK+ D G K+ D + C T Y APEV + S+ + VD WA+
Sbjct: 130 ENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEV-IQSKGHNKAVDWWAL 184
Query: 176 GAIMFEMLSFRILFPGKNSADQIYK 200
G +++EML F N IY+
Sbjct: 185 GILIYEMLVGYPPFFDDNP-FGIYE 208
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-19
Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 37/287 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G +G+V + +G+ A KKL+KK E+ L E + L K+N+ +V L
Sbjct: 11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAY 69
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQ-NFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ + + +V M LK G F E+ ++ GL +HR+ +RDLK
Sbjct: 70 ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLK 129
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
P N+L+ G I+I DLG+ EI V T Y APEV + +E Y D W +G
Sbjct: 130 PENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEV-VKNERYTFSPDWWGLG 188
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+++EM+ + F + + ++ + + E
Sbjct: 189 CLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE-------------------------- 222
Query: 237 ELSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRSCHF 278
E S S + S+ +L + +P R A E HPFFR+ +F
Sbjct: 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-19
Identities = 78/301 (25%), Positives = 131/301 (43%), Gaps = 49/301 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS G VF A + V V K+ +K +L E+ L+ V NHP+++++++ +
Sbjct: 77 GSEGRVFVATKPGQPDPV-VLKIGQKGTTLIEAMLLQNV-------NHPSVIRMKDTLVS 128
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+V + SDL + +R+ D+ + Q+ +GL Y+H Q HRD+K N
Sbjct: 129 GAITCMVLPHYSSDLYTYLTKRSRP-LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTEN 187
Query: 121 LLV-SKGVIKIGDLG-----MVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
+ + + IGDLG +V L T V T APEVL + Y + D+W+
Sbjct: 188 IFINDVDQVCIGDLGAAQFPVVAPAFLGLAGT--VET---NAPEVLARDK-YNSKADIWS 241
Query: 175 MGAIMFEMLSF-RILF---------PGKNSADQIYKICQVIG-SPTEDSWPLGIQLASNL 223
G ++FEML++ +F K+ + KI + P E G +L
Sbjct: 242 AGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGF 301
Query: 224 ----------DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
++P VNL + L+ ++ +++ MRP+A E L +P F
Sbjct: 302 IEYASLERQPYTRYPCFQRVNLPI-------DGEFLVHKMLTFDAAMRPSAEEILNYPMF 354
Query: 274 R 274
Sbjct: 355 A 355
|
Length = 357 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 10/202 (4%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V A K +F AVK L+KK +E + E L K HP +V L
Sbjct: 6 GSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 65
Query: 59 KEHEDVFIVFEYMESDLL--KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + ++ V +Y+ L L +ER F E R ++ L Y+H +RDL
Sbjct: 66 QTADKLYFVLDYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 117 KPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
KP N+L+ S+G I + D G+ KE I+ + + + T Y APEV L + Y VD W
Sbjct: 123 KPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV-LHKQPYDRTVDWWC 181
Query: 175 MGAIMFEMLSFRILFPGKNSAD 196
+GA+++EML F +N+A+
Sbjct: 182 LGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-19
Identities = 57/189 (30%), Positives = 98/189 (51%), Gaps = 14/189 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
GS+G V A K +GE+ A+K LKK+ I + + +++ + K + +HP IV + +
Sbjct: 29 GSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88
Query: 60 EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ V+ + E++ L +AG+ F D + ++ Y+H + +RDLKP
Sbjct: 89 DENRVYFLLEFVVGGELFTHLRKAGR-FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPE 147
Query: 120 NLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW----YRAPEVLLLSEIYGPEVDMWA 174
NLL+ +KG +K+ D G K++ D T Y APEV + S+ +G VD W
Sbjct: 148 NLLLDNKGHVKVTDFGFAKKV------PDRTFTLCGTPEYLAPEV-IQSKGHGKAVDWWT 200
Query: 175 MGAIMFEML 183
MG +++E +
Sbjct: 201 MGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-19
Identities = 74/282 (26%), Positives = 128/282 (45%), Gaps = 46/282 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLK-----KKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G+ G VF A+D +G+ VA+K++ KK ++E +KE+K +PNIV
Sbjct: 30 GASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK-------NPNIVNFL 82
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ +++F+V EY+ L ++ E E ++ +C + Q L ++H HR
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTETC---MDEAQIAAVCRECLQALEFLHANQVIHR 139
Query: 115 DLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEIYGPEVDM 172
D+K N+L+ G +K+ D G +I + V T ++ APEV + + YGP+VD+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VTRKAYGPKVDI 198
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
W++G + EM+ + +N +Y I G+P
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQ--------------------- 236
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
N +LSP ++R + R +A E L+HPF +
Sbjct: 237 -NPEKLSPIFR----DFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-19
Identities = 58/213 (27%), Positives = 111/213 (52%), Gaps = 20/213 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V++ L + VAVK LK ++D L E + ++K+ HP +++L +
Sbjct: 17 GQFGEVWEGLWNNTTP-VAVKTLKPG--TMDPKDFLAEAQIMKKLR-HPKLIQLYAVCTL 72
Query: 61 HEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E ++IV E M+ LL+ ++ AG+ ++ ++ QV G+ Y+ Q Y HRDL
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAAR 132
Query: 120 NLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYGPEVD 171
N+LV + + K+ D G+ + I Y +W APE L + + + D
Sbjct: 133 NVLVGENNICKVADFGLARVIKED----IYEAREGAKFPIKW-TAPEAALYNR-FSIKSD 186
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKICQ 203
+W+ G ++ E++++ R+ +PG +A+ + ++ Q
Sbjct: 187 VWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ 219
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-19
Identities = 76/287 (26%), Positives = 124/287 (43%), Gaps = 37/287 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G +G+V + +G+ A K+L+KK ES L E + L K+N+ +V L
Sbjct: 11 GGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNLAYAY 69
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQ-NFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ + + +V M LK G F E+ ++ GL +HR+ +RDLK
Sbjct: 70 ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLK 129
Query: 118 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
P N+L+ G I+I DLG+ +I V T Y APEV L ++ Y D W +G
Sbjct: 130 PENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEV-LNNQRYTLSPDYWGLG 188
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+++EM+ + F G+ + ++ + + TE+ +
Sbjct: 189 CLIYEMIEGQSPFRGRKEKVKREEVDRRV-LETEEVY----------------------- 224
Query: 237 ELSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRSCHF 278
S S E+ S+ L + +P R A E HPFFR+ +F
Sbjct: 225 --SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 8e-19
Identities = 54/187 (28%), Positives = 95/187 (50%), Gaps = 8/187 (4%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLR--KMNNHPNIVKLRNLV 58
G+YG V++ +G VA+K + D S +EV L + + PNI K
Sbjct: 12 GAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY 71
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ ++I+ EY E + LMK +E + + +V L Y+H+ G HRD+K
Sbjct: 72 LKGPRLWIIMEYAEGGSVRTLMK---AGPIAEKYISVIIREVLVALKYIHKVGVIHRDIK 128
Query: 118 PSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
+N+LV+ G +K+ D G+ ++ S + +V T ++ APEV+ + Y + D+W++
Sbjct: 129 AANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSL 188
Query: 176 GAIMFEM 182
G ++EM
Sbjct: 189 GITIYEM 195
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-19
Identities = 75/290 (25%), Positives = 132/290 (45%), Gaps = 49/290 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN---LKEVKCLRKMNNHPNIVKLRNL 57
G+YG V++ L + +G +A+K+++ LDES+ + E+ L K + P IV
Sbjct: 12 GNYGSVYKVLHRPTGVTMAMKEIR---LELDESKFNQIIMELDILHKAVS-PYIVDFYGA 67
Query: 58 VKEHEDVFIVFEYMESDLL-KLMKE-RAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHR 114
V++ EYM++ L KL A + ED +R + + V +GL ++ + HR
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHR 127
Query: 115 DLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE---VLLLSEI--YGP 168
D+KP+N+LV G +K+ D G+ + +SL T+ + + Y APE ++ Y
Sbjct: 128 DVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-IGCQSYMAPERIKSGGPNQNPTYTV 186
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSAD---QIYKICQVIGSPTEDSWPLGIQLASNLDW 225
+ D+W++G + EM R +P + A+ Q+ I G P
Sbjct: 187 QSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPP---------------- 228
Query: 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
L S ++ +++ + P+ RPT A+ LEHP+
Sbjct: 229 -----------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 61/204 (29%), Positives = 106/204 (51%), Gaps = 7/204 (3%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESR--NLKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V A K + E A+K LKK + D+ + E + L P + +L +
Sbjct: 11 GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF 70
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ + ++ V EY+ L ++ G+ F E ++ GL ++H +G +RDLK
Sbjct: 71 QTMDRLYFVMEYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKL 129
Query: 119 SNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+++ S+G IKI D GM KE + + + T Y APE++ + YG VD WA G
Sbjct: 130 DNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFG 188
Query: 177 AIMFEMLSFRILFPGKNSADQIYK 200
+++EML+ + F G++ D++++
Sbjct: 189 VLLYEMLAGQAPFEGEDE-DELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-18
Identities = 59/224 (26%), Positives = 120/224 (53%), Gaps = 21/224 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V+ + VA+K LK+ S+ L E ++++ HP +V+L +V +
Sbjct: 17 GQFGEVWMGYYNGHTK-VAIKSLKQG--SMSPEAFLAEANLMKQLQ-HPRLVRLYAVVTQ 72
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E ++I+ EYME+ L+ +K G + +++ ++ Q+ +G+ ++ R+ Y HRDL+ +
Sbjct: 73 -EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAA 131
Query: 120 NLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVT-------TRWYRAPEVLLLSEIYGPEVD 171
N+LVS+ + KI D G+ + I+ + +Y +W APE + + + D
Sbjct: 132 NILVSETLCCKIADFGLARLIEDN----EYTAREGAKFPIKW-TAPEAINYG-TFTIKSD 185
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWP 214
+W+ G ++ E++++ RI +PG + + I + + P D+ P
Sbjct: 186 VWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCP 229
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-18
Identities = 62/193 (32%), Positives = 104/193 (53%), Gaps = 18/193 (9%)
Query: 1 GSYGDVFQALDKKSGEF-VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G +G V K G++ VA+K +K+ S DE ++E K + K++ H +V+L +
Sbjct: 15 GQFGVV--KYGKWRGQYDVAIKMIKEGSMSEDEF--IEEAKVMMKLS-HEKLVQLYGVCT 69
Query: 60 EHEDVFIVFEYMESD-LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ ++IV EYM + LL ++E G+ F ++ +C V +G+ Y+ + + HRDL
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLRE-HGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAA 128
Query: 119 SNLLV-SKGVIKIGDLGMVK-----EIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
N LV +G +K+ D G+ + E SS+ V RW PEVLL S+ + + D+
Sbjct: 129 RNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV--RW-SPPEVLLYSK-FSSKSDV 184
Query: 173 WAMGAIMFEMLSF 185
WA G +M+E+ S
Sbjct: 185 WAFGVLMWEVYSL 197
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-18
Identities = 71/283 (25%), Positives = 130/283 (45%), Gaps = 48/283 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLK-----KKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G+ G V+ A+D +G+ VA+K++ KK ++E ++E N +PNIV
Sbjct: 30 GASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE-------NKNPNIVNYL 82
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ +++++V EY+ L ++ E E ++ +C + Q L ++H HR
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALDFLHSNQVIHR 139
Query: 115 DLKPSNLLVS-KGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
D+K N+L+ G +K+ D G +I + S T V T ++ APEV + + YGP+VD
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEV-VTRKAYGPKVD 197
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231
+W++G + EM+ + +N +Y I G+P + + P+
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTP---------------ELQNPERL 241
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
R+ ++R + R +A E L+HPF +
Sbjct: 242 SAVFRD-----------FLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-18
Identities = 58/224 (25%), Positives = 114/224 (50%), Gaps = 21/224 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V+ A K + VAVK +K S+ L E ++ + H +VKL + V
Sbjct: 17 GQFGEVWMATYNKHTK-VAVKTMKPGSMSV--EAFLAEANVMKTLQ-HDKLVKL-HAVVT 71
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E ++I+ E+M LL +K G ++ + Q+ +G+ ++ ++ Y HRDL+ +
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA 131
Query: 120 NLLVSKGVI-KIGDLGMVKEIDSSLPCTDYVT-------TRWYRAPEVLLLSEIYGPEVD 171
N+LVS ++ KI D G+ + I+ + +Y +W APE + + + D
Sbjct: 132 NILVSASLVCKIADFGLARVIEDN----EYTAREGAKFPIKW-TAPEAINFGS-FTIKSD 185
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWP 214
+W+ G ++ E++++ RI +PG ++ + I + + P ++ P
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCP 229
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-18
Identities = 71/283 (25%), Positives = 121/283 (42%), Gaps = 38/283 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ G V++ KK+G +AVK++++ + R L ++ + K ++ P IVK
Sbjct: 26 GTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYM-HRQGYFHRDLKPS 119
DVFI E M + L KL+K R ED + + + + LHY+ + G HRD+KPS
Sbjct: 86 DSDVFICMELMSTCLDKLLK-RIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPS 144
Query: 120 NLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI---YGPEVDMWAM 175
N+L+ + G +K+ D G+ + S T Y APE + + Y D+W++
Sbjct: 145 NILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSL 204
Query: 176 GAIMFEMLSFRILFPGKNSA-DQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
G + E+ + + + + + + KI Q
Sbjct: 205 GISLVELATGQFPYKNCKTEFEVLTKILQ-----------------------------EE 235
Query: 235 LRELSPSA--SRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
L P+ S + S + + + RP E L+HPF R
Sbjct: 236 PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-18
Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 12/207 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL-KEVKCLRKMNNHPNIVKLRNLVK 59
G +G+V++ L K VA+K LK L + ++ KEV+ L+++ H +++ L +
Sbjct: 17 GYFGEVWEGLWKNRVR-VAIKILKSD--DLLKQQDFQKEVQALKRLR-HKHLISLFAVCS 72
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
E V+I+ E ME LL ++ GQ + ++ QV +G+ Y+ Q HRDL
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAA 132
Query: 119 SNLLVSKG-VIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N+LV + V K+ D G+ + I D L + +W APE + + D+W+
Sbjct: 133 RNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPEA-ASHGTFSTKSDVWSF 190
Query: 176 GAIMFEMLSF-RILFPGKNSADQIYKI 201
G +++EM ++ ++ +PG N+ + +I
Sbjct: 191 GILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 3e-18
Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLK-----KKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G+ G V+ A+D +G+ VA++++ KK ++E ++E N +PNIV
Sbjct: 31 GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-------NKNPNIVNYL 83
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ +++++V EY+ L ++ E E ++ +C + Q L ++H HR
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 115 DLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEIYGPEVDM 172
D+K N+L+ G +K+ D G +I + V T ++ APEV + + YGP+VD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV-VTRKAYGPKVDI 199
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKI 201
W++G + EM+ + +N +Y I
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-18
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 34/218 (15%)
Query: 1 GSYGDVFQA-----LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G VFQA L + VAVK LK++ S D + + L +HPNIVKL
Sbjct: 16 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLL 74
Query: 56 NLVKEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVR---------------NLC 96
+ + + ++FEYM ++ L+ RA + S LC
Sbjct: 75 GVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLC 134
Query: 97 F--QVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPC----TDYV 149
QV G+ Y+ + + HRDL N LV + V+KI D G+ + I S+ D +
Sbjct: 135 IAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI 194
Query: 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRI 187
RW PE + + Y E D+WA G +++E+ S+ +
Sbjct: 195 PIRWM-PPESIFYNR-YTTESDVWAYGVVLWEIFSYGM 230
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-18
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 44/217 (20%)
Query: 1 GSYGDVFQA-----LDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVK 53
G++G VF + E VAVK LK+ + +++R +E + L H NIVK
Sbjct: 16 GAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQ-HENIVK 72
Query: 54 LRNLVKEHEDVFIVFEYME-SDLLKLMK------------ERAGQNFSEDEVRNLCFQVF 100
+ E + +VFEYME DL K ++ + + ++ + Q+
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 101 QGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDY--------VTT 151
G+ Y+ Q + HRDL N LV V+KIGD GM +++ + TDY +
Sbjct: 133 SGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT----TDYYRVGGHTMLPI 188
Query: 152 RWYRAPEVLLLSEIYGP---EVDMWAMGAIMFEMLSF 185
RW PE S +Y E D+W+ G +++E+ ++
Sbjct: 189 RWM-PPE----SIMYRKFTTESDVWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 5e-18
Identities = 73/281 (25%), Positives = 117/281 (41%), Gaps = 65/281 (23%)
Query: 6 VFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEV--KCLRKMNNHPNIVKLRNLVKEHED 63
V +D ++ + +K L+K S + SR + C+ PN+V L + +
Sbjct: 9 VLLVMDTRTQQTFILKGLRK---SSEYSRERLTIIPHCV------PNMVCLHKYIVSEDS 59
Query: 64 VFIVFEYME-----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
VF+V ++ E S + K + N E+ V+ ++ L +HR+G RDL P
Sbjct: 60 VFLVLQHAEGGKLWSHISKFL------NIPEECVKRWAAEMVVALDALHREGIVCRDLNP 113
Query: 119 SNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
+N+L+ +G I++ E++ S C Y APEV +SE D W++GA
Sbjct: 114 NNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEE-TEACDWWSLGA 170
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
I+FE+L+ G + P GI + L N+ E
Sbjct: 171 ILFELLT---------------------GKTLVECHPSGINTHTTL----------NIPE 199
Query: 238 LSPSASRESISLISRLCSWNPHMRPTAAEA-----LEHPFF 273
S E+ SL+ +L +NP R A A HPFF
Sbjct: 200 W---VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-18
Identities = 77/280 (27%), Positives = 124/280 (44%), Gaps = 40/280 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKI---FSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G+YGDV++A + +GE AVK +K + FSL + +C H NIV
Sbjct: 20 GTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-----KHCNIVAYFGS 74
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
E ++I EY L+ + G SE ++ +C + QGL Y+H +G HRD+K
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGP-LSELQIAYVCRETLQGLAYLHSKGKMHRDIK 133
Query: 118 PSN-LLVSKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEI--YGPEVDMW 173
+N LL G +K+ D G+ +I +++ ++ T ++ APEV + + Y D+W
Sbjct: 134 GANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIW 193
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPL-GIQLASNLDWKFPQMGG 232
A+G E+ + P D P+ + L S +++ P++
Sbjct: 194 AVGITAIELAELQ--------------------PPMFDLHPMRALFLMSKSNFQPPKLKD 233
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
+ S + ISL NP RPTA L H F
Sbjct: 234 -KTKWSSTFHNFVKISLTK-----NPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-18
Identities = 50/190 (26%), Positives = 98/190 (51%), Gaps = 10/190 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G YG+V++ + KK VAVK LK+ ++E LKE ++++ HPN+V+L +
Sbjct: 17 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEI-KHPNLVQLLGVCTR 73
Query: 61 HEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+I+ E+M +LL ++E Q + + + Q+ + Y+ ++ + HRDL
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 133
Query: 120 NLLVSKG-VIKIGDLG---MVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N LV + ++K+ D G ++ + +W APE L ++ + + D+WA
Sbjct: 134 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW-TAPESLAYNK-FSIKSDVWAF 191
Query: 176 GAIMFEMLSF 185
G +++E+ ++
Sbjct: 192 GVLLWEIATY 201
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-18
Identities = 57/192 (29%), Positives = 102/192 (53%), Gaps = 16/192 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
G++G V++A +K++G A K + K S +E + + E+ L + HPNIVKL +
Sbjct: 16 GAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCD-HPNIVKLLDAFY 72
Query: 60 EHEDVFIVFEYMES---DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+++I+ E+ D + L ER +E ++R +C Q + L+Y+H HRDL
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 117 KPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLLS----EIYGPEV 170
K N+L + G IK+ D G+ + ++ D ++ T ++ APEV++ Y +
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 189
Query: 171 DMWAMGAIMFEM 182
D+W++G + EM
Sbjct: 190 DVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-18
Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 18/197 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL--- 57
G+YG VF+ L+KK+G AVK L I +DE E L+ +++HPN+VK +
Sbjct: 29 GTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIE-AEYNILKALSDHPNVVKFYGMYYK 86
Query: 58 --VKEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
VK + +++V E +DL+K +R G+ E + + + GL ++H
Sbjct: 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVNKT 145
Query: 112 FHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLL----LSEI 165
HRD+K +N LL ++G +K+ D G+ ++ S+ L V T ++ APEV+ L
Sbjct: 146 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDST 205
Query: 166 YGPEVDMWAMGAIMFEM 182
Y D+W++G E+
Sbjct: 206 YDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 83/295 (28%), Positives = 135/295 (45%), Gaps = 63/295 (21%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G+ G V A GE AVK + + S D++R EV CL +N ++VK
Sbjct: 43 GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCL--LN-----CDFFSIVK 95
Query: 60 EHED--------------VFIVFEYMES-DLLKLMKERA--GQNFSEDEVRNLCFQVFQG 102
HED + +V +Y + DL + +K RA + F E E L QV
Sbjct: 96 CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155
Query: 103 LHYMHRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYV-----TTRWYRA 156
+H++H + HRD+K +N LL S G++K+GD G K +++ +D V T +Y A
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATV--SDDVGRTFCGTPYYVA 213
Query: 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLG 216
PE+ Y + DM+++G +++E+L+ + F G+N + ++K
Sbjct: 214 PEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK---------------- 256
Query: 217 IQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHP 271
LA D L PS S E +++ L S +P RP++++ L P
Sbjct: 257 -TLAGRYD------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-17
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 1 GSYGDVFQA----LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G +G V L +GE VAVK L S +E++ LR ++ H NIVK +
Sbjct: 15 GHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD-HENIVKYKG 73
Query: 57 LVKE--HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ ++ + ++ EY+ S L+ +R + + Q+ +G+ Y+ Q Y HR
Sbjct: 74 VCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHR 133
Query: 115 DLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTR--------WYRAPEVLLLSEI 165
DL N+LV S+ ++KI D G+ K + DY + WY APE L S+
Sbjct: 134 DLAARNILVESEDLVKISDFGLAKVLPED---KDYYYVKEPGESPIFWY-APECLRTSKF 189
Query: 166 YGPEVDMWAMGAIMFEMLSF 185
D+W+ G ++E+ ++
Sbjct: 190 SS-ASDVWSFGVTLYELFTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-17
Identities = 69/278 (24%), Positives = 128/278 (46%), Gaps = 43/278 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+G+VF+ +D ++ + VA+K + + + DE ++++ + + P + K +
Sbjct: 15 GSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 73
Query: 61 HEDVFIVFEYMES----DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
++I+ EY+ DLL RAG F E ++ + ++ +GL Y+H + HRD+
Sbjct: 74 GTKLWIIMEYLGGGSALDLL-----RAGP-FDEFQIATMLKEILKGLDYLHSEKKIHRDI 127
Query: 117 KPSNLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
K +N+L+S+ G +K+ D G+ ++ D+ + +V T ++ APEV+ S Y + D+W+
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA-YDSKADIWS 186
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G E+ P D P+ + L K
Sbjct: 187 LGITAIELAKGE--------------------PPNSDMHPMRVLF---LIPKNNP----- 218
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
L+ S+ I + +P RPTA E L+H F
Sbjct: 219 -PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-17
Identities = 61/215 (28%), Positives = 114/215 (53%), Gaps = 29/215 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS----LDESRNLKEVKCLRKMNNHPNIVKLRN 56
G +G+V+ + + VAVK LK S L+E++ +K+++ H +V+L
Sbjct: 17 GQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKLR-------HDKLVQLYA 68
Query: 57 LVKEHEDVFIVFEYM-ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+V E E ++IV EYM + LL +K+ G+ + ++ QV G+ Y+ R Y HRD
Sbjct: 69 VVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRD 127
Query: 116 LKPSNLLVSKGVI-KIGDLGMVKEIDSSLPCTDYVT-------TRWYRAPEVLLLSEIYG 167
L+ +N+LV G++ KI D G+ + I+ + +Y +W APE L +
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDN----EYTARQGAKFPIKW-TAPEAALYGR-FT 181
Query: 168 PEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+ D+W+ G ++ E+++ R+ +PG N+ + + ++
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-17
Identities = 60/214 (28%), Positives = 116/214 (54%), Gaps = 15/214 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN----LKEVKCLRKMNNHPNIVKLRN 56
G + +V++A + VA+KK++ IF + +++ +KE+ L+++N HPN++K +
Sbjct: 13 GQFSEVYRATCLLDRKPVALKKVQ--IFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLD 69
Query: 57 LVKEHEDVFIVFEYMES-DLLKLMKERAGQN--FSEDEVRNLCFQVFQGLHYMHRQGYFH 113
E ++ IV E ++ DL +++K Q E V Q+ + +MH + H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMH 129
Query: 114 RDLKPSNLLVS-KGVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
RD+KP+N+ ++ GV+K+GDLG+ + S + V T +Y +PE + Y + D
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSD 188
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVI 205
+W++G +++EM + + F G ++ +CQ I
Sbjct: 189 IWSLGCLLYEMAALQSPFYGDKM--NLFSLCQKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 38/244 (15%)
Query: 38 EVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES-DLLKLMKERAGQN--FSEDEVRN 94
E+ CL + H IVK + K + + ++ EY DL K +K+R ++ F E EV
Sbjct: 115 ELHCLAACD-HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 95 LCFQVFQGLHYMHRQGYFHRDLKPSNL-LVSKGVIKIGDLGMVKEIDSSLP---CTDYVT 150
L +Q+ L +H + HRDLK +N+ L+ G+IK+GD G K+ S+ + +
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233
Query: 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTE 210
T +Y APE L + Y + DMW++G I++E+L+ F G + + I Q +
Sbjct: 234 TPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE----IMQQVLYGKY 288
Query: 211 DSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
D +P + S +L+ L S NP +RPT + L
Sbjct: 289 DPFPCPV-------------------------SSGMKALLDPLLSKNPALRPTTQQLLHT 323
Query: 271 PFFR 274
F +
Sbjct: 324 EFLK 327
|
Length = 478 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-17
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESR--NLKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V A K GE+ AVK LKK + +D+ + E + L +P + L
Sbjct: 6 GSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF 65
Query: 59 KEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ E +F V E++ DL+ ++++ F ++ GL ++H +G +RDLK
Sbjct: 66 QTKEHLFFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLK 123
Query: 118 PSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N+++ + G IKI D GM KE + + + T Y APE+ L Y VD W+
Sbjct: 124 LDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI-LQGLKYTFSVDWWSF 182
Query: 176 GAIMFEMLSFRILFPGKNSADQIYK 200
G +++EML + F G + D++++
Sbjct: 183 GVLLYEMLIGQSPFHGDDE-DELFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-17
Identities = 53/196 (27%), Positives = 104/196 (53%), Gaps = 17/196 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRN-LV 58
G+YG V++ K+G+ A+K + + DE +K E+ L+K ++H NI +
Sbjct: 27 GTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 59 KE----HED-VFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
K+ H+D +++V E+ + + L+K G ED + +C ++ +GL ++H
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVI 143
Query: 113 HRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLLSE----IY 166
HRD+K N+L+++ +K+ D G+ ++D ++ + ++ T ++ APEV+ E Y
Sbjct: 144 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY 203
Query: 167 GPEVDMWAMGAIMFEM 182
D+W++G EM
Sbjct: 204 DYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-17
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 8/204 (3%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD--ESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G +G+V K +G+ A KKL KK E L E + L K+N+ P IV L
Sbjct: 4 GGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLAYAF 62
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSE-DEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ + +V M LK G+ E + V + Q+ G+ ++H +RD+K
Sbjct: 63 ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMK 122
Query: 118 PSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
P N+L+ +G ++ DLG+ E+ T T Y APE+L E Y VD +AMG
Sbjct: 123 PENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILK-EEPYSYPVDWFAMG 181
Query: 177 AIMFEMLSFRILFPGKNSADQIYK 200
++EM++ R P K+ +++ K
Sbjct: 182 CSIYEMVAGRT--PFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-17
Identities = 49/171 (28%), Positives = 87/171 (50%), Gaps = 9/171 (5%)
Query: 18 VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77
VA+K +++ S E ++E + + K++ HP +V+L + E + +VFE+ME L
Sbjct: 31 VAIKTIREGAMS--EEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLVFEFMEHGCLS 87
Query: 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMV 136
FS++ + +C V +G+ Y+ HRDL N LV + V+K+ D GM
Sbjct: 88 DYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT 147
Query: 137 KEIDSSLPCTDYVT---TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS 184
+ + + T +W +PEV S+ Y + D+W+ G +M+E+ S
Sbjct: 148 RFVLDDQYTSSTGTKFPVKW-SSPEVFSFSK-YSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 4e-17
Identities = 50/196 (25%), Positives = 103/196 (52%), Gaps = 17/196 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKL----- 54
G+YG V++ K+G+ A+K + + DE +K E+ L+K ++H NI
Sbjct: 17 GTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 55 -RNLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+N + +++V E+ + + L+K G E+ + +C ++ +GL ++H+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI 133
Query: 113 HRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLLSE----IY 166
HRD+K N+L+++ +K+ D G+ ++D ++ + ++ T ++ APEV+ E Y
Sbjct: 134 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY 193
Query: 167 GPEVDMWAMGAIMFEM 182
+ D+W++G EM
Sbjct: 194 DFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-17
Identities = 72/282 (25%), Positives = 120/282 (42%), Gaps = 41/282 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKC---LRKMNNHPNIVKLRNL 57
G++G V+ D +G +A K+++ S + S+ + ++C L K H IV+
Sbjct: 13 GAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72
Query: 58 VKEHED--VFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+++ + + I EYM +K + G +E R Q+ +G+ Y+H HRD
Sbjct: 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLHSNMIVHRD 131
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKEID----SSLPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
+K +N+L S G +K+GD G K + S T ++ +PEV + E YG +
Sbjct: 132 IKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV-ISGEGYGRKA 190
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
D+W++G + EML+ + + + I+KI PT PQ+
Sbjct: 191 DVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTN-----------------PQL 230
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
PS E RP+A E L HPF
Sbjct: 231 ---------PSHISEHARDFLGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-17
Identities = 57/196 (29%), Positives = 99/196 (50%), Gaps = 16/196 (8%)
Query: 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +G+VF+ + K G VA+K LK L E + + ++H NI++L +
Sbjct: 16 GEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH-NIIRLEGV 74
Query: 58 VKEHEDVFIVFEYMESDLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
V + + I+ EYME+ L K +++ G+ FS ++ + + G+ Y+ Y HRDL
Sbjct: 75 VTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLRGIAAGMKYLSDMNYVHRDL 133
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPEVLLLSEIYGPE 169
N+LV S K+ D G+ + ++ P Y T+ RW APE + + +
Sbjct: 134 AARNILVNSNLECKVSDFGLSRVLEDD-PEGTYTTSGGKIPIRW-TAPEAIAYRK-FTSA 190
Query: 170 VDMWAMGAIMFEMLSF 185
D+W+ G +M+E++SF
Sbjct: 191 SDVWSFGIVMWEVMSF 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-17
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 22/198 (11%)
Query: 1 GSYGDVFQA--LDKKSGEF-VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G++G V + L K E VAVK LK++ + + L+E + +++ HP IV+L +
Sbjct: 6 GNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIVRLIGV 64
Query: 58 VKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
K E + +V E LLK +K+R + +++ L QV G+ Y+ + + HRDL
Sbjct: 65 CKG-EPLMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121
Query: 117 KPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRAPEVLLLSEIYG 167
N LLV++ KI D GM + + +DY +WY APE + +
Sbjct: 122 AARNVLLVNRHQAKISDFGMSRALG---AGSDYYRATTAGRWPLKWY-APECINYG-KFS 176
Query: 168 PEVDMWAMGAIMFEMLSF 185
+ D+W+ G ++E S+
Sbjct: 177 SKSDVWSYGVTLWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-17
Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 9/218 (4%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ G VF+ K SG +A K + +I ++ ++E++ L + N+ P IV
Sbjct: 16 GNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYS 74
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYM-HRQGYFHRDLKPS 119
++ I E+M+ L + ++AG+ E + + V +GL Y+ + HRD+KPS
Sbjct: 75 DGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 133
Query: 120 NLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAI 178
N+LV S+G IK+ D G+ ++ S+ +V TR Y +PE L + Y + D+W+MG
Sbjct: 134 NILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLS 191
Query: 179 MFEML--SFRILFPGKNSADQIYKICQVIGSPTEDSWP 214
+ EM + I P + ++ C V G P E
Sbjct: 192 LVEMAIGRYPIPPPDAKELELMFG-CPVEGDPAESETS 228
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-17
Identities = 52/230 (22%), Positives = 104/230 (45%), Gaps = 26/230 (11%)
Query: 4 GDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHED 63
G++ ++ S VA+K LK+ + ++ L HPNIV L + + +
Sbjct: 24 GELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82
Query: 64 VFIVFEYME-SDLLKLMKERA--------------GQNFSEDEVRNLCFQVFQGLHYMHR 108
++FEY+ DL + + + + + ++ Q+ G+ Y+
Sbjct: 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS 142
Query: 109 QGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLLLS 163
+ HRDL N LV +G +KI D G+ ++I S+ + + RW PE +L
Sbjct: 143 HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWM-PPEAILYG 201
Query: 164 EIYGPEVDMWAMGAIMFEMLSFRIL-FPGKNSADQIYKI--CQVIGSPTE 210
+ + E D+W+ G +++E+ S+ + + G ++ + I I Q++ P +
Sbjct: 202 K-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 1e-16
Identities = 63/230 (27%), Positives = 111/230 (48%), Gaps = 33/230 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLK-KKIFSLDESRNLKEVKCLRKMNNHPNIVKL--RNL 57
G +G+VF K++ EF K + + + ++S+ + EV +R++ H NIV+ R L
Sbjct: 24 GRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK-HKNIVRYIDRFL 82
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNF---SEDEVRNLCFQVFQGLHYMHR------ 108
K ++ ++I+ E+ ++ L ++ + F E + ++ Q+ L Y H
Sbjct: 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPN 142
Query: 109 -QGYFHRDLKPSNLLVSKG------------------VIKIGDLGMVKEIDSSLPCTDYV 149
+ HRDLKP N+ +S G + KIGD G+ K I V
Sbjct: 143 GERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV 202
Query: 150 TTRWYRAPEVLLL-SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQI 198
T +Y +PE+LL ++ Y + DMWA+G I++E+ S + F N+ Q+
Sbjct: 203 GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-16
Identities = 79/289 (27%), Positives = 128/289 (44%), Gaps = 49/289 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVK--------KLKKKIFSLDESRNLKEVKCLRKMNNHPNIV 52
G+ G V + K +G A+K L+K+I +E++ + P IV
Sbjct: 12 GAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQIL--------RELEINKSCK-SPYIV 62
Query: 53 KLRN-LVKEHE-DVFIVFEYMES----DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYM 106
K + E + I EY E + K +K+R G+ E + + V +GL Y+
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLKGLSYL 121
Query: 107 HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI 165
H + HRD+KPSN+L++ KG +K+ D G+ E+ +SL T + T +Y APE + +
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPE-RIQGKP 179
Query: 166 YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLG-IQLASN-L 223
Y D+W++G + E+ R FP E PLG I+L S +
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFP------------------PEGEPPLGPIELLSYIV 221
Query: 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
+ P++ + S E I + +P RPT + LEHP+
Sbjct: 222 NMPNPEL--KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 54/198 (27%), Positives = 100/198 (50%), Gaps = 19/198 (9%)
Query: 1 GSYGDVFQA----LDKKSGEF-VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G V +A L K VAVK LK S + + E+K + + NH NIV L
Sbjct: 46 GAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLL 105
Query: 56 NLVKEHEDVFIVFEY-MESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ ++ EY DLL ++ + + +++ + +QV +G+ ++ + HR
Sbjct: 106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHR 165
Query: 115 DLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVT-------TRWYRAPEVLLLSEIY 166
DL N+L++ G ++KI D G+ ++I + ++YV +W APE + + +Y
Sbjct: 166 DLAARNVLLTHGKIVKICDFGLARDIMND---SNYVVKGNARLPVKWM-APES-IFNCVY 220
Query: 167 GPEVDMWAMGAIMFEMLS 184
E D+W+ G +++E+ S
Sbjct: 221 TFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 60/192 (31%), Positives = 97/192 (50%), Gaps = 13/192 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G+V K S + A+K L K ++ +S E + + N IV+L +
Sbjct: 54 GAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ 113
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ + +++V EYM DL+ LM + + E R +V L +H G+ HRD+KP
Sbjct: 114 DDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 170
Query: 119 SNLLVSK-GVIKIGDLG--MVKEIDSSLPCTDYVTTRWYRAPEVLLLSE----IYGPEVD 171
N+L+ K G +K+ D G M + + + C V T Y +PEV L S+ YG E D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEV-LKSQGGDGYYGRECD 229
Query: 172 MWAMGAIMFEML 183
W++G ++EML
Sbjct: 230 WWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 59/191 (30%), Positives = 96/191 (50%), Gaps = 11/191 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G+V K S + A+K L K ++ +S E + + N P +V+L +
Sbjct: 54 GAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ + +++V EYM DL+ LM + + E + +V L +H G HRD+KP
Sbjct: 114 DDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKP 170
Query: 119 SNLLVSK-GVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLS---EIYGPEVDM 172
N+L+ K G +K+ D G ++D + + C V T Y +PEVL YG E D
Sbjct: 171 DNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 173 WAMGAIMFEML 183
W++G +FEML
Sbjct: 231 WSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-16
Identities = 55/191 (28%), Positives = 95/191 (49%), Gaps = 10/191 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G+VF + VAVK ++ + +++ L+E + L K +HPNIV+L + +
Sbjct: 6 GNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARIL-KQYSHPNIVRLIGVCTQ 64
Query: 61 HEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ ++IV E ++ D L ++ G E+ + G+ Y+ + HRDL
Sbjct: 65 KQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAAR 123
Query: 120 NLLVS-KGVIKIGDLGMVKE----IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
N LV+ K V+KI D GM +E + +S + +W APE L Y E D+W+
Sbjct: 124 NCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEALNYGR-YSSESDVWS 181
Query: 175 MGAIMFEMLSF 185
G +++E S
Sbjct: 182 FGILLWEAFSL 192
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-16
Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 15/224 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKC---LRKMNNHPNIVKLRNL 57
G++G V+ D +G +AVK+++ S + S+ + ++C L K H IV+
Sbjct: 13 GAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72
Query: 58 VKEHED--VFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+++ + + I E+M +K + G +E+ R Q+ +G+ Y+H HRD
Sbjct: 73 LRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGVSYLHSNMIVHRD 131
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKEID----SSLPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
+K +N+L S G +K+GD G K + S T ++ +PEV + E YG +
Sbjct: 132 IKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV-ISGEGYGRKA 190
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP 214
D+W++G + EML+ + + + I+KI PT P
Sbjct: 191 DIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTNPVLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 5e-16
Identities = 54/191 (28%), Positives = 90/191 (47%), Gaps = 23/191 (12%)
Query: 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +G V + K FV K +K K F+ E V L M ++PN +KL
Sbjct: 27 GKFGKVS--VLKHKPTQKLFV-QKIIKAKNFNAIEP----MVHQL--MKDNPNFIKLYYS 77
Query: 58 VKEHEDVFIVFEYM-ESDLLKLMK-ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
V + ++ +Y+ + DL L+K E SE EV+ + Q+ + L+ +H+ H D
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALNDLHKHNIIHND 134
Query: 116 LKPSNLL--VSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMW 173
+K N+L +K I + D G+ K I + P T ++ +PE + Y D W
Sbjct: 135 IKLENVLYDRAKDRIYLCDYGLCKIIGT--PSCYDGTLDYF-SPEK-IKGHNYDVSFDWW 190
Query: 174 AMGAIMFEMLS 184
A+G + +E+L+
Sbjct: 191 AVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-16
Identities = 58/199 (29%), Positives = 105/199 (52%), Gaps = 6/199 (3%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ G V + L + SG +A K + +I ++ ++E+K L + N+ P IV
Sbjct: 12 GNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNS-PYIVGFYGAFYS 70
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMH-RQGYFHRDLKPS 119
++ I E+M+ L + ++AG+ E+ + + V +GL Y+ + HRD+KPS
Sbjct: 71 DGEISICMEHMDGGSLDQVLKKAGR-IPENILGKISIAVLRGLTYLREKHKIMHRDVKPS 129
Query: 120 NLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAI 178
N+LV S+G IK+ D G+ ++ S+ + +V TR Y +PE L + Y + D+W++G
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTH-YTVQSDIWSLGLS 187
Query: 179 MFEMLSFRILFPGKNSADQ 197
+ EM R P ++ +
Sbjct: 188 LVEMAIGRYPIPPPDAKEL 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-16
Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 44/285 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL----KKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G+YG V+ L G+ +AVK++ + + E L+E L K H NIV+
Sbjct: 11 GAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLG 69
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + I E++ + + R G E Q+ G+ Y+H HRD+
Sbjct: 70 TCLDDNTISIFMEFVPGGSISSILNRFGP-LPEPVFCKYTKQILDGVAYLHNNCVVHRDI 128
Query: 117 KPSN-LLVSKGVIKIGDLGMVKEI--------DSSLPCTDYVTTRWYRAPEVLLLSEIYG 167
K +N +L+ G+IK+ D G + + S++ + + T W APEV+ S YG
Sbjct: 129 KGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM-APEVINESG-YG 186
Query: 168 PEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227
+ D+W++G +FEM + + P S D++ + IG+ L L F
Sbjct: 187 RKSDIWSIGCTVFEMATGK---PPLASMDRLAAMF-YIGA--------HRGLMPRLPDSF 234
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
S +I ++ + + H RP+A + L H F
Sbjct: 235 ---------------SAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-16
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +G+V K G+ VA+K LK L E + + + HPNI+ L +
Sbjct: 15 GEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGV 73
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
V + + V IV EYME+ L + F+ ++ + + G+ Y+ GY HRDL
Sbjct: 74 VTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 133
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPEVLLLSEIYGPEV 170
N+LV S V K+ D G+ + ++ P Y T RW APE + + +
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRVLEDD-PEAAYTTRGGKIPIRW-TAPEAIAYRK-FTSAS 190
Query: 171 DMWAMGAIMFEMLSF 185
D+W+ G +M+E++S+
Sbjct: 191 DVWSYGIVMWEVMSY 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-15
Identities = 61/236 (25%), Positives = 117/236 (49%), Gaps = 21/236 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V+ + + VA+K LK + L+E + ++K+ H +V L +V E
Sbjct: 17 GCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAF--LQEAQIMKKLR-HDKLVPLYAVVSE 72
Query: 61 HEDVFIVFEYM-ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E ++IV E+M + LL +KE G+ ++ ++ Q+ G+ Y+ R Y HRDL+ +
Sbjct: 73 -EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA 131
Query: 120 NLLVSKGVI-KIGDLGMVKEIDSSLPCTDYVT-------TRWYRAPEVLLLSEIYGPEVD 171
N+LV ++ KI D G+ + I+ + +Y +W APE L + + D
Sbjct: 132 NILVGDNLVCKIADFGLARLIEDN----EYTARQGAKFPIKW-TAPEAALYGR-FTIKSD 185
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226
+W+ G ++ E+++ R+ +PG + + + ++ + P P + L WK
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWK 241
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-15
Identities = 50/190 (26%), Positives = 103/190 (54%), Gaps = 18/190 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-----LKEVKCLRKMNNHPNIVKLR 55
GS+G+VF+ +D ++ + VA+K I L+E+ + +E+ L + ++ P + K
Sbjct: 15 GSFGEVFKGIDNRTQKVVAIK-----IIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYY 68
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ ++I+ EY+ L L++ E ++ + ++ +GL Y+H + HR
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKKIHR 125
Query: 115 DLKPSNLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
D+K +N+L+S+ G +K+ D G+ ++ D+ + +V T ++ APEV+ S Y + D+
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADI 184
Query: 173 WAMGAIMFEM 182
W++G E+
Sbjct: 185 WSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-15
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 28/205 (13%)
Query: 1 GSYGDVFQALDKKSGE-----FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G +G+VF A K E V VK L+K +S +E+ RK++ H N+V+L
Sbjct: 16 GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-HKNVVRLL 74
Query: 56 NLVKEHEDVFIVFEYME-SDLLKLMKERAG-------QNFSEDEVRNLCFQVFQGLHYMH 107
L +E E +++ EY + DL + ++ S + LC Q+ G+ ++
Sbjct: 75 GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134
Query: 108 RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDY-------VTTRWYRAPEV 159
+ HRDL N LV S+ +K+ L + K++ +S +Y + RW APE
Sbjct: 135 NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS----EYYKLRNALIPLRWL-APEA 189
Query: 160 LLLSEIYGPEVDMWAMGAIMFEMLS 184
+ + + + D+W+ G +M+E+ +
Sbjct: 190 -VQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V++ +KK G AVK L I +DE E L+ + NHPN+VK + +
Sbjct: 33 GTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIE-AEYNILQSLPNHPNVVKFYGMFYK 90
Query: 61 HE-----DVFIVFEYMES-DLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ +++V E + +L+K GQ E + + + GL ++H
Sbjct: 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRII 150
Query: 113 HRDLKPSN-LLVSKGVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPEVLLLSE----IY 166
HRD+K +N LL ++G +K+ D G+ ++ S+ L V T ++ APEV+ + Y
Sbjct: 151 HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSY 210
Query: 167 GPEVDMWAMGAIMFEM 182
D+W++G E+
Sbjct: 211 DARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 90/300 (30%), Positives = 128/300 (42%), Gaps = 58/300 (19%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLR---KMNNHPNIVKLRN 56
G+YG V+ K++ + A+KK+ K+ L RN +++V R +P +V +
Sbjct: 12 GAYGAVYLVRHKETRQRFAMKKINKQNLIL---RNQIQQVFVERDILTFAENPFVVSMFC 68
Query: 57 LVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+ + +V EY+E D L+K D R + L Y+H G HRD
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLHNYGIVHRD 126
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDY----------------VTTRWYRAPE 158
LKP NLL+ S G IK+ D G+ K SL Y T Y APE
Sbjct: 127 LKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
Query: 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQ 218
V +L + YG VD WAMG I++E L + F G ++ ++++ QVI E WP G
Sbjct: 187 V-ILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFG--QVISDDIE--WPEG-- 238
Query: 219 LASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMR---PTAAEALEHPFFRS 275
D P ++ LISRL NP R A E +H FF
Sbjct: 239 -----DEALPA---------------DAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 23/199 (11%)
Query: 1 GSYGDV----FQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G +G V + + +GE VAVK LK++ + S KE+ L+ + H NIVK +
Sbjct: 15 GHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY-HENIVKYKG 73
Query: 57 LVKEHED--VFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
E + ++ EY+ L L + ++ Q+ +G+ Y+H Q Y HR
Sbjct: 74 CCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHR 131
Query: 115 DLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTTR--------WYRAPEVLLLSEI 165
DL N+L+ ++KIGD G+ K + +Y R WY A E L ++
Sbjct: 132 DLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWY-AVECLKENKF 187
Query: 166 YGPEVDMWAMGAIMFEMLS 184
D+W+ G ++E+L+
Sbjct: 188 SYAS-DVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-15
Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 1 GSYGDVFQA----LDKKSGEF-VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G V +A LD + VAVK LK D S + E++ ++ + H NI+ L
Sbjct: 23 GAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 82
Query: 56 NLVKEHEDVFIVFEY---------------MESDLLKLMKERAGQNFSEDEVRNLCFQVF 100
+ + +++V EY + ++ ++ + +QV
Sbjct: 83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVA 142
Query: 101 QGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGM---VKEIDSSLPCTD-YVTTRWYR 155
+G+ ++ + HRDL N+LV++ V+KI D G+ + ID T+ + +W
Sbjct: 143 RGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWM- 201
Query: 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
APE L +Y + D+W+ G +++E+ +
Sbjct: 202 APEA-LFDRVYTHQSDVWSFGVLLWEIFTL 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-15
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN-LVK 59
G +GDV L G VAVK +K + L E + ++ H N+V+L +V+
Sbjct: 17 GEFGDVM--LGDYRGNKVAVKCIKNDATA---QAFLAEASVMTQLR-HSNLVQLLGVIVE 70
Query: 60 EHEDVFIVFEYM-ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
E ++IV EYM + L+ ++ R D + V + + Y+ + HRDL
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130
Query: 119 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
N+LVS+ V K+ D G+ KE SS T + +W APE L + + + D+W+ G
Sbjct: 131 RNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKW-TAPEA-LREKKFSTKSDVWSFGI 187
Query: 178 IMFEMLSF-RILFP 190
+++E+ SF R+ +P
Sbjct: 188 LLWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-15
Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 37/287 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G +G+V + +G+ A KKL+KK ES L E + L K+N+ +V L
Sbjct: 11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR-FVVSLAYAY 69
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQ-NFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ + + +V M LK G+ F E ++ GL +H++ +RDLK
Sbjct: 70 ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLK 129
Query: 118 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
P N+L+ G I+I DLG+ + V T Y APEV + +E Y D WA+G
Sbjct: 130 PENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV-VKNERYTFSPDWWALG 188
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+++EM++ + F + + ++ +++ E
Sbjct: 189 CLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE-------------------------- 222
Query: 237 ELSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRSCHF 278
E S S ++ SL L +P R A E EHP F+ +F
Sbjct: 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-15
Identities = 80/332 (24%), Positives = 136/332 (40%), Gaps = 84/332 (25%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G+V K +G+ A+K L K ++F D+ ++K + + ++ P +V L +
Sbjct: 12 GAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ + ++++ E++ DL+ ++ + FSED R + + +H+ G+ HRD+KP
Sbjct: 72 DAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKP 129
Query: 119 SNLLVSK-GVIKIGDLG---------------------------------MVKEIDSSLP 144
N+L+ + G IK+ D G V I+ ++
Sbjct: 130 DNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMS 189
Query: 145 CTDYVTTRW----------------YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRIL 188
D + T W Y APE+ L + YG E D W++GAIMFE L
Sbjct: 190 SKDQIAT-WKKNRRLMAYSTVGTPDYIAPEI-FLQQGYGQECDWWSLGAIMFECLIGWPP 247
Query: 189 FPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESIS 248
F +NS + KI +W + ++ LS A
Sbjct: 248 FCSENSHETYRKII---------NWRETLYFPDDI-------------HLSVEAE----D 281
Query: 249 LISRLCSWNPHM--RPTAAEALEHPFFRSCHF 278
LI RL + + R A E HPFFR +
Sbjct: 282 LIRRLITNAENRLGRGGAHEIKSHPFFRGVDW 313
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-15
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G+VF+ K VAVK K+ + + + L E + L K +HPNIVKL + +
Sbjct: 6 GNFGEVFKGTLKDKTP-VAVKTCKEDLPQELKIKFLSEARIL-KQYDHPNIVKLIGVCTQ 63
Query: 61 HEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ ++IV E + D L ++++ + ++ V+ G+ Y+ + HRDL
Sbjct: 64 RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVK-FALDAAAGMAYLESKNCIHRDLAAR 122
Query: 120 NLLVSKG-VIKIGDLGMVKEIDSSLPCTD---YVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N LV + V+KI D GM ++ D + + + +W APE L Y E D+W+
Sbjct: 123 NCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW-TAPEALNYGR-YSSESDVWSY 180
Query: 176 GAIMFEMLSFRIL-FPG 191
G +++E S + +PG
Sbjct: 181 GILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 68/224 (30%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 14 SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN------NHPNIVKLRNLVKEHED-VFI 66
+G VA+K L+ D + R+ HPNIV L + + +F
Sbjct: 2 TGHEVAIKLLRT-----DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA 56
Query: 67 VFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-K 125
VFEY+ L+ + G + + R L QV L H QG HRDLKP N++VS
Sbjct: 57 VFEYVPGRTLREVLAADGALPAGETGR-LMLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115
Query: 126 GV---IKIGDLGM------VKEIDSS--LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
GV K+ D G+ V++ D + T+ + T Y APE L E P D++A
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLYA 174
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQ 218
G I E L+ + + G + A+ +Y+ Q+ SP + S P I
Sbjct: 175 WGLIFLECLTGQRVVQGASVAEILYQ--QL--SPVDVSLPPWIA 214
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-15
Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 16/197 (8%)
Query: 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +G+V + K G+ FVA+K LK ++ + R+ + +HPNI+ L +
Sbjct: 15 GEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGV 73
Query: 58 VKEHEDVFIVFEYMESDLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
V + V I+ E+ME+ L +++ GQ F+ ++ + + G+ Y+ Y HRDL
Sbjct: 74 VTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYLSEMNYVHRDL 132
Query: 117 KPSNLLV-SKGVIKIGDLGMVK--EIDSSLPCTDY-----VTTRWYRAPEVLLLSEIYGP 168
N+LV S V K+ D G+ + E D+S P + RW APE + + +
Sbjct: 133 AARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW-TAPEAIAYRK-FTS 190
Query: 169 EVDMWAMGAIMFEMLSF 185
D+W+ G +M+E++S+
Sbjct: 191 ASDVWSYGIVMWEVMSY 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 6e-15
Identities = 72/294 (24%), Positives = 130/294 (44%), Gaps = 53/294 (18%)
Query: 1 GSYGDVF---QALDKKSGEFVAVKKLKK-----KIFSLDESRNLKEVKCLRKMNNHPNIV 52
G+YG VF + +G+ A+K L+K K +++ +R + V L + P +V
Sbjct: 11 GAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV--LEHVRQSPFLV 68
Query: 53 KLRNLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
L + + ++ +Y+ ++ + +R NFSEDEVR ++ L ++H+ G
Sbjct: 69 TLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGI 126
Query: 112 FHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSEIYGP 168
+RD+K N+L+ S+G + + D G+ KE + + T Y APE++ +G
Sbjct: 127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGK 186
Query: 169 EVDMWAMGAIMFEMLSFRILFP---GKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225
VD W++G ++FE+L+ F +N+ ++ + P
Sbjct: 187 AVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP----------------- 229
Query: 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMR----PTAAEAL-EHPFFR 274
FP + P A L+ +L +P R P A + EHPFF+
Sbjct: 230 -FPSF-------IGPEAQ----DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-15
Identities = 74/288 (25%), Positives = 124/288 (43%), Gaps = 39/288 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G +G+V + +G+ A KKL+KK E+ L E + L K+N+ +V L
Sbjct: 11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR-FVVSLAYAY 69
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCF--QVFQGLHYMHRQGYFHRDL 116
+ + + +V M LK G N DE R + + ++ GL + R+ +RDL
Sbjct: 70 ETKDALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDL 128
Query: 117 KPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
KP N+L+ +G I+I DLG+ +I V T Y APEV + +E Y D W +
Sbjct: 129 KPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEV-INNEKYTFSPDWWGL 187
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G +++EM+ + F + + ++ + + E
Sbjct: 188 GCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE------------------------- 222
Query: 236 RELSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRSCHF 278
E S S ++ S+ L + NP R AA +HP F++ +F
Sbjct: 223 -EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-15
Identities = 58/191 (30%), Positives = 94/191 (49%), Gaps = 11/191 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G+V K + + A+K L K ++ +S E + + N P +V+L +
Sbjct: 54 GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ +++V EYM DL+ LM + + E R +V L +H G+ HRD+KP
Sbjct: 114 DDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 170
Query: 119 SNLLVSK-GVIKIGDLG--MVKEIDSSLPCTDYVTTRWYRAPEVLLLS---EIYGPEVDM 172
N+L+ K G +K+ D G M + + C V T Y +PEVL YG E D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 173 WAMGAIMFEML 183
W++G ++EML
Sbjct: 231 WSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-15
Identities = 73/294 (24%), Positives = 125/294 (42%), Gaps = 52/294 (17%)
Query: 1 GSYGDVF---QALDKKSGEFVAVKKLKK-----KIFSLDESRNLKEVKCLRKMNNHPNIV 52
G+YG VF + +G+ A+K LKK K + + +R ++V L + P +V
Sbjct: 11 GAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQV--LEAVRRCPFLV 68
Query: 53 KLRNLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
L + + ++ +Y+ +L + +R ++F+E EVR ++ L ++H+ G
Sbjct: 69 TLHYAFQTDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGI 126
Query: 112 FHRDLKPSN-LLVSKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSEI-YG 167
+RD+K N LL S+G + + D G+ KE + + T Y APEV+ +
Sbjct: 127 IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHD 186
Query: 168 PEVDMWAMGAIMFEMLSFRILFP---GKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224
VD W++G + FE+L+ F +NS +I + P
Sbjct: 187 KAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP---------------- 230
Query: 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMR---PTAAEALEHPFFRS 275
FP + S E+ I +L +P R A E HPFF+
Sbjct: 231 --FP-----------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 8e-15
Identities = 79/280 (28%), Positives = 122/280 (43%), Gaps = 40/280 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDE-SRNLKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V Q + + A+K ++K I S E + L E L ++N P IV L+
Sbjct: 4 GSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNC-PFIVPLKFSF 62
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ E +++V ++ L +R G+ F R ++ L +H+ +RDLKP
Sbjct: 63 QSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLHKFNVIYRDLKP 121
Query: 119 SNLLVS-KGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+L+ +G I + D G+ K T+ + T Y APE LLL Y VD W +G
Sbjct: 122 ENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPE-LLLGHGYTKAVDWWTLG 180
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+++EML+ F +N + KI Q PL +FP G +
Sbjct: 181 VLLYEMLTGLPPFYDENVNEMYRKILQE---------PL----------RFPD--GFD-- 217
Query: 237 ELSPSASRESISLISRLCSWNPHMR---PTAAEALEHPFF 273
R++ L+ L S +P R A E HPFF
Sbjct: 218 -------RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-15
Identities = 78/329 (23%), Positives = 131/329 (39%), Gaps = 80/329 (24%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G+V + A+K L+K + +++ ++K + + ++ +VKL +
Sbjct: 12 GAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ ++++ V +Y+ D++ L+ F ED R ++ + +H+ G+ HRD+KP
Sbjct: 72 DKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKP 129
Query: 119 SNLLVSK-GVIKIGDLGM-----------------------------VKEIDSSLP---- 144
N+L+ + G IK+ D G+ EID
Sbjct: 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLE 189
Query: 145 ---------CTDY--VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKN 193
C + V T Y APEVLL + Y D W++G I++EML + F
Sbjct: 190 RRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPF---- 244
Query: 194 SADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRL 253
AD +P E + I + L P + SRE+ LI RL
Sbjct: 245 LAD----------TPAETQLKV-INWETTLH--IPSQAKL---------SREASDLILRL 282
Query: 254 CSWNPHMR---PTAAEALEHPFFRSCHFV 279
C R A E HPFF+ F
Sbjct: 283 CC-GAEDRLGKNGADEIKAHPFFKGIDFA 310
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 51/190 (26%), Positives = 102/190 (53%), Gaps = 18/190 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-----LKEVKCLRKMNNHPNIVKLR 55
GS+G+V++ +D ++ E VA+K I L+E+ + +E+ L + ++ P I +
Sbjct: 15 GSFGEVYKGIDNRTKEVVAIK-----IIDLEEAEDEIEDIQQEITVLSQCDS-PYITRYY 68
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ ++I+ EY+ L L+K E + + ++ +GL Y+H + HR
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSERKIHR 125
Query: 115 DLKPSNLLVS-KGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
D+K +N+L+S +G +K+ D G+ ++ D+ + +V T ++ APEV+ S Y + D+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDFKADI 184
Query: 173 WAMGAIMFEM 182
W++G E+
Sbjct: 185 WSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 32/209 (15%)
Query: 1 GSYGDVFQALDK--KSGEF---VAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKL 54
GS+G V++ L K GE VA+K + + S+ E L E +++ N H ++V+L
Sbjct: 17 GSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCH-HVVRL 74
Query: 55 RNLVKEHEDVFIVFEYM-ESDLLKLMKERAGQN--------FSEDEVRNLCFQVFQGLHY 105
+V + +V E M + DL ++ R + + + + ++ G+ Y
Sbjct: 75 LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAY 134
Query: 106 MHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDY--------VTTRWYRA 156
+ + + HRDL N +V++ +KIGD GM ++I TDY + RW A
Sbjct: 135 LAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE----TDYYRKGGKGLLPVRWM-A 189
Query: 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
PE L ++ + D+W+ G +++EM +
Sbjct: 190 PES-LKDGVFTTKSDVWSFGVVLWEMATL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-14
Identities = 56/201 (27%), Positives = 105/201 (52%), Gaps = 21/201 (10%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V+ + VA+K LK S + L+E + ++K+ H +V+L +V E
Sbjct: 17 GCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAF--LQEAQVMKKLR-HEKLVQLYAVVSE 72
Query: 61 HEDVFIVFEYM-ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E ++IV EYM + LL +K G+ ++ ++ Q+ G+ Y+ R Y HRDL+ +
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 131
Query: 120 NLLVSKGVI-KIGDLGMVKEIDSSLPCTDYVT-------TRWYRAPEVLLLSEIYGPEVD 171
N+LV + ++ K+ D G+ + I+ + +Y +W APE L + + D
Sbjct: 132 NILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKW-TAPEAALYGR-FTIKSD 185
Query: 172 MWAMGAIMFEMLSF-RILFPG 191
+W+ G ++ E+ + R+ +PG
Sbjct: 186 VWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-14
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 38/208 (18%)
Query: 1 GSYGDV----FQALDKKSGEFVAVKKLKKKIFSLDESRNL-KEVKCLRKMNNHPNIVKLR 55
G++G V + L +GE VAVKKL+ + + R+ +E++ L+ + H NIVK +
Sbjct: 15 GNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQ-HDNIVKYK 71
Query: 56 NLVKE--HEDVFIVFEYMES----DLLKLMKERAGQNFSEDEVRNLCF--QVFQGLHYMH 107
+ ++ +V EY+ D L+ +ER D + L + Q+ +G+ Y+
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL------DHRKLLLYASQICKGMEYLG 125
Query: 108 RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC-TDYVTTR--------WYRAP 157
+ Y HRDL N+LV S+ +KIGD G+ K LP +Y R WY AP
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTK----VLPQDKEYYKVREPGESPIFWY-AP 180
Query: 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
E L S + D+W+ G +++E+ ++
Sbjct: 181 ESLTES-KFSVASDVWSFGVVLYELFTY 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 54/295 (18%)
Query: 1 GSYGDVF---QALDKKSGEFVAVKKLKK-----KIFSLDESRNLKEVKCLRKMNNHPNIV 52
G+YG VF + SG+ A+K LKK K + + +R ++V L + P +V
Sbjct: 11 GAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV--LEHIRQSPFLV 68
Query: 53 KLRNLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
L + + ++ +Y+ +L + +R + F E EV+ ++ L ++H+ G
Sbjct: 69 TLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGI 126
Query: 112 FHRDLKPSNLLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSEI-YG 167
+RD+K N+L+ S G + + D G+ KE D + T Y AP+++ + +
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD 186
Query: 168 PEVDMWAMGAIMFEMLSFRILFP---GKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224
VD W+MG +M+E+L+ F KNS +I + +++ S +
Sbjct: 187 KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR--RILKS----------------E 228
Query: 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMR----PTAAEAL-EHPFFR 274
+PQ E+S A +I RL +P R P+ A+ + +HPFF+
Sbjct: 229 PPYPQ-------EMSALAK----DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 74/304 (24%), Positives = 133/304 (43%), Gaps = 54/304 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ G F +D K+ E V +K ++ E LR +N HP+I++L+
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKAGQRG-------GTATEAHILRAIN-HPSIIQLKGTFTY 154
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ ++DL + + +N + ++ + V + + Y+H HRD+K N
Sbjct: 155 NKFTCLILPRYKTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAEN 212
Query: 121 LLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWY--------RAPEVLLLSEIYGPEVD 171
+ ++ G + +GD G + P D ++Y APE LL + YGP VD
Sbjct: 213 IFINHPGDVCLGDFGA-----ACFP-VDINANKYYGWAGTIATNAPE-LLARDPYGPAVD 265
Query: 172 MWAMGAIMFEMLSFRILFPGKNSAD-------QIYKICQVIGS-PTEDSWPLGIQLASNL 223
+W+ G ++FEM + K+ D QI I + G+ P E +P+ Q +NL
Sbjct: 266 IWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE--FPIDAQ--ANL 321
Query: 224 DWKFPQMGG------------VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHP 271
D + + NL EL + LI ++ +++ H RP+A L+
Sbjct: 322 DEIYIGLAKKSSRKPGSRPLWTNLYEL----PIDLEYLICKMLAFDAHHRPSAEALLDFA 377
Query: 272 FFRS 275
F+
Sbjct: 378 AFQD 381
|
Length = 391 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-14
Identities = 53/191 (27%), Positives = 100/191 (52%), Gaps = 20/191 (10%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G V Q + +G+ VAVK +K + + L+E + K++ H N+V+L ++
Sbjct: 17 GEFGAVLQG--EYTGQKVAVKNIKCDVTA---QAFLEETAVMTKLH-HKNLVRLLGVIL- 69
Query: 61 HEDVFIVFEYM-ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
H ++IV E M + +L+ ++ R S ++ V +G+ Y+ + HRDL
Sbjct: 70 HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAAR 129
Query: 120 NLLVSK-GVIKIGDLGMVK----EIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
N+LVS+ GV K+ D G+ + +D+S + +W APE L + + + D+W+
Sbjct: 130 NILVSEDGVAKVSDFGLARVGSMGVDNSK-----LPVKW-TAPEALKHKK-FSSKSDVWS 182
Query: 175 MGAIMFEMLSF 185
G +++E+ S+
Sbjct: 183 YGVLLWEVFSY 193
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-14
Identities = 52/188 (27%), Positives = 90/188 (47%), Gaps = 7/188 (3%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL----KEVKCLRKMNNHPNIVKLRN 56
G +G+V+ +G+ A+K L KK + + L + + L + P IV +
Sbjct: 5 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTY 64
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + + + M L + G FSE E+R ++ GL +MH + +RDL
Sbjct: 65 AFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNRFVVYRDL 123
Query: 117 KPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
KP+N+L+ + G ++I DLG+ + P V T Y APEVL Y D +++
Sbjct: 124 KPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWFSL 182
Query: 176 GAIMFEML 183
G ++F++L
Sbjct: 183 GCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-14
Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 36/278 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ G V++A + +AVK + I + + + E++ L K ++ P I+
Sbjct: 12 GNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-PYIIGFYGAFFV 70
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+ I E+M+ L + ++ E + + V +GL Y+ HRD+KPSN
Sbjct: 71 ENRISICTEFMDGGSLDVYRK-----IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 121 LLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
+LV ++G +K+ D G+ ++ +S+ T YV T Y APE + E YG D+W++G
Sbjct: 126 MLVNTRGQVKLCDFGVSTQLVNSIAKT-YVGTNAYMAPE-RISGEQYGIHSDVWSLGISF 183
Query: 180 FEMLSFRILFPG--KNSADQI-YKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
E+ R +P KN + ++ Q I P+G
Sbjct: 184 MELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG-------------------- 223
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+ S + I++ P RP ++HPF
Sbjct: 224 QFSEKF----VHFITQCMRKQPKERPAPENLMDHPFIV 257
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-14
Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 37/216 (17%)
Query: 1 GSYGDVFQA----LDK---KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVK 53
G +G V A +DK K VAVK LK D S + E++ ++ + H NI+
Sbjct: 26 GCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 85
Query: 54 LRNLVKEHEDVFIVFEYM-ESDLLKLMKER--AGQNFSEDEVR------------NLCFQ 98
L + ++++ EY + +L + ++ R G +S D R + +Q
Sbjct: 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQ 145
Query: 99 VFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--------V 149
V +G+ Y+ Q HRDL N+LV++ V+KI D G+ +++++ DY +
Sbjct: 146 VARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN----IDYYKKTTNGRL 201
Query: 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
+W APE L +Y + D+W+ G +M+E+ +
Sbjct: 202 PVKWM-APEA-LFDRVYTHQSDVWSFGVLMWEIFTL 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-14
Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 20/197 (10%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRK------MNNHPNIVKL 54
G++G+V K +G+ A+K L K E E C R+ + I L
Sbjct: 12 GAFGEVAVVKMKNTGQVYAMKILNKW-----EMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 55 RNLVKEHEDVFIVFEY-MESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
++ ++++V +Y + DLL L+ + ED R ++ + +H+ GY H
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH 125
Query: 114 RDLKPSNLLVSK-GVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSE----IY 166
RD+KP N+L+ K G I++ D G + D ++ V T Y +PE+L E Y
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRY 185
Query: 167 GPEVDMWAMGAIMFEML 183
GPE D W++G M+EML
Sbjct: 186 GPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-14
Identities = 69/300 (23%), Positives = 117/300 (39%), Gaps = 43/300 (14%)
Query: 6 VFQALDKKSGEFVAVKKLKKKIFSLDE------SRNLKEVKCLRKMNNHPNIVKLRNLVK 59
V A K + VAVKK +LD +E+ R++ HPNI+
Sbjct: 16 VHLAKHKPTNTLVAVKK-----INLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFI 69
Query: 60 EHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
++++V M DLLK + E + + V L Y+H +G+ HR
Sbjct: 70 VDSELYVVSPLMAYGSCEDLLK---THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRS 126
Query: 116 LKPSNLLVS-KGVIKIGDL----GMVKEIDSSLPCTDYVTT-----RWYRAPEVL---LL 162
+K S++L+S G + + L M+K D+ + W +PEVL L
Sbjct: 127 VKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL-SPEVLQQNLQ 185
Query: 163 SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTE--DSWPLGIQLA 220
Y + D++++G E+ + + P K+ + +V G+ D +
Sbjct: 186 G--YNEKSDIYSVGITACELANGHV--PFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241
Query: 221 SNLDWKFPQMGGVNLRELSPSASR---ESISLISRLC-SWNPHMRPTAAEALEHPFFRSC 276
S + N + +R E LC +P RP+A++ L H FF+ C
Sbjct: 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 9e-14
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 7/202 (3%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL----KEVKCLRKMNNHPNIVKLRN 56
G +G+V+ +G+ A+K L KK + + L + + L + P IV +
Sbjct: 5 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 64
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + + + M L + G FSE E+R ++ GL +MH + +RDL
Sbjct: 65 AFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRFVVYRDL 123
Query: 117 KPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
KP+N+L+ + G ++I DLG+ + P V T Y APEVL Y D +++
Sbjct: 124 KPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSL 182
Query: 176 GAIMFEMLSFRILFPGKNSADQ 197
G ++F++L F + D+
Sbjct: 183 GCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 54/192 (28%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G+V K + A+K L K ++ E+ +E + + + I L +
Sbjct: 12 GAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71
Query: 60 EHEDVFIVFEY-MESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ +++V +Y + DLL L+ + ED R ++ +H +H+ Y HRD+KP
Sbjct: 72 DENYLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKP 130
Query: 119 SNLLVS-KGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSE----IYGPEVD 171
N+L+ G I++ D G ++ D ++ + V T Y +PE+L E YGPE D
Sbjct: 131 DNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 190
Query: 172 MWAMGAIMFEML 183
W++G M+EML
Sbjct: 191 WWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 1 GSYGDVFQALDKKSG-EFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
G++G V +A+ KK G + A K+ K+ S ++ R+ E++ L K+ +HPNI+ L
Sbjct: 13 GNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC 72
Query: 59 KEHEDVFIVFEY---------------MESDLLKLMKERAGQNFSEDEVRNLCFQVFQGL 103
+ ++I EY +E+D + + ++ V G+
Sbjct: 73 ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGM 132
Query: 104 HYMHRQGYFHRDLKPSNLLVSKGVI-KIGDLGM-------VKEIDSSLPCTDYVTTRWYR 155
Y+ + + HRDL N+LV + + KI D G+ VK+ LP RW
Sbjct: 133 QYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP------VRWM- 185
Query: 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
A E L S +Y + D+W+ G +++E++S
Sbjct: 186 AIESLNYS-VYTTKSDVWSFGVLLWEIVSL 214
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-13
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 1 GSYGDVFQALDKKS-GEF--VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
GS+G V + S G+ VAVK LK S LKE + ++ H N+++L +
Sbjct: 6 GSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRLYGV 64
Query: 58 VKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
V H + +V E LL +++ A +F + + Q+ G+ Y+ + + HRDL
Sbjct: 65 VLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDL 123
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYR-------APEVLLLSEIYGP 168
N+L+ S +KIGD G+++ + + D+ + APE L +
Sbjct: 124 AARNILLASDDKVKIGDFGLMRALPQN---EDHYVMEEHLKVPFAWCAPESLRTRT-FSH 179
Query: 169 EVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
D+W G ++EM ++ + G + + + KI
Sbjct: 180 ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 38/213 (17%)
Query: 1 GSYGDVFQA-----LDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVK 53
G++G VF A ++ VAVK LK + D +R +E + L + H +IVK
Sbjct: 16 GAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQ-HEHIVK 71
Query: 54 LRNLVKEHEDVFIVFEYME-SDLLKLMKERAGQ-----------NFSEDEVRNLCFQVFQ 101
+ E + + +VFEYM+ DL K ++ ++ ++ ++ Q+
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 102 GLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--------VTTR 152
G+ Y+ Q + HRDL N LV + ++KIGD GM +++ S TDY + R
Sbjct: 132 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS----TDYYRVGGHTMLPIR 187
Query: 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
W PE ++ + + E D+W++G +++E+ ++
Sbjct: 188 WM-PPESIMYRK-FTTESDVWSLGVVLWEIFTY 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 54/189 (28%), Positives = 89/189 (47%), Gaps = 27/189 (14%)
Query: 17 FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES-DL 75
VAVK L+ + + LKE+K + ++ +PNI++L + + + ++ EYME+ DL
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 76 LKLMKERA-------GQNFSEDEVRNLCF---QVFQGLHYMHRQGYFHRDLKPSNLLVSK 125
+ + +R N + NL + Q+ G+ Y+ + HRDL N LV
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164
Query: 126 G-VIKIGDLGMVKEIDSSLPCTDY--------VTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
IKI D GM + + S DY + RW A E +LL + + D+WA G
Sbjct: 165 HYTIKIADFGMSRNLYSG----DYYRIQGRAVLPIRWM-AWESILLGK-FTTASDVWAFG 218
Query: 177 AIMFEMLSF 185
++EM +
Sbjct: 219 VTLWEMFTL 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-13
Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 17/197 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK----EVKCLRKMNNHPNIVKLRN 56
G +G+V + +G+ A KKL KK L + + + E + L K+++ IV L
Sbjct: 4 GGFGEVSACQMRATGKLYACKKLNKK--RLKKRKGYEGAMVEKRILAKVHSR-FIVSLAY 60
Query: 57 LVKEHEDVFIVFEYMESDLLK-----LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
+ D+ +V M L+ + +E G F E Q+ GL ++H++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQRRI 118
Query: 112 FHRDLKPSN-LLVSKGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEIYGPE 169
+RDLKP N LL + G ++I DLG+ E+ D Y T + APE LL E Y
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPE-LLQGEEYDFS 177
Query: 170 VDMWAMGAIMFEMLSFR 186
VD +A+G ++EM++ R
Sbjct: 178 VDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 36/242 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKI--FSLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G G+V+ A D VA+KK+++ + L + R L+E K + HP IV + ++
Sbjct: 13 GGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSIC 71
Query: 59 KEHEDVFIVFEYMESDLLKLM------KERAGQNFSEDEVRNLCFQVF----QGLHYMHR 108
+ + V+ Y+E LK + KE + +E +F + Y+H
Sbjct: 72 SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS 131
Query: 109 QGYFHRDLKPSNLLVSK-GVIKIGDLGMVK--------EIDSSLPCTDY----------- 148
+G HRDLKP N+L+ G + I D G +D + +
Sbjct: 132 KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKI 191
Query: 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSP 208
V T Y APE LL D++A+G I+++ML+ FP + + VI SP
Sbjct: 192 VGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLS--FPYRRKKGRKISYRDVILSP 248
Query: 209 TE 210
E
Sbjct: 249 IE 250
|
Length = 932 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 56/189 (29%), Positives = 90/189 (47%), Gaps = 30/189 (15%)
Query: 18 VAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYME-SD 74
VAVK L+ + D +R LKEVK L +++ PNI +L + + ++ EYME D
Sbjct: 49 VAVKVLRPD--ASDNAREDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGD 105
Query: 75 LLKLMKERAGQN---------FSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK 125
L + +++ + S + + Q+ G+ Y+ + HRDL N LV K
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165
Query: 126 G-VIKIGDLGMVKEIDSSLPCTDY--------VTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
IKI D GM +L +DY + RW A E +LL + + + D+WA G
Sbjct: 166 NYTIKIADFGM----SRNLYSSDYYRVQGRAPLPIRWM-AWESVLLGK-FTTKSDVWAFG 219
Query: 177 AIMFEMLSF 185
++E+L+
Sbjct: 220 VTLWEILTL 228
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 53/192 (27%), Positives = 97/192 (50%), Gaps = 10/192 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G+V K + + A+K L K ++ E+ +E + + ++ I L +
Sbjct: 12 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71
Query: 60 EHEDVFIVFEY-MESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ ++++V +Y + DLL L+ + ED R ++ + +H+ Y HRD+KP
Sbjct: 72 DENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKP 130
Query: 119 SNLLVS-KGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSE----IYGPEVD 171
N+L+ G I++ D G ++ D ++ + V T Y +PE+L E YGPE D
Sbjct: 131 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECD 190
Query: 172 MWAMGAIMFEML 183
W++G M+EML
Sbjct: 191 WWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 36/213 (16%)
Query: 1 GSYGDVFQA-----LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G VF A L ++ VAVK LK+ S ++ + L + H +IV+
Sbjct: 16 GAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFY 73
Query: 56 NLVKEHEDVFIVFEYM--------------ESDLLKLMKERAGQNFSEDEVRNLCFQVFQ 101
+ E + +VFEYM ++ +L ++ A + ++ + Q+
Sbjct: 74 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIAS 133
Query: 102 GLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--------VTTR 152
G+ Y+ + HRDL N LV +G V+KIGD GM ++I S TDY + R
Sbjct: 134 GMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTMLPIR 189
Query: 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
W PE +L + + E D+W+ G +++E+ ++
Sbjct: 190 WM-PPESILYRK-FTTESDIWSFGVVLWEIFTY 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 37/214 (17%)
Query: 1 GSYGDVFQA-----LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G VF A K VAVK LK + + +E + L + H +IVK
Sbjct: 16 GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ-REAELLTNLQ-HEHIVKFY 73
Query: 56 NLVKEHEDVFIVFEYME-SDLLKLMKE--------------RAGQNFSEDEVRNLCFQVF 100
+ + + + +VFEYM+ DL K ++ +A ++ ++ Q+
Sbjct: 74 GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 133
Query: 101 QGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--------VTT 151
G+ Y+ Q + HRDL N LV ++KIGD GM +++ S TDY +
Sbjct: 134 SGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS----TDYYRVGGHTMLPI 189
Query: 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
RW PE ++ + + E D+W+ G I++E+ ++
Sbjct: 190 RWM-PPESIMYRK-FTTESDVWSFGVILWEIFTY 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-13
Identities = 50/192 (26%), Positives = 97/192 (50%), Gaps = 24/192 (12%)
Query: 15 GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYM-ES 73
+ VA+K LK I + + ++ L +HPNIV L +V + + V ++FEY+ +
Sbjct: 34 AQLVAIKTLKD-INNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQG 92
Query: 74 DLLKLMKERA-----GQNFSED----------EVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
DL + + R+ G + ED + ++ Q+ G+ Y+ + H+DL
Sbjct: 93 DLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAA 152
Query: 119 SNLLVSKGV-IKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMW 173
N+L+ + + +KI DLG+ +EI S+ + + RW PE ++ + + + D+W
Sbjct: 153 RNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM-PPEAIMYGK-FSSDSDIW 210
Query: 174 AMGAIMFEMLSF 185
+ G +++E+ SF
Sbjct: 211 SFGVVLWEIFSF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-13
Identities = 60/215 (27%), Positives = 108/215 (50%), Gaps = 12/215 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ G V + K SG +A K + +I ++ ++E++ L + N+ P IV
Sbjct: 16 GNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYS 74
Query: 61 HEDVFIVFEYMESDLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYM-HRQGYFHRDLKP 118
++ I E+M+ L +++KE + E+ + + V +GL Y+ + HRD+KP
Sbjct: 75 DGEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKP 132
Query: 119 SNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
SN+LV S+G IK+ D G+ ++ S+ +V TR Y +PE L + Y + D+W+MG
Sbjct: 133 SNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGL 190
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDS 212
+ E+ R P ++ + + + G P D
Sbjct: 191 SLVELAIGRYPIPPPDAKE----LEAIFGRPVVDG 221
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 71/276 (25%), Positives = 112/276 (40%), Gaps = 88/276 (31%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V +A D+K E+ AVK IV RN+ K
Sbjct: 140 GTFGKVVEAWDRKRKEYCAVK-----------------------------IV--RNVPKY 168
Query: 61 HEDVFIVFEYME-------SDLLKLMK-ERAGQN-------------------------F 87
D I ++ME +D LMK +R QN F
Sbjct: 169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPF 228
Query: 88 SEDEVRNLCFQVFQGLHYMHRQGYF-HRDLKPSNLLVSKG-----------------VIK 129
S + + FQ L Y H + + H DLKP N+L+ ++
Sbjct: 229 SHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVR 288
Query: 130 IGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL-LSEIYGPEVDMWAMGAIMFEMLSFRIL 188
I DLG D T V+TR YR+PEV+L L +Y DMW+MG I++E+ + ++L
Sbjct: 289 ICDLGGC--CDERHSRTAIVSTRHYRSPEVVLGLGWMY--STDMWSMGCIIYELYTGKLL 344
Query: 189 FPGKNSADQIYKICQVIGS-PTEDSWPLGIQLASNL 223
+ ++ + ++ + + +G P+E + G + A L
Sbjct: 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLL 380
|
Length = 467 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 35/211 (16%)
Query: 1 GSYGDVFQALDKKSGEFV--AVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNL 57
G++G V +A KK G + A+K++K+ S D+ R+ E++ L K+ +HPNI+ L
Sbjct: 18 GNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGA 76
Query: 58 VKEHEDVFIVFEY---------------MESDLLKLMKERAGQNFSEDEVRNLCFQVFQG 102
+ +++ EY +E+D + S ++ + V +G
Sbjct: 77 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 136
Query: 103 LHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGM-------VKEIDSSLPCTDYVTTRWY 154
+ Y+ ++ + HRDL N+LV + V KI D G+ VK+ LP RW
Sbjct: 137 MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP------VRWM 190
Query: 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
A E L S +Y D+W+ G +++E++S
Sbjct: 191 -AIESLNYS-VYTTNSDVWSYGVLLWEIVSL 219
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 62/252 (24%), Positives = 111/252 (44%), Gaps = 19/252 (7%)
Query: 38 EVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSED---EVRN 94
E+ L ++N H NI+K+ +++ + +++ + + DL M + A + R
Sbjct: 213 EILALGRLN-HENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRA 271
Query: 95 LCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY--VTT 151
+ Q+ + Y+H + HRD+K N+ ++ G I +GD G + DY V T
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGT 331
Query: 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFP----GKNSADQIYKICQVIGS 207
+PE+L + Y D+W+ G I+ +MLS P G Q+ KI +
Sbjct: 332 VATNSPEILA-GDGYCEITDIWSCGLILLDMLSHDFC-PIGDGGGKPGKQLLKIIDSLSV 389
Query: 208 PTEDSWPLGIQLASNLDWKFPQMGGVN----LRELSPSASRESISLISRLCSWNPHMRPT 263
E+ +L +D G + +R L A E + ++ +++ H+RP
Sbjct: 390 CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP--LVKMLTFDWHLRPG 447
Query: 264 AAEALEHPFFRS 275
AAE L P F +
Sbjct: 448 AAELLALPLFSA 459
|
Length = 501 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-12
Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 26/188 (13%)
Query: 17 FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES-DL 75
VAVK L++ + LKE+K + ++ + PNI++L + + + ++ EYME+ DL
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKD-PNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 76 LKLMKERAGQNFSEDE------VRNLCF---QVFQGLHYMHRQGYFHRDLKPSNLLVSKG 126
+ + Q +E L F Q+ G+ Y+ + HRDL N LV K
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN 166
Query: 127 -VIKIGDLGMVKEIDSSLPCTDY--------VTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
IKI D GM + + S DY + RW +LL + D+WA G
Sbjct: 167 YTIKIADFGMSRNLYSG----DYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGV 220
Query: 178 IMFEMLSF 185
++E+L+
Sbjct: 221 TLWEILTL 228
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 49/191 (25%), Positives = 94/191 (49%), Gaps = 30/191 (15%)
Query: 18 VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYM-ESDLL 76
VAVK LK D S + E++ ++ + H NI+ L + ++++ EY + +L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 77 KLMKER--AGQNFSEDEVR------------NLCFQVFQGLHYMHRQGYFHRDLKPSNLL 122
+ ++ R G ++S D + + +QV +G+ Y+ Q HRDL N+L
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166
Query: 123 VSK-GVIKIGDLGMVKEIDSSLPCTDY--------VTTRWYRAPEVLLLSEIYGPEVDMW 173
V++ V+KI D G+ +++ + DY + +W APE L +Y + D+W
Sbjct: 167 VTEDNVMKIADFGLARDVHN----IDYYKKTTNGRLPVKWM-APEA-LFDRVYTHQSDVW 220
Query: 174 AMGAIMFEMLS 184
+ G +++E+ +
Sbjct: 221 SFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 78/308 (25%), Positives = 130/308 (42%), Gaps = 66/308 (21%)
Query: 1 GSYGDVFQALDKK--SGEF---VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
GS+G V++ + GE VAVK + + + L E ++ H ++V+L
Sbjct: 17 GSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLL 75
Query: 56 NLVKEHEDVFIVFEYM-ESDL---LKLMKERAGQNFSE-----DEVRNLCFQVFQGLHYM 106
+V + + +V E M DL L+ ++ A N E+ + ++ G+ Y+
Sbjct: 76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL 135
Query: 107 HRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--------VTTRWYRAP 157
+ + + HRDL N +V+ +KIGD GM ++I TDY + RW AP
Sbjct: 136 NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE----TDYYRKGGKGLLPVRWM-AP 190
Query: 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGI 217
E L ++ DMW+ G +++E+ S A+Q Y+
Sbjct: 191 ES-LKDGVFTTSSDMWSFGVVLWEITSL---------AEQPYQ----------------- 223
Query: 218 QLASNLDWKFPQMGGVNLRELSPSASRESISLISRLC-SWNPHMRPTAAEALE------H 270
L++ KF GG + P E ++ + R+C +NP MRPT E + H
Sbjct: 224 GLSNEQVLKFVMDGGYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280
Query: 271 PFFRSCHF 278
P F F
Sbjct: 281 PSFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-12
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 33/210 (15%)
Query: 1 GSYGDVFQALDKKSG-EFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
G++G V +A KK G A K K+ S D+ R+ E++ L K+ +HPNI+ L
Sbjct: 6 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 65
Query: 59 KEHEDVFIVFEY---------------MESDLLKLMKERAGQNFSEDEVRNLCFQVFQGL 103
+ +++ EY +E+D + S ++ + V +G+
Sbjct: 66 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 125
Query: 104 HYMHRQGYFHRDLKPSNLLVSKGVI-KIGDLGM-------VKEIDSSLPCTDYVTTRWYR 155
Y+ ++ + HRDL N+LV + + KI D G+ VK+ LP RW
Sbjct: 126 DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP------VRWM- 178
Query: 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
A E L S +Y D+W+ G +++E++S
Sbjct: 179 AIESLNYS-VYTTNSDVWSYGVLLWEIVSL 207
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 37/216 (17%)
Query: 1 GSYGDVFQA----LDKKSGEF---VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVK 53
G +G V A LDK+ VAVK LK D S + E++ ++ + H NI+
Sbjct: 29 GCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 88
Query: 54 LRNLVKEHEDVFIVFEYM-ESDLLKLMKER--------------AGQNFSEDEVRNLCFQ 98
L + ++++ EY + +L + ++ R + S ++ + +Q
Sbjct: 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQ 148
Query: 99 VFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDY--------V 149
V +G+ Y+ + HRDL N+LV++ V+KI D G+ ++I DY +
Sbjct: 149 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH----IDYYKKTTNGRL 204
Query: 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
+W APE L IY + D+W+ G +++E+ +
Sbjct: 205 PVKWM-APEA-LFDRIYTHQSDVWSFGVLLWEIFTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-12
Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 1 GSYGDVFQA----LDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVK 53
G +G V +A +DK + VAVK LK D + + E++ ++ + H NI+
Sbjct: 23 GCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIIN 82
Query: 54 LRNLVKEHEDVFIVFEYM-ESDLLKLMKER--AGQNFSEDEVR----NLCF--------Q 98
L + + ++++ EY + +L + ++ R G +++ D + L F Q
Sbjct: 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQ 142
Query: 99 VFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGM---VKEIDSSLPCTD-YVTTRW 153
V +G+ Y+ + HRDL N+LV++ V+KI D G+ V +ID ++ + +W
Sbjct: 143 VARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKW 202
Query: 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
APE L +Y + D+W+ G +M+E+ +
Sbjct: 203 M-APEA-LFDRVYTHQSDVWSFGILMWEIFTL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-12
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN-----NHPNIVKLR 55
G+ G V + +G +A KK+ + ++++ + LR++ P IV
Sbjct: 16 GNGGSVSKVKHIPTGTVMA-----KKVVHIGAKSSVRK-QILRELQIMHECRSPYIVSFY 69
Query: 56 NLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYM---HRQGYF 112
++ + E+M+ L + ++ G + + + V +GL Y+ HR
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIYKKGGP-IPVEILGKIAVAVVEGLTYLYNVHR--IM 126
Query: 113 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
HRD+KPSN+LV S+G IK+ D G+ E+ +S+ T +V T Y +PE + Y + D
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-FVGTSTYMSPE-RIQGGKYTVKSD 184
Query: 172 MWAMGAIMFEMLSFRILFPGKNSAD 196
+W++G + E+ + F N D
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDD 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-12
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 20/197 (10%)
Query: 1 GSYGDVFQAL--DKKSGEFVAVKKLKKKIFSLDESRN---LKEVKCLRKMNNHPNIVKLR 55
G++G V + + KKS + VAVK LK + D + L+E +++++N P IV++
Sbjct: 6 GNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDELLREANVMQQLDN-PYIVRMI 62
Query: 56 NLVKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ E E +V E E L K +++ ++ +E + L QV G+ Y+ + HR
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 115 DLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTT-----RWYRAPEVLLLSEIYGP 168
DL N LLV++ KI D G+ K + + T +WY APE + + +
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APECMNYYK-FSS 177
Query: 169 EVDMWAMGAIMFEMLSF 185
+ D+W+ G +M+E S+
Sbjct: 178 KSDVWSFGVLMWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 50/196 (25%), Positives = 86/196 (43%), Gaps = 31/196 (15%)
Query: 18 VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEY------- 70
VAVK LK+ S + L E L+++N HP+++KL + + ++ EY
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLR 91
Query: 71 --------MESDLLKLMKERAGQNFSEDEVRNL--------CFQVFQGLHYMHRQGYFHR 114
+ L R + R L +Q+ +G+ Y+ HR
Sbjct: 92 SFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151
Query: 115 DLKPSNLLVSKG-VIKIGDLGM---VKEIDSSLP-CTDYVTTRWYRAPEVLLLSEIYGPE 169
DL N+LV++G +KI D G+ V E DS + + +W A E L IY +
Sbjct: 152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWM-AIES-LFDHIYTTQ 209
Query: 170 VDMWAMGAIMFEMLSF 185
D+W+ G +++E+++
Sbjct: 210 SDVWSFGVLLWEIVTL 225
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 8/156 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRK---MNNHPNIVKLRNL 57
G++G V+ K + + AVK +KK + + +V+ R ++ P IV L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKA--DMINKNMVHQVQAERDALALSKSPFIVHLYYS 72
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
++ +V++V EY+ +K + G F E+ +V L Y+HR G HRDLK
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 118 PSNLLVS-KGVIKIGDLGMVK-EIDSSLPCTDYVTT 151
P N+L+S +G IK+ D G+ K ++ L D +TT
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTT 167
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 75/331 (22%), Positives = 132/331 (39%), Gaps = 82/331 (24%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G+V A + A+K L+KK + + ++ ++K + + ++ +VKL +
Sbjct: 12 GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ 71
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ ++++ V +Y+ D++ L+ + F E R ++ + +H+ G+ HRD+KP
Sbjct: 72 DKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKP 129
Query: 119 SNLLVS-KGVIKIGDLGMVKEI-----------------DSSLP-----------CTD-- 147
N+L+ G IK+ D G+ DS P C D
Sbjct: 130 DNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRL 189
Query: 148 ------------------YVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILF 189
V T Y APEV LL + Y D W++G I+FEML + F
Sbjct: 190 KTLEQRATKQHQRCLAHSLVGTPNYIAPEV-LLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
Query: 190 PGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISL 249
+ K+ +W + + + +LSP E++ L
Sbjct: 249 LAPTPTETQLKVI---------NWENTLHIPPQV-------------KLSP----EAVDL 282
Query: 250 ISRLCSWNPHM--RPTAAEALEHPFFRSCHF 278
I++LC R A + HPFF F
Sbjct: 283 ITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-11
Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 32/219 (14%)
Query: 1 GSYGDVFQAL--DKKSGEF-VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +GDV+Q + ++ + VAVK K + L+E +R+ + HP+IVKL +
Sbjct: 17 GQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD-HPHIVKLIGV 75
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNL---CFQVFQGLHYMHRQGYFHR 114
+ E V+IV ME L ++ N ++ +L +Q+ L Y+ + + HR
Sbjct: 76 ITE-NPVWIV---MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHR 131
Query: 115 DLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPE---- 169
D+ N+LV S +K+GD G+ + ++ +Y+A + L + PE
Sbjct: 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDE---------SYYKASKGKLPIKWMAPESINF 182
Query: 170 ------VDMWAMGAIMFEMLSFRIL-FPGKNSADQIYKI 201
D+W G M+E+L + F G + D I +I
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-11
Identities = 55/188 (29%), Positives = 89/188 (47%), Gaps = 11/188 (5%)
Query: 1 GSYGDVFQALDKKSGEF--VAVKKLKK-KIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
GS+G V A K+ +F VA+K+ +K KI + ++ + + NHP V L
Sbjct: 41 GSFGRVILA-TYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGS 99
Query: 58 VKEHEDVFIVFEY-MESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
K+ +++V E+ + + + R + F D Q+ Y+ +RDL
Sbjct: 100 FKDESYLYLVLEFVIGGEFFTFL--RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDL 157
Query: 117 KPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
KP NLL+ K G IK+ D G K +D+ T Y APE+ LL+ +G D W +
Sbjct: 158 KPENLLLDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEI-LLNVGHGKAADWWTL 214
Query: 176 GAIMFEML 183
G ++E+L
Sbjct: 215 GIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 24/199 (12%)
Query: 4 GDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHED 63
G+V V VK+L+ ++ + L+E + R + H N+++ E
Sbjct: 14 GEVNSGYTPAQ---VVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTP 69
Query: 64 VFIVFEYMESDLLK--LMKERAGQNFSED--EVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+V E+ LK L R + + D ++ + ++ GL ++H+ + H DL
Sbjct: 70 YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALR 129
Query: 120 N-LLVSKGVIKIGDLGMV----KEIDSSLPCTDYVTTRWYRAPEVLLLSEIYG------- 167
N LL + +KIGD G+ KE P +V RW APE L+ E++G
Sbjct: 130 NCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APE--LVDEVHGNLLVVDQ 186
Query: 168 -PEVDMWAMGAIMFEMLSF 185
E ++W++G ++E+
Sbjct: 187 TKESNVWSLGVTIWELFEL 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 54/225 (24%), Positives = 105/225 (46%), Gaps = 48/225 (21%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPN---IVKLRNL 57
G++G+V K +G A+K L+K + E + ++ R + + +VK+
Sbjct: 12 GAFGEVRLVQKKDTGHVYAMKILRKA--DMLEKEQVGHIRAERDILVEADSLWVVKMFYS 69
Query: 58 VKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
++ +++++ E++ D++ L+ ++ +E+E + + + +H+ G+ HRD+
Sbjct: 70 FQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDI 127
Query: 117 KPSNLLV-SKGVIKIGDLGMV------------KEIDSSLPCTDY--------------- 148
KP NLL+ SKG +K+ D G+ + ++ SLP +D+
Sbjct: 128 KPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP-SDFTFQNMNSKRKAETWK 186
Query: 149 ----------VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEML 183
V T Y APEV + + Y D W++G IM+EML
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 1 GSYGDVFQA---LDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVK--- 53
G +G V +A + S + VAVK LK IF S D L+E C+++ +HPN++K
Sbjct: 10 GEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIG 68
Query: 54 --LRNLVKEHEDV-FIVFEYMESDLLK--LMKERAGQ---NFSEDEVRNLCFQVFQGLHY 105
LR+ K + ++ +M+ L L+ R G+ + + G+ Y
Sbjct: 69 VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEY 128
Query: 106 MHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVL 160
+ + + HRDL N ++++ + + + D G+ K+I S C + +W
Sbjct: 129 LSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES-- 186
Query: 161 LLSEIYGPEVDMWAMGAIMFEMLS 184
L +Y D+WA G M+E+++
Sbjct: 187 LADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 51/224 (22%), Positives = 101/224 (45%), Gaps = 46/224 (20%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPN---IVKLRNL 57
G++G+V K +G A+K L+K + E + ++ R + + +VK+
Sbjct: 12 GAFGEVRLVQKKDTGHIYAMKILRKA--DMLEKEQVAHIRAERDILVEADGAWVVKMFYS 69
Query: 58 VKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
++ +++++ E++ D++ L+ ++ SE+ + + + +H+ G+ HRD+
Sbjct: 70 FQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDI 127
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSL-----------PCTDY---------------- 148
KP NLL+ +KG +K+ D G+ + + P +D+
Sbjct: 128 KPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKK 187
Query: 149 ---------VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEML 183
V T Y APEV + + Y D W++G IM+EML
Sbjct: 188 NRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 25/203 (12%)
Query: 4 GDVFQALDKKSGEFVAVKKLKKKI-FSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE 62
G +F + + VA+K LK K L E K +R HPNIV L +V + +
Sbjct: 24 GHLFGTAPGEQTQAVAIKTLKDKAEGPLREE--FKHEAMMRSRLQHPNIVCLLGVVTKEQ 81
Query: 63 DVFIVFEYME-SDLLKLMKERA-----GQNFSEDEVRN---------LCFQVFQGLHYMH 107
+ ++F Y SDL + + R+ G + V++ + Q+ G+ ++
Sbjct: 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS 141
Query: 108 RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLLL 162
H+DL N+LV K +KI DLG+ +E+ ++ L + RW +PE ++
Sbjct: 142 SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWM-SPEAIMY 200
Query: 163 SEIYGPEVDMWAMGAIMFEMLSF 185
+ + + D+W+ G +++E+ S+
Sbjct: 201 GK-FSIDSDIWSYGVVLWEVFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 69/269 (25%), Positives = 114/269 (42%), Gaps = 49/269 (18%)
Query: 38 EVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCF 97
E + LR+++ HP ++ L ++ +V SDL + R + +V +
Sbjct: 210 EARLLRRLS-HPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARL-RPLGLAQVTAVAR 267
Query: 98 QVFQGLHYMHRQGYFHRDLKPSNLLVSKGV-IKIGDLG---MVKEIDSSLPCTDYVTTRW 153
Q+ + Y+H +G HRD+K N+LV+ I +GD G + S+ T
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEM-LSFRILF-----PGKNSAD-QIYKICQVIG 206
APEV L + Y P VD+W+ G ++FE + LF + D QI +I +
Sbjct: 328 TNAPEV-LAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR--- 383
Query: 207 SPTEDSWPLGIQLASNLDWKFPQMGGVNL---------RELSPSASRESIS--------- 248
Q ++D +FPQ G L R P+ +R + +
Sbjct: 384 -----------QAQVHVD-EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDV 431
Query: 249 --LISRLCSWNPHMRPTAAEALEHPFFRS 275
L+ R +++ RP+AAE L P F+S
Sbjct: 432 EYLVCRALTFDGARRPSAAELLRLPLFQS 460
|
Length = 461 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-10
Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 1 GSYGDVFQALDKKSGEF----VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G++G V++ + GE VA+K L+++ L E + ++ HP++V+L
Sbjct: 18 GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVVRLLG 76
Query: 57 LVKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+ V ++ + M LL ++ N + N C Q+ +G+ Y+ + HRD
Sbjct: 77 ICLS-SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRD 134
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDY----VTTRWYRAPEVLLLSEIYGPEV 170
L N+LV + +KI D G+ K +D V +W A E +L IY +
Sbjct: 135 LAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM-ALESILHR-IYTHKS 192
Query: 171 DMWAMGAIMFEMLSF 185
D+W+ G ++E+++F
Sbjct: 193 DVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 78/332 (23%), Positives = 135/332 (40%), Gaps = 84/332 (25%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G+V A + A+K L+KK + ++ ++K + + ++ +V+L +
Sbjct: 12 GAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ 71
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ ++++ V +Y+ D++ L+ R G F ED R ++ + +H+ G+ HRD+KP
Sbjct: 72 DKDNLYFVMDYIPGGDMMSLLI-RMGI-FPEDLARFYIAELTCAVESVHKMGFIHRDIKP 129
Query: 119 SNLLVSK-GVIKIGDLGMVK----------------------------EIDSSLPCTD-- 147
N+L+ + G IK+ D G+ ++ C D
Sbjct: 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRL 189
Query: 148 ------------------YVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILF 189
V T Y APEVLL + Y D W++G I++EML + F
Sbjct: 190 KPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPF 248
Query: 190 PGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISL 249
+ + K+ W + + PQ +LSP AS L
Sbjct: 249 LAQTPLETQMKVIN---------WQTSLHIP-------PQA------KLSPEAS----DL 282
Query: 250 ISRLCSWNPHMR---PTAAEALEHPFFRSCHF 278
I +LC P R A E HPFF++ F
Sbjct: 283 IIKLCR-GPEDRLGKNGADEIKAHPFFKTIDF 313
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-10
Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 18/196 (9%)
Query: 1 GSYGDVFQALDK--KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G++G V + + K K VA+K LK + ++E + + +++N P IV++ +
Sbjct: 6 GNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN-PYIVRMIGVC 64
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
E E + +V E L + V L QV G+ Y+ + + HRDL
Sbjct: 65 -EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAA 123
Query: 119 SN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTR--------WYRAPEVLLLSEIYGPE 169
N LLV++ KI D G+ K + + Y R WY APE + + +
Sbjct: 124 RNVLLVNQHYAKISDFGLSKALGAD---DSYYKARSAGKWPLKWY-APECINFRK-FSSR 178
Query: 170 VDMWAMGAIMFEMLSF 185
D+W+ G M+E S+
Sbjct: 179 SDVWSYGITMWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 65/301 (21%), Positives = 123/301 (40%), Gaps = 36/301 (11%)
Query: 6 VFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVF 65
V+ A +G V V+ + + + + L+ L HPNI+ + ++
Sbjct: 16 VYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLW 75
Query: 66 IVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 124
++ +M L+K + SE + N+ F +GL+Y+H+ GY HR++K S++L+S
Sbjct: 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS 135
Query: 125 -KGVIKIGDLG----MVKEIDSSLPCTDY----VTTRWYRAPEVLLLSEIYGPEV--DMW 173
G++ + L +V+ + D+ + + +PE LL ++YG V D++
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE-LLRQDLYGYNVKSDIY 194
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG-- 231
++G E+ + R+ F + + Q + P + K Q G
Sbjct: 195 SVGITACELATGRVPF---QDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVD 251
Query: 232 -GVN----------------LRELSPSASRESISLISRLC-SWNPHMRPTAAEALEHPFF 273
G+ LR S + + LC +P RP+A+ L H FF
Sbjct: 252 SGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311
Query: 274 R 274
+
Sbjct: 312 K 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 62/257 (24%), Positives = 116/257 (45%), Gaps = 33/257 (12%)
Query: 37 KEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLC 96
+E+ L+ ++ H I+ L + + V +V + DL + +R+G ++ +
Sbjct: 135 REIDILKTIS-HRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV-DRSGP-LPLEQAITIQ 191
Query: 97 FQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTR 152
++ + L Y+H +G HRD+K N+ + + +GD G ++D+ C + T
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTL 251
Query: 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGK---NSADQ---IYKICQV-- 204
+PE+L L + Y + D+W+ G ++FEM + GK +S+ Q I + QV
Sbjct: 252 ETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310
Query: 205 IGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE--LSPSASRESIS------LISRLCSW 256
+ P S +NL F Q + LR P R+ LI+++ ++
Sbjct: 311 LEFPQNGS--------TNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTF 361
Query: 257 NPHMRPTAAEALEHPFF 273
+ RP+A + L P F
Sbjct: 362 DQEFRPSAQDILSLPLF 378
|
Length = 392 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 44/200 (22%)
Query: 17 FVAVKKLKKKIFSLDESRN-----LKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYM 71
VAVK L+ D ++N LKEVK L ++ + PNI++L + + + + ++ EYM
Sbjct: 48 LVAVKILRP-----DANKNARNDFLKEVKILSRLKD-PNIIRLLGVCVDEDPLCMITEYM 101
Query: 72 ES-DLLKLMKER-----------------AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
E+ DL + + S + ++ Q+ G+ Y+ + H
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161
Query: 114 RDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDY--------VTTRWYRAPEVLLLSE 164
RDL N LV + + IKI D GM + +L DY + RW A E +L+ +
Sbjct: 162 RDLATRNCLVGENLTIKIADFGMSR----NLYAGDYYRIQGRAVLPIRWM-AWECILMGK 216
Query: 165 IYGPEVDMWAMGAIMFEMLS 184
+ D+WA G ++E+L
Sbjct: 217 -FTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-09
Identities = 63/292 (21%), Positives = 128/292 (43%), Gaps = 60/292 (20%)
Query: 1 GSYGDVFQALDK-----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
GS+G V++ + K + VA+K + + + L E +++ N H ++V+L
Sbjct: 17 GSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLL 75
Query: 56 NLVKEHEDVFIVFEYM-ESDL---LKLMKERAGQNFSE-----DEVRNLCFQVFQGLHYM 106
+V + + ++ E M DL L+ ++ N + ++ + ++ G+ Y+
Sbjct: 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL 135
Query: 107 HRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--------VTTRWYRAP 157
+ + HRDL N +V++ +KIGD GM ++I TDY + RW +P
Sbjct: 136 NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----TDYYRKGGKGLLPVRWM-SP 190
Query: 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGI 217
E L ++ D+W+ G +++E+ + A+Q Y+
Sbjct: 191 ES-LKDGVFTTYSDVWSFGVVLWEIATL---------AEQPYQ----------------- 223
Query: 218 QLASNLDWKFPQMGGVNLRELSPSASRESISLISRLC-SWNPHMRPTAAEAL 268
+++ +F GG+ + P + + + R+C +NP MRP+ E +
Sbjct: 224 GMSNEQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 48/208 (23%), Positives = 90/208 (43%), Gaps = 40/208 (19%)
Query: 70 YMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VI 128
Y++ D+ + E +++ + +QV +G+ ++ + HRDL N+L++ G +
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253
Query: 129 KIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE-----IYGPEVDMWAMGAIMFEML 183
KI D G+ ++I + ++YV R P + E +Y E D+W+ G +++E+
Sbjct: 254 KICDFGLARDIRND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 310
Query: 184 SFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSAS 243
S +GS P +D KF +M R LSP +
Sbjct: 311 S--------------------LGSSPYPGMP--------VDSKFYKMIKEGYRMLSPECA 342
Query: 244 RESISLISRLCSWN--PHMRPTAAEALE 269
+ I + C W+ P RPT + ++
Sbjct: 343 PSEMYDIMKSC-WDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 13/175 (7%)
Query: 18 VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL- 76
VA+ L+ L E L + + H NIV+L ++ + IV EYM + L
Sbjct: 36 VAIHTLRAGCSDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGM 135
+++ GQ ++ + + G+ Y+ GY H+ L +LV+ V KI
Sbjct: 95 SFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRR 153
Query: 136 VKEIDSSLPCTDYVTTR-----WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
++E S Y T + APE + + D+W+ G +M+E++S+
Sbjct: 154 LQEDKSE---AIYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSY 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-08
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 25/205 (12%)
Query: 1 GSYGDVFQA-LDKKSGEF--VAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRN 56
G +G V + L + G VAVK +K I + E L E C++ + HPN++KL
Sbjct: 10 GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-HPNVMKLIG 68
Query: 57 LVKEHEDV------FIVFEYME-----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHY 105
+ E + ++ +M+ S LL + + + G+ Y
Sbjct: 69 VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEY 128
Query: 106 MHRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE 164
+ + + HRDL N ++ + + + + D G+ K+I S Y R + P + E
Sbjct: 129 LSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG---DYYRQGRIAKMPVKWIAIE 185
Query: 165 -----IYGPEVDMWAMGAIMFEMLS 184
+Y + D+WA G M+E+ +
Sbjct: 186 SLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 31/126 (24%), Positives = 70/126 (55%), Gaps = 8/126 (6%)
Query: 72 ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKI 130
+S++ L+ + + + ++ + +QV +G+ ++ + HRDL N+L+++G ++KI
Sbjct: 219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI 278
Query: 131 GDLGMVKEI--DSSLPC--TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF- 185
D G+ ++I DS+ + ++ +W APE + +Y D+W+ G +++E+ S
Sbjct: 279 CDFGLARDIMHDSNYVSKGSTFLPVKWM-APES-IFDNLYTTLSDVWSYGILLWEIFSLG 336
Query: 186 RILFPG 191
+PG
Sbjct: 337 GTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 19/100 (19%)
Query: 97 FQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI----------DSSLPC 145
FQV +G+ ++ + HRDL N+L+S V+KI D G+ ++I D+ LP
Sbjct: 186 FQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP- 244
Query: 146 TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
+W APE + +Y + D+W+ G +++E+ S
Sbjct: 245 -----LKWM-APET-IFDRVYTIQSDVWSFGVLLWEIFSL 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 8e-08
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 27/203 (13%)
Query: 1 GSYGDVFQ--ALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G +G V A S V VK+L+ ++ L+EV+ R++N HPN+++
Sbjct: 6 GWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN-HPNVLQCLGQC 64
Query: 59 KEHEDVFIVFEYMESDLLK--LMKERA--GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
E +V E+ LK L R Q +D ++ + +V GL ++H+ + H
Sbjct: 65 IESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHS 124
Query: 115 DLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRAPEVL----- 160
DL N L + +KIGD G+ E DY T RW APE++
Sbjct: 125 DLALRNCQLTADLSVKIGDYGLALEQYPE----DYYITKDCHAVPLRWL-APELVEIRGQ 179
Query: 161 -LLSEIYGPEVDMWAMGAIMFEM 182
LL + + ++W++G M+E+
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-07
Identities = 39/192 (20%), Positives = 67/192 (34%), Gaps = 38/192 (19%)
Query: 84 GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR-DLKPSNLLVSKGVIKIGDLGMVKEIDSS 142
G+ +E+E+ +C Q L +HRQ L LL G +
Sbjct: 11 GRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAF-----------K 59
Query: 143 LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKIC 202
P + APEV + + Y + D++++G ++E L + + + + I +I
Sbjct: 60 TPEQSRPDPYF-MAPEV-IQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEI- 116
Query: 203 QVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSAS-RESISL-ISRLCSWNPHM 260
++ D NL +S + S + + L SRL P
Sbjct: 117 -LLNGMPADD----------------PRDRSNLEGVSAARSFEDFMRLCASRL----PQR 155
Query: 261 RPTAAEALEHPF 272
R A L H
Sbjct: 156 REAANHYLAHCR 167
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 60/291 (20%), Positives = 116/291 (39%), Gaps = 29/291 (9%)
Query: 12 KKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYM 71
K +GE+V V+++ + + + L+ + K+ NHPNIV R ++++V +M
Sbjct: 22 KPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81
Query: 72 ESDLLK-LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS------ 124
K L+ SE + + V + L Y+H GY HR +K S++L+S
Sbjct: 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 141
Query: 125 ----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS-EIYGPEVDMWAMGAIM 179
+ + + + G + P W +PEVL + + Y + D++++G
Sbjct: 142 LSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWL-SPEVLQQNLQGYDAKSDIYSVGITA 200
Query: 180 FE----------MLSFRILFPGKNSA------DQIYKICQVIGSPTEDSWPLGIQLASNL 223
E M + ++L N ++ P+ G+ ++ +
Sbjct: 201 CELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTV 260
Query: 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P G + + + S + + NP RP+A+ L H FF+
Sbjct: 261 STPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 49/184 (26%), Positives = 81/184 (44%), Gaps = 44/184 (23%)
Query: 97 FQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT---- 151
FQV +G+ ++ + HRDL N+L+S V+KI D G+ ++I DYV
Sbjct: 180 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD---PDYVRKGDAR 236
Query: 152 ---RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSP 208
+W APE + ++Y + D+W+ G +++E+ S SP
Sbjct: 237 LPLKWM-APES-IFDKVYTTQSDVWSFGVLLWEIFSLG-------------------ASP 275
Query: 209 TEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSW--NPHMRPTAAE 266
+P G+Q+ + + G +R +P + I I C W NP RPT +E
Sbjct: 276 ----YP-GVQIDEEFCRRLKE--GTRMR--APEYATPEIYSIMLDC-WHNNPEDRPTFSE 325
Query: 267 ALEH 270
+E
Sbjct: 326 LVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 33/121 (27%), Positives = 63/121 (52%), Gaps = 14/121 (11%)
Query: 90 DEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY 148
D++ QV QG+ ++ + HRD+ N+L++ G V KI D G+ ++I + ++Y
Sbjct: 212 DDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND---SNY 268
Query: 149 VT-------TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYK 200
V +W APE + +Y + D+W+ G +++E+ S + +PG + YK
Sbjct: 269 VVKGNARLPVKWM-APESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326
Query: 201 I 201
+
Sbjct: 327 M 327
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 13/97 (13%)
Query: 97 FQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT---- 151
FQV +G+ ++ + HRDL N+L+S+ V+KI D G+ ++I DYV
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD---PDYVRKGSAR 237
Query: 152 ---RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
+W APE + ++Y + D+W+ G +++E+ S
Sbjct: 238 LPLKWM-APES-IFDKVYTTQSDVWSFGVLLWEIFSL 272
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-07
Identities = 33/143 (23%), Positives = 65/143 (45%), Gaps = 6/143 (4%)
Query: 47 NHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYM 106
+H IV+L + + LL +++ + + N C Q+ +G++Y+
Sbjct: 67 DHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYL 125
Query: 107 HRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEI---DSSLPCTDYVTTRWYRAPEVLLL 162
HR+L N LL S +++I D G+ + D +++ T + A E +L
Sbjct: 126 EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 163 SEIYGPEVDMWAMGAIMFEMLSF 185
Y + D+W+ G ++EM+S+
Sbjct: 186 GR-YTHQSDVWSYGVTVWEMMSY 207
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 47/200 (23%), Positives = 94/200 (47%), Gaps = 25/200 (12%)
Query: 1 GSYGDVFQALDKKSGEF----VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G++G V++ L GE VA+K+L++ L E + ++ +P++ +L
Sbjct: 18 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLG 76
Query: 57 LVKEHEDVFIVFEYMES----DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ V ++ + M D ++ K+ G + + N C Q+ +G++Y+ +
Sbjct: 77 ICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQY----LLNWCVQIAKGMNYLEERRLV 131
Query: 113 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDY------VTTRWYRAPEVLLLSEI 165
HRDL N+LV + +KI D G+ K + + +Y V +W + L I
Sbjct: 132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADE--KEYHAEGGKVPIKWMALESI--LHRI 187
Query: 166 YGPEVDMWAMGAIMFEMLSF 185
Y + D+W+ G ++E+++F
Sbjct: 188 YTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-06
Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 28/190 (14%)
Query: 14 SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73
V VK+LK S +++ L++ R + HPNI++ E +VFEY E
Sbjct: 21 GVARVVVKELKANASSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYCEL 79
Query: 74 DLLKLMKERAGQNFSEDEV----RNLCFQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGVI 128
LK + + ++ R C ++ G+ +MH+ + H DL N L S +
Sbjct: 80 GDLKSYLSQEQWHRRNSQLLLLQRMAC-EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTV 138
Query: 129 KIGDLGMVKEIDSSLPCTDYVTT--------RWYRAPEV-------LLLSEIYGPEVDMW 173
K+GD G I S DY+ T RW APE+ L+ +E P ++W
Sbjct: 139 KVGDYG----IGPSRYKEDYIETEDDKCVPLRWL-APELVGEFHGGLITAEQTKPS-NVW 192
Query: 174 AMGAIMFEML 183
A+G ++E+
Sbjct: 193 ALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 1 GSYGDVFQAL----DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G++G +F + E V VK +K + + L+E L ++ H NI+ + +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS-HQNILPILH 75
Query: 57 LVKE-HEDVFIVFEYMESDLLKLM-------KERAGQNFSEDEVRNLCFQVFQGLHYMHR 108
+ E E F+++ YM LKL + Q S ++ ++ Q+ G+ Y+H+
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 109 QGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSL-----PCTDYVT--------TRWYR 155
+G H+D+ N + I + VK D++L P DY +W
Sbjct: 136 RGVIHKDIAARNCV-------IDEELQVKITDNALSRDLFP-MDYHCLGDNENRPVKWM- 186
Query: 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLS 184
A E L+++ Y D+W+ G +++E+++
Sbjct: 187 ALES-LVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-06
Identities = 33/118 (27%), Positives = 60/118 (50%), Gaps = 12/118 (10%)
Query: 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDL 133
LL ++E + S+D + N C Q+ +G+ Y+ HRDL N+LV S +KI D
Sbjct: 95 LLDYVRENKDRIGSQD-LLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDF 153
Query: 134 GMVKEIDSSLPCTDY------VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
G+ + +D + T+Y V +W + L + + D+W+ G ++E+++F
Sbjct: 154 GLARLLD--IDETEYHADGGKVPIKWMALESI--LHRRFTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 47/194 (24%), Positives = 87/194 (44%), Gaps = 13/194 (6%)
Query: 1 GSYGDVFQALDKKSGEFV----AVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G++G V++ + GE V A+K L + + E + M+ HP++V+L
Sbjct: 18 GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD-HPHLVRLLG 76
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + +V + M L N + N C Q+ +G+ Y+ + HRDL
Sbjct: 77 VCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDL 135
Query: 117 KPSNLLV-SKGVIKIGDLGMVK--EIDSSLPCTD--YVTTRWYRAPEVLLLSEIYGPEVD 171
N+LV S +KI D G+ + E D D + +W A E + + + + D
Sbjct: 136 AARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM-ALECIHYRK-FTHQSD 193
Query: 172 MWAMGAIMFEMLSF 185
+W+ G ++E+++F
Sbjct: 194 VWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 27/104 (25%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 87 FSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEI--DSSL 143
S ++ +QV G+ ++ + HRDL N+L+ +G ++KI D G+ ++I DS+
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY 295
Query: 144 --PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
+ ++ +W APE + + +Y D+W+ G +++E+ +
Sbjct: 296 ISKGSTFLPLKWM-APES-IFNNLYTTLSDVWSFGILLWEIFTL 337
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 92 VRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL---PCTD 147
++ + QV GL +HR G HRD+KP NLLV+ G +KI D G ++ + + P
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG 370
Query: 148 YVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179
+ R Y PE L++ + P AM A++
Sbjct: 371 MLDPR-YSPPEELVMPQSC-PRAPAPAMAALL 400
|
Length = 507 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-05
Identities = 46/205 (22%), Positives = 89/205 (43%), Gaps = 30/205 (14%)
Query: 1 GSYGDVFQALDKKSGEF--VAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNL 57
G +G V + + VAVK +K I + E + L E C+++ + HPN+++L +
Sbjct: 10 GEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HPNVMRLIGV 68
Query: 58 V---KEHEDV---FIVFEYMESDLLK--LMKERAG---QNFSEDEVRNLCFQVFQGLHYM 106
E E ++ +M+ L L+ R G Q + + G+ Y+
Sbjct: 69 CLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL 128
Query: 107 HRQGYFHRDLKPSNLLVSKGV-IKIGDLGMVKEIDSSLPCTDY--------VTTRWYRAP 157
+ + HRDL N ++++ + + + D G+ K+I + DY + +W
Sbjct: 129 SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG----DYYRQGRIAKMPVKWIAIE 184
Query: 158 EVLLLSEIYGPEVDMWAMGAIMFEM 182
L +Y + D+W+ G M+E+
Sbjct: 185 S--LADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 24/71 (33%), Positives = 35/71 (49%), Gaps = 8/71 (11%)
Query: 65 FIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS 124
IV EY+E +LLK E A + + R + G +H+ G H DL SN+++S
Sbjct: 75 LIVMEYIEGELLKDALEEARPDLLREVGRLV------GK--LHKAGIVHGDLTTSNIILS 126
Query: 125 KGVIKIGDLGM 135
G I D G+
Sbjct: 127 GGRIYFIDFGL 137
|
Length = 204 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 44/185 (23%), Positives = 83/185 (44%), Gaps = 31/185 (16%)
Query: 18 VAVKKLKKKIFSLDE-SRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76
AVK L + I L+E + LKE + K +HPN++ L + E +V +L
Sbjct: 26 CAVKSLNR-ITDLEEVEQFLKE-GIIMKDFSHPNVLSLLGICLPSEGSPLV-------VL 76
Query: 77 KLMKERAGQNFSEDEVRN--------LCFQVFQGLHYMHRQGYFHRDLKPSN-LLVSKGV 127
MK +NF E N QV +G+ Y+ + + HRDL N +L
Sbjct: 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT 136
Query: 128 IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV--------LLLSEIYGPEVDMWAMGAIM 179
+K+ D G+ ++I +Y + + ++ L ++ + + D+W+ G ++
Sbjct: 137 VKVADFGLARDIYDK----EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 192
Query: 180 FEMLS 184
+E+++
Sbjct: 193 WELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|233667 TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 18/87 (20%)
Query: 62 EDVFIVFEYME----SDLLKLMKERAGQN---FSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
E V E+++ SD+ L + AG + +E+ R+ QV R G+FH
Sbjct: 232 ERVL-TMEWIDGIPLSDIAAL--DEAGLDRKALAENLARSFLNQVL-------RDGFFHA 281
Query: 115 DLKPSNLLVSK-GVIKIGDLGMVKEID 140
DL P N+ V K G I D G+V +
Sbjct: 282 DLHPGNIFVLKDGKIIALDFGIVGRLS 308
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol -> 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]. Length = 437 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 55/215 (25%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G G ++ K+G VK++ + S+ S E+ + K+ HPNIVKL L +
Sbjct: 701 GKKGASYKGKSIKNGMQFVVKEIND-VNSIPSS----EIADMGKLQ-HPNIVKLIGLCRS 754
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG---------- 110
+ +++ EY+E G+N SE V + L + R+
Sbjct: 755 EKGAYLIHEYIE-----------GKNLSE---------VLRNLSWERRRKIAIGIAKALR 794
Query: 111 YFHRDLKPS----NLLVSKGVIKIGDLGMVKEIDSSLP---CTDY--VTTRWYRAPEVLL 161
+ H P+ NL K +I D + SLP CTD + Y APE
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKD---EPHLRLSLPGLLCTDTKCFISSAYVAPETRE 851
Query: 162 LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSAD 196
+I + D++ G I+ E+L+ GK+ AD
Sbjct: 852 TKDI-TEKSDIYGFGLILIELLT------GKSPAD 879
|
Length = 968 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.002
Identities = 33/145 (22%), Positives = 52/145 (35%), Gaps = 26/145 (17%)
Query: 61 HEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVF--QGLHYMHRQGYFHR 114
V + E+++ SD+ L E+ L + F Q L G+FH
Sbjct: 239 TRRV-LTMEWIDGIKISDIAALKS----AGIDRKELAELLVRAFLRQLLRD----GFFHA 289
Query: 115 DLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWY--------RAPEVLLLSEI 165
D P N+LV S G I + D G+V +D Y+ R E+ +
Sbjct: 290 DPHPGNILVRSDGRIVLLDFGIVGRLDPKFR--RYLAELLLAFLNRDYDRVAELHVELGY 347
Query: 166 YGPEVDMWAMGAIMFEMLSFRILFP 190
P+ D + A + +L P
Sbjct: 348 VPPDTDRDPLAAAIRAVLEPIYGKP 372
|
Length = 517 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 282 | |||
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.6 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.56 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.56 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.47 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.41 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.33 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.32 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.3 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.27 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.04 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.94 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.82 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.81 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.8 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.79 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.67 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.6 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.58 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.55 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.38 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.3 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.2 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.16 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.16 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.13 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.94 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.88 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.87 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.82 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.73 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.71 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.66 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.66 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.61 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.59 | |
| PLN02236 | 344 | choline kinase | 97.55 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.47 | |
| PTZ00384 | 383 | choline kinase; Provisional | 97.44 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.42 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.29 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.27 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.17 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.91 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.83 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.82 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.79 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.77 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.66 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.54 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.48 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 96.44 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.41 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.21 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.2 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.06 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.05 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.81 |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-62 Score=390.15 Aligned_cols=277 Identities=52% Similarity=0.991 Sum_probs=265.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCC-cEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE-DVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-~~~lv~e~~~~~~l~~~ 79 (282)
|.||.||+|+.+++|+.||||..++....-++...++|++.++++..||||+++.+++.+++ .+|+|||+|+..+++.+
T Consensus 21 GTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~NLYqLm 100 (538)
T KOG0661|consen 21 GTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDCNLYQLM 100 (538)
T ss_pred CcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhhhHHHHH
Confidence 89999999999999999999999998888888888999999999977999999999998887 99999999999999988
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
..+ ++.|++..++.|+.||++||+|+|.+|+.|||+||+|||+. ...+||+|||+|+.+....+.+.++.|..|+|||
T Consensus 101 K~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPE 179 (538)
T KOG0661|consen 101 KDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPE 179 (538)
T ss_pred hhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchH
Confidence 887 67899999999999999999999999999999999999999 7899999999999999998999999999999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
++.....|+.+.|+|++||+++|+.+-+..|.+.+..|++.++++.+|.|....|+.+..+....+..+++.....+..+
T Consensus 180 vLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L 259 (538)
T KOG0661|consen 180 VLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDL 259 (538)
T ss_pred HhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHh
Confidence 99988889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....+.++.++|.+||.+||.+||||+++|+||||+....
T Consensus 260 ~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 260 LPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred CcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 9999999999999999999999999999999999986544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-59 Score=367.67 Aligned_cols=250 Identities=30% Similarity=0.464 Sum_probs=211.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch------HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL------DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~------~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|+||.|-+|..+.||+.||||+++++.... ......+|+.+++++ +|||||+++++|+..+..||||||++|+
T Consensus 183 Gafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~ds~YmVlE~v~GG 261 (475)
T KOG0615|consen 183 GAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVPDSSYMVLEYVEGG 261 (475)
T ss_pred CceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecCCceEEEEEEecCc
Confidence 899999999999999999999998876543 223346899999999 4999999999999999999999999865
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCC----cEEEeecCcccccCCCCCCCCccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSSLPCTDYVT 150 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~----~~~l~df~~~~~~~~~~~~~~~~~ 150 (282)
-|-...... +.+.+..-+.+++|++.|+.|||++||+||||||+|||+++. .+|++|||+|...+...-....+|
T Consensus 262 eLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCG 340 (475)
T KOG0615|consen 262 ELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCG 340 (475)
T ss_pred cHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcC
Confidence 554444443 479999999999999999999999999999999999999743 699999999999987777788999
Q ss_pred cccccCchhhhccc--cCCCcchhHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 151 TRWYRAPEVLLLSE--IYGPEVDMWAMGAIMFEMLSFRILFPGKNSAD-QIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 151 ~~~~~aPE~~~~~~--~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
||.|.|||++...+ .+..+.|+||+||++|-+++|..||....... ...++..+.-...+
T Consensus 341 TpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p----------------- 403 (475)
T KOG0615|consen 341 TPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP----------------- 403 (475)
T ss_pred CccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC-----------------
Confidence 99999999996443 34568899999999999999999998766555 55555443322222
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
..+..++++..+||.+||..||++|||++|+|+||||+.+..
T Consensus 404 ---------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 404 ---------LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred ---------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 234578999999999999999999999999999999997763
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-58 Score=357.09 Aligned_cols=247 Identities=30% Similarity=0.493 Sum_probs=214.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCC-cEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE-DVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-~~~lv~e~~~~~~l~~~ 79 (282)
|..|+||+|+|+.|++.+|+|++..........++.+|+.++++. +||+||.+||.|..++ ...|+||||++++|+.+
T Consensus 90 G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~ 168 (364)
T KOG0581|consen 90 GNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDI 168 (364)
T ss_pred CCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHH
Confidence 788999999999999999999997766667778899999999999 6999999999999988 49999999999999998
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
....+ .+++..+..|+.++++||.|||+ .+|+||||||+|||++ .|.|||||||.+..+... ...+..||..||||
T Consensus 169 ~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsP 246 (364)
T KOG0581|consen 169 LKRVG-RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSP 246 (364)
T ss_pred HhhcC-CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hcccccccccccCh
Confidence 88764 69999999999999999999995 8999999999999998 599999999999887665 55778999999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCC--CChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGK--NSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|.+.+.. |+.++||||||+.++|+++|+.||... ...+.+..+..-...++
T Consensus 247 ERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp-------------------------- 299 (364)
T KOG0581|consen 247 ERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP-------------------------- 299 (364)
T ss_pred hhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC--------------------------
Confidence 9998554 899999999999999999999999874 22333333333222222
Q ss_pred cccCCC-CChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 236 RELSPS-ASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 236 ~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
+.++.+ +++++++||..||+.||.+|||+.|+++|||++...
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 233444 899999999999999999999999999999998654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-57 Score=345.85 Aligned_cols=274 Identities=29% Similarity=0.577 Sum_probs=230.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHH-HHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE-SRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~-~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|+++.||+.||||++..+.-.... .-.++|+.+++++. |||+|.++++|.....+++|+|||+.+.|+.+
T Consensus 13 GSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLVFE~~dhTvL~eL 91 (396)
T KOG0593|consen 13 GSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLVFEYCDHTVLHEL 91 (396)
T ss_pred CcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEEeeecchHHHHHH
Confidence 89999999999999999999999776543433 34589999999996 99999999999999999999999999999887
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aP 157 (282)
.... ..++...+.+++.|++.|+.|+|+++++||||||+||+++. |.+||||||+|+.+. .....+.+..|..|+||
T Consensus 92 e~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaP 170 (396)
T KOG0593|consen 92 ERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAP 170 (396)
T ss_pred Hhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccCh
Confidence 6654 46999999999999999999999999999999999999985 899999999999886 44455677889999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc-cc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN-LR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 236 (282)
|.+.+...|+.+.|||++||++.||++|...|.+.++-++++.+...+|...+...........-.-..++.....+ ++
T Consensus 171 ELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe 250 (396)
T KOG0593|consen 171 ELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLE 250 (396)
T ss_pred hhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchh
Confidence 99998888999999999999999999999999999999999999999998776644332222211112222222111 11
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.--+..+.-+.+|+++||+.||++|++.+++|.|++|.+.
T Consensus 251 ~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 251 RKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred hhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 1223456789999999999999999999999999999653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-57 Score=370.17 Aligned_cols=242 Identities=34% Similarity=0.553 Sum_probs=216.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|||++||.+++..+|+.||+|++.+.... .......+|+.+.+++. |||||.++++|++..+.|||.|+|..+++..
T Consensus 29 GgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYivLELC~~~sL~e 107 (592)
T KOG0575|consen 29 GGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIVLELCHRGSLME 107 (592)
T ss_pred CcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEEEEecCCccHHH
Confidence 89999999999999999999999875432 34567788999999995 9999999999999999999999999888888
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCC-cEEEeecCcccccCCC-CCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSS-LPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~-~~~l~df~~~~~~~~~-~~~~~~~~~~~~~a 156 (282)
+.++. +.++|.+++.+++||+.||.|||+++|+|||||..|++++++ .||++|||+|+.+... ......+|||.|.|
T Consensus 108 l~Krr-k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIA 186 (592)
T KOG0575|consen 108 LLKRR-KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIA 186 (592)
T ss_pred HHHhc-CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccC
Confidence 88754 689999999999999999999999999999999999999975 9999999999998744 55577899999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++...+ ++..+||||+||+||-|+.|++||+..+-.+.+..+...--
T Consensus 187 PEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y------------------------------ 235 (592)
T KOG0575|consen 187 PEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY------------------------------ 235 (592)
T ss_pred hhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc------------------------------
Confidence 99998555 89999999999999999999999999988888887766321
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
.+|..++.+.++||.+||++||.+|||+++||.|+||++
T Consensus 236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 234578999999999999999999999999999999943
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-56 Score=330.38 Aligned_cols=273 Identities=38% Similarity=0.670 Sum_probs=243.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|.||.||+|++..||+.||||+++.....+ -....++|++.++.+. ||||+.++++|...+.+.+|+||+.-++...+
T Consensus 13 G~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lVfEfm~tdLe~vI 91 (318)
T KOG0659|consen 13 GTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLVFEFMPTDLEVVI 91 (318)
T ss_pred cceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEEEEeccccHHHHh
Confidence 889999999999999999999998765433 3456789999999996 99999999999999999999999987765544
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCC-ccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~aP 157 (282)
+.....++...++.++.++++|++|||+++|+||||||+|+|++ +|.+|+.|||+++..+....... ...|..|+||
T Consensus 92 -kd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAP 170 (318)
T KOG0659|consen 92 -KDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAP 170 (318)
T ss_pred -cccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccCh
Confidence 44446799999999999999999999999999999999999997 59999999999998876554333 3678999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+.+.|+...|+||+||++.||+-+...|.+.++-+++..+...+|+|.++.||....+....+.. +........
T Consensus 171 ELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~--~~P~~~~~~ 248 (318)
T KOG0659|consen 171 ELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ--QFPKPPLNN 248 (318)
T ss_pred HHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh--cCCCCcccc
Confidence 999999999999999999999999999999999999999999999999999999999999999888777 333444444
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
+....+++..+|+.+||..||.+|+|++|+|+|+||++..
T Consensus 249 lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 249 LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 7778899999999999999999999999999999999743
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-55 Score=353.04 Aligned_cols=274 Identities=36% Similarity=0.654 Sum_probs=240.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~l~ 77 (282)
|.||.||+|++..||+.||+|++..+... .......+|+.+|+++ +||||+++.+...+. +.+|+|+|||+.++.-
T Consensus 128 GTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siYlVFeYMdhDL~G 206 (560)
T KOG0600|consen 128 GTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSG 206 (560)
T ss_pred cchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEEEEEecccchhhh
Confidence 89999999999999999999999877643 3345567999999999 599999999998665 7899999999987665
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC--CCCCCccccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS--LPCTDYVTTRWY 154 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~--~~~~~~~~~~~~ 154 (282)
.+ ...+-.|++.+++.++.||++||+|||++|++|||||.+|||||+ |.+||.|||+|+..... ...+..+.|+.|
T Consensus 207 Ll-~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWY 285 (560)
T KOG0600|consen 207 LL-SSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWY 285 (560)
T ss_pred hh-cCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeec
Confidence 44 444457999999999999999999999999999999999999996 89999999999966443 345677889999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||++.+...|+.+.|+||+||||.||+.|+..|.+.+..+++..+.+..|.|..+.|+ ...+......+-.+...+.
T Consensus 286 RpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~ 364 (560)
T KOG0600|consen 286 RPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRR 364 (560)
T ss_pred cChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccch
Confidence 999999999889999999999999999999999999999999999999999999999999 5666654445555555666
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
+.+..+.++....+|+..||..||++|.||.++|.|+||+...
T Consensus 365 l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 365 LRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred HHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence 7777889999999999999999999999999999999995443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-54 Score=330.81 Aligned_cols=276 Identities=40% Similarity=0.675 Sum_probs=236.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccc--cCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVK--EHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~~~~~l~ 77 (282)
|+||.||+|+++.|++.||+|.++-+.... -....++|+.++.+.. |||||.+-.+.. +-+..|+|||||..++..
T Consensus 87 GtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLks 165 (419)
T KOG0663|consen 87 GTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKS 165 (419)
T ss_pred CcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC-CCCeeeeEEEEeccccceeeeeHHHHHhhHHH
Confidence 899999999999999999999998654221 1234588999999996 999999998864 445799999999886555
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCcccccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYR 155 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~ 155 (282)
. +...+.++...+++.++.|+++|++|||.++|+||||||+|+|+++ |.+|++|||+|+.++.+ .+.+....|..|+
T Consensus 166 l-~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYR 244 (419)
T KOG0663|consen 166 L-METMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYR 244 (419)
T ss_pred H-HHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeec
Confidence 4 4444568999999999999999999999999999999999999985 99999999999988765 4456678899999
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||.+.+.+.|+.+.|+||+||++.|++++...|.+....+++..+...++.|....||............++...-..+
T Consensus 245 aPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~l 324 (419)
T KOG0663|consen 245 APELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNL 324 (419)
T ss_pred CHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhh
Confidence 99999999999999999999999999999999999999999999999999999999999888777665555554433222
Q ss_pred cccCC--CCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 236 RELSP--SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 236 ~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
..... .+++...+|++.+|..||.+|.|+++.|.|+||++.+.
T Consensus 325 r~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 325 RKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred hhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 22222 26699999999999999999999999999999998654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-54 Score=334.69 Aligned_cols=246 Identities=33% Similarity=0.520 Sum_probs=215.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+++.+.|++.||+|++++..... +.+....|..++.++ +||.|+.++-.|++++.+|+|+||+.|+-|..
T Consensus 36 G~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~ 114 (357)
T KOG0598|consen 36 GSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYLVLDYLNGGELFY 114 (357)
T ss_pred cCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEEEEeccCCccHHH
Confidence 899999999999999999999998876544 356678899999997 59999999999999999999999999866666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccccc-CCCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~a 156 (282)
.+++.+ .+++..++-++.+|+.||.|||++||+||||||+|||+|+ |.++|+|||++... .........+||+.|+|
T Consensus 115 hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmA 193 (357)
T KOG0598|consen 115 HLQREG-RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMA 193 (357)
T ss_pred HHHhcC-CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccC
Confidence 666554 7999999999999999999999999999999999999985 99999999999854 44445566799999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+.+ ++.++|.||||+++|+|++|..||.+.+.......+..... .
T Consensus 194 PEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-----------------------------~ 243 (357)
T KOG0598|consen 194 PEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-----------------------------P 243 (357)
T ss_pred hHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-----------------------------C
Confidence 99998664 99999999999999999999999999998888887766431 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCC----CHHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRP----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~~ll~~~~~~~~~~ 278 (282)
..+...+.+.+++++++|..||++|. .+.++-+||||+++.|
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 22334789999999999999999996 6889999999999876
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-53 Score=332.95 Aligned_cols=247 Identities=28% Similarity=0.490 Sum_probs=217.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|+++.++..||||.+.+... .+.......|+.+++.+. |||||.++++...++++|+|||||+|+.|..+
T Consensus 21 GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~y 99 (429)
T KOG0595|consen 21 GSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDY 99 (429)
T ss_pred cceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEEEEEEeCCCCCHHHH
Confidence 8999999999999999999999988753 445566689999999996 99999999999999999999999999999888
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-------CcEEEeecCcccccCCCCCCCCccccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-------GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-------~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
+.+.+ .+++.+++.++.||+.||++||+++|+||||||+|||++. -.+||.|||+|+.+.........+|++
T Consensus 100 i~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSp 178 (429)
T KOG0595|consen 100 IRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSP 178 (429)
T ss_pred HHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCc
Confidence 88875 7999999999999999999999999999999999999964 259999999999998887778899999
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
.|||||++.... |+.|+|+||+|+++|++++|+.||...+..+....+... .
T Consensus 179 lYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~---------------------------~ 230 (429)
T KOG0595|consen 179 LYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG---------------------------N 230 (429)
T ss_pred cccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc---------------------------c
Confidence 999999998555 999999999999999999999999999988887744332 1
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
...+..+...+..+.+++...++.+|.+|.+..+-..|+++..-.
T Consensus 231 ~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 231 EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 222344556677888999999999999999999999999886544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-53 Score=342.93 Aligned_cols=246 Identities=33% Similarity=0.539 Sum_probs=213.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHH--HHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc-cHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE--SRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES-DLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~--~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~-~~l~ 77 (282)
|+|++|++|+.+.+++.||||++.+.....+. ...-.|-..|.++.+||+|++++-.|++...+|+|+||+.+ ++++
T Consensus 84 GSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~ 163 (604)
T KOG0592|consen 84 GSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLD 163 (604)
T ss_pred ccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHH
Confidence 89999999999999999999999887654433 23456888899998899999999999999999999999985 5555
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCC------------C
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL------------P 144 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~------------~ 144 (282)
.+... +.|++...+.++.||+.||+|||++||+||||||+|||+| +++++|+|||.|..++... .
T Consensus 164 ~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~ 241 (604)
T KOG0592|consen 164 LIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQAS 241 (604)
T ss_pred HHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCccccc
Confidence 54444 4799999999999999999999999999999999999998 5899999999988663221 1
Q ss_pred C--CCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccccc
Q 044127 145 C--TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN 222 (282)
Q Consensus 145 ~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (282)
. ...+||..|.+||++..+ ..+..+|+|+|||++|+|+.|..||.+.+.--...+++...-
T Consensus 242 s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y---------------- 304 (604)
T KOG0592|consen 242 SRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY---------------- 304 (604)
T ss_pred CcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc----------------
Confidence 1 457899999999999854 489999999999999999999999999998888888877532
Q ss_pred CCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 223 LDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
++++++++.+++||+++|..||++|+|+++|.+||||.++.|.
T Consensus 305 --------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 305 --------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred --------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 3456789999999999999999999999999999999999874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-52 Score=323.46 Aligned_cols=275 Identities=36% Similarity=0.712 Sum_probs=238.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCC-eeeeccccccCC------cEEEEEecCC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPN-IVKLRNLVKEHE------DVFIVFEYME 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~-i~~~~~~~~~~~------~~~lv~e~~~ 72 (282)
|+||+||+|+.+.+|+.||+|++..+... ......++|+.+++.++ |+| |+.+++++...+ .+++|+|+++
T Consensus 22 Gtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d 100 (323)
T KOG0594|consen 22 GTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD 100 (323)
T ss_pred CCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccccceEEEEEEeec
Confidence 89999999999999999999999876432 23345588999999996 888 999999987766 8999999999
Q ss_pred ccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCc
Q 044127 73 SDLLKLMKERAG--QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDY 148 (282)
Q Consensus 73 ~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~ 148 (282)
..+-..+-.... ..++...++.+++||+.||+|||+++|+||||||+||++++ |.+||+|||+|.....+. .....
T Consensus 101 ~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~e 180 (323)
T KOG0594|consen 101 RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPE 180 (323)
T ss_pred ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCccccccc
Confidence 887776655432 35888999999999999999999999999999999999985 899999999999776333 35677
Q ss_pred cccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 149 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
.+|..|+|||++.+...++...||||+||+++||++++..|.+....+++..+.+.++.|....||.......... .++
T Consensus 181 vvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~-~f~ 259 (323)
T KOG0594|consen 181 VVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA-PFP 259 (323)
T ss_pred EEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccc-cCc
Confidence 8999999999999887899999999999999999999999999999999999999999999999998888777655 333
Q ss_pred CCC-CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 229 QMG-GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 229 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
... ...+....+...+...+++.+||+.+|.+|.|++.+|.||||....
T Consensus 260 ~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 260 KWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 332 4555555666678999999999999999999999999999998764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-52 Score=337.21 Aligned_cols=271 Identities=33% Similarity=0.634 Sum_probs=224.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..++..||+|+++............+|+.+++++ +||||+++++++...+..++||||+++++.+.+.
T Consensus 16 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~l~ 94 (288)
T cd07871 16 GTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLD 94 (288)
T ss_pred CCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEeCCCcCHHHHHH
Confidence 899999999999999999999987654333445567899999998 4999999999999999999999999987666554
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
. .+..+++..+..++.||+.||.+||++|++|+||||+||++++ +.+||+|||++....... ......+++.|+|||
T Consensus 95 ~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE 173 (288)
T cd07871 95 N-CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173 (288)
T ss_pred h-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChH
Confidence 4 3446899999999999999999999999999999999999975 799999999987653222 223456788999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+...++.++|||||||++|+|++|+.||.+.+..+....+....+.+....|+............++..........
T Consensus 174 ~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (288)
T cd07871 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINH 253 (288)
T ss_pred HhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHh
Confidence 98765668999999999999999999999999999889898898888888888877654443333333433333333344
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
....+.++++||++||+.||.+|||++|+++||||
T Consensus 254 ~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 254 APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 45678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-52 Score=341.34 Aligned_cols=243 Identities=32% Similarity=0.514 Sum_probs=209.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc----hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc-cH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS----LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES-DL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~----~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~-~~ 75 (282)
|+||+|+.|.+..++..||+|++++.... .......+|+.+++++..||||+++++++......++|||||.| .+
T Consensus 28 GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL 107 (370)
T KOG0583|consen 28 GSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDL 107 (370)
T ss_pred CCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccH
Confidence 78999999999999999999988775221 22334457999999997799999999999999999999999997 55
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCccccc-CCCCCCCCccccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEI-DSSLPCTDYVTTR 152 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~-~~~~~~~~~~~~~ 152 (282)
++.+.. . +++.+..++.+++|+++|+.|||++||+||||||+|++++. +.+||+|||++... .........+|++
T Consensus 108 ~~~i~~-~-g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp 185 (370)
T KOG0583|consen 108 FDYIVN-K-GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSP 185 (370)
T ss_pred HHHHHH-c-CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCc
Confidence 555555 3 57999999999999999999999999999999999999985 69999999999988 4666678889999
Q ss_pred cccCchhhhccc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSE-IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||++.+.. ..+.++||||+|+++|.|++|+.||...+.......+....
T Consensus 186 ~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~-------------------------- 239 (370)
T KOG0583|consen 186 AYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE-------------------------- 239 (370)
T ss_pred ccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC--------------------------
Confidence 999999998766 55799999999999999999999999977777666643321
Q ss_pred CCcccccCCCC-ChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 232 GVNLRELSPSA-SRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 232 ~~~~~~~~~~~-~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
-.++..+ +.++++|+.+||..||.+|+|+.++++||||+.
T Consensus 240 ----~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 240 ----FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ----ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1233345 899999999999999999999999999999996
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-53 Score=328.42 Aligned_cols=268 Identities=35% Similarity=0.633 Sum_probs=231.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc-----CCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE-----HEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|...++++.||||+.-.+. ...-+|+.+++.+ .||||+++.-+|.. .-+..+||||++.++
T Consensus 35 GsFg~Vyq~~~~e~~~~vAIKKv~~d~-----r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL 108 (364)
T KOG0658|consen 35 GSFGVVYQAKLRETEEEVAIKKVLQDK-----RYKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETL 108 (364)
T ss_pred cccceEEEEEEcCCCceeEEEEecCCC-----CcCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHHHhchHHH
Confidence 899999999999999999999886543 2233588888877 59999999888742 226679999999998
Q ss_pred HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCCCCCcccc
Q 044127 76 LKLMKER--AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 76 l~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
...+... .+..++.-.++-+..||++||.|||+.||+||||||+|+|+|. +.+||||||.|..+....+..++..|
T Consensus 109 ~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicS 188 (364)
T KOG0658|consen 109 YRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICS 188 (364)
T ss_pred HHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEe
Confidence 8876642 3467999999999999999999999999999999999999984 89999999999999888888999999
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
..|+|||.+.+...|+.+.||||.||++.||+.|+..|.+.+..+++..+++.+|.|+.+........ ..+..+++..
T Consensus 189 RyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~--y~~~~~p~ik 266 (364)
T KOG0658|consen 189 RYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN--YTEFKFPQIK 266 (364)
T ss_pred ccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc--cccccCcccc
Confidence 99999999999988999999999999999999999999999999999999999999987755433322 2245556665
Q ss_pred CCcccc-cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 232 GVNLRE-LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 232 ~~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
...... .....+++..+|+.++|..+|.+|.++.++|.||||...
T Consensus 267 ~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 267 AHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred cccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 555544 677889999999999999999999999999999999754
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=325.11 Aligned_cols=276 Identities=38% Similarity=0.658 Sum_probs=231.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeecccccc-----CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVKE-----HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~e~~~~~ 74 (282)
|+||.|..|.++.+|+.||+|++........ ....++|+..++.++ |+||+.+.+++.. -...|+|+|+|+..
T Consensus 33 GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~~~f~DvYiV~elMetD 111 (359)
T KOG0660|consen 33 GAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSRDKFNDVYLVFELMETD 111 (359)
T ss_pred cceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccccccccceeEEehhHHhhH
Confidence 8999999999999999999999986554443 345589999999997 9999999999854 46799999999555
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC---CCCCCCccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS---SLPCTDYVT 150 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~---~~~~~~~~~ 150 (282)
+.+.+.+. +.+++..+..++.||+.||+|+|+.+++||||||.|++++. ..+|++|||+|+..+. ....+.+..
T Consensus 112 L~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVa 189 (359)
T KOG0660|consen 112 LHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVA 189 (359)
T ss_pred HHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhccee
Confidence 55444443 35999999999999999999999999999999999999985 7899999999998864 333466788
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccc-cccccCCccccC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGI-QLASNLDWKFPQ 229 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 229 (282)
|..|+|||.+.....++.+.||||+||++.||++|+..|.+.+..+++..+....+.|.++...... ......-...++
T Consensus 190 TRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~ 269 (359)
T KOG0660|consen 190 TRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQ 269 (359)
T ss_pred eeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCC
Confidence 9999999999877779999999999999999999999999999999999999999999766553222 111112223455
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
........+.+..++...+|+.+||..||.+|+|++|+|+||||...+-.
T Consensus 270 ~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 270 IPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred CCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 55566677778999999999999999999999999999999999877643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-52 Score=340.41 Aligned_cols=245 Identities=28% Similarity=0.532 Sum_probs=215.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+.|.||.|+...+++.||+|.+.... +....-.++|+.+++... |+|||.+++.|-..+.+|+||||++|+.|.+..
T Consensus 284 gaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvV 361 (550)
T KOG0578|consen 284 GATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLH-HPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVV 361 (550)
T ss_pred ccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhcc-chHHHHHHHHhcccceeEEEEeecCCCchhhhh
Confidence 788999999999999999999998765 445667789999999995 999999999999999999999999998898888
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
... .++|.+++.|++++++||+|||.+||+|+|||.+||+++ +|.+||+|||++..+.... ......|||.|+|||
T Consensus 362 t~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPE 439 (550)
T KOG0578|consen 362 TKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPE 439 (550)
T ss_pred hcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchh
Confidence 763 699999999999999999999999999999999999998 5899999999998875544 456678999999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
+.. .+.|+.+.||||||+|++||+.|..||-..++...++.+.... .| ....
T Consensus 440 Vvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng-~P--------------------------~lk~ 491 (550)
T KOG0578|consen 440 VVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TP--------------------------KLKN 491 (550)
T ss_pred hhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC-CC--------------------------CcCC
Confidence 998 4559999999999999999999999999888887777765532 22 1233
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
+..+++.+++|+.+||+.|+.+|+++.+||+||||+...
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 457899999999999999999999999999999996543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-52 Score=327.14 Aligned_cols=247 Identities=33% Similarity=0.530 Sum_probs=206.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCC--cEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE--DVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~ 78 (282)
|+||.||++.+..+|...|+|.+....... .....+|+.++.++. |||||+++|...... .++++|||+.++++..
T Consensus 28 Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~ 105 (313)
T KOG0198|consen 28 GSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSD 105 (313)
T ss_pred ccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEeeeeccCCCcHHH
Confidence 899999999999999999999987763222 556788999999997 999999999754443 6999999999988888
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCC----CCCCCCccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDS----SLPCTDYVTTR 152 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~----~~~~~~~~~~~ 152 (282)
++.+.+..+++..+..+.+||++||+|||++|++|+||||+|||++. +.+||+|||++..... ........||+
T Consensus 106 ~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp 185 (313)
T KOG0198|consen 106 LIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTP 185 (313)
T ss_pred HHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCc
Confidence 88877657999999999999999999999999999999999999987 6999999999887663 22234578999
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCC-CCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPG-KNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||++..+.....++|||||||++.||+||..||.. ....+....+...
T Consensus 186 ~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~--------------------------- 238 (313)
T KOG0198|consen 186 NYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE--------------------------- 238 (313)
T ss_pred cccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc---------------------------
Confidence 999999998543344699999999999999999999987 3333333332221
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
...+.++..++.+.++||.+|+..||.+||||+++|+|||.++..
T Consensus 239 -~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 239 -DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred -CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 122366778999999999999999999999999999999997644
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-51 Score=332.21 Aligned_cols=276 Identities=33% Similarity=0.574 Sum_probs=214.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+++.||+|++.............+|+.+++.+ +||||+++++++.++...++||||+.+++++.+.
T Consensus 16 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~ 94 (303)
T cd07869 16 GSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMD 94 (303)
T ss_pred cCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEEEEECCCcCHHHHHH
Confidence 889999999999999999999987654444445567899999988 4999999999999999999999999998887766
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE 158 (282)
... ..+++..+..++.||+.||.|||+.|++|+||||+||++++ +.++|+|||++...... .......+++.|+|||
T Consensus 95 ~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE 173 (303)
T cd07869 95 KHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPD 173 (303)
T ss_pred hCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChH
Confidence 543 46999999999999999999999999999999999999975 89999999998754322 2223456788999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS-ADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
.+.+...++.++|||||||++|+|++|..||.+..+ .+.+..+....+.+....|+............+.......+..
T Consensus 174 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (303)
T cd07869 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQ 253 (303)
T ss_pred HHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHH
Confidence 987655678999999999999999999999987644 3445555555566665555543322211111111111111111
Q ss_pred c--CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 238 L--SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 238 ~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
. ....+..+.+|+++||+.||++|||++++++||||+++..
T Consensus 254 ~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 254 AWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred HhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 0 1124678999999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-52 Score=342.78 Aligned_cols=247 Identities=28% Similarity=0.472 Sum_probs=218.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCC-ccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYME-SDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~-~~~l~ 77 (282)
|+.|.|-+|+|..||+..|||++.+... ....+.+.+|+.+++-+. |||++.++++++++.++|+|.||+. |++++
T Consensus 23 Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lylvlEyv~gGELFd 101 (786)
T KOG0588|consen 23 GSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYLVLEYVPGGELFD 101 (786)
T ss_pred CCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEEEEEecCCchhHH
Confidence 7889999999999999999999987632 233456678888888774 9999999999999999999999998 56666
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
.+..+ +++++.+++++++||+.|+.|+|..+|+|+|+||+|+++|. +.||+.|||+|............||+|-|.|
T Consensus 102 ylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~ 179 (786)
T KOG0588|consen 102 YLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAA 179 (786)
T ss_pred HHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCC
Confidence 66655 47999999999999999999999999999999999999985 6799999999998888888899999999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+..+.+.++||||.||+||.|++|..||+..+....+.++..+. -
T Consensus 180 PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~------------------------------f 229 (786)
T KOG0588|consen 180 PEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV------------------------------F 229 (786)
T ss_pred chhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc------------------------------c
Confidence 9999988888999999999999999999999999877777776665532 2
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
+++..++.++++||++||.+||.+|.|.++|++|||+.+..-.|
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 56678899999999999999999999999999999998876554
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=330.89 Aligned_cols=277 Identities=34% Similarity=0.640 Sum_probs=227.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+++.||+|.++............+|+..++++. ||||+++++++..++..+++|||+.+++.+.+.
T Consensus 17 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~ 95 (309)
T cd07872 17 GTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMD 95 (309)
T ss_pred cCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEEEeCCCCCHHHHHH
Confidence 8999999999999999999999876544444445678999998885 999999999999999999999999988776655
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
.. +..+++..+..++.||+.||.+||++|++|+||||+||++++ +.++|+|||++....... ......+++.|+|||
T Consensus 96 ~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE 174 (309)
T cd07872 96 DC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 174 (309)
T ss_pred hc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCH
Confidence 44 346899999999999999999999999999999999999975 799999999987543322 223346788999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+...++.++|||||||++|+|++|+.||...+..+....+....+.+....|+.........+..++..........
T Consensus 175 ~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (309)
T cd07872 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINH 254 (309)
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhh
Confidence 98766668999999999999999999999999999888888898888888887776544433333333333322222334
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
...++++++++|++||+.||.+|||++|+++||||+.....
T Consensus 255 ~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 295 (309)
T cd07872 255 APRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR 295 (309)
T ss_pred ccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence 45678899999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=328.94 Aligned_cols=249 Identities=33% Similarity=0.522 Sum_probs=211.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|+.+.||+.||+|+++++... ........|..+|... .+|.||+++-.|++..++|+||||++||...-
T Consensus 152 GAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mT 230 (550)
T KOG0605|consen 152 GAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMT 230 (550)
T ss_pred ccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEEEEEecCCccHHH
Confidence 89999999999999999999999886543 2334556677777774 69999999999999999999999999888877
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC----------------
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS---------------- 141 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~---------------- 141 (282)
++.+.+ .|++..++..+.+++.|+..+|+.|++|+||||+|+|||. |.+||+|||++..+..
T Consensus 231 LL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~ 309 (550)
T KOG0605|consen 231 LLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQIN 309 (550)
T ss_pred HHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhh
Confidence 777765 7999999999999999999999999999999999999996 9999999999863311
Q ss_pred -------CCC-----C--------------------CCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCC
Q 044127 142 -------SLP-----C--------------------TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILF 189 (282)
Q Consensus 142 -------~~~-----~--------------------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~ 189 (282)
..+ . .+..|||-|+|||++.+.+ ++...|.||||||||||+.|..||
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~ImyEmLvGyPPF 388 (550)
T KOG0605|consen 310 LSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIMYEMLVGYPPF 388 (550)
T ss_pred hccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHHHHHHHhCCCCC
Confidence 000 0 0247899999999999666 899999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCC---HHH
Q 044127 190 PGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPT---AAE 266 (282)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ 266 (282)
.+.++.+...+++.+.... .++. ....+++.++||.++|. ||.+|.. ++|
T Consensus 389 ~s~tp~~T~rkI~nwr~~l-----------------~fP~---------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 389 CSETPQETYRKIVNWRETL-----------------KFPE---------EVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred CCCCHHHHHHHHHHHhhhc-----------------cCCC---------cCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 9999999999988865322 2221 12456899999999999 9999995 899
Q ss_pred HhcCcccccccCc
Q 044127 267 ALEHPFFRSCHFV 279 (282)
Q Consensus 267 ll~~~~~~~~~~~ 279 (282)
|-.||||+++.|-
T Consensus 442 IK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 442 IKKHPFFKGVDWD 454 (550)
T ss_pred HhcCCccccCCcc
Confidence 9999999999874
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-51 Score=338.38 Aligned_cols=273 Identities=33% Similarity=0.539 Sum_probs=226.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCC-----CeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHP-----NIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp-----~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+|-+|.+..|++.||||+++... .-..+...|+.+|..+..|. |+|+++++|...+++|||+|.++.++
T Consensus 197 GtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~NL 274 (586)
T KOG0667|consen 197 GSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLSTNL 274 (586)
T ss_pred cccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhhhH
Confidence 899999999999999999999998763 44556677999999887333 79999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC---CcEEEeecCcccccCCCCCCCCccccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~---~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
.+.+..+.-..|+...++.++.||+.||.+||+.||+|+||||+|||+.+ ..||++|||+++...... ..+..+.
T Consensus 275 YellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v--ytYiQSR 352 (586)
T KOG0667|consen 275 YELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV--YTYIQSR 352 (586)
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc--eeeeecc
Confidence 99998887778999999999999999999999999999999999999964 589999999998776554 4788899
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc-cc----
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW-KF---- 227 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---- 227 (282)
.|+|||++.+.+ ++.+.|||||||+++||++|..+|.+.+..+++..+++.+|.|++..+.........++. ..
T Consensus 353 fYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~ 431 (586)
T KOG0667|consen 353 FYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRL 431 (586)
T ss_pred ccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceee
Confidence 999999999555 999999999999999999999999999999999999999998886544333322222221 00
Q ss_pred -----------------------cCC----CCCcccccCC-CCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 228 -----------------------PQM----GGVNLRELSP-SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 228 -----------------------~~~----~~~~~~~~~~-~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
... ....+..... .....+.+||++||.+||.+|+|+.++|+||||++...
T Consensus 432 ~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 432 CVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred eeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccccc
Confidence 000 0011111112 34566899999999999999999999999999995543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-51 Score=307.96 Aligned_cols=244 Identities=29% Similarity=0.467 Sum_probs=215.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.|.+++++.+|..||+|++++...- +......+|..+++.+. ||.++++++.+.+.+.+|+||||.+|+-+..
T Consensus 55 GSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lymvmeyv~GGElFS 133 (355)
T KOG0616|consen 55 GSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYMVMEYVPGGELFS 133 (355)
T ss_pred CccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEEEEeccCCccHHH
Confidence 89999999999999999999999876532 33455678989999996 9999999999999999999999999766666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++.+.+ ++++..++-++.||+.||+|||+++|++|||||+|||+|. |.+|++|||+|...... ..+.+|||.|+||
T Consensus 134 ~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAP 210 (355)
T KOG0616|consen 134 YLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAP 210 (355)
T ss_pred HHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EEEecCCccccCh
Confidence 666553 7999999999999999999999999999999999999995 99999999999988776 3788999999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+... .++.++|.|+||+++|||+.|..||...++...+.+++...- .
T Consensus 211 Eii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v------------------------------~ 259 (355)
T KOG0616|consen 211 EIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV------------------------------K 259 (355)
T ss_pred HHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc------------------------------c
Confidence 999844 499999999999999999999999999999998888877421 2
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccCc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHFV 279 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~~ 279 (282)
+|..++..+++||.++|+.|-.+|. ...+|.+||||+++.|.
T Consensus 260 fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 260 FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence 3456799999999999999999993 56899999999998774
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=321.42 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=212.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc-HHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD-LLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~-~l~~~ 79 (282)
|..++||+|++..++..||||+++.+....+.....+|+..+..+ +||||++++..|..+..+|+||++|.++ .++.+
T Consensus 37 G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIi 115 (516)
T KOG0582|consen 37 GASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDII 115 (516)
T ss_pred cceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeEEeehhhcCCcHHHHH
Confidence 566899999999999999999999988888888888999988888 5999999999999999999999999854 45555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCC-----CCcccccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC-----TDYVTTRW 153 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~ 153 (282)
.......++|..|+.|+++++.||.|||++|.+|||||+.|||++ +|.|+|+|||.+..+...... ....++++
T Consensus 116 k~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~ 195 (516)
T KOG0582|consen 116 KTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPC 195 (516)
T ss_pred HHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCccc
Confidence 555566799999999999999999999999999999999999998 599999999987766333221 34578999
Q ss_pred ccCchhh-hccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 154 YRAPEVL-LLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 154 ~~aPE~~-~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|+|||++ +....|+.|+||||||++..||.+|..||....+...+....++ .|+.. ...
T Consensus 196 wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn--~pp~~------------------~t~ 255 (516)
T KOG0582|consen 196 WMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN--DPPTL------------------LTS 255 (516)
T ss_pred ccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC--CCCCc------------------ccc
Confidence 9999995 44455899999999999999999999999999888877654442 22100 011
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
....+..+.++..++.+|..||+.||++|||++++|+|+||+...
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 111223345677999999999999999999999999999998764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-52 Score=306.00 Aligned_cols=245 Identities=30% Similarity=0.473 Sum_probs=210.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc-cHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES-DLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~-~~l~~ 78 (282)
|.|+.||++.+..||+.+++|+++....... ..+..+|+.+.+.+ +||||+++.+.+.+.+..|+|+|++.| .+...
T Consensus 22 G~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~e 100 (355)
T KOG0033|consen 22 GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFED 100 (355)
T ss_pred CchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcccceeEEEEecccchHHHHH
Confidence 7899999999999999999999987655443 34455677777667 599999999999999999999999986 55556
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCCCCCccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWY 154 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 154 (282)
+.++ .-+++..+...++||++||.|+|.+||+|||+||+|+++-. .-+||+|||+|..++...--....|+|.|
T Consensus 101 IV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~f 178 (355)
T KOG0033|consen 101 IVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGY 178 (355)
T ss_pred HHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcc
Confidence 6665 36899999999999999999999999999999999999942 36999999999988855555667899999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||++. ..+++..+|||+.|+++|-|+.|+.||.+.+....+.++....-......
T Consensus 179 maPEvvr-kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~---------------------- 235 (355)
T KOG0033|consen 179 LSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE---------------------- 235 (355)
T ss_pred cCHHHhh-cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc----------------------
Confidence 9999998 45599999999999999999999999999998888888877543333333
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
+.+++++.++|+++||..||.+|.|+.|.|+|||+++
T Consensus 236 ----w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 236 ----WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ----cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 3578999999999999999999999999999999976
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=320.55 Aligned_cols=269 Identities=35% Similarity=0.649 Sum_probs=214.6
Q ss_pred CCcceEEEEEecC-CCcEEEEEEccccccch-HHHHHHHHHHHHHHhC--CCCCeeeeccccc-----cCCcEEEEEecC
Q 044127 1 GSYGDVFQALDKK-SGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMN--NHPNIVKLRNLVK-----EHEDVFIVFEYM 71 (282)
Q Consensus 1 G~~g~Vy~~~~~~-~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~--~hp~i~~~~~~~~-----~~~~~~lv~e~~ 71 (282)
|+||+||+|++.. ++..||+|.++...... ......+|+..++.+. .||||+++++++. .....+++||++
T Consensus 12 G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~ 91 (290)
T cd07862 12 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 91 (290)
T ss_pred CCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccC
Confidence 8999999999854 47889999887543322 2234456777666654 5999999999874 345689999999
Q ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccc
Q 044127 72 ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVT 150 (282)
Q Consensus 72 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~ 150 (282)
++++.+.+.......+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||.+.............+
T Consensus 92 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (290)
T cd07862 92 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 171 (290)
T ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccc
Confidence 988777766655556999999999999999999999999999999999999974 8999999999887655444455678
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
++.|+|||.+.+. .++.++|||||||++|+|++|..||.+....+.+..+....+.+.+..++....... ..+...
T Consensus 172 ~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~ 247 (290)
T cd07862 172 TLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR---QAFHSK 247 (290)
T ss_pred cccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccc---hhccCC
Confidence 9999999998744 478999999999999999999999999999999988888887776666554332211 112222
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
....+......+++.+.+++.+||+.||++|||+.++|+||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 248 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 2223334445678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-51 Score=306.08 Aligned_cols=249 Identities=31% Similarity=0.476 Sum_probs=213.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc---hH----HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCC-
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS---LD----ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYME- 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~---~~----~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~- 72 (282)
|..++|-++.++.+|+.+++|++...... +. ...-..|+.+++++.+||+|+.+.++|+.+...++|+|.|+
T Consensus 28 gvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~pr 107 (411)
T KOG0599|consen 28 GVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPR 107 (411)
T ss_pred cchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhccc
Confidence 55678888999999999999998643321 11 23346799999999999999999999999999999999998
Q ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccc
Q 044127 73 SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 73 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
|.+++.+.+. ..+++....+|++|+++|++|||.++|||+||||+||++|+ -+++++|||+++.+.........+||
T Consensus 108 GELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGT 185 (411)
T KOG0599|consen 108 GELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGT 185 (411)
T ss_pred chHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCC
Confidence 6666666665 47999999999999999999999999999999999999987 58999999999999988888899999
Q ss_pred ccccCchhhhcc-----ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcc
Q 044127 152 RWYRAPEVLLLS-----EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226 (282)
Q Consensus 152 ~~~~aPE~~~~~-----~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
|.|+|||.+.+. +.|+...|+|++|++||-|+.|..||......-++..++++.-......|
T Consensus 186 PgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW------------- 252 (411)
T KOG0599|consen 186 PGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW------------- 252 (411)
T ss_pred CcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch-------------
Confidence 999999998542 44788999999999999999999999988877777777665444433333
Q ss_pred ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
...+...++||.+||+.||.+|.|++|+|+||||.++.
T Consensus 253 -------------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 253 -------------ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred -------------hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 46788999999999999999999999999999996543
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=320.98 Aligned_cols=274 Identities=31% Similarity=0.647 Sum_probs=223.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|++..+++.|++|.+.............+|+..++.+. ||||+++++++..+...+++|||+++++...+.
T Consensus 17 g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv~e~~~~~l~~~l~ 95 (301)
T cd07873 17 GTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD 95 (301)
T ss_pred CcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEEEeccccCHHHHHH
Confidence 7899999999999999999999876543334445678999999995 999999999999999999999999987766554
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
.. +..+++..+..++.||+.||.+||+.|++|+||+|+||++++ +.++|+|||.+....... ......+++.|+|||
T Consensus 96 ~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE 174 (301)
T cd07873 96 DC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPD 174 (301)
T ss_pred hc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcH
Confidence 43 346999999999999999999999999999999999999985 789999999987643322 223345688899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+...++.++||||||+++|+|++|+.||...+..+....+....+.+....|+.............+..........
T Consensus 175 ~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (301)
T cd07873 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNH 254 (301)
T ss_pred HHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhh
Confidence 98766667889999999999999999999999888888888888888877777776543333333333333333333445
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
...+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus 255 ~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 255 APRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 56778999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=326.15 Aligned_cols=245 Identities=32% Similarity=0.499 Sum_probs=202.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|+++.+|+.||+|++..... ........+|+.++.++ +||||+++++.+..++..++||||+.++.+..
T Consensus 6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 84 (323)
T cd05571 6 GTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANGGELFF 84 (323)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHH
Confidence 8999999999999999999999976532 22334567888999888 49999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||+|||+.|++|+||||+||+++. +.++|+|||++.... .........|++.|+|
T Consensus 85 ~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~a 163 (323)
T cd05571 85 HLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163 (323)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccC
Confidence 65554 47999999999999999999999999999999999999975 789999999987532 2222344578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++|||||||++|+|++|..||...+.......+.... .
T Consensus 164 PE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~------------------------------~ 212 (323)
T cd05571 164 PEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE------------------------------I 212 (323)
T ss_pred hhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC------------------------------C
Confidence 99987544 7999999999999999999999998766544443332110 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
..+..+++.+.+||++||+.||++|| ++.++++||||+++.+
T Consensus 213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 22346789999999999999999999 8999999999988643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-49 Score=318.15 Aligned_cols=270 Identities=33% Similarity=0.612 Sum_probs=210.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|+++.+++.|++|++...... .......+|+.+++.+. ||||+++++++...+..++||||+.+++++.+
T Consensus 12 g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~ 90 (287)
T cd07848 12 GAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLVFEYVEKNMLELL 90 (287)
T ss_pred cCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEEEecCCCCHHHHH
Confidence 78999999999999999999998765332 23445678999998885 99999999999999999999999999988876
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccC
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~a 156 (282)
.... ..+++..++.++.||+.||.+||+.|++|+||||+||+++. +.++|+|||++....... ......+++.|+|
T Consensus 91 ~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~a 169 (287)
T cd07848 91 EEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169 (287)
T ss_pred HhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCC
Confidence 6543 46999999999999999999999999999999999999975 789999999988764322 2234568899999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC--CCc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG--GVN 234 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 234 (282)
||.+.+.. ++.++|+|||||++|+|++|+.||...+..+....+....+......+..............+... ...
T Consensus 170 PE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (287)
T cd07848 170 PELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSL 248 (287)
T ss_pred cHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccH
Confidence 99997554 799999999999999999999999988777776666665554443322211111100001111000 000
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
........+..+.+||++||+.||++|||++++|+||||
T Consensus 249 ~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 249 ERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 112233468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=326.76 Aligned_cols=243 Identities=27% Similarity=0.492 Sum_probs=209.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||.||+|+++.|.+.||+|.+++.... ++.....+|+.++++++ ||||+.++++|+...++|+|+|||.|++...
T Consensus 13 Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vVte~a~g~L~~i- 90 (808)
T KOG0597|consen 13 GSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVVTEYAVGDLFTI- 90 (808)
T ss_pred CccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEEehhhhhhHHHH-
Confidence 89999999999999999999999876544 35566788999999996 9999999999999999999999999955544
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aP 157 (282)
++.. +.++++.+..+..++++||.|||+++|.|+|+||.||+++. +.+|+||||+|+.+..... ..+..|||.|+||
T Consensus 91 l~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAP 169 (808)
T KOG0597|consen 91 LEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAP 169 (808)
T ss_pred HHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCH
Confidence 4444 47999999999999999999999999999999999999986 7999999999998765433 3456799999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|+.. +.+++..+|+|||||++||+++|++||...........+.+.-- .
T Consensus 170 Elv~-e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v------------------------------~ 218 (808)
T KOG0597|consen 170 ELVE-EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV------------------------------K 218 (808)
T ss_pred HHHc-CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC------------------------------C
Confidence 9998 55599999999999999999999999987766655555444111 1
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.+...+..+++|++.+|..||.+|.|..+++.|||+++..
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 2336789999999999999999999999999999998643
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=315.86 Aligned_cols=269 Identities=36% Similarity=0.671 Sum_probs=214.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhC--CCCCeeeecccccc-----CCcEEEEEecCC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMN--NHPNIVKLRNLVKE-----HEDVFIVFEYME 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~--~hp~i~~~~~~~~~-----~~~~~lv~e~~~ 72 (282)
|+||+||+|+++.+++.||+|.++...... ......+|+..++.+. +||||+++++++.. ....++++|++.
T Consensus 11 g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~ 90 (288)
T cd07863 11 GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD 90 (288)
T ss_pred cCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc
Confidence 899999999999999999999987543222 1223445666666553 59999999998754 345899999999
Q ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccc
Q 044127 73 SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 73 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
+++.+.+.......+++..+..++.||+.||.|||+.|++|+||||+||++++ +.++|+|||++.............++
T Consensus 91 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 170 (288)
T cd07863 91 QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVT 170 (288)
T ss_pred cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCcccc
Confidence 88777665554456999999999999999999999999999999999999974 89999999998876554444556778
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
..|+|||.+.+.. ++.++|||||||++|+|++|..||......+....+....+.+....|+....... ..+....
T Consensus 171 ~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 246 (288)
T cd07863 171 LWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR---GAFSPRG 246 (288)
T ss_pred ccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc---cccCCCC
Confidence 8999999987544 89999999999999999999999998888888888888777766665553322111 1122222
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
..........+++.+.++|.+||+.||++|||+.+++.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 247 PRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 233344555678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=318.75 Aligned_cols=243 Identities=26% Similarity=0.366 Sum_probs=203.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.++.+++.||+|++...... .....+.+|+.+++++. ||||+++++++.+....+++|||+.++.+..
T Consensus 12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 90 (291)
T cd05612 12 GTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYMLMEYVPGGELFS 90 (291)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEEEeCCCCCCHHH
Confidence 89999999999999999999998754322 23345677889898885 9999999999999999999999998776666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++... ..+++..+..++.||+.||.+||++|++|+||||+||++++ +.++|+|||++....... ....+++.|+||
T Consensus 91 ~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aP 167 (291)
T cd05612 91 YLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--WTLCGTPEYLAP 167 (291)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--ccccCChhhcCH
Confidence 65554 46999999999999999999999999999999999999975 799999999987664332 345689999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+.. ++.++|||||||++|+|++|..||......+....+.... ..
T Consensus 168 E~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------------------------------~~ 216 (291)
T cd05612 168 EVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK------------------------------LE 216 (291)
T ss_pred HHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------------------------cC
Confidence 9987544 7999999999999999999999998877666555443311 12
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccC
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHF 278 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~ 278 (282)
.+...+..++++|++||+.||.+||+ ++++++||||+.+.+
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 23456889999999999999999995 999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=318.03 Aligned_cols=238 Identities=27% Similarity=0.418 Sum_probs=204.0
Q ss_pred CCcceEEEEEecCCCcE-EEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeeccccccCC-cEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEF-VAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE-DVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~-v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-~~~lv~e~~~~~~l~ 77 (282)
|+||+||++.++ |.. ||+|++........ ...+.+|+.++.++. |||||.++|++.++. .+++||||+.++++.
T Consensus 52 G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~ 128 (362)
T KOG0192|consen 52 GSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLCIVTEYMPGGSLS 128 (362)
T ss_pred CCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceEEEEEeCCCCcHH
Confidence 899999999877 445 99999987654433 567889999999985 999999999999887 799999999998888
Q ss_pred HHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccCCCCCceeeeC-C-cEEEeecCcccccCCC-CCCCCccccc
Q 044127 78 LMKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQG-YFHRDLKPSNLLVSK-G-VIKIGDLGMVKEIDSS-LPCTDYVTTR 152 (282)
Q Consensus 78 ~~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~-~~H~dl~p~nili~~-~-~~~l~df~~~~~~~~~-~~~~~~~~~~ 152 (282)
.++.. ....++...+..|+.||+.|+.|||+.+ |+|+||||+|||++. . ++||+|||+++..... .......||+
T Consensus 129 ~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~ 208 (362)
T KOG0192|consen 129 VLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTY 208 (362)
T ss_pred HHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCc
Confidence 88876 3568999999999999999999999999 999999999999996 4 8999999999877654 3445578999
Q ss_pred cccCchhhhc-cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLL-SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~-~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||++.+ ...++.++||||||+++|||+||..||...........+.....++
T Consensus 209 ~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp----------------------- 265 (362)
T KOG0192|consen 209 RWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP----------------------- 265 (362)
T ss_pred cccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-----------------------
Confidence 9999999985 3559999999999999999999999999998866666665443333
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.++...++.+..++.+||+.||.+||++.+++.
T Consensus 266 -----~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 -----PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -----CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 233457899999999999999999999998874
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=316.15 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=204.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.+..+++.||+|.+...... .....+.+|+.++.++ +|++++++++.+.+.+..+++|||+.++.+..
T Consensus 11 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 89 (285)
T cd05631 11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLTIMNGGDLKF 89 (285)
T ss_pred CCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEEecCCCcHHH
Confidence 89999999999999999999998764322 2234567899999998 59999999999999999999999999877765
Q ss_pred HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 79 MKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
.+.. ....+++..+..++.|++.||.|||++|++|+||||+||++++ +.++|+|||++.............+++.|+|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~a 169 (285)
T cd05631 90 HIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMA 169 (285)
T ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccC
Confidence 5443 3346999999999999999999999999999999999999975 8999999999887654444445678999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+. .++.++|||||||++|+|++|..||...........+....... ..
T Consensus 170 PE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------------------~~ 222 (285)
T cd05631 170 PEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--------------------------QE 222 (285)
T ss_pred HhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--------------------------cc
Confidence 9999854 48999999999999999999999998765543333222211110 11
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~ 278 (282)
..+..++..+.+|+++||+.||.+||+ ++++++||||+++.+
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 234467889999999999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=321.15 Aligned_cols=246 Identities=33% Similarity=0.528 Sum_probs=215.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc-HHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD-LLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~-~l~ 77 (282)
|.||.||.|+++.||+.+|+|++.+..... ......+|+.+++++..||||+.++++|++...+++|||+|.|+ +++
T Consensus 46 G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd 125 (382)
T KOG0032|consen 46 GQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFD 125 (382)
T ss_pred CCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHH
Confidence 899999999999999999999998766533 34677899999999988999999999999999999999999964 445
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-----CcEEEeecCcccccCCCCCCCCccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-----GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-----~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
.+... .+++..+..+++|++.|+.|||+.|++|+|+||+|+++.. +.++++|||++............+||+
T Consensus 126 ~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp 202 (382)
T KOG0032|consen 126 RIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTP 202 (382)
T ss_pred HHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCc
Confidence 54444 3999999999999999999999999999999999999952 379999999999888766677889999
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
.|+|||++.. ..++...|+||+|+++|.|++|..||.+.........+....-....
T Consensus 203 ~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~---------------------- 259 (382)
T KOG0032|consen 203 EYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS---------------------- 259 (382)
T ss_pred cccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC----------------------
Confidence 9999999874 45899999999999999999999999999988888766664333332
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
..+..++..+++||+.||..||.+|+|+.++|+|||+++.
T Consensus 260 ----~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 260 ----EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ----CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 2345779999999999999999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=304.21 Aligned_cols=233 Identities=29% Similarity=0.474 Sum_probs=195.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeecc-ccccCCc-EEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRN-LVKEHED-VFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~-~~~~~~~-~~lv~e~~~~~~l~ 77 (282)
|.||+||++++..+|+.+|.|.+....... .......|+.+++++. ||||+++++ -|.++.. ++|+||+|+++.+.
T Consensus 30 GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evlnivmE~c~~GDLs 108 (375)
T KOG0591|consen 30 GSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVLNIVMELCDAGDLS 108 (375)
T ss_pred CcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhhHHHHHhhcccCHH
Confidence 899999999999999999999998655443 3456688999999995 999999998 4554444 89999999988777
Q ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH--cC--ccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC-CCc
Q 044127 78 LMKERA---GQNFSEDEVRNLCFQVFQGLHYMHR--QG--YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC-TDY 148 (282)
Q Consensus 78 ~~~~~~---~~~l~~~~~~~i~~qi~~~l~~Lh~--~~--~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~-~~~ 148 (282)
.+++.. .+.+++..+|+++.|++.||.++|+ .. +.||||||.||+++. |.+||+|||+++.+...... .+.
T Consensus 109 qmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~ 188 (375)
T KOG0591|consen 109 QMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSL 188 (375)
T ss_pred HHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhh
Confidence 766542 3569999999999999999999999 44 999999999999985 89999999999987655432 467
Q ss_pred cccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 149 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
.|||.|+|||.+.+.+ ++.+|||||+||++|||+.-+.||.+.+-.+.-.++.++.-++
T Consensus 189 VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~-------------------- 247 (375)
T KOG0591|consen 189 VGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP-------------------- 247 (375)
T ss_pred cCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC--------------------
Confidence 8999999999998555 9999999999999999999999999986555555554432221
Q ss_pred CCCCCcccccC-CCCChhhHHHHHHHhCCCCCCCCCH
Q 044127 229 QMGGVNLRELS-PSASRESISLISRLCSWNPHMRPTA 264 (282)
Q Consensus 229 ~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~ 264 (282)
++ ..++.++..+|..|+.+||..||+.
T Consensus 248 ---------~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 248 ---------LPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ---------CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 22 3578999999999999999999985
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=333.65 Aligned_cols=269 Identities=31% Similarity=0.539 Sum_probs=212.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc--------CCcEEEEEecCC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE--------HEDVFIVFEYME 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--------~~~~~lv~e~~~ 72 (282)
|+||.||+|++..+++.||+|++.... ....+|+.+++.+. ||||+++++++.. ...++++|||++
T Consensus 77 G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~ 150 (440)
T PTZ00036 77 GSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLN-HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP 150 (440)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcC-CCCCcceeeeEeecccccCCCceEEEEEEecCC
Confidence 899999999999999999999885432 12235888888884 9999999887632 235779999999
Q ss_pred ccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCCCCCc
Q 044127 73 SDLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDY 148 (282)
Q Consensus 73 ~~~l~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~~~~~ 148 (282)
+++.+.+.. ..+..+++..++.++.||+.||.|||++|++||||||+||+++. +.+||+|||++............
T Consensus 151 ~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~ 230 (440)
T PTZ00036 151 QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY 230 (440)
T ss_pred ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccC
Confidence 987765543 23457999999999999999999999999999999999999974 47999999999876554444566
Q ss_pred cccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 149 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
.+++.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+....+.+....+..... ...+..++
T Consensus 231 ~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~--~~~~~~~~ 308 (440)
T PTZ00036 231 ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP--NYADIKFP 308 (440)
T ss_pred CCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch--hhhcccCC
Confidence 7899999999987666689999999999999999999999999988888888888887765543322110 11112222
Q ss_pred CCCCCcc-cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 229 QMGGVNL-RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 229 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
......+ ..++...++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus 309 ~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 309 DVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred ccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 2211111 123456788999999999999999999999999999997653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-49 Score=322.65 Aligned_cols=242 Identities=26% Similarity=0.397 Sum_probs=202.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|+++.+++.||+|++...... .....+.+|+.++.++ +||||+++++.+.+++..+++|||+.++.+..
T Consensus 29 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 107 (329)
T PTZ00263 29 GSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYFLLEFVVGGELFT 107 (329)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEEEEcCCCCChHHH
Confidence 89999999999999999999998765322 2334567899999998 59999999999999999999999998877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
.+... ..+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++....... ....+++.|+||
T Consensus 108 ~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aP 184 (329)
T PTZ00263 108 HLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAP 184 (329)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--ceecCChhhcCH
Confidence 66554 46999999999999999999999999999999999999975 799999999988664432 345789999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+.. ++.++|||||||++|+|++|..||...........+.... ..
T Consensus 185 E~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~------------------------------~~ 233 (329)
T PTZ00263 185 EVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR------------------------------LK 233 (329)
T ss_pred HHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------------------------cC
Confidence 9987554 7899999999999999999999998776555444432210 01
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCccccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCH 277 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~ 277 (282)
.+..++..+++||++||+.||.+|++ ++++++||||++..
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 23346788999999999999999997 79999999998754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=319.78 Aligned_cols=246 Identities=31% Similarity=0.506 Sum_probs=203.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++..... .........|...+....+||||+++++.+...+..|+||||+.++.+..
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~ 85 (320)
T cd05590 6 GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMF 85 (320)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHH
Confidence 8999999999999999999999876432 22344566788888877789999999999999999999999999877776
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.|++.||.|||+.|++|+||||+||++++ +.++|+|||++.... .........|++.|+|
T Consensus 86 ~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~a 164 (320)
T cd05590 86 HIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIA 164 (320)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccC
Confidence 66554 46999999999999999999999999999999999999975 799999999987532 2222344578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+. .++.++|||||||++|+|++|+.||...+..+....+.... .
T Consensus 165 PE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~------------------------------~ 213 (320)
T cd05590 165 PEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE------------------------------V 213 (320)
T ss_pred HHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC------------------------------C
Confidence 9998744 47999999999999999999999998877666554443210 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH------HHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA------AEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~~~~~~~~~~ 278 (282)
..+...+..+.++|++||+.||.+||++ +++++||||+++.+
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 1223468899999999999999999998 99999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=318.65 Aligned_cols=244 Identities=28% Similarity=0.420 Sum_probs=201.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++..... .........|+.++.++ +||||+++++.+..++..+++|||+.++.+..
T Consensus 4 G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 82 (312)
T cd05585 4 GSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGELFH 82 (312)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCcHHH
Confidence 8999999999999999999999875432 23345567788889888 59999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++...... .......|++.|+|
T Consensus 83 ~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~a 161 (312)
T cd05585 83 HLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLA 161 (312)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCC
Confidence 66554 46999999999999999999999999999999999999975 89999999998754222 22234578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++|||||||++|+|++|..||...........+... ..
T Consensus 162 PE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~------------------------------~~ 210 (312)
T cd05585 162 PELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE------------------------------PL 210 (312)
T ss_pred HHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC------------------------------CC
Confidence 99997544 799999999999999999999999877655544433221 01
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCC---CHHHHhcCccccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRP---TAAEALEHPFFRSCH 277 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~~ 277 (282)
..+...++.+.++|.+||+.||.+|| ++.++++||||++..
T Consensus 211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 23346788999999999999999997 579999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=321.78 Aligned_cols=276 Identities=36% Similarity=0.627 Sum_probs=208.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeeccccccC-----CcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH-----EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~ 74 (282)
|+||.||+|+++.+++.||+|++..... ......+.+|+.+++.+. ||||+++++++... ...|++||||+++
T Consensus 11 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~ 89 (338)
T cd07859 11 GSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFELMESD 89 (338)
T ss_pred cCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCceEEEEEecCCCC
Confidence 8999999999999999999999875322 233445778999999985 99999999987432 3589999999887
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC----CCCCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL----PCTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~----~~~~~~ 149 (282)
+.+.+... ..+++..+..++.||++||.|||++|++|+||||+||++++ +.++|+|||++....... ......
T Consensus 90 L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd07859 90 LHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167 (338)
T ss_pred HHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCC
Confidence 76655443 36999999999999999999999999999999999999985 799999999987543221 113456
Q ss_pred ccccccCchhhhcc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccccc-CCccc
Q 044127 150 TTRWYRAPEVLLLS-EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN-LDWKF 227 (282)
Q Consensus 150 ~~~~~~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 227 (282)
+++.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.......+....+.+.............. .-...
T Consensus 168 ~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (338)
T cd07859 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSM 247 (338)
T ss_pred CCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhh
Confidence 88999999998642 45789999999999999999999999988777766666666665544332211100000 00000
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
...............++.+.++|.+||+.||++|||++++++||||++....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 248 RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV 299 (338)
T ss_pred cccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence 0111111122233567889999999999999999999999999999886553
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=311.05 Aligned_cols=271 Identities=40% Similarity=0.801 Sum_probs=217.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|.+..+++.|++|+++............+|+..+.++.+|||++++++++.++ +..++++||+.+++++.
T Consensus 10 g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~ 89 (282)
T cd07831 10 GTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYEL 89 (282)
T ss_pred cccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCccHHHH
Confidence 7899999999999999999999876543444445567888899987899999999999877 88999999999988877
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
+.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++++.++|+|||.+.............++..|+|||
T Consensus 90 l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE 168 (282)
T cd07831 90 IKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPE 168 (282)
T ss_pred HHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCeEEEecccccccccCCCcCCCCCCcccCChh
Confidence 66543 46999999999999999999999999999999999999999999999999998775554445566788999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+......+.++|+|||||++|+|++|..||...+..+.........+.+..... .........+..++......+...
T Consensus 169 ~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 247 (282)
T cd07831 169 CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL-KKFRKSRHMNYNFPSKKGTGLRKL 247 (282)
T ss_pred HhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHH-HhhcccccccccCcccccccHHHH
Confidence 8765566789999999999999999999999988877777777666555443221 111111111222222222233334
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
....+..+.++|.+||+.+|++|||++++++||||
T Consensus 248 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 248 LPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 45678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=319.15 Aligned_cols=245 Identities=30% Similarity=0.489 Sum_probs=203.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|++..+|+.||+|++..... .........|..+++.+ +||||+++++.+..++..++||||+.++.+..
T Consensus 6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~ 84 (323)
T cd05595 6 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANGGELFF 84 (323)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCCCcHHH
Confidence 8999999999999999999999876532 22344556788888888 59999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..++.++.||+.||.|||++|++|+||||+||++++ +.++|+|||++..... ........+++.|+|
T Consensus 85 ~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~a 163 (323)
T cd05595 85 HLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 163 (323)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCC
Confidence 66554 46999999999999999999999999999999999999985 7999999998875322 222234578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+. .++.++|||||||++|+|++|..||...+.......+.... .
T Consensus 164 PE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~------------------------------~ 212 (323)
T cd05595 164 PEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE------------------------------I 212 (323)
T ss_pred cccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------------------------C
Confidence 9998754 47999999999999999999999998776655544432210 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
..+..+++.+.++|.+||+.||++|+ ++.++++|+||.+..+
T Consensus 213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 213 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 12346789999999999999999998 8999999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=319.03 Aligned_cols=245 Identities=31% Similarity=0.498 Sum_probs=202.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|++..+++.||+|++..... ......+.+|+.+++.+ +||||+++++.+...+..++||||+.++.+..
T Consensus 6 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~ 84 (328)
T cd05593 6 GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNGGELFF 84 (328)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCCCCHHH
Confidence 8999999999999999999999976532 23345567788888888 59999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++..... ........+++.|+|
T Consensus 85 ~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~a 163 (328)
T cd05593 85 HLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLA 163 (328)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccC
Confidence 55544 46999999999999999999999999999999999999985 7999999999875322 222234578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++|||||||++|+|++|..||...+.......+... ..
T Consensus 164 PE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~------------------------------~~ 212 (328)
T cd05593 164 PEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------------------------DI 212 (328)
T ss_pred hhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC------------------------------Cc
Confidence 99987544 799999999999999999999999876655444332110 01
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
.++..++..+.+||++||+.||++|+ ++.++++||||.++.+
T Consensus 213 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 213 KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 23346789999999999999999997 8999999999987644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=317.62 Aligned_cols=246 Identities=31% Similarity=0.480 Sum_probs=203.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++..... .........|..++..+.+||||+++++.+..++..|+||||+.++.+..
T Consensus 6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~ 85 (321)
T cd05591 6 GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMF 85 (321)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHH
Confidence 8999999999999999999999876532 22334556788888877789999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++..... ........+++.|+|
T Consensus 86 ~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~a 164 (321)
T cd05591 86 QIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIA 164 (321)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccC
Confidence 66544 46999999999999999999999999999999999999985 7999999998875422 222334568999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+. .++.++|||||||++|+|++|+.||...+..+....+.... .
T Consensus 165 PE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~------------------------------~ 213 (321)
T cd05591 165 PEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD------------------------------V 213 (321)
T ss_pred HHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------------------------C
Confidence 9998744 47999999999999999999999999887666655443310 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCC-------CHHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRP-------TAAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rp-------s~~~ll~~~~~~~~~~ 278 (282)
..+...+.++.++|.+||+.||++|| +++++++||||+++.+
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 12234678999999999999999999 8999999999987644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=325.29 Aligned_cols=246 Identities=33% Similarity=0.480 Sum_probs=215.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|.||+|++|..+.+++.||||++++.... ++......|..++....+||.++.++..|+.++++|+||||+.|+.+-.
T Consensus 379 GsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~ 458 (694)
T KOG0694|consen 379 GSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMH 458 (694)
T ss_pred CcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEE
Confidence 89999999999999999999999987653 3455667788888777789999999999999999999999999987333
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
+.. ...|++..+.-++.+|+.||.|||++||++||||.+|||+| +|.+||+|||++.... ......+.+|||.|+|
T Consensus 459 ~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~a 536 (694)
T KOG0694|consen 459 HIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLA 536 (694)
T ss_pred EEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcC
Confidence 333 25799999999999999999999999999999999999999 5999999999998653 5556678999999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+.. |+.+.|.|+|||+||||+.|..||.+.+.++....++.-. .
T Consensus 537 PEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~------------------------------~ 585 (694)
T KOG0694|consen 537 PEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE------------------------------V 585 (694)
T ss_pred hhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------------------------C
Confidence 99998665 9999999999999999999999999999998888775521 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccCc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHFV 279 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~~ 279 (282)
..+..++.+..++++++|..+|++|.. +++|..|||||++.|.
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence 234567999999999999999999995 5899999999998763
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=316.29 Aligned_cols=246 Identities=28% Similarity=0.442 Sum_probs=200.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|+++.+|+.||+|+++.... .........|...+....+||+|+++++.+.+.+..|+||||+.++.+..
T Consensus 6 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~ 85 (316)
T cd05620 6 GSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMF 85 (316)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHH
Confidence 8999999999999999999999976532 22344556677777776679999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||+|||++|++|+||||+||+++. +.++|+|||++..... ........+++.|+|
T Consensus 86 ~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~a 164 (316)
T cd05620 86 HIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIA 164 (316)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccC
Confidence 55543 46999999999999999999999999999999999999975 7999999998864321 222244578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++|||||||++|+|++|..||...+.......+.... .
T Consensus 165 PE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~------------------------------~ 213 (316)
T cd05620 165 PEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT------------------------------P 213 (316)
T ss_pred HHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------------------------C
Confidence 99997544 8999999999999999999999998776554444332110 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH-HHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA-AEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~ll~~~~~~~~~~ 278 (282)
..+...+.+++++|++||+.||++||++ +++++||||++..+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 1233468899999999999999999997 58999999988653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=316.23 Aligned_cols=246 Identities=32% Similarity=0.523 Sum_probs=202.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.+..+++.||+|++..... .........|..++..+.+||||+++++++...+..++||||+.++.+..
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 85 (318)
T cd05570 6 GSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMF 85 (318)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHH
Confidence 8999999999999999999999986532 22344556788888877789999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++.... .........+++.|+|
T Consensus 86 ~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~a 164 (318)
T cd05570 86 HIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIA 164 (318)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccC
Confidence 66554 36999999999999999999999999999999999999975 799999999886532 2222234568899999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+. .++.++|+|||||++|+|++|..||...+.......+.... .
T Consensus 165 PE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~------------------------------~ 213 (318)
T cd05570 165 PEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE------------------------------V 213 (318)
T ss_pred HHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC------------------------------C
Confidence 9999754 47999999999999999999999998776555444332210 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH-----HHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA-----AEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~~~~ 278 (282)
..+...+..+.++|++||+.||++|||+ .+++.||||+.+.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 1234568899999999999999999999 99999999988654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=323.17 Aligned_cols=274 Identities=32% Similarity=0.563 Sum_probs=213.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCC-----cEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE-----DVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-----~~~lv~e~~~~~ 74 (282)
|+||+||+|.+..+++.||+|++...... .......+|+.+++.+. ||||+++++++.... ..|+++||+.++
T Consensus 11 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~ 89 (372)
T cd07853 11 GAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEEIYVVTELMQSD 89 (372)
T ss_pred CCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccceEEEEeeccccC
Confidence 89999999999999999999998654322 23445678999999985 999999999998766 789999999988
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC--CCCCCcccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS--LPCTDYVTT 151 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~--~~~~~~~~~ 151 (282)
+.+.+... ..+++..+..++.||+.||.|||+.|++|+||||+||++++ +.++|+|||++...... .......++
T Consensus 90 l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~ 167 (372)
T cd07853 90 LHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVT 167 (372)
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcC
Confidence 77665443 47999999999999999999999999999999999999985 79999999998765322 222334678
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccC--CccccC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL--DWKFPQ 229 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 229 (282)
+.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+....+.+....+.......... ......
T Consensus 168 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (372)
T cd07853 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKP 247 (372)
T ss_pred CCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCC
Confidence 889999999866667999999999999999999999999998888888887777766543322111000000 000000
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.............++++.+||.+||+.||.+|||++++|+||||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 248 PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred CchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 000111123445688999999999999999999999999999998853
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-48 Score=320.38 Aligned_cols=269 Identities=32% Similarity=0.527 Sum_probs=206.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccC------CcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH------EDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~------~~~~lv~e~~~~ 73 (282)
|+||.||+|.+..+|+.||+|++...... .......+|+.+++.+ +||||+++++++... ...|++|||+++
T Consensus 32 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~ 110 (359)
T cd07876 32 GAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA 110 (359)
T ss_pred CCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccccceeEEEEeCCCc
Confidence 89999999999999999999998764332 3344567888888888 499999999988543 357999999999
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++...+.. .+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++.............+++
T Consensus 111 ~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~ 186 (359)
T cd07876 111 NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTR 186 (359)
T ss_pred CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccC
Confidence 87766532 5889999999999999999999999999999999999974 899999999987655444445567889
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccccc----------
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN---------- 222 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 222 (282)
.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+..+....+....+.+..............
T Consensus 187 ~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (359)
T cd07876 187 YYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPG 265 (359)
T ss_pred CCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCC
Confidence 999999997544 889999999999999999999999988877776666666555443221110000000
Q ss_pred --CCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 223 --LDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 223 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
....++..............++.+++||.+||+.||++|||++|+|+||||+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 266 ISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred cchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00000000011111223345788999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-48 Score=314.95 Aligned_cols=246 Identities=31% Similarity=0.490 Sum_probs=201.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|+++..... ........|...+....+||||+++++++..+...++||||+.++.+..
T Consensus 6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~ 85 (316)
T cd05592 6 GSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMF 85 (316)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHH
Confidence 89999999999999999999999765322 2333445677777766679999999999999999999999999877776
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||.|||+.|++|+||||+||+++. +.++|+|||++..... ........|++.|+|
T Consensus 86 ~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~a 164 (316)
T cd05592 86 HIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIA 164 (316)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccC
Confidence 66554 36999999999999999999999999999999999999974 7999999999875422 222344578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++|||||||++|+|++|..||.+.+..+....+.... .
T Consensus 165 PE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~------------------------------~ 213 (316)
T cd05592 165 PEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR------------------------------P 213 (316)
T ss_pred HHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------------------------C
Confidence 99987544 7999999999999999999999998877655554432210 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH-HHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA-AEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-~~ll~~~~~~~~~~ 278 (282)
..+...+.++.++|.+||+.||++||++ ++++.||||+++.+
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 2234568899999999999999999986 58899999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-48 Score=317.70 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=206.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|++..+++.||+|++...... .....+..|+.++..+. ||||+++++++.+....++||||+.++.+..
T Consensus 12 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~ 90 (333)
T cd05600 12 GGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRT 90 (333)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEEEeCCCCCCHHH
Confidence 89999999999999999999999765322 23445678888888885 9999999999999999999999999877777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++... ..+++..+..++.||+.||.+||+.|++|+||||+||+++. +.++|+|||++..... ......+++.|+||
T Consensus 91 ~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aP 167 (333)
T cd05600 91 LLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAP 167 (333)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCcccCccccCh
Confidence 77654 36999999999999999999999999999999999999975 7999999999876544 22456789999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+. .++.++|||||||++|+|++|..||...+..+....+........... ...
T Consensus 168 E~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----------------------~~~ 224 (333)
T cd05600 168 EVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPV----------------------YDD 224 (333)
T ss_pred hHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCC----------------------CCc
Confidence 998755 589999999999999999999999988777666555443221110000 000
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
....+++++.++|.+||..+|.+||+++++++||||+++.
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 0135688999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-48 Score=318.03 Aligned_cols=243 Identities=28% Similarity=0.388 Sum_probs=201.5
Q ss_pred CCcceEEEEEecCCC-cEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSG-EFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~-~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||.||+|.+..++ ..||+|++..... ......+..|+.++..+. ||||+++++++.+++..+++|||+.++.+.
T Consensus 41 G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~ 119 (340)
T PTZ00426 41 GSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119 (340)
T ss_pred cCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEEEEEEeCCCCCcHH
Confidence 899999999876654 6899999875432 223345677888888884 999999999999999999999999887776
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
.++... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++....... ....+++.|+|
T Consensus 120 ~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~--~~~~gt~~y~a 196 (340)
T PTZ00426 120 TFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT--YTLCGTPEYIA 196 (340)
T ss_pred HHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc--ceecCChhhcC
Confidence 666654 46999999999999999999999999999999999999974 899999999987664332 45678999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+.. ++.++|+|||||++|+|++|..||...+.......+.... .
T Consensus 197 PE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~------------------------------~ 245 (340)
T PTZ00426 197 PEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI------------------------------I 245 (340)
T ss_pred HHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC------------------------------C
Confidence 99997544 7899999999999999999999998876655554443211 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
..+...++.+.++|++||+.||.+|+ +++++++||||+++.+
T Consensus 246 ~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 246 YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 12345688899999999999999995 8999999999998754
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=315.87 Aligned_cols=247 Identities=29% Similarity=0.447 Sum_probs=198.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|+++.+++.||+|+++..... .....+..|..++..+.+||||+++++.+.+....|+|||||.++.+..
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 85 (329)
T cd05588 6 GSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMF 85 (329)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHH
Confidence 89999999999999999999999865432 2234466788888888789999999999999999999999999876665
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccccc-CCCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++... ..........|++.|+|
T Consensus 86 ~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~a 164 (329)
T cd05588 86 HMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIA 164 (329)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccC
Confidence 55543 47999999999999999999999999999999999999975 79999999998643 22222345678999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSA--------DQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
||.+.+. .++.++|+|||||++|+|++|..||...... +........
T Consensus 165 PE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~------------------------ 219 (329)
T cd05588 165 PEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE------------------------ 219 (329)
T ss_pred HHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc------------------------
Confidence 9999754 4789999999999999999999999643211 111111110
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCC------HHHHhcCcccccccC
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPT------AAEALEHPFFRSCHF 278 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~~ll~~~~~~~~~~ 278 (282)
....++..++..+.++|++||+.||.+|+| ++++++||||+.+.+
T Consensus 220 -----~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 220 -----KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 001234467889999999999999999997 789999999987644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=306.87 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=199.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||++.++.+++.||+|++....... ....+..|+.+++.+ +||||+++.+.+..+...+++|||+.++.+..
T Consensus 4 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~ 82 (280)
T cd05608 4 GGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRY 82 (280)
T ss_pred CCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHH
Confidence 899999999999999999999987643322 224456788888888 59999999999999999999999999877765
Q ss_pred HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCcccccc
Q 044127 79 MKER---AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRW 153 (282)
Q Consensus 79 ~~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~ 153 (282)
.+.. ....+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||.+........ .....+++.
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~ 162 (280)
T cd05608 83 HIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPG 162 (280)
T ss_pred HHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcC
Confidence 5432 2346999999999999999999999999999999999999975 7899999999876543322 234578899
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
|+|||.+.+. .++.++|+|||||++|+|++|+.||...................
T Consensus 163 y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------------------- 216 (280)
T cd05608 163 FMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND------------------------- 216 (280)
T ss_pred ccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-------------------------
Confidence 9999999855 47899999999999999999999997654332222221111000
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
....+..++..+.+++.+||+.||++|| +++++++||||++..+
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~ 265 (280)
T cd05608 217 -SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW 265 (280)
T ss_pred -CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence 0122345788999999999999999999 8899999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=296.16 Aligned_cols=253 Identities=29% Similarity=0.461 Sum_probs=207.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc----CCcEEEEEecCCc-cH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE----HEDVFIVFEYMES-DL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~~~lv~e~~~~-~~ 75 (282)
|-.|.|-.+.++.||+.+|+|++... ....+|+..-.....|||||.++++|++ ..++.+|||.|.| .+
T Consensus 73 GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeL 146 (400)
T KOG0604|consen 73 GINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGEL 146 (400)
T ss_pred ccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHH
Confidence 56799999999999999999997542 3344577777777789999999999864 4678899999985 56
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCCCCCcccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
+..+..+....+++.++..|++||..|+.|||+.+|.||||||+|+|+.. ..+||+|||+|..-.........+.|
T Consensus 147 fsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~T 226 (400)
T KOG0604|consen 147 FSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFT 226 (400)
T ss_pred HHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCccc
Confidence 66666666678999999999999999999999999999999999999963 47999999999988777777888999
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
|.|.|||++...+ ++...|+||+||+||-|++|..||.+.....+-..+...++. -...|+.
T Consensus 227 PyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~---------------gqy~FP~-- 288 (400)
T KOG0604|consen 227 PYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT---------------GQYEFPE-- 288 (400)
T ss_pred ccccCHHHhCchh-cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc---------------cCccCCC--
Confidence 9999999986444 899999999999999999999999876543332222222111 1111221
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCccCC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~ 282 (282)
+-+..+++..+++|+++|..+|++|.|++++++|||+.+...+|+.
T Consensus 289 -----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~t 334 (400)
T KOG0604|consen 289 -----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQT 334 (400)
T ss_pred -----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCC
Confidence 2234679999999999999999999999999999999999998863
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=307.53 Aligned_cols=270 Identities=33% Similarity=0.624 Sum_probs=211.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||+|+++.+|+.|++|.+...... .......+|+..++++ +|||++++++++.+....++++||+++++++.+
T Consensus 11 g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~ 89 (284)
T cd07839 11 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYF 89 (284)
T ss_pred cCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEEecCCCCHHHHH
Confidence 78999999999999999999998754322 2234556789999888 599999999999999999999999999887766
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aP 157 (282)
.... ..+++..++.++.||++||.+||+.|++|+||+|+||+++. +.++|+|||.+....... ......+++.|+||
T Consensus 90 ~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aP 168 (284)
T cd07839 90 DSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 168 (284)
T ss_pred HhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcCh
Confidence 5543 46999999999999999999999999999999999999974 799999999987654322 12334567889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCC-CCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILF-PGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.+...++.++|||||||++|+|++|..|+ ...+..+....+....+.+....++............. ........
T Consensus 169 E~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 247 (284)
T cd07839 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM-YPATTSLV 247 (284)
T ss_pred HHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC-CCCcchhh
Confidence 99876666799999999999999999998875 55555566666666666665555543332222211110 00111122
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
+....+++.+.++|++||+.||.+|||++++++||||
T Consensus 248 ~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 248 NVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred hhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 3445678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=315.25 Aligned_cols=246 Identities=30% Similarity=0.451 Sum_probs=198.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||+|++...... ........|...+.+..+||||+++++.+.+.+..++||||+.++.+..
T Consensus 6 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 85 (323)
T cd05575 6 GSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFF 85 (323)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHH
Confidence 89999999999999999999998764322 2233445565555444469999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++.... .........+++.|+|
T Consensus 86 ~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~a 164 (323)
T cd05575 86 HLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLA 164 (323)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcC
Confidence 66554 47999999999999999999999999999999999999975 799999999986532 2222344578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+. .++.++|||||||++|+|++|..||...+..+....+.... .
T Consensus 165 PE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------------------~ 213 (323)
T cd05575 165 PEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------------------------------L 213 (323)
T ss_pred hhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC------------------------------C
Confidence 9998754 48999999999999999999999998876655544433210 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH----HHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA----AEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~~~~~~~~~~ 278 (282)
......+..+.++|++||+.||.+||++ .++++||||++..+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 1233568899999999999999999987 69999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=307.65 Aligned_cols=271 Identities=35% Similarity=0.691 Sum_probs=214.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|+||+|++..++..|++|++....... ......+|+.+++++. |||++++++++.++...++||||+.+++.+.+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~ 89 (285)
T cd07861 11 GTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYL 89 (285)
T ss_pred cCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEEecCCCCHHHHH
Confidence 789999999999999999999987543222 2345667889998885 99999999999999999999999998777665
Q ss_pred HHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccC
Q 044127 80 KERA-GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~~-~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~a 156 (282)
.... +..+++..++.++.||+.||.+||+.|++|+||+|+||++++ +.++|+|||++....... ......+++.|+|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~a 169 (285)
T cd07861 90 DSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRA 169 (285)
T ss_pred hcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccC
Confidence 4433 256999999999999999999999999999999999999974 899999999987553322 1123456788999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+...++.++|+||||+++|+|++|+.||......+.........+.+....|+....... ....++........
T Consensus 170 PE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 248 (285)
T cd07861 170 PEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD-YKNTFPKWKKGSLR 248 (285)
T ss_pred hHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH-HHhhccccCcchhH
Confidence 99987666678999999999999999999999998887777777777766665555543222111 11112222222233
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.....+++++.++|++||+.||.+|||++++++||||
T Consensus 249 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 249 SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 3445689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-48 Score=316.77 Aligned_cols=245 Identities=31% Similarity=0.494 Sum_probs=201.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++...... ........|...+..+ +||||+++++.+..++..++||||+.++.+..
T Consensus 6 G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~ 84 (325)
T cd05594 6 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANGGELFF 84 (325)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCCCcHHH
Confidence 89999999999999999999999765322 2334556788888887 59999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~ 155 (282)
.+... ..+++..+..++.||+.||.|||+ .|++|+||||+||++++ +.++|+|||++.... .........+++.|+
T Consensus 85 ~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~ 163 (325)
T cd05594 85 HLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 163 (325)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccC
Confidence 66554 469999999999999999999997 79999999999999975 789999999987532 222223456899999
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||.+.+.. ++.++|||||||++|+|++|..||...+.......+....
T Consensus 164 aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~------------------------------ 212 (325)
T cd05594 164 APEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE------------------------------ 212 (325)
T ss_pred CHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC------------------------------
Confidence 999987544 7999999999999999999999998766554444332110
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
...+...++++.++|++||+.||++|+ ++.++++||||+++.+
T Consensus 213 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 260 (325)
T cd05594 213 IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVW 260 (325)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence 112345788999999999999999997 9999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=307.24 Aligned_cols=272 Identities=37% Similarity=0.661 Sum_probs=222.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||+|.+..+|+.|++|++..... ......+.+|+..++++. |||++++++++......++|+||+ ++.+..+
T Consensus 11 g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~ 88 (286)
T cd07832 11 GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEV 88 (286)
T ss_pred CCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEeccc-CCCHHHH
Confidence 7899999999999999999999876543 233456778999999995 999999999999999999999999 5445444
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccC
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~a 156 (282)
+......+++..++.++.||+.||.+||+.|++|+||+|+||++++ +.++++|||.+....... ......++..|+|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~a 168 (286)
T cd07832 89 LRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRA 168 (286)
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccC
Confidence 4444467999999999999999999999999999999999999985 789999999988764432 1234567888999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+...++.++||||+|+++|+|++|..+|...........+....+.+....|+............+.......+.
T Consensus 169 PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd07832 169 PELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLE 248 (286)
T ss_pred ceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHH
Confidence 99987666678999999999999999999999988888888888888777777766665444433333333333333344
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 274 (282)
......+..+.++|++||+.||.+|||++++++||||.
T Consensus 249 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 249 EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred HhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 45566789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=311.79 Aligned_cols=246 Identities=30% Similarity=0.481 Sum_probs=200.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|+++.... .........|...+....+||||+++++++.+++..++||||+.++.+..
T Consensus 6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~ 85 (316)
T cd05619 6 GSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMF 85 (316)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHH
Confidence 8999999999999999999999876532 22334556677777776679999999999999999999999998777766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.|++.||.|||+.|++|+||||+||+++. +.++|+|||++..... ........+++.|+|
T Consensus 86 ~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~a 164 (316)
T cd05619 86 HIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIA 164 (316)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccC
Confidence 66543 46999999999999999999999999999999999999975 7899999999875322 122234568899999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++|||||||++|+|++|..||...+..+....+... . .
T Consensus 165 PE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~-----------------------------~ 213 (316)
T cd05619 165 PEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-N-----------------------------P 213 (316)
T ss_pred HHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-C-----------------------------C
Confidence 99987544 799999999999999999999999877655544433211 0 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHH-HHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAA-EALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~ll~~~~~~~~~~ 278 (282)
..+...+..+.++|.+||+.||++||++. ++++||||+++.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 12234678899999999999999999996 9999999988653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=304.88 Aligned_cols=273 Identities=53% Similarity=1.011 Sum_probs=231.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|+||+|+...+++.|++|.+.............+|+..+.++.+|||++++++++..++..+++|||+++++++.+.
T Consensus 10 g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~ 89 (283)
T cd07830 10 GTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMK 89 (283)
T ss_pred CCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecCCCCHHHHHH
Confidence 78999999999988999999998766544444556678888888866999999999999999999999999888777776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCchh
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 159 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~ 159 (282)
...+..+++..+..++.|++.+|.+||++|++|+||+|+||++++ +.++|+|||.+.............++..|+|||.
T Consensus 90 ~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~ 169 (283)
T cd07830 90 DRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169 (283)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCcee
Confidence 654457899999999999999999999999999999999999986 8999999999887665444455667888999998
Q ss_pred hhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccC
Q 044127 160 LLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239 (282)
Q Consensus 160 ~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
+.....++.++|+||||+++++|++|+.||......+.........+.+....|+.............+......+....
T Consensus 170 ~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (283)
T cd07830 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLI 249 (283)
T ss_pred eecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHc
Confidence 86666679999999999999999999999999999999999988888888877776665555555555444444444444
Q ss_pred CCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
...+..+.++|++||+.||.+|||++|++.||||
T Consensus 250 ~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 250 PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 4558899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=318.34 Aligned_cols=248 Identities=33% Similarity=0.505 Sum_probs=203.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++...... .....+..|..++..+. ||||+++++.+.+++..++||||+.++.+..
T Consensus 12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 90 (350)
T cd05573 12 GAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMN 90 (350)
T ss_pred CCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEEEcCCCCCCHHH
Confidence 89999999999999999999999765322 23445667888888884 9999999999999999999999998766666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--------------
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-------------- 143 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-------------- 143 (282)
++... ..+++..++.++.||+.||.+||+.|++|+||||+||+++. +.++|+|||++.......
T Consensus 91 ~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 169 (350)
T cd05573 91 LLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169 (350)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccc
Confidence 66554 47999999999999999999999999999999999999985 799999999987664432
Q ss_pred ----------------CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCC
Q 044127 144 ----------------PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGS 207 (282)
Q Consensus 144 ----------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 207 (282)
......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~ 248 (350)
T cd05573 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKES 248 (350)
T ss_pred cccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCc
Confidence 22345689999999999855 4899999999999999999999999988766655554432111
Q ss_pred CCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCC-HHHHhcCcccccccC
Q 044127 208 PTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPT-AAEALEHPFFRSCHF 278 (282)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll~~~~~~~~~~ 278 (282)
.. . .....+++.+.++|++||. ||.+||+ ++++++||||+++.+
T Consensus 249 ~~-----------------~---------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 249 LR-----------------F---------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred cc-----------------C---------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 10 0 0111268999999999998 9999999 999999999988654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=312.17 Aligned_cols=246 Identities=29% Similarity=0.468 Sum_probs=202.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|++..+++.||+|++..... .........|..++..+.+|++|+.+++.+.+.+..|+||||+.++.+..
T Consensus 11 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~ 90 (324)
T cd05587 11 GSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 90 (324)
T ss_pred ccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHH
Confidence 8999999999999999999999876532 23344567788888888756779999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++.... .........|++.|+|
T Consensus 91 ~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~a 169 (324)
T cd05587 91 HIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIA 169 (324)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccC
Confidence 66554 36899999999999999999999999999999999999975 799999999886432 2222234568999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++|||||||++|+|++|+.||......+....+.... .
T Consensus 170 PE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------------------------~ 218 (324)
T cd05587 170 PEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------------------------V 218 (324)
T ss_pred hhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------------------------------C
Confidence 99997544 7999999999999999999999998877665555443211 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH-----HHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA-----AEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~~~~ 278 (282)
..+...+..+.+++.+||+.||.+|++. +++++||||+.+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 219 SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 2234578899999999999999999986 89999999988654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=316.38 Aligned_cols=248 Identities=24% Similarity=0.416 Sum_probs=198.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++...... .....+..|..++.++ +||+|+++++.+.+....|+|||||.|+.+..
T Consensus 12 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~ 90 (363)
T cd05628 12 GAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMT 90 (363)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEEEcCCCCCcHHH
Confidence 89999999999999999999999764322 2234456788888888 59999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-------------
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP------------- 144 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~------------- 144 (282)
++... ..+++..+..++.|++.||.|||++|++||||||+||++++ +.++|+|||++........
T Consensus 91 ~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 169 (363)
T cd05628 91 LLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169 (363)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccc
Confidence 66554 47999999999999999999999999999999999999975 8999999999875432110
Q ss_pred -----------------------CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Q 044127 145 -----------------------CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKI 201 (282)
Q Consensus 145 -----------------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~ 201 (282)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+....+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i 248 (363)
T cd05628 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKV 248 (363)
T ss_pred cccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 12347899999999997544 899999999999999999999999887776666555
Q ss_pred HHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCC---CCCCHHHHhcCcccccccC
Q 044127 202 CQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPH---MRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~---~Rps~~~ll~~~~~~~~~~ 278 (282)
....... .++ -...+++.++++|.+|+. +|. .||+++++++||||+++.+
T Consensus 249 ~~~~~~~-----------------~~p---------~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 249 MNWKETL-----------------IFP---------PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDW 301 (363)
T ss_pred HcCcCcc-----------------cCC---------CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCH
Confidence 4321111 000 012467899999999775 444 4689999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=312.50 Aligned_cols=247 Identities=30% Similarity=0.474 Sum_probs=198.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++...... ........|..++.++.+||||+++++++..++..++||||+.++.+..
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~ 85 (329)
T cd05618 6 GSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMF 85 (329)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHH
Confidence 89999999999999999999999865332 2334456788888888789999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++.... .........|++.|+|
T Consensus 86 ~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~a 164 (329)
T cd05618 86 HMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 164 (329)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccC
Confidence 65544 47999999999999999999999999999999999999975 799999999987532 2222344578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSA--------DQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
||.+.+.. ++.++|+|||||++|+|++|..||...... +........
T Consensus 165 PE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~------------------------ 219 (329)
T cd05618 165 PEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE------------------------ 219 (329)
T ss_pred HHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc------------------------
Confidence 99997544 789999999999999999999999632111 111111100
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCC------HHHHhcCcccccccC
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPT------AAEALEHPFFRSCHF 278 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~~ll~~~~~~~~~~ 278 (282)
....++...+..+.++|++||+.||++||+ ++++++||||+++.+
T Consensus 220 -----~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 220 -----KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 001234567889999999999999999998 589999999988754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=316.34 Aligned_cols=269 Identities=32% Similarity=0.522 Sum_probs=208.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccC------CcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH------EDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~------~~~~lv~e~~~~ 73 (282)
|+||.||+|.+..+++.||+|++...... .......+|+..++.+ +||||+.+++++... ...|+||||+++
T Consensus 35 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~ 113 (364)
T cd07875 35 GAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA 113 (364)
T ss_pred CCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccccCeEEEEEeCCCC
Confidence 89999999999999999999998765432 3344567788888888 599999999987543 357999999999
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++...+.. .+++..+..++.|++.||.+||++|++|+||||+||+++. +.++|+|||++...+.........+++
T Consensus 114 ~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~ 189 (364)
T cd07875 114 NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189 (364)
T ss_pred CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccC
Confidence 87766532 5889999999999999999999999999999999999974 799999999998766554445567899
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccC---------
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL--------- 223 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 223 (282)
.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+..+....+....+.+.+..+..........
T Consensus 190 ~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (364)
T cd07875 190 YYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAG 268 (364)
T ss_pred CcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCC
Confidence 999999997544 8999999999999999999999999988888887777776665543222111100000
Q ss_pred ---CccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 224 ---DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 224 ---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
...+...............+..+++||.+||+.||.+|||++++|+||||..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 269 YSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred CChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0000000000011122234678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=305.77 Aligned_cols=271 Identities=35% Similarity=0.655 Sum_probs=213.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|.++.+++.|++|.+.............+|+.+++++ +||||+++++++.++...++||||+.+++.+.+.
T Consensus 16 g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~ 94 (291)
T cd07844 16 GSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMD 94 (291)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEEEecCCCCHHHHHH
Confidence 789999999999899999999987654333334566799999999 5999999999999999999999999987665544
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
. .+..+++..++.++.|+++||.+||+.|++|+||+|+||++++ +.++|+|||.+....... ......++..|+|||
T Consensus 95 ~-~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE 173 (291)
T cd07844 95 D-CGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPD 173 (291)
T ss_pred h-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcH
Confidence 3 3347899999999999999999999999999999999999985 789999999986543221 112234678899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKN-SADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
.+.+...++.++||||+|+++|+|++|..||.... ..+....+.+..+.+.+..++.......................
T Consensus 174 ~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd07844 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLIN 253 (291)
T ss_pred HhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHH
Confidence 98765557899999999999999999999997665 45556666667777766666554444333333333322222223
Q ss_pred cCCCCC--hhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 238 LSPSAS--RESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 238 ~~~~~~--~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.....+ ..+.+++.+||+.+|++|||++++++||||
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 254 HAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 333444 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=316.52 Aligned_cols=247 Identities=29% Similarity=0.427 Sum_probs=199.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhC--CCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMN--NHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~--~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|+++.+++.||+|++...... ........|..++.... +||+|+.+++.+.+....++||||+.++.+
T Consensus 4 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L 83 (330)
T cd05586 4 GTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGEL 83 (330)
T ss_pred CCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChH
Confidence 89999999999999999999998754322 22334455666666654 799999999999999999999999987766
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWY 154 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~~~ 154 (282)
...+... ..+++..++.++.||++||+|||++|++|+||||+||++++ +.++|+|||++..... ........|++.|
T Consensus 84 ~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y 162 (330)
T cd05586 84 FWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEY 162 (330)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccc
Confidence 6555544 46999999999999999999999999999999999999975 7999999999875422 2223456789999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||.+.+...++.++|||||||++|+|++|..||...+..+....+..... .+
T Consensus 163 ~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------~~------- 216 (330)
T cd05586 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV-------------------RF------- 216 (330)
T ss_pred cCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC-------------------CC-------
Confidence 9999987655579999999999999999999999988766555444322100 00
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCC----CHHHHhcCccccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRP----TAAEALEHPFFRSCH 277 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp----s~~~ll~~~~~~~~~ 277 (282)
....+++.+.++|++||+.||.+|| +++++++||||++..
T Consensus 217 ---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 217 ---PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred ---CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 0123688999999999999999998 799999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=309.60 Aligned_cols=269 Identities=24% Similarity=0.375 Sum_probs=203.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|++..++..|++|++...........+.+|+.++.++. ||||+++++++..++..+++|||+.++++..++
T Consensus 16 G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 94 (331)
T cd06649 16 GNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 94 (331)
T ss_pred CCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEEeecCCCCcHHHHH
Confidence 8999999999999999999999876543344566788999999984 999999999999999999999999988777776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
... ..+++..+..++.|++.||.|||++ +++|+||||+||++++ +.++|+|||++....... .....+++.|+|||
T Consensus 95 ~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~g~~~y~aPE 172 (331)
T cd06649 95 KEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPE 172 (331)
T ss_pred HHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-cccCCCCcCcCCHh
Confidence 654 3699999999999999999999986 5999999999999975 799999999987654332 24457899999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCC---Cccccc-ccc----ccCCcc----
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTED---SWPLGI-QLA----SNLDWK---- 226 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-~~~----~~~~~~---- 226 (282)
.+.+.. ++.++|||||||++|+|++|+.||......+....+ +.+... ..+... ... ......
T Consensus 173 ~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (331)
T cd06649 173 RLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF----GRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDS 247 (331)
T ss_pred HhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh----cccccccccCCccccCccccccccccccccccc
Confidence 987544 899999999999999999999999876654432221 111100 000000 000 000000
Q ss_pred ---------ccCC-CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 227 ---------FPQM-GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 227 ---------~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.... ............++++++||.+||+.||++|||++++++||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 248 RPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0000 00000111224678999999999999999999999999999997653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=304.52 Aligned_cols=278 Identities=33% Similarity=0.653 Sum_probs=222.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|+||+|.++.+++.|++|.+...... .....+.+|+..++++ +|||++++++++.+....++||||+++++.+.+
T Consensus 13 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~ 91 (294)
T PLN00009 13 GTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHM 91 (294)
T ss_pred CCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEEEecccccHHHHH
Confidence 78999999999999999999998765332 2234567799999999 599999999999999999999999998888777
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCC-CCCCccccccccC
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~a 156 (282)
....+..+++..+..++.||+.||++||++|++|+||+|+||++++ +.++++|||++....... ......+++.|+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~ 171 (294)
T PLN00009 92 DSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRA 171 (294)
T ss_pred HhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccC
Confidence 6655555789999999999999999999999999999999999984 579999999987654322 1233456788999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+...++.++||||||+++|+|++|..||......+....+....+.+....|+........ ...++........
T Consensus 172 PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 250 (294)
T PLN00009 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY-KSAFPKWPPKDLA 250 (294)
T ss_pred HHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh-hhhcccCCCCCHH
Confidence 999876566789999999999999999999999988888888887777777766655433222221 1111111122223
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
......++.+.+++.+||+.+|++||+++++++||||+++..+|
T Consensus 251 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~~ 294 (294)
T PLN00009 251 TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDAP 294 (294)
T ss_pred HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcCC
Confidence 33456788999999999999999999999999999999987665
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=307.45 Aligned_cols=277 Identities=38% Similarity=0.644 Sum_probs=217.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~l~ 77 (282)
|+||.||+|.++.+|+.|++|+++....... .....+|+.+++++. |||++++++++... +..++||||+.+++.+
T Consensus 18 g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~ 96 (309)
T cd07845 18 GTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSIFLVMEYCEQDLAS 96 (309)
T ss_pred cCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeEEEEEecCCCCHHH
Confidence 7899999999999999999999875433222 234467899999885 99999999998654 5689999999987666
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCcccccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYR 155 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~ 155 (282)
.+... ...+++..+..++.||+.||.+||+.|++|+||+|+||++++ +.++|+|||.+....... ......+++.|+
T Consensus 97 ~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~ 175 (309)
T cd07845 97 LLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYR 175 (309)
T ss_pred HHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCccccccccc
Confidence 55443 357999999999999999999999999999999999999985 799999999988664332 222334577899
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||.+.+...++.++|+||||+++|+|++|..||...+..+....+....+.+....|+.....................
T Consensus 176 aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (309)
T cd07845 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNL 255 (309)
T ss_pred ChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCch
Confidence 99998765668999999999999999999999999999999998888888877776665443333221111111111112
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
.......++.+.++|++||+.||++|||++++++||||++....
T Consensus 256 ~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 256 KHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred HHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 22233458889999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=312.92 Aligned_cols=251 Identities=26% Similarity=0.404 Sum_probs=198.4
Q ss_pred CCcceEEEEEec---CCCcEEEEEEccccccc---hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDK---KSGEFVAVKKLKKKIFS---LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~---~~~~~v~vK~~~~~~~~---~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|+||+||+|++. .+++.||+|++...... ........|+.++..+.+||+|+.+++.+..++..+++|||+.++
T Consensus 11 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g 90 (332)
T cd05614 11 GAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGG 90 (332)
T ss_pred cCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCC
Confidence 899999999864 47899999998754322 223445678899999988999999999999999999999999976
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC--CCCCCcccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS--LPCTDYVTT 151 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~--~~~~~~~~~ 151 (282)
.+...+... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++...... .......|+
T Consensus 91 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt 169 (332)
T cd05614 91 EMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGT 169 (332)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCC
Confidence 665555443 46999999999999999999999999999999999999974 79999999998764322 122345789
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
+.|+|||.+.+...++.++|||||||++|+|++|..||...........+.......
T Consensus 170 ~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~----------------------- 226 (332)
T cd05614 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC----------------------- 226 (332)
T ss_pred ccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC-----------------------
Confidence 999999998755557889999999999999999999997543322222111111000
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
....+..++..+.++|.+||+.||++|| +++++++||||++..+
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 227 ---DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 0123345788999999999999999999 8899999999987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=297.53 Aligned_cols=248 Identities=30% Similarity=0.466 Sum_probs=207.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH--HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD--ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~--~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|.-|+||+|..+.++..+|+|++++...... ......|..+|..+ +||.++.+|..|+.+.+.|++||||+|+.|..
T Consensus 88 GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl~meyCpGGdL~~ 166 (459)
T KOG0610|consen 88 GDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCLVMEYCPGGDLHS 166 (459)
T ss_pred CCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEEEEecCCCccHHH
Confidence 7789999999999999999999988765432 23345677788888 69999999999999999999999999877766
Q ss_pred HHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCC---------------
Q 044127 79 MKE-RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDS--------------- 141 (282)
Q Consensus 79 ~~~-~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~--------------- 141 (282)
+.+ +.++.+++..++-++.+++-||+|||..||++|||||+|||+. +|.|.|+||.++.....
T Consensus 167 LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~ 246 (459)
T KOG0610|consen 167 LRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGS 246 (459)
T ss_pred HHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCC
Confidence 655 4567899999999999999999999999999999999999996 59999999998653210
Q ss_pred ------------------C-C-----------------------CCCCccccccccCchhhhccccCCCcchhHHHHHHH
Q 044127 142 ------------------S-L-----------------------PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIM 179 (282)
Q Consensus 142 ------------------~-~-----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll 179 (282)
. . .....+||-.|+|||++.+.+ ++.+.|.|+||+++
T Consensus 247 ~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-HgsAVDWWtfGIfl 325 (459)
T KOG0610|consen 247 QPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGSAVDWWTFGIFL 325 (459)
T ss_pred CcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-CCchhhHHHHHHHH
Confidence 0 0 001235677899999998666 89999999999999
Q ss_pred HHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCC
Q 044127 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPH 259 (282)
Q Consensus 180 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 259 (282)
|||+.|.-||.+.+..+.+.+++...- .|+. ...++..+++||+++|..||+
T Consensus 326 YEmLyG~TPFKG~~~~~Tl~NIv~~~l-------------------~Fp~---------~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 326 YEMLYGTTPFKGSNNKETLRNIVGQPL-------------------KFPE---------EPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred HHHHhCCCCcCCCCchhhHHHHhcCCC-------------------cCCC---------CCcchhHHHHHHHHHhccChh
Confidence 999999999999999999988766321 1111 114578899999999999999
Q ss_pred CCCC----HHHHhcCcccccccC
Q 044127 260 MRPT----AAEALEHPFFRSCHF 278 (282)
Q Consensus 260 ~Rps----~~~ll~~~~~~~~~~ 278 (282)
+|.. +.||-+||||+++.|
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred hhhccccchHHhhcCccccCCCh
Confidence 9998 999999999999987
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=313.88 Aligned_cols=271 Identities=35% Similarity=0.635 Sum_probs=208.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccC------CcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH------EDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~------~~~~lv~e~~~~ 73 (282)
|+||+||+|.+..+++.||+|++...... .......+|+.+++++. ||||+++++++... ...+++++++++
T Consensus 26 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (343)
T cd07878 26 GAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSIENFNEVYLVTNLMGA 104 (343)
T ss_pred CCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhcccccccccCcEEEEeecCCC
Confidence 89999999999999999999998764322 22345668999999995 99999999987533 457999999977
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++... ... ..+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++....... ....+++
T Consensus 105 ~l~~~-~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~t~ 179 (343)
T cd07878 105 DLNNI-VKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM--TGYVATR 179 (343)
T ss_pred CHHHH-Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCCc--CCccccc
Confidence 66543 332 46999999999999999999999999999999999999984 799999999988765432 4457889
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccc-ccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA-SNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (282)
.|+|||++.+...++.++|||||||++|+|++|..||...+..+....+....+.+............ .......+...
T Consensus 180 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (343)
T cd07878 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMP 259 (343)
T ss_pred cccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhcccccc
Confidence 99999998765568999999999999999999999999888777777777766655433221110000 00000011111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
...........++.+.+||.+||+.||.+|||++++|+||||.+..
T Consensus 260 ~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 260 QQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred chhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 1122223345677899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=302.71 Aligned_cols=251 Identities=26% Similarity=0.368 Sum_probs=199.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||++.++.+|+.|++|.+...... ........|..+++++ +||||+++++.+..+...+++|||+.|+.+..
T Consensus 4 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~ 82 (277)
T cd05607 4 GGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKY 82 (277)
T ss_pred CCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCCHHH
Confidence 89999999999999999999998754322 1233445688889888 59999999999999999999999998776655
Q ss_pred HHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 79 MKE-RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~-~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
... .....+++..+..++.||+.||.+||+.|++|+||||+||++++ +.++|+|||++.............++..|+|
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~a 162 (277)
T cd05607 83 HIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMA 162 (277)
T ss_pred HHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccC
Confidence 543 33346899999999999999999999999999999999999975 7899999999887655444345578889999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++|+|||||++|+|++|..||................... ...
T Consensus 163 PE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------~~~ 216 (277)
T cd05607 163 PEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-------------------------EVK 216 (277)
T ss_pred HHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-------------------------ccc
Confidence 99987555 8999999999999999999999997654322211111111000 000
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH----HHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA----AEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~~~~~~~~~~ 278 (282)
.....+++++++++++||+.||.+||++ ++++.|+||+++.+
T Consensus 217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 1113568899999999999999999999 77889999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=310.65 Aligned_cols=246 Identities=28% Similarity=0.466 Sum_probs=202.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|++..+++.||+|++...... ........|..++....+||+|+.+++.+...+..++||||+.++.+..
T Consensus 11 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~ 90 (323)
T cd05616 11 GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 90 (323)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHH
Confidence 89999999999999999999998765422 2233456677777777779999999999999999999999998766665
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++..... ........|++.|+|
T Consensus 91 ~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~a 169 (323)
T cd05616 91 QIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIA 169 (323)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcC
Confidence 55544 36999999999999999999999999999999999999975 7999999999875432 222345578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++|||||||++|+|++|..||...+..+....+.... .
T Consensus 170 PE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------------------------~ 218 (323)
T cd05616 170 PEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN------------------------------V 218 (323)
T ss_pred HHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------------------------C
Confidence 99997544 8999999999999999999999998877666555543311 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH-----HHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA-----AEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~~~~ 278 (282)
..+...+.++.+++.+||+.||.+|+++ .++++||||+.+.+
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence 1234578899999999999999999984 89999999987754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=304.10 Aligned_cols=250 Identities=29% Similarity=0.437 Sum_probs=203.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||++.+..+++.||+|++....... ......+|+.+++++ +||||+++++.+..+...+++|||+.++.+..
T Consensus 11 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 89 (285)
T cd05605 11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 89 (285)
T ss_pred CCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEEeccCCCcHHH
Confidence 899999999999999999999987643222 234456799999999 59999999999999999999999999777765
Q ss_pred HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 79 MKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
.... ....+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||++.............+++.|+|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~a 169 (285)
T cd05605 90 HIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMA 169 (285)
T ss_pred HHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccC
Confidence 5543 3346999999999999999999999999999999999999985 7899999999887654433344578899999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++||||+||++|++++|..||.+.........+....... ..
T Consensus 170 PE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------------------------~~ 222 (285)
T cd05605 170 PEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--------------------------QE 222 (285)
T ss_pred cHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--------------------------cc
Confidence 99987544 7899999999999999999999998766544433332221110 01
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
..+..++..+.+|+++||+.||.+|| +++++++||||+...+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence 22345788999999999999999999 9999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=310.62 Aligned_cols=244 Identities=32% Similarity=0.465 Sum_probs=198.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHh--CCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKM--NNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~--~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||.||+|.+..+++.||+|+++..... ........|...+..+ .+||||+++++++...+..|+||||+.++.+
T Consensus 10 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L 89 (324)
T cd05589 10 GHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL 89 (324)
T ss_pred cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcH
Confidence 89999999999999999999999765321 2223445555554332 2599999999999999999999999998877
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWY 154 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~~~ 154 (282)
...+.. ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++..... ........+++.|
T Consensus 90 ~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y 167 (324)
T cd05589 90 MMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEF 167 (324)
T ss_pred HHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccc
Confidence 766554 47999999999999999999999999999999999999974 8999999998765322 2223446789999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||.+.+. .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 168 ~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------------------------- 217 (324)
T cd05589 168 LAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------------------------- 217 (324)
T ss_pred cCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------------------------
Confidence 999998754 47999999999999999999999998877666555443311
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCccccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCH 277 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~ 277 (282)
...+..++..+.++|++||+.||.+|| +++++++||||+++.
T Consensus 218 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 218 -VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 012345688999999999999999999 799999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=304.56 Aligned_cols=271 Identities=36% Similarity=0.703 Sum_probs=216.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||+|++..+++.|++|.+....... ....+..|+..++++ +||||+++++++.+.+..+++|||+.+++...+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~ 89 (284)
T cd07860 11 GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFM 89 (284)
T ss_pred CCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEeeccccCHHHHH
Confidence 789999999999999999999987543322 234567899999999 499999999999999999999999988776666
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aP 157 (282)
....+..+++..+..++.|++.||+|||+.+++|+||+|+||++++ +.++|+|||.+....... ......++..|+||
T Consensus 90 ~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aP 169 (284)
T cd07860 90 DASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169 (284)
T ss_pred HhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCC
Confidence 5554567999999999999999999999999999999999999975 799999999987654322 12334567889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+...++.++|+||||+++|+|++|..||...+..+...+.....+.+....++....... ....+.+........
T Consensus 170 E~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 248 (284)
T cd07860 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD-YKPSFPKWARQDFSK 248 (284)
T ss_pred eEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH-HHhhcccccccCHHH
Confidence 9887656578899999999999999999999998888888888888777776555543222111 111222222222333
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
....++..++++|.+||+.||++|||++++++||||
T Consensus 249 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 249 VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=308.60 Aligned_cols=249 Identities=24% Similarity=0.422 Sum_probs=220.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|-|+.|.+|+|.-||..||||++++..... .....+.|+..++-+ +|||||++|++......+|+|.|.-+++.+.++
T Consensus 29 GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKlyLiLELGD~GDl~Dy 107 (864)
T KOG4717|consen 29 GHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKLYLILELGDGGDLFDY 107 (864)
T ss_pred CceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcccceEEEEEEecCCchHHHH
Confidence 668899999999999999999998876543 345667888888777 499999999999999999999999987666666
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+..+...+.+....+++.||+.|+.|+|+..+||+||||+||.+-+ |-|||.|||++............+|++.|.||
T Consensus 108 ImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAP 187 (864)
T KOG4717|consen 108 IMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAP 187 (864)
T ss_pred HHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCc
Confidence 6666678999999999999999999999999999999999998864 89999999999998888888899999999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+..+.-++.||||||||+|-|++|+.||...++.+.+..++.+.- .
T Consensus 188 EILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY------------------------------t 237 (864)
T KOG4717|consen 188 EILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY------------------------------T 237 (864)
T ss_pred hhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc------------------------------c
Confidence 9999877667889999999999999999999999998888887776532 3
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
++..++.++++||..||..||++|.+.++|.+++|++.+..-+
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 4557899999999999999999999999999999999876543
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=316.65 Aligned_cols=248 Identities=30% Similarity=0.496 Sum_probs=200.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++...... .....+.+|+.++..+. ||||+++++.+.++...++|||||.++.+..
T Consensus 12 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~ 90 (364)
T cd05599 12 GAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLIMEYLPGGDMMT 90 (364)
T ss_pred cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEEECCCCCcHHHH
Confidence 89999999999999999999999764322 22344567888888884 9999999999999999999999999877777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--------------
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-------------- 143 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-------------- 143 (282)
++... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 91 ~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 169 (364)
T cd05599 91 LLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169 (364)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccc
Confidence 66654 36999999999999999999999999999999999999985 899999999886542211
Q ss_pred -------------------------CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHH
Q 044127 144 -------------------------PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQI 198 (282)
Q Consensus 144 -------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~ 198 (282)
......||+.|+|||++.... ++.++|||||||++|+|++|..||......+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~ 248 (364)
T cd05599 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPPFCSDNPQETY 248 (364)
T ss_pred cccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHHHhhcCCCCCCCCCHHHHH
Confidence 001235899999999987544 799999999999999999999999887766655
Q ss_pred HHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCC---HHHHhcCccccc
Q 044127 199 YKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPT---AAEALEHPFFRS 275 (282)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~~~~~~ 275 (282)
..+....... .+ .....+++.+.++|++|+. +|.+|++ ++++++||||++
T Consensus 249 ~~i~~~~~~~-----------------~~---------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 249 RKIINWKETL-----------------QF---------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred HHHHcCCCcc-----------------CC---------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 5443321100 00 0112468899999999997 9999998 999999999988
Q ss_pred ccC
Q 044127 276 CHF 278 (282)
Q Consensus 276 ~~~ 278 (282)
..+
T Consensus 302 ~~~ 304 (364)
T cd05599 302 VDW 304 (364)
T ss_pred CCH
Confidence 654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=309.58 Aligned_cols=244 Identities=34% Similarity=0.513 Sum_probs=200.0
Q ss_pred CCcceEEEEEec---CCCcEEEEEEccccccc---hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDK---KSGEFVAVKKLKKKIFS---LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~---~~~~~v~vK~~~~~~~~---~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|+||.||+|++. .+++.||+|++...... ........|+.+++.+. ||||+++++.+..++..|++|||+.++
T Consensus 7 G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (323)
T cd05584 7 GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLILEYLSGG 85 (323)
T ss_pred cCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEEeCCCCc
Confidence 899999999864 46889999998764321 22344567888898885 999999999999999999999999987
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTR 152 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~ 152 (282)
.+...+... ..+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++..... ........+++
T Consensus 86 ~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 164 (323)
T cd05584 86 ELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTI 164 (323)
T ss_pred hHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCc
Confidence 777666654 46899999999999999999999999999999999999974 8999999999864322 22223457899
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
.|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+....
T Consensus 165 ~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--------------------------- 216 (323)
T cd05584 165 EYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--------------------------- 216 (323)
T ss_pred cccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------------------------
Confidence 999999987544 7899999999999999999999998877655554433211
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCccccccc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCH 277 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~ 277 (282)
..++...++.+.++|++||+.||++|| +++++++||||+...
T Consensus 217 ---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 217 ---LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 123345688999999999999999999 899999999998753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=314.84 Aligned_cols=249 Identities=29% Similarity=0.413 Sum_probs=201.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|+++.+++.||+|++...... .....+..|+.+++.+ +||||+++++.+.++...++||||+.++.+..
T Consensus 54 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~ 132 (370)
T cd05596 54 GAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN 132 (370)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEEcCCCCCcHHH
Confidence 89999999999999999999998754322 2233456788888887 59999999999999999999999999877777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~ 155 (282)
++.. ..+++..+..++.||+.||.|||+.|++|+||||+||++++ +.++|+|||.+....... ......|++.|+
T Consensus 133 ~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~ 210 (370)
T cd05596 133 LMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYI 210 (370)
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeE
Confidence 6655 36899999999999999999999999999999999999974 899999999987664322 123457899999
Q ss_pred Cchhhhcc---ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 156 APEVLLLS---EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 156 aPE~~~~~---~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|||.+... ..++.++|||||||++|+|++|..||...........+........ +
T Consensus 211 aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------------~----- 268 (370)
T cd05596 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT-----------------F----- 268 (370)
T ss_pred CHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC-----------------C-----
Confidence 99998643 2378899999999999999999999998776655555433211100 0
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCC--CCCHHHHhcCcccccccC
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHM--RPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~~~~~~~~~ 278 (282)
.....++..+.+||++||+.+|.+ |+|++++++||||++..+
T Consensus 269 ----~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 269 ----PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred ----CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 011246889999999999999988 999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=312.61 Aligned_cols=244 Identities=25% Similarity=0.437 Sum_probs=212.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|.||.||+|.+..+++.||+|+++.+....+..+...|+..+.++. ++||.++|+.|-.+..++++||||.|++...++
T Consensus 24 GsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL 102 (467)
T KOG0201|consen 24 GSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLL 102 (467)
T ss_pred cccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHHHHHHhcCcchhhhh
Confidence 8999999999999999999999999888888888889999999996 899999999999999999999999998888877
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE 158 (282)
+..+ .+++..+..++++++.|+.|||+.+.+|+|||+.||++.. |.+||+|||.+..+..... .....||+.|||||
T Consensus 103 ~~~~-~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPE 181 (467)
T KOG0201|consen 103 KSGN-ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPE 181 (467)
T ss_pred ccCC-CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchh
Confidence 7643 5699999999999999999999999999999999999974 8999999999887754332 36789999999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
++.+.. |+.++||||||++.+||++|.+|+....++..+..+-+ ..++.+
T Consensus 182 VI~~~~-Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-----------------------------~~PP~L 231 (467)
T KOG0201|consen 182 VIKQSG-YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-----------------------------SAPPRL 231 (467)
T ss_pred hhcccc-ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-----------------------------CCCCcc
Confidence 999444 99999999999999999999999988776443322211 112233
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
...+++.+++||..||..||+.||+|.++|+|+|++..
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 44778999999999999999999999999999999874
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=314.46 Aligned_cols=249 Identities=30% Similarity=0.444 Sum_probs=201.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|+++..... .....+..|..++..+ +||||+++++.+.+....++||||+.++.+..
T Consensus 12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 90 (330)
T cd05601 12 GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS 90 (330)
T ss_pred ccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEEECCCCCCCHHH
Confidence 89999999999999999999999865431 2233445566666666 69999999999999999999999998877777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~ 155 (282)
++......+++..+..++.||+.||.+||+.|++|+||||+||+++. +.++|+|||++........ .....+++.|+
T Consensus 91 ~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~ 170 (330)
T cd05601 91 LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYI 170 (330)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCcccc
Confidence 77665457999999999999999999999999999999999999985 8999999999876643322 12346889999
Q ss_pred Cchhhhc-----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 156 APEVLLL-----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 156 aPE~~~~-----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
|||.+.. ...++.++|||||||++|+|++|..||...........+....... .+
T Consensus 171 aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-----------------~~--- 230 (330)
T cd05601 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL-----------------KF--- 230 (330)
T ss_pred CHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc-----------------CC---
Confidence 9999863 3346889999999999999999999998877666655544321100 00
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
......+..+.+||++||. +|.+|||++++++||||+.+.
T Consensus 231 ------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 231 ------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred ------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 0112468899999999998 999999999999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=315.60 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=197.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++...... .....+..|+.++..+ +||||+++++.+.+.+..++||||+.++.+..
T Consensus 12 G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~ 90 (381)
T cd05626 12 GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMS 90 (381)
T ss_pred cCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEEecCCCCcHHH
Confidence 89999999999999999999999764322 2344567788888888 59999999999999999999999998877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--------------
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-------------- 143 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-------------- 143 (282)
++... ..+++..++.++.||+.||.+||+.|++|+||||+||+++. +.++|+|||++.......
T Consensus 91 ~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~ 169 (381)
T cd05626 91 LLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169 (381)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccccccccccc
Confidence 66554 36999999999999999999999999999999999999974 899999999875321000
Q ss_pred ----------------------------------CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCC
Q 044127 144 ----------------------------------PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILF 189 (282)
Q Consensus 144 ----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~ 189 (282)
......||+.|+|||.+.+.. ++.++|||||||++|||++|..||
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf 248 (381)
T cd05626 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILFEMLVGQPPF 248 (381)
T ss_pred ccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHHHHHHhCCCCC
Confidence 012346899999999987544 799999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHh--CCCCCCCCCHHHH
Q 044127 190 PGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLC--SWNPHMRPTAAEA 267 (282)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l--~~dp~~Rps~~~l 267 (282)
......+....+........ . .....+++++.+||.+|+ ..+|.+|++++++
T Consensus 249 ~~~~~~~~~~~i~~~~~~~~-----------------~---------~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 249 LAPTPTETQLKVINWENTLH-----------------I---------PPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred cCCCHHHHHHHHHccccccC-----------------C---------CCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 88776555544432211110 0 011246889999999966 4455569999999
Q ss_pred hcCcccccccC
Q 044127 268 LEHPFFRSCHF 278 (282)
Q Consensus 268 l~~~~~~~~~~ 278 (282)
++||||+++.+
T Consensus 303 l~hp~f~~~~~ 313 (381)
T cd05626 303 KAHPFFSEVDF 313 (381)
T ss_pred hcCcccCCCCh
Confidence 99999988654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=307.34 Aligned_cols=269 Identities=30% Similarity=0.602 Sum_probs=199.3
Q ss_pred CCcceEEEEEec--CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc--cCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDK--KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK--EHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|+++ .+++.|++|.+..... .....+|+.+++++. ||||+++++.+. .+...++++||+++++.
T Consensus 12 G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~ 87 (317)
T cd07868 12 GTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLW 87 (317)
T ss_pred CCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEEeccCCCHH
Confidence 899999999976 3678899999865432 234567999999984 999999999884 34578999999998877
Q ss_pred HHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-----CCcEEEeecCcccccCCCC-
Q 044127 77 KLMKERA-------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSSL- 143 (282)
Q Consensus 77 ~~~~~~~-------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-----~~~~~l~df~~~~~~~~~~- 143 (282)
..+.... ...+++..++.++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++.......
T Consensus 88 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~ 167 (317)
T cd07868 88 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167 (317)
T ss_pred HHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCc
Confidence 6554321 23589999999999999999999999999999999999994 2689999999997654322
Q ss_pred ---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCC---------hHHHHHHHHHhCCCCCC
Q 044127 144 ---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS---------ADQIYKICQVIGSPTED 211 (282)
Q Consensus 144 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~~~ 211 (282)
......+++.|+|||.+.+...++.++||||+||++|+|++|..||..... .+....+....+.+...
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (317)
T cd07868 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK 247 (317)
T ss_pred cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChH
Confidence 123457789999999998666689999999999999999999999975442 24455566666655554
Q ss_pred CccccccccccCCc--cccC--CCC----CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 212 SWPLGIQLASNLDW--KFPQ--MGG----VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 212 ~~~~~~~~~~~~~~--~~~~--~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.|............ .+.. ... ..........+..+.+||++||+.||.+|||++|+|+||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 248 DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 44332211111000 0000 000 00111122345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=313.89 Aligned_cols=270 Identities=32% Similarity=0.543 Sum_probs=207.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccC------CcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEH------EDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~------~~~~lv~e~~~~ 73 (282)
|+||.||+|.+..+++.||+|++....... ......+|+..++.+ +||||+++++++... ...+++|||+++
T Consensus 28 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (355)
T cd07874 28 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA 106 (355)
T ss_pred cCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccccceeEEEhhhhcc
Confidence 899999999999999999999987654332 334566788888888 599999999987543 357999999999
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++.+.+.. .+++..+..++.|++.||.+||++|++|+||||+||++++ +.++|+|||++.............+++
T Consensus 107 ~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~ 182 (355)
T cd07874 107 NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 182 (355)
T ss_pred cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccC
Confidence 87765532 5899999999999999999999999999999999999974 799999999998766555455667899
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccC--------C
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL--------D 224 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 224 (282)
.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+..+.........+.+.+..+.......... .
T Consensus 183 ~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (355)
T cd07874 183 YYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG 261 (355)
T ss_pred CccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCcccc
Confidence 999999987544 8999999999999999999999999888777777777766655433221110000000 0
Q ss_pred cccc----CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 225 WKFP----QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 225 ~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
..++ ..............+..+++||.+||+.||++|||++++|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 262 LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred ccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0000 000000111223346788999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=311.90 Aligned_cols=246 Identities=32% Similarity=0.455 Sum_probs=198.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||+|++...... ........|...+.+..+||||+++++.+..++..++||||+.++.+..
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 85 (325)
T cd05604 6 GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFF 85 (325)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHH
Confidence 89999999999999999999998764322 2233445566555554469999999999999999999999999877665
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++.... .........+++.|+|
T Consensus 86 ~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~a 164 (325)
T cd05604 86 HLQRE-RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLA 164 (325)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCC
Confidence 55543 47999999999999999999999999999999999999975 899999999987532 2222345578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++|||||||++|+|++|..||...+..+....+.... .
T Consensus 165 PE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------------------------------~ 213 (325)
T cd05604 165 PEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------------------------------L 213 (325)
T ss_pred HHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC------------------------------c
Confidence 99987544 7899999999999999999999998876655544433210 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH----HHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA----AEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~~~~~~~~~~ 278 (282)
......+..+.++|++||+.||.+||++ .++++||||++..+
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 1223568889999999999999999977 59999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=315.49 Aligned_cols=265 Identities=25% Similarity=0.408 Sum_probs=198.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|++..+++.||+|.... ....+|+.+++++. ||||+++++++..+...++++|++.++++..+.
T Consensus 103 G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~~~L~~~l~ 174 (391)
T PHA03212 103 GAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLA 174 (391)
T ss_pred CCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeEEEEecCCCCHHHHHH
Confidence 8999999999999999999997532 23567999999995 999999999999999999999999988777665
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC--CCCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~aP 157 (282)
.. ..+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++...... .......+++.|+||
T Consensus 175 ~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aP 252 (391)
T PHA03212 175 AK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAP 252 (391)
T ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCCh
Confidence 54 46899999999999999999999999999999999999975 88999999998643221 122345789999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCC-------ChHHHHHHHHHhCCCCCCCcccccc--ccccC---Cc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKN-------SADQIYKICQVIGSPTEDSWPLGIQ--LASNL---DW 225 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~ 225 (282)
|++.+. .++.++|||||||++|+|++|..||.... ....+..+....+..... ++.... ..... ..
T Consensus 253 E~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~-~~~~~~~~~~~~~~~~~~ 330 (391)
T PHA03212 253 ELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE-FPIDAQANLDEIYIGLAK 330 (391)
T ss_pred hhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh-cCcchhHHHHHHHHHHHh
Confidence 998754 48999999999999999999998764332 234445555554443221 111000 00000 00
Q ss_pred cccCC-CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 226 KFPQM-GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 226 ~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
..... ............+.++.+||.+||+.||.+|||++|+|+||||+++.
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 331 KSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred ccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 00000 00000011123567899999999999999999999999999999864
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=303.74 Aligned_cols=271 Identities=40% Similarity=0.704 Sum_probs=215.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~l~ 77 (282)
|++|.||+|.++.+++.+++|.++....... .....+|+..+.++. ||||+++++++... ...++++||+.+++.+
T Consensus 16 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~ 94 (293)
T cd07843 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKS 94 (293)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEEEEehhcCcCHHH
Confidence 7899999999999999999999876543322 234567899999995 99999999998776 8999999999986655
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCcccccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYR 155 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~ 155 (282)
.+.. ....+++..++.++.||+.||.+||+.|++|+||+|+||++++ +.++|+|||.+...... .......+++.|+
T Consensus 95 ~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~ 173 (293)
T cd07843 95 LMET-MKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR 173 (293)
T ss_pred HHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccccccccccccc
Confidence 5444 3346999999999999999999999999999999999999985 79999999998876543 2223455678899
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||.+.+....+.++|+||||+++|+|++|..||......+....+....+.+.+..|+....................+
T Consensus 174 aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (293)
T cd07843 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQL 253 (293)
T ss_pred CchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhh
Confidence 99998766557899999999999999999999999998888888888888877777666444333322222111111111
Q ss_pred cc-cCCC-CChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 236 RE-LSPS-ASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 236 ~~-~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.. .+.. +++.+.++|++||+.||++|||++|+|.||||
T Consensus 254 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 254 RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 11 2222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=307.91 Aligned_cols=247 Identities=28% Similarity=0.427 Sum_probs=199.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++...... .....+..|..++.++.+||+|+.+++.+......++||||+.++.+..
T Consensus 6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 85 (327)
T cd05617 6 GSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMF 85 (327)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHH
Confidence 89999999999999999999999865432 2334566788888888789999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||+|||++|++|+||||+||+++. +.++|+|||++.... .........+++.|+|
T Consensus 86 ~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~a 164 (327)
T cd05617 86 HMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIA 164 (327)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCC
Confidence 55543 46999999999999999999999999999999999999975 899999999987532 2223345678999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCC------hHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS------ADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
||.+.+. .++.++|||||||++|+|++|..||..... .+........ .
T Consensus 165 PE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~----------------------- 218 (327)
T cd05617 165 PEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K----------------------- 218 (327)
T ss_pred HHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C-----------------------
Confidence 9998754 479999999999999999999999964321 1222221110 0
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCC------HHHHhcCcccccccC
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPT------AAEALEHPFFRSCHF 278 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~~ll~~~~~~~~~~ 278 (282)
....+...+..+.++|++||+.||++|++ ++++++||||+++.+
T Consensus 219 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 219 ----PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred ----CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 01234457889999999999999999998 579999999988753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=308.05 Aligned_cols=234 Identities=26% Similarity=0.481 Sum_probs=198.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc-HHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD-LLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~-~l~~~ 79 (282)
|-||.||.|.+..+. .|++|.++.. .-....+++|+++++++. |++||++++++..++.++||||||..+ +++.+
T Consensus 217 G~FG~V~~g~~~~~~-~vavk~ik~~--~m~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yL 292 (468)
T KOG0197|consen 217 GQFGEVWLGKWNGST-KVAVKTIKEG--SMSPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYL 292 (468)
T ss_pred CccceEEEEEEcCCC-cccceEEecc--ccChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceEEEEEecccCcHHHHh
Confidence 789999999887543 5899998765 234466778999999995 999999999999988999999999854 55555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCccccccccC
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~a 156 (282)
....+..+...+...++.|||+|++||++++++||||...|||+++ ..+|++|||+|+..+...- ......+-.|.|
T Consensus 293 r~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtA 372 (468)
T KOG0197|consen 293 RTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTA 372 (468)
T ss_pred hhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecC
Confidence 5546678999999999999999999999999999999999999986 7899999999995543322 122233556999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||++..+. ++.+|||||||++|||++| |+.|+.+....+.+..+.++.+-+.|+
T Consensus 373 PEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~------------------------ 427 (468)
T KOG0197|consen 373 PEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPE------------------------ 427 (468)
T ss_pred HHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCC------------------------
Confidence 99998666 8999999999999999999 899999999999999888776666543
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEAL 268 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 268 (282)
.+|+++.++++.||+.+|++|||++.+.
T Consensus 428 -----~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 428 -----GCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -----CCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 5689999999999999999999998764
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=311.18 Aligned_cols=245 Identities=28% Similarity=0.475 Sum_probs=196.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.|++|++...........+.+|+.+++.+. ||||+++++++..++..+++|||+.++.+...
T Consensus 85 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~- 162 (353)
T PLN00034 85 GAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT- 162 (353)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEEEEecCCCCccccc-
Confidence 8999999999999999999999876543444566788999999985 99999999999999999999999998776431
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
...++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++....... ......++..|+|||
T Consensus 163 ----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE 238 (353)
T PLN00034 163 ----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPE 238 (353)
T ss_pred ----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCcc
Confidence 24678889999999999999999999999999999999985 789999999987654322 223457899999999
Q ss_pred hhhc----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 159 VLLL----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 159 ~~~~----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
.+.. +...+.++|||||||++|+|++|+.||......+........... .
T Consensus 239 ~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--------------------------~ 292 (353)
T PLN00034 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS--------------------------Q 292 (353)
T ss_pred ccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc--------------------------C
Confidence 8742 233456899999999999999999999754433322222111100 0
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
........+..+.+||.+||+.||++|||++++++||||.+..
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 1122345688999999999999999999999999999998864
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=306.52 Aligned_cols=246 Identities=29% Similarity=0.480 Sum_probs=202.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++..... .........|..++..+.+||+|+.+++.+.+.+..|+||||+.++.+..
T Consensus 11 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~ 90 (323)
T cd05615 11 GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMY 90 (323)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHH
Confidence 8999999999999999999999876532 22334456788888888777889999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||.+||++|++|+||||+||+++. +.++|+|||++...... .......+++.|+|
T Consensus 91 ~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~a 169 (323)
T cd05615 91 HIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIA 169 (323)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccC
Confidence 66554 36999999999999999999999999999999999999985 78999999998754322 22234568999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+. .++.++|+|||||++|+|++|..||...........+.... .
T Consensus 170 PE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------------------------~ 218 (323)
T cd05615 170 PEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------------------------V 218 (323)
T ss_pred HHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------------------------C
Confidence 9998754 47999999999999999999999998877665555443311 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~ 278 (282)
..+...+..+.+++.+||+.||.+|++ .+++++||||+.+.+
T Consensus 219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 219 SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 123456889999999999999999997 479999999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=308.80 Aligned_cols=246 Identities=29% Similarity=0.431 Sum_probs=196.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++...... ........|...+.+..+||||+++++.+.+.+..++||||+.++.+..
T Consensus 6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 85 (321)
T cd05603 6 GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFF 85 (321)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHH
Confidence 89999999999999999999998764322 2233445565544444469999999999999999999999999776655
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccccc-CCCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++... ..........+++.|+|
T Consensus 86 ~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~a 164 (321)
T cd05603 86 HLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLA 164 (321)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCC
Confidence 55543 46999999999999999999999999999999999999975 89999999998753 22222344578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+. .++.++|||||||++|+|++|..||...+.......+... ..
T Consensus 165 PE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------------------------------~~ 213 (321)
T cd05603 165 PEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK------------------------------PL 213 (321)
T ss_pred HHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC------------------------------CC
Confidence 9998744 4899999999999999999999999887655544433221 01
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH----HHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA----AEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~~~~~~~~~~ 278 (282)
..+...+..+.++|.+||+.||.+||++ .++++|+||+.+.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 2334568889999999999999999975 59999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=308.79 Aligned_cols=246 Identities=30% Similarity=0.435 Sum_probs=198.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++...... ........|...+.+..+||||+++++.+...+..++||||+.++.+..
T Consensus 6 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 85 (325)
T cd05602 6 GSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFY 85 (325)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHH
Confidence 89999999999999999999998764322 2233445555544444469999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++.... .........+++.|+|
T Consensus 86 ~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~a 164 (325)
T cd05602 86 HLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLA 164 (325)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccC
Confidence 66554 46899999999999999999999999999999999999974 799999999987532 2222345578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+. .++.++|||||||++|+|++|..||...+..+....+.... .
T Consensus 165 PE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------------------------------~ 213 (325)
T cd05602 165 PEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP------------------------------L 213 (325)
T ss_pred HHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC------------------------------c
Confidence 9998754 48999999999999999999999998877666554443210 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHH----HHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAA----EALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~----~ll~~~~~~~~~~ 278 (282)
......+..+.++|++||+.||.+|+++. ++++|+||+...+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 12335788999999999999999999876 8999999977543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=315.08 Aligned_cols=247 Identities=31% Similarity=0.465 Sum_probs=196.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.++.+++.||+|++..... ......+.+|+.++.++ +||||+++++++.++...|+||||+.++.+..
T Consensus 12 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~ 90 (377)
T cd05629 12 GAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMT 90 (377)
T ss_pred cCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEEEeCCCCCcHHH
Confidence 8999999999999999999999865432 12234556788888887 59999999999999999999999998777766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--------------
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-------------- 143 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-------------- 143 (282)
++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++. +.++|+|||++.......
T Consensus 91 ~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~ 169 (377)
T cd05629 91 MLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169 (377)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccc
Confidence 66544 47999999999999999999999999999999999999974 899999999985321100
Q ss_pred ----------------------------------CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCC
Q 044127 144 ----------------------------------PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILF 189 (282)
Q Consensus 144 ----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~ 189 (282)
......|++.|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf 248 (377)
T cd05629 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMFECLIGWPPF 248 (377)
T ss_pred ccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeEecchhhhhhhcCCCCC
Confidence 001246889999999987544 799999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCC---CCHHH
Q 044127 190 PGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMR---PTAAE 266 (282)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~~ 266 (282)
......+....+....... .++ .....+..+.+||.+||. +|.+| +++.+
T Consensus 249 ~~~~~~~~~~~i~~~~~~~-----------------~~p---------~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 249 CSENSHETYRKIINWRETL-----------------YFP---------DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred CCCCHHHHHHHHHccCCcc-----------------CCC---------CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 8877666555443321110 000 012467899999999998 67765 59999
Q ss_pred HhcCccccccc
Q 044127 267 ALEHPFFRSCH 277 (282)
Q Consensus 267 ll~~~~~~~~~ 277 (282)
+++||||+++.
T Consensus 302 ~l~hp~~~~~~ 312 (377)
T cd05629 302 IKSHPFFRGVD 312 (377)
T ss_pred HhcCCCcCCCC
Confidence 99999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=315.07 Aligned_cols=248 Identities=28% Similarity=0.444 Sum_probs=198.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++..... ......+..|+.+++++ +||||+++++.+.++...++|||||.++.+..
T Consensus 12 G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~ 90 (382)
T cd05625 12 GAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMS 90 (382)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHH
Confidence 8999999999999999999999876432 22334566788888888 59999999999999999999999999776666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC---------------
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS--------------- 142 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~--------------- 142 (282)
++... ..+++..++.++.||+.||.+||++||+|+||||+||+++. +.++|+|||++......
T Consensus 91 ~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~ 169 (382)
T cd05625 91 LLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQD 169 (382)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccc
Confidence 65554 36899999999999999999999999999999999999974 89999999987532100
Q ss_pred ---------------------------------CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCC
Q 044127 143 ---------------------------------LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILF 189 (282)
Q Consensus 143 ---------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~ 189 (282)
.......|++.|+|||++.+.. ++.++|||||||++|||++|..||
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf 248 (382)
T cd05625 170 SMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPF 248 (382)
T ss_pred cccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHHHHHHhCCCCC
Confidence 0011246889999999987544 899999999999999999999999
Q ss_pred CCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCC---HHH
Q 044127 190 PGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPT---AAE 266 (282)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ 266 (282)
...+..+....+........ ......+++++.++|.+|+ .+|.+|++ +++
T Consensus 249 ~~~~~~~~~~~i~~~~~~~~--------------------------~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 249 LAQTPLETQMKVINWQTSLH--------------------------IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred CCCCHHHHHHHHHccCCCcC--------------------------CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 88776655544433211110 0112356889999999976 59999997 999
Q ss_pred HhcCcccccccC
Q 044127 267 ALEHPFFRSCHF 278 (282)
Q Consensus 267 ll~~~~~~~~~~ 278 (282)
+++||||+++.+
T Consensus 302 i~~hp~f~~~~~ 313 (382)
T cd05625 302 IKAHPFFKTIDF 313 (382)
T ss_pred HhcCCCcCCcCh
Confidence 999999988754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=298.97 Aligned_cols=241 Identities=26% Similarity=0.468 Sum_probs=210.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH--HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD--ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~--~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|.||.|-+|+....|+.||||.++++..... ...+.+|+.++..+ +||||+.+|++|++.+..+|||||..++-|-+
T Consensus 64 GTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKIvivMEYaS~GeLYD 142 (668)
T KOG0611|consen 64 GTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKIVIVMEYASGGELYD 142 (668)
T ss_pred CcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceEEEEEEecCCccHHH
Confidence 8899999999988999999999988765433 34557899999999 59999999999999999999999998655545
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++... +.|++.+++.+++||.+|+.|+|+++++|+|||.+|||+|+ +.+|+.|||++..+....-.+..+|++.|.+|
T Consensus 143 YiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASP 221 (668)
T KOG0611|consen 143 YISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASP 221 (668)
T ss_pred HHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCc
Confidence 55544 47999999999999999999999999999999999999996 79999999999988877778899999999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|...+...-++..|-||||+++|-|+.|.+||++.+....+.++..+.-.
T Consensus 222 EIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr------------------------------ 271 (668)
T KOG0611|consen 222 EIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR------------------------------ 271 (668)
T ss_pred cccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc------------------------------
Confidence 99987776799999999999999999999999999887777766543211
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 274 (282)
.+.-+....-||++||..+|++|.|++++.+|=|++
T Consensus 272 -EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 272 -EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 123467789999999999999999999999998874
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=301.23 Aligned_cols=272 Identities=36% Similarity=0.676 Sum_probs=213.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCc-----EEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHED-----VFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~-----~~lv~e~~~~~ 74 (282)
|+||.||+|.+..+++.|++|......... ....+.+|+.++.++.+|||++++++++..... .+++|||+.++
T Consensus 12 g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 91 (295)
T cd07837 12 GTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSD 91 (295)
T ss_pred cCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCcC
Confidence 789999999999999999999987653222 234567799999999878999999999876555 89999999998
Q ss_pred HHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCC-CCCCCc
Q 044127 75 LLKLMKERA---GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSS-LPCTDY 148 (282)
Q Consensus 75 ~l~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~-~~~~~~ 148 (282)
+.+.+.... +..+++..++.++.||+.||.|||++|++|+||+|+||++++ +.++|+|||.+...... ......
T Consensus 92 l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 171 (295)
T cd07837 92 LKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171 (295)
T ss_pred HHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCc
Confidence 777665432 235899999999999999999999999999999999999985 68999999988755322 112233
Q ss_pred cccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 149 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
.+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+....+.+....++......... .++
T Consensus 172 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 249 (295)
T cd07837 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWH--EFP 249 (295)
T ss_pred ccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchh--hcC
Confidence 567789999998766667999999999999999999999999888888777777776666555544322222111 111
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccc
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 274 (282)
+.....+....+..++.+.+||++||+.||.+||++++++.||||+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 250 QWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 2122222333456789999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=310.42 Aligned_cols=245 Identities=30% Similarity=0.474 Sum_probs=200.1
Q ss_pred CCcceEEEEEe---cCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALD---KKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~---~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||.||++++ ..+|+.||+|++...... ........|+.++.++ +||||+++++.+.+++..|+||||+.++.+
T Consensus 7 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 85 (318)
T cd05582 7 GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDFLRGGDL 85 (318)
T ss_pred CCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcCCCCCcH
Confidence 89999999986 357899999999765432 2334456788888888 499999999999999999999999987666
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWY 154 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~ 154 (282)
...+... ..+++..+..++.||+.||.|||+.|++|+||||+||++++ +.++|+|||++...... .......+++.|
T Consensus 86 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y 164 (318)
T cd05582 86 FTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 164 (318)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhh
Confidence 6555543 46999999999999999999999999999999999999975 79999999998765433 222345788999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||.+.+.. ++.++|||||||++|+|++|..||......+....+....
T Consensus 165 ~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~----------------------------- 214 (318)
T cd05582 165 MAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK----------------------------- 214 (318)
T ss_pred cCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-----------------------------
Confidence 9999987544 7899999999999999999999998876655554432210
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccC
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHF 278 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~ 278 (282)
..++...++.+.++|++||+.||.+||+ +++++.||||+++.+
T Consensus 215 -~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 215 -LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 1223456889999999999999999999 788999999987643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=307.71 Aligned_cols=244 Identities=29% Similarity=0.514 Sum_probs=215.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc-EEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHED-VFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~-~~lv~e~~~~~~l~~ 78 (282)
|+||.++.++++..++.|++|.+...... ........|..++.++. ||||+.+.+.|.+++. ++|+|+||+|+++..
T Consensus 15 GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~ 93 (426)
T KOG0589|consen 15 GAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQ 93 (426)
T ss_pred cccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEEEEeecCCCCHHH
Confidence 89999999999999999999999876543 34457788999999985 9999999999998888 999999999877765
Q ss_pred HHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCcccccccc
Q 044127 79 MKE-RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~-~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~ 155 (282)
.+. ..+..++++.+..|+.||+.|+.|||+++|+|||||+.||+++. +.|+|+|||+|..+.... ...+..||+.|+
T Consensus 94 ~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~Ym 173 (426)
T KOG0589|consen 94 LIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYM 173 (426)
T ss_pred HHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCccc
Confidence 544 44578999999999999999999999999999999999999984 788999999999987765 567789999999
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
+||.+.+ .+++.++|||||||++|||++-+.+|.+.+......++......|
T Consensus 174 cPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P--------------------------- 225 (426)
T KOG0589|consen 174 CPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP--------------------------- 225 (426)
T ss_pred CHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC---------------------------
Confidence 9999984 459999999999999999999999999999999999888765444
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
++..++.+++.+|..||..+|..||++.+||.+|.+..
T Consensus 226 --lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 226 --LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred --CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 34467899999999999999999999999999987764
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=299.46 Aligned_cols=271 Identities=36% Similarity=0.719 Sum_probs=218.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|+||+|++..+|..|++|++..............|+..++++ +|||++++++.+.+.+..+++|||+.+++.+.+.
T Consensus 11 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~ 89 (284)
T cd07836 11 GTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMD 89 (284)
T ss_pred CCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEEecCCccHHHHHH
Confidence 789999999999999999999987665444445667899999998 5999999999999999999999999987766654
Q ss_pred Hhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCc
Q 044127 81 ERA-GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~-~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aP 157 (282)
... ...+++..+..++.|+++||.+||+.|++|+||+|+||++++ +.++|+|||.+....... ......++..|+||
T Consensus 90 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~P 169 (284)
T cd07836 90 THGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAP 169 (284)
T ss_pred hcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccCh
Confidence 432 246899999999999999999999999999999999999975 799999999987553321 12234567889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+...++.++|+||||+++|++++|..||...+..+....+......+....++..... ......++.........
T Consensus 170 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 248 (284)
T cd07836 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL-PEYKPTFPRYPPQDLQQ 248 (284)
T ss_pred HHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC-chhcccccCCChHHHHH
Confidence 99876555789999999999999999999999998888888888777777766655433322 12222223222222333
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
+....+..+.+++.+||+.||.+||++.++++||||
T Consensus 249 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 249 LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=303.81 Aligned_cols=269 Identities=30% Similarity=0.585 Sum_probs=200.2
Q ss_pred CCcceEEEEEecC--CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc--cCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKK--SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK--EHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|+++. ++..|++|.+..... .....+|+.+++.+. ||||+++++++. .+...++++||+.++++
T Consensus 12 G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~ 87 (317)
T cd07867 12 GTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLFDYAEHDLW 87 (317)
T ss_pred CCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEEeeeCCcHH
Confidence 8999999999754 568899998865432 234567899999885 999999999874 45678999999999877
Q ss_pred HHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-----CCcEEEeecCcccccCCCC-
Q 044127 77 KLMKER-------AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSSL- 143 (282)
Q Consensus 77 ~~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-----~~~~~l~df~~~~~~~~~~- 143 (282)
+.+... ....+++..+..++.||+.||.+||+.|++|+||||+||++. ++.++|+|||++.......
T Consensus 88 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~ 167 (317)
T cd07867 88 HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167 (317)
T ss_pred HHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcc
Confidence 765432 122488999999999999999999999999999999999993 3689999999997654332
Q ss_pred ---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCC---------hHHHHHHHHHhCCCCCC
Q 044127 144 ---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS---------ADQIYKICQVIGSPTED 211 (282)
Q Consensus 144 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~~~ 211 (282)
......+++.|+|||.+.+...++.++|||||||++|+|++|..||..... ......+....+.+...
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (317)
T cd07867 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADK 247 (317)
T ss_pred cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChh
Confidence 123346788999999987656689999999999999999999999975432 34455566666655555
Q ss_pred CccccccccccCCccc----cCCCCC----cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 212 SWPLGIQLASNLDWKF----PQMGGV----NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 212 ~~~~~~~~~~~~~~~~----~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.|..........+... ...... .........+..+.++|.+||+.||.+|||++|+|+||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 248 DWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 5543322221111110 000000 0111223456779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=315.39 Aligned_cols=247 Identities=28% Similarity=0.432 Sum_probs=197.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++...... .....+.+|+.++.++ +||||+++++.+.+++..++|||||.++.+..
T Consensus 12 G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~ 90 (376)
T cd05598 12 GAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMS 90 (376)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEEEeCCCCCcHHH
Confidence 89999999999999999999998754321 2234456788888888 59999999999999999999999999877776
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC---------------
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS--------------- 142 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~--------------- 142 (282)
++... ..+++..++.++.||+.||+|||+.|++|+||||+||+++. +.++|+|||++......
T Consensus 91 ~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~ 169 (376)
T cd05598 91 LLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169 (376)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccc
Confidence 66654 36899999999999999999999999999999999999984 89999999987532100
Q ss_pred -----------------------------CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 044127 143 -----------------------------LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKN 193 (282)
Q Consensus 143 -----------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~ 193 (282)
.......|++.|+|||++.+.. ++.++|||||||++|+|++|..||....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~ 248 (376)
T cd05598 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPFLADT 248 (376)
T ss_pred cccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccceeeehhhCCCCCCCCC
Confidence 0011346899999999987544 7999999999999999999999998877
Q ss_pred ChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCC---CHHHHhcC
Q 044127 194 SADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRP---TAAEALEH 270 (282)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~~ 270 (282)
..+....+........ ......+++.+.++|.+|+ .+|.+|+ +++++++|
T Consensus 249 ~~~~~~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 249 PAETQLKVINWETTLH--------------------------IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred HHHHHHHHhccCcccc--------------------------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 6655544332111000 0011246889999999976 5999999 99999999
Q ss_pred ccccccc
Q 044127 271 PFFRSCH 277 (282)
Q Consensus 271 ~~~~~~~ 277 (282)
|||+++.
T Consensus 302 ~~~~~~~ 308 (376)
T cd05598 302 PFFKGID 308 (376)
T ss_pred CCcCCCC
Confidence 9998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=303.40 Aligned_cols=247 Identities=31% Similarity=0.480 Sum_probs=202.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-------------HHHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEE
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-------------DESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVF 65 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-------------~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~ 65 (282)
|.||.|-+|++..+++.||||++.+..... ......+|+.+++++. |||||+++++..+. +.+|
T Consensus 108 G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nVV~LiEvLDDP~s~~~Y 186 (576)
T KOG0585|consen 108 GQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNVVKLIEVLDDPESDKLY 186 (576)
T ss_pred CccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCeeEEEEeecCcccCceE
Confidence 889999999999999999999997643221 1245678999999995 99999999999764 5799
Q ss_pred EEEecCCccHHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCC--
Q 044127 66 IVFEYMESDLLKLMKERAGQN-FSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDS-- 141 (282)
Q Consensus 66 lv~e~~~~~~l~~~~~~~~~~-l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~-- 141 (282)
||+|||..+-....-. +++ +++.+++.++++++.||+|||.+||+||||||+|+|++ +|++||+|||.+.....
T Consensus 187 lVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~ 264 (576)
T KOG0585|consen 187 LVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGS 264 (576)
T ss_pred EEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCC
Confidence 9999999765544322 234 99999999999999999999999999999999999997 49999999998876522
Q ss_pred ----CCCCCCccccccccCchhhhccc---cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcc
Q 044127 142 ----SLPCTDYVTTRWYRAPEVLLLSE---IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP 214 (282)
Q Consensus 142 ----~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (282)
........|||.|+|||...++. ..+.+.||||+||+||.|+.|+.||.+....+...++....-
T Consensus 265 ~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL-------- 336 (576)
T KOG0585|consen 265 DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPL-------- 336 (576)
T ss_pred ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcc--------
Confidence 22233568999999999997633 357789999999999999999999999888887777655211
Q ss_pred ccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 215 LGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
.|+ ..+.+.+.+++||.+||..||.+|.++.+|..|||....-.
T Consensus 337 -----------~fP---------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 337 -----------EFP---------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred -----------cCC---------CcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 111 11246889999999999999999999999999999976533
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=309.77 Aligned_cols=248 Identities=28% Similarity=0.396 Sum_probs=198.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|+++.+++.||+|++.+.... .....+..|..+++.+ +||||+++++.+.++...++|||||.++.+..
T Consensus 54 G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~ 132 (370)
T cd05621 54 GAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN 132 (370)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHH
Confidence 89999999999999999999998753322 2233455677777666 59999999999999999999999999877777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~ 155 (282)
++.. ..+++..+..++.||+.||++||++|++||||||+||++++ +.+||+|||++....... ......|++.|+
T Consensus 133 ~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~ 210 (370)
T cd05621 133 LMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYI 210 (370)
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccC
Confidence 6655 36899999999999999999999999999999999999975 899999999988664322 123557899999
Q ss_pred Cchhhhccc---cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 156 APEVLLLSE---IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 156 aPE~~~~~~---~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|||++.... .++.++|+|||||++|+|++|..||...+.......+........ +
T Consensus 211 aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~------------------- 268 (370)
T cd05621 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN---F------------------- 268 (370)
T ss_pred CHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC---C-------------------
Confidence 999986432 368899999999999999999999998776666555443211110 0
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCC--CCCHHHHhcCccccccc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHM--RPTAAEALEHPFFRSCH 277 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~~~~~~~~ 277 (282)
.....++..+++++.+||..++.+ |+|++++++||||+...
T Consensus 269 ----p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 269 ----PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred ----CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 011246888999999999865544 89999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=297.55 Aligned_cols=271 Identities=35% Similarity=0.577 Sum_probs=207.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.+..+++.|++|++.............+|+..++.+. |+||+++++++..+...++++||+.++++..+.
T Consensus 16 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~l~~~~~ 94 (291)
T cd07870 16 GSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFVFEYMHTDLAQYMI 94 (291)
T ss_pred cCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEEEEecccCCHHHHHH
Confidence 7899999999999999999999876543333345678999898884 999999999999999999999999988887765
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
... ..+++..+..++.|++.||.+||+.|++|+||||+||+++. +.++|+|||++....... ......+++.|+|||
T Consensus 95 ~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE 173 (291)
T cd07870 95 QHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPD 173 (291)
T ss_pred hCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCc
Confidence 543 46889999999999999999999999999999999999974 899999999887543221 123345688899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS-ADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
.+.+...++.++|+||||+++|+|++|..||..... .+.+.......+.+.+..++.......................
T Consensus 174 ~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd07870 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRV 253 (291)
T ss_pred eeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhh
Confidence 987555578899999999999999999999976554 3444555555555555444333322222222111111111111
Q ss_pred cCC--CCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 238 LSP--SASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 238 ~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
... ..+..+.+++.+|++.||++|||+++++.||||
T Consensus 254 ~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 254 VWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 111 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=299.84 Aligned_cols=274 Identities=36% Similarity=0.650 Sum_probs=216.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc---h-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS---L-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~---~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|++|.||+|.+..+++.|++|.+...... . .......|+..+.++. |||++++++++.+....++||||+ ++.+
T Consensus 11 g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~-~~~L 88 (298)
T cd07841 11 GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINLVFEFM-ETDL 88 (298)
T ss_pred ccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEEEEccc-CCCH
Confidence 78999999999999999999999765433 1 2234467888888885 999999999999999999999999 4455
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWY 154 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~ 154 (282)
..++......+++..+..++.||++||.+||++|++|+||+|+||+++. +.++|+|||.+....... ......++..|
T Consensus 89 ~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y 168 (298)
T cd07841 89 EKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWY 168 (298)
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceee
Confidence 5555543336999999999999999999999999999999999999985 899999999988664432 22233557789
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||.+.+...++.++|+|||||++|++++|..+|......+....+....+.+....++......... .........
T Consensus 169 ~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 246 (298)
T cd07841 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV--EFKPFPPTP 246 (298)
T ss_pred eCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc--cccccCCcc
Confidence 999998765667899999999999999999988898888877777777766666655554433332211 111222222
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
........+..+.++|.+||+.||++|||+.+++.|+||++...
T Consensus 247 ~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 247 LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred hhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 33445567889999999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=263.82 Aligned_cols=274 Identities=32% Similarity=0.642 Sum_probs=236.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|.||+||+|+++.+++-||+|.+..+.-.+ .....++|+-+++.++ |.||++++++...+..+.+|+|+|...+.+.+
T Consensus 13 gtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk-hknivrl~dvlhsdkkltlvfe~cdqdlkkyf 91 (292)
T KOG0662|consen 13 GTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF 91 (292)
T ss_pred CcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeHHHhhHHHHHHH
Confidence 789999999999999999999988765433 3456789999999996 99999999999999999999999999877776
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC-CCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aP 157 (282)
-+-+| .++.+.+++++.|+++||.++|+.++.|+|+||+|.+|+ +|.+|+.|||+++..+-+.. ......|..|++|
T Consensus 92 dslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrpp 170 (292)
T KOG0662|consen 92 DSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 170 (292)
T ss_pred HhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCc
Confidence 66554 699999999999999999999999999999999999998 48999999999988766542 3456779999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
.++.+.+.++...|+||-||++.|+.. |+..|.+.+..+++.++...++.+..+.||....+....-.-.-+ ....+.
T Consensus 171 dvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~yp-attsws 249 (292)
T KOG0662|consen 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYP-ATTSWS 249 (292)
T ss_pred ceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCcc-ccchHH
Confidence 999999999999999999999999986 788899999999999999999999999999877766543322111 122334
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
++-+.++..-+++++++|..+|.+|.++++.|+||+|.+..
T Consensus 250 qivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 250 QIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred HHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 45566778889999999999999999999999999998753
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=298.28 Aligned_cols=271 Identities=36% Similarity=0.724 Sum_probs=215.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||+|.++.+|..|++|++....... ....+.+|+..++.+. |||++++++++.+++..++++||+++++.+.+
T Consensus 10 g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e~~~~~l~~~~ 88 (283)
T cd07835 10 GTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFEFLDLDLKKYM 88 (283)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEeccCcCHHHHH
Confidence 789999999999999999999987654322 2345677999998885 99999999999999999999999987766665
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aP 157 (282)
.......+++..+..++.|++.||.+||+.+++|+||+|+||++++ +.++|+|||.+....... ......++..|+||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aP 168 (283)
T cd07835 89 DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAP 168 (283)
T ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCC
Confidence 5543346999999999999999999999999999999999999975 799999999987654322 11233557889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+...++.++|+||||+++|+|++|..||...+..+....+.+..+.+....|+...... .....+..........
T Consensus 169 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 247 (283)
T cd07835 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP-DYKPTFPKWARQDLSK 247 (283)
T ss_pred ceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch-hhhhhcccccccchhh
Confidence 988765557899999999999999999999999888877777777777766655543322221 1112222222233334
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.....+..+.++|.+||+.||.+|||+++++.||||
T Consensus 248 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 248 VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 456678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=318.54 Aligned_cols=268 Identities=24% Similarity=0.367 Sum_probs=197.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhC-----CCCCeeeeccccccC-CcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN-----NHPNIVKLRNLVKEH-EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~-----~hp~i~~~~~~~~~~-~~~~lv~e~~~~~ 74 (282)
|+||+||+|.+..+++.||||+++... ........|+..+..+. +|++++.+++++..+ .+++++||+++++
T Consensus 140 G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~g~~ 217 (467)
T PTZ00284 140 GTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPC 217 (467)
T ss_pred ccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEeccCCC
Confidence 899999999999999999999986432 12223344555555543 355688898888654 5789999999888
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeCC-----------------cEEEeecCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSKG-----------------VIKIGDLGMV 136 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~~-----------------~~~l~df~~~ 136 (282)
+++.+... ..+++..+..++.||+.||.|||+ .||+|+||||+||+++.+ .+||+|||.+
T Consensus 218 l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~ 295 (467)
T PTZ00284 218 LLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC 295 (467)
T ss_pred HHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCcc
Confidence 88876654 469999999999999999999998 599999999999999742 4999999987
Q ss_pred cccCCCCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccc
Q 044127 137 KEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLG 216 (282)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (282)
...... .....+++.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+....+.+... |...
T Consensus 296 ~~~~~~--~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~-~~~~ 371 (467)
T PTZ00284 296 CDERHS--RTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSE-WAGR 371 (467)
T ss_pred ccCccc--cccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHH-HHhh
Confidence 643322 24567899999999998554 8999999999999999999999999988888877777766655322 1111
Q ss_pred ccccc---------cCCccccCCCC----CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 217 IQLAS---------NLDWKFPQMGG----VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 217 ~~~~~---------~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
..... ........... ...........+.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 372 CGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred ccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 00000 00000000000 00000001125678899999999999999999999999999874
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=302.09 Aligned_cols=276 Identities=22% Similarity=0.279 Sum_probs=197.6
Q ss_pred CcceEEEEEecCCCcEEEEEEccccccchHH-HHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 2 SYGDVFQALDKKSGEFVAVKKLKKKIFSLDE-SRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 2 ~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~-~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
+|++||+++++.+|+.||+|.++........ .....|+.+++.+ +||||+++++++..++..++||||+.++.+..++
T Consensus 12 ~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 90 (327)
T cd08227 12 DLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI 90 (327)
T ss_pred ceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHH
Confidence 6789999999999999999999766443333 3445677777777 5999999999999999999999999987776666
Q ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--------CCCccc
Q 044127 81 ER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--------CTDYVT 150 (282)
Q Consensus 81 ~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--------~~~~~~ 150 (282)
.. ....+++..++.++.|++.||.|||++|++|+||||+||+++. +.++++||+.+........ .....+
T Consensus 91 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (327)
T cd08227 91 CTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVK 170 (327)
T ss_pred HhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccc
Confidence 43 3346999999999999999999999999999999999999985 7899999986543311100 112345
Q ss_pred cccccCchhhhcc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCC--Cccccc--------cc
Q 044127 151 TRWYRAPEVLLLS-EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTED--SWPLGI--------QL 219 (282)
Q Consensus 151 ~~~~~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--------~~ 219 (282)
+..|+|||.+.+. ..++.++|||||||++|+|++|..||.....................+ ..+... ..
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T cd08227 171 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGA 250 (327)
T ss_pred eecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCC
Confidence 6679999998753 347899999999999999999999998765544333322211000000 000000 00
Q ss_pred cccC------CccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 220 ASNL------DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 220 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
.... ..................+++.+.+||++||+.||++|||++++++||||++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~ 315 (327)
T cd08227 251 NSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 315 (327)
T ss_pred cCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcch
Confidence 0000 0000000111112233456788999999999999999999999999999987653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=296.06 Aligned_cols=271 Identities=32% Similarity=0.609 Sum_probs=208.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||+|.++.+++.|++|++....... ....+.+|+.+++++. |||++++++++......+++|||++++++..+
T Consensus 12 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~ 90 (286)
T cd07847 12 GSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNEL 90 (286)
T ss_pred cCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEEEeccCccHHHHH
Confidence 789999999999999999999986543222 2334567899999985 99999999999999999999999999999887
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aP 157 (282)
.... ..+++..+..++.||+.||.+||+.|++|+||+|+||++++ +.++|+|||.+....... ......++..|+||
T Consensus 91 ~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aP 169 (286)
T cd07847 91 EKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAP 169 (286)
T ss_pred HhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCH
Confidence 6654 36999999999999999999999999999999999999985 789999999988764433 22334567889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC-CCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ-MGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (282)
|.+.+...++.++|+||||+++|+|++|..||.+....+....+....+...+.................+. .......
T Consensus 170 E~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd07847 170 ELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLE 249 (286)
T ss_pred HHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHH
Confidence 998765667899999999999999999999999888777766665554433221110000000000000000 0011111
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.....++..+.+|+.+||+.||++|||+.+++.||||
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 250 SKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 2234568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=297.13 Aligned_cols=271 Identities=44% Similarity=0.845 Sum_probs=224.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||+|.+..+++.+++|.+...... ........|+..++++. |||++++++++..+...++++||+.+++...+
T Consensus 10 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~l 88 (283)
T cd05118 10 GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLI 88 (283)
T ss_pred CCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEeccCCCHHHHH
Confidence 78999999999999999999998765433 23456677889999995 99999999999999999999999998777766
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aP 157 (282)
.... ..+++..+..++.|++.||.+||+.+++|+||+|+||++++ +.++++|||.+....... ......++..|+||
T Consensus 89 ~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~P 167 (283)
T cd05118 89 KDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAP 167 (283)
T ss_pred Hhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCc
Confidence 5543 47999999999999999999999999999999999999985 789999999987765443 22334577889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+....+.++|+||||+++|++++|+.||...+..+....+....+.+.+..++............+..........
T Consensus 168 E~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (283)
T cd05118 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPK 247 (283)
T ss_pred HHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHH
Confidence 99876646899999999999999999999999998888888888877777776666655543333334444444444445
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.....+.++.++|++||+.||.+||++.+++.||||
T Consensus 248 ~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 248 LFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 556789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=298.24 Aligned_cols=250 Identities=28% Similarity=0.419 Sum_probs=200.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.+..+++.|++|.+....... .......|+.+++++ +|++++.+++.+.+.+..+++|||+.++.+..
T Consensus 11 G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~ 89 (285)
T cd05630 11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 89 (285)
T ss_pred CCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEEEecCCCcHHH
Confidence 899999999999999999999987643322 234456799998888 59999999999999999999999998777765
Q ss_pred HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 79 MKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
.+.. ....+++..+..++.|++.||.|||+.|++|+||||+||++++ +.++|+|||++.............++..|+|
T Consensus 90 ~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~a 169 (285)
T cd05630 90 HIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 169 (285)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccC
Confidence 5543 3346999999999999999999999999999999999999985 7899999999876544433344578899999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++||||||+++|+|++|..||................... ..
T Consensus 170 PE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~--------------------------~~ 222 (285)
T cd05630 170 PEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--------------------------QE 222 (285)
T ss_pred hHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh--------------------------hh
Confidence 99987544 8999999999999999999999998654322111111110000 00
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~ 278 (282)
..+...++.+.+|+++||+.||.+||| ++++++||||+++.+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 123456888999999999999999999 899999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=310.61 Aligned_cols=248 Identities=25% Similarity=0.435 Sum_probs=198.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++..... ......+..|..++..+ +||+|+++++.+.+.+..++|||||.|+.+..
T Consensus 12 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~ 90 (360)
T cd05627 12 GAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMT 90 (360)
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEeCCCCccHHH
Confidence 8999999999999999999999875432 22334556788888888 59999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--------------
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-------------- 143 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-------------- 143 (282)
++... ..+++..+..++.|++.||.+||+.|++|+||||+||+++. +.++|+|||++.......
T Consensus 91 ~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~ 169 (360)
T cd05627 91 LLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169 (360)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcc
Confidence 66554 46999999999999999999999999999999999999974 899999999986442110
Q ss_pred ----------------------CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Q 044127 144 ----------------------PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKI 201 (282)
Q Consensus 144 ----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~ 201 (282)
......|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...........+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i 248 (360)
T cd05627 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKV 248 (360)
T ss_pred cccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCCCCCCHHHHHHHH
Confidence 011346899999999987544 899999999999999999999999888776665554
Q ss_pred HHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCC---CHHHHhcCcccccccC
Q 044127 202 CQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRP---TAAEALEHPFFRSCHF 278 (282)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~~~ 278 (282)
....... .++ .....++.++++|.+|+. ||.+|+ +++++++||||+++.+
T Consensus 249 ~~~~~~~-----------------~~p---------~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 249 MNWKETL-----------------VFP---------PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred HcCCCce-----------------ecC---------CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 3321100 000 011368899999999875 999998 4899999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=277.42 Aligned_cols=243 Identities=28% Similarity=0.419 Sum_probs=212.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCC-ccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYME-SDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~-~~~l~ 77 (282)
|-||.||.|+.+.++.-||+|++.++... ....+..+|+.+...+. ||||+++|++|-+....|+++||.. |+++.
T Consensus 33 gkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riyLilEya~~gel~k 111 (281)
T KOG0580|consen 33 GKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIYLILEYAPRGELYK 111 (281)
T ss_pred CccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeEEEEEecCCchHHH
Confidence 78999999999999999999998776432 23456678888888885 9999999999999999999999986 78888
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
.+.....+.+++...+.++.|++.||.|+|.++++||||||+|+|++ ++.+|+.|||.+...+ .......+||.-|.+
T Consensus 112 ~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~ 190 (281)
T KOG0580|consen 112 DLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLP 190 (281)
T ss_pred HHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCceeeecccccCC
Confidence 88876677899999999999999999999999999999999999998 5899999999988766 444567899999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||...+. .++...|+|++|++.||++.|..||+.....+.+.++....-
T Consensus 191 pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~------------------------------ 239 (281)
T KOG0580|consen 191 PEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL------------------------------ 239 (281)
T ss_pred HhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc------------------------------
Confidence 9988744 489999999999999999999999999987777777655321
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.++..++..+.++|.+|+..+|.+|.+..|++.|||+...
T Consensus 240 ~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 240 KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 2235789999999999999999999999999999998753
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=302.29 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=198.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+++++.+++.||+|++.+.... .....+..|..++..+ +||||+.+++.+.+++..|+||||+.++.+..
T Consensus 12 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~ 90 (331)
T cd05597 12 GAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLVMDYYVGGDLLT 90 (331)
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEEEecCCCCcHHH
Confidence 89999999999999999999998753221 1233355677777666 69999999999999999999999998877777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC--CCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~ 155 (282)
++...+..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++......... ....+++.|+
T Consensus 91 ~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~ 170 (331)
T cd05597 91 LLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYI 170 (331)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceecccccc
Confidence 77665567999999999999999999999999999999999999974 89999999998765433221 2246899999
Q ss_pred Cchhhhc----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 156 APEVLLL----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 156 aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
|||++.. ...++.++|||||||++|+|++|+.||......+....+.......
T Consensus 171 aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------- 227 (331)
T cd05597 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF----------------------- 227 (331)
T ss_pred CHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc-----------------------
Confidence 9999863 2346889999999999999999999998776655554433211000
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCC--CCCHHHHhcCcccccccC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHM--RPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~~~~~~~~~ 278 (282)
.........++.++++|++||..++.+ |++++++++||||++..+
T Consensus 228 --~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 228 --QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred --cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 011112347889999999999765544 789999999999987654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=301.97 Aligned_cols=273 Identities=25% Similarity=0.365 Sum_probs=201.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.+..++..+++|.+...........+.+|+.++.++. ||||+++++++.+++..+++|||+.++.|..++
T Consensus 16 g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 94 (333)
T cd06650 16 GNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 94 (333)
T ss_pred CCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEEEEEecCCCCcHHHHH
Confidence 7899999999999999999998876543344566788999999995 999999999999999999999999987777766
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
... ..+++..+..++.|++.||.|||+. +++|+||||+||++++ +.++|+|||++....... .....++..|+|||
T Consensus 95 ~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~y~aPE 172 (333)
T cd06650 95 KKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPE 172 (333)
T ss_pred HHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-cccCCCCccccCHH
Confidence 654 3689999999999999999999985 7999999999999975 789999999987553322 23456888999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHh-CCCCCCCccccccccccCCccccCCC------
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVI-GSPTEDSWPLGIQLASNLDWKFPQMG------ 231 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~------ 231 (282)
.+.+. .++.++|+|||||++|++++|+.||......+......... +.+..................+....
T Consensus 173 ~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (333)
T cd06650 173 RLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAI 251 (333)
T ss_pred HhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccH
Confidence 98754 47899999999999999999999998665433322111000 00000000000000000000000000
Q ss_pred --------CCccccc-CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 232 --------GVNLREL-SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 232 --------~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
....+.. ....+.++++||.+||+.||++|||+++++.||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 252 FELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred HHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0000011 123578899999999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=306.26 Aligned_cols=264 Identities=25% Similarity=0.401 Sum_probs=193.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|++..+++.|++|+.... ....|+.+++++ +||||+++++++......++++|++.++++..+.
T Consensus 77 G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~ 148 (357)
T PHA03209 77 GSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLT 148 (357)
T ss_pred CCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEEEEccCCcHHHHHH
Confidence 89999999999999999999985432 224578888888 4999999999999999999999999998887765
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCchh
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 159 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~ 159 (282)
... ..+++..+..|+.||+.||.|||+.|++|+||||+||+++. +.++|+|||++.............++..|+|||.
T Consensus 149 ~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~ 227 (357)
T PHA03209 149 KRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEV 227 (357)
T ss_pred hcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCee
Confidence 543 57999999999999999999999999999999999999985 7899999999875443333345678999999999
Q ss_pred hhccccCCCcchhHHHHHHHHHHHhCCCC-CCCCCC---------hHHHHHHHHHhCCCCCCCcccc---ccccccCCcc
Q 044127 160 LLLSEIYGPEVDMWAMGAIMFEMLSFRIL-FPGKNS---------ADQIYKICQVIGSPTEDSWPLG---IQLASNLDWK 226 (282)
Q Consensus 160 ~~~~~~~~~~~DiwslG~ll~~l~~g~~~-~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 226 (282)
+.+.. ++.++|||||||++|+|+++..+ |..... ...+..+....+... ..++.. ..........
T Consensus 228 ~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 305 (357)
T PHA03209 228 LARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP-EEFPRDPGSRLVRGFIEYA 305 (357)
T ss_pred cCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh-hhcCCCCccHHHHHHHhhc
Confidence 87544 89999999999999999986544 443222 122223333332221 111100 0000000000
Q ss_pred ---ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 227 ---FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 227 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
..+.... ........+..+.+||++||+.||.+|||++|+|+||||+++
T Consensus 306 ~~~~~~~~~~-~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 306 SLERQPYTRY-PCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred ccCCCccccc-HHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 0000000 000112457788899999999999999999999999999874
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=306.68 Aligned_cols=248 Identities=27% Similarity=0.388 Sum_probs=197.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|+++.+++.||+|++...... .....+.+|..+++.+ +||||+++++.+.++...++|||||+++.+..
T Consensus 54 G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~ 132 (371)
T cd05622 54 GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 132 (371)
T ss_pred cCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHH
Confidence 89999999999999999999998653322 2233445677777766 59999999999999999999999999877777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~ 155 (282)
++.. ..+++..+..++.||+.||.+||++|++|+||||+||+++. +.++|+|||++....... ......|++.|+
T Consensus 133 ~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~ 210 (371)
T cd05622 133 LMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210 (371)
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCcccc
Confidence 7665 35899999999999999999999999999999999999975 899999999988664322 223457899999
Q ss_pred Cchhhhccc---cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 156 APEVLLLSE---IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 156 aPE~~~~~~---~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|||++.... .++.++|||||||++|+|++|..||...+.......+........ +
T Consensus 211 aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~------------------- 268 (371)
T cd05622 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---F------------------- 268 (371)
T ss_pred CHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc---C-------------------
Confidence 999986432 368899999999999999999999988776655555433211100 0
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCC--CCCHHHHhcCccccccc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHM--RPTAAEALEHPFFRSCH 277 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~~~~~~~~ 277 (282)
.....++..++++|.+||..++.+ |++++++++|+||++..
T Consensus 269 ----~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 269 ----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred ----CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 112357889999999999844443 78999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=294.85 Aligned_cols=250 Identities=29% Similarity=0.445 Sum_probs=203.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.+..+++.||+|.+....... ......+|+.+++.+ +|++++.+.+.+..++..+++|||+.++.+..
T Consensus 11 G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 89 (285)
T cd05632 11 GGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLTIMNGGDLKF 89 (285)
T ss_pred CCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEEeccCccHHH
Confidence 899999999999999999999987643322 234457799999888 59999999999999999999999999877765
Q ss_pred HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 79 MKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
.+.. ....+++..+..++.|++.||.|||+.|++|+||+|+||++++ +.++|+|||++.............++..|+|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~a 169 (285)
T cd05632 90 HIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMA 169 (285)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccC
Confidence 5543 3346999999999999999999999999999999999999975 7899999999876544333345578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++|+||||+++|++++|..||...........+........ .
T Consensus 170 PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--------------------------~ 222 (285)
T cd05632 170 PEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE--------------------------E 222 (285)
T ss_pred hHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--------------------------c
Confidence 99987544 89999999999999999999999987665444433322221111 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~ 278 (282)
..+...+..+.+|+.+||+.||++||+ +++++.|+||++..+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 123456888999999999999999999 889999999988643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=300.24 Aligned_cols=273 Identities=36% Similarity=0.637 Sum_probs=216.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-------------HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEE
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-------------ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIV 67 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-------------~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv 67 (282)
|+||+||+|.++.+++.|++|++........ .....+|+.++.++. ||||+++++++..++..+++
T Consensus 20 G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 98 (335)
T PTZ00024 20 GTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMGLVDVYVEGDFINLV 98 (335)
T ss_pred CCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-CcceeeeeEEEecCCcEEEE
Confidence 8899999999999999999999875432221 123567889999985 99999999999999999999
Q ss_pred EecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC----
Q 044127 68 FEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---- 142 (282)
Q Consensus 68 ~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~---- 142 (282)
||++.+++.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+......
T Consensus 99 ~e~~~~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~ 176 (335)
T PTZ00024 99 MDIMASDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176 (335)
T ss_pred EeccccCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecccccccc
Confidence 999998777665443 46999999999999999999999999999999999999985 78999999998765411
Q ss_pred -----------CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCC
Q 044127 143 -----------LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTED 211 (282)
Q Consensus 143 -----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (282)
.......++..|+|||.+.+...++.++|+|||||++|+|++|..||...+..+....+....+.+...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~ 256 (335)
T PTZ00024 177 TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNED 256 (335)
T ss_pred cccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchh
Confidence 111223457789999998765667899999999999999999999999998888888888888777766
Q ss_pred CccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 212 SWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
.|+........... ...............+..+.++|++||+.+|++|||++++|.||||++...
T Consensus 257 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 257 NWPQAKKLPLYTEF--TPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred hCcchhhccccccc--CcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 66543322211111 111111222334456888999999999999999999999999999987644
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=293.16 Aligned_cols=248 Identities=26% Similarity=0.459 Sum_probs=202.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|+||+|.+..++..+++|.+.... ......+..|+.+++++. |||++++++.+..+...+++|||++++++..++
T Consensus 16 g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 93 (280)
T cd06611 16 GAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWILIEFCDGGALDSIM 93 (280)
T ss_pred CCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEEEeeccCCCcHHHHH
Confidence 789999999999899999999986542 233456678999999996 999999999999999999999999998888887
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
...+..+++..+..++.|++.||.+||++|++|+||+|+||++++ +.++|+|||.+....... ......+++.|+|||
T Consensus 94 ~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE 173 (280)
T cd06611 94 LELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE 173 (280)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHH
Confidence 766667999999999999999999999999999999999999974 899999999876553322 223346788899999
Q ss_pred hhhc----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 159 VLLL----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 159 ~~~~----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
.+.. ...++.++|+||||+++|+|++|..||...........+... .. .
T Consensus 174 ~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~------------------------~ 226 (280)
T cd06611 174 VVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS---EP------------------------P 226 (280)
T ss_pred HHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC---CC------------------------C
Confidence 9752 234678999999999999999999999877655444332211 00 0
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
....+..++..+.++|++||+.+|.+||+++++++||||++..
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 227 TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 0112235678999999999999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=291.77 Aligned_cols=250 Identities=25% Similarity=0.424 Sum_probs=202.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.+..++..+++|.+.... ......+.+|+..++.+ +|||++++++.+......++++||++++++..+.
T Consensus 16 g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~ 93 (282)
T cd06643 16 GAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 93 (282)
T ss_pred CCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHH
Confidence 789999999999999999999986543 23445567888888888 5999999999999999999999999988887766
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE 158 (282)
.....++++..+..++.|++.||.+||+.|++|+||+|+||+++. +.++++|||++...... .......+++.|+|||
T Consensus 94 ~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 173 (282)
T cd06643 94 LELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 173 (282)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHh
Confidence 554457999999999999999999999999999999999999974 78999999998654322 1223446788899999
Q ss_pred hhh----ccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 159 VLL----LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 159 ~~~----~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
.+. ....++.++|+|||||++|+|++|..||...+..............
T Consensus 174 ~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--------------------------- 226 (282)
T cd06643 174 VVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP--------------------------- 226 (282)
T ss_pred hccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC---------------------------
Confidence 974 2334678999999999999999999999877655544443221100
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
....+..++..+.++|++||+.||.+||+++++++||||+.....
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 271 (282)
T cd06643 227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK 271 (282)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCCC
Confidence 001223567899999999999999999999999999999865443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=284.13 Aligned_cols=248 Identities=30% Similarity=0.486 Sum_probs=202.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc-cHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES-DLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~-~~l~~~ 79 (282)
|+|+.|-.+....+|..||||++.+. ..-.....++|+.++.+.++|+||+.++++|+++...|+|||-|.| .+|.++
T Consensus 89 GAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI 167 (463)
T KOG0607|consen 89 GAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHI 167 (463)
T ss_pred ccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHH
Confidence 88999999999999999999999987 3556777899999999999999999999999999999999999985 666666
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCC--------CCC
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLP--------CTD 147 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~--------~~~ 147 (282)
.++ +.+++.++.+++++|+.||.|||.+||.|||+||+|||-.+ .-+|||||.+...+....+ ..+
T Consensus 168 ~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~t 245 (463)
T KOG0607|consen 168 QKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLT 245 (463)
T ss_pred HHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccC
Confidence 666 57999999999999999999999999999999999999864 3699999998775422211 124
Q ss_pred ccccccccCchhhh----ccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChH---------------HHHHHHHHhCCC
Q 044127 148 YVTTRWYRAPEVLL----LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSAD---------------QIYKICQVIGSP 208 (282)
Q Consensus 148 ~~~~~~~~aPE~~~----~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~---------------~~~~~~~~~~~~ 208 (282)
.+|+..|||||+.. ....|+.+.|.||||+++|-|++|+.||.+....+ ....+.++.
T Consensus 246 PvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk--- 322 (463)
T KOG0607|consen 246 PVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK--- 322 (463)
T ss_pred cccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC---
Confidence 57788899999862 23568999999999999999999999997654321 111111111
Q ss_pred CCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 209 TEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
..|+ ..-+..++.+.++++..+|..|+.+|.++.++++|||++.+.
T Consensus 323 ----------------YeFP-------dkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 323 ----------------YEFP-------DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred ----------------CcCC-------hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 1111 122346799999999999999999999999999999998753
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=293.10 Aligned_cols=251 Identities=26% Similarity=0.450 Sum_probs=201.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|++..+++.|++|.+.... ......+..|+..++.+. |||++++++.+..++..+++|||++++++..+.
T Consensus 23 g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 100 (292)
T cd06644 23 GAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCN-HPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIM 100 (292)
T ss_pred CCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHH
Confidence 789999999999999999999987542 334455677888888885 999999999999999999999999988887766
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCC-CCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE 158 (282)
......+++..+..++.|++.||.+||+.|++|+||+|+||+++ ++.++|+|||.+...... .......+++.|+|||
T Consensus 101 ~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 180 (292)
T cd06644 101 LELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180 (292)
T ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCce
Confidence 55445799999999999999999999999999999999999998 579999999987654322 1123446778899999
Q ss_pred hhhc----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 159 VLLL----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 159 ~~~~----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
.+.. ...++.++|+|||||++|+|++|..||...+........... ..+
T Consensus 181 ~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~------------------------ 233 (292)
T cd06644 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPP------------------------ 233 (292)
T ss_pred eeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---CCc------------------------
Confidence 8852 234678999999999999999999999776544433332111 000
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
....+..++..+.++|++||+.||++||+++++++||||+.+...+
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 0012235678899999999999999999999999999999876544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=312.65 Aligned_cols=244 Identities=26% Similarity=0.422 Sum_probs=198.6
Q ss_pred CCcceEEEEEecCC-CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKS-GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~-~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||+|.+..+ +..|++|.+.... ......+..|+..+..+ +||||+++++.+..++..++||||+.++.|...
T Consensus 78 G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~ 155 (478)
T PTZ00267 78 NPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ 155 (478)
T ss_pred CCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEEEEEECCCCCCHHHH
Confidence 88999999998877 7889999775432 23334556789988888 599999999999999999999999987666554
Q ss_pred HHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---CCCccccc
Q 044127 80 KER---AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTR 152 (282)
Q Consensus 80 ~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~---~~~~~~~~ 152 (282)
+.. ...++++..+..++.||+.||.+||+.|++||||||+||+++. +.++|+|||++........ .....|++
T Consensus 156 l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~ 235 (478)
T PTZ00267 156 IKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTP 235 (478)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCc
Confidence 432 2346899999999999999999999999999999999999985 7999999999986643321 23456899
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
.|+|||.+.+. .++.++|||||||++|+|++|..||......+....+.....
T Consensus 236 ~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-------------------------- 288 (478)
T PTZ00267 236 YYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-------------------------- 288 (478)
T ss_pred cccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------------------------
Confidence 99999998754 489999999999999999999999987766655554433111
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
...+..++..+.++|.+||+.||++||++++++.|+|++..
T Consensus 289 ---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 289 ---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred ---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 01233567899999999999999999999999999998753
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=295.40 Aligned_cols=248 Identities=34% Similarity=0.634 Sum_probs=199.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHH-HHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDES-RNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~-~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|++..+++.||+|++.......... ....|+..++++ +||||+++++++......+++||++.++.+..+
T Consensus 10 G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~ 88 (260)
T PF00069_consen 10 GGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDY 88 (260)
T ss_dssp ESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEEEETTEBHHHH
T ss_pred CCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-ccccccccccccccccccccccccccccccccc
Confidence 899999999999999999999998765443332 335689999999 599999999999999999999999998555555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCccccc-CCCCCCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~aP 157 (282)
+... ..+++..+..++.||++||.+||+.|++|+||||+||+++ ++.++|+|||.+... ..........++..|.||
T Consensus 89 l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aP 167 (260)
T PF00069_consen 89 LQKN-KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAP 167 (260)
T ss_dssp HHHH-SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCH
T ss_pred cccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 5532 4799999999999999999999999999999999999998 589999999998763 333344566788999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+......+.++|+||||+++++|++|..||......+................. .
T Consensus 168 E~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~ 224 (260)
T PF00069_consen 168 EVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-----------------------Q 224 (260)
T ss_dssp HHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-----------------------T
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-----------------------c
Confidence 99874555899999999999999999999999987444444333332211100000 0
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.....++.+.++|++||+.||++|||++++++||||
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 001123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=302.48 Aligned_cols=269 Identities=32% Similarity=0.564 Sum_probs=204.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccC------CcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH------EDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~------~~~~lv~e~~~~ 73 (282)
|+||.||+|++..+++.|++|.+...... .......+|+.+++++ +||||+++++++... ...|+||||+.+
T Consensus 27 g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~ 105 (353)
T cd07850 27 GAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA 105 (353)
T ss_pred CCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccccCcEEEEEeccCC
Confidence 78999999999999999999998754322 2334566788888888 599999999987533 357999999998
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++.+.+.. .+++..+..++.|++.||.+||+.|++|+||||+||+++. +.++|+|||.+.............++.
T Consensus 106 ~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 181 (353)
T cd07850 106 NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 181 (353)
T ss_pred CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccc
Confidence 77765533 3899999999999999999999999999999999999985 789999999998765544444556788
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccccc----------
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN---------- 222 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 222 (282)
.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+..+....+....+.+..............
T Consensus 182 ~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (353)
T cd07850 182 YYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAG 260 (353)
T ss_pred cccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCC
Confidence 899999997544 799999999999999999999999988777777776666665543211110000000
Q ss_pred --CCccccCCCCC-cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 223 --LDWKFPQMGGV-NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 223 --~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
+...+...... .........++.++++|.+||+.||++|||++++|.||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 261 YSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred cchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 00000000000 000112345677899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=290.89 Aligned_cols=249 Identities=29% Similarity=0.411 Sum_probs=195.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHH--hCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRK--MNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~--~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||.||++.+..+++.+++|.+...... ........|...+.. ..+||+++.+++.+..++..++||||+.++.+
T Consensus 5 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 84 (279)
T cd05633 5 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDL 84 (279)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCH
Confidence 89999999999999999999998764332 122223334333332 23699999999999988999999999998878
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 155 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 155 (282)
..++... ..+++..+..++.|++.||.+||+.+++|+||||+||++++ +.++|+|||++........ ....++..|+
T Consensus 85 ~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~ 162 (279)
T cd05633 85 HYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-HASVGTHGYM 162 (279)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-cCcCCCcCcc
Confidence 7766654 36999999999999999999999999999999999999975 7899999999876543322 3456889999
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||.+..+..++.++|+||+||++|+|++|..||.......... ....... ..
T Consensus 163 aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~--------------------------~~ 215 (279)
T cd05633 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT--------------------------VN 215 (279)
T ss_pred CHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhhc--------------------------CC
Confidence 99998655557899999999999999999999997654332211 1110000 00
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
..++...+..+.++|++||+.||++|| |++++++||||++..+
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 123446788999999999999999999 6999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=293.73 Aligned_cols=271 Identities=36% Similarity=0.639 Sum_probs=213.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCC----------cEEEEEe
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE----------DVFIVFE 69 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----------~~~lv~e 69 (282)
|++|+||+|.++.+++.|++|+++..... .......+|+.+++++. |||++++++++.+.. ..++++|
T Consensus 18 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e 96 (302)
T cd07864 18 GTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFE 96 (302)
T ss_pred cCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhhhccccCCcEEEEEc
Confidence 78999999999999999999998754322 22345567889999894 999999999886554 7999999
Q ss_pred cCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCC
Q 044127 70 YMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCT 146 (282)
Q Consensus 70 ~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~ 146 (282)
|++++++..+... ...+++..+..++.||+.||++||+.|++|+||+|+||++++ +.++|+|||.+....... ...
T Consensus 97 ~~~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (302)
T cd07864 97 YMDHDLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175 (302)
T ss_pred ccCccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccc
Confidence 9999877766544 346999999999999999999999999999999999999986 789999999987654332 112
Q ss_pred CccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcc
Q 044127 147 DYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226 (282)
Q Consensus 147 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
...++..|+|||.+.+...++.++|||||||++++|++|+.||...+..+....+....+.+.+..++............
T Consensus 176 ~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T cd07864 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMK 255 (302)
T ss_pred cceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccc
Confidence 23457789999988755557899999999999999999999999888888888888877777766665443322221111
Q ss_pred ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
................+..+.+++.+||+.||++|||+++++.||||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 256 PKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 11111112222334568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=292.76 Aligned_cols=271 Identities=32% Similarity=0.608 Sum_probs=208.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||.||+|.+..+++.|++|.+....... ....+.+|+..+..+ +|||++++++++..++..++++||+.++++..+
T Consensus 12 g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 90 (286)
T cd07846 12 GSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL 90 (286)
T ss_pred CCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEEEecCCccHHHHH
Confidence 789999999999899999999987644332 234566788888888 599999999999999999999999999998877
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aP 157 (282)
.... ..+++..+..++.||+.||.|||+.|++|+||+|+||++++ +.++|+|||++....... ......++..|+||
T Consensus 91 ~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aP 169 (286)
T cd07846 91 EKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAP 169 (286)
T ss_pred Hhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCc
Confidence 6654 35999999999999999999999999999999999999975 789999999987654322 22334578889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC-CCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM-GGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 236 (282)
|.+.+...++.++||||||+++|+|++|..||......+....+....+.....................+.. ......
T Consensus 170 E~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (286)
T cd07846 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLE 249 (286)
T ss_pred HHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHH
Confidence 9987655578899999999999999999999988777666666665554432211100000000000001100 001112
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
...+.++..+.+++++||+.+|++||++.+++.||||
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 250 KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 2345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=301.27 Aligned_cols=274 Identities=39% Similarity=0.670 Sum_probs=207.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC-----CcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH-----EDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~ 75 (282)
|++|.||+|++..+|+.|++|++..............|+.+++++. ||||+++++++... ...++++|++.+.+
T Consensus 16 G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l 94 (336)
T cd07849 16 GAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMETDL 94 (336)
T ss_pred cCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccccceEEEEehhcccCH
Confidence 7899999999999999999999865333334455678999999995 99999999886543 35899999999877
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC----CCCccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP----CTDYVT 150 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~----~~~~~~ 150 (282)
...+.. ..+++..++.++.|++.||.+||+.|++|+||||+||+++. +.++|+|||++........ .....+
T Consensus 95 ~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 171 (336)
T cd07849 95 YKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171 (336)
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCc
Confidence 665533 46999999999999999999999999999999999999985 7899999999876533221 123467
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc-cCCccccC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS-NLDWKFPQ 229 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 229 (282)
++.|+|||.+.+...++.++||||||+++|+|++|+.||...+.......+....+.+..+.+........ ......+.
T Consensus 172 ~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T cd07849 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPF 251 (336)
T ss_pred CCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCc
Confidence 88899999876555578999999999999999999999988776666666666555544332211100000 00000011
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
.............++.+.++|++||+.||.+|||+.++++||||++..-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 252 KPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred CCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 1111112223456888999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=288.37 Aligned_cols=242 Identities=26% Similarity=0.441 Sum_probs=197.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc----hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS----LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~----~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|++|.||.|.+..+++.|++|.+...... .....+.+|+..++++ +||||+++++++.++...++++|++.++.+
T Consensus 13 g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 91 (263)
T cd06625 13 GAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLSIFMEYMPGGSV 91 (263)
T ss_pred CCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEEEEEEECCCCcH
Confidence 78999999999999999999998754322 1234567788888888 599999999999999999999999987777
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC----CCcccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC----TDYVTT 151 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~----~~~~~~ 151 (282)
...+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+......... ....++
T Consensus 92 ~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 170 (263)
T cd06625 92 KDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170 (263)
T ss_pred HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcC
Confidence 6666554 36899999999999999999999999999999999999985 79999999998755332111 234567
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
..|+|||.+.+.. .+.++||||||+++|++++|+.||................
T Consensus 171 ~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------------------------- 223 (263)
T cd06625 171 PYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-------------------------- 223 (263)
T ss_pred ccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC--------------------------
Confidence 8899999987554 8899999999999999999999998765554443322210
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.....+...+..+.++|++||..+|.+|||+.++++|+||
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 224 --TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0112345678899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=291.58 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=198.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|+++.+|+.||+|.++.............|+....+..+|||++++++.+..+...+++|||+++++.+.+.
T Consensus 12 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~ 91 (283)
T cd06617 12 GAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYK 91 (283)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhcccHHHHHH
Confidence 89999999999999999999998876555555666777777666668999999999999999999999999987655544
Q ss_pred Hh--cCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 81 ER--AGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~--~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
.. ....+++..++.++.||+.||.+||++ +++|+||+|+||+++. +.++|+|||.+.............++..|+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~a 171 (283)
T cd06617 92 KVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMA 171 (283)
T ss_pred HhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccC
Confidence 32 234699999999999999999999997 9999999999999975 7999999999876644333333567888999
Q ss_pred chhhhcc---ccCCCcchhHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 157 PEVLLLS---EIYGPEVDMWAMGAIMFEMLSFRILFPGKN-SADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 157 PE~~~~~---~~~~~~~DiwslG~ll~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
||.+.+. ..++.++|+|||||++|+|++|..||.... ..+........ ..+
T Consensus 172 PE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~---------------------- 226 (283)
T cd06617 172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE---PSP---------------------- 226 (283)
T ss_pred hhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc---CCC----------------------
Confidence 9988642 336889999999999999999999996533 22322222111 000
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
......++..+.++|++||..+|.+||+++++++||||+....
T Consensus 227 ---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 227 ---QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred ---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 0011246889999999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=291.76 Aligned_cols=252 Identities=26% Similarity=0.426 Sum_probs=200.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH-
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM- 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~- 79 (282)
|+||.||++.+..+++.|++|.+...........+..|+..+.++.+||||+++++++..+...+++||++.+++.+..
T Consensus 15 G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~ 94 (288)
T cd06616 15 GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYK 94 (288)
T ss_pred CCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccCCHHHHHH
Confidence 7899999999999999999999876554555667788999999997799999999999988999999999987554432
Q ss_pred --HHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccccccc
Q 044127 80 --KERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 155 (282)
Q Consensus 80 --~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 155 (282)
.......+++..+..++.|++.||+|||+. +++|+||+|+||+++. +.++|+|||++.............++..|+
T Consensus 95 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~ 174 (288)
T cd06616 95 YVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYM 174 (288)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCcc
Confidence 222335799999999999999999999975 9999999999999985 789999999987665444334456788899
Q ss_pred Cchhhhcc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 156 APEVLLLS--EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 156 aPE~~~~~--~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
|||.+... ..++.++||||||+++|+|++|+.||.... .....+........+..
T Consensus 175 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~--------------------- 231 (288)
T cd06616 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPIL--------------------- 231 (288)
T ss_pred CHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcC---------------------
Confidence 99998755 357899999999999999999999997654 12222222111110000
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.......++..+.+||.+||+.||++|||+++++.||||+..
T Consensus 232 -~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 232 -SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred -CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 011123478899999999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=290.70 Aligned_cols=270 Identities=40% Similarity=0.759 Sum_probs=219.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||+|++..+++.|++|++...... ........|+..++++. |||++++++++.+.+..++++|++++++.+.+
T Consensus 10 g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~i 88 (282)
T cd07829 10 GTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFEYCDMDLKKYL 88 (282)
T ss_pred cCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEecCcCcCHHHHH
Confidence 78999999999999999999999865422 22345567888888885 99999999999999999999999998655554
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aP 157 (282)
... ...+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+....... .......+..|+||
T Consensus 89 ~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aP 167 (282)
T cd07829 89 DKR-PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAP 167 (282)
T ss_pred Hhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCCh
Confidence 443 246999999999999999999999999999999999999986 899999999987664432 22334557779999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.....++.++|+||||+++|++++|..||......+....+....+.+....|+...... ..+..+..........
T Consensus 168 E~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 246 (282)
T cd07829 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP-DYKPTFPKFPPKDLEK 246 (282)
T ss_pred HHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-cccccccccCccchHH
Confidence 998766468999999999999999999999999988888888888888887777666554443 2333333333333333
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.....+..+.++|++||..||++||++++++.||||
T Consensus 247 ~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 247 VLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred hcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 344558899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=287.82 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=198.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|.+..+++.|++|++...... ........|...+....+|||++++++.+..++..++++||+.++.+..
T Consensus 7 g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 86 (260)
T cd05611 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCAS 86 (260)
T ss_pred CCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHH
Confidence 78999999999999999999998754321 1223344555555555579999999999999999999999999888877
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++... ..+++..+..++.|++.||.+||+.+++|+||+|+||++++ +.++|+|||.+..... .....++..|+||
T Consensus 87 ~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~p 162 (260)
T cd05611 87 LIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAP 162 (260)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcCccCh
Confidence 77654 36999999999999999999999999999999999999985 7899999998875433 2344677889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+.. ++.++|+||||+++|++++|..||...+.......+....... ...
T Consensus 163 e~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~ 215 (260)
T cd05611 163 ETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW--------------------------PEE 215 (260)
T ss_pred hhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC--------------------------CCc
Confidence 9987555 7899999999999999999999998776655544432211000 011
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCC---HHHHhcCcccccccC
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPT---AAEALEHPFFRSCHF 278 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~~ 278 (282)
....+++.+.+++.+||+.||++||+ ++|+++||||+++.+
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 22356889999999999999999994 579999999998876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=294.57 Aligned_cols=271 Identities=33% Similarity=0.579 Sum_probs=205.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCC--------cEEEEEecC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE--------DVFIVFEYM 71 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--------~~~lv~e~~ 71 (282)
|+||.||+|.+..+++.|++|.+....... ......+|+..++++ +||||+++++++.... ..+++|||+
T Consensus 23 g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~ 101 (310)
T cd07865 23 GTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNRYKGSFYLVFEFC 101 (310)
T ss_pred CCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccCCCceEEEEEcCC
Confidence 789999999999999999999886543222 223446788888888 4999999999875443 459999999
Q ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-----C
Q 044127 72 ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-----C 145 (282)
Q Consensus 72 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-----~ 145 (282)
.+++.+.+... +..+++.+++.++.||++||.+||+.|++|+||+|+||+++. +.++|+|||.+........ .
T Consensus 102 ~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 180 (310)
T cd07865 102 EHDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180 (310)
T ss_pred CcCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCc
Confidence 98777665543 346999999999999999999999999999999999999985 7899999999876533221 1
Q ss_pred CCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc
Q 044127 146 TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225 (282)
Q Consensus 146 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
....++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+...+..++...........
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (310)
T cd07865 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKM 260 (310)
T ss_pred cCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhc
Confidence 23356778999999876555788999999999999999999999988877777766666666666555543322221111
Q ss_pred cccCCCCCccc-c-cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 226 KFPQMGGVNLR-E-LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 226 ~~~~~~~~~~~-~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
..+........ . .+...+..+.++|.+||+.||.+|||++++|+||||
T Consensus 261 ~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 261 ELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 11111100000 0 111246778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=290.95 Aligned_cols=271 Identities=37% Similarity=0.654 Sum_probs=211.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||+|.++.+++.|++|+++...... ....+.+|+..++++. ||||+++++.+..++..++++||++++++..+
T Consensus 12 g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~ 90 (288)
T cd07833 12 GAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLVFEYVERTLLELL 90 (288)
T ss_pred cCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEEEecCCCCHHHHH
Confidence 789999999999999999999987654332 3456678999999996 99999999999999999999999999988876
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccC
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~a 156 (282)
.... ..+++..++.++.||+.||.+||+.+++|+||+|+||++++ +.++|+|||.+....... ......++..|+|
T Consensus 91 ~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~ 169 (288)
T cd07833 91 EASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRA 169 (288)
T ss_pred HhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcC
Confidence 6554 46999999999999999999999999999999999999985 899999999988765443 3334567888999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC-cc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV-NL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (282)
||.+.+...++.++|+||||+++|++++|..||......+.........+...+................+.+.... ..
T Consensus 170 PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
T cd07833 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESL 249 (288)
T ss_pred CchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHH
Confidence 99998664689999999999999999999999988877777766666555444322211111100000011110000 00
Q ss_pred -cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 236 -RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 236 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
...+..++..+.+||++||..+|++|||+++++.||||
T Consensus 250 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 250 ERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 11233458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=299.21 Aligned_cols=273 Identities=35% Similarity=0.657 Sum_probs=210.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeeccccccC-----CcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH-----EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~ 74 (282)
|+||+||+|++..+++.|++|.+..... .........|+.+++.+ +||||+++++++... ...++++||++++
T Consensus 16 G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 94 (337)
T cd07858 16 GAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFNDVYIVYELMDTD 94 (337)
T ss_pred CCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccCcEEEEEeCCCCC
Confidence 8899999999999999999999875422 22334556788888888 599999999987543 3589999999987
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTR 152 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~ 152 (282)
+.+.+... ..+++..+..++.|++.||.+||+++++|+||+|+||+++. +.++|+|||++...... .......++.
T Consensus 95 L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 172 (337)
T cd07858 95 LHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR 172 (337)
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCccccccccccc
Confidence 76655443 46999999999999999999999999999999999999984 78999999998866433 2223446788
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCC--ccccCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD--WKFPQM 230 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 230 (282)
.|+|||.+.....++.++|+|||||++|+|++|+.||.+.+.......+....+.+.+..+..... ....+ ......
T Consensus 173 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 251 (337)
T cd07858 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN-EKARRYIRSLPYT 251 (337)
T ss_pred CccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc-hhhhHHHHhcCcc
Confidence 899999987555589999999999999999999999998877777777777666655443311000 00000 001111
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
...........+++.+.++|++||+.||.+|||++++++||||+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 252 PRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred cccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 11222334456889999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=281.92 Aligned_cols=279 Identities=33% Similarity=0.633 Sum_probs=224.5
Q ss_pred CCcceEEEEEecCCCc----EEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeecccccc-CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGE----FVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKE-HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~----~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~~~ 74 (282)
|.||.||+|..+.++. .||+|+++...-. .-.-...+|+..++.+. |||++.+..+|-. +..+++++||...+
T Consensus 35 GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d~~v~l~fdYAEhD 113 (438)
T KOG0666|consen 35 GTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK-HPNVISLVKVFLSHDKKVWLLFDYAEHD 113 (438)
T ss_pred cccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc-CCcchhHHHHHhccCceEEEEehhhhhh
Confidence 7899999997665433 6899999865322 22345578999999995 9999999999876 78899999999999
Q ss_pred HHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-C----CcEEEeecCcccccCCCC---
Q 044127 75 LLKLMKER---AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-K----GVIKIGDLGMVKEIDSSL--- 143 (282)
Q Consensus 75 ~l~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~----~~~~l~df~~~~~~~~~~--- 143 (282)
++..+.-. ..+.++...+++|+.||+.|+.|||++.+.||||||.||++. + |+||++|+|+++......
T Consensus 114 L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl 193 (438)
T KOG0666|consen 114 LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPL 193 (438)
T ss_pred HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcccccc
Confidence 98765432 235699999999999999999999999999999999999994 3 899999999999765432
Q ss_pred -CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCC---------ChHHHHHHHHHhCCCCCCCc
Q 044127 144 -PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKN---------SADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 144 -~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~ 213 (282)
+......|..|+|||.+.+.+-++.+.|||+.||++.||++-...|.+.. ..+++.++...++.|....|
T Consensus 194 ~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~W 273 (438)
T KOG0666|consen 194 ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDW 273 (438)
T ss_pred ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccc
Confidence 33456778899999999999989999999999999999999998886543 46778899999999999999
Q ss_pred cccccccccCCcc--cc--CCCCC---cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 214 PLGIQLASNLDWK--FP--QMGGV---NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 214 ~~~~~~~~~~~~~--~~--~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
|.....++..+.. ++ ...+. ..-+..+.-++...+|+.+||+.||.+|.|+++.|+|+||+.-...|
T Consensus 274 p~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lpp 347 (438)
T KOG0666|consen 274 PDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLPP 347 (438)
T ss_pred hhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCCC
Confidence 9888877763322 11 11111 11122333456699999999999999999999999999999876554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=298.48 Aligned_cols=240 Identities=23% Similarity=0.376 Sum_probs=187.6
Q ss_pred CCcceEEEEEec-----CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC-CcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDK-----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH-EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-~~~~lv~e~~~~~ 74 (282)
|+||.||+|.+. .++..||+|++...........+.+|+.++..+.+||||+++++++... ...+++|||+.++
T Consensus 18 G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g 97 (338)
T cd05102 18 GAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYG 97 (338)
T ss_pred CCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCC
Confidence 899999999752 3467899999876544445567889999999997799999999987654 4689999999987
Q ss_pred HHHHHHHhcC-------------------------------------------------------------CCCCHHHHH
Q 044127 75 LLKLMKERAG-------------------------------------------------------------QNFSEDEVR 93 (282)
Q Consensus 75 ~l~~~~~~~~-------------------------------------------------------------~~l~~~~~~ 93 (282)
.+..++.... .++++..+.
T Consensus 98 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 177 (338)
T cd05102 98 NLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLI 177 (338)
T ss_pred cHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHH
Confidence 7766554321 247888999
Q ss_pred HHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC---CCCCccccccccCchhhhccccCCCc
Q 044127 94 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEIYGPE 169 (282)
Q Consensus 94 ~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~ 169 (282)
.++.||++||+|||++|++|+||||+||++++ +.++|+|||++....... ......+++.|+|||.+.+. .++.+
T Consensus 178 ~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~ 256 (338)
T cd05102 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK-VYTTQ 256 (338)
T ss_pred HHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcC-CCCcc
Confidence 99999999999999999999999999999984 789999999987653221 11233456789999998744 48999
Q ss_pred chhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHH
Q 044127 170 VDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESIS 248 (282)
Q Consensus 170 ~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
+|||||||++|||++ |..||......+........... ...+...++.+.+
T Consensus 257 sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~ 308 (338)
T cd05102 257 SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR----------------------------MRAPENATPEIYR 308 (338)
T ss_pred cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC----------------------------CCCCCCCCHHHHH
Confidence 999999999999997 99999876554433332221000 0123356788999
Q ss_pred HHHHHhCCCCCCCCCHHHHhc
Q 044127 249 LISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 249 li~~~l~~dp~~Rps~~~ll~ 269 (282)
++.+||+.||.+|||+.++++
T Consensus 309 li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=298.28 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=198.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+++++.+++.||+|++.+.... .....+..|..++..+ +||+|+++++.+.+....++||||+.++.+..
T Consensus 12 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~ 90 (332)
T cd05623 12 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLVMDYYVGGDLLT 90 (332)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEEEeccCCCcHHH
Confidence 89999999999999999999998653221 1223345666666666 69999999999999999999999998777777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~ 155 (282)
++......+++..+..++.||+.||.+||+.|++|+||||+||+++. +.++|+|||++........ .....|++.|+
T Consensus 91 ~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~ 170 (332)
T cd05623 91 LLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 170 (332)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCcccc
Confidence 76654557999999999999999999999999999999999999974 7999999999875533221 22356899999
Q ss_pred Cchhhhc----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 156 APEVLLL----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 156 aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
|||++.. ...++.++|||||||++|+|++|+.||...+..+....+.......
T Consensus 171 aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------- 227 (332)
T cd05623 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF----------------------- 227 (332)
T ss_pred CHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc-----------------------
Confidence 9999862 3347889999999999999999999998877666555443211000
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCC--CCCHHHHhcCcccccccC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHM--RPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~~~~~~~~~ 278 (282)
..+.....+++.+++||++||..++.+ |++++++++||||+++.+
T Consensus 228 --~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 228 --QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred --cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 011122356889999999999665544 689999999999998653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=292.32 Aligned_cols=271 Identities=36% Similarity=0.673 Sum_probs=213.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~l~ 77 (282)
|++|.||+|.+..+++.+++|.+..... ......+..|+..++.+. |||++++++++... +..++++||+++++..
T Consensus 10 g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~ 88 (287)
T cd07840 10 GTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG 88 (287)
T ss_pred CCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEEeccccccHHH
Confidence 7899999999999999999999987641 223345677999999885 99999999999887 8999999999986655
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWY 154 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~ 154 (282)
.+... ...+++..++.++.||+.||++||+.|++|+||+|+||++++ +.++++|||.+....... ......++..|
T Consensus 89 ~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y 167 (287)
T cd07840 89 LLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167 (287)
T ss_pred HHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccccccccccc
Confidence 55443 347999999999999999999999999999999999999985 799999999988765443 12334567789
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||.+.+...++.++||||||+++|+|++|..||...+.......+....+.+....++....................
T Consensus 168 ~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (287)
T cd07840 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRR 247 (287)
T ss_pred CCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhH
Confidence 99998775555789999999999999999999999998888888888777777776666543332111111111111111
Q ss_pred ccccCCC-CChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 235 LRELSPS-ASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 235 ~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
..+.... ++..+.+++++||+.+|.+||++.+++.||||
T Consensus 248 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 248 LREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred HHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 1122222 48899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=291.43 Aligned_cols=246 Identities=26% Similarity=0.497 Sum_probs=201.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|+||+|.+..+++.|++|.+..... .....+.+|+..++.+ +|||++++++.+......++++||+.++++..+.
T Consensus 30 g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 107 (296)
T cd06655 30 GASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV 107 (296)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEEEEEecCCCcHHHHH
Confidence 7899999999999999999999875432 3345567788888888 4999999999999999999999999988888777
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE 158 (282)
.. ..+++.++..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||++........ .....++..|+|||
T Consensus 108 ~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 185 (296)
T cd06655 108 TE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185 (296)
T ss_pred Hh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcc
Confidence 65 36899999999999999999999999999999999999974 7999999998876543221 23346788899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.... ++.++|+|||||++|++++|..||...+........... ..+ ....
T Consensus 186 ~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~--------------------------~~~~ 237 (296)
T cd06655 186 VVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP--------------------------ELQN 237 (296)
T ss_pred hhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCc--------------------------ccCC
Confidence 987544 789999999999999999999999887665444332211 000 0112
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
+..+++.+.++|++||..||.+|||+.+++.||||+....
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 3456889999999999999999999999999999987554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=299.60 Aligned_cols=277 Identities=39% Similarity=0.682 Sum_probs=219.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeeccccccCC-----cEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE-----DVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-----~~~lv~e~~~~~ 74 (282)
|++|.||+|++..+++.|++|.+..... ......+.+|+..++++. ||||+++.+++.... ..|++|||+.++
T Consensus 11 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 89 (330)
T cd07834 11 GAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFNDVYIVTELMETD 89 (330)
T ss_pred CCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccceEEEecchhhh
Confidence 7899999999998999999999876542 334456778999999995 999999999987765 789999999976
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC----CCCCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL----PCTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~----~~~~~~ 149 (282)
+.+.+ ... ..+++..++.++.||+.||.+||+.|++|+||+|+||++++ +.++|+|||.+....... ......
T Consensus 90 l~~~l-~~~-~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~ 167 (330)
T cd07834 90 LHKVI-KSP-QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167 (330)
T ss_pred HHHHH-hCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccc
Confidence 55544 333 37999999999999999999999999999999999999985 799999999998765442 233456
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccc-ccccCCcccc
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQ-LASNLDWKFP 228 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 228 (282)
++..|+|||.+.+....+.++|+||||+++|+|++|..||...+..+....+....+.+....+..... .....-....
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
T cd07834 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLP 247 (330)
T ss_pred cccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcc
Confidence 788899999998664689999999999999999999999999998888888888777766554431110 0000001111
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
..............+..+.++|++||+.+|.+|||+++++.||||++....+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~ 299 (330)
T cd07834 248 KKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299 (330)
T ss_pred cCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence 2222223334455789999999999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=305.93 Aligned_cols=267 Identities=21% Similarity=0.389 Sum_probs=199.2
Q ss_pred CCcceEEEEEec--CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDK--KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|... .+++.|++|.+... ....+|+.+++.+. ||||+++++.+......+++||++.+++++.
T Consensus 103 G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~ 175 (392)
T PHA03207 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTIS-HRAIINLIHAYRWKSTVCMVMPKYKCDLFTY 175 (392)
T ss_pred CCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcC-CCCccceeeeEeeCCEEEEEehhcCCCHHHH
Confidence 899999999764 35678999987643 22346889999884 9999999999999999999999999888877
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---CCCccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWY 154 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~---~~~~~~~~~~ 154 (282)
+.. ...+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++........ .....+++.|
T Consensus 176 l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y 253 (392)
T PHA03207 176 VDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253 (392)
T ss_pred HHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCc
Confidence 632 247999999999999999999999999999999999999985 7999999999876543322 1245689999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHHhCCCCCCCcccccc--cccc-CCcccc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS---ADQIYKICQVIGSPTEDSWPLGIQ--LASN-LDWKFP 228 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~ 228 (282)
+|||.+... .++.++|||||||++|+|++|+.||.+... ...+..+....+..... ++.... .... ......
T Consensus 254 ~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 331 (392)
T PHA03207 254 NSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE-FPQNGSTNLCKHFKQYAIV 331 (392)
T ss_pred cCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc-cCCccchhHHHHHHhhccc
Confidence 999998744 489999999999999999999999976543 44455555554433221 111000 0000 000000
Q ss_pred CCCCCcccc--cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 229 QMGGVNLRE--LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 229 ~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
.......+. ....++..+.++|++||+.||.+|||+.++|+||||+...+
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 332 LRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred ccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 000000111 11245778999999999999999999999999999987554
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=294.54 Aligned_cols=271 Identities=35% Similarity=0.626 Sum_probs=213.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeecccccc--------CCcEEEEEecC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKE--------HEDVFIVFEYM 71 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--------~~~~~lv~e~~ 71 (282)
|+||.||+|.++.+++.+++|++....... ......+|+..++++ +||||+++++++.+ ....++++||+
T Consensus 19 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~ 97 (311)
T cd07866 19 GTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM 97 (311)
T ss_pred CCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccccCceEEEEEecC
Confidence 789999999999999999999986543222 223456788989888 49999999998743 33579999999
Q ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC-----
Q 044127 72 ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC----- 145 (282)
Q Consensus 72 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~----- 145 (282)
.+++...+... ...+++..+..++.|+++||.+||++|++|+||+|+||++++ +.++|+|||++.........
T Consensus 98 ~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 176 (311)
T cd07866 98 DHDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176 (311)
T ss_pred CcCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCC
Confidence 98877666543 347999999999999999999999999999999999999985 79999999998765332211
Q ss_pred -------CCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccc
Q 044127 146 -------TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQ 218 (282)
Q Consensus 146 -------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (282)
....+++.|+|||.+.+...++.++||||||+++|+|++|..||...+..+....+....+.+.+..++....
T Consensus 177 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T cd07866 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRS 256 (311)
T ss_pred cccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhh
Confidence 1234577899999987655678999999999999999999999999888888888888877777666655444
Q ss_pred ccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 219 LASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
................+........+.+.++|++||+.||.+|||+.+++.||||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 257 LPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred cccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 3333222222222222233334566889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=287.06 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=202.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|++|.||+|++..+++.|++|++...... .....+.+|+..++.+ +||||+++++.+.++...++++||+.++.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 82 (262)
T cd05572 4 GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGELWT 82 (262)
T ss_pred CCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCcHHH
Confidence 78999999999999999999998765432 3345677888888888 59999999999999999999999999877776
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++... ..+++..+..++.||+.||.+||++|++|+||+|+||++++ +.++|+|||.+.............++..|+||
T Consensus 83 ~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~P 161 (262)
T cd05572 83 ILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAP 161 (262)
T ss_pred HHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccCh
Confidence 66654 36899999999999999999999999999999999999975 79999999998876554333445678889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCC--ChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKN--SADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|.+.... ++.++|+||||+++|++++|..||.... .......+.... ..
T Consensus 162 E~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~ 212 (262)
T cd05572 162 EIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN----------------------------GK 212 (262)
T ss_pred hHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC----------------------------CC
Confidence 9987444 7899999999999999999999998766 222222221100 01
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccC
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHF 278 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~ 278 (282)
...+...++.+.++|.+||+.+|++||+ ++|+++||||++..+
T Consensus 213 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 213 LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 1223345789999999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=288.66 Aligned_cols=244 Identities=25% Similarity=0.442 Sum_probs=202.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|++..+++.|++|++...........+.+|+.+++.+. |||++++++.+.++...++++|++.++.+..+.
T Consensus 12 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 90 (274)
T cd06609 12 GSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL 90 (274)
T ss_pred CCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHH
Confidence 7899999999999999999999976654445566778999999885 999999999999999999999999987777666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
... ++++..++.++.|++.||.+||+.+++|+||+|+||++++ +.++|+|||.+....... ......++..|+|||
T Consensus 91 ~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE 168 (274)
T cd06609 91 KPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPE 168 (274)
T ss_pred hhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChh
Confidence 653 7999999999999999999999999999999999999985 799999999988765442 223456778899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+.. ++.++|+||||+++|++++|..||...+.......+.... ....
T Consensus 169 ~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~ 218 (274)
T cd06609 169 VIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-----------------------------PPSL 218 (274)
T ss_pred hhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-----------------------------CCCC
Confidence 987555 8999999999999999999999998766444333222110 0011
Q ss_pred CCC-CChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 239 SPS-ASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 239 ~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
... ++..+.+++.+||..||++|||++++++||||++..
T Consensus 219 ~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 112 678899999999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=288.09 Aligned_cols=249 Identities=24% Similarity=0.421 Sum_probs=203.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhC--CCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN--NHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~--~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|.+..+++.|++|.++..........+.+|+..++++. .|||++++++++.++...+++|||+.++.+..
T Consensus 12 g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (277)
T cd06917 12 GAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT 91 (277)
T ss_pred cCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHH
Confidence 7899999999999999999999876554555566778888888885 59999999999999999999999999887777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~a 156 (282)
+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+........ .....++..|+|
T Consensus 92 ~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~a 169 (277)
T cd06917 92 LMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMA 169 (277)
T ss_pred HHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeC
Confidence 7655 37999999999999999999999999999999999999985 8999999999887644322 233467888999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+..+..++.++|+||||+++|+|++|..||.............. . ...
T Consensus 170 PE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~----~-------------------------~~~ 220 (277)
T cd06917 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK----S-------------------------KPP 220 (277)
T ss_pred HHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc----C-------------------------CCC
Confidence 99987666678999999999999999999999976554332221100 0 000
Q ss_pred ccCC-CCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 237 ELSP-SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 237 ~~~~-~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
.+.. ..+..+.+++.+||+.||++||++.+++.|+||++....+
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~~ 265 (277)
T cd06917 221 RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTP 265 (277)
T ss_pred CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccCc
Confidence 1111 2678899999999999999999999999999998866543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=306.01 Aligned_cols=263 Identities=26% Similarity=0.363 Sum_probs=193.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.+..+++.|++|.... ....+|+.+++++. ||||+++++++..++..+++||++.++++..+.
T Consensus 180 G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~lv~e~~~~~L~~~l~ 251 (461)
T PHA03211 180 GSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLG 251 (461)
T ss_pred CCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEEEEccCCCHHHHHH
Confidence 7999999999999999999996432 23457899999994 999999999999999999999999988877765
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---CCCccccccccC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~a 156 (282)
... ..+++..+..++.||+.||.|||++||+|+||||+||+++. +.++|+|||++........ .....|++.|+|
T Consensus 252 ~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~A 330 (461)
T PHA03211 252 ARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNA 330 (461)
T ss_pred hcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcC
Confidence 543 46999999999999999999999999999999999999985 7899999999876533211 123468999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCC-CCCC------ChHHHHHHHHHhCCCCCCCcccccc--cccc-C---
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILF-PGKN------SADQIYKICQVIGSPTEDSWPLGIQ--LASN-L--- 223 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~-~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~--- 223 (282)
||.+.+.. ++.++|||||||++|||++|..++ .... ....+.++....+.... .++.... .... .
T Consensus 331 PE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~-~~~~~~~~~l~~~~~~~~ 408 (461)
T PHA03211 331 PEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD-EFPQHAGSRLVSQYRHRA 408 (461)
T ss_pred HHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc-cCCCCcchHHHHHHHhhh
Confidence 99997544 899999999999999999987654 2221 12334444443322211 1110000 0000 0
Q ss_pred -CccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 224 -DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
.............. ....+..+.+||++||+.||.+|||+.|+|+||||++
T Consensus 409 ~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 409 ARNRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hcccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00000000000111 1145678999999999999999999999999999975
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=289.14 Aligned_cols=250 Identities=29% Similarity=0.395 Sum_probs=201.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.+..+|+.|++|.+...... .....+..|+.+++++. |||++++++.+...+..|+||||+.++.+..
T Consensus 4 g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 82 (277)
T cd05577 4 GGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGDLKY 82 (277)
T ss_pred CCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCcHHH
Confidence 89999999999999999999998754322 22344567999999995 9999999999999999999999999776665
Q ss_pred HHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 79 MKERA-GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~-~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
.+... ...+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+.............++..|+|
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~ 162 (277)
T cd05577 83 HIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMA 162 (277)
T ss_pred HHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCC
Confidence 55443 346999999999999999999999999999999999999985 7899999998876654433344567788999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++|+||||+++|+|++|..||...........+..... ....
T Consensus 163 PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------------~~~~ 215 (277)
T cd05577 163 PEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL--------------------------EMAV 215 (277)
T ss_pred HHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc--------------------------cccc
Confidence 99987555 88999999999999999999999976654222222111100 0011
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
..+...++.+.++|.+||+.||.+|| ++.++++||||++..+
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 23445689999999999999999999 8899999999988765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=285.01 Aligned_cols=241 Identities=26% Similarity=0.472 Sum_probs=198.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|++..+++.|++|.+..... ...+.+|+..++++ +|||++++++.+.+....++++|+++++.+..++
T Consensus 14 g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l 89 (256)
T cd06612 14 GSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM 89 (256)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHH
Confidence 7899999999998899999999876432 56677899999988 6999999999999999999999999988888877
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
...+..+++..+..++.|++.||.+||+.+++|+||+|+||++++ +.++|+|||++....... ......++..|+|||
T Consensus 90 ~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE 169 (256)
T cd06612 90 KITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE 169 (256)
T ss_pred HhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHH
Confidence 765668999999999999999999999999999999999999975 789999999988765433 223345678899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+. .++.++||||||+++|+|++|..||............... . ......
T Consensus 170 ~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~----~-----------------------~~~~~~ 221 (256)
T cd06612 170 VIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK----P-----------------------PPTLSD 221 (256)
T ss_pred HHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC----C-----------------------CCCCCc
Confidence 98755 4789999999999999999999999865544332211100 0 000112
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
+..++..+.++|.+||+.||++|||++++|.||||
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 23467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=297.05 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=198.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+++++.+++.||+|++...... .....+..|..++..+ +||+|+.+++.+.+++..|+||||+.|+.+..
T Consensus 12 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~ 90 (331)
T cd05624 12 GAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLVMDYYVGGDLLT 90 (331)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHH
Confidence 89999999999999999999998753221 1223345566666666 69999999999999999999999999887777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC--CCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~ 155 (282)
++......+++..+..++.|++.||++||++|++|+||||+||+++. +.++|+|||++......... ....|++.|+
T Consensus 91 ~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~ 170 (331)
T cd05624 91 LLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYI 170 (331)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccC
Confidence 77665557999999999999999999999999999999999999975 78999999998765433221 2346899999
Q ss_pred Cchhhhcc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 156 APEVLLLS----EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 156 aPE~~~~~----~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
|||.+.+. ..++.++|+|||||++|+|++|+.||...+..+....+.......
T Consensus 171 aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------- 227 (331)
T cd05624 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF----------------------- 227 (331)
T ss_pred CHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc-----------------------
Confidence 99998642 346889999999999999999999998776665554443211000
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCC--CCCHHHHhcCcccccccC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHM--RPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~~~~~~~~~ 278 (282)
..+.....+++.++++|++||..++.+ |++++++++|+||+++.+
T Consensus 228 --~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 228 --QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred --cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence 011112346889999999999876654 568999999999987643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=288.68 Aligned_cols=269 Identities=36% Similarity=0.702 Sum_probs=209.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhC--CCCCeeeeccccccCCc-----EEEEEecCC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMN--NHPNIVKLRNLVKEHED-----VFIVFEYME 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~--~hp~i~~~~~~~~~~~~-----~~lv~e~~~ 72 (282)
|++|.||+|.++.+++.|++|++....... ......+|+..+.++. +|||++++++++..... .+++||++.
T Consensus 10 g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~ 89 (287)
T cd07838 10 GAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD 89 (287)
T ss_pred cCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc
Confidence 789999999999889999999997543322 2234456777666664 59999999999987766 999999999
Q ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccc
Q 044127 73 SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 73 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
+++.+.+.......+++..++.++.|++.||.+||+.+++|+||+|+||++++ +.++|+|||.+.............++
T Consensus 90 ~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 169 (287)
T cd07838 90 QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVT 169 (287)
T ss_pred cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCccccccccc
Confidence 87666554443346999999999999999999999999999999999999985 78999999998877555444455678
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
..|+|||.+.+.. .+.++|+|||||++|+|++|..||......+....+.+....+....++....... ..+....
T Consensus 170 ~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 245 (287)
T cd07838 170 LWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR---SSFPSYT 245 (287)
T ss_pred ccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch---hhccccc
Confidence 8899999987544 78999999999999999999999998888888887777665544433332211100 0111111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
...........+..+.++|++||+.||++||++++++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 246 PRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 122233334567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=289.40 Aligned_cols=249 Identities=25% Similarity=0.475 Sum_probs=201.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.+..++..|++|.+...........+.+|+..+.++ +||||+++++.+..++..+++|||+.++.+..++
T Consensus 12 g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 90 (286)
T cd06622 12 GNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLY 90 (286)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEEEeecCCCCHHHHH
Confidence 889999999999999999999887644344456778899999998 5999999999999999999999999988777776
Q ss_pred Hhc--CCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 81 ERA--GQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~~--~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++. +.++|+|||.+........ ....+++.|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~a 169 (286)
T cd06622 91 AGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-KTNIGCQSYMA 169 (286)
T ss_pred HhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-ccCCCccCccC
Confidence 653 2369999999999999999999997 59999999999999985 7899999999876543322 33457788999
Q ss_pred chhhhccc-----cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 157 PEVLLLSE-----IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 157 PE~~~~~~-----~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
||.+.+.. .++.++|+|||||++|++++|..||...................
T Consensus 170 PE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------- 226 (286)
T cd06622 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD----------------------- 226 (286)
T ss_pred cchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-----------------------
Confidence 99985433 25789999999999999999999997655444333322211111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
....+..++.++.++|.+||+.+|++||+++++++||||....
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 227 ---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred ---CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 1123345789999999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=286.95 Aligned_cols=243 Identities=24% Similarity=0.456 Sum_probs=193.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc------CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE------HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~------~~~~~lv~e~~~~~ 74 (282)
|+||.||+|.+..+++.|++|++.... ........|+..+.++.+|||++++++.+.. ....+++|||++++
T Consensus 17 g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~ 94 (272)
T cd06637 17 GTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAG 94 (272)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCC
Confidence 789999999999999999999987543 3344567788888888779999999999864 24689999999986
Q ss_pred HHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCcccc
Q 044127 75 LLKLMKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTT 151 (282)
Q Consensus 75 ~l~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~ 151 (282)
.+..++.. ....+++..+..++.|++.||+|||+.+++|+||+|+||++++ +.++|+|||++....... ......++
T Consensus 95 ~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~ 174 (272)
T cd06637 95 SVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 174 (272)
T ss_pred cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCccccc
Confidence 66666554 3346899999999999999999999999999999999999985 789999999987654321 22345678
Q ss_pred ccccCchhhhc----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 152 RWYRAPEVLLL----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 152 ~~~~aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
..|+|||.+.+ ...++.++|+||+||++|+|++|..||.............. ..
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~------------------- 232 (272)
T cd06637 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NP------------------- 232 (272)
T ss_pred ccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---CC-------------------
Confidence 88999999853 22478899999999999999999999976554333322111 00
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.........+..+.+|+.+||+.||.+|||+++++.||||
T Consensus 233 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 ------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0001123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=290.25 Aligned_cols=244 Identities=30% Similarity=0.455 Sum_probs=202.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|++|.||+|.+..+++.|++|++...... .......+|+..++++. ||||+++++++.++...+++|||+.++.+..
T Consensus 12 g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 90 (290)
T cd05580 12 GSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLVMEYVPGGELFS 90 (290)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEEEecCCCCCHHH
Confidence 78999999999999999999998754322 23455678999999995 9999999999999999999999997666665
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++... ..+++..+..++.||+.||.+||+.|++|+||+|+||++++ +.++|+|||++...... .....+++.|+||
T Consensus 91 ~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aP 167 (290)
T cd05580 91 HLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAP 167 (290)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCCCCCccccCh
Confidence 55554 47999999999999999999999999999999999999974 79999999998876544 2445678899999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+... ..+.++|+||||+++|+|++|..||...........+.... ..
T Consensus 168 E~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------------------~~ 216 (290)
T cd05580 168 EIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK------------------------------VR 216 (290)
T ss_pred hhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------------------------cc
Confidence 998754 47899999999999999999999998776444343332110 12
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccCc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHFV 279 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~~ 279 (282)
++...+..++++|++||..||.+|+ +++++++||||+...+.
T Consensus 217 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 217 FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 2345688999999999999999999 99999999999988754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=305.93 Aligned_cols=248 Identities=27% Similarity=0.487 Sum_probs=215.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|..+.++-..|.|++.... .....+++-|+.++.... ||+|+++++.|..++.+||+.|+|+|+-.+.++
T Consensus 43 GAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkLwiliEFC~GGAVDaim 120 (1187)
T KOG0579|consen 43 GAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKLWILIEFCGGGAVDAIM 120 (1187)
T ss_pred ccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCceEEEEeecCCchHhHHH
Confidence 899999999999999988999886543 556778899999999995 999999999999889999999999999999998
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCccccc-CCCCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~aPE 158 (282)
-..+..|.+.+|.-+++|++.||.|||+++|+|+|||..|||+. +|.++|.|||.+... ..........|||.|+|||
T Consensus 121 lEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPE 200 (1187)
T KOG0579|consen 121 LELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPE 200 (1187)
T ss_pred HHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccch
Confidence 88888999999999999999999999999999999999999998 799999999987654 2333346789999999999
Q ss_pred hhhc----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 159 VLLL----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 159 ~~~~----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+..+ ..+|+.++||||||++|.||..+.+|-...+++..+-.+..- .+.
T Consensus 201 VvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---------------------------ePP 253 (1187)
T KOG0579|consen 201 VVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---------------------------EPP 253 (1187)
T ss_pred heeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---------------------------CCC
Confidence 9854 456899999999999999999999998888887776665431 111
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
-...+...+..+.+|+.+||..||..||++.+||.||||.++.
T Consensus 254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 1233456788999999999999999999999999999998764
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=274.07 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=210.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|.-|+|++++.+.+|..+|||...+....++...++..+.++..-..+|.||+++|+|..+...+|.||.|+.- .+.++
T Consensus 103 GtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C-~ekLl 181 (391)
T KOG0983|consen 103 GTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTC-AEKLL 181 (391)
T ss_pred CCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHH-HHHHH
Confidence 67799999999999999999999988877788888889998888777999999999999999999999988643 34444
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
.+..++++|..+..+...++.||.||..+ |++|||+||+|||+|+ |.+||||||.+..+-.+.-.....|.+.|+|||
T Consensus 182 krik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPE 261 (391)
T KOG0983|consen 182 KRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPE 261 (391)
T ss_pred HHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCcc
Confidence 44446899999999999999999999975 6999999999999996 999999999999887777778889999999999
Q ss_pred hhhc--cccCCCcchhHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 159 VLLL--SEIYGPEVDMWAMGAIMFEMLSFRILFPGKN-SADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 159 ~~~~--~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
.+.- ...|+.++||||||+.++||.||+.||.+.+ +.+.+..+.+.. .| .
T Consensus 262 Ridp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e-PP--------------------------~ 314 (391)
T KOG0983|consen 262 RIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE-PP--------------------------L 314 (391)
T ss_pred ccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC-CC--------------------------C
Confidence 9853 2347899999999999999999999998754 455555554411 11 1
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.....++++.+++|+..||+.|+.+||...++|+|||++.+.
T Consensus 315 L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 315 LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 122234799999999999999999999999999999987654
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=307.94 Aligned_cols=252 Identities=28% Similarity=0.407 Sum_probs=207.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|.||+||.|+++.|...+|||.+.... +....-...|+..-+++ .|.|||+++|.+.++++.-|+||-.+|+++..++
T Consensus 586 GTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~L-rHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLL 663 (1226)
T KOG4279|consen 586 GTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTL-RHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLL 663 (1226)
T ss_pred CceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHH-hhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHH
Confidence 889999999999999999999987543 22223334466666666 5999999999999999999999999998888887
Q ss_pred HhcCCCC--CHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCC-CCCcccccccc
Q 044127 81 ERAGQNF--SEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYR 155 (282)
Q Consensus 81 ~~~~~~l--~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~ 155 (282)
...=+++ .+.++..+.+||++||+|||++.|||||||-+||+++. |.+|++|||-+..+..-.+ ....-||..|+
T Consensus 664 rskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYM 743 (1226)
T KOG4279|consen 664 RSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM 743 (1226)
T ss_pred HhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhh
Confidence 7654577 89999999999999999999999999999999999985 8999999998887754433 34668999999
Q ss_pred Cchhhhc-cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 156 APEVLLL-SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 156 aPE~~~~-~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
|||++.. .+.|+.++|||||||++.||.||++||-.........=.+.....
T Consensus 744 APEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKv--------------------------- 796 (1226)
T KOG4279|consen 744 APEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKV--------------------------- 796 (1226)
T ss_pred ChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceec---------------------------
Confidence 9999953 455899999999999999999999999877655544322221110
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCccC
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPR 281 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~ 281 (282)
-+.++..++.+++.||.+|+.+||.+||++.++|.+||++.-...|+
T Consensus 797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r 843 (1226)
T KOG4279|consen 797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPR 843 (1226)
T ss_pred CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCC
Confidence 13566788999999999999999999999999999999987654443
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=293.41 Aligned_cols=248 Identities=32% Similarity=0.486 Sum_probs=201.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|++|+||+|.+..+++.|++|.+....... ....+..|+..+..+. ||||+++++.+.+....+++|||+.++.+..
T Consensus 12 g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 90 (316)
T cd05574 12 GDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLVMDYCPGGELFR 90 (316)
T ss_pred CccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEEEEecCCCCHHH
Confidence 789999999999999999999998754442 4455678888888885 9999999999999999999999998766666
Q ss_pred HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC------------
Q 044127 79 MKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP------------ 144 (282)
Q Consensus 79 ~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~------------ 144 (282)
++.. .+..+++..+..++.|++.||.|||+.|++|+||||+||+++ ++.++|+|||++........
T Consensus 91 ~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 170 (316)
T cd05574 91 LLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170 (316)
T ss_pred HHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccccccccccccc
Confidence 6554 345799999999999999999999999999999999999998 47999999998775432211
Q ss_pred ------------------CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhC
Q 044127 145 ------------------CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIG 206 (282)
Q Consensus 145 ------------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~ 206 (282)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~ 249 (316)
T cd05574 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEV 249 (316)
T ss_pred ccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCc
Confidence 11235678899999987544 78999999999999999999999987776655544332100
Q ss_pred CCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCC----HHHHhcCcccccccC
Q 044127 207 SPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPT----AAEALEHPFFRSCHF 278 (282)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~~~~~~~~~~ 278 (282)
. + ......+..+.++|.+||+.||++||| ++++++||||++..+
T Consensus 250 ~-----~-----------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~ 297 (316)
T cd05574 250 T-----F-----------------------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNW 297 (316)
T ss_pred c-----C-----------------------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCCh
Confidence 0 0 001126889999999999999999999 999999999998753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=301.83 Aligned_cols=248 Identities=30% Similarity=0.446 Sum_probs=215.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|-||+||-|+++.+|+.||||++++-.+. ..+.+..+|+.+++.+ .||+||.+--.|+..+..++|||-+.|..|+.+
T Consensus 575 GQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMI 653 (888)
T KOG4236|consen 575 GQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPERVFVVMEKLHGDMLEMI 653 (888)
T ss_pred CcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCceEEEEehhhcchHHHHH
Confidence 78999999999999999999999886664 3456667899999999 599999999999999999999999999999999
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCCCCCcccccccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 155 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 155 (282)
+..-..+|++...+-++.||+.||.|||.++|+|+||||+|||+.. .++||||||+|+.+++..-.....|||.|+
T Consensus 654 LSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYL 733 (888)
T KOG4236|consen 654 LSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYL 733 (888)
T ss_pred HHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCcccc
Confidence 8877778999999999999999999999999999999999999964 489999999999999888778899999999
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||++...+ ++..-|+||+|+++|.-++|..||+... ++-.++.+.....+
T Consensus 734 aPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyP-------------------------- 784 (888)
T KOG4236|consen 734 APEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYP-------------------------- 784 (888)
T ss_pred CHHHHhhcc-ccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccC--------------------------
Confidence 999998555 8999999999999999999999997543 22222222111111
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
+.-++.+++...+||+.+|+..-.+|.|++.-|.|||+++..+
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~ 827 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQT 827 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchH
Confidence 2334578999999999999999999999999999999998753
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=291.69 Aligned_cols=248 Identities=25% Similarity=0.474 Sum_probs=200.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|.+..+++.|++|.+..... .....+..|+..++.+ +|||++++++.+..+...++||||++++++..+.
T Consensus 30 g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 107 (297)
T cd06656 30 GASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV 107 (297)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEEEeecccCCCCHHHHH
Confidence 7899999999999999999999875442 2344567788888887 5999999999999999999999999987777766
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE 158 (282)
.. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++. +.++++|||.+........ .....+++.|+|||
T Consensus 108 ~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE 185 (297)
T cd06656 108 TE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185 (297)
T ss_pred Hh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHH
Confidence 54 36899999999999999999999999999999999999974 7899999999876543322 23346788899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+.. ++.++|+|||||++|++++|..||...+.......... ........
T Consensus 186 ~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~---------------------------~~~~~~~~ 237 (297)
T cd06656 186 VVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---------------------------NGTPELQN 237 (297)
T ss_pred HHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc---------------------------CCCCCCCC
Confidence 987544 78999999999999999999999976554332211100 00001112
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
+...+..+.+++.+||+.||++||++++++.||||+.....+
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 345678899999999999999999999999999998876654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=287.89 Aligned_cols=245 Identities=25% Similarity=0.417 Sum_probs=196.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|++..+++.|++|++...........+.+|+.++.++ +|||++++++.+...+..+++|||+.++++...
T Consensus 12 g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~- 89 (279)
T cd06619 12 GNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICTEFMDGGSLDVY- 89 (279)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEEecCCCCChHHh-
Confidence 789999999999999999999987654444455677899999888 599999999999999999999999998877543
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCchh
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 159 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~ 159 (282)
..+++..+..++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||++....... .....++..|+|||.
T Consensus 90 ----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~ 164 (279)
T cd06619 90 ----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-AKTYVGTNAYMAPER 164 (279)
T ss_pred ----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-ccCCCCChhhcCcee
Confidence 25789999999999999999999999999999999999975 899999999987654332 234578889999999
Q ss_pred hhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 160 LLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQI---YKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 160 ~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
+.+.. ++.++|+||||+++|+|++|..||......... ............. .
T Consensus 165 ~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~ 219 (279)
T cd06619 165 ISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP------------------------V 219 (279)
T ss_pred ecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC------------------------C
Confidence 87554 799999999999999999999999653321110 0111111000000 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
......++.+.+++.+||+.||.+||++++++.||||+...
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 01224678899999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=296.91 Aligned_cols=272 Identities=33% Similarity=0.575 Sum_probs=202.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC--------------CcEEE
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--------------EDVFI 66 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--------------~~~~l 66 (282)
|+||.||+|++..+++.|++|++..... .......+|+.+++++ +||||+++++.+... ...++
T Consensus 16 g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 93 (342)
T cd07854 16 GSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYI 93 (342)
T ss_pred CCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhc-CCCcchhhHhhhcccccccccccccccccceEEE
Confidence 7899999999999999999999866543 3445567899999998 599999999876543 35799
Q ss_pred EEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCC
Q 044127 67 VFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLP 144 (282)
Q Consensus 67 v~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~ 144 (282)
++||+++++.+.+. . ..+++..++.++.||++||.+||+.|++|+||||+||+++. +.++++|||.+........
T Consensus 94 v~e~~~~~L~~~~~-~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~ 170 (342)
T cd07854 94 VQEYMETDLANVLE-Q--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170 (342)
T ss_pred EeecccccHHHHHH-c--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccc
Confidence 99999976554443 2 36999999999999999999999999999999999999973 5799999999876532211
Q ss_pred ----CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccc
Q 044127 145 ----CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA 220 (282)
Q Consensus 145 ----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
.....++..|+|||.+.....++.++|||||||++|+|++|+.||......+........................
T Consensus 171 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (342)
T cd07854 171 HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVI 250 (342)
T ss_pred cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhh
Confidence 1233567789999988655668899999999999999999999998877766655554433222211111000000
Q ss_pred ccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 221 SNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
......................+.++.+||++||+.||.+|||+++++.||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 251 PSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred hhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 000000001111112233456788999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=291.26 Aligned_cols=245 Identities=28% Similarity=0.508 Sum_probs=199.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||++.+..++..|++|.+.... ......+.+|+..++.+ +|||++++++.+..++..+++|||++++++..++
T Consensus 33 g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 110 (292)
T cd06658 33 GSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV 110 (292)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHH
Confidence 789999999999999999999986543 33445567888888888 5999999999999999999999999988887776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE 158 (282)
.. ..+++..+..++.||+.||.+||++|++|+||+|+||++++ +.++|+|||++........ .....++..|+|||
T Consensus 111 ~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 188 (292)
T cd06658 111 TH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE 188 (292)
T ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHH
Confidence 54 36899999999999999999999999999999999999985 7999999998875533221 23346788899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+. .++.++|+||||+++|++++|..||...........+........ ..
T Consensus 189 ~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~ 240 (292)
T cd06658 189 VISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV---------------------------KD 240 (292)
T ss_pred HHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc---------------------------cc
Confidence 98644 478999999999999999999999987666554443322111000 01
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
....+..+.+++++||..||.+|||++++++||||+...
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 124578899999999999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=297.15 Aligned_cols=275 Identities=40% Similarity=0.688 Sum_probs=211.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccc----cCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVK----EHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~----~~~~~~lv~e~~~~~~ 75 (282)
|++|.||+|.++.+++.|++|++...... .......+|+.+++++. ||||+++++++. .....++++||+.+++
T Consensus 16 g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l 94 (334)
T cd07855 16 GAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFKDVYVVMDLMESDL 94 (334)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCceEEEEEehhhhhH
Confidence 78999999999999999999998764322 23445567899999995 999999999875 3356899999998765
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-----CCCcc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-----CTDYV 149 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-----~~~~~ 149 (282)
.+.+.. . ..+++..++.++.||+.||.+||+.|++|+||||+||++++ +.++|+|||.+........ .....
T Consensus 95 ~~~~~~-~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 172 (334)
T cd07855 95 HHIIHS-D-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172 (334)
T ss_pred HHHhcc-C-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCccccccc
Confidence 554433 2 46999999999999999999999999999999999999985 7999999999876533221 12346
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccc-ccCCcccc
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA-SNLDWKFP 228 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 228 (282)
++..|+|||.+.....++.++|+||||+++|+|++|+.||...+.......+....+.+....+....... ......++
T Consensus 173 ~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 252 (334)
T cd07855 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLP 252 (334)
T ss_pred ccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcc
Confidence 78889999998755557999999999999999999999999888877777777777766544332111100 00000112
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
..............+..+.++|++||+.||.+|||+++++.||||++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 253 RKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred cCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 22222223344567899999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=282.39 Aligned_cols=242 Identities=26% Similarity=0.449 Sum_probs=199.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||+|.+..+++.|++|.+..... ......+..|+..++.+ +|||++++++.+.+.+..+++|||+.++.+..+
T Consensus 11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (256)
T cd08529 11 GSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVMEYAENGDLHKL 89 (256)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEEEeCCCCcHHHH
Confidence 7899999999999999999999875433 33455667899988888 499999999999999999999999987666666
Q ss_pred HHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccC
Q 044127 80 KERA-GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~~-~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~a 156 (282)
+... +..+++..++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||++........ .....+++.|+|
T Consensus 90 l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~a 169 (256)
T cd08529 90 LKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLS 169 (256)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccC
Confidence 5543 567999999999999999999999999999999999999985 8999999998876543322 223467888999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.... ++.++|+||||+++++|++|..||...+............ ..
T Consensus 170 PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~ 219 (256)
T cd08529 170 PELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-----------------------------FP 219 (256)
T ss_pred HHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------------------------CC
Confidence 99987544 7899999999999999999999998776544443332211 01
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
..+..++..+.+++++||+.+|++||++.+++.|||+
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 1223568899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=290.29 Aligned_cols=272 Identities=24% Similarity=0.358 Sum_probs=200.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||++.+..++..+++|.+...........+.+|+.++.++ +||||+++++.+..++..+++|||++++.+..++
T Consensus 12 G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l 90 (308)
T cd06615 12 GNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 90 (308)
T ss_pred CCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHH
Confidence 899999999999999999999987654334455677899999999 5999999999999999999999999987777776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
... ..+++..+..++.|+++||.|||+ .+++|+||+|+||++++ +.++|+|||.+....... .....++..|+|||
T Consensus 91 ~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE 168 (308)
T cd06615 91 KKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPE 168 (308)
T ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-cccCCCCcCccChh
Confidence 654 469999999999999999999998 58999999999999975 789999999887553322 23456788999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcc-------ccCCC
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK-------FPQMG 231 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~ 231 (282)
.+.+. .++.++|+||||+++|++++|..||...+................................. .....
T Consensus 169 ~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (308)
T cd06615 169 RLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIV 247 (308)
T ss_pred HhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHh
Confidence 98644 47899999999999999999999997665333222111110000000000000000000000 00000
Q ss_pred CCcccccC-CCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 232 GVNLRELS-PSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 232 ~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
....+..+ ..++.++.+|+.+||..||++|||+.++++||||.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 248 NEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00001111 1367889999999999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=284.42 Aligned_cols=244 Identities=27% Similarity=0.375 Sum_probs=194.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|++..++..|++|.+.... ......+.+|+.++.++. ||||+++++++..++..++++||+.++.+...+
T Consensus 19 g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 96 (268)
T cd06624 19 GTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL 96 (268)
T ss_pred CCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEecCCCCCHHHHH
Confidence 789999999999999999999886543 334456678889888884 999999999999999999999999987777766
Q ss_pred HhcCCCC--CHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCC-CCCcccccccc
Q 044127 81 ERAGQNF--SEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYR 155 (282)
Q Consensus 81 ~~~~~~l--~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~ 155 (282)
......+ ++..+..++.||+.||.+||++|++|+||+|+||+++. +.++|+|||.+........ .....+++.|+
T Consensus 97 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 176 (268)
T cd06624 97 RSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYM 176 (268)
T ss_pred HHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCcccc
Confidence 6543355 88999999999999999999999999999999999974 6899999999876533221 22345788899
Q ss_pred Cchhhhcc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 156 APEVLLLS-EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 156 aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
|||.+... ..++.++|+||||+++|+|++|..||................ ..
T Consensus 177 aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------------~~ 229 (268)
T cd06624 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF---------------------------KI 229 (268)
T ss_pred ChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh---------------------------cc
Confidence 99998643 236889999999999999999999997654322221110000 01
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
...++...++.+++++++||+.+|.+|||+.+++.||||
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 122345678899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=289.20 Aligned_cols=245 Identities=25% Similarity=0.487 Sum_probs=198.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|++..++..|++|.+...... ....+.+|+.+++.+ +|||++++++.+..+...++||||+.++++..++
T Consensus 31 g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 108 (296)
T cd06654 31 GASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV 108 (296)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHH
Confidence 78999999999999999999998765433 345567788888887 5999999999999999999999999987776666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE 158 (282)
.. ..++..++..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+........ .....+++.|+|||
T Consensus 109 ~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 186 (296)
T cd06654 109 TE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186 (296)
T ss_pred Hh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHH
Confidence 54 36899999999999999999999999999999999999975 7899999998876543221 23346788899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+.. .+.++|+|||||++|+|++|+.||............... ..+ ....
T Consensus 187 ~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~--------------------------~~~~ 238 (296)
T cd06654 187 VVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP--------------------------ELQN 238 (296)
T ss_pred HHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCC--------------------------CCCC
Confidence 987544 789999999999999999999999876554333221110 000 0112
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
+..++..+.+++.+||..||.+|||+.++++||||+...
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 335678899999999999999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=284.67 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=202.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|+||+|.+..++..+++|++...........+.+|+..++.+ +|||++++++.+......++++|++.++.+..++
T Consensus 12 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~ 90 (267)
T cd06610 12 GATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIM 90 (267)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHH
Confidence 789999999999899999999997665555666778899988888 5999999999999999999999999987777766
Q ss_pred Hhc-C-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC-----CCccccc
Q 044127 81 ERA-G-QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC-----TDYVTTR 152 (282)
Q Consensus 81 ~~~-~-~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~-----~~~~~~~ 152 (282)
... . ..+++..++.++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+......... ....++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~ 170 (267)
T cd06610 91 KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170 (267)
T ss_pred HHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCCh
Confidence 543 2 46899999999999999999999999999999999999985 78999999988766433221 3345788
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
.|+|||.+......+.++|+||||+++++|++|..||...+........... . +...
T Consensus 171 ~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~-~~~~------------------- 227 (267)
T cd06610 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---D-PPSL------------------- 227 (267)
T ss_pred hhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---C-CCCc-------------------
Confidence 8999999876646899999999999999999999999877665444433221 0 0000
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
........+++.+.+++++||+.||++|||+.+++.||||
T Consensus 228 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 228 -ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0000123568899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=295.14 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=190.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
||.+.||++.... ...|++|.+..... ......+..|+..|.++++|.+|+.++||=..++++|+|||+-+-.+-..+
T Consensus 372 GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL 450 (677)
T KOG0596|consen 372 GGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDIDLNKIL 450 (677)
T ss_pred CCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccccHHHHH
Confidence 8899999998654 44566776654443 345677899999999999999999999998889999999996666655554
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccccCCCCC---CCCccccccccC
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~a 156 (282)
.+. ....+.-.++.+..|++.|+.+.|+.||||.||||.|+++-.|++||+|||.|..+....+ ....+||+.|+|
T Consensus 451 ~k~-~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMs 529 (677)
T KOG0596|consen 451 KKK-KSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMS 529 (677)
T ss_pred Hhc-cCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEeeeechhcccCccccceeeccccCcccccC
Confidence 444 3455656999999999999999999999999999999999999999999999988765443 345689999999
Q ss_pred chhhhccc----------cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcc
Q 044127 157 PEVLLLSE----------IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226 (282)
Q Consensus 157 PE~~~~~~----------~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
||++.... ..+.++|||||||++|+|+.|+.||..... ...++.. +..|. ....
T Consensus 530 PEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~a-I~~P~-------------~~Ie 593 (677)
T KOG0596|consen 530 PEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHA-ITDPN-------------HEIE 593 (677)
T ss_pred HHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHh-hcCCC-------------cccc
Confidence 99995321 257899999999999999999999964321 1111111 11110 0011
Q ss_pred ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
|+ +++ -..++.++++.||..||++|||+.+||+|||+..
T Consensus 594 fp--------~~~--~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 594 FP--------DIP--ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred cc--------CCC--CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 11 111 1233999999999999999999999999999976
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=284.92 Aligned_cols=250 Identities=29% Similarity=0.405 Sum_probs=195.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHH--hCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRK--MNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~--~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||.||+|.+..+++.||+|.+...... ........|...++. ..+||+++.+++.+..++..++||||+.|+.+
T Consensus 5 g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L 84 (278)
T cd05606 5 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 84 (278)
T ss_pred CCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcH
Confidence 88999999999999999999998764322 112223333333322 23699999999999999999999999998877
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 155 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 155 (282)
...+... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++. +.++|+|||.+........ ....++..|+
T Consensus 85 ~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~y~ 162 (278)
T cd05606 85 HYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-HASVGTHGYM 162 (278)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-cCcCCCcCCc
Confidence 7766654 46999999999999999999999999999999999999974 7899999999876543322 3456888999
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||.+.++..++.++||||+|+++|+|++|..||............... .. ..
T Consensus 163 aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~--------------------------~~ 215 (278)
T cd05606 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LT--------------------------MA 215 (278)
T ss_pred CcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hc--------------------------cC
Confidence 9999875555789999999999999999999999876432221111000 00 01
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccCc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHFV 279 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~~ 279 (282)
...+...+..+.+++.+||..+|.+|| ++.++++||||++..+.
T Consensus 216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 123345689999999999999999999 99999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=286.50 Aligned_cols=243 Identities=24% Similarity=0.442 Sum_probs=192.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc------cCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK------EHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~------~~~~~~lv~e~~~~~ 74 (282)
|+||+||+|.+..+++.+++|++.... ........|+..+.++.+|||++++++++. .....+++|||++++
T Consensus 27 g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~ 104 (282)
T cd06636 27 GTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAG 104 (282)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCC
Confidence 789999999999999999999986542 334456778888888878999999999984 346789999999986
Q ss_pred HHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCcccc
Q 044127 75 LLKLMKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTT 151 (282)
Q Consensus 75 ~l~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~ 151 (282)
++..+... .+..+++..+..++.||+.||.|||+.|++|+||+|+||++++ +.++|+|||.+....... ......++
T Consensus 105 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 184 (282)
T cd06636 105 SVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 184 (282)
T ss_pred cHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCccccc
Confidence 66655544 3456899999999999999999999999999999999999985 789999999987654321 22345678
Q ss_pred ccccCchhhhc----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 152 RWYRAPEVLLL----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 152 ~~~~aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
+.|+|||.+.. ...++.++|+|||||++|+|++|..||....+.......... .
T Consensus 185 ~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~------------------- 242 (282)
T cd06636 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P------------------- 242 (282)
T ss_pred ccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---C-------------------
Confidence 88999998752 234678999999999999999999999765543333221110 0
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
........++..+.+||++||+.||.+|||+.+++.||||
T Consensus 243 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 243 ------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 0001123468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=292.83 Aligned_cols=272 Identities=36% Similarity=0.664 Sum_probs=204.5
Q ss_pred CCcceEEEEEecC--CCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKK--SGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~--~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~ 74 (282)
|++|.||+|.+.. ++..||+|.+..... ........+|+.++..+ +||||+++++++.+. ...++|||++.++
T Consensus 11 g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 89 (316)
T cd07842 11 GTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSVYLLFDYAEHD 89 (316)
T ss_pred CCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceEEEEEeCCCcC
Confidence 7899999999988 899999999886431 12234456788888888 499999999999887 8899999999988
Q ss_pred HHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-----CcEEEeecCcccccCCCCC--
Q 044127 75 LLKLMKERA---GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-----GVIKIGDLGMVKEIDSSLP-- 144 (282)
Q Consensus 75 ~l~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-----~~~~l~df~~~~~~~~~~~-- 144 (282)
++..+.... ...+++..++.++.||+.||.|||+.+++|+||+|+||+++. +.++|+|||++........
T Consensus 90 l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 169 (316)
T cd07842 90 LWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169 (316)
T ss_pred HHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccc
Confidence 777654322 236899999999999999999999999999999999999974 6899999999886543321
Q ss_pred --CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCCh---------HHHHHHHHHhCCCCCCCc
Q 044127 145 --CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSA---------DQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 145 --~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~ 213 (282)
.....++..|+|||.+.+...++.++|+||||+++++|++|..||...... .....++..++.+.+..+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 249 (316)
T cd07842 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDW 249 (316)
T ss_pred cccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHH
Confidence 223466788999999876666789999999999999999999999766543 244455555555544444
Q ss_pred cccccccccCCc-------cccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 214 PLGIQLASNLDW-------KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 214 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
+........... .++........+.....+..+.+++++||+.||++|||++++++||||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 250 PDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 322222111110 000000000011112678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=286.46 Aligned_cols=248 Identities=30% Similarity=0.496 Sum_probs=200.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|.++.+++.+++|.+...........+.+|+..++++. ||||+++++.+......++++|++.+..+..++
T Consensus 12 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 90 (265)
T cd06605 12 GNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL 90 (265)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEEEEecCCCcHHHHH
Confidence 7899999999999999999999877654555667788999999986 999999999999999999999999977777777
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
......+++..+..++.|++.||++||+ .|++|+||+|+||++++ +.++|+|||.+......... ...++..|+|||
T Consensus 91 ~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~y~~PE 169 (265)
T cd06605 91 KEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPE 169 (265)
T ss_pred HHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-cccCChhccCHH
Confidence 6654679999999999999999999999 99999999999999985 78999999988765432221 266788899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS-ADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
.+.+. .++.++|+||||+++|++++|..||..... .+............. ...
T Consensus 170 ~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~ 223 (265)
T cd06605 170 RIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-------------------------PPR 223 (265)
T ss_pred HHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-------------------------CCC
Confidence 98754 589999999999999999999999965421 111111111111000 001
Q ss_pred cCCC-CChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 238 LSPS-ASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 238 ~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.+.. ++..+.++|.+||..||++|||+.+++.||||+..
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 1122 68889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=284.21 Aligned_cols=241 Identities=31% Similarity=0.555 Sum_probs=196.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--------HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--------DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYME 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--------~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 72 (282)
|++|.||+|.+..+++.|++|.+....... ....+.+|+.++.++ +||||+++++++.+....++++||+.
T Consensus 11 g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06628 11 GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDADHLNIFLEYVP 89 (267)
T ss_pred CCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCccEEEEEecC
Confidence 789999999999899999999886543221 123456788888888 59999999999999999999999999
Q ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-------
Q 044127 73 SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP------- 144 (282)
Q Consensus 73 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~------- 144 (282)
++.+..++... ..+++..+..++.|++.||.+||++|++|+||+|+||++++ +.++|+|||.+........
T Consensus 90 ~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 168 (267)
T cd06628 90 GGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168 (267)
T ss_pred CCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCcccc
Confidence 87777777654 46899999999999999999999999999999999999975 7899999998876642211
Q ss_pred CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCC
Q 044127 145 CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224 (282)
Q Consensus 145 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
.....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||................
T Consensus 169 ~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------- 228 (267)
T cd06628 169 RPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA------------------- 228 (267)
T ss_pred ccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC-------------------
Confidence 11235678899999987544 7889999999999999999999998765544433322210
Q ss_pred ccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
....+...+..+.++|++||+.||.+||+++++++||||
T Consensus 229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 ----------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ----------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 112334578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=317.10 Aligned_cols=247 Identities=28% Similarity=0.461 Sum_probs=198.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeecccccc--CCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKE--HEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|++..++..|++|++...... .....+..|+.++.++. ||||++++++|.. ...+||||||+.++.|.
T Consensus 24 GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~ 102 (1021)
T PTZ00266 24 GRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKANQKLYILMEFCDAGDLS 102 (1021)
T ss_pred CCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecCCCEEEEEEeCCCCCcHH
Confidence 89999999999999999999998765433 34456778999999995 9999999998843 45789999999976665
Q ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc-------CccccCCCCCceeeeC------------------CcEE
Q 044127 78 LMKERA---GQNFSEDEVRNLCFQVFQGLHYMHRQ-------GYFHRDLKPSNLLVSK------------------GVIK 129 (282)
Q Consensus 78 ~~~~~~---~~~l~~~~~~~i~~qi~~~l~~Lh~~-------~~~H~dl~p~nili~~------------------~~~~ 129 (282)
.++... ...+++..++.|+.||+.||.|||+. +|+|+||||+|||++. ..++
T Consensus 103 ~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVK 182 (1021)
T PTZ00266 103 RNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182 (1021)
T ss_pred HHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceE
Confidence 554431 24699999999999999999999985 4999999999999953 2489
Q ss_pred EeecCcccccCCCCCCCCccccccccCchhhhcc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCC
Q 044127 130 IGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS-EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSP 208 (282)
Q Consensus 130 l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 208 (282)
|+|||++.............+++.|+|||++.+. ..++.++|||||||++|+|++|..||........+....... +
T Consensus 183 LsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~--p 260 (1021)
T PTZ00266 183 IGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG--P 260 (1021)
T ss_pred EccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC--C
Confidence 9999999876554444556789999999998643 347899999999999999999999998766554443332211 0
Q ss_pred CCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 209 TEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
. ......+..+.+||..||+.+|.+||++.++|.|+|++.+.
T Consensus 261 ~---------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 261 D---------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred C---------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 0 00124578899999999999999999999999999998664
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=282.91 Aligned_cols=237 Identities=24% Similarity=0.383 Sum_probs=188.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+++++.++..+++|.+........ |......+.+|||++++++.+..++..++||||++++.+..++
T Consensus 27 g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l 100 (267)
T PHA03390 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL 100 (267)
T ss_pred CCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHH
Confidence 7899999999999999999999875432211 2222222336999999999999999999999999877776666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C-cEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G-VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
.... .+++..+..++.||++||.+||+.|++|+||+|+||+++. + .++++|||.+...+.. ....++..|+|||
T Consensus 101 ~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE 176 (267)
T PHA03390 101 KKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPE 176 (267)
T ss_pred HhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccCCCCCcccChh
Confidence 6543 7999999999999999999999999999999999999985 4 7999999998766533 2346788899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQI-YKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
++.+.. ++.++|+||||+++|+|++|..||......... ........ ....
T Consensus 177 ~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~ 228 (267)
T PHA03390 177 KIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ---------------------------KKLP 228 (267)
T ss_pred hhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc---------------------------ccCC
Confidence 997544 789999999999999999999999855443321 11111110 0112
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCC-HHHHhcCccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPT-AAEALEHPFFRS 275 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll~~~~~~~ 275 (282)
.....++.+.+||.+||+.||.+||+ ++++|+||||++
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 229 FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred cccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 23367899999999999999999996 699999999974
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=284.26 Aligned_cols=247 Identities=32% Similarity=0.510 Sum_probs=202.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|.+..+++.+++|++...... ........|+..+.++. |||++++++.+..+...++++|++.++.+..
T Consensus 4 g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 82 (265)
T cd05579 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGDLAS 82 (265)
T ss_pred CCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCcHHH
Confidence 78999999999999999999998765332 33455677888888885 9999999999999999999999999877777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC---------CCCCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---------PCTDY 148 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~---------~~~~~ 148 (282)
++.+.+ .+++..+..++.||+.||.+||+.|++|+||+|+||++++ +.++|+|||++....... .....
T Consensus 83 ~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 161 (265)
T cd05579 83 LLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161 (265)
T ss_pred HHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCc
Confidence 776654 7999999999999999999999999999999999999985 799999999887543321 12334
Q ss_pred cccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 149 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
.++..|+|||...... .+.++|+||||+++|++++|..||......+........ ... ++
T Consensus 162 ~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---~~-------------- 221 (265)
T cd05579 162 VGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KIE---WP-------------- 221 (265)
T ss_pred ccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CcC---CC--------------
Confidence 5678899999987555 789999999999999999999999877765554433220 000 00
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCH---HHHhcCcccccccC
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTA---AEALEHPFFRSCHF 278 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~---~~ll~~~~~~~~~~ 278 (282)
.....+..+.+++++||+.+|++|||+ .++|+||||+++.|
T Consensus 222 ---------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 222 ---------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred ---------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 001248899999999999999999999 99999999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=281.39 Aligned_cols=242 Identities=26% Similarity=0.435 Sum_probs=200.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||+|.+..+++.+++|.+..... ......+..|+..++++. |||++++++.+...+..++|+|++.++.+..+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (256)
T cd08220 11 GAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVMEYAPGGTLAEY 89 (256)
T ss_pred cCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEEecCCCCCHHHH
Confidence 7899999999999999999999876533 234456678889998884 99999999999999999999999987666555
Q ss_pred HHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 80 KER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
+.. .+..+++..+..++.|++.||.+||++|++|+||+|+||++++ +.++|+|||.+.............++..|+|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~a 169 (256)
T cd08220 90 IQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYIS 169 (256)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccC
Confidence 543 3456899999999999999999999999999999999999974 4689999999987765554455677889999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+. ..+.++|+||||+++|+|++|..||...+............. .
T Consensus 170 PE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~ 219 (256)
T cd08220 170 PELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-----------------------------A 219 (256)
T ss_pred chhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-----------------------------C
Confidence 9998754 478999999999999999999999988766555444322111 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
..+...+..+.+++.+||+.+|++|||++++++||||
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 1233568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=290.08 Aligned_cols=276 Identities=20% Similarity=0.274 Sum_probs=201.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKI-FSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||.+++..+++.||+|++.... .......+..|+..+..+. ||||+++++.+.+....+++|||+.++++..+
T Consensus 11 ~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 11 EDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred cCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence 567889999989999999999987653 3345566778999999985 99999999999999999999999997777666
Q ss_pred HHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--------CCCcc
Q 044127 80 KER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--------CTDYV 149 (282)
Q Consensus 80 ~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--------~~~~~ 149 (282)
+.. .+..+++..+..++.|++.||.|||+++++|+||+|+||++++ +.++++||+.+........ .....
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 554 3456999999999999999999999999999999999999985 8999999998765432111 12334
Q ss_pred ccccccCchhhhcc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCC--CCCCccccccccccCC--
Q 044127 150 TTRWYRAPEVLLLS-EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSP--TEDSWPLGIQLASNLD-- 224 (282)
Q Consensus 150 ~~~~~~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-- 224 (282)
++..|+|||.+... ..++.++|+||+||++|+|++|..||................... .....+..........
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 56779999998643 347889999999999999999999998765544433222211000 0000000000000000
Q ss_pred ccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.................++..+.+|+.+||+.||++|||++++|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00000011111122334567899999999999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=283.07 Aligned_cols=244 Identities=26% Similarity=0.450 Sum_probs=193.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|++..+++.|++|+++... ........+|+..++.+ +||||+++++.+...+..++++||+.++.+..++
T Consensus 20 g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 97 (267)
T cd06645 20 GTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY 97 (267)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHH
Confidence 899999999999999999999987543 23334556788888888 5999999999999999999999999987777766
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
...+ .+++.+++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+....... ......++..|+|||
T Consensus 98 ~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 176 (267)
T cd06645 98 HVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPE 176 (267)
T ss_pred HhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChh
Confidence 6543 6999999999999999999999999999999999999984 789999999987553322 223456888999999
Q ss_pred hhh--ccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 159 VLL--LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 159 ~~~--~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
.+. ....++.++|+|||||++|+|++|..||................ ..+.. .
T Consensus 177 ~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~--~~~~~----------------------~- 231 (267)
T cd06645 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN--FQPPK----------------------L- 231 (267)
T ss_pred hhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC--CCCCc----------------------c-
Confidence 874 23347889999999999999999999987655443332221110 00000 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 272 (282)
.....++..+.++|.+||+.+|++|||+++++.|||
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 001245778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=283.54 Aligned_cols=243 Identities=26% Similarity=0.436 Sum_probs=201.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|.+..+++.|++|++...... .....+.+|+..++++ +||||+++++.+.++...++++||+.++.+..
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 89 (258)
T cd05578 11 GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRY 89 (258)
T ss_pred CCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEEeCCCCCCHHH
Confidence 78999999999999999999999765432 3445677889999988 59999999999999999999999999888877
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
.+... .++++..+..++.||++||.+||++|++|+||+|+||++++ +.++|+|||.+.............++..|+||
T Consensus 90 ~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~P 168 (258)
T cd05578 90 HLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAP 168 (258)
T ss_pred HHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCH
Confidence 77654 47999999999999999999999999999999999999985 79999999998876554444556778889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.... .+.++|+||||+++|++++|..||....... ...+...... ....
T Consensus 169 E~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~--------------------------~~~~ 220 (258)
T cd05578 169 EVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-RDQIRAKQET--------------------------ADVL 220 (258)
T ss_pred HHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccH-HHHHHHHhcc--------------------------cccc
Confidence 9987544 7999999999999999999999998776521 1111111110 0112
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCH--HHHhcCccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTA--AEALEHPFF 273 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~--~~ll~~~~~ 273 (282)
.+...+..+.++|++||+.||.+||++ +++++||||
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 334567999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=287.13 Aligned_cols=245 Identities=23% Similarity=0.408 Sum_probs=199.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.+..++..|++|.+...........+.+|+..+.++ +||||+++++.+..+...++|+||++++.+..++
T Consensus 15 g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 93 (277)
T cd06642 15 GSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL 93 (277)
T ss_pred CCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEEEEEccCCCcHHHHh
Confidence 789999999999999999999987655444555677899999888 4999999999999999999999999987777666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE 158 (282)
.. ..+++..+..++.|++.|+.+||++|++|+||+|+||++++ +.++++|||++........ .....++..|+|||
T Consensus 94 ~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 171 (277)
T cd06642 94 KP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171 (277)
T ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHH
Confidence 54 46899999999999999999999999999999999999975 7899999999876543221 12345678899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+.. ++.++|+||||+++|++++|..||...........+... .....
T Consensus 172 ~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-----------------------------~~~~~ 221 (277)
T cd06642 172 VIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN-----------------------------SPPTL 221 (277)
T ss_pred HhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC-----------------------------CCCCC
Confidence 987544 789999999999999999999998765443332211100 01122
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....+..+.+++.+||+.+|++||++.++++||||+....
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK 261 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence 3356788999999999999999999999999999986543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=304.48 Aligned_cols=244 Identities=28% Similarity=0.462 Sum_probs=196.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCC--------cEEEEEecC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE--------DVFIVFEYM 71 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--------~~~lv~e~~ 71 (282)
|+||+||+|++..+++.||+|++...... .......+|+..+..+ +|+|++++++.+.... ..++||||+
T Consensus 43 G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~ 121 (496)
T PTZ00283 43 GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNPENVLMIALVLDYA 121 (496)
T ss_pred CCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCcccceEEEEEEeCC
Confidence 89999999999999999999998765433 3344567788888887 5999999988764322 368999999
Q ss_pred CccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC---CC
Q 044127 72 ESDLLKLMKER---AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LP 144 (282)
Q Consensus 72 ~~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~---~~ 144 (282)
.++.+...+.. ....+++..+..++.|++.||.|||+.+++|+||||+||+++. +.++|+|||++...... ..
T Consensus 122 ~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 201 (496)
T PTZ00283 122 NAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201 (496)
T ss_pred CCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccc
Confidence 97666554432 2346999999999999999999999999999999999999985 79999999998765332 12
Q ss_pred CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCC
Q 044127 145 CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224 (282)
Q Consensus 145 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
.....|++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+..+..........
T Consensus 202 ~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~------------------ 262 (496)
T PTZ00283 202 GRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY------------------ 262 (496)
T ss_pred cccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC------------------
Confidence 23457899999999997544 89999999999999999999999987766555444322111
Q ss_pred ccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
...+...++.+.+++.+||+.||.+||++.++++|||++.
T Consensus 263 -----------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 263 -----------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred -----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 1234467889999999999999999999999999999875
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=284.56 Aligned_cols=245 Identities=24% Similarity=0.426 Sum_probs=200.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.+..++..|++|++...........+.+|+..+.++ +|||++++++.+.++...+++|||++++++..++
T Consensus 15 g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i 93 (277)
T cd06640 15 GSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL 93 (277)
T ss_pred CCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHH
Confidence 789999999999999999999987655445556677899989888 5999999999999999999999999987776666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
.. .++++..+..++.|++.||.+||+.+++|+||+|+||+++. +.++++|||.+....... ......++..|+|||
T Consensus 94 ~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE 171 (277)
T cd06640 94 RA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171 (277)
T ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHh
Confidence 54 46899999999999999999999999999999999999985 789999999987654322 122345677899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+.. .+.++|+||||+++|+|++|..||...........+... ..+..
T Consensus 172 ~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-----------------------------~~~~~ 221 (277)
T cd06640 172 VIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-----------------------------NPPTL 221 (277)
T ss_pred HhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-----------------------------CCCCC
Confidence 987544 799999999999999999999999876544433221000 01122
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....+..+.+++.+||+.+|++||++++++.|+||.....
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 3356788999999999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=284.72 Aligned_cols=245 Identities=25% Similarity=0.426 Sum_probs=192.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC-----CcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH-----EDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.+..+++.+++|++.... ........|+..++++.+|||++++++++... +..++++||+.+++
T Consensus 33 g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~s 110 (291)
T cd06639 33 GTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGS 110 (291)
T ss_pred CCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCc
Confidence 789999999999999999999986532 22344567888888887799999999998643 46899999998877
Q ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccc
Q 044127 76 LKLMKER---AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVT 150 (282)
Q Consensus 76 l~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~ 150 (282)
+..++.. .+..+++..++.++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+....... ......+
T Consensus 111 L~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 190 (291)
T cd06639 111 VTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 190 (291)
T ss_pred HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccC
Confidence 7665432 3457999999999999999999999999999999999999975 789999999987654322 1233467
Q ss_pred cccccCchhhhccc----cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcc
Q 044127 151 TRWYRAPEVLLLSE----IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226 (282)
Q Consensus 151 ~~~~~aPE~~~~~~----~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
+..|+|||.+.... .++.++|+|||||++|+|++|+.||...........+... ....
T Consensus 191 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~~--------------- 252 (291)
T cd06639 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPPT--------------- 252 (291)
T ss_pred CccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CCCC---------------
Confidence 88899999875432 2578999999999999999999999876554444332211 0000
Q ss_pred ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccc
Q 044127 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274 (282)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 274 (282)
...+...+..+.++|.+||+.+|++||++.++++||||+
T Consensus 253 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 ---------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ---------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 011224567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=287.31 Aligned_cols=246 Identities=28% Similarity=0.504 Sum_probs=200.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.+..+++.|++|++..... .....+.+|+..+..+ +|||++++++.+..+...++++||+.++++..+.
T Consensus 32 g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~ 109 (297)
T cd06659 32 GSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV 109 (297)
T ss_pred CCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEEEecCCCCCHHHHH
Confidence 7899999999998999999999865432 3345567888888888 5999999999999999999999999987777766
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE 158 (282)
.. ..+++..++.++.|++.||.+||++|++|+||+|+||+++. +.++|+|||++........ .....++..|+|||
T Consensus 110 ~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 187 (297)
T cd06659 110 SQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 187 (297)
T ss_pred hh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHH
Confidence 54 46899999999999999999999999999999999999984 7999999998875533221 23456788999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+.. ++.++|+|||||++|+|++|..||......+....+.. ... . ....
T Consensus 188 ~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~-~-----------------------~~~~ 239 (297)
T cd06659 188 VISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPP-P-----------------------KLKN 239 (297)
T ss_pred HHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCC-C-----------------------Cccc
Confidence 987544 78999999999999999999999987655444433211 000 0 0111
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....+..+.++|++||+.+|.+||+++++++||||.+...
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 2346788999999999999999999999999999987754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=281.97 Aligned_cols=245 Identities=28% Similarity=0.484 Sum_probs=199.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|.+..+++.+++|++...... ......+|+..++++ +|||++++++.+.+...++++|||++++.+..+.
T Consensus 14 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~ 91 (262)
T cd06613 14 GTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIY 91 (262)
T ss_pred CCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 78999999999999999999998765422 455677888988888 5999999999999999999999999998888777
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
......+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+....... ......++..|+|||
T Consensus 92 ~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe 171 (262)
T cd06613 92 QVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPE 171 (262)
T ss_pred HhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCch
Confidence 665457999999999999999999999999999999999999985 789999999987654332 223446778899999
Q ss_pred hhhcc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 159 VLLLS--EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 159 ~~~~~--~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
.+... ..++.++|+||||+++|+|++|..||..................+. ..
T Consensus 172 ~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~ 226 (262)
T cd06613 172 VAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP-------------------------KL 226 (262)
T ss_pred hhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-------------------------cc
Confidence 98644 2478899999999999999999999987765554443222100000 00
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 272 (282)
......+..+.+++++||..+|.+|||+++++.|+|
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 112245678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=283.41 Aligned_cols=244 Identities=27% Similarity=0.470 Sum_probs=194.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC------CcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH------EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~------~~~~lv~e~~~~~ 74 (282)
|++|.||+|.++.+++.+++|++.... .....+..|+.+++++..||||+++++.+... ...+++|||+.++
T Consensus 17 g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 94 (275)
T cd06608 17 GTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGG 94 (275)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCC
Confidence 789999999999899999999987653 23456778999999987799999999998654 3589999999987
Q ss_pred HHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCcc
Q 044127 75 LLKLMKERA---GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~ 149 (282)
.+..+.... +..+++..++.++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+........ .....
T Consensus 95 ~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 174 (275)
T cd06608 95 SVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174 (275)
T ss_pred cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCcc
Confidence 776665432 357999999999999999999999999999999999999974 7899999999876533221 23456
Q ss_pred ccccccCchhhhcc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc
Q 044127 150 TTRWYRAPEVLLLS----EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225 (282)
Q Consensus 150 ~~~~~~aPE~~~~~----~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
++..|+|||.+... ..++.++||||||+++|++++|..||...........+... +.+.
T Consensus 175 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~-------------- 237 (275)
T cd06608 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PPPT-------------- 237 (275)
T ss_pred ccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CCCC--------------
Confidence 78889999987532 33678899999999999999999999765544444332211 0000
Q ss_pred cccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.......++.+.++|++||..||++|||++++++|||+
T Consensus 238 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 ----------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ----------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 01112367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=283.81 Aligned_cols=235 Identities=18% Similarity=0.242 Sum_probs=190.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH--HHHHHHHHHHHHHhCCCCCeeeecccccc----CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD--ESRNLKEVKCLRKMNNHPNIVKLRNLVKE----HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~--~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~~~lv~e~~~~~ 74 (282)
|++|.||+|.. +|+.||+|++........ ...+.+|+.++.++. ||||+++++++.+ ....+++|||+.++
T Consensus 31 g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g 107 (283)
T PHA02988 31 NDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILEYCTRG 107 (283)
T ss_pred CCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEEeCCCC
Confidence 78999999976 688999999976543221 345668999999995 9999999999865 45789999999988
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
+|..++... ..+++.....++.|++.||.+||+. +++|+||||+||++++ +.+|++|||++....... ....++.
T Consensus 108 ~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~ 184 (283)
T PHA02988 108 YLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKNVNFM 184 (283)
T ss_pred cHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--ccccCcc
Confidence 887776654 4689999999999999999999984 8999999999999985 799999999987654322 3456788
Q ss_pred cccCchhhhcc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLS-EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+.+. ..++.++|||||||++|||++|..||...+..+....+......+
T Consensus 185 ~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------------- 241 (283)
T PHA02988 185 VYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL----------------------- 241 (283)
T ss_pred cccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-----------------------
Confidence 89999998642 457999999999999999999999999877666555443321111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...++.+.+++.+||+.||++|||++++++
T Consensus 242 -----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 242 -----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 122356889999999999999999999999985
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=277.95 Aligned_cols=242 Identities=28% Similarity=0.505 Sum_probs=194.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeecccccc-CCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKE-HEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~ 78 (282)
|++|.||++.++.+++.|++|.+...... ........|+..++++ +|||++++++.+.. ....++++|+++++.+..
T Consensus 11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 89 (257)
T cd08223 11 GSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYH 89 (257)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEEecccCCCcHHH
Confidence 78999999999999999999998765433 3344567788888888 49999999998764 446899999998766655
Q ss_pred HHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCcccccccc
Q 044127 79 MKE-RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~-~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~ 155 (282)
++. ..+..+++.++..++.|++.|+.+||++|++|+||+|+||++++ +.++|+|||++....... ......+++.|+
T Consensus 90 ~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~ 169 (257)
T cd08223 90 KLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYM 169 (257)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCcc
Confidence 444 34456999999999999999999999999999999999999985 789999999987654322 223346788899
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||.+.+.. ++.++|+||||++++++++|..||...+............ .
T Consensus 170 aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-----------------------------~ 219 (257)
T cd08223 170 SPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK-----------------------------L 219 (257)
T ss_pred ChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-----------------------------C
Confidence 999987544 7889999999999999999999998766544433332211 0
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
...+...++.+.+++.+||+.||.+|||+.++++||||
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11234578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=279.60 Aligned_cols=238 Identities=24% Similarity=0.410 Sum_probs=191.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|+++.+++.|++|.+...........+.+|+..++.+ +||||+++++++......+++|||+.++.+..++
T Consensus 6 g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 84 (252)
T cd05084 6 GNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL 84 (252)
T ss_pred ccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHH
Confidence 789999999999999999999987654444556778899999888 5999999999999999999999999987777776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC---CCccccccccC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC---TDYVTTRWYRA 156 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~a 156 (282)
...+..+++..++.++.|+++||.|||++|++|+||+|+||++++ +.++|+|||.+......... .....+..|+|
T Consensus 85 ~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 164 (252)
T cd05084 85 RTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTA 164 (252)
T ss_pred HhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecC
Confidence 655557999999999999999999999999999999999999985 78999999998754322111 11122456999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+.++. ++.++|+||||+++|++++ |..||......+..........
T Consensus 165 PE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~----------------------------- 214 (252)
T cd05084 165 PEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR----------------------------- 214 (252)
T ss_pred chhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-----------------------------
Confidence 99987554 7899999999999999998 8888876554433322211100
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.+++++||+.+|++|||++++++
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0123356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=281.95 Aligned_cols=238 Identities=20% Similarity=0.300 Sum_probs=192.8
Q ss_pred CCcceEEEEEec---CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDK---KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~---~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||.||+|.++ ..+..|++|+++..........+.+|+..+..+ +||||+++++++..+...++||||++++++.
T Consensus 16 G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (266)
T cd05064 16 GRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94 (266)
T ss_pred cCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCcEEEEEeCCCCcHH
Confidence 899999999765 346689999998765445556778899999888 5999999999999999999999999998888
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCccccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWY 154 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~ 154 (282)
.++......+++..+..++.||+.||++||++|++|+||||+||++++ +.++++|||.+........ .....++..|
T Consensus 95 ~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y 174 (266)
T cd05064 95 SFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW 174 (266)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceee
Confidence 877765557999999999999999999999999999999999999975 7899999998665322211 1122345679
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
+|||.+.+.. ++.++|||||||++|++++ |..||......+....+.....
T Consensus 175 ~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~--------------------------- 226 (266)
T cd05064 175 AAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR--------------------------- 226 (266)
T ss_pred cCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC---------------------------
Confidence 9999987544 8999999999999999875 9999987766655444322111
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.+++.+||+.+|.+||++++|++
T Consensus 227 --~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 227 --LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 0123456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=280.44 Aligned_cols=242 Identities=26% Similarity=0.458 Sum_probs=195.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-----hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-----LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-----~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|.. .+++.+++|.+...... .....+.+|+..++++. |+||+++++++.+.+..++++||+.++.
T Consensus 11 g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (265)
T cd06631 11 GAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTISIFMEFVPGGS 88 (265)
T ss_pred cCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEEEEEecCCCCc
Confidence 78999999986 46888999988654321 22345667888888885 9999999999999999999999999888
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCC-------CCCCC
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSS-------LPCTD 147 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~-------~~~~~ 147 (282)
+..++.+.+ ++++..+..++.|++.||.+||+.+++|+||+|+||+++ ++.++|+|||.+...... .....
T Consensus 89 L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 167 (265)
T cd06631 89 ISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167 (265)
T ss_pred HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccc
Confidence 887776543 689999999999999999999999999999999999997 489999999988754221 11123
Q ss_pred ccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 148 YVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 148 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
..++..|+|||.+.+.. ++.++|+||||+++|++++|..||...+.............
T Consensus 168 ~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------- 225 (265)
T cd06631 168 MHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG--------------------- 225 (265)
T ss_pred cCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC---------------------
Confidence 45788899999987544 78999999999999999999999987654443332221100
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.....+..++..+.++|++||+.+|.+||++.++++||||
T Consensus 226 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 226 ------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1122345678999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=282.43 Aligned_cols=244 Identities=27% Similarity=0.445 Sum_probs=192.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|++..+++.|++|++.... ......+.+|+..+.++ +||||+++++.+..++..+++|||++++.+..++
T Consensus 20 g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~ 97 (267)
T cd06646 20 GTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIY 97 (267)
T ss_pred CCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 789999999999999999999986543 22334566788888888 5999999999999999999999999987777666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+....... ......++..|+|||
T Consensus 98 ~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE 176 (267)
T cd06646 98 HVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPE 176 (267)
T ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHh
Confidence 544 46999999999999999999999999999999999999985 789999999987654322 123446788899999
Q ss_pred hhhc--cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 159 VLLL--SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 159 ~~~~--~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
.+.. ...++.++|+||+||++|+|++|+.||...........+... .+.. . ..
T Consensus 177 ~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~---------------------~~~~---~-~~ 231 (267)
T cd06646 177 VAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS---------------------NFQP---P-KL 231 (267)
T ss_pred HcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC---------------------CCCC---C-CC
Confidence 8742 333678999999999999999999998655433222111000 0000 0 00
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 272 (282)
.....++..+.++|++||+.||++|||++++++|+|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 112246789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=290.04 Aligned_cols=251 Identities=30% Similarity=0.443 Sum_probs=215.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
||||.||-++.+.||+-||+|.+.+.... ......++|-.++.++. .+.||.+--.|+..+.+|+|+..|+|+.+..
T Consensus 196 GGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LClVLtlMNGGDLkf 274 (591)
T KOG0986|consen 196 GGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCLVLTLMNGGDLKF 274 (591)
T ss_pred ccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEEEEEeecCCceeE
Confidence 89999999999999999999998765433 23455678999999994 8999999999999999999999999988886
Q ss_pred HHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 79 MKERAG-QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~-~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
.+.+.+ ..+++..+.-.+.+|+.||++||+.+||+||+||+|||+|+ |.++|+|+|+|..+....+...-.||..|||
T Consensus 275 Hiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMA 354 (591)
T KOG0986|consen 275 HIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMA 354 (591)
T ss_pred EeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccC
Confidence 666554 45999999999999999999999999999999999999997 9999999999999988888777799999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.... |+...|.|||||++|+|+.|+.||..........++-.... .+..
T Consensus 355 PEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~--------------------------~~~~ 407 (591)
T KOG0986|consen 355 PEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL--------------------------EDPE 407 (591)
T ss_pred HHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh--------------------------cchh
Confidence 99998666 99999999999999999999999987655444433322211 1123
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccCc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHFV 279 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~~ 279 (282)
..+..++++++++.+.+|+.||.+|. +++++-+||||+++.|.
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 45678899999999999999999998 46799999999998875
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=306.26 Aligned_cols=236 Identities=27% Similarity=0.438 Sum_probs=192.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccc-cc----cC--CcEEEEEecCC-
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL-VK----EH--EDVFIVFEYME- 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~-~~----~~--~~~~lv~e~~~- 72 (282)
|||+.||+|++...|..||+|+.-... ........+|+.+++.+++|||||.++|. .. ++ -.+.|+||||.
T Consensus 48 GGFa~VYla~~~~~~~~~AlKrm~~~d-e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~g 126 (738)
T KOG1989|consen 48 GGFAQVYLAQDVKGGKKYALKRMYVND-EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKG 126 (738)
T ss_pred CCcEEEEEEEecCCCceeeeeeeecCC-HHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccC
Confidence 999999999999887999999876652 34455678899999999999999999993 21 11 35789999999
Q ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC----
Q 044127 73 SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG--YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC---- 145 (282)
Q Consensus 73 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~--~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~---- 145 (282)
|++++.+.++....|++.++.+|+.++++|+++||... |+|||||-+|||++. +..||||||.|+..-.....
T Consensus 127 g~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~ 206 (738)
T KOG1989|consen 127 GSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEV 206 (738)
T ss_pred CcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHH
Confidence 69999988877778999999999999999999999998 999999999999985 88999999998754222211
Q ss_pred ------CCccccccccCchhhh--ccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccc
Q 044127 146 ------TDYVTTRWYRAPEVLL--LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGI 217 (282)
Q Consensus 146 ------~~~~~~~~~~aPE~~~--~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (282)
.....|+.|+|||.+. .+..++.|+|||+|||+||.|+....||+......++..
T Consensus 207 ~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng----------------- 269 (738)
T KOG1989|consen 207 NYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNG----------------- 269 (738)
T ss_pred HHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEec-----------------
Confidence 1235689999999873 355689999999999999999999999987654333211
Q ss_pred cccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 218 QLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
++.++. ...++..+.+||+.||++||.+||++-+++.
T Consensus 270 ------~Y~~P~---------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 270 ------NYSFPP---------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred ------cccCCC---------CccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 111111 1467899999999999999999999999885
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=280.31 Aligned_cols=246 Identities=25% Similarity=0.433 Sum_probs=197.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-----hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-----LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-----~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|++|.||+|.+..+++.|++|++...... .....+..|+..++++. |||++++++++.+.+..++++||+.+++
T Consensus 11 g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~ 89 (268)
T cd06630 11 GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFNLFVEWMAGGS 89 (268)
T ss_pred cCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEEEEEeccCCCc
Confidence 78999999999999999999998753321 12356678999999985 9999999999999999999999999888
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCC-----CCCc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLP-----CTDY 148 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~-----~~~~ 148 (282)
+..++... .++++..+..++.||+.||.+||++|++|+||+|+||+++. ..++|+|||.+........ ....
T Consensus 90 L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 168 (268)
T cd06630 90 VSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168 (268)
T ss_pred HHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccccc
Confidence 87777654 36999999999999999999999999999999999999974 3699999999876643211 1234
Q ss_pred cccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 149 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
.++..|+|||.+.+. .++.++|+||||++++++++|..||...........+......
T Consensus 169 ~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------- 226 (268)
T cd06630 169 LGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA--------------------- 226 (268)
T ss_pred ccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---------------------
Confidence 567889999998744 4789999999999999999999999755443322222111100
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccc
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 274 (282)
......+...++.+.+++.+||..+|.+||++.++++||||+
T Consensus 227 ----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 ----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ----CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 011233445788999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=290.13 Aligned_cols=277 Identities=19% Similarity=0.249 Sum_probs=194.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||.|++..+|+.||+|+......... ...+.+|+.+++.+ +||||+++++++..++..++++||+.++.+..+
T Consensus 11 ~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~ 89 (328)
T cd08226 11 CNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSL 89 (328)
T ss_pred cCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEecccCCCHHHH
Confidence 5889999999999999999999876543333 34455666666666 599999999999999999999999997666655
Q ss_pred HHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC--------CCcc
Q 044127 80 KER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC--------TDYV 149 (282)
Q Consensus 80 ~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~--------~~~~ 149 (282)
+.. ....+++..+..++.|++.||.|||++|++|+||||+||+++. +.++++||+.+......... ....
T Consensus 90 l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (328)
T cd08226 90 LKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169 (328)
T ss_pred HHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccccccccc
Confidence 544 3346999999999999999999999999999999999999984 78999999865433211110 1112
Q ss_pred ccccccCchhhhcc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc--c
Q 044127 150 TTRWYRAPEVLLLS-EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW--K 226 (282)
Q Consensus 150 ~~~~~~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 226 (282)
++..|+|||.+.+. ..++.++|||||||++|+|++|..||..................................+. .
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (328)
T cd08226 170 SVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSG 249 (328)
T ss_pred CccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhh
Confidence 35569999998653 23689999999999999999999999876654443333221111000000000000000000 0
Q ss_pred c---------c-----CCC-CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 227 F---------P-----QMG-GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 227 ~---------~-----~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
. . ... ..........++..+.+|+++||+.||++|||++++|+||||++..-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 250 VDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 0 0 000 00001123346788999999999999999999999999999987643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=292.84 Aligned_cols=241 Identities=24% Similarity=0.375 Sum_probs=189.0
Q ss_pred CCcceEEEEEe-----cCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALD-----KKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~-----~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|++ ..++..||+|+++..........+.+|+.++..+.+||||+++++++...+..++|||||.++.
T Consensus 46 G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~ 125 (375)
T cd05104 46 GAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGD 125 (375)
T ss_pred CccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCc
Confidence 89999999974 3467789999997655445556778899999999779999999999999999999999998766
Q ss_pred HHHHHHhc------------------------------------------------------------------------
Q 044127 76 LKLMKERA------------------------------------------------------------------------ 83 (282)
Q Consensus 76 l~~~~~~~------------------------------------------------------------------------ 83 (282)
+..++...
T Consensus 126 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (375)
T cd05104 126 LLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILE 205 (375)
T ss_pred HHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHh
Confidence 65444321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---CCCccccccccCc
Q 044127 84 --GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAP 157 (282)
Q Consensus 84 --~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aP 157 (282)
...+++..+..++.||+.||.|||+.|++|+||||+||++++ +.++|+|||++........ .....++..|+||
T Consensus 206 ~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 285 (375)
T cd05104 206 EDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAP 285 (375)
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeCh
Confidence 124788999999999999999999999999999999999986 6899999999876543221 1123345679999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.+. .++.++|||||||++|+|++ |..||..................+
T Consensus 286 E~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------- 336 (375)
T cd05104 286 ESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM---------------------------- 336 (375)
T ss_pred hHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC----------------------------
Confidence 998754 48999999999999999998 888987765544443332211000
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...+.++.+++.+||+.||++|||++++++.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1122347789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=280.12 Aligned_cols=242 Identities=26% Similarity=0.455 Sum_probs=191.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc----hHHHHHHHHHHHHHHhCCCCCeeeecccccc--CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS----LDESRNLKEVKCLRKMNNHPNIVKLRNLVKE--HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~----~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~~~~ 74 (282)
|+||.||+|.+..++..|++|++...... .....+.+|+.+++++. ||||+++++.+.+ ....++++||+.++
T Consensus 13 g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~l~~e~~~~~ 91 (266)
T cd06651 13 GAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKTLTIFMEYMPGG 91 (266)
T ss_pred CCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCEEEEEEeCCCCC
Confidence 78999999999999999999988654322 22345677889999984 9999999998865 36789999999877
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC----CCCCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL----PCTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~----~~~~~~ 149 (282)
.+...+... ..+++..++.++.|++.||.+||+.+++|+||+|+||++++ +.++|+|||++....... ......
T Consensus 92 ~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 170 (266)
T cd06651 92 SVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT 170 (266)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCC
Confidence 666666554 36899999999999999999999999999999999999975 689999999987553211 112345
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||............... ..
T Consensus 171 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~-------------------- 226 (266)
T cd06651 171 GTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT-------------------- 226 (266)
T ss_pred ccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC--------------------
Confidence 778899999987544 789999999999999999999999876544433322111 10
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 274 (282)
....+...++.+.+++ +||..+|++||+++++++||||+
T Consensus 227 -----~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 -----NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred -----CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 1123345678889999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=290.91 Aligned_cols=275 Identities=39% Similarity=0.679 Sum_probs=208.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeecccccc--CCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE--HEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~l~ 77 (282)
|+||.||+|.+..+++.+++|++..... ........+|+..+.++.+||||+++++++.. ....++|||++.+++..
T Consensus 18 g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~ 97 (337)
T cd07852 18 GAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHA 97 (337)
T ss_pred CCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccccCHHH
Confidence 7899999999998999999998865322 22334556799999999669999999998754 34689999999986655
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC------CCCCccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL------PCTDYVT 150 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~------~~~~~~~ 150 (282)
.+... .+++..+..++.||+.||.+||+.|++|+||+|+||++++ +.++|+|||.+....... ......+
T Consensus 98 ~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~ 174 (337)
T cd07852 98 VIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174 (337)
T ss_pred HHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccc
Confidence 54332 6889999999999999999999999999999999999985 799999999887653322 1223457
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccccc-CCccccC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN-LDWKFPQ 229 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 229 (282)
+..|+|||.+.+....+.++|+||||+++|+|++|+.||......+....+....+.+....+......... .-.....
T Consensus 175 ~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (337)
T cd07852 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPS 254 (337)
T ss_pred cccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhccc
Confidence 888999999876666789999999999999999999999988877777776666554433222111000000 0001111
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
..........+..+..+.++|.+||+.||++|||+.++++||||++...
T Consensus 255 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 255 RPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred ccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 1112223333457899999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=289.69 Aligned_cols=276 Identities=33% Similarity=0.585 Sum_probs=210.3
Q ss_pred CCcceEEEEEecCC--CcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccc----cCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKS--GEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVK----EHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~--~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~----~~~~~~lv~e~~~~ 73 (282)
|+||.||++.+..+ +..||+|.+....... ......+|+..++++.+||||+++++... .....+++++++++
T Consensus 11 G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~ 90 (332)
T cd07857 11 GAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA 90 (332)
T ss_pred cCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecccC
Confidence 78999999999888 8999999987543222 23456779999999878999999998643 23567899999988
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-----CCCC
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-----PCTD 147 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-----~~~~ 147 (282)
++.+.+... ..+++..++.++.||+.||.+||++|++|+||||+||++++ +.++|+|||.+....... ....
T Consensus 91 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 168 (332)
T cd07857 91 DLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTE 168 (332)
T ss_pred CHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccC
Confidence 776665443 47999999999999999999999999999999999999975 789999999987653221 1123
Q ss_pred ccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc-cCCcc
Q 044127 148 YVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS-NLDWK 226 (282)
Q Consensus 148 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 226 (282)
..+++.|+|||.+.+...++.++|+||+|+++|++++|..||...+.......+....+.+....+........ .....
T Consensus 169 ~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (332)
T cd07857 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRS 248 (332)
T ss_pred cccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHh
Confidence 46788999999987655689999999999999999999999998888888888887777655433221111000 00000
Q ss_pred ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
................+..+.+|+.+||+.||.+|||+++++.||||+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 249 LPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred ccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 1111111222233456889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=282.94 Aligned_cols=244 Identities=25% Similarity=0.415 Sum_probs=191.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccc-----ccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV-----KEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.+..+++.+++|++.... ........|+.+++.+.+|||++++++++ ..+...+++|||+++++
T Consensus 29 g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 106 (286)
T cd06638 29 GTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGS 106 (286)
T ss_pred CCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCC
Confidence 789999999999999999999876532 22345567888888886799999999987 34567899999999877
Q ss_pred HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccc
Q 044127 76 LKLMKER---AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVT 150 (282)
Q Consensus 76 l~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~ 150 (282)
+..++.. ....+++..+..++.|++.||.+||+.+++|+||+|+||++++ +.++|+|||++....... ......+
T Consensus 107 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 186 (286)
T cd06638 107 VTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 186 (286)
T ss_pred HHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccC
Confidence 7655432 2346899999999999999999999999999999999999985 789999999987654322 2234468
Q ss_pred cccccCchhhhc----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcc
Q 044127 151 TRWYRAPEVLLL----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226 (282)
Q Consensus 151 ~~~~~aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
++.|+|||.+.. ...++.++|+|||||++|+|++|..||............... .
T Consensus 187 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~------------------ 245 (286)
T cd06638 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---P------------------ 245 (286)
T ss_pred CCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---C------------------
Confidence 889999998753 233688999999999999999999999766543332221110 0
Q ss_pred ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
......+...+..+.++|.+||+.||++|||+.++++|+||
T Consensus 246 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 ------PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ------CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00001123357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=293.58 Aligned_cols=240 Identities=24% Similarity=0.352 Sum_probs=189.0
Q ss_pred CCcceEEEEEecCC-----CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKS-----GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|++..+ +..||+|+++..........+.+|+.+++.+.+||||+++++.+...+..+++||||.++.
T Consensus 49 G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~ 128 (374)
T cd05106 49 GAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGD 128 (374)
T ss_pred CCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCc
Confidence 89999999986543 3579999998665445556678899999998679999999999999999999999999766
Q ss_pred HHHHHHhc---------------------------------------------------------------------CCC
Q 044127 76 LKLMKERA---------------------------------------------------------------------GQN 86 (282)
Q Consensus 76 l~~~~~~~---------------------------------------------------------------------~~~ 86 (282)
+..++... ..+
T Consensus 129 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (374)
T cd05106 129 LLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWP 208 (374)
T ss_pred HHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCC
Confidence 66554321 124
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC---CCccccccccCchhhhc
Q 044127 87 FSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC---TDYVTTRWYRAPEVLLL 162 (282)
Q Consensus 87 l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~ 162 (282)
+++..+.+++.||+.||.|||++|++|+||||+||++++ +.++|+|||++......... ....++..|+|||++..
T Consensus 209 l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 288 (374)
T cd05106 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD 288 (374)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC
Confidence 788999999999999999999999999999999999985 78999999998765432211 12234567999999874
Q ss_pred cccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCC
Q 044127 163 SEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPS 241 (282)
Q Consensus 163 ~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (282)
. .++.++|||||||++|+|++ |..||..................+ ..+..
T Consensus 289 ~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~ 339 (374)
T cd05106 289 C-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM----------------------------SRPDF 339 (374)
T ss_pred C-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc----------------------------cCCCC
Confidence 4 48999999999999999997 999998765544443333211000 11224
Q ss_pred CChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 242 ASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.++++.+++.+||+.||.+|||++++++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=284.16 Aligned_cols=248 Identities=30% Similarity=0.400 Sum_probs=198.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||++.+..+++.|++|.+..... ......+..|+..+..+ +||||+++++.+..++..+++|||+.|+.+..
T Consensus 12 g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~ 90 (305)
T cd05609 12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMVMEYVEGGDCAT 90 (305)
T ss_pred CCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEEEecCCCCcHHH
Confidence 7899999999999999999999876542 12334566788888887 59999999999999999999999999888877
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--------------
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-------------- 143 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-------------- 143 (282)
++... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++++|||.+.......
T Consensus 91 ~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 169 (305)
T cd05609 91 LLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169 (305)
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchh
Confidence 77665 46999999999999999999999999999999999999985 799999999875311000
Q ss_pred --CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 144 --PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 144 --~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
......++..|+|||.+.... ++.++|+||||+++|++++|..||.+....+............
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------- 235 (305)
T cd05609 170 EFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW------------- 235 (305)
T ss_pred hccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC-------------
Confidence 001234677899999987544 7999999999999999999999998766555444433211000
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCC---HHHHhcCcccccccC
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPT---AAEALEHPFFRSCHF 278 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~~ 278 (282)
+......+..+.++|++||+.||++||+ +.++|+||||+...+
T Consensus 236 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 236 --------------PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred --------------CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 0111246888999999999999999998 799999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=291.56 Aligned_cols=271 Identities=39% Similarity=0.654 Sum_probs=203.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccC------CcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEH------EDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~------~~~~lv~e~~~~ 73 (282)
|+||.||+|++..+++.||+|++....... ......+|+.+++.+ +||||+++++++... ...++++||+..
T Consensus 26 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~ 104 (342)
T cd07879 26 GAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT 104 (342)
T ss_pred cCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCCceEEEEeccccc
Confidence 789999999999999999999987543222 234567899999888 599999999988644 346999999986
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
.+... . +..+++..+..++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||++....... ....++.
T Consensus 105 ~l~~~-~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 178 (342)
T cd07879 105 DLQKI-M---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVVTR 178 (342)
T ss_pred CHHHH-H---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC--CCceeee
Confidence 54432 2 246899999999999999999999999999999999999974 899999999987654322 3456788
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccccc-CCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN-LDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (282)
.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+.......+....+.+.+............ .....+...
T Consensus 179 ~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (342)
T cd07879 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYP 258 (342)
T ss_pred cccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcc
Confidence 8999999875555789999999999999999999999988777777666665554433221111000000 000001111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...........+..+.+||++||+.||.+||++++++.||||++...
T Consensus 259 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 259 RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 11112223456888999999999999999999999999999988753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=276.70 Aligned_cols=242 Identities=30% Similarity=0.514 Sum_probs=200.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||.||.+++..+++.+++|.+...... .....+.+|+.+++++ +|+||+++++++.+.+..+++|||+.++.+..+
T Consensus 11 g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~ 89 (256)
T cd08221 11 GAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDK 89 (256)
T ss_pred cCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEEEecCCCcHHHH
Confidence 78999999999999999999998765432 3345567899999998 599999999999999999999999987666665
Q ss_pred HHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccC
Q 044127 80 KERA-GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~~-~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~a 156 (282)
+... +..+++.++..++.|++.||.+||+.|++|+||+|+||++++ +.++++|||.+....... ......+++.|.|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~a 169 (256)
T cd08221 90 IVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMS 169 (256)
T ss_pred HHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccC
Confidence 5543 456999999999999999999999999999999999999985 789999999987664433 2234567889999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. .+.++|+||||+++|+|++|..||......+....+..... .
T Consensus 170 pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-----------------------------~ 219 (256)
T cd08221 170 PELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY-----------------------------T 219 (256)
T ss_pred HhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-----------------------------C
Confidence 99987544 78899999999999999999999987766555544432110 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
......+.++.+++.+||+.+|.+||++.++|+|+|+
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 1123568899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=277.56 Aligned_cols=243 Identities=30% Similarity=0.541 Sum_probs=199.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc----chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF----SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~----~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|++|+||+|.+..++..|++|.+..... .+....+..|+..++.+ +|||++++++++.+....++++||++++++
T Consensus 11 g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (258)
T cd06632 11 GSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYIFLELVPGGSL 89 (258)
T ss_pred cCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEEEEEecCCCcH
Confidence 7899999999998899999999865432 12345667888888888 599999999999999999999999998777
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 155 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 155 (282)
..++...+ .+++..+..++.||+.||++||+.|++|+||+|+||+++. +.++|+|||.+.............++..|+
T Consensus 90 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~ 168 (258)
T cd06632 90 AKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWM 168 (258)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCCccee
Confidence 77776653 6899999999999999999999999999999999999974 789999999987665443334566788899
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||.+.....++.++|+||||+++|+|++|..||......+......... ..
T Consensus 169 ~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------------------------~~ 220 (258)
T cd06632 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK----------------------------EL 220 (258)
T ss_pred CHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc----------------------------cC
Confidence 99998644447899999999999999999999997765433333221100 11
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
...+..+++.+.+++.+||+.+|.+||++.+++.|||+
T Consensus 221 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 221 PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 12344678899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=291.98 Aligned_cols=273 Identities=37% Similarity=0.663 Sum_probs=207.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc------EEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHED------VFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~------~~lv~e~~~~ 73 (282)
|++|.||+|++..++..|++|++...... .......+|+.+++++ .|||++++.+++..... .++++|++++
T Consensus 26 g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~ 104 (343)
T cd07851 26 GAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA 104 (343)
T ss_pred CCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccccccEEEEEecCCC
Confidence 78999999999999999999998754322 2334556789988888 59999999998866554 8999999987
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++.+.+.. ..+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+....... ....++.
T Consensus 105 ~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 179 (343)
T cd07851 105 DLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM--TGYVATR 179 (343)
T ss_pred CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccccc--cCCcccc
Confidence 66554433 46999999999999999999999999999999999999985 789999999988765432 3456788
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccc-ccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA-SNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (282)
.|+|||.+.+....+.++||||||+++|++++|+.||......+....+....+.+.+..+....... ...-.......
T Consensus 180 ~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (343)
T cd07851 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMP 259 (343)
T ss_pred cccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccC
Confidence 89999998755457899999999999999999999999888777777666665544432211110000 00000000111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
..........+++.+.++|.+||+.||.+|||+.+|++||||++....
T Consensus 260 ~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 260 KKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred CCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 111122234568899999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=278.87 Aligned_cols=248 Identities=29% Similarity=0.460 Sum_probs=202.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|++..+++.|++|++...........+..|+..+.++. |||++++++.+......++++||+.++++..++
T Consensus 12 g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 90 (264)
T cd06623 12 GSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL 90 (264)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEEEecCCCcHHHHH
Confidence 7899999999999999999999887654445667788999999996 999999999999999999999999977777776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCC-CccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCT-DYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~aP 157 (282)
... ..+++..+..++.|+++|+.+||+ .+++|+||+|+||+++. +.++|+|||.+.......... ...++..|+||
T Consensus 91 ~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~p 169 (264)
T cd06623 91 KKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169 (264)
T ss_pred HHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCH
Confidence 654 479999999999999999999999 99999999999999975 789999999988765433322 45678889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+... .++.++|+||||+++|+|++|..||......+............ ...
T Consensus 170 E~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~ 222 (264)
T cd06623 170 ERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP--------------------------PPS 222 (264)
T ss_pred hhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC--------------------------CCC
Confidence 998754 57899999999999999999999998775311111111111100 011
Q ss_pred cCCC-CChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 238 LSPS-ASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 238 ~~~~-~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.+.. ++..+.++|++||..+|++|||+.++++||||+.+.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 2223 688999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=281.27 Aligned_cols=246 Identities=29% Similarity=0.524 Sum_probs=199.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||++.+..+++.+++|++.... ......+.+|+.+++.+ +|||++++++++...+..++++||+.++.+..++
T Consensus 30 g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 107 (285)
T cd06648 30 GSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV 107 (285)
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEEEeccCCCCHHHHH
Confidence 789999999999899999999886533 23344567888888888 5999999999999999999999999887777776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE 158 (282)
.. .++++..+..++.|++.||.+||++|++|+||+|+||++++ +.++|+|||.+........ .....+++.|+|||
T Consensus 108 ~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE 185 (285)
T cd06648 108 TH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 185 (285)
T ss_pred Hh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHH
Confidence 65 46999999999999999999999999999999999999985 7999999998765533221 12345788899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+. .++.++|+||||+++|+|++|..||...+............ .+. ...
T Consensus 186 ~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~--------------------------~~~ 237 (285)
T cd06648 186 VISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPK--------------------------LKN 237 (285)
T ss_pred HhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCC--------------------------Ccc
Confidence 98744 47899999999999999999999998766554444332210 000 001
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....+..+.+++++||+.+|++|||+.++++||||+....
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 1236789999999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=278.06 Aligned_cols=242 Identities=29% Similarity=0.523 Sum_probs=197.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||.+++..+++.|++|.+..... ......+.+|+..++++. ||||+++++.+.+.+..++++||+.++.+...
T Consensus 11 g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 89 (256)
T cd08218 11 GSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVMDYCEGGDLYKK 89 (256)
T ss_pred CCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEEecCCCCcHHHH
Confidence 7899999999999999999999875432 234456778889998885 99999999999999999999999986555444
Q ss_pred H-HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccC
Q 044127 80 K-ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRA 156 (282)
Q Consensus 80 ~-~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~a 156 (282)
. ...+..+++..+..++.|++.||.+||++|++|+||+|+||+++. +.++++|||.+........ .....+++.|+|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (256)
T cd08218 90 INAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLS 169 (256)
T ss_pred HHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccC
Confidence 4 433446899999999999999999999999999999999999984 7899999999876543221 123457788999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. .+.++|+||||++++++++|..||......+....+..... .
T Consensus 170 pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-----------------------------~ 219 (256)
T cd08218 170 PEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-----------------------------P 219 (256)
T ss_pred HHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-----------------------------C
Confidence 99987544 78899999999999999999999987766555544332111 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
..+...+..+.++|.+||+.+|++||++.++++||||
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 1234568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=282.57 Aligned_cols=248 Identities=28% Similarity=0.433 Sum_probs=196.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|.+..+++.|++|.+..............|+..+.+..+||||+++++++.+....+++|||+.+.+...+.
T Consensus 26 g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~l~~ 105 (296)
T cd06618 26 GTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLK 105 (296)
T ss_pred cCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCcCHHHHHH
Confidence 78999999999999999999999765444455566778777777767999999999999999999999999876555444
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
. ....+++..+..++.||+.||.|||+ .|++|+||+|+||++++ +.++|+|||.+.............++..|+|||
T Consensus 106 ~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE 184 (296)
T cd06618 106 R-IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPE 184 (296)
T ss_pred H-hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHh
Confidence 4 33479999999999999999999997 59999999999999975 789999999987665443334445778899999
Q ss_pred hhhcc---ccCCCcchhHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 159 VLLLS---EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSA-DQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 159 ~~~~~---~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
.+.+. ..++.++|+||||+++|+|++|+.||...... +.+..... .... ..
T Consensus 185 ~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~-~~--------------------- 239 (296)
T cd06618 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---EEPP-SL--------------------- 239 (296)
T ss_pred hcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---CCCC-CC---------------------
Confidence 98643 23688999999999999999999999764332 22222111 0000 00
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.....++..+.+|+.+||+.||.+||++++++.|+||+..
T Consensus 240 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 240 --PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 0111467889999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=279.80 Aligned_cols=272 Identities=27% Similarity=0.460 Sum_probs=211.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCC----eeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN-NHPN----IVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~-~hp~----i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|.||.|-.+.+.+++..||+|+++... .-....+-|+.+++++. +.|+ ++.+.++|+..++.|||+|.++.++
T Consensus 100 GtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~ 177 (415)
T KOG0671|consen 100 GTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELLGLST 177 (415)
T ss_pred CcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEeccChhH
Confidence 889999999999999999999997653 33344566899999884 3333 7888899999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC---------------------CcEEEeecC
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK---------------------GVIKIGDLG 134 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~---------------------~~~~l~df~ 134 (282)
.+.+.++.-.+++...+..+.+|+++++++||+.+++|.||||+||++.+ -.|+++|||
T Consensus 178 ~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFG 257 (415)
T KOG0671|consen 178 FDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFG 257 (415)
T ss_pred HHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecC
Confidence 99988877778999999999999999999999999999999999999821 149999999
Q ss_pred cccccCCCCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcc
Q 044127 135 MVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP 214 (282)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (282)
.|+...... .....|..|+|||++.+-+ ++.+.||||+||||+|+.+|..+|...++.+.+.-+...+|.++.....
T Consensus 258 sAtf~~e~h--s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~ 334 (415)
T KOG0671|consen 258 SATFDHEHH--STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIK 334 (415)
T ss_pred CcceeccCc--ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhh
Confidence 998765443 5667899999999999555 9999999999999999999999999999988887666666654433222
Q ss_pred ccc----cccccCCccccCCC---------CCcccc---cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 215 LGI----QLASNLDWKFPQMG---------GVNLRE---LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 215 ~~~----~~~~~~~~~~~~~~---------~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
... .....++|--.... ...+.. .....-..+.+||++||..||.+|+|+.|+|.||||+...
T Consensus 335 r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 335 KTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred hhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 110 00001111100000 000111 1112344589999999999999999999999999998754
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=278.58 Aligned_cols=247 Identities=30% Similarity=0.491 Sum_probs=194.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch---------HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL---------DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYM 71 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~---------~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 71 (282)
|++|.||+|.+..+++.|++|.+....... ....+..|+..+.++ +|||++++++++......+++|||+
T Consensus 12 g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 90 (272)
T cd06629 12 GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTEEYLSIFLEYV 90 (272)
T ss_pred cCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccCCceEEEEecC
Confidence 889999999999999999999886432211 123456788888888 5999999999999999999999999
Q ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---CCC
Q 044127 72 ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTD 147 (282)
Q Consensus 72 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~---~~~ 147 (282)
.++.+...+... ..+++..+..++.||+.||.+||+++++|+||+|+||+++. +.++++|||.+........ ...
T Consensus 91 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 169 (272)
T cd06629 91 PGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS 169 (272)
T ss_pred CCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccccccccccc
Confidence 987777766655 36999999999999999999999999999999999999974 8999999999876532211 123
Q ss_pred ccccccccCchhhhccc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcc
Q 044127 148 YVTTRWYRAPEVLLLSE-IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226 (282)
Q Consensus 148 ~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
..++..|+|||.+.... .++.++|+||||+++|++++|..||..........+......
T Consensus 170 ~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 229 (272)
T cd06629 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-------------------- 229 (272)
T ss_pred ccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc--------------------
Confidence 45778899999986443 368899999999999999999999975544433322211000
Q ss_pred ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
...........++..+.++|.+||+.||++|||++++++||||
T Consensus 230 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 230 ----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0000112234568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=280.14 Aligned_cols=244 Identities=24% Similarity=0.438 Sum_probs=199.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.+..++..|++|.+...........+.+|+..+.++ +|||++++++.+..+...++||||++++++..++
T Consensus 15 G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i 93 (277)
T cd06641 15 GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL 93 (277)
T ss_pred cCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHH
Confidence 789999999999899999999987554444455667788888888 5999999999999999999999999987777766
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
.. ..++...+..++.|++.|+.+||+.|++|+||+|+||++++ +.++++|||++....... ......++..|+|||
T Consensus 94 ~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE 171 (277)
T cd06641 94 EP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171 (277)
T ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChh
Confidence 54 46899999999999999999999999999999999999985 789999999886553321 112345677899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+... ..+.++|+|||||++|++++|..||...........+... .....
T Consensus 172 ~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------------------------~~~~~ 221 (277)
T cd06641 172 VIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-----------------------------NPPTL 221 (277)
T ss_pred hhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-----------------------------CCCCC
Confidence 88744 4788999999999999999999999766544433322110 01122
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
....+..+.+++.+||+.+|.+||++.++++||||+...
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 345688899999999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=282.41 Aligned_cols=244 Identities=23% Similarity=0.340 Sum_probs=188.0
Q ss_pred CCcceEEEEEecC----------------CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcE
Q 044127 1 GSYGDVFQALDKK----------------SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDV 64 (282)
Q Consensus 1 G~~g~Vy~~~~~~----------------~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 64 (282)
|+||.||+|.+.. ++..||+|.+...........+.+|+.++.++ +||||+++++++.+.+..
T Consensus 16 G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 94 (304)
T cd05096 16 GQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNIIRLLGVCVDEDPL 94 (304)
T ss_pred cCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEecCCce
Confidence 8999999997532 34579999987654444556778899999998 599999999999999999
Q ss_pred EEEEecCCccHHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-
Q 044127 65 FIVFEYMESDLLKLMKERAG------------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK- 125 (282)
Q Consensus 65 ~lv~e~~~~~~l~~~~~~~~------------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~- 125 (282)
+++|||+.++.+..++.... ..++...+..++.||+.||.+||+.|++|+||||+||++++
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~ 174 (304)
T cd05096 95 CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGEN 174 (304)
T ss_pred EEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCC
Confidence 99999998766666554321 23677889999999999999999999999999999999985
Q ss_pred CcEEEeecCcccccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh--CCCCCCCCCChHHHHH
Q 044127 126 GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS--FRILFPGKNSADQIYK 200 (282)
Q Consensus 126 ~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~--g~~~~~~~~~~~~~~~ 200 (282)
+.++|+|||++........ .....++..|+|||.+..+. ++.++||||||+++|+|++ +..||......+....
T Consensus 175 ~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~ 253 (304)
T cd05096 175 LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253 (304)
T ss_pred ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHH
Confidence 7899999999876533221 12334467899999987544 8999999999999999986 5678877666555544
Q ss_pred HHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh
Q 044127 201 ICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268 (282)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 268 (282)
............ ....+...+..+.+++.+||+.||++|||+++|.
T Consensus 254 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 254 AGEFFRDQGRQV----------------------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HHHHhhhccccc----------------------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 333221111000 0112235678999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=277.54 Aligned_cols=242 Identities=26% Similarity=0.494 Sum_probs=196.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccc--cCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVK--EHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~~~~~l~ 77 (282)
|+||.||+|.+..++..|++|++...... .....+..|+..++.+. |||++++++.+. .....+++|||++++.+.
T Consensus 11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~ 89 (265)
T cd08217 11 GSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLA 89 (265)
T ss_pred CCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEEEehhccCCCHH
Confidence 78999999999999999999998764433 33455677888888885 999999999764 445689999999977666
Q ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----HcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCC
Q 044127 78 LMKERA---GQNFSEDEVRNLCFQVFQGLHYMH-----RQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTD 147 (282)
Q Consensus 78 ~~~~~~---~~~l~~~~~~~i~~qi~~~l~~Lh-----~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~ 147 (282)
.++... +.++++..++.++.||+.||.+|| +.+++|+||+|+||++++ +.++|+|||++........ ...
T Consensus 90 ~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 169 (265)
T cd08217 90 QLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT 169 (265)
T ss_pred HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccccc
Confidence 555432 357999999999999999999999 889999999999999986 8999999999887765443 334
Q ss_pred ccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 148 YVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 148 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
..+++.|+|||.+.... .+.++|+||||++++++++|..||...........+...
T Consensus 170 ~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------------------- 225 (265)
T cd08217 170 YVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG----------------------- 225 (265)
T ss_pred cccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-----------------------
Confidence 56788999999987544 789999999999999999999999877643333222110
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
....++...+..+.+++.+||+.+|++||++.++++|||+
T Consensus 226 ------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 226 ------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0112344678899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=285.69 Aligned_cols=272 Identities=35% Similarity=0.618 Sum_probs=206.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeecccccc-CCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKE-HEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|.+..+++.|++|++...... ........|+.++..+. |||++++.+++.. ....++++|++++++...
T Consensus 21 g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~lv~e~~~~~L~~~ 99 (328)
T cd07856 21 GAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLEDIYFVTELLGTDLHRL 99 (328)
T ss_pred cCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCCcEEEEeehhccCHHHH
Confidence 78999999999999999999988654322 23455668999998885 9999999999865 567899999997765443
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
... .++++..+..++.|+++||.+||+.|++|+||+|+||++++ +.++|+|||.+....... ....++..|+||
T Consensus 100 -~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~y~aP 174 (328)
T cd07856 100 -LTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM--TGYVSTRYYRAP 174 (328)
T ss_pred -Hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc--CCCcccccccCc
Confidence 332 36899999999999999999999999999999999999975 789999999987654332 344667889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc--cccCCCCCcc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW--KFPQMGGVNL 235 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (282)
|.+.+...++.++|+||||+++|+|++|..||...........+.+..+.+..+........ ..... ..........
T Consensus 175 E~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 253 (328)
T cd07856 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE-NTLRFVQSLPKREPVPF 253 (328)
T ss_pred eeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch-hhHHHHhhccccCCCcH
Confidence 98865556899999999999999999999999888776666666666555442221100000 00000 0011111112
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
.+.....++.+.++|++||+.+|++|||+++++.||||......
T Consensus 254 ~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 254 SEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 22334578899999999999999999999999999999765544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=276.90 Aligned_cols=240 Identities=29% Similarity=0.500 Sum_probs=195.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH-H
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL-M 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~-~ 79 (282)
|+||.||++.+..+++.|++|.++.............|...++.+ +|||++++++.+..++..++++||++++.+.. +
T Consensus 11 g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 89 (255)
T cd08219 11 GSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKI 89 (255)
T ss_pred cCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHH
Confidence 789999999999999999999987654444556667788888888 49999999999999999999999998655544 4
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aP 157 (282)
....+..+++..+..++.||+.||.+||++|++|+||+|+||++++ +.++++|||.+........ .....+++.|+||
T Consensus 90 ~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aP 169 (255)
T cd08219 90 KLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP 169 (255)
T ss_pred HhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCH
Confidence 4444556899999999999999999999999999999999999975 7999999999876543222 2335678889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+.. ++.++|+||||+++|+|++|..||...+............. ..
T Consensus 170 E~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~ 219 (255)
T cd08219 170 EIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-----------------------------KP 219 (255)
T ss_pred HHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-----------------------------CC
Confidence 9987544 78999999999999999999999987665555443322111 11
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHP 271 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 271 (282)
.+...+..+.++|.+||+.||.+|||+.++++--
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence 2335678899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=261.89 Aligned_cols=242 Identities=26% Similarity=0.400 Sum_probs=189.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC-----CcEEEEEecCC-cc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH-----EDVFIVFEYME-SD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~e~~~-~~ 74 (282)
|||+-||++++..+++.||+|++..+. .++....++|+...+++. |||+++++++...+ ...|++++|.. |+
T Consensus 32 GGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gs 109 (302)
T KOG2345|consen 32 GGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGS 109 (302)
T ss_pred CCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCceeEEEEeehhcccc
Confidence 899999999999999999999998876 567777889999999995 89999999986433 45899999987 55
Q ss_pred HHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCC---
Q 044127 75 LLKLMKER--AGQNFSEDEVRNLCFQVFQGLHYMHRQG--YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCT--- 146 (282)
Q Consensus 75 ~l~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~Lh~~~--~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~--- 146 (282)
+++.+... .+..+++.++..|+.+|++||++||+.. ++|+||||.||++++ +.+++.|||.++...-.....
T Consensus 110 l~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a 189 (302)
T KOG2345|consen 110 LLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQA 189 (302)
T ss_pred HHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHH
Confidence 77665443 3446999999999999999999999999 999999999999987 899999999988654322211
Q ss_pred -------CccccccccCchhhhcc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccc
Q 044127 147 -------DYVTTRWYRAPEVLLLS--EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGI 217 (282)
Q Consensus 147 -------~~~~~~~~~aPE~~~~~--~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (282)
....|..|+|||.+... -..+.++|||||||++|.|+.|..||+..-. ..++......
T Consensus 190 ~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------~GgSlaLAv~---- 256 (302)
T KOG2345|consen 190 LRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------QGGSLALAVQ---- 256 (302)
T ss_pred HHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------cCCeEEEeee----
Confidence 24568889999998533 3368999999999999999999999963211 0011100000
Q ss_pred cccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 218 QLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
+-+..+++ ...+++.+.++|+.||++||.+||++.+++++
T Consensus 257 ----n~q~s~P~---------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 257 ----NAQISIPN---------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ----ccccccCC---------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00111111 12479999999999999999999999999864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=288.11 Aligned_cols=272 Identities=36% Similarity=0.616 Sum_probs=204.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccC------CcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH------EDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~------~~~~lv~e~~~~ 73 (282)
|+||.||+|.+..+++.||+|++...... .......+|+..+.++. ||||+++++++... ...+++++++++
T Consensus 28 G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~ 106 (345)
T cd07877 28 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 106 (345)
T ss_pred cCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecccccccccEEEEehhccc
Confidence 78999999999999999999998764322 22345678999999985 99999999987532 457899998876
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++.+ +... ..+++..++.++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||++....... ....++.
T Consensus 107 ~L~~-~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~--~~~~~~~ 181 (345)
T cd07877 107 DLNN-IVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATR 181 (345)
T ss_pred CHHH-HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccccc--cccccCC
Confidence 6544 4433 36999999999999999999999999999999999999985 799999999987654322 3456788
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc-cCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS-NLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (282)
.|+|||.+.+...++.++|||||||++|+|++|..||...........+....+.+.+...+....... ......+...
T Consensus 182 ~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (345)
T cd07877 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMP 261 (345)
T ss_pred CccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccC
Confidence 899999987545578999999999999999999999988777777776666665544333221110000 0000000111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...........++.+.++|.+||+.||.+||++.++++||||++...
T Consensus 262 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 262 KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred CcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 11111222356888999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=279.75 Aligned_cols=246 Identities=28% Similarity=0.484 Sum_probs=200.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||++.++.+++.|++|++.... ......+.+|+..++.+. |||++++++.+...+..+++|||++++.+..+.
T Consensus 31 g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 108 (292)
T cd06657 31 GSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGALTDIV 108 (292)
T ss_pred CCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEEecCCCCcHHHHH
Confidence 789999999999999999999886432 334556778988888884 999999999999999999999999988887766
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
.. ..+++..+..++.|++.||++||+.|++|+||+|+||+++. +.++|+|||.+....... ......+++.|+|||
T Consensus 109 ~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE 186 (292)
T cd06657 109 TH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 186 (292)
T ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHH
Confidence 54 36899999999999999999999999999999999999985 789999999876553322 123346788899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.... ++.++|+||+|+++|+|++|..||................... ...
T Consensus 187 ~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~ 238 (292)
T cd06657 187 LISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK---------------------------LKN 238 (292)
T ss_pred HhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc---------------------------cCC
Confidence 886444 7899999999999999999999998766554443332211000 011
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....+..+.+++.+||+.||.+||++.++++||||.....
T Consensus 239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred cccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 1346788999999999999999999999999999987764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=275.75 Aligned_cols=242 Identities=26% Similarity=0.461 Sum_probs=192.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc----hHHHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS----LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~----~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~ 74 (282)
|+||.||.|.+..+++.|++|.+...... .....+.+|+..++++ +||||+++++.+.+. ..++++|||++++
T Consensus 13 g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~ 91 (265)
T cd06652 13 GAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERTLSIFMEHMPGG 91 (265)
T ss_pred CCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCceEEEEEEecCCC
Confidence 78999999999999999999987643211 2234566788999888 599999999988653 5688999999987
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC----CCCCCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS----LPCTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~----~~~~~~~ 149 (282)
.+..++... ..+++..+..++.|++.||.+||+++++|+||+|+||++++ +.++|+|||.+...... .......
T Consensus 92 ~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 170 (265)
T cd06652 92 SIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT 170 (265)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCC
Confidence 777666654 35899999999999999999999999999999999999985 78999999988754321 1122345
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++..|+|||.+.+.. .+.++|+||||+++|+|++|+.||............. ..+.
T Consensus 171 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~-------------------- 226 (265)
T cd06652 171 GTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPT-------------------- 226 (265)
T ss_pred CCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCC--------------------
Confidence 788899999987544 7899999999999999999999997664444332221 1110
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 274 (282)
....+...+..+.++|++|+. +|.+||+++++++|||++
T Consensus 227 -----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 -----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred -----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 012234567889999999995 999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=282.49 Aligned_cols=244 Identities=27% Similarity=0.462 Sum_probs=197.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.+..+++.|++|++..... ......+.+|+..++.+ +|||++++.+++.++...++|+||+.+++.+.
T Consensus 26 g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~g~l~~~ 104 (307)
T cd06607 26 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHTAWLVMEYCLGSASDI 104 (307)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCeEEEEHHhhCCCHHHH
Confidence 7899999999999999999999864332 22334567899989888 49999999999999999999999999887776
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++ +.++|+|||++...... ....++..|+||
T Consensus 105 ~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aP 180 (307)
T cd06607 105 LEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NSFVGTPYWMAP 180 (307)
T ss_pred HHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CCccCCccccCc
Confidence 65433 46999999999999999999999999999999999999975 79999999988654432 345677889999
Q ss_pred hhhhc--cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 158 EVLLL--SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 158 E~~~~--~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|.+.+ ...++.++||||||+++|+|++|..||...+............ + +
T Consensus 181 E~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~--~-~------------------------- 232 (307)
T cd06607 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--S-P------------------------- 232 (307)
T ss_pred eeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC--C-C-------------------------
Confidence 98742 3447889999999999999999999998766554433321110 0 0
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.......+..+.++|.+||+.||++||++.+++.||||..-.
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 001123577899999999999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=279.14 Aligned_cols=245 Identities=26% Similarity=0.443 Sum_probs=208.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.|+++|..+|+|.+.- ..+...++.|+.++++.. .|++|++||.|-....+|||||||+.++..+++
T Consensus 44 GSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~ 119 (502)
T KOG0574|consen 44 GSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIM 119 (502)
T ss_pred CcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEeehhhcCCCcHHHHH
Confidence 8999999999999999999999865 356777889999999995 999999999999999999999999988888888
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccC-CCCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~aPE 158 (282)
....++|++.++..+++.-+.||+|||...-+|||||..|||++ +|..||.|||.|..+. .-.......||+.|+|||
T Consensus 120 R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 199 (502)
T KOG0574|consen 120 RARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 199 (502)
T ss_pred HHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHH
Confidence 87788999999999999999999999999999999999999997 5999999999987663 233346789999999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
++..-+ |+.++||||||++..||..|+.||..-.++..+.-+ ...++..+ .-
T Consensus 200 VI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI----PT~PPPTF-----------------------~K 251 (502)
T KOG0574|consen 200 VIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI----PTKPPPTF-----------------------KK 251 (502)
T ss_pred HHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEec----cCCCCCCC-----------------------CC
Confidence 998555 899999999999999999999999766554433211 11111111 12
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
+...+.++-+|++.||...|++|.|+.++++|+|+++..
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 334688899999999999999999999999999998764
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=287.96 Aligned_cols=271 Identities=38% Similarity=0.653 Sum_probs=203.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCC------cEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE------DVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~------~~~lv~e~~~~ 73 (282)
|+||.||+|.+..++..||+|++....... ......+|+.+++++ +||||+++++++.... ..+++||++++
T Consensus 26 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~ 104 (343)
T cd07880 26 GAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGT 104 (343)
T ss_pred cCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccccccceEEEEEecCCC
Confidence 889999999999999999999986543222 234567899999999 5999999999986543 45899999966
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++. .+... ..+++..+..++.||+.||.+||+.|++|+||+|+||++++ +.++|+|||.+....... ....+++
T Consensus 105 ~l~-~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~ 179 (343)
T cd07880 105 DLG-KLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM--TGYVVTR 179 (343)
T ss_pred CHH-HHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccCc--cccccCC
Confidence 554 44443 47999999999999999999999999999999999999974 789999999987654432 3446688
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccc-cccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQL-ASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 231 (282)
.|+|||.+.+...++.++|+||||+++|++++|..||...+.......+.................. ........+...
T Consensus 180 ~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (343)
T cd07880 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFR 259 (343)
T ss_pred cccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccC
Confidence 8999999875445789999999999999999999999887766666665554333221110000000 000000011111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
...........+..+.++|.+||+.||++|||+.+++.||||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 260 KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred cchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 1122334456788999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=281.00 Aligned_cols=244 Identities=28% Similarity=0.469 Sum_probs=198.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.|++|++...... .....+..|+..++.+. |||++++++++.+....+++|||+.+++++.
T Consensus 32 g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~ 110 (313)
T cd06633 32 GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAWLVMEYCLGSASDL 110 (313)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEEEEEecCCCCHHHH
Confidence 78999999999999999999998754322 23345678899998884 9999999999999999999999999887766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+... ..++++..+..++.||+.||.+||++|++|+||+|+||++++ +.++|+|||.+..... .....++..|+||
T Consensus 111 l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aP 186 (313)
T cd06633 111 LEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAP 186 (313)
T ss_pred HHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCccccccccCh
Confidence 6544 347999999999999999999999999999999999999975 7899999998764332 2345678889999
Q ss_pred hhhhc--cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 158 EVLLL--SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 158 E~~~~--~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|.+.. ...++.++|+||||+++|+|++|..||...+............. +
T Consensus 187 E~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-~--------------------------- 238 (313)
T cd06633 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-P--------------------------- 238 (313)
T ss_pred hhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-C---------------------------
Confidence 99842 34478899999999999999999999987766555544322100 0
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.......+..+.+|+.+||+.+|.+||++.+++.||||+...
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 011224567899999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=278.26 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=194.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc--CCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE--HEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~ 78 (282)
|++|.||+|.+..+++.+++|.+...........+.+|+..+.++ +||||+++++++.. ...++++|||++++.+..
T Consensus 12 g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 90 (287)
T cd06621 12 GAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS 90 (287)
T ss_pred CCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHH
Confidence 789999999999999999999988665445566778899999888 59999999998754 347899999998766655
Q ss_pred HHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccc
Q 044127 79 MKE---RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWY 154 (282)
Q Consensus 79 ~~~---~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 154 (282)
+.. .....+++..+..++.||+.||.|||+.|++|+||+|+||++++ +.++|+|||++........ ....++..|
T Consensus 91 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y 169 (287)
T cd06621 91 IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-GTFTGTSFY 169 (287)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc-ccccCCccc
Confidence 433 22346899999999999999999999999999999999999985 7899999999876543322 234567789
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS--ADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
+|||.+.+.. ++.++|+||||+++|+|++|..||..... ..... ............. .
T Consensus 170 ~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~--------------~---- 229 (287)
T cd06621 170 MAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIE-LLSYIVNMPNPEL--------------K---- 229 (287)
T ss_pred cCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHH-HHHHHhcCCchhh--------------c----
Confidence 9999987444 78999999999999999999999986632 11111 1111111000000 0
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.........++.+.+||.+||..+|++|||+.+++.||||++..
T Consensus 230 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 230 -DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred -cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 00001113467899999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=281.61 Aligned_cols=245 Identities=26% Similarity=0.490 Sum_probs=197.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||++.+..+++.|++|.+.... ......+.+|+..++.+. |||++++++.+...+..++|+||+.++.+..++
T Consensus 30 g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 107 (293)
T cd06647 30 GASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENK-HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV 107 (293)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcEEEEEecCCCCcHHHHH
Confidence 789999999998899999999986543 233456678888888885 999999999999999999999999987777776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
.. ..+++..+..++.|++.||.+||++|++|+||+|+||++++ +.++|+|||.+....... ......+++.|+|||
T Consensus 108 ~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE 185 (293)
T cd06647 108 TE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185 (293)
T ss_pred hh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCch
Confidence 65 35889999999999999999999999999999999999985 789999999876553322 123345778899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.... ++.++|+||||+++|++++|..||...+........... +. .....
T Consensus 186 ~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~--------------------------~~~~~ 237 (293)
T cd06647 186 VVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GT--------------------------PELQN 237 (293)
T ss_pred hhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CC--------------------------CCCCC
Confidence 987544 789999999999999999999999876544332211100 00 00112
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
+..++..+.+++++||..+|.+||++++++.|+||+...
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 234677899999999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=271.95 Aligned_cols=242 Identities=29% Similarity=0.540 Sum_probs=200.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||++.+..+++.+++|++..... .....+.+|+..++.+. ||+++.+++.+......++++||+++..+..+.
T Consensus 11 g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 88 (253)
T cd05122 11 GGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL 88 (253)
T ss_pred CCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEEecCCCCcHHHHH
Confidence 7899999999998999999999977543 35567778999898886 999999999999999999999999987787777
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCchh
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 159 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~ 159 (282)
......+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+.............++..|+|||.
T Consensus 89 ~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~ 168 (253)
T cd05122 89 KSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEV 168 (253)
T ss_pred hhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHH
Confidence 665457999999999999999999999999999999999999985 7899999999887655432345677888999999
Q ss_pred hhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccC
Q 044127 160 LLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239 (282)
Q Consensus 160 ~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
+.+.. .+.++|+||||+++|++++|..||...+........... ..+. ....
T Consensus 169 ~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~--------------------------~~~~ 220 (253)
T cd05122 169 INGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG--------------------------LRNP 220 (253)
T ss_pred HcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCC--------------------------cCcc
Confidence 87554 789999999999999999999999877554444332220 0000 0001
Q ss_pred CCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcc
Q 044127 240 PSASRESISLISRLCSWNPHMRPTAAEALEHPF 272 (282)
Q Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 272 (282)
..++..+.++|++||+.||++|||+.+++.|||
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 123788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=278.53 Aligned_cols=249 Identities=28% Similarity=0.501 Sum_probs=201.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|.+..++..|++|++..... ....+..|+..+..+ +|||++++++.+......++++||+.++.+..++
T Consensus 30 g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 106 (286)
T cd06614 30 GASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDC-KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII 106 (286)
T ss_pred CCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHH
Confidence 7899999999998899999999876543 455677899988888 4999999999999999999999999977777777
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
......++...+..++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+....... ......++..|+|||
T Consensus 107 ~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE 186 (286)
T cd06614 107 TQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186 (286)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHh
Confidence 665447999999999999999999999999999999999999984 799999999876553321 112334677899999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+.. ++.++|+||||+++|+|++|..||................ .. ....
T Consensus 187 ~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-------------------------~~~~ 238 (286)
T cd06614 187 VIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG--IP-------------------------PLKN 238 (286)
T ss_pred HhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC--CC-------------------------CCcc
Confidence 887544 7999999999999999999999998765554443322110 00 0011
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
...++..+.++|++||+.+|.+|||+.++++|+||++.-+.+
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 280 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKE 280 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCchH
Confidence 123678899999999999999999999999999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=279.47 Aligned_cols=238 Identities=31% Similarity=0.491 Sum_probs=187.4
Q ss_pred CCcceEEEEEec----CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDK----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~----~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|.||.||+|... ..+..|+||+++..........+.+|+..+.++ +||||+++++++...+..++|+|||.++.+
T Consensus 10 G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L 88 (259)
T PF07714_consen 10 GSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFLVMEYCPGGSL 88 (259)
T ss_dssp ESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEEEEE--TTEBH
T ss_pred CCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccccccccccccccccccc
Confidence 889999999987 456789999996654444577889999999999 699999999999988889999999986555
Q ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC---CCCcccc
Q 044127 77 KLMKERA-GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP---CTDYVTT 151 (282)
Q Consensus 77 ~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~---~~~~~~~ 151 (282)
..++... ...++...+..|+.||+.||.|||+++++|++|+++||+++ ++.+||+|||++........ .......
T Consensus 89 ~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~ 168 (259)
T PF07714_consen 89 DDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLP 168 (259)
T ss_dssp HHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 5555543 56799999999999999999999999999999999999998 58999999999887632211 1234566
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
..|+|||.+.... ++.++||||||+++||+++ |..||......+....+.+...
T Consensus 169 ~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~------------------------ 223 (259)
T PF07714_consen 169 LRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR------------------------ 223 (259)
T ss_dssp GGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE------------------------
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc------------------------
Confidence 7799999987555 7999999999999999999 6789888766665555533211
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.++|..||..||.+|||++++++
T Consensus 224 -----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 -----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1223457889999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=291.85 Aligned_cols=243 Identities=30% Similarity=0.466 Sum_probs=210.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||-||-|++..+...||||+...+.- ...+.+++.|+..++++. |||++.+-|.|-.+...|+|||||-|+-.+.
T Consensus 37 GSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~TaWLVMEYClGSAsDl 115 (948)
T KOG0577|consen 37 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREHTAWLVMEYCLGSASDL 115 (948)
T ss_pred CccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccchHHHHHHHHhccHHHH
Confidence 8999999999999999999999875432 355678899999999996 9999999999999999999999998865543
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+.-..+++.+.+|+.|+.+.+.||+|||+.+.+|+|||..|||+++ |.|||.|||.|...... .+.+|||.|+||
T Consensus 116 -leVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---nsFvGTPywMAP 191 (948)
T KOG0577|consen 116 -LEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---NSFVGTPYWMAP 191 (948)
T ss_pred -HHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---hcccCCccccch
Confidence 4444468999999999999999999999999999999999999986 89999999999876654 678999999999
Q ss_pred hhhh--ccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 158 EVLL--LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 158 E~~~--~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|++. ..+.|+-++||||||+++.||...++|+-+.+.+..++-+..+-. |.
T Consensus 192 EVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes-Pt-------------------------- 244 (948)
T KOG0577|consen 192 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PT-------------------------- 244 (948)
T ss_pred hHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-CC--------------------------
Confidence 9984 445689999999999999999999999999988888887765321 11
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
--....+..+++|+..||+.-|.+|||.+++|.|+|....
T Consensus 245 -Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 245 -LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred -CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 0134568899999999999999999999999999998643
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=277.77 Aligned_cols=239 Identities=22% Similarity=0.373 Sum_probs=192.2
Q ss_pred CCcceEEEEEecCCC-----cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSG-----EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.+...+ ..|++|.+...........+.+|+..+.++ +||||+++++++......+++|||+.++.
T Consensus 16 G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 94 (283)
T cd05048 16 GAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQPTCMLFEYLAHGD 94 (283)
T ss_pred ccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCCceEEEEecCCCCc
Confidence 789999999876554 679999987655444455677899999888 49999999999999899999999998766
Q ss_pred HHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccccc
Q 044127 76 LKLMKERAG---------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI 139 (282)
Q Consensus 76 l~~~~~~~~---------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~ 139 (282)
+..++.... ..+++..+..++.|++.||.+||++|++|+||||+||++++ +.++|+|||++...
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~ 174 (283)
T cd05048 95 LHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174 (283)
T ss_pred HHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeec
Confidence 665554321 35889999999999999999999999999999999999975 68999999998754
Q ss_pred CCCC---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccc
Q 044127 140 DSSL---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPL 215 (282)
Q Consensus 140 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (282)
.... ......+++.|+|||.+.... ++.++|||||||++|||++ |..||.+....+....+....
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~---------- 243 (283)
T cd05048 175 YSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ---------- 243 (283)
T ss_pred cccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 3221 122345577899999987544 7999999999999999998 999998877665544432211
Q ss_pred cccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 216 GIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
....+..+++.+.+++.+||+.||.+||++++++++
T Consensus 244 -------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 244 -------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred -------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=278.12 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=197.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||++.+..+++.|++|++...........+.+|+.++..+ +||||+++++.+.....++++|||++++++..+.
T Consensus 16 g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 94 (284)
T cd06620 16 GNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY 94 (284)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEEEecCCCCCHHHHH
Confidence 789999999999999999999887654344456778899999998 4999999999999999999999999988887776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
... +.+++..+..++.|++.||.|||+ .+++|+||+|+||++++ +.++|+|||++....... .....++..|+|||
T Consensus 95 ~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-~~~~~~~~~~~aPE 172 (284)
T cd06620 95 KKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-ADTFVGTSTYMSPE 172 (284)
T ss_pred Hhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-cCccccCcccCCHH
Confidence 654 369999999999999999999997 58999999999999985 789999999876543322 23456888999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHH----HH---HHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQ----IY---KICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~----~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.+.+. .++.++|+|||||++|++++|..||........ .. ..........
T Consensus 173 ~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------- 229 (284)
T cd06620 173 RIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---------------------- 229 (284)
T ss_pred HHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----------------------
Confidence 98754 478999999999999999999999986554211 00 1111100000
Q ss_pred CCcccccC-CCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 232 GVNLRELS-PSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 232 ~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
....+ ...+..+.+|+.+||+.||.+|||++++++|+||.+.
T Consensus 230 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 230 ---PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred ---CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00011 1257789999999999999999999999999999553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=281.16 Aligned_cols=240 Identities=25% Similarity=0.376 Sum_probs=187.3
Q ss_pred CCcceEEEEEecCCCcE--EEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEF--VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~--v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.++.++.. +++|.............+.+|+.++.++.+||||+++++++...+..++++||+.++.+..
T Consensus 18 G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 97 (303)
T cd05088 18 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 97 (303)
T ss_pred CCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHH
Confidence 89999999998877754 5777766543344555677899999999779999999999999999999999998766665
Q ss_pred HHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC
Q 044127 79 MKERA---------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 142 (282)
Q Consensus 79 ~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~ 142 (282)
++... +..+++..+..++.||+.||.+||++|++|+||||+||++++ +.++|+|||++......
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 177 (303)
T cd05088 98 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 177 (303)
T ss_pred HHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchh
Confidence 55432 135889999999999999999999999999999999999974 79999999998643222
Q ss_pred CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 143 LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 143 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
........+..|+|||.+.+. .++.++|||||||++|+|++ |..||......+.........
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---------------- 240 (303)
T cd05088 178 VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---------------- 240 (303)
T ss_pred hhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC----------------
Confidence 111222335679999988644 47899999999999999998 999997766554433221100
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
....+...+..+.+++.+||+.+|++||++++++.+
T Consensus 241 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 -------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred -------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001123457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=272.49 Aligned_cols=245 Identities=30% Similarity=0.520 Sum_probs=197.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||+|.+..+++.|++|.++..... .....+..|+.+++++ +||||+++++.+...+..++++||+.++++..+
T Consensus 11 G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (264)
T cd06626 11 GTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFMEYCSGGTLEEL 89 (264)
T ss_pred CCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEEecCCCCcHHHH
Confidence 88999999999989999999998766543 3556678899999999 599999999999999999999999998888777
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCC-----Ccccccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCT-----DYVTTRW 153 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~-----~~~~~~~ 153 (282)
.... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+.......... ...++..
T Consensus 90 ~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T cd06626 90 LEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168 (264)
T ss_pred Hhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcC
Confidence 7654 35899999999999999999999999999999999999985 789999999988764432211 2456788
Q ss_pred ccCchhhhccc--cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 154 YRAPEVLLLSE--IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 154 ~~aPE~~~~~~--~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
|+|||.+.... ..+.++||||||++++++++|+.||............... +. ....
T Consensus 169 ~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~--~~~~------------------ 227 (264)
T cd06626 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GH--KPPI------------------ 227 (264)
T ss_pred ccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CC--CCCC------------------
Confidence 99999987433 2688999999999999999999999765433322221111 10 0000
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
......++.+.++|++||+.+|.+|||+.+++.|||+
T Consensus 228 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 228 -----PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred -----CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0112348889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=291.02 Aligned_cols=239 Identities=29% Similarity=0.483 Sum_probs=197.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+|+.|-.+.+..+++.+++|++.+. ..+..+|..++....+|||++++.+++.++.+.|+|||.+.|+.+-..+
T Consensus 333 gs~s~~~~~~~~~t~~~~~vkii~~~-----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri 407 (612)
T KOG0603|consen 333 GSFSAVKYCESSPTDQEPAVKIISKR-----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRI 407 (612)
T ss_pred CCccceeeeeccccccchhheecccc-----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHH
Confidence 68899999999999999999999775 2333446667777778999999999999999999999999975554444
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee--CCcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
... +.....+..|+.+|+.|+.+||++|++||||||+|||++ .+.++|+|||.+...... ....+-|..|.|||
T Consensus 408 ~~~--~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APE 483 (612)
T KOG0603|consen 408 RSK--PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPE 483 (612)
T ss_pred Hhc--chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChh
Confidence 432 334478888999999999999999999999999999994 478999999999877665 35567788999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
+.... .++.++|+||||++||+|++|+.||........+. ..++.+ ..
T Consensus 484 vl~~~-~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~---~~i~~~----------------------------~~ 531 (612)
T KOG0603|consen 484 VLAIQ-EYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH---TRIQMP----------------------------KF 531 (612)
T ss_pred hhccC-CCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH---HhhcCC----------------------------cc
Confidence 99844 48999999999999999999999998877763332 322222 12
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
...+|+..++||+.||++||.+||++++++.||||-+..+.|
T Consensus 532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t~p 573 (612)
T KOG0603|consen 532 SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPTFP 573 (612)
T ss_pred ccccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCCCCC
Confidence 246899999999999999999999999999999995544433
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=273.66 Aligned_cols=242 Identities=33% Similarity=0.588 Sum_probs=196.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||.||+|.++.+|..+++|.+...... .......+|+..++.+. |||++++++.+......++++||+.++.+..+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (257)
T cd08225 11 GSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVMEYCDGGDLMKR 89 (257)
T ss_pred CCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEEecCCCCcHHHH
Confidence 78999999999999999999998765332 23445668999888884 99999999999999999999999987666555
Q ss_pred HHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCC--cEEEeecCcccccCCCCCC-CCcccccccc
Q 044127 80 KER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG--VIKIGDLGMVKEIDSSLPC-TDYVTTRWYR 155 (282)
Q Consensus 80 ~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~--~~~l~df~~~~~~~~~~~~-~~~~~~~~~~ 155 (282)
... .+..+++..+..++.|+++||.+||+.+++|+||+|+||++++. .++++|||.+......... ....+++.|+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 169 (257)
T cd08225 90 INRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYL 169 (257)
T ss_pred HHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCcccc
Confidence 443 33458999999999999999999999999999999999999753 5799999988766443221 2345788899
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||.+... .++.++|+||||++++++++|..||...+............ .
T Consensus 170 ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~ 219 (257)
T cd08225 170 SPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-----------------------------F 219 (257)
T ss_pred CHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-----------------------------C
Confidence 99988744 47899999999999999999999998766555444322210 0
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.......+..+.++|.+||..+|++|||+++++.||||
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 11234567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=276.61 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=193.3
Q ss_pred CCcceEEEEEecC-----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKK-----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.++. .+..|++|.+...........+.+|...++.+ +||||+++++++.+....+++|||+.++.
T Consensus 17 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 95 (288)
T cd05061 17 GSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKGQPTLVVMELMAHGD 95 (288)
T ss_pred CCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEeCCCCCC
Confidence 8999999997652 35579999987654444445567888888888 59999999999999999999999998766
Q ss_pred HHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-
Q 044127 76 LKLMKERAG---------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP- 144 (282)
Q Consensus 76 l~~~~~~~~---------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~- 144 (282)
+..++.... ...+...+..++.|++.||.+||+++++|+||||+||++++ +.++|+|||.+........
T Consensus 96 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~ 175 (288)
T cd05061 96 LKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 175 (288)
T ss_pred HHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccc
Confidence 666654321 23567788999999999999999999999999999999985 7899999999875432211
Q ss_pred --CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 145 --CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 145 --~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
.....++..|+|||.+.++. ++.++|+|||||++|++++ |..||......+....+.....
T Consensus 176 ~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~--------------- 239 (288)
T cd05061 176 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY--------------- 239 (288)
T ss_pred cccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 12223466799999987544 7999999999999999998 7888987665554433322100
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc------CcccccccC
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE------HPFFRSCHF 278 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------~~~~~~~~~ 278 (282)
...+...++.+.+++++||+.||++|||+.++++ ||||+++.|
T Consensus 240 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 240 --------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 0112345788999999999999999999999987 999999865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=272.96 Aligned_cols=242 Identities=30% Similarity=0.575 Sum_probs=200.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||++.+..+++.|++|++...... ........|+..++.+. |||++++.+.+......++++|+++++.+...
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 89 (258)
T cd08215 11 GSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVMEYADGGDLSQK 89 (258)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEEEecCCCcHHHH
Confidence 78999999999989999999998765433 44556678888898885 99999999999999999999999997666655
Q ss_pred HHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccc
Q 044127 80 KERA---GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWY 154 (282)
Q Consensus 80 ~~~~---~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~ 154 (282)
+... +..+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+....... ......+++.|
T Consensus 90 l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y 169 (258)
T cd08215 90 IKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYY 169 (258)
T ss_pred HHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecc
Confidence 5543 357999999999999999999999999999999999999986 899999999988765443 22345678889
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||.+.... .+.++|+||+|++++++++|..||......+.........
T Consensus 170 ~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------------- 219 (258)
T cd08215 170 LSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ----------------------------- 219 (258)
T ss_pred cChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-----------------------------
Confidence 9999887444 7899999999999999999999998776554444332211
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
....+...+..+.+++++||..+|++|||+.++|+||||
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 112233668899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=278.93 Aligned_cols=240 Identities=25% Similarity=0.351 Sum_probs=188.2
Q ss_pred CCcceEEEEEecCCCc--EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGE--FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~--~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|..+.++. .+++|.++..........+..|+.++.++.+||||+++++++...+..++++||+.++.+..
T Consensus 13 g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (297)
T cd05089 13 GNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLD 92 (297)
T ss_pred CCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHH
Confidence 8999999999877664 46888876433334455678899999999779999999999999999999999998766655
Q ss_pred HHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC
Q 044127 79 MKERAG---------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 142 (282)
Q Consensus 79 ~~~~~~---------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~ 142 (282)
++.... ..+++..+..++.|++.||++||++|++|+||||+||++++ +.++|+|||++......
T Consensus 93 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 172 (297)
T cd05089 93 FLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY 172 (297)
T ss_pred HHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccce
Confidence 554321 24889999999999999999999999999999999999975 78999999998643322
Q ss_pred CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 143 LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 143 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
........+..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+..........
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~--------------- 236 (297)
T cd05089 173 VKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--------------- 236 (297)
T ss_pred eccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence 2222223355699999887444 7999999999999999997 9999987766554443322110
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+..++..+.+|+.+||+.+|.+|||++++++.
T Consensus 237 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 --------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01233568899999999999999999999999653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=272.91 Aligned_cols=239 Identities=26% Similarity=0.445 Sum_probs=198.4
Q ss_pred CCcceEEEEEecCC---CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKS---GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||.||+|.+... +..|++|.+...........+..|+..+..+. |||++++++++......+++|||+.++.+.
T Consensus 6 g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 84 (262)
T cd00192 6 GAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEYMEGGDLL 84 (262)
T ss_pred CCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEeccCCcHH
Confidence 89999999998866 88999999987655444667788999999996 999999999999999999999999877776
Q ss_pred HHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC---CC
Q 044127 78 LMKERA--------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PC 145 (282)
Q Consensus 78 ~~~~~~--------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~---~~ 145 (282)
.++... +..+++..++.++.|++.||++||++|++|+||+|+||++++ +.++|+|||.+....... ..
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 164 (262)
T cd00192 85 DYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK 164 (262)
T ss_pred HHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccc
Confidence 666654 357999999999999999999999999999999999999986 899999999998765432 22
Q ss_pred CCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCC
Q 044127 146 TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224 (282)
Q Consensus 146 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
....++..|+|||.+... .++.++||||||+++|+|++ |..||......+....+....
T Consensus 165 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------------------- 224 (262)
T cd00192 165 TGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY------------------- 224 (262)
T ss_pred cCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------------
Confidence 344567889999998755 48999999999999999999 589998876555444433210
Q ss_pred ccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
....+...+..+.+++.+||..+|++|||+++++++
T Consensus 225 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 ----------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ----------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 012234568899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=271.16 Aligned_cols=243 Identities=30% Similarity=0.522 Sum_probs=201.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~l~ 77 (282)
|++|.||+|.+..+++.|++|++...... .....+.+|+..++++. ||||+++++.+... ...++++|++.++.+.
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (260)
T cd06606 11 GSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLS 89 (260)
T ss_pred cCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEEEEEecCCCcHH
Confidence 78999999999999999999998765432 33456678889999985 99999999999888 8899999999887777
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---CCCcccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRW 153 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~---~~~~~~~~~ 153 (282)
.+..... .+++..++.++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+........ .....++..
T Consensus 90 ~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 168 (260)
T cd06606 90 SLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168 (260)
T ss_pred HHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCcc
Confidence 7776654 7999999999999999999999999999999999999985 8999999999887765543 345677888
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
|+|||.+.... .+.++|+||||+++++|++|..||.......... ..... ..
T Consensus 169 y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~-------------------------~~ 220 (260)
T cd06606 169 WMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL--YKIGS-------------------------SG 220 (260)
T ss_pred ccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH--Hhccc-------------------------cC
Confidence 99999987554 7999999999999999999999998766222111 11000 01
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
....++...+..+.+++.+||+.||++||++.+++.||||
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 1123445668999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=275.20 Aligned_cols=239 Identities=25% Similarity=0.395 Sum_probs=191.3
Q ss_pred CCcceEEEEEecC-----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKK-----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|++|.||+|.+.. ++..|++|.+...........+..|+..++++ +||||+++++++.+....+++|||+.++.
T Consensus 17 g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 95 (277)
T cd05036 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFERLPRFILLELMAGGD 95 (277)
T ss_pred CCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCcEEEEecCCCCC
Confidence 7899999999987 77889999987655445566788899999998 49999999999988889999999998777
Q ss_pred HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCC-
Q 044127 76 LKLMKERAG------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLP- 144 (282)
Q Consensus 76 l~~~~~~~~------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~- 144 (282)
+..++.... ..+++..+..++.||+.||.|||+++++|+||+|+||++++ ..++|+|||++........
T Consensus 96 L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~ 175 (277)
T cd05036 96 LKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175 (277)
T ss_pred HHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccce
Confidence 766655432 25899999999999999999999999999999999999974 2599999999876532211
Q ss_pred --CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 145 --CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 145 --~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
......+..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+... ..
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~-------------- 239 (277)
T cd05036 176 RKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GR-------------- 239 (277)
T ss_pred ecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc--------------
Confidence 11223346799999997554 8999999999999999997 89999876655543322111 00
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+...+..+.+++++||+.+|++|||+.++++|
T Consensus 240 --------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 --------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01234568899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=273.27 Aligned_cols=239 Identities=23% Similarity=0.362 Sum_probs=192.6
Q ss_pred CCcceEEEEEecCC---CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKS---GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||.||+|.++.+ ...|++|.++..........+.+|+..+.++ +||||+++++.+...+..+++||++.++.+.
T Consensus 15 g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 93 (266)
T cd05033 15 GEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPVMIITEYMENGSLD 93 (266)
T ss_pred CccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCceEEEEEcCCCCCHH
Confidence 89999999988654 4579999987655455556778899999888 4999999999999999999999999987777
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---CCCcccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRW 153 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~---~~~~~~~~~ 153 (282)
.++......++...+..++.|++.||.+||+++++|+||+|+||++++ +.++|+|||.+........ .....++..
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 173 (266)
T cd05033 94 KFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR 173 (266)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCcc
Confidence 777665557999999999999999999999999999999999999985 7899999999887642111 112234567
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|+|||.+... .++.++||||||+++|++++ |..||...........+......
T Consensus 174 y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------- 227 (266)
T cd05033 174 WTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL------------------------- 227 (266)
T ss_pred ccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-------------------------
Confidence 9999998744 47999999999999999998 99999776655544333221110
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++.+.+++.+||+.+|++||++++++++
T Consensus 228 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 228 ----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=289.58 Aligned_cols=244 Identities=25% Similarity=0.425 Sum_probs=213.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|.|++|.+|++.-|+..||||.+++...... .....+|+.++..+ +||||++++.+.+....+|+||||+.++-+.++
T Consensus 67 g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~y 145 (596)
T KOG0586|consen 67 GNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYLVMEYASGGELFDY 145 (596)
T ss_pred ceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEEEEEeccCchhHHH
Confidence 7899999999999999999999998765443 35578999999999 599999999999999999999999998777777
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCC-cEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
+.+++ .+.+..+..++.|+.+|++|||+++|+|+|||++||+++.. .+||+|||++..+.........+|++.|.|||
T Consensus 146 l~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPE 224 (596)
T KOG0586|consen 146 LVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPE 224 (596)
T ss_pred HHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccccCCCCCccChH
Confidence 77776 57779999999999999999999999999999999999975 59999999999998888888999999999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
++.+....+++.|+||+|+++|-|++|..||++.+-.+.-....... -.+
T Consensus 225 l~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk------------------------------~rI 274 (596)
T KOG0586|consen 225 LFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK------------------------------YRI 274 (596)
T ss_pred hhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee------------------------------ecc
Confidence 99988878999999999999999999999999876554433322211 123
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
+--++.++.++|+++|..+|.+|+++++++.|.|...-
T Consensus 275 p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 275 PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred cceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 34578899999999999999999999999999998653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=271.42 Aligned_cols=228 Identities=28% Similarity=0.403 Sum_probs=181.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|.+|.||+|+++.+++.|++|.+..... ...|...+... .|||++++++++.+....+++|||+.++.+..++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~------~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE------YSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh------hhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 8899999999999999999999876431 12233333344 4999999999999999999999999976665555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCchh
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 159 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~ 159 (282)
... ..+++..+..++.|+++||.+||++|++|+||||+||+++. +.++++|||.+....... ....++..|+|||.
T Consensus 77 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~ 153 (237)
T cd05576 77 SKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPEV 153 (237)
T ss_pred HHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCccccCCcc
Confidence 443 36999999999999999999999999999999999999985 789999999876654432 33455677999998
Q ss_pred hhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccC
Q 044127 160 LLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239 (282)
Q Consensus 160 ~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
+.... .+.++|+||+|+++|++++|..|+....... . .......+
T Consensus 154 ~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------~-------------------------~~~~~~~~ 198 (237)
T cd05576 154 GGISE-ETEACDWWSLGAILFELLTGKTLVECHPSGI---------N-------------------------THTTLNIP 198 (237)
T ss_pred cCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchhc---------c-------------------------cccccCCc
Confidence 86444 6889999999999999999998765321100 0 00001233
Q ss_pred CCCChhhHHHHHHHhCCCCCCCCCH-----HHHhcCccc
Q 044127 240 PSASRESISLISRLCSWNPHMRPTA-----AEALEHPFF 273 (282)
Q Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~~~~ 273 (282)
..+++.+.++|.+||+.||++||++ +++++||||
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 4578899999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=270.66 Aligned_cols=240 Identities=35% Similarity=0.538 Sum_probs=197.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||++.+..+++.+++|++....... ....+..|+..++++. |||++++++.+..+...+++||++.++.+..
T Consensus 4 G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 82 (250)
T cd05123 4 GSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGELFS 82 (250)
T ss_pred CCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCcHHH
Confidence 899999999999889999999987654322 3446677888888885 9999999999999999999999997666665
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~a 156 (282)
+.... ..+++..+..++.|++.||.+||+.+++|+||+|+||++++ +.++|+|||.+...... .......++..|+|
T Consensus 83 ~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (250)
T cd05123 83 HLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLA 161 (250)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccC
Confidence 55554 36899999999999999999999999999999999999985 78999999998776443 22345567888999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||...+.. .+.++|+||||+++|++++|..||...+.......+.. . ..
T Consensus 162 Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~----------------------------~~ 210 (250)
T cd05123 162 PEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D----------------------------PL 210 (250)
T ss_pred hHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C----------------------------CC
Confidence 99987544 78899999999999999999999977665443333222 0 01
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH---HHHhcCccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA---AEALEHPFF 273 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~---~~ll~~~~~ 273 (282)
..+...+..+.+++++||..||++||++ +++++||||
T Consensus 211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 2334558899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=282.07 Aligned_cols=241 Identities=25% Similarity=0.381 Sum_probs=187.9
Q ss_pred CCcceEEEEEecC-----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc-cCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKK-----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK-EHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-~~~~~~lv~e~~~~~ 74 (282)
|+||.||+|.+.. +++.|++|++..............|+..+.++.+||||+++++.+. .....++++||+.++
T Consensus 18 G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~ 97 (337)
T cd05054 18 GAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFG 97 (337)
T ss_pred CcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCC
Confidence 8999999997543 4578999999765434444567789999999977999999999875 446788999999987
Q ss_pred HHHHHHHhc------------------------------------------------------------CCCCCHHHHHH
Q 044127 75 LLKLMKERA------------------------------------------------------------GQNFSEDEVRN 94 (282)
Q Consensus 75 ~l~~~~~~~------------------------------------------------------------~~~l~~~~~~~ 94 (282)
.+..++... ...++...+..
T Consensus 98 ~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 177 (337)
T cd05054 98 NLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLIS 177 (337)
T ss_pred CHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHH
Confidence 776665431 12588999999
Q ss_pred HHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC---CCCCccccccccCchhhhccccCCCcc
Q 044127 95 LCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEIYGPEV 170 (282)
Q Consensus 95 i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~ 170 (282)
++.||+.||.|||++|++|+||||+||++++ +.++|+|||++..+.... ......++..|+|||.+.+. .++.++
T Consensus 178 ~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~ 256 (337)
T cd05054 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK-VYTTQS 256 (337)
T ss_pred HHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCC-CCCccc
Confidence 9999999999999999999999999999984 789999999988653221 11233456779999998754 489999
Q ss_pred hhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHH
Q 044127 171 DMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISL 249 (282)
Q Consensus 171 DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (282)
|||||||++|+|++ |..||......+........... ...+...++.+.++
T Consensus 257 Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~l 308 (337)
T cd05054 257 DVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR----------------------------MRAPEYATPEIYSI 308 (337)
T ss_pred cHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC----------------------------CCCCccCCHHHHHH
Confidence 99999999999998 99999775544433322221000 01123567889999
Q ss_pred HHHHhCCCCCCCCCHHHHhcC
Q 044127 250 ISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 250 i~~~l~~dp~~Rps~~~ll~~ 270 (282)
+.+||+.+|++||++++++++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=289.84 Aligned_cols=239 Identities=22% Similarity=0.327 Sum_probs=195.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|.||+||+|++=+ .||||+++-...+.. ...+.+|+..+++.+ |.||+.+.|++..+.. .||+-||.|++|-..
T Consensus 403 GsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~h 477 (678)
T KOG0193|consen 403 GSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR-HENILLFMGACMNPPL-AIITQWCEGSSLYTH 477 (678)
T ss_pred ccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCce-eeeehhccCchhhhh
Confidence 8999999998753 599999987665544 456778999999996 9999999999999877 999999999777666
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccccc---CCCCCCCCcccccccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI---DSSLPCTDYVTTRWYR 155 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~---~~~~~~~~~~~~~~~~ 155 (282)
+.....+|.......|++||++|+.|||.++|+|+|||..||++.+ +.|||+|||++... ..........+...|+
T Consensus 478 lHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwm 557 (678)
T KOG0193|consen 478 LHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWM 557 (678)
T ss_pred ccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhh
Confidence 5555567999999999999999999999999999999999999986 89999999998854 2233334557788899
Q ss_pred Cchhhhcc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 156 APEVLLLS--EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 156 aPE~~~~~--~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
|||++..+ .+++..+||||||+++|||++|..||.....+.++..+-++ +...
T Consensus 558 APEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG-------------------------~l~p 612 (678)
T KOG0193|consen 558 APEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG-------------------------YLMP 612 (678)
T ss_pred cHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc-------------------------ccCc
Confidence 99999643 56899999999999999999999999955554444322111 1122
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
++.......+.++++|+..||..++++||++.+||.
T Consensus 613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 333444567889999999999999999999999886
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=275.20 Aligned_cols=238 Identities=26% Similarity=0.410 Sum_probs=192.5
Q ss_pred CCcceEEEEEecC-----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKK-----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.+.. ++..|++|.++..........+.+|+.+++.+. ||||+++++++......+++|||+.++.
T Consensus 16 g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 94 (280)
T cd05049 16 GAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ-HENIVKFYGVCTEGDPPIMVFEYMEHGD 94 (280)
T ss_pred cCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC-CCCchheeeEEecCCCeEEEEecCCCCC
Confidence 8999999998753 467899999977654445667788999999985 9999999999999999999999999877
Q ss_pred HHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC
Q 044127 76 LKLMKERAG-------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS 141 (282)
Q Consensus 76 l~~~~~~~~-------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~ 141 (282)
+..++...+ ..+++..+..++.|++.|+.+||++|++|+||+|+||++++ +.++|+|||.+.....
T Consensus 95 L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~ 174 (280)
T cd05049 95 LNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT 174 (280)
T ss_pred HHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceeccc
Confidence 777665432 34789999999999999999999999999999999999974 8999999999875432
Q ss_pred CC---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccc
Q 044127 142 SL---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGI 217 (282)
Q Consensus 142 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (282)
.. ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+....
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~------------ 241 (280)
T cd05049 175 TDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR------------ 241 (280)
T ss_pred CcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence 21 112334567899999987544 8999999999999999998 999998776665544432110
Q ss_pred cccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 218 QLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+...+..+.+++++||+.||.+||+++++++
T Consensus 242 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 242 -----------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred -----------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 01122356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=276.89 Aligned_cols=243 Identities=28% Similarity=0.447 Sum_probs=198.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|++..++..|++|++...... .....+..|+..++++. |||++++++++.++...+++|||+.|++++.
T Consensus 36 G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g~l~~~ 114 (317)
T cd06635 36 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTAWLVMEYCLGSASDL 114 (317)
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeEEEEEeCCCCCHHHH
Confidence 78999999999999999999998754322 23346678999998884 9999999999999999999999999887766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+... ..++++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||++...... ....++..|+||
T Consensus 115 ~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aP 190 (317)
T cd06635 115 LEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---NSFVGTPYWMAP 190 (317)
T ss_pred HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---ccccCCccccCh
Confidence 5543 356999999999999999999999999999999999999975 78999999987654432 345678889999
Q ss_pred hhhhc--cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 158 EVLLL--SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 158 E~~~~--~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|.+.. ....+.++|+|||||++|+|++|..||...........+.......
T Consensus 191 E~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------- 243 (317)
T cd06635 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--------------------------- 243 (317)
T ss_pred hhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------------------------
Confidence 99742 3447889999999999999999999998766555554443321100
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
......++.+.+++.+||+.+|.+||++.++++|+|+...
T Consensus 244 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 244 -LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred -CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 1122457789999999999999999999999999998554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=268.82 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=208.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+|++..++.+|+..|||.+.......+..+++.|.....+-.++|+||++||..-.++..||-||.|+-++-..+.
T Consensus 75 G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~SlDklYk 154 (361)
T KOG1006|consen 75 GAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISLDKLYK 154 (361)
T ss_pred CcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhHHHHHH
Confidence 89999999999999999999999987766777888899999888889999999999998889999999999865544332
Q ss_pred ---HhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccccccc
Q 044127 81 ---ERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 155 (282)
Q Consensus 81 ---~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 155 (282)
......++|+.+..|......||.||.. ..|+|||+||+|||++. |.+||||||.+..+..+.-.+...|...|+
T Consensus 155 ~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYm 234 (361)
T KOG1006|consen 155 RVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYM 234 (361)
T ss_pred HHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCcccc
Confidence 2223469999999999999999999986 47999999999999996 999999999988877666667778889999
Q ss_pred Cchhhhcccc-CCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 156 APEVLLLSEI-YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 156 aPE~~~~~~~-~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
|||.+..... ++.+||+||||++|||+.||..|+...++ ...+++.....-++.....
T Consensus 235 APERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~~------------------- 293 (361)
T KOG1006|consen 235 APERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLFD------------------- 293 (361)
T ss_pred ChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecCc-------------------
Confidence 9999964443 89999999999999999999999987654 3333333221111111100
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.-.-.++..++.||..||..|-+.||..++++.+||++...
T Consensus 294 --~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 294 --KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred --ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 01124788999999999999999999999999999998653
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=273.44 Aligned_cols=239 Identities=26% Similarity=0.374 Sum_probs=187.1
Q ss_pred CCcceEEEEEecCCCc--EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGE--FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~--~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|++..++. .+++|.++..........+..|+..+.++.+||||+++++++...+..+++|||+.++.+..
T Consensus 6 g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 85 (270)
T cd05047 6 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85 (270)
T ss_pred CCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHH
Confidence 8999999999888775 46888887543344455677899999999779999999999999999999999998766665
Q ss_pred HHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC
Q 044127 79 MKERAG---------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 142 (282)
Q Consensus 79 ~~~~~~---------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~ 142 (282)
++.... ..+++..+..++.|++.||++||++|++|+||||+||++++ +.++++|||++......
T Consensus 86 ~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~ 165 (270)
T cd05047 86 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 165 (270)
T ss_pred HHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchh
Confidence 554321 24889999999999999999999999999999999999975 79999999997643322
Q ss_pred CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 143 LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 143 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
........+..|+|||.+... .++.++|+||||+++|+|++ |..||...+..+....+....
T Consensus 166 ~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---------------- 228 (270)
T cd05047 166 VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---------------- 228 (270)
T ss_pred hhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC----------------
Confidence 111222335679999988644 47999999999999999997 999997765544433321100
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+...+..+.+++.+||..||.+|||+++++.
T Consensus 229 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 -------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00112346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=271.63 Aligned_cols=236 Identities=24% Similarity=0.424 Sum_probs=189.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|.++.+++.|++|.+... ......+.+|+..++++. |||++++++++......+++|||++++.+..++
T Consensus 17 g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 93 (263)
T cd05052 17 GQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 93 (263)
T ss_pred cccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEEEEEeCCCCcHHHHH
Confidence 78999999999999999999998754 233456778999999984 999999999999999999999999876666555
Q ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCC--CccccccccC
Q 044127 81 ER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCT--DYVTTRWYRA 156 (282)
Q Consensus 81 ~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~a 156 (282)
.. ....+++..+..++.|+++||++||++|++|+||+|+||++++ +.++|+|||.+.......... ....+..|+|
T Consensus 94 ~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~a 173 (263)
T cd05052 94 RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 173 (263)
T ss_pred HhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCC
Confidence 43 3446899999999999999999999999999999999999975 789999999987664332111 1223457999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+.+.. ++.++|||||||++|+|++ |..||......+....+.....
T Consensus 174 PE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------- 223 (263)
T cd05052 174 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR----------------------------- 223 (263)
T ss_pred HHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-----------------------------
Confidence 99887444 7899999999999999998 8999987655444333221100
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 1223457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=276.73 Aligned_cols=244 Identities=28% Similarity=0.454 Sum_probs=197.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|++|+||+|+++.++..+++|.+..... ......+..|+..++.+ +|||++++.+++......++|+||+.+++.+.
T Consensus 26 g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~ 104 (308)
T cd06634 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 104 (308)
T ss_pred CCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeEEEEEccCCCHHHH
Confidence 7899999999999999999999864322 23344567899989988 59999999999999999999999999877665
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+... ...+++..+..++.|++.||.+||+.+++|+||+|+||++++ +.++++|||++...... ....++..|+||
T Consensus 105 ~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aP 180 (308)
T cd06634 105 LEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAP 180 (308)
T ss_pred HHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---ccccCCccccCH
Confidence 5443 356999999999999999999999999999999999999975 78999999988765432 344678889999
Q ss_pred hhhhc--cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 158 EVLLL--SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 158 E~~~~--~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|.+.+ ....+.++|||||||++|+|++|..||......+.......... .
T Consensus 181 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~ 232 (308)
T cd06634 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES----------------------------P 232 (308)
T ss_pred HHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC----------------------------C
Confidence 99752 23468899999999999999999999877655444433322110 0
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.......+..+.++|++||+.+|.+||+++++++|+|+....
T Consensus 233 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 011235678899999999999999999999999999997653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=275.24 Aligned_cols=241 Identities=31% Similarity=0.505 Sum_probs=197.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|++|.||+|.+..+++.|++|++...... ........|..++.++.+||||+++++++..++..+++||++.++.+..
T Consensus 12 g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (280)
T cd05581 12 GSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQ 91 (280)
T ss_pred CCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHH
Confidence 78999999999999999999998764322 2345567788888888569999999999999999999999997766666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-------------
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP------------- 144 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~------------- 144 (282)
++...+ .+++..+..++.|++.||.+||+.|++|+||+|+||+++. +.++++|||.+........
T Consensus 92 ~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~ 170 (280)
T cd05581 92 YIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170 (280)
T ss_pred HHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccc
Confidence 666543 6999999999999999999999999999999999999985 8999999999876543221
Q ss_pred --------CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccc
Q 044127 145 --------CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLG 216 (282)
Q Consensus 145 --------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (282)
.....++..|+|||.+.... .+.++|+||||++++++++|..||................
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 238 (280)
T cd05581 171 QIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE----------- 238 (280)
T ss_pred cccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC-----------
Confidence 11234577899999887444 7889999999999999999999998776444433332110
Q ss_pred ccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCH----HHHhcCccc
Q 044127 217 IQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTA----AEALEHPFF 273 (282)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~~~~~ 273 (282)
...+..+++.+.++|++||+.+|++|||+ +++++||||
T Consensus 239 -------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 -------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred -------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 12234568899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=269.58 Aligned_cols=237 Identities=22% Similarity=0.325 Sum_probs=188.4
Q ss_pred CCcceEEEEEec--CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDK--KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|.+. .++..|++|+............+.+|+.+++++ +||||+++++++.. ...++||||+.++.+..
T Consensus 6 G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~ 83 (257)
T cd05115 6 GNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA-EALMLVMEMASGGPLNK 83 (257)
T ss_pred CCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHH
Confidence 899999999765 445679999987654444455677899999998 59999999998864 57899999999877777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC----CCcccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC----TDYVTTRW 153 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~----~~~~~~~~ 153 (282)
++......+++..++.++.||+.||.+||++|++|+||||+||++++ +.++|+|||.+......... ....++..
T Consensus 84 ~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 163 (257)
T cd05115 84 FLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK 163 (257)
T ss_pred HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcc
Confidence 76654457999999999999999999999999999999999999985 68999999998755332211 11223467
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|+|||.+.... ++.++||||||+++|++++ |..||......+....+.....
T Consensus 164 y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------------------- 216 (257)
T cd05115 164 WYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR-------------------------- 216 (257)
T ss_pred cCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--------------------------
Confidence 99999987444 7899999999999999996 9999988766655443322110
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...++.+.+++.+||..||++||+++++++
T Consensus 217 ---~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 ---LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1223456889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=269.94 Aligned_cols=235 Identities=27% Similarity=0.439 Sum_probs=187.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||++..+. +..+++|.+.... .....+.+|+..++++. ||||+++++++.+....+++|||+.++.+..++
T Consensus 15 G~~~~vy~~~~~~-~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~ 90 (256)
T cd05114 15 GQFGVVHLGKWRA-QIKVAIKAINEGA--MSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL 90 (256)
T ss_pred CcCceEEEEEecc-CceEEEEecccCC--ccHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEEEEcCCCCcHHHHH
Confidence 8999999998764 5579999876543 23456778999999985 999999999999999999999999876666665
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC--CCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aP 157 (282)
......+++..+..++.|++.||.+||++|++|+||+|+||++++ +.++++|||.+......... ....++..|+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aP 170 (256)
T cd05114 91 RQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPP 170 (256)
T ss_pred HhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCCh
Confidence 543346899999999999999999999999999999999999975 78999999988765332211 122345679999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+... .++.++|+||||+++|++++ |+.||...+..+....+......
T Consensus 171 E~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----------------------------- 220 (256)
T cd05114 171 EVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL----------------------------- 220 (256)
T ss_pred hhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-----------------------------
Confidence 998744 47899999999999999999 89999877766655554331110
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...+..+.+++.+||+.+|++|||++++++
T Consensus 221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=297.97 Aligned_cols=274 Identities=23% Similarity=0.370 Sum_probs=187.0
Q ss_pred CCcceEEEEEecCCC-cEEEEE--------------Ecccc--ccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 044127 1 GSYGDVFQALDKKSG-EFVAVK--------------KLKKK--IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHED 63 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~-~~v~vK--------------~~~~~--~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~ 63 (282)
|+||+||+|..+... ...+.| .+.+. ........+.+|+.++.++ +||||+++++++...+.
T Consensus 159 G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 237 (501)
T PHA03210 159 GAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEILRSEAN 237 (501)
T ss_pred CCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCcCcEeEEEEECCe
Confidence 899999998765322 112222 11110 0112234567899999999 49999999999999999
Q ss_pred EEEEEecCCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccccc
Q 044127 64 VFIVFEYMESDLLKLMKERA---GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI 139 (282)
Q Consensus 64 ~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~ 139 (282)
.|++++++.++++..+.... ........+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++...
T Consensus 238 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~ 317 (501)
T PHA03210 238 TYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317 (501)
T ss_pred eEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceec
Confidence 99999999988887665421 122446778899999999999999999999999999999974 89999999999866
Q ss_pred CCCCC--CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCC---ChHHHHHHHHHhCCCCCCCcc
Q 044127 140 DSSLP--CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKN---SADQIYKICQVIGSPTEDSWP 214 (282)
Q Consensus 140 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 214 (282)
..... .....|+..|+|||++.+.. ++.++|||||||++|||++|..++.... ....+..+........ ..++
T Consensus 318 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~p 395 (501)
T PHA03210 318 EKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCD-EEFP 395 (501)
T ss_pred CcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccCh-hhcC
Confidence 43321 22357899999999987554 8999999999999999999876443222 2333344433332221 1121
Q ss_pred cccc-ccccCC-ccccCCCC-CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 215 LGIQ-LASNLD-WKFPQMGG-VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 215 ~~~~-~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.... ....+. ..+..... ..........+..+.++|.+||+.||.+|||+.|+|+||||.+..
T Consensus 396 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 396 DPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred CcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 1100 000000 00000000 000011124577889999999999999999999999999998753
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=297.12 Aligned_cols=237 Identities=29% Similarity=0.461 Sum_probs=200.5
Q ss_pred CCcceEEEEEecC-----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKK-----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|+... ....||||.++.....+...+|.+|+..+..+. |||||+++|++.+++.+++|+|||..+.
T Consensus 497 gaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~P~~MvFEYm~~GD 575 (774)
T KOG1026|consen 497 GAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ-HPNIVRLLGVCREGDPLCMVFEYMDHGD 575 (774)
T ss_pred chhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCCeeEEEEEeccccc
Confidence 7899999997532 345799999998877778889999999999995 9999999999999999999999999666
Q ss_pred HHHHHHhc---------CCC----CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC
Q 044127 76 LKLMKERA---------GQN----FSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS 141 (282)
Q Consensus 76 l~~~~~~~---------~~~----l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~ 141 (282)
|..++... +.. |+..+...|+.|||.|+.||-++.+||+||...|+|+.+ -.|||+|||+++.+-.
T Consensus 576 L~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYs 655 (774)
T KOG1026|consen 576 LHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYS 655 (774)
T ss_pred HHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhh
Confidence 66554432 122 889999999999999999999999999999999999987 5899999999986532
Q ss_pred CC---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccc
Q 044127 142 SL---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGI 217 (282)
Q Consensus 142 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (282)
.. -.....-+.+|||||.++.++ ++.+|||||+||+|||+++ |..||.+....+.+..+..+
T Consensus 656 sDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g------------- 721 (774)
T KOG1026|consen 656 SDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG------------- 721 (774)
T ss_pred hhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC-------------
Confidence 21 112333466799999999766 8999999999999999998 88999999999988876542
Q ss_pred cccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh
Q 044127 218 QLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268 (282)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 268 (282)
.+..-+...|.++++|+..||+..|++||++.||=
T Consensus 722 ----------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 722 ----------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred ----------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 23455678899999999999999999999999873
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=269.81 Aligned_cols=236 Identities=25% Similarity=0.423 Sum_probs=188.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||.|.+.. +..+++|.+..... ....+.+|+..+.++. ||||+++++++.+....+++|||+.++.+..++
T Consensus 15 G~~~~vy~~~~~~-~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i 90 (256)
T cd05113 15 GQFGVVKYGKWRG-QYDVAIKMIKEGSM--SEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL 90 (256)
T ss_pred cccceEEEEEecC-CCcEEEEEcCCCcc--cHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHH
Confidence 7899999998764 44699998875432 2355778999999885 999999999999988999999999887777666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aP 157 (282)
......+++..++.++.||+.||.+||+.|++|+||+|+||++++ +.++|+|||.+........ .....++..|+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~p 170 (256)
T cd05113 91 REHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170 (256)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCH
Confidence 654457999999999999999999999999999999999999985 7899999998875533221 1122345679999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.+.. ++.++||||||+++|+|++ |..||...+..+....+......
T Consensus 171 e~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------- 220 (256)
T cd05113 171 EVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL----------------------------- 220 (256)
T ss_pred HHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----------------------------
Confidence 9987544 7899999999999999998 99999877665554443322110
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...+..+++++.+||+.||.+||++.+++.+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 1122357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=276.10 Aligned_cols=240 Identities=24% Similarity=0.403 Sum_probs=191.3
Q ss_pred CCcceEEEEEecCC-----CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKS-----GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||++.+... ...+++|.+...........+.+|+..++++.+||||+++++++..++..+++|||+.++.
T Consensus 23 g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~ 102 (293)
T cd05053 23 GAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGN 102 (293)
T ss_pred cccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCc
Confidence 78999999987643 3789999987654444555678899999998679999999999999999999999998777
Q ss_pred HHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccccc
Q 044127 76 LKLMKER---------------AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI 139 (282)
Q Consensus 76 l~~~~~~---------------~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~ 139 (282)
+..++.. ....+++..+..++.|++.||.|||+.|++|+||||+||++++ +.++|+|||.+...
T Consensus 103 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 182 (293)
T cd05053 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182 (293)
T ss_pred HHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCcccccccc
Confidence 7666543 2346899999999999999999999999999999999999985 78999999998765
Q ss_pred CCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccc
Q 044127 140 DSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPL 215 (282)
Q Consensus 140 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (282)
..... .....++..|+|||.+.+. .++.++|||||||++|++++ |..||......+.........
T Consensus 183 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---------- 251 (293)
T cd05053 183 HHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY---------- 251 (293)
T ss_pred ccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 43221 1122345679999988644 47999999999999999997 899998766555443322110
Q ss_pred cccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 216 GIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
....+...+..+.+|+.+||..||.+|||+.+++++
T Consensus 252 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 252 -------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred -------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 001223567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=264.21 Aligned_cols=273 Identities=32% Similarity=0.573 Sum_probs=221.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeecccccc--------CCcEEEEEecC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKE--------HEDVFIVFEYM 71 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--------~~~~~lv~e~~ 71 (282)
|.||.||+|+.+.+|+.|++|+.--.... .--...++|+.++..++ |+|++.+++++.. ....|+|+++|
T Consensus 28 GtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~~r~r~t~ylVf~~c 106 (376)
T KOG0669|consen 28 GTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPTNRDRATFYLVFDFC 106 (376)
T ss_pred chHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCcccccceeeeeHHHh
Confidence 78999999999999999999876432211 12345678999999996 9999999998742 23589999999
Q ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC-----
Q 044127 72 ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC----- 145 (282)
Q Consensus 72 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~----- 145 (282)
...+.-.+-.. ..+++..++..++.++.+||.|+|...|+|||+||+|++|+. +.++|.|||+++....+...
T Consensus 107 ehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kpry 185 (376)
T KOG0669|consen 107 EHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRY 185 (376)
T ss_pred hhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCc
Confidence 87766554333 347999999999999999999999999999999999999985 99999999999765433221
Q ss_pred CCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc
Q 044127 146 TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225 (282)
Q Consensus 146 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
.....|..|++||.+.+.+.++++.|||.-||++.||+++...+.++.....+..+....+....+.||.....+-....
T Consensus 186 tnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~si 265 (376)
T KOG0669|consen 186 TNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSI 265 (376)
T ss_pred ccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhc
Confidence 22345888999999999888999999999999999999999999999999999999999999999999987776655444
Q ss_pred cccC---CCCCcccccCC--CCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 226 KFPQ---MGGVNLRELSP--SASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 226 ~~~~---~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
...+ ...+.+++..+ .-.++..+|+..+|..||.+|+.++++++|.||..
T Consensus 266 e~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 266 ELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred cCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 3222 12222222222 22567899999999999999999999999999964
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=288.48 Aligned_cols=243 Identities=28% Similarity=0.446 Sum_probs=203.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc---hHHHHHHHHHHHHHHhCCCCCeeeeccccccCC--cEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS---LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE--DVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~---~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~lv~e~~~~~~ 75 (282)
|+|-+||+|.+..+|..||--.++.+... .....+..|+.+|+.+. ||||+++++.|.+.. ...+|+|.+..|+
T Consensus 51 GafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in~iTEL~TSGt 129 (632)
T KOG0584|consen 51 GAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTINFITELFTSGT 129 (632)
T ss_pred ccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCceeeeeeecccCCc
Confidence 78889999999999999886555443332 33456778999999995 999999999997654 5889999999888
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeeC--CcEEEeecCcccccCCCCCCCCcccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG--YFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~--~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
|..+..+.+ .++...++.|++||+.||.|||++. |+|||||-+||+++. |.|||+|+|+|+....+.- ....||
T Consensus 130 Lr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a-ksvIGT 207 (632)
T KOG0584|consen 130 LREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA-KSVIGT 207 (632)
T ss_pred HHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc-ceeccC
Confidence 887777764 6999999999999999999999997 999999999999984 8999999999998765543 337999
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
|.|||||.+. ..|+...||||||+.|+||+|+.+||.......++++.+.-..
T Consensus 208 PEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi------------------------- 260 (632)
T KOG0584|consen 208 PEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI------------------------- 260 (632)
T ss_pred ccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC-------------------------
Confidence 9999999886 4589999999999999999999999987777777665544222
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.+..+.+--.+++++||.+||.. .+.|||+.|||.||||..-
T Consensus 261 --KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 261 --KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred --CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 22234445588999999999999 9999999999999999763
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=283.78 Aligned_cols=240 Identities=22% Similarity=0.356 Sum_probs=188.1
Q ss_pred CCcceEEEEEecC-----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKK-----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.+.. ++..||+|++...........+.+|+.++.++..||||+++++++.+....++|||||.++.
T Consensus 48 G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~ 127 (400)
T cd05105 48 GAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGD 127 (400)
T ss_pred CCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCc
Confidence 8999999998643 34579999997655444556788999999999679999999999999999999999998766
Q ss_pred HHHHHHhc------------------------------------------------------------------------
Q 044127 76 LKLMKERA------------------------------------------------------------------------ 83 (282)
Q Consensus 76 l~~~~~~~------------------------------------------------------------------------ 83 (282)
|..++...
T Consensus 128 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (400)
T cd05105 128 LVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSN 207 (400)
T ss_pred HHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCc
Confidence 65544321
Q ss_pred -----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccccc
Q 044127 84 -----------------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI 139 (282)
Q Consensus 84 -----------------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~ 139 (282)
...+++..+..++.||+.||.|||+.+++|+||||+||++++ +.++|+|||++...
T Consensus 208 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~ 287 (400)
T cd05105 208 YDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI 287 (400)
T ss_pred ccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceec
Confidence 124788889999999999999999999999999999999986 68999999998765
Q ss_pred CCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccc
Q 044127 140 DSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPL 215 (282)
Q Consensus 140 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (282)
..... .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||......+...........
T Consensus 288 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~-------- 358 (400)
T cd05105 288 MHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR-------- 358 (400)
T ss_pred cccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCC--------
Confidence 33221 1233456789999998744 47999999999999999997 88999776544433332221100
Q ss_pred cccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 216 GIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.+++.+||+.||++|||+.+|.+
T Consensus 359 --------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 359 --------------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred --------------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 0122356889999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=274.03 Aligned_cols=240 Identities=24% Similarity=0.375 Sum_probs=190.6
Q ss_pred CCcceEEEEEe-----cCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALD-----KKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~-----~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.+ ..++..|++|+++..........+..|+..++++.+||||+++++.+...+..+++|||+.++.
T Consensus 46 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 125 (302)
T cd05055 46 GAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125 (302)
T ss_pred cCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCc
Confidence 78999999975 3346689999987654444455677899999999679999999999999999999999998766
Q ss_pred HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---CCCccc
Q 044127 76 LKLMKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVT 150 (282)
Q Consensus 76 l~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~---~~~~~~ 150 (282)
+..++.. .+..+++.++..++.|++.||.|||+++++|+||+|+||++++ +.++++|||.+........ .....+
T Consensus 126 L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 205 (302)
T cd05055 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205 (302)
T ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCc
Confidence 6665543 3334899999999999999999999999999999999999985 6899999999876543221 122345
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
+..|+|||.+.+.. ++.++||||+||++|++++ |..||......+...........
T Consensus 206 ~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------------------- 262 (302)
T cd05055 206 PVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR---------------------- 262 (302)
T ss_pred ccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc----------------------
Confidence 67899999987554 7899999999999999998 99999876655544433221100
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...++.+.+++.+||+.+|++|||+++++.
T Consensus 263 ------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 263 ------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0112345789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=278.88 Aligned_cols=238 Identities=21% Similarity=0.341 Sum_probs=185.8
Q ss_pred CCcceEEEEEecCCCcE----EEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEF----VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~----v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|++..++.. |++|++...........+..|+.+++.+ +||||+++++++... ..+++++++.++.+
T Consensus 18 G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~~~~v~e~~~~g~l 95 (316)
T cd05108 18 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQLMPFGCL 95 (316)
T ss_pred CCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-CceeeeecCCCCCH
Confidence 89999999998766554 8999987654444555677888888888 599999999998765 56799999986666
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC---CCccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC---TDYVTTR 152 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~---~~~~~~~ 152 (282)
...+......++...+..++.||+.||+|||+.|++|+||||+||++++ +.++|+|||++......... .....+.
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 175 (316)
T cd05108 96 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175 (316)
T ss_pred HHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccce
Confidence 5555554456899999999999999999999999999999999999975 78999999999876433221 1223356
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+... .++.++||||||+++|+|++ |..||.+....+.. .+......+
T Consensus 176 ~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~----------------------- 230 (316)
T cd05108 176 KWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERL----------------------- 230 (316)
T ss_pred eecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCC-----------------------
Confidence 79999998744 47999999999999999997 99999876544432 222211000
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...+..+.+++.+||..||.+||++.+++.+
T Consensus 231 -----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 231 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1123457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=271.89 Aligned_cols=239 Identities=21% Similarity=0.358 Sum_probs=188.0
Q ss_pred CCcceEEEEEecC-----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKK-----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|.++. ++..|++|++...........+.+|+..++.+ +||||+++++++.++...+++|||+.++.
T Consensus 17 G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~~~ 95 (277)
T cd05062 17 GSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGD 95 (277)
T ss_pred ccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCeEEEEecCCCCC
Confidence 8999999998653 35679999986544344555677899988888 59999999999999999999999999877
Q ss_pred HHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-
Q 044127 76 LKLMKERAG---------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP- 144 (282)
Q Consensus 76 l~~~~~~~~---------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~- 144 (282)
+..++.... ..++...+..++.|++.||.+||+.|++|+||||+||++++ +.++|+|||++........
T Consensus 96 L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 175 (277)
T cd05062 96 LKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 175 (277)
T ss_pred HHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCccee
Confidence 776655421 23577889999999999999999999999999999999985 7899999999875533221
Q ss_pred --CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 145 --CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 145 --~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
.....++..|+|||.+.++. ++.++||||||+++|+|++ |..||................
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~---------------- 238 (277)
T cd05062 176 RKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG---------------- 238 (277)
T ss_pred ecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 11234467799999987544 7999999999999999999 688988776555444332210
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
....+...+..+.+++.+||+.||++|||+.+++++
T Consensus 239 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 -------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred -------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011223567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=268.69 Aligned_cols=236 Identities=22% Similarity=0.396 Sum_probs=187.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.++. +..+++|++..... ....+..|+..++++. ||||+++++++...+..+++||+++++.+..++
T Consensus 15 G~~~~v~~~~~~~-~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 90 (256)
T cd05059 15 GQFGVVHLGKWRG-KIDVAIKMIREGAM--SEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL 90 (256)
T ss_pred CCCceEEEeEecC-CccEEEEEeccCCC--CHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEEEecCCCCCHHHHH
Confidence 7899999998764 66799999865432 2345677999998884 999999999999999999999999877666666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC--CCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aP 157 (282)
......+++..+..++.|++.||++||+.|++|+||+|+||++++ +.++++|||.+......... ....++..|+||
T Consensus 91 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~P 170 (256)
T cd05059 91 RERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPP 170 (256)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCH
Confidence 554457899999999999999999999999999999999999975 78999999988765332111 112234579999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.+.. ++.++|+||||+++|++++ |..||......+....+....+ .
T Consensus 171 e~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~ 220 (256)
T cd05059 171 EVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR-----------------------------L 220 (256)
T ss_pred HHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-----------------------------C
Confidence 9987544 7899999999999999999 7899987665554443322110 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...+..+.+++.+||..+|++|||+.++++.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1223568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=270.36 Aligned_cols=242 Identities=32% Similarity=0.557 Sum_probs=192.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc----chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF----SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~----~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||++.+..++..+++|+.+.... .........|..+++.+ +|||++++++.+.+....++++||+.++.+
T Consensus 11 g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 89 (260)
T cd08222 11 GSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCIITEYCEGRDL 89 (260)
T ss_pred CCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEEEEEeCCCCCH
Confidence 8999999999988777677776654221 22333455688888888 599999999999999999999999998777
Q ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccccCCCC-CCCCccccc
Q 044127 77 KLMKER---AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSL-PCTDYVTTR 152 (282)
Q Consensus 77 ~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~~~~~~-~~~~~~~~~ 152 (282)
..++.. .+..+++..++.++.|++.||.+||+.|++|+||+|+||+++++.++|+|||.+....... ......+++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 169 (260)
T cd08222 90 DCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDFGVSRLLMGSCDLATTFTGTP 169 (260)
T ss_pred HHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeecccCceeecCCCcccccCCCCCc
Confidence 665542 2356999999999999999999999999999999999999999999999999887653322 223445778
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
.|+|||.+.+. .++.++|+||||+++|+|++|..||............... .
T Consensus 170 ~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~---~------------------------ 221 (260)
T cd08222 170 YYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG---P------------------------ 221 (260)
T ss_pred CccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC---C------------------------
Confidence 89999988644 4788999999999999999999999765544433332110 0
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
....+..++..+.++|.+||..+|++||++.++++||||
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 222 --TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred --CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 112234668899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=266.32 Aligned_cols=237 Identities=24% Similarity=0.421 Sum_probs=190.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|... ++..+++|.+...........+.+|+..+..+ +|||++++++++...+..+++|||+.++.+..+.
T Consensus 6 g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 83 (250)
T cd05085 6 GNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL 83 (250)
T ss_pred CCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCCCcHHHHH
Confidence 899999999865 57889999987765444455678899999888 5999999999999999999999999877777666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC--CCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~aP 157 (282)
......+++..+..++.|++.||.+||++|++|+||+|+||++++ +.++|+|||++......... .....+..|+||
T Consensus 84 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aP 163 (250)
T cd05085 84 RKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAP 163 (250)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCH
Confidence 654456899999999999999999999999999999999999975 78999999998654332111 122335679999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.... ++.++||||||+++|++++ |..||...........+..... .
T Consensus 164 E~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~ 213 (250)
T cd05085 164 EALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR-----------------------------M 213 (250)
T ss_pred HHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC-----------------------------C
Confidence 9987544 7899999999999999998 8999987655444333221100 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...+..+.+++.+||..+|.+||++.++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 122356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=268.40 Aligned_cols=246 Identities=31% Similarity=0.487 Sum_probs=210.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|.||.|-+++-+.+++.||+|++++.... .+.+.-+.|-.+++... ||.+..+.-.|+..+.+|+||||..|+-|-.
T Consensus 179 GTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlCFVMeyanGGeLf~ 257 (516)
T KOG0690|consen 179 GTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLCFVMEYANGGELFF 257 (516)
T ss_pred CccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEEEEEEEccCceEee
Confidence 88999999999999999999999987643 34455677888888885 9999999999999999999999998765544
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCccccc-CCCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~a 156 (282)
.+++. +.+++...+-....|++||.|||+++||+||+|.+|.++| +|.+|+.|||++..- .........+|||.|+|
T Consensus 258 HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLA 336 (516)
T KOG0690|consen 258 HLSRE-RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLA 336 (516)
T ss_pred ehhhh-hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcC
Confidence 44443 4699999999999999999999999999999999999998 599999999998743 33445577899999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.... ++.+.|.|.+|++||||++|+.||...+.......+...- .
T Consensus 337 PEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-------------------~----------- 385 (516)
T KOG0690|consen 337 PEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-------------------L----------- 385 (516)
T ss_pred chhhcccc-ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-------------------c-----------
Confidence 99998666 8999999999999999999999999888777666554421 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccCc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHFV 279 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~~ 279 (282)
.++..++++.+.|+..+|..||.+|. .+.++.+|+||.++.|.
T Consensus 386 kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 386 KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 23457899999999999999999998 47899999999998874
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=269.50 Aligned_cols=234 Identities=19% Similarity=0.285 Sum_probs=181.6
Q ss_pred CCcceEEEEEecC------------CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEE
Q 044127 1 GSYGDVFQALDKK------------SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVF 68 (282)
Q Consensus 1 G~~g~Vy~~~~~~------------~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~ 68 (282)
|+||+||+|+... ....+++|++.... ......+..|+..+..+ +||||+++++++..+...+++|
T Consensus 6 G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 83 (262)
T cd05077 6 GTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQV-SHKHIVLLYGVCVRDVENIMVE 83 (262)
T ss_pred CCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCEEEE
Confidence 8999999997532 23358899876543 22334556677777777 5999999999999888999999
Q ss_pred ecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C-------cEEEeecCcccccC
Q 044127 69 EYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G-------VIKIGDLGMVKEID 140 (282)
Q Consensus 69 e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~-------~~~l~df~~~~~~~ 140 (282)
||+.++.++.+.......+++..+..++.||++||.|||++|++|+||||+||+++. + .++++|||.+....
T Consensus 84 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~ 163 (262)
T cd05077 84 EFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL 163 (262)
T ss_pred ecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCcccc
Confidence 999988888777765567999999999999999999999999999999999999974 2 38999999886543
Q ss_pred CCCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHH-hCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccc
Q 044127 141 SSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEML-SFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQL 219 (282)
Q Consensus 141 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (282)
.. ....++..|+|||.+.....++.++|||||||++|+|+ .|..||......+.. ..... .
T Consensus 164 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~---~----------- 225 (262)
T cd05077 164 SR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG---Q----------- 225 (262)
T ss_pred Cc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc---C-----------
Confidence 22 23456778999998875566899999999999999998 578887665433221 11110 0
Q ss_pred cccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 220 ASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
.......++.+.++|.+||+.||.+||++.+|+.+
T Consensus 226 ----------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 ----------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ----------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00112345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=271.73 Aligned_cols=239 Identities=21% Similarity=0.374 Sum_probs=188.9
Q ss_pred CCcceEEEEEe----cCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALD----KKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~----~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|.. ..++..+++|.+...........+.+|+..++++. ||||+++++++......+++|||+.++.+
T Consensus 16 g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L 94 (283)
T cd05090 16 CAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94 (283)
T ss_pred cCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCceEEEEEcCCCCcH
Confidence 89999999985 34567899999976544444456778999999994 99999999999999999999999997766
Q ss_pred HHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccccc
Q 044127 77 KLMKERA----------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI 139 (282)
Q Consensus 77 ~~~~~~~----------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~ 139 (282)
..++... ...+++..+..++.|++.||.|||++|++|+||||+||++++ +.++|+|||++...
T Consensus 95 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (283)
T cd05090 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREI 174 (283)
T ss_pred HHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccc
Confidence 6655321 124788999999999999999999999999999999999985 68999999998765
Q ss_pred CCCC---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccc
Q 044127 140 DSSL---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPL 215 (282)
Q Consensus 140 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (282)
.... ......++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+....+....+....
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---------- 243 (283)
T cd05090 175 YSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ---------- 243 (283)
T ss_pred cCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 3221 112334466799999987544 7999999999999999998 888997765544433322110
Q ss_pred cccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 216 GIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
....+...+..+.+++.+||+.||.+||++.+++++
T Consensus 244 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 244 -------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred -------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 012334568899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=271.55 Aligned_cols=239 Identities=20% Similarity=0.299 Sum_probs=188.8
Q ss_pred CCcceEEEEEecCC-----CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKS-----GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.+..+ ++.|++|+++..........+..|..++..+ +||||+++++++......++++||+.++.
T Consensus 16 G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~~~~e~~~~~~ 94 (283)
T cd05091 16 DRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQPLSMIFSYCSHSD 94 (283)
T ss_pred CCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCCceEEEEEcCCCCc
Confidence 78999999987543 5789999998654333345566788777777 59999999999999999999999999777
Q ss_pred HHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccccc
Q 044127 76 LKLMKERA---------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI 139 (282)
Q Consensus 76 l~~~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~ 139 (282)
+..++... ...+++..+..++.|++.||.+||+.|++|+||||+||++++ +.++|+|||++...
T Consensus 95 l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (283)
T cd05091 95 LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174 (283)
T ss_pred HHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEeccccccccc
Confidence 66665321 124888999999999999999999999999999999999975 78999999998765
Q ss_pred CCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccc
Q 044127 140 DSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPL 215 (282)
Q Consensus 140 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (282)
..... .....+++.|+|||.+..+. ++.++|||||||++|||++ |..||.+....+....+.....
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~--------- 244 (283)
T cd05091 175 YAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV--------- 244 (283)
T ss_pred ccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc---------
Confidence 33221 12334567899999987554 7999999999999999998 7888877666555544333111
Q ss_pred cccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 216 GIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+...+..+.+++..||+.+|.+||+++++++.
T Consensus 245 --------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 245 --------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 12234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=266.38 Aligned_cols=237 Identities=25% Similarity=0.424 Sum_probs=191.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|.+.. ++.|++|.+...........+..|+..++++. ||||+++++++.+....++++|++.++.+..++
T Consensus 6 g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l 83 (251)
T cd05041 6 GNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL 83 (251)
T ss_pred CCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHH
Confidence 7899999999887 89999999877654445567788999888884 999999999999999999999999887777766
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC---CCccccccccC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC---TDYVTTRWYRA 156 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~a 156 (282)
......++...+..++.|++.||.+||+++++|+||+|+||++++ +.++|+|||.+......... .....+..|+|
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~ 163 (251)
T cd05041 84 RKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA 163 (251)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCC
Confidence 555557899999999999999999999999999999999999985 78999999998755421111 11233556999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+.++ .++.++|+||||+++|+|++ |..||...........+....+
T Consensus 164 PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~----------------------------- 213 (251)
T cd05041 164 PEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR----------------------------- 213 (251)
T ss_pred hHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-----------------------------
Confidence 9998754 47999999999999999999 7888877665443333211100
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.+++.+||..+|.+|||++++++
T Consensus 214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0122356789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=267.30 Aligned_cols=236 Identities=23% Similarity=0.355 Sum_probs=187.9
Q ss_pred CCcceEEEEEecCCC---cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSG---EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~---~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||.||+|....++ ..+++|.+...........+..|+..++.+ +|||++++++++.. ...+++|||+.++.+.
T Consensus 6 G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~ 83 (257)
T cd05060 6 GNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKG-EPLMLVMELAPLGPLL 83 (257)
T ss_pred cCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC-CceEEEEEeCCCCcHH
Confidence 899999999876544 789999998766555566778899999888 59999999998764 4689999999876666
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCC----Cccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCT----DYVTTR 152 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~----~~~~~~ 152 (282)
.++.... .+++..+..++.|++.||.+||+.+++|+||+|+||++++ +.++|+|||.+.......... ...++.
T Consensus 84 ~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~ 162 (257)
T cd05060 84 KYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPL 162 (257)
T ss_pred HHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccc
Confidence 6665543 6999999999999999999999999999999999999975 789999999988664332211 112235
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+.+.. ++.++||||||+++|++++ |..||...+..+....+.....
T Consensus 163 ~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------------------- 216 (257)
T cd05060 163 KWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER------------------------- 216 (257)
T ss_pred cccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-------------------------
Confidence 699999987444 8999999999999999998 9999987765544433322100
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.+++.+||..+|++||++.++++
T Consensus 217 ----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 ----LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1123456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=267.20 Aligned_cols=241 Identities=28% Similarity=0.509 Sum_probs=197.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||++.++.+++.+++|.+...... ........|+..++++. ||||+++++.+......++++||++++.+..+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 89 (256)
T cd08530 11 GSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKA 89 (256)
T ss_pred CCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEehhcCCCCHHHH
Confidence 78999999999999999999998764432 33455678888898885 99999999999999999999999987666655
Q ss_pred HHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccccccc
Q 044127 80 KER---AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 155 (282)
Q Consensus 80 ~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 155 (282)
+.. .+..+++..++.++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||++...... ......+++.|+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~ 168 (256)
T cd08530 90 ISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYM 168 (256)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-CcccccCCcccc
Confidence 443 1346899999999999999999999999999999999999985 78999999998876554 223456788899
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||.+.+. .++.++|+||||++++++++|+.||...+........... ..
T Consensus 169 ~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----------------------------~~ 218 (256)
T cd08530 169 APEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG-----------------------------KY 218 (256)
T ss_pred CHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------------------CC
Confidence 99998744 4788999999999999999999999877654433332110 01
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
...+...+.++.+++.+||+.+|.+|||+.++++||++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 12233568889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=265.76 Aligned_cols=241 Identities=30% Similarity=0.577 Sum_probs=200.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|++|.||++++..+++.|++|.+...... .....+.+|+..+.++. |||++++++++.+....++++|++.++.+..+
T Consensus 11 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 89 (254)
T cd06627 11 GAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIILEYAENGSLRQI 89 (254)
T ss_pred cCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEEecCCCCcHHHH
Confidence 78999999999999999999999776432 34456778999999995 99999999999999999999999998777777
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aP 157 (282)
.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+........ .....++..|+||
T Consensus 90 ~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~p 168 (254)
T cd06627 90 IKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAP 168 (254)
T ss_pred HHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCH
Confidence 6655 47999999999999999999999999999999999999985 7899999999887654432 2335678889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|...+.. .+.++|+||||+++|++++|..||............... ....
T Consensus 169 e~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------------------------~~~~ 218 (254)
T cd06627 169 EVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-----------------------------DHPP 218 (254)
T ss_pred hhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-----------------------------CCCC
Confidence 9987544 789999999999999999999999876543333322110 0112
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.+...++.+.+++.+||..+|++|||+.+++.||||
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 344668899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=285.34 Aligned_cols=229 Identities=27% Similarity=0.439 Sum_probs=194.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+-|-||.|+.. ++.||||+++.-. ..+++.|+++. ||||+.+.|+|.....+|||||||..+-|...+
T Consensus 135 GaQGAVF~Grl~--netVAVKKV~elk--------ETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VL 203 (904)
T KOG4721|consen 135 GAQGAVFLGRLH--NETVAVKKVRELK--------ETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVL 203 (904)
T ss_pred Ccccceeeeecc--CceehhHHHhhhh--------hhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccccccHHHHH
Confidence 778999999765 7889999875421 23678889995 999999999999999999999999955555444
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCccccccccCchh
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 159 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~ 159 (282)
+.. ..+.......|..+||.|+.|||...|+|||||.-||||+ ++.|||+|||-+..+....+....+||..|||||+
T Consensus 204 ka~-~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEv 282 (904)
T KOG4721|consen 204 KAG-RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEV 282 (904)
T ss_pred hcc-CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHH
Confidence 443 5799999999999999999999999999999999999998 57999999999988877777788999999999999
Q ss_pred hhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccC
Q 044127 160 LLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELS 239 (282)
Q Consensus 160 ~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
+. ..+.+.+.|||||||+||||+||..||...+...++..+ -++..-..++
T Consensus 283 Ir-nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV----------------------------GsNsL~LpvP 333 (904)
T KOG4721|consen 283 IR-NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV----------------------------GSNSLHLPVP 333 (904)
T ss_pred hh-cCCcccccceehhHHHHHHHHhcCCCccccchheeEEec----------------------------cCCcccccCc
Confidence 98 555999999999999999999999999876655443211 1222234567
Q ss_pred CCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 240 PSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...++.++=||+.||+-.|..||++.++|.|
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 7899999999999999999999999999988
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=271.84 Aligned_cols=237 Identities=25% Similarity=0.407 Sum_probs=187.7
Q ss_pred CCcceEEEEEe-----cCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALD-----KKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~-----~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||++.+ ..++..+++|.+.... ......+.+|+..+.++. |||++++++++......+++|||+.++.
T Consensus 16 G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 93 (288)
T cd05093 16 GAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGDPLIMVFEYMKHGD 93 (288)
T ss_pred cCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCccEEEEEcCCCCC
Confidence 78999999985 2346679999886543 334456778999999995 9999999999999999999999999777
Q ss_pred HHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC
Q 044127 76 LKLMKERAG------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 142 (282)
Q Consensus 76 l~~~~~~~~------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~ 142 (282)
+..++...+ ..+++..+..++.|++.||++||++|++|+||||+||++++ +.++|+|||.+......
T Consensus 94 L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 173 (288)
T cd05093 94 LNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 173 (288)
T ss_pred HHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCC
Confidence 766655332 24899999999999999999999999999999999999975 78999999998765322
Q ss_pred CC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCcccccc
Q 044127 143 LP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQ 218 (282)
Q Consensus 143 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (282)
.. .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||......+....+.....
T Consensus 174 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~------------ 240 (288)
T cd05093 174 DYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV------------ 240 (288)
T ss_pred ceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc------------
Confidence 11 1223346779999998754 47999999999999999998 8999987766555444322110
Q ss_pred ccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 219 LASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.+++.+||+.||.+|||+++++.
T Consensus 241 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 241 -----------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0112356788999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=271.07 Aligned_cols=234 Identities=17% Similarity=0.285 Sum_probs=183.2
Q ss_pred CCcceEEEEEecCCCc-------EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGE-------FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~-------~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||+||+|.+..++. .+++|...... ......+..|...++.+ +|||++++++++..+...++||||+++
T Consensus 6 G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (258)
T cd05078 6 GTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIMVQEYVKF 83 (258)
T ss_pred ccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEEEEecCCC
Confidence 8999999998865443 48888875432 22334556677777777 599999999999998899999999998
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C--------cEEEeecCcccccCCCCC
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G--------VIKIGDLGMVKEIDSSLP 144 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~--------~~~l~df~~~~~~~~~~~ 144 (282)
+++..++...+..+++..+..++.||+.||.|||++|++|+||||+||++++ + .++++|||.+......
T Consensus 84 g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-- 161 (258)
T cd05078 84 GSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-- 161 (258)
T ss_pred CcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc--
Confidence 8887777665557899999999999999999999999999999999999974 2 2799999988655432
Q ss_pred CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCC-CCCCCCCChHHHHHHHHHhCCCCCCCccccccccccC
Q 044127 145 CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFR-ILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL 223 (282)
Q Consensus 145 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
....++..|+|||.+.+...++.++||||||+++|++++|. .||.......... ....
T Consensus 162 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~------------------- 220 (258)
T cd05078 162 -EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED------------------- 220 (258)
T ss_pred -hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc-------------------
Confidence 33456778999999976555789999999999999999985 5665544433222 1110
Q ss_pred CccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
....+...+.++.+++.+||+.||++|||++++++.
T Consensus 221 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 221 -----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 011233456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=271.89 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=196.9
Q ss_pred CCcceEEEEEec---CCCcEEEEEEcccccc---chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDK---KSGEFVAVKKLKKKIF---SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~---~~~~~v~vK~~~~~~~---~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|+||.||.|.+. .+|+.|++|++..... .........|+.++.++.+||+|+.+++.+..+...++++||+.++
T Consensus 11 G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (290)
T cd05613 11 GAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGG 90 (290)
T ss_pred CCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCC
Confidence 889999999875 4789999999875432 1223445678889999978999999999999999999999999976
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCcccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTT 151 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~ 151 (282)
.+...+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||++....... ......++
T Consensus 91 ~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 169 (290)
T cd05613 91 ELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169 (290)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCC
Confidence 666655544 46899999999999999999999999999999999999974 799999999987653321 12234578
Q ss_pred ccccCchhhhcc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 152 RWYRAPEVLLLS-EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 152 ~~~~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
..|+|||.+... ...+.++||||||+++|++++|..||...........+.......
T Consensus 170 ~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 227 (290)
T cd05613 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---------------------- 227 (290)
T ss_pred cccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc----------------------
Confidence 889999998643 236789999999999999999999997544332222222211100
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
....+..++..+.+++++||+.||++|| ++++++.||||+...+
T Consensus 228 ----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 228 ----EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred ----CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 0112345688899999999999999997 8999999999988763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=268.17 Aligned_cols=240 Identities=25% Similarity=0.412 Sum_probs=188.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|++..+++.|++|.+..... ......+.+|+..++.+. |||++++++.+...+..++++||+.++.+..
T Consensus 13 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 91 (267)
T cd08228 13 GQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIVLELADAGDLSQ 91 (267)
T ss_pred CCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEEEEecCCCcHHH
Confidence 7899999999999999999998764322 233445678999999994 9999999999999999999999999876665
Q ss_pred HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCcccccc
Q 044127 79 MKER---AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRW 153 (282)
Q Consensus 79 ~~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~ 153 (282)
++.. ....+++..+..++.||+.||.|||++|++|+||+|+||+++. +.++++|||.+........ .....+++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 171 (267)
T cd08228 92 MIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171 (267)
T ss_pred HHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCcc
Confidence 5432 2345899999999999999999999999999999999999985 7899999998876543221 123467788
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSA-DQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|+|||.+.+.. .+.++|+||||+++|+|++|+.||...... ............+
T Consensus 172 ~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------ 226 (267)
T cd08228 172 YMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP------------------------ 226 (267)
T ss_pred ccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCC------------------------
Confidence 99999987544 789999999999999999999998654332 1111111111100
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.......+..+.+++.+||+.+|++||++.++++
T Consensus 227 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 227 ---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred ---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 0112245788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=269.07 Aligned_cols=238 Identities=24% Similarity=0.392 Sum_probs=190.6
Q ss_pred CCcceEEEEEecCCCc---EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||.||+|.++.+++ .|++|.+...........+..|+..++.+ +||||+++++++.++...+++|||+.++++.
T Consensus 15 g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T cd05065 15 GEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPVMIITEFMENGALD 93 (269)
T ss_pred CCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCceEEEEecCCCCcHH
Confidence 8999999999887665 59999987654344456678899988888 5999999999999999999999999988888
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCC---cc---c
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTD---YV---T 150 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~---~~---~ 150 (282)
.++...+..++...+..++.|++.||.+||++|++|+||+|+||+++. +.++|+|||.+........... .. .
T Consensus 94 ~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 173 (269)
T cd05065 94 SFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173 (269)
T ss_pred HHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCc
Confidence 777765567999999999999999999999999999999999999975 6899999998875533221111 11 1
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
+..|+|||.+.... ++.++|||||||++||+++ |..||......+....+......
T Consensus 174 ~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~---------------------- 230 (269)
T cd05065 174 PIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL---------------------- 230 (269)
T ss_pred ceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC----------------------
Confidence 34699999987544 7999999999999999886 99999877655544433211100
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...+..+.+++.+||+.+|.+||++++++.
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 231 -------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=267.75 Aligned_cols=238 Identities=22% Similarity=0.377 Sum_probs=191.4
Q ss_pred CCcceEEEEEecCCCc---EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|++|.||+|.++.++. .+++|.+...........+..|+..+.++ +|||++++.+++...+..+++||+++++++.
T Consensus 16 g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (268)
T cd05063 16 GEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPAMIITEYMENGALD 94 (268)
T ss_pred CCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCcEEEEEcCCCCCHH
Confidence 7899999999876654 69999987654444556678899888888 5999999999999999999999999988887
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCC----Cccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCT----DYVTTR 152 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~----~~~~~~ 152 (282)
.++......+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++++|||.+.......... ....+.
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 174 (268)
T cd05063 95 KYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174 (268)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCc
Confidence 777665557999999999999999999999999999999999999975 789999999987654322111 112345
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+.... ++.++|||||||++|++++ |..||......+....+......
T Consensus 175 ~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~------------------------ 229 (268)
T cd05063 175 RWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL------------------------ 229 (268)
T ss_pred eecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC------------------------
Confidence 699999987544 7899999999999999997 99999877665544443321110
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...+..+.+++.+||+.+|++||++.++++
T Consensus 230 -----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 230 -----PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 112245788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=268.16 Aligned_cols=238 Identities=24% Similarity=0.380 Sum_probs=190.5
Q ss_pred CCcceEEEEEecCCCc---EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||.||+|+++.++. .+++|.++..........+.+|+..+.++ +||||+++++++..++..+++|||+.++.+.
T Consensus 15 g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (267)
T cd05066 15 GEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 93 (267)
T ss_pred cCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEEcCCCCCHH
Confidence 7899999998865443 79999987654444556778899999888 5999999999999999999999999987777
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC----CCccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC----TDYVTTR 152 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~----~~~~~~~ 152 (282)
.++...+..++..++..++.|++.||.+||++|++|+||+|+||++++ +.++++|||.+......... ....++.
T Consensus 94 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 173 (267)
T cd05066 94 AFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 173 (267)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccce
Confidence 777665557899999999999999999999999999999999999975 78999999998765432211 1112245
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+.+.. ++.++|+||||+++|++++ |..||......+....+....+.
T Consensus 174 ~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------------------ 228 (267)
T cd05066 174 RWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL------------------------ 228 (267)
T ss_pred eecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC------------------------
Confidence 799999987544 7999999999999999886 99999877655544433221100
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...++.+.+++.+|++.+|.+||++.++++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 -----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=269.77 Aligned_cols=237 Identities=19% Similarity=0.313 Sum_probs=185.3
Q ss_pred CCcceEEEEEecCCCc----EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGE----FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|++..++. .||+|++...........+.+|...+..+ +||||+++++++... ..+++++++.++.+
T Consensus 18 G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l 95 (279)
T cd05109 18 GAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLTS-TVQLVTQLMPYGCL 95 (279)
T ss_pred CCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcCC-CcEEEEEcCCCCCH
Confidence 8999999999877766 48999987655455556677888888888 599999999988754 57799999986555
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC---CCccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC---TDYVTTR 152 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~---~~~~~~~ 152 (282)
..........+++..+..++.||+.||.|||+++++|+||||+||++++ +.++|+|||++......... ....++.
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~ 175 (279)
T cd05109 96 LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175 (279)
T ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccch
Confidence 5555544456999999999999999999999999999999999999975 78999999998766432221 1223456
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||...+.. ++.++|||||||++||+++ |..||........... ......+
T Consensus 176 ~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~----------------------- 230 (279)
T cd05109 176 KWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL-LEKGERL----------------------- 230 (279)
T ss_pred hhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCcC-----------------------
Confidence 799999987554 7899999999999999998 8899876654443332 2211100
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...+..+.+++.+||+.||.+||++.+++.
T Consensus 231 -----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 -----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112346788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=269.07 Aligned_cols=234 Identities=16% Similarity=0.234 Sum_probs=182.0
Q ss_pred CCcceEEEEEecCC------------------------CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecc
Q 044127 1 GSYGDVFQALDKKS------------------------GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56 (282)
Q Consensus 1 G~~g~Vy~~~~~~~------------------------~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~ 56 (282)
|+||.||+|....+ ...|++|++.... ......+..|+..++.+ +||||+++++
T Consensus 6 G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l-~h~niv~~~~ 83 (274)
T cd05076 6 GTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQV-SHIHLAFVHG 83 (274)
T ss_pred ccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcC-CCCCeeeEEE
Confidence 89999999975321 2358889886543 22334556677777777 5999999999
Q ss_pred ccccCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--------CcE
Q 044127 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--------GVI 128 (282)
Q Consensus 57 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--------~~~ 128 (282)
++.++...++||||++++.++.++......+++..+..++.||+.||.|||++|++|+||||+||+++. ..+
T Consensus 84 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~ 163 (274)
T cd05076 84 VCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFI 163 (274)
T ss_pred EEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcccee
Confidence 999999999999999998888887665567999999999999999999999999999999999999963 248
Q ss_pred EEeecCcccccCCCCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHH-hCCCCCCCCCChHHHHHHHHHhCC
Q 044127 129 KIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEML-SFRILFPGKNSADQIYKICQVIGS 207 (282)
Q Consensus 129 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~-~g~~~~~~~~~~~~~~~~~~~~~~ 207 (282)
+++|||.+...... ....++..|+|||.+.+...++.++||||||+++|+++ +|..||......+.... .....
T Consensus 164 kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~- 238 (274)
T cd05076 164 KLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF-YEKKH- 238 (274)
T ss_pred eecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH-HHhcc-
Confidence 99999987544222 22346777999998875555799999999999999985 68899987655443221 11000
Q ss_pred CCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 208 PTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++.+.++|++||+.+|++|||+++++++
T Consensus 239 -----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 239 -----------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -----------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 1112345679999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=268.62 Aligned_cols=238 Identities=23% Similarity=0.391 Sum_probs=189.4
Q ss_pred CCcceEEEEEecCC-----CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKS-----GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.++.. +..|++|.+...........+.+|+..+..+ +||||+++++++......+++|||+.++.
T Consensus 17 g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 95 (277)
T cd05032 17 GSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTGQPTLVVMELMAKGD 95 (277)
T ss_pred CCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCCCCcEEEEecCCCCC
Confidence 89999999987643 4789999987665445556677899988888 59999999999999999999999998766
Q ss_pred HHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--
Q 044127 76 LKLMKERA---------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-- 143 (282)
Q Consensus 76 l~~~~~~~---------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-- 143 (282)
+..++... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++. +.++|+|||.+.......
T Consensus 96 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~ 175 (277)
T cd05032 96 LKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175 (277)
T ss_pred HHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCccc
Confidence 66555432 123688899999999999999999999999999999999985 899999999987653322
Q ss_pred -CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 144 -PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 144 -~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
......++..|+|||.+..+. .+.++|||||||++|++++ |..||...+..+........ .
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~--------------- 238 (277)
T cd05032 176 RKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-G--------------- 238 (277)
T ss_pred ccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-C---------------
Confidence 112334567899999987444 7999999999999999998 88999876665554433211 0
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+...+..+.+++++||+.+|++|||+.++++
T Consensus 239 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 -------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 01123345889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=267.40 Aligned_cols=236 Identities=26% Similarity=0.423 Sum_probs=190.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.+.. +..+++|++.... ......+..|+..++.+ +|||++++++++.+....+++|||+.++.+..++
T Consensus 17 g~~~~vy~~~~~~-~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 93 (261)
T cd05148 17 GYFGEVWEGLWKN-RVRVAIKILKSDD-LLKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFL 93 (261)
T ss_pred CCCccEEEeEecC-CCcEEEEeccccc-hhhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEEEEeecccCCHHHHH
Confidence 7899999999887 8889999987654 22344567788888888 4999999999999999999999999875555554
Q ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccCc
Q 044127 81 ER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aP 157 (282)
.. .+..++...+..++.||+.||.+||++|++|+||+|+||++++ +.++++|||.+........ .....++..|+||
T Consensus 94 ~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~P 173 (261)
T cd05148 94 RSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAP 173 (261)
T ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCH
Confidence 43 4457999999999999999999999999999999999999985 7999999999876543221 1223445679999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+... .++.++|+||||+++|+|++ |..||......+....+......
T Consensus 174 E~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------- 223 (261)
T cd05148 174 EAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM----------------------------- 223 (261)
T ss_pred HHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-----------------------------
Confidence 998754 47899999999999999998 89999877665555544321111
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...++.+.+++.+||+.||.+|||++++++
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 123466889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=271.99 Aligned_cols=240 Identities=24% Similarity=0.387 Sum_probs=189.9
Q ss_pred CCcceEEEEEec-------CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDK-------KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~-------~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||.||+|++. .++..|++|.+...........+.+|+..+..+.+||||+++++.+......+++|||+.+
T Consensus 26 G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (304)
T cd05101 26 GCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105 (304)
T ss_pred cCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCC
Confidence 899999999753 2345799999876544455567788999999886799999999999999999999999998
Q ss_pred cHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccc
Q 044127 74 DLLKLMKERA---------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK 137 (282)
Q Consensus 74 ~~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~ 137 (282)
+.+..++... ...++...+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||.+.
T Consensus 106 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~ 185 (304)
T cd05101 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185 (304)
T ss_pred CcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccce
Confidence 7776665542 134788899999999999999999999999999999999975 789999999988
Q ss_pred ccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCc
Q 044127 138 EIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 138 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (282)
....... .....++..|+|||.+.+.. ++.++||||||+++|++++ |..||......+....+.....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------- 257 (304)
T cd05101 186 DVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR------- 257 (304)
T ss_pred ecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-------
Confidence 6643221 12234456799999987544 7899999999999999998 7888877665554443321100
Q ss_pred cccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 258 ----------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 258 ----------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 01123568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=272.12 Aligned_cols=239 Identities=23% Similarity=0.390 Sum_probs=189.2
Q ss_pred CCcceEEEEEecC-------CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKK-------SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||.||+|++.. ....+++|.+...........+..|+..++++.+||||+++++++...+..+++|||+.+
T Consensus 23 G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 102 (314)
T cd05099 23 GCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAK 102 (314)
T ss_pred CCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCC
Confidence 8899999998642 345799999876554555667788999999887799999999999998999999999997
Q ss_pred cHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccc
Q 044127 74 DLLKLMKERA---------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK 137 (282)
Q Consensus 74 ~~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~ 137 (282)
+.+..++... ...++...+..++.||+.||.+||++|++|+||||+||++++ +.++|+|||.+.
T Consensus 103 g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~ 182 (314)
T cd05099 103 GNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182 (314)
T ss_pred CcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccc
Confidence 7776665432 135889999999999999999999999999999999999984 789999999987
Q ss_pred ccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCc
Q 044127 138 EIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 138 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (282)
....... .....++..|+|||.+.+. .++.++||||||+++|++++ |..||......+....+....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------- 253 (314)
T cd05099 183 GVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH-------- 253 (314)
T ss_pred cccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 6543211 1122334579999998754 47999999999999999999 888997766555444332210
Q ss_pred cccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+...+..+.+++.+||..||++|||+.++++
T Consensus 254 ---------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 254 ---------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred ---------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00123356788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=272.80 Aligned_cols=240 Identities=23% Similarity=0.372 Sum_probs=188.4
Q ss_pred CCcceEEEEEecC-------CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKK-------SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||.||+|++.. +...+++|.+...........+..|+.+++.+.+||||+++++++...+..+++|||+.+
T Consensus 29 G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (307)
T cd05098 29 GCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 108 (307)
T ss_pred CCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCC
Confidence 8999999998653 234699999986544455566788999999997799999999999999999999999997
Q ss_pred cHHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccc
Q 044127 74 DLLKLMKERAG---------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK 137 (282)
Q Consensus 74 ~~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~ 137 (282)
+.+..++.... ..++..++..++.|++.||++||+.|++|+||||+||++++ +.++|+|||.+.
T Consensus 109 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~ 188 (307)
T cd05098 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188 (307)
T ss_pred CcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccc
Confidence 66666655421 24889999999999999999999999999999999999984 789999999987
Q ss_pred ccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCc
Q 044127 138 EIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 138 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (282)
....... .....+++.|+|||.+.+.. ++.++|+|||||++|+|++ |..||......+....+... .
T Consensus 189 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~------- 259 (307)
T cd05098 189 DIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-H------- 259 (307)
T ss_pred cccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcC-C-------
Confidence 6543211 11223346799999987544 7899999999999999998 78888765544333322111 0
Q ss_pred cccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
....+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 260 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 260 ---------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred ---------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 012234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=265.35 Aligned_cols=238 Identities=27% Similarity=0.438 Sum_probs=193.1
Q ss_pred CCcceEEEEEecCCC----cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSG----EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~----~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||.||++.+..++ ..|++|++...........+..|+..+..+ +|||++++++.+.+.+..+++||++.++.+
T Consensus 10 g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l 88 (258)
T smart00219 10 GAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMIVMEYMEGGDL 88 (258)
T ss_pred CCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEEEEeccCCCCH
Confidence 899999999998766 889999997665444566778899999998 699999999999999999999999987766
Q ss_pred HHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCC--Cccccc
Q 044127 77 KLMKERAGQN-FSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCT--DYVTTR 152 (282)
Q Consensus 77 ~~~~~~~~~~-l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~--~~~~~~ 152 (282)
..+....... +++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+.......... ...+++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 168 (258)
T smart00219 89 LDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPI 168 (258)
T ss_pred HHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcc
Confidence 6665543323 999999999999999999999999999999999999986 689999999987665432211 123567
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+. ...++.++|+||||+++++|++ |..||......+..........
T Consensus 169 ~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------------- 222 (258)
T smart00219 169 RWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR------------------------- 222 (258)
T ss_pred cccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-------------------------
Confidence 899999985 4447999999999999999998 7888887655555444322110
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.+++.+||..||++|||+.++++
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 ----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0122346889999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=265.63 Aligned_cols=241 Identities=27% Similarity=0.467 Sum_probs=192.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccc----cchHHHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKI----FSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~----~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~ 74 (282)
|++|.||+|++..+++.|++|.+.... .......+.+|+..++++. ||||+++++.+.+. ...++++||+.++
T Consensus 13 g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~v~e~~~~~ 91 (264)
T cd06653 13 GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKKLSIFVEYMPGG 91 (264)
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCEEEEEEEeCCCC
Confidence 789999999999999999999875322 1233456678999999995 99999999998653 4688999999887
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC----CCCCCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS----LPCTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~----~~~~~~~ 149 (282)
.+...+...+ .+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+...... .......
T Consensus 92 ~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 170 (264)
T cd06653 92 SIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170 (264)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccC
Confidence 7766665543 5899999999999999999999999999999999999985 78999999998765321 1112345
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++..|+|||.+.+.. .+.++|+|||||++|+|++|..||..........+.. ..+.
T Consensus 171 ~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~-------------------- 226 (264)
T cd06653 171 GTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPT-------------------- 226 (264)
T ss_pred CcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCC--------------------
Confidence 788899999987544 7899999999999999999999998765444433321 1111
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
...++..+++.+.++|++||+ +|.+||++.++++|||.
T Consensus 227 -----~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 -----KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -----CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 113445678999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=264.50 Aligned_cols=236 Identities=24% Similarity=0.361 Sum_probs=186.2
Q ss_pred CCcceEEEEEe--cCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALD--KKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~--~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||.||+|.+ ..+++.+++|+++...... ....+..|+.++..+ +||||+++++++.. ...+++|||+.++.+.
T Consensus 6 G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~ 83 (257)
T cd05116 6 GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEA-ESWMLVMELAELGPLN 83 (257)
T ss_pred cCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCcEEEEecCCCCcHH
Confidence 89999999964 4568899999987554332 345567888888888 59999999998764 4678999999987776
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC----CCccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC----TDYVTTR 152 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~----~~~~~~~ 152 (282)
.++... ..+++..+..++.|++.||.+||++|++|+||||+||++++ +.++|+|||.+......... ....++.
T Consensus 84 ~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 162 (257)
T cd05116 84 KFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPV 162 (257)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCc
Confidence 666543 46999999999999999999999999999999999999985 67999999998766443221 1223356
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+... .++.++|+|||||++||+++ |..||......+....+....
T Consensus 163 ~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-------------------------- 215 (257)
T cd05116 163 KWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-------------------------- 215 (257)
T ss_pred cccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC--------------------------
Confidence 89999988644 47889999999999999998 999998766554444332110
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+...++++.++|.+||+.||++||++++|..
T Consensus 216 ---~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 216 ---RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 01223457899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=288.04 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=200.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc------CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE------HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~------~~~~~lv~e~~~~~ 74 (282)
||||.||+++++.+|+.||||.++........+...+|+++++++. |||||+++++=+. .....++||||.|+
T Consensus 24 Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gG 102 (732)
T KOG4250|consen 24 GAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGG 102 (732)
T ss_pred CccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCcccccceEEEeecCCC
Confidence 8999999999999999999999998877777778889999999996 9999999998543 34578999999988
Q ss_pred HHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC---C--cEEEeecCcccccCCCCCCCC
Q 044127 75 LLKLMKERA--GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK---G--VIKIGDLGMVKEIDSSLPCTD 147 (282)
Q Consensus 75 ~l~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~---~--~~~l~df~~~~~~~~~~~~~~ 147 (282)
++...+++. ...|++.++..++.++..||.|||++||+||||||.||++-. | ..||+|||.|+.++......+
T Consensus 103 sL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S 182 (732)
T KOG4250|consen 103 SLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTS 182 (732)
T ss_pred cHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeee
Confidence 888777653 235999999999999999999999999999999999999953 2 599999999999999999999
Q ss_pred ccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 148 YVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 148 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
..||+.|++||.+..++.++...|.|||||++|+++||..||.......-.+.+.-......+...-......++....+
T Consensus 183 ~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~ 262 (732)
T KOG4250|consen 183 LVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEW 262 (732)
T ss_pred ecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceee
Confidence 99999999999998667799999999999999999999999976554432222222222222222222222222211111
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCC
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRP 262 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 262 (282)
... -+.........-..+-..+..+|..+|.+|-
T Consensus 263 s~~-lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 263 SST-LPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ecc-CCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 100 0011223333445566788999999999998
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=278.13 Aligned_cols=241 Identities=23% Similarity=0.358 Sum_probs=190.9
Q ss_pred CCcceEEEEEec-----CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDK-----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|++. .+++.||+|+++..........+.+|+.++.++..||||+++++.+..++..++|||||.++.
T Consensus 48 G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~ 127 (401)
T cd05107 48 GAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGD 127 (401)
T ss_pred CCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCc
Confidence 899999999854 346789999998765444455678899999999669999999999999999999999999766
Q ss_pred HHHHHHhcC-----------------------------------------------------------------------
Q 044127 76 LKLMKERAG----------------------------------------------------------------------- 84 (282)
Q Consensus 76 l~~~~~~~~----------------------------------------------------------------------- 84 (282)
|..++....
T Consensus 128 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (401)
T cd05107 128 LVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESS 207 (401)
T ss_pred HHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhcc
Confidence 665553321
Q ss_pred --------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccc
Q 044127 85 --------------------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK 137 (282)
Q Consensus 85 --------------------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~ 137 (282)
..++...+..++.||+.||.|||+.+++|+||||+||++++ +.++|+|||++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~ 287 (401)
T cd05107 208 NYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287 (401)
T ss_pred CcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcce
Confidence 23677788999999999999999999999999999999986 789999999987
Q ss_pred ccCCCC---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCc
Q 044127 138 EIDSSL---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 138 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (282)
...... ......++..|+|||.+... .++.++||||||+++||+++ |..||......+...........
T Consensus 288 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~------ 360 (401)
T cd05107 288 DIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR------ 360 (401)
T ss_pred ecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCC------
Confidence 543221 11234567789999998754 47899999999999999998 88999876655554443321100
Q ss_pred cccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+...+..+.+++.+||+.+|.+||++++|+..
T Consensus 361 ----------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 361 ----------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 01233568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=270.04 Aligned_cols=238 Identities=24% Similarity=0.387 Sum_probs=187.4
Q ss_pred CCcceEEEEEecC-----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKK-----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|++.. ....+++|.+...........+.+|+..+..+ +||||+++++.+...+..++++||+.++.
T Consensus 11 g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (290)
T cd05045 11 GEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGS 89 (290)
T ss_pred cCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCCcEEEEEecCCCC
Confidence 8999999998753 23568999887655444556678899999888 59999999999999999999999999777
Q ss_pred HHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEe
Q 044127 76 LKLMKERA-----------------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIG 131 (282)
Q Consensus 76 l~~~~~~~-----------------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~ 131 (282)
+..++... ...+++..+..++.|++.||++||+++++|+||+|+||++++ +.++|+
T Consensus 90 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~ 169 (290)
T cd05045 90 LRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKIS 169 (290)
T ss_pred HHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEec
Confidence 77665431 124889999999999999999999999999999999999985 789999
Q ss_pred ecCcccccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCC
Q 044127 132 DLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGS 207 (282)
Q Consensus 132 df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~ 207 (282)
|||++........ .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+...............
T Consensus 170 dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~- 247 (290)
T cd05045 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR- 247 (290)
T ss_pred cccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-
Confidence 9999875432211 1223456679999988644 47999999999999999998 9999977655443332211100
Q ss_pred CCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 208 PTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.+++..||+.+|.+||+++++++
T Consensus 248 ----------------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 248 ----------------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0123456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=299.63 Aligned_cols=250 Identities=29% Similarity=0.445 Sum_probs=208.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||.|.+++++.|++.||+|++++-... .....++.|..-+....+.+=|+.++-.|+++.++|+|||||.||.+-.+
T Consensus 86 GaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltL 165 (1317)
T KOG0612|consen 86 GAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTL 165 (1317)
T ss_pred cccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHH
Confidence 89999999999999999999999874332 23334444444444555688899999999999999999999998877777
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCccccccccC
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~a 156 (282)
+.+.+ ++++..++-++..|..||..+|+.|+|||||||+|||+|. |.+||.|||.+..++.... ....+|||-|.|
T Consensus 166 lSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYIS 244 (1317)
T KOG0612|consen 166 LSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYIS 244 (1317)
T ss_pred HhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccC
Confidence 88776 7999999999999999999999999999999999999995 9999999999988865443 345689999999
Q ss_pred chhhhc---c-ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 157 PEVLLL---S-EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 157 PE~~~~---~-~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
||++.. + ..|+...|.||+||++|||+.|.-||....-.+.+.+++..... ..|+.
T Consensus 245 PEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~-----------------l~FP~--- 304 (1317)
T KOG0612|consen 245 PEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES-----------------LSFPD--- 304 (1317)
T ss_pred HHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh-----------------cCCCc---
Confidence 999852 2 45899999999999999999999999998888888877664211 11110
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCC---HHHHhcCcccccccC
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPT---AAEALEHPFFRSCHF 278 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~~ 278 (282)
...+|+..++||++.+. +|+.|.. ++++-+||||.++.|
T Consensus 305 ------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 305 ------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 12479999999999776 8999998 999999999999887
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=263.98 Aligned_cols=238 Identities=24% Similarity=0.345 Sum_probs=190.1
Q ss_pred CCcceEEEEEecC-CC--cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKK-SG--EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~-~~--~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|++|+||+|.+.. ++ ..|++|.+...........+..|+..+.++. ||||+++++.+.. ...++++|++.++.+.
T Consensus 6 g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~ 83 (257)
T cd05040 6 GSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTELAPLGSLL 83 (257)
T ss_pred cCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEecCCCcHH
Confidence 8899999998865 33 3699999987665455667788999999995 9999999999988 8899999999866555
Q ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC----CCCcccc
Q 044127 78 LMKERAG-QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP----CTDYVTT 151 (282)
Q Consensus 78 ~~~~~~~-~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~----~~~~~~~ 151 (282)
..+.... ..+++..++.++.|++.||.+||++|++|+||+|+||+++. +.++|+|||.+........ .....++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 163 (257)
T cd05040 84 DRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP 163 (257)
T ss_pred HHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCC
Confidence 5554433 46899999999999999999999999999999999999984 8999999999887644211 1223456
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
..|+|||.+.... ++.++|||||||++|+|++ |..||......+....+.....
T Consensus 164 ~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------------ 218 (257)
T cd05040 164 FAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE------------------------ 218 (257)
T ss_pred ceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC------------------------
Confidence 7899999887444 7899999999999999998 9999987766655544332100
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+...+..+.+++.+||+.+|++|||++++++
T Consensus 219 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 219 ----RLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ----cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 00122346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=269.14 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=191.9
Q ss_pred CCcceEEEEEecCCC----------------cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcE
Q 044127 1 GSYGDVFQALDKKSG----------------EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDV 64 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~----------------~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 64 (282)
|+||.||+|.+..++ ..|++|.+...........+.+|+.++.++. |||++++++++..++..
T Consensus 16 G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 94 (296)
T cd05051 16 GQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS-DPNIARLLGVCTVDPPL 94 (296)
T ss_pred CCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC-CCCEeEEEEEEecCCCc
Confidence 899999999876543 5689999887654455667788999999995 99999999999999999
Q ss_pred EEEEecCCccHHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeec
Q 044127 65 FIVFEYMESDLLKLMKERAG----------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDL 133 (282)
Q Consensus 65 ~lv~e~~~~~~l~~~~~~~~----------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df 133 (282)
++++|++.++.+..++.... ..+++..++.++.|++.||.+||+.|++|+||||+||++++ +.++|+||
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~df 174 (296)
T cd05051 95 CMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADF 174 (296)
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccc
Confidence 99999998776766655432 25899999999999999999999999999999999999985 79999999
Q ss_pred CcccccCCCC---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh--CCCCCCCCCChHHHHHHHHHhCCC
Q 044127 134 GMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS--FRILFPGKNSADQIYKICQVIGSP 208 (282)
Q Consensus 134 ~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~--g~~~~~~~~~~~~~~~~~~~~~~~ 208 (282)
|.+....... ......++..|+|||.+.... ++.++|||||||++|+|++ +..||......+............
T Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 253 (296)
T cd05051 175 GMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDD 253 (296)
T ss_pred cceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccc
Confidence 9987543221 122344567899999987544 7999999999999999998 677887776666555443322111
Q ss_pred CCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 209 TEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.. ......+...+.++.+++.+||+.||.+|||+.+|++
T Consensus 254 ~~----------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 254 GR----------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cc----------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 00 0001122346789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=269.27 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=194.4
Q ss_pred CCcceEEEEEec---CCCcEEEEEEccccccc---hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDK---KSGEFVAVKKLKKKIFS---LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~---~~~~~v~vK~~~~~~~~---~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|++|.||+|++. .+++.|++|++...... .....+..|+.++.++.+||+++++++.+..+...++||||+.++
T Consensus 11 G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (288)
T cd05583 11 GAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGG 90 (288)
T ss_pred CCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCC
Confidence 889999999864 46788999998754221 223455679999999988999999999999999999999999876
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCcccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTT 151 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~ 151 (282)
.+....... ..+++..+..++.|+++||.+||+.+++|+||+|+||+++. +.++|+|||++........ .....++
T Consensus 91 ~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 169 (288)
T cd05583 91 ELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169 (288)
T ss_pred cHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCC
Confidence 665555443 46899999999999999999999999999999999999975 7899999998876533221 1224578
Q ss_pred ccccCchhhhccc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 152 RWYRAPEVLLLSE-IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 152 ~~~~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.......
T Consensus 170 ~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------------------- 227 (288)
T cd05583 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS---------------------- 227 (288)
T ss_pred ccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc----------------------
Confidence 8899999986432 26789999999999999999999996543322222211111000
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCC---HHHHhcCcccccccC
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPT---AAEALEHPFFRSCHF 278 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~~ 278 (282)
....+..++..+.++|.+||+.||++||| +.++|+||||+++.+
T Consensus 228 ----~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 228 ----KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred ----CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 01223456788999999999999999998 567799999998765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=266.88 Aligned_cols=237 Identities=18% Similarity=0.295 Sum_probs=181.6
Q ss_pred CCcceEEEEEecCCCc----EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGE----FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|.+..++. .+++|.+...........+..|+..+.++ +||||+++++++.. ...++++|++.++++
T Consensus 18 G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL 95 (279)
T cd05111 18 GVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG-ASLQLVTQLSPLGSL 95 (279)
T ss_pred cCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC-CccEEEEEeCCCCcH
Confidence 8999999999877766 47778775433223334556677777777 59999999998764 457789999987666
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC---CCCCccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTR 152 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~---~~~~~~~~~ 152 (282)
..++......+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||.+....... ......++.
T Consensus 96 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 175 (279)
T cd05111 96 LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175 (279)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcc
Confidence 6666555567999999999999999999999999999999999999985 689999999987653221 122344567
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+.++. ++.++||||||+++||+++ |..||.+....... +.......+
T Consensus 176 ~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~----------------------- 230 (279)
T cd05111 176 KWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGERL----------------------- 230 (279)
T ss_pred cccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcC-----------------------
Confidence 899999987544 8999999999999999998 99999776544332 222211100
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...+..+.+++.+|+..||.+|||+.++++
T Consensus 231 -----~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 -----AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111234677899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=268.87 Aligned_cols=245 Identities=24% Similarity=0.357 Sum_probs=188.8
Q ss_pred CCcceEEEEEecCC--------------CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEE
Q 044127 1 GSYGDVFQALDKKS--------------GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFI 66 (282)
Q Consensus 1 G~~g~Vy~~~~~~~--------------~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~l 66 (282)
|+||.||+|++..+ ...|++|.+...........+.+|+..+.++. |||++++++++......++
T Consensus 16 G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~l 94 (295)
T cd05097 16 GQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK-NPNIIRLLGVCVSDDPLCM 94 (295)
T ss_pred CCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEcCCCccEE
Confidence 89999999987543 23589999876544444556788999999995 9999999999999999999
Q ss_pred EEecCCccHHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecC
Q 044127 67 VFEYMESDLLKLMKERAG-----------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLG 134 (282)
Q Consensus 67 v~e~~~~~~l~~~~~~~~-----------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~ 134 (282)
+|||+.++.+..++.... ..+++..+..++.|++.||.+||+.|++|+||||+||++++ +.++|+|||
T Consensus 95 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg 174 (295)
T cd05097 95 ITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFG 174 (295)
T ss_pred EEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccc
Confidence 999999877766654321 23788999999999999999999999999999999999975 689999999
Q ss_pred cccccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh--CCCCCCCCCChHHHHHHHHHhCCCC
Q 044127 135 MVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS--FRILFPGKNSADQIYKICQVIGSPT 209 (282)
Q Consensus 135 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~--g~~~~~~~~~~~~~~~~~~~~~~~~ 209 (282)
++........ .....++..|+|||.+..+. ++.++|+||||+++|+|++ +..||......+.............
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 253 (295)
T cd05097 175 MSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQG 253 (295)
T ss_pred cccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhcc
Confidence 9875432211 12234466899999987554 7999999999999999988 5678887766665544333211100
Q ss_pred CCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 210 EDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.. .....+...++.+.+++.+||+.||++|||++++++
T Consensus 254 ~~----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 254 RQ----------------------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cc----------------------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 001123346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=274.60 Aligned_cols=241 Identities=23% Similarity=0.372 Sum_probs=185.8
Q ss_pred CCcceEEEEEe-----cCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc-CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALD-----KKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE-HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~-----~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~~~ 74 (282)
|+||+||+|++ ..+++.||+|+++..........+.+|+.++.++.+||||+++++++.. +...+++||||+++
T Consensus 18 G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g 97 (343)
T cd05103 18 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 97 (343)
T ss_pred CccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCC
Confidence 89999999984 3467889999997655444556678899999999889999999998754 45689999999987
Q ss_pred HHHHHHHhcC------------------------------------------------------------------CCCC
Q 044127 75 LLKLMKERAG------------------------------------------------------------------QNFS 88 (282)
Q Consensus 75 ~l~~~~~~~~------------------------------------------------------------------~~l~ 88 (282)
.+..++.... ..++
T Consensus 98 ~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (343)
T cd05103 98 NLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLT 177 (343)
T ss_pred cHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCC
Confidence 7766654321 2367
Q ss_pred HHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC---CCCCccccccccCchhhhccc
Q 044127 89 EDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSE 164 (282)
Q Consensus 89 ~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~ 164 (282)
...+..++.||++||.|||++|++|+||||+||++++ +.++|+|||++....... ......++..|+|||.+.+.
T Consensus 178 ~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~- 256 (343)
T cd05103 178 LEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR- 256 (343)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCC-
Confidence 8888999999999999999999999999999999984 899999999987642221 11223345679999998744
Q ss_pred cCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCC
Q 044127 165 IYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSAS 243 (282)
Q Consensus 165 ~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (282)
.++.++||||||+++|++++ |..||.................. ...+...+
T Consensus 257 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~ 308 (343)
T cd05103 257 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR----------------------------MRAPDYTT 308 (343)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC----------------------------CCCCCCCC
Confidence 47999999999999999997 88898765543333222211100 01122356
Q ss_pred hhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 244 RESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 244 ~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
+.+.+++..||+.||++|||+.++++|
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=263.71 Aligned_cols=235 Identities=23% Similarity=0.417 Sum_probs=187.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|.+. ++..|++|.+.... .....+.+|+.+++++. ||||+++++.+...+..++++||+.++.+..++
T Consensus 17 g~~g~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 92 (261)
T cd05072 17 GQFGEVWMGYYN-NSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL 92 (261)
T ss_pred cCCceEEEEEec-CCceEEEEEccCCc--hhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHH
Confidence 789999999865 45679999876532 23456678999998884 999999999999999999999999865555554
Q ss_pred H-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCccccccccC
Q 044127 81 E-RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRA 156 (282)
Q Consensus 81 ~-~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~a 156 (282)
. ..+..++...+..++.|++.||.+||+.+++|+||+|+||++++ +.++|+|||.+........ .....++..|+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~a 172 (261)
T cd05072 93 KSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA 172 (261)
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCC
Confidence 4 34457899999999999999999999999999999999999985 7899999999986643221 122334567999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+.... ++.++||||||+++|+|++ |..||......+....+......
T Consensus 173 PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---------------------------- 223 (261)
T cd05072 173 PEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM---------------------------- 223 (261)
T ss_pred HHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----------------------------
Confidence 99987544 7889999999999999998 89999877665555443221110
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
......+..+.+++.+||..+|++|||++++++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 -PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=267.99 Aligned_cols=237 Identities=25% Similarity=0.391 Sum_probs=187.2
Q ss_pred CCcceEEEEEec-----CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDK-----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.+. .++..+++|.+.... ......+.+|+..++++. ||||+++++++......+++|||+.++.
T Consensus 16 g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 93 (291)
T cd05094 16 GAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGD 93 (291)
T ss_pred cCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCceEEEEecCCCCc
Confidence 789999999854 345668899886543 233345678889898884 9999999999999999999999999877
Q ss_pred HHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccccc
Q 044127 76 LKLMKERAG---------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI 139 (282)
Q Consensus 76 l~~~~~~~~---------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~ 139 (282)
+..++...+ ..+++..++.++.||+.||++||++|++|+||||+||++++ +.++|+|||.+...
T Consensus 94 L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~ 173 (291)
T cd05094 94 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 173 (291)
T ss_pred HHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCccccc
Confidence 777665432 24889999999999999999999999999999999999985 78999999998765
Q ss_pred CCCC---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccc
Q 044127 140 DSSL---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPL 215 (282)
Q Consensus 140 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (282)
.... ......++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+....
T Consensus 174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---------- 242 (291)
T cd05094 174 YSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR---------- 242 (291)
T ss_pred CCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC----------
Confidence 3321 11234457789999998754 47899999999999999998 999997776655443321100
Q ss_pred cccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 216 GIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+...+..+.+++.+||+.||++|||++++++
T Consensus 243 -------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 243 -------------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred -------------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 00112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=264.73 Aligned_cols=243 Identities=22% Similarity=0.324 Sum_probs=185.0
Q ss_pred CCcceEEEEEecC--CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKK--SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.... ....+++|.+...........+.+|+..++.+ +||||+++++.+......+++|||+.++++..
T Consensus 6 G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~ 84 (269)
T cd05042 6 GWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFCPLGDLKN 84 (269)
T ss_pred cCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeCCCCcHHH
Confidence 8999999996433 34578899876554444455677888888887 59999999999999999999999999877776
Q ss_pred HHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC---CCCCccc
Q 044127 79 MKERAG----QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVT 150 (282)
Q Consensus 79 ~~~~~~----~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~---~~~~~~~ 150 (282)
++.... ...++..+..++.||+.||+|||++|++|+||||+||++++ +.++++|||.+....... ......+
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 164 (269)
T cd05042 85 YLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV 164 (269)
T ss_pred HHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCC
Confidence 665432 23567888999999999999999999999999999999985 799999999986542211 1122345
Q ss_pred cccccCchhhhc------cccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccC
Q 044127 151 TRWYRAPEVLLL------SEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL 223 (282)
Q Consensus 151 ~~~~~aPE~~~~------~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
+..|+|||++.. ...++.++|||||||++|+|++ |..||......+............
T Consensus 165 ~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~--------------- 229 (269)
T cd05042 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK--------------- 229 (269)
T ss_pred cccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc---------------
Confidence 667999999753 2346789999999999999999 788887776665554443321110
Q ss_pred CccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+......+..+.+++..|+ .||++|||+++|++
T Consensus 230 ---------~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 230 ---------LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ---------CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0111234467888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=264.19 Aligned_cols=239 Identities=21% Similarity=0.326 Sum_probs=182.4
Q ss_pred CCcceEEEEEecC---CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc-cCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKK---SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK-EHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|.+.. .+..+++|.+...........+..|...++.+ +|||++++++++. .++..++++||+.++.+
T Consensus 6 g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 84 (262)
T cd05058 6 GHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLPYMKHGDL 84 (262)
T ss_pred cCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEecCCCCCH
Confidence 8999999998653 34579999986543334455667788888887 5999999999764 55678999999997777
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-----CCCCccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-----PCTDYVT 150 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-----~~~~~~~ 150 (282)
..++......++...+..++.||++||.+||+.+++|+||+|+||++++ +.++|+|||++....... ......+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 164 (262)
T cd05058 85 RNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164 (262)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcC
Confidence 7776655456788889999999999999999999999999999999985 789999999987543211 1123345
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
+..|+|||.+.... ++.++||||||+++|+|++| ..||...+..+..........
T Consensus 165 ~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~----------------------- 220 (262)
T cd05058 165 PVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR----------------------- 220 (262)
T ss_pred CccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-----------------------
Confidence 66799999987544 78999999999999999995 556665544443332211100
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+...++.+.+++.+||+.+|++||++.+++..
T Consensus 221 ------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 221 ------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred ------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 01122457789999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=262.96 Aligned_cols=243 Identities=18% Similarity=0.232 Sum_probs=185.3
Q ss_pred CCcceEEEEEec--CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDK--KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|... .++..+++|.+...........+.+|+..+.++. ||||+++++.+.+....+++|||+.++.+..
T Consensus 6 G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 84 (269)
T cd05087 6 GWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG 84 (269)
T ss_pred cCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECCCCCcHHH
Confidence 899999999754 3466799999877654455567788999999885 9999999999999899999999999777766
Q ss_pred HHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC---CCCCccc
Q 044127 79 MKERA----GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVT 150 (282)
Q Consensus 79 ~~~~~----~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~---~~~~~~~ 150 (282)
++... ....+...+..++.|++.||.+||+.+++|+||||+||+++. +.++|+|||.+....... ......+
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~ 164 (269)
T cd05087 85 YLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV 164 (269)
T ss_pred HHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCC
Confidence 65432 124567788899999999999999999999999999999985 689999999986543221 1123456
Q ss_pred cccccCchhhhccc------cCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccC
Q 044127 151 TRWYRAPEVLLLSE------IYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL 223 (282)
Q Consensus 151 ~~~~~aPE~~~~~~------~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
+..|+|||++.... .++.++|+||||+++|+|++ |..||......+............
T Consensus 165 ~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 229 (269)
T cd05087 165 PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLK--------------- 229 (269)
T ss_pred cccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCC---------------
Confidence 77899999985321 24789999999999999996 999998766555433222111000
Q ss_pred CccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+......++.+.++++.|+ .+|++|||+++|+.
T Consensus 230 ---------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 230 ---------LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ---------CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0011222346778999999998 58999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=266.66 Aligned_cols=237 Identities=24% Similarity=0.389 Sum_probs=187.3
Q ss_pred CCcceEEEEEe-----cCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALD-----KKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~-----~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.. ..++..+++|.+.... ......+.+|+..+..+ +||||+++++++......+++|||+.++.
T Consensus 16 g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 93 (280)
T cd05092 16 GAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVL-QHQHIVRFYGVCTEGRPLLMVFEYMRHGD 93 (280)
T ss_pred ccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCCceEEEEecCCCCC
Confidence 89999999964 3356789999876532 33455677899988888 59999999999999999999999999777
Q ss_pred HHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC
Q 044127 76 LKLMKERAG--------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID 140 (282)
Q Consensus 76 l~~~~~~~~--------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~ 140 (282)
+..++...+ ..+++..+..++.||+.||+|||+.|++|+||||+||++++ +.++|+|||++....
T Consensus 94 L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 173 (280)
T cd05092 94 LNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 173 (280)
T ss_pred HHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcC
Confidence 766655432 24889999999999999999999999999999999999975 789999999987543
Q ss_pred CCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCcccc
Q 044127 141 SSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLG 216 (282)
Q Consensus 141 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (282)
.... .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||......+..........
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---------- 242 (280)
T cd05092 174 STDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE---------- 242 (280)
T ss_pred CCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCcc----------
Confidence 2211 12233467799999987544 7999999999999999998 8999977666555443322110
Q ss_pred ccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 217 IQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+..+++.+.+++.+||+.||.+||+++++++
T Consensus 243 -------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 243 -------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred -------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0122356888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=295.85 Aligned_cols=238 Identities=24% Similarity=0.415 Sum_probs=201.3
Q ss_pred CCcceEEEEEecCCCc-----EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGE-----FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~-----~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|.||.||.|....... .|++|.+.+.....+..++++|..++..+ +||||++++|++-+....+|++|||.|+.
T Consensus 703 G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~~~~i~leyM~gGD 781 (1025)
T KOG1095|consen 703 GAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSGPPLILLEYMEGGD 781 (1025)
T ss_pred ccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCCCcEEEehhcccCc
Confidence 8999999998765322 39999998887778889999999999999 59999999999999999999999999877
Q ss_pred HHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC---
Q 044127 76 LKLMKERA------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC--- 145 (282)
Q Consensus 76 l~~~~~~~------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~--- 145 (282)
|..+++.. ...++......++.|||+|+.||++++++||||...|+|++. ..+|++|||+|+.+-...-.
T Consensus 782 L~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~ 861 (1025)
T KOG1095|consen 782 LLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKH 861 (1025)
T ss_pred HHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheecc
Confidence 77776665 556999999999999999999999999999999999999996 78999999999955222111
Q ss_pred CCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCC
Q 044127 146 TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224 (282)
Q Consensus 146 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
....-+..|+|||.+.. ..++.++|||||||++||+++ |..||...+..+.........+
T Consensus 862 ~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR------------------ 922 (1025)
T KOG1095|consen 862 GEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR------------------ 922 (1025)
T ss_pred CccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc------------------
Confidence 11123456999999986 459999999999999999999 8899999988888775555332
Q ss_pred ccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.+.+..+++.+.++|..||+.+|++||++..|++
T Consensus 923 -----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 -----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 1334567999999999999999999999999986
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=263.26 Aligned_cols=235 Identities=26% Similarity=0.446 Sum_probs=186.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|.+.. ++.|++|.+..... ....+.+|+..++++. |||++++++++...+..+++||++.++.+..++
T Consensus 17 g~~~~v~~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 92 (261)
T cd05068 17 GQFGEVWEGLWNN-TTPVAVKTLKPGTM--DPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL 92 (261)
T ss_pred cCCccEEEEEecC-CeEEEEEeeCCCcc--cHHHHHHHHHHHHHCC-CCCccceeEEEecCCCeeeeeecccCCcHHHHH
Confidence 7899999998754 56799999875432 2445678999999995 999999999999999999999999766565555
Q ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCC--CccccccccC
Q 044127 81 ER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCT--DYVTTRWYRA 156 (282)
Q Consensus 81 ~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~a 156 (282)
.. .+..++...+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||++.......... ....+..|+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~a 172 (261)
T cd05068 93 QGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA 172 (261)
T ss_pred hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccC
Confidence 43 3456999999999999999999999999999999999999975 789999999988765322111 1122357999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+.+.. ++.++|+||||+++|+|++ |..||.+.........+.....
T Consensus 173 PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------- 222 (261)
T cd05068 173 PEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR----------------------------- 222 (261)
T ss_pred ccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------------------
Confidence 99887444 7999999999999999999 9999987765554443322110
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.+++.+||+.+|.+||+++++++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0112356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=276.97 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=186.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCC-cEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE-DVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-~~~lv~e~~~~~~l~~~ 79 (282)
|+||.||+|.... |..||||.+....... ..++.+|+.++.++. |||+++++|+|.+.+ ..++|+||+..++|+..
T Consensus 86 Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~ 162 (361)
T KOG1187|consen 86 GGFGTVYKGVLSD-GTVVAVKRLSSNSGQG-EREFLNEVEILSRLR-HPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDH 162 (361)
T ss_pred CCCeEEEEEEECC-CCEEEEEEecCCCCcc-hhHHHHHHHHHhcCC-CcCcccEEEEEecCCceEEEEEEccCCCCHHHH
Confidence 8999999998654 5889999887655433 556999999999996 999999999999988 59999999997777666
Q ss_pred HHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcC---ccccCCCCCceeee-CCcEEEeecCcccccCC-CCCCCCc-cccc
Q 044127 80 KERAGQ-NFSEDEVRNLCFQVFQGLHYMHRQG---YFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDS-SLPCTDY-VTTR 152 (282)
Q Consensus 80 ~~~~~~-~l~~~~~~~i~~qi~~~l~~Lh~~~---~~H~dl~p~nili~-~~~~~l~df~~~~~~~~-~~~~~~~-~~~~ 152 (282)
+..... ++++.++.+|+.++|.||+|||+.. |+||||||+|||+| +...||+|||+|...+. ....... .||.
T Consensus 163 L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~ 242 (361)
T KOG1187|consen 163 LHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTF 242 (361)
T ss_pred hCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCC
Confidence 655444 8999999999999999999999864 99999999999999 47999999999966554 3332333 8999
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHH-HHHhCCCCCCCccccccccccCCccccC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQ--IYKI-CQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
.|++||.+..+. .+.++||||||+++.||++|+.+.+....... +... ....... ...+..+.....
T Consensus 243 gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~---------~~~eiiD~~l~~ 312 (361)
T KOG1187|consen 243 GYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG---------KLREIVDPRLKE 312 (361)
T ss_pred ccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc---------chhheeCCCccC
Confidence 999999997544 89999999999999999999988775431111 1111 1111110 000111111100
Q ss_pred CCCCcccccCC-CCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 230 MGGVNLRELSP-SASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 230 ~~~~~~~~~~~-~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..... ..-..+..+..+|++.+|.+||++.+++.
T Consensus 313 ------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 313 ------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred ------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 00110 12234677889999999999999999754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=295.78 Aligned_cols=245 Identities=33% Similarity=0.509 Sum_probs=191.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc--------------------
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE-------------------- 60 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-------------------- 60 (282)
||||.||+|+++-+|..||||++............++|+..+.++ +|||||+++..+.+
T Consensus 490 GGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQ 568 (1351)
T KOG1035|consen 490 GGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTVLEIVASDSESRSQ 568 (1351)
T ss_pred CCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCccccccccccchhhhcc
Confidence 899999999999999999999998876555667788999999999 59999998755410
Q ss_pred --------------------------------------------------------------------------------
Q 044127 61 -------------------------------------------------------------------------------- 60 (282)
Q Consensus 61 -------------------------------------------------------------------------------- 60 (282)
T Consensus 569 s~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~es 648 (1351)
T KOG1035|consen 569 SASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSES 648 (1351)
T ss_pred cCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhh
Confidence
Q ss_pred -----------C--------CcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCce
Q 044127 61 -----------H--------EDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNL 121 (282)
Q Consensus 61 -----------~--------~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~ni 121 (282)
+ ..+||-||||...++..++.+....-.....++++++|++||+|+|+.|++||||||.||
T Consensus 649 s~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NI 728 (1351)
T KOG1035|consen 649 SESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNI 728 (1351)
T ss_pred hhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCccee
Confidence 0 146899999999999998887532115889999999999999999999999999999999
Q ss_pred eeeC-CcEEEeecCccccc-------------------CCCCCCCCccccccccCchhhhccc--cCCCcchhHHHHHHH
Q 044127 122 LVSK-GVIKIGDLGMVKEI-------------------DSSLPCTDYVTTRWYRAPEVLLLSE--IYGPEVDMWAMGAIM 179 (282)
Q Consensus 122 li~~-~~~~l~df~~~~~~-------------------~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~DiwslG~ll 179 (282)
+++. +.|||+|||+|+.. ......+...||..|.|||++.+.. .++.|+|+||||+++
T Consensus 729 FLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVl 808 (1351)
T KOG1035|consen 729 FLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVL 808 (1351)
T ss_pred EEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHH
Confidence 9985 79999999999861 1111334568999999999997655 699999999999999
Q ss_pred HHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCC
Q 044127 180 FEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPH 259 (282)
Q Consensus 180 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 259 (282)
+||+. ||... ++-. .+...++.+.... ...+....-+.-.++|++||+.||+
T Consensus 809 FEM~y---PF~Ts--MERa-~iL~~LR~g~iP~----------------------~~~f~~~~~~~e~slI~~Ll~hdP~ 860 (1351)
T KOG1035|consen 809 FEMLY---PFGTS--MERA-SILTNLRKGSIPE----------------------PADFFDPEHPEEASLIRWLLSHDPS 860 (1351)
T ss_pred HHHhc---cCCch--HHHH-HHHHhcccCCCCC----------------------CcccccccchHHHHHHHHHhcCCCc
Confidence 99987 45422 2222 2222222211100 0122333445567899999999999
Q ss_pred CCCCHHHHhcCcccc
Q 044127 260 MRPTAAEALEHPFFR 274 (282)
Q Consensus 260 ~Rps~~~ll~~~~~~ 274 (282)
+||||.|||++.||-
T Consensus 861 kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 861 KRPTATELLNSELLP 875 (1351)
T ss_pred cCCCHHHHhhccCCC
Confidence 999999999999986
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=261.55 Aligned_cols=232 Identities=26% Similarity=0.410 Sum_probs=187.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||+|... |+.|++|.+..... ....+.+|+..+.++. |||++++++++.+....+++||++.++.+..++
T Consensus 17 g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 91 (256)
T cd05039 17 GEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL 91 (256)
T ss_pred CCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEEEEEecCCCcHHHHH
Confidence 789999999764 78899999976643 4566788999999995 999999999999889999999999976666555
Q ss_pred Hhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 81 ERA-GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~-~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
... ...+++..+..++.|++.||.+||++|++|+||+|+||++++ +.++|+|||.+....... .....+..|+|||
T Consensus 92 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape 169 (256)
T cd05039 92 RSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--DSGKLPVKWTAPE 169 (256)
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--ccCCCcccccCch
Confidence 443 236999999999999999999999999999999999999985 789999999988764332 2334456799999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
.+..+ .++.++|+||||+++|++++ |..||......+......... ...
T Consensus 170 ~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~ 219 (256)
T cd05039 170 ALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY-----------------------------RME 219 (256)
T ss_pred hhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC-----------------------------CCC
Confidence 98744 47889999999999999997 999997765544333221100 001
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.+...++.+.++|++||..+|++|||++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 23356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=272.21 Aligned_cols=240 Identities=23% Similarity=0.377 Sum_probs=189.5
Q ss_pred CCcceEEEEEecCC-------CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKS-------GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||.||+|++... +..|++|.+...........+.+|+..++++.+||||+++++.+...+..++++||+++
T Consensus 23 G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 102 (334)
T cd05100 23 GCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASK 102 (334)
T ss_pred ccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCC
Confidence 89999999986532 23689999876544455667788999999997799999999999999999999999987
Q ss_pred cHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCccc
Q 044127 74 DLLKLMKERA---------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVK 137 (282)
Q Consensus 74 ~~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~ 137 (282)
+.+..++... ...++..++..++.|++.||.+||++|++|+||+|+||+++ ++.++|+|||++.
T Consensus 103 g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~ 182 (334)
T cd05100 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182 (334)
T ss_pred CcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccce
Confidence 7666665432 12478889999999999999999999999999999999998 4789999999987
Q ss_pred ccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCc
Q 044127 138 EIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 138 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (282)
....... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------- 253 (334)
T cd05100 183 DVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH-------- 253 (334)
T ss_pred ecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 6543221 1222334679999998744 47899999999999999998 888898766555444332210
Q ss_pred cccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
....+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 254 ---------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 254 ---------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred ---------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 011233567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=263.55 Aligned_cols=241 Identities=27% Similarity=0.444 Sum_probs=188.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|++|.||+|++..+++.+++|.+...... .....+.+|+..++.+ +||||+++++.+..++..+++||++.++.+..
T Consensus 13 g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 91 (267)
T cd08229 13 GQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDLSR 91 (267)
T ss_pred cCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEEEEecCCCCHHH
Confidence 78999999999999999999987653322 2335667899988888 59999999999999999999999999876666
Q ss_pred HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCcccccc
Q 044127 79 MKER---AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRW 153 (282)
Q Consensus 79 ~~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~ 153 (282)
++.. ....+++..++.++.||+.||.+||++|++|+||+|+||+++. +.++++|||.+........ .....++..
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 171 (267)
T cd08229 92 MIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171 (267)
T ss_pred HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcC
Confidence 5542 2346899999999999999999999999999999999999975 7899999998876543322 223467888
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
|+|||.+.+.. .+.++|+||||+++|+|++|..||....... ............
T Consensus 172 ~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~----------------------- 225 (267)
T cd08229 172 YMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIEQCDY----------------------- 225 (267)
T ss_pred ccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchH--HHHhhhhhcCCC-----------------------
Confidence 99999987544 7889999999999999999999997543321 111111110000
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
........++.+.+++.+||+.||.+|||+++|++
T Consensus 226 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 226 -PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 00112346789999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=267.11 Aligned_cols=238 Identities=27% Similarity=0.377 Sum_probs=186.9
Q ss_pred CCcceEEEEEecC-----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKK-----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.+.. ++..|++|++...........+.+|+..+.++ +|||++++++++.+....++++||++++.
T Consensus 16 g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 94 (288)
T cd05050 16 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAVGKPMCLLFEYMAYGD 94 (288)
T ss_pred cccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCccEEEEecCCCCC
Confidence 7899999998753 57889999987654444455677899999998 59999999999999999999999999766
Q ss_pred HHHHHHhc---------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeec
Q 044127 76 LKLMKERA---------------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDL 133 (282)
Q Consensus 76 l~~~~~~~---------------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df 133 (282)
+..++... ...+++..++.++.|++.||.+||+++++|+||+|+||++++ +.++|+||
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~df 174 (288)
T cd05050 95 LNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 174 (288)
T ss_pred HHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECcc
Confidence 66555421 124788999999999999999999999999999999999974 78999999
Q ss_pred CcccccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCC
Q 044127 134 GMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPT 209 (282)
Q Consensus 134 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~ 209 (282)
|.+........ ......+..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~---- 249 (288)
T cd05050 175 GLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN---- 249 (288)
T ss_pred ccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----
Confidence 98875432211 12233456799999987544 8999999999999999997 778887766555443332110
Q ss_pred CCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 210 EDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 250 -------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 250 -------------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00122356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=264.69 Aligned_cols=237 Identities=22% Similarity=0.344 Sum_probs=188.7
Q ss_pred CCcceEEEEEecCCCc----EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGE----FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|.++.+|. .+++|.............+.+|+..+.++ +|||++++++++.. ...++++|++.++.+
T Consensus 18 g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L 95 (279)
T cd05057 18 GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQVQLITQLMPLGCL 95 (279)
T ss_pred CCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-CceEEEEecCCCCcH
Confidence 8999999999876654 58999887665444556777899999998 59999999999877 789999999987766
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCC---ccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTD---YVTTR 152 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~---~~~~~ 152 (282)
...+......+++..+..++.||+.||++||+.|++|+||+|+||++++ +.++|+|||.+........... ...+.
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~ 175 (279)
T cd05057 96 LDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175 (279)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccc
Confidence 6666655456999999999999999999999999999999999999975 7899999999876543222111 12345
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+... .++.++|+||||+++|++++ |..||......+....+.....
T Consensus 176 ~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------------------- 229 (279)
T cd05057 176 KWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER------------------------- 229 (279)
T ss_pred cccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-------------------------
Confidence 79999988644 47899999999999999998 9999988765554433322110
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.+++.+||..||.+||++.++++
T Consensus 230 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 230 ----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0112345678999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=265.17 Aligned_cols=238 Identities=29% Similarity=0.465 Sum_probs=186.6
Q ss_pred CCcceEEEEEecCCC------cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSG------EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~------~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|+||.||+|+++... +.+++|.+...........+.+|+..++.+ +||||+++++++...+..+++|||+.++
T Consensus 6 g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (269)
T cd05044 6 GAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYIIMELMEGG 84 (269)
T ss_pred ccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEEEeccCCC
Confidence 789999999876543 679999887654444566778899999888 4999999999999999999999999876
Q ss_pred HHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C-----cEEEeecCcccccCCC
Q 044127 75 LLKLMKER------AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G-----VIKIGDLGMVKEIDSS 142 (282)
Q Consensus 75 ~l~~~~~~------~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~-----~~~l~df~~~~~~~~~ 142 (282)
.+..++.. ....+++..+..++.|++.||.|||+.+++|+||+|+||++++ + .++++|||++......
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~ 164 (269)
T cd05044 85 DLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS 164 (269)
T ss_pred cHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccc
Confidence 66555432 1234788999999999999999999999999999999999985 4 6999999998755322
Q ss_pred CC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCcccccc
Q 044127 143 LP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQ 218 (282)
Q Consensus 143 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (282)
.. ......+..|+|||.+.++. ++.++||||||+++|+|++ |..||......+....+... .
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~------------ 230 (269)
T cd05044 165 DYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G------------ 230 (269)
T ss_pred cccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C------------
Confidence 11 11224457799999987554 7999999999999999998 99999866554443332110 0
Q ss_pred ccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 219 LASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+...+..+.+++.+||..+|.+||+++++++
T Consensus 231 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 ----------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ----------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00122356788999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=293.56 Aligned_cols=239 Identities=26% Similarity=0.388 Sum_probs=185.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|++..+++.||+|++...... .....+.+|+.++.++. ||||+++++++.+++..+++|||+.|+.+..
T Consensus 13 GgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~ 91 (932)
T PRK13184 13 GGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYTMPYIEGYTLKS 91 (932)
T ss_pred CCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEEEEcCCCCCHHH
Confidence 89999999999999999999998764322 23445778999999985 9999999999999999999999999877766
Q ss_pred HHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-----
Q 044127 79 MKERA----------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS----- 142 (282)
Q Consensus 79 ~~~~~----------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~----- 142 (282)
++... ...++...+..++.||++||.+||++|++||||||+||+++. +.++++|||++......
T Consensus 92 lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~ 171 (932)
T PRK13184 92 LLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171 (932)
T ss_pred HHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceeccccccccc
Confidence 65431 123567788999999999999999999999999999999985 89999999998765111
Q ss_pred --------------CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCC
Q 044127 143 --------------LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSP 208 (282)
Q Consensus 143 --------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 208 (282)
.......|++.|+|||.+.+.. ++.++|||||||++|+|++|..||........... .....+
T Consensus 172 ~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~--~~i~~P 248 (932)
T PRK13184 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR--DVILSP 248 (932)
T ss_pred ccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--hhccCh
Confidence 0011246899999999987544 79999999999999999999999977544332211 000000
Q ss_pred CCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh
Q 044127 209 TEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268 (282)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 268 (282)
. . ......+++.+.+++.+||+.||++|++..+.+
T Consensus 249 ~--~-----------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 249 I--E-----------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred h--h-----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 0 0 001135688899999999999999998765444
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=263.25 Aligned_cols=231 Identities=20% Similarity=0.308 Sum_probs=182.4
Q ss_pred CCcceEEEEEecCCC----------cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEec
Q 044127 1 GSYGDVFQALDKKSG----------EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEY 70 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~----------~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 70 (282)
|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++++ +|||++++++++.. ...++++||
T Consensus 6 G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~e~ 81 (259)
T cd05037 6 GTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQL-SHKHLVKLYGVCVR-DENIMVEEY 81 (259)
T ss_pred cccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcC-CCcchhheeeEEec-CCcEEEEEc
Confidence 899999999998776 35788877654322 56667888888888 59999999999877 778999999
Q ss_pred CCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C-------cEEEeecCcccccCCC
Q 044127 71 MESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G-------VIKIGDLGMVKEIDSS 142 (282)
Q Consensus 71 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~-------~~~l~df~~~~~~~~~ 142 (282)
+.++++..++...+..++...+..++.||+.||.|||++|++|+||||+||+++. + .++|+|||.+......
T Consensus 82 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~ 161 (259)
T cd05037 82 VKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161 (259)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccccc
Confidence 9988888777765547999999999999999999999999999999999999985 3 5999999998865542
Q ss_pred CCCCCccccccccCchhhhcc-ccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccc
Q 044127 143 LPCTDYVTTRWYRAPEVLLLS-EIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA 220 (282)
Q Consensus 143 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
....++..|+|||.+.+. ..++.++|+||||+++|+|++ |..||.............. ..
T Consensus 162 ---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~~----------- 223 (259)
T cd05037 162 ---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----QH----------- 223 (259)
T ss_pred ---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----CC-----------
Confidence 234456779999998755 357899999999999999999 5777766543322221110 00
Q ss_pred ccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 221 SNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+......+.+++.+||..+|.+|||+.++++
T Consensus 224 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 ----------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ----------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 001112378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=263.89 Aligned_cols=239 Identities=21% Similarity=0.334 Sum_probs=183.8
Q ss_pred CCcceEEEEEecCCCc--EEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeecccccc------CCcEEEEEecC
Q 044127 1 GSYGDVFQALDKKSGE--FVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKE------HEDVFIVFEYM 71 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~--~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~------~~~~~lv~e~~ 71 (282)
|+||.||+|++..++. .+++|.++..... .....+..|...++.+ +||||+++++.+.. ....++++||+
T Consensus 10 G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~ 88 (272)
T cd05075 10 GEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPSPVVILPFM 88 (272)
T ss_pred ccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCCcEEEEEeC
Confidence 8999999999877765 6899988765333 3345667788888888 59999999987532 23578999999
Q ss_pred CccHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-
Q 044127 72 ESDLLKLMKER-----AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP- 144 (282)
Q Consensus 72 ~~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~- 144 (282)
.++.+..++.. ....+++..+..++.|++.||.|||+++++|+||||+||++++ +.++|+|||.+........
T Consensus 89 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 168 (272)
T cd05075 89 KHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY 168 (272)
T ss_pred CCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccce
Confidence 87666554421 2235899999999999999999999999999999999999985 7899999999886543221
Q ss_pred --CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 145 --CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 145 --~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
......++.|+|||.+... .++.++||||||+++|++++ |..||......+....+.....
T Consensus 169 ~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------- 232 (272)
T cd05075 169 RQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR--------------- 232 (272)
T ss_pred ecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 1223456679999998744 47999999999999999999 7889987655544433322100
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+...+..+.++|.+||+.||++|||++++++.
T Consensus 233 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 --------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01123567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=262.09 Aligned_cols=234 Identities=25% Similarity=0.424 Sum_probs=183.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..++ .|++|++..... ....+.+|+..++++. ||||+++++.+.+ ...+++|||+.++.+..++
T Consensus 17 g~~~~v~~~~~~~~~-~valK~~~~~~~--~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~ 91 (262)
T cd05071 17 GCFGEVWMGTWNGTT-RVAIKTLKPGTM--SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 91 (262)
T ss_pred CCCCcEEEEEecCCc-eEEEEecccCcc--CHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCcEEEEEcCCCCcHHHHH
Confidence 889999999887654 599999876432 2345677999999984 9999999998755 4679999999876665555
Q ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC--CCccccccccC
Q 044127 81 ER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRA 156 (282)
Q Consensus 81 ~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~a 156 (282)
.. .+..+++..+..++.|++.||.+||+.+++|+||+|+||++++ +.++|+|||.+......... ....++..|+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~ 171 (262)
T cd05071 92 KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 171 (262)
T ss_pred hhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecC
Confidence 43 3446899999999999999999999999999999999999985 78999999998765433211 12345667999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||...+.. ++.++|+||||+++|++++ |..||......+....+.....
T Consensus 172 PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~----------------------------- 221 (262)
T cd05071 172 PEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------------------------- 221 (262)
T ss_pred HhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-----------------------------
Confidence 99887444 7999999999999999999 7888887765554433221100
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.+++.+|++.||.+||++.++++
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0112356888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=278.42 Aligned_cols=238 Identities=25% Similarity=0.440 Sum_probs=198.4
Q ss_pred CCcceEEEEEecCCCc---E-EEEEEccc--cccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGE---F-VAVKKLKK--KIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~---~-v~vK~~~~--~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|+||.||+|..+..+. . ||+|..+. .........++.|..+++.+ +||||++++|+......+++|||+|.|+
T Consensus 168 GaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~Pl~ivmEl~~gG 246 (474)
T KOG0194|consen 168 GAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEPLMLVMELCNGG 246 (474)
T ss_pred ccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCccEEEEEecCCC
Confidence 8999999998765422 3 89999885 23345667889999999998 5999999999999999999999999998
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCC-Cccccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCT-DYVTTR 152 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~-~~~~~~ 152 (282)
.|+.+++..+..++..+...++.+++.||+|||+++++||||..+|+|++. +.+|++|||++..-....... ...-+.
T Consensus 247 sL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPi 326 (474)
T KOG0194|consen 247 SLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPI 326 (474)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcc
Confidence 888888877667999999999999999999999999999999999999997 566999999987553211111 223456
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHH-HhCCCCCCCccccccccccCCccccCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQ-VIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
.|+|||.+..+ .++.++|||||||++||+++ |..||.+....+....+.. ..+.+
T Consensus 327 rWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~---------------------- 383 (474)
T KOG0194|consen 327 RWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP---------------------- 383 (474)
T ss_pred eecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC----------------------
Confidence 79999999865 69999999999999999999 8889999998888777733 22222
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.+...+..+..++..|+..+|++|||+.++.+
T Consensus 384 -------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 384 -------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 23356889999999999999999999988764
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=265.89 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=186.8
Q ss_pred CCcceEEEEEecC----------------CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcE
Q 044127 1 GSYGDVFQALDKK----------------SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDV 64 (282)
Q Consensus 1 G~~g~Vy~~~~~~----------------~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 64 (282)
|+||+||+|.+.. ++..+++|++...........+..|+..++.+ +||||+++++++...+..
T Consensus 16 G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~ 94 (296)
T cd05095 16 GQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNIIRLLAVCITSDPL 94 (296)
T ss_pred CCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcc
Confidence 8999999986432 34569999987654444456778899999999 599999999999999999
Q ss_pred EEEEecCCccHHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeec
Q 044127 65 FIVFEYMESDLLKLMKERAG----------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDL 133 (282)
Q Consensus 65 ~lv~e~~~~~~l~~~~~~~~----------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df 133 (282)
+++|||+.++.+..++.... ..+++.++..++.|++.||.+||+.|++|+||||+||++++ +.++|+||
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~df 174 (296)
T cd05095 95 CMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADF 174 (296)
T ss_pred EEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccC
Confidence 99999998766666554421 23778899999999999999999999999999999999974 78999999
Q ss_pred CcccccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh--CCCCCCCCCChHHHHHHHHHhCCC
Q 044127 134 GMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS--FRILFPGKNSADQIYKICQVIGSP 208 (282)
Q Consensus 134 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~--g~~~~~~~~~~~~~~~~~~~~~~~ 208 (282)
|.+........ ......+..|++||...++. ++.++|+|||||++|||++ |..||......+............
T Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 253 (296)
T cd05095 175 GMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQ 253 (296)
T ss_pred cccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhc
Confidence 99876533221 12233456799999887544 8999999999999999998 678887766655544332211100
Q ss_pred CCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 209 TEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.. ......+...+..+.+|+.+||+.||++||+++++++
T Consensus 254 ~~----------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 254 GR----------------------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cc----------------------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 0001122346788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=263.48 Aligned_cols=239 Identities=21% Similarity=0.329 Sum_probs=185.6
Q ss_pred CCcceEEEEEecCC---CcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCC------cEEEEEec
Q 044127 1 GSYGDVFQALDKKS---GEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE------DVFIVFEY 70 (282)
Q Consensus 1 G~~g~Vy~~~~~~~---~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~------~~~lv~e~ 70 (282)
|+||.||.|.+..+ +..||+|.+...... .....+..|+..++.+ +|||++++++++.... ..++++||
T Consensus 10 G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~ 88 (273)
T cd05035 10 GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKIPKPMVILPF 88 (273)
T ss_pred CCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccCcccEEEEec
Confidence 89999999987653 478999998765433 3345677888888888 5999999999875544 37999999
Q ss_pred CCccHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC
Q 044127 71 MESDLLKLMKER-----AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP 144 (282)
Q Consensus 71 ~~~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~ 144 (282)
+.++.+..+... ....+++..+..++.|++.||.+||+.+++|+||||+||++++ +.++|+|||.+........
T Consensus 89 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 168 (273)
T cd05035 89 MKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY 168 (273)
T ss_pred cCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeecccccc
Confidence 997666655432 1236899999999999999999999999999999999999985 6899999999876543221
Q ss_pred ---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccc
Q 044127 145 ---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA 220 (282)
Q Consensus 145 ---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
......+..|+|||.+.. ..++.++|||||||++|||++ |..||......+....+....
T Consensus 169 ~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--------------- 232 (273)
T cd05035 169 YRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--------------- 232 (273)
T ss_pred ccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 112234567999998864 447999999999999999999 888997766555443332210
Q ss_pred ccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 221 SNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
....+...+..+.+++++||+.||++|||+.+++.+
T Consensus 233 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 --------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=264.78 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=186.7
Q ss_pred CCcceEEEEEe----cCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCcc
Q 044127 1 GSYGDVFQALD----KKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~----~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~ 74 (282)
|+||.||.|+. ..+++.|++|.++..........+.+|+..++++ +|||++++++++... ...+++|||+.++
T Consensus 15 g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~ 93 (284)
T cd05079 15 GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSG 93 (284)
T ss_pred CCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCceEEEEEccCCC
Confidence 89999999974 4578899999987654444455678899999998 599999999988764 5789999999987
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC----CCCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP----CTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~----~~~~~ 149 (282)
.+..++......+++..+..++.|++.||++||++|++|+||||+||++++ +.++|+|||.+........ .....
T Consensus 94 ~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 173 (284)
T cd05079 94 SLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD 173 (284)
T ss_pred CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCC
Confidence 787777655456899999999999999999999999999999999999975 7899999999886643221 12334
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++..|+|||.+.+. .++.++||||||+++|+|++++.|...... .. ....+... ...+..... ...
T Consensus 174 ~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~-~~~~~~~~~-~~~------ 239 (284)
T cd05079 174 SPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTH-GQMTVTRLV-RVL------ 239 (284)
T ss_pred CCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhccccc-ccccHHHHH-HHH------
Confidence 56679999998754 478999999999999999998765433211 00 00000000 000000000 000
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
........+..++..+.+|+.+||+.||.+|||++++++.
T Consensus 240 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 240 -EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred -HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0000012234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=264.81 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=185.3
Q ss_pred CCcceEEEEE----ecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc--CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQAL----DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE--HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~----~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~~~~ 74 (282)
|+||+||++. ...++..|++|.+...........+.+|+..++++ +||||+++++++.. ....+++|||+.++
T Consensus 15 g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 93 (283)
T cd05080 15 GHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGKGLQLIMEYVPLG 93 (283)
T ss_pred CCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCceEEEEecCCCCC
Confidence 8999998765 34568889999997654444556677899999998 59999999998754 34689999999988
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC----CCCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP----CTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~----~~~~~ 149 (282)
.+..++.. ..+++..+..++.|++.||.+||++|++|+||||+||++++ +.++|+|||++........ .....
T Consensus 94 ~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 171 (283)
T cd05080 94 SLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171 (283)
T ss_pred CHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCC
Confidence 77777665 36999999999999999999999999999999999999975 7899999999876543221 11223
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++..|+|||.+.... ++.++||||||+++|+|++|..||......- ........ ..... ... .+. .
T Consensus 172 ~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~----~~~~~-~~~---~~~-~-- 237 (283)
T cd05080 172 SPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQ----GQMTV-VRL---IEL-L-- 237 (283)
T ss_pred CCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccc----cccch-hhh---hhh-h--
Confidence 456699999887444 7899999999999999999999986543211 11111000 00000 000 000 0
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
........+...+..+.+++..||+.||++|||++++++
T Consensus 238 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 -ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred -hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000011234567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=262.51 Aligned_cols=241 Identities=24% Similarity=0.435 Sum_probs=191.6
Q ss_pred CCcceEEEEEecC-CCcEEEEEEccccc---------cchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEec
Q 044127 1 GSYGDVFQALDKK-SGEFVAVKKLKKKI---------FSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEY 70 (282)
Q Consensus 1 G~~g~Vy~~~~~~-~~~~v~vK~~~~~~---------~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 70 (282)
|+||.||+|.+.. +++.+++|.+.... ..........|+..+.+..+|||++++++++..++..+++|||
T Consensus 11 G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 90 (269)
T cd08528 11 GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDL 90 (269)
T ss_pred CCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEec
Confidence 7899999999887 68889999875322 1223345667888887766799999999999999999999999
Q ss_pred CCccHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC
Q 044127 71 MESDLLKLMKE---RAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC 145 (282)
Q Consensus 71 ~~~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~ 145 (282)
+.++.+..++. ..+..+++..++.++.|++.||.+||+ .+++|+||+|+||++++ +.++|+|||.+.........
T Consensus 91 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 170 (269)
T cd08528 91 IEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL 170 (269)
T ss_pred CCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccccc
Confidence 98766655442 234569999999999999999999996 68999999999999975 78999999998866544334
Q ss_pred CCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc
Q 044127 146 TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225 (282)
Q Consensus 146 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..................+
T Consensus 171 ~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 232 (269)
T cd08528 171 TSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP----------------- 232 (269)
T ss_pred ccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-----------------
Confidence 4567788899999997544 7999999999999999999999998766555444333211110
Q ss_pred cccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
......++.+.++|++||+.||++||++.++.++
T Consensus 233 -----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 -----------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -----------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0112457899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=262.80 Aligned_cols=238 Identities=25% Similarity=0.398 Sum_probs=188.5
Q ss_pred CCcceEEEEEecCC---CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKS---GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||.||+|.+..+ ...|++|.+...........+.+|+..++++. |||++++++++.++ ..+++|||+.++.+.
T Consensus 17 g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~ 94 (270)
T cd05056 17 GQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD-HPHIVKLIGVITEN-PVWIVMELAPLGELR 94 (270)
T ss_pred ccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCchhceeEEEcCC-CcEEEEEcCCCCcHH
Confidence 78999999987643 45689998876543445556788999999885 99999999998764 578999999987777
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCccccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWY 154 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~ 154 (282)
.++......+++..+..++.|++.||.+||+.|++|+||+|+||+++. +.++++|||++........ .....++..|
T Consensus 95 ~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y 174 (270)
T cd05056 95 SYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKW 174 (270)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccc
Confidence 777665556999999999999999999999999999999999999985 7899999999876543321 1122334679
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
+|||.+... .++.++||||||+++|++++ |..||......+....+.....
T Consensus 175 ~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~--------------------------- 226 (270)
T cd05056 175 MAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER--------------------------- 226 (270)
T ss_pred cChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc---------------------------
Confidence 999988644 47899999999999999986 9999987766555443322110
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+...+..+.+++.+|+..+|.+|||+.+++..
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 227 --LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01234568899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=260.44 Aligned_cols=236 Identities=25% Similarity=0.440 Sum_probs=188.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.+.. +..+++|.+...... ...+..|+..++++ +||+++++++++......++++||+.++.+..++
T Consensus 15 g~~g~v~~~~~~~-~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 90 (256)
T cd05112 15 GQFGLVWLGYWLE-KRKVAIKTIREGAMS--EEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL 90 (256)
T ss_pred cccceEEEEEEeC-CCeEEEEECCCCCCC--HHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHH
Confidence 7899999998764 668999998754332 34567899999998 5999999999999999999999999988887777
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aP 157 (282)
......+++..+..++.|++.|+++||+.+++|+||+|+||++++ +.++|+|||.+........ .....++..|+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aP 170 (256)
T cd05112 91 RAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP 170 (256)
T ss_pred HhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCH
Confidence 655457899999999999999999999999999999999999985 7899999998875533221 1122345679999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.++. ++.++|+||||+++|++++ |..||...........+..... .
T Consensus 171 e~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~ 220 (256)
T cd05112 171 EVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR-----------------------------L 220 (256)
T ss_pred hHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC-----------------------------C
Confidence 9987544 7889999999999999998 8999987665554443321100 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++.+.+++.+||+.+|++|||++++++.
T Consensus 221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 1122357889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=260.12 Aligned_cols=240 Identities=28% Similarity=0.497 Sum_probs=188.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|++|.||+|.+..+|+.|++|.++.... ........+|+..++++ +|++++++++.+...+..+++|||+.++.+..
T Consensus 13 g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (267)
T cd08224 13 GQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIVLELADAGDLSR 91 (267)
T ss_pred CCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEEEecCCCCCHHH
Confidence 7899999999999999999998864322 22345677899999998 59999999999999999999999999766665
Q ss_pred HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCC-CCCCcccccc
Q 044127 79 MKER---AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL-PCTDYVTTRW 153 (282)
Q Consensus 79 ~~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~ 153 (282)
++.. .+..+++..+..++.|++.||.+||+.|++|+||+|+||+++ ++.++++|||.+....... ......++..
T Consensus 92 ~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 171 (267)
T cd08224 92 MIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 171 (267)
T ss_pred HHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCcc
Confidence 5543 234589999999999999999999999999999999999997 4889999999987654322 1233467788
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
|.|||.+.+.. ++.++|+||||+++|+|++|..||...... ............
T Consensus 172 y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~------------------------ 224 (267)
T cd08224 172 YMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEKCD------------------------ 224 (267)
T ss_pred ccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhhcCC------------------------
Confidence 99999987444 789999999999999999999998654321 111111110000
Q ss_pred cccccC-CCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 234 NLRELS-PSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 234 ~~~~~~-~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+ ...+..+.++|.+||..+|++|||+.+|++
T Consensus 225 -~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 225 -YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00111 256788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=259.62 Aligned_cols=231 Identities=24% Similarity=0.413 Sum_probs=182.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccc-ccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV-KEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||.||++... |..+++|...... ....+.+|+..++++ +|||++++++++ ..+...++++||++++.+..+
T Consensus 17 g~~~~v~~~~~~--~~~~~~k~~~~~~---~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 90 (256)
T cd05082 17 GEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 90 (256)
T ss_pred cCCCeEEEEEEc--CCcEEEEEeCCCc---hHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHH
Confidence 789999999654 7789999986532 344567899988888 599999999875 556679999999987555555
Q ss_pred HHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 80 KER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+.. ....+++..+..++.|++.||++||++|++|+||+|+||++++ +.++|+|||++....... .....+..|+||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aP 168 (256)
T cd05082 91 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAP 168 (256)
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--CCCccceeecCH
Confidence 443 3345899999999999999999999999999999999999974 789999999987654332 233445679999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.... ++.++|||||||++|+|++ |..||......+....+.... ..
T Consensus 169 E~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~ 218 (256)
T cd05082 169 EALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-----------------------------KM 218 (256)
T ss_pred HHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----------------------------CC
Confidence 9987444 7899999999999999997 899987665544443322110 01
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...++.+.+++.+||+.+|++|||++++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 123456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.08 Aligned_cols=246 Identities=30% Similarity=0.491 Sum_probs=209.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|.||.||.|.+..+|...|+|.+.-.... .......+|..++..+. |||+++++|+=...+..+|.||||.|+++..+
T Consensus 1246 G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHRekv~IFMEyC~~GsLa~l 1324 (1509)
T KOG4645|consen 1246 GTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHREKVYIFMEYCEGGSLASL 1324 (1509)
T ss_pred cceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc-CccccccCceeecHHHHHHHHHHhccCcHHHH
Confidence 78999999999999999999988765433 22234467888888885 99999999998888889999999999999998
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-----CCCCcccccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-----PCTDYVTTRW 153 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-----~~~~~~~~~~ 153 (282)
.+.. ...++.....+..|++.|+.|||+.|||||||||+||+++. |.+|++|||.|..+.... ......||+.
T Consensus 1325 l~~g-ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~ 1403 (1509)
T KOG4645|consen 1325 LEHG-RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPM 1403 (1509)
T ss_pred HHhc-chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCch
Confidence 8875 46889999999999999999999999999999999999985 899999999998775543 2235689999
Q ss_pred ccCchhhhccc--cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 154 YRAPEVLLLSE--IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 154 ~~aPE~~~~~~--~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
|+|||++.+.. ....++|||||||+..||+||+.||...+..=.+...+...+.|
T Consensus 1404 YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P----------------------- 1460 (1509)
T KOG4645|consen 1404 YMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP----------------------- 1460 (1509)
T ss_pred hcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC-----------------------
Confidence 99999997543 35789999999999999999999998887777766655554444
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
++|..++.+-++||..||+.||++|-++.||++|.|-+..
T Consensus 1461 -----q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1461 -----QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred -----CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 4566789999999999999999999999999999887643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=265.28 Aligned_cols=275 Identities=31% Similarity=0.492 Sum_probs=202.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCC-------Ceeeeccccc----cCCcEEEEEe
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHP-------NIVKLRNLVK----EHEDVFIVFE 69 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp-------~i~~~~~~~~----~~~~~~lv~e 69 (282)
|-|++||+|.+..+.+.||+|+.+.. ..-....++|+.++++++.+. +||++++.|. ++.++|+|+|
T Consensus 89 GHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfE 166 (590)
T KOG1290|consen 89 GHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFE 166 (590)
T ss_pred cccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEeh
Confidence 67999999999999999999998753 222345578999999887432 6999999985 5568999999
Q ss_pred cCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeCC----------------------
Q 044127 70 YMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSKG---------------------- 126 (282)
Q Consensus 70 ~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~~---------------------- 126 (282)
+++..+|..++...-+.++...+++|++||+.||.|||. .||+|.||||+|||+.-+
T Consensus 167 vLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s 246 (590)
T KOG1290|consen 167 VLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMS 246 (590)
T ss_pred hhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCC
Confidence 999999999988877789999999999999999999996 589999999999995100
Q ss_pred --------------------------------------------------------------------------------
Q 044127 127 -------------------------------------------------------------------------------- 126 (282)
Q Consensus 127 -------------------------------------------------------------------------------- 126 (282)
T Consensus 247 ~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~ 326 (590)
T KOG1290|consen 247 PSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSN 326 (590)
T ss_pred cccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccc
Confidence
Q ss_pred -----------------------------------------------------------------cEEEeecCcccccCC
Q 044127 127 -----------------------------------------------------------------VIKIGDLGMVKEIDS 141 (282)
Q Consensus 127 -----------------------------------------------------------------~~~l~df~~~~~~~~ 141 (282)
++||.|||-|+....
T Consensus 327 ~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k 406 (590)
T KOG1290|consen 327 ENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK 406 (590)
T ss_pred cccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhh
Confidence 011111111111000
Q ss_pred CCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCC------CCChHHHHHHHHHhCCCCCCCccc
Q 044127 142 SLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPG------KNSADQIYKICQVIGSPTEDSWPL 215 (282)
Q Consensus 142 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 215 (282)
.. +....|..|+|||++.+.+ |+..+||||++|++|||+||..+|+. ..+++.+..+++.++..+......
T Consensus 407 hF--T~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~ 483 (590)
T KOG1290|consen 407 HF--TEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALG 483 (590)
T ss_pred hh--chhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhc
Confidence 00 1112345599999999666 99999999999999999999999964 457899999999999877554432
Q ss_pred cccccccCCcc-----ccCCCCCcc-------cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 216 GIQLASNLDWK-----FPQMGGVNL-------RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 216 ~~~~~~~~~~~-----~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
+.....-++.. +....-..+ -..+.....++.+|+.-||+.+|.+||||.+.|+|||++.+...+
T Consensus 484 Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~~ 560 (590)
T KOG1290|consen 484 GKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGPP 560 (590)
T ss_pred CcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCCc
Confidence 22222111111 001011111 123445567799999999999999999999999999999876543
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=258.76 Aligned_cols=233 Identities=27% Similarity=0.432 Sum_probs=183.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|.+. ++..+++|.+...... ...+.+|+..++++ +||+++++++++.. ...+++|||+.++.+..++
T Consensus 17 g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~ 91 (260)
T cd05070 17 GQFGEVWMGTWN-GNTKVAVKTLKPGTMS--PESFLEEAQIMKKL-RHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 91 (260)
T ss_pred ccCceEEEEEec-CCceeEEEEecCCCCC--HHHHHHHHHHHHhc-CCCceEEEEeEECC-CCcEEEEEecCCCcHHHHH
Confidence 899999999876 4566999998765432 34577899999998 59999999998864 5688999999876665555
Q ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC--CCccccccccC
Q 044127 81 ER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRA 156 (282)
Q Consensus 81 ~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~a 156 (282)
.. ....+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+......... ....++..|+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~a 171 (260)
T cd05070 92 KDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA 171 (260)
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccC
Confidence 43 3456899999999999999999999999999999999999986 68999999998765432211 12234567999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+.... ++.++|+||||+++|++++ |..||......+....+.....
T Consensus 172 PE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------- 221 (260)
T cd05070 172 PEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR----------------------------- 221 (260)
T ss_pred hHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------------------
Confidence 99887444 7899999999999999999 8889987665554444322110
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEAL 268 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 268 (282)
...+...+..+.+++.+||..+|++|||++++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 012345678899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=260.40 Aligned_cols=235 Identities=25% Similarity=0.421 Sum_probs=187.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|+||+|.+.. +..+++|.+..... ....+.+|+..++++. |||++++++++......+++||++.++.+..++
T Consensus 17 g~~~~v~~~~~~~-~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i 92 (261)
T cd05034 17 GQFGEVWMGTWNG-TTKVAVKTLKPGTM--SPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL 92 (261)
T ss_pred CcceEEEEEEEcC-CceEEEEEecCCcc--CHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCceEEEEeccCCCCHHHHH
Confidence 7899999999764 57799999876433 3455778999998885 999999999999988999999999876665555
Q ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC--CCccccccccC
Q 044127 81 ER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC--TDYVTTRWYRA 156 (282)
Q Consensus 81 ~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~a 156 (282)
.. .+..++...+..++.|++.|+.+||++|++|+||+|+||++++ +.++|+|||.+......... .....+..|+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~ 172 (261)
T cd05034 93 KSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA 172 (261)
T ss_pred hccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccC
Confidence 43 3457999999999999999999999999999999999999974 89999999998765432111 12233567999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+.+.. .+.++|+||||+++|++++ |+.||.+.........+......
T Consensus 173 PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---------------------------- 223 (261)
T cd05034 173 PEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM---------------------------- 223 (261)
T ss_pred HHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------------------
Confidence 99987544 7899999999999999998 99999877665555544322111
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...+..+.+++.+||+.+|++||+++++++
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 112345788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=258.52 Aligned_cols=234 Identities=25% Similarity=0.406 Sum_probs=182.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|+||+|.+..++ .+++|.+..... ....+.+|+..++++. |||++++++++.. ...+++|||+.++.+..++
T Consensus 17 g~~~~v~~~~~~~~~-~~~lK~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~ 91 (260)
T cd05069 17 GCFGEVWMGTWNGTT-KVAIKTLKPGTM--MPEAFLQEAQIMKKLR-HDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFL 91 (260)
T ss_pred cCCCeEEEEEEcCCc-eEEEEEcccCCc--cHHHHHHHHHHHHhCC-CCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHH
Confidence 789999999877654 589998765432 2345677889998885 9999999998865 4688999999875444444
Q ss_pred -HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCccccccccC
Q 044127 81 -ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRA 156 (282)
Q Consensus 81 -~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~a 156 (282)
...+..+++..+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+........ .....++..|+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~ 171 (260)
T cd05069 92 KEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTA 171 (260)
T ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCC
Confidence 434456899999999999999999999999999999999999975 7899999999876533221 112345567999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||...+.. .+.++|+||||+++|++++ |..||......+....+.....
T Consensus 172 Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------- 221 (260)
T cd05069 172 PEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR----------------------------- 221 (260)
T ss_pred HHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------------------------
Confidence 99887444 7899999999999999999 8999987766555443322110
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.+++++||..||.+||+++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0122356788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=276.14 Aligned_cols=248 Identities=26% Similarity=0.410 Sum_probs=217.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
||||.|=++........+|+|++++... +........|-.++.... .|.|+++|..|.++.+.|++||.|-|+-+-.
T Consensus 431 GgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmLmEaClGGElWT 509 (732)
T KOG0614|consen 431 GGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYMLMEACLGGELWT 509 (732)
T ss_pred CccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhhHHhhcCchhhh
Confidence 8999999997766555589999887654 334556678999999985 9999999999999999999999997554444
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++... +.|++.+.+-++.++++|+.|||++||++|||||+|.+++. |.+||.|||+|..++........+|||.|.||
T Consensus 510 iLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAP 588 (732)
T KOG0614|consen 510 ILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAP 588 (732)
T ss_pred hhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccc
Confidence 44443 47999999999999999999999999999999999999985 89999999999999998888999999999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+...+ ++.++|.|+||+++|||++|..||.+.+++..+..+.+++... +
T Consensus 589 EIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i----------------------------~ 639 (732)
T KOG0614|consen 589 EIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI----------------------------E 639 (732)
T ss_pred hhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----------------------------h
Confidence 9998555 8999999999999999999999999999999999888765432 4
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccCc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHFV 279 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~~ 279 (282)
+|..++....++|++++..+|.+|.. +.++-.|.||.+..|.
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 56678899999999999999999996 8999999999887764
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=258.68 Aligned_cols=234 Identities=25% Similarity=0.455 Sum_probs=184.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH-HH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK-LM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~-~~ 79 (282)
|+||.||+|... +++.|++|.+..... ....+.+|+..++++. |||++++++++.. +..+++||++.++.+. .+
T Consensus 17 G~~g~v~~~~~~-~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~ 91 (260)
T cd05067 17 GQFGEVWMGYYN-GHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQ-HPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 91 (260)
T ss_pred CccceEEeeecC-CCceEEEEEecCCCC--cHHHHHHHHHHHHhcC-CcCeeeEEEEEcc-CCcEEEEEcCCCCCHHHHH
Confidence 899999999865 467899999876543 3356778999999884 9999999998754 5689999999865544 44
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCccccccccC
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~a 156 (282)
....+..++..++..++.|++.||++||+.|++|+||+|+||++++ +.++|+|||.+........ .....++..|+|
T Consensus 92 ~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~ 171 (260)
T cd05067 92 KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTA 171 (260)
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccC
Confidence 4444557899999999999999999999999999999999999985 7899999999876542211 112344567999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+.... ++.++||||||+++|++++ |..||...+..+....+....+.
T Consensus 172 pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------------- 222 (260)
T cd05067 172 PEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM---------------------------- 222 (260)
T ss_pred HHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC----------------------------
Confidence 99887444 7899999999999999999 99999877665554443221110
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...+..+.+++.+||..+|++|||++++++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 -PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 122356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=261.34 Aligned_cols=238 Identities=20% Similarity=0.340 Sum_probs=187.0
Q ss_pred CCcceEEEEEecC----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc-CCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKK----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE-HEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.+.. ++..|++|++...........+.+|...++++ +|||++++++++.. +...+++++++.++.
T Consensus 17 g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (280)
T cd05043 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGEPPFVLYPYMNWGN 95 (280)
T ss_pred cCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCCEEEEEcCCCCc
Confidence 8999999999876 35789999987654445566678899999999 59999999998654 577899999998766
Q ss_pred HHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---
Q 044127 76 LKLMKERAG-------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--- 144 (282)
Q Consensus 76 l~~~~~~~~-------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--- 144 (282)
+..++.... ..+++..+..++.|++.||+|||+.+++|+||+|+||++++ +.++++|||++........
T Consensus 96 L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 175 (280)
T cd05043 96 LKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL 175 (280)
T ss_pred HHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEe
Confidence 666654321 35899999999999999999999999999999999999975 8999999999875532211
Q ss_pred CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccC
Q 044127 145 CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL 223 (282)
Q Consensus 145 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
.....++..|+|||.+... .++.++||||||+++|++++ |..||...+..+..........
T Consensus 176 ~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------- 237 (280)
T cd05043 176 GDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR----------------- 237 (280)
T ss_pred CCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC-----------------
Confidence 1223456679999998744 47999999999999999998 9999987765554332221100
Q ss_pred CccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.......++.+.+++.+||..||++|||+.++++
T Consensus 238 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 238 ------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0112245788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=259.82 Aligned_cols=240 Identities=25% Similarity=0.413 Sum_probs=188.2
Q ss_pred CCcceEEEEEecC-----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKK-----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|+.+. +.+.|++|.+...........+..|+.+++++ +|||++++++++.+....+++|||+.++.
T Consensus 16 g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 94 (275)
T cd05046 16 GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAEPHYMILEYTDLGD 94 (275)
T ss_pred cceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCCcceEEEEecCCCc
Confidence 8999999999754 35679999887644333445678899999999 59999999999999999999999999777
Q ss_pred HHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC--CC
Q 044127 76 LKLMKERAG--------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS--LP 144 (282)
Q Consensus 76 l~~~~~~~~--------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~--~~ 144 (282)
+..++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++. +.++++|||++...... ..
T Consensus 95 L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~ 174 (275)
T cd05046 95 LKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK 174 (275)
T ss_pred HHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccc
Confidence 776665432 15899999999999999999999999999999999999985 78999999987644221 11
Q ss_pred CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccC
Q 044127 145 CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL 223 (282)
Q Consensus 145 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
.....++..|+|||.+.+.. .+.++||||||+++|++++ |..||................ .
T Consensus 175 ~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~--~--------------- 236 (275)
T cd05046 175 LRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK--L--------------- 236 (275)
T ss_pred cCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC--c---------------
Confidence 22335567799999887554 7889999999999999998 788887665544433321100 0
Q ss_pred CccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
. ...+...+..+.+++.+||+.+|.+|||+.+++..
T Consensus 237 --~---------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 --E---------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred --C---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0 01123568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=264.34 Aligned_cols=238 Identities=19% Similarity=0.322 Sum_probs=183.9
Q ss_pred CCcceEEEEEecCCCc----EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGE----FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||.||+|++..++. .+++|.+...........+.+|...+..+ +||||+++++++... ..++++|++.++.+
T Consensus 18 G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~~~~v~e~~~~g~l 95 (303)
T cd05110 18 GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-TIQLVTQLMPHGCL 95 (303)
T ss_pred CCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-CceeeehhcCCCCH
Confidence 8999999999887776 47888887654334444667888888888 599999999998764 46789999986655
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---CCCccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTR 152 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~---~~~~~~~~ 152 (282)
..+.......+++..+..++.|++.||.|||++|++|+||||+||++++ +.++|+|||.+........ .....++.
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~ 175 (303)
T cd05110 96 LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175 (303)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCcccc
Confidence 5555554456899999999999999999999999999999999999975 7899999999986543221 12233466
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+.+. .++.++||||||+++|++++ |..||.+....+.. ........+
T Consensus 176 ~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~----------------------- 230 (303)
T cd05110 176 KWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERL----------------------- 230 (303)
T ss_pred ccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCC-----------------------
Confidence 79999998744 47999999999999999997 88999776533322 222211100
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...+..+.+++..|+..+|.+||+++++++.
T Consensus 231 -----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 -----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1122356789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=243.97 Aligned_cols=269 Identities=26% Similarity=0.504 Sum_probs=212.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~l~~ 78 (282)
|.|+.||.|.+..+++.++||+++.. ....+.+|+.+++.+.++|||+.++++..++ ..+.+|+|+.+...+..
T Consensus 49 GKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ 124 (338)
T KOG0668|consen 49 GKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQ 124 (338)
T ss_pred ccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHH
Confidence 78999999999999999999998753 4567788999999999999999999998754 56889999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
+.. .++.-.+...+.+++.||.|+|+.||.|||+||.|++||. ..++|+|+|+|...-......--..+..|-.
T Consensus 125 ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKG 200 (338)
T KOG0668|consen 125 LYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 200 (338)
T ss_pred Hhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCC
Confidence 554 5889999999999999999999999999999999999985 6899999999987755544444556777899
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCC-CCCCChHHHHHHHHHhCCCCCCCccccccc--cccCCccccCCCCC
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILF-PGKNSADQIYKICQVIGSPTEDSWPLGIQL--ASNLDWKFPQMGGV 233 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (282)
||.+..-..++.+-|+|||||++..|+..+.|| .+.+..+++.++...+|......+-..... ...++....+....
T Consensus 201 PELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk 280 (338)
T KOG0668|consen 201 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRK 280 (338)
T ss_pred chheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccc
Confidence 999987777899999999999999999987665 688888999888888876554333211111 11111111111110
Q ss_pred cc-----cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 234 NL-----RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 234 ~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.+ .+...-.++++.+|+.++|..|-.+|+|+.|.+.||||..+.
T Consensus 281 ~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 281 PWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred cHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 00 111122478999999999999999999999999999997653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=253.43 Aligned_cols=243 Identities=38% Similarity=0.659 Sum_probs=198.4
Q ss_pred CcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHHH
Q 044127 2 SYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMKE 81 (282)
Q Consensus 2 ~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 81 (282)
+||.||+|.+..+++.+++|++...........+.+|+..++++ +|+|++++++.+......++++|++.++.+..+..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 68999999999889999999997765433356777888988888 69999999999999899999999999866666655
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCchhh
Q 044127 82 RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL 160 (282)
Q Consensus 82 ~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~ 160 (282)
... .++...+..++.+++.++.+||+.+++|+||+|+||++++ +.++++|||.+.............++..|+|||.+
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 433 3899999999999999999999999999999999999985 79999999999887665444566778889999998
Q ss_pred hccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCC
Q 044127 161 LLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240 (282)
Q Consensus 161 ~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
.... .+.++|+||||++++++++|..||......+...+......... .....
T Consensus 159 ~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~ 211 (244)
T smart00220 159 LGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF--------------------------PPPEW 211 (244)
T ss_pred ccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC--------------------------ccccc
Confidence 7444 78899999999999999999999987444443333222111000 01111
Q ss_pred CCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
.++..+.+++++||..+|++||++.++++||||
T Consensus 212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 212 KISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred cCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 167899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=255.14 Aligned_cols=243 Identities=21% Similarity=0.256 Sum_probs=182.1
Q ss_pred CCcceEEEEEecCC--CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKS--GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~--~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||++....+ ...+++|.+...........+.+|...++.+ +|||++++++.+......+++|||+.++.+..
T Consensus 6 G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 84 (268)
T cd05086 6 GWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCELGDLKS 84 (268)
T ss_pred CcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCCCCcHHH
Confidence 89999999975433 3456777776554444556778888888888 59999999999999999999999999777766
Q ss_pred HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC---CCCCCcccc
Q 044127 79 MKERA---GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTT 151 (282)
Q Consensus 79 ~~~~~---~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~---~~~~~~~~~ 151 (282)
++... ...+++..+..++.||+.||.|||+.+++|+||||+||+++. +.++|+|||++...... .......++
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 164 (268)
T cd05086 85 YLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164 (268)
T ss_pred HHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCc
Confidence 55432 234677888999999999999999999999999999999975 78999999987543211 112344677
Q ss_pred ccccCchhhhcc------ccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCC
Q 044127 152 RWYRAPEVLLLS------EIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224 (282)
Q Consensus 152 ~~~~aPE~~~~~------~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
..|+|||++... ...+.++||||||+++|+|++ |..||......+.............
T Consensus 165 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~--------------- 229 (268)
T cd05086 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKL--------------- 229 (268)
T ss_pred ccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccccc---------------
Confidence 889999987521 124778999999999999997 4668876666555554433211100
Q ss_pred ccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+......++.+.++++.|+ .+|++||+++++++
T Consensus 230 ---------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 230 ---------FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ---------CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 001223356788999999999 67999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=258.47 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=181.9
Q ss_pred CCcceEEEEEe----cCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc--cCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALD----KKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK--EHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~----~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~~~~ 74 (282)
|+||.||.|.. ..+++.|++|.+.... ......+.+|+.++.++. |||++++++++. +....++++||+.++
T Consensus 15 g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 92 (284)
T cd05081 15 GNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92 (284)
T ss_pred CCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCCCceEEEEEecCCC
Confidence 89999999973 4578899999986543 233456678999999985 999999999764 345689999999877
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC----CCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC----TDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~----~~~~ 149 (282)
.+..++......+++..+..++.|++.||.+||++|++|+||||+||++++ +.++|+|||++......... ....
T Consensus 93 ~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 172 (284)
T cd05081 93 SLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172 (284)
T ss_pred CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCC
Confidence 777666554456999999999999999999999999999999999999975 78999999998866433211 1122
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++..|+|||.+.+. .++.++|+||||+++|||++|..++...... .. ...+...... ..........
T Consensus 173 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~----~~~~~~~~~~-~~~~~~~~~~------ 239 (284)
T cd05081 173 SPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FM----RMMGNDKQGQ-MIVYHLIELL------ 239 (284)
T ss_pred CceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hh----hhcccccccc-cchHHHHHHH------
Confidence 34459999998744 4789999999999999999987765433211 11 0000000000 0000000000
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
........+...+..+.+++.+||..+|++|||++++++
T Consensus 240 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 -KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred -hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000011223456889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=255.27 Aligned_cols=230 Identities=24% Similarity=0.401 Sum_probs=181.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||++. .+++.|++|.+.... ....+.+|+..+.++ +|||++++++.+..+ ..+++|||+.++.+..++
T Consensus 17 g~~g~v~~~~--~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l 89 (254)
T cd05083 17 GEFGAVLQGE--YTGQKVAVKNIKCDV---TAQAFLEETAVMTKL-HHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFL 89 (254)
T ss_pred CCCCceEecc--cCCCceEEEeecCcc---hHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHH
Confidence 8999999985 468889999986542 334567888988888 599999999998765 478999999875555555
Q ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 81 ER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
.. ....+++..+..++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+....... .....+..|+|||
T Consensus 90 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~y~~pe 167 (254)
T cd05083 90 RTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--DNSKLPVKWTAPE 167 (254)
T ss_pred HhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC--CCCCCCceecCHH
Confidence 43 3346899999999999999999999999999999999999985 789999999887543221 2334456799999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
.+..+ .++.++|+||||+++|+|++ |..||......+....+..... ..
T Consensus 168 ~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~ 217 (254)
T cd05083 168 ALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-----------------------------ME 217 (254)
T ss_pred HhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC-----------------------------CC
Confidence 88744 47899999999999999997 8999987765544333221100 01
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.....+..+.+++++||+.+|.+||++++++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 12356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=254.55 Aligned_cols=234 Identities=25% Similarity=0.424 Sum_probs=183.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.+.. +..+++|.+.... .....+.+|+.+++++ +|+|++++++.+.+ ...+++|||++++.+..++
T Consensus 17 g~~~~vy~~~~~~-~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~ 91 (260)
T cd05073 17 GQFGEVWMATYNK-HTKVAVKTMKPGS--MSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL 91 (260)
T ss_pred ccceEEEEEEecC-CccEEEEecCCCh--hHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHH
Confidence 7899999998654 5569999886542 2345677899999888 49999999999887 7789999999865555444
Q ss_pred H-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCccccccccC
Q 044127 81 E-RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRA 156 (282)
Q Consensus 81 ~-~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~a 156 (282)
. ..+..++...+..++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+........ .....++..|+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~ 171 (260)
T cd05073 92 KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 171 (260)
T ss_pred HhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccC
Confidence 4 34456889999999999999999999999999999999999985 7999999999876543221 112234567999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+..+ .++.++|+||||+++|++++ |..||...+..+....+.....
T Consensus 172 PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------- 221 (260)
T cd05073 172 PEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR----------------------------- 221 (260)
T ss_pred HhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-----------------------------
Confidence 9998744 47889999999999999998 8999987665554433221100
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.......+..+.+++.+||+.+|++||+++++++
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0122356889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=263.27 Aligned_cols=246 Identities=30% Similarity=0.491 Sum_probs=213.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH--HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD--ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~--~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.|-+|..+.+.+.||||+++++...++ ..--+.|-.++.-...-|.++.++..|+.-+.+|+||||+.|+.|-.
T Consensus 360 GSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMy 439 (683)
T KOG0696|consen 360 GSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMY 439 (683)
T ss_pred CccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhh
Confidence 8999999999999999999999998765433 33345666666666567889999999999999999999999988887
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCccccc-CCCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~a 156 (282)
.++..| .+.+..+.-++.+|+-||-+||++||++||||.+||++| +|.+||.|||++... -...+....+|||.|+|
T Consensus 440 hiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiA 518 (683)
T KOG0696|consen 440 HIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIA 518 (683)
T ss_pred HHHHhc-ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccc
Confidence 777776 699999999999999999999999999999999999998 599999999998754 33444567899999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+..+ +|+.+.|.||+|++||||+.|+.||++.+..+....+.+.. -
T Consensus 519 PEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn------------------------------v 567 (683)
T KOG0696|consen 519 PEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN------------------------------V 567 (683)
T ss_pred cceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc------------------------------C
Confidence 9998844 48999999999999999999999999999998888776632 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH-----HHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA-----AEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~~~~ 278 (282)
..++.++.+..++....|...|.+|..+ .++-.|||||.+.|
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 3567889999999999999999999965 68999999999876
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=283.53 Aligned_cols=135 Identities=32% Similarity=0.485 Sum_probs=116.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.+..+++.||+|++...... .....+..|+..+..+ +||||+++++.+......|+||||+.++.|..
T Consensus 15 G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~ 93 (669)
T cd05610 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKS 93 (669)
T ss_pred CCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEEEeCCCCCCHHH
Confidence 89999999999999999999998754322 2234566777777777 59999999999999999999999998777766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK 137 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~ 137 (282)
++... ..+++..++.++.||+.||.|||+++|+|+||||+||+++. +.++|+|||++.
T Consensus 94 li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 94 LLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 66554 36899999999999999999999999999999999999975 899999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=256.97 Aligned_cols=242 Identities=24% Similarity=0.399 Sum_probs=185.8
Q ss_pred CCcceEEEEEec----CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc--CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDK----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE--HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~----~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~~~~ 74 (282)
|+||.||+|... .+++.|++|.+...........+.+|+..++.+ +||||+++++++.. ....+++|||+.++
T Consensus 15 g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 93 (284)
T cd05038 15 GHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGRSLRLIMEYLPSG 93 (284)
T ss_pred CCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCCceEEEEecCCCC
Confidence 789999999854 348899999987654333456678899999888 59999999999876 56899999999877
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC----CCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC----TDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~----~~~~ 149 (282)
.+..++......++...+..++.|++.||++||++|++|+||+|+||+++. +.++|+|||.+......... ....
T Consensus 94 ~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 173 (284)
T cd05038 94 SLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGE 173 (284)
T ss_pred CHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCC
Confidence 777666655446999999999999999999999999999999999999985 78999999998876532211 1223
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHH-----------HHHHHHHhCCCCCCCcccccc
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQ-----------IYKICQVIGSPTEDSWPLGIQ 218 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 218 (282)
.+..|+|||.+... .++.++|+||||+++++|++|..|+........ ...........
T Consensus 174 ~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 242 (284)
T cd05038 174 SPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG---------- 242 (284)
T ss_pred CcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC----------
Confidence 44569999988754 478999999999999999999998865432110 11111111000
Q ss_pred ccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 219 LASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.....+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 243 ---------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 243 ---------------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ---------------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000112345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=251.65 Aligned_cols=264 Identities=32% Similarity=0.532 Sum_probs=211.5
Q ss_pred eEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeecccccc------CCcEEEEEecCCccHHH
Q 044127 5 DVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKE------HEDVFIVFEYMESDLLK 77 (282)
Q Consensus 5 ~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~------~~~~~lv~e~~~~~~l~ 77 (282)
.|-.|.+.-.+.+|++|+...+... .......+|...+..+. |+||++++.+|.- ....|+|||+|..++-+
T Consensus 31 ~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~ 109 (369)
T KOG0665|consen 31 IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQ 109 (369)
T ss_pred eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHH
Confidence 3666667777889999988766433 33455678999888885 9999999999843 34679999999998877
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
.... .++-..+..|+.|++.|+++||+.||+||||||+||++. +..+|+.|||++..-+.....+.+..+..|+|
T Consensus 110 vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyra 185 (369)
T KOG0665|consen 110 VILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRA 185 (369)
T ss_pred HHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccC
Confidence 6663 478899999999999999999999999999999999997 48999999999998877767788899999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc------------cCC
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS------------NLD 224 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~ 224 (282)
||++.+-. +...+||||+||++.||++|...|.+.+.-++..++.+.++.+.+.-......... .+.
T Consensus 186 pevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~ 264 (369)
T KOG0665|consen 186 PEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFS 264 (369)
T ss_pred chheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchh
Confidence 99998666 89999999999999999999999999999999999999888887653321111111 111
Q ss_pred ccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccc
Q 044127 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274 (282)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 274 (282)
..++........+.++.-...+++++.+||..||++|.|++++|+||+++
T Consensus 265 ~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 265 ELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 11222222222333334466789999999999999999999999999998
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=253.03 Aligned_cols=275 Identities=29% Similarity=0.554 Sum_probs=215.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCC-----cEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE-----DVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-----~~~lv~e~~~~~ 74 (282)
|+||.||.+++..+|+.|++|++...... ..-..+++|+.++..++ |.|++..+++.+-.. ..|+++|.|..+
T Consensus 64 GAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqEiYV~TELmQSD 142 (449)
T KOG0664|consen 64 GAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQELYVLTELMQSD 142 (449)
T ss_pred cceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHHHHHHHHHHHhh
Confidence 89999999999999999999998764432 23456788999999886 999999999876442 467888888776
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCcccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTT 151 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~ 151 (282)
+-+.+.+ +..++...++-++.||++||+|||+.+|.||||||.|.+++. -.+|+||||+++..+... .......|
T Consensus 143 LHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVT 220 (449)
T KOG0664|consen 143 LHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVT 220 (449)
T ss_pred hhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHH
Confidence 6554444 357999999999999999999999999999999999999985 589999999999765433 23445678
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC-
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM- 230 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
..|+|||.+++.+.++.+.||||+||++.||+..+..|...++-+.+..+.+.++.|..+.....+.-..+--.+-...
T Consensus 221 QYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~ 300 (449)
T KOG0664|consen 221 QYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRA 300 (449)
T ss_pred HHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCC
Confidence 8899999999999999999999999999999999999999999999999999999988664432222111111111110
Q ss_pred -CCCcc--cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 231 -GGVNL--RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 231 -~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
.-.-+ ..-+.....+...+++.||.+||++|.+.++.+.|++.....+
T Consensus 301 Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 301 PDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred CCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 00001 1112244567888999999999999999999999999866543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=273.15 Aligned_cols=246 Identities=23% Similarity=0.411 Sum_probs=203.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc-----cCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK-----EHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~e~~~~~~ 75 (282)
|.+|.||+++++.++...|+|+....... ..++..|..+++....|||++.++++|. .++.+|+|||+|+|++
T Consensus 30 Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGS 107 (953)
T KOG0587|consen 30 GTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGS 107 (953)
T ss_pred ccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCcc
Confidence 78999999999999999999998776433 3344558888999999999999999983 5678999999999888
Q ss_pred HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccc
Q 044127 76 LKLMKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTR 152 (282)
Q Consensus 76 l~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~ 152 (282)
..++.+. .+..+.+..++.|++.++.|+.+||.+.++|+|||-.|||+++ +.|||+|||.+..++. ........||+
T Consensus 108 VTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP 187 (953)
T KOG0587|consen 108 VTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTP 187 (953)
T ss_pred HHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCc
Confidence 8777654 3678999999999999999999999999999999999999985 8999999999887643 33446778999
Q ss_pred cccCchhhhccc----cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 153 WYRAPEVLLLSE----IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 153 ~~~aPE~~~~~~----~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
.|+|||++.+.. -++..+|+||||++..||..|..|+-..-+.-.+..+- +.|++
T Consensus 188 ~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip---RNPPP------------------ 246 (953)
T KOG0587|consen 188 YWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPPP------------------ 246 (953)
T ss_pred ccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC---CCCCc------------------
Confidence 999999996543 36788999999999999999999987766655443321 11111
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
-..-++..++++.+||..||..|-.+||+..++|.|||++.
T Consensus 247 ------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 247 ------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ------cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 11224567889999999999999999999999999999983
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=264.79 Aligned_cols=271 Identities=25% Similarity=0.478 Sum_probs=214.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCC-----CCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNN-----HPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~-----hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|-||+|-.|.+...|..||||++..+. .-...-+.|+.+|+++.. --|+++++-.|...+++|+|+|.+.-.+
T Consensus 443 GvFs~Vvra~D~~r~~~vAiKIIRnNE--~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~LslNL 520 (752)
T KOG0670|consen 443 GVFSTVVRARDQARGQEVAIKIIRNNE--VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSLNL 520 (752)
T ss_pred ceeeeeeeccccCCCCeeEEEEeecch--HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhchH
Confidence 679999999999889999999998753 222334679999998863 2379999999999999999999999887
Q ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCCCCCccccc
Q 044127 76 LKLMKERA-GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 76 l~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
.+.+.... ...|....+..++.|+.-||..|...|++|.||||+|||+++ ..+||||||.|...+... ...+..+.
T Consensus 521 RevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene-itPYLVSR 599 (752)
T KOG0670|consen 521 REVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENE-ITPYLVSR 599 (752)
T ss_pred HHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccccccc-ccHHHHHH
Confidence 77766543 234888999999999999999999999999999999999986 589999999998776554 35677788
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCC----cccc
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD----WKFP 228 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~ 228 (282)
.|.|||.+.+ -+|+...|+||+||.||||.||+..|.+.....++...+...|..+......+.....-++ +.+.
T Consensus 600 FYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~ 678 (752)
T KOG0670|consen 600 FYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYI 678 (752)
T ss_pred hccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEE
Confidence 8999999984 4599999999999999999999999999999999999999988877665544333222222 1111
Q ss_pred ---CCCCCcc--------------------cccCC---CCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 229 ---QMGGVNL--------------------RELSP---SASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 229 ---~~~~~~~--------------------~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
..++... ..++. ..-..+++|+.+||..||.+|.|+.++|.||||..
T Consensus 679 e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 679 EVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred eccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 1111000 00111 12345888999999999999999999999999974
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=275.61 Aligned_cols=238 Identities=24% Similarity=0.392 Sum_probs=210.5
Q ss_pred CCcceEEEEEecCCCc---EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|.||.|+.|+.+..|+ .||||.++.....+...+|+.|..++-++ +||||+++.|+........||+|||..+.|+
T Consensus 640 GEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvMIiTEyMENGsLD 718 (996)
T KOG0196|consen 640 GEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVMIITEYMENGSLD 718 (996)
T ss_pred ccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeEEEhhhhhCCcHH
Confidence 7899999999887664 59999999888788899999999999999 5999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCC---ccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTD---YVTTR 152 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~---~~~~~ 152 (282)
.++..++..|+.-++..+++.|+.|++||-+.|+|||||...|||++. -.+|++|||+++.+..... ... ..-+.
T Consensus 719 sFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPi 798 (996)
T KOG0196|consen 719 SFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPI 798 (996)
T ss_pred HHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccce
Confidence 888887778999999999999999999999999999999999999985 5899999999997744431 111 11246
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
+|.|||++..++ ++.+|||||+|++|||.++ |..||......+.+..+.+..+-|++
T Consensus 799 RWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP--------------------- 856 (996)
T KOG0196|consen 799 RWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP--------------------- 856 (996)
T ss_pred eecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC---------------------
Confidence 799999998555 8999999999999999887 89999999999999998887776653
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.+.|..+.+|+..||+.|-.+||.+++|++
T Consensus 857 --------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 857 --------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred --------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 367889999999999999999999999986
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=250.08 Aligned_cols=239 Identities=23% Similarity=0.366 Sum_probs=182.1
Q ss_pred CCcceEEEEEec---CCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCC------cEEEEEec
Q 044127 1 GSYGDVFQALDK---KSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE------DVFIVFEY 70 (282)
Q Consensus 1 G~~g~Vy~~~~~---~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~------~~~lv~e~ 70 (282)
|+||.||+|.+. .++..|++|++...... .....+.+|+..++.+ +|||++++++++.... ..++++||
T Consensus 10 g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 88 (273)
T cd05074 10 GEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRLPIPMVILPF 88 (273)
T ss_pred CCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcccceEEEEec
Confidence 899999999865 35789999998765433 3345667899988888 4999999999875432 34788999
Q ss_pred CCccHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-
Q 044127 71 MESDLLKLMKERA-----GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL- 143 (282)
Q Consensus 71 ~~~~~l~~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~- 143 (282)
+.++.+..++... ...++...+..++.||+.||+|||+.|++|+||||+||++++ +.++++|||.+.......
T Consensus 89 ~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~ 168 (273)
T cd05074 89 MKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY 168 (273)
T ss_pred CCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcc
Confidence 9876665543221 124789999999999999999999999999999999999984 789999999988653321
Q ss_pred --CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccc
Q 044127 144 --PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA 220 (282)
Q Consensus 144 --~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
......+++.|++||.+.... ++.++|||||||++|+|++ |..||......+....+....
T Consensus 169 ~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--------------- 232 (273)
T cd05074 169 YRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN--------------- 232 (273)
T ss_pred eecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 112334456799999887444 7889999999999999999 888887665544333222110
Q ss_pred ccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 221 SNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
....+...+..+.+++.+||+.+|++|||+.+++..
T Consensus 233 --------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 233 --------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred --------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001123467899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=262.26 Aligned_cols=236 Identities=25% Similarity=0.427 Sum_probs=196.9
Q ss_pred CCcceEEEEEecCC----CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKS----GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|-||.||+|....- .-.||||+.+.+....+...++.|..+++.+ +||||++++|++.+. ..|||||.+.-+-|
T Consensus 400 GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~-P~WivmEL~~~GEL 477 (974)
T KOG4257|consen 400 GQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ-PMWIVMELAPLGEL 477 (974)
T ss_pred CcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc-ceeEEEecccchhH
Confidence 78999999975432 3359999999988788889999999999999 599999999999875 68999999996666
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccc--ccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVT--TRW 153 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~--~~~ 153 (282)
..+++.....++......++.||..||+|||++++|||||...||++.. ..+||+|||+++.++...-.....+ +--
T Consensus 478 r~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIK 557 (974)
T KOG4257|consen 478 REYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIK 557 (974)
T ss_pred HHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhcccccccee
Confidence 6666666678999999999999999999999999999999999999976 6899999999998865543333232 334
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|+|||.+.-.+ ++.+||||.|||.|||++. |..||.+....+.+..+.++.+
T Consensus 558 WmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-------------------------- 610 (974)
T KOG4257|consen 558 WMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-------------------------- 610 (974)
T ss_pred ecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC--------------------------
Confidence 99999987555 8999999999999999887 8899988877766654433322
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 268 (282)
...++.+++.+..++.+||..||.+||++.++.
T Consensus 611 ---lP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 611 ---LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ---CCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 345667899999999999999999999998765
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=263.85 Aligned_cols=249 Identities=26% Similarity=0.448 Sum_probs=198.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-h-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-L-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+|.+++...|...||+|.+.+.... . ..+....|..+|... +.+=||++|-.|++.+.+|+||||+.|+.+-.
T Consensus 640 GAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVMdYIPGGDmMS 718 (1034)
T KOG0608|consen 640 GAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMS 718 (1034)
T ss_pred cccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEEeccCCccHHH
Confidence 89999999999999999999998764322 1 223334566666666 58899999999999999999999999876666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCC--C------CC-----
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDS--S------LP----- 144 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~--~------~~----- 144 (282)
++-+.+ -|.|..++-++.++..|+++.|..|++||||||+||||| +|.|||+|||+++-... . ..
T Consensus 719 LLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqD 797 (1034)
T KOG0608|consen 719 LLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQD 797 (1034)
T ss_pred HHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccc
Confidence 666554 699999999999999999999999999999999999999 59999999999873210 0 00
Q ss_pred ------------------------------CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044127 145 ------------------------------CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS 194 (282)
Q Consensus 145 ------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~ 194 (282)
-....||+.|+|||++...+ ++...|.||.||+||||+.|+.||-...+
T Consensus 798 Smep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 798 SMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred cCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence 01347899999999998555 89999999999999999999999988877
Q ss_pred hHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCC---CHHHHhcCc
Q 044127 195 ADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRP---TAAEALEHP 271 (282)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~~~ 271 (282)
.+.-.++..+..... + ..-..++.++.++|++++. +++.|. .+++|-+||
T Consensus 877 ~~tq~kv~nw~~~l~-----------------~---------~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHp 929 (1034)
T KOG0608|consen 877 GETQYKVINWRNFLH-----------------I---------PYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHP 929 (1034)
T ss_pred Ccceeeeeehhhccc-----------------c---------ccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCc
Confidence 665555444322111 0 1123578999999998654 888888 467899999
Q ss_pred ccccccCc
Q 044127 272 FFRSCHFV 279 (282)
Q Consensus 272 ~~~~~~~~ 279 (282)
||+++.|.
T Consensus 930 fFkgIDfs 937 (1034)
T KOG0608|consen 930 FFKGIDFS 937 (1034)
T ss_pred cccccchH
Confidence 99999864
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=265.07 Aligned_cols=240 Identities=22% Similarity=0.340 Sum_probs=201.5
Q ss_pred CCcceEEEEEecCC-C--cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCC-ccHH
Q 044127 1 GSYGDVFQALDKKS-G--EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYME-SDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~-~--~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~-~~~l 76 (282)
|+||.|++|.+... | -.||||.+..........++++|+..+.++. |||++++||+..+ ....+|||.+. |+++
T Consensus 121 GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~mMV~ELaplGSLl 198 (1039)
T KOG0199|consen 121 GSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPAMMVFELAPLGSLL 198 (1039)
T ss_pred cceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc-CcceeEEeeeecc-chhhHHhhhcccchHH
Confidence 89999999998753 3 3599999998887778899999999999996 9999999999987 56889999998 5666
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCC----cccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTD----YVTT 151 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~----~~~~ 151 (282)
+.+.......|.......++.|||.|+.||.+++++||||...|+++- ...|||+|||+.+.++....... ..-.
T Consensus 199 drLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvP 278 (1039)
T KOG0199|consen 199 DRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVP 278 (1039)
T ss_pred HHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCc
Confidence 666654556799999999999999999999999999999999999996 48899999999998876553321 1234
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
..|+|||.+.... ++.++|||++||++|||++ |..||.+....+++.++-..
T Consensus 279 fAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-------------------------- 331 (1039)
T KOG0199|consen 279 FAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-------------------------- 331 (1039)
T ss_pred ccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc--------------------------
Confidence 5699999998555 8999999999999999998 68899999888877765321
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcc
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 272 (282)
+...-++.+++.++++++.||..+|.+|||+..|.+.-+
T Consensus 332 ---erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 332 ---ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ---ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 223445678999999999999999999999999865433
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=250.19 Aligned_cols=241 Identities=16% Similarity=0.163 Sum_probs=171.3
Q ss_pred CCcceEEEEEecCC---CcEEEEEEccccccchHH----------HHHHHHHHHHHHhCCCCCeeeeccccccCC----c
Q 044127 1 GSYGDVFQALDKKS---GEFVAVKKLKKKIFSLDE----------SRNLKEVKCLRKMNNHPNIVKLRNLVKEHE----D 63 (282)
Q Consensus 1 G~~g~Vy~~~~~~~---~~~v~vK~~~~~~~~~~~----------~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----~ 63 (282)
|+||+||+|.+..+ +..+++|+.......... .....+...+..+ .|++++.+++...... .
T Consensus 23 G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~ 101 (294)
T PHA02882 23 GGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYYGCGSFKRCRMYY 101 (294)
T ss_pred CCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEEEeeeEecCCceE
Confidence 89999999998877 667788865433211100 0111222333344 5999999998654332 4
Q ss_pred EEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC
Q 044127 64 VFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 142 (282)
Q Consensus 64 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~ 142 (282)
.+++++++..++.+.+... ...++..+..++.|++.||.+||+++++||||||+||+++. +.++|+|||++......
T Consensus 102 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~ 179 (294)
T PHA02882 102 RFILLEKLVENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIH 179 (294)
T ss_pred EEEEEehhccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccC
Confidence 5788888876655444332 34688999999999999999999999999999999999975 78999999998765321
Q ss_pred --------CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHH-HhCCCCCCC
Q 044127 143 --------LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSAD-QIYKICQ-VIGSPTEDS 212 (282)
Q Consensus 143 --------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~-~~~~~~~-~~~~~~~~~ 212 (282)
.......+++.|+|||++.+.. ++.++|||||||++|+|++|..||....... ....... .........
T Consensus 180 ~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (294)
T PHA02882 180 GKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGK 258 (294)
T ss_pred CcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhh
Confidence 1112346899999999987544 8999999999999999999999998774332 2221111 111110000
Q ss_pred ccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 213 WPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
......++.+.++++.|+..+|++||+.+++++
T Consensus 259 ------------------------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 259 ------------------------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ------------------------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 011245788999999999999999999999874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=254.11 Aligned_cols=251 Identities=27% Similarity=0.474 Sum_probs=201.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHH------HHHHHHHHHHHhCCCCCeeeeccccc-cCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDES------RNLKEVKCLRKMNNHPNIVKLRNLVK-EHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~------~~~~e~~~l~~~~~hp~i~~~~~~~~-~~~~~~lv~e~~~~ 73 (282)
|||+.||+|.+....+.||+|+-.....+.++. ...+|..+-+.+ +||-||++|++|. +.+..|-|+|||.|
T Consensus 474 GGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslDtdsFCTVLEYceG 552 (775)
T KOG1151|consen 474 GGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLDTDSFCTVLEYCEG 552 (775)
T ss_pred ccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-CcceeeeeeeeeeeccccceeeeeecCC
Confidence 899999999999999999999876554443322 235677777777 6999999999996 55678999999999
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeeC----CcEEEeecCcccccCCCCCC--
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG--YFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPC-- 145 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~--~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~~-- 145 (282)
..|+.+++.+ +.+++.++++|+.||+.||.||.... |+|-||||.|||+.+ |.+|++|||++..++.....
T Consensus 553 NDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~v 631 (775)
T KOG1151|consen 553 NDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSV 631 (775)
T ss_pred CchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcc
Confidence 9999998876 47999999999999999999999875 999999999999965 57999999999988544322
Q ss_pred ------CCccccccccCchhhhcc---ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccc
Q 044127 146 ------TDYVTTRWYRAPEVLLLS---EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLG 216 (282)
Q Consensus 146 ------~~~~~~~~~~aPE~~~~~---~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (282)
....||.+|++||.|.-+ ...+.+.||||+||++|.++.|+.||........+...-..+.
T Consensus 632 dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk---------- 701 (775)
T KOG1151|consen 632 DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK---------- 701 (775)
T ss_pred cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc----------
Confidence 345789999999998533 3478899999999999999999999987766554433211110
Q ss_pred ccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 217 IQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.....|+. .+.++.+.++||++||+..-.+|..+.++..||+|....
T Consensus 702 -----AtEVqFP~---------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 702 -----ATEVQFPP---------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred -----ceeccCCC---------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 01111221 234688999999999999999999999999999997643
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=257.02 Aligned_cols=243 Identities=23% Similarity=0.341 Sum_probs=204.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|-||.|.+|.-. .+.+||+|+++.........++.+|++++.+++ ||||++++++|..++.+++|+||+..+.+..++
T Consensus 549 GqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePicmI~EYmEnGDLnqFl 626 (807)
T KOG1094|consen 549 GQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLCMITEYMENGDLNQFL 626 (807)
T ss_pred cccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchHHHHHHHhcCcHHHHH
Confidence 789999999744 368999999998876666789999999999995 999999999999999999999999977777666
Q ss_pred HhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC---CCCCcccccccc
Q 044127 81 ERAGQ-NFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTRWYR 155 (282)
Q Consensus 81 ~~~~~-~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~ 155 (282)
..+.. .+......+|+.||++|++||.+.++|||||.+.|+|++. .++|++|||.++.+-... -..+..-+.+|+
T Consensus 627 ~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwm 706 (807)
T KOG1094|consen 627 SAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWM 706 (807)
T ss_pred HhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeeh
Confidence 66532 2466777789999999999999999999999999999985 799999999988552221 112334467899
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHh--CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLS--FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
|||.+..++ ++.+||+|+||+++||+++ ...||....+++...+....+..+....++
T Consensus 707 awEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l------------------- 766 (807)
T KOG1094|consen 707 AWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL------------------- 766 (807)
T ss_pred hHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec-------------------
Confidence 999998676 8999999999999999875 678999999999888887777666555443
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 268 (282)
..+.-++..+.+++-+||..|-++|||++++-
T Consensus 767 ---~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 767 ---SRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred ---cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 45667899999999999999999999999974
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=268.41 Aligned_cols=263 Identities=19% Similarity=0.254 Sum_probs=166.6
Q ss_pred CCcceEEEEEecCC----CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccc------cccCCcEEEEEec
Q 044127 1 GSYGDVFQALDKKS----GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL------VKEHEDVFIVFEY 70 (282)
Q Consensus 1 G~~g~Vy~~~~~~~----~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~------~~~~~~~~lv~e~ 70 (282)
|+||+||+|++..+ +..||+|++..... ... ...+ .+... .+.++..+... .......++++||
T Consensus 143 G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~-~~~e--~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey 216 (566)
T PLN03225 143 GAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEI-WMNE--RVRRA-CPNSCADFVYGFLEPVSSKKEDEYWLVWRY 216 (566)
T ss_pred CCCeEEEEEEEcCCccccCcEEEEEEecccch--hHH-HHHH--HHHhh-chhhHHHHHHhhhcccccccCCceEEEEEe
Confidence 89999999999988 89999998754321 111 1111 11111 12222222222 2455679999999
Q ss_pred CCccHHHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEE
Q 044127 71 MESDLLKLMKERAGQN-------------------FSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIK 129 (282)
Q Consensus 71 ~~~~~l~~~~~~~~~~-------------------l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~ 129 (282)
++++.+..++...... .....+..++.||+.||.|||+++|+|+||||+||++++ +.+|
T Consensus 217 ~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~K 296 (566)
T PLN03225 217 EGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFK 296 (566)
T ss_pred cCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEE
Confidence 9987766655432211 123457789999999999999999999999999999984 6899
Q ss_pred EeecCcccccCCC--CCCCCccccccccCchhhhccc---------------------cCCCcchhHHHHHHHHHHHhCC
Q 044127 130 IGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLSE---------------------IYGPEVDMWAMGAIMFEMLSFR 186 (282)
Q Consensus 130 l~df~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~---------------------~~~~~~DiwslG~ll~~l~~g~ 186 (282)
|+|||++...... .......+++.|+|||.+.... .++.++|||||||++|||+++.
T Consensus 297 L~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~ 376 (566)
T PLN03225 297 IIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPN 376 (566)
T ss_pred EEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCc
Confidence 9999999765322 2224457889999999764221 1334569999999999999876
Q ss_pred CCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHH
Q 044127 187 ILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAE 266 (282)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 266 (282)
.++. .............+.. ...|... ....... ......+.........++||++||+.||++|||+++
T Consensus 377 ~~~~--~~~~~~~~~l~~~~~~-~~~~~~~------~~~~~~~-~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e 446 (566)
T PLN03225 377 LRSD--SNLIQFNRQLKRNDYD-LVAWRKL------VEPRASP-DLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKA 446 (566)
T ss_pred CCCc--hHHHHHHHHHHhcCCc-HHHHHHh------hccccch-hhhhhhhhccccchHHHHHHHHHccCCcccCCCHHH
Confidence 5533 2222222222211110 0000000 0000000 000001112223445679999999999999999999
Q ss_pred HhcCcccccccCc
Q 044127 267 ALEHPFFRSCHFV 279 (282)
Q Consensus 267 ll~~~~~~~~~~~ 279 (282)
+|+||||++....
T Consensus 447 ~L~Hpff~~~~~~ 459 (566)
T PLN03225 447 ALAHPYFDREGLL 459 (566)
T ss_pred HhCCcCcCCCCcc
Confidence 9999999876553
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=258.32 Aligned_cols=234 Identities=24% Similarity=0.456 Sum_probs=195.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCC-ccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYME-SDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~-~~~l~~~ 79 (282)
|-||.||.+.++.-.-.||||.++.+ .-....++.|..+++.+. |||+|+++|+|..+...|||+|||. |.+|+.+
T Consensus 278 GQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYL 354 (1157)
T KOG4278|consen 278 GQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYL 354 (1157)
T ss_pred Ccccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEEEEecccCccHHHHH
Confidence 67999999999988888999999876 345678899999999996 9999999999999999999999986 7888887
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccc---ccccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVT---TRWYR 155 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~---~~~~~ 155 (282)
.+.....++.-....++.||.+|+.||..++++||||...|+|+.+ ..+|+.|||+++.+.... .....| +.-|.
T Consensus 355 Recnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YTAHAGAKFPIKWT 433 (1157)
T KOG4278|consen 355 RECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YTAHAGAKFPIKWT 433 (1157)
T ss_pred HHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-eecccCccCccccc
Confidence 7766667888899999999999999999999999999999999986 689999999998875432 223333 34599
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
|||.+.... ++.++|||+|||+|||+.| |-.||.+.+..+.+..+.+..+.
T Consensus 434 APEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM--------------------------- 485 (1157)
T KOG4278|consen 434 APESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM--------------------------- 485 (1157)
T ss_pred Ccccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc---------------------------
Confidence 999987555 8999999999999999998 67788887655555444333221
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 268 (282)
+-+.++++.+.+|++.||+++|.+||++.|+-
T Consensus 486 --~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 486 --DGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred --cCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 23457899999999999999999999998863
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=237.57 Aligned_cols=247 Identities=29% Similarity=0.459 Sum_probs=204.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH--HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD--ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~--~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+|++|-.++++.|.+-||+|++++.....+ ..-...|-.+..+..+||.++-++..|+.+..+++|.||.+|+.+-.
T Consensus 261 gsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmf 340 (593)
T KOG0695|consen 261 GSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMF 340 (593)
T ss_pred cchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceee
Confidence 7899999999999999999999998765543 34456677888888899999999999999999999999999877765
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCccccc-CCCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~a 156 (282)
.+++. .+++++.++-+..+|.-||.|||++||+++|||.+||++| +|.+||+|+|.+..- .........+|||.|.|
T Consensus 341 hmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyia 419 (593)
T KOG0695|consen 341 HMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIA 419 (593)
T ss_pred ehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccc
Confidence 55554 4799999999999999999999999999999999999998 599999999988753 45556678899999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCC-------CChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGK-------NSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
||.+.+.. ++...|.|+||++|+||+.|+.||+-. +.++.+.++.-..+
T Consensus 420 peilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq----------------------- 475 (593)
T KOG0695|consen 420 PEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ----------------------- 475 (593)
T ss_pred hhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-----------------------
Confidence 99998555 899999999999999999999999632 12222222221100
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCC------HHHHhcCcccccccC
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPT------AAEALEHPFFRSCHF 278 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~~ll~~~~~~~~~~ 278 (282)
-.++..++-....+++..|+.||++|.. +.++-.|+|||.+.|
T Consensus 476 ------iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 476 ------IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred ------ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 0234466778889999999999999984 589999999998876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=220.81 Aligned_cols=203 Identities=27% Similarity=0.480 Sum_probs=175.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.|=+.++..+|...|+|.+.....++.....+.|+.+..+...+|.++.++|.+..++..+|.||.|+-++-..+.
T Consensus 57 GayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tSldkfy~ 136 (282)
T KOG0984|consen 57 GAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTSLDKFYR 136 (282)
T ss_pred CccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhhHHHHHH
Confidence 78999999999999999999999988888888999999999999889999999999999999999999999876655443
Q ss_pred H--hcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 81 E--RAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~--~~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
+ ..+..++|..+.+|+..+..||.|||++ .++|||+||+|||++ +|++|+||||.+..+..+.-.+...|...|+|
T Consensus 137 ~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYma 216 (282)
T KOG0984|consen 137 KVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMA 216 (282)
T ss_pred HHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCC
Confidence 3 3456899999999999999999999976 799999999999999 59999999999887766655555678888999
Q ss_pred chhhhc---cccCCCcchhHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHH
Q 044127 157 PEVLLL---SEIYGPEVDMWAMGAIMFEMLSFRILFPGKN-SADQIYKICQ 203 (282)
Q Consensus 157 PE~~~~---~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~-~~~~~~~~~~ 203 (282)
||.+.. +..|+.+|||||||+.+.||.+++.||+... +.+++.+++.
T Consensus 217 PEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 217 PERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 999853 2358899999999999999999999998664 3444444433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=264.13 Aligned_cols=238 Identities=28% Similarity=0.431 Sum_probs=181.6
Q ss_pred CCcc-eEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYG-DVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g-~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+.| .||+|... |+.||||.+-.. ...-..+|+..++.-..||||+++++.=.+..+.||..|.|..++-+.+
T Consensus 520 Gs~Gt~Vf~G~ye--~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~dli 593 (903)
T KOG1027|consen 520 GSNGTVVFRGVYE--GREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQDLI 593 (903)
T ss_pred CCCCcEEEEEeeC--CceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHHHH
Confidence 4455 59999654 889999987543 3344567999999888999999999999999999999999999877665
Q ss_pred HHh-cC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC------CcEEEeecCcccccCCCCC----CCC
Q 044127 80 KER-AG-QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK------GVIKIGDLGMVKEIDSSLP----CTD 147 (282)
Q Consensus 80 ~~~-~~-~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~------~~~~l~df~~~~~~~~~~~----~~~ 147 (282)
... .. .....-..+.++.|+++||++||+.+|+||||||+||||+- .+++|+|||++..++.... ...
T Consensus 594 e~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~ 673 (903)
T KOG1027|consen 594 ESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSG 673 (903)
T ss_pred hccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccC
Confidence 552 11 11122455788999999999999999999999999999963 3799999999998865432 234
Q ss_pred ccccccccCchhhhccccCCCcchhHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcc
Q 044127 148 YVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226 (282)
Q Consensus 148 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
..||-.|.|||.+.... -..+.|||||||++|+.++| ..||...-..+ .++..
T Consensus 674 ~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~----------------------- 727 (903)
T KOG1027|consen 674 GSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILT----------------------- 727 (903)
T ss_pred CCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhc-----------------------
Confidence 57899999999998655 57799999999999999996 88997543222 11111
Q ss_pred ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccc
Q 044127 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274 (282)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 274 (282)
...++..+......+..+||.+|+++||..||+|.+||.||+|=
T Consensus 728 ----~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 728 ----GNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred ----CccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 11111112222222899999999999999999999999999993
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=243.66 Aligned_cols=270 Identities=29% Similarity=0.462 Sum_probs=206.6
Q ss_pred CCcceEEEEEecC---CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKK---SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|.|++||++.+.. ....||+|.+.... .......|+..+..+.++.||+.+.+.+..++...+|+||+......
T Consensus 47 GsFssv~~a~~~~~~~~~~~valk~i~~ts---~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~ 123 (418)
T KOG1167|consen 47 GSFSSVYKATDIEQDTKRRYVALKAIYRTS---SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFR 123 (418)
T ss_pred cchhhhhhhhHhhhccccceEeeeeccccc---CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHH
Confidence 8899999999887 78899999987643 34457789999999999999999999999999999999999987666
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCC-------------
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSS------------- 142 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~------------- 142 (282)
.+.. .++...+...++.++.||.++|.+||+||||||+|++++. ++-.|+|||+|...+..
T Consensus 124 ~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~ 199 (418)
T KOG1167|consen 124 DLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRH 199 (418)
T ss_pred HHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhccc
Confidence 6665 4789999999999999999999999999999999999985 78999999998722100
Q ss_pred -CC-----------------C--------------CCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCC-
Q 044127 143 -LP-----------------C--------------TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILF- 189 (282)
Q Consensus 143 -~~-----------------~--------------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~- 189 (282)
.. . -...||+.|+|||++..-..-+.+.||||.|+++.-++++..||
T Consensus 200 ~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 200 ATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred CCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccc
Confidence 00 0 02357899999999986666789999999999999999998886
Q ss_pred CCCCChHHHHHHHHHhCCCCCCCccccccc--c---cc------CCcccc-----CCC-----CCcccccCCCCChhhHH
Q 044127 190 PGKNSADQIYKICQVIGSPTEDSWPLGIQL--A---SN------LDWKFP-----QMG-----GVNLRELSPSASRESIS 248 (282)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~---~~------~~~~~~-----~~~-----~~~~~~~~~~~~~~~~~ 248 (282)
...++.+.+..++..++...-.......+. . .+ ....+. ... ...........+..+.+
T Consensus 280 ~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~d 359 (418)
T KOG1167|consen 280 KAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLD 359 (418)
T ss_pred cCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHH
Confidence 456666666666665554332221111111 0 00 000011 111 12233344456678999
Q ss_pred HHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 249 LISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 249 li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
|+.+||..||.+|.|+++.|.||||....
T Consensus 360 lLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 360 LLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred HHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 99999999999999999999999998654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=248.21 Aligned_cols=258 Identities=19% Similarity=0.323 Sum_probs=170.4
Q ss_pred CCcceEEEEEec----------------CCCcEEEEEEccccccch-------------HHHHHHHHHHHHHHhCCCC--
Q 044127 1 GSYGDVFQALDK----------------KSGEFVAVKKLKKKIFSL-------------DESRNLKEVKCLRKMNNHP-- 49 (282)
Q Consensus 1 G~~g~Vy~~~~~----------------~~~~~v~vK~~~~~~~~~-------------~~~~~~~e~~~l~~~~~hp-- 49 (282)
|+||+||+|... ..++.||||.+....... .......|+..+.++.+++
T Consensus 156 GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~ 235 (507)
T PLN03224 156 GNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIA 235 (507)
T ss_pred CCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccch
Confidence 899999999752 235679999986532111 1112334666677775332
Q ss_pred --Ceeeecccccc--------CCcEEEEEecCCccHHHHHHHhcC-----------------------CCCCHHHHHHHH
Q 044127 50 --NIVKLRNLVKE--------HEDVFIVFEYMESDLLKLMKERAG-----------------------QNFSEDEVRNLC 96 (282)
Q Consensus 50 --~i~~~~~~~~~--------~~~~~lv~e~~~~~~l~~~~~~~~-----------------------~~l~~~~~~~i~ 96 (282)
+++.+++++.. .+..++|+||+.++++..++.... ..++...++.++
T Consensus 236 ~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~ 315 (507)
T PLN03224 236 AASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVM 315 (507)
T ss_pred hhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHH
Confidence 24566666642 356899999999877765554211 124567889999
Q ss_pred HHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCC--ccccccccCchhhhcccc--------
Q 044127 97 FQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTD--YVTTRWYRAPEVLLLSEI-------- 165 (282)
Q Consensus 97 ~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~aPE~~~~~~~-------- 165 (282)
.|++.||.+||+.+++|+||||+||+++. +.++|+|||++........... ...++.|+|||.+.....
T Consensus 316 ~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~ 395 (507)
T PLN03224 316 RQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPA 395 (507)
T ss_pred HHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhh
Confidence 99999999999999999999999999975 7899999999876543222222 234788999998753211
Q ss_pred -----------C--CCcchhHHHHHHHHHHHhCCC-CCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 166 -----------Y--GPEVDMWAMGAIMFEMLSFRI-LFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 166 -----------~--~~~~DiwslG~ll~~l~~g~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
+ ..+.|+||+||++|+|++|.. ||.............. .....|.. ....
T Consensus 396 ~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~----~~~~~~r~------------~~~~ 459 (507)
T PLN03224 396 MAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYD----NDLNRWRM------------YKGQ 459 (507)
T ss_pred hhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhcc----chHHHHHh------------hccc
Confidence 1 234799999999999999875 6643322111110000 00000000 0000
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCC---CCCCCHHHHhcCccccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNP---HMRPTAAEALEHPFFRS 275 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp---~~Rps~~~ll~~~~~~~ 275 (282)
.... ......++..++|+.+||..+| .+|+|++|+|+||||..
T Consensus 460 ~~~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 0011 1234568899999999999866 78999999999999964
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=254.92 Aligned_cols=240 Identities=26% Similarity=0.480 Sum_probs=191.5
Q ss_pred CCcceEEEEEecC-------CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKK-------SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|.||+|++|.-.. ....||||..+......+...+..|+.++..+..|||++.+++.+...+..++|+||+..
T Consensus 307 g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~ 386 (609)
T KOG0200|consen 307 GAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEH 386 (609)
T ss_pred ccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccC
Confidence 7899999997431 145699999998877778888999999999999999999999999999999999999985
Q ss_pred -cHHHHHHHhc------C--------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccc
Q 044127 74 -DLLKLMKERA------G--------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK 137 (282)
Q Consensus 74 -~~l~~~~~~~------~--------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~ 137 (282)
.+++.+.... . ..++......+..||+.|++||++++++||||...||++.+ ..+|++|||+++
T Consensus 387 G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar 466 (609)
T KOG0200|consen 387 GDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLAR 466 (609)
T ss_pred CcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEcccccee
Confidence 5554444432 0 24999999999999999999999999999999999999986 589999999998
Q ss_pred ccCCCCCCC--Ccc--ccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCC
Q 044127 138 EIDSSLPCT--DYV--TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDS 212 (282)
Q Consensus 138 ~~~~~~~~~--~~~--~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (282)
......... ... -+..|+|||.+.. ..++.+|||||+|++|||+++ |..|+.+......+.+.......
T Consensus 467 ~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r----- 540 (609)
T KOG0200|consen 467 DHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNR----- 540 (609)
T ss_pred ccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCC-----
Confidence 654332221 111 2345999999986 669999999999999999999 78899875533333332221111
Q ss_pred ccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 213 WPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...++++.++++.||+.+|++||++.++..
T Consensus 541 -----------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 541 -----------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 1234567999999999999999999999988763
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=271.07 Aligned_cols=242 Identities=20% Similarity=0.291 Sum_probs=172.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|++..++..||+|.+...... ...|+..++++ +||||+++++++.+....++||||+.++.+..++
T Consensus 701 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l 774 (968)
T PLN00113 701 GKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKL-QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774 (968)
T ss_pred CCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhC-CCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHH
Confidence 89999999999889999999998653221 12356777777 5999999999999999999999999988887777
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMH---RQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh---~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
. .+++..+..++.||++||+||| +.+++|+||||+||+++. +..++. ++........ ....+++.|+|
T Consensus 775 ~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---~~~~~t~~y~a 846 (968)
T PLN00113 775 R----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---TKCFISSAYVA 846 (968)
T ss_pred h----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---CCccccccccC
Confidence 5 3889999999999999999999 669999999999999986 444443 5543322111 23367889999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSA-DQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+.+. .++.++|||||||++|||++|+.||...... .............. .. ....+..... .
T Consensus 847 PE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~------~~~~~~~~~~-----~ 912 (968)
T PLN00113 847 PETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC--HL------DMWIDPSIRG-----D 912 (968)
T ss_pred cccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc--ch------hheeCccccC-----C
Confidence 9998754 4899999999999999999999998543211 11111111100000 00 0000000000 0
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
.........++.+++.+||+.||++|||++++++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00111223457889999999999999999999864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=246.52 Aligned_cols=237 Identities=22% Similarity=0.324 Sum_probs=194.9
Q ss_pred CCcceEEEEEecCCCc----EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGE----FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|.+...|+ +|++|++......+...++++|+.++.++. |||++++++++.... +-||++|++.+.|
T Consensus 707 gAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~qlvtq~mP~G~L 784 (1177)
T KOG1025|consen 707 GAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-LQLVTQLMPLGCL 784 (1177)
T ss_pred ccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-HHHHHHhcccchH
Confidence 8999999999865544 588998877766677788999999999995 999999999998765 7899999996666
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCc---cccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDY---VTTR 152 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~---~~~~ 152 (282)
.++.+....++.......|..||++|+.|||.++++||||...|||+.. +.+|+.|||++............ ....
T Consensus 785 lDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pi 864 (1177)
T KOG1025|consen 785 LDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPI 864 (1177)
T ss_pred HHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCc
Confidence 6665555568999999999999999999999999999999999999987 89999999999877554332222 2345
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
-|+|-|.+. .+.++.++||||+||++||++| |..|+.+....++-..+....+
T Consensus 865 kwmale~i~-~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR------------------------- 918 (1177)
T KOG1025|consen 865 KWMALESIR-IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER------------------------- 918 (1177)
T ss_pred HHHHHHHhh-ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-------------------------
Confidence 589999887 4459999999999999999999 8889988776665544433222
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...++..+.++..++.+||..|+..||+++++.+
T Consensus 919 ----LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 919 ----LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ----CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 2335577899999999999999999999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=213.22 Aligned_cols=209 Identities=39% Similarity=0.662 Sum_probs=179.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|.||++....+++.+++|++...........+.+|+..++.+. |++++++++++......++++|++++..+..++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~ 82 (215)
T cd00180 4 GGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL 82 (215)
T ss_pred CCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCcHHHHH
Confidence 7899999999988899999999987654334566788999999985 899999999999989999999999977777776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCC-CCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aP 157 (282)
......++...+..++.+++.++.+||+.|++|+||+|.||++++ +.++++||+.+....... ......+...|.+|
T Consensus 83 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p 162 (215)
T cd00180 83 KENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162 (215)
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccCh
Confidence 654346899999999999999999999999999999999999986 799999999987664432 12345677789999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+......+.++|+|++|++++++
T Consensus 163 e~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------------- 187 (215)
T cd00180 163 EVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------------- 187 (215)
T ss_pred hHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------------
Confidence 9987543578999999999999999
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHP 271 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 271 (282)
..+.+++..|++.||++||++.++++++
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2477999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=244.86 Aligned_cols=248 Identities=30% Similarity=0.478 Sum_probs=201.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|.||.||+|+++.++++.|+|+++... ..+......|+-+++..+ ||||+.+++.+-....+|+.||||+|++++++.
T Consensus 26 gTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dklwicMEycgggslQdiy 103 (829)
T KOG0576|consen 26 GTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIY 103 (829)
T ss_pred CcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCC-CcChHHHHhhhhhhcCcEEEEEecCCCccccee
Confidence 789999999999999999999998754 344445556777787885 999999999999999999999999999998877
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE 158 (282)
.-.+ ++++.++..+++..+.|++|||+.|=+|||||-.||++++ +.+|+.|||.+..+... .......|++.|+|||
T Consensus 104 ~~Tg-plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapE 182 (829)
T KOG0576|consen 104 HVTG-PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPE 182 (829)
T ss_pred eecc-cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchh
Confidence 6654 7999999999999999999999999999999999999975 99999999988776432 2235678999999999
Q ss_pred hhh--ccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 159 VLL--LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 159 ~~~--~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
+.. ....++..+|||++|+...|+..-+.|-...-++..+..+.+-...+.. .
T Consensus 183 vaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~-------------------------l 237 (829)
T KOG0576|consen 183 VAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT-------------------------L 237 (829)
T ss_pred HHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc-------------------------c
Confidence 873 2334899999999999999998877775555444444433221111110 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.-....++.+.+|++.+|..+|++|||++.+|.|||..+.
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 1123568889999999999999999999999999998765
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=219.73 Aligned_cols=238 Identities=15% Similarity=0.265 Sum_probs=194.1
Q ss_pred CCcceEEEEEecCC-----CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc-cCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKS-----GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK-EHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-~~~~~~lv~e~~~~~ 74 (282)
|.||.||.|.+++. .+.|.+|.++...+.-....++.|.-.+.... |||++.+.++.. +....++++++++-+
T Consensus 295 GtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ie~~~~P~V~y~~~~~g 373 (563)
T KOG1024|consen 295 GTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIEDYATPFVLYPATGVG 373 (563)
T ss_pred CchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCc-CCCccceeEEEeeccCcceEEEeccCcc
Confidence 89999999977642 34578888887776666677778877777774 999999999864 556789999999966
Q ss_pred HHHHHHH-------hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC---CC
Q 044127 75 LLKLMKE-------RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS---SL 143 (282)
Q Consensus 75 ~l~~~~~-------~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~---~~ 143 (282)
.++.++. ...+.++..++..++.|++.|+.|||+.|++|.||...|++||+ -++||+|=.+++.+-. .-
T Consensus 374 NLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhc 453 (563)
T KOG1024|consen 374 NLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHC 453 (563)
T ss_pred hHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccc
Confidence 6766655 12245788889999999999999999999999999999999987 6999999999886622 22
Q ss_pred CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccccc
Q 044127 144 PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN 222 (282)
Q Consensus 144 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (282)
.......+..|+|||.+.... ++.++|+||||++||||+| |+.|+..-++.+....+.++.+-.
T Consensus 454 LGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla-------------- 518 (563)
T KOG1024|consen 454 LGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA-------------- 518 (563)
T ss_pred cCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec--------------
Confidence 234456677899999998544 8999999999999999998 889999888888877766644322
Q ss_pred CCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 223 LDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.+-.+|+++..++-.||..+|++||+++++..
T Consensus 519 ---------------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 519 ---------------QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ---------------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 23467999999999999999999999999864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=214.01 Aligned_cols=244 Identities=18% Similarity=0.299 Sum_probs=189.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccc-cccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL-VKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~-~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|.||.+-+|.|+.++..+++|-+..+ ....+++.+|..--.-+..|.||+.-|++ |+..+.+++++||++.+.|..-
T Consensus 35 G~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~sn 112 (378)
T KOG1345|consen 35 GRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSN 112 (378)
T ss_pred cceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhh
Confidence 88999999999999999999999876 45667888888877777789999998886 7888899999999997666554
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee---CCcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
... ..+.+...+.++.|+++|+.|||++++||||||.+|||+- .-++||||||+....+.-- ........|.+
T Consensus 113 v~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~ 188 (378)
T KOG1345|consen 113 VEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV--KYLEYVNNYHA 188 (378)
T ss_pred cCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee--hhhhhhcccCC
Confidence 443 3589999999999999999999999999999999999994 3589999999987655432 23344566899
Q ss_pred chhhhc----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHH-HHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 157 PEVLLL----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQ-IYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 157 PE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
||+... .-...+.+|+|.||+++|.+++|..||.....++. +.+...+.+...+
T Consensus 189 pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~--------------------- 247 (378)
T KOG1345|consen 189 PELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP--------------------- 247 (378)
T ss_pred cHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc---------------------
Confidence 998742 22357889999999999999999999975444333 3344444333221
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCC---CCHHHHhcCccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMR---PTAAEALEHPFF 273 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~~ll~~~~~ 273 (282)
.++.....+++.+..+.++-|.++|++| -++.......|.
T Consensus 248 --~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 248 --ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred --cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 2334556789999999999999999999 344444444443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=229.62 Aligned_cols=189 Identities=29% Similarity=0.413 Sum_probs=161.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-------HHHHHHHHHHHHHhC--CCCCeeeeccccccCCcEEEEEecC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-------ESRNLKEVKCLRKMN--NHPNIVKLRNLVKEHEDVFIVFEYM 71 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-------~~~~~~e~~~l~~~~--~hp~i~~~~~~~~~~~~~~lv~e~~ 71 (282)
|+||.|+.|.++++...|++|.+.+...-.+ ....-.|+.++..+. +|+||++++++|++++++|++||.-
T Consensus 572 GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~h 651 (772)
T KOG1152|consen 572 GAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVH 651 (772)
T ss_pred cccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCC
Confidence 8999999999999999999999887543211 122345888888775 5999999999999999999999987
Q ss_pred C-ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCcc
Q 044127 72 E-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYV 149 (282)
Q Consensus 72 ~-~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~ 149 (282)
+ |-.|.+++... ..++|.+++.|++|++.|+++||+.||+|||||-+||.++ +|-+||+|||.+.... +.+.....
T Consensus 652 g~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~k-sgpfd~f~ 729 (772)
T KOG1152|consen 652 GEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK-SGPFDVFV 729 (772)
T ss_pred CCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhc-CCCcceee
Confidence 6 44445556665 4799999999999999999999999999999999999998 5899999999887543 45667889
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPG 191 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~ 191 (282)
||..|.|||++.+.+..+...|||+||+++|-++....||..
T Consensus 730 gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 730 GTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999999888889999999999999999998888853
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=217.60 Aligned_cols=181 Identities=26% Similarity=0.342 Sum_probs=144.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCeeeeccccccC----CcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN-NHPNIVKLRNLVKEH----EDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~-~hp~i~~~~~~~~~~----~~~~lv~e~~~~~~ 75 (282)
|.||.||+|+. +++.||||++... +.+.+..|-.+..-.. .|+||+++++.=... ..+++|++|-..++
T Consensus 221 Grfg~V~KaqL--~~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGs 294 (534)
T KOG3653|consen 221 GRFGCVWKAQL--DNRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGS 294 (534)
T ss_pred Cccceeehhhc--cCceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCc
Confidence 89999999954 4799999999653 4555555655554322 599999999875443 38999999999777
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CccccCCCCCceeee-CCcEEEeecCcccccCCCCC-
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ---------GYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP- 144 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~---------~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~- 144 (282)
|.+++.. ..++.....+|+..+++||+|||+- .|+|||||..|||+. |.+..|+|||+|..+....+
T Consensus 295 L~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~ 372 (534)
T KOG3653|consen 295 LCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQ 372 (534)
T ss_pred HHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCC
Confidence 7777776 3799999999999999999999973 399999999999996 58999999999998754333
Q ss_pred --CCCccccccccCchhhhccccCC-----CcchhHHHHHHHHHHHhCCCCC
Q 044127 145 --CTDYVTTRWYRAPEVLLLSEIYG-----PEVDMWAMGAIMFEMLSFRILF 189 (282)
Q Consensus 145 --~~~~~~~~~~~aPE~~~~~~~~~-----~~~DiwslG~ll~~l~~g~~~~ 189 (282)
.....||.+|||||++.+.-.+. .+.||||+|.++||+++....+
T Consensus 373 ~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 373 GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 23468999999999997554333 3579999999999999864433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=249.29 Aligned_cols=195 Identities=16% Similarity=0.216 Sum_probs=139.7
Q ss_pred CCeeeecccc-------ccCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCce
Q 044127 49 PNIVKLRNLV-------KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNL 121 (282)
Q Consensus 49 p~i~~~~~~~-------~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~ni 121 (282)
+||+.++++| ......+.++|++++++.+.+. .....+++.+++.+++||++||.|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~-~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLD-NPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCCccHHHHHh-cccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777778877 2334677888988776665553 3345699999999999999999999999999999999999
Q ss_pred eeeC-C-------------------cEEEeecCcccccCCCC-----------------CCCCccccccccCchhhhccc
Q 044127 122 LVSK-G-------------------VIKIGDLGMVKEIDSSL-----------------PCTDYVTTRWYRAPEVLLLSE 164 (282)
Q Consensus 122 li~~-~-------------------~~~l~df~~~~~~~~~~-----------------~~~~~~~~~~~~aPE~~~~~~ 164 (282)
|++. + .+|++|||++....... ......+++.|+|||++.+..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 9952 3 45666666654321100 001135688899999987555
Q ss_pred cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCCh
Q 044127 165 IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASR 244 (282)
Q Consensus 165 ~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (282)
++.++|||||||++|||++|..|+.... .....+..... + + . ......
T Consensus 192 -~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~-~-~--------------------------~-~~~~~~ 239 (793)
T PLN00181 192 -SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL-P-P--------------------------Q-ILLNWP 239 (793)
T ss_pred -CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc-C-h--------------------------h-hhhcCH
Confidence 7999999999999999999888765321 11111111100 0 0 0 001134
Q ss_pred hhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 245 ESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 245 ~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
...+++.+||++||.+||++.++++||||...
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 56789999999999999999999999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=200.89 Aligned_cols=199 Identities=38% Similarity=0.633 Sum_probs=165.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|++|+||++.+..+++.+++|.+...........+.+|+..+.++ +|+|++++++.+......++++|++.+..+..+.
T Consensus 10 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 88 (225)
T smart00221 10 GAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYL 88 (225)
T ss_pred CCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEeccCCCCHHHHH
Confidence 789999999999889999999998754332456677899988888 5999999999999889999999999986666666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aP 157 (282)
......+++..+..++.+++.++.+||+.+++|+|++|.||+++. +.++|+|||.+....... ......++..|++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~p 168 (225)
T smart00221 89 RKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAP 168 (225)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCH
Confidence 554322899999999999999999999999999999999999985 899999999988765442 23445667789999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCC-CCChHHHHH
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPG-KNSADQIYK 200 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~-~~~~~~~~~ 200 (282)
|.+.+...++.++|+|+||++++++++|+.||.. .+......+
T Consensus 169 e~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~ 212 (225)
T smart00221 169 EVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSD 212 (225)
T ss_pred hHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHH
Confidence 9884345577899999999999999999999977 444434443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=208.37 Aligned_cols=235 Identities=28% Similarity=0.416 Sum_probs=166.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHH-hCCCCCeeeeccccc--cC--CcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRK-MNNHPNIVKLRNLVK--EH--EDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~-~~~hp~i~~~~~~~~--~~--~~~~lv~e~~~~~~ 75 (282)
|.||+||+|.++ |+.||||++... ++...++|.++.+. +.+|+||+.+++.=. ++ .++|+|++|-..++
T Consensus 222 GRyGEVwrG~wr--Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GS 295 (513)
T KOG2052|consen 222 GRFGEVWRGRWR--GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGS 295 (513)
T ss_pred ccccceeecccc--CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCc
Confidence 889999999877 889999998653 44455556555553 226999999987632 22 37899999998666
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCceeee-CCcEEEeecCcccccCCC----
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ--------GYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSS---- 142 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~--------~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~---- 142 (282)
|.+++.+ ..++.+...+++..+|+||++||.. .|+|||||..||++. ++...+.|+|+|......
T Consensus 296 L~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~i 373 (513)
T KOG2052|consen 296 LYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTI 373 (513)
T ss_pred HHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcc
Confidence 6666665 4799999999999999999999963 299999999999997 589999999999876544
Q ss_pred -CCCCCccccccccCchhhhcccc---C--CCcchhHHHHHHHHHHHh----C------CCCCCCCCCh----HHHHHHH
Q 044127 143 -LPCTDYVTTRWYRAPEVLLLSEI---Y--GPEVDMWAMGAIMFEMLS----F------RILFPGKNSA----DQIYKIC 202 (282)
Q Consensus 143 -~~~~~~~~~~~~~aPE~~~~~~~---~--~~~~DiwslG~ll~~l~~----g------~~~~~~~~~~----~~~~~~~ 202 (282)
......+||.+|+|||++...-. + -..+||||||.++||++. | +.||....+. +...+++
T Consensus 374 di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVV 453 (513)
T KOG2052|consen 374 DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVV 453 (513)
T ss_pred cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcce
Confidence 22345689999999999853211 1 236899999999999884 2 3466443322 2222222
Q ss_pred HH--hCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHH
Q 044127 203 QV--IGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEA 267 (282)
Q Consensus 203 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 267 (282)
+. .+...++.|. +...-..+-++++.||..+|..|.|+-.+
T Consensus 454 Cv~~~RP~ipnrW~------------------------s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 454 CVQKLRPNIPNRWK------------------------SDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred eecccCCCCCcccc------------------------cCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 11 1111111110 01122346779999999999999998544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=193.25 Aligned_cols=164 Identities=21% Similarity=0.324 Sum_probs=122.2
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWY 154 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 154 (282)
|..++...+..+++..++.++.||+.||.|||+.+ ||+||++++ +.+++ ||.+....... ..+++.|
T Consensus 3 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~~y 70 (176)
T smart00750 3 LADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDPYF 70 (176)
T ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcccc
Confidence 34444444457999999999999999999999998 999999985 67887 99887654432 3678999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSA-DQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
+|||++.+.. ++.++|||||||++|||++|..||...... ..............+...
T Consensus 71 ~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------- 129 (176)
T smart00750 71 MAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR-------------------- 129 (176)
T ss_pred cChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccc--------------------
Confidence 9999997554 799999999999999999999999765443 222222222111100000
Q ss_pred cccccCCCCCh--hhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 234 NLRELSPSASR--ESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 234 ~~~~~~~~~~~--~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
......+. .+.+++.+||..||.+||++.++++|+|+..
T Consensus 130 ---~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 130 ---SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ---ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 00112223 6999999999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=217.74 Aligned_cols=253 Identities=25% Similarity=0.318 Sum_probs=182.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccc----ccchHHH-HHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKK----IFSLDES-RNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~----~~~~~~~-~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|++|.|+.+......+.+..|.+... ....... ....|+.+-..+ .|||++.....+.+.....-.||||++ .
T Consensus 329 ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~mE~~~~-D 406 (601)
T KOG0590|consen 329 GAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGILQSMEYCPY-D 406 (601)
T ss_pred cccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccchhhhhcccH-H
Confidence 56777777776665555666655421 1111111 123344444445 599998888887666555555999999 4
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-----CCCCCcc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-----LPCTDYV 149 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-----~~~~~~~ 149 (282)
+-.++... ..+....+..++.|++.|+.|+|+.|+.|+|+|++|+++.. +.+|++|||.+...... .......
T Consensus 407 lf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~ 485 (601)
T KOG0590|consen 407 LFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIV 485 (601)
T ss_pred HHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcc
Confidence 44444443 36999999999999999999999999999999999999986 69999999988755322 2224567
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
|+..|+|||++.+...-....||||.|+++..|.+|+.||......+........ ....
T Consensus 486 gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~---------------------~~~~ 544 (601)
T KOG0590|consen 486 GSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY---------------------SDQR 544 (601)
T ss_pred cCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc---------------------cccc
Confidence 8899999999987776677889999999999999999999876554433200000 0000
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
........+...++...+.+|.+||++||.+|.|+++|++++||+.+.
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 111222344556788999999999999999999999999999999874
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-26 Score=185.69 Aligned_cols=241 Identities=22% Similarity=0.272 Sum_probs=181.7
Q ss_pred CCcceEEEEEecCCC-cEEEEEEccccccchHHHHHHHHHHHHHHhC---CCCCeeeecccc-ccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSG-EFVAVKKLKKKIFSLDESRNLKEVKCLRKMN---NHPNIVKLRNLV-KEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~---~hp~i~~~~~~~-~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||.|.+..++ +.+|+|+.......... ....|..++..+. ..+++..+++.. ..+.+.++||+.++.++
T Consensus 29 G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~G~sL 107 (322)
T KOG1164|consen 29 GGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLLGPSL 107 (322)
T ss_pred cCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEeccCccH
Confidence 899999999988764 67899987765333222 5556777777775 346899999998 58889999999999888
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC------CcEEEeecCccc--ccC-CCC---
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK------GVIKIGDLGMVK--EID-SSL--- 143 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~------~~~~l~df~~~~--~~~-~~~--- 143 (282)
.+.......+.++..++..|+.|++.+|+++|+.|++||||||+|+++.. ..+.|.|||+++ ... ...
T Consensus 108 ~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~ 187 (322)
T KOG1164|consen 108 EDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNL 187 (322)
T ss_pred HHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCccc
Confidence 87665555578999999999999999999999999999999999999963 359999999998 321 110
Q ss_pred ----C-CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccc
Q 044127 144 ----P-CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQ 218 (282)
Q Consensus 144 ----~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (282)
. .....||..|.|+++..+.. .+.+.|+||++.++.++..|..||.......................
T Consensus 188 ~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~------ 260 (322)
T KOG1164|consen 188 RPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDR------ 260 (322)
T ss_pred ccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcccc------
Confidence 1 12345899999999988555 79999999999999999999999977665444433333221111000
Q ss_pred ccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh
Q 044127 219 LASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268 (282)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 268 (282)
.....+..+.++...+-..+...+|....+.
T Consensus 261 -------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~ 291 (322)
T KOG1164|consen 261 -------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLA 291 (322)
T ss_pred -------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence 1223456777777777778888888776654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=161.82 Aligned_cols=194 Identities=24% Similarity=0.350 Sum_probs=161.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.+|.|....+|..||||+.+... ...+...|..+...++...+|..+..+..+..+-++|||.++.++-+.+
T Consensus 26 GSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLLGPsLEdLf- 101 (341)
T KOG1163|consen 26 GSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLLGPSLEDLF- 101 (341)
T ss_pred CchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeeccCccHHHHH-
Confidence 899999999999999999999976543 3445677889999998899999999999999999999999987655544
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCC--------CCCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLP--------CTDY 148 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~--------~~~~ 148 (282)
+.....++..++.-++-|++.-++|+|.++++|+||||+|+++.- +.+.|+|||++...-...+ ....
T Consensus 102 nfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~l 181 (341)
T KOG1163|consen 102 NFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNL 181 (341)
T ss_pred HHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCcc
Confidence 444467999999999999999999999999999999999999963 6899999999986533221 2345
Q ss_pred cccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHH
Q 044127 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIY 199 (282)
Q Consensus 149 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~ 199 (282)
.||..|.|-.+..+.. -+.+.|+-|+|.++.+..-|..||.+........
T Consensus 182 tGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q 231 (341)
T KOG1163|consen 182 TGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ 231 (341)
T ss_pred ceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence 7889999988776544 6889999999999999999999998876554443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-23 Score=173.05 Aligned_cols=251 Identities=31% Similarity=0.525 Sum_probs=194.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||.+.+. ..+++|.+....... ....+.+|...+..+..+++++++.+.+......+++++++.++.+..
T Consensus 11 g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~ 87 (384)
T COG0515 11 GSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLED 87 (384)
T ss_pred CCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHH
Confidence 788999999887 778999998776655 367778899989999744489999999977777899999999877776
Q ss_pred HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C-cEEEeecCcccccCCCC-------CCCC
Q 044127 79 MKERAG--QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G-VIKIGDLGMVKEIDSSL-------PCTD 147 (282)
Q Consensus 79 ~~~~~~--~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~-~~~l~df~~~~~~~~~~-------~~~~ 147 (282)
+..... ..++......++.|++.++.++|+.+++|+|+||+||+++. + .++++|||.+....... ....
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 167 (384)
T COG0515 88 LLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167 (384)
T ss_pred HHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccc
Confidence 555543 26999999999999999999999999999999999999986 4 69999999987554332 2356
Q ss_pred ccccccccCchhhhcc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHHhCCC-CCCCccccccccc
Q 044127 148 YVTTRWYRAPEVLLLS--EIYGPEVDMWAMGAIMFEMLSFRILFPGKNS---ADQIYKICQVIGSP-TEDSWPLGIQLAS 221 (282)
Q Consensus 148 ~~~~~~~~aPE~~~~~--~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 221 (282)
..++..|.|||.+.+. ...+...|+||+|++++++++|..||..... .............+ ......
T Consensus 168 ~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 240 (384)
T COG0515 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS------- 240 (384)
T ss_pred cccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccC-------
Confidence 7889999999999863 4589999999999999999999999877764 33333333322211 000000
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
..........+.+++..++..+|..|.+..+...+++...
T Consensus 241 --------------~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 241 --------------PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred --------------ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 0000122367899999999999999999998888766544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=174.35 Aligned_cols=225 Identities=20% Similarity=0.304 Sum_probs=140.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCC---------CCCeeeeccccc---------c
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNN---------HPNIVKLRNLVK---------E 60 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~---------hp~i~~~~~~~~---------~ 60 (282)
|+++.||.+++.+||+.+++|++..... .....+..+|......+.. |-.++..++... .
T Consensus 23 g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~ 102 (288)
T PF14531_consen 23 GGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFER 102 (288)
T ss_dssp ETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEE
T ss_pred CCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceec
Confidence 6899999999999999999999865542 1223333333333322221 212333333321 1
Q ss_pred C---C-----cEEEEEecCCccHHHHHH---HhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C
Q 044127 61 H---E-----DVFIVFEYMESDLLKLMK---ERAGQ--NFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G 126 (282)
Q Consensus 61 ~---~-----~~~lv~e~~~~~~l~~~~---~~~~~--~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~ 126 (282)
. . ..+++|+-+.+++.+... ..... .+.......+..|++..+++||+.|++|+||+|+|++++. |
T Consensus 103 ~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G 182 (288)
T PF14531_consen 103 GPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDG 182 (288)
T ss_dssp CETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS
T ss_pred CCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCC
Confidence 1 1 347889988887665432 22111 1334555667789999999999999999999999999985 9
Q ss_pred cEEEeecCcccccCCCCCCCCccccccccCchhhhcc-------ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHH
Q 044127 127 VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS-------EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIY 199 (282)
Q Consensus 127 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~ 199 (282)
.++|+||+.+...+..... ...+..|.+||..... -.++.+.|.|+||+++|.|+++..||+.........
T Consensus 183 ~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~ 260 (288)
T PF14531_consen 183 GVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE 260 (288)
T ss_dssp -EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG
T ss_pred CEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc
Confidence 9999999988876655432 3445678999987532 236788999999999999999999998654322111
Q ss_pred HHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCC
Q 044127 200 KICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMR 261 (282)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 261 (282)
. ...... .+|+.++.||+++|+.||.+|
T Consensus 261 ~---------------------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 261 W---------------------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp G---------------------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred c---------------------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 0 111122 679999999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=170.29 Aligned_cols=229 Identities=17% Similarity=0.259 Sum_probs=173.8
Q ss_pred cceEEEEEecCCCcEEEEEEccccccchHH-HHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCC-ccHHHHHH
Q 044127 3 YGDVFQALDKKSGEFVAVKKLKKKIFSLDE-SRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYME-SDLLKLMK 80 (282)
Q Consensus 3 ~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~-~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~-~~~l~~~~ 80 (282)
.|+.|++++. |..+++|++.-...+... .++-.|.-.++.+ +||||+++++.+..+..+.++..||+ |+++..+.
T Consensus 203 sgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacnsppnlv~isq~mp~gslynvlh 279 (448)
T KOG0195|consen 203 SGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLH 279 (448)
T ss_pred Cccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccCCCCceEeeeeccchHHHHHHh
Confidence 4788999766 556788888766554443 3444555555555 69999999999999999999999999 55555555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeeCC---cEEEeecCcccccCCCCCCCCcccccccc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQG--YFHRDLKPSNLLVSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYR 155 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~--~~H~dl~p~nili~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 155 (282)
...+--++..++.+++.++++|++|||+.. |.--.|....|++|++ ++-+.|--++.. ......+|.|+
T Consensus 280 e~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq------e~gr~y~pawm 353 (448)
T KOG0195|consen 280 EQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------EVGRAYSPAWM 353 (448)
T ss_pred cCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee------ccccccCcccC
Confidence 555555788999999999999999999986 5555688999999863 555566444321 12334578899
Q ss_pred Cchhhhcccc--CCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 156 APEVLLLSEI--YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 156 aPE~~~~~~~--~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
|||.++.... .-.++|+|||++++|||.|...||....+++-..++.-..-
T Consensus 354 spealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl--------------------------- 406 (448)
T KOG0195|consen 354 SPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL--------------------------- 406 (448)
T ss_pred CHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc---------------------------
Confidence 9999974432 34678999999999999999999999888877665432110
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 268 (282)
-..++++.+..+..|++-|+..||.+||.++.++
T Consensus 407 -rv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 407 -RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -cccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1245678899999999999999999999998764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-26 Score=199.17 Aligned_cols=232 Identities=21% Similarity=0.324 Sum_probs=167.3
Q ss_pred cceEEEEEecCCCcEEEEEEccccccch---HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 3 YGDVFQALDKKSGEFVAVKKLKKKIFSL---DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 3 ~g~Vy~~~~~~~~~~v~vK~~~~~~~~~---~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|=+|.+|++.+ | .|++|++-+..-.. ...+.+.|++ ..+.++||++++.-+...+...|+|-+|...++.+.+
T Consensus 36 FlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylvRqyvkhnLyDRl 111 (1431)
T KOG1240|consen 36 FLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLVRQYVKHNLYDRL 111 (1431)
T ss_pred hhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHHHHHHhhhhhhhh
Confidence 34566776553 4 49999987765333 3344455555 3444699999999988888888999999999999887
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccccc--C--CCCCC----CCccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI--D--SSLPC----TDYVT 150 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~--~--~~~~~----~~~~~ 150 (282)
-.+ .-+..-+.+.|+.|++.||..+|..|++|||||.+|||++. +.+.|+||..-... + ++... .....
T Consensus 112 STR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrR 189 (1431)
T KOG1240|consen 112 STR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRR 189 (1431)
T ss_pred ccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCc
Confidence 665 35888999999999999999999999999999999999987 89999999865432 1 11111 12233
Q ss_pred cccccCchhhhcc----------ccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccc
Q 044127 151 TRWYRAPEVLLLS----------EIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQL 219 (282)
Q Consensus 151 ~~~~~aPE~~~~~----------~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (282)
-.+|.|||.|... ...+++.||||+||+++||++ |+.||+-.. +-....+.
T Consensus 190 RtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~-------------- 251 (1431)
T KOG1240|consen 190 RTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGN-------------- 251 (1431)
T ss_pred eeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccC--------------
Confidence 4569999998642 125778999999999999998 577775221 11111100
Q ss_pred cccCCccccCCCCCcc-cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 220 ASNLDWKFPQMGGVNL-RELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 220 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
.... ..+.+-.+..++++|..|++.||++|.++++.|+-
T Consensus 252 ------------~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ------------ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ------------ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000 01112235589999999999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=165.36 Aligned_cols=192 Identities=23% Similarity=0.330 Sum_probs=162.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|.||.++.|.+.-++++||||...... +.-+...|....+.+...++|...|-+..++.+-.+|+|.++.++- ++.
T Consensus 39 GsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLGPSLE-DLF 114 (449)
T KOG1165|consen 39 GSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLGPSLE-DLF 114 (449)
T ss_pred CcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhCcCHH-HHH
Confidence 899999999999999999999876532 3344556777788888899999999999999999999999877654 455
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC------CcEEEeecCcccccCCCCCC--------C
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK------GVIKIGDLGMVKEIDSSLPC--------T 146 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~------~~~~l~df~~~~~~~~~~~~--------~ 146 (282)
.-.+..|+..++..++.|++.-++++|++.++.|||||+|+||.. +.|.++|||+|.......+. .
T Consensus 115 D~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~K 194 (449)
T KOG1165|consen 115 DLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHK 194 (449)
T ss_pred HHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccc
Confidence 555678999999999999999999999999999999999999952 57999999999977544332 2
Q ss_pred CccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHH
Q 044127 147 DYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQ 197 (282)
Q Consensus 147 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~ 197 (282)
+..||.+|||-....+.+ -+.+.|+-|||-++++.+-|..||.+......
T Consensus 195 SLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn 244 (449)
T KOG1165|consen 195 SLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTN 244 (449)
T ss_pred ccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcch
Confidence 457899999999888666 69999999999999999999999987654443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.4e-24 Score=167.53 Aligned_cols=190 Identities=21% Similarity=0.310 Sum_probs=148.6
Q ss_pred hCCCCCeeeecccccc---------------------------CCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHH
Q 044127 45 MNNHPNIVKLRNLVKE---------------------------HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCF 97 (282)
Q Consensus 45 ~~~hp~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~ 97 (282)
+..||||+.+.+.|.+ +..+|+||..++.++...+-.+ ..+.....-++.
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~---~~s~r~~~~~la 348 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR---HRSYRTGRVILA 348 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC---CCchHHHHHHHH
Confidence 3469999999888732 4478999999999888877765 578888899999
Q ss_pred HHHHHHHHHHHcCccccCCCCCceeee---C--CcEEEeecCcccccC-------CCCCCCCccccccccCchhhhccc-
Q 044127 98 QVFQGLHYMHRQGYFHRDLKPSNLLVS---K--GVIKIGDLGMVKEID-------SSLPCTDYVTTRWYRAPEVLLLSE- 164 (282)
Q Consensus 98 qi~~~l~~Lh~~~~~H~dl~p~nili~---~--~~~~l~df~~~~~~~-------~~~~~~~~~~~~~~~aPE~~~~~~- 164 (282)
|+++|+.|||+.|+.|+|+|.+||++. | -.+++.|||++-.-+ ..+......|+...+|||+.....
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999999999999999999994 3 379999999865322 122223446777899999885321
Q ss_pred ----cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCC
Q 044127 165 ----IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240 (282)
Q Consensus 165 ----~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
..-.++|.|+.|-+.||+++-..||.....+.. ....+....++.++.
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L----------------------------~~r~Yqe~qLPalp~ 480 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL----------------------------DTRTYQESQLPALPS 480 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchhee----------------------------chhhhhhhhCCCCcc
Confidence 123589999999999999999999987432211 112245556778889
Q ss_pred CCChhhHHHHHHHhCCCCCCCCCHH
Q 044127 241 SASRESISLISRLCSWNPHMRPTAA 265 (282)
Q Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ 265 (282)
.+++.+++++..+|+.||++|++++
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCcc
Confidence 9999999999999999999999864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=159.93 Aligned_cols=136 Identities=25% Similarity=0.343 Sum_probs=102.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHH-------------------------HHHHHHHHHHHHhCCCCCeeeec
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE-------------------------SRNLKEVKCLRKMNNHPNIVKLR 55 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~-------------------------~~~~~e~~~l~~~~~hp~i~~~~ 55 (282)
|++|+||+|.+. +|+.||+|+++........ .....|...+.++. ++++....
T Consensus 8 G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~v~~p~ 85 (190)
T cd05147 8 GKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TAGIPCPE 85 (190)
T ss_pred ccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HCCCCCCc
Confidence 899999999987 8999999999764321111 11234888888885 66653333
Q ss_pred cccccCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHcCccccCCCCCceeeeCCcEEEeecC
Q 044127 56 NLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYM-HRQGYFHRDLKPSNLLVSKGVIKIGDLG 134 (282)
Q Consensus 56 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-h~~~~~H~dl~p~nili~~~~~~l~df~ 134 (282)
.+... ..++||||++|+.+....... ..++...+..++.|++.+|.++ |+.|++|+||||+||+++++.++|+|||
T Consensus 86 ~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~~~v~LiDFG 162 (190)
T cd05147 86 PILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHDGKLYIIDVS 162 (190)
T ss_pred EEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEECCcEEEEEcc
Confidence 22222 238999999987654332222 4799999999999999999999 7999999999999999999999999999
Q ss_pred cccccCC
Q 044127 135 MVKEIDS 141 (282)
Q Consensus 135 ~~~~~~~ 141 (282)
++...+.
T Consensus 163 ~a~~~~~ 169 (190)
T cd05147 163 QSVEHDH 169 (190)
T ss_pred ccccCCC
Confidence 9875443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-25 Score=185.72 Aligned_cols=237 Identities=30% Similarity=0.440 Sum_probs=188.5
Q ss_pred CCcceEEEEEe---cCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALD---KKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~---~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||.|++++. ...+..|++|+.++..... .......|..++....+||.++++.-.++.+...+++.++..|+.+
T Consensus 5 g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~l 84 (612)
T KOG0603|consen 5 GSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDL 84 (612)
T ss_pred CCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchh
Confidence 78888888753 2357779999887643321 1123345777777777799999999999999999999999987544
Q ss_pred -HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCccccccc
Q 044127 77 -KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWY 154 (282)
Q Consensus 77 -~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 154 (282)
...... ..+.+...+.....++-++.++|+.+++|+|+|++||+++ +|.+++.|||++...-... ..+|+..|
T Consensus 85 ft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---~~cgt~ey 159 (612)
T KOG0603|consen 85 FTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---IACGTYEY 159 (612)
T ss_pred hhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh---hcccchhh
Confidence 444333 4688888888999999999999999999999999999998 5899999999987654332 22899999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||++. .+..++|.||+|+++++|++|..||.. +....+....
T Consensus 160 mApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~----------------------------- 203 (612)
T KOG0603|consen 160 RAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE----------------------------- 203 (612)
T ss_pred hhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-----------------------------
Confidence 9999886 368999999999999999999999988 3333333311
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCH-----HHHhcCcccccccCc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTA-----AEALEHPFFRSCHFV 279 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~~~~~ 279 (282)
..++...+..+++++..++..+|..|... .++++|+||.++.+.
T Consensus 204 -~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 204 -LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred -cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 13445678899999999999999999854 799999999988765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=169.54 Aligned_cols=148 Identities=20% Similarity=0.235 Sum_probs=112.0
Q ss_pred CCcceEEEEEecC-CCcEEEEEEcccccc----chHHHHHHHHHHHHHHhCCCCCeee-eccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKK-SGEFVAVKKLKKKIF----SLDESRNLKEVKCLRKMNNHPNIVK-LRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~-~~~~v~vK~~~~~~~----~~~~~~~~~e~~~l~~~~~hp~i~~-~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|+||+||+|+++. ++..+|+|+...... ......+.+|+.++.++. |+|++. +++. +..++||||+.|+
T Consensus 29 G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~----~~~~LVmE~~~G~ 103 (365)
T PRK09188 29 DVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT----GKDGLVRGWTEGV 103 (365)
T ss_pred cCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc----CCcEEEEEccCCC
Confidence 8999999999876 677789998653311 123445778999999995 889874 5442 3579999999987
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCC-CCCceeeeC-CcEEEeecCcccccCCCCCC-------
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL-KPSNLLVSK-GVIKIGDLGMVKEIDSSLPC------- 145 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl-~p~nili~~-~~~~l~df~~~~~~~~~~~~------- 145 (282)
.|... . ... ...++.|+++||.+||+.|++|+|| ||+||+++. +.++|+|||++.........
T Consensus 104 ~L~~~-~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~ 175 (365)
T PRK09188 104 PLHLA-R----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYE 175 (365)
T ss_pred CHHHh-C----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhh
Confidence 77532 1 111 1467899999999999999999999 999999974 78999999999866443321
Q ss_pred --CCccccccccCchhhh
Q 044127 146 --TDYVTTRWYRAPEVLL 161 (282)
Q Consensus 146 --~~~~~~~~~~aPE~~~ 161 (282)
....+++.|.|||.+.
T Consensus 176 d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 176 DLRHLLKHKRTYAPDALT 193 (365)
T ss_pred hhhhhhccCccCCcccCC
Confidence 2335677789999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=181.41 Aligned_cols=210 Identities=32% Similarity=0.460 Sum_probs=155.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||-||.++|+.+.+.+|+|+=++.. +++. +......|.++ |.-.+. .
T Consensus 94 gAygavylvrh~~trqrfa~kiNkq~l-------ilRn---ilt~a~npfvv--------------------gDc~tl-l 142 (1205)
T KOG0606|consen 94 GAYGAVYLVRHKETRQRFAMKINKQNL-------ILRN---ILTFAGNPFVV--------------------GDCATL-L 142 (1205)
T ss_pred CCCCceeeeeccccccchhhcccccch-------hhhc---cccccCCccee--------------------chhhhh-c
Confidence 799999999999999999995432211 0100 11111233333 222222 2
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC----------------
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---------------- 143 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~---------------- 143 (282)
+.. ++++... +.+++|||+.||+|+|+||+|.+|.- |.+|++|||+........
T Consensus 143 k~~-g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef 213 (1205)
T KOG0606|consen 143 KNI-GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEF 213 (1205)
T ss_pred ccC-CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHh
Confidence 222 2455544 66899999999999999999999986 999999999876431111
Q ss_pred CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccC
Q 044127 144 PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL 223 (282)
Q Consensus 144 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
.....++++.|.|||++...+ |+...|.|++|+++|+.+.|..||.+..+++.+...+.-.....
T Consensus 214 ~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp-------------- 278 (1205)
T KOG0606|consen 214 QDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP-------------- 278 (1205)
T ss_pred hhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc--------------
Confidence 112458999999999998666 89999999999999999999999999999998887766332211
Q ss_pred CccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCC---CHHHHhcCcccccccC
Q 044127 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRP---TAAEALEHPFFRSCHF 278 (282)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp---s~~~ll~~~~~~~~~~ 278 (282)
+-....++++++++..+|+.+|..|. .+-++.+|+||+...|
T Consensus 279 -------------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 279 -------------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred -------------ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 12346789999999999999999998 4568889999998765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=150.81 Aligned_cols=135 Identities=24% Similarity=0.315 Sum_probs=103.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-------------------------HHHHHHHHHHHHHhCCCCCeeeec
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-------------------------ESRNLKEVKCLRKMNNHPNIVKLR 55 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-------------------------~~~~~~e~~~l~~~~~hp~i~~~~ 55 (282)
|++|+||+|.+. +|+.||+|+++....... ......|...+.++. ++++....
T Consensus 8 G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~ 85 (190)
T cd05145 8 GKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EAGVPVPE 85 (190)
T ss_pred CCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hCCCCCce
Confidence 899999999987 899999999886531100 111235777788885 77764433
Q ss_pred cccccCCcEEEEEecCCccHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeCCcEEEeec
Q 044127 56 NLVKEHEDVFIVFEYMESDLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSKGVIKIGDL 133 (282)
Q Consensus 56 ~~~~~~~~~~lv~e~~~~~~l-~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~~~~~l~df 133 (282)
.+... ..++||||++|+.+ ...... ..++...+..++.|++.++.++|+ .|++|+||||+||+++++.++|+||
T Consensus 86 ~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~~~~~~liDF 161 (190)
T cd05145 86 PILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYHDGKPYIIDV 161 (190)
T ss_pred EEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEECCCEEEEEc
Confidence 33322 24899999998633 332332 368899999999999999999999 9999999999999999899999999
Q ss_pred CcccccCC
Q 044127 134 GMVKEIDS 141 (282)
Q Consensus 134 ~~~~~~~~ 141 (282)
|++...+.
T Consensus 162 G~a~~~~~ 169 (190)
T cd05145 162 SQAVELDH 169 (190)
T ss_pred ccceecCC
Confidence 99876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=146.56 Aligned_cols=178 Identities=16% Similarity=0.148 Sum_probs=130.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH---HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD---ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~---~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||.+.. .+.+++.+.+........ ...+.+|+.+++++.++++++.++++ ...+++|||+.|..+.
T Consensus 13 ~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~ 86 (218)
T PRK12274 13 DTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMY 86 (218)
T ss_pred CCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHH
Confidence 78999998854 577888787776654322 22456899999999878889999886 3469999999987775
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCC-CCCceeee-CCcEEEeecCcccccCCCCCCC---------
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL-KPSNLLVS-KGVIKIGDLGMVKEIDSSLPCT--------- 146 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl-~p~nili~-~~~~~l~df~~~~~~~~~~~~~--------- 146 (282)
..... . ...++.|++.+|.++|++|++|+|| ||+||+++ ++.++|+|||++..........
T Consensus 87 ~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~ 158 (218)
T PRK12274 87 QRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLR 158 (218)
T ss_pred hhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHH
Confidence 32211 1 1357889999999999999999999 79999997 4789999999998655433210
Q ss_pred -----CccccccccCchhhhccccCC-CcchhHHHHHHHHHHHhCCCCCCCC
Q 044127 147 -----DYVTTRWYRAPEVLLLSEIYG-PEVDMWAMGAIMFEMLSFRILFPGK 192 (282)
Q Consensus 147 -----~~~~~~~~~aPE~~~~~~~~~-~~~DiwslG~ll~~l~~g~~~~~~~ 192 (282)
....++.+++|+....-...+ .+.+.++.|+.+|.++|++.+..+.
T Consensus 159 ~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 159 HLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 012356677776543221123 5668889999999999999887543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=152.05 Aligned_cols=160 Identities=17% Similarity=0.168 Sum_probs=117.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHH--H------HHHHHHHHHHhCCCCCeeeeccccccC--------CcE
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDES--R------NLKEVKCLRKMNNHPNIVKLRNLVKEH--------EDV 64 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~--~------~~~e~~~l~~~~~hp~i~~~~~~~~~~--------~~~ 64 (282)
|+||.||.+.. ++..+++|++.......... . +.+|+..+.++ .||+|..+.+++... +..
T Consensus 42 ~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~~~~~~~~~~~~~ 118 (232)
T PRK10359 42 IDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLLAERKTLRYAHTY 118 (232)
T ss_pred CCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeeecccccccccCCe
Confidence 78999999754 46679999997654332221 1 45788889999 499999998886532 358
Q ss_pred EEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccccCCCCC
Q 044127 65 FIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLP 144 (282)
Q Consensus 65 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~~~~~~~ 144 (282)
+++|||++|..+..+. .+++. ...+++.++..+|+.|++|+|++|+||+++.+.++++|||.........
T Consensus 119 ~lvmEyi~G~tL~~~~-----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~gi~liDfg~~~~~~e~~- 188 (232)
T PRK10359 119 IMLIEYIEGVELNDMP-----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNGLRIIDLSGKRCTAQRK- 188 (232)
T ss_pred EEEEEEECCccHHHhh-----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCCEEEEECCCcccccchh-
Confidence 9999999998776652 23332 4569999999999999999999999999986449999999876442211
Q ss_pred CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh
Q 044127 145 CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS 184 (282)
Q Consensus 145 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~ 184 (282)
|-+.+.....++.++|+||||+++.....
T Consensus 189 -----------a~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 189 -----------AKDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred -----------hHHHHHHHhHhcccccccceeEeehHHHH
Confidence 11112223346689999999998876654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=157.36 Aligned_cols=202 Identities=21% Similarity=0.290 Sum_probs=151.5
Q ss_pred CCCCeeeeccccccCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCc-cccCCCCCceeeeC
Q 044127 47 NHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY-FHRDLKPSNLLVSK 125 (282)
Q Consensus 47 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~-~H~dl~p~nili~~ 125 (282)
.|.|+.+++|.+.++...++|.++|..+++.+.+......++......++++|+.||.|+|+..+ .|+.+++.|+++|.
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~ 84 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDS 84 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeee
Confidence 49999999999999999999999999888888887766789999999999999999999998765 99999999999997
Q ss_pred -CcEEEeecCcccccCC---CCCCCCccccccccCchhhhccc------cCCCcchhHHHHHHHHHHHhCCCCCCCCCCh
Q 044127 126 -GVIKIGDLGMVKEIDS---SLPCTDYVTTRWYRAPEVLLLSE------IYGPEVDMWAMGAIMFEMLSFRILFPGKNSA 195 (282)
Q Consensus 126 -~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~------~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~ 195 (282)
-.+|++|||+...... ............|.|||.+.... ..+.+.|+||+|++++|+++...||......
T Consensus 85 ~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~ 164 (484)
T KOG1023|consen 85 RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLV 164 (484)
T ss_pred eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccccccc
Confidence 5899999999776542 11112223455699999986531 1467799999999999999999999764332
Q ss_pred HHHHHHHHHhCC-CCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh
Q 044127 196 DQIYKICQVIGS-PTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268 (282)
Q Consensus 196 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 268 (282)
....++...... ......| .+... ...++.+..+++.||..+|.+||+++++-
T Consensus 165 ~~~~eii~~~~~~~~~~~rP-------------------~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 165 EDPDEIILRVKKGGSNPFRP-------------------SIELL-NELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred CChHHHHHHHHhcCCCCcCc-------------------chhhh-hhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 221222222111 1000000 00001 14456899999999999999999998874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-21 Score=158.40 Aligned_cols=176 Identities=30% Similarity=0.431 Sum_probs=133.8
Q ss_pred CcEEEEEecCCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccc
Q 044127 62 EDVFIVFEYMESDLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE 138 (282)
Q Consensus 62 ~~~~lv~e~~~~~~l~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~ 138 (282)
.++||.|++|....+..++. ..+..-+......++.|++.|+.| +|.+|+|+||.||++.+ +.+++.|||+++.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 46899999999988888885 334567889999999999999999 99999999999999975 6799999999998
Q ss_pred cCCCC-------CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHhCCCCC
Q 044127 139 IDSSL-------PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTE 210 (282)
Q Consensus 139 ~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g-~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (282)
+.... ......++..|++||.+.+.. ++.++|||+||++++||+.. .-.++.....+ ....
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~----------d~r~ 474 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERIATLT----------DIRD 474 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHHHhhh----------hhhc
Confidence 76554 455678999999999998555 89999999999999999982 22221111111 0111
Q ss_pred CCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 211 DSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
..+| .....-.+.-..|++.|+.+.|.+||++.+.-.|.|.
T Consensus 475 g~ip----------------------~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 475 GIIP----------------------PEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CCCC----------------------hHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 1111 1111224456689999999999999988877777764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-19 Score=135.97 Aligned_cols=128 Identities=16% Similarity=0.231 Sum_probs=99.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhC----CCCCeeeeccccccCC---cEE-EEEecCC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN----NHPNIVKLRNLVKEHE---DVF-IVFEYME 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~----~hp~i~~~~~~~~~~~---~~~-lv~e~~~ 72 (282)
|++|.||. ++.++.. +||+..... ........+|+..++.+. .||||++++++++++. ..+ +|+||++
T Consensus 13 G~~~~Vy~--hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G 88 (210)
T PRK10345 13 GRHRKCYA--HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDG 88 (210)
T ss_pred CCceEEEE--CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCC
Confidence 89999995 7777766 689886543 224456788999999884 4899999999998763 433 7899954
Q ss_pred --ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHcCccccCCCCCceeeeC-----CcEEEeecCcc
Q 044127 73 --SDLLKLMKERAGQNFSEDEVRNLCFQVFQGL-HYMHRQGYFHRDLKPSNLLVSK-----GVIKIGDLGMV 136 (282)
Q Consensus 73 --~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l-~~Lh~~~~~H~dl~p~nili~~-----~~~~l~df~~~ 136 (282)
+++|..++... .+++. ..++.|++.++ +|||+++|+|+||||+||+++. ..++|+|++.+
T Consensus 89 ~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 89 KPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 66777777652 46666 36678888877 8999999999999999999963 37999995543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=141.43 Aligned_cols=136 Identities=24% Similarity=0.303 Sum_probs=102.0
Q ss_pred CCcceEEEEE-ecCCCcEEEEEEccccccch-----------------------HHHHHHHHHHHHHHhCC-CCCeeeec
Q 044127 1 GSYGDVFQAL-DKKSGEFVAVKKLKKKIFSL-----------------------DESRNLKEVKCLRKMNN-HPNIVKLR 55 (282)
Q Consensus 1 G~~g~Vy~~~-~~~~~~~v~vK~~~~~~~~~-----------------------~~~~~~~e~~~l~~~~~-hp~i~~~~ 55 (282)
|++|.||+|. +..+|..||+|+++...... .......|...+.++.. ...+..++
T Consensus 39 G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~ 118 (237)
T smart00090 39 GKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPI 118 (237)
T ss_pred CcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeee
Confidence 7899999998 67789999999987543110 01223568888888852 12334444
Q ss_pred cccccCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC-ccccCCCCCceeeeCCcEEEeecC
Q 044127 56 NLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG-YFHRDLKPSNLLVSKGVIKIGDLG 134 (282)
Q Consensus 56 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~-~~H~dl~p~nili~~~~~~l~df~ 134 (282)
+. . ..++||||++|..+....... ..+....+..++.||+.++.+||+.| ++|+||||+||+++++.++|+|||
T Consensus 119 ~~---~-~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~~~~i~LiDFg 193 (237)
T smart00090 119 AW---R-RNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVHDGKVVIIDVS 193 (237)
T ss_pred Ee---c-CceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEECCCEEEEECh
Confidence 32 2 358999999997665443222 35677778899999999999999999 999999999999998899999999
Q ss_pred cccccCC
Q 044127 135 MVKEIDS 141 (282)
Q Consensus 135 ~~~~~~~ 141 (282)
.+...+.
T Consensus 194 ~a~~~~~ 200 (237)
T smart00090 194 QSVELDH 200 (237)
T ss_pred hhhccCC
Confidence 8765443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=162.12 Aligned_cols=179 Identities=21% Similarity=0.294 Sum_probs=139.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhC--CCCCeeeeccccccCCcEEEEEecCC-ccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN--NHPNIVKLRNLVKEHEDVFIVFEYME-SDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~--~hp~i~~~~~~~~~~~~~~lv~e~~~-~~~l~ 77 (282)
|+||+||+|.+.. |+.||+|+-+.....+- .--.+++.+++ .-+.|..+...+.-.+..++|+||.+ |++++
T Consensus 709 g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf----YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld 783 (974)
T KOG1166|consen 709 GSYGSVYVATHSN-GKLVALKVEKPPNPWEF----YICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLD 783 (974)
T ss_pred ccceEEEEeecCC-CcEEEEEeecCCCceee----eehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHH
Confidence 8999999999877 99999999876654422 11223333332 23556666666666667889999998 55555
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--------CcEEEeecCccccc---CCCCCCC
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--------GVIKIGDLGMVKEI---DSSLPCT 146 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--------~~~~l~df~~~~~~---~~~~~~~ 146 (282)
... ..+.+++..+..+..|++..+++||..+|+||||||+|+++-. .-++|+|||.+..+ .......
T Consensus 784 ~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~ 861 (974)
T KOG1166|consen 784 LIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFK 861 (974)
T ss_pred hhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEe
Confidence 444 3467999999999999999999999999999999999999942 36999999999876 3334445
Q ss_pred CccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCC
Q 044127 147 DYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRI 187 (282)
Q Consensus 147 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~ 187 (282)
....+-.+-.+|... +++|+...|.|.|+-+++-|+.|++
T Consensus 862 ~~~~td~f~C~EM~~-grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 862 AVWHTDLFDCIEMRE-GRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeccccchhHHHhc-CCCCchhhhhHHHHHHHHHHHHHHH
Confidence 567788888999776 5669999999999999999999865
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-18 Score=133.49 Aligned_cols=130 Identities=22% Similarity=0.295 Sum_probs=104.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-------HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-------DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-------~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|++|.||+|.+ +|..+++|+........ ......+|...+..+. |+++.....++......+++|||++|
T Consensus 7 G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e~~~G 83 (211)
T PRK14879 7 GAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVMEYIEG 83 (211)
T ss_pred CceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEEEEeCC
Confidence 78999999976 57789999865432211 1234567888888885 88887766666667788999999998
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKE 138 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~ 138 (282)
..+..+.... .. ....++.+++.+|.++|+.|++|+|++|.||+++++.++++|||.+..
T Consensus 84 ~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~~~~~liDf~~a~~ 143 (211)
T PRK14879 84 EPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIYLIDFGLAEF 143 (211)
T ss_pred cCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEECCCEEEEECCcccC
Confidence 7777766542 12 888999999999999999999999999999999988999999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.1e-18 Score=130.40 Aligned_cols=127 Identities=21% Similarity=0.284 Sum_probs=97.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-------hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-------LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-------~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|++|.||+|.. ++..+++|........ .......+|...+..+. ++++.....++......+++|||++|
T Consensus 5 G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 5 GAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEEEECC
Confidence 88999999974 5778999986543211 11234567888888885 66654444444455567899999998
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKE 138 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~ 138 (282)
..+........ . .++.+++.+|.+||+.|++|+|++|.||+++++.++++|||++..
T Consensus 82 ~~l~~~~~~~~----~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~~~~~liDfg~a~~ 138 (199)
T TIGR03724 82 KPLKDVIEEGN----D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYLIDFGLGKY 138 (199)
T ss_pred ccHHHHHhhcH----H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEECCcEEEEECCCCcC
Confidence 77776654321 1 789999999999999999999999999999989999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.2e-18 Score=142.53 Aligned_cols=247 Identities=23% Similarity=0.239 Sum_probs=192.0
Q ss_pred CCcceEEEEEe--cCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALD--KKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~--~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|.+|.||.+.. ..++..+++|.-+..... .....-.+|+.....+..|++.++.+..++..+..++-+|.|+..+..
T Consensus 127 g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~~sl~~ 206 (524)
T KOG0601|consen 127 GSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCGESLQS 206 (524)
T ss_pred CCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccccchhHH
Confidence 78999999998 889999999985544332 233445678888888888999999999999999999999999977766
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCCCC-----
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQ----GLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCT----- 146 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~----~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~~~----- 146 (282)
...... ..++...++..+.+..+ ||.++|+.+++|.|++|+||+... ...+++|||++..+.......
T Consensus 207 ~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~ 285 (524)
T KOG0601|consen 207 YCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVS 285 (524)
T ss_pred hhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeee
Confidence 655543 35899999999999999 999999999999999999999964 589999999998876543221
Q ss_pred -CccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc
Q 044127 147 -DYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225 (282)
Q Consensus 147 -~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
...+...|++||+.. ..++..+|++++|.++.+..++..+..... ++.
T Consensus 286 ~r~~~~~~Y~~ke~~~--~l~~~~~di~sl~ev~l~~~l~~~~~~~g~-----------------------------~~~ 334 (524)
T KOG0601|consen 286 KRPEGDCIYAAKELLN--GLATFASDIFSLGEVILEAILGSHLPSVGK-----------------------------NSS 334 (524)
T ss_pred ecCCCCceEeChhhhc--cccchHhhhcchhhhhHhhHhhcccccCCC-----------------------------CCC
Confidence 225677799999875 447999999999999999998766554321 011
Q ss_pred cccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
+..........++-.+.+..+...+..|++.+|..|++++.++++++...-.++
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~ 388 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFV 388 (524)
T ss_pred ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhh
Confidence 111112222333444567777889999999999999999999999998765544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-19 Score=156.72 Aligned_cols=250 Identities=23% Similarity=0.302 Sum_probs=183.6
Q ss_pred CCcceEEEEEecC-CCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKK-SGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~-~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+|+.|-.+.... +...++.|.+....... .....-.|...-..+.+|+|++..++...+.+..++++++..|+.+-.
T Consensus 31 gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~ 110 (601)
T KOG0590|consen 31 GSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFS 110 (601)
T ss_pred cccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccccccc
Confidence 4555555554432 23345666554432111 112222355554555459999999999999999999999988766655
Q ss_pred HH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCceeeeC-C-cEEEeecCcccccCC-C---CCCCCccc
Q 044127 79 MK-ERAGQNFSEDEVRNLCFQVFQGLHYMH-RQGYFHRDLKPSNLLVSK-G-VIKIGDLGMVKEIDS-S---LPCTDYVT 150 (282)
Q Consensus 79 ~~-~~~~~~l~~~~~~~i~~qi~~~l~~Lh-~~~~~H~dl~p~nili~~-~-~~~l~df~~~~~~~~-~---~~~~~~~~ 150 (282)
.. .......+.......+.|+..++.|+| ..++.|+|++|+|.+++. + .+++.|||+|..... . ......+|
T Consensus 111 ~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g 190 (601)
T KOG0590|consen 111 KISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCG 190 (601)
T ss_pred ccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccC
Confidence 55 333226788889999999999999999 999999999999999985 5 799999999987654 2 22234467
Q ss_pred -cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 151 -TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 151 -~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++.|.|||...+.....+..|+||.|+++.-+++|..|+......+..+.-.. .
T Consensus 191 ~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~-------------------------~ 245 (601)
T KOG0590|consen 191 SSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK-------------------------S 245 (601)
T ss_pred CCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec-------------------------c
Confidence 99999999998666678899999999999999999999987665442211000 0
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
.....-...+...+....+++.+++..+|..|.+.+++-.++|+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0111122345677889999999999999999999999999999987
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=6e-17 Score=141.48 Aligned_cols=126 Identities=23% Similarity=0.221 Sum_probs=97.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccc-cc------hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKI-FS------LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~-~~------~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||+||++.+... .+++|+..... .. .....+.+|+..+..+. |++++....+.......+++|||+.|
T Consensus 344 G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~E~~~g 420 (535)
T PRK09605 344 GAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVDPEEKTIVMEYIGG 420 (535)
T ss_pred CCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEeCCCCEEEEEecCC
Confidence 89999999976543 34444322111 11 11234678999999985 89988877766666678999999998
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKE 138 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~ 138 (282)
+.+..... ....++.+++.+|.+||+.|++|+|+||+||+++++.++++|||++..
T Consensus 421 ~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~~~~~~liDFGla~~ 476 (535)
T PRK09605 421 KDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVRDDRLYLIDFGLGKY 476 (535)
T ss_pred CcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEECCcEEEEeCccccc
Confidence 87776554 346789999999999999999999999999999889999999999764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.6e-17 Score=124.35 Aligned_cols=128 Identities=24% Similarity=0.287 Sum_probs=94.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc---------------------hHHHHHHHHHHHHHHhCCCCC--eeeeccc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS---------------------LDESRNLKEVKCLRKMNNHPN--IVKLRNL 57 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~---------------------~~~~~~~~e~~~l~~~~~hp~--i~~~~~~ 57 (282)
|+||.||++.+. +|+.|++|++...... ........|...+..+. +++ +...++
T Consensus 26 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~v~~~~~- 102 (198)
T cd05144 26 GKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EEGFPVPKPID- 102 (198)
T ss_pred CcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-HcCCCCCceee-
Confidence 789999999875 7999999987643211 01112456777777774 553 344433
Q ss_pred cccCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcc
Q 044127 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMV 136 (282)
Q Consensus 58 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~ 136 (282)
....+++|||+.|..+..+.. ......++.+++.++.++|+.|++|+||+|+||+++ ++.++|+|||.+
T Consensus 103 ---~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~ 172 (198)
T cd05144 103 ---WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQM 172 (198)
T ss_pred ---cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCcc
Confidence 234589999999977754432 134567889999999999999999999999999998 589999999998
Q ss_pred cccCC
Q 044127 137 KEIDS 141 (282)
Q Consensus 137 ~~~~~ 141 (282)
.....
T Consensus 173 ~~~~~ 177 (198)
T cd05144 173 VSTDH 177 (198)
T ss_pred ccCCC
Confidence 65443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.1e-17 Score=122.66 Aligned_cols=129 Identities=29% Similarity=0.404 Sum_probs=90.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHH-H----------------------HHHHHHHHHhCCC-CCeeeecc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESR-N----------------------LKEVKCLRKMNNH-PNIVKLRN 56 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~-~----------------------~~e~~~l~~~~~h-p~i~~~~~ 56 (282)
|+||+||+|.+. ++..|++|++........... . ..|...+.++..+ -.+..+++
T Consensus 8 G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~ 86 (187)
T cd05119 8 GKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPID 86 (187)
T ss_pred ccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEe
Confidence 899999999977 789999999875432211111 0 2344444444311 12333333
Q ss_pred ccccCCcEEEEEecCCc-----cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeCCcEEE
Q 044127 57 LVKEHEDVFIVFEYMES-----DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSKGVIKI 130 (282)
Q Consensus 57 ~~~~~~~~~lv~e~~~~-----~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~~~~~l 130 (282)
. ...+++|||+++ ..+.... . ...+..++.+++.++.++|+ .|++|+||+|+||+++++.+++
T Consensus 87 ~----~~~~lv~e~~~g~~~~~~~l~~~~------~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~~~~~~l 155 (187)
T cd05119 87 L----NRHVLVMEFIGGDGIPAPRLKDVR------L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVDDGKVYI 155 (187)
T ss_pred c----CCCEEEEEEeCCCCccChhhhhhh------h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEECCcEEE
Confidence 2 235899999998 3332221 1 16788999999999999999 9999999999999999889999
Q ss_pred eecCcccccCC
Q 044127 131 GDLGMVKEIDS 141 (282)
Q Consensus 131 ~df~~~~~~~~ 141 (282)
+|||.+.....
T Consensus 156 iDfg~a~~~~~ 166 (187)
T cd05119 156 IDVPQAVEIDH 166 (187)
T ss_pred EECcccccccC
Confidence 99999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.2e-15 Score=119.34 Aligned_cols=129 Identities=17% Similarity=0.228 Sum_probs=94.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc------------chHHHHHHHHHHHHHHhCCCCCe--eeeccccccC-C---
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF------------SLDESRNLKEVKCLRKMNNHPNI--VKLRNLVKEH-E--- 62 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~------------~~~~~~~~~e~~~l~~~~~hp~i--~~~~~~~~~~-~--- 62 (282)
||.|+||.+... +..+++|.+..... ........+|+..+..+. |+++ +..+++.... .
T Consensus 43 ~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~~~~~~~ 119 (239)
T PRK01723 43 KGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVVRHGLFY 119 (239)
T ss_pred CCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeeeecCcce
Confidence 688999999654 77899998854211 122345577999999885 7664 5666653322 2
Q ss_pred cEEEEEecCCc-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccc
Q 044127 63 DVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE 138 (282)
Q Consensus 63 ~~~lv~e~~~~-~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~ 138 (282)
..++|||++.| ..+..++.. .++++.. +.+|+.+|.+||++|++|+||||+||+++. +.++|+|||.+..
T Consensus 120 ~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 120 RADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred eeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 23599999986 566655544 3466543 578999999999999999999999999984 6899999998654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.5e-15 Score=111.01 Aligned_cols=124 Identities=22% Similarity=0.256 Sum_probs=102.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCC-CCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNH-PNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~h-p~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|.++.||++.... ..+++|....... ...+..|...+..+.++ +++++++.+....+..++++||+.+..+..+
T Consensus 9 g~~~~v~~~~~~~--~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~ 83 (155)
T cd05120 9 GLTNRVYLLGTKD--EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV 83 (155)
T ss_pred ccccceEEEEecC--CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC
Confidence 7889999998653 6799999866532 45667788888888644 6888888888887889999999988655432
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CccccCCCCCceeeeC-CcEEEeecCccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQ---GYFHRDLKPSNLLVSK-GVIKIGDLGMVK 137 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~---~~~H~dl~p~nili~~-~~~~l~df~~~~ 137 (282)
+......++.+++++++.+|.. +++|+|++|+||++++ +.++++||+.+.
T Consensus 84 --------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 84 --------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred --------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 5667778899999999999985 6999999999999987 899999999865
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.6e-14 Score=119.47 Aligned_cols=169 Identities=21% Similarity=0.335 Sum_probs=125.2
Q ss_pred EE-EEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHHHhcC
Q 044127 6 VF-QALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMKERAG 84 (282)
Q Consensus 6 Vy-~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 84 (282)
+| .|..+.++.++.+..++.... .......+.++.++.++ ||+|+++++.++..+..|+|+|.+.. +....+
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk--- 99 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTERVRP--LETVLK--- 99 (690)
T ss_pred cccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEeecccc--HHHHHH---
Confidence 44 466778899999999887654 23344556677777785 99999999999999999999999875 122222
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccCchhhh
Q 044127 85 QNFSEDEVRNLCFQVFQGLHYMH-RQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRAPEVLL 161 (282)
Q Consensus 85 ~~l~~~~~~~i~~qi~~~l~~Lh-~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~ 161 (282)
.+....+...+.||+.||.||| +.+++|++|.-+.|+++. |..||++|..+........ .....---.|..|+.+.
T Consensus 100 -~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 100 -ELGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID 178 (690)
T ss_pred -HhHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcC
Confidence 2347788888999999999998 567999999999999985 8999999999865543321 11111222355665432
Q ss_pred ccccCCCcchhHHHHHHHHHHHhC
Q 044127 162 LSEIYGPEVDMWAMGAIMFEMLSF 185 (282)
Q Consensus 162 ~~~~~~~~~DiwslG~ll~~l~~g 185 (282)
.. .-..|.|.|||++++++.|
T Consensus 179 ~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc---ccchhhhhHHHHHHHHhCc
Confidence 11 1346999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-15 Score=118.66 Aligned_cols=201 Identities=23% Similarity=0.323 Sum_probs=135.2
Q ss_pred HHHhCCCCCeeeeccccccC-----CcEEEEEecCCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC--c
Q 044127 42 LRKMNNHPNIVKLRNLVKEH-----EDVFIVFEYMESDLLKLMKER---AGQNFSEDEVRNLCFQVFQGLHYMHRQG--Y 111 (282)
Q Consensus 42 l~~~~~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~--~ 111 (282)
+.++ -|.|+++++.++.+. ....+++|||.-+.+..++++ ..+.+......+|+.||++||.|||+.. +
T Consensus 121 llql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 121 LLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 3344 399999999998644 457899999997777666543 3456889999999999999999999986 9
Q ss_pred cccCCCCCceeeeC-CcEEEeecCcccccCC-----CCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhC
Q 044127 112 FHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-----SLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185 (282)
Q Consensus 112 ~H~dl~p~nili~~-~~~~l~df~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g 185 (282)
+|+++.-+.|++.. +-+|++.-........ ........+-+.|.|||.=. ....+.++|||++|+...++..+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHh
Confidence 99999999999975 5555543222111110 01112234466788888533 22357789999999999999887
Q ss_pred CCCCCCCC-ChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCH
Q 044127 186 RILFPGKN-SADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTA 264 (282)
Q Consensus 186 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 264 (282)
..--.... ....-..+.+.. .......-+.++.+|++..|..||++
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i---------------------------------~~len~lqr~~i~kcl~~eP~~rp~a 325 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVI---------------------------------IGLENGLQRGSITKCLEGEPNGRPDA 325 (458)
T ss_pred eeccCCCcceeehhhhhhhhe---------------------------------eeccCccccCcCcccccCCCCCCcch
Confidence 65432221 111111111100 00112234568899999999999999
Q ss_pred HHHhcCccccccc
Q 044127 265 AEALEHPFFRSCH 277 (282)
Q Consensus 265 ~~ll~~~~~~~~~ 277 (282)
.+++.||.+=.++
T Consensus 326 r~llfHpllfeVh 338 (458)
T KOG1266|consen 326 RLLLFHPLLFEVH 338 (458)
T ss_pred hhhhcCceeeecc
Confidence 9999999875554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1e-13 Score=103.81 Aligned_cols=135 Identities=19% Similarity=0.231 Sum_probs=95.5
Q ss_pred CCcceEEEEEecC------CCcEEEEEEccccccc---------------------hHHHH----HHHHHHHHHHhCCC-
Q 044127 1 GSYGDVFQALDKK------SGEFVAVKKLKKKIFS---------------------LDESR----NLKEVKCLRKMNNH- 48 (282)
Q Consensus 1 G~~g~Vy~~~~~~------~~~~v~vK~~~~~~~~---------------------~~~~~----~~~e~~~l~~~~~h- 48 (282)
|--+.||.|.... .+..+|+|+++..... ..... ..+|...|.++...
T Consensus 8 GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl~~~G 87 (197)
T cd05146 8 GKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRMQKAG 87 (197)
T ss_pred CcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHHHHcC
Confidence 5567899997543 3578999998633210 00111 12688888877532
Q ss_pred CCeeeeccccccCCcEEEEEecCCccHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHcCccccCCCCCceeeeCC
Q 044127 49 PNIVKLRNLVKEHEDVFIVFEYMESDLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYM-HRQGYFHRDLKPSNLLVSKG 126 (282)
Q Consensus 49 p~i~~~~~~~~~~~~~~lv~e~~~~~~l-~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L-h~~~~~H~dl~p~nili~~~ 126 (282)
-++..++++ ...++|||+++++.+ ...+.. ..++......+..+++.+|..| |+.|++|+||++.||+++++
T Consensus 88 v~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~~ 161 (197)
T cd05146 88 IPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHDG 161 (197)
T ss_pred CCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEECC
Confidence 355566654 356899999986422 222222 2466677788899999999998 89999999999999999999
Q ss_pred cEEEeecCcccccCC
Q 044127 127 VIKIGDLGMVKEIDS 141 (282)
Q Consensus 127 ~~~l~df~~~~~~~~ 141 (282)
.+.++||+.+...+.
T Consensus 162 ~v~iIDF~qav~~~h 176 (197)
T cd05146 162 KVWFIDVSQSVEPTH 176 (197)
T ss_pred cEEEEECCCceeCCC
Confidence 999999998876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.6e-14 Score=104.33 Aligned_cols=122 Identities=16% Similarity=0.076 Sum_probs=88.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|.++.||++... +..|++|+...... .......|...++.+.....+.+++.... ...++||||++|..+...
T Consensus 9 G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~- 81 (170)
T cd05151 9 GMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTE- 81 (170)
T ss_pred cccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccccc-
Confidence 667899999754 77899999865431 22345567888877753333445554433 235799999998765432
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCc-----cccCCCCCceeeeCCcEEEeecCccc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY-----FHRDLKPSNLLVSKGVIKIGDLGMVK 137 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~-----~H~dl~p~nili~~~~~~l~df~~~~ 137 (282)
......++.+++++|+.||+.++ +|+|++|.||+++++.++++||+.+.
T Consensus 82 --------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~liDf~~a~ 135 (170)
T cd05151 82 --------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLWLIDWEYAG 135 (170)
T ss_pred --------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEEEEeccccc
Confidence 01123456789999999999985 99999999999998899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-14 Score=121.70 Aligned_cols=238 Identities=21% Similarity=0.231 Sum_probs=173.4
Q ss_pred CCcceEEEEEec-CCCcEEEEEEccccccchHH-HHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDK-KSGEFVAVKKLKKKIFSLDE-SRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~-~~~~~v~vK~~~~~~~~~~~-~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|.|+.|+.+... .++..|++|...+....... ..-+.|+.+...+..|.+++.++..|...+..|+--|||.+.+...
T Consensus 276 ~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l 355 (524)
T KOG0601|consen 276 GNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSL 355 (524)
T ss_pred CccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhh
Confidence 456666666544 66778999988776554333 3346788888888889999999999988888899999998766654
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCCCCCcccccccc-
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR- 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~- 155 (282)
... ....+++...+++..|++.++.++|+..++|+|++|+||++.+ +..++.||+....+.... ......-.+.
T Consensus 356 ~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~--~~~~~~~r~~p 432 (524)
T KOG0601|consen 356 RSV-TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS--GVFHHIDRLYP 432 (524)
T ss_pred hhH-HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec--ccccccccccc
Confidence 442 2246899999999999999999999999999999999999986 789999999887533222 2222333344
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
..|.+.....+..+.|++|||.-+.+.+++...-......-.+. . ..
T Consensus 433 ~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~---~------------------------------~~ 479 (524)
T KOG0601|consen 433 IAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIR---S------------------------------GD 479 (524)
T ss_pred cchhhccccccccccccccccccccccccCcccCcccccceeee---c------------------------------cc
Confidence 35666656678999999999999999999876543221111000 0 00
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 274 (282)
..........+..+.+.+..+++..||++.++..|.-|.
T Consensus 480 ~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 480 TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 111223347888999999999999999999998876553
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.1e-13 Score=115.74 Aligned_cols=136 Identities=24% Similarity=0.303 Sum_probs=88.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH---------------------------------------HHHHHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD---------------------------------------ESRNLKEVKC 41 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~---------------------------------------~~~~~~e~~~ 41 (282)
|++|+||+|+.+ +|+.||||+.+......- +-++..|...
T Consensus 128 aSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n 206 (437)
T TIGR01982 128 ASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAAN 206 (437)
T ss_pred eehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHH
Confidence 688999999865 689999999864321100 0112334444
Q ss_pred HHHhC----CCCCeeeeccccccCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHHcCccccCC
Q 044127 42 LRKMN----NHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQ-GLHYMHRQGYFHRDL 116 (282)
Q Consensus 42 l~~~~----~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~-~l~~Lh~~~~~H~dl 116 (282)
+.++. +++++.-..-+.......+++|||+.|..+...........+ ...++.+++. .+..+|..|++|+|+
T Consensus 207 ~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~ 283 (437)
T TIGR01982 207 ASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADL 283 (437)
T ss_pred HHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCC
Confidence 44432 344432222222334457999999999777665443211222 3345555555 477889999999999
Q ss_pred CCCceeee-CCcEEEeecCcccccC
Q 044127 117 KPSNLLVS-KGVIKIGDLGMVKEID 140 (282)
Q Consensus 117 ~p~nili~-~~~~~l~df~~~~~~~ 140 (282)
+|.||+++ ++.++++|||++..++
T Consensus 284 hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 284 HPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CcccEEECCCCcEEEEeCCCeeECC
Confidence 99999997 4799999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.9e-14 Score=127.55 Aligned_cols=203 Identities=27% Similarity=0.350 Sum_probs=156.8
Q ss_pred CCCeeeeccccccCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CC
Q 044127 48 HPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KG 126 (282)
Q Consensus 48 hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~ 126 (282)
+|.++...-.+......++++++.+++.+...+...+ +.+.+.....+..+..++++||+..+.|+|++|.|.++. ++
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g 941 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG 941 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccC
Confidence 4555555555555667899999998766666666554 678888888888999999999999999999999999986 47
Q ss_pred cEEEeecCcccccCCC--------------------------------CCCCCccccccccCchhhhccccCCCcchhHH
Q 044127 127 VIKIGDLGMVKEIDSS--------------------------------LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174 (282)
Q Consensus 127 ~~~l~df~~~~~~~~~--------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diws 174 (282)
..++.||+.....+.. .......+++.|.+||...+.. ....+|.|+
T Consensus 942 h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~ 1020 (1205)
T KOG0606|consen 942 HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWS 1020 (1205)
T ss_pred CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhh
Confidence 8888888732211000 0112345788899999988555 789999999
Q ss_pred HHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHh
Q 044127 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLC 254 (282)
Q Consensus 175 lG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 254 (282)
+|+.+++.++|..||+...+......+.... ..++..+...+...++++...+
T Consensus 1021 ~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~---------------------------~~~p~g~~~~s~~aq~~~~~ll 1073 (1205)
T KOG0606|consen 1021 SGVCLFEVLTGIPPFNAETPQQIFENILNRD---------------------------IPWPEGPEEGSYEAQDLINRLL 1073 (1205)
T ss_pred hhhhhhhhhcCCCCCCCcchhhhhhccccCC---------------------------CCCCCCccccChhhhhhhhhhh
Confidence 9999999999999999988877775544321 1223344567889999999999
Q ss_pred CCCCCCCCCHH---HHhcCcccccccCc
Q 044127 255 SWNPHMRPTAA---EALEHPFFRSCHFV 279 (282)
Q Consensus 255 ~~dp~~Rps~~---~ll~~~~~~~~~~~ 279 (282)
..+|.+|..+. ++-.|+||+++.|-
T Consensus 1074 ~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1074 TEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred ccCchhccCcccccccccCCccCCCCcc
Confidence 99999999987 88999999998763
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.3e-12 Score=92.64 Aligned_cols=127 Identities=25% Similarity=0.271 Sum_probs=91.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccc-cccchHH------HHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDE------SRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~-~~~~~~~------~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+-+.+|.+... |.++++|.-.. .-..+.. ....+|..++.+.. --+|....=+..++....|+|||..|
T Consensus 7 GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~me~I~G 83 (204)
T COG3642 7 GAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVMEYIEG 83 (204)
T ss_pred CcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEEEEeCC
Confidence 667788888554 44577775332 2212222 23356888888775 33444444444566677899999999
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKE 138 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~ 138 (282)
..+...+... ...+++.+-.-+.-||.+||+||||.++||.+..+.+.++|||++..
T Consensus 84 ~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~~IDfGLg~~ 140 (204)
T COG3642 84 ELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIYFIDFGLGEF 140 (204)
T ss_pred hhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEEEEECCcccc
Confidence 9999777753 25567778888889999999999999999999999999999999753
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.9e-13 Score=114.43 Aligned_cols=134 Identities=26% Similarity=0.368 Sum_probs=84.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch---------------------------------------HHHHHHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL---------------------------------------DESRNLKEVKC 41 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~---------------------------------------~~~~~~~e~~~ 41 (282)
|++|+||+|+.+.+|+.||||+.+...... .+-++.+|...
T Consensus 130 aSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N 209 (537)
T PRK04750 130 ASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAAN 209 (537)
T ss_pred CCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHH
Confidence 789999999998889999999987542100 00112334433
Q ss_pred HHHhC---CCCCeeeeccccc-cCCcEEEEEecCCccHHHHHH--HhcCC---CCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 044127 42 LRKMN---NHPNIVKLRNLVK-EHEDVFIVFEYMESDLLKLMK--ERAGQ---NFSEDEVRNLCFQVFQGLHYMHRQGYF 112 (282)
Q Consensus 42 l~~~~---~hp~i~~~~~~~~-~~~~~~lv~e~~~~~~l~~~~--~~~~~---~l~~~~~~~i~~qi~~~l~~Lh~~~~~ 112 (282)
+.++. .+.+.+.+-.++. .....+++|||+.|..+.... ...+. .+.+..+..++.|++ ..|++
T Consensus 210 ~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~Gff 282 (537)
T PRK04750 210 ASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFF 282 (537)
T ss_pred HHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCee
Confidence 33332 1333333333332 244578999999987766532 22211 233444444444444 58999
Q ss_pred ccCCCCCceeeeC-C----cEEEeecCcccccCC
Q 044127 113 HRDLKPSNLLVSK-G----VIKIGDLGMVKEIDS 141 (282)
Q Consensus 113 H~dl~p~nili~~-~----~~~l~df~~~~~~~~ 141 (282)
|+|++|.||+++. + +++++|||.+..++.
T Consensus 283 HaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 283 HADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred eCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 9999999999974 5 899999999876643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.5e-11 Score=99.99 Aligned_cols=211 Identities=16% Similarity=0.227 Sum_probs=149.4
Q ss_pred ceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc----cCCcEEEEEecCC--ccHHH
Q 044127 4 GDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK----EHEDVFIVFEYME--SDLLK 77 (282)
Q Consensus 4 g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~----~~~~~~lv~e~~~--~~~l~ 77 (282)
.+.|++....+|..|++|.++..... .......-++.++++ .|+|++++.++|. ....+++|++|.+ +++.+
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeecccccc-CcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 47899999999999999998432211 111112235566677 4999999999986 3446899999987 46666
Q ss_pred HHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCC-cEEEeecCcccccCCCC
Q 044127 78 LMKERA-------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSL 143 (282)
Q Consensus 78 ~~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~-~~~l~df~~~~~~~~~~ 143 (282)
.+.... +...+++.+|.++.|+..||.++|+.|+...-|.|.+|+++.. +++++..|....+....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 553321 2347899999999999999999999999999999999999876 99999888755443322
Q ss_pred CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHHhCCCCCCCcccccccccc
Q 044127 144 PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKN-SADQIYKICQVIGSPTEDSWPLGIQLASN 222 (282)
Q Consensus 144 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (282)
.+ .+. -..+-|.-.||.+++.|.||..--...+ ......
T Consensus 448 -----------~~--~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~----------------------- 487 (655)
T KOG3741|consen 448 -----------TE--PLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHL----------------------- 487 (655)
T ss_pred -----------Cc--chh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHH-----------------------
Confidence 11 111 2345789999999999999865321111 111111
Q ss_pred CCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 223 LDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+-..++.+++++|.-....++.+ -++.+++.+
T Consensus 488 -------------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 488 -------------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -------------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1223367889999999888888886 678887754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.1e-13 Score=112.92 Aligned_cols=154 Identities=18% Similarity=0.266 Sum_probs=114.7
Q ss_pred HHHHHHHHHHHH-cCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC----------CCccccccccCchhhhccc
Q 044127 97 FQVFQGLHYMHR-QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC----------TDYVTTRWYRAPEVLLLSE 164 (282)
Q Consensus 97 ~qi~~~l~~Lh~-~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~aPE~~~~~~ 164 (282)
.+++.|+.++|. .++||++|.|++|.++. +..|+++|+++......... .-......|.|||.+.. .
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 355589999995 58999999999999986 78999999988765432111 01234566999999875 5
Q ss_pred cCCCcchhHHHHHHHHHHH-hCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCC
Q 044127 165 IYGPEVDMWAMGAIMFEML-SFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSAS 243 (282)
Q Consensus 165 ~~~~~~DiwslG~ll~~l~-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (282)
..+.++|++|+|+++|.+. .|+..+............... .+......+..++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~--------------------------~~~~~~~~s~~~p 238 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL--------------------------LNAGAFGYSNNLP 238 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc--------------------------cccccccccccCc
Confidence 5799999999999999999 566666555443333221111 1111123346789
Q ss_pred hhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 244 RESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 244 ~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
+++++=+.+++..++..||++..++..+||.+..
T Consensus 239 ~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 239 SELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred HHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 9999999999999999999999999999998764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.3e-11 Score=92.24 Aligned_cols=128 Identities=29% Similarity=0.408 Sum_probs=82.4
Q ss_pred eEEEEEecCCCcEEEEEEccccccc-------------------------hHHHHHHHHHHHHHHhCCC-CCeeeecccc
Q 044127 5 DVFQALDKKSGEFVAVKKLKKKIFS-------------------------LDESRNLKEVKCLRKMNNH-PNIVKLRNLV 58 (282)
Q Consensus 5 ~Vy~~~~~~~~~~v~vK~~~~~~~~-------------------------~~~~~~~~e~~~l~~~~~h-p~i~~~~~~~ 58 (282)
.||.|... +|..+|+|++...... .......+|...|.++... -++..++++-
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999764 4779999998642110 0112335688888888633 2456666542
Q ss_pred ccCCcEEEEEecCC--ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHcCccccCCCCCceeeeCCcEEEeecCc
Q 044127 59 KEHEDVFIVFEYME--SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHY-MHRQGYFHRDLKPSNLLVSKGVIKIGDLGM 135 (282)
Q Consensus 59 ~~~~~~~lv~e~~~--~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~-Lh~~~~~H~dl~p~nili~~~~~~l~df~~ 135 (282)
..+|||||++ |..+..+... .++......++.+++..+.. +|..|++|||+++.||+++++.+.++|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGKVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTCEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecceEEEEecCc
Confidence 3479999999 7555544442 22345567778888885555 679999999999999999999999999998
Q ss_pred ccccC
Q 044127 136 VKEID 140 (282)
Q Consensus 136 ~~~~~ 140 (282)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 76544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=6.9e-11 Score=85.60 Aligned_cols=136 Identities=18% Similarity=0.204 Sum_probs=93.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccc-cch------HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKI-FSL------DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~-~~~------~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+-+.|+++.+ .|+..+||.-.... ..+ .......|...+.++. --+|.-..-++.+...-.|.|||.+|
T Consensus 18 GAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i~ME~~~g 94 (229)
T KOG3087|consen 18 GAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQIYMEFIDG 94 (229)
T ss_pred cceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeEEEEeccc
Confidence 56677888854 48887888533211 111 2233456777777765 33554444455666677899999998
Q ss_pred --cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--C--cEEEeecCccccc
Q 044127 74 --DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--G--VIKIGDLGMVKEI 139 (282)
Q Consensus 74 --~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~--~~~l~df~~~~~~ 139 (282)
+.-+.+...............+++.|-+.+.-||.++++||||..+||++.. + .+.++|||++...
T Consensus 95 ~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 95 ASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred hhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 4444555444434444445889999999999999999999999999999953 3 4699999997643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.5e-10 Score=90.95 Aligned_cols=185 Identities=12% Similarity=0.128 Sum_probs=121.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccc------c-ccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL------V-KEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~------~-~~~~~~~lv~e~~~~ 73 (282)
|+-+.+|.. .+-+. -+.|++...... ... ..+..+.....||-+-.-+.+ . ....-..++|+..+|
T Consensus 22 Ggea~ly~l--~e~~d-~VAKIYh~Pppa-~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v~g 94 (637)
T COG4248 22 GGEADLYTL--GEVRD-QVAKIYHAPPPA-AQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKVSG 94 (637)
T ss_pred Cccceeeec--chhhc-hhheeecCCCch-HHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccCCC
Confidence 455566655 22233 345888765321 111 123334455556654331111 1 122237888998876
Q ss_pred --cHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCC
Q 044127 74 --DLLKLMKERA----GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCT 146 (282)
Q Consensus 74 --~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~ 146 (282)
.....+.... -.........++.+.++.+.+.||..|.+-||+.++|+++++ +.++|.|-..-....+.....
T Consensus 95 ~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~ 174 (637)
T COG4248 95 KEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHL 174 (637)
T ss_pred ccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccCCceEe
Confidence 2222221111 123778899999999999999999999999999999999975 789999877555444444445
Q ss_pred CccccccccCchhhhccc----cCCCcchhHHHHHHHHHHHhC-CCCCCCC
Q 044127 147 DYVTTRWYRAPEVLLLSE----IYGPEVDMWAMGAIMFEMLSF-RILFPGK 192 (282)
Q Consensus 147 ~~~~~~~~~aPE~~~~~~----~~~~~~DiwslG~ll~~l~~g-~~~~~~~ 192 (282)
-..+...|.+||.-.-+. --+...|.|.||+++++++.| +.||.+-
T Consensus 175 cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 175 CPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 567888999999753111 136778999999999999986 8999754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.3e-10 Score=89.09 Aligned_cols=123 Identities=16% Similarity=0.111 Sum_probs=85.8
Q ss_pred CCcEEEEEEccccccch----------HHHHHHHHHHHHHHhCCCCCe--eeecccccc-----CCcEEEEEecCCcc-H
Q 044127 14 SGEFVAVKKLKKKIFSL----------DESRNLKEVKCLRKMNNHPNI--VKLRNLVKE-----HEDVFIVFEYMESD-L 75 (282)
Q Consensus 14 ~~~~v~vK~~~~~~~~~----------~~~~~~~e~~~l~~~~~hp~i--~~~~~~~~~-----~~~~~lv~e~~~~~-~ 75 (282)
.|+.|.||......... ......+|...+.++. .-+| +.++++.+. ....++|||++++. +
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~s 122 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTIS 122 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCcc
Confidence 47789999775433111 1113567777777764 2222 233333322 23578999999985 5
Q ss_pred HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--------CcEEEeecCccc
Q 044127 76 LKLMKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--------GVIKIGDLGMVK 137 (282)
Q Consensus 76 l~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--------~~~~l~df~~~~ 137 (282)
+..+... ...+.+......++.+++..+..||+.|++|+|+++.||+++. ..+.++||+.+.
T Consensus 123 L~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 123 LEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 6555542 1235667888899999999999999999999999999999973 479999999764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-10 Score=90.51 Aligned_cols=134 Identities=19% Similarity=0.261 Sum_probs=94.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCC-CCeeeeccccccC---CcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNH-PNIVKLRNLVKEH---EDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~h-p~i~~~~~~~~~~---~~~~lv~e~~~~~~l 76 (282)
|..+.||++.... |+.+++|................|...+..+..+ ..+.+++.+.... +..+++||++.|..+
T Consensus 9 G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l 87 (223)
T cd05154 9 GQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVL 87 (223)
T ss_pred CccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEec
Confidence 6688999997643 5789999986643222344567788888888642 3456666666553 367899999998765
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHR------------------------------------------------ 108 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~------------------------------------------------ 108 (282)
...... ..+++.....++.+++.+|..||+
T Consensus 88 ~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (223)
T cd05154 88 RDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLE 165 (223)
T ss_pred CCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHH
Confidence 543221 246667777777777777777763
Q ss_pred --------cCccccCCCCCceeeeC--C-cEEEeecCccc
Q 044127 109 --------QGYFHRDLKPSNLLVSK--G-VIKIGDLGMVK 137 (282)
Q Consensus 109 --------~~~~H~dl~p~nili~~--~-~~~l~df~~~~ 137 (282)
..++|+|+.|.||+++. + .+.++||+.+.
T Consensus 166 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 166 AHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred hhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23689999999999987 3 57899999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.6e-09 Score=79.67 Aligned_cols=104 Identities=18% Similarity=0.257 Sum_probs=76.0
Q ss_pred HHHHHHHHHHHhCC-CCCeeeeccccccC----CcEEEEEecCCc-cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 044127 34 RNLKEVKCLRKMNN-HPNIVKLRNLVKEH----EDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMH 107 (282)
Q Consensus 34 ~~~~e~~~l~~~~~-hp~i~~~~~~~~~~----~~~~lv~e~~~~-~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh 107 (282)
...+|...+..+.. .-..+.++++.+.. ...++|+|.+++ ..+..+..... ..+......++.+++..+.-||
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHHH
Confidence 45567666666541 11234444444332 345899999987 45666666533 2778888999999999999999
Q ss_pred HcCccccCCCCCceeeeCC----cEEEeecCcccc
Q 044127 108 RQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKE 138 (282)
Q Consensus 108 ~~~~~H~dl~p~nili~~~----~~~l~df~~~~~ 138 (282)
++|++|+|+++.|||++.+ .+.++||+.+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999864 599999997653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.7e-08 Score=74.25 Aligned_cols=133 Identities=15% Similarity=0.162 Sum_probs=94.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-----chHHHHHHHHHHHHHHhC--CCCCeeeeccccc---c--CCcEEEEE
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-----SLDESRNLKEVKCLRKMN--NHPNIVKLRNLVK---E--HEDVFIVF 68 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-----~~~~~~~~~e~~~l~~~~--~hp~i~~~~~~~~---~--~~~~~lv~ 68 (282)
||.|.|+..... |+.|-+|.-..... .-....+.+|...+.++. +-| +..+. ++. . ...-+||+
T Consensus 29 gG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 29 NGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccc-eeeeeccCCceEEEEEE
Confidence 678889988544 44688897642211 124566788888888775 223 44444 322 1 22468999
Q ss_pred ecCCc-cHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCc--EEEeecCccc
Q 044127 69 EYMES-DLLKLMKERA-GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGV--IKIGDLGMVK 137 (282)
Q Consensus 69 e~~~~-~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~--~~l~df~~~~ 137 (282)
|-++| ..|..+.... -.+.+......++.+++..+.-||+.|+.|+|+.+.||+++ ++. +.++||.-+.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 98874 4455444432 23567888899999999999999999999999999999997 455 9999998654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.7e-08 Score=77.20 Aligned_cols=135 Identities=21% Similarity=0.275 Sum_probs=89.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHH-----------------------HHHHHHHHHHHHhC-CCCCeeeecc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE-----------------------SRNLKEVKCLRKMN-NHPNIVKLRN 56 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~-----------------------~~~~~e~~~l~~~~-~hp~i~~~~~ 56 (282)
|.-+.||+|.. .++..+|+|++......... .-..+|...|+++. .+-.+.+.++
T Consensus 59 GKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~ 137 (268)
T COG1718 59 GKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIA 137 (268)
T ss_pred CcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCcee
Confidence 44568999864 45889999999754322111 11123555555543 1233344444
Q ss_pred ccccCCcEEEEEecCCccH-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeCCcEEEeecC
Q 044127 57 LVKEHEDVFIVFEYMESDL-LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSKGVIKIGDLG 134 (282)
Q Consensus 57 ~~~~~~~~~lv~e~~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~~~~~l~df~ 134 (282)
+. ...++||+++..- -.-.++. .++.......+..++++.+.-|-. .++||+||+.-|||+.++.+.++|++
T Consensus 138 ~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~~p~iID~~ 211 (268)
T COG1718 138 FR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDGEPYIIDVS 211 (268)
T ss_pred ec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECCeEEEEECc
Confidence 33 3469999998541 1111111 234444678888899999999887 89999999999999999999999999
Q ss_pred cccccCCC
Q 044127 135 MVKEIDSS 142 (282)
Q Consensus 135 ~~~~~~~~ 142 (282)
.|...+++
T Consensus 212 QaV~~~hp 219 (268)
T COG1718 212 QAVTIDHP 219 (268)
T ss_pred cccccCCC
Confidence 98766543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=8.6e-08 Score=74.24 Aligned_cols=129 Identities=23% Similarity=0.294 Sum_probs=90.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc---------------------chHHHHHHHHHHHHHHhCCC-CCeeeecccc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF---------------------SLDESRNLKEVKCLRKMNNH-PNIVKLRNLV 58 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~---------------------~~~~~~~~~e~~~l~~~~~h-p~i~~~~~~~ 58 (282)
|.-|.||.|.+. .|.++++|.-+.... .-......+|...|.++... -.+.+.+++
T Consensus 102 GKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~- 179 (304)
T COG0478 102 GKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW- 179 (304)
T ss_pred CccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc-
Confidence 566899999876 588899996432110 01223445688888888422 135555543
Q ss_pred ccCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccc
Q 044127 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK 137 (282)
Q Consensus 59 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~ 137 (282)
+.-.+|||+..|..+... +++.+....++..|++-+..+-..|++|||+++-||++++ |.+.++||=.+.
T Consensus 180 ---nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 180 ---NRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred ---ccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcccc
Confidence 345799999998544321 2346667777788888888777999999999999999986 699999998765
Q ss_pred ccC
Q 044127 138 EID 140 (282)
Q Consensus 138 ~~~ 140 (282)
..+
T Consensus 251 ~~~ 253 (304)
T COG0478 251 PIS 253 (304)
T ss_pred cCC
Confidence 443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.7e-09 Score=92.37 Aligned_cols=238 Identities=14% Similarity=0.056 Sum_probs=159.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCC-eeeeccccccCCcEEEEEecCCcc-HHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPN-IVKLRNLVKEHEDVFIVFEYMESD-LLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~-i~~~~~~~~~~~~~~lv~e~~~~~-~l~~ 78 (282)
|+++.+++.+...+...+ .+.+... ....-++.+|.+. +||| .+..++-++.+...++.+++++++ +...
T Consensus 253 ~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~ 324 (829)
T KOG0576|consen 253 GALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKV-NNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL 324 (829)
T ss_pred HHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHc-cCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence 456677777655444433 5555433 2333467778888 5999 777777788888999999999865 2222
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
........+..-+...+.+.-+++++++|+.--+|+| ||+..++..+..+|+....+..........+++.++|||
T Consensus 325 ~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pe 400 (829)
T KOG0576|consen 325 EMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPE 400 (829)
T ss_pred cCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccccccccccCCcccCcccccccCCCCCCCCCch
Confidence 2222223466677778888888999999988778888 888888999999999988887766667788999999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
+...+. +...-|.|++|.-..++.-|-.|-... ........... +...+..-
T Consensus 401 v~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P----------------~~~~~~~g~~p-----------~s~~L~~~ 452 (829)
T KOG0576|consen 401 VIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSP----------------PAVLPMIGNGP-----------NSPMLTDK 452 (829)
T ss_pred hhcccc-cccCCCccCCCcchhhcCCCCCCCCCC----------------ccccCCCCCCC-----------Cccccchh
Confidence 987554 788999999998767776666654431 11111000000 00000000
Q ss_pred CCCCChhh-HHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 239 SPSASRES-ISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 239 ~~~~~~~~-~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
...+.-. .++...|+..-|..|+..-..+.|.+|++..+.
T Consensus 453 -~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~ 493 (829)
T KOG0576|consen 453 -SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLR 493 (829)
T ss_pred -hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCccc
Confidence 0011111 146778889999999999999999988877653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.80 E-value=6.5e-08 Score=73.24 Aligned_cols=117 Identities=19% Similarity=0.311 Sum_probs=73.4
Q ss_pred cCCCcEEEEEEccccccchHH--------HHHHHHHHHHHHhC--CCCCeeeeccc-----cccCCcEEEEEecCCccHH
Q 044127 12 KKSGEFVAVKKLKKKIFSLDE--------SRNLKEVKCLRKMN--NHPNIVKLRNL-----VKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 12 ~~~~~~v~vK~~~~~~~~~~~--------~~~~~e~~~l~~~~--~hp~i~~~~~~-----~~~~~~~~lv~e~~~~~~l 76 (282)
.-+|+.+++|........... ....+.+..+.++. +......++.+ +......+++|||++|..+
T Consensus 51 ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l 130 (229)
T PF06176_consen 51 EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVEL 130 (229)
T ss_pred EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeec
Confidence 445788999987654321111 01122333333332 12222222222 2233456789999999665
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVK 137 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~ 137 (282)
..... +++ .+...|.+++..+|+.|++|||..|.|++++++.++++|++...
T Consensus 131 ~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~i~iID~~~k~ 182 (229)
T PF06176_consen 131 NDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNGIRIIDTQGKR 182 (229)
T ss_pred ccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCcEEEEECcccc
Confidence 44322 233 24456778899999999999999999999999999999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.79 E-value=8.8e-08 Score=87.33 Aligned_cols=204 Identities=19% Similarity=0.207 Sum_probs=136.4
Q ss_pred HHHHHHHHHhCCCCCeeeeccccccCCcE----EEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 044127 36 LKEVKCLRKMNNHPNIVKLRNLVKEHEDV----FIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111 (282)
Q Consensus 36 ~~e~~~l~~~~~hp~i~~~~~~~~~~~~~----~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~ 111 (282)
..|...+.... |+|+..++.+..+.... .+..++|....+...++..+ .++..+.+.+..++.+|+.++|+...
T Consensus 230 E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 230 EIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 34666666774 99999999886544333 24457787655555555543 68999999999999999999999855
Q ss_pred cccCCCCCcee---ee-CCcEEEe--ecCcccccCCCCCCCCccccccccCchhhhcccc-CCCcchhHHHHHHHHHHHh
Q 044127 112 FHRDLKPSNLL---VS-KGVIKIG--DLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI-YGPEVDMWAMGAIMFEMLS 184 (282)
Q Consensus 112 ~H~dl~p~nil---i~-~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~DiwslG~ll~~l~~ 184 (282)
.|.-+..+... .+ ++.+..+ ||+.+...+..........+..+.++|....... .....|+|++|.+...+..
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~ 387 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQ 387 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhh
Confidence 44444443221 11 2345555 8888777665554455555666778887653321 2334799999999999998
Q ss_pred CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCH
Q 044127 185 FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTA 264 (282)
Q Consensus 185 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 264 (282)
|..+-........+. +........+.+.+|+..++++|+++
T Consensus 388 ~~~i~~~~~~~~~~l---------------------------------------~~~~~~~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 388 GEDISEKSAVPVSLL---------------------------------------DVLSTSELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred cCcccccccchhhhh---------------------------------------ccccchhhhhhhhhhcchhhhhccch
Confidence 765433221111110 01112267788999999999999999
Q ss_pred HHHhcCcccccccCcc
Q 044127 265 AEALEHPFFRSCHFVP 280 (282)
Q Consensus 265 ~~ll~~~~~~~~~~~~ 280 (282)
.+++.|+|.+.....+
T Consensus 429 ~~ll~~~f~~~~~~~~ 444 (1351)
T KOG1035|consen 429 LELLTHPFLRFPTDNE 444 (1351)
T ss_pred hhhhhchhcccccccc
Confidence 9999999998765544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.4e-07 Score=78.84 Aligned_cols=138 Identities=25% Similarity=0.371 Sum_probs=83.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHH---------------------------------------HHHHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE---------------------------------------SRNLKEVKC 41 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~---------------------------------------~~~~~e~~~ 41 (282)
++-|+||+|+.+. |+.||||+........-. -++.+|...
T Consensus 136 ASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n 214 (517)
T COG0661 136 ASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAAN 214 (517)
T ss_pred hhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHH
Confidence 3568999998765 999999998644211100 011123333
Q ss_pred HHHhC----CCCCeeeeccccccCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Q 044127 42 LRKMN----NHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117 (282)
Q Consensus 42 l~~~~----~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~ 117 (282)
+.++. +.|++.-..=+++-.+.-+++|||+.|.-+..........++...+...+.++. +..+-..|+.|.|..
T Consensus 215 ~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpH 292 (517)
T COG0661 215 AERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFFHADPH 292 (517)
T ss_pred HHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCccccCCC
Confidence 33222 233333222233445567899999999655554322223455444433332222 333444899999999
Q ss_pred CCceeeeC-CcEEEeecCcccccCC
Q 044127 118 PSNLLVSK-GVIKIGDLGMVKEIDS 141 (282)
Q Consensus 118 p~nili~~-~~~~l~df~~~~~~~~ 141 (282)
|.||+++. +++.+.|||....++.
T Consensus 293 pGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 293 PGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccceEEecCCcEEEEcCcceecCCH
Confidence 99999984 7999999999876544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.60 E-value=8.6e-07 Score=68.91 Aligned_cols=67 Identities=15% Similarity=0.193 Sum_probs=46.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCC-CeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHP-NIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp-~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|..+.||+. .+..+++|...... ......+|...+..+.... .+.+++++.+..+..+++||+++|.
T Consensus 12 G~t~~~y~~----~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 12 GGNGESYTH----KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred CCCcceeEe----cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 667789974 24467889886532 2334567888888775332 2566777777777788999999985
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.58 E-value=1e-06 Score=69.53 Aligned_cols=68 Identities=9% Similarity=0.030 Sum_probs=47.9
Q ss_pred ceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 4 GDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 4 g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
+.||++... +..+++|...... .....+|...+..+..+--+.+++++....+..++|||++.|..+.
T Consensus 13 ~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 13 ATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred CeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 678999643 4678889876542 2345568888877765545667777776666789999999986554
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.4e-06 Score=68.29 Aligned_cols=73 Identities=15% Similarity=0.204 Sum_probs=45.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCC-CCeeeecccc---ccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNH-PNIVKLRNLV---KEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~h-p~i~~~~~~~---~~~~~~~lv~e~~~~~~l 76 (282)
|..+.||.+.... ..+++|..... ........|...++.+..+ ..+..++... ......+++|+++.|..+
T Consensus 8 G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~ 82 (239)
T PF01636_consen 8 GFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPL 82 (239)
T ss_dssp SSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEH
T ss_pred CCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccc
Confidence 5567899997654 47999997654 3344555677776666533 2345555432 334457999999988644
Q ss_pred HH
Q 044127 77 KL 78 (282)
Q Consensus 77 ~~ 78 (282)
..
T Consensus 83 ~~ 84 (239)
T PF01636_consen 83 DD 84 (239)
T ss_dssp HH
T ss_pred cc
Confidence 44
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.38 E-value=3.8e-06 Score=77.62 Aligned_cols=75 Identities=19% Similarity=0.304 Sum_probs=50.7
Q ss_pred CCcceEEEEEecCCC--cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCe--eeeccccccC---CcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSG--EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNI--VKLRNLVKEH---EDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~--~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i--~~~~~~~~~~---~~~~lv~e~~~~ 73 (282)
|.++.+|.......+ ..+++|+............+.+|...++.+..|+++ .+++.++.+. +..|+|||+++|
T Consensus 49 G~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G 128 (822)
T PLN02876 49 GQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEG 128 (822)
T ss_pred CCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCC
Confidence 456688988655432 467888765543333345677899999888655554 6777776654 468899999988
Q ss_pred cH
Q 044127 74 DL 75 (282)
Q Consensus 74 ~~ 75 (282)
..
T Consensus 129 ~~ 130 (822)
T PLN02876 129 RI 130 (822)
T ss_pred cc
Confidence 53
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.4e-05 Score=58.23 Aligned_cols=122 Identities=21% Similarity=0.212 Sum_probs=84.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|.+|.||++.+. |..+++|+-..+ .....+..|.+++..+..----.+++.+-.+ ++.|||..|..+....
T Consensus 33 G~~s~Vyl~~~~--~~~~a~Kvrr~d---s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~ 103 (201)
T COG2112 33 GTTSVVYLGEWR--GGEVALKVRRRD---SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLE 103 (201)
T ss_pred ccccEEEEeecc--CceEEEEEecCC---cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhh
Confidence 788999999765 668999987664 3455666788888887644444566665444 3559999985554433
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCC--CceeeeCCcEEEeecCccccc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP--SNLLVSKGVIKIGDLGMVKEI 139 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p--~nili~~~~~~l~df~~~~~~ 139 (282)
.. .+ .+-+..+++..--|-..||-|+.|+- .||++.++.+.|+||..|+..
T Consensus 104 ~~----~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 104 IG----GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hc----cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 21 12 22334566666677788999999874 466667789999999988743
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.3e-05 Score=67.63 Aligned_cols=137 Identities=23% Similarity=0.313 Sum_probs=80.7
Q ss_pred CcceEEEEEecCCCcEEEEEEccccccch------------------------------------HHHHHHHHHHHHHHh
Q 044127 2 SYGDVFQALDKKSGEFVAVKKLKKKIFSL------------------------------------DESRNLKEVKCLRKM 45 (282)
Q Consensus 2 ~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~------------------------------------~~~~~~~e~~~l~~~ 45 (282)
+.|+||+|+.+. |+.||||+-+...... .+-++..|.+-..+.
T Consensus 173 SlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~ 251 (538)
T KOG1235|consen 173 SLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERF 251 (538)
T ss_pred chhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHH
Confidence 468999999776 9999999976432111 011122233332222
Q ss_pred C---CCCCe---eeecccc-ccCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCC
Q 044127 46 N---NHPNI---VKLRNLV-KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118 (282)
Q Consensus 46 ~---~hp~i---~~~~~~~-~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p 118 (282)
+ .|-+. +.+-.++ .-....+++||||+|.-++++..-....++...+..-+.++.. .-+=..|++|+|-.|
T Consensus 252 ~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHP 329 (538)
T KOG1235|consen 252 RENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGFFHADPHP 329 (538)
T ss_pred HHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCC
Confidence 1 23331 1122222 2334578999999984444333222235676654443333322 223346899999999
Q ss_pred Cceeee-----CCcEEEeecCcccccCC
Q 044127 119 SNLLVS-----KGVIKIGDLGMVKEIDS 141 (282)
Q Consensus 119 ~nili~-----~~~~~l~df~~~~~~~~ 141 (282)
.||++. +..+.+-|+|+...+..
T Consensus 330 GNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 330 GNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CcEEEecCCCCCccEEEEcccccccccH
Confidence 999998 35899999999776543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.6e-05 Score=63.26 Aligned_cols=131 Identities=15% Similarity=0.199 Sum_probs=72.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH--
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL-- 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~-- 78 (282)
|-.+.+|+.. .+++.+++|........- ......|...++.+..+.-..+++.... .++|+||+.|..+..
T Consensus 7 G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~ 79 (256)
T TIGR02721 7 GLTNRSWRIE--HPGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQ 79 (256)
T ss_pred cCcCCeEEEE--eCCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccccc
Confidence 4456899886 456778899865432111 1234567777777754322233333322 368999998754321
Q ss_pred ---------H----HHhc-----CCCCCH-HHHHHHHHHH---------HHHHHHHHH--------cCccccCCCCCcee
Q 044127 79 ---------M----KERA-----GQNFSE-DEVRNLCFQV---------FQGLHYMHR--------QGYFHRDLKPSNLL 122 (282)
Q Consensus 79 ---------~----~~~~-----~~~l~~-~~~~~i~~qi---------~~~l~~Lh~--------~~~~H~dl~p~nil 122 (282)
+ .+-+ +.+++. ..+.....++ ...+..+-. ..++|+|+.|.||+
T Consensus 80 ~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil 159 (256)
T TIGR02721 80 FVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLV 159 (256)
T ss_pred ccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEE
Confidence 1 0111 111221 1112221111 112222222 14899999999999
Q ss_pred eeCCcEEEeecCcccc
Q 044127 123 VSKGVIKIGDLGMVKE 138 (282)
Q Consensus 123 i~~~~~~l~df~~~~~ 138 (282)
++++.+.++||+.+..
T Consensus 160 ~~~~~~~lIDwE~a~~ 175 (256)
T TIGR02721 160 VTPQGLKLIDWEYASD 175 (256)
T ss_pred EeCCCCEEEeccccCc
Confidence 9986799999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.4e-05 Score=61.39 Aligned_cols=28 Identities=43% Similarity=0.758 Sum_probs=24.2
Q ss_pred CccccCCCCCceeeeCCcE-EEeecCccc
Q 044127 110 GYFHRDLKPSNLLVSKGVI-KIGDLGMVK 137 (282)
Q Consensus 110 ~~~H~dl~p~nili~~~~~-~l~df~~~~ 137 (282)
+++|+|+.|.||+++++.+ -++||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 4899999999999998765 599999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.13 E-value=5.7e-05 Score=59.27 Aligned_cols=69 Identities=14% Similarity=0.196 Sum_probs=40.6
Q ss_pred CCcceEEEEEecC-CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKK-SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|-...+|++.... +++.|++|+..... .......+|...+..+..+.-.++++..... .++|||+.|..
T Consensus 9 G~tN~~~~v~~~~~~~~~~vlR~~~~~~--~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~~ 78 (235)
T cd05157 9 GITNKLVKVSNKEDNQDAVLVRVYGNKT--ELIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGRT 78 (235)
T ss_pred cccceEEEEEcCCCCCCeEEEEEccCCc--cceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCCc
Confidence 3345899886443 35678999876432 1122334577777777533334455444332 48999988744
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.0004 Score=58.41 Aligned_cols=71 Identities=23% Similarity=0.259 Sum_probs=44.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccc------ccchHHHHHHHHHHHHHHhCCC--CCeeeeccccccCCcEEEEEecCC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKK------IFSLDESRNLKEVKCLRKMNNH--PNIVKLRNLVKEHEDVFIVFEYME 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~------~~~~~~~~~~~e~~~l~~~~~h--p~i~~~~~~~~~~~~~~lv~e~~~ 72 (282)
|.+..||++.....++.++||.-... ...........|...+..+..+ .++++++.+ +....++|||+++
T Consensus 37 Gn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME~L~ 114 (401)
T PRK09550 37 GNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVMEDLS 114 (401)
T ss_pred CceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEecCC
Confidence 56678999987644458999985421 1112233445567777665432 346666666 3355789999987
Q ss_pred c
Q 044127 73 S 73 (282)
Q Consensus 73 ~ 73 (282)
+
T Consensus 115 ~ 115 (401)
T PRK09550 115 D 115 (401)
T ss_pred C
Confidence 5
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.88 E-value=7.1e-05 Score=60.93 Aligned_cols=29 Identities=24% Similarity=0.266 Sum_probs=24.9
Q ss_pred cCccccCCCCCceeeeCCc-EEEeecCccc
Q 044127 109 QGYFHRDLKPSNLLVSKGV-IKIGDLGMVK 137 (282)
Q Consensus 109 ~~~~H~dl~p~nili~~~~-~~l~df~~~~ 137 (282)
.+++|+|+.|.||+++++. +.++||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 3699999999999999765 5799999765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.87 E-value=3.4e-05 Score=65.43 Aligned_cols=179 Identities=18% Similarity=0.275 Sum_probs=110.7
Q ss_pred chHHHHHHHHHHHHHHhCCCCCeeeeccccccC-CcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 044127 29 SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH-EDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMH 107 (282)
Q Consensus 29 ~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh 107 (282)
.....+.+.....++.+. |+|...++++-+.. ....+|+|++..++.+....+. +-.... +
T Consensus 23 t~~s~~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~---l~~~s~----------~---- 84 (725)
T KOG1093|consen 23 TPNSIQILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN---LKDESL----------L---- 84 (725)
T ss_pred CCcHHHHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhhccchHHHHHhcc---cchhhh----------c----
Confidence 345566777788888885 99999999886533 4588999999988877665542 111111 1
Q ss_pred HcCccccCCCCCceeeeCCcEEEeecCcccccCCCCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCC
Q 044127 108 RQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRI 187 (282)
Q Consensus 108 ~~~~~H~dl~p~nili~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~ 187 (282)
+|+=+ +- +.++.+| .++... | .+..+++||||+|.++.++.-|..
T Consensus 85 ----~~~~~-~~------~~~~~td-~~~t~~-----------------~------~~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 85 ----AHGVL-HL------NIIYITD-HFLTKY-----------------P------SPIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred ----ccccc-ee------hhhhccc-cccccC-----------------C------CCCCcchhhhhHHHHHHHHHHhhH
Confidence 22211 11 1223333 111100 0 012359999999999999999988
Q ss_pred CCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHH
Q 044127 188 LFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEA 267 (282)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 267 (282)
.+......+....+......+......... ..+-..+++....+...|+-..|..||...++
T Consensus 130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e------------------~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYTDDQELLSTAME------------------HLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHHHH------------------HHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 876665555554444433222211110000 01223467788999999999999999999999
Q ss_pred hcCcccccccC
Q 044127 268 LEHPFFRSCHF 278 (282)
Q Consensus 268 l~~~~~~~~~~ 278 (282)
..++-|..+-.
T Consensus 192 ~k~~i~~ev~~ 202 (725)
T KOG1093|consen 192 SKRCSFTEVYK 202 (725)
T ss_pred hcCccHHHHHh
Confidence 99998876543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00015 Score=59.16 Aligned_cols=136 Identities=23% Similarity=0.284 Sum_probs=88.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-----------------------hHHH--HHHHHHHHHHHhCCCCCeeeec
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-----------------------LDES--RNLKEVKCLRKMNNHPNIVKLR 55 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-----------------------~~~~--~~~~e~~~l~~~~~hp~i~~~~ 55 (282)
|--+.||.|. ..+|..+|||+++.+... .... ....|+.-|.++. .-+|.- -
T Consensus 155 GKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~aGIP~-P 231 (520)
T KOG2270|consen 155 GKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-NAGIPC-P 231 (520)
T ss_pred CccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-hcCCCC-C
Confidence 4456799997 456888999999754311 0111 1234555666663 222211 1
Q ss_pred cccccCCcEEEEEecCCccHHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeCCcEEEeec
Q 044127 56 NLVKEHEDVFIVFEYMESDLLK-LMKERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSKGVIKIGDL 133 (282)
Q Consensus 56 ~~~~~~~~~~lv~e~~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~~~~~l~df 133 (282)
.-..- ..-++||+++++.-+. -.+.. ..++...+..+-.|++.-+.-|.+ .++||.||+--|+|+.+|.+.++|.
T Consensus 232 ePIlL-k~hVLVM~FlGrdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~lyiIDV 308 (520)
T KOG2270|consen 232 EPILL-KNHVLVMEFLGRDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGKLYIIDV 308 (520)
T ss_pred Cceee-ecceEeeeeccCCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCEEEEEEc
Confidence 11111 2347999999853222 12222 357888888888888888887764 5899999999999999999999999
Q ss_pred CcccccCCC
Q 044127 134 GMVKEIDSS 142 (282)
Q Consensus 134 ~~~~~~~~~ 142 (282)
+.+...+.+
T Consensus 309 SQSVE~DHP 317 (520)
T KOG2270|consen 309 SQSVEHDHP 317 (520)
T ss_pred cccccCCCh
Confidence 987765544
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00018 Score=58.77 Aligned_cols=28 Identities=21% Similarity=0.370 Sum_probs=24.8
Q ss_pred CccccCCCCCceeeeC-----CcEEEeecCccc
Q 044127 110 GYFHRDLKPSNLLVSK-----GVIKIGDLGMVK 137 (282)
Q Consensus 110 ~~~H~dl~p~nili~~-----~~~~l~df~~~~ 137 (282)
.++|+|+.|.||++++ +.+.++||+.+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4899999999999975 789999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.0011 Score=54.58 Aligned_cols=29 Identities=24% Similarity=0.290 Sum_probs=25.3
Q ss_pred cCccccCCCCCceeeeCCcE-EEeecCccc
Q 044127 109 QGYFHRDLKPSNLLVSKGVI-KIGDLGMVK 137 (282)
Q Consensus 109 ~~~~H~dl~p~nili~~~~~-~l~df~~~~ 137 (282)
.+++|+|+.|+||+++++.+ -++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 37999999999999997765 799999865
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.0018 Score=49.04 Aligned_cols=122 Identities=18% Similarity=0.296 Sum_probs=77.6
Q ss_pred CcceEEEEEecCCCcEEEEEEccccc---------------cchHHHHHHHHHHHHHHhC-----CCCCeeeeccccccC
Q 044127 2 SYGDVFQALDKKSGEFVAVKKLKKKI---------------FSLDESRNLKEVKCLRKMN-----NHPNIVKLRNLVKEH 61 (282)
Q Consensus 2 ~~g~Vy~~~~~~~~~~v~vK~~~~~~---------------~~~~~~~~~~e~~~l~~~~-----~hp~i~~~~~~~~~~ 61 (282)
+.-.||.- +.+- ...||+..... ......+..+|+.....+. .+.+|.+++|+.+.+
T Consensus 13 ~~R~cy~H--P~dp-~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~ 89 (199)
T PF10707_consen 13 GERDCYQH--PDDP-NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETN 89 (199)
T ss_pred CCceEEEC--CCCC-CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecC
Confidence 33345543 4333 35688877654 0112334444555444442 477899999999999
Q ss_pred CcEEEEEecCC---c---cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC---C--cEEE
Q 044127 62 EDVFIVFEYME---S---DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK---G--VIKI 130 (282)
Q Consensus 62 ~~~~lv~e~~~---~---~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~---~--~~~l 130 (282)
....+|+|... | .++..+... ..+++ ...+ .+-+-..+|-+.+|+.+|++|+||++.. + .+++
T Consensus 90 ~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvl 163 (199)
T PF10707_consen 90 LGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVL 163 (199)
T ss_pred CceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEE
Confidence 99999999763 2 345555544 24655 3333 3444556778899999999999999953 2 5777
Q ss_pred ee
Q 044127 131 GD 132 (282)
Q Consensus 131 ~d 132 (282)
+|
T Consensus 164 ID 165 (199)
T PF10707_consen 164 ID 165 (199)
T ss_pred Ee
Confidence 77
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00021 Score=53.82 Aligned_cols=97 Identities=21% Similarity=0.240 Sum_probs=75.0
Q ss_pred HHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH----HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---c
Q 044127 37 KEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK----LMKERAGQNFSEDEVRNLCFQVFQGLHYMHR---Q 109 (282)
Q Consensus 37 ~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~----~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~---~ 109 (282)
.|..+++.+...+++++++|++-. ++++|+.+.+.+. .+.+. ..-++..+.+|+.++++.+.+|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 367777777766799999999844 5788998854221 11111 135799999999999999999998 3
Q ss_pred CccccCCCCCceeeeC-CcEEEeecCccccc
Q 044127 110 GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI 139 (282)
Q Consensus 110 ~~~H~dl~p~nili~~-~~~~l~df~~~~~~ 139 (282)
.+.-.|++|+|+-+++ +++|++|.+.+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 4888999999999986 69999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0014 Score=53.75 Aligned_cols=29 Identities=28% Similarity=0.370 Sum_probs=25.0
Q ss_pred cCccccCCCCCceeeeCCc-EEEeecCccc
Q 044127 109 QGYFHRDLKPSNLLVSKGV-IKIGDLGMVK 137 (282)
Q Consensus 109 ~~~~H~dl~p~nili~~~~-~~l~df~~~~ 137 (282)
.+++|+|+.+.||+++++. +.++||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5799999999999998755 5899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0014 Score=49.44 Aligned_cols=116 Identities=22% Similarity=0.239 Sum_probs=74.0
Q ss_pred CCc-ceEEEEEecCCCcEEEEEEccc---ccc-------c----------hHHHHHHHHHHHHHHhC--CCCCe--eeec
Q 044127 1 GSY-GDVFQALDKKSGEFVAVKKLKK---KIF-------S----------LDESRNLKEVKCLRKMN--NHPNI--VKLR 55 (282)
Q Consensus 1 G~~-g~Vy~~~~~~~~~~v~vK~~~~---~~~-------~----------~~~~~~~~e~~~l~~~~--~hp~i--~~~~ 55 (282)
|.- |.||++.- .|+.||+|++.. ... . .-...+..|....-++. ++.++ ++++
T Consensus 48 g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~ 125 (207)
T PF13095_consen 48 GSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCH 125 (207)
T ss_pred CCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEee
Confidence 445 78999954 478999999321 110 0 00123445655555554 34455 8888
Q ss_pred ccccc------------------CCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Q 044127 56 NLVKE------------------HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117 (282)
Q Consensus 56 ~~~~~------------------~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~ 117 (282)
|+..- .....||-||..... .+..+. +.+|++-+..+|..||+-+|++
T Consensus 126 Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~dl~~~~k~gI~~~Dv~ 191 (207)
T PF13095_consen 126 GYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLRDLKILHKLGIVPRDVK 191 (207)
T ss_pred EEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHHHHHHHHHCCeeeccCc
Confidence 88611 112467778776543 123333 4567888899999999999999
Q ss_pred CCceeeeCCcEEEeecCcc
Q 044127 118 PSNLLVSKGVIKIGDLGMV 136 (282)
Q Consensus 118 p~nili~~~~~~l~df~~~ 136 (282)
+.|.. .-+|+|||.+
T Consensus 192 ~~ny~----~G~lvDfs~~ 206 (207)
T PF13095_consen 192 PRNYR----GGKLVDFSSS 206 (207)
T ss_pred ccccc----CCEEEecccC
Confidence 99986 5788999864
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.001 Score=55.36 Aligned_cols=132 Identities=19% Similarity=0.189 Sum_probs=73.2
Q ss_pred CCcceEEEEEecC----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKK----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|-...+|++.... +++.|++|+..... ........|..+++.+..+.--.++++.+... .|++|+.+..+
T Consensus 47 GlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l 120 (344)
T PLN02236 47 AMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTL 120 (344)
T ss_pred cccceeEEEEeCCCCCCCCCeEEEEEccCCC--CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCC
Confidence 3445788886432 24679999886542 22233456777777776443345566666443 57888876433
Q ss_pred HHH---------------HHhcCC-------CCCHHHHHHHHHHHH-----------------HHHHHHH--------Hc
Q 044127 77 KLM---------------KERAGQ-------NFSEDEVRNLCFQVF-----------------QGLHYMH--------RQ 109 (282)
Q Consensus 77 ~~~---------------~~~~~~-------~l~~~~~~~i~~qi~-----------------~~l~~Lh--------~~ 109 (282)
... .+-+.. ......+..++.++. ..+..|. ..
T Consensus 121 ~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~ 200 (344)
T PLN02236 121 SAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEI 200 (344)
T ss_pred CHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCc
Confidence 210 001100 011223333332221 1111221 12
Q ss_pred CccccCCCCCceeeeC--CcEEEeecCcccc
Q 044127 110 GYFHRDLKPSNLLVSK--GVIKIGDLGMVKE 138 (282)
Q Consensus 110 ~~~H~dl~p~nili~~--~~~~l~df~~~~~ 138 (282)
.++|+|+++.||++++ +.+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 4899999999999975 5799999998653
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.002 Score=52.35 Aligned_cols=134 Identities=15% Similarity=0.192 Sum_probs=73.3
Q ss_pred eEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCC-CCeeeeccccccCC--cEEEEEecCCccHHHHH--
Q 044127 5 DVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNH-PNIVKLRNLVKEHE--DVFIVFEYMESDLLKLM-- 79 (282)
Q Consensus 5 ~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~h-p~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~~-- 79 (282)
.+|.... +++.+++..-.............+|...+..+... .-+...++.+.++. ..+.||+|+.|......
T Consensus 40 ~t~~~~~--~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGD--TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEec--CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 3454433 27778888332223344555666788888887431 22344455555544 67999999988321100
Q ss_pred --------HH---------hc----------CC--CCCHHHHHHHHHHH--------------HHHHHHHHHc-------
Q 044127 80 --------KE---------RA----------GQ--NFSEDEVRNLCFQV--------------FQGLHYMHRQ------- 109 (282)
Q Consensus 80 --------~~---------~~----------~~--~l~~~~~~~i~~qi--------------~~~l~~Lh~~------- 109 (282)
.. -+ +. .....++..+..+. ..-..+++.+
T Consensus 118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~ 197 (321)
T COG3173 118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP 197 (321)
T ss_pred cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence 00 00 00 01112222222222 1123333332
Q ss_pred -CccccCCCCCceeeeC-CcEEEeecCcccccC
Q 044127 110 -GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID 140 (282)
Q Consensus 110 -~~~H~dl~p~nili~~-~~~~l~df~~~~~~~ 140 (282)
.++|||+.+.|+++++ +-+-++||+++..-+
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 3899999999999986 458999999876543
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0022 Score=53.96 Aligned_cols=30 Identities=23% Similarity=0.125 Sum_probs=26.6
Q ss_pred cCccccCCCCCceeeeCCcEEEeecCcccc
Q 044127 109 QGYFHRDLKPSNLLVSKGVIKIGDLGMVKE 138 (282)
Q Consensus 109 ~~~~H~dl~p~nili~~~~~~l~df~~~~~ 138 (282)
...+|.|+-+.||+.+++.+.++||..|..
T Consensus 227 ~VfCHNDL~~gNIL~~~~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecCCCEEEEEeccccC
Confidence 457999999999999888999999998763
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00084 Score=55.49 Aligned_cols=29 Identities=24% Similarity=0.359 Sum_probs=25.0
Q ss_pred ccccCCCCCceeeeC--CcEEEeecCccccc
Q 044127 111 YFHRDLKPSNLLVSK--GVIKIGDLGMVKEI 139 (282)
Q Consensus 111 ~~H~dl~p~nili~~--~~~~l~df~~~~~~ 139 (282)
.+|+|+.+.||++++ +.++++||+.|...
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 799999999999963 67999999987643
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00052 Score=52.91 Aligned_cols=28 Identities=32% Similarity=0.633 Sum_probs=19.5
Q ss_pred CccccCCCCCceee--eCCcEEEeecCccc
Q 044127 110 GYFHRDLKPSNLLV--SKGVIKIGDLGMVK 137 (282)
Q Consensus 110 ~~~H~dl~p~nili--~~~~~~l~df~~~~ 137 (282)
-++|+|+.|.||++ .++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 38999999999999 57899999999764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0027 Score=51.02 Aligned_cols=27 Identities=26% Similarity=0.427 Sum_probs=23.4
Q ss_pred ccccCCCCCceeeeC-Cc-EEEeecCccc
Q 044127 111 YFHRDLKPSNLLVSK-GV-IKIGDLGMVK 137 (282)
Q Consensus 111 ~~H~dl~p~nili~~-~~-~~l~df~~~~ 137 (282)
++|+|+.|.||++++ +. .-++||+.+.
T Consensus 187 lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 187 LVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 899999999999987 65 5699999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0071 Score=50.06 Aligned_cols=28 Identities=25% Similarity=0.316 Sum_probs=25.2
Q ss_pred CccccCCCCCceeeeCCcEEEeecCccc
Q 044127 110 GYFHRDLKPSNLLVSKGVIKIGDLGMVK 137 (282)
Q Consensus 110 ~~~H~dl~p~nili~~~~~~l~df~~~~ 137 (282)
.++|||+.+.||+++++.++++|+..+.
T Consensus 193 ~llHGDl~~gNi~~~~~~~~~iD~e~~~ 220 (370)
T TIGR01767 193 TLLHGDLHSGSIFVSEHETKVIDPEFAF 220 (370)
T ss_pred eeeeccCCcccEEEcCCCCEEEcCcccc
Confidence 4899999999999998889999998764
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.018 Score=48.55 Aligned_cols=28 Identities=18% Similarity=0.285 Sum_probs=24.8
Q ss_pred CccccCCCCCceeeeCCcEEEeecCccc
Q 044127 110 GYFHRDLKPSNLLVSKGVIKIGDLGMVK 137 (282)
Q Consensus 110 ~~~H~dl~p~nili~~~~~~l~df~~~~ 137 (282)
.++|||+.|.||+++++..+++|..++.
T Consensus 231 ~L~HGDl~~g~i~~~~~~~~~id~ef~~ 258 (418)
T PLN02756 231 ALVHGDLHTGSVMVTPDSTQVIDPEFAF 258 (418)
T ss_pred ceeecCCCCCcEEEcCCCceEecchhhc
Confidence 4899999999999998889999987654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.031 Score=45.80 Aligned_cols=28 Identities=14% Similarity=0.025 Sum_probs=24.8
Q ss_pred CccccCCCCCceeeeC-CcEEEeecCccc
Q 044127 110 GYFHRDLKPSNLLVSK-GVIKIGDLGMVK 137 (282)
Q Consensus 110 ~~~H~dl~p~nili~~-~~~~l~df~~~~ 137 (282)
+++|+|+.++||++++ +.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 6999999999999975 689999999764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.01 Score=50.94 Aligned_cols=29 Identities=17% Similarity=0.358 Sum_probs=25.7
Q ss_pred CccccCCCCCceeeeCCcEEEeecCcccc
Q 044127 110 GYFHRDLKPSNLLVSKGVIKIGDLGMVKE 138 (282)
Q Consensus 110 ~~~H~dl~p~nili~~~~~~l~df~~~~~ 138 (282)
-++|+|+.+.||+.+++.++++||..|..
T Consensus 285 VfCHNDl~~~NiL~~~~~l~LIDfEYAg~ 313 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKCLRLIDFEYSGY 313 (442)
T ss_pred eEEeCCCCccceeecCCCEEEEeeccccc
Confidence 38999999999999888899999998753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0037 Score=51.34 Aligned_cols=105 Identities=12% Similarity=0.249 Sum_probs=71.4
Q ss_pred ccCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeeCCcEEEeecCccc
Q 044127 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSKGVIKIGDLGMVK 137 (282)
Q Consensus 59 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~~~~~~l~df~~~~ 137 (282)
.+..+.|++|++-++.+.-. +....+++..++++.+..+.-+..+ ..-|+++.-.||+|++|.|.|+||.+++
T Consensus 296 de~~y~yl~~kdhgt~is~i------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId~GnvtLIDfklsR 369 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILIDEGNVTLIDFKLSR 369 (488)
T ss_pred CCceEEEEEEecCCceeeee------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeeecCceEEEEeeeee
Confidence 45567788888776654321 1245788899999999988888865 5899999999999999999999999987
Q ss_pred ccCCCCCCCCccccccccCchhhhccccCCCcchhHHH
Q 044127 138 EIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175 (282)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Diwsl 175 (282)
..-. .....-..+--|-.+.+. -+..-+||-+
T Consensus 370 l~~~----q~~isy~rldhp~lF~G~--dd~QFeIYrl 401 (488)
T COG5072 370 LSYS----QGIISYNRLDHPDLFNGV--DDYQFEIYRL 401 (488)
T ss_pred cccC----CceeeccccCchhhhcCc--cceeeeHHHH
Confidence 3221 111112223334444422 2566677654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.012 Score=47.95 Aligned_cols=98 Identities=11% Similarity=0.078 Sum_probs=65.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCC--CCeeeecccccc---CCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNH--PNIVKLRNLVKE---HEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~h--p~i~~~~~~~~~---~~~~~lv~e~~~~~~ 75 (282)
|..+.||..... +..+++|..+. ......+..|...++.+..+ -.+.++++++.. .+..++|||++.|..
T Consensus 25 G~~~~vy~~~~~--~~~~~~k~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~ 99 (297)
T PRK10593 25 QPYAALWALYDS--QGNPMPLMARS---FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVS 99 (297)
T ss_pred ccceeEEEEEcC--CCCEEEEEecc---cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEe
Confidence 667889988532 23467787533 11234667788888887644 356777776643 466899999999865
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ 109 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~ 109 (282)
+... ..+......+..+++++|+.||+.
T Consensus 100 ~~~~------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 100 VEAP------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred cCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 5431 133455666778888999999975
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.026 Score=46.49 Aligned_cols=27 Identities=26% Similarity=0.370 Sum_probs=24.2
Q ss_pred ccccCCCCCceeeeCCc--EEEeecCccc
Q 044127 111 YFHRDLKPSNLLVSKGV--IKIGDLGMVK 137 (282)
Q Consensus 111 ~~H~dl~p~nili~~~~--~~l~df~~~~ 137 (282)
++|+|+.|+||+++.+. +.++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 89999999999999764 9999999764
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.02 Score=48.04 Aligned_cols=29 Identities=21% Similarity=0.265 Sum_probs=26.1
Q ss_pred CccccCCCCCceeeeCCcEEEeecCcccc
Q 044127 110 GYFHRDLKPSNLLVSKGVIKIGDLGMVKE 138 (282)
Q Consensus 110 ~~~H~dl~p~nili~~~~~~l~df~~~~~ 138 (282)
-++|||+.|.||+++++.+|++|..++..
T Consensus 228 aLlHGDlHtGSI~v~~~~~kvIDpEFAfy 256 (409)
T PRK12396 228 ALIHGDLHTGSVFVKNDSTKVIDPEFAFY 256 (409)
T ss_pred hhccCcCCCCCEEecCCceEEEccccccc
Confidence 38999999999999999999999887653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.058 Score=51.58 Aligned_cols=30 Identities=27% Similarity=0.339 Sum_probs=24.7
Q ss_pred cCccccCCCCCceeeeCC---cEE-EeecCcccc
Q 044127 109 QGYFHRDLKPSNLLVSKG---VIK-IGDLGMVKE 138 (282)
Q Consensus 109 ~~~~H~dl~p~nili~~~---~~~-l~df~~~~~ 138 (282)
.+++|+|+.++||+++.+ ++. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 469999999999999854 455 999997653
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.064 Score=42.95 Aligned_cols=29 Identities=31% Similarity=0.381 Sum_probs=26.4
Q ss_pred ccccCCCCCceeeeC-CcEEEeecCccccc
Q 044127 111 YFHRDLKPSNLLVSK-GVIKIGDLGMVKEI 139 (282)
Q Consensus 111 ~~H~dl~p~nili~~-~~~~l~df~~~~~~ 139 (282)
.+|+|+.|+|++.++ +.++|+||..|...
T Consensus 155 ~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~ 184 (269)
T COG0510 155 PCHNDLNPGNLLLTDKGGLFLIDWEYAGLN 184 (269)
T ss_pred eecCCCCccceEEcCCCcEEEEecccCCCc
Confidence 899999999999998 99999999987643
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.18 Score=41.67 Aligned_cols=28 Identities=25% Similarity=0.243 Sum_probs=23.8
Q ss_pred cCccccCCCCCceeeeCCcEEEeecCccc
Q 044127 109 QGYFHRDLKPSNLLVSKGVIKIGDLGMVK 137 (282)
Q Consensus 109 ~~~~H~dl~p~nili~~~~~~l~df~~~~ 137 (282)
.+++|+|+.+.||++++ .+.++||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWRD-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhccccC-CcEEEeCCCCC
Confidence 35899999999999965 68899999753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.034 Score=42.65 Aligned_cols=100 Identities=19% Similarity=0.315 Sum_probs=64.0
Q ss_pred EEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHH
Q 044127 18 VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCF 97 (282)
Q Consensus 18 v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~ 97 (282)
..+|++......-...-+..+..++.+. -+|+++.. .+...+.++.|.|...... .. .++.
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Arm---hGilrL~N--Dn~~~yGvIlE~Cy~~~i~----------~~----N~i~ 148 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARM---HGILRLKN--DNNYKYGVILERCYKIKIN----------FS----NFIT 148 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHh---hheeEeec--CCCceeEEEEeeccCcccc----------hh----HHHH
Confidence 4566665544443445556676666666 25666663 2455678999999652111 11 1111
Q ss_pred HHHHHHHHHHH--cCccccCCCCCceeeeC-CcEEEeecCcc
Q 044127 98 QVFQGLHYMHR--QGYFHRDLKPSNLLVSK-GVIKIGDLGMV 136 (282)
Q Consensus 98 qi~~~l~~Lh~--~~~~H~dl~p~nili~~-~~~~l~df~~~ 136 (282)
.=+.+|.-+|+ .+..|||..|+||+-|. |.+||.|-+..
T Consensus 149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 22456777884 46999999999999985 89999997753
|
The function of this family is unknown. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.036 Score=44.76 Aligned_cols=68 Identities=18% Similarity=0.247 Sum_probs=40.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhC--CCCCeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN--NHPNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~--~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|..+.+|... .+++.+.+|+-.. .....+..|...++.+. ..-.+.+++++....+..++++||++.+
T Consensus 28 G~i~~a~~~~--~~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 28 GDINEAYRLD--TDGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp SSSSEEEEEE--TTS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred CChhheEEEE--CCCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 5567788875 6688899998652 22344556777777773 3445677888776666779999998744
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.017 Score=47.33 Aligned_cols=29 Identities=21% Similarity=0.446 Sum_probs=25.8
Q ss_pred cCccccCCCCCceeeeCCcEEEeecCccc
Q 044127 109 QGYFHRDLKPSNLLVSKGVIKIGDLGMVK 137 (282)
Q Consensus 109 ~~~~H~dl~p~nili~~~~~~l~df~~~~ 137 (282)
.+++|||+.+.||+++++.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKDNEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeCCcEEEEECcccc
Confidence 46899999999999998889999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.0016 Score=62.64 Aligned_cols=152 Identities=14% Similarity=0.026 Sum_probs=101.5
Q ss_pred HHHHHHHHHhCCCCCeeeeccccc--cCCcEEEEEecCCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc-
Q 044127 36 LKEVKCLRKMNNHPNIVKLRNLVK--EHEDVFIVFEYMESDLLKLMKERAG---QNFSEDEVRNLCFQVFQGLHYMHRQ- 109 (282)
Q Consensus 36 ~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~Lh~~- 109 (282)
+.|....+.. .|+++...+.-.. +....+..++++.++.+...+-+.. ..++...+-....+...+..-.|+.
T Consensus 1277 l~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1277 LSERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3444434444 3888887776653 3446688889988655554443321 2344455555445546666666643
Q ss_pred --C--ccccCCCCCceeeeC-CcEEEeecCcccc-cCCCCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHH
Q 044127 110 --G--YFHRDLKPSNLLVSK-GVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEML 183 (282)
Q Consensus 110 --~--~~H~dl~p~nili~~-~~~~l~df~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~ 183 (282)
| -+|.++++-|.+|.. -.+++.++|+... ...........+++.|++|+....-. ++.++|+|..|+.+|.+.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHHHHh
Confidence 2 689999999999985 5799999999883 33333334556777788888765333 677799999999999998
Q ss_pred hCCCCC
Q 044127 184 SFRILF 189 (282)
Q Consensus 184 ~g~~~~ 189 (282)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 877665
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.013 Score=47.57 Aligned_cols=127 Identities=17% Similarity=0.253 Sum_probs=77.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc---------------------hHHHHHHHHHHHHHHhCCCCC-eeeecccc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS---------------------LDESRNLKEVKCLRKMNNHPN-IVKLRNLV 58 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~---------------------~~~~~~~~e~~~l~~~~~hp~-i~~~~~~~ 58 (282)
|.-+.||.+-+.. |.+.++|.-.....+ -+.-...+|..-++.+..|.. +.+.++
T Consensus 103 GKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkpiD-- 179 (465)
T KOG2268|consen 103 GKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVPKPID-- 179 (465)
T ss_pred ccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCCCccc--
Confidence 4557899997654 778888864321111 011122345555555543322 233333
Q ss_pred ccCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCccc
Q 044127 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVK 137 (282)
Q Consensus 59 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~ 137 (282)
.+.-++|||++.|-.+..... ......+...+..-+.-|-..|++|+|..-=||+++ ++.++++||=...
T Consensus 180 --~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 180 --HNRHCVVMELVDGYPLRQVRH-------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred --ccceeeHHHhhcccceeeeee-------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhh
Confidence 345679999888744332211 122233445566667788889999999999999998 5789999997654
Q ss_pred cc
Q 044127 138 EI 139 (282)
Q Consensus 138 ~~ 139 (282)
..
T Consensus 251 S~ 252 (465)
T KOG2268|consen 251 ST 252 (465)
T ss_pred cc
Confidence 43
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 282 | ||||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-49 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-49 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-49 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-49 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-49 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-49 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-49 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-49 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-49 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-49 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-49 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-49 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-49 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-49 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-49 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-49 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-49 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-49 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-49 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-49 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-49 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-49 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-49 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-49 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-49 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-49 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-49 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-49 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-48 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-48 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-48 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-48 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-48 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-48 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-48 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-47 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-47 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-46 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-46 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-46 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-46 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-46 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-46 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-45 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-45 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-45 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-45 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-45 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-45 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-45 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-45 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-45 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-45 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-45 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-45 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-45 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-45 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-45 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-45 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-44 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-44 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-44 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-44 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-43 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-43 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-43 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-43 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-43 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-43 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-43 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-43 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-43 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-43 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-43 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-43 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-42 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-42 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-42 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-42 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-42 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-42 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-42 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-42 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-42 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-42 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-42 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-42 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-42 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-42 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-42 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-42 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-42 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-42 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-42 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-42 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-42 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-42 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-42 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-42 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-42 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-42 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-42 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-42 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-42 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-42 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-42 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-42 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-42 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-42 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-42 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-42 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-42 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-42 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-42 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-42 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-42 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-42 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-42 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-42 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-42 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-42 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-42 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-42 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-41 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-41 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-41 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-41 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-41 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-41 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-41 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-41 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-41 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-41 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-40 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-40 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-40 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-40 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-40 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-40 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-40 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-40 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-40 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-39 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-39 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-39 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-38 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-38 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-38 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-37 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-37 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-37 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-37 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-37 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-37 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-37 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-37 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-37 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-36 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-36 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-36 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-36 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-36 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-36 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-36 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-36 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-36 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-36 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-36 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-36 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-36 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-35 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-35 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-35 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-34 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-34 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-34 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-34 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-34 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-34 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-34 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-34 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-34 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-34 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-34 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-34 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-34 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-34 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-34 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-34 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-33 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-33 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-33 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-33 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-33 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-33 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-33 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-33 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-33 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-33 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-33 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-32 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-32 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-32 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-32 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-32 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-32 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-32 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-32 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-32 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-32 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-31 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-31 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-31 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-31 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-31 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-28 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-27 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-26 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-25 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-25 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-25 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-25 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-25 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-25 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-24 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-24 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-24 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-24 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-24 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-22 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-22 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-22 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-22 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-22 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-21 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-21 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-21 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-21 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-21 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-21 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-21 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-21 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-21 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-21 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-21 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-21 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-21 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-21 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-21 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-21 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-21 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-21 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-21 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-21 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-21 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-21 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-21 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-21 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-21 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-21 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-21 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-21 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-21 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-21 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-21 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-21 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-21 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 9e-21 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-21 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-20 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-20 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-20 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-20 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-20 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-20 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-20 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-20 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-20 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-20 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-20 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-20 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-20 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-20 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-20 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-20 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-20 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-20 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-20 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-20 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-20 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-20 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-20 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-20 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-20 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-19 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-19 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-19 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-19 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-19 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-19 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-19 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-19 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-19 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-19 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-19 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-19 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-19 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-19 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-19 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-18 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-18 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-18 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-18 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-18 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-18 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-18 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-18 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-18 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-18 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-18 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-18 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-17 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-17 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-17 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-17 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-17 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-17 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-17 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-17 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-16 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-16 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-16 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-16 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-16 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-16 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-16 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-16 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-16 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-16 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-16 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-16 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-16 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-16 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-16 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-16 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-16 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-16 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-16 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-16 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-16 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-15 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-15 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-15 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-15 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-14 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-14 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-14 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-14 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-14 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-13 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-12 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-12 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-12 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-12 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-08 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 2e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-08 |
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 282 | |||
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-113 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-109 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-103 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-103 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-102 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-102 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-99 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-99 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-99 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 4e-99 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 7e-99 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 4e-98 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-94 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 9e-94 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-93 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-93 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-93 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-92 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-91 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-91 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-90 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 9e-90 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-89 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-88 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-87 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-87 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 6e-87 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 9e-87 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-86 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-66 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-63 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-61 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-61 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-60 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-59 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 5e-58 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-57 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-57 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-57 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-56 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-56 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-55 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-55 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-55 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-55 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-54 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-54 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-54 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 8e-54 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-53 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-53 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-53 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-53 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 7e-53 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-52 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-52 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-52 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 3e-52 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-52 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-52 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-52 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 6e-52 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 6e-52 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-51 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-51 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 5e-51 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 6e-51 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 7e-51 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 8e-51 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-50 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-50 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-50 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-50 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-50 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 5e-50 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 7e-50 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-49 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 4e-49 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 4e-49 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-49 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 9e-49 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-48 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-48 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-48 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-48 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-48 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 3e-48 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-48 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 3e-48 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 6e-48 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 9e-48 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-47 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 6e-47 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 7e-47 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-46 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 5e-46 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-44 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-43 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-43 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 6e-43 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-42 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-42 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 5e-42 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-41 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-41 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 4e-41 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-41 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-40 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 3e-40 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-39 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-39 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-39 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-39 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 6e-39 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-38 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-38 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-38 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-38 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 3e-38 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 5e-38 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-37 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 5e-37 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 7e-37 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 9e-37 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-36 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-36 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-36 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-36 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-36 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-36 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-36 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-36 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 4e-36 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 4e-36 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 5e-36 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 8e-36 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-35 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-35 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-35 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-35 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-35 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 5e-35 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 6e-35 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-34 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-34 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-34 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-34 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-34 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-34 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-34 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-34 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 4e-34 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 6e-34 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-33 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-33 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-33 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 4e-33 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 5e-33 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-32 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-31 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-31 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-30 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-30 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-30 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 4e-30 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-29 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-29 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-29 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-29 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-29 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 5e-29 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 6e-29 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 7e-29 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 7e-29 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 9e-29 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 9e-29 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-28 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-28 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 3e-28 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 4e-28 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 6e-28 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 6e-28 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 6e-28 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 7e-28 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 8e-28 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-27 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-27 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-27 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-27 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-27 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-27 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-27 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 6e-27 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 8e-27 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-26 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-26 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 9e-26 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 9e-26 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-25 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-25 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-25 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-25 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-25 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 5e-25 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 6e-25 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 7e-25 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 8e-25 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-24 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-24 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-24 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 4e-24 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-24 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 5e-24 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-23 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-23 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 4e-23 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-23 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-22 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-22 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-22 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-21 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-20 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 9e-17 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 1e-16 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 9e-16 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-15 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-15 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-14 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 6e-14 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-12 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-10 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 4e-10 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-09 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-06 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-04 |
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 327 bits (842), Expect = e-113
Identities = 86/285 (30%), Positives = 148/285 (51%), Gaps = 6/285 (2%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
GSYG VF+ ++ +G+ VA+KK + + + L+E++ L+++ HPN+V L + +
Sbjct: 14 GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEVFR 72
Query: 60 EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ +VFEY + +L + +R + E V+++ +Q Q +++ H+ HRD+KP
Sbjct: 73 RKRRLHLVFEYCDHTVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPE 131
Query: 120 NLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
N+L++K VIK+ D G + + D V TRWYR+PE+L+ YGP VD+WA+G
Sbjct: 132 NILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGC 191
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM-GGVNLR 236
+ E+LS L+PGK+ DQ+Y I + +G + K P L
Sbjct: 192 VFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLE 251
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPR 281
P+ S ++ L+ +P R T + L HP+F + +
Sbjct: 252 LKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 319 bits (819), Expect = e-109
Identities = 91/287 (31%), Positives = 143/287 (49%), Gaps = 10/287 (3%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE---SRNLKEVKCLRKMNNHPNIVKLRNL 57
GSYG V + +K +G VA+KK + D+ ++E+K L+++ H N+V L +
Sbjct: 36 GSYGMVMKCRNKDTGRIVAIKKFLES--DDDKMVKKIAMREIKLLKQLR-HENLVNLLEV 92
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
K+ + ++VFE+++ +L + E V+ FQ+ G+ + H HRD+K
Sbjct: 93 CKKKKRWYLVFEFVDHTILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIK 151
Query: 118 PSNLLVSK-GVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
P N+LVS+ GV+K+ D G + + + D V TRWYRAPE+L+ YG VD+WA+
Sbjct: 152 PENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAI 211
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG-GVN 234
G ++ EM LFPG + DQ+Y I +G+ L + + P++
Sbjct: 212 GCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREP 271
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPR 281
L P S I L + +P RP AE L H FF+ F R
Sbjct: 272 LERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAER 318
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = e-103
Identities = 97/297 (32%), Positives = 149/297 (50%), Gaps = 26/297 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN---------LKEVKCLRKMN--NHP 49
G+YG V++A D SG FVA+K ++ + ++EV LR++ HP
Sbjct: 20 GAYGTVYKARDPHSGHFVALKSVR-----VPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 50 NIVKLRNLV-----KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLH 104
N+V+L ++ V +VFE+++ DL + + + +++L Q +GL
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 105 YMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS 163
++H HRDLKP N+LV+ G +K+ D G+ + + T V T WYRAPEVLL S
Sbjct: 135 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQS 194
Query: 164 EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL 223
Y VDMW++G I EM + LF G + ADQ+ KI +IG P ED WP + L
Sbjct: 195 T-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP--- 250
Query: 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280
FP G ++ + P L+ + ++NPH R +A AL+H + P
Sbjct: 251 RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNP 307
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = e-102
Identities = 91/288 (31%), Positives = 151/288 (52%), Gaps = 19/288 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+G V+QA SGE VA+KK+ D+ +E++ +RK++ H NIV+LR
Sbjct: 65 GSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLD-HCNIVRLRYFFYS 118
Query: 61 HEDVF------IVFEYMESDLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ +V +Y+ + ++ + RA Q V+ +Q+F+ L Y+H G
Sbjct: 119 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 178
Query: 113 HRDLKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
HRD+KP NLL+ V+K+ D G K++ P Y+ +R+YRAPE++ + Y +
Sbjct: 179 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSI 238
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
D+W+ G ++ E+L + +FPG + DQ+ +I +V+G+PT + + ++KFPQ+
Sbjct: 239 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR--EMNPNYTEFKFPQI 296
Query: 231 GGVNLRE-LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+ P E+I+L SRL + P R T EA H FF
Sbjct: 297 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-102
Identities = 98/287 (34%), Positives = 162/287 (56%), Gaps = 22/287 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN------LKEVKCLRKMNNHPNIVKL 54
G + V++A DK + + VA+KK+K + E+++ L+E+K L++++ HPNI+ L
Sbjct: 21 GQFATVYKARDKNTNQIVAIKKIK--LGHRSEAKDGINRTALREIKLLQELS-HPNIIGL 77
Query: 55 RNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ ++ +VF++ME+DL ++K+ + ++ QGL Y+H+ HR
Sbjct: 78 LDAFGHKSNISLVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHR 136
Query: 115 DLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEV 170
DLKP+NLL+ GV+K+ D G+ K P Y V TRWYRAPE+L + +YG V
Sbjct: 137 DLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 194
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL-DWK-FP 228
DMWA+G I+ E+L PG + DQ+ +I + +G+PTE+ WP + +L D+ F
Sbjct: 195 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP-DM---CSLPDYVTFK 250
Query: 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
G+ L + +A + + LI L +NP R TA +AL+ +F +
Sbjct: 251 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 2e-99
Identities = 92/289 (31%), Positives = 161/289 (55%), Gaps = 27/289 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN------LKEVKCLRKMNNHPNIVKL 54
G+YG VF+A ++++ E VA+K+++ LD+ L+E+ L+++ H NIV+L
Sbjct: 13 GTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKELK-HKNIVRL 66
Query: 55 RNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+++ + + +VFE+ + DL K + + + V++ FQ+ +GL + H + HR
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 115 DLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEV 170
DLKP NLL++ G +K+ + G+ + +P Y V T WYR P+VL +++Y +
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 171 DMWAMGAIMFEMLSFRI-LFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL-DWK-F 227
DMW+ G I E+ + LFPG + DQ+ +I +++G+PTE+ WP + + L D+K +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP-SM---TKLPDYKPY 239
Query: 228 PQM-GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
P +L + P + L+ L NP R +A EAL+HP+F
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 2e-99
Identities = 87/285 (30%), Positives = 155/285 (54%), Gaps = 23/285 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN------LKEVKCLRKMNNHPNIVKL 54
G+YG V++A + GE A+KK++ L++ ++E+ L+++ H NIVKL
Sbjct: 13 GTYGVVYKAQNN-YGETFALKKIR-----LEKEDEGIPSTTIREISILKELK-HSNIVKL 65
Query: 55 RNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+++ + + +VFE+++ DL KL+ + ++ Q+ G+ Y H + HR
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 115 DLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEIYGPEVDM 172
DLKP NLL++ +G +KI D G+ + + T + T WYRAP+VL+ S+ Y +D+
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL-DWK--FPQ 229
W++G I EM++ LFPG + ADQ+ +I +++G+P +WP + + L + F
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP-NV---TELPKYDPNFTV 240
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+ I L+S++ +P+ R TA +ALEH +F+
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 3e-99
Identities = 90/288 (31%), Positives = 152/288 (52%), Gaps = 20/288 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+G VFQA +S E VA+KK+ D+ +E++ +R + HPN+V L+
Sbjct: 51 GSFGVVFQAKLVESDE-VAIKKVL-----QDKRFKNRELQIMRIVK-HPNVVDLKAFFYS 103
Query: 61 HE------DVFIVFEYMESDLLKLMK--ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ + +V EY+ + + + + Q ++ +Q+ + L Y+H G
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGIC 163
Query: 113 HRDLKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
HRD+KP NLL+ GV+K+ D G K + + P Y+ +R+YRAPE++ + Y +
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNI 223
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
D+W+ G +M E++ + LFPG++ DQ+ +I +V+G+P+ + + ++ KFPQ+
Sbjct: 224 DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK--TMNPNYMEHKFPQI 281
Query: 231 GGVNLRE-LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+ P ++I LISRL + P R TA EAL HPFF
Sbjct: 282 RPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 4e-99
Identities = 93/290 (32%), Positives = 158/290 (54%), Gaps = 28/290 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN------LKEVKCLRKMNNHPNIVKL 54
G+YG V++A D G VA+K+++ LD ++E+ L++++ HPNIV L
Sbjct: 32 GTYGVVYKAKDS-QGRIVALKRIR-----LDAEDEGIPSTAIREISLLKELH-HPNIVSL 84
Query: 55 RNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+++ + +VFE+ME DL K++ E + +++ +Q+ +G+ + H+ HR
Sbjct: 85 IDVIHSERCLTLVFEFMEKDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHR 143
Query: 115 DLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEV 170
DLKP NLL++ G +K+ D G+ + +P Y V T WYRAP+VL+ S+ Y V
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV 201
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL-DWK--- 226
D+W++G I EM++ + LFPG DQ+ KI ++G+P WP + L WK
Sbjct: 202 DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP-QV---QELPLWKQRT 257
Query: 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276
F + P +E I L+S + ++P+ R +A +A+ HP+F+
Sbjct: 258 FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 7e-99
Identities = 94/288 (32%), Positives = 161/288 (55%), Gaps = 26/288 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE-----SRNLKEVKCLRKMNNHPNIVKLR 55
G+Y V++ K + VA+K+++ L+ ++EV L+ + H NIV L
Sbjct: 13 GTYATVYKGKSKLTDNLVALKEIR-----LEHEEGAPCTAIREVSLLKDLK-HANIVTLH 66
Query: 56 NLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+++ + + +VFEY++ DL + + + G + V+ FQ+ +GL Y HRQ HRD
Sbjct: 67 DIIHTEKSLTLVFEYLDKDLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRD 125
Query: 116 LKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYGPEVD 171
LKP NLL++ +G +K+ D G+ + S+P Y V T WYR P++LL S Y ++D
Sbjct: 126 LKPQNLLINERGELKLADFGLARAK--SIPTKTYDNEVVTLWYRPPDILLGSTDYSTQID 183
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL-DWK---F 227
MW +G I +EM + R LFPG +Q++ I +++G+PTE++WP GI + ++K +
Sbjct: 184 MWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP-GI---LSNEEFKTYNY 239
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
P+ L +P + L+++L + R +A +A++HPFF S
Sbjct: 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS 287
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 4e-98
Identities = 93/290 (32%), Positives = 147/290 (50%), Gaps = 24/290 (8%)
Query: 1 GSYGDVFQALDKKS-GEFVAVKKLKKKIFSLDESRN------LKEVKCLRKMN--NHPNI 51
G+YG VF+A D K+ G FVA+K+++ + ++EV LR + HPN+
Sbjct: 22 GAYGKVFKARDLKNGGRFVALKRVR-----VQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 52 VKLRNLV-----KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYM 106
V+L ++ + +VFE+++ DL + + + ++++ FQ+ +GL ++
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 107 HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI 165
H HRDLKP N+LV+ G IK+ D G+ + + T V T WYRAPEVLL S
Sbjct: 137 HSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS- 195
Query: 166 YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225
Y VD+W++G I EM + LF G + DQ+ KI VIG P E+ WP + L
Sbjct: 196 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP---RQ 252
Query: 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
F + + L+ + ++NP R +A AL HP+F+
Sbjct: 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 3e-97
Identities = 99/299 (33%), Positives = 167/299 (55%), Gaps = 33/299 (11%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN------LKEVKCLRKMNNHPNIVKL 54
G+YG+V++A+D + E VA+K+++ L+ ++EV L+++ H NI++L
Sbjct: 45 GTYGEVYKAIDTVTNETVAIKRIR-----LEHEEEGVPGTAIREVSLLKELQ-HRNIIEL 98
Query: 55 RNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
++++ + + ++FEY E+DL K M + S +++ +Q+ G+++ H + HR
Sbjct: 99 KSVIHHNHRLHLIFEYAENDLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHR 156
Query: 115 DLKPSNLLVS------KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEI 165
DLKP NLL+S V+KIGD G+ + +P + + T WYR PE+LL S
Sbjct: 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEILLGSRH 214
Query: 166 YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL-D 224
Y VD+W++ I EML LFPG + DQ++KI +V+G P + +WP G+ + L D
Sbjct: 215 YSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP-GV---TALPD 270
Query: 225 WK--FPQMGGVNLRELSPSA-SRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280
WK FP+ G L+ + + E + L++ + +P R +A ALEHP+F F P
Sbjct: 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 4e-97
Identities = 94/296 (31%), Positives = 161/296 (54%), Gaps = 33/296 (11%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE-----SRNLKEVKCLRKMNNHPNIVKLR 55
G+Y V++ L+K +G +VA+K++K LD S ++E+ ++++ H NIV+L
Sbjct: 16 GTYATVYKGLNKTTGVYVALKEVK-----LDSEEGTPSTAIREISLMKELK-HENIVRLY 69
Query: 56 NLVKEHEDVFIVFEYMESDLLKLMKERA----GQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
+++ + +VFE+M++DL K M R + + V+ +Q+ QGL + H
Sbjct: 70 DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKI 129
Query: 112 FHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDY---VTTRWYRAPEVLLLSEIYG 167
HRDLKP NLL++ +G +K+GD G+ + +P + V T WYRAP+VL+ S Y
Sbjct: 130 LHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDVLMGSRTYS 187
Query: 168 PEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL-DWK 226
+D+W+ G I+ EM++ + LFPG N +Q+ I ++G+P E WP + + L +
Sbjct: 188 TSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP-SV---TKLPKYN 243
Query: 227 --FPQMGGVNLRELSPSASRESIS-----LISRLCSWNPHMRPTAAEALEHPFFRS 275
Q +LR++ ++E + + L NP MR +A +AL HP+F
Sbjct: 244 PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 2e-94
Identities = 106/287 (36%), Positives = 160/287 (55%), Gaps = 18/287 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G+YG V A+DK+SGE VA+KKL + F + R +E+ L+ M H N++ L ++
Sbjct: 35 GAYGSVCSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVF 92
Query: 59 K------EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
D ++V +M++DL K+M FSE++++ L +Q+ +GL Y+H G
Sbjct: 93 TPASSLRNFYDFYLVMPFMQTDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 113 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
HRDLKP NL V +KI D G+ + D+ + T YV TRWYRAPEV+L Y VD
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVVTRWYRAPEVILSWMHYNQTVD 206
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP-LGIQLASNLDWKFPQM 230
+W++G IM EML+ + LF GK+ DQ+ +I +V G P + L + A + PQ
Sbjct: 207 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT 266
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+ +L P AS ++ L+ ++ + R TAA+AL HPFF
Sbjct: 267 PRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 9e-94
Identities = 97/298 (32%), Positives = 155/298 (52%), Gaps = 27/298 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G+YG V A K +GE VA+KK++ F L R L+E+K L+ H NI+ + N+
Sbjct: 22 GAYGVVCSATHKPTGEIVAIKKIE--PFDKPLFALRTLREIKILKHFK-HENIITIFNIQ 78
Query: 59 K-----EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
+ +V+I+ E M++DL +++ Q S+D ++ +Q + + +H H
Sbjct: 79 RPDSFENFNEVYIIQELMQTDLHRVIS---TQMLSDDHIQYFIYQTLRAVKVLHGSNVIH 135
Query: 114 RDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC-----------TDYVTTRWYRAPEVLL 161
RDLKPSNLL+ S +K+ D G+ + ID S ++V TRWYRAPEV+L
Sbjct: 136 RDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML 195
Query: 162 LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPT--EDSWPLGIQL 219
S Y +D+W+ G I+ E+ R +FPG++ Q+ I +IG+P D +
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPR 255
Query: 220 ASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
A P L ++ P + + I L+ R+ ++P R TA EALEHP+ ++ H
Sbjct: 256 AREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 1e-93
Identities = 83/297 (27%), Positives = 146/297 (49%), Gaps = 29/297 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN------LKEVKCLRKMNNHPNIVKL 54
G++G+VF+A +K+G+ VA+KK+ ++ + L+E+K L+ + H N+V L
Sbjct: 28 GTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKILQLLK-HENVVNL 81
Query: 55 RNLV--------KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYM 106
+ + +++VF++ E DL L+ F+ E++ + + GL+Y+
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYI 140
Query: 107 HRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC-----TDYVTTRWYRAPEVL 160
HR HRD+K +N+L++ GV+K+ D G+ + + T+ V T WYR PE+L
Sbjct: 141 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 200
Query: 161 LLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA 220
L YGP +D+W G IM EM + + G Q+ I Q+ GS T + WP
Sbjct: 201 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 260
Query: 221 SNLDWKFPQMGGVNLRELSPS--ASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
+ + +++ + ++ LI +L +P R + +AL H FF S
Sbjct: 261 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 2e-93
Identities = 104/287 (36%), Positives = 160/287 (55%), Gaps = 17/287 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G+YG V A+D ++G VA+KKL + F L R +E++ L+ M H N++ L ++
Sbjct: 36 GAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMR-HENVIGLLDVF 93
Query: 59 K------EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ D ++V +M +DL KLMK + ED ++ L +Q+ +GL Y+H G
Sbjct: 94 TPDETLDDFTDFYLVMPFMGTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAGII 150
Query: 113 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
HRDLKP NL V +KI D G+ ++ DS + T YV TRWYRAPEV+L Y VD
Sbjct: 151 HRDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRWYRAPEVILNWMRYTQTVD 208
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPT-EDSWPLGIQLASNLDWKFPQM 230
+W++G IM EM++ + LF G + DQ+ +I +V G+P E L A N P++
Sbjct: 209 IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL 268
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+ + +AS +++L+ ++ + R TA EAL HP+F S H
Sbjct: 269 EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 3e-93
Identities = 103/288 (35%), Positives = 161/288 (55%), Gaps = 15/288 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK- 59
G+YG V A D + VA+KK+ R L+E+K L + H NI+ + ++++
Sbjct: 38 GAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRA 96
Query: 60 ----EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+ +DV+IV + ME+DL KL+K Q+ S D + +Q+ +GL Y+H HRD
Sbjct: 97 PTIEQMKDVYIVQDLMETDLYKLLK---TQHLSNDHICYFLYQILRGLKYIHSANVLHRD 153
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC----TDYVTTRWYRAPEVLLLSEIYGPEV 170
LKPSNLL+ + +KI D G+ + D T+YV TRWYRAPE++L S+ Y +
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 213
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPT-EDSWPLGIQLASNLDWKFPQ 229
D+W++G I+ EMLS R +FPGK+ DQ+ I ++GSP+ ED + A N P
Sbjct: 214 DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 273
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
V L P+A +++ L+ ++ ++NPH R +AL HP+ +
Sbjct: 274 KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 1e-92
Identities = 90/299 (30%), Positives = 148/299 (49%), Gaps = 29/299 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G G VF A+D + VA+KK+ + + L+E+K +R+++ H NIVK+ ++
Sbjct: 22 GGNGLVFSAVDNDCDKRVAIKKI---VLTDPQSVKHALREIKIIRRLD-HDNIVKVFEIL 77
Query: 59 K--------------EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLH 104
E V+IV EYME+DL +++ E+ R +Q+ +GL
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE---QGPLLEEHARLFMYQLLRGLK 134
Query: 105 YMHRQGYFHRDLKPSNLLVSKG--VIKIGDLGMVKEIDSSLPC----TDYVTTRWYRAPE 158
Y+H HRDLKP+NL ++ V+KIGD G+ + +D ++ + T+WYR+P
Sbjct: 135 YIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR 194
Query: 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQ 218
+LL Y +DMWA G I EML+ + LF G + +Q+ I + I E+ +
Sbjct: 195 LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS 254
Query: 219 LASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+ L +L P SRE++ + ++ +++P R TA EAL HP+
Sbjct: 255 VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 1e-91
Identities = 101/287 (35%), Positives = 155/287 (54%), Gaps = 17/287 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G+YG V A D K+G VAVKKL + F + R +E++ L+ M H N++ L ++
Sbjct: 40 GAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVF 97
Query: 59 K------EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
E DV++V M +DL ++K Q ++D V+ L +Q+ +GL Y+H
Sbjct: 98 TPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADII 154
Query: 113 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
HRDLKPSNL V +KI D G+ + + T YV TRWYRAPE++L Y VD
Sbjct: 155 HRDLKPSNLAVNEDCELKILDFGLARHTADEM--TGYVATRWYRAPEIMLNWMHYNQTVD 212
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPT-EDSWPLGIQLASNLDWKFPQM 230
+W++G IM E+L+ R LFPG + DQ+ I +++G+P E + + A N QM
Sbjct: 213 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 272
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+N + A+ ++ L+ ++ + R TAA+AL H +F H
Sbjct: 273 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 1e-91
Identities = 87/295 (29%), Positives = 146/295 (49%), Gaps = 21/295 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDES----------RNLKEVKCLRKMNNHPN 50
GSYG V +D + G VA+K++ + R L+E++ L + HPN
Sbjct: 33 GSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPN 90
Query: 51 IVKLRNLVK-----EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHY 105
I+ LR++ +++V E M +DL +++ ++ S ++ + + GLH
Sbjct: 91 ILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHV 149
Query: 106 MHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE 164
+H G HRDL P N+L+ I I D + +E + T YVT RWYRAPE+++ +
Sbjct: 150 LHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFK 209
Query: 165 IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPT-EDSWPLGIQLASN- 222
+ VDMW+ G +M EM + + LF G +Q+ KI +V+G+P ED A +
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDY 269
Query: 223 LDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
L + + P+A ++ LI+++ +NP R + +AL HP+F S
Sbjct: 270 LRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 1e-90
Identities = 85/296 (28%), Positives = 150/296 (50%), Gaps = 26/296 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKK-LKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV- 58
G++G V +K +G VA+KK ++ F R L+ ++ L ++ HPNIV+L++
Sbjct: 34 GTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN---RELQIMQDLAVLH-HPNIVQLQSYFY 89
Query: 59 ----KEHEDVF--IVFEYMESDLLKLMK--ERAGQNFSEDEVRNLCFQVFQGLHYMHRQ- 109
++ D++ +V EY+ L + + R ++ FQ+ + + +H
Sbjct: 90 TLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS 149
Query: 110 -GYFHRDLKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIY 166
HRD+KP N+LV + G +K+ D G K++ S P Y+ +R+YRAPE++ ++ Y
Sbjct: 150 VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHY 209
Query: 167 GPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL-DW 225
VD+W++G I EM+ +F G NSA Q+++I +V+G P+ + +L + D
Sbjct: 210 TTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLR---KLNPSHTDV 266
Query: 226 KFPQMGGVN----LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
G+ + S ++E+ L+S L + P R EAL HP+F H
Sbjct: 267 DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 9e-90
Identities = 101/345 (29%), Positives = 165/345 (47%), Gaps = 72/345 (20%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
GSYG V +A DK VA+KK+ + +F +D R L+E+ L ++N H ++VK+ ++V
Sbjct: 64 GSYGHVCEAYDKLEKRVVAIKKILR-VFEDLIDCKRILREIAILNRLN-HDHVVKVLDIV 121
Query: 59 K-----EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
+ +++++V E +SD KL R +E ++ L + + G+ Y+H G H
Sbjct: 122 IPKDVEKFDELYVVLEIADSDFKKLF--RTPVYLTELHIKTLLYNLLVGVKYVHSAGILH 179
Query: 114 RDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC--------------------------- 145
RDLKP+N LV +K+ D G+ + +D
Sbjct: 180 RDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQ 239
Query: 146 -TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF-----------RILFPGKN 193
T +V TRWYRAPE++LL E Y +D+W++G I E+L+ LFPG +
Sbjct: 240 LTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS 299
Query: 194 --------------------SADQIYKICQVIGSPTEDSWP-LGIQLASNLDWKFPQMGG 232
+ DQ+ I ++G+P+E+ L + A FP+ G
Sbjct: 300 CFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREG 359
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+L E P++S ++I L+ R+ +NP+ R T E L HPFF+
Sbjct: 360 TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 270 bits (691), Expect = 3e-89
Identities = 89/312 (28%), Positives = 155/312 (49%), Gaps = 41/312 (13%)
Query: 1 GSYGDVFQALDK--KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G+YG V++A K K + A+K+++ S+ +E+ LR++ HPN++ L+ +
Sbjct: 32 GTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS---ACREIALLRELK-HPNVISLQKVF 87
Query: 59 KEHED--VFIVFEYMESDLLKLMK-------ERAGQNFSEDEVRNLCFQVFQGLHYMHRQ 109
H D V+++F+Y E DL ++K + V++L +Q+ G+HY+H
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 110 GYFHRDLKPSNLLVS-----KGVIKIGDLGMVKEIDSSL-PCTDY---VTTRWYRAPEVL 160
HRDLKP+N+LV +G +KI D+G + +S L P D V T WYRAPE+L
Sbjct: 148 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 207
Query: 161 LLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKN---------SADQIYKICQVIGSPTED 211
L + Y +D+WA+G I E+L+ +F + DQ+ +I V+G P +
Sbjct: 208 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK 267
Query: 212 SWPLGIQL--ASNLDWKFPQMGGVN------LRELSPSASRESISLISRLCSWNPHMRPT 263
W ++ S L F + N + + ++ L+ +L + +P R T
Sbjct: 268 DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327
Query: 264 AAEALEHPFFRS 275
+ +A++ P+F
Sbjct: 328 SEQAMQDPYFLE 339
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 2e-88
Identities = 95/321 (29%), Positives = 168/321 (52%), Gaps = 48/321 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G+YG V++++D+++GE VAVKK+ F D R +E+ L +++ H NIV L N++
Sbjct: 20 GAYGIVWKSIDRRTGEVVAVKKIFD-AFQNSTDAQRTFREIMILTELSGHENIVNLLNVL 78
Query: 59 K--EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ DV++VF+YME+DL +++ + + +Q+ + + Y+H G HRD+
Sbjct: 79 RADNDRDVYLVFDYMETDLHAVIR---ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDM 135
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPC----------------------TDYVTTRW 153
KPSN+L+ ++ +K+ D G+ + + TDYV TRW
Sbjct: 136 KPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRW 195
Query: 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTED-- 211
YRAPE+LL S Y +DMW++G I+ E+L + +FPG ++ +Q+ +I VI P+ +
Sbjct: 196 YRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDV 255
Query: 212 -------------SWPLGIQLASNLDWKFPQMGGVNLRELSPSA--SRESISLISRLCSW 256
S +++ + L +++P A + E++ L+ +L +
Sbjct: 256 ESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315
Query: 257 NPHMRPTAAEALEHPFFRSCH 277
NP+ R +A +AL+HPF H
Sbjct: 316 NPNKRISANDALKHPFVSIFH 336
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 3e-87
Identities = 96/337 (28%), Positives = 164/337 (48%), Gaps = 64/337 (18%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
GSYG V+ A DK + + VA+KK+ + +F +D R L+E+ L ++ I++L +L+
Sbjct: 37 GSYGYVYLAYDKNTEKNVAIKKVNR-MFEDLIDCKRILREITILNRLK-SDYIIRLYDLI 94
Query: 59 K-----EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
+ ++++IV E +SDL KL + +E+ ++ + + + G +++H G H
Sbjct: 95 IPDDLLKFDELYIVLEIADSDLKKLF--KTPIFLTEEHIKTILYNLLLGENFIHESGIIH 152
Query: 114 RDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC-----------------------TDYV 149
RDLKP+N L+ +K+ D G+ + I+S T +V
Sbjct: 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV 212
Query: 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-----------FRILFPG------- 191
TRWYRAPE++LL E Y +D+W+ G I E+L+ LFPG
Sbjct: 213 VTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLS 272
Query: 192 ----------KNSADQIYKICQVIGSPT-EDSWPLGIQLASNLDWKFPQMGGVNLRELSP 240
K++ DQ+ I +IG+PT +D + FP +NL++ P
Sbjct: 273 PDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332
Query: 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
S S + I+L+ + +NP+ R T +AL+HP+ +
Sbjct: 333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 4e-87
Identities = 82/321 (25%), Positives = 156/321 (48%), Gaps = 53/321 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+G V + D +SG+ A+KK+ D +E+ ++ ++ H NI+KL +
Sbjct: 18 GSFGIVCEVFDIESGKRFALKKVL-----QDPRYKNRELDIMKVLD-HVNIIKLVDYFYT 71
Query: 61 HE--------------------------------------DVFIVFEYMESDLLKLMK-- 80
+ ++ EY+ L K++K
Sbjct: 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSF 131
Query: 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV--SKGVIKIGDLGMVKE 138
R+G++ + + +Q+F+ + ++H G HRD+KP NLLV +K+ D G K+
Sbjct: 132 IRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKK 191
Query: 139 IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQI 198
+ S P Y+ +R+YRAPE++L + Y P +D+W++G + E++ + LF G+ S DQ+
Sbjct: 192 LIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQL 251
Query: 199 YKICQVIGSPTEDSWPLGIQLASNLDW-KFPQMGGVNLRELSPSAS-RESISLISRLCSW 256
+I Q++G+PT++ ++ + +FP + + R++ P + +I L+ ++ +
Sbjct: 252 VRIIQIMGTPTKEQMI---RMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308
Query: 257 NPHMRPTAAEALEHPFFRSCH 277
P +R EA+ HPFF
Sbjct: 309 EPDLRINPYEAMAHPFFDHLR 329
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 6e-87
Identities = 69/290 (23%), Positives = 138/290 (47%), Gaps = 22/290 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK- 59
G Y +VF+A++ + E V VK LK + + + +E+K L + PNI+ L ++VK
Sbjct: 47 GKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKD 102
Query: 60 --EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ +D +L Q ++ ++R +++ + L Y H G HRD+K
Sbjct: 103 PVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVK 157
Query: 118 PSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
P N+++ +++ D G+ + V +R+++ PE+L+ ++Y +DMW++
Sbjct: 158 PHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSL 217
Query: 176 GAIMFEMLSFRI-LFPGKNSADQIYKICQVIGSPTEDSWP--LGIQLASNLDWKFPQMGG 232
G ++ M+ + F G ++ DQ+ +I +V+G+ + I+L + +
Sbjct: 218 GCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSR 277
Query: 233 VNLRELSPS-----ASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
S S E++ + +L ++ R TA EA+EHP+F +
Sbjct: 278 KRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 9e-87
Identities = 88/298 (29%), Positives = 148/298 (49%), Gaps = 28/298 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G+ G V A D VA+KKL + F R +E+ ++ +N H NI+ L N+
Sbjct: 36 GAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVF 93
Query: 59 K------EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
E +DV+IV E M+++L ++++ + + L +Q+ G+ ++H G
Sbjct: 94 TPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGII 149
Query: 113 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
HRDLKPSN++V S +KI D G+ + +S T YV TR+YRAPEV+L Y VD
Sbjct: 150 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVD 208
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP------------LGIQL 219
+W++G IM EM+ +LFPG + DQ K+ + +G+P +
Sbjct: 209 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYA 268
Query: 220 ASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+ + FP + E + + ++ L+S++ + R + EAL+HP+ +
Sbjct: 269 GYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 264 bits (675), Expect = 4e-86
Identities = 88/298 (29%), Positives = 148/298 (49%), Gaps = 28/298 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G+ G V A D VA+KKL + F R +E+ ++ +N H NI+ L N+
Sbjct: 73 GAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVF 130
Query: 59 K------EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
E +DV++V E M+++L ++++ + + L +Q+ G+ ++H G
Sbjct: 131 TPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGII 186
Query: 113 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
HRDLKPSN++V S +KI D G+ + +S T YV TR+YRAPEV+L Y VD
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVD 245
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP------------LGIQL 219
+W++G IM EM+ +ILFPG++ DQ K+ + +G+P +
Sbjct: 246 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA 305
Query: 220 ASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
FP E + + ++ L+S++ +P R + +AL+HP+ +
Sbjct: 306 GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-66
Identities = 64/276 (23%), Positives = 108/276 (39%), Gaps = 36/276 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
GSYG+VF+ K+ G AVK+ + L EV K+ HP V+L +
Sbjct: 68 GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127
Query: 60 EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E +++ E L + + G + E +V L ++H QG H D+KP+
Sbjct: 128 EGGILYLQTELCGPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPA 186
Query: 120 NLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAI 178
N+ + G K+GD G++ E+ ++ Y APE+ L YG D++++G
Sbjct: 187 NIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL--LQGSYGTAADVFSLGLT 244
Query: 179 MFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238
+ E+ L + + ++ Q P E
Sbjct: 245 ILEVACNMELP---HGGEGWQQLRQGYLPP----------------------------EF 273
Query: 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+ S E S++ + +P +R TA L P R
Sbjct: 274 TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 3e-63
Identities = 76/307 (24%), Positives = 115/307 (37%), Gaps = 62/307 (20%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKL------ 54
G++G V +A + + A+KK++ S L EV L +N H +V+
Sbjct: 17 GAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLN-HQYVVRYYAAWLE 73
Query: 55 -------RNLVKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYM 106
VK+ +FI EY E L L+ N DE L Q+ + L Y+
Sbjct: 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYI 132
Query: 107 HRQGYFHRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVT--------------- 150
H QG HRDLKP N + +KIGD G+ K + SL +
Sbjct: 133 HSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192
Query: 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTE 210
T Y A EVL + Y ++DM+++G I FEM+ G I K + +
Sbjct: 193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERV-NILKKLRSV----- 244
Query: 211 DSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
+FP + + + +I L +P+ RP A L
Sbjct: 245 -------------SIEFPP-------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284
Query: 271 PFFRSCH 277
+ H
Sbjct: 285 GWLPVKH 291
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-61
Identities = 71/279 (25%), Positives = 128/279 (45%), Gaps = 35/279 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
GS+G + G +K++ S E +EV L M HPNIV+ R +
Sbjct: 35 GSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESFE 93
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
E+ ++IV +Y E DL K + + G F ED++ + Q+ L ++H + HRD+K
Sbjct: 94 ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKS 153
Query: 119 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+ ++K G +++GD G+ + ++S++ + T +Y +PE+ ++ Y + D+WA+G
Sbjct: 154 QNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI-CENKPYNNKSDIWALG 212
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+++E+ + + F + + + KI FP
Sbjct: 213 CVLYELCTLKHAFEAGSMKNLVLKIISG---------------------SFPP------- 244
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
+S S + SL+S+L NP RP+ LE F
Sbjct: 245 -VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-61
Identities = 67/292 (22%), Positives = 120/292 (41%), Gaps = 59/292 (20%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G VF+A + G+ +K++K + + +EVK L K++ H NIV
Sbjct: 22 GGFGQVFKAKHRIDGKTYVIKRVKY-----NNEKAEREVKALAKLD-HVNIVHYNGCWDG 75
Query: 61 HED----------------VFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGL 103
+ +FI E+ + L + +++R G+ + L Q+ +G+
Sbjct: 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135
Query: 104 HYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL 162
Y+H + +RDLKPSN+ + +KIGD G+V + + T T Y +PE +
Sbjct: 136 DYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQ-IS 194
Query: 163 SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN 222
S+ YG EVD++A+G I+ E+L + ++ + I
Sbjct: 195 SQDYGKEVDLYALGLILAELLH--VCDTAFETSKFFTDLRDGI----------------- 235
Query: 223 LDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+S ++ +L+ +L S P RP +E L
Sbjct: 236 ---------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 3e-60
Identities = 56/289 (19%), Positives = 109/289 (37%), Gaps = 18/289 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ +VF+ KK+G+ A+K F ++E + L+K+N H NIVKL + +E
Sbjct: 20 GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEE 78
Query: 61 HED--VFIVFEYMES-DLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
++ E+ L L + E E + V G++++ G HR++
Sbjct: 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138
Query: 117 KPSNLLVS-----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL-------LLSE 164
KP N++ + V K+ D G +E++ T Y P++ +
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQK 198
Query: 165 IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224
YG VD+W++G + + + F + ++ I + G+Q A N
Sbjct: 199 KYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGP 258
Query: 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
+ V+ LS +++ + + +
Sbjct: 259 IDWSGDMPVSCS-LSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-59
Identities = 56/290 (19%), Positives = 116/290 (40%), Gaps = 47/290 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMN-NHPNIVKLRNLV 58
G VFQ L++ + A+K + + + + E+ L K+ + I++L +
Sbjct: 39 GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ +++V E DL +K++ ++ E ++ + + +H +H+ G H DLKP
Sbjct: 98 ITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 155
Query: 119 SNLLVSKGVIKIGDLGMVKEIDS---SLPCTDYVTTRWYRAPEVLLLS----------EI 165
+N L+ G++K+ D G+ ++ S+ V T Y PE +
Sbjct: 156 ANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 215
Query: 166 YGPEVDMWAMGAIMFEMLSFRILFPG-KNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224
P+ D+W++G I++ M + F N +++ I N +
Sbjct: 216 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-----------------PNHE 258
Query: 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+FP ++ ++ +P R + E L HP+ +
Sbjct: 259 IEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 5e-58
Identities = 56/290 (19%), Positives = 116/290 (40%), Gaps = 47/290 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMN-NHPNIVKLRNLV 58
G VFQ L++ + A+K + + + + E+ L K+ + I++L +
Sbjct: 20 GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ +++V E DL +K++ ++ E ++ + + +H +H+ G H DLKP
Sbjct: 79 ITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 136
Query: 119 SNLLVSKGVIKIGDLGMVKEIDS---SLPCTDYVTTRWYRAPEVLLLS----------EI 165
+N L+ G++K+ D G+ ++ S+ V T Y PE +
Sbjct: 137 ANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 196
Query: 166 YGPEVDMWAMGAIMFEMLSFRILFPG-KNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224
P+ D+W++G I++ M + F N +++ I N +
Sbjct: 197 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-----------------PNHE 239
Query: 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+FP ++ ++ +P R + E L HP+ +
Sbjct: 240 IEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-57
Identities = 69/309 (22%), Positives = 120/309 (38%), Gaps = 61/309 (19%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN---- 56
G +G VF+A +K A+K+++ L + ++EVK L K+ HP IV+ N
Sbjct: 16 GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLE 74
Query: 57 --------LVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSE-DEVRNLCFQVFQGLHYM 106
++I + +L M R E ++ Q+ + + ++
Sbjct: 75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFL 134
Query: 107 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC-------------TDYVTTR 152
H +G HRDLKPSN+ + V+K+GD G+V +D T V T+
Sbjct: 135 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTK 194
Query: 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDS 212
Y +PE + Y +VD++++G I+FE+L F + + +
Sbjct: 195 LYMSPEQ-IHGNSYSHKVDIFSLGLILFELL---YPFSTQMERVRTLTDVR--------- 241
Query: 213 WPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
+ KFP L ++ + S +P RP A +E+
Sbjct: 242 -----------NLKFP--------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282
Query: 273 FRSCHFVPR 281
F F +
Sbjct: 283 FEDLDFPGK 291
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 7e-57
Identities = 60/290 (20%), Positives = 113/290 (38%), Gaps = 26/290 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV-- 58
G+ +VF+ KK+G+ A+K F ++E + L+K+N H NIVKL +
Sbjct: 20 GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEE 78
Query: 59 KEHEDVFIVFEYMES-DLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
++ E+ L L + E E + V G++++ G HR++
Sbjct: 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138
Query: 117 KPSNLLVS-----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVL-------LLSE 164
KP N++ + V K+ D G +E++ T Y P++ +
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQK 198
Query: 165 IYGPEVDMWAMGAIMFEMLS----FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA 220
YG VD+W++G + + FR + + + +YKI + G P+ G+Q A
Sbjct: 199 KYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI--ITGKPSG--AISGVQKA 254
Query: 221 SNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
N + V+ LS +++ + + +
Sbjct: 255 ENGPIDWSGDMPVSCS-LSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 7e-57
Identities = 71/287 (24%), Positives = 125/287 (43%), Gaps = 44/287 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL-KEVKCLRKMNNHPNIVKLRNLVK 59
GSYG + K G+ + K+L + E + L EV LR++ HPNIV+ + +
Sbjct: 17 GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRII 75
Query: 60 EHED--VFIVFEYMES-DLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF-- 112
+ + ++IV EY E DL ++ + + Q E+ V + Q+ L HR+
Sbjct: 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135
Query: 113 ---HRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLLSEIYG 167
HRDLKP+N L K +K+GD G+ + ++ +V T +Y +PE + Y
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN-RMSYN 194
Query: 168 PEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227
+ D+W++G +++E+ + F + + KI + G
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKF------------------- 233
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
R + S E +I+R+ + + RP+ E LE+P
Sbjct: 234 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-56
Identities = 55/290 (18%), Positives = 115/290 (39%), Gaps = 47/290 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMN-NHPNIVKLRNLV 58
G VFQ L++ + A+K + + + + E+ L K+ + I++L +
Sbjct: 67 GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ +++V E DL +K++ ++ E ++ + + +H +H+ G H DLKP
Sbjct: 126 ITDQYIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 183
Query: 119 SNLLVSKGVIKIGDLGMVKEIDS---SLPCTDYVTTRWYRAPEVLLLS----------EI 165
+N L+ G++K+ D G+ ++ S+ V Y PE +
Sbjct: 184 ANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 166 YGPEVDMWAMGAIMFEMLSFRILFPG-KNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224
P+ D+W++G I++ M + F N +++ I N +
Sbjct: 244 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-----------------PNHE 286
Query: 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+FP ++ ++ +P R + E L HP+ +
Sbjct: 287 IEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 3e-56
Identities = 81/319 (25%), Positives = 143/319 (44%), Gaps = 42/319 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHP-----NIVKLR 55
GS+G V +A D K + VA+K ++ + ++ +E++ L + N++ +
Sbjct: 108 GSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA--AEEIRILEHLRKQDKDNTMNVIHML 165
Query: 56 NLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+ + FE + +L +L+K+ Q FS VR + Q L +H+ H D
Sbjct: 166 ENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCD 225
Query: 116 LKPSNLLV---SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
LKP N+L+ + IK+ D G + Y+ +R+YRAPEV+L + YG +DM
Sbjct: 226 LKPENILLKQQGRSGIKVIDFGSSCYEHQRV--YTYIQSRFYRAPEVILGAR-YGMPIDM 282
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSP---------------TEDSWPLGI 217
W++G I+ E+L+ L PG++ DQ+ + +++G P + +P
Sbjct: 283 WSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYC 342
Query: 218 QLASNLDWKFPQMGGVNLRE--LSPSASRES------------ISLISRLCSWNPHMRPT 263
+ + D GG + R P SRE + + + W+P +R T
Sbjct: 343 TVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT 402
Query: 264 AAEALEHPFFRSCHFVPRS 282
+AL HP+ R P +
Sbjct: 403 PGQALRHPWLRRRLPKPPT 421
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-55
Identities = 71/299 (23%), Positives = 120/299 (40%), Gaps = 59/299 (19%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
G +G VF+ + + G A+K+ KK + + +N L+EV + H ++V+ +
Sbjct: 22 GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA 81
Query: 60 EHEDVFIVFEYME-SDLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
E + + I EY L + E R F E E+++L QV +GL Y+H H D+
Sbjct: 82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDI 141
Query: 117 KPSNLLVSK--------------------GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156
KPSN+ +S+ + KIGDLG V I S + A
Sbjct: 142 KPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLA 198
Query: 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLG 216
EVL + + P+ D++A+ + L + DQ ++I Q G
Sbjct: 199 NEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHEIRQ--G---------- 243
Query: 217 IQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
+ P+ + S+E L+ + +P RP+A ++H S
Sbjct: 244 ---------RLPR--------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-55
Identities = 64/287 (22%), Positives = 112/287 (39%), Gaps = 44/287 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ G + VAVK++ + FS + +EV+ LR+ + HPN+++ K+
Sbjct: 35 GAEGTIVYR-GMFDNRDVAVKRILPECFSFAD----REVQLLRESDEHPNVIRYFCTEKD 89
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+ +I E + L + ++++ E L Q GL ++H HRDLKP N
Sbjct: 90 RQFQYIAIELCAATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHN 148
Query: 121 LLV------SKGVIKIGDLGMVKEID----SSLPCTDYVTTRWYRAPEVLL--LSEIYGP 168
+L+ K I D G+ K++ S + T + APE+L E
Sbjct: 149 ILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTY 208
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228
VD+++ G + + ++S GK+ Q +
Sbjct: 209 TVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE--------------- 253
Query: 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
+ LI ++ + +P RP+A L+HPFF S
Sbjct: 254 -----------KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 4e-55
Identities = 75/289 (25%), Positives = 121/289 (41%), Gaps = 43/289 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK--------EVKCLRKMNNHPNIV 52
G V + + K + + AVK + + ++ EV LRK++ HPNI+
Sbjct: 28 GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87
Query: 53 KLRNLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
+L++ + + F+VF+ M+ +L + E+ SE E R + + + + +H+
Sbjct: 88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNI 145
Query: 112 FHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI----- 165
HRDLKP N+L+ IK+ D G ++D + T Y APE++ S
Sbjct: 146 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPG 205
Query: 166 YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225
YG EVDMW+ G IM+ +L+ F + + I W
Sbjct: 206 YGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD----------- 254
Query: 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+ S + L+SR P R TA EAL HPFF+
Sbjct: 255 -----------DYSDTV----KDLVSRFLVVQPQKRYTAEEALAHPFFQ 288
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 5e-55
Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 43/289 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-------EVKCLRKMNNHPNIVK 53
G+ G+V A ++K+ + VA++ + K+ F++ +R E++ L+K+N HP I+K
Sbjct: 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIK 204
Query: 54 LRNLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
++N + ED +IV E ME +L + + E + +Q+ + Y+H G
Sbjct: 205 IKNFF-DAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGII 261
Query: 113 HRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI--Y 166
HRDLKP N+L+S +IKI D G K + + T Y APEVL+ Y
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 321
Query: 167 GPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226
VD W++G I+F LS F + + Q+ + ++
Sbjct: 322 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD--QI--------------TSGKYNFI 365
Query: 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
V S +++ L+ +L +P R T EAL HP+ +
Sbjct: 366 PEVWAEV---------SEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-54
Identities = 71/281 (25%), Positives = 126/281 (44%), Gaps = 37/281 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++GDV ++ SG +K + K + + E++ L+ ++ HPNI+K+ + ++
Sbjct: 33 GAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFED 91
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQ--NFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ +++IV E E +LL+ + + SE V L Q+ L Y H Q H+DLK
Sbjct: 92 YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLK 151
Query: 118 PSNLLVS----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMW 173
P N+L IKI D G+ + S T+ T Y APEV + D+W
Sbjct: 152 PENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV--FKRDVTFKCDIW 209
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
+ G +M+ +L+ + F G + + K + + P
Sbjct: 210 SAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP------------------- 250
Query: 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
L+P A + L+ ++ + +P RP+AA+ L H +F+
Sbjct: 251 ----LTPQA----VDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-54
Identities = 86/280 (30%), Positives = 137/280 (48%), Gaps = 37/280 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
GS+G+V + D+ + + AVK + K + D S L+EV+ L+K++ HPNI+KL +++
Sbjct: 33 GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILE 91
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ +IV E +L + +R + FSE + + QVF G+ YMH+ HRDLKP
Sbjct: 92 DSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 119 SN-LLVSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
N LL SK IKI D G+ + D + T +Y APEV L Y + D+W+
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV--LRGTYDEKCDVWS 207
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
G I++ +LS F GKN D + ++ + W
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR-------------------- 247
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+S A LI ++ +++P +R TA + LEHP+ +
Sbjct: 248 --TISDDA----KDLIRKMLTFHPSLRITATQCLEHPWIQ 281
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-54
Identities = 77/281 (27%), Positives = 136/281 (48%), Gaps = 37/281 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G+YG+V DK + A+K + K + + S+ L+EV L+ ++ HPNI+KL + +
Sbjct: 48 GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKLYDFFE 106
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ + ++V E + +L + R F+E + + QV G+ Y+H+ HRDLKP
Sbjct: 107 DKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKP 164
Query: 119 SNLLVS----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
NLL+ +IKI D G+ ++ + + T +Y APEV L + Y + D+W+
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV--LRKKYDEKCDVWS 222
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G I+F +L+ F G+ + + K+ + G T DS W
Sbjct: 223 IGVILFILLAGYPPFGGQTDQEILRKVEK--GKYTFDSPE----------W--------- 261
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
+ S + LI ++ ++ R +A +ALEHP+ +
Sbjct: 262 -----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 8e-54
Identities = 68/282 (24%), Positives = 126/282 (44%), Gaps = 41/282 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLK-KKIFSLDESRNL-KEVKCLRKMNNHPNIVKLRNLV 58
G + +V++A G VA+KK++ + + KE+ L+++N HPN++K
Sbjct: 43 GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASF 101
Query: 59 KEHEDVFIVFEYMES-DLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
E ++ IV E ++ DL +++K + + E V Q+ L +MH + HRD
Sbjct: 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRD 161
Query: 116 LKPSNLLVSK-GVIKIGDLGMVKEIDS--SLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
+KP+N+ ++ GV+K+GDLG+ + S + + V T +Y +PE + + Y + D+
Sbjct: 162 IKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHENG-YNFKSDI 219
Query: 173 WAMGAIMFEMLSFRILFPGK--NSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
W++G +++EM + + F G N KI Q +P +
Sbjct: 220 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---------------------DYPPL 258
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
S S E L++ + +P RP +
Sbjct: 259 -------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-53
Identities = 82/282 (29%), Positives = 135/282 (47%), Gaps = 38/282 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK--IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
GS+G+V DK +G+ AVK + K+ D+ L+EV+ L++++ HPNI+KL
Sbjct: 37 GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFF 95
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
++ ++V E +L + R + FSE + + QV G+ YMH+ HRDLK
Sbjct: 96 EDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLK 153
Query: 118 PSNLLVS----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMW 173
P NLL+ I+I D G+ ++S D + T +Y APEV L Y + D+W
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV--LHGTYDEKCDVW 211
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
+ G I++ +LS F G N D + K+ + G T + W
Sbjct: 212 STGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFELPQ----------W-------- 251
Query: 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
S + LI ++ ++ P MR +A +AL+H + ++
Sbjct: 252 ------KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 3e-53
Identities = 47/308 (15%), Positives = 85/308 (27%), Gaps = 57/308 (18%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL-- 57
G VF D + E A+K S E L E + + R+
Sbjct: 73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132
Query: 58 ------------------------VKEHEDVFIVFEYMESDLLKLMKE-----RAGQNFS 88
+ ++ DL L +
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 89 EDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTD 147
+ L Q+ + + +G H P NL + G + +GD+ + ++ + P +
Sbjct: 193 ILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS- 251
Query: 148 YVTTRWYRAPEVLLLSEI-YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIG 206
Y E L S + ++ W +G ++ + + F + +
Sbjct: 252 -SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLR 310
Query: 207 SPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAE 266
P DS G + L LI R +++ R E
Sbjct: 311 VPGTDSLAFG-----------------SCTPLPDFVKT----LIGRFLNFDRRRRLLPLE 349
Query: 267 ALEHPFFR 274
A+E P F
Sbjct: 350 AMETPEFL 357
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-53
Identities = 74/281 (26%), Positives = 127/281 (45%), Gaps = 36/281 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLVK 59
G++ V + + K +G A K + K S + + L+ E + RK+ HPNIV+L + ++
Sbjct: 17 GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ 75
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
E ++VF+ + +L + + R + +SE + + Q+ + + Y H G HR+LKP
Sbjct: 76 EESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKP 133
Query: 119 SN-LLVSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
N LL SK +K+ D G+ E++ S + T Y +PEV L + Y VD+WA
Sbjct: 134 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-LKKDPYSKPVDIWA 192
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
G I++ +L F ++ +I W
Sbjct: 193 CGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD-------------------- 232
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
++P A SLI + + NP R TA +AL+ P+ +
Sbjct: 233 --TVTPEA----KSLIDSMLTVNPKKRITADQALKVPWICN 267
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-53
Identities = 87/281 (30%), Positives = 139/281 (49%), Gaps = 37/281 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
GS+G+V + D+ + + AVK + K + D S L+EV+ L+K++ HPNI+KL +++
Sbjct: 33 GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILE 91
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ +IV E +L + +R + FSE + + QVF G+ YMH+ HRDLKP
Sbjct: 92 DSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKP 149
Query: 119 SN-LLVSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
N LL SK IKI D G+ + D + T +Y APEV L Y + D+W+
Sbjct: 150 ENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV--LRGTYDEKCDVWS 207
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
G I++ +LS F GKN D + ++ G D W
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDLPQ----------W--------- 246
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
+ S ++ LI ++ +++P +R TA + LEHP+ +
Sbjct: 247 -----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-53
Identities = 74/280 (26%), Positives = 124/280 (44%), Gaps = 37/280 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+G+V A+ K + A KK+ K D R +E++ ++ ++ HPNI++L ++
Sbjct: 20 GSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLD-HPNIIRLYETFED 77
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ D+++V E +L + + + + F E + + V + Y H+ HRDLKP
Sbjct: 78 NTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPE 135
Query: 120 NLLVS----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N L +K+ D G+ V T +Y +P+VL YGPE D W+
Sbjct: 136 NFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSA 193
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G +M+ +L F ++ + KI + + E W
Sbjct: 194 GVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWL--------------------- 232
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
+SP A SLI RL + +P R T+ +ALEH +F
Sbjct: 233 -NVSPQA----ESLIRRLLTKSPKQRITSLQALEHEWFEK 267
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-52
Identities = 76/293 (25%), Positives = 117/293 (39%), Gaps = 46/293 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR----N 56
G G V Q +K++ E A+K L+ + +EV+ + + P+IV++ N
Sbjct: 73 GINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYEN 126
Query: 57 LVKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
L + + IV E ++ +L +++R Q F+E E + + + + Y+H HRD
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 186
Query: 116 LKPSNLL-VSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
+KP NLL SK ++K+ D G KE S T T +Y APEV L E Y D
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCD 245
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSP----TEDSWPLGIQLASNLDWKF 227
MW++G IM+ +L F + + I W
Sbjct: 246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS------------- 292
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280
E+S LI L P R T E + HP+ VP
Sbjct: 293 ---------EVSEEV----KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 332
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-52
Identities = 75/321 (23%), Positives = 131/321 (40%), Gaps = 59/321 (18%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN----------NHPN 50
G + V+ A D + VA+K ++ + + E+K L+++N +
Sbjct: 30 GHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA--EDEIKLLQRVNDADNTKEDSMGANH 87
Query: 51 IVKL------RNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLH 104
I+KL + H V +VFE + +LL L+K+ + V+ + Q+ GL
Sbjct: 88 ILKLLDHFNHKGPNGVH--VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 145
Query: 105 YMHRQ-GYFHRDLKPSNLLVS-------KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156
YMHR+ G H D+KP N+L+ IKI DLG T+ + TR YR+
Sbjct: 146 YMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSIQTREYRS 203
Query: 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGK------NSADQIYKICQVIGSPTE 210
PEVLL + +G D+W+ ++FE+++ LF D I +I +++G
Sbjct: 204 PEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL-- 260
Query: 211 DSWPLGIQLASNLDWKF----------PQMGGVNLRELSPSASRES-------ISLISRL 253
P + F ++ L ++ + S +S +
Sbjct: 261 ---PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 317
Query: 254 CSWNPHMRPTAAEALEHPFFR 274
+P R A + HP+ +
Sbjct: 318 LQLDPRKRADAGGLVNHPWLK 338
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-52
Identities = 80/290 (27%), Positives = 130/290 (44%), Gaps = 45/290 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-------EVKCLRKMNNHPNIVK 53
G+ G+V A ++K+ + VA+K + K+ F++ +R E++ L+K+N HP I+K
Sbjct: 21 GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIK 79
Query: 54 LRNLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
++N + ED +IV E ME +L + + E + +Q+ + Y+H G
Sbjct: 80 IKNFF-DAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGII 136
Query: 113 HRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI--Y 166
HRDLKP N+L+S +IKI D G K + + T Y APEVL+ Y
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY 196
Query: 167 GPEVDMWAMGAIMFEMLSFRILFPGKNSADQIY-KICQVIGSPTEDSWPLGIQLASNLDW 225
VD W++G I+F LS F + + +I + + W
Sbjct: 197 NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA----------- 245
Query: 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
E+S A + L+ +L +P R T EAL HP+ +
Sbjct: 246 -----------EVSEKA----LDLVKKLLVVDPKARFTTEEALRHPWLQD 280
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-52
Identities = 73/293 (24%), Positives = 113/293 (38%), Gaps = 47/293 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR----N 56
G G V + +++G+ A+K L + +EV + + P+IV + N
Sbjct: 40 GVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVCILDVYEN 93
Query: 57 LVKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+ + I+ E ME +L ++ER Q F+E E + + + ++H HRD
Sbjct: 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRD 153
Query: 116 LKPSNLL-VSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
+KP NLL SK V+K+ D G KE + T +Y APEV L E Y D
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEV-LGPEKYDKSCD 211
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSP----TEDSWPLGIQLASNLDWKF 227
MW++G IM+ +L F + + I W
Sbjct: 212 MWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS------------- 258
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280
E+S A LI L +P R T + + HP+ VP
Sbjct: 259 ---------EVSEDAK----QLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-52
Identities = 75/295 (25%), Positives = 122/295 (41%), Gaps = 58/295 (19%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-------DESRNLKEVKCLRKMNNHPNIVK 53
G V + + + +G AVK ++ L +E LR++ HP+I+
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 54 LRNLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
L + + +F+VF+ M +L + E+ SE E R++ + + + ++H
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIV 222
Query: 113 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI-----Y 166
HRDLKP N+L+ I++ D G ++ + T Y APE+L S Y
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 167 GPEVDMWAMGAIMFEMLS----FRILFPGKNSADQIYKICQVI--GSPTEDS--WPLGIQ 218
G EVD+WA G I+F +L+ F + + ++I G S W
Sbjct: 283 GKEVDLWACGVILFTLLAGSPPF--------WHRRQILMLRMIMEGQYQFSSPEWD---- 330
Query: 219 LASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
+ S + LISRL +P R TA +AL+HPFF
Sbjct: 331 ------------------DRSSTVK----DLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-52
Identities = 71/281 (25%), Positives = 121/281 (43%), Gaps = 33/281 (11%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLVK 59
G + V Q + K +G+ A K LKK+ D + E+ L + P ++ L + +
Sbjct: 40 GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99
Query: 60 EHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
++ ++ EY ++ L + SE++V L Q+ +G++Y+H+ H DLKP
Sbjct: 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKP 159
Query: 119 SNLLV----SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
N+L+ G IKI D GM ++I + + + T Y APE+L + DMW
Sbjct: 160 QNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN-YDPITTATDMWN 218
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G I + +L+ F G+++ + I QV + +
Sbjct: 219 IGIIAYMLLTHTSPFVGEDNQETYLNISQV-------------------NVDYS------ 253
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
E S S+ + I L NP RPTA L H + +
Sbjct: 254 -EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 4e-52
Identities = 74/281 (26%), Positives = 127/281 (45%), Gaps = 36/281 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLVK 59
G++ V + + K +G A K + K S + + L+ E + RK+ HPNIV+L + ++
Sbjct: 40 GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQ 98
Query: 60 EHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
E ++VF+ + +L + + R + +SE + + Q+ + + Y H G HR+LKP
Sbjct: 99 EESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKP 156
Query: 119 SN-LLVSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
N LL SK +K+ D G+ E++ S + T Y +PEV L + Y VD+WA
Sbjct: 157 ENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-LKKDPYSKPVDIWA 215
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
G I++ +L F ++ +I W
Sbjct: 216 CGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD-------------------- 255
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
++P A SLI + + NP R TA +AL+ P+ +
Sbjct: 256 --TVTPEA----KSLIDSMLTVNPKKRITADQALKVPWICN 290
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 6e-52
Identities = 88/318 (27%), Positives = 138/318 (43%), Gaps = 49/318 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHP-----NIVKLR 55
GS+G V +A D+ E+VA+K +K K L+++ EV+ L MN H IV L+
Sbjct: 65 GSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA--QIEVRLLELMNKHDTEMKYYIVHLK 122
Query: 56 NLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ--GYFH 113
+ +VFE + +L L++ + S + R Q+ L ++ H
Sbjct: 123 RHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIH 182
Query: 114 RDLKPSNLLV---SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
DLKP N+L+ + IKI D G ++ + Y+ +R+YR+PEVLL Y +
Sbjct: 183 CDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI--YQYIQSRFYRSPEVLLGMP-YDLAI 239
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSP---------------------- 208
DMW++G I+ EM + LF G N DQ+ KI +V+G P
Sbjct: 240 DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGT 299
Query: 209 ----------TEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRES--ISLISRLCSW 256
E P +L + L + GG E + + LI R+ +
Sbjct: 300 WNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359
Query: 257 NPHMRPTAAEALEHPFFR 274
+P R AL+H FF+
Sbjct: 360 DPKTRIQPYYALQHSFFK 377
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 6e-52
Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 20/286 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G V + + + +GE VA+K+ ++++ + R E++ ++K+N HPN+V R +
Sbjct: 25 GGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDG 83
Query: 61 HEDV------FIVFEYMES-DLLKLMKERAGQN-FSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ + + EY E DL K + + E +R L + L Y+H
Sbjct: 84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRII 143
Query: 113 HRDLKPSNLLVSKG----VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGP 168
HRDLKP N+++ G + KI DLG KE+D CT++V T Y APE+ L + Y
Sbjct: 144 HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL-LEQKKYTV 202
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228
VD W+ G + FE ++ F Q + + + + + L + +
Sbjct: 203 TVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVVYDDLTGAVKFSSV 259
Query: 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
LS + + + + W+ R T + F+
Sbjct: 260 LP---TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-51
Identities = 75/293 (25%), Positives = 131/293 (44%), Gaps = 51/293 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
GS+ V++A +G VA+K + KK ++ + ++ EVK ++ HP+I++L N
Sbjct: 22 GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYF 80
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
++ V++V E + ++ + +K R FSE+E R+ Q+ G+ Y+H G HRDL
Sbjct: 81 EDSNYVYLVLEMCHNGEMNRYLKNRVKP-FSENEARHFMHQIITGMLYLHSHGILHRDLT 139
Query: 118 PSNLLV-SKGVIKIGDLGM--VKEIDSSLPCT-----DYVTTRWYRAPEVLLLSEIYGPE 169
SNLL+ IKI D G+ ++ T +Y+ +PE+ +G E
Sbjct: 140 LSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYI------SPEI-ATRSAHGLE 192
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
D+W++G + + +L R F + + K+ D++ P
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-------------------DYEMP- 232
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282
LS A LI +L NP R + + L+HPF + +S
Sbjct: 233 ------SFLSIEAKD----LIHQLLRRNPADRLSLSSVLDHPFMSR-NSSTKS 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-51
Identities = 71/305 (23%), Positives = 115/305 (37%), Gaps = 59/305 (19%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS G V G VAVK++ + E+K L + ++HPN+++
Sbjct: 26 GSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIAL----MEIKLLTESDDHPNVIRYYCSETT 80
Query: 61 HEDVFIVFEYMESDLLKLMKER-----AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
++I E +L L++ + + E +L Q+ G+ ++H HRD
Sbjct: 81 DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRD 140
Query: 116 LKPSNLLVSK--------------GVIKIGDLGMVKEIDS-----SLPCTDYVTTRWYRA 156
LKP N+LVS I I D G+ K++DS + T +RA
Sbjct: 141 LKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRA 200
Query: 157 PEVLLLSEI------YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTE 210
PE+L S +D+++MG + + +LS G + I +
Sbjct: 201 PELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY-SRESNIIR------- 252
Query: 211 DSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
GI + S E+ LIS++ +P RPTA + L H
Sbjct: 253 -----GIFSLDEMKCLHD-----------RSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296
Query: 271 PFFRS 275
P F
Sbjct: 297 PLFWP 301
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 5e-51
Identities = 77/292 (26%), Positives = 127/292 (43%), Gaps = 48/292 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK------------IFSLDESRNLKEVKCLRKMNNH 48
G+YG+V +K A+K +KK E+ L+ ++ H
Sbjct: 47 GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-H 105
Query: 49 PNIVKLRNLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMH 107
PNI+KL ++ ++ + ++V E+ E +L + + R F E + N+ Q+ G+ Y+H
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLH 163
Query: 108 RQGYFHRDLKPSN-LLVSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS 163
+ HRD+KP N LL +K IKI D G+ D + T +Y APEV L
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV--LK 221
Query: 164 EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL 223
+ Y + D+W+ G IM+ +L F G+N D I K+ + G D
Sbjct: 222 KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK--GKYYFDFND--------- 270
Query: 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
W + S E+ LI + +++ + R TA EAL + +
Sbjct: 271 -W--------------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 6e-51
Identities = 59/294 (20%), Positives = 106/294 (36%), Gaps = 51/294 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL-KEVKCLRKMNNHPNIVKLR---- 55
G + V G F A+K++ + +E R N HPNI++L
Sbjct: 40 GGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFN-HPNILRLVAYCL 96
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKER--AGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ +++ + + L ++ G +ED++ L + +GL +H +GY
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYA 156
Query: 113 HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTD----------YVTTRWYRAPEVLL 161
HRDLKP+N+L+ G + DLG + + + + T YRAPE+
Sbjct: 157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS 216
Query: 162 LS--EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQL 219
+ + D+W++G +++ M+ + L
Sbjct: 217 VQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA------------------L 258
Query: 220 ASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
A PQ SP S L++ + + +PH RP L
Sbjct: 259 AVQNQLSIPQ---------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 7e-51
Identities = 76/287 (26%), Positives = 126/287 (43%), Gaps = 43/287 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS----LDESRNLKEVKCLRKMNNHPNIVKLRN 56
G + V + +++++G+ AVK + F+ L +E + HP+IV+L
Sbjct: 35 GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLE 93
Query: 57 LVKEHEDVFIVFEYME-SDLLK--LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
+++VFE+M+ +DL + + AG +SE + Q+ + L Y H H
Sbjct: 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIH 153
Query: 114 RDLKPSN-LLVSKG---VIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEIYGP 168
RD+KP LL SK +K+G G+ ++ +S L V T + APEV + E YG
Sbjct: 154 RDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV-VKREPYGK 212
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSADQIY-KICQVIGSPTEDSWPLGIQLASNLDWKF 227
VD+W G I+F +LS + F G ++++ I + W
Sbjct: 213 PVDVWGCGVILFILLSGCLPFYGTK--ERLFEGIIKGKYKMNPRQWS------------- 257
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+S SA L+ R+ +P R T EAL HP+ +
Sbjct: 258 ---------HISESA----KDLVRRMLMLDPAERITVYEALNHPWLK 291
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 8e-51
Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 52/293 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
G + F+ D + E A K + K + + + E+ R + H ++V
Sbjct: 26 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFF 84
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
++++ VF+V E LL+L K R + +E E R Q+ G Y+HR HRDLK
Sbjct: 85 EDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 118 PSNLLV-SKGVIKIGDLGM--VKEIDSSLPCT-----DYVTTRWYRAPEVLLLSEIYGPE 169
NL + +KIGD G+ E D +Y+ APEV L + + E
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI------APEV-LSKKGHSFE 195
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
VD+W++G IM+ +L + F + +I + ++ P
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------------------EYSIP- 235
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282
+ ++P A+ LI ++ +P RPT E L FF S ++P
Sbjct: 236 ------KHINPVAAS----LIQKMLQTDPTARPTINELLNDEFFTS-GYIPAR 277
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-50
Identities = 86/326 (26%), Positives = 131/326 (40%), Gaps = 79/326 (24%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK----IFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
GSYG V A++ ++ A+K + K I D R EV+ ++K++ HPNI +L
Sbjct: 37 GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYE 95
Query: 57 LVKEHEDVFIVFEYME---------------------------------------SDLLK 77
+ ++ + + +V E + +
Sbjct: 96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIH 155
Query: 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK---GVIKIGDLG 134
+E E + N+ Q+F LHY+H QG HRD+KP N L S IK+ D G
Sbjct: 156 GFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFG 215
Query: 135 MVKEIDSSLP-----CTDYVTTRWYRAPEVL-LLSEIYGPEVDMWAMGAIMFEMLSFRIL 188
+ KE T T ++ APEVL +E YGP+ D W+ G ++ +L +
Sbjct: 216 LSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
Query: 189 FPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESIS 248
FPG N AD I ++ L L ++ P LSP A
Sbjct: 276 FPGVNDADTISQV-----------------LNKKLCFENPN-----YNVLSPLA----RD 309
Query: 249 LISRLCSWNPHMRPTAAEALEHPFFR 274
L+S L + N R A AL+HP+
Sbjct: 310 LLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-50
Identities = 71/283 (25%), Positives = 120/283 (42%), Gaps = 49/283 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
G +G+V+ A +K+S +A+K L K ++ L+ EV+ + HPNI++L
Sbjct: 20 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYF 78
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ V+++ EY + + +++ F E ++ L Y H + HRD+K
Sbjct: 79 HDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIK 136
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCT-----DYVTTRWYRAPEVLLLSEIYGPEVD 171
P NLL+ S G +KI D G SS DY+ PE+ + ++ +VD
Sbjct: 137 PENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPEM-IEGRMHDEKVD 189
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231
+W++G + +E L + F + +I +V ++ FP
Sbjct: 190 LWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------------EFTFP--- 227
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+ + LISRL NP RP E LEHP+
Sbjct: 228 --------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-50
Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 52/293 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
G + F+ D + E A K + K + + + E+ R + H ++V
Sbjct: 52 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFF 110
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
++++ VF+V E LL+L K R + +E E R Q+ G Y+HR HRDLK
Sbjct: 111 EDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 118 PSNLLV-SKGVIKIGDLGM--VKEIDSSLPCT-----DYVTTRWYRAPEVLLLSEIYGPE 169
NL + +KIGD G+ E D +Y+ APEV L + + E
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI------APEV-LSKKGHSFE 221
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
VD+W++G IM+ +L + F + +I + ++ P
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------------------EYSIP- 261
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPRS 282
+ ++P A+ LI ++ +P RPT E L FF S ++P
Sbjct: 262 ------KHINPVAAS----LIQKMLQTDPTARPTINELLNDEFFTS-GYIPAR 303
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-50
Identities = 75/287 (26%), Positives = 125/287 (43%), Gaps = 38/287 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GSY + + K + AVK + K D + E++ L + HPNI+ L+++ +
Sbjct: 33 GSYSVCKRCIHKATNMEFAVKIIDKS--KRDPTE---EIEILLRYGQHPNIITLKDVYDD 87
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ V++V E M+ +LL + + + FSE E + F + + + Y+H QG HRDLKPS
Sbjct: 88 GKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPS 145
Query: 120 NLLVS-----KGVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMW 173
N+L I+I D G K++ + + T + APEV L + Y D+W
Sbjct: 146 NILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV-LERQGYDAACDIW 204
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
++G +++ ML+ F +I I + V
Sbjct: 205 SLGVLLYTMLTGYTPFANGPDDTP-EEILARI-------------GSGKFSLSGGYWNSV 250
Query: 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280
S +A L+S++ +PH R TAA L HP+ +P
Sbjct: 251 -----SDTAK----DLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-50
Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 46/293 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+ + + KKS + AVK + K+ E+ KE+ L+ HPNIVKL + +
Sbjct: 22 GSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHD 77
Query: 61 HEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
F+V E + +L + +K++ ++FSE E + ++ + +MH G HRDLKP
Sbjct: 78 QLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPE 135
Query: 120 NLL-VSKG---VIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
NLL + IKI D G + + P T Y APE+ L Y D+W+
Sbjct: 136 NLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL-LNQNGYDESCDLWS 194
Query: 175 MGAIMFEMLSFRILFPGKN---SADQIYKICQVIGSP----TEDSWPLGIQLASNLDWKF 227
+G I++ MLS ++ F + + +I + I ++W
Sbjct: 195 LGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK------------- 241
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280
+S A LI L + +P+ R + + + + +
Sbjct: 242 ---------NVSQEAK----DLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 5e-50
Identities = 72/296 (24%), Positives = 129/296 (43%), Gaps = 37/296 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++ V ++ + + AVK ++K+ SR +EV+ L + H N+++L +E
Sbjct: 24 GAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFREVEMLYQCQGHRNVLELIEFFEE 82
Query: 61 HEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ ++VFE M +L + +R ++F+E E + V L ++H +G HRDLKP
Sbjct: 83 EDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPE 140
Query: 120 NLL-VSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRW--------YRAPEVL----LLS 163
N+L +KI D + I + C+ T Y APEV+ +
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 164 EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQ---LA 220
IY D+W++G I++ +LS F G+ +D C + +
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD-----CGWDRGEACPACQNMLFESIQE 255
Query: 221 SNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276
++ + S +A LIS+L + R +AA+ L+HP+ + C
Sbjct: 256 GKYEFPDKDWAHI-----SCAAK----DLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-50
Identities = 62/279 (22%), Positives = 118/279 (42%), Gaps = 35/279 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G V + ++ S + K +K K D+ KE+ L H NI+ L +
Sbjct: 16 GEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIAR-HRNILHLHESFES 72
Query: 61 HEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E++ ++FE++ D+ + + +E E+ + QV + L ++H H D++P
Sbjct: 73 MEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPE 131
Query: 120 NLL-VSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N++ ++ IKI + G +++ T Y APEV ++ DMW++G
Sbjct: 132 NIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV-HQHDVVSTATDMWSLG 190
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+++ +LS F + + I I + E+++
Sbjct: 191 TLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK---------------------- 228
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
E+S A + + RL R TA+EAL+HP+ +
Sbjct: 229 EISIEA----MDFVDRLLVKERKSRMTASEALQHPWLKQ 263
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-49
Identities = 72/284 (25%), Positives = 129/284 (45%), Gaps = 41/284 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLVK 59
G++ V + + +G+ A + K S + + L+ E + R + HPNIV+L + +
Sbjct: 22 GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK-HPNIVRLHDSIS 80
Query: 60 EHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
E +++F+ + +L + + R + +SE + + Q+ + + + H+ G HR+LKP
Sbjct: 81 EEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKP 138
Query: 119 SNLL-VSKG---VIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMW 173
NLL SK +K+ D G+ E++ + T Y +PEV L + YG VD+W
Sbjct: 139 ENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV-LRKDPYGKPVDLW 197
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPT--EDSWPLGIQLASNLDWKFPQMG 231
A G I++ +L F ++ +I G+ W
Sbjct: 198 ACGVILYILLVGYPPFWDEDQHRLYQQIKA--GAYDFPSPEWD----------------- 238
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
++P A LI+++ + NP R TAAEAL+HP+
Sbjct: 239 -----TVTPEA----KDLINKMLTINPSKRITAAEALKHPWISH 273
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-49
Identities = 64/323 (19%), Positives = 122/323 (37%), Gaps = 59/323 (18%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHP----NIVKLRN 56
G++G V + ++ AVK ++ + E L+K+ N NIVK
Sbjct: 46 GTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA--KIEADILKKIQNDDINNNNIVKYHG 103
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
++ + ++FE + L +++ F ++++ C ++ + L+Y+ + H DL
Sbjct: 104 KFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDL 163
Query: 117 KPSN-LLVSKGVIKIGDLGM-----------------VKEID--SSLPCTD------YVT 150
KP N LL K +K ID + +
Sbjct: 164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIIN 221
Query: 151 TRWYRAPEVLL-LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPT 209
TR YRAPEV+L L + DMW+ G ++ E+ + +LF + + + +I
Sbjct: 222 TRQYRAPEVILNLG--WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIP 279
Query: 210 EDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESI-------------------SLI 250
++ + + K+ + L ++S SI +
Sbjct: 280 KN---MLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336
Query: 251 SRLCSWNPHMRPTAAEALEHPFF 273
+ +P +RP+ AE L+H F
Sbjct: 337 YSILQIDPTLRPSPAELLKHKFL 359
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-49
Identities = 76/286 (26%), Positives = 128/286 (44%), Gaps = 41/286 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-----EVKCLRKMNNHPNIVKLR 55
G + V + K +G+ A K +KK+ S + EV LR++ HPNI+ L
Sbjct: 16 GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLH 74
Query: 56 NLVKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
++ + DV ++ E + +L + E+ ++ +EDE Q+ G+HY+H + H
Sbjct: 75 DIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHF 132
Query: 115 DLKPSN-LLVSKGV----IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPE 169
DLKP N +L+ K V IK+ D G+ +I++ + T + APE++ E G E
Sbjct: 133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN-YEPLGLE 191
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
DMW++G I + +LS F G+ + + I V E+ +
Sbjct: 192 ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS--------------- 236
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
S A I RL +P R T A++LEH + ++
Sbjct: 237 -------NTSELA----KDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-49
Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 41/282 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ V++ K + + A+K LKK + D+ E+ L +++ HPNI+KL+ + +
Sbjct: 64 GATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLS-HPNIIKLKEIFET 119
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
++ +V E + +L + E+ +SE + + Q+ + + Y+H G HRDLKP
Sbjct: 120 PTEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177
Query: 120 NLL-VSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
NLL + +KI D G+ K ++ + T Y APE+ L YGPEVDMW++
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI-LRGCAYGPEVDMWSV 236
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPT--EDSWPLGIQLASNLDWKFPQMGGV 233
G I + +L F + +++ W
Sbjct: 237 GIITYILLCGFEPFYDERGDQFMFRRILN-CEYYFISPWWD------------------- 276
Query: 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
E+S +A L+ +L +P R T +AL+HP+
Sbjct: 277 ---EVSLNA----KDLVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 9e-49
Identities = 63/278 (22%), Positives = 119/278 (42%), Gaps = 34/278 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V + ++K +G K + + LD+ E+ + +++ HP ++ L + ++
Sbjct: 62 GAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLH-HPKLINLHDAFED 119
Query: 61 HEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
++ ++ E++ +L + SE EV N Q +GL +MH H D+KP
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPE 178
Query: 120 NLLVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N++ +KI D G+ +++ T + APE+ + E G DMWA+G
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI-VDREPVGFYTDMWAIG 237
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+ + +LS F G++ + + + + ED++
Sbjct: 238 VLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS---------------------- 275
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+SP A I L P R T +ALEHP+ +
Sbjct: 276 SVSPEA----KDFIKNLLQKEPRKRLTVHDALEHPWLK 309
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-48
Identities = 72/284 (25%), Positives = 119/284 (41%), Gaps = 43/284 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKL----R 55
GS+ V++ LD ++ VA +L+ + + E + K E + L+ + HPNIV+
Sbjct: 37 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWE 95
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF-- 112
+ VK + + +V E M S L +K + +R+ C Q+ +GL ++H +
Sbjct: 96 STVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 113 HRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
HRDLK N+ ++ G +KIGDLG+ +S T + APE+ E Y V
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFM-APEM--YEEKYDESV 210
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
D++A G M EM + + +A QIY+ T P + + K
Sbjct: 211 DVYAFGMCMLEMATSEYPYSECQNAAQIYRR------VTSGVKPASFDKVAIPEVK---- 260
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+I N R + + L H FF+
Sbjct: 261 -----------------EIIEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-48
Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 41/286 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-----EVKCLRKMNNHPNIVKLR 55
G + V + +K +G A K +KK+ + EV LR++ H N++ L
Sbjct: 23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLH 81
Query: 56 NLVKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
++ + DV ++ E + +L + ++ ++ SE+E + Q+ G++Y+H + H
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 115 DLKPSNLLVS-----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPE 169
DLKP N+++ IK+ D G+ EI+ + + T + APE++ E G E
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-YEPLGLE 198
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
DMW++G I + +LS F G + + I V + F
Sbjct: 199 ADMWSIGVITYILLSGASPFLGDTKQETLANITSV-------------------SYDFD- 238
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
E S + I +L R T EAL HP+
Sbjct: 239 ------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-48
Identities = 68/285 (23%), Positives = 118/285 (41%), Gaps = 39/285 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLVK 59
G+YG V+ D + +A+K++ ++ S+ L E+ + + H NIV+
Sbjct: 33 GTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLK-HKNIVQYLGSFS 89
Query: 60 EHEDVFIVFEYMESD-LLKLMKERAGQ-NFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
E+ + I E + L L++ + G +E + Q+ +GL Y+H HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 118 PSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVT-TRWYRAPEVLLLSEI-YGPEVDMW 173
N+L++ GV+KI D G K + PCT+ T T Y APE++ YG D+W
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIW 209
Query: 174 AMGAIMFEMLSFRILFPGKNSADQ-IYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
++G + EM + + F ++K+ P
Sbjct: 210 SLGCTIIEMATGKPPFYELGEPQAAMFKV------GMFKVHP------------------ 245
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
E+ S S E+ + I + +P R A + L F +
Sbjct: 246 ----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 2e-48
Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 36/279 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V + ++ +G A K + S D+ KE++ + + HP +V L + ++
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLR-HPTLVNLHDAFED 225
Query: 61 HEDVFIVFEYME-SDLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
++ +++E+M +L K+ E SEDE QV +GL +MH Y H DLKP
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 283
Query: 119 SNLL-VSKGV--IKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N++ +K +K+ D G+ +D T + APEV + G DMW++
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV-AEGKPVGYYTDMWSV 342
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G + + +LS F G+N + + + DW
Sbjct: 343 GVLSYILLSGLSPFGGENDDETLRNVKSC-------------------DWNMD------- 376
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
S + I +L +P+ R T +ALEHP+
Sbjct: 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 2e-48
Identities = 71/280 (25%), Positives = 116/280 (41%), Gaps = 37/280 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++ +VF + +G+ A+K +KK +S E+ L+K+ H NIV L ++ +
Sbjct: 20 GAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIK-HENIVTLEDIYES 77
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
++V + + +L + ER ++E + + QV + Y+H G HRDLKP
Sbjct: 78 TTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPE 135
Query: 120 NLLV-SKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
NLL + I I D G+ K + + T Y APEV L + Y VD W++
Sbjct: 136 NLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEV-LAQKPYSKAVDCWSI 193
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G I + +L F + + KI + W
Sbjct: 194 GVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWD--------------------- 232
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
++S SA I L +P+ R T +AL HP+
Sbjct: 233 -DISESA----KDFICHLLEKDPNERYTCEKALSHPWIDG 267
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-48
Identities = 68/286 (23%), Positives = 121/286 (42%), Gaps = 41/286 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-----EVKCLRKMNNHPNIVKLR 55
G + V + +K +G A K +KK+ + EV L+++ HPN++ L
Sbjct: 22 GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLH 80
Query: 56 NLVKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ + DV ++ E + +L + E+ ++ +E+E Q+ G++Y+H H
Sbjct: 81 EVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 115 DLKPSNLLVS-----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPE 169
DLKP N+++ K IKI D G+ +ID + T + APE+ + E G E
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-VNYEPLGLE 197
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
DMW++G I + +LS F G + + + V ++ +
Sbjct: 198 ADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS--------------- 242
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
S A I RL +P R T ++L+HP+ +
Sbjct: 243 -------NTSALA----KDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-48
Identities = 66/279 (23%), Positives = 118/279 (42%), Gaps = 36/279 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLVK 59
G +G V + + +G +A K +K + + + +K E+ + +++ H N+++L + +
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLD-HANLIQLYDAFE 156
Query: 60 EHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
D+ +V EY++ +L + + N +E + Q+ +G+ +MH+ H DLKP
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKP 215
Query: 119 SNLLVS---KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N+L IKI D G+ + T + APEV + + DMW++
Sbjct: 216 ENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDFVSFPTDMWSV 274
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G I + +LS F G N A+ + I W
Sbjct: 275 GVIAYMLLSGLSPFLGDNDAETLNNILAC-------------------RWDLE------- 308
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
E S E+ IS+L R +A+EAL+HP+
Sbjct: 309 DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-48
Identities = 68/291 (23%), Positives = 108/291 (37%), Gaps = 63/291 (21%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR----N 56
G G V Q +K++ E A+K L+ + +EV+ + + P+IV++ N
Sbjct: 29 GINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYEN 82
Query: 57 LVKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
L + + IV E ++ +L +++R Q F+E E + + + + Y+H HRD
Sbjct: 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 116 LKPSNLL-VSKG---VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
+KP NLL SK ++K+ D G A E E Y D
Sbjct: 143 VKPENLLYTSKRPNAILKLTDFGF--------------------AKET--TGEKYDKSCD 180
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVI--GSPTEDSWPLGIQLASNLDWKFPQ 229
MW++G IM+ +L F + + I G + W
Sbjct: 181 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE----------W---- 226
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280
S E LI L P R T E + HP+ VP
Sbjct: 227 ----------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-48
Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 49/283 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
G +G+V+ A +K++ +A+K L K ++ L+ E++ + HPNI+++ N
Sbjct: 25 GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYF 83
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ + ++++ E+ +L K +++ F E ++ LHY H + HRD+K
Sbjct: 84 HDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIK 141
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCT-----DYVTTRWYRAPEVLLLSEIYGPEVD 171
P NLL+ KG +KI D G S T DY+ PE+ + + + +VD
Sbjct: 142 PENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPEM-IEGKTHDEKVD 194
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231
+W G + +E L F + + +I V D KFP
Sbjct: 195 LWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-------------------DLKFP--- 232
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
P S S LIS+L ++P R +EHP+ +
Sbjct: 233 --------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 9e-48
Identities = 70/286 (24%), Positives = 120/286 (41%), Gaps = 41/286 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-----EVKCLRKMNNHPNIVKLR 55
G + V + +K +G A K +KK+ + EV LR++ HPNI+ L
Sbjct: 23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLH 81
Query: 56 NLVKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
++ + DV ++ E + +L + ++ ++ SE+E + Q+ G++Y+H + H
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 115 DLKPSNLLVS-----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPE 169
DLKP N+++ IK+ D G+ EI+ + + T + APE++ E G E
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-YEPLGLE 198
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
DMW++G I + +LS F G + + I V + F
Sbjct: 199 ADMWSIGVITYILLSGASPFLGDTKQETLANITAV-------------------SYDFD- 238
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
E S + I +L R T EAL HP+
Sbjct: 239 ------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-47
Identities = 74/319 (23%), Positives = 127/319 (39%), Gaps = 55/319 (17%)
Query: 1 GSYGDVFQALD-KKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN-----NHPNIVKL 54
G++G V + LD + VA+K ++ + + E+ L+K+ N V +
Sbjct: 30 GTFGKVVECLDHARGKSQVALKIIRNVGKYREAA--RLEINVLKKIKEKDKENKFLCVLM 87
Query: 55 RNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ H + I FE + + + +KE Q + VR++ +Q+ L ++H H
Sbjct: 88 SDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHT 147
Query: 115 DLKPSN-LLVSKGVIKIGDLGM-----------VKEID--SSLPCTD------YVTTRWY 154
DLKP N L V+ + + ++ D S+ D V TR Y
Sbjct: 148 DLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHY 205
Query: 155 RAPEVLL-LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSW 213
R PEV+L L + D+W++G I+FE LF + + + + +++G
Sbjct: 206 RPPEVILELG--WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHM- 262
Query: 214 PLGIQLAS--------NLDW-------KFPQMGGVNLRELSPSASRE---SISLISRLCS 255
I L W ++ + L+ S E L+ R+
Sbjct: 263 ---IHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319
Query: 256 WNPHMRPTAAEALEHPFFR 274
++P R T AEAL HPFF
Sbjct: 320 FDPAQRITLAEALLHPFFA 338
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 6e-47
Identities = 81/319 (25%), Positives = 136/319 (42%), Gaps = 55/319 (17%)
Query: 1 GSYGDVFQALDKKSG-EFVAVKKLKKKIFSLDESRNLKEVKCLRKMN-----NHPNIVKL 54
G++G V + +D K+G VAVK +K + + E++ L +N + V++
Sbjct: 25 GAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA--RSEIQVLEHLNTTDPNSTFRCVQM 82
Query: 55 RNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ H + IVFE + +KE F D +R + +Q+ + ++++H H
Sbjct: 83 LEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHT 142
Query: 115 DLKPSN-LLVSKGVIKIGDLGM-----------VKEID--SSLPCTD------YVTTRWY 154
DLKP N L V + + + +K +D S+ D V+TR Y
Sbjct: 143 DLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHY 200
Query: 155 RAPEVLL-LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSW 213
RAPEV+L L + D+W++G I+ E +FP +S + + + +++G +
Sbjct: 201 RAPEVILALG--WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHM- 257
Query: 214 PLGIQLAS--------NLDWKFPQMGGV-------NLRELSPSASRES---ISLISRLCS 255
IQ LDW G L+E S E LI ++
Sbjct: 258 ---IQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314
Query: 256 WNPHMRPTAAEALEHPFFR 274
++P R T EAL+HPFF
Sbjct: 315 YDPAKRITLREALKHPFFD 333
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-47
Identities = 73/300 (24%), Positives = 118/300 (39%), Gaps = 62/300 (20%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKL----- 54
G + V++A D SG A+K+L +++R + EV ++K++ HPNIV+
Sbjct: 39 GGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96
Query: 55 ---RNLVKEHEDVFIVFEYMESDLLKLMKERAGQN-FSEDEVRNLCFQVFQGLHYMHRQG 110
+ ++ E + L++ +K+ + S D V + +Q + + +MHRQ
Sbjct: 97 IGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK 156
Query: 111 --YFHRDLKPSNLLVSK-GVIKIGDLG----MVKEIDSSLPCTD---------YVTTRWY 154
HRDLK NLL+S G IK+ D G + D S TT Y
Sbjct: 157 PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMY 216
Query: 155 RAPEVLLLS--EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDS 212
R PE++ L G + D+WA+G I++ + + P ED
Sbjct: 217 RTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ--------------------HPFEDG 256
Query: 213 WPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
L I N + P + SLI + NP R + AE +
Sbjct: 257 AKLRIV---NGKYSIPP---------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-46
Identities = 56/306 (18%), Positives = 117/306 (38%), Gaps = 52/306 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK---------------KIFSLDESRNLK-EVKCLRK 44
G + + +K +F A+KK +K KI + + K E++ +
Sbjct: 42 GKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99
Query: 45 MNNHPNIVKLRNLVKEHEDVFIVFEYMES----DLL---KLMKERAGQNFSEDEVRNLCF 97
+ + + ++ +++V+I++EYME+ ++ + ++ +
Sbjct: 100 IK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 98 QVFQGLHYMHRQ-GYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCT-----DYVT 150
V Y+H + HRD+KPSN+L+ G +K+ D G + + +++
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFM- 217
Query: 151 TRWYRAPEVLLLSEIY-GPEVDMWAMGAIMFEMLSFRILFPGKNSADQIY-KICQVIGSP 208
PE Y G +VD+W++G ++ M + F K S +++ I
Sbjct: 218 -----PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN--- 269
Query: 209 TEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268
I+ + + + + S E I + NP R T+ +AL
Sbjct: 270 --------IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL 321
Query: 269 EHPFFR 274
+H +
Sbjct: 322 KHEWLA 327
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-46
Identities = 38/318 (11%), Positives = 93/318 (29%), Gaps = 81/318 (25%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLK-EVKCLRKMN------------ 46
+A D+++GE V + + + +K EV LR +
Sbjct: 84 EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143
Query: 47 ------------NHPNIVKLRNLVKEHE--DVFIVFEYMESDLLKLMKE-----RAGQNF 87
++++R ++ F ++ M+S+L + ++
Sbjct: 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203
Query: 88 SEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCT 146
L QV + L +H G H L+P ++++ + G + + + +
Sbjct: 204 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---V 260
Query: 147 DYVTTRWYRAPEVLLLSE----------IYGPEVDMWAMGAIMFEMLSFRILFPGKNSAD 196
+R + PE+ + D WA+G +++ + + +
Sbjct: 261 VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG 320
Query: 197 QIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSW 256
I + + + + +L+ +
Sbjct: 321 GSEWIFR------------------------------SCKNIPQPVR----ALLEGFLRY 346
Query: 257 NPHMRPTAAEALEHPFFR 274
R +A+E P +
Sbjct: 347 PKEDRLLPLQAMETPEYE 364
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-44
Identities = 65/293 (22%), Positives = 104/293 (35%), Gaps = 52/293 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+G+V + DK++G AVKK++ ++F ++E + + P IV L V+E
Sbjct: 69 GSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGL-------SSPRIVPLYGAVRE 121
Query: 61 HEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
V I E +E L+K ED Q +GL Y+H + H D+
Sbjct: 122 GPWVNIFMELLEGGSLGQLIK-----QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 117 KPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVT------TRWYRAPEVLLLSEIYGP 168
K N+L+S + D G + +T T + APEV++
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDA 235
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228
+VD+W+ +M ML+ + KI +E P
Sbjct: 236 KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEPP---------------P 274
Query: 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPR 281
RE+ PS + + I P R +A E
Sbjct: 275 I------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-43
Identities = 61/282 (21%), Positives = 119/282 (42%), Gaps = 35/282 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR-NLVK 59
G+ G V++ +K+G +AVK++++ + R L ++ + K ++ P IV+ +
Sbjct: 36 GTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95
Query: 60 EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKP 118
DVFI E M + KL K G E + + + + L+Y+ + G HRD+KP
Sbjct: 96 NT-DVFIAMELMGTCAEKLKKRMQGP-IPERILGKMTVAIVKALYYLKEKHGVIHRDVKP 153
Query: 119 SNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI----YGPEVDMW 173
SN+L+ +G IK+ D G+ + Y APE + + Y D+W
Sbjct: 154 SNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVW 213
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
++G + E+ + + + + +++ + E+ P L ++ +
Sbjct: 214 SLGISLVELATGQFPYKNCKT---DFEVLTKV--LQEEP-P---LLPGHMGF-------- 256
Query: 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
S + S + + + RP + LEH F +
Sbjct: 257 ---------SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-43
Identities = 66/287 (22%), Positives = 121/287 (42%), Gaps = 41/287 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK---EVKCLRKMNNHPNIVKLRNL 57
GSYG V + LD ++ AVK LKKK + E++ LR++ H N+++L ++
Sbjct: 16 GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDV 74
Query: 58 VKEHE--DVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+ E +++V EY + +++ + F + Q+ GL Y+H QG H+D
Sbjct: 75 LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKD 134
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVT---TRWYRAPEVLLLSEIY-GPEV 170
+KP NLL+ + G +KI LG+ + + T + ++ PE+ + + G +V
Sbjct: 135 IKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKV 194
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
D+W+ G ++ + + F G N I + P
Sbjct: 195 DIWSAGVTLYNITTGLYPFEGDNIYKLFENIG-------------------KGSYAIP-- 233
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+ P S L+ + + P R + + +H +FR H
Sbjct: 234 -----GDCGPPLSD----LLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-43
Identities = 66/289 (22%), Positives = 122/289 (42%), Gaps = 46/289 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++ V A +G VA+K + K ++ + +EV+ + K+ NHPNIVKL +++
Sbjct: 26 GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM-KILNHPNIVKLFEVIE 84
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ ++++ EY ++ + E E R+ Q+ + Y H++ HRDLK
Sbjct: 85 TEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKA 142
Query: 119 SNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW-----YRAPEVLLLSEIYGPEVDM 172
NLL+ + IKI D G S+ + Y APE+ + GPEVD+
Sbjct: 143 ENLLLDADMNIKIADFGF-----SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDV 197
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
W++G I++ ++S + F G+N + ++ + G +
Sbjct: 198 WSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFY------------------- 236
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPR 281
+S +L+ R NP R T + ++ + + H
Sbjct: 237 -----MSTDC----ENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-42
Identities = 62/287 (21%), Positives = 111/287 (38%), Gaps = 51/287 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLK----EVKCLRKMNN---HPNIV 52
G +G VF VA+K + + ++ + EV L K+ HP ++
Sbjct: 42 GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101
Query: 53 KLRNLVKEHEDVFIVFEYMES--DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG 110
+L + + E +V E DL + E+ E R QV + + H +G
Sbjct: 102 RLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRG 159
Query: 111 YFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGP 168
HRD+K N+L+ +G K+ D G + P TD+ TR Y PE + + +
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHAL 218
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228
+W++G ++++M+ I F ++ +I + + FP
Sbjct: 219 PATVWSLGILLYDMVCGDIPF------ERDQEILEA-------------------ELHFP 253
Query: 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
S + +LI R + P RP+ E L P+ ++
Sbjct: 254 -----------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQT 289
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-42
Identities = 62/310 (20%), Positives = 111/310 (35%), Gaps = 41/310 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN------LKEVKCLRKMNNHPNIVKL 54
V A K +GE+V V+ +L+ N E+ + N HPNIV
Sbjct: 38 EDLMTVNLARYKPTGEYVTVR-----RINLEACSNEMVTFLQGELHVSKLFN-HPNIVPY 91
Query: 55 RNLVKEHEDVFIVFEYME--SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
R ++++V +M S L+ +E + + V + L Y+H GY
Sbjct: 92 RATFIADNELWVVTSFMAYGS-AKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV 150
Query: 113 HRDLKPSNLLVSK-GVIKIGDLG--------MVKEIDSSLPCTDYVTTRWYRAPEVLLLS 163
HR +K S++L+S G + + L ++ V + +PEVL +
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN 210
Query: 164 EI-YGPEVDMWAMG--AI--------MFEMLSFRILF------PGKNSADQIYKICQVIG 206
Y + D++++G A +M + ++L ++
Sbjct: 211 LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTM 270
Query: 207 SPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAE 266
SP+ G+ + P G + S + + NP RP+A+
Sbjct: 271 SPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330
Query: 267 ALEHPFFRSC 276
L H FF+
Sbjct: 331 LLNHSFFKQI 340
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 5e-42
Identities = 40/314 (12%), Positives = 90/314 (28%), Gaps = 74/314 (23%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLK-EVKCLRKMN------------ 46
+A D+++GE V + + + +K EV LR +
Sbjct: 89 EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148
Query: 47 ---------NHPNIVKLRNLVKEHED-----VFIVFEYMESDLLKLMKE-----RAGQNF 87
P K+ + + D F ++ M+S+L + ++
Sbjct: 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 208
Query: 88 SEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--P 144
L QV + L +H G H L+P ++++ + G + + + +S P
Sbjct: 209 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSP 268
Query: 145 CTDYVTTRWYRAPEVLLLSE----IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYK 200
A +L + + D W +G ++ + + +
Sbjct: 269 IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW 328
Query: 201 ICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHM 260
I + + + + +L+ +
Sbjct: 329 IFR------------------------------SCKNIPQPVR----ALLEGFLRYPKED 354
Query: 261 RPTAAEALEHPFFR 274
R +A+E P +
Sbjct: 355 RLLPLQAMETPEYE 368
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-41
Identities = 62/285 (21%), Positives = 115/285 (40%), Gaps = 49/285 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLK----EVKCLRKMNN-HPNIVKL 54
G +G V+ + VA+K + K +I E N EV L+K+++ +++L
Sbjct: 54 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113
Query: 55 RNLVKEHEDVFIVFEYMES--DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ + + ++ E E DL + ER E+ R+ +QV + + + H G
Sbjct: 114 LDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVL 171
Query: 113 HRDLKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
HRD+K N+L+ ++G +K+ D G + ++ TD+ TR Y PE + +G
Sbjct: 172 HRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSA 230
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
+W++G ++++M+ I F + +I + +
Sbjct: 231 AVWSLGILLYDMVCGDIPF------EHDEEI---------------------IRGQV--- 260
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
S E LI + P RPT E HP+ +
Sbjct: 261 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-41
Identities = 69/294 (23%), Positives = 123/294 (41%), Gaps = 24/294 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVK-LRNLVK 59
G+ G VF+ K SG +A K + +I ++ ++E++ L + N P IV
Sbjct: 44 GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE-CNSPYIVGFYGAFYS 102
Query: 60 EHEDVFIVFEYMESD-LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY-FHRDLK 117
+ ++ I E+M+ L +++K+ E + + V +GL Y+ + HRD+K
Sbjct: 103 DG-EISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVK 159
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
PSN+LV S+G IK+ D G+ ++ S+ +V TR Y +PE L Y + D+W+MG
Sbjct: 160 PSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPER-LQGTHYSVQSDIWSMG 217
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN-- 234
+ EM R P ++ + + ++ P L+
Sbjct: 218 LSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277
Query: 235 -------LRELSPSA-----SRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276
+ E P S E +++ NP R + + H F +
Sbjct: 278 FELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-41
Identities = 69/284 (24%), Positives = 129/284 (45%), Gaps = 36/284 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR-NLVK 59
G+YG V + + K SG+ +AVK+++ + ++ + L ++ + + ++ P IV+ L +
Sbjct: 33 GAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92
Query: 60 EHEDVFIVFEYME---SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY-FHRD 115
E D +I E M K + E+ + + + L+++ HRD
Sbjct: 93 EG-DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRD 151
Query: 116 LKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI---YGPEVD 171
+KPSN+L+ G IK+ D G+ ++ S+ T R Y APE + S Y D
Sbjct: 152 IKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSD 211
Query: 172 MWAMGAIMFEMLSFRILFPGKNS-ADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
+W++G ++E+ + R +P NS DQ+ ++ D P QL+++ + +F
Sbjct: 212 VWSLGITLYELATGRFPYPKWNSVFDQLTQV------VKGDP-P---QLSNSEEREF--- 258
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
S I+ ++ + + RP E L+HPF
Sbjct: 259 ------------SPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-41
Identities = 62/347 (17%), Positives = 112/347 (32%), Gaps = 104/347 (29%)
Query: 1 GSYGDVFQALDKKSGEFVAVK------------KLKKKIFSLDESRNLKEVKC------- 41
G +G VF+A +K A+K K+ +++ +L + + V+
Sbjct: 17 GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLET 76
Query: 42 -------------------------------------LRKMNNHPNIVKLRNLVKEHEDV 64
+ N V +
Sbjct: 77 PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYL 136
Query: 65 FIVFEYME-SDLLKLMKERAGQNFSE-DEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN-L 121
+I + +L M R E ++ Q+ + + ++H +G HRDLKPSN
Sbjct: 137 YIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIF 196
Query: 122 LVSKGVIKIGDLGMVKEIDSSLPC-------------TDYVTTRWYRAPEVLLLSEIYGP 168
V+K+GD G+V +D T V T+ Y +PE + Y
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ-IHGNNYSH 255
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228
+VD++++G I+FE+L I + + KFP
Sbjct: 256 KVDIFSLGLILFELLY--SFSTQMERVRIITDVRNL---------------------KFP 292
Query: 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
L + ++ + S +P RP A + +E+ F +
Sbjct: 293 --------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-40
Identities = 72/282 (25%), Positives = 125/282 (44%), Gaps = 36/282 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR-NLVK 59
G+YG V + SG+ +AVK+++ + S ++ R L ++ + + P V L +
Sbjct: 18 GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR 77
Query: 60 EHEDVFIVFEYMESDLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF-HRDL 116
E DV+I E M++ L K K+ GQ ED + + + + L ++H + HRD+
Sbjct: 78 EG-DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDV 136
Query: 117 KPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI---YGPEVDM 172
KPSN+L++ G +K+ D G+ + + + Y APE + Y + D+
Sbjct: 137 KPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDI 196
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
W++G M E+ R FP + ++ QV+ P+ PQ+
Sbjct: 197 WSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS------------------PQLP- 235
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+ S E + S+ N RPT E ++HPFF
Sbjct: 236 ------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-39
Identities = 77/282 (27%), Positives = 122/282 (43%), Gaps = 46/282 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
GS+G V A K+ + VA+K + ++ + D ++ E+ L K+ HP+I+KL +++
Sbjct: 20 GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL-KLLRHPHIIKLYDVI 78
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
D+ +V EY +L + E+ + +EDE R Q+ + Y HR HRDLKP
Sbjct: 79 TTPTDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKP 136
Query: 119 SNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW-----YRAPEVLLLSEIYGPEVDM 172
NLL+ +KI D G+ S++ Y APEV+ GPEVD+
Sbjct: 137 ENLLLDDNLNVKIADFGL-----SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDV 191
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
W+ G +++ ML R+ F + + K+ +
Sbjct: 192 WSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS--CVYVMPDF------------------- 230
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
LSP A SLI R+ +P R T E P+F
Sbjct: 231 -----LSPGA----QSLIRRMIVADPMQRITIQEIRRDPWFN 263
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-39
Identities = 77/283 (27%), Positives = 122/283 (43%), Gaps = 47/283 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
G++G V + +G VAVK L ++KI SLD +K E++ L K+ HP+I+KL ++
Sbjct: 22 GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL-KLFRHPHIIKLYQVI 80
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
D F+V EY+ +L + + E E R L Q+ + Y HR HRDLK
Sbjct: 81 STPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW-----YRAPEVLLLSEIYGPEVD 171
P N+L+ + KI D G+ S++ Y APEV+ GPEVD
Sbjct: 139 PENVLLDAHMNAKIADFGL-----SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVD 193
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231
+W+ G I++ +L + F ++ KI + P
Sbjct: 194 IWSCGVILYALLCGTLPFDDEHVPTLFKKI-------------------RGGVFYIP--- 231
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
L+ S +L+ + +P R T + EH +F+
Sbjct: 232 ----EYLNRSV----ATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 76/279 (27%), Positives = 113/279 (40%), Gaps = 35/279 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G DK + E VAVK +++ + + +E+ R + HPNIV+ + ++
Sbjct: 31 GNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLR-HPNIVRFKEVILT 87
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ I+ EY +L + + FSEDE R Q+ G+ Y H HRDLK
Sbjct: 88 PTHLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE 145
Query: 120 NLLV---SKGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N L+ +KI D G K S P + V T Y APEVLL E G D+W+
Sbjct: 146 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRQEYDGKIADVWSC 204
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G ++ ML F K Q I ++ + P +
Sbjct: 205 GVTLYVMLVGAYPFEDPEEPRDYRKTIQRI---------------LSVKYSIPDDIRI-- 247
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
S E LISR+ +P R + E H +F
Sbjct: 248 -------SPECCHLISRIFVADPATRISIPEIKTHSWFL 279
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-39
Identities = 78/309 (25%), Positives = 126/309 (40%), Gaps = 70/309 (22%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNL----------------------- 36
GSYG V A ++ + A+K L KKK+
Sbjct: 24 GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83
Query: 37 -KEVKCLRKMNNHPNIVKLRNLVKEHED--VFIVFEYMESDLLKLMKERAGQNFSEDEVR 93
+E+ L+K++ HPN+VKL ++ + + +++VFE + +M+ + SED+ R
Sbjct: 84 YQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQG--PVMEVPTLKPLSEDQAR 140
Query: 94 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTR 152
+ +G+ Y+H Q HRD+KPSNLLV G IKI D G+ E S D + +
Sbjct: 141 FYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS----DALLSN 196
Query: 153 W-----YRAPEVLL-LSEIY-GPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVI 205
+ APE L +I+ G +D+WAMG ++ + + F + KI
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI---- 252
Query: 206 GSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAA 265
+ +FP P + + LI+R+ NP R
Sbjct: 253 ---------------KSQALEFPD---------QPDIAEDLKDLITRMLDKNPESRIVVP 288
Query: 266 EALEHPFFR 274
E HP+
Sbjct: 289 EIKLHPWVT 297
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-39
Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 41/289 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++ +V K++G+ A+K + K + E +E + + + I +L +
Sbjct: 72 GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ +++V EY DLL L+ + G+ + R ++ + +HR GY HRD+KP
Sbjct: 132 DENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190
Query: 119 SNLLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLL------LSEIYGPE 169
N+L+ G I++ D G ++ D ++ V T Y +PE+L + YGPE
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE 250
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
D WA+G +EM + F ++A+ KI + P
Sbjct: 251 CDWWALGVFAYEMFYGQTPFYADSTAETYGKI-----------------VHYKEHLSLPL 293
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMR---PTAAEALEHPFFRS 275
+ E+ I RL P R A + HPFF
Sbjct: 294 V--------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-38
Identities = 70/286 (24%), Positives = 116/286 (40%), Gaps = 41/286 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G+V K + + A+K L K + +S E + + N P +V+L +
Sbjct: 80 GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139
Query: 60 EHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ +++V EYM DL+ LM + E R +V L +H G+ HRD+KP
Sbjct: 140 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKP 196
Query: 119 SNLLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLL---LSEIYGPEVDM 172
N+L+ G +K+ D G ++ + + C V T Y +PEVL YG E D
Sbjct: 197 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 256
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
W++G ++EML F + KI + FP
Sbjct: 257 WSVGVFLYEMLVGDTPFYADSLVGTYSKI-----------------MNHKNSLTFPD--- 296
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMR---PTAAEALEHPFFRS 275
S+E+ +LI + + +R E H FF++
Sbjct: 297 ------DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 335
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-38
Identities = 59/290 (20%), Positives = 110/290 (37%), Gaps = 47/290 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLKEVKCLR-----KMNNHPNIVKL 54
G++G V+ A+DK+ + V VK + K+K+ + K K H NI+K+
Sbjct: 35 GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94
Query: 55 RNLVKEHEDVFIVFEYMES--DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
++ + +V E S DL + E + Q+ + Y+ +
Sbjct: 95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDII 152
Query: 113 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
HRD+K N+++ IK+ D G ++ + T Y APEVL+ + GPE++
Sbjct: 153 HRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELE 212
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231
MW++G ++ ++ F ++ + + P
Sbjct: 213 MWSLGVTLYTLVFEENPF------CELEETVEA-------------------AIHPP--- 244
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPR 281
S+E +SL+S L P R T + + P+ +
Sbjct: 245 --------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLAD 286
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-38
Identities = 64/280 (22%), Positives = 116/280 (41%), Gaps = 37/280 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG+V A+++ + E VAVK + K KE+ KM NH N+VK +E
Sbjct: 18 GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN-KMLNHENVVKFYGHRRE 76
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
++ EY +L ++ G E + + Q+ G+ Y+H G HRD+KP
Sbjct: 77 GNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 120 NLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVT---TRWYRAPEVLLLSEIYGPEVDMWAM 175
NLL+ + +KI D G+ + T Y APE+L E + VD+W+
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 176 GAIMFEMLSFRILFPGKNSADQIY-KICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
G ++ ML+ + + + + Q Y + + W
Sbjct: 195 GIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPW--------------------- 231
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+++ + ++L+ ++ NP R T + + ++
Sbjct: 232 -KKIDSAP----LALLHKILVENPSARITIPDIKKDRWYN 266
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 37/286 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G+V K + + A+K L K + E+ +E + + + I L +
Sbjct: 85 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ ++++V +Y DLL L+ + E+ R ++ + +H+ Y HRD+KP
Sbjct: 145 DDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKP 203
Query: 119 SNLLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSEI----YGPEVD 171
N+L+ G I++ D G ++ D ++ + V T Y +PE+L E YGPE D
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECD 263
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231
W++G M+EML F ++ + KI + ++FP
Sbjct: 264 WWSLGVCMYEMLYGETPFYAESLVETYGKI-----------------MNHKERFQFPT-- 304
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHM--RPTAAEALEHPFFRS 275
+ ++S +A LI RL H + + +HPFF
Sbjct: 305 --QVTDVSENA----KDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-38
Identities = 69/283 (24%), Positives = 115/283 (40%), Gaps = 35/283 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G +G+V + +G+ A KKL+KK I K + + N +V L +
Sbjct: 195 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254
Query: 60 EHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ + +V M DL + F E ++ GL +HR+ +RDLKP
Sbjct: 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314
Query: 119 SNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
N+L+ G I+I DLG+ + V T Y APEV + +E Y D WA+G
Sbjct: 315 ENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV-VKNERYTFSPDWWALGC 373
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
+++EM++ + F + + ++ +++ E
Sbjct: 374 LLYEMIAGQSPFQQRKKKIKREEVERLV-------------KEVPE-------------E 407
Query: 238 LSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRS 275
S S ++ SL S+L +P R +A E EHP F+
Sbjct: 408 YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-37
Identities = 47/288 (16%), Positives = 108/288 (37%), Gaps = 53/288 (18%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
G +G V+ GE VA++ + + + D+ + +EV R+ H N+V
Sbjct: 44 GRFGQVYHGRWH--GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTR-HENVVLFMGACM 99
Query: 60 EHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ I+ + L ++++ ++ R + ++ +G+ Y+H +G H+DLK
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKS 158
Query: 119 SNLLVSKGVIKIGDLGM--VKEIDSSLPCTDYVTTR--WYR--APEVL--------LLSE 164
N+ G + I D G+ + + + D + + W APE++
Sbjct: 159 KNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKL 218
Query: 165 IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224
+ D++A+G I +E+ + F + + I+++
Sbjct: 219 PFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM----------------------- 255
Query: 225 WKFPQMGGVNLRELSP--SASRESISLISRLCSWNPHMRPTAAEALEH 270
G ++ +E ++ ++ RPT + ++
Sbjct: 256 -------GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-37
Identities = 68/279 (24%), Positives = 121/279 (43%), Gaps = 43/279 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
GS+G V +A G VAVK L ++ F + L+EV ++++ HPNIV V
Sbjct: 48 GSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVT 104
Query: 60 EHEDVFIVFEYME-SDLLK-LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF--HRD 115
+ ++ IV EY+ L + L K A + E ++ + V +G++Y+H + HR+
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRN 164
Query: 116 LKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYV--TTRWYRAPEVLLLSEIYGPEVDM 172
LK NLLV K +K+ D G+ + S+ + T W APEV L E + D+
Sbjct: 165 LKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW-MAPEV-LRDEPSNEKSDV 222
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
++ G I++E+ + + + N A + +
Sbjct: 223 YSFGVILWELATLQQPWGNLNPAQVVAAVGF----------------------------- 253
Query: 233 VNLR-ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
R E+ + + + ++I + P RP+ A ++
Sbjct: 254 KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 7e-37
Identities = 69/289 (23%), Positives = 119/289 (41%), Gaps = 49/289 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
GS+ V A + + A+K L+K+ I ++ + E + +++ HP VKL
Sbjct: 41 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTF 99
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
++ E ++ Y ++ +LLK ++ + G F E R ++ L Y+H +G HRDLK
Sbjct: 100 QDDEKLYFGLSYAKNGELLKYIR-KIGS-FDETCTRFYTAEIVSALEYLHGKGIIHRDLK 157
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVT---TRWYRAPEVLLLSEIYGPEVDMW 173
P N+L+ I+I D G K + + T Y +PE+L + D+W
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT-EKSACKSSDLW 216
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIY-KICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
A+G I++++++ F N I+ KI L++ FP
Sbjct: 217 ALGCIIYQLVAGLPPFRAGNE-YLIFQKII-------------------KLEYDFP---- 252
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPT------AAEALEHPFFRS 275
+ P A L+ +L + R HPFF S
Sbjct: 253 ---EKFFPKA----RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-37
Identities = 63/280 (22%), Positives = 115/280 (41%), Gaps = 37/280 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG+V A+++ + E VAVK + K KE+ + +N H N+VK +E
Sbjct: 18 GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRRE 76
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
++ EY +L ++ G E + + Q+ G+ Y+H G HRD+KP
Sbjct: 77 GNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPE 134
Query: 120 NLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVT---TRWYRAPEVLLLSEIYGPEVDMWAM 175
NLL+ + +KI D G+ + T Y APE+L E + VD+W+
Sbjct: 135 NLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSC 194
Query: 176 GAIMFEMLSFRILFPGKNSADQIY-KICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
G ++ ML+ + + + + Q Y + + WK
Sbjct: 195 GIVLTAMLAGELPWDQPSDSCQEYSDWKE-----KKTYLN---------PWKK------- 233
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
+ + ++L+ ++ NP R T + + ++
Sbjct: 234 ---IDSAP----LALLHKILVENPSARITIPDIKKDRWYN 266
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-36
Identities = 74/287 (25%), Positives = 116/287 (40%), Gaps = 51/287 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
GS+G VF A KK+ +F A+K LKK + D+ E + L HP + +
Sbjct: 28 GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87
Query: 59 KEHEDVFIVFEYMES-DLLK-LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ E++F V EY+ DL+ + F ++ GL ++H +G +RDL
Sbjct: 88 QTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKGIVYRDL 144
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------YRAPEVLLLSEIYGPE 169
K N+L+ G IKI D GM KE T Y APE+LL + Y
Sbjct: 145 KLDNILLDKDGHIKIADFGMCKE-----NMLGDAKTNTFCGTPDYIAPEILL-GQKYNHS 198
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
VD W+ G +++EML + F G++ + + I + +P
Sbjct: 199 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-------------------MDNPFYP- 238
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEAL-EHPFFRS 275
+E+ L+ +L P R + +HP FR
Sbjct: 239 ----------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-36
Identities = 67/302 (22%), Positives = 129/302 (42%), Gaps = 71/302 (23%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL-KEVKCLRKMNNHPNIVKL----- 54
G+YG V++ K+G+ A+K + + DE + +E+ L+K ++H NI
Sbjct: 35 GTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 55 -RNLVKEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ 109
+N + +++V E+ +DL+K K E+ + +C ++ +GL ++H+
Sbjct: 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT---LKEEWIAYICREILRGLSHLHQH 148
Query: 110 GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEI-- 165
HRD+K N+L+++ +K+ D G+ ++D ++ ++ T ++ APEV+ E
Sbjct: 149 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 208
Query: 166 --YGPEVDMWAMG--AI--------MFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSW 213
Y + D+W++G AI + +M R LF I P +
Sbjct: 209 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----------LI------PRNPA- 251
Query: 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273
P++ S++ S I N RP + ++HPF
Sbjct: 252 --------------PRLKSKKW-------SKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290
Query: 274 RS 275
R
Sbjct: 291 RD 292
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 37/282 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V + + A+K + K K +E RN KE++ ++ + HP +V L
Sbjct: 26 GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSF 84
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
++ ED+F+V + + DL +++ +F E+ V+ ++ L Y+ Q HRD+K
Sbjct: 85 QDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMK 142
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI--YGPEVDMWA 174
P N+L+ G + I D + + T T+ Y APE+ + Y VD W+
Sbjct: 143 PDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWS 202
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G +E+L R + + S+ +I + + +P
Sbjct: 203 LGVTAYELLRGRRPYHIR-SSTSSKEIVHTF-------------ETTVV--TYP------ 240
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEAL-EHPFFRS 275
+ S+E +SL+ +L NP R + + P+
Sbjct: 241 -----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 70/287 (24%), Positives = 113/287 (39%), Gaps = 40/287 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G +G+VF K +G+ A KKL KK + + K + + IV L +
Sbjct: 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255
Query: 60 EHEDVFIVFEYMES-DL---LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
D+ +V M D+ + + E F E Q+ GL ++H++ +RD
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMW 173
LKP N+L+ G ++I DLG+ E Y T + APE+ LL E Y VD +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL-LLGEEYDFSVDYF 373
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
A+G ++EM++ R F + + ++ Q + L + +P
Sbjct: 374 ALGVTLYEMIAARGPFRARGEKVENKELKQRV-------------LEQAV--TYP----- 413
Query: 234 NLRELSPSASRESISLISRLCSWNPHMR----PTAAEAL-EHPFFRS 275
S S L +P R + + L HP FR
Sbjct: 414 ------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-36
Identities = 59/287 (20%), Positives = 114/287 (39%), Gaps = 54/287 (18%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN---LKEVKCLRKMNNHPNIVKLRNL 57
G +G V++A G+ VAVK + +E K + HPNI+ LR +
Sbjct: 18 GGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGV 74
Query: 58 VKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF---H 113
+ ++ +V E+ L +++ + D + N Q+ +G++Y+H + H
Sbjct: 75 CLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 114 RDLKPSNLLVSKG---------VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE 164
RDLK SN+L+ + ++KI D G+ +E + + W APEV + +
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAW-MAPEV-IRAS 189
Query: 165 IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224
++ D+W+ G +++E+L+ + F G + Y +
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM--------------------- 228
Query: 225 WKFPQMGGVNLR-ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
L + + L+ + +PH RP+ L+
Sbjct: 229 --------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-36
Identities = 76/291 (26%), Positives = 124/291 (42%), Gaps = 55/291 (18%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
GS+G V + K + E AVK LKK + D+ E + L P + +L +
Sbjct: 31 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90
Query: 59 KEHEDVFIVFEYMES-DL-LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + ++ V EY+ DL + + F E ++ GL ++ +G +RDL
Sbjct: 91 QTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------YRAPEVLLLSEIYGPE 169
K N+++ S+G IKI D GM KE D VTT+ Y APE++ + YG
Sbjct: 148 KLDNVMLDSEGHIKIADFGMCKE-----NIWDGVTTKTFCGTPDYIAPEIIA-YQPYGKS 201
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
VD WA G +++EML+ + F G++ + I + +P
Sbjct: 202 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-------------------EHNVAYP- 241
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMR----PTAAEAL-EHPFFRS 275
S S+E++++ L + +P R P + EH FFR
Sbjct: 242 ----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-36
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
GS+G V++ G+ VAVK L + + + EV LRK H NI+
Sbjct: 35 GSFGTVYKGKWH--GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST 90
Query: 60 EHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ IV ++ E S L + + F ++ ++ Q +G+ Y+H + HRDLK
Sbjct: 91 A-PQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKSIIHRDLKS 148
Query: 119 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYV----TTRWYRAPEVLLLSEI--YGPEVD 171
+N+ + + +KIGD G+ E + + W APEV+ + + Y + D
Sbjct: 149 NNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW-MAPEVIRMQDSNPYSFQSD 207
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIY 199
++A G +++E+++ ++ + N+ DQI
Sbjct: 208 VYAFGIVLYELMTGQLPYSNINNRDQII 235
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 81/283 (28%), Positives = 126/283 (44%), Gaps = 47/283 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-KKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
G++G V + +G VAVK L ++KI SLD ++ E++ L K+ HP+I+KL ++
Sbjct: 27 GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL-KLFRHPHIIKLYQVI 85
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
D+F+V EY+ +L + + E E R L Q+ G+ Y HR HRDLK
Sbjct: 86 STPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW-----YRAPEVLLLSEIYGPEVD 171
P N+L+ + KI D G+ S++ Y APEV+ GPEVD
Sbjct: 144 PENVLLDAHMNAKIADFGL-----SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVD 198
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231
+W+ G I++ +L + F + KIC G +
Sbjct: 199 IWSSGVILYALLCGTLPFDDDHVPTLFKKICD--GIFYTPQY------------------ 238
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
L+PS ISL+ + +P R T + EH +F+
Sbjct: 239 ------LNPSV----ISLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 83/292 (28%), Positives = 122/292 (41%), Gaps = 56/292 (19%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
GS+G V A K++G+ AVK LKK I D+ E + L NHP + +L
Sbjct: 34 GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93
Query: 59 KEHEDVFIVFEYMES-DL-LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + +F V E++ DL + K R F E R ++ L ++H +G +RDL
Sbjct: 94 QTPDRLFFVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHDKGIIYRDL 150
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------YRAPEVLLLSEIYGPE 169
K N+L+ +G K+ D GM KE + VTT Y APE+L +YGP
Sbjct: 151 KLDNVLLDHEGHCKLADFGMCKE-----GICNGVTTATFCGTPDYIAPEILQ-EMLYGPA 204
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
VD WAMG +++EML F +N D I N + +P
Sbjct: 205 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-------------------NDEVVYP- 244
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMR----PTAAEA--LEHPFFRS 275
++ ++ + NP MR E L HPFF+
Sbjct: 245 ----------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-36
Identities = 56/288 (19%), Positives = 101/288 (35%), Gaps = 52/288 (18%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN------LKEVKCLRKMNNHPNIVKL 54
G +G V + K VA+K L + +EV + + NHPNIVKL
Sbjct: 30 GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKL 88
Query: 55 RNLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF- 112
L+ +V E++ DL + ++ L + G+ YM Q
Sbjct: 89 YGLMH--NPPRMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145
Query: 113 -HRDLKPSNLLVSKG------VIKIGDLGMVKEIDSSLPCTDYV-TTRWYRAPEVLLL-S 163
HRDL+ N+ + K+ D G+ ++ S+ + + +W APE +
Sbjct: 146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV--SGLLGNFQW-MAPETIGAEE 202
Query: 164 EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL 223
E Y + D ++ I++ +L+ F + +I I +
Sbjct: 203 ESYTEKADTYSFAMILYTILTGEGPFDEYSYG-KIKFINMIREE---------------- 245
Query: 224 DWKFPQMGGVNLR-ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
LR + ++I S +P RP + ++
Sbjct: 246 ----------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-36
Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 39/285 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRN-LKEVKCLRKMNN--HPNIVKLRN 56
G +G+V+ +G+ A+K L KK I L E L ++ P IV +
Sbjct: 200 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 259
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + + + M L + G FSE ++R ++ GL +MH + +RDL
Sbjct: 260 AFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMHNRFVVYRDL 318
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
KP+N+L+ G ++I DLG+ + P V T Y APEVL Y D +++
Sbjct: 319 KPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADWFSL 377
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G ++F++L F + D+ ++I ++ L + + P
Sbjct: 378 GCMLFKLLRGHSPFRQHKTKDK-HEIDRMT-------------LTMAV--ELP------- 414
Query: 236 RELSPSASRESISLISRLCSWNPHMR----PTAAEAL-EHPFFRS 275
S S E SL+ L + + R A+ + E PFFRS
Sbjct: 415 ----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 78/290 (26%), Positives = 125/290 (43%), Gaps = 54/290 (18%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G V +K +G + A+K L+K+ I + DE + + + HP + L+ +
Sbjct: 16 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75
Query: 60 EHEDVFIVFEYME-SDLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
H+ + V EY +L L +ER F+E+ R ++ L Y+H + +RD+K
Sbjct: 76 THDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRDVVYRDIK 132
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------YRAPEVLLLSEIYGPEV 170
NL++ G IKI D G+ KE +D T + Y APEV L YG V
Sbjct: 133 LENLMLDKDGHIKITDFGLCKE-----GISDGATMKTFCGTPEYLAPEV-LEDNDYGRAV 186
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
D W +G +M+EM+ R+ F ++ I + +FP
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-------------------MEEIRFP-- 225
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRS 275
+ S E+ SL++ L +P R A E +EH FF S
Sbjct: 226 ---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 36/239 (15%), Positives = 81/239 (33%), Gaps = 32/239 (13%)
Query: 1 GSYGDVFQA-----LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++ V++A D K+ + +K K + E ++ K + +K
Sbjct: 76 GAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFY 133
Query: 56 NLVKEHEDVFIVFEYMES----DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
+ +V E + + L K + + V + ++ + +H
Sbjct: 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEI 193
Query: 112 FHRDLKPSNLLV------------SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW----YR 155
H D+KP N ++ + + DLG ++ P T + ++
Sbjct: 194 IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM-KLFPKGTIFTAKCETSGFQ 252
Query: 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVI-GSPTEDSW 213
E+ L ++ + ++D + + A ++ ML + K + P D W
Sbjct: 253 CVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE--GGECKPEGLFRRLPHLDMW 308
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-35
Identities = 71/291 (24%), Positives = 115/291 (39%), Gaps = 58/291 (19%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL--KEVKCLRKMNNHPNIVKLRNLV 58
GS+G V+ A D ++ E VA+KK+ +E KEV+ L+K+ HPN ++ R
Sbjct: 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCY 123
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
++V EY L++ E E+ + QGL Y+H HRD+K
Sbjct: 124 LREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 182
Query: 119 SN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSE--IYGPEVDMWAM 175
N LL G++K+GD G + + +V T ++ APEV+L + Y +VD+W++
Sbjct: 183 GNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 239
Query: 176 G--AI--------MFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225
G I +F M + L+ I +S
Sbjct: 240 GITCIELAERKPPLFNMNAMSALY----------HI------AQNES------------- 270
Query: 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276
P + + S + + P RPT+ L+H F
Sbjct: 271 --PALQSGHW-------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 3e-35
Identities = 76/291 (26%), Positives = 124/291 (42%), Gaps = 55/291 (18%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
GS+G V + K + E AVK LKK + D+ E + L P + +L +
Sbjct: 352 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411
Query: 59 KEHEDVFIVFEYMES-DL-LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + ++ V EY+ DL + + F E ++ GL ++ +G +RDL
Sbjct: 412 QTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------YRAPEVLLLSEIYGPE 169
K N+++ S+G IKI D GM KE D VTT+ Y APE++ + YG
Sbjct: 469 KLDNVMLDSEGHIKIADFGMCKE-----NIWDGVTTKTFCGTPDYIAPEIIA-YQPYGKS 522
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
VD WA G +++EML+ + F G++ + I + +P
Sbjct: 523 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-------------------EHNVAYP- 562
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMR----PTAAEAL-EHPFFRS 275
S S+E++++ L + +P R P + EH FFR
Sbjct: 563 ----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-35
Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 62/292 (21%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS G V A +K SG VAVK + + EV +R H N+V++
Sbjct: 56 GSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRD-YQHFNVVEMYKSYLV 113
Query: 61 HEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
E+++++ E+++ +D++ ++ +E+++ +C V Q L Y+H QG HRD+
Sbjct: 114 GEELWVLMEFLQGGALTDIVSQVR------LNEEQIATVCEAVLQALAYLHAQGVIHRDI 167
Query: 117 KPSN-LLVSKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
K + LL G +K+ D G +I +P V T ++ APEV+ S Y EVD+W+
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL-YATEVDIWS 226
Query: 175 MG--AI--------MFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224
+G I F + + ++ P L ++
Sbjct: 227 LGIMVIEMVDGEPPYFSDSPVQAMK----------RLRDS-PPPK---------LKNSHK 266
Query: 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276
S + R+ +P R TA E L+HPF
Sbjct: 267 V-----------------SPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-35
Identities = 78/290 (26%), Positives = 115/290 (39%), Gaps = 54/290 (18%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
GS+G V A K F AVK L+KK I E +++ E L K HP +V L
Sbjct: 49 GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108
Query: 59 KEHEDVFIVFEYME-SDL-LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + ++ V +Y+ +L L +ER F E R ++ L Y+H +RDL
Sbjct: 109 QTADKLYFVLDYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLHSLNIVYRDL 165
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------YRAPEVLLLSEIYGPE 169
KP N+L+ S+G I + D G+ KE TT Y APEV L + Y
Sbjct: 166 KPENILLDSQGHIVLTDFGLCKE-----NIEHNSTTSTFCGTPEYLAPEV-LHKQPYDRT 219
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
VD W +GA+++EML F +N+A+ I N +
Sbjct: 220 VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-------------------NKPLQLK- 259
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMR----PTAAEALEHPFFRS 275
P+ + + L+ L + R E H FF
Sbjct: 260 ----------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-35
Identities = 79/293 (26%), Positives = 127/293 (43%), Gaps = 56/293 (19%)
Query: 1 GSYGDVFQA---LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLR------KMNNHPNI 51
G YG VFQ +G+ A+K LKK + RN K+ + + HP I
Sbjct: 28 GGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV----RNAKDTAHTKAERNILEEVKHPFI 83
Query: 52 VKLRNLVKEHEDVFIVFEYMES-DL-LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ 109
V L + ++++ EY+ +L ++L +E F ED ++ L ++H++
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK 140
Query: 110 GYFHRDLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYG 167
G +RDLKP N+++ +G +K+ D G+ KE I + T Y APE+L+ S +
Sbjct: 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG-HN 199
Query: 168 PEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227
VD W++GA+M++ML+ F G+N I KI
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL-------------------KCKLNL 240
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMR----PTAAEAL-EHPFFRS 275
P P ++E+ L+ +L N R P A + HPFFR
Sbjct: 241 P-----------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 72/297 (24%), Positives = 129/297 (43%), Gaps = 65/297 (21%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNL-KEVKCLRKMNNHPNIVKLRNLVK 59
G++G V++A +K++G A K ++ K S +E + E++ L + HP IVKL
Sbjct: 30 GAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCD-HPYIVKLLGAYY 86
Query: 60 EHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
++I+ E+ ++ + +E +++ +C Q+ + L+++H + HRD
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSKRIIHRD 142
Query: 116 LKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLLSEI----YGPE 169
LK N L+ +G I++ D G+ + +L D ++ T ++ APEV++ + Y +
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYK 202
Query: 170 VDMWAMG--AI--------MFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQL 219
D+W++G I E+ R+L KI + PT L
Sbjct: 203 ADIWSLGITLIEMAQIEPPHHELNPMRVLL----------KIAKS-DPPT---------L 242
Query: 220 ASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276
+ W S E + NP RP+AA+ LEHPF S
Sbjct: 243 LTPSKW-----------------SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-34
Identities = 65/305 (21%), Positives = 122/305 (40%), Gaps = 65/305 (21%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-----LKEVKCLRKMNNHPNIVKLR 55
G+ V A E VA+K++ L++ + LKE++ + +HPNIV
Sbjct: 26 GATAVVQAAYCAPKKEKVAIKRIN-----LEKCQTSMDELLKEIQAM-SQCHHPNIVSYY 79
Query: 56 NLVKEHEDVFIVFEYME----SDLLKLMKERAGQN---FSEDEVRNLCFQVFQGLHYMHR 108
+++++V + + D++K + + E + + +V +GL Y+H+
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 109 QGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTD------YVTTRWYRAPEVLL 161
G HRD+K N+L+ G ++I D G+ + + T +V T + APEV+
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 162 LSEIYGPEVDMWAMGAIMFEMLS----------FRILFPGKNSADQIYKICQVIGSPTED 211
Y + D+W+ G E+ + ++L Q P+ +
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM----------LTLQN-DPPSLE 248
Query: 212 SWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHP 271
+ ++ F +M + L++ +P RPTAAE L H
Sbjct: 249 TGVQDKEMLKKYGKSFRKMISLCLQK-------------------DPEKRPTAAELLRHK 289
Query: 272 FFRSC 276
FF+
Sbjct: 290 FFQKA 294
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-34
Identities = 66/289 (22%), Positives = 118/289 (40%), Gaps = 56/289 (19%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ G V+ A+D +G+ VA++++ + + + E+ +R+ N +PNIV +
Sbjct: 31 GASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRE-NKNPNIVNYLDSYLV 88
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+++++V EY+ L ++ E E ++ +C + Q L ++H HRD+K
Sbjct: 89 GDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145
Query: 120 N-LLVSKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG- 176
N LL G +K+ D G +I + V T ++ APEV+ YGP+VD+W++G
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGI 204
Query: 177 -AI--------MFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227
AI R L+ I G+P L +
Sbjct: 205 MAIEMIEGEPPYLNENPLRALY----------LIATN-GTPE---------LQNPEKL-- 242
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276
S ++R + R +A E L+H F +
Sbjct: 243 ---------------SAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 44/219 (20%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
G +G + +++GE + +K+L + +E++ LKEVK +R + HPN++K ++
Sbjct: 21 GCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLE-HPNVLKFIGVL 76
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ + + + EY++ L ++K Q + + + + G+ Y+H HRDL
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135
Query: 118 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYV----------------TTRWYRAPEVL 160
N LV + + + D G+ + + + + W APE+
Sbjct: 136 SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM-APEM- 193
Query: 161 LLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIY 199
+ Y +VD+++ G ++ E++ P +
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 80/359 (22%), Positives = 128/359 (35%), Gaps = 93/359 (25%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN----NHPNIVKLRN 56
G + V+ + D + +FVA+K +K + + + E++ L+ + N PN R
Sbjct: 48 GHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIRLLKSVRNSDPNDPN----RE 101
Query: 57 LVKEHEDVF-----------IVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHY 105
+V + D F +VFE + LLK + + Q V+ + QV QGL Y
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161
Query: 106 MHRQ-GYFHRDLKPSNLLV----------------------------------------- 123
+H + H D+KP N+L+
Sbjct: 162 LHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221
Query: 124 ---------SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
K +KI DLG + T+ + TR YR+ EVL+ S Y D+W+
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSG-YNTPADIWS 278
Query: 175 MGAIMFEMLSFRILFPGKNS------ADQIYKICQVIGSPTEDSWPLGIQLA----SNLD 224
+ FE+ + LF + D I I +++G G D
Sbjct: 279 TACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338
Query: 225 WKF-PQMGGVNLRE-------LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
K ++ L E S + + + P R TAAE L HP+ S
Sbjct: 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 80/286 (27%), Positives = 123/286 (43%), Gaps = 45/286 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G V +K +G + A+K LKK+ I + DE + + + + HP + L+ +
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218
Query: 60 EHEDVFIVFEYME-SDLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYMH-RQGYFHRDL 116
H+ + V EY +L L +ER FSED R ++ L Y+H + +RDL
Sbjct: 219 THDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLHSEKNVVYRDL 275
Query: 117 KPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
K NL++ G IKI D G+ KE I + T Y APEVL YG VD W
Sbjct: 276 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWG 334
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G +M+EM+ R+ F ++ I + +FP
Sbjct: 335 LGVVMYEMMCGRLPFYNQDHEKLFELIL-------------------MEEIRFP------ 369
Query: 235 LRELSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRS 275
+ E+ SL+S L +P R A E ++H FF
Sbjct: 370 -----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 71/292 (24%), Positives = 125/292 (42%), Gaps = 62/292 (21%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GSYG V++A+ K++G+ VA+K++ D +KE+ +++ + P++VK +
Sbjct: 40 GSYGSVYKAIHKETGQIVAIKQVP---VESDLQEIIKEISIMQQ-CDSPHVVKYYGSYFK 95
Query: 61 HEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ D++IV EY SD+++L + +EDE+ + +GL Y+H HRD+
Sbjct: 96 NTDLWIVMEYCGAGSVSDIIRLRNKT----LTEDEIATILQSTLKGLEYLHFMRKIHRDI 151
Query: 117 KPSN-LLVSKGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
K N LL ++G K+ D G+ ++ ++ + T ++ APEV+ Y D+W+
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWS 210
Query: 175 MG--AI--------MFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224
+G AI ++ R +F I PT
Sbjct: 211 LGITAIEMAEGKPPYADIHPMRAIF----------MIPTN-PPPT---------FRKPEL 250
Query: 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276
W S + + +P R TA + L+HPF RS
Sbjct: 251 W-----------------SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 80/288 (27%), Positives = 124/288 (43%), Gaps = 48/288 (16%)
Query: 1 GSYGDVFQA---LDKKSGEFVAVKKLKKK-IFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
GS+G VF + + A+K LKK + D R E L ++N HP IVKL
Sbjct: 35 GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHY 93
Query: 57 LVKEHEDVFIVFEYMES-DL-LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ ++++ +++ DL +L KE F+E++V+ ++ L ++H G +R
Sbjct: 94 AFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLGIIYR 150
Query: 115 DLKPSNLLV-SKGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
DLKP N+L+ +G IK+ D G+ KE ID + T Y APEV+ + D
Sbjct: 151 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADW 209
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
W+ G +MFEML+ + F GK+ + + I P
Sbjct: 210 WSFGVLMFEMLTGTLPFQGKDRKETMTMIL-------------------KAKLGMP---- 246
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMR----PTAAEAL-EHPFFRS 275
S E+ SL+ L NP R P E + H FF +
Sbjct: 247 -------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 83/297 (27%), Positives = 131/297 (44%), Gaps = 57/297 (19%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
GSY V KK+ A+K +KK+ + ++ ++ E + +NHP +V L +
Sbjct: 20 GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79
Query: 59 KEHEDVFIVFEYMES-DLLK-LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ +F V EY+ DL+ + ++R E+ R ++ L+Y+H +G +RDL
Sbjct: 80 QTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDL 136
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------YRAPEVLLLSEIYGPE 169
K N+L+ S+G IK+ D GM KE TT Y APE+L E YG
Sbjct: 137 KLDNVLLDSEGHIKLTDYGMCKE-----GLRPGDTTSTFCGTPNYIAPEILR-GEDYGFS 190
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIY-----KICQVIGSPTEDSWPLGIQLASNLD 224
VD WA+G +MFEM++ R F S+D + QVI L +
Sbjct: 191 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------------LEKQI- 236
Query: 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMR------PTAAEALEHPFFRS 275
+ P S S ++ S++ + +P R A+ HPFFR+
Sbjct: 237 -RIP-----------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 82/297 (27%), Positives = 131/297 (44%), Gaps = 57/297 (19%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKK-IFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
GSY V KK+ A++ +KK+ + ++ ++ E + +NHP +V L +
Sbjct: 63 GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122
Query: 59 KEHEDVFIVFEYMES-DLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ +F V EY+ DL+ + ++R E+ R ++ L+Y+H +G +RDL
Sbjct: 123 QTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERGIIYRDL 179
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRW------YRAPEVLLLSEIYGPE 169
K N+L+ S+G IK+ D GM KE TT Y APE+L E YG
Sbjct: 180 KLDNVLLDSEGHIKLTDYGMCKE-----GLRPGDTTSTFCGTPNYIAPEILR-GEDYGFS 233
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIY-----KICQVIGSPTEDSWPLGIQLASNLD 224
VD WA+G +MFEM++ R F S+D + QVI L +
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------------LEKQI- 279
Query: 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMR------PTAAEALEHPFFRS 275
+ P S S ++ S++ + +P R A+ HPFFR+
Sbjct: 280 -RIP-----------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 70/292 (23%), Positives = 123/292 (42%), Gaps = 46/292 (15%)
Query: 1 GSYGDVFQA---LDKKSGEFVAVKKLKKK-IFSLDESRN--LKEVKCLRKMNNHPNIVKL 54
G+YG VF +G+ A+K LKK I ++ E + L + P +V L
Sbjct: 65 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 124
Query: 55 RNLVKEHEDVFIVFEYMES-DL-LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ + ++ +Y+ +L L + F+E EV+ ++ L ++H+ G
Sbjct: 125 HYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLGII 181
Query: 113 HRDLKPSNLLV-SKGVIKIGDLGMVKE--IDSSLPCTDYVTTRWYRAPEVLLLSEI-YGP 168
+RD+K N+L+ S G + + D G+ KE D + D+ T Y AP+++ + +
Sbjct: 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK 241
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228
VD W++G +M+E+L+ F + +I + I L S +P
Sbjct: 242 AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-------------LKSEP--PYP 286
Query: 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMR----PTAAEAL-EHPFFRS 275
S + LI RL +P R P A+ + EH FF+
Sbjct: 287 -----------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 71/279 (25%), Positives = 120/279 (43%), Gaps = 49/279 (17%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
G++G V +A K + VA+K+++ + E + + E++ L ++N HPNIVKL
Sbjct: 19 GAFGVVCKA--KWRAKDVAIKQIESE----SERKAFIVELRQLSRVN-HPNIVKLYGACL 71
Query: 60 EHEDVFIVFEYMESDLLK--LMKERAGQNFSEDEVRNLCFQVFQGLHYMHR---QGYFHR 114
V +V EY E L L ++ + C Q QG+ Y+H + HR
Sbjct: 72 NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 115 DLKPSNLLVSKG--VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
DLKP NLL+ G V+KI D G +I + + T+ + + APEV Y + D+
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEV-FEGSNYSEKCDV 186
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
++ G I++E+++ R F I + +
Sbjct: 187 FSWGIILWEVITRRKPFDEIGGPAFR--IMWAVHN------------------------- 219
Query: 233 VNLR-ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
R L + + SL++R S +P RP+ E ++
Sbjct: 220 -GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-33
Identities = 70/290 (24%), Positives = 126/290 (43%), Gaps = 57/290 (19%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
GS+G V + +G + A+K LKK + L + + E L + HP I+++
Sbjct: 17 GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTF 75
Query: 59 KEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
++ + +F++ +Y+E +L L++ ++ + F + +V L Y+H + +RDLK
Sbjct: 76 QDAQQIFMIMDYIEGGELFSLLR-KSQR-FPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 133
Query: 118 PSNLLV-SKGVIKIGDLGMVKEID---SSLPC--TDYVTTRWYRAPEVLLLSEIYGPEVD 171
P N+L+ G IKI D G K + +L C DY+ APEV + ++ Y +D
Sbjct: 134 PENILLDKNGHIKITDFGFAKYVPDVTYTL-CGTPDYI------APEV-VSTKPYNKSID 185
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIY-KICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
W+ G +++EML+ F N+ + Y KI + +FP
Sbjct: 186 WWSFGILIYEMLAGYTPFYDSNT-MKTYEKILNA-------------------ELRFP-- 223
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRS 275
+ L+SRL + + R + HP+F+
Sbjct: 224 -----PFFNEDV----KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-33
Identities = 42/280 (15%), Positives = 95/280 (33%), Gaps = 46/280 (16%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
G++++ + G + VK LK + +S +SR+ +E LR + HPN++ + +
Sbjct: 21 NHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQ 77
Query: 60 E--HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF--HR 114
++ +M L ++ E + + + +G+ ++H
Sbjct: 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRH 137
Query: 115 DLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL--LSEIYGPEVD 171
L ++++ + +I + S W APE L + D
Sbjct: 138 ALNSRSVMIDEDMTARISMADVKFSFQSP---GRMYAPAWV-APEALQKKPEDTNRRSAD 193
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231
MW+ +++E+++ + F ++ + K+
Sbjct: 194 MWSFAVLLWELVTREVPFADLSNMEIGMKVAL---------------------------- 225
Query: 232 GVNLR-ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
LR + P S L+ + +P RP +
Sbjct: 226 -EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-33
Identities = 74/290 (25%), Positives = 117/290 (40%), Gaps = 57/290 (19%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLV 58
GS+G V K+SG A+K L K K+ L + + E + L+ +N P +VKL
Sbjct: 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSF 110
Query: 59 KEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
K++ ++++V EY+ ++ + R FSE R Q+ Y+H +RDLK
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVT-----TRWYRAPEVLLLSEIYGPEVD 171
P NLL+ +G I++ D G K + T T APE+ +LS+ Y VD
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKG-------RTWTLCGTPEALAPEI-ILSKGYNKAVD 220
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIY-KICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
WA+G +++EM + F QIY KI +FP
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQP-IQIYEKIVSG-------------------KVRFP-- 258
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRS 275
S + L+ L + R + H +F +
Sbjct: 259 ---------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 64/290 (22%), Positives = 124/290 (42%), Gaps = 59/290 (20%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+G+VF+ +D ++ + VA+K + + + +E+ L + + P + K +
Sbjct: 33 GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLK 91
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
++I+ EY+ L L++ E ++ + ++ +GL Y+H + HRD+K +
Sbjct: 92 DTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKKIHRDIKAA 148
Query: 120 NLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG- 176
N+L+S+ G +K+ D G+ ++ + +V T ++ APEV+ S Y + D+W++G
Sbjct: 149 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGI 207
Query: 177 -AI--------MFEMLSFRILFPGKNSADQIYKICQVIGSPT-EDSWPLGIQLASNLDWK 226
AI E+ ++LF I + PT E ++
Sbjct: 208 TAIELARGEPPHSELHPMKVLF----------LIPKN-NPPTLEGNY------------- 243
Query: 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276
S+ + + P RPTA E L+H F
Sbjct: 244 ----------------SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G+VF + VAVK ++ + +++ L+E + L++ + HPNIV+L + +
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQ 183
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ ++IV E ++ D L ++ G + + G+ Y+ + HRDL
Sbjct: 184 KQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAAR 242
Query: 120 NLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRAPEVLLLSEIYGPEV 170
N LV+ K V+KI D GM +E Y + +W APE L Y E
Sbjct: 243 NCLVTEKNVLKISDFGMSREEAD----GVYAASGGLRQVPVKWT-APEALNYG-RYSSES 296
Query: 171 DMWAMGAIMFEMLSF-RILFPGKNSADQIYKICQ 203
D+W+ G +++E S +P ++ + +
Sbjct: 297 DVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 66/305 (21%), Positives = 107/305 (35%), Gaps = 64/305 (20%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKL----RN 56
G +G V++A E+VAVK + +N EV L M H NI++ +
Sbjct: 35 GRFGCVWKAQLL--NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMK-HENILQFIGAEKR 89
Query: 57 LVKEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMH----- 107
D++++ + E SD LK S +E+ ++ + +GL Y+H
Sbjct: 90 GTSVDVDLWLITAFHEKGSLSDFLK------ANVVSWNELCHIAETMARGLAYLHEDIPG 143
Query: 108 -----RQGYFHRDLKPSNLLVSK-GVIKIGDLGM--VKEIDSSLPCTDYVT-TRWYRAPE 158
+ HRD+K N+L+ I D G+ E S T TR Y APE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 159 VL----LLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP 214
VL +DM+AMG +++E+ S G + P E+
Sbjct: 204 VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML---------PFEEEIG 254
Query: 215 LGIQLASNLDWKFPQMGGV----NLRELSPSA--SRESISLISRLCS--W--NPHMRPTA 264
M V R + ++++ W + R +A
Sbjct: 255 --------QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 265 AEALE 269
E
Sbjct: 307 GCVGE 311
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-30
Identities = 53/211 (25%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G YG+V++ + KK VAVK LK+ +++ LKE ++++ HPN+V+L +
Sbjct: 24 GQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTR 80
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+I+ E+M +LL ++E Q S + + Q+ + Y+ ++ + HRDL
Sbjct: 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 120 NLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYGPEVD 171
N LV ++K+ D G+ + + Y +W APE L + + + D
Sbjct: 141 NCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWT-APESLAYN-KFSIKSD 194
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+WA G +++E+ ++ +PG + + +
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 66/306 (21%), Positives = 101/306 (33%), Gaps = 66/306 (21%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKL----RN 56
G YG+V++ + GE VAVK + E+ + H NI+
Sbjct: 19 GRYGEVWRGSWQ--GENVAVKIFSSR--DEKSWFRETELYNTVMLR-HENILGFIASDMT 73
Query: 57 LVKEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
++++ Y E D L+ + + GL ++H + +
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 113 --------HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVT-----TRWYRAPE 158
HRDLK N+LV K G I DLG+ S D T+ Y APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 159 VL-----LLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSW 213
VL + VD+WA G +++E+ R++ G + P D
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKP---------PFYDVV 237
Query: 214 PLGIQLASNLDWKFPQMGGV----NLR-ELSPSASRESI-----SLISRLCSWNPHMRPT 263
P D F M V R + + L+ NP R T
Sbjct: 238 P--------NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 264 AAEALE 269
A +
Sbjct: 290 ALRIKK 295
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-30
Identities = 53/213 (24%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G YG+V++ + KK VAVK LK+ ++E LKE ++++ HPN+V+L +
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF--LKEAAVMKEIK-HPNLVQLLGVCTR 287
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+I+ E+M +LL ++E Q S + + Q+ + Y+ ++ + HR+L
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 347
Query: 120 NLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYGPEVD 171
N LV ++K+ D G+ + + Y +W APE L + + + D
Sbjct: 348 NCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWT-APESLAYN-KFSIKSD 401
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKICQ 203
+WA G +++E+ ++ +PG + + + +
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-30
Identities = 53/211 (25%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G V + VA+K +++ ++ E ++E + + K++ HP +V+L + E
Sbjct: 19 GQFGLVHLGYWLNKDK-VAIKTIRE--GAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLE 74
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ +V E+ME L ++ + G F+ + + +C V +G+ Y+ HRDL
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEEACVIHRDLAAR 133
Query: 120 NLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYGPEVD 171
N LV VIK+ D GM + + Y ++ +W +PEV S Y + D
Sbjct: 134 NCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWA-SPEVFSFS-RYSSKSD 187
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+W+ G +M+E+ S +I + +++++ + I
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 54/211 (25%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G V + + VA+K +K+ S+ E ++E K + ++ H +V+L + +
Sbjct: 35 GQFGVVKYGKWRGQYD-VAIKMIKEG--SMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTK 90
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+FI+ EYM + LL ++E + F ++ +C V + + Y+ + + HRDL
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR 149
Query: 120 NLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYGPEVD 171
N LV+ +GV+K+ D G+ + + +Y ++ RW PEVL+ S + + D
Sbjct: 150 NCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWS-PPEVLMYS-KFSSKSD 203
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+WA G +M+E+ S ++ + +++ I
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 17/213 (7%)
Query: 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +G+V K + VA+K LK L E + + + HPNI++L +
Sbjct: 56 GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGV 114
Query: 58 VKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
V + + V IV EYME+ L +++ Q F+ ++ + + G+ Y+ GY HRDL
Sbjct: 115 VTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLSDMGYVHRDL 173
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPEVLLLSEIYGPE 169
N+L+ S V K+ D G+ + ++ P Y T RW +PE + +
Sbjct: 174 AARNILINSNLVCKVSDFGLGRVLEDD-PEAAYTTRGGKIPIRWT-SPEAIAYR-KFTSA 230
Query: 170 VDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
D+W+ G +++E++S+ + ++ D I +
Sbjct: 231 SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 17/213 (7%)
Query: 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G G+V + G+ VA+K LK L E + + + HPNI++L +
Sbjct: 60 GDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD-HPNIIRLEGV 118
Query: 58 VKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
V IV EYME+ L ++ GQ F+ ++ + V G+ Y+ GY HRDL
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDLGYVHRDL 177
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPEVLLLSEIYGPE 169
N+LV S V K+ D G+ + ++ P Y TT RW APE + +
Sbjct: 178 AARNVLVDSNLVCKVSDFGLSRVLEDD-PDAAYTTTGGKIPIRWT-APEAIAFR-TFSSA 234
Query: 170 VDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
D+W+ G +M+E+L++ + + D I +
Sbjct: 235 SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-29
Identities = 54/211 (25%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G V K + VAVK +K+ S+ E +E + + K++ HP +VK + +
Sbjct: 19 GQFGVVKLGKWKGQYD-VAVKMIKEG--SMSEDEFFQEAQTMMKLS-HPKLVKFYGVCSK 74
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
++IV EY+ + LL ++ G+ ++ +C+ V +G+ ++ + HRDL
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAAR 133
Query: 120 NLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYGPEVD 171
N LV +K+ D GM + + YV++ +W APEV Y + D
Sbjct: 134 NCLVDRDLCVKVSDFGMTRYVLD----DQYVSSVGTKFPVKWS-APEVFHYF-KYSSKSD 187
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+WA G +M+E+ S ++ + +++ + K+
Sbjct: 188 VWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-29
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 29/204 (14%)
Query: 1 GSYGDVFQALDKK-SGEFVAVKKLKKKIFSLDES---RNLKEVKCLRKMNNHPNIVKLRN 56
G G ++ ALD+ +G V +K L S D + E + L ++ HP+IV++ N
Sbjct: 91 GGLGWIYLALDRNVNGRPVVLKGLV---HSGDAEAQAMAMAERQFLAEVV-HPSIVQIFN 146
Query: 57 LVKEHEDV------FIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG 110
V EH D +IV EY+ LK GQ E ++ L Y+H G
Sbjct: 147 FV-EHTDRHGDPVGYIVMEYVGGQSLK---RSKGQKLPVAEAIAYLLEILPALSYLHSIG 202
Query: 111 YFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVT-TRWYRAPEVLLLSEIYGPE 169
+ DLKP N+++++ +K+ DLG V I+S Y+ T ++APE++ GP
Sbjct: 203 LVYNDLKPENIMLTEEQLKLIDLGAVSRINS----FGYLYGTPGFQAPEIVR----TGPT 254
Query: 170 V--DMWAMGAIMFEMLSFRILFPG 191
V D++ +G + + G
Sbjct: 255 VATDIYTVGRTLAALTLDLPTRNG 278
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-29
Identities = 34/222 (15%), Positives = 85/222 (38%), Gaps = 30/222 (13%)
Query: 1 GSYGDVFQALDKKSGEF-------VAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIV 52
G++ +F+ + ++ G++ V +K L K + S + + + K++ H ++V
Sbjct: 19 GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLS-HKHLV 75
Query: 53 KLRNLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
+ ++ +V E+++ L +K+ + + Q+ +H++
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFLEENTL 134
Query: 112 FHRDLKPSNLLVSK---------GVIKIGDLGMVKEIDSSLPCTDYVTT--RWYRAPEVL 160
H ++ N+L+ + IK+ D G+ + D + W PE +
Sbjct: 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----DILQERIPWV-PPECI 189
Query: 161 LLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+ D W+ G ++E+ S +S ++
Sbjct: 190 ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-29
Identities = 70/306 (22%), Positives = 111/306 (36%), Gaps = 66/306 (21%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKL----RN 56
G +G+V++ + GE VAVK + E+ + H NI+
Sbjct: 53 GRFGEVWRGKWR--GEEVAVKIFSSR--EERSWFREAEIYQTVMLR-HENILGFIAADNK 107
Query: 57 LVKEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+++V +Y E D L + + + L GL ++H +
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 113 --------HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVT-----TRWYRAPE 158
HRDLK N+LV K G I DLG+ DS+ D T+ Y APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 159 VL-----LLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSW 213
VL + D++AMG + +E+ R G + Q+ P D
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQL---------PYYDLV 271
Query: 214 PLGIQLASNLDWKFPQMGGV----NLRELSPSA--SRESISLISRLCS--W--NPHMRPT 263
P D +M V LR P+ S E++ +++++ W N R T
Sbjct: 272 P--------SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323
Query: 264 AAEALE 269
A +
Sbjct: 324 ALRIKK 329
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-29
Identities = 56/211 (26%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V+ + VA+K LK ++ L+E + ++K+ H +V+L +V E
Sbjct: 195 GCFGEVWMGTWNGTTR-VAIKTLKP--GTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE 250
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E ++IV EYM LL +K G+ ++ ++ Q+ G+ Y+ R Y HRDL+ +
Sbjct: 251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 309
Query: 120 NLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYGPEVD 171
N+LV V K+ D G+ + I+ + +Y +W APE L + + D
Sbjct: 310 NILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKWT-APEAALYG-RFTIKSD 363
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+W+ G ++ E+ + R+ +PG + + + ++
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-29
Identities = 56/211 (26%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V+ + VA+K LK ++ L+E + ++K+ H +V+L +V E
Sbjct: 278 GCFGEVWMGTWNGTTR-VAIKTLKP--GTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE 333
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E ++IV EYM LL +K G+ ++ ++ Q+ G+ Y+ R Y HRDL+ +
Sbjct: 334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 392
Query: 120 NLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYGPEVD 171
N+LV V K+ D G+ + I+ + +Y +W APE L + + D
Sbjct: 393 NILVGENLVCKVADFGLARLIEDN----EYTARQGAKFPIKWT-APEAALYG-RFTIKSD 446
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+W+ G ++ E+ + R+ +PG + + + ++
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-29
Identities = 56/214 (26%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 1 GSYGDVFQALDKKSGEF----VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G +G+V++ + K S VA+K LK L E + + + H NI++L
Sbjct: 55 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEG 113
Query: 57 LVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
++ +++ + I+ EYME+ L K ++E+ G+ FS ++ + + G+ Y+ Y HRD
Sbjct: 114 VISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANMNYVHRD 172
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPEVLLLSEIYGP 168
L N+LV S V K+ D G+ + ++ P Y T+ RW APE + +
Sbjct: 173 LAARNILVNSNLVCKVSDFGLSRVLEDD-PEATYTTSGGKIPIRWT-APEAISYR-KFTS 229
Query: 169 EVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
D+W+ G +M+E++++ + ++ + + I
Sbjct: 230 ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 70/306 (22%), Positives = 103/306 (33%), Gaps = 66/306 (21%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKL----RN 56
G YG+V+ K GE VAVK E+ M H NI+
Sbjct: 48 GRYGEVWMG--KWRGEKVAVKVFFTT--EEASWFRETEIYQTVLMR-HENILGFIAADIK 102
Query: 57 LVKEHEDVFIVFEYME----SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
++++ +Y E D LK + L + GL ++H + +
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 113 --------HRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVT-----TRWYRAPE 158
HRDLK N+LV K G I DLG+ + S D T+ Y PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 159 VL-----LLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSW 213
VL DM++ G I++E+ R + G Q+ P D
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQL---------PYHDLV 266
Query: 214 PLGIQLASNLDWKFPQMGGV----NLR------ELSPSASRESISLISRLCSWNPHMRPT 263
P D + M + LR S R+ L++ + NP R T
Sbjct: 267 P--------SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
Query: 264 AAEALE 269
A +
Sbjct: 319 ALRVKK 324
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 1 GSYGDVFQALDKKSGEF---VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +GDV Q + VA+K K + L+E +R+ + HP+IVKL +
Sbjct: 26 GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGV 84
Query: 58 VKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ E V+I+ E +L ++ R + +Q+ L Y+ + + HRD+
Sbjct: 85 ITE-NPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESKRFVHRDI 142
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYGP 168
N+LV S +K+GD G+ + ++ S Y +W APE + +
Sbjct: 143 AARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWM-APESINFR-RFTS 196
Query: 169 EVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
D+W G M+E+L F G + D I +I
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 66/288 (22%), Positives = 109/288 (37%), Gaps = 57/288 (19%)
Query: 1 GSYGDVFQA----LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G +G V + +GE VAVK LK S +E+ LR + H +I+K +
Sbjct: 42 GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEHIIKYKG 100
Query: 57 LVKEH--EDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
++ + +V EY+ L + + ++ Q+ +G+ Y+H Q Y H
Sbjct: 101 CCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIH 157
Query: 114 RDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRAPEVLLLSE 164
RDL N+L+ ++KIGD G+ K + +Y WY APE L
Sbjct: 158 RDLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWY-APECLKEY- 212
Query: 165 IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224
+ D+W+ G ++E+L+ +S K ++IG
Sbjct: 213 KFYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIA---------------- 251
Query: 225 WKFPQMGGVNLREL--------SPSASRESISLISRLC-SWNPHMRPT 263
QM + L EL P + + + C RPT
Sbjct: 252 --QGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPT 297
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-28
Identities = 68/290 (23%), Positives = 117/290 (40%), Gaps = 59/290 (20%)
Query: 1 GSYGDVFQA----LDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKL 54
G +G V +GE VAVK LK + S KE++ LR + H NIVK
Sbjct: 32 GHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLY-HENIVKY 88
Query: 55 RNLVKEHED--VFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
+ + E + ++ E++ S L + + + + + + Q+ +G+ Y+ + Y
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGSRQY 147
Query: 112 FHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRAPEVLLL 162
HRDL N+LV S+ +KIGD G+ K I++ +Y T WY APE L+
Sbjct: 148 VHRDLAARNVLVESEHQVKIGDFGLTKAIETD---KEYYTVKDDRDSPVFWY-APECLMQ 203
Query: 163 SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN 222
S + D+W+ G + E+L++ + + + ++IG
Sbjct: 204 S-KFYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPT-------------- 243
Query: 223 LDWKFPQMGGVNLREL--------SPSASRESISLISRLC-SWNPHMRPT 263
QM L P + + + R C + P R +
Sbjct: 244 ----HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTS 289
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-28
Identities = 52/202 (25%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 1 GSYGDVFQA----LDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLR 55
G++G V L +GE VAVKKL+ + + R+ +E++ L+ + H NIVK +
Sbjct: 52 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDNIVKYK 108
Query: 56 NLVKE--HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ ++ ++ EY+ L +++ + ++ Q+ +G+ Y+ + Y
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKRYI 167
Query: 113 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRAPEVLLLS 163
HRDL N+LV ++ +KIGD G+ K + +Y WY APE L S
Sbjct: 168 HRDLATRNILVENENRVKIGDFGLTKVLPQD---KEYYKVKEPGESPIFWY-APESLTES 223
Query: 164 EIYGPEVDMWAMGAIMFEMLSF 185
+ D+W+ G +++E+ ++
Sbjct: 224 -KFSVASDVWSFGVVLYELFTY 244
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-28
Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 1 GSYGDVFQALDKKSGEF--VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G++G V Q + + + VA+K LK+ D ++E + + +++ +P IV+L +
Sbjct: 21 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVC 79
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ E + +V E L K + + + V L QV G+ Y+ + + HRDL
Sbjct: 80 QA-EALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYGPE 169
N+L+ ++ KI D G+ K + + Y +WY APE + +
Sbjct: 138 ARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWY-APECINFR-KFSSR 193
Query: 170 VDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
D+W+ G M+E LS+ + + + + I
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-28
Identities = 55/211 (26%), Positives = 110/211 (52%), Gaps = 21/211 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V+ + VAVK LK+ S+ L E ++++ H +V+L +V +
Sbjct: 24 GQFGEVWMGYYNGHTK-VAVKSLKQG--SMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ 79
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E ++I+ EYME+ L+ +K +G + +++ ++ Q+ +G+ ++ + Y HRDL+ +
Sbjct: 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA 138
Query: 120 NLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYGPEVD 171
N+LVS KI D G+ + I+ +Y +W APE + + + D
Sbjct: 139 NILVSDTLSCKIADFGLARLIED----NEYTAREGAKFPIKWT-APEAINYG-TFTIKSD 192
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+W+ G ++ E+++ RI +PG + + I +
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-28
Identities = 51/202 (25%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 1 GSYGDVFQA----LDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLR 55
G++G V L +GE VAVKKL+ + + R+ +E++ L+ + H NIVK +
Sbjct: 21 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQ-HDNIVKYK 77
Query: 56 NLVKE--HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ ++ ++ EY+ L +++ + ++ Q+ +G+ Y+ + Y
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTKRYI 136
Query: 113 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRAPEVLLLS 163
HRDL N+LV ++ +KIGD G+ K + ++ WY APE L S
Sbjct: 137 HRDLATRNILVENENRVKIGDFGLTKVLPQD---KEFFKVKEPGESPIFWY-APESLTES 192
Query: 164 EIYGPEVDMWAMGAIMFEMLSF 185
+ D+W+ G +++E+ ++
Sbjct: 193 -KFSVASDVWSFGVVLYELFTY 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-28
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 1 GSYGDVFQALDKKSGEF---VAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLR 55
GS+G V + VAVK LK + S E+ + ++EV + ++ H N+++L
Sbjct: 29 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLY 87
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+V + +V E LL +++ G F + QV +G+ Y+ + + HR
Sbjct: 88 GVVLT-PPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLESKRFIHR 145
Query: 115 DLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIY 166
DL NLL+ ++ ++KIGD G+++ + + YV W APE L +
Sbjct: 146 DLAARNLLLATRDLVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWC-APESLKTR-TF 201
Query: 167 GPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
D W G ++EM ++ + + G N + ++KI
Sbjct: 202 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-27
Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 1 GSYGDVFQALDKKSGEF--VAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNL 57
G++G V + + VAVK LK + L E +++++ +P IV++ +
Sbjct: 28 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGI 86
Query: 58 VKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ E +V E E L K +++ ++ + + L QV G+ Y+ + HRDL
Sbjct: 87 CEA-ESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 143
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRAPEVLLLSEIYG 167
N+L+ ++ KI D G+ K + + +Y +WY APE + +
Sbjct: 144 AARNVLLVTQHYAKISDFGLSKALRAD---ENYYKAQTHGKWPVKWY-APECINYY-KFS 198
Query: 168 PEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+ D+W+ G +M+E S+ + + G ++ +
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-27
Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 12/195 (6%)
Query: 4 GDVFQALDKKSGEFVAVKKLKKKIFSLDES---RNLKEVKCLRKMNNHPNIVKLRNLVKE 60
V+ A D VA+K + E R +EV +++ H NIV + ++ +E
Sbjct: 25 STVYLAEDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEE 82
Query: 61 HEDVFIVFEYMESDLLK-LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ ++V EY+E L ++ S D N Q+ G+ + H HRD+KP
Sbjct: 83 DDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQ 140
Query: 120 NLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVT-TRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+L+ +KI D G+ K + ++SL T++V T Y +PE E D++++G
Sbjct: 141 NILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QAKGEATDECTDIYSIG 199
Query: 177 AIMFEMLSFRILFPG 191
+++EML F G
Sbjct: 200 IVLYEMLVGEPPFNG 214
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 50/216 (23%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 1 GSYGDVFQALDKKSGEF---VAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLR 55
G +G+V++ + VAVK KK +++ + E ++ ++ HP+IVKL
Sbjct: 23 GFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLD-HPHIVKLI 79
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+++E E +I+ E +L ++ + Q+ + + Y+ HR
Sbjct: 80 GIIEE-EPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESINCVHR 137
Query: 115 DLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIY 166
D+ N+LV S +K+GD G+ + I+ DY +W +PE + +
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIEDE----DYYKASVTRLPIKWM-SPESINFR-RF 191
Query: 167 GPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
D+W M+E+LSF + F + D I +
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 57/211 (27%), Positives = 109/211 (51%), Gaps = 21/211 (9%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V+ A K + VAVK +K S+ L E ++ + H +VKL +V +
Sbjct: 199 GQFGEVWMATYNKHTK-VAVKTMKP--GSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK 254
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E ++I+ E+M LL +K G ++ + Q+ +G+ ++ ++ Y HRDL+ +
Sbjct: 255 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA 313
Query: 120 NLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYGPEVD 171
N+LVS V KI D G+ + I+ + +Y +W APE + + + D
Sbjct: 314 NILVSASLVCKIADFGLARVIEDN----EYTAREGAKFPIKWT-APEAINFG-SFTIKSD 367
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+W+ G ++ E++++ RI +PG ++ + I +
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 48/215 (22%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 1 GSYGDVFQALDKKSGEF----VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G++G V++ L GE VA+K+L++ L E + ++ +P++ +L
Sbjct: 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLG 84
Query: 57 LVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+ V ++ + M LL ++E + N C Q+ +G++Y+ + HRD
Sbjct: 85 ICLT-STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRLVHRD 142
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYG 167
L N+LV + +KI D G+ K + + +W A E +L IY
Sbjct: 143 LAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWM-ALESILHR-IYT 197
Query: 168 PEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+ D+W+ G ++E+++F + G +++ +
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
G +GDV + G VAVK +K D + L E + ++ H N+V+L ++
Sbjct: 32 GEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQLR-HSNLVQLLGVI 83
Query: 59 -KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+E ++IV EYM L+ ++ R D + V + + Y+ + HRDL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 143
Query: 117 KPSNLLVS-KGVIKIGDLGMVKEIDSS-----LPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
N+LVS V K+ D G+ KE S+ LP +W APE L + +
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWT-APEALREK-KFSTKS 195
Query: 171 DMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
D+W+ G +++E+ SF R+ +P D + ++
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 27/214 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
G +GDV + G VAVK +K D + L E + ++ H N+V+L ++
Sbjct: 204 GEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQLR-HSNLVQLLGVI 255
Query: 59 -KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+E ++IV EYM L+ ++ R D + V + + Y+ + HRDL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315
Query: 117 KPSNLLVS-KGVIKIGDLGMVKEIDSS-----LPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
N+LVS V K+ D G+ KE S+ LP +W APE L + +
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWT-APEALREK-KFSTKS 367
Query: 171 DMWAMGAIMFEMLSF-RILFPGKNSADQIYKICQ 203
D+W+ G +++E+ SF R+ +P D + ++ +
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-27
Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 26/202 (12%)
Query: 1 GSYGDVFQA----LDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLR 55
G++G V L +G VAVK+L+ D+ R+ +E++ L+ ++ IVK R
Sbjct: 34 GNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALH-SDFIVKYR 90
Query: 56 NLVKE--HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ + + +V EY+ S L ++ + + Q+ +G+ Y+ +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSRRCV 149
Query: 113 HRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRAPEVLLLS 163
HRDL N+LV S+ +KI D G+ K + DY WY APE L +
Sbjct: 150 HRDLAARNILVESEAHVKIADFGLAKLLPLD---KDYYVVREPGQSPIFWY-APESLSDN 205
Query: 164 EIYGPEVDMWAMGAIMFEMLSF 185
I+ + D+W+ G +++E+ ++
Sbjct: 206 -IFSRQSDVWSFGVVLYELFTY 226
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-27
Identities = 73/313 (23%), Positives = 106/313 (33%), Gaps = 69/313 (22%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKL-----R 55
G YG V++ VAVK + N K + + M H NI + R
Sbjct: 24 GRYGAVYKG--SLDERPVAVKVFSFA--NRQNFINEKNIYRVPLME-HDNIARFIVGDER 78
Query: 56 NLVKEHEDVFIVFEYME--SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF- 112
+ +V EY S L K + L V +GL Y+H +
Sbjct: 79 VTADGRMEYLLVMEYYPNGS----LXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 113 --------HRDLKPSNLLV-SKGVIKIGDLGM---------VKEIDSSLPCTDYVTTRWY 154
HRDL N+LV + G I D G+ V+ + V T Y
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 155 RAPEVL------LLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGS 207
APEVL E +VDM+A+G I +E+ LFPG++ + Y++
Sbjct: 195 MAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE--YQM------ 246
Query: 208 PTEDSWPLGIQLASNLDWKFPQMGGV----NLRELSPSASRESISLISRLCS-----W-- 256
+ F M + R P A +E+ + L W
Sbjct: 247 AFQTEVG--------NHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 257 NPHMRPTAAEALE 269
+ R TA A E
Sbjct: 299 DAEARLTAQXAEE 311
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 51/214 (23%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 1 GSYGDVFQALDKKSGE--FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G++G V Q + + + VA+K LK+ D ++E + + +++ +P IV+L +
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVC 405
Query: 59 KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ E + +V E L K + + + V L QV G+ Y+ + + HR+L
Sbjct: 406 QA-EALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRAPEVLLLSEIYGP 168
N+L+ ++ KI D G+ K + + Y T +WY APE + +
Sbjct: 464 ARNVLLVNRHYAKISDFGLSKALGAD---DSYYTARSAGKWPLKWY-APECINFR-KFSS 518
Query: 169 EVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
D+W+ G M+E LS+ + + + + I
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 22/214 (10%)
Query: 1 GSYGDVFQALDKKSGEF---VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +GDV Q + VA+K K + L+E +R+ + HP+IVKL +
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGV 459
Query: 58 VKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ E V+I+ E +L ++ R + +Q+ L Y+ + + HRD+
Sbjct: 460 ITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESKRFVHRDI 517
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYGP 168
N+LV S +K+GD G+ + ++ S Y +W APE + +
Sbjct: 518 AARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWM-APESINFR-RFTS 571
Query: 169 EVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
D+W G M+E+L F G + D I +I
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-26
Identities = 53/225 (23%), Positives = 97/225 (43%), Gaps = 31/225 (13%)
Query: 1 GSYGDVFQAL-----DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G+V++ + S VAVK L + DE L E + K N H NIV+
Sbjct: 41 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCI 99
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKER-----AGQNFSEDEVRNLCFQVFQGLHYMHRQ 109
+ + FI+ E M DL ++E + + ++ ++ + G Y+
Sbjct: 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 159
Query: 110 GYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRAP 157
+ HRD+ N L++ V KIGD GM ++I Y +W P
Sbjct: 160 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----ASYYRKGGCAMLPVKWM-PP 214
Query: 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
E + I+ + D W+ G +++E+ S + +P K++ + + +
Sbjct: 215 EAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-26
Identities = 53/226 (23%), Positives = 100/226 (44%), Gaps = 32/226 (14%)
Query: 1 GSYGDVFQALDKKSGEF---VAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKL-- 54
G +G V +A K+ VAVK LK I + + L+E C+++ + HP++ KL
Sbjct: 34 GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HPHVAKLVG 92
Query: 55 ----RNLVKEHEDVFIVFEYMES-DLLK-LMKERAGQNFSEDEVRNL---CFQVFQGLHY 105
++ +M+ DL L+ R G+N ++ L + G+ Y
Sbjct: 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEY 152
Query: 106 MHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRA 156
+ + + HRDL N ++++ + + D G+ ++I S DY +W A
Sbjct: 153 LSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG----DYYRQGCASKLPVKWL-A 207
Query: 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
E L + +Y D+WA G M+E+++ + + G +A+ +
Sbjct: 208 LESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL 252
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 42/215 (19%), Positives = 89/215 (41%), Gaps = 22/215 (10%)
Query: 1 GSYGDVFQALDKKSGE----FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G +G V + + GE V +K ++ K + + ++ H +IV+L
Sbjct: 24 GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAHIVRLLG 82
Query: 57 LVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
L + +V +Y+ LL +++ G + N Q+ +G++Y+ G HR+
Sbjct: 83 LCPG-SSLQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEHGMVHRN 140
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYG 167
L N+L+ S +++ D G+ + + +W A E + Y
Sbjct: 141 LAARNVLLKSPSQVQVADFGVADLLPPD---DKQLLYSEAKTPIKWM-ALESIHFG-KYT 195
Query: 168 PEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+ D+W+ G ++E+++F + G A+ +
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 51/225 (22%), Positives = 91/225 (40%), Gaps = 31/225 (13%)
Query: 1 GSYGDVFQALDKKSGEF---VAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKL-- 54
G +G V + K+ VAVK +K S E L E C++ + HPN+++L
Sbjct: 45 GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPNVIRLLG 103
Query: 55 ---RNLVKEHEDVFIVFEYMES-DLLK-LMKERAGQNFSEDEVRNL---CFQVFQGLHYM 106
+ ++ +M+ DL L+ R ++ L + G+ Y+
Sbjct: 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL 163
Query: 107 HRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRAP 157
+ + HRDL N ++ + + D G+ K+I S DY +W A
Sbjct: 164 SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS----GDYYRQGRIAKMPVKWI-AI 218
Query: 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
E L +Y + D+WA G M+E+ + +PG + + +
Sbjct: 219 ESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 39/215 (18%)
Query: 1 GSYGDVFQA-----LDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKL 54
G++G VF A K VAVK LK +L ++ +E + L H +IVK
Sbjct: 26 GAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAE-LLTNLQHEHIVKF 82
Query: 55 RNLVKEHEDVFIVFEYMES-DLLKLMKER--------------AGQNFSEDEVRNLCFQV 99
+ + + + +VFEYM+ DL K ++ A ++ ++ Q+
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 100 FQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT------- 151
G+ Y+ Q + HRDL N LV ++KIGD GM +++ S TDY
Sbjct: 143 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS----TDYYRVGGHTMLP 198
Query: 152 -RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
RW PE ++ + E D+W+ G I++E+ ++
Sbjct: 199 IRWM-PPESIMYR-KFTTESDVWSFGVILWEIFTY 231
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 48/215 (22%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 1 GSYGDVFQALDKKSGE----FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G++G V++ L GE VA+K+L++ L E + ++ +P++ +L
Sbjct: 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLG 84
Query: 57 LVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+ V ++ + M LL ++E + N C Q+ +G++Y+ + HRD
Sbjct: 85 ICLT-STVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRLVHRD 142
Query: 116 LKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYG 167
L N+LV + +KI D G+ K + + +W A E +L IY
Sbjct: 143 LAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEGGKVPIKWM-ALESILHR-IYT 197
Query: 168 PEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+ D+W+ G ++E+++F + G +++ +
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 30/208 (14%)
Query: 1 GSYGDVFQAL-----DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G+V++ + S VAVK L + DE L E + K N H NIV+
Sbjct: 82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCI 140
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKER-----AGQNFSEDEVRNLCFQVFQGLHYMHRQ 109
+ + FI+ E M DL ++E + + ++ ++ + G Y+
Sbjct: 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 200
Query: 110 GYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSSLPCTDYVTT--------RWYRAP 157
+ HRD+ N L++ V KIGD GM ++I Y +W P
Sbjct: 201 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR----AGYYRKGGCAMLPVKWM-PP 255
Query: 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
E + I+ + D W+ G +++E+ S
Sbjct: 256 EAFMEG-IFTSKTDTWSFGVLLWEIFSL 282
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-25
Identities = 34/271 (12%), Positives = 74/271 (27%), Gaps = 59/271 (21%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDES---RNLKEVKCLRKMNNHPNIVKLRNL 57
+QALD VA+ + + L + L L +++ P + ++ ++
Sbjct: 42 VPPLQFWQALDTALDRQVALTFVDPQ-GVLPDDVLQETLSRTLRLSRID-KPGVARVLDV 99
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
V +V E++ L+ E A + S + HR G
Sbjct: 100 VHTRAGGLVVAEWIRGGSLQ---EVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDH 156
Query: 118 PSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
PS + VS G + + P+ D+ +G
Sbjct: 157 PSRVRVSIDGDVVLAYPA-------------------TMPDA--------NPQDDIRGIG 189
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
A ++ +L R P + + +
Sbjct: 190 ASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP-----------------------IEPA 226
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEA 267
++ + ++ +R + +R +
Sbjct: 227 DIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 47/212 (22%), Positives = 90/212 (42%), Gaps = 38/212 (17%)
Query: 1 GSYGDVFQA----LDKKSGEF-VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
GS+G V++ + K E VA+K + + + L E + K N ++V+L
Sbjct: 36 GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM-KEFNCHHVVRLL 94
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNL--------CFQVFQGLHYM 106
+V + + ++ E M DL ++ + + ++ G+ Y+
Sbjct: 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 154
Query: 107 HRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTTRWYR---------- 155
+ + HRDL N +V++ +KIGD GM ++I TDY YR
Sbjct: 155 NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----TDY-----YRKGGKGLLPVR 205
Query: 156 --APEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
+PE L ++ D+W+ G +++E+ +
Sbjct: 206 WMSPESLKDG-VFTTYSDVWSFGVVLWEIATL 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 38/214 (17%)
Query: 1 GSYGDVFQA-----LDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKL 54
G++G VF A L ++ VAVK LK+ S ++ +E + L M H +IV+
Sbjct: 52 GAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAE-LLTMLQHQHIVRF 108
Query: 55 RNLVKEHEDVFIVFEYMES-DLLKLMKER-------------AGQNFSEDEVRNLCFQVF 100
+ E + +VFEYM DL + ++ A ++ + QV
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 101 QGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT-------- 151
G+ Y+ + HRDL N LV +G V+KIGD GM ++I S TDY
Sbjct: 169 AGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTMLPI 224
Query: 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
RW PE +L + E D+W+ G +++E+ ++
Sbjct: 225 RWM-PPESILYR-KFTTESDVWSFGVVLWEIFTY 256
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-25
Identities = 43/204 (21%), Positives = 83/204 (40%), Gaps = 13/204 (6%)
Query: 4 GDVFQALDKKSGEFVAVKKLKKKIFSLDES---RNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GDV++A D VA+K + + S D R +E + ++ P++V + + +
Sbjct: 48 GDVYEAEDTVRERIVALKLMSET-LSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEI 105
Query: 61 HEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+++ + DL +++ + + + Q+ L H G HRD+KP
Sbjct: 106 DGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPE 163
Query: 120 NLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVT-TRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+LVS + D G+ D L T +Y APE D++A+
Sbjct: 164 NILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE-RFSESHATYRADIYALT 222
Query: 177 AIMFEMLSFRILFPGKNSADQIYK 200
+++E L+ + G + +
Sbjct: 223 CVLYECLTGSPPYQG-DQLSVMGA 245
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-24
Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 4 GDVFQALDKKSGEFVAVKKLKKKIFSLDES---RNLKEVKCLRKMNNHPNIVKL----RN 56
+V A D + VAVK L+ + D S R +E + +N HP IV +
Sbjct: 26 SEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEA 83
Query: 57 LVKEHEDVFIVFEYMESDLLK-LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+IV EY++ L+ ++ + + Q L++ H+ G HRD
Sbjct: 84 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRD 141
Query: 116 LKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVT-------TRWYRAPEVLLLSEIYG 167
+KP+N+++S +K+ D G+ + I S + VT T Y +PE +
Sbjct: 142 VKPANIMISATNAVKVMDFGIARAIADS---GNSVTQTAAVIGTAQYLSPE-QARGDSVD 197
Query: 168 PEVDMWAMGAIMFEMLSFRILFPGKN 193
D++++G +++E+L+ F G +
Sbjct: 198 ARSDVYSLGCVLYEVLTGEPPFTGDS 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-24
Identities = 45/214 (21%), Positives = 94/214 (43%), Gaps = 17/214 (7%)
Query: 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +G V+ + AVK L + + S+ L E ++ + HPN++ L +
Sbjct: 36 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGI 94
Query: 58 VKEHED-VFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
E +V YM+ DL ++ N + ++ QV +G+ Y+ + + HRD
Sbjct: 95 CLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRD 153
Query: 116 LKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPEVLLLSEIYGP 168
L N ++ + +K+ D G+ +++ + + T +W A E L +
Sbjct: 154 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-ALESLQTQ-KFTT 211
Query: 169 EVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+ D+W+ G +++E+++ +P N+ D +
Sbjct: 212 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-24
Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 36/214 (16%)
Query: 1 GSYGDVFQA-----LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
+G V++ + + VA+K LK K E LR HPN+V L
Sbjct: 20 DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA-MLRARLQHPNVVCLL 78
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKER--------------AGQNFSEDEVRNLCFQVF 100
+V + + + ++F Y DL + + R + +L Q+
Sbjct: 79 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIA 138
Query: 101 QGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT-------- 151
G+ Y+ H+DL N+LV +KI DLG+ +E+ + DY
Sbjct: 139 AGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA----ADYYKLLGNSLLPI 194
Query: 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
RW APE ++ + + D+W+ G +++E+ S+
Sbjct: 195 RWM-APEAIMYG-KFSIDSDIWSYGVVLWEVFSY 226
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-24
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 35/211 (16%)
Query: 1 GSYGDVFQALDKKSGEF--VAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNL 57
G++G V +A KK G A+K++K+ S D+ R+ E++ L K+ +HPNI+ L
Sbjct: 36 GNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 94
Query: 58 VKEHEDVFIVFEYMES-DLLK-LMKERAGQNFSEDEVRNL-------------CFQVFQG 102
+ +++ EY +LL L K R + + N V +G
Sbjct: 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 154
Query: 103 LHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT-------RWY 154
+ Y+ ++ + HRDL N+LV + V KI D G+ + + YV RW
Sbjct: 155 MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE------VYVKKTMGRLPVRWM 208
Query: 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
A E L S +Y D+W+ G +++E++S
Sbjct: 209 -AIESLNYS-VYTTNSDVWSYGVLLWEIVSL 237
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 4e-24
Identities = 43/214 (20%), Positives = 93/214 (43%), Gaps = 17/214 (7%)
Query: 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +G V+ + AVK L + + S+ L E ++ + HPN++ L +
Sbjct: 100 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGI 158
Query: 58 VKEHED-VFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
E +V YM+ DL ++ + ++ QV +G+ ++ + + HRD
Sbjct: 159 CLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMKFLASKKFVHRD 217
Query: 116 LKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPEVLLLSEIYGP 168
L N ++ + +K+ D G+ +++ + + T +W A E L +
Sbjct: 218 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-ALESLQTQ-KFTT 275
Query: 169 EVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+ D+W+ G +++E+++ +P N+ D +
Sbjct: 276 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-24
Identities = 44/214 (20%), Positives = 93/214 (43%), Gaps = 17/214 (7%)
Query: 1 GSYGDVFQALDKKSGEF---VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +G V+ + A+K L + L+E +R +N HPN++ L +
Sbjct: 32 GHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN-HPNVLALIGI 90
Query: 58 V-KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+ ++ YM DLL+ ++ +N + ++ + QV +G+ Y+ Q + HRD
Sbjct: 91 MLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRD 149
Query: 116 LKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT------RWYRAPEVLLLSEIYGP 168
L N ++ + +K+ D G+ ++I + +W A E L +
Sbjct: 150 LAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-ALESLQTY-RFTT 207
Query: 169 EVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKI 201
+ D+W+ G +++E+L+ + + D + +
Sbjct: 208 KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-23
Identities = 57/227 (25%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 1 GSYGDVFQA----LDKKSGEF-VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G V +A L K+ VAVK LK + ++ + E+K + + H NIV L
Sbjct: 57 GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNL------------CFQVFQG 102
V ++ EY DLL ++ ++ ++ QV QG
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQG 176
Query: 103 LHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT-------RWY 154
+ ++ + HRD+ N+L++ G V KIGD G+ ++I + ++Y+ +W
Sbjct: 177 MAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND---SNYIVKGNARLPVKWM 233
Query: 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYK 200
APE + +Y + D+W+ G +++E+ S +PG + YK
Sbjct: 234 -APESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 38/232 (16%)
Query: 1 GSYGDVFQA----LDKKSGE-FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G V +A L K VAVK LK + + E+K L + NH NIV L
Sbjct: 34 GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNL----------------CFQ 98
++ EY DLL ++ + + +Q
Sbjct: 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQ 153
Query: 99 VFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--VTT---- 151
V +G+ ++ + HRDL N+L++ G + KI D G+ ++I + V
Sbjct: 154 VAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN----DSNYVVKGNARL 209
Query: 152 --RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYK 200
+W APE + +Y E D+W+ G ++E+ S +PG + YK
Sbjct: 210 PVKWM-APESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-23
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 37/216 (17%)
Query: 1 GSYGDVFQAL-------DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVK 53
G++G V A K VAVK LK D S + E++ ++ + H NI+
Sbjct: 46 GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105
Query: 54 LRNLVKEHEDVFIVFEYMES-DLLK-LMKERAGQNFSEDEVRNL-------------CFQ 98
L + ++++ EY +L + L R ++ + +Q
Sbjct: 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 165
Query: 99 VFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--VTT---- 151
+ +G+ Y+ Q HRDL N+LV++ V+KI D G+ ++I++ DY TT
Sbjct: 166 LARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN----IDYYKKTTNGRL 221
Query: 152 --RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
+W APE L +Y + D+W+ G +M+E+ +
Sbjct: 222 PVKWM-APEALFDR-VYTHQSDVWSFGVLMWEIFTL 255
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-23
Identities = 54/231 (23%), Positives = 101/231 (43%), Gaps = 37/231 (16%)
Query: 1 GSYGDVFQA----LDKKSGE-FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G V +A +DK + VAVK LK+ + + E+K L + +H N+V L
Sbjct: 38 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97
Query: 56 NLV-KEHEDVFIVFEYMES-DLLK-LMKERAGQNFSEDEVRNL-------------CFQV 99
K + ++ E+ + +L L +R + +L FQV
Sbjct: 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 157
Query: 100 FQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT------- 151
+G+ ++ + HRDL N+L+S+ V+KI D G+ ++I
Sbjct: 158 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK----DPDYVRKGDARLP 213
Query: 152 -RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYK 200
+W APE + +Y + D+W+ G +++E+ S +PG ++ +
Sbjct: 214 LKWM-APETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 44/222 (19%)
Query: 1 GSYGDVFQA-----LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G VFQA L + VAVK LK++ + ++ +E + + + +PNIVKL
Sbjct: 58 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLL 116
Query: 56 NLVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNL------------------- 95
+ + + ++FEYM DL + ++ + +L
Sbjct: 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ 176
Query: 96 ---CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--V 149
QV G+ Y+ + + HRDL N LV + V+KI D G+ + I S DY
Sbjct: 177 LCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS----ADYYKA 232
Query: 150 TT------RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
RW PE + + Y E D+WA G +++E+ S+
Sbjct: 233 DGNDAIPIRWM-PPESIFYN-RYTTESDVWAYGVVLWEIFSY 272
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-22
Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 37/216 (17%)
Query: 1 GSYGDVFQA----LDKKSGEF---VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVK 53
G +G V A +DK + VAVK LK D S + E++ ++ + H NI+
Sbjct: 92 GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 151
Query: 54 LRNLVKEHEDVFIVFEYMES-DLLK-LMKERAGQNFSEDEVRNL-------------CFQ 98
L + ++++ EY +L + L R ++ + +Q
Sbjct: 152 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 211
Query: 99 VFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--VTT---- 151
+ +G+ Y+ Q HRDL N+LV++ V+KI D G+ ++I++ DY TT
Sbjct: 212 LARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN----IDYYKKTTNGRL 267
Query: 152 --RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
+W APE L +Y + D+W+ G +M+E+ +
Sbjct: 268 PVKWM-APEALFDR-VYTHQSDVWSFGVLMWEIFTL 301
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-22
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 37/216 (17%)
Query: 1 GSYGDVFQA----LDKKSGEF---VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVK 53
G++G V A LDK VAVK LK D S + E++ ++ + H NI+
Sbjct: 80 GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 139
Query: 54 LRNLVKEHEDVFIVFEYMES-DLLKLMKER------AGQNFSEDEVRNL--------CFQ 98
L + ++++ EY +L + ++ R N S + L +Q
Sbjct: 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 199
Query: 99 VFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT------ 151
V +G+ Y+ + HRDL N+LV++ V+KI D G+ ++I DY
Sbjct: 200 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH----IDYYKKTTNGRL 255
Query: 152 --RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
+W APE L IY + D+W+ G +++E+ +
Sbjct: 256 PVKWM-APEALFDR-IYTHQSDVWSFGVLLWEIFTL 289
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 43/237 (18%)
Query: 1 GSYGDVFQA----LDKKSGE-FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G V A + K VAVK LK+K S + + E+K + ++ +H NIV L
Sbjct: 56 GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 115
Query: 56 NLVKEHEDVFIVFEYMES-DLLK-LMKERAGQNFSEDEVRNL------------------ 95
++++FEY DLL L +R + E E N
Sbjct: 116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 175
Query: 96 --CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--VT 150
+QV +G+ ++ + HRDL N+LV+ G V+KI D G+ ++I S V
Sbjct: 176 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS----DSNYVVR 231
Query: 151 T------RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYK 200
+W APE L IY + D+W+ G +++E+ S +PG YK
Sbjct: 232 GNARLPVKWM-APESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 286
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-20
Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 44/222 (19%)
Query: 1 GSYGDVFQA----LDKKSGE-FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G +G V +A L ++G VAVK LK+ + L E L K NHP+++KL
Sbjct: 34 GEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVL-KQVNHPHVIKLY 92
Query: 56 NLVKEHEDVFIVFEYMES-DLLK-LMKERAGQNFSEDEVRNL------------------ 95
+ + ++ EY + L L + R +
Sbjct: 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDL 152
Query: 96 ---CFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-VIKIGDLGMVKEIDSSLPCTDY--V 149
+Q+ QG+ Y+ HRDL N+LV++G +KI D G+ +++ D
Sbjct: 153 ISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE----EDSYVK 208
Query: 150 TT------RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF 185
+ +W A E L IY + D+W+ G +++E+++
Sbjct: 209 RSQGRIPVKWM-AIESLFDH-IYTTQSDVWSFGVLLWEIVTL 248
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 9e-17
Identities = 35/142 (24%), Positives = 62/142 (43%), Gaps = 8/142 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+G+++ + ++ E VA+K K + L E K R + I +R E
Sbjct: 18 GSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQGGTGIPNVRWFGVE 74
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+ +V + + L L + S V L Q+ + ++H + + HRD+KP N
Sbjct: 75 GDYNVLVMDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133
Query: 121 LLVSKG----VIKIGDLGMVKE 138
L+ G + I D G+ K+
Sbjct: 134 FLMGLGRRANQVYIIDFGLAKK 155
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 41/143 (28%), Positives = 64/143 (44%), Gaps = 10/143 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLVK 59
GS+GD++ D +GE VA+K K + L E K + M I +R
Sbjct: 20 GSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 60 EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E + +V E + L L + FS V L Q+ + Y+H + + HRD+KP
Sbjct: 76 EGDYNVMVMELLGPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPD 134
Query: 120 NLLVSKG----VIKIGDLGMVKE 138
N L+ G ++ I D G+ K+
Sbjct: 135 NFLMGLGKKGNLVYIIDFGLAKK 157
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 9e-16
Identities = 32/144 (22%), Positives = 62/144 (43%), Gaps = 10/144 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+G +F+ + + + VA+K ++ D + E + + + I + +E
Sbjct: 21 GSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 77
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+V + + L L+ G+ FS V Q+ + +H + +RD+KP N
Sbjct: 78 GLHNVLVIDLLGPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDN 136
Query: 121 LLVSKG------VIKIGDLGMVKE 138
L+ + +I + D GMVK
Sbjct: 137 FLIGRPNSKNANMIYVVDFGMVKF 160
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 31/144 (21%), Positives = 61/144 (42%), Gaps = 10/144 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G++ + + E+VA+K K + E + +++ + I ++
Sbjct: 20 GNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+ +V E + L L + FS V + Q+ + Y+H + +RD+KP N
Sbjct: 77 GKYNAMVLELLGPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPEN 135
Query: 121 LLVSKG------VIKIGDLGMVKE 138
L+ + VI I D + KE
Sbjct: 136 FLIGRPGNKTQQVIHIIDFALAKE 159
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.1 bits (181), Expect = 2e-15
Identities = 47/328 (14%), Positives = 93/328 (28%), Gaps = 79/328 (24%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKL-------------KKKIFSLDESRNLKEVKCLR--KM 45
G +G+VFQ + VA+K + K L E KE+ L
Sbjct: 31 GVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVC 88
Query: 46 NNHPNIVKLRN-----------LVKEHED-------------------VFIVFEYMESDL 75
N + L + L+K + +FIV E+
Sbjct: 89 NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE--FG 146
Query: 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSKGVIKIGDLG 134
+++ + S +++ Q+ L + HRDL N+L+ K
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT-------S 199
Query: 135 MVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS 194
+ K + + + + + + Y + ++ LF G
Sbjct: 200 LKKLHYTLNGKSSTIPSCGLQVSIID-----YTLSRLERDGIVVFCDVSMDEDLFTG--D 252
Query: 195 ADQIYKICQVIGSPTEDSWPLGIQLASNLDW---------KFPQMGGVNLRELSPSASRE 245
D + I +++ + W SN+ W K R+
Sbjct: 253 GDYQFDIYRLMKKENNNRWG-EYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRK 311
Query: 246 SISLISRLCSWNPHMRPTAAEALEHPFF 273
+ +++ +A + L
Sbjct: 312 IQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 22/159 (13%), Positives = 52/159 (32%), Gaps = 22/159 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN---LKEVKCLRKMNNHPNIVKLRNL 57
+ G +++A + + + +K L ++++ E ++ + K + L
Sbjct: 53 DNQGILYEAAPTSTLTCDSGPQKQKFSLKL-DAKDGRLFNEQNFFQRAAKPLQVNKWKKL 111
Query: 58 VK-------------EHEDV--FIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQG 102
H+D F+V + L + SE V + ++
Sbjct: 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDA 171
Query: 103 LHYMHRQGYFHRDLKPSNLLVSKG---VIKIGDLGMVKE 138
L ++H Y H ++ N+ V + + G
Sbjct: 172 LEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 6e-14
Identities = 32/159 (20%), Positives = 56/159 (35%), Gaps = 25/159 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL--- 57
G +G ++ A E A +K + + E+K +++ I K
Sbjct: 48 GGFGLIYLAFPTNKPEKDARHVVKVE--YQENGPLFSELKFYQRVAKKDCIKKWIERKQL 105
Query: 58 ---------------VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQG 102
K F+V E + DL K+ + F + V L ++
Sbjct: 106 DYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN--GTFKKSTVLQLGIRMLDV 163
Query: 103 LHYMHRQGYFHRDLKPSNLLVSKG---VIKIGDLGMVKE 138
L Y+H Y H D+K +NLL+ + + D G+
Sbjct: 164 LEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 35/160 (21%), Positives = 57/160 (35%), Gaps = 24/160 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVK-KLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL-- 57
G +G ++ A D S E V K+ D E+K ++ I K
Sbjct: 46 GGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRK 104
Query: 58 ----------------VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQ 101
F++ + SDL K+ + + FS V L ++
Sbjct: 105 LKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEAN-AKRFSRKTVLQLSLRILD 163
Query: 102 GLHYMHRQGYFHRDLKPSNLLVSKG---VIKIGDLGMVKE 138
L Y+H Y H D+K SNLL++ + + D G+
Sbjct: 164 ILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 48/171 (28%), Positives = 76/171 (44%), Gaps = 22/171 (12%)
Query: 1 GSYGDVFQ-ALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G +G V++ L G VA+K+ + ++E E++ L HP++V L
Sbjct: 50 GVFGKVYKGVLR--DGAKVALKRRTPESSQGIEEFET--EIETLSFCR-HPHLVSLIGFC 104
Query: 59 KEHEDVFIVFEYMESDLLK--LMKERAGQNFSEDEVR-NLCFQVFQGLHYMHRQGYFHRD 115
E ++ ++++YME+ LK L E R +C +GLHY+H + HRD
Sbjct: 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRD 164
Query: 116 LKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTD--YVTTRW-----YRAPE 158
+K N LL V KI D G+ K D +++T Y PE
Sbjct: 165 VKSINILLDENFVPKITDFGISK----KGTELDQTHLSTVVKGTLGYIDPE 211
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 57/254 (22%), Positives = 100/254 (39%), Gaps = 46/254 (18%)
Query: 1 GSYGDVFQA-LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G +G V++ L G VAVK+LK++ E + EV+ + H N+++LR
Sbjct: 41 GGFGKVYKGRL--ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCM 97
Query: 60 EHEDVFIVFEYME-SDLLKLMKERAGQNFSED-EVR-NLCFQVFQGLHYMHRQGY---FH 113
+ +V+ YM + ++ER D R + +GL Y+H H
Sbjct: 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIH 157
Query: 114 RDLKPSNLLVSKGVI-KIGDLGMVKEIDSSLPCTDYVTTRW-----YRAPEVLL---LSE 164
RD+K +N+L+ + +GD G+ K +D +VTT + APE L SE
Sbjct: 158 RDVKAANILLDEEFEAVVGDFGLAKLMDYK---DTHVTTAVRGTIGHIAPEYLSTGKSSE 214
Query: 165 IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224
+ D++ G ++ E+++ + + + LD
Sbjct: 215 ----KTDVFGYGVMLLELITGQ--------------------RAFDLARLANDDDVMLLD 250
Query: 225 WKFPQMGGVNLREL 238
W + L L
Sbjct: 251 WVKGLLKEKKLEAL 264
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 44/208 (21%), Positives = 87/208 (41%), Gaps = 19/208 (9%)
Query: 2 SYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH 61
+G++ L K EFV K + + V R++++ + +
Sbjct: 110 KFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169
Query: 62 EDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNL 121
E E E+ ++ + + + FQV +G+ ++ + HRDL N+
Sbjct: 170 EKSLSDVEEEEA-----PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 224
Query: 122 LVSKG-VIKIGDLGMVKEIDSSLPCTDYVTT-------RWYRAPEVLLLSEIYGPEVDMW 173
L+S+ V+KI D G+ ++I DYV +W APE + +Y + D+W
Sbjct: 225 LLSEKNVVKICDFGLARDIYKDP---DYVRKGDARLPLKWM-APET-IFDRVYTIQSDVW 279
Query: 174 AMGAIMFEMLSF-RILFPGKNSADQIYK 200
+ G +++E+ S +PG ++ +
Sbjct: 280 SFGVLLWEIFSLGASPYPGVKIDEEFCR 307
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 28/160 (17%), Positives = 60/160 (37%), Gaps = 13/160 (8%)
Query: 1 GSYGDVFQA----LDKKSGEF-VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G V +A +DK + VAVK LK+ + + E+K L + +H N+V L
Sbjct: 33 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92
Query: 56 NLV-KEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
K + ++ E+ + +L ++ + +E + + G
Sbjct: 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKR------NEFVPYKTKGARFRQGKDYVGAIP 146
Query: 114 RDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRW 153
DLK ++ + ++ S + + +
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-09
Identities = 56/298 (18%), Positives = 112/298 (37%), Gaps = 64/298 (21%)
Query: 1 GSYGDVFQ-ALDKKSGEFVAVKKLKKKIFSLDESRN-----LKEVKCLRKMNNHPNIVKL 54
G +G V++ ++ VAVKKL + + +E+K + K H N+V+L
Sbjct: 42 GGFGVVYKGYVN---NTTVAVKKLAAMV--DITTEELKQQFDQEIKVMAKCQ-HENLVEL 95
Query: 55 RNLVKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVR-NLCFQVFQGLHYMHRQGYF 112
+ +D+ +V+ YM LL + G +R + G++++H +
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 113 HRDLKPSN-LLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRW-----YRAPEVL--LLSE 164
HRD+K +N LL KI D G+ + + +T+R Y APE L ++
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKF--AQTVMTSRIVGTTAYMAPEALRGEITP 213
Query: 165 IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDS-----WPL---G 216
+ D+++ G ++ E+++ G + D+ +
Sbjct: 214 ----KSDIYSFGVVLLEIIT------GLPAVDE---------HREPQLLLDIKEEIEDEE 254
Query: 217 IQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLC-SWNPHMRPTAAE---ALEH 270
+ +D +M + + S ++ C + RP + L+
Sbjct: 255 KTIEDYID---KKMNDADSTSVEAMYS------VASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 7e-05
Identities = 37/286 (12%), Positives = 83/286 (29%), Gaps = 75/286 (26%)
Query: 3 YGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIV--------K- 53
Y D Q K + V +L+ + L+ + L ++ N++ K
Sbjct: 120 YNDN-QVFAKYN-----VSRLQPYL-------KLR--QALLELRPAKNVLIDGVLGSGKT 164
Query: 54 ------LRNLVKEHEDVFIVFEYM-------ESDLLKLMKERAGQNFSEDEVRNLCFQVF 100
+ + + F +F ++ +L+++ Q N +
Sbjct: 165 WVALDVCLSYKVQCKMDFKIF-WLNLKNCNSPETVLEML-----QKLLYQIDPNWTSRSD 218
Query: 101 QGLHYMHR--------QGYFHRDLKPSNLLV-----SKGVIKIGDLGMVKEIDSSLPCTD 147
+ R + + LLV + +L C
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS----------CKI 268
Query: 148 YVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSAD---QIYKI--- 201
+TTR+ + + L + +D +M E+ S + + D ++
Sbjct: 269 LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR 328
Query: 202 -CQVIGSPTEDSWPLGIQLASNLD-WKFPQMGGVNLRELSPSASRE 245
+I D +++ K + +L L P+ R+
Sbjct: 329 RLSIIAESIRD-GLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRK 373
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 3e-04
Identities = 44/307 (14%), Positives = 99/307 (32%), Gaps = 58/307 (18%)
Query: 5 DVFQALDKKSGEFVAVKKLKKKIFSLDESRNL------KEVKCLRK--MNNHPNIVKL-R 55
V L + +++ + DE ++L + L + + +P + +
Sbjct: 276 QVTDFLSAATTTHISLDHHSMT-LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA 334
Query: 56 NLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+++ + ++++ D L + E + E R ++F L F
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR----KMFDRL------SVFPPS 384
Query: 116 LK-PSNLLVS--KGVIKIGDLGMVKE-IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
P+ LL VIK + +V + SL + P + L E+ +
Sbjct: 385 AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST-ISIPSIYL--ELKVKLEN 441
Query: 172 MWAMGAIMFEMLSFRILFP----GKNSADQIYKICQVIG---SPTE--DSWPLGIQLASN 222
+A+ + + + F DQ Y IG E + L + +
Sbjct: 442 EYALHRSIVDHYNIPKTFDSDDLIPPYLDQ-Y-FYSHIGHHLKNIEHPERMTLFRMVFLD 499
Query: 223 LDW---KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC--- 276
+ K + + +AS ++ + +L + P++ P +
Sbjct: 500 FRFLEQK------IRHDSTAWNASGSILNTLQQLKFYKPYICD------NDPKYERLVNA 547
Query: 277 --HFVPR 281
F+P+
Sbjct: 548 ILDFLPK 554
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 282 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.47 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.11 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.92 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.85 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.76 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.43 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.31 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.13 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.12 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.08 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.93 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.87 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.63 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.59 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.34 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.32 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.29 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.25 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.24 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.24 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.21 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.88 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.4 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.74 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.79 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-64 Score=397.82 Aligned_cols=242 Identities=31% Similarity=0.518 Sum_probs=195.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||+|++++..... ....+.+|+.+++++. ||||+++++++++++.+|+|||||+|++++.
T Consensus 24 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~ivmEy~~g~L~~~ 102 (275)
T 3hyh_A 24 GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMVIEYAGNELFDY 102 (275)
T ss_dssp ---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCCEEHHHH
T ss_pred CcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEEEeCCCCCHHHH
Confidence 899999999999999999999997654332 2346788999999995 9999999999999999999999999888887
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+.+. .++++..++.++.||+.||+|||++||+||||||+||++++ +.+||+|||+|............+||+.|+||
T Consensus 103 l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~AP 180 (275)
T 3hyh_A 103 IVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP 180 (275)
T ss_dssp HHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------------CTTSCH
T ss_pred HHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCCh
Confidence 7654 47999999999999999999999999999999999999985 79999999999877665555678999999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+....+.++|||||||++|+|++|+.||.+.+.......+.... ..
T Consensus 181 E~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------------------------~~ 230 (275)
T 3hyh_A 181 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------------------------YT 230 (275)
T ss_dssp HHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------------------------CC
T ss_pred hhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------------------------------CC
Confidence 999866655789999999999999999999999877666655554421 12
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
++..+++++++||++||+.||++|||++|+++||||+.
T Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 23467899999999999999999999999999999985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-63 Score=405.02 Aligned_cols=245 Identities=29% Similarity=0.490 Sum_probs=210.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+|+.||||+++.... .....+.+|+.+++++. ||||++++++|.+++.+|||||||.|+.|..++
T Consensus 85 G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l 162 (346)
T 4fih_A 85 GSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGALTDIV 162 (346)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEECCCTTEEHHHHH
T ss_pred CcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHH
Confidence 8999999999999999999999976543 33456788999999994 999999999999999999999999987777777
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCC-CCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE 158 (282)
.. ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|...... ......+||+.|+|||
T Consensus 163 ~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPE 240 (346)
T 4fih_A 163 TH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 240 (346)
T ss_dssp HH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHH
T ss_pred Hc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHH
Confidence 66 3699999999999999999999999999999999999998 489999999999876543 3345678999999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
++.+. .++.++|||||||++|||++|..||.+.+..+.+..+..... +. ...
T Consensus 241 vl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~--------------------------~~~ 292 (346)
T 4fih_A 241 LISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR--------------------------LKN 292 (346)
T ss_dssp HHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CC--------------------------CSC
T ss_pred HHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC--------------------------CCc
Confidence 98754 489999999999999999999999998877777666544211 10 011
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
+..+++++++||.+||+.||++|||++|+|+||||++..
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 235789999999999999999999999999999998753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-63 Score=400.93 Aligned_cols=245 Identities=25% Similarity=0.404 Sum_probs=210.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||+|++.+... ......+.+|+.+++++ +||||++++++|++++.+|+|||||.|+.|..
T Consensus 43 G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~ 121 (311)
T 4aw0_A 43 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 121 (311)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCTTEEHHH
T ss_pred ccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCCCCHHH
Confidence 8999999999999999999999976532 22345678899999999 59999999999999999999999999766665
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC---CCCCCccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWY 154 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~---~~~~~~~~~~~~ 154 (282)
++... +.+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|...... ......+||+.|
T Consensus 122 ~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~Y 200 (311)
T 4aw0_A 122 YIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200 (311)
T ss_dssp HHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGG
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCccc
Confidence 55554 37999999999999999999999999999999999999974 89999999999876432 233456899999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 201 mAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~----------------------------- 250 (311)
T 4aw0_A 201 VSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE----------------------------- 250 (311)
T ss_dssp CCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----------------------------
T ss_pred CCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------------------------
Confidence 9999998544 8999999999999999999999999888777776665521
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHH------HhcCcccccccC
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAE------ALEHPFFRSCHF 278 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~------ll~~~~~~~~~~ 278 (282)
..++..+++++++||++||+.||++|||++| |++||||+++.|
T Consensus 251 -~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 251 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred -CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 0223467899999999999999999999988 589999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-62 Score=405.95 Aligned_cols=245 Identities=29% Similarity=0.494 Sum_probs=211.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+|+.||||++.... ......+.+|+.+++++. ||||++++++|.+++.+|||||||.|+.|..++
T Consensus 162 G~fG~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i 239 (423)
T 4fie_A 162 GSTGIVCIATVRSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGALTDIV 239 (423)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEESTT-CSSGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTEEHHHHH
T ss_pred CcCcEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEEEEEEeCCCCCcHHHHH
Confidence 899999999999999999999997654 233456788999999994 999999999999999999999999988777777
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCC-CCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE 158 (282)
.. ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|...... ......+||+.|+|||
T Consensus 240 ~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPE 317 (423)
T 4fie_A 240 TH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE 317 (423)
T ss_dssp HH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHH
T ss_pred hc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHH
Confidence 65 3699999999999999999999999999999999999998 489999999999876543 3345678999999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
++.+. .++.++|||||||++|||++|..||.+.+..+.+..+..... +. ...
T Consensus 318 vl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~--------------------------~~~ 369 (423)
T 4fie_A 318 LISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR--------------------------LKN 369 (423)
T ss_dssp HHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC--------------------------CSC
T ss_pred HHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC--------------------------Ccc
Confidence 98754 489999999999999999999999998887777766544211 10 112
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
+..+++++++||.+||+.||++|||++|+|+||||+...
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 346789999999999999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-62 Score=390.18 Aligned_cols=243 Identities=28% Similarity=0.436 Sum_probs=202.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeecccccc----CCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKE----HEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|+++.++..||+|++....... ....+.+|+.+++++. ||||++++++|.+ +..+|||||||.|++
T Consensus 37 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~ 115 (290)
T 3fpq_A 37 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGT 115 (290)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEEEEEEEECCCSCB
T ss_pred CcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcEEEEEEeCCCCCC
Confidence 899999999999999999999997655433 3456788999999995 9999999999864 456899999999877
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeee--CCcEEEeecCcccccCCCCCCCCcccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG--YFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~--~~H~dl~p~nili~--~~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
|..++... ..+++..+..++.||+.||.|||++| |+||||||+|||++ ++.+||+|||+|...... .....+||
T Consensus 116 L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-~~~~~~GT 193 (290)
T 3fpq_A 116 LKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGT 193 (290)
T ss_dssp HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSS
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-ccCCcccC
Confidence 77666654 47999999999999999999999998 99999999999997 479999999999765433 33567899
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
+.|+|||++. +. ++.++|||||||++|||++|+.||........+........
T Consensus 194 p~YmAPE~~~-~~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~------------------------- 246 (290)
T 3fpq_A 194 PEFMAPEMYE-EK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV------------------------- 246 (290)
T ss_dssp CCCCCGGGGG-TC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-------------------------
T ss_pred ccccCHHHcC-CC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCC-------------------------
Confidence 9999999886 33 89999999999999999999999987766665544332111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
.....+...++++++||.+||+.||++|||++|+|+||||++
T Consensus 247 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 247 --KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp --CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred --CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 011233456889999999999999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-62 Score=399.65 Aligned_cols=245 Identities=27% Similarity=0.490 Sum_probs=205.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|+++.+|+.||||++...... .....+.+|+.+++++. ||||+++++++++++.+|||||||.|+.|..+
T Consensus 35 G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~ 113 (350)
T 4b9d_A 35 GSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKR 113 (350)
T ss_dssp ----CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTCBHHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEEEeCCCCCcHHHH
Confidence 89999999999999999999999765443 34566789999999995 99999999999999999999999987555544
Q ss_pred H-HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCccccccccC
Q 044127 80 K-ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRWYRA 156 (282)
Q Consensus 80 ~-~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~a 156 (282)
+ ...+..+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+|........ ....+||+.|+|
T Consensus 114 i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmA 193 (350)
T 4b9d_A 114 INAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193 (350)
T ss_dssp HHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCC
T ss_pred HHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccC
Confidence 4 444456899999999999999999999999999999999999974 8999999999987643221 234579999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+..... +
T Consensus 194 PE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-----------------------------~ 243 (350)
T 4b9d_A 194 PEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-----------------------------P 243 (350)
T ss_dssp HHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----------------------------C
T ss_pred HHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-----------------------------C
Confidence 9999854 489999999999999999999999999888777777655321 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
..+..+++++++||.+||+.||++|||++|+|+||||++-
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 2234678999999999999999999999999999999754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-61 Score=399.20 Aligned_cols=274 Identities=37% Similarity=0.656 Sum_probs=224.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccc------cCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVK------EHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~------~~~~~~lv~e~~~~ 73 (282)
|+||+||+|+++.+|+.||||+++...... ....+++|+.+++++. ||||+++++++. +.+.+|||||||+|
T Consensus 65 G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g 143 (398)
T 4b99_A 65 GAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPYGEFKSVYVVLDLMES 143 (398)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCTTTCCCEEEEEECCSE
T ss_pred ccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC-CCCcceEeeeeecccccccCCEEEEEEeCCCC
Confidence 899999999999999999999997654333 3456788999999995 999999999865 44689999999999
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-----CCCCCC
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-----SLPCTD 147 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-----~~~~~~ 147 (282)
++.+.+... ..+++..++.+++||+.||.|||++||+||||||+|||++. +.+|++|||++..... ......
T Consensus 144 ~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~ 221 (398)
T 4b99_A 144 DLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTE 221 (398)
T ss_dssp EHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCS
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCcccccccccc
Confidence 877666543 47999999999999999999999999999999999999985 8999999999986532 223346
Q ss_pred ccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc-cCCcc
Q 044127 148 YVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS-NLDWK 226 (282)
Q Consensus 148 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 226 (282)
.+||+.|+|||++.+...++.++||||+||++|||++|+.||.+.+..+.+..+....+.+....+........ .....
T Consensus 222 ~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~ 301 (398)
T 4b99_A 222 YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQS 301 (398)
T ss_dssp SCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHS
T ss_pred ceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhc
Confidence 78999999999998767689999999999999999999999999999999999999999887665542211110 01111
Q ss_pred ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
++......+.......++++++||++||+.||++|||++|+|+||||++..
T Consensus 302 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 302 LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred CCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 222233334455567899999999999999999999999999999998764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-62 Score=391.35 Aligned_cols=245 Identities=29% Similarity=0.444 Sum_probs=201.3
Q ss_pred CCcceEEEEEec---CCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDK---KSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~---~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|++. .+++.||+|+++..... .....+.+|+.+++++ +||||+++++++++++.+|+|||||.|+.|
T Consensus 35 G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L 113 (304)
T 3ubd_A 35 GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKLYLILDFLRGGDL 113 (304)
T ss_dssp GGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTEEEEEECCCTTCEE
T ss_pred CCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEEcCCCCCH
Confidence 899999999874 46889999999765432 2334567788888888 599999999999999999999999997666
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWY 154 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~~~ 154 (282)
..++... ..+++..++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|..... .......+||+.|
T Consensus 114 ~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~Y 192 (304)
T 3ubd_A 114 FTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192 (304)
T ss_dssp HHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGG
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCccc
Confidence 6666554 37999999999999999999999999999999999999985 8999999999986533 3334567899999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 193 mAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~----------------------------- 242 (304)
T 3ubd_A 193 MAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK----------------------------- 242 (304)
T ss_dssp CCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-----------------------------
T ss_pred CCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC-----------------------------
Confidence 999999854 48999999999999999999999999988777776665421
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccC
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHF 278 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~ 278 (282)
...+..+++++++||++||+.||++||| ++|+++||||+++.|
T Consensus 243 -~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 243 -LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 1223467899999999999999999998 589999999998764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-61 Score=391.17 Aligned_cols=242 Identities=27% Similarity=0.353 Sum_probs=203.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+|+.||||+++.... ..+|+.+++++ +||||+++++++.+++.+|||||||.|+.|..++
T Consensus 69 G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l 141 (336)
T 4g3f_A 69 GSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI 141 (336)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTC-CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHH
Confidence 8999999999999999999999976432 24588888888 5999999999999999999999999987776666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C-cEEEeecCcccccCCCCC------CCCccccc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G-VIKIGDLGMVKEIDSSLP------CTDYVTTR 152 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~-~~~l~df~~~~~~~~~~~------~~~~~~~~ 152 (282)
...+ ++++..+..++.||+.||.|||++||+||||||+|||++. + .+||+|||+|........ ....+||+
T Consensus 142 ~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~ 220 (336)
T 4g3f_A 142 KQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220 (336)
T ss_dssp HHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCG
T ss_pred HHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCc
Confidence 6554 7999999999999999999999999999999999999984 5 699999999987643221 22357999
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+....+....
T Consensus 221 ~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--------------------------- 272 (336)
T 4g3f_A 221 THMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--------------------------- 272 (336)
T ss_dssp GGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC---------------------------
T ss_pred cccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC---------------------------
Confidence 99999999854 48999999999999999999999999887766666554411
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHH-------------hcCcccccccC
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEA-------------LEHPFFRSCHF 278 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l-------------l~~~~~~~~~~ 278 (282)
.....++..+++.+.+||++||+.||.+|||++|+ |+|||++...-
T Consensus 273 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 273 PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 11224556789999999999999999999999997 67999988754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-59 Score=383.95 Aligned_cols=270 Identities=27% Similarity=0.416 Sum_probs=203.5
Q ss_pred CCcceEEEEEec---CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDK---KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~---~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|+++ .+++.||+|++.... ......+|+.+++.+.+||||++++++|++++++|+|||||+|+.+.
T Consensus 32 G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~ 108 (361)
T 4f9c_A 32 GTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFL 108 (361)
T ss_dssp CSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHH
T ss_pred ccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHH
Confidence 899999999875 467899999886542 33456789999999988999999999999999999999999876665
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCC------------
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSL------------ 143 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~------------ 143 (282)
.++. .+++.+++.++.||+.||+|||++||+||||||+|||++. +.+||+|||+|.......
T Consensus 109 ~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~ 184 (361)
T 4f9c_A 109 DILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQ 184 (361)
T ss_dssp HHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-----
T ss_pred HHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccc
Confidence 5553 5999999999999999999999999999999999999984 689999999997543221
Q ss_pred -----------------CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCC-CCCChHHHHHHHHHh
Q 044127 144 -----------------PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFP-GKNSADQIYKICQVI 205 (282)
Q Consensus 144 -----------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~-~~~~~~~~~~~~~~~ 205 (282)
.....+||+.|+|||++.+...++.++||||+||++|+|++|+.||. +.+..+.+..+....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~ 264 (361)
T 4f9c_A 185 QERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIR 264 (361)
T ss_dssp ---------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhc
Confidence 12235799999999999866668999999999999999999999985 455566666666655
Q ss_pred CCCCCCCccccc-------------------cccccCCccccC-----CCCCcccccCCCCChhhHHHHHHHhCCCCCCC
Q 044127 206 GSPTEDSWPLGI-------------------QLASNLDWKFPQ-----MGGVNLRELSPSASRESISLISRLCSWNPHMR 261 (282)
Q Consensus 206 ~~~~~~~~~~~~-------------------~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 261 (282)
+.+....+.... ......+...+. ............+++++++||++||+.||++|
T Consensus 265 G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R 344 (361)
T 4f9c_A 265 GSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASR 344 (361)
T ss_dssp CHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTS
T ss_pred CCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHC
Confidence 532211110000 000000000000 00011123345689999999999999999999
Q ss_pred CCHHHHhcCccccccc
Q 044127 262 PTAAEALEHPFFRSCH 277 (282)
Q Consensus 262 ps~~~ll~~~~~~~~~ 277 (282)
||++|+|+||||+++.
T Consensus 345 ~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 345 ITAEEALLHPFFKDMS 360 (361)
T ss_dssp CCHHHHHTSGGGTTC-
T ss_pred cCHHHHhcCcccCCCC
Confidence 9999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-59 Score=374.05 Aligned_cols=247 Identities=27% Similarity=0.449 Sum_probs=185.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCC------------cEEEEE
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE------------DVFIVF 68 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~------------~~~lv~ 68 (282)
|+||+||+|+++.+|+.||||+++..........+.+|+.+++++ +||||++++++|.+.+ ++|++|
T Consensus 16 G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivm 94 (299)
T 4g31_A 16 GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQM 94 (299)
T ss_dssp CC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC----------CEEEEEEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccccCCCcEEEEEE
Confidence 899999999999999999999997665444556778999999999 5999999999986443 479999
Q ss_pred ecCCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC-
Q 044127 69 EYMESDLLKLMKERAG--QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP- 144 (282)
Q Consensus 69 e~~~~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~- 144 (282)
|||.|+.+..++...+ ...+...++.++.||++||+|||++||+||||||+|||++ ++.+||+|||+|........
T Consensus 95 E~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~ 174 (299)
T 4g31_A 95 QLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174 (299)
T ss_dssp ECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC---------
T ss_pred ecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccc
Confidence 9999877777766543 1255677899999999999999999999999999999997 48999999999987643221
Q ss_pred ------------CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCC
Q 044127 145 ------------CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDS 212 (282)
Q Consensus 145 ------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (282)
....+||+.|+|||++.+. .++.++|||||||++|||++ ||.... +....+........+
T Consensus 175 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~~~~~~~~~p-- 246 (299)
T 4g31_A 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTLTDVRNLKFP-- 246 (299)
T ss_dssp -----------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHHHHHHTTCCC--
T ss_pred cccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHHHHHhcCCCC--
Confidence 1235799999999999854 48999999999999999996 665322 222222221111110
Q ss_pred ccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 213 WPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
......++...+||++||+.||.+|||+.|+|+||||+++.+..
T Consensus 247 ------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 247 ------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290 (299)
T ss_dssp ------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred ------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence 11123356788999999999999999999999999999987643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=360.94 Aligned_cols=241 Identities=23% Similarity=0.320 Sum_probs=193.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|++.. .||||+++..... .....+.+|+.++.++. ||||+++++++.+ +.++||||||.+++|..+
T Consensus 47 G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~ 121 (307)
T 3omv_A 47 GSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DNLAIVTQWCEGSSLYKH 121 (307)
T ss_dssp CSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEEEEECCSSCBHHHH
T ss_pred CCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHH
Confidence 8999999998653 5999998754433 34566789999999995 9999999998865 468999999998777777
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC---CCCCCcccccccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYR 155 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~ 155 (282)
+.....++++.++..|+.||+.||+|||+++|+||||||+|||+++ +.+||+|||+|...... .......||+.|+
T Consensus 122 l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ym 201 (307)
T 3omv_A 122 LHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWM 201 (307)
T ss_dssp HHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSC
T ss_pred HhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCcc
Confidence 7665567999999999999999999999999999999999999986 69999999999865432 2234568999999
Q ss_pred Cchhhhcc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 156 APEVLLLS--EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 156 aPE~~~~~--~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
|||++.+. ..++.++|||||||++|||+||+.||.+.+....+.......... .
T Consensus 202 APE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~------------------------p 257 (307)
T 3omv_A 202 APEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS------------------------P 257 (307)
T ss_dssp CHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC------------------------C
T ss_pred CHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC------------------------C
Confidence 99999643 358999999999999999999999999888777666554422111 1
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
.+...+..+++.+.+|+.+||+.||++|||+++|+++
T Consensus 258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1223455788999999999999999999999987643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-57 Score=363.71 Aligned_cols=239 Identities=21% Similarity=0.305 Sum_probs=198.6
Q ss_pred CCcceEEEEEec-----CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDK-----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|+.. .+++.||||+++..........+.+|+.++.++. ||||++++|++.+++..++|||||++++
T Consensus 37 G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~~~~~lV~Ey~~~G~ 115 (308)
T 4gt4_A 37 DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGD 115 (308)
T ss_dssp CSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCSSCB
T ss_pred CCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEECCEEEEEEEcCCCCc
Confidence 899999999864 4678899999987655555677889999999995 9999999999999999999999999776
Q ss_pred HHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccccc
Q 044127 76 LKLMKERA---------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI 139 (282)
Q Consensus 76 l~~~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~ 139 (282)
|..++... ...+++..+..|+.||++||+|||+++++||||||+|||+++ +.+||+|||++...
T Consensus 116 L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~ 195 (308)
T 4gt4_A 116 LHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 195 (308)
T ss_dssp HHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGG
T ss_pred HHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceec
Confidence 76665432 135899999999999999999999999999999999999986 79999999999865
Q ss_pred CCC---CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccc
Q 044127 140 DSS---LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPL 215 (282)
Q Consensus 140 ~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (282)
... .......||+.|+|||++.++. ++.++|||||||++|||+| |..||.+.+..+....+.....
T Consensus 196 ~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~--------- 265 (308)
T 4gt4_A 196 YAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV--------- 265 (308)
T ss_dssp GGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCC---------
T ss_pred cCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 322 2234567899999999998555 8999999999999999998 8999998887776655543211
Q ss_pred cccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 216 GIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+..+++.+.+|+.+||+.||++|||+++|+++
T Consensus 266 --------------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 266 --------------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp --------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 12345678999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=365.53 Aligned_cols=241 Identities=24% Similarity=0.405 Sum_probs=198.3
Q ss_pred CCcceEEEEEec-----CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDK-----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|++. .++..||||+++... ......+.+|+.++.++. ||||+++++++.+++..++|||||.+++
T Consensus 24 G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~~~~lV~Ey~~~G~ 101 (299)
T 4asz_A 24 GAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGDPLIMVFEYMKHGD 101 (299)
T ss_dssp --CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred CCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCEEEEEEEcCCCCc
Confidence 899999999865 357889999997542 344567889999999995 9999999999999999999999999777
Q ss_pred HHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC
Q 044127 76 LKLMKERA------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 142 (282)
Q Consensus 76 l~~~~~~~------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~ 142 (282)
|..++... ...+++.++..++.||++||.|||+++|+||||||+|||+++ +.+||+|||++......
T Consensus 102 L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 181 (299)
T 4asz_A 102 LNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 181 (299)
T ss_dssp HHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGG
T ss_pred HHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCC
Confidence 76666542 246999999999999999999999999999999999999985 79999999999765332
Q ss_pred C---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCcccccc
Q 044127 143 L---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQ 218 (282)
Q Consensus 143 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (282)
. ......+|+.|+|||++.++. ++.++|||||||++|||+| |+.||.+.+..+....+.....
T Consensus 182 ~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~------------ 248 (299)
T 4asz_A 182 DYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV------------ 248 (299)
T ss_dssp GCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC------------
T ss_pred CceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 2 123346899999999998554 8999999999999999998 8999999887777666554321
Q ss_pred ccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 219 LASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
...+..+++++.+|+.+||+.||++|||+++| ++|+++
T Consensus 249 -----------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 249 -----------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred -----------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 12345678999999999999999999999998 456654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-57 Score=390.31 Aligned_cols=249 Identities=29% Similarity=0.420 Sum_probs=201.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHh--CCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKM--NNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~--~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|+++.+|+.||||++++.... ........|...+..+ .+||||++++++|++++.+|+|||||.|+.|
T Consensus 200 G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL 279 (689)
T 3v5w_A 200 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 279 (689)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred ccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcH
Confidence 89999999999999999999999765322 1122233443333322 2699999999999999999999999997666
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 155 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 155 (282)
..++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. |.+||+|||+|........ ...+||+.|+
T Consensus 280 ~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~-~t~~GTp~Ym 357 (689)
T 3v5w_A 280 HYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-HASVGTHGYM 357 (689)
T ss_dssp HHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCC-CSCCSCGGGC
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCCC-CCccCCcCcc
Confidence 66665543 7999999999999999999999999999999999999985 8999999999987755433 5578999999
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||++..+..++.++|+|||||++|||++|..||.+.+..+........... .
T Consensus 358 APEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---------------------------~ 410 (689)
T 3v5w_A 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---------------------------A 410 (689)
T ss_dssp CHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---------------------------C
T ss_pred CHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---------------------------C
Confidence 9999976666899999999999999999999999865443322211111100 0
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccC
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHF 278 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~ 278 (282)
...+..+++++++||.+||+.||.+|++ ++|+++||||+++.|
T Consensus 411 ~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 1234568999999999999999999998 799999999999865
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-56 Score=363.50 Aligned_cols=238 Identities=24% Similarity=0.373 Sum_probs=192.6
Q ss_pred CCcceEEEEEec-----CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDK-----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|+++ .++..||||+++... ......+.+|+.++.++ +|||||++++++.+++..+||||||.+++
T Consensus 52 G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~ 129 (329)
T 4aoj_A 52 GAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGD 129 (329)
T ss_dssp CSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred CCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence 899999999864 468899999997542 34456788999999999 49999999999999999999999999877
Q ss_pred HHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC
Q 044127 76 LKLMKERA--------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID 140 (282)
Q Consensus 76 l~~~~~~~--------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~ 140 (282)
|..++... ..++++.++..|+.||++||+|||+++|+||||||+|||+++ +.+||+|||++....
T Consensus 130 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~ 209 (329)
T 4aoj_A 130 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209 (329)
T ss_dssp HHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred HHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceecc
Confidence 77766542 235999999999999999999999999999999999999986 799999999998653
Q ss_pred CCC---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCcccc
Q 044127 141 SSL---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLG 216 (282)
Q Consensus 141 ~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (282)
... ......+|+.|+|||++.+.. ++.++|||||||++|||+| |+.||...+..+....+......
T Consensus 210 ~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~--------- 279 (329)
T 4aoj_A 210 STDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGREL--------- 279 (329)
T ss_dssp ----------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCC---------
T ss_pred CCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 322 223467899999999998554 8999999999999999999 89999988877776665543211
Q ss_pred ccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 217 IQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+..+++++.+|+.+||+.||++|||++||+++
T Consensus 280 --------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 280 --------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred --------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 2344678999999999999999999999999764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-57 Score=392.81 Aligned_cols=249 Identities=25% Similarity=0.401 Sum_probs=213.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+|+.||+|++.... ......+.+|+.+++.+. ||||++++++|++++.+|++||||.|+.|..++
T Consensus 168 G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i 245 (573)
T 3uto_A 168 GAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 245 (573)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSEEEEEEECCCCCBHHHHH
T ss_pred ccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEEEEeecCCCcHHHHH
Confidence 899999999999999999999987643 234556778999999995 999999999999999999999999876555555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC---CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
......+++..++.+++||+.||.|||++||+||||||+||+++. +.+||+|||++..+.........+||+.|+||
T Consensus 246 ~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~AP 325 (573)
T 3uto_A 246 ADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325 (573)
T ss_dssp TCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCH
T ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCH
Confidence 433357999999999999999999999999999999999999973 68999999999988766655667899999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+......+. ..
T Consensus 326 Ev~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~ 378 (573)
T 3uto_A 326 EVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD--------------------------DS 378 (573)
T ss_dssp HHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC--------------------------SG
T ss_pred HHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC--------------------------cc
Confidence 999854 489999999999999999999999999888777766654322211 12
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....+++.+++||++||+.||.+|||++|+|+||||+...+
T Consensus 379 ~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 23467899999999999999999999999999999997654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=361.75 Aligned_cols=241 Identities=23% Similarity=0.352 Sum_probs=199.8
Q ss_pred CCcceEEEEEecCC-----CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc-CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKS-----GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE-HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~-----~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~~~ 74 (282)
|+||+||+|++..+ ++.||+|++...........+.+|+.++.++.+||||+++++++.+ ++.++||||||.++
T Consensus 75 G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G 154 (353)
T 4ase_A 75 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 154 (353)
T ss_dssp CSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTE
T ss_pred CCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCC
Confidence 89999999987654 4689999998766556667789999999999877999999999865 46789999999977
Q ss_pred HHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccc
Q 044127 75 LLKLMKERA---------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE 138 (282)
Q Consensus 75 ~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~ 138 (282)
.|..++... ...+++..+..++.||++||+|||+++++||||||+|||+++ +.+||+|||+|+.
T Consensus 155 ~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~ 234 (353)
T 4ase_A 155 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 234 (353)
T ss_dssp EHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred CHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhh
Confidence 776665432 234899999999999999999999999999999999999985 7999999999987
Q ss_pred cCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCcc
Q 044127 139 IDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWP 214 (282)
Q Consensus 139 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (282)
...... .....+|+.|+|||++.+.. ++.++|||||||++|||+| |..||.+....+.+...+.....+
T Consensus 235 ~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~------ 307 (353)
T 4ase_A 235 IYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------ 307 (353)
T ss_dssp TTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC------
T ss_pred cccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCC------
Confidence 644322 23457899999999998554 8999999999999999998 899999877666555444422111
Q ss_pred ccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 215 LGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++++.++|.+||+.||++|||+++|++|
T Consensus 308 ----------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 308 ----------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 2334678999999999999999999999999987
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=353.57 Aligned_cols=275 Identities=32% Similarity=0.637 Sum_probs=229.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|++. +++.||+|++....... ....+.+|+.+++++. ||||+++++++.++...++||||+.+++++.+
T Consensus 32 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~ 109 (311)
T 3niz_A 32 GTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVL 109 (311)
T ss_dssp CSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCSSCEEEEEECCSEEHHHHH
T ss_pred CCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccCCEEEEEEcCCCCCHHHHH
Confidence 899999999985 48899999987654322 2356678999999994 99999999999999999999999999888776
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aP 157 (282)
.... ..+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++...+.. .......+++.|+||
T Consensus 110 ~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aP 188 (311)
T 3niz_A 110 DENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188 (311)
T ss_dssp HTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCH
T ss_pred Hhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCH
Confidence 6543 46999999999999999999999999999999999999974 89999999999876533 223445789999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+...++.++|||||||++|+|++|..||.+....+....+....+.+.+..++............+..........
T Consensus 189 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (311)
T 3niz_A 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSS 268 (311)
T ss_dssp HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHH
T ss_pred HHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHH
Confidence 99986666899999999999999999999999999999999999999999988888765554444333344344444555
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....+++++.+||++||+.||++|||++|+|+||||+++..
T Consensus 269 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 269 IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 66778999999999999999999999999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=343.89 Aligned_cols=274 Identities=31% Similarity=0.613 Sum_probs=227.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|+++.+++.||+|++....... ......+|+.+++++. ||||+++++++.+++..++||||+++++++.+
T Consensus 13 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~ 91 (292)
T 3o0g_A 13 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF 91 (292)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCSEEHHHHH
T ss_pred CCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEEEecCCCCHHHHH
Confidence 899999999999999999999997654333 3456678999999985 99999999999999999999999999998887
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aP 157 (282)
.... ..+++..++.++.||+.||.+||++|++|+||||+||+++. +.++|+|||++...+.. .......+++.|+||
T Consensus 92 ~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aP 170 (292)
T 3o0g_A 92 DSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170 (292)
T ss_dssp HHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCH
T ss_pred HhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcCh
Confidence 7654 47999999999999999999999999999999999999985 79999999999876433 223455789999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCC-CCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRIL-FPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|++.+...++.++|||||||++|+|++|..| |...+..+....+....+.+....|+.............. .......
T Consensus 171 E~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 249 (292)
T 3o0g_A 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY-PATTSLV 249 (292)
T ss_dssp HHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC-CTTCCCT
T ss_pred HHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccc-cCCcchh
Confidence 9998666689999999999999999988776 6677777888888888888888887765544333221111 1122334
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
......++.+++||++||+.||++|||++|+|+||||++..
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 250 NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred hcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 45567899999999999999999999999999999999854
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=355.41 Aligned_cols=276 Identities=32% Similarity=0.626 Sum_probs=228.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.||+|++.............+|+.+++++. ||||+++++++.+++..++||||+++++.+.+.
T Consensus 13 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~ 91 (324)
T 3mtl_A 13 GTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD 91 (324)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEEEECCSEEHHHHHH
T ss_pred CCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEEecccccCHHHHHH
Confidence 8999999999999999999999876543333334557889898885 999999999999999999999999998777665
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE 158 (282)
.. +..+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++...... .......+++.|+|||
T Consensus 92 ~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE 170 (324)
T 3mtl_A 92 DC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPD 170 (324)
T ss_dssp HT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHH
T ss_pred hc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChh
Confidence 54 457999999999999999999999999999999999999985 79999999998765432 2233457799999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+...++.++|||||||++|+|++|..||.+.+..+....+....+.+....|+............++..........
T Consensus 171 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (324)
T 3mtl_A 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH 250 (324)
T ss_dssp HHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHH
T ss_pred hhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhh
Confidence 99866668999999999999999999999999999999999999999999998887665554444444454444555566
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...+++.+.+||.+||+.||.+|||++|+|+||||++...
T Consensus 251 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 251 APRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 6788999999999999999999999999999999988754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=344.45 Aligned_cols=275 Identities=35% Similarity=0.630 Sum_probs=224.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch----HHHHHHHHHHHHHHhC--CCCCeeeeccccccCC-----cEEEEEe
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL----DESRNLKEVKCLRKMN--NHPNIVKLRNLVKEHE-----DVFIVFE 69 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~----~~~~~~~e~~~l~~~~--~hp~i~~~~~~~~~~~-----~~~lv~e 69 (282)
|+||+||+|++..+++.||+|++....... ......+|+..++.+. +||||+++++++.... ..+++||
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e 99 (308)
T 3g33_A 20 GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFE 99 (308)
T ss_dssp SSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEE
T ss_pred CCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEeh
Confidence 899999999999999999999987543211 1234445666666554 4999999999987654 5899999
Q ss_pred cCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCc
Q 044127 70 YMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDY 148 (282)
Q Consensus 70 ~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~ 148 (282)
++.+++.+.+.......+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++............
T Consensus 100 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 179 (308)
T 3g33_A 100 HVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV 179 (308)
T ss_dssp CCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGG
T ss_pred hhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCc
Confidence 99998777776655455999999999999999999999999999999999999974 89999999999887766666677
Q ss_pred cccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 149 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
.+++.|+|||.+.+.. ++.++|||||||++|+|++|..||......+....+....+.+....|+....... ..+.
T Consensus 180 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~ 255 (308)
T 3g33_A 180 VVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR---GAFP 255 (308)
T ss_dssp GCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCG---GGSC
T ss_pred cccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccc---cccC
Confidence 8899999999998555 89999999999999999999999999999999999999999888887765444332 2233
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
.............+++.+.+||.+||+.||++|||++++|+||||++....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~~ 306 (308)
T 3g33_A 256 PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGN 306 (308)
T ss_dssp CCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC------
T ss_pred CCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCCC
Confidence 334444555667889999999999999999999999999999999976543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=344.75 Aligned_cols=276 Identities=32% Similarity=0.613 Sum_probs=224.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+++.||+|++.............+|+.+++++. ||||+++++++..++..++||||+.+++.+.+.
T Consensus 16 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~ 94 (317)
T 2pmi_A 16 GTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMD 94 (317)
T ss_dssp ---CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEEEEECCCCBHHHHHH
T ss_pred CCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEEEEEecCCCHHHHHH
Confidence 8999999999999999999999976544444456778999999994 999999999999999999999999998877665
Q ss_pred Hhc----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccc
Q 044127 81 ERA----GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWY 154 (282)
Q Consensus 81 ~~~----~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~ 154 (282)
... ...+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++...... .......+++.|
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y 174 (317)
T 2pmi_A 95 SRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174 (317)
T ss_dssp HHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTT
T ss_pred hccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccc
Confidence 543 235999999999999999999999999999999999999975 89999999999876433 223456789999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+....+.+....|+......... ..........
T Consensus 175 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 253 (317)
T 2pmi_A 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN-PNIQQRPPRD 253 (317)
T ss_dssp CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCC-TTCCCCCCCC
T ss_pred cCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcc-cccccccchh
Confidence 999999865668999999999999999999999999999999999999988888877776544332211 1111111111
Q ss_pred -----ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 235 -----LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 235 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
........+..+.+||++||+.||.+|||++++|+||||++...
T Consensus 254 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 254 LRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp SHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred HHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 12234467899999999999999999999999999999998643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=347.21 Aligned_cols=245 Identities=26% Similarity=0.425 Sum_probs=209.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||.||+|++..+|+.||+|++....... ....+.+|+.+++.+. ||||+++++++...+..++||||+.++.+..+
T Consensus 26 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~ 104 (328)
T 3fe3_A 26 GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDY 104 (328)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCTTCBHHHH
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEEEEECCCCCcHHHH
Confidence 899999999999999999999997765433 3456678999999995 99999999999999999999999986555555
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
+... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++.............+++.|+|||
T Consensus 105 l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE 183 (328)
T 3fe3_A 105 LVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPE 183 (328)
T ss_dssp HHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHH
T ss_pred HHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcc
Confidence 4443 46999999999999999999999999999999999999985 799999999998776655556778999999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+....+.++|||||||++|+|++|..||.+.+..+....+..... ..
T Consensus 184 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------------------------~~ 233 (328)
T 3fe3_A 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY------------------------------RI 233 (328)
T ss_dssp HHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------------------CC
T ss_pred cccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------------------CC
Confidence 998666556899999999999999999999998877666665544211 12
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
+...++.+.+||++||+.||.+|||++++++||||+...
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 335689999999999999999999999999999998643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=350.17 Aligned_cols=276 Identities=34% Similarity=0.658 Sum_probs=220.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|++..+++.||+|++....... ....+.+|+.+++++ +||||+++++++.++...++||||+.+++.+.+
T Consensus 45 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~ 123 (329)
T 3gbz_A 45 GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYM 123 (329)
T ss_dssp CSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHH
T ss_pred cCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCEEEEEEecCCCCHHHHH
Confidence 899999999999999999999997654332 234567899999999 599999999999999999999999999777766
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC------CcEEEeecCcccccCCC-CCCCCccccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK------GVIKIGDLGMVKEIDSS-LPCTDYVTTR 152 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~------~~~~l~df~~~~~~~~~-~~~~~~~~~~ 152 (282)
... ..+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++...... .......+++
T Consensus 124 ~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~ 201 (329)
T 3gbz_A 124 DKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201 (329)
T ss_dssp HHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CC
T ss_pred hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCc
Confidence 554 36999999999999999999999999999999999999952 45999999999866432 2234456799
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
.|+|||++.+...++.++|||||||++|+|++|..||......+....+....+.+....++.......... .++....
T Consensus 202 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 280 (329)
T 3gbz_A 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQ-SFPKFRG 280 (329)
T ss_dssp TTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-TCCCCCC
T ss_pred cccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhh-hhhhhcc
Confidence 999999998666689999999999999999999999999999999999999998888877765444333222 1111111
Q ss_pred C-cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 233 V-NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 233 ~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
. ........+++.+.+||.+||+.||.+|||++++|+||||++..+.|
T Consensus 281 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~P 329 (329)
T 3gbz_A 281 KTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFDP 329 (329)
T ss_dssp CCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSCC
T ss_pred ccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCCC
Confidence 1 11223334789999999999999999999999999999999998876
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-53 Score=339.40 Aligned_cols=272 Identities=32% Similarity=0.619 Sum_probs=219.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|++ .+++.||+|++....... ....+.+|+.+++++. ||||+++++++.+.+..++|||++.+++.+.+
T Consensus 13 G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~ 90 (288)
T 1ob3_A 13 GTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLL 90 (288)
T ss_dssp ETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEEEECCSEEHHHHH
T ss_pred CCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEEEEecCCCHHHHH
Confidence 79999999998 578899999987553222 2345678999998885 99999999999999999999999999776665
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aP 157 (282)
... ...+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++...... .......+++.|+||
T Consensus 91 ~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aP 169 (288)
T 1ob3_A 91 DVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169 (288)
T ss_dssp HTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCH
T ss_pred Hhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCc
Confidence 443 357999999999999999999999999999999999999974 89999999998866432 222345789999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+...++.++|||||||++|+|++|..||.+....+....+....+.+....|+....... .+..+..........
T Consensus 170 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 248 (288)
T 1ob3_A 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK-YDPNFTVYEPLPWES 248 (288)
T ss_dssp HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT-CCTTCCCCCCCCGGG
T ss_pred hheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc-cccccccccCccHHH
Confidence 9997666689999999999999999999999999998888888888888887777764433222 111222222233445
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
....+++.+.+||++||+.||++|||++++|+||||++.
T Consensus 249 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 566789999999999999999999999999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=349.04 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=209.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-----HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-----DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-----~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|+++.+|+.||+|++....... ....+.+|+.++.++. ||||+++++++.+....++||||+.|+.
T Consensus 23 G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~gg~ 101 (361)
T 2yab_A 23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGE 101 (361)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred CcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEEeCCEEEEEEEcCCCCc
Confidence 899999999999999999999998654322 2356778999999985 9999999999999999999999998766
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C----cEEEeecCcccccCCCCCCCCccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G----VIKIGDLGMVKEIDSSLPCTDYVT 150 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~----~~~l~df~~~~~~~~~~~~~~~~~ 150 (282)
+..++... ..+++..+..++.||+.||.|||++|++|+||||+||++++ + .++|+|||++.............|
T Consensus 102 L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~g 180 (361)
T 2yab_A 102 LFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180 (361)
T ss_dssp HHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCS
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCC
Confidence 66666544 47999999999999999999999999999999999999964 3 799999999988766655567789
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 181 t~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--------------------- 238 (361)
T 2yab_A 181 TPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD--------------------- 238 (361)
T ss_dssp CGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC---------------------
T ss_pred CccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---------------------
Confidence 9999999998744 489999999999999999999999998877766655543211111
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
...+...++.+++||++||..||.+|||++++|+||||++..
T Consensus 239 -----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 239 -----EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp -----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred -----chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 122346789999999999999999999999999999998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-53 Score=347.94 Aligned_cols=246 Identities=30% Similarity=0.496 Sum_probs=204.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++..... .........|..++..+.+||||+++++++.+.+..|+|||||.|+.+..
T Consensus 34 G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~ 113 (353)
T 3txo_A 34 GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMF 113 (353)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred CCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHH
Confidence 8999999999999999999999976532 22334567788888888789999999999999999999999999766655
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
++... ..+++..++.++.||+.||.|||++|++||||||+||+++. +.+||+|||++.... ........+||+.|+|
T Consensus 114 ~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~a 192 (353)
T 3txo_A 114 HIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIA 192 (353)
T ss_dssp HHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCC
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEC
Confidence 55544 46999999999999999999999999999999999999974 899999999987543 2233345689999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+.. ++.++|||||||++|+|++|..||...+..+....+.....
T Consensus 193 PE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~------------------------------ 241 (353)
T 3txo_A 193 PEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV------------------------------ 241 (353)
T ss_dssp HHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------------------
T ss_pred hhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------------------
Confidence 99987544 89999999999999999999999998887777766655211
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH------HHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA------AEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~~~~~~~~~~ 278 (282)
..+..+++.+.+||++||+.||.+||++ +++++||||+++.+
T Consensus 242 ~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 242 VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 1234578899999999999999999998 89999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=340.80 Aligned_cols=245 Identities=30% Similarity=0.487 Sum_probs=206.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||+|+++.... ........+|..++..+ +||||+++++++...+..++||||+.|+.+..
T Consensus 16 G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~ 94 (337)
T 1o6l_A 16 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANGGELFF 94 (337)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEEEeCCCCCcHHH
Confidence 8999999999999999999999976532 22345567888988888 59999999999999999999999998766655
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++.... ........+||+.|+|
T Consensus 95 ~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~a 173 (337)
T 1o6l_A 95 HLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173 (337)
T ss_dssp HHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCC
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCC
Confidence 55544 46999999999999999999999999999999999999974 899999999987642 2333456789999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+. .++.++|+|||||++|+|++|..||...+.......+.... .
T Consensus 174 PE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------------------------------~ 222 (337)
T 1o6l_A 174 PEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE------------------------------I 222 (337)
T ss_dssp GGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------------------------C
T ss_pred hhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------------------------C
Confidence 9998754 48999999999999999999999998877666555544311 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
..+..+++.+.+||++||+.||.+|| +++++++||||+++.+
T Consensus 223 ~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 12346789999999999999999999 8999999999988754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=336.48 Aligned_cols=247 Identities=24% Similarity=0.452 Sum_probs=208.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.||+|++..... .....+.+|+..++++ +||||+++++++..++..++||||+.++++..++
T Consensus 31 G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 108 (297)
T 3fxz_A 31 GASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV 108 (297)
T ss_dssp ETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred CCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHH
Confidence 8999999999999999999999876543 2345567899999888 5999999999999999999999999877777776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
.. ..+++..++.++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++....... ......+++.|+|||
T Consensus 109 ~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE 186 (297)
T 3fxz_A 109 TE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186 (297)
T ss_dssp HH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHH
T ss_pred hh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChh
Confidence 65 3699999999999999999999999999999999999998 5899999999988764432 234567899999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+.. ++.++|||||||++|+|++|..||...+.......+....... ...
T Consensus 187 ~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------------------~~~ 238 (297)
T 3fxz_A 187 VVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE---------------------------LQN 238 (297)
T ss_dssp HHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC---------------------------CSC
T ss_pred hhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------------------------CCC
Confidence 998554 8999999999999999999999998887766665554432111 012
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
+..+++.+.+||.+||+.||.+|||++++++||||+.....
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 279 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPL 279 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCcc
Confidence 23568899999999999999999999999999999976543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=358.86 Aligned_cols=270 Identities=32% Similarity=0.563 Sum_probs=210.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccC------CcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH------EDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~------~~~~lv~e~~~~ 73 (282)
|+||+||+|++..+++.||+|++...... .......+|+.+++.+ +||||+++++++... ...|+||||+++
T Consensus 73 G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~ 151 (464)
T 3ttj_A 73 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 151 (464)
T ss_dssp CSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE
T ss_pred CCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccCCeEEEEEeCCCC
Confidence 89999999999999999999999765433 3345667899999998 599999999998544 467999999999
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++++.+. ..+++..+..++.||+.||+|||++|++||||||+||+++. +.+||+|||++.............+|+
T Consensus 152 ~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~ 227 (464)
T 3ttj_A 152 NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 227 (464)
T ss_dssp EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCC
T ss_pred CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccc
Confidence 9777653 25999999999999999999999999999999999999985 799999999998877665566778999
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....+.+.+..+..............+....
T Consensus 228 ~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (464)
T 3ttj_A 228 YYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG 306 (464)
T ss_dssp TTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCC
T ss_pred cccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCC
Confidence 99999999865 48999999999999999999999999999999999999999888765443221111100000111111
Q ss_pred CcccccCC------------CCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 233 VNLRELSP------------SASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 233 ~~~~~~~~------------~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
........ ..++.+++||++||+.||++|||++|+|+||||+..
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 307 LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp CCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred CChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 11111110 115679999999999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-53 Score=345.52 Aligned_cols=246 Identities=24% Similarity=0.364 Sum_probs=209.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.||+|++... ......+.+|+.++..+. ||||+++++++.+.+..++|||||.|+.+...+
T Consensus 16 G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l 92 (321)
T 1tki_A 16 GEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIAR-HRNILHLHESFESMEELVMIFEFISGLDIFERI 92 (321)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEEEEEECCCCCCBHHHHH
T ss_pred CCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHH
Confidence 89999999999999999999998754 344556678999999885 999999999999999999999999976666666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee---CCcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
...+..+++..++.++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++.............+++.|+||
T Consensus 93 ~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP 172 (321)
T 1tki_A 93 NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172 (321)
T ss_dssp TSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCH
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCc
Confidence 55555799999999999999999999999999999999999997 478999999999887665555566789999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+. .++.++|||||||++|+|++|..||......+....+........ ..
T Consensus 173 E~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--------------------------~~ 225 (321)
T 1tki_A 173 EVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD--------------------------EE 225 (321)
T ss_dssp HHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--------------------------HH
T ss_pred HHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC--------------------------hh
Confidence 999754 479999999999999999999999998877776666655322111 11
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
....+++.+.+||++||+.||.+|||++++|+||||++.
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 223578999999999999999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=341.80 Aligned_cols=246 Identities=30% Similarity=0.476 Sum_probs=207.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||+|+++.... .........|..++..+.+||||+++++++.+.+..|+||||+.|+.+..
T Consensus 28 G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~ 107 (345)
T 1xjd_A 28 GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMY 107 (345)
T ss_dssp CSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHH
Confidence 8999999999999999999999976532 22334566788888887679999999999999999999999998766665
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
++... ..+++..+..++.||+.||.|||++|++||||||+||+++. +.++|+|||++.... ........+||+.|+|
T Consensus 108 ~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~a 186 (345)
T 1xjd_A 108 HIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 186 (345)
T ss_dssp HHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCC
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCC
Confidence 55544 36999999999999999999999999999999999999984 899999999987643 2233456789999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+.. ++.++|+|||||++|+|++|..||.+.+..+....+.... .
T Consensus 187 PE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------------------------------~ 235 (345)
T 1xjd_A 187 PEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN------------------------------P 235 (345)
T ss_dssp HHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------------------------C
T ss_pred hhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC------------------------------C
Confidence 99998544 8999999999999999999999999887766665554311 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHH-HHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAA-EALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~ll~~~~~~~~~~ 278 (282)
..+..+++.+.+||++||+.||.+||++. ++++||||+++.+
T Consensus 236 ~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 236 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 12345789999999999999999999998 9999999998764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=341.40 Aligned_cols=273 Identities=35% Similarity=0.658 Sum_probs=224.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH----HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD----ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~----~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|++..+|+.||+|++........ ...+.+|+.++.++. ||||+++++++.+.+..++||||+.+++.
T Consensus 21 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~l~ 99 (346)
T 1ua2_A 21 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFMETDLE 99 (346)
T ss_dssp ETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEECCSEEHH
T ss_pred cCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeCCceEEEEEcCCCCHH
Confidence 7999999999999999999999976433221 235678999999995 99999999999999999999999999766
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWY 154 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~ 154 (282)
..+.. ....+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++...... .......+++.|
T Consensus 100 ~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y 178 (346)
T 1ua2_A 100 VIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWY 178 (346)
T ss_dssp HHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTT
T ss_pred HHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccc
Confidence 55544 3456999999999999999999999999999999999999985 79999999999876433 233456789999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||.+.+...++.++|||||||++|+|++|..||.+....+.+..+....+.+....|+........... .......
T Consensus 179 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 256 (346)
T 1ua2_A 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF--KSFPGIP 256 (346)
T ss_dssp CCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC--CCCCCCC
T ss_pred cCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccc--cccCCCC
Confidence 99999976666899999999999999999999999999999999999999999888888765554433221 1222233
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
........++.+.+||++||+.||.+|||++|+|+||||++..
T Consensus 257 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 257 LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 3445567899999999999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=335.41 Aligned_cols=277 Identities=31% Similarity=0.554 Sum_probs=214.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|++..+|+.||+|++........ ...+.+|+.+++++. ||||+++++++.+.+..++||||++++++..+
T Consensus 14 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 92 (311)
T 4agu_A 14 GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL 92 (311)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCSEEHHHHH
T ss_pred cCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEEEEEeCCCchHHHH
Confidence 8999999999999999999999876543333 445678999999995 99999999999999999999999999999887
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aP 157 (282)
.... ..+++..+..++.|++.||.+||++|++|+||||+||+++. +.++|+|||.+...... .......+++.|+||
T Consensus 93 ~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aP 171 (311)
T 4agu_A 93 DRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171 (311)
T ss_dssp HHTS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCH
T ss_pred Hhhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccCh
Confidence 7654 46999999999999999999999999999999999999984 89999999999876532 223455789999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC-CCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ-MGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 236 (282)
|.+.+...++.++||||||+++|+|++|..||.+....+....+....+...+.................+. .......
T Consensus 172 E~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (311)
T 4agu_A 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLE 251 (311)
T ss_dssp HHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHH
T ss_pred HHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhh
Confidence 999866668999999999999999999999999998888888877776655432221111100000001110 0111112
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
.....+++.+.+||++||+.||.+|||++++|+||||+++...
T Consensus 252 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 252 LKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp HHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred hhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 2234678899999999999999999999999999999987644
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=343.54 Aligned_cols=247 Identities=30% Similarity=0.469 Sum_probs=203.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++++..... .......|..++.++.+||||+++++++.+.+..++||||+.|+.+..
T Consensus 63 G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~ 142 (396)
T 4dc2_A 63 GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMF 142 (396)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHH
Confidence 899999999999999999999998754332 234467788888888789999999999999999999999998766655
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccccc-CCCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~a 156 (282)
.+... ..+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||++... .........+||+.|+|
T Consensus 143 ~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~a 221 (396)
T 4dc2_A 143 HMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221 (396)
T ss_dssp HHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCC
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCC
Confidence 55544 46999999999999999999999999999999999999985 89999999999863 33344556789999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSA--------DQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
||++.+. .++.++|+|||||++|+|++|..||...... +.........
T Consensus 222 PE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----------------------- 277 (396)
T 4dc2_A 222 PEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------------------- 277 (396)
T ss_dssp HHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-----------------------
T ss_pred chhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-----------------------
Confidence 9999854 4899999999999999999999999754321 1122111110
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCH------HHHhcCcccccccC
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTA------AEALEHPFFRSCHF 278 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~~~~~~~~~~ 278 (282)
...++..++..+.+||++||+.||.+||++ +++++||||+++.|
T Consensus 278 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 278 ------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred ------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 012345678999999999999999999985 79999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=346.25 Aligned_cols=274 Identities=34% Similarity=0.624 Sum_probs=209.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|.++.+|+.||+|++...... .......+|+..+.++.+||||+++++++..+ ...|+|||||.+++..
T Consensus 20 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~ 99 (388)
T 3oz6_A 20 GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHA 99 (388)
T ss_dssp ----CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSEEHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCcCHHH
Confidence 89999999999999999999998654333 34456678999999997899999999998643 4799999999987766
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC--------------
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-------------- 142 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-------------- 142 (282)
.+.. ..+++..+..++.||+.||+|||++|++||||||+||+++. +.+||+|||++......
T Consensus 100 ~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~ 176 (388)
T 3oz6_A 100 VIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176 (388)
T ss_dssp HHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC--
T ss_pred HHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccccccccccc
Confidence 6554 37999999999999999999999999999999999999985 79999999999765321
Q ss_pred --------CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcc
Q 044127 143 --------LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP 214 (282)
Q Consensus 143 --------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (282)
.......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....+.
T Consensus 177 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 256 (388)
T 3oz6_A 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVE 256 (388)
T ss_dssp -------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 112345789999999999865668999999999999999999999999999999999998888877654322
Q ss_pred ccccc----------------cccCCccccCCCC-CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 215 LGIQL----------------ASNLDWKFPQMGG-VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 215 ~~~~~----------------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
..... .......++.... ..........++.+.+||++||+.||.+|||++++|+||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 257 SIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp TSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred hccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 11000 0000000000000 000011236788999999999999999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=343.76 Aligned_cols=243 Identities=30% Similarity=0.459 Sum_probs=204.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++....... ....+.+|+..++.+. ||||+++++++..++..++||||++|++++.
T Consensus 20 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~g~l~~~ 98 (336)
T 3h4j_B 20 GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIVMVIEYAGGELFDY 98 (336)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEECCCCEEHHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEEEECCCCcHHHH
Confidence 899999999999999999999987643221 2345678999888885 9999999999999999999999999998888
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+... ..+++..++.++.||+.||.|||+.|++|+||||+||++++ +.+||+|||++.............|++.|+||
T Consensus 99 l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aP 176 (336)
T 3h4j_B 99 IVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAP 176 (336)
T ss_dssp HHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCG
T ss_pred HHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCH
Confidence 7776 46999999999999999999999999999999999999985 79999999999877665555677899999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+....+.++|||||||++|+|++|..||......+.... .......
T Consensus 177 E~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~------------------------------i~~~~~~ 226 (336)
T 3h4j_B 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK------------------------------VNSCVYV 226 (336)
T ss_dssp GGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC------------------------------CCSSCCC
T ss_pred HHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH------------------------------HHcCCCC
Confidence 9998665458899999999999999999999976432221100 0011123
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.+...++.+.+||++||+.||.+|||++++++||||+..
T Consensus 227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 445678999999999999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=352.53 Aligned_cols=275 Identities=35% Similarity=0.656 Sum_probs=206.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccc-----cCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVK-----EHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~e~~~~~ 74 (282)
|+||+||+|+++.+++.||||++...... .....+.+|+.+++.+ +||||+++++++. ....+|+|||+++++
T Consensus 64 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~ 142 (458)
T 3rp9_A 64 GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD 142 (458)
T ss_dssp ----CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEEEECCCSEE
T ss_pred cCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCceEEEEEeccccc
Confidence 89999999999999999999998764433 2345677899999999 5999999999983 346799999999988
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC----------
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---------- 143 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~---------- 143 (282)
+.+.+... ..+++..++.++.||+.||+|||++|++||||||+||+++. +.+||+|||++.......
T Consensus 143 L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 220 (458)
T 3rp9_A 143 FKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220 (458)
T ss_dssp HHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---
T ss_pred hhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCc
Confidence 77766543 46999999999999999999999999999999999999985 799999999998764321
Q ss_pred ------------------CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-----------CCCCCCCCCC
Q 044127 144 ------------------PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-----------FRILFPGKNS 194 (282)
Q Consensus 144 ------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-----------g~~~~~~~~~ 194 (282)
......+|+.|+|||++.....++.++|||||||++|||++ |..+|.+...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~ 300 (458)
T 3rp9_A 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSC 300 (458)
T ss_dssp ------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC----
T ss_pred cccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcc
Confidence 12345679999999988656668999999999999999998 6677765542
Q ss_pred --------------------hHHHHHHHHHhCCCCCCCcccccccc-ccCCccccCCCCCcccccCCCCChhhHHHHHHH
Q 044127 195 --------------------ADQIYKICQVIGSPTEDSWPLGIQLA-SNLDWKFPQMGGVNLRELSPSASRESISLISRL 253 (282)
Q Consensus 195 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 253 (282)
.+.+..+....+.+....+....... ......++......+.......++.+.+||++|
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~m 380 (458)
T 3rp9_A 301 FPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRM 380 (458)
T ss_dssp ----------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHH
T ss_pred ccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHH
Confidence 45666677777776654332211100 001111223333444555667799999999999
Q ss_pred hCCCCCCCCCHHHHhcCcccccccC
Q 044127 254 CSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 254 l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
|..||.+|||++|+|+||||+++..
T Consensus 381 L~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 381 LVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp SCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred hccCccccCCHHHHhcCHhhhhcCC
Confidence 9999999999999999999998864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=338.32 Aligned_cols=248 Identities=26% Similarity=0.415 Sum_probs=209.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-----HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-----DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-----~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|+++.+++.||+|++....... ....+.+|+.++.++. ||||+++++++.+....++||||+.++.
T Consensus 22 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 100 (326)
T 2y0a_A 22 GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGE 100 (326)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEEEEEcCCCCC
Confidence 899999999999999999999987654321 3456778999999995 9999999999999999999999998766
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C----cEEEeecCcccccCCCCCCCCccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G----VIKIGDLGMVKEIDSSLPCTDYVT 150 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~----~~~l~df~~~~~~~~~~~~~~~~~ 150 (282)
+..++... ..+++..+..++.||+.||.|||++|++|+||||+||++++ + .++|+|||++.............+
T Consensus 101 L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g 179 (326)
T 2y0a_A 101 LFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179 (326)
T ss_dssp HHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCS
T ss_pred HHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccC
Confidence 66666543 47999999999999999999999999999999999999975 4 799999999988765555566789
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
++.|+|||++.+. .++.++|||||||++|+|++|..||.+....+....+........
T Consensus 180 t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------------------- 237 (326)
T 2y0a_A 180 TPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE--------------------- 237 (326)
T ss_dssp CTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC---------------------
T ss_pred CcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC---------------------
Confidence 9999999998744 489999999999999999999999988777666655544211110
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.......++.+.+||++||+.||.+|||++++|+||||++..
T Consensus 238 -----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 238 -----DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp -----HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred -----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 112245688999999999999999999999999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=339.49 Aligned_cols=277 Identities=30% Similarity=0.540 Sum_probs=222.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeecccccc--------CCcEEEEEecC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKE--------HEDVFIVFEYM 71 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--------~~~~~lv~e~~ 71 (282)
|+||+||+|+++.+|+.||+|++....... ......+|+.+++.+. ||||+++++++.. .+..++||||+
T Consensus 28 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~ 106 (351)
T 3mi9_A 28 GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFC 106 (351)
T ss_dssp CSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC--------CEEEEEEECC
T ss_pred CCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCcccHhheeeccccccccCCceEEEEEecc
Confidence 899999999999999999999986654332 2345678999999995 9999999999876 45689999999
Q ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-----CCCC
Q 044127 72 ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-----SLPC 145 (282)
Q Consensus 72 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-----~~~~ 145 (282)
.++++..+.... ..+++..++.++.||+.||.+||++|++|+||||+||+++. +.++|+|||++..... ....
T Consensus 107 ~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 185 (351)
T 3mi9_A 107 EHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185 (351)
T ss_dssp SEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCC
T ss_pred CCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccccccccccccc
Confidence 998888776654 46999999999999999999999999999999999999984 8999999999976542 2222
Q ss_pred CCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc
Q 044127 146 TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225 (282)
Q Consensus 146 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
....+++.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+....+.+.+..++...........
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 265 (351)
T 3mi9_A 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL 265 (351)
T ss_dssp CSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSS
T ss_pred CCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhccc
Confidence 44577999999999986666899999999999999999999999999999999999999998888777654433222222
Q ss_pred cccCCCCCccccc--CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 226 KFPQMGGVNLREL--SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 226 ~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
............. ....++.+.+||++||+.||.+|||++|+|+||||++....
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 266 ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp CCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred ccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 1111111110000 00136779999999999999999999999999999876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=335.07 Aligned_cols=243 Identities=28% Similarity=0.469 Sum_probs=206.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||+|++...... .......+|..++..+ +||||+++++++.+....++||||+.|+.+..
T Consensus 17 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~ 95 (318)
T 1fot_A 17 GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 95 (318)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEEEeCCCCCCHHH
Confidence 89999999999999999999999765321 2334556788888877 59999999999999999999999999766666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++... ..+++..++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++...... .....||+.|+||
T Consensus 96 ~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aP 172 (318)
T 1fot_A 96 LLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAP 172 (318)
T ss_dssp HHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCH
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--cccccCCccccCH
Confidence 66554 46999999999999999999999999999999999999974 89999999999876543 2456899999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+. .++.++|+|||||++|+|++|..||...+..+....+.... ..
T Consensus 173 E~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------------------~~ 221 (318)
T 1fot_A 173 EVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------------------------LR 221 (318)
T ss_dssp HHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC------------------------------CC
T ss_pred hHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------------------------CC
Confidence 998754 48999999999999999999999999887766666554421 01
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 238 LSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
.+..+++.+.++|++||+.||.+|| +++++++||||+++.+
T Consensus 222 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 2345789999999999999999999 9999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=347.15 Aligned_cols=247 Identities=27% Similarity=0.407 Sum_probs=205.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|.++.+|+.||+|++...... .....+.+|+.+++.+ +||||+++++++.+++..++|||||.|+.+...
T Consensus 22 G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 100 (444)
T 3soa_A 22 GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFED 100 (444)
T ss_dssp C--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSSEEEEEECCCBCCBHHHH
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHH
Confidence 89999999999999999999998765433 3345567899999999 599999999999999999999999987555444
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee----CCcEEEeecCcccccCCCCC-CCCccccccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSSLP-CTDYVTTRWY 154 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~----~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~ 154 (282)
+... ..+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++........ .....|++.|
T Consensus 101 i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y 179 (444)
T 3soa_A 101 IVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179 (444)
T ss_dssp HHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGG
T ss_pred HHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCccc
Confidence 4443 4699999999999999999999999999999999999997 36899999999987654332 2456899999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.........
T Consensus 180 ~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------ 234 (444)
T 3soa_A 180 LSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS------------------------ 234 (444)
T ss_dssp CCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT------------------------
T ss_pred CCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc------------------------
Confidence 999998754 4899999999999999999999999988777777666553322211
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.....+++.+.+||.+||+.||.+|||+.++|+||||++.
T Consensus 235 --~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 235 --PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp --TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 1123578999999999999999999999999999999754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=336.51 Aligned_cols=247 Identities=30% Similarity=0.475 Sum_probs=202.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|+++.+++.||+|++...... ........|..++.++.+||||+++++++.+.+..|+||||+.|+.+..
T Consensus 20 G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~ 99 (345)
T 3a8x_A 20 GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMF 99 (345)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred cCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHH
Confidence 89999999999999999999999876433 2334567788888888679999999999999999999999998766655
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
++... ..+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++.... .........|++.|+|
T Consensus 100 ~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~a 178 (345)
T 3a8x_A 100 HMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178 (345)
T ss_dssp HHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCC
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccC
Confidence 55544 36999999999999999999999999999999999999974 899999999998642 2333456689999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSA--------DQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
||++.+.. ++.++|+|||||++|+|++|..||...... ..........
T Consensus 179 PE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~----------------------- 234 (345)
T 3a8x_A 179 PEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------------------- 234 (345)
T ss_dssp HHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-----------------------
T ss_pred ccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-----------------------
Confidence 99998544 799999999999999999999999753221 1111111110
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCH------HHHhcCcccccccC
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTA------AEALEHPFFRSCHF 278 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~------~~ll~~~~~~~~~~ 278 (282)
...++..++..+.+||++||+.||.+||++ +++++||||+++.|
T Consensus 235 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 235 ------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred ------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 012344678999999999999999999995 89999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=340.01 Aligned_cols=246 Identities=28% Similarity=0.463 Sum_probs=206.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|+++.... .........|..++..+.+||+|+++++++.+.+..|+||||+.|+.+..
T Consensus 31 G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~ 110 (353)
T 2i0e_A 31 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 110 (353)
T ss_dssp ETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHH
Confidence 8999999999999999999999976532 22334566788888877679999999999999999999999998766655
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
++... ..+++..++.++.||+.||.|||++|++||||||+||+++. +.++|+|||++.... ........+|++.|+|
T Consensus 111 ~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~a 189 (353)
T 2i0e_A 111 HIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIA 189 (353)
T ss_dssp HHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCC
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccC
Confidence 55544 36999999999999999999999999999999999999984 899999999998643 2333456689999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+.. ++.++|+|||||++|+|++|..||.+.+..+....+.... .
T Consensus 190 PE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~------------------------------~ 238 (353)
T 2i0e_A 190 PEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN------------------------------V 238 (353)
T ss_dssp HHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------------------------C
T ss_pred hhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC------------------------------C
Confidence 99997544 8999999999999999999999999887776666655421 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~ 278 (282)
..+..+++.+.+||++||+.||.+||+ ++++++||||+++.|
T Consensus 239 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 239 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 123467899999999999999999994 699999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=341.01 Aligned_cols=249 Identities=23% Similarity=0.414 Sum_probs=208.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|+++.+++.||+|++..... ......+.+|+.+++.+ +||||+++++++.+.+..++||||+.|+.+..
T Consensus 26 G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~ 104 (384)
T 4fr4_A 26 GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRY 104 (384)
T ss_dssp CTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCTTEEHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCCCCcHHH
Confidence 8999999999999999999999876432 22345667899999999 59999999999999999999999998877776
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++... ..+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++.............||+.|+||
T Consensus 105 ~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aP 183 (384)
T 4fr4_A 105 HLQQN-VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAP 183 (384)
T ss_dssp HHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCG
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCC
Confidence 66654 46999999999999999999999999999999999999975 89999999999987766666778899999999
Q ss_pred hhhhc--cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 158 EVLLL--SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 158 E~~~~--~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|++.. +..++.++|||||||++|+|++|..||.................. .
T Consensus 184 E~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---------------------------~ 236 (384)
T 4fr4_A 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT---------------------------V 236 (384)
T ss_dssp GGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC---------------------------C
T ss_pred eeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc---------------------------c
Confidence 99864 234789999999999999999999999865443322221111110 1
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCC-HHHHhcCcccccccC
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPT-AAEALEHPFFRSCHF 278 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~ll~~~~~~~~~~ 278 (282)
...+..+++.+.+||++||+.||.+||+ ++++++||||+++.+
T Consensus 237 ~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 237 VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 1234467899999999999999999998 899999999998765
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=341.14 Aligned_cols=272 Identities=36% Similarity=0.614 Sum_probs=215.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccC------CcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEH------EDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~------~~~~lv~e~~~~ 73 (282)
|+||+||+|++..+|+.||+|++....... ....+.+|+.+++.+. ||||+++++++... ...|+|||++++
T Consensus 36 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~ 114 (367)
T 1cm8_A 36 GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT 114 (367)
T ss_dssp ----CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTTTCCCCEEEEECCSE
T ss_pred cCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCccccCceEEEEEecCCC
Confidence 899999999999999999999996654333 3455678999999995 99999999998765 346999999965
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++.+ ++.. ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++...... .....+++
T Consensus 115 ~L~~-~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~ 189 (367)
T 1cm8_A 115 DLGK-LMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTR 189 (367)
T ss_dssp EHHH-HHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCG
T ss_pred CHHH-HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc--cCcCcCCC
Confidence 5544 4444 46999999999999999999999999999999999999985 79999999999876543 24567899
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccc-ccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA-SNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (282)
.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+....... ...-...+...
T Consensus 190 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (367)
T 1cm8_A 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 269 (367)
T ss_dssp GGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCC
T ss_pred CcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCC
Confidence 99999999865668999999999999999999999999999999999998888877654332111000 00001112222
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...........++.+.+||.+||+.||.+|||++++|+||||++...
T Consensus 270 ~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 270 KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp CCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred CCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 33344556678999999999999999999999999999999987653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=346.06 Aligned_cols=275 Identities=28% Similarity=0.484 Sum_probs=215.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhC-----CCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN-----NHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~-----~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|++..+++.||+|++.... .......+|+.++..+. +|+||+.+++.+......+++||++++++
T Consensus 108 G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L 185 (429)
T 3kvw_A 108 GSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNL 185 (429)
T ss_dssp SSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCCCBH
T ss_pred CccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccCCCH
Confidence 899999999999999999999987542 33345566777777663 57899999999999999999999999998
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-Cc--EEEeecCcccccCCCCCCCCccccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GV--IKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~--~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
.+.+.......+++..++.++.||+.||.|||++|++|+||||+||+++. +. +||+|||++....... ....+++
T Consensus 186 ~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~--~~~~gt~ 263 (429)
T 3kvw_A 186 YELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV--YTYIQSR 263 (429)
T ss_dssp HHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCC--CSSCSCG
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCcc--cccCCCC
Confidence 88877765556999999999999999999999999999999999999985 44 9999999997655433 4568899
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcc------
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK------ 226 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 226 (282)
.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....+.........++..
T Consensus 264 ~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 342 (429)
T 3kvw_A 264 FYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYC 342 (429)
T ss_dssp GGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTS
T ss_pred CccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccc
Confidence 999999998555 8999999999999999999999999999999999998888877654332111110000000
Q ss_pred -----------------------ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 227 -----------------------FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 227 -----------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
.......-...+....++.+.+||++||+.||++|||++|+|+||||++....|
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~~~ 419 (429)
T 3kvw_A 343 TVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP 419 (429)
T ss_dssp CEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC------
T ss_pred cccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCCCC
Confidence 000000001112334578899999999999999999999999999999876544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=333.81 Aligned_cols=242 Identities=27% Similarity=0.403 Sum_probs=197.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|+++.+++.||||++...... ......+.|+..+.++.+||||+++++++.+++..++|||++++++.+.+
T Consensus 68 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~ 147 (311)
T 3p1a_A 68 GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHC 147 (311)
T ss_dssp ETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCCCBHHHHH
T ss_pred CCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEeccCCCHHHHH
Confidence 89999999999999999999997654433 34455677888888887899999999999999999999999988888776
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
.... ..+++..++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++.............+++.|+|||
T Consensus 148 ~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE 226 (311)
T 3p1a_A 148 EAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226 (311)
T ss_dssp HHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGG
T ss_pred HhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHh
Confidence 6653 57999999999999999999999999999999999999974 899999999998876665556677999999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
++.+ .++.++|||||||++|+|++|..++..... ...+.. .......
T Consensus 227 ~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~----------------------------~~~~~~~ 273 (311)
T 3p1a_A 227 LLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQ----------------------------GYLPPEF 273 (311)
T ss_dssp GGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTT----------------------------TCCCHHH
T ss_pred HhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhc----------------------------cCCCccc
Confidence 8874 489999999999999999999776654321 111110 0011123
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
+..+++.+.+||.+||+.||.+|||++++|+||||+++
T Consensus 274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~p 311 (311)
T 3p1a_A 274 TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP 311 (311)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSCC
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccCC
Confidence 44678999999999999999999999999999999873
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=339.60 Aligned_cols=246 Identities=28% Similarity=0.413 Sum_probs=207.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||.||+|.++.+++.||+|++...... .....+.+|+.+++++. ||||+++++++.+.+..++||||+.++.+...
T Consensus 40 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~ 118 (362)
T 2bdw_A 40 GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFED 118 (362)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEEEecCCCCCHHHH
Confidence 79999999999999999999999765443 33456678999999994 99999999999999999999999987555544
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCCCCCcccccccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 155 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 155 (282)
+... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++.............+++.|+
T Consensus 119 l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~ 197 (362)
T 2bdw_A 119 IVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 197 (362)
T ss_dssp HTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTC
T ss_pred HHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCcccc
Confidence 4443 46999999999999999999999999999999999999963 369999999998876655556678999999
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||++.+. .++.++|||||||++|+|++|..||...+.......+.........
T Consensus 198 aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------------------- 251 (362)
T 2bdw_A 198 SPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS------------------------- 251 (362)
T ss_dssp CHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-------------------------
T ss_pred CHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc-------------------------
Confidence 99998754 4899999999999999999999999987776666655443221111
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
.....+++.+.+||.+||+.||.+|||++++|+||||++
T Consensus 252 -~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 252 -PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp -TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred -ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 112356889999999999999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=340.26 Aligned_cols=272 Identities=38% Similarity=0.671 Sum_probs=221.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC-----CcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH-----EDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~ 75 (282)
|+||+||+|++..+++.||+|++...........+.+|+.++.++. ||||+++++++... ...+++||++++++
T Consensus 38 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L 116 (364)
T 3qyz_A 38 GAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMETDL 116 (364)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTCCCEEEEEECCSEEH
T ss_pred CCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCccccceEEEEEcccCcCH
Confidence 8999999999999999999999976544445567789999999995 99999999998654 47899999999987
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC----CCCccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP----CTDYVT 150 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~----~~~~~~ 150 (282)
.+.+.. ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++........ .....+
T Consensus 117 ~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~g 193 (364)
T 3qyz_A 117 YKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193 (364)
T ss_dssp HHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCS
T ss_pred HHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCcccccccccc
Confidence 766544 36999999999999999999999999999999999999985 7999999999986643221 234578
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc-cCCccccC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS-NLDWKFPQ 229 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 229 (282)
++.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+....+.+....+........ ......+.
T Consensus 194 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (364)
T 3qyz_A 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 273 (364)
T ss_dssp CGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCC
T ss_pred ccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCC
Confidence 99999999987666689999999999999999999999999999999999988888776544322111100 00111122
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.............++.+.+||++||+.||.+|||++++|+||||++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 274 KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred ccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 22233344556789999999999999999999999999999999876
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=337.17 Aligned_cols=243 Identities=27% Similarity=0.409 Sum_probs=206.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|+++.+|+.||+|++..... ........+|..++..+ +||||+++++++.+....|+||||+.|+.+..
T Consensus 52 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~ 130 (350)
T 1rdq_E 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130 (350)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHH
T ss_pred CcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHH
Confidence 8999999999999999999999876532 12344567888888888 59999999999999999999999998655555
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++... ..+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++....... ....|++.|+||
T Consensus 131 ~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~--~~~~gt~~y~aP 207 (350)
T 1rdq_E 131 HLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WTLCGTPEALAP 207 (350)
T ss_dssp HHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--CCCEECGGGCCH
T ss_pred HHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCc--ccccCCccccCH
Confidence 55544 36999999999999999999999999999999999999984 899999999998765432 456899999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+.. ++.++|+|||||++|+|++|..||...+..+....+.... ..
T Consensus 208 E~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------------------------------~~ 256 (350)
T 1rdq_E 208 EIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------------------------------VR 256 (350)
T ss_dssp HHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------------------------CC
T ss_pred HHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC------------------------------CC
Confidence 9998544 8999999999999999999999999887766666554421 01
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccC
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHF 278 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~ 278 (282)
.+..+++.+.++|++||+.||.+||+ ++++++||||+++.+
T Consensus 257 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 23467899999999999999999998 999999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=343.55 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=209.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|.++.+++.||+|++.... ......+.+|+.++.++ +||||+++++++.+....++||||+.++.+..++
T Consensus 62 G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l 139 (387)
T 1kob_A 62 GAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI 139 (387)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHT
T ss_pred CCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHH
Confidence 799999999999999999999987643 23445677899999888 5999999999999999999999999876666666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC---CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
...+..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++.............+++.|+||
T Consensus 140 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aP 219 (387)
T 1kob_A 140 AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219 (387)
T ss_dssp TCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCH
T ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCc
Confidence 555557999999999999999999999999999999999999963 57999999999887665554556789999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+. .++.++|||||||++|+|++|..||.+.+..+....+........ ..
T Consensus 220 E~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~ 272 (387)
T 1kob_A 220 EIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD--------------------------ED 272 (387)
T ss_dssp HHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC--------------------------SS
T ss_pred hhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------------------cc
Confidence 998754 489999999999999999999999998776666655544211111 12
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
....+++.+.+||++||+.||.+|||++++|+||||++..
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 2346789999999999999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=343.98 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=205.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+|+.||+|++.... ......+.+|+.++.++ +||||+++++++.+.+..++||||+.++.+...+
T Consensus 100 G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l 177 (373)
T 2x4f_A 100 GRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI 177 (373)
T ss_dssp ----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHH
T ss_pred CcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHH
Confidence 899999999999999999999987643 23455678899999999 5999999999999999999999999875554444
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee---CCcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
......+++..+..++.||+.||.|||+.|++|+||||+||+++ ++.++|+|||++.............+++.|+||
T Consensus 178 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aP 257 (373)
T 2x4f_A 178 IDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257 (373)
T ss_dssp HHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCH
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeCh
Confidence 44334699999999999999999999999999999999999994 368999999999887665555566799999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......... .
T Consensus 258 E~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--------------------------~ 310 (373)
T 2x4f_A 258 EVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED--------------------------E 310 (373)
T ss_dssp HHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS--------------------------G
T ss_pred hhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh--------------------------h
Confidence 99874 44899999999999999999999999988877777666553221111 1
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
....+++.+.+||.+||+.||.+|||++++|+||||++..
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 2235789999999999999999999999999999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=342.61 Aligned_cols=268 Identities=30% Similarity=0.586 Sum_probs=216.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc---------------------
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK--------------------- 59 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--------------------- 59 (282)
|+||+||+|++..+|+.||+|++..... ...+|+.+++.+ +||||+++++++.
T Consensus 18 G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (383)
T 3eb0_A 18 GSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGG 91 (383)
T ss_dssp C-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTC-CCTTBCCEEEEEEEC-------------------
T ss_pred ccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHc-CCCCccchhheeeecCcccccccccccccccccc
Confidence 8999999999999999999999865422 123588888888 5999999999983
Q ss_pred -----------------cCCcEEEEEecCCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCc
Q 044127 60 -----------------EHEDVFIVFEYMESDLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120 (282)
Q Consensus 60 -----------------~~~~~~lv~e~~~~~~l~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~n 120 (282)
+..+.++||||+++++.+.+.. ..+..+++..++.++.||+.||.|||++|++|+||||+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~N 171 (383)
T 3eb0_A 92 KNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171 (383)
T ss_dssp ------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGG
T ss_pred cccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHH
Confidence 3445899999999986665543 234579999999999999999999999999999999999
Q ss_pred eeee--CCcEEEeecCcccccCCCCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHH
Q 044127 121 LLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQI 198 (282)
Q Consensus 121 ili~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~ 198 (282)
|+++ ++.++|+|||++.............+++.|+|||.+.+...++.++|||||||++|+|++|..||.+....+.+
T Consensus 172 il~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 251 (383)
T 3eb0_A 172 LLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQL 251 (383)
T ss_dssp EEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9997 47899999999988766666667788999999999986666899999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCccccccccccCCccccCCCCCcc-cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 199 YKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL-RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
..+....+.+....+..... ......++....... ...+...++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 252 ~~i~~~~g~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 252 VRIIQIMGTPTKEQMIRMNP--HYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp HHHHHHHCCCCHHHHHHHCT--TC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred HHHHHHhCCCCHHHHHHhCc--ccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 99999888876554322111 111112222222111 22455689999999999999999999999999999999865
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=346.82 Aligned_cols=275 Identities=35% Similarity=0.638 Sum_probs=211.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccC-----CcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH-----EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~ 74 (282)
|+||+||+|+++.+++.||||++...... .....+.+|+.+++++. ||||+++++++... ...|+|||+++++
T Consensus 37 G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~ 115 (432)
T 3n9x_A 37 GSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIADSD 115 (432)
T ss_dssp ETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTTCCCEEEEEECCSEE
T ss_pred cCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCCCcCCeEEEEEecCCcC
Confidence 89999999999999999999999765433 33456788999999995 99999999998765 5799999999987
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---------
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--------- 144 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--------- 144 (282)
+.+.+... ..+++..++.++.||+.||+|||++|++||||||+||+++. +.+||+|||++........
T Consensus 116 L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 193 (432)
T 3n9x_A 116 LKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193 (432)
T ss_dssp HHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--------------
T ss_pred HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccc
Confidence 77665443 46999999999999999999999999999999999999985 7999999999987643321
Q ss_pred --------------CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhC-----------CCCCCCCC------
Q 044127 145 --------------CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF-----------RILFPGKN------ 193 (282)
Q Consensus 145 --------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g-----------~~~~~~~~------ 193 (282)
.....+|+.|+|||++.....++.++|||||||++|||++| ..+|.+.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~ 273 (432)
T 3n9x_A 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSP 273 (432)
T ss_dssp -----------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC---
T ss_pred cccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCc
Confidence 24567899999999986666689999999999999999984 44444433
Q ss_pred -----------ChHHHHHHHHHhCCCCCCCccccccccc-cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCC
Q 044127 194 -----------SADQIYKICQVIGSPTEDSWPLGIQLAS-NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMR 261 (282)
Q Consensus 194 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 261 (282)
..+.+..+....+.+....+........ ......+..............++.+.+||++||+.||.+|
T Consensus 274 ~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 353 (432)
T 3n9x_A 274 DRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKR 353 (432)
T ss_dssp -------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTS
T ss_pred ccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccC
Confidence 2566677777777776543321111000 0000111122222333445689999999999999999999
Q ss_pred CCHHHHhcCcccccccC
Q 044127 262 PTAAEALEHPFFRSCHF 278 (282)
Q Consensus 262 ps~~~ll~~~~~~~~~~ 278 (282)
||++|+|+||||+++..
T Consensus 354 ~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 354 ITIDQALDHPYLKDVRK 370 (432)
T ss_dssp CCHHHHHTCGGGTTTCC
T ss_pred CCHHHHhcChhhhhccC
Confidence 99999999999998754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=339.70 Aligned_cols=269 Identities=22% Similarity=0.403 Sum_probs=210.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhC----CCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN----NHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~----~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|++..+++.||+|++... .........|..+++.+. +||||+++++++...+..++|||++++++.
T Consensus 46 G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~ 123 (360)
T 3llt_A 46 GTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY 123 (360)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCCCCBHH
T ss_pred cCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCCCCCHH
Confidence 89999999999999999999998753 233445566888888886 599999999999999999999999977777
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee--------------------------CCcEEE
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS--------------------------KGVIKI 130 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~--------------------------~~~~~l 130 (282)
+.+.......+++..++.++.||+.||.|||++|++|+||||+||+++ ++.++|
T Consensus 124 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 203 (360)
T 3llt_A 124 EIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203 (360)
T ss_dssp HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEE
T ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEE
Confidence 776665545699999999999999999999999999999999999996 468999
Q ss_pred eecCcccccCCCCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCC
Q 044127 131 GDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTE 210 (282)
Q Consensus 131 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (282)
+|||++....... ....+++.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+....+.++.
T Consensus 204 ~DFG~a~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~ 280 (360)
T 3llt_A 204 IDFGCATFKSDYH--GSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPK 280 (360)
T ss_dssp CCCTTCEETTSCC--CSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCH
T ss_pred EeccCceecCCCC--cCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCH
Confidence 9999998655433 4567899999999998554 899999999999999999999999998888888777776665543
Q ss_pred CCcccccccccc-------CCccccCCCC---------CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccc
Q 044127 211 DSWPLGIQLASN-------LDWKFPQMGG---------VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274 (282)
Q Consensus 211 ~~~~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 274 (282)
..+......... ....++.... ...+......++.+.+||++||+.||.+|||++++|+||||+
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 281 NMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 322111110000 0000000000 001111223457788999999999999999999999999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=343.56 Aligned_cols=269 Identities=33% Similarity=0.590 Sum_probs=216.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc------CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE------HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~------~~~~~lv~e~~~~~ 74 (282)
|+||+||+|++..+|+.||||++.... ....+|+.+++.+. ||||+++++++.. ..++++||||+.++
T Consensus 65 G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~ 138 (420)
T 1j1b_A 65 GSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET 138 (420)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCC-CTTBCCEEEEEEEEETTTTEEEEEEEEECCCEE
T ss_pred CCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcC-CCCccceeeEEeccCCCCcceeEEeehhccccc
Confidence 899999999999999999999986542 22235889998884 9999999998732 23478999999998
Q ss_pred HHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCCCCCccc
Q 044127 75 LLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVT 150 (282)
Q Consensus 75 ~l~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~~~~~~~ 150 (282)
+++.+.. .....+++..++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++.............+
T Consensus 139 l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 218 (420)
T 1j1b_A 139 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218 (420)
T ss_dssp HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCS
T ss_pred HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeee
Confidence 7765543 33457999999999999999999999999999999999999983 5689999999987765555566788
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
++.|+|||++.+...++.++|||||||++|||++|+.||.+.+..+.+..+....+.+....+..... ......++..
T Consensus 219 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~--~~~~~~~p~~ 296 (420)
T 1j1b_A 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP--NYTEFKFPQI 296 (420)
T ss_dssp CTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS--CCCCCCCCCC
T ss_pred CCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh--hhhhhccCcc
Confidence 99999999997665689999999999999999999999999998999999998888776554432211 1111222222
Q ss_pred CCCccc-ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 231 GGVNLR-ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 231 ~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
...... .+....++++.+||++||+.||.+|||+.++++||||++..
T Consensus 297 ~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 297 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred CCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 221111 13456789999999999999999999999999999998764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=335.65 Aligned_cols=252 Identities=29% Similarity=0.449 Sum_probs=207.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|+++.+++.||+|++...... .....+.+|+..+..+.+||||+++++++.+.+..++||||+.++.+..+
T Consensus 40 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 119 (327)
T 3lm5_A 40 GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119 (327)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGG
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHH
Confidence 89999999999999999999998765433 23556788999999998899999999999999999999999987655554
Q ss_pred HH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCCCCCccccccc
Q 044127 80 KE-RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWY 154 (282)
Q Consensus 80 ~~-~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 154 (282)
+. .....+++..++.++.||+.||.+||++|++|+||||+||+++. +.++|+|||++.............+++.|
T Consensus 120 ~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y 199 (327)
T 3lm5_A 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY 199 (327)
T ss_dssp GSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGG
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCc
Confidence 43 33457999999999999999999999999999999999999975 78999999999887666555667899999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||.+.+. .++.++||||||+++|+|++|..||......+....+.........
T Consensus 200 ~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------------------ 254 (327)
T 3lm5_A 200 LAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE------------------------ 254 (327)
T ss_dssp CCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT------------------------
T ss_pred cCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc------------------------
Confidence 999998744 4899999999999999999999999988777766665543222211
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
.....+++.+.+||++||+.||.+|||++++|+||||++..+.
T Consensus 255 --~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 255 --ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp --TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred --hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 2234678899999999999999999999999999999987653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=325.71 Aligned_cols=246 Identities=28% Similarity=0.458 Sum_probs=198.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc-cHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES-DLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~-~~l~~~ 79 (282)
|+||+||+|.+..++..+++|++...........+.+|+.+++++. ||||+++++++.+....++||||+.+ ++.+.+
T Consensus 33 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 111 (285)
T 3is5_A 33 GAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERI 111 (285)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEECCCSCCBHHHHH
T ss_pred CCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCC-CchHHhHHHheecCCeEEEEEEeCCCCcHHHHH
Confidence 8999999999999999999999987765555677788999999995 99999999999999999999999986 455544
Q ss_pred HHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCCCCCcccccc
Q 044127 80 KER--AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRW 153 (282)
Q Consensus 80 ~~~--~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~ 153 (282)
... .+..+++..++.++.||+.||.+||++|++|+||||+||++++ +.++|+|||++.............+++.
T Consensus 112 ~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~ 191 (285)
T 3is5_A 112 VSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTAL 191 (285)
T ss_dssp HHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGG
T ss_pred HhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccC
Confidence 332 2457999999999999999999999999999999999999953 5799999999987766555566788999
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
|+|||.+. + .++.++||||||+++|+|++|..||......+............
T Consensus 192 y~aPE~~~-~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------------------- 244 (285)
T 3is5_A 192 YMAPEVFK-R-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY------------------------- 244 (285)
T ss_dssp GCCHHHHT-T-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------------------
T ss_pred cCChHHhc-c-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc-------------------------
Confidence 99999885 3 37899999999999999999999998876655544332211100
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.......++.+.+||++||+.||++|||++|+|+||||++.
T Consensus 245 --~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 245 --AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp --CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred --ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 01112468899999999999999999999999999999863
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=335.11 Aligned_cols=276 Identities=32% Similarity=0.558 Sum_probs=216.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|++..+++.||+|++........ ...+.+|+.+++++. ||||+++++++.+.+..++||||+.++++..+
T Consensus 36 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~ 114 (331)
T 4aaa_A 36 GSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWYLVFEFVDHTILDDL 114 (331)
T ss_dssp GTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCSEEHHHHH
T ss_pred cCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEEEEEEecCCcchHHHH
Confidence 8999999999999999999999876544333 344568999999995 99999999999999999999999999999887
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aP 157 (282)
.... ..+++..+..++.||+.||.+||++|++|+||||+||+++. +.++|+|||++...... .......+++.|+||
T Consensus 115 ~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aP 193 (331)
T 4aaa_A 115 ELFP-NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAP 193 (331)
T ss_dssp HHST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCH
T ss_pred Hhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCc
Confidence 6654 46999999999999999999999999999999999999975 79999999999765432 223445789999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC-CCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM-GGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 236 (282)
|.+.+...++.++|||||||++|+|++|..||......+....+....+...+.................+.. ......
T Consensus 194 E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (331)
T 4aaa_A 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLE 273 (331)
T ss_dssp HHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHH
T ss_pred ccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhh
Confidence 9998665689999999999999999999999999988888888877766554332211111111111111111 111122
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
.....+++.+.+||++||+.||.+|||++++|+||||+...+
T Consensus 274 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 315 (331)
T 4aaa_A 274 RRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF 315 (331)
T ss_dssp HHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGH
T ss_pred hcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCCh
Confidence 334467999999999999999999999999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=334.34 Aligned_cols=251 Identities=28% Similarity=0.410 Sum_probs=183.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+++.||+|++... ......+|+..++.+.+||||+++++++.+....++||||+.++.+..++
T Consensus 22 G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 97 (325)
T 3kn6_A 22 GSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI 97 (325)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHH
Confidence 89999999999999999999998653 33455679999999978999999999999999999999999876665555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C---cEEEeecCcccccCCC-CCCCCcccccccc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G---VIKIGDLGMVKEIDSS-LPCTDYVTTRWYR 155 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~---~~~l~df~~~~~~~~~-~~~~~~~~~~~~~ 155 (282)
... ..+++..+..++.||+.||.|||++|++|+||||+||++++ + .++|+|||++...... .......+++.|+
T Consensus 98 ~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~ 176 (325)
T 3kn6_A 98 KKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176 (325)
T ss_dssp HHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------------
T ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCcc
Confidence 554 47999999999999999999999999999999999999975 3 7999999999865432 2234557799999
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQ---IYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|||.+.+.. ++.++|||||||++|+|++|..||........ ...+.........
T Consensus 177 aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~---------------------- 233 (325)
T 3kn6_A 177 APELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF---------------------- 233 (325)
T ss_dssp -------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC----------------------
T ss_pred CHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC----------------------
Confidence 999987544 89999999999999999999999986543211 1111111111000
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
.........+++.+.+||++||+.||.+|||++++++||||++....
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~ 280 (325)
T 3kn6_A 234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280 (325)
T ss_dssp CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence 00011223578999999999999999999999999999999876544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=329.68 Aligned_cols=274 Identities=34% Similarity=0.634 Sum_probs=223.3
Q ss_pred CCcceEEEEEec-CCCcEEEEEEccccccch-HHHHHHHHHHHHHHhC--CCCCeeeeccccc-----cCCcEEEEEecC
Q 044127 1 GSYGDVFQALDK-KSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMN--NHPNIVKLRNLVK-----EHEDVFIVFEYM 71 (282)
Q Consensus 1 G~~g~Vy~~~~~-~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~--~hp~i~~~~~~~~-----~~~~~~lv~e~~ 71 (282)
|+||+||+|++. .+++.||+|++....... ......+|+..++.+. +||||+++++++. .....+++|||+
T Consensus 22 G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 101 (326)
T 1blx_A 22 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 101 (326)
T ss_dssp ETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECC
T ss_pred cccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecC
Confidence 799999999985 678999999987654322 2234556777766663 6999999999986 567899999999
Q ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccc
Q 044127 72 ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVT 150 (282)
Q Consensus 72 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~ 150 (282)
.+++.+.+.......+++..++.++.||+.||.+||++|++|+||||+||+++. +.++|+|||++.............+
T Consensus 102 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (326)
T 1blx_A 102 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181 (326)
T ss_dssp SCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCC
T ss_pred CCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCCCcccccc
Confidence 988777766655456999999999999999999999999999999999999974 8999999999987654444455678
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+....+....+....+.+....|+....... ..+...
T Consensus 182 ~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~ 257 (326)
T 1blx_A 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR---QAFHSK 257 (326)
T ss_dssp CCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCG---GGSCCC
T ss_pred ccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccch---hhhccc
Confidence 99999999997554 89999999999999999999999999998888888888888877666654332221 112222
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...........+++.+.+||.+||+.||.+|||+.++++||||++...
T Consensus 258 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 258 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 233345566778999999999999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=334.74 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=200.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.||+|++...........+.+|+.+++.+. ||||+++++++.+++..++|||||.++.+..++
T Consensus 18 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 96 (323)
T 3tki_A 18 GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI 96 (323)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCTTEEGGGGS
T ss_pred CCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHH
Confidence 7999999999999999999999876554444566778999998884 999999999999999999999999876665555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC---CCCCCccccccccC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~a 156 (282)
... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++...... .......+++.|+|
T Consensus 97 ~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 175 (323)
T 3tki_A 97 EPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175 (323)
T ss_dssp BTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSC
T ss_pred hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccC
Confidence 443 46999999999999999999999999999999999999985 89999999999765322 22245678999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+....+.++|||||||++|+|++|..||................... .
T Consensus 176 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~---------------------------~ 228 (323)
T 3tki_A 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------------------L 228 (323)
T ss_dssp HHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT---------------------------S
T ss_pred cHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc---------------------------C
Confidence 9999866655789999999999999999999998766544333222211100 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.....+++.+.+||++||+.||.+|||++|+++||||++..
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 11235688999999999999999999999999999998654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=342.84 Aligned_cols=249 Identities=28% Similarity=0.396 Sum_probs=206.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++.+.... .....+..|..++..+ +||||+++++++.+....|+|||||.|+.+..
T Consensus 80 G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~ 158 (410)
T 3v8s_A 80 GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 158 (410)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTTEEHHH
T ss_pred CCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCCCCcHHH
Confidence 89999999999999999999998764321 1223456788888888 59999999999999999999999998766666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~ 155 (282)
++.. ..+++..++.++.||+.||.|||++|++||||||+||+++. +.+||+|||++....... .....+||+.|+
T Consensus 159 ~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~ 236 (410)
T 3v8s_A 159 LMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236 (410)
T ss_dssp HHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGC
T ss_pred HHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCcccc
Confidence 6665 36999999999999999999999999999999999999975 899999999998765432 223568999999
Q ss_pred Cchhhhccc---cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 156 APEVLLLSE---IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 156 aPE~~~~~~---~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+........ +
T Consensus 237 APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-----------------~----- 294 (410)
T 3v8s_A 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT-----------------F----- 294 (410)
T ss_dssp CHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-----------------C-----
T ss_pred CHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc-----------------C-----
Confidence 999997443 267899999999999999999999998887777776655321110 0
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCC--CCCHHHHhcCcccccccC
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHM--RPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~~~~~~~~~ 278 (282)
.....+++.+++||++||+.+|.+ ||+++++++||||+++.|
T Consensus 295 ----p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 295 ----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp ----CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred ----CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 011357899999999999999988 999999999999999765
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=340.32 Aligned_cols=269 Identities=33% Similarity=0.591 Sum_probs=216.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC------CcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH------EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~------~~~~lv~e~~~~~ 74 (282)
|+||+||+|++..+++ +++|++..... ...+|+.+++.+. ||||+++++++... ...++||||+.++
T Consensus 51 G~~g~V~~a~~~~~~~-~aikk~~~~~~-----~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~ 123 (394)
T 4e7w_A 51 GSFGVVFQAKLVESDE-VAIKKVLQDKR-----FKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET 123 (394)
T ss_dssp ETTEEEEEEEETTTEE-EEEEEEECCTT-----SCCHHHHHHHTCC-CTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE
T ss_pred CCCeEEEEEEECCCCe-EEEEEEecCcc-----hHHHHHHHHHhCC-CCCcceEEEEEEecCCCCCceEEEEEeeccCcc
Confidence 8999999999887766 88887754321 1225888888884 99999999998433 3488999999998
Q ss_pred HHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee--CCcEEEeecCcccccCCCCCCCCccc
Q 044127 75 LLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVT 150 (282)
Q Consensus 75 ~l~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~--~~~~~l~df~~~~~~~~~~~~~~~~~ 150 (282)
++..+.. .....+++..++.++.||+.||+|||++|++|+||||+||+++ ++.+||+|||++.............+
T Consensus 124 l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 203 (394)
T 4e7w_A 124 VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203 (394)
T ss_dssp HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCS
T ss_pred HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCccccc
Confidence 8876543 2245799999999999999999999999999999999999998 47999999999988766666667788
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+..... ......++..
T Consensus 204 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~--~~~~~~~~~~ 281 (394)
T 4e7w_A 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP--NYMEHKFPQI 281 (394)
T ss_dssp CGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG--GGSSSCCCCC
T ss_pred CcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh--hhhhhccccc
Confidence 99999999997666689999999999999999999999999999999999999888877654432211 1111222222
Q ss_pred CCCcc-cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 231 GGVNL-RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 231 ~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
..... .......++.+.+||.+||+.||.+|||+.++++||||++...
T Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 282 RPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred cCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 22221 2244568899999999999999999999999999999987643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=345.06 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=208.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++...... .....+..|..++..+ +||||+++++++.+.+..|+|||||.|+.+..
T Consensus 85 G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~ 163 (437)
T 4aw2_A 85 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT 163 (437)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCTTCBHHH
T ss_pred CCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEEEEEecCCCCcHHH
Confidence 89999999999999999999999764321 1223366788888887 59999999999999999999999998777766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC--CCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP--CTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~ 155 (282)
++......+++..++.++.||+.||.|||++|++||||||+||+++ ++.+||+|||++........ ....+||+.|+
T Consensus 164 ~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~ 243 (437)
T 4aw2_A 164 LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243 (437)
T ss_dssp HHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGC
T ss_pred HHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCee
Confidence 6665456799999999999999999999999999999999999998 48999999999976644332 23467999999
Q ss_pred Cchhhhc----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 156 APEVLLL----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 156 aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
|||++.. ...++.++|||||||++|||++|..||.+.+..+....+........
T Consensus 244 APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---------------------- 301 (437)
T 4aw2_A 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---------------------- 301 (437)
T ss_dssp CHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC----------------------
T ss_pred ChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccccc----------------------
Confidence 9999862 34589999999999999999999999999887777776654321110
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCC--CCCHHHHhcCcccccccC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHM--RPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~--Rps~~~ll~~~~~~~~~~ 278 (282)
.+.....+++.+++||++||..+|++ |++++++++||||+++.|
T Consensus 302 ---~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 302 ---FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp ---CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred ---CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 01122357899999999999998888 999999999999998765
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-51 Score=337.97 Aligned_cols=248 Identities=30% Similarity=0.366 Sum_probs=188.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+++.||+|++...... .....+|+..++++. ||||+++++++.+.+..++||||+.++.+..++
T Consensus 31 G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 107 (361)
T 3uc3_A 31 GNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIIMEYASGGELYERI 107 (361)
T ss_dssp STTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred CCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHH
Confidence 89999999999999999999999764322 344668999999885 999999999999999999999999875555555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C--cEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G--VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
... ..+++..++.++.||+.||.|||++|++|+||||+||+++. + .+||+|||++.............+++.|+||
T Consensus 108 ~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP 186 (361)
T 3uc3_A 108 CNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 186 (361)
T ss_dssp HHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCH
T ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCCh
Confidence 443 36999999999999999999999999999999999999974 3 4999999998765444444566899999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+....+.++|||||||++|+|++|..||..................... .+ .
T Consensus 187 E~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------------~~---------~ 242 (361)
T 3uc3_A 187 EVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY---------------SI---------P 242 (361)
T ss_dssp HHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC---------------CC---------C
T ss_pred hhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC---------------CC---------C
Confidence 99986664445599999999999999999999876554333333332211100 00 1
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
....+++.+.+||++||+.||.+|||++++++||||+..
T Consensus 243 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 243 DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 122568999999999999999999999999999999653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=333.73 Aligned_cols=245 Identities=29% Similarity=0.417 Sum_probs=197.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|.++.+++.||+|++..... ...+|+.++.++.+||||+++++++.++...|+|||||.|+.+...+
T Consensus 33 G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i 107 (342)
T 2qr7_A 33 GSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI 107 (342)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHH
Confidence 8999999999999999999999976532 23458888888877999999999999999999999999875555444
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-----CcEEEeecCcccccCCC-CCCCCccccccc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-----GVIKIGDLGMVKEIDSS-LPCTDYVTTRWY 154 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-----~~~~l~df~~~~~~~~~-~~~~~~~~~~~~ 154 (282)
... ..+++..+..++.||+.||.|||++|++|+||||+||++.+ +.++|+|||++...... .......+++.|
T Consensus 108 ~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y 186 (342)
T 2qr7_A 108 LRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF 186 (342)
T ss_dssp HTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSC
T ss_pred HHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccc
Confidence 443 46999999999999999999999999999999999999843 25999999999866433 233456789999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS---ADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
+|||++.+.. ++.++|||||||++|+|++|..||..... .+....+.......
T Consensus 187 ~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~----------------------- 242 (342)
T 2qr7_A 187 VAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL----------------------- 242 (342)
T ss_dssp CCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC-----------------------
T ss_pred cCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc-----------------------
Confidence 9999987544 78999999999999999999999986432 22222222211000
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....+..+++.+.+||++||+.||.+|||+.++++||||.+...
T Consensus 243 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 243 ---SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp ---CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred ---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 01223467899999999999999999999999999999976543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=325.61 Aligned_cols=248 Identities=27% Similarity=0.434 Sum_probs=189.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.||+|++..............|...+.+..+||||+++++++.+++..++||||+++++.+.+.
T Consensus 18 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~ 97 (290)
T 3fme_A 18 GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYK 97 (290)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSEEHHHHHH
T ss_pred CCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhccchHHHHH
Confidence 89999999999999999999999876555555555666666555557999999999999999999999999997766554
Q ss_pred H--hcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 81 E--RAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~--~~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
. ..+..+++..++.++.||+.||.+||++ |++|+||||+||+++. +.++|+|||++.............+++.|+|
T Consensus 98 ~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~a 177 (290)
T 3fme_A 98 QVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMA 177 (290)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSC
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccC
Confidence 3 2345799999999999999999999998 9999999999999986 8999999999987766555556688999999
Q ss_pred chhh---hccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 157 PEVL---LLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQI-YKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 157 PE~~---~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
||.+ .....++.++||||||+++|+|++|..||......... ...... ..+
T Consensus 178 PE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~------------------------ 232 (290)
T 3fme_A 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-PSP------------------------ 232 (290)
T ss_dssp HHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-CCC------------------------
T ss_pred hhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc-CCC------------------------
Confidence 9997 23455789999999999999999999999875443332 222221 100
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
......+++.+.++|.+||+.||.+|||++++++||||+..
T Consensus 233 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 233 ---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp ---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 01123568899999999999999999999999999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=340.77 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=206.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||+|++++.... .....+..|..++..+ +||||+++++++.+.+..|+||||+.|+.+..
T Consensus 72 G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~ 150 (412)
T 2vd5_A 72 GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYLVMEYYVGGDLLT 150 (412)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHH
Confidence 89999999999999999999999764321 1223456788888887 59999999999999999999999998766666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~ 155 (282)
++...+..+++..++.++.||+.||.|||++|++||||||+||+++. +.+||+|||++........ ....+||+.|+
T Consensus 151 ~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~ 230 (412)
T 2vd5_A 151 LLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230 (412)
T ss_dssp HHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGC
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcC
Confidence 66655557999999999999999999999999999999999999985 8999999999987654332 23458999999
Q ss_pred Cchhhhc------cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 156 APEVLLL------SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 156 aPE~~~~------~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
|||++.. ...++.++|+|||||++|||++|..||...+..+....+........
T Consensus 231 APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------- 290 (412)
T 2vd5_A 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS-------------------- 290 (412)
T ss_dssp CHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--------------------
T ss_pred CHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC--------------------
Confidence 9999873 24579999999999999999999999998887777666654221110
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCC---CCHHHHhcCcccccccC
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMR---PTAAEALEHPFFRSCHF 278 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---ps~~~ll~~~~~~~~~~ 278 (282)
.+.....+++++++||++||. +|.+| |+++++++||||+++.|
T Consensus 291 -----~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 291 -----LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp -----CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred -----CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 111234679999999999999 99998 59999999999998865
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=336.95 Aligned_cols=270 Identities=39% Similarity=0.660 Sum_probs=213.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeeccccccCCcE------EEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDV------FIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~------~lv~e~~~~ 73 (282)
|+||+||+|+++.+|+.||+|++........ ...+.+|+.+++.+. ||||+++++++...+.. +++|||+.+
T Consensus 53 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~ 131 (371)
T 4exu_A 53 GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT 131 (371)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSSTTCCCCEEEEECCCE
T ss_pred CCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCCcccceeEEEEEccccc
Confidence 8999999999999999999999976543333 456678999999995 99999999999876654 999999998
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++.+.+ +..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++...+... ....+++
T Consensus 132 ~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~t~ 205 (371)
T 4exu_A 132 DLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVVTR 205 (371)
T ss_dssp EHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----------CTTCCC
T ss_pred cHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccCc--CCcccCc
Confidence 766544 246999999999999999999999999999999999999985 799999999998665433 4567899
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccc-ccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA-SNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (282)
.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+....+.+....+....... ........+..
T Consensus 206 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (371)
T 4exu_A 206 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTP 285 (371)
T ss_dssp TTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCC
T ss_pred cccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCc
Confidence 99999999865668999999999999999999999999999889888888887766543322111000 00001111222
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
...........++.+.+||++||+.||.+|||++++|+||||++..
T Consensus 286 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 286 RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred chhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 2333445567899999999999999999999999999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=339.40 Aligned_cols=272 Identities=36% Similarity=0.608 Sum_probs=203.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccC------CcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH------EDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~------~~~~lv~e~~~~ 73 (282)
|+||.||+|++..+|+.||+|++...... .......+|+.+++.+. ||||+++++++... ...++++|++++
T Consensus 40 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~ 118 (367)
T 2fst_X 40 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 118 (367)
T ss_dssp ---CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGGGCCCCEEEEECCCE
T ss_pred cCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCccccCCeEEEEecccCC
Confidence 89999999999999999999999765433 33456678999999995 99999999998643 568999999976
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++.+.+ .. ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++...... .....+++
T Consensus 119 ~L~~~~-~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~ 193 (367)
T 2fst_X 119 DLNNIV-KC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATR 193 (367)
T ss_dssp ECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------------CCC
T ss_pred CHHHHH-hc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc--CCCcCcCc
Confidence 655443 33 47999999999999999999999999999999999999985 79999999999876543 24567899
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccc-ccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA-SNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (282)
.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+....... ...........
T Consensus 194 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 273 (367)
T 2fst_X 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMP 273 (367)
T ss_dssp TTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCC
T ss_pred CccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCC
Confidence 99999999865668999999999999999999999999999999999999988877654332211100 00001111222
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...........++.+.+||++||+.||.+|||++++|+||||++...
T Consensus 274 ~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 274 KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp CCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 22333445577899999999999999999999999999999987643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-51 Score=336.19 Aligned_cols=247 Identities=28% Similarity=0.434 Sum_probs=199.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc----hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS----LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~----~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|+++.+++.||+|++...... .....+.+|+.+++.+ +||||+++++++.+.+..++|||||.++.+
T Consensus 35 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 113 (351)
T 3c0i_A 35 GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADL 113 (351)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSSCBH
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEeCCCCCCH
Confidence 89999999999999999999998654321 1345677899999998 499999999999999999999999986555
Q ss_pred -HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCC-CCCc
Q 044127 77 -KLMKER--AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLP-CTDY 148 (282)
Q Consensus 77 -~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~-~~~~ 148 (282)
+.+... .+..+++..++.++.||+.||.|||++|++|+||||+||+++. ..++|+|||++........ ....
T Consensus 114 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 193 (351)
T 3c0i_A 114 CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193 (351)
T ss_dssp HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCC
T ss_pred HHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCC
Confidence 444332 2345899999999999999999999999999999999999974 2499999999987755432 3456
Q ss_pred cccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 149 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
.+++.|+|||++.+. .++.++|||||||++|+|++|..||.... ......+........
T Consensus 194 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~------------------- 252 (351)
T 3c0i_A 194 VGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN------------------- 252 (351)
T ss_dssp CSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC-------------------
T ss_pred cCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC-------------------
Confidence 789999999998754 47999999999999999999999998743 233333322111000
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
......+++.+.+||++||+.||.+|||+.++|+||||++.
T Consensus 253 -------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 253 -------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp -------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred -------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 11123568999999999999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=345.91 Aligned_cols=244 Identities=29% Similarity=0.452 Sum_probs=208.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+|+.||+|++...... .....+.+|+.+++.+. ||||+++++++...+..++||||+.++.+..
T Consensus 27 G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~ 105 (476)
T 2y94_A 27 GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIFMVMEYVSGGELFD 105 (476)
T ss_dssp CSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCSSEEHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEeCCCCCcHHH
Confidence 89999999999999999999999765322 22345678999888884 9999999999999999999999998766666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++... ..+++..++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++............++++.|+||
T Consensus 106 ~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aP 184 (476)
T 2y94_A 106 YICKN-GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 184 (476)
T ss_dssp HTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCH
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeECh
Confidence 55543 46999999999999999999999999999999999999985 79999999999887665555667899999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+....+.++|||||||++|+|++|..||...........+..... .
T Consensus 185 E~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~------------------------------~ 234 (476)
T 2y94_A 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF------------------------------Y 234 (476)
T ss_dssp HHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC------------------------------C
T ss_pred hhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc------------------------------C
Confidence 9998665557899999999999999999999998877776665543211 1
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.+..+++.+.+||++||+.||.+|||++++++||||++.
T Consensus 235 ~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 233568899999999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=322.12 Aligned_cols=249 Identities=29% Similarity=0.433 Sum_probs=208.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH-HH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL-KL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l-~~ 78 (282)
|+||+||+|.++.+++.|++|++....... ....+.+|+.+++++. ||||+++++++.+....+++|||+.++.+ +.
T Consensus 17 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~ 95 (284)
T 3kk8_A 17 GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFED 95 (284)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred cCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCEEEEEEecCCCCCHHHH
Confidence 799999999999999999999997765443 3455678999999994 99999999999999999999999987555 44
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCCCCCccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWY 154 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 154 (282)
+... ..+++..+..++.|++.||.+||++|++|+||||+||+++. +.++|+|||.+.............+++.|
T Consensus 96 ~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y 173 (284)
T 3kk8_A 96 IVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY 173 (284)
T ss_dssp HHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGG
T ss_pred HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCC
Confidence 4443 46999999999999999999999999999999999999963 34999999999877666555667899999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||.+.+.. ++.++||||||+++|+|++|..||...........+.........
T Consensus 174 ~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------------ 228 (284)
T 3kk8_A 174 LSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS------------------------ 228 (284)
T ss_dssp CCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT------------------------
T ss_pred cCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc------------------------
Confidence 9999987544 799999999999999999999999888776666655443221111
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
.....+++.+.+||.+||+.||++|||++++++||||++....
T Consensus 229 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 229 --PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 271 (284)
T ss_dssp --TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred --hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence 1123568899999999999999999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=328.62 Aligned_cols=246 Identities=28% Similarity=0.486 Sum_probs=205.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+|+.||||++.... ......+.+|+..+.++. ||||+++++++...+..++||||+.++++..++
T Consensus 56 G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 133 (321)
T 2c30_A 56 GSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV 133 (321)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHH
T ss_pred CCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEEecCCCCCHHHHH
Confidence 799999999999999999999987543 233456778999998884 999999999999999999999999988777776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
.. ..+++..+..++.||+.||.|||+.|++|+||||+||+++ ++.++|+|||++....... ......+++.|+|||
T Consensus 134 ~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE 211 (321)
T 2c30_A 134 SQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 211 (321)
T ss_dssp TT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHH
T ss_pred Hh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHh
Confidence 64 4699999999999999999999999999999999999998 4899999999988765432 234567899999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+. .++.++||||||+++|+|++|..||......+....+..... +. ...
T Consensus 212 ~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~--------------------------~~~ 263 (321)
T 2c30_A 212 VISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PK--------------------------LKN 263 (321)
T ss_dssp HHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CC--------------------------CTT
T ss_pred hhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CC--------------------------cCc
Confidence 98754 489999999999999999999999988776655544433111 00 011
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....++.+.++|.+||+.||.+|||++++++||||++...
T Consensus 264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 264 SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGL 303 (321)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCC
Confidence 2246888999999999999999999999999999987653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=331.01 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=208.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-----HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-----DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-----~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|+++.+|+.||+|++....... ....+.+|+.++.++. ||||+++++++.+....++||||+.++.
T Consensus 23 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 101 (321)
T 2a2a_A 23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGE 101 (321)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred cCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEEEEEEEcCCCCc
Confidence 899999999999999999999987654322 2456778999999995 9999999999999999999999998766
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C----cEEEeecCcccccCCCCCCCCccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G----VIKIGDLGMVKEIDSSLPCTDYVT 150 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~----~~~l~df~~~~~~~~~~~~~~~~~ 150 (282)
+..++... ..+++..++.++.||+.||.+||++|++|+||||+||++++ + .++|+|||++.............+
T Consensus 102 L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g 180 (321)
T 2a2a_A 102 LFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180 (321)
T ss_dssp HHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCS
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCC
Confidence 66666553 46999999999999999999999999999999999999975 4 699999999988766655566789
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
++.|+|||.+.+. .++.++||||||+++|+|++|..||.+....+....+.......
T Consensus 181 t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~---------------------- 237 (321)
T 2a2a_A 181 TPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF---------------------- 237 (321)
T ss_dssp CGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC----------------------
T ss_pred CCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc----------------------
Confidence 9999999998744 47999999999999999999999998877666655543321110
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
........++.+.+||++||+.||.+|||++++++||||+++.
T Consensus 238 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 238 ----DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp ----CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred ----ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 0122346788999999999999999999999999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=332.92 Aligned_cols=242 Identities=26% Similarity=0.273 Sum_probs=174.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCC----cEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE----DVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----~~~lv~e~~~~~~l 76 (282)
|+||+||+|++ +|+.||||+++... ........|+..+.++ +||||+++++++.+++ .++||||||++++|
T Consensus 14 G~fG~Vy~~~~--~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL 88 (303)
T 3hmm_A 14 GRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL 88 (303)
T ss_dssp CSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred CCCeEEEEEEE--CCEEEEEEEECccc--hhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEEecCCCCCcH
Confidence 89999999976 58899999987542 2222222344444556 5999999999987543 58999999998777
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ--------GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--- 144 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~--------~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--- 144 (282)
..++.. .+++++.+.+++.|++.||+|||++ +|+||||||+|||+++ +.+||+|||++........
T Consensus 89 ~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 166 (303)
T 3hmm_A 89 FDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 166 (303)
T ss_dssp HHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEES
T ss_pred HHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCcee
Confidence 777765 4699999999999999999999987 8999999999999985 7999999999986644322
Q ss_pred --CCCccccccccCchhhhccc-----cCCCcchhHHHHHHHHHHHhCCCCCCCCCChH-----------HHHHHHHHhC
Q 044127 145 --CTDYVTTRWYRAPEVLLLSE-----IYGPEVDMWAMGAIMFEMLSFRILFPGKNSAD-----------QIYKICQVIG 206 (282)
Q Consensus 145 --~~~~~~~~~~~aPE~~~~~~-----~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~-----------~~~~~~~~~~ 206 (282)
.....||+.|+|||++.+.. .++.++|||||||++|||+||..||....... ....+.....
T Consensus 167 ~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 246 (303)
T 3hmm_A 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246 (303)
T ss_dssp CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT
T ss_pred eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHh
Confidence 22457999999999986432 35779999999999999999987764332111 0001111000
Q ss_pred CCCCCCccccccccccCCccccCCCCCcccc--cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 207 SPTEDSWPLGIQLASNLDWKFPQMGGVNLRE--LSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
. ... .+.++. .....++.+.+|+.+||+.||++|||+.+|++.
T Consensus 247 ~-----------------~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 247 E-----------------QKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp T-----------------SCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred c-----------------ccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0 000 000000 011234568899999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=336.68 Aligned_cols=246 Identities=30% Similarity=0.441 Sum_probs=199.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++.+..... .......|..++.+..+||||+++++++.+.+..|+||||+.|+.+..
T Consensus 49 G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~ 128 (373)
T 2r5t_A 49 GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFY 128 (373)
T ss_dssp CTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHH
Confidence 899999999999999999999998765332 233445566654444469999999999999999999999998766655
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCccccc-CCCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~-~~~~~~~~~~~~~~~~a 156 (282)
++... ..+++..++.++.||+.||.|||++|++||||||+||+++ ++.+||+|||++... .........+||+.|+|
T Consensus 129 ~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~a 207 (373)
T 2r5t_A 129 HLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLA 207 (373)
T ss_dssp HHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCC
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccC
Confidence 55544 3699999999999999999999999999999999999997 489999999999864 33334456789999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+. .++.++|+|||||++|+|++|..||...+..+....+.... .
T Consensus 208 PE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~------------------------------~ 256 (373)
T 2r5t_A 208 PEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP------------------------------L 256 (373)
T ss_dssp HHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC------------------------------C
T ss_pred HHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc------------------------------c
Confidence 9999854 48999999999999999999999999887777666655421 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH----HHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA----AEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~----~~ll~~~~~~~~~~ 278 (282)
..+..++..+.+||++||+.||.+||++ +++++||||+++.|
T Consensus 257 ~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 257 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 2234678999999999999999999987 69999999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=339.93 Aligned_cols=274 Identities=30% Similarity=0.589 Sum_probs=206.1
Q ss_pred CCcceEEEEEec--CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccc--ccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDK--KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV--KEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~--~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|+++ .+++.||+|++...... ..+.+|+.+++++. ||||+++++++ ......++||||+.++++
T Consensus 32 G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~ 107 (405)
T 3rgf_A 32 GTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLW 107 (405)
T ss_dssp ----EEEEEEESSSSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCC-CTTBCCCCEEEEETTTTEEEEEEECCSEEHH
T ss_pred cCCeEEEEEEEccCCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcC-CCCeeeEeeEEecCCCCeEEEEEeCCCCCHH
Confidence 899999999966 56889999999764322 35678999999995 99999999999 457789999999999888
Q ss_pred HHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceee----e-CCcEEEeecCcccccCCC--
Q 044127 77 KLMKERA-------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV----S-KGVIKIGDLGMVKEIDSS-- 142 (282)
Q Consensus 77 ~~~~~~~-------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili----~-~~~~~l~df~~~~~~~~~-- 142 (282)
+.+.... ...+++..++.++.||+.||.|||++|++|+||||+||++ + ++.+||+|||++......
T Consensus 108 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~ 187 (405)
T 3rgf_A 108 HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187 (405)
T ss_dssp HHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-------
T ss_pred HHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCc
Confidence 7765322 1249999999999999999999999999999999999999 3 378999999999876432
Q ss_pred --CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCC---------hHHHHHHHHHhCCCCCC
Q 044127 143 --LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS---------ADQIYKICQVIGSPTED 211 (282)
Q Consensus 143 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~~~ 211 (282)
.......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+... .+.+..+...++.+...
T Consensus 188 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~ 267 (405)
T 3rgf_A 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK 267 (405)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTT
T ss_pred ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChh
Confidence 2224467899999999998666689999999999999999999999976654 47888899999998888
Q ss_pred CccccccccccCCcc--c--cCCCCCc----ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 212 SWPLGIQLASNLDWK--F--PQMGGVN----LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 212 ~~~~~~~~~~~~~~~--~--~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
.|+............ + ....... ........++.+.+||++||+.||.+|||++|+|+||||++...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 268 DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp TCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred hcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 776544332211110 0 0000000 11122334788999999999999999999999999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=341.30 Aligned_cols=246 Identities=28% Similarity=0.400 Sum_probs=190.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc----CCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE----HEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|+++.+++.||+|++... ....+|+..+.+..+||||+++++++.. ...+|+|||||.|+.+
T Consensus 73 G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L 146 (400)
T 1nxk_A 73 GINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 146 (400)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEH
T ss_pred ccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcH
Confidence 79999999999999999999998642 3445688887777789999999998865 6679999999987555
Q ss_pred HHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee----CCcEEEeecCcccccCCCCCCCCcccc
Q 044127 77 KLMKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 77 ~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~----~~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
..++.. ....+++..++.++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++.............+|
T Consensus 147 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt 226 (400)
T 1nxk_A 147 FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226 (400)
T ss_dssp HHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCC
Confidence 555543 334699999999999999999999999999999999999997 468999999999877655555667889
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChH----HHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSAD----QIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
+.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+.......
T Consensus 227 ~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~------------------- 286 (400)
T 1nxk_A 227 PYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF------------------- 286 (400)
T ss_dssp CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC-------------------
T ss_pred CCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC-------------------
Confidence 999999998744 48999999999999999999999997665332 222222110000
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
+ ......+++.+.+||++||+.||.+|||++++++||||.+....
T Consensus 287 ~-------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 331 (400)
T 1nxk_A 287 P-------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331 (400)
T ss_dssp C-------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTS
T ss_pred C-------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCC
Confidence 0 01224578999999999999999999999999999999875543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=334.23 Aligned_cols=273 Identities=30% Similarity=0.502 Sum_probs=212.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCC-------cEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE-------DVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-------~~~lv~e~~~~ 73 (282)
|+||+||+|+++.+++.||+|++..... .......++..+..+ +||||+++++++...+ ..++||||+.+
T Consensus 34 G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 110 (360)
T 3e3p_A 34 GTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD 110 (360)
T ss_dssp -----CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC
T ss_pred CCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccccceeEEEEeecccc
Confidence 8999999999999999999998865432 223445567777777 5999999999985433 38899999999
Q ss_pred cHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH--HcCccccCCCCCceeee--CCcEEEeecCcccccCCCCCCCC
Q 044127 74 DLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMH--RQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTD 147 (282)
Q Consensus 74 ~~l~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~Lh--~~~~~H~dl~p~nili~--~~~~~l~df~~~~~~~~~~~~~~ 147 (282)
+++..+.. .....+++..+..++.|++.||.+|| +.|++|+||||+||+++ ++.++|+|||++...........
T Consensus 111 ~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~ 190 (360)
T 3e3p_A 111 TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190 (360)
T ss_dssp BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCS
T ss_pred cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCccc
Confidence 88776554 23457999999999999999999999 99999999999999997 47999999999988776666667
Q ss_pred ccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 148 YVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 148 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
..+++.|+|||++.+...++.++|||||||++|+|++|..||...+..+....+....+.+....+.......... .+
T Consensus 191 ~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 268 (360)
T 3e3p_A 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDV--DL 268 (360)
T ss_dssp TTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCG--GG
T ss_pred ccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhc--cc
Confidence 7889999999999766668999999999999999999999999999999999888888777654433221111111 11
Q ss_pred cCCCCCc----ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 228 PQMGGVN----LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 228 ~~~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....... ........++.+.+||.+||+.||.+|||++++|+||||++...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 269 YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp GCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred cccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 1111111 11223346788999999999999999999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=340.07 Aligned_cols=270 Identities=31% Similarity=0.527 Sum_probs=199.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCC------cEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE------DVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~------~~~lv~e~~~~ 73 (282)
|+||+||+|++..+++.||+|++....... ....+.+|+.+++.+ +||||+++++++.... ..++||||+++
T Consensus 36 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~ 114 (371)
T 2xrw_A 36 GAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA 114 (371)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE
T ss_pred cCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccccceEEEEEcCCC
Confidence 899999999999999999999997654333 345567899999888 5999999999987654 78999999999
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++.+.+. ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++.............+++
T Consensus 115 ~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~ 190 (371)
T 2xrw_A 115 NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190 (371)
T ss_dssp EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----------------C
T ss_pred CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecC
Confidence 8777653 25999999999999999999999999999999999999984 799999999998776554455678899
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....+.+.+..+..............+....
T Consensus 191 ~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (371)
T 2xrw_A 191 YYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAG 269 (371)
T ss_dssp TTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCC
T ss_pred CccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccc
Confidence 99999999854 48999999999999999999999999988888887777766665443222111000000000000000
Q ss_pred Cccc------------ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 233 VNLR------------ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 233 ~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.... ......+..+++||++||+.||.+|||++++|+||||+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 270 YSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp CCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 0000 0011125679999999999999999999999999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=322.64 Aligned_cols=246 Identities=29% Similarity=0.437 Sum_probs=207.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|.+..++..+++|++..... .....+.+|+.+++++ +||||+++++++.+....++||||+.++.+....
T Consensus 20 G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 97 (277)
T 3f3z_A 20 GSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERV 97 (277)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred cCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHH
Confidence 7999999999999999999999876543 3355677899999999 5999999999999999999999999875555444
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceee---e-CCcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV---S-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili---~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
... ..+++..++.++.|++.||.+||++|++|+||||+||++ + ++.++|+|||++.............+++.|+|
T Consensus 98 ~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~a 176 (277)
T 3f3z_A 98 VHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176 (277)
T ss_dssp HHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCC
T ss_pred HHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccC
Confidence 443 469999999999999999999999999999999999999 4 37899999999988766666667789999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+ . ++.++||||||+++|+|++|..||......+....+.........
T Consensus 177 PE~~~~-~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------- 228 (277)
T 3f3z_A 177 PQVLEG-L-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE-------------------------- 228 (277)
T ss_dssp HHHHTT-C-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH--------------------------
T ss_pred hHHhcc-c-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc--------------------------
Confidence 998863 3 799999999999999999999999988777666665443221111
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.....+++.+.++|++||+.||.+|||+.++|+||||++..
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 11125688999999999999999999999999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=333.78 Aligned_cols=246 Identities=28% Similarity=0.431 Sum_probs=188.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.||+|++.... ....+.+|+.++.++. ||||+++++++.+.+..++||||+.++.+...+
T Consensus 64 G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 139 (349)
T 2w4o_A 64 GATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRI 139 (349)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred CCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCC-CCCCcceeeeEecCCeEEEEEEeCCCCCHHHHH
Confidence 899999999999999999999987642 3345667999999995 999999999999999999999999876665555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee----CCcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~----~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
... ..+++..++.++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++.............+++.|+|
T Consensus 140 ~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~a 218 (349)
T 2w4o_A 140 VEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218 (349)
T ss_dssp TTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSC
T ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccC
Confidence 543 4699999999999999999999999999999999999996 57899999999987765544456678999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+. .++.++|||||||++|+|++|..||................... ...
T Consensus 219 PE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-------------------------~~~ 272 (349)
T 2w4o_A 219 PEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-------------------------FIS 272 (349)
T ss_dssp HHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-------------------------CCT
T ss_pred HHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-------------------------cCC
Confidence 9998754 48999999999999999999999998777665433322211100 011
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.....++..+.+||++||+.||++|||+.++|+||||++..
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 22346789999999999999999999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=336.55 Aligned_cols=276 Identities=22% Similarity=0.283 Sum_probs=200.5
Q ss_pred CcceEEEEEecCCCcEEEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 2 SYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 2 ~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
+||+||+|+++.+++.||+|++........ ...+.+|+.+++.+. ||||+++++++.+++..++|||||.++.+..++
T Consensus 39 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 117 (389)
T 3gni_B 39 DLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLI 117 (389)
T ss_dssp TTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred CceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECCEEEEEEEccCCCCHHHHH
Confidence 899999999999999999999987654443 345567999998885 999999999999999999999999976666555
Q ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCC--------CCCCCccc
Q 044127 81 ER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSS--------LPCTDYVT 150 (282)
Q Consensus 81 ~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~--------~~~~~~~~ 150 (282)
.. ....+++..++.++.||+.||.|||++|++|+||||+||+++ ++.++|+|||.+...... .......+
T Consensus 118 ~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~g 197 (389)
T 3gni_B 118 CTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197 (389)
T ss_dssp HHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTT
T ss_pred hhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccc
Confidence 44 345699999999999999999999999999999999999998 589999999987643211 11123478
Q ss_pred cccccCchhhhcc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCC--ccccc----------
Q 044127 151 TRWYRAPEVLLLS-EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDS--WPLGI---------- 217 (282)
Q Consensus 151 ~~~~~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---------- 217 (282)
++.|+|||++.+. ..++.++|||||||++|+|++|..||......+................ .+...
T Consensus 198 t~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (389)
T 3gni_B 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVA 277 (389)
T ss_dssp TGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------------------------
T ss_pred cccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccc
Confidence 8889999999753 4589999999999999999999999988777666554433211100000 00000
Q ss_pred --cccccCC--ccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 218 --QLASNLD--WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 218 --~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....... ..............+..+++.+.+||++||+.||.+|||++++|+||||++...
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 278 NSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp ----------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred ccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 0000000 000001111122355678999999999999999999999999999999998754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=322.08 Aligned_cols=251 Identities=29% Similarity=0.375 Sum_probs=208.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--------chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--------SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYME 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--------~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 72 (282)
|+||.||+|+++.+++.||+|++..... ......+.+|+.+++++.+||||+++++++..+...++||||+.
T Consensus 28 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (298)
T 1phk_A 28 GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMK 107 (298)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccC
Confidence 8999999999999999999999875431 12234567899999999779999999999999999999999998
Q ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccc
Q 044127 73 SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 73 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
++.+..++... ..+++..++.++.||+.||.+||++|++|+||+|+||+++. +.++|+|||.+.............++
T Consensus 108 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 186 (298)
T 1phk_A 108 KGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT 186 (298)
T ss_dssp TCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSC
T ss_pred CCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCC
Confidence 75555555543 46999999999999999999999999999999999999985 79999999999887666555667889
Q ss_pred ccccCchhhhc-----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcc
Q 044127 152 RWYRAPEVLLL-----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226 (282)
Q Consensus 152 ~~~~aPE~~~~-----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
+.|+|||.+.+ ...++.++||||||+++|+|++|..||...........+.........
T Consensus 187 ~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------- 250 (298)
T 1phk_A 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS---------------- 250 (298)
T ss_dssp GGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----------------
T ss_pred ccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc----------------
Confidence 99999999852 344788999999999999999999999887766655554442211110
Q ss_pred ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
.....++..+.++|.+||+.||.+|||++++++||||++...
T Consensus 251 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 251 ----------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp ----------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred ----------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 111356889999999999999999999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=344.94 Aligned_cols=245 Identities=31% Similarity=0.493 Sum_probs=197.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|+++.+|+.||+|++..... .........|+.++..+. ||||+++++++.+.+..++||||+.++.+..
T Consensus 159 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~ 237 (446)
T 4ejn_A 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANGGELFF 237 (446)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEEEEECCCSSCBHHH
T ss_pred CcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEEEEEeeCCCCcHHH
Confidence 8999999999999999999999976532 223345567888887774 9999999999999999999999999766665
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~ 155 (282)
.+... ..+++..+..++.||+.||.|||+ .|++|+||||+||+++. +.++|+|||++.... .........||+.|+
T Consensus 238 ~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~ 316 (446)
T 4ejn_A 238 HLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316 (446)
T ss_dssp HHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGC
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCcccc
Confidence 55544 479999999999999999999998 99999999999999974 899999999987642 233345578999999
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||++.+.. ++.++|||||||++|+|++|..||...+.......+....
T Consensus 317 aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------------------------------ 365 (446)
T 4ejn_A 317 APEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE------------------------------ 365 (446)
T ss_dssp CHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------------------------
T ss_pred CHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC------------------------------
Confidence 999997544 8999999999999999999999998877766665554321
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
...+..+++.+.+||.+||+.||.+|| +++++++||||+++.+
T Consensus 366 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 366 IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 112345789999999999999999999 9999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=329.16 Aligned_cols=250 Identities=27% Similarity=0.402 Sum_probs=193.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.||+|++.... ......+.+|+..+.++.+||||+++++++.+++..++||||+.++.+..++
T Consensus 24 G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 102 (316)
T 2ac3_A 24 GAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI 102 (316)
T ss_dssp CSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred CceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHH
Confidence 899999999999999999999997653 3345567889999999778999999999999999999999999865555555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C---cEEEeecCcccccCCCC--------CCCCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G---VIKIGDLGMVKEIDSSL--------PCTDY 148 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~---~~~l~df~~~~~~~~~~--------~~~~~ 148 (282)
... ..+++..++.++.||+.||.+||++|++|+||||+||+++. + .++|+|||++....... .....
T Consensus 103 ~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 181 (316)
T 2ac3_A 103 HKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181 (316)
T ss_dssp HHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------
T ss_pred hcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccc
Confidence 443 46999999999999999999999999999999999999975 3 39999999987653211 11234
Q ss_pred cccccccCchhhhc----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChH---------------HHHHHHHHhCCCC
Q 044127 149 VTTRWYRAPEVLLL----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSAD---------------QIYKICQVIGSPT 209 (282)
Q Consensus 149 ~~~~~~~aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~---------------~~~~~~~~~~~~~ 209 (282)
.+++.|+|||.+.. ...++.++|||||||++|+|++|..||......+ ....+.... .
T Consensus 182 ~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--~- 258 (316)
T 2ac3_A 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK--Y- 258 (316)
T ss_dssp CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCC--C-
T ss_pred cCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccC--c-
Confidence 58999999999864 2347899999999999999999999998764321 111111100 0
Q ss_pred CCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 210 EDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
.+ .......+++.+.+||++||+.||.+|||++++|+||||++...
T Consensus 259 ----------------~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 259 ----------------EF-------PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp ----------------CC-------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred ----------------cc-------CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 00 00112356889999999999999999999999999999997543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=335.14 Aligned_cols=274 Identities=31% Similarity=0.566 Sum_probs=210.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch----------HHHHHHHHHHHHHHhCCCCCeeeecccc-----ccCCcEE
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL----------DESRNLKEVKCLRKMNNHPNIVKLRNLV-----KEHEDVF 65 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~----------~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~ 65 (282)
|+||.||+|.+.. ++.||+|++....... ....+.+|+.++.++. ||||+++++++ ......+
T Consensus 33 G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 110 (362)
T 3pg1_A 33 GSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLY 110 (362)
T ss_dssp ETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEEEECCTTTCCEEE
T ss_pred CCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccceeeeEEeccCCCcceEE
Confidence 8999999999865 8999999986543221 1256788999999995 99999999998 3445789
Q ss_pred EEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC
Q 044127 66 IVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP 144 (282)
Q Consensus 66 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~ 144 (282)
+||||+.+++++.+... ...+++..+..++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++........
T Consensus 111 lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (362)
T 3pg1_A 111 LVTELMRTDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189 (362)
T ss_dssp EEEECCSEEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC---------
T ss_pred EEEccCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccccc
Confidence 99999999888877654 34799999999999999999999999999999999999998 48999999999987665555
Q ss_pred CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccc--cccc
Q 044127 145 CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQ--LASN 222 (282)
Q Consensus 145 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 222 (282)
.....+++.|+|||.+.+...++.++|||||||++|+|++|..||.+....+....+....+.+....+..... ....
T Consensus 190 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 269 (362)
T 3pg1_A 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDY 269 (362)
T ss_dssp ------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHH
T ss_pred cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHH
Confidence 56678899999999998656689999999999999999999999999998888888888877665432211000 0001
Q ss_pred CCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 223 LDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
....................++.+.+||.+||+.||.+|||++++|+||||+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 270 LRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp TTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 1111122222333445567789999999999999999999999999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=331.20 Aligned_cols=248 Identities=28% Similarity=0.402 Sum_probs=205.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-------hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-------LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-------~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||+||+|+++.+|+.||||++...... .....+.+|+.++.++.+||||+++++++......++||||+.|
T Consensus 105 G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g 184 (365)
T 2y7j_A 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK 184 (365)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTT
T ss_pred CCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCC
Confidence 88999999999999999999998754321 11345568999999997799999999999999999999999997
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
+.+..++... ..+++..+..++.||+.||.|||+.|++|+||||+||++++ +.++|+|||++.............+++
T Consensus 185 ~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~ 263 (365)
T 2y7j_A 185 GELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTP 263 (365)
T ss_dssp CBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCG
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCC
Confidence 6665555543 46999999999999999999999999999999999999985 799999999998877666566778999
Q ss_pred cccCchhhhcc-----ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 153 WYRAPEVLLLS-----EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 153 ~~~aPE~~~~~-----~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
.|+|||.+.+. ..++.++|||||||++|+|++|..||...........+........
T Consensus 264 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~------------------ 325 (365)
T 2y7j_A 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS------------------ 325 (365)
T ss_dssp GGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------------------
T ss_pred CccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC------------------
Confidence 99999998632 2478899999999999999999999988766655555443211110
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
.......+..+.++|++||+.||.+|||++++|+||||+.
T Consensus 326 --------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 326 --------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp --------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred --------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 0112356888999999999999999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=345.58 Aligned_cols=246 Identities=33% Similarity=0.525 Sum_probs=205.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH-HH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL-KL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l-~~ 78 (282)
|+||+||+|+++.+++.||+|++..... ......+.+|+.+++++ +||||+++++++.+....++|||||.++.+ +.
T Consensus 33 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 111 (486)
T 3mwu_A 33 GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDE 111 (486)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred cCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHH
Confidence 8999999999999999999999875432 23456678899999999 599999999999999999999999986544 44
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCCCCCccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWY 154 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 154 (282)
+... ..+++..++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++.............+++.|
T Consensus 112 ~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y 189 (486)
T 3mwu_A 112 IIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189 (486)
T ss_dssp HHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGG
T ss_pred HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCC
Confidence 4444 47999999999999999999999999999999999999952 57999999999877666555667899999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||++.+ .++.++|||||||++|+|++|..||.+....+....+.........
T Consensus 190 ~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------------------ 243 (486)
T 3mwu_A 190 IAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL------------------------ 243 (486)
T ss_dssp CCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS------------------------
T ss_pred CCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC------------------------
Confidence 99999863 3899999999999999999999999988877776666553221111
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
..+..+++.+++||++||+.||.+|||+.++|+||||++..
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 244 --PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp --GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred --cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 11235688999999999999999999999999999998754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=330.46 Aligned_cols=274 Identities=35% Similarity=0.619 Sum_probs=216.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC-----CcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH-----EDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~ 75 (282)
|+||+||+|++..+|+.||+|++...........+.+|+.+++++. ||||+++++++... ...+++||++.+++
T Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L 100 (353)
T 2b9h_A 22 GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTDL 100 (353)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCSTTCCCEEEEECCCSEEH
T ss_pred CCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccccCccceEEEEEeccCccH
Confidence 8999999999999999999999975443444566778999999995 99999999987543 67999999999876
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC----------
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---------- 144 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~---------- 144 (282)
.+.+.. ..+++..+..++.||+.||.+||++|++|+||||+||+++. +.++|+|||++........
T Consensus 101 ~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 177 (353)
T 2b9h_A 101 HRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177 (353)
T ss_dssp HHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--------------
T ss_pred HHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCcccccc
Confidence 665544 36999999999999999999999999999999999999985 7999999999986643211
Q ss_pred -CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccccc-
Q 044127 145 -CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN- 222 (282)
Q Consensus 145 -~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 222 (282)
.....+++.|+|||++.....++.++|||||||++|+|++|..||.+.+..+....+....+.+..............
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 2b9h_A 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAR 257 (353)
T ss_dssp --CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHH
T ss_pred chhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhh
Confidence 123467999999999876566899999999999999999999999999888888888877776653322111000000
Q ss_pred -CCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 223 -LDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 223 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...................+++.+.+||++||+.||++|||++++++||||++...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 258 EYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 00001111222233445678999999999999999999999999999999987654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=328.10 Aligned_cols=243 Identities=28% Similarity=0.459 Sum_probs=205.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++...... .....+.+|+.++.++. ||||+++++++..++..++||||+.|++.+.
T Consensus 65 G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~g~l~~~ 143 (348)
T 1u5q_A 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDL 143 (348)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCSEEHHHH
T ss_pred CCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCeEEEEEecCCCCHHHH
Confidence 89999999999999999999998764332 23356788999999995 9999999999999999999999999988877
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+.... ..+++..+..++.|++.||.|||++|++|+||||+||++++ +.+||+|||++...... ....+++.|+||
T Consensus 144 l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aP 219 (348)
T 1u5q_A 144 LEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAP 219 (348)
T ss_dssp HHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCH
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---CcccCCcceeCH
Confidence 65543 57999999999999999999999999999999999999985 89999999998766533 346789999999
Q ss_pred hhhhc--cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 158 EVLLL--SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 158 E~~~~--~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|++.. ...++.++|||||||++|+|++|..||...+..+....+......
T Consensus 220 E~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~---------------------------- 271 (348)
T 1u5q_A 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP---------------------------- 271 (348)
T ss_dssp HHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC----------------------------
T ss_pred hhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------------------------
Confidence 99852 445899999999999999999999999887766666554432110
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.......++.+.+||.+||+.||.+|||++++++||||...
T Consensus 272 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 01123568899999999999999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-50 Score=327.59 Aligned_cols=245 Identities=32% Similarity=0.510 Sum_probs=195.7
Q ss_pred CCcceEEEEEec---CCCcEEEEEEccccccc---hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDK---KSGEFVAVKKLKKKIFS---LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~---~~~~~v~vK~~~~~~~~---~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|+||+||+|++. .+++.||+|+++..... .......+|+.+++.+. ||||+++++++...+..++||||+.++
T Consensus 28 G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~ 106 (327)
T 3a62_A 28 GGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGGKLYLILEYLSGG 106 (327)
T ss_dssp ETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECSSCEEEEEECCTTE
T ss_pred CCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcCCEEEEEEeCCCCC
Confidence 799999999985 68999999999765322 23345567999999985 999999999999999999999999876
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTR 152 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~ 152 (282)
.+..++... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++...... .......+++
T Consensus 107 ~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 185 (327)
T 3a62_A 107 ELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTI 185 (327)
T ss_dssp EHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCC
T ss_pred cHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCc
Confidence 665555544 36999999999999999999999999999999999999974 89999999998754322 2234567899
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+.....
T Consensus 186 ~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-------------------------- 238 (327)
T 3a62_A 186 EYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-------------------------- 238 (327)
T ss_dssp TTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------------------------
T ss_pred CccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--------------------------
Confidence 999999987544 79999999999999999999999998877766665544211
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
..+..+++.+.++|++||+.||.+|| +++++++||||+++.+
T Consensus 239 ----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 239 ----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred ----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 12345789999999999999999999 8899999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=327.66 Aligned_cols=244 Identities=30% Similarity=0.454 Sum_probs=194.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-------------------------HHHHHHHHHHHHHHhCCCCCeeeec
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-------------------------DESRNLKEVKCLRKMNNHPNIVKLR 55 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-------------------------~~~~~~~e~~~l~~~~~hp~i~~~~ 55 (282)
|+||+||+|++..+++.||+|++....... ....+.+|+.+++++. ||||++++
T Consensus 24 G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~ 102 (298)
T 2zv2_A 24 GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD-HPNVVKLV 102 (298)
T ss_dssp --CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC-CTTBCCEE
T ss_pred cCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC-CCCCCeEE
Confidence 899999999999999999999987643211 1245678999999994 99999999
Q ss_pred ccccc--CCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEee
Q 044127 56 NLVKE--HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGD 132 (282)
Q Consensus 56 ~~~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~d 132 (282)
+++.+ ....++||||+.++.+..+... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|
T Consensus 103 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 180 (298)
T 2zv2_A 103 EVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIAD 180 (298)
T ss_dssp EEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred EEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEec
Confidence 99876 5689999999997666554332 47999999999999999999999999999999999999974 7999999
Q ss_pred cCcccccCCCC-CCCCccccccccCchhhhcccc--CCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCC
Q 044127 133 LGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEI--YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPT 209 (282)
Q Consensus 133 f~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~--~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 209 (282)
||++....... ......+++.|+|||.+.+... .+.++|||||||++|+|++|..||...........+.......
T Consensus 181 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 259 (298)
T 2zv2_A 181 FGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF- 259 (298)
T ss_dssp CTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-
T ss_pred CCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCC-
Confidence 99998765432 2244578999999999875432 4778999999999999999999998776555444333211000
Q ss_pred CCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 210 EDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
.....+++.+.++|.+||+.||.+|||++++++||||+.
T Consensus 260 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 260 ---------------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp ---------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred ---------------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 012357889999999999999999999999999999963
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=354.87 Aligned_cols=246 Identities=28% Similarity=0.471 Sum_probs=209.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||||+++.... .........|..++..+.+||+|+.+++++++.+.+|+||||+.|+.|..
T Consensus 352 G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~ 431 (674)
T 3pfq_A 352 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY 431 (674)
T ss_dssp TTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHH
T ss_pred CCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHH
Confidence 8999999999999999999999976432 23344567788888888789999999999999999999999998766666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccC-CCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEID-SSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~-~~~~~~~~~~~~~~~a 156 (282)
++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||++.... .........||+.|+|
T Consensus 432 ~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~A 510 (674)
T 3pfq_A 432 HIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIA 510 (674)
T ss_dssp HHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCC
T ss_pred HHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccC
Confidence 655543 6999999999999999999999999999999999999985 899999999998642 3334456789999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+. .++.++|||||||++|||++|..||.+.+..+....+.... .
T Consensus 511 PE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~------------------------------~ 559 (674)
T 3pfq_A 511 PEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN------------------------------V 559 (674)
T ss_dssp HHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC------------------------------C
T ss_pred HhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC------------------------------C
Confidence 9999754 48999999999999999999999999887777666654311 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCH-----HHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTA-----AEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~-----~~ll~~~~~~~~~~ 278 (282)
.++..+++++.+||++||+.||.+||++ ++|++||||+++.|
T Consensus 560 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 560 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 2345679999999999999999999997 99999999998764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=345.31 Aligned_cols=245 Identities=30% Similarity=0.506 Sum_probs=203.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH-HH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL-KL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l-~~ 78 (282)
|+||+||+|+++.++..||+|++...... .....+.+|+.+++.+ +||||+++++++.+....++|||||.++.+ +.
T Consensus 48 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 126 (494)
T 3lij_A 48 GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDE 126 (494)
T ss_dssp C---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred CCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHH
Confidence 89999999999999999999998765432 2345677899999888 599999999999999999999999986544 54
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCCCCCccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWY 154 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 154 (282)
+... ..+++..++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++.............+++.|
T Consensus 127 ~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y 204 (494)
T 3lij_A 127 IIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYY 204 (494)
T ss_dssp HHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTT
T ss_pred HHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCe
Confidence 4444 46999999999999999999999999999999999999963 45999999999887766555667899999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||++. + .++.++|||||||++|+|++|..||.+....+....+..........
T Consensus 205 ~aPE~l~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------------------- 259 (494)
T 3lij_A 205 IAPEVLR-K-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP----------------------- 259 (494)
T ss_dssp CCHHHHT-T-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG-----------------------
T ss_pred eCHHHHc-c-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch-----------------------
Confidence 9999885 3 48999999999999999999999999988777776665533222111
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
....+++.+.+||++||+.||.+|||++++|+||||++.
T Consensus 260 ---~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 260 ---EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp ---GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred ---hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 123578999999999999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=346.60 Aligned_cols=246 Identities=30% Similarity=0.471 Sum_probs=204.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc------------hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEE
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS------------LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVF 68 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~------------~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~ 68 (282)
|+||+||+|+++.+++.||+|++...... .....+.+|+.+++++. ||||+++++++.++...++||
T Consensus 47 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~ 125 (504)
T 3q5i_A 47 GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVT 125 (504)
T ss_dssp --CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEEEEE
Confidence 89999999999999999999998765432 22456778999999995 999999999999999999999
Q ss_pred ecCCccHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCC----cEEEeecCcccccCCCC
Q 044127 69 EYMESDLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG----VIKIGDLGMVKEIDSSL 143 (282)
Q Consensus 69 e~~~~~~l-~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~----~~~l~df~~~~~~~~~~ 143 (282)
|||.++.+ +.+... ..+++..++.++.||+.||.|||++|++|+||||+||+++.. .++|+|||++.......
T Consensus 126 e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 203 (504)
T 3q5i_A 126 EFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203 (504)
T ss_dssp ECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC
Confidence 99986544 544444 469999999999999999999999999999999999999752 69999999998877666
Q ss_pred CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccC
Q 044127 144 PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNL 223 (282)
Q Consensus 144 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
......+++.|+|||++. + .++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 204 ~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------------- 267 (504)
T 3q5i_A 204 KLRDRLGTAYYIAPEVLK-K-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD-------------- 267 (504)
T ss_dssp CBCCCCSCTTTCCHHHHT-T-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------
T ss_pred ccccccCCcCCCCHHHhc-c-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence 666778999999999986 3 489999999999999999999999999887777766654221111
Q ss_pred CccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
...+..+++.+++||++||+.||.+|||++++|+||||++..
T Consensus 268 ------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 268 ------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp ------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred ------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 111245789999999999999999999999999999998653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=348.27 Aligned_cols=247 Identities=29% Similarity=0.452 Sum_probs=205.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|+++.+|+.||+|++..... ........+|..++..+ +||||+++++++.+.+..|+||||+.|+.+..
T Consensus 195 G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~ 273 (576)
T 2acx_A 195 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 273 (576)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHH
Confidence 8999999999999999999999976432 22345567899999998 59999999999999999999999998766665
Q ss_pred HHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 79 MKERA-GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~-~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
++... ...+++..++.++.||+.||.|||++||+|+||||+||+++. +.+||+|||++.............||+.|+|
T Consensus 274 ~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~A 353 (576)
T 2acx_A 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 353 (576)
T ss_dssp HHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCC
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccC
Confidence 55543 345999999999999999999999999999999999999985 8999999999988766555556789999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSA---DQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
||++.+.. ++.++|||||||++|+|++|..||...... ..+........
T Consensus 354 PEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~--------------------------- 405 (576)
T 2acx_A 354 PEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--------------------------- 405 (576)
T ss_dssp HHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC---------------------------
T ss_pred HHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc---------------------------
Confidence 99998544 899999999999999999999999876532 22222222110
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
...+..+++.+.+||++||+.||.+|| +++++++||||+++.+
T Consensus 406 --~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 406 --EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred --ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 123346789999999999999999999 7999999999998653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=337.48 Aligned_cols=270 Identities=28% Similarity=0.433 Sum_probs=208.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhC-------CCCCeeeeccccc----cCCcEEEEEe
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN-------NHPNIVKLRNLVK----EHEDVFIVFE 69 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~-------~hp~i~~~~~~~~----~~~~~~lv~e 69 (282)
|+||+||+|++..+++.||+|++... ......+.+|+.+++.+. +||||+++++.+. +....++|||
T Consensus 48 G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e 125 (397)
T 1wak_A 48 GHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE 125 (397)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEe
Confidence 89999999999999999999998754 233456678888888875 2788999999987 5678999999
Q ss_pred cCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeeCC----------------------
Q 044127 70 YMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSKG---------------------- 126 (282)
Q Consensus 70 ~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~~~---------------------- 126 (282)
++++++++.+.......+++..++.++.||+.||.|||++ |++|+||||+||+++..
T Consensus 126 ~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (397)
T 1wak_A 126 VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205 (397)
T ss_dssp CCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC----------
T ss_pred ccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCC
Confidence 9999999998887656799999999999999999999998 99999999999999743
Q ss_pred ----------------------------cEEEeecCcccccCCCCCCCCccccccccCchhhhccccCCCcchhHHHHHH
Q 044127 127 ----------------------------VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAI 178 (282)
Q Consensus 127 ----------------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~l 178 (282)
.++|+|||.+....... ....+|+.|+|||++.+.. ++.++|||||||+
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~i 282 (397)
T 1wak_A 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIGSG-YNTPADIWSTACM 282 (397)
T ss_dssp -----------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS--CSCCSCGGGCCHHHHHTSC-CCTHHHHHHHHHH
T ss_pred CCCccccCCcccccccccccccccccccceEeccccccccccccC--ccCCCCCcccCChhhcCCC-CCcHHHHHHHHHH
Confidence 79999999998765432 4567899999999998554 8999999999999
Q ss_pred HHHHHhCCCCCCCCC------ChHHHHHHHHHhCCCCCCCccccccccccCCcc--ccCCCCC----------cccccCC
Q 044127 179 MFEMLSFRILFPGKN------SADQIYKICQVIGSPTEDSWPLGIQLASNLDWK--FPQMGGV----------NLRELSP 240 (282)
Q Consensus 179 l~~l~~g~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----------~~~~~~~ 240 (282)
+|+|++|..||.... ..+....+....+.+....+............. ....... .....+.
T Consensus 283 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (397)
T 1wak_A 283 AFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQ 362 (397)
T ss_dssp HHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCH
T ss_pred HHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccch
Confidence 999999999998665 344555666666655432221111100000000 0000000 0001223
Q ss_pred CCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 241 SASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
..+..+.+||.+||+.||.+|||++++|+||||++
T Consensus 363 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 363 EEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 34567899999999999999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=328.89 Aligned_cols=268 Identities=25% Similarity=0.475 Sum_probs=206.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc--CCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE--HEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++... ....+.+|+.+++++.+||||+++++++.+ ....+++|||+.++.+..
T Consensus 47 G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 122 (330)
T 3nsz_A 47 GKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 122 (330)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHH
T ss_pred cCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHH
Confidence 89999999999999999999998643 235567899999999889999999999987 677999999999887776
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CC-cEEEeecCcccccCCCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KG-VIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
+.. .+++..+..++.||+.||.|||++|++|+||||+||+++ ++ .++|+|||++.............+++.|+|
T Consensus 123 ~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~a 198 (330)
T 3nsz_A 123 LYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 198 (330)
T ss_dssp HGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCC
T ss_pred HHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccC
Confidence 654 489999999999999999999999999999999999998 44 899999999987766555566788999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCC-CChHHHHHHHHHhCCCCCCCc---------cccccccccCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGK-NSADQIYKICQVIGSPTEDSW---------PLGIQLASNLDWK 226 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 226 (282)
||.+.+...++.++|||||||++|+|++|..||... ...+.+..+....+.+....+ +........ ..
T Consensus 199 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 276 (330)
T 3nsz_A 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR--HS 276 (330)
T ss_dssp HHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCC--CC
T ss_pred hhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhh--cc
Confidence 999986566899999999999999999999998544 333444333333321110000 000000000 00
Q ss_pred ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...............+++.+.+||++||+.||.+|||++++|+||||+++..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 277 RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp CCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred ccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 0000001111222347899999999999999999999999999999998764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=347.10 Aligned_cols=247 Identities=32% Similarity=0.484 Sum_probs=208.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++..... ......+.+|+.+++++ +||||+++++++.+.+..++|||||.++.+..
T Consensus 37 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~ 115 (484)
T 3nyv_A 37 GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFD 115 (484)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCCCCCHHH
Confidence 8999999999999999999999876533 23456678899999999 59999999999999999999999998655554
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee----CCcEEEeecCcccccCCCCCCCCccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWY 154 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~----~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 154 (282)
.+... ..+++..++.++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++.............+++.|
T Consensus 116 ~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y 194 (484)
T 3nyv_A 116 EIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194 (484)
T ss_dssp HHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGT
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccc
Confidence 44443 4799999999999999999999999999999999999994 368999999999877666555667899999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.........
T Consensus 195 ~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------------------ 248 (484)
T 3nyv_A 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL------------------------ 248 (484)
T ss_dssp CCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS------------------------
T ss_pred cCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC------------------------
Confidence 99999864 4899999999999999999999999998877777666553221111
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
..+..+++.+++||++||+.||.+|||++++|+||||+...
T Consensus 249 --~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 249 --PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp --GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred --cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 11235789999999999999999999999999999998754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=319.62 Aligned_cols=246 Identities=29% Similarity=0.455 Sum_probs=201.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.+..++..||+|++....... ....+.+|+..+.++. ||||+++++++.+.+..+++|||+.++.+..
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 98 (279)
T 3fdn_A 20 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYR 98 (279)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEECCCTTEEHHH
T ss_pred CCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEEEEEecCCCCcHHH
Confidence 899999999999999999999986643222 2345677888888885 9999999999999999999999999765555
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
.+... ..+++..+..++.||+.||.+||++|++|+||+|+||+++. +.++|+|||++....... .....+++.|+||
T Consensus 99 ~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aP 176 (279)
T 3fdn_A 99 ELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPP 176 (279)
T ss_dssp HHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---------CCCCTTCCH
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-ccccCCCCCccCH
Confidence 55544 36999999999999999999999999999999999999974 899999999886554332 2455789999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+. .++.++||||||+++|+|++|..||......+....+..... .
T Consensus 177 E~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------------------~ 225 (279)
T 3fdn_A 177 EMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------------------------------T 225 (279)
T ss_dssp HHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC------------------------------C
T ss_pred hHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC------------------------------C
Confidence 998744 479999999999999999999999998776666555433211 1
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
.+...++.+.+||.+||+.||.+|||++++++||||++....|
T Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~ 268 (279)
T 3fdn_A 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268 (279)
T ss_dssp CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence 2345688999999999999999999999999999998866544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=326.95 Aligned_cols=275 Identities=33% Similarity=0.564 Sum_probs=205.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc--------------cCCcEEE
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK--------------EHEDVFI 66 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--------------~~~~~~l 66 (282)
|+||+||+|++..+++.||+|++.... ......+.+|+.+++++. ||||+++++++. +....++
T Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~l 99 (320)
T 2i6l_A 22 GGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYI 99 (320)
T ss_dssp ----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSCBCCC----CCSCSEEEE
T ss_pred CCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcC-CCCeeEEEEeccccccccccccccccccCceeE
Confidence 889999999999999999999987542 334556778999999994 999999998863 4467899
Q ss_pred EEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee--CCcEEEeecCcccccCCC--
Q 044127 67 VFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSS-- 142 (282)
Q Consensus 67 v~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~--~~~~~l~df~~~~~~~~~-- 142 (282)
||||+.+++.+.+ .. .++++..++.++.||+.||.+||++|++|+||||+||+++ ++.++|+|||++......
T Consensus 100 v~e~~~~~L~~~~-~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 176 (320)
T 2i6l_A 100 VQEYMETDLANVL-EQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176 (320)
T ss_dssp EEECCSEEHHHHH-TT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC-----
T ss_pred EeeccCCCHHHHh-hc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcc
Confidence 9999998766554 33 4799999999999999999999999999999999999997 358999999999866432
Q ss_pred --CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccc
Q 044127 143 --LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA 220 (282)
Q Consensus 143 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
.......+++.|+|||.+.....++.++||||||+++|+|++|..||......+....+...........+.......
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (320)
T 2i6l_A 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVI 256 (320)
T ss_dssp ---CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTS
T ss_pred cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcC
Confidence 122344568889999998765668999999999999999999999999888777777666654333221111000000
Q ss_pred ccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 221 SNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
.....................+++.+.+||++||+.||.+|||++++|+||||+...+.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 257 PVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred cccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 000000000111223344567899999999999999999999999999999999876654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=326.58 Aligned_cols=265 Identities=21% Similarity=0.317 Sum_probs=202.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCC--cEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE--DVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++...........+.+|+.+++++. ||||+++++++.... ..++||||+.++++..
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 98 (319)
T 4euu_A 20 GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYT 98 (319)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEEEEEECCTTCBHHH
T ss_pred CCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCceEEEEEeCCCCCCHHH
Confidence 8999999999999999999999987655555566778999999995 999999999987654 7899999998766666
Q ss_pred HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceee----eC-CcEEEeecCcccccCCCCCCCCcccc
Q 044127 79 MKERAG--QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV----SK-GVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 79 ~~~~~~--~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili----~~-~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
++.... ..+++..++.++.||+.||.|||++|++|+||||+||++ +. +.+||+|||++.............++
T Consensus 99 ~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt 178 (319)
T 4euu_A 99 VLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGT 178 (319)
T ss_dssp HHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSC
T ss_pred HHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccC
Confidence 655432 239999999999999999999999999999999999998 33 57999999999887766666667899
Q ss_pred ccccCchhhhc-------cccCCCcchhHHHHHHHHHHHhCCCCCCCCCC----hHHHHHHHHHhCCCCCCCcccccccc
Q 044127 152 RWYRAPEVLLL-------SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS----ADQIYKICQVIGSPTEDSWPLGIQLA 220 (282)
Q Consensus 152 ~~~~aPE~~~~-------~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
+.|+|||++.. +..++.++|||||||++|+|++|..||..... .+....+.... ....+..... .
T Consensus 179 ~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~-~ 254 (319)
T 4euu_A 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK---PSGAISGVQK-A 254 (319)
T ss_dssp GGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC---CTTCCEEEEC-S
T ss_pred CCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC---Ccccchhhhc-c
Confidence 99999999863 34589999999999999999999999975443 33333333321 1111111111 1
Q ss_pred ccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCc
Q 044127 221 SNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHP 271 (282)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 271 (282)
....+.+.. .......++..++..+.++|++||+.||++|||++|+|+||
T Consensus 255 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 255 ENGPIDWSG-DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp TTCCEEEES-SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cCCccccCc-cCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 111111110 00111233445677899999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=328.20 Aligned_cols=271 Identities=39% Similarity=0.650 Sum_probs=210.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeeccccccCCc------EEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHED------VFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~------~~lv~e~~~~ 73 (282)
|+||+||+|+++.+|+.||+|++........ ...+.+|+.+++.+. ||||+++++++..... .+++||++.+
T Consensus 35 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~ 113 (353)
T 3coi_A 35 GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT 113 (353)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGGGCCCCEEEEECCSE
T ss_pred CCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCcccHhheEecccccccceeEEEEeccccC
Confidence 8999999999999999999999876543333 456678999999985 9999999999876653 4999999998
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++.+.+ ...+++..+..++.||+.||.+||++|++|+||||+||+++. +.++|+|||++....... ....+++
T Consensus 114 ~l~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~t~ 187 (353)
T 3coi_A 114 DLQKIM----GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM--TGYVVTR 187 (353)
T ss_dssp EGGGTT----TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----------CCSB
T ss_pred CHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCCc--cccccCc
Confidence 655433 236999999999999999999999999999999999999985 799999999998655432 4557899
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccc-ccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA-SNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (282)
.|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+....+....+.+....+....... .......+...
T Consensus 188 ~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (353)
T 3coi_A 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTP 267 (353)
T ss_dssp CCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCS
T ss_pred CcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCC
Confidence 99999999865668999999999999999999999999998888888888777665433221110000 00000111111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...........++.+.+||.+||+.||.+|||++++++||||+....
T Consensus 268 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 268 RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp SCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred CccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 22233445678999999999999999999999999999999987643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=328.17 Aligned_cols=239 Identities=24% Similarity=0.339 Sum_probs=200.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-------HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-------DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-------~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||+||+|+++.+++.||+|++....... ....+.+|+.++.++ +||||+++++++.+.+..++|||++.+
T Consensus 35 G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 113 (335)
T 3dls_A 35 GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQGFFQLVMEKHGS 113 (335)
T ss_dssp SSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEeeCCEEEEEEEeCCC
Confidence 899999999999999999999987654221 233556799999999 599999999999999999999999865
Q ss_pred c-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccc
Q 044127 74 D-LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 74 ~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
+ .+..++... ..+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++.............++
T Consensus 114 g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt 192 (335)
T 3dls_A 114 GLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGT 192 (335)
T ss_dssp SCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSC
T ss_pred CccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCC
Confidence 3 555555544 46999999999999999999999999999999999999985 79999999999887766655667899
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
+.|+|||.+.+....+.++|||||||++|+|++|..||....... .
T Consensus 193 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------~------------------------- 238 (335)
T 3dls_A 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------E------------------------- 238 (335)
T ss_dssp GGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------T-------------------------
T ss_pred ccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------h-------------------------
Confidence 999999999866655889999999999999999999996521100 0
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.....+..+++.+.+||.+||+.||.+|||++++++||||++..
T Consensus 239 --~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 239 --AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp --TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred --hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 00112334789999999999999999999999999999998754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=318.04 Aligned_cols=245 Identities=29% Similarity=0.460 Sum_probs=180.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.|++|++....... ....+.+|+..+.++. ||||+++++++.+.+..+++|||+.++++..
T Consensus 22 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 100 (278)
T 3cok_A 22 GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVYLVLEMCHNGEMNR 100 (278)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEEEEEEECCTTEEHHH
T ss_pred CCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeEEEEEecCCCCcHHH
Confidence 899999999999999999999987543221 2345677888888884 9999999999999999999999998877777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~a 156 (282)
++......+++..++.++.||+.||.+||++|++|+||+|+||+++. +.++|+|||++....... ......+++.|+|
T Consensus 101 ~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~a 180 (278)
T 3cok_A 101 YLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYIS 180 (278)
T ss_dssp HHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----------------
T ss_pred HHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCC
Confidence 77665567999999999999999999999999999999999999975 799999999988764322 2234578899999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+. .++.++||||||+++|+|++|..||......+....... ...
T Consensus 181 PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------------------------~~~ 229 (278)
T 3cok_A 181 PEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------------------------ADY 229 (278)
T ss_dssp ------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------------------------SCC
T ss_pred cchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------------------------ccc
Confidence 9998744 479999999999999999999999987654433221100 001
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
..+...+..+.++|.+||+.||.+|||++++++||||++..
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 23345788999999999999999999999999999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=317.08 Aligned_cols=245 Identities=27% Similarity=0.412 Sum_probs=194.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|.+..+++.|++|++...... .....+.+|+..++.+. ||||+++++++.+.+..+++||++.++.+..
T Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 100 (276)
T 2h6d_A 22 GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTDFFMVMEYVSGGELFD 100 (276)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred CCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCeEEEEEeccCCCcHHH
Confidence 89999999999999999999998764321 22345678899998885 9999999999999999999999998755555
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++... ..+++..+..++.||+.||.+||++|++|+||+|+||+++. +.++|+|||++.............+++.|+||
T Consensus 101 ~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aP 179 (276)
T 2h6d_A 101 YICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179 (276)
T ss_dssp HHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCT
T ss_pred HHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCH
Confidence 55544 36999999999999999999999999999999999999985 79999999999877655444556789999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+....+.++||||||+++|+|++|..||...........+.... ..
T Consensus 180 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------------------~~ 229 (276)
T 2h6d_A 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV------------------------------FY 229 (276)
T ss_dssp GGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------------------------CC
T ss_pred HHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc------------------------------cc
Confidence 998755544689999999999999999999998776555544433211 01
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.+...+..+.++|.+||+.||.+|||++++++||||++..
T Consensus 230 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 2345688999999999999999999999999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=328.47 Aligned_cols=245 Identities=22% Similarity=0.376 Sum_probs=194.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCC-CCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNN-HPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.+.. ++.||+|++...... .....+.+|+.++.++.+ ||||+++++++..++..++|||+.++++.+.
T Consensus 67 G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~ 145 (390)
T 2zmd_A 67 GGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSW 145 (390)
T ss_dssp CSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCSEEHHHH
T ss_pred CCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEecCCCCHHHH
Confidence 8999999999875 889999998765433 344667889999999974 7999999999999999999999666666655
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccccCCCC---CCCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSL---PCTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~ 155 (282)
+... ..+++..+..++.||+.||.|||++|++|+||||+||+++++.+||+|||++....... ......+++.|+
T Consensus 146 l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 223 (390)
T 2zmd_A 146 LKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223 (390)
T ss_dssp HHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEECCCSSSCCC---------CCSCCCGGGC
T ss_pred HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEEecCccccccCCCccccCCCCCcCCCcc
Confidence 5443 47999999999999999999999999999999999999999999999999998764332 123567999999
Q ss_pred Cchhhhc----------cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHHHhCCCCCCCccccccccccCC
Q 044127 156 APEVLLL----------SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSAD-QIYKICQVIGSPTEDSWPLGIQLASNLD 224 (282)
Q Consensus 156 aPE~~~~----------~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
|||++.+ ...++.++|||||||++|+|++|..||....... .+..+.. ....
T Consensus 224 aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~---~~~~-------------- 286 (390)
T 2zmd_A 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID---PNHE-------------- 286 (390)
T ss_dssp CHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC---TTSC--------------
T ss_pred ChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC---cccc--------------
Confidence 9999864 1347889999999999999999999998654432 2222211 1000
Q ss_pred ccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
...+...+..+.+||++||+.||.+|||++++|+||||+..
T Consensus 287 -----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 287 -----------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp -----------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred -----------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 11223447889999999999999999999999999999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=319.79 Aligned_cols=249 Identities=28% Similarity=0.442 Sum_probs=202.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-----HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-----DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-----~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|++..+++.|++|++....... ....+.+|+.+++++. ||||+++++++.+....+++||++.++.
T Consensus 16 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 94 (283)
T 3bhy_A 16 GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKTDVVLILELVSGGE 94 (283)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred cCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCCeEEEEEeecCCCc
Confidence 899999999999999999999987654322 2456778999999995 9999999999999999999999998666
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C----cEEEeecCcccccCCCCCCCCccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G----VIKIGDLGMVKEIDSSLPCTDYVT 150 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~----~~~l~df~~~~~~~~~~~~~~~~~ 150 (282)
+..++... ..+++..+..++.||+.||.+||++|++|+||+|+||++++ + .++|+|||.+.............+
T Consensus 95 L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 173 (283)
T 3bhy_A 95 LFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG 173 (283)
T ss_dssp HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CC
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCC
Confidence 65555543 46999999999999999999999999999999999999975 3 799999999987765555556678
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
++.|+|||.+.+. .++.++||||||+++|+|++|..||......+....+.......
T Consensus 174 ~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 230 (283)
T 3bhy_A 174 TPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF---------------------- 230 (283)
T ss_dssp CGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC----------------------
T ss_pred CcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC----------------------
Confidence 9999999998744 48999999999999999999999998877665554433211100
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
........++.+.++|++||+.||.+|||++++++||||++...
T Consensus 231 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 231 ----DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp ----CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred ----cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 11223457889999999999999999999999999999988654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=316.88 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=203.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.|++|++...........+.+|+..++.+ +||||+++++++.+.+..++||||+.++.+..++
T Consensus 18 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 96 (276)
T 2yex_A 18 GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI 96 (276)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGS
T ss_pred CCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHH
Confidence 899999999999999999999997665555566778899988888 5999999999999999999999999876665555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC---CCCCCccccccccC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~a 156 (282)
... ..+++..+..++.||+.||.+||++|++|+||+|+||+++. +.++|+|||.+...... .......+++.|+|
T Consensus 97 ~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 175 (276)
T 2yex_A 97 EPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175 (276)
T ss_dssp BTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCC
T ss_pred hhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccC
Confidence 433 46999999999999999999999999999999999999985 89999999998765322 12344578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+....+.++||||||+++|+|++|..||................... .
T Consensus 176 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~ 228 (276)
T 2yex_A 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------------------L 228 (276)
T ss_dssp GGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT---------------------------S
T ss_pred hHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc---------------------------c
Confidence 9999866545789999999999999999999998766543322221110000 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
......++.+.++|++||+.||.+|||++++++||||++...
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 112356889999999999999999999999999999987654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=322.59 Aligned_cols=245 Identities=22% Similarity=0.379 Sum_probs=193.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCC-CCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNH-PNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~h-p~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.+. +++.||+|++....... ....+.+|+.++.++.+| |||+++++++.++...++|||+.++++.+.
T Consensus 20 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~ 98 (343)
T 3dbq_A 20 GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSW 98 (343)
T ss_dssp CSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHH
T ss_pred CCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCCCCCHHHH
Confidence 899999999875 58899999987654333 345667899999999733 999999999999999999999777776666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccccCCCCC---CCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLP---CTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~ 155 (282)
+... ..+++..+..++.||+.||.|||++|++|+||||+||+++++.+||+|||++........ .....+++.|+
T Consensus 99 l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~ 176 (343)
T 3dbq_A 99 LKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176 (343)
T ss_dssp HHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCCC------------CCCCSSC
T ss_pred HHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEEeecccccccCcccccccCCCCcCCcCcC
Confidence 5553 479999999999999999999999999999999999999999999999999987643322 23457899999
Q ss_pred Cchhhhc----------cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc
Q 044127 156 APEVLLL----------SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225 (282)
Q Consensus 156 aPE~~~~----------~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
|||++.+ ...++.++|||||||++|+|++|..||......... .........
T Consensus 177 aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~---------------- 238 (343)
T 3dbq_A 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--LHAIIDPNH---------------- 238 (343)
T ss_dssp CHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--HHHHHCTTS----------------
T ss_pred CHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH--HHHHhcCCc----------------
Confidence 9999864 245788999999999999999999999765443221 112111111
Q ss_pred cccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
....+...+..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 239 ---------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 239 ---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp ---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred ---------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 01223345778999999999999999999999999999974
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=328.84 Aligned_cols=251 Identities=31% Similarity=0.443 Sum_probs=203.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc----chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF----SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~----~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|++..+++.||+|++..... ......+.+|+.+++++. ||||+++++++.+.+..++|||||.++.+
T Consensus 37 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~gg~L 115 (345)
T 3hko_A 37 GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHL 115 (345)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred cCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhccCCeEEEEEeCCCCCcH
Confidence 8999999999999999999999876431 234566788999999995 99999999999999999999999987666
Q ss_pred HHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Q 044127 77 KLMKERA---------------------------------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117 (282)
Q Consensus 77 ~~~~~~~---------------------------------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~ 117 (282)
..++... ...+++..++.++.||+.||.|||++|++|+|||
T Consensus 116 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 195 (345)
T 3hko_A 116 LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIK 195 (345)
T ss_dssp HHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 6655310 1124688899999999999999999999999999
Q ss_pred CCceeeeC-C--cEEEeecCcccccCCCC-----CCCCccccccccCchhhhcc-ccCCCcchhHHHHHHHHHHHhCCCC
Q 044127 118 PSNLLVSK-G--VIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEVLLLS-EIYGPEVDMWAMGAIMFEMLSFRIL 188 (282)
Q Consensus 118 p~nili~~-~--~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~~ 188 (282)
|+||+++. + .++|+|||++....... ......+++.|+|||.+.+. ..++.++||||||+++|+|++|..|
T Consensus 196 p~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p 275 (345)
T 3hko_A 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275 (345)
T ss_dssp GGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred hhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999974 3 79999999998653211 22456789999999998642 5578999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh
Q 044127 189 FPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268 (282)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 268 (282)
|......+....+......... .....+++.+.+||.+||+.||.+|||+.++|
T Consensus 276 f~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 276 FPGVNDADTISQVLNKKLCFEN--------------------------PNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp SCCSSHHHHHHHHHHCCCCTTS--------------------------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CCCCChHHHHHHHHhcccccCC--------------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 9988877777666553221111 11124688999999999999999999999999
Q ss_pred cCcccccccC
Q 044127 269 EHPFFRSCHF 278 (282)
Q Consensus 269 ~~~~~~~~~~ 278 (282)
+||||++...
T Consensus 330 ~hp~~~~~~~ 339 (345)
T 3hko_A 330 QHPWISQFSD 339 (345)
T ss_dssp HSHHHHTTSS
T ss_pred cChhhccChH
Confidence 9999998764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=339.87 Aligned_cols=246 Identities=27% Similarity=0.410 Sum_probs=203.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||+|++...... .....+..|..++.++ +||||+++++++.+...+|+||||+.|+.+..
T Consensus 196 G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~ 274 (543)
T 3c4z_A 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRY 274 (543)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTTCBHHH
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEEEEEeccCCCHHH
Confidence 89999999999999999999999765322 2234567899999998 59999999999999999999999999776666
Q ss_pred HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCCcccccc
Q 044127 79 MKERA---GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTDYVTTRW 153 (282)
Q Consensus 79 ~~~~~---~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~~~~~~~ 153 (282)
++... ...+++..++.++.||+.||.|||++|++|+||||+||+++. +.+||+|||++........ .....||+.
T Consensus 275 ~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~ 354 (543)
T 3c4z_A 275 HIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354 (543)
T ss_dssp HHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTT
T ss_pred HHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCcc
Confidence 65543 246999999999999999999999999999999999999985 8999999999987654433 234589999
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCCh----HHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSA----DQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
|+|||++.+. .++.++|+|||||++|+|++|..||...... .....+...
T Consensus 355 Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~------------------------- 408 (543)
T 3c4z_A 355 FMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ------------------------- 408 (543)
T ss_dssp TSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-------------------------
T ss_pred ccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-------------------------
Confidence 9999999854 4899999999999999999999999876432 222222211
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccC
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHF 278 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~ 278 (282)
....+..+++.+.+||++||+.||.+||+ ++++++||||+++.+
T Consensus 409 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 409 -----AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred -----ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 01223467899999999999999999996 589999999998654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=327.56 Aligned_cols=272 Identities=31% Similarity=0.512 Sum_probs=209.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCC-----eeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPN-----IVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~-----i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|++..+++.||+|++.... ........|+..+..+..|++ ++.+++++...+..++|||++++++
T Consensus 65 G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L 142 (382)
T 2vx3_A 65 GSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNL 142 (382)
T ss_dssp ETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCCBH
T ss_pred cCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCCCH
Confidence 799999999999999999999997542 233455667777777765664 8999999999999999999999988
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HcCccccCCCCCceeee---CCcEEEeecCcccccCCCCCCCCccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMH--RQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSSLPCTDYVT 150 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh--~~~~~H~dl~p~nili~---~~~~~l~df~~~~~~~~~~~~~~~~~ 150 (282)
.+.+.......+++..+..++.||+.||.+|| +.|++|+||||+||+++ ++.+||+|||++...+... ....+
T Consensus 143 ~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~--~~~~~ 220 (382)
T 2vx3_A 143 YDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI--YQYIQ 220 (382)
T ss_dssp HHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCC--CSSCS
T ss_pred HHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccccc--ccccC
Confidence 88777665456999999999999999999999 57999999999999995 3679999999998775433 45688
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc------cCC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS------NLD 224 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 224 (282)
++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....+.+....++....... ...
T Consensus 221 t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (382)
T 2vx3_A 221 SRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGT 299 (382)
T ss_dssp CGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSC
T ss_pred CccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccc
Confidence 99999999998554 89999999999999999999999999999999988888877665433221110000 000
Q ss_pred cccc----------CCCCCccccc------------------CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 225 WKFP----------QMGGVNLREL------------------SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 225 ~~~~----------~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
|... ......+... .....+.+.+||++||+.||++|||++|+|+||||++.
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 300 WNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp EEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred cccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 0000 0000000000 00011478999999999999999999999999999875
Q ss_pred c
Q 044127 277 H 277 (282)
Q Consensus 277 ~ 277 (282)
.
T Consensus 380 ~ 380 (382)
T 2vx3_A 380 A 380 (382)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=318.47 Aligned_cols=242 Identities=29% Similarity=0.400 Sum_probs=196.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|++..+++.||+|++..... ........+|+..+..+.+||||+++++++.+.+..++||||+.++.+..+
T Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 101 (289)
T 1x8b_A 22 GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADA 101 (289)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHH
T ss_pred CCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHH
Confidence 7899999999999999999999876533 345567788999999986799999999999999999999999987555555
Q ss_pred HHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--------------------CcEEEeecCcc
Q 044127 80 KERA---GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--------------------GVIKIGDLGMV 136 (282)
Q Consensus 80 ~~~~---~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--------------------~~~~l~df~~~ 136 (282)
+... ...+++..++.++.||+.||.+||++|++|+||||+||+++. ..++|+|||.+
T Consensus 102 l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 181 (289)
T 1x8b_A 102 ISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181 (289)
T ss_dssp HHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTC
T ss_pred HHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccc
Confidence 4432 246999999999999999999999999999999999999962 36999999999
Q ss_pred cccCCCCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccc
Q 044127 137 KEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLG 216 (282)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (282)
...... ....+++.|+|||.+.+...++.++|||||||++|+|++|..++.... ....+...
T Consensus 182 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~------------ 243 (289)
T 1x8b_A 182 TRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQG------------ 243 (289)
T ss_dssp EETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTT------------
T ss_pred cccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcC------------
Confidence 876543 334689999999999866556789999999999999999988765432 22221110
Q ss_pred ccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 217 IQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.....+..+++.+.++|.+||+.||.+|||++++++||||++..
T Consensus 244 -----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 244 -----------------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp -----------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred -----------------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 01223456789999999999999999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=319.09 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=201.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+|+.||+|++.... ......+.+|+..+.++ +||||+++++++.+....+++|||+.++.+...+
T Consensus 20 G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 97 (304)
T 2jam_A 20 GAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKI-KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI 97 (304)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred CCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhC-CCCCeeehhhhcccCCEEEEEEEcCCCccHHHHH
Confidence 899999999999999999999997643 22334567899999999 4999999999999999999999999865554444
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceee---e-CCcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV---S-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili---~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
... ..+++..+..++.||+.||.+||++|++|+||+|+||++ + ++.++|+|||++...... ......+++.|+|
T Consensus 98 ~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~a 175 (304)
T 2jam_A 98 LER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVA 175 (304)
T ss_dssp HHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCC
T ss_pred HHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccC
Confidence 433 369999999999999999999999999999999999999 3 478999999998754432 2234568999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+. .++.++||||||+++|+|++|..||......+....+........ .
T Consensus 176 PE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~--------------------------~ 228 (304)
T 2jam_A 176 PEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE--------------------------S 228 (304)
T ss_dssp TTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC--------------------------T
T ss_pred hHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC--------------------------c
Confidence 9998744 489999999999999999999999988776666555544221110 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
.....+++.+.+||.+||+.||.+|||++++++||||++....
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (304)
T 2jam_A 229 PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL 271 (304)
T ss_dssp TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCcc
Confidence 2234678999999999999999999999999999999876544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=319.94 Aligned_cols=249 Identities=25% Similarity=0.443 Sum_probs=200.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.|++|++.... ......+.+|+..+..+ +||||+++++++...+..++||||+.++++..+.
T Consensus 30 G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 107 (302)
T 2j7t_A 30 GAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM 107 (302)
T ss_dssp STTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHH
T ss_pred CCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHH
Confidence 899999999999999999999987643 23345677899999988 5999999999999999999999999987777776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCC-CCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE 158 (282)
......+++..+..++.||+.||.+||++|++|+||+|+||+++ ++.++|+|||++..... ........+++.|+|||
T Consensus 108 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE 187 (302)
T 2j7t_A 108 LELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187 (302)
T ss_dssp HHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHH
T ss_pred HhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCe
Confidence 66556799999999999999999999999999999999999998 58999999998753311 11123457889999999
Q ss_pred hhh----ccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 159 VLL----LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 159 ~~~----~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
.+. ....++.++||||||+++|+|++|..||...+.......+.......
T Consensus 188 ~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------- 241 (302)
T 2j7t_A 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-------------------------- 241 (302)
T ss_dssp HHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------------------------
T ss_pred eeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc--------------------------
Confidence 984 24457899999999999999999999998877666555443321100
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...+..++..+.++|.+||+.||.+|||++++++||||++...
T Consensus 242 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 242 -LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp -CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred -cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 0112356889999999999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=322.75 Aligned_cols=243 Identities=27% Similarity=0.438 Sum_probs=191.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCC------------------
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE------------------ 62 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~------------------ 62 (282)
|+||+||+|+++.+++.||+|++...........+.+|+.+++++ +||||+++++++.+..
T Consensus 17 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (332)
T 3qd2_B 17 GGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDEST 95 (332)
T ss_dssp C-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHHHHC--------
T ss_pred CCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhhhhhhhhccccc
Confidence 899999999999999999999998665555667788999999999 4999999999874432
Q ss_pred ---------------------------------------cEEEEEecCCccHHHHHHHhcC--CCCCHHHHHHHHHHHHH
Q 044127 63 ---------------------------------------DVFIVFEYMESDLLKLMKERAG--QNFSEDEVRNLCFQVFQ 101 (282)
Q Consensus 63 ---------------------------------------~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~ 101 (282)
..+++||||.++.+..++.... ...++..++.++.||+.
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~ 175 (332)
T 3qd2_B 96 DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE 175 (332)
T ss_dssp ------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHH
T ss_pred cccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHH
Confidence 3899999999877777766542 23566779999999999
Q ss_pred HHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCC-------------CCCCccccccccCchhhhccccCC
Q 044127 102 GLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL-------------PCTDYVTTRWYRAPEVLLLSEIYG 167 (282)
Q Consensus 102 ~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~-------------~~~~~~~~~~~~aPE~~~~~~~~~ 167 (282)
||.|||++|++|+||||+||+++ ++.++|+|||++....... ......+++.|+|||.+.+. .++
T Consensus 176 aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~ 254 (332)
T 3qd2_B 176 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN-NYS 254 (332)
T ss_dssp HHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCC-CCC
T ss_pred HHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCC-CCc
Confidence 99999999999999999999998 5899999999998765432 22345789999999999854 489
Q ss_pred CcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhH
Q 044127 168 PEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESI 247 (282)
Q Consensus 168 ~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (282)
.++|||||||++|+|++|..|+.. ............ .+......++.+.
T Consensus 255 ~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 255 HKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLK--------------------------FPLLFTQKYPQEH 303 (332)
T ss_dssp THHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTC--------------------------CCHHHHHHCHHHH
T ss_pred chhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccC--------------------------CCcccccCChhHH
Confidence 999999999999999998765421 111111111100 0011123467789
Q ss_pred HHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 248 SLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 248 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
+||++||+.||.+|||++++|+||||+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred HHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 99999999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=313.12 Aligned_cols=244 Identities=28% Similarity=0.430 Sum_probs=199.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeecccccc----CCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKE----HEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|.+..++..|++|++....... ....+.+|+.+++++ +||||+++++++.. ....++||||+.+++
T Consensus 37 G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~ 115 (290)
T 1t4h_A 37 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT 115 (290)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEECCCSCB
T ss_pred CCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCceEEEEEEecCCCC
Confidence 899999999999999999999988665443 345567888988888 59999999998754 466899999998766
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeee--CCcEEEeecCcccccCCCCCCCCcccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG--YFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~--~~H~dl~p~nili~--~~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
+..++... ..+++..++.++.||+.||.+||+.| ++|+||||+||+++ ++.++|+|||++...... ......++
T Consensus 116 L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t 193 (290)
T 1t4h_A 116 LKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGT 193 (290)
T ss_dssp HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSS
T ss_pred HHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc-ccccccCC
Confidence 66666554 46999999999999999999999999 99999999999997 479999999998755443 23445789
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
+.|+|||.+. +. ++.++||||||+++|+|++|..||.................
T Consensus 194 ~~y~aPE~~~-~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------------------------- 246 (290)
T 1t4h_A 194 PEFMAPEMYE-EK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV------------------------- 246 (290)
T ss_dssp CCCCCGGGGG-TC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-------------------------
T ss_pred cCcCCHHHHh-cc-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC-------------------------
Confidence 9999999876 33 79999999999999999999999988766655544322111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.....+...++.+.++|.+||+.||.+|||++++++||||++-
T Consensus 247 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 247 --KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp --CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred --CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 1112334567889999999999999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=335.25 Aligned_cols=250 Identities=30% Similarity=0.458 Sum_probs=192.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-------hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-------LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-------~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||+||+|.++.+++.||+|++...... .....+.+|+.+++++ +||||+++++++..+ ..++||||+.+
T Consensus 146 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~~~lv~e~~~~ 223 (419)
T 3i6u_A 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAE-DYYIVLELMEG 223 (419)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEESS-EEEEEEECCTT
T ss_pred CCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-ceEEEEEcCCC
Confidence 89999999999999999999998764321 1223467899999999 599999999998654 57899999987
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCCCCCcc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYV 149 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~~~~~~ 149 (282)
+.+...+... ..+++..++.++.||+.||.|||++|++|+||||+||+++. ..+||+|||++...+.........
T Consensus 224 g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~ 302 (419)
T 3i6u_A 224 GELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 302 (419)
T ss_dssp CBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC---------
T ss_pred CcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccC
Confidence 6665544433 47999999999999999999999999999999999999963 359999999998877665556678
Q ss_pred ccccccCchhhhc--cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 150 TTRWYRAPEVLLL--SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 150 ~~~~~~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
+++.|+|||.+.+ ...++.++|||||||++|+|++|..||..................
T Consensus 303 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~-------------------- 362 (419)
T 3i6u_A 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY-------------------- 362 (419)
T ss_dssp --CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC--------------------
T ss_pred CCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC--------------------
Confidence 9999999999853 344788999999999999999999999876544333332221110
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...+.....+++.+.+||++||+.||.+|||++++|+||||++...
T Consensus 363 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 408 (419)
T 3i6u_A 363 -----NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 408 (419)
T ss_dssp -----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHH
T ss_pred -----CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhH
Confidence 0111233467899999999999999999999999999999987643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=318.16 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=186.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+|+.||+|++............+.|...+.+..+||||+++++++.+++..++||||+++ ++..+.
T Consensus 36 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~~~l~ 114 (318)
T 2dyl_A 36 GTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGT-CAEKLK 114 (318)
T ss_dssp ----CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHH
T ss_pred cCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEeccCC-cHHHHH
Confidence 7899999999999999999999987654445555566666555555799999999999999999999999954 445555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
......+++..+..++.||+.||.+||++ |++|+||+|+||+++. +.++|+|||++.............+++.|+|||
T Consensus 115 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE 194 (318)
T 2dyl_A 115 KRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPE 194 (318)
T ss_dssp HHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHH
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChh
Confidence 54446799999999999999999999996 9999999999999975 799999999998765555455667899999999
Q ss_pred hhh----ccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 159 VLL----LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSAD-QIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 159 ~~~----~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
.+. ....++.++||||||+++|+|++|..||....... ....+..... +.
T Consensus 195 ~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~------------------------ 249 (318)
T 2dyl_A 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP-PL------------------------ 249 (318)
T ss_dssp HHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-CC------------------------
T ss_pred hcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-CC------------------------
Confidence 985 23447889999999999999999999998754433 3333322110 00
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
......+++.+.++|.+||+.||.+|||++++++||||++..
T Consensus 250 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 250 --LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp --CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred --CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 011235688999999999999999999999999999998653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=320.40 Aligned_cols=244 Identities=27% Similarity=0.421 Sum_probs=204.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|++..+++.|++|++...... .....+.+|+.+++.+ +||||+++++++.+.+..+++|||+.++.+..
T Consensus 52 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 130 (335)
T 2owb_A 52 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 130 (335)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCTTCBHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEecCCCCCHHH
Confidence 79999999999999999999998765432 3345667899989888 59999999999999999999999999766665
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~a 156 (282)
+.... ..+++..+..++.||+.||.+||++|++|+||||+||+++. +.++|+|||++...... .......+++.|+|
T Consensus 131 ~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~a 209 (335)
T 2owb_A 131 LHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 209 (335)
T ss_dssp HHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCC
T ss_pred HHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccC
Confidence 55544 47999999999999999999999999999999999999985 79999999999876432 22345678999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++||||||+++|+|++|..||......+....+.... .
T Consensus 210 PE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------------------------~ 258 (335)
T 2owb_A 210 PEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE------------------------------Y 258 (335)
T ss_dssp HHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC------------------------------C
T ss_pred HHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC------------------------------C
Confidence 99997544 7999999999999999999999998877665554443311 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
..+..+++.+.+||++||+.||.+|||++++++||||++..
T Consensus 259 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 259 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 12345688999999999999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=314.87 Aligned_cols=243 Identities=26% Similarity=0.433 Sum_probs=201.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.|++|++...... .....+.+|+..+.++. ||||+++++++.+.+..+++|||+.++.+..
T Consensus 25 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 103 (284)
T 2vgo_A 25 GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYK 103 (284)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEECCCTTEEHHH
T ss_pred CCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEEEEEEEeCCCCcHHH
Confidence 89999999999999999999998764322 12345678999998885 9999999999999999999999998655544
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++... ..+++..+..++.||+.||.+||++|++|+||+|+||+++ ++.++|+|||++...... ......+++.|+||
T Consensus 104 ~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aP 181 (284)
T 2vgo_A 104 ELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPP 181 (284)
T ss_dssp HHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCH
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-ccccccCCCCcCCH
Confidence 44443 3699999999999999999999999999999999999997 489999999998765432 23456789999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+. .++.++||||||+++|+|++|..||......+....+.... ..
T Consensus 182 E~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------------------------~~ 230 (284)
T 2vgo_A 182 EMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD------------------------------LK 230 (284)
T ss_dssp HHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC------------------------------CC
T ss_pred HHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc------------------------------cC
Confidence 998754 47999999999999999999999998876655544433210 01
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.+..++..+.++|.+||+.||.+|||++++++||||++..
T Consensus 231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 2345788999999999999999999999999999998754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=316.50 Aligned_cols=247 Identities=26% Similarity=0.467 Sum_probs=203.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc---chHHHHHHHHHHHHHHhCCCCCeeeecccc--ccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF---SLDESRNLKEVKCLRKMNNHPNIVKLRNLV--KEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~--~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.+..+++.|++|++..... ......+.+|+..++++. ||||+++++++ .+....++||||+.+++
T Consensus 16 G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l 94 (305)
T 2wtk_C 16 GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQKMYMVMEYCVCGM 94 (305)
T ss_dssp CSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---CEEEEEECCSEEH
T ss_pred CCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCCeEEEEehhccCCH
Confidence 8999999999999999999999976532 234566788999999985 99999999998 55668999999999997
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC---CCCCCcccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTT 151 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~---~~~~~~~~~ 151 (282)
.+.+.......+++..+..++.||+.||.+||++|++|+||||+||+++. +.++|+|||.+...... .......++
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 174 (305)
T 2wtk_C 95 QEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174 (305)
T ss_dssp HHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSC
T ss_pred HHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCC
Confidence 77766655567999999999999999999999999999999999999974 89999999999866432 222345689
Q ss_pred ccccCchhhhccc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 152 RWYRAPEVLLLSE-IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 152 ~~~~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
+.|+|||.+.+.. ..+.++||||||+++|+|++|..||......+....+....
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~------------------------- 229 (305)
T 2wtk_C 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS------------------------- 229 (305)
T ss_dssp GGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-------------------------
T ss_pred CCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-------------------------
Confidence 9999999987533 34779999999999999999999998876655554443311
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...+...++.+.++|.+||+.||.+|||++++++||||++...
T Consensus 230 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 230 -----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp -----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred -----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 0123457889999999999999999999999999999987654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=314.22 Aligned_cols=245 Identities=27% Similarity=0.421 Sum_probs=204.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.+..+++.|++|++...... .....+.+|+..++.+ +||||+++++++.+.+..+++|||+.++++..
T Consensus 26 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 104 (294)
T 2rku_A 26 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE 104 (294)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHH
T ss_pred cCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEEEEEecCCCCCHHH
Confidence 79999999999999999999998765432 2345667899999888 59999999999999999999999999766666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~a 156 (282)
+.... ..+++..+..++.||+.||.+||++|++|+||+|+||+++. +.++|+|||.+...... .......+++.|+|
T Consensus 105 ~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~a 183 (294)
T 2rku_A 105 LHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIA 183 (294)
T ss_dssp HHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCC
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCC
Confidence 55544 47999999999999999999999999999999999999985 79999999999876432 22344578999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||.+.+.. ++.++||||||+++|+|++|..||......+....+.... .
T Consensus 184 PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------------------~ 232 (294)
T 2rku_A 184 PEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE------------------------------Y 232 (294)
T ss_dssp HHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC------------------------------C
T ss_pred cchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc------------------------------C
Confidence 99987544 7999999999999999999999998876655544332210 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
..+...++.+.++|++||+.||++|||++++++||||++...
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 123457889999999999999999999999999999987543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=321.41 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=183.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.||+|++...........+.+|+..+.++ +||||+++++++...+..++||||+.++++..++
T Consensus 26 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 104 (303)
T 2vwi_A 26 GATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDII 104 (303)
T ss_dssp --CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHH
T ss_pred ccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCcEEEehhccCCchHHHH
Confidence 899999999999899999999997655444556677888888888 4999999999999999999999999876555554
Q ss_pred Hh-------cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC------CCC
Q 044127 81 ER-------AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL------PCT 146 (282)
Q Consensus 81 ~~-------~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~------~~~ 146 (282)
.. ....+++..+..++.||+.||.+||++|++|+||+|+||+++. +.++|+|||.+....... ...
T Consensus 105 ~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 184 (303)
T 2vwi_A 105 KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184 (303)
T ss_dssp HHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC------------
T ss_pred HHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhc
Confidence 42 2346999999999999999999999999999999999999974 899999999987654321 123
Q ss_pred CccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcc
Q 044127 147 DYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226 (282)
Q Consensus 147 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
...+++.|+|||.+.+...++.++||||||+++|+|++|..||.....................
T Consensus 185 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------- 248 (303)
T 2vwi_A 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE---------------- 248 (303)
T ss_dssp ---CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT----------------
T ss_pred ccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc----------------
Confidence 4568899999999875455899999999999999999999999887766655433221110000
Q ss_pred ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
...........++..+.++|.+||+.||.+|||++++++||||++....
T Consensus 249 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 249 ----TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp ----C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred ----cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 0011123345678999999999999999999999999999999986543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=321.44 Aligned_cols=272 Identities=27% Similarity=0.448 Sum_probs=208.2
Q ss_pred CCcceEEEEEe-cCCCcEEEEEEccccccchHHHHHHHHHHHHHHhC-----CCCCeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALD-KKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN-----NHPNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~-~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~-----~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|+||+||+|.+ ..+++.||+|++.... .......+|+.+++.+. .|++++++++++...+..++||||++++
T Consensus 25 G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (339)
T 1z57_A 25 GAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLS 102 (339)
T ss_dssp ETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECCCCB
T ss_pred CCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCCCCC
Confidence 78999999998 5678999999987542 33455667888777764 2345999999999999999999999888
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--------------------CcEEEeecC
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--------------------GVIKIGDLG 134 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--------------------~~~~l~df~ 134 (282)
+.+.+......++++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||
T Consensus 103 l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg 182 (339)
T 1z57_A 103 TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182 (339)
T ss_dssp HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCS
T ss_pred HHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCc
Confidence 888777665557999999999999999999999999999999999999963 469999999
Q ss_pred cccccCCCCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcc
Q 044127 135 MVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP 214 (282)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (282)
++....... ....+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+..+....+....+..+...+.
T Consensus 183 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~ 259 (339)
T 1z57_A 183 SATYDDEHH--STLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259 (339)
T ss_dssp SCEETTSCC--CSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccccCcccc--ccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 998755433 4567899999999998544 8999999999999999999999999988888777777666654432211
Q ss_pred cccccc----ccCCccccC----------CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 215 LGIQLA----SNLDWKFPQ----------MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 215 ~~~~~~----~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
...... ...+|.... .............++.+.+||++||+.||.+|||++|+++||||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp HCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred hccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 110000 000000000 000000111223467799999999999999999999999999999764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=315.67 Aligned_cols=244 Identities=23% Similarity=0.427 Sum_probs=206.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.|++|++...........+.+|+..+.++ +||||+++++++.+....++||||+.++++..+.
T Consensus 33 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 111 (303)
T 3a7i_A 33 GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL 111 (303)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHH
T ss_pred cCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHH
Confidence 899999999999999999999998765555567778899999998 5999999999999999999999999987777666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
.. .++++..+..++.||+.||.+||++|++|+||+|+||+++. +.++|+|||.+....... ......+++.|+|||
T Consensus 112 ~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE 189 (303)
T 3a7i_A 112 EP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 189 (303)
T ss_dssp TT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHH
T ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHH
Confidence 54 47999999999999999999999999999999999999975 799999999997764332 234557899999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+. .++.++||||||+++|+|++|..||...........+.... ....
T Consensus 190 ~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~ 239 (303)
T 3a7i_A 190 VIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-----------------------------PPTL 239 (303)
T ss_dssp HHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----------------------------CCCC
T ss_pred HHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-----------------------------CCCC
Confidence 98754 47899999999999999999999998776655544432211 0123
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
...++..+.++|.+||+.||.+|||++++++||||....
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 346788999999999999999999999999999996543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=316.12 Aligned_cols=246 Identities=26% Similarity=0.461 Sum_probs=201.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.+..+|+.|++|++.... ....+.+|+..+.++ +||||+++++++...+..++||||+.++++..++
T Consensus 40 G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 115 (314)
T 3com_A 40 GSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII 115 (314)
T ss_dssp ---CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHH
Confidence 789999999999999999999987643 234567899999998 5999999999999999999999999987777666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCC-CCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE 158 (282)
......+++..+..++.||+.||.+||+.|++|+||+|+||+++ ++.++|+|||.+....... ......+++.|+|||
T Consensus 116 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE 195 (314)
T 3com_A 116 RLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPE 195 (314)
T ss_dssp HHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHH
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChh
Confidence 65556899999999999999999999999999999999999997 4899999999997664432 234457899999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
.+.+.. ++.++||||||+++|+|++|..||...........+.... .. ....
T Consensus 196 ~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~-------------------------~~~~ 247 (314)
T 3com_A 196 VIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP--PP-------------------------TFRK 247 (314)
T ss_dssp HHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CC-------------------------CCSS
T ss_pred hcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--Cc-------------------------ccCC
Confidence 987544 8999999999999999999999998776555444332211 00 0011
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
+..++..+.++|.+||..||.+|||++++++||||++...
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 2346889999999999999999999999999999987653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=323.89 Aligned_cols=273 Identities=25% Similarity=0.415 Sum_probs=210.2
Q ss_pred CCcceEEEEEecCCC-cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCC------eeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSG-EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPN------IVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~-~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~------i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||+||+|++..++ ..||+|++... .........|+..++.+. |++ ++.+++++...+..++|||++++
T Consensus 30 G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (355)
T 2eu9_A 30 GTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIK-EKDKENKFLCVLMSDWFNFHGHMCIAFELLGK 106 (355)
T ss_dssp ETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHH-HHCTTSCSCBCCEEEEEEETTEEEEEEECCCC
T ss_pred cCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHh-hcCCCCceeEEEeeeeeeeCCeEEEEEeccCC
Confidence 789999999998776 68999998753 233455667888888775 444 89999999999999999999999
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceee-------------------e-CCcEEEeec
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-------------------S-KGVIKIGDL 133 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili-------------------~-~~~~~l~df 133 (282)
++++.+.......+++..++.++.||+.||.|||++|++|+||||+||++ + ++.++|+||
T Consensus 107 ~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 186 (355)
T 2eu9_A 107 NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186 (355)
T ss_dssp BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCC
T ss_pred ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeec
Confidence 99998887765679999999999999999999999999999999999999 3 468999999
Q ss_pred CcccccCCCCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCc
Q 044127 134 GMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (282)
|++....... ....+++.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+....+.++...+
T Consensus 187 g~~~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~ 263 (355)
T 2eu9_A 187 GSATFDHEHH--TTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMI 263 (355)
T ss_dssp TTCEETTSCC--CSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred Cccccccccc--cCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHh
Confidence 9998654433 4567899999999998544 899999999999999999999999998888877777777665543222
Q ss_pred ccccccccc----CCccccC----------CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCc
Q 044127 214 PLGIQLASN----LDWKFPQ----------MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFV 279 (282)
Q Consensus 214 ~~~~~~~~~----~~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 279 (282)
......... ..+.... .............+..+.+||++||+.||.+|||++++|+||||+++...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 264 HRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE 343 (355)
T ss_dssp HHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCHH
T ss_pred hhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCChh
Confidence 111000000 0000000 00000001112235578999999999999999999999999999987643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=311.35 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=198.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..++..|++|++.... ......+.+|+..+..+ +||||+++++++.+.+..+++||++.++++..++
T Consensus 33 G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 110 (295)
T 2clq_A 33 GTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL 110 (295)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHH
T ss_pred cCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHH
Confidence 899999999999999999999987653 33445667888988888 5999999999999999999999999876666666
Q ss_pred HhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee--CCcEEEeecCcccccCCCC-CCCCcccccccc
Q 044127 81 ERAG--QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYR 155 (282)
Q Consensus 81 ~~~~--~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~--~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~ 155 (282)
.... ..+++..++.++.||+.||.+||++|++|+||+|+||+++ ++.++|+|||.+....... ......+++.|+
T Consensus 111 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~ 190 (295)
T 2clq_A 111 RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM 190 (295)
T ss_dssp HHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGC
T ss_pred HhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCcccc
Confidence 5532 3467999999999999999999999999999999999998 4799999999988764322 224457899999
Q ss_pred Cchhhhcc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 156 APEVLLLS-EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 156 aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
|||.+.+. ..++.++||||||+++|+|++|..||..................
T Consensus 191 aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------------------- 243 (295)
T 2clq_A 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV--------------------------- 243 (295)
T ss_dssp CHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC---------------------------
T ss_pred ChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc---------------------------
Confidence 99998744 23688999999999999999999999765544433222111110
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
....+..+++.+.++|.+||+.||.+|||++++|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 1123456789999999999999999999999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=326.67 Aligned_cols=273 Identities=25% Similarity=0.361 Sum_probs=201.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.||+|++...........+.+|+.++.++ +||||+++++++.+++..++||||+.++++..++
T Consensus 44 G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 122 (360)
T 3eqc_A 44 GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122 (360)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHH
T ss_pred CCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHH
Confidence 899999999999999999999998765445556778899999888 5999999999999999999999999876666665
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
... ..+++..+..++.|++.||.+||++ |++|+||||+||+++ ++.++|+|||++...... ......+++.|+|||
T Consensus 123 ~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE 200 (360)
T 3eqc_A 123 KKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE 200 (360)
T ss_dssp HHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHH
T ss_pred HHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccCCCCCCCeECHH
Confidence 554 3699999999999999999999996 999999999999998 489999999998755322 123457899999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCC-ccccC--------
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD-WKFPQ-------- 229 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-------- 229 (282)
++.+. .++.++|||||||++|+|++|..||......+.................+.......... .....
T Consensus 201 ~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (360)
T 3eqc_A 201 RLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFE 279 (360)
T ss_dssp HHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHH
T ss_pred HHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchh
Confidence 99754 489999999999999999999999987765544332211111000000000000000000 00000
Q ss_pred -----CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 230 -----MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 230 -----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
............++..+.+||++||+.||.+|||++++|+||||++..
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 280 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp HHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred hhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 000011112234688999999999999999999999999999998754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=313.37 Aligned_cols=247 Identities=33% Similarity=0.519 Sum_probs=204.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH-HH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL-KL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l-~~ 78 (282)
|+||+||+|++..+++.|++|++...... .....+.+|+..++++ +||||+++++++.+....+++||++.++.+ +.
T Consensus 33 G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 111 (287)
T 2wei_A 33 GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDE 111 (287)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred CCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCeEEEEEEccCCCCHHHH
Confidence 78999999999999999999998765432 3455677899999999 599999999999999999999999976544 44
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCCCCCccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWY 154 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 154 (282)
+... ..+++..++.++.||+.||.+||++|++|+||+|+||+++. ..++|+|||++.............+++.|
T Consensus 112 l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y 189 (287)
T 2wei_A 112 IIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189 (287)
T ss_dssp HHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTT
T ss_pred HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccc
Confidence 4443 36999999999999999999999999999999999999963 36999999999877665555566789999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||.+.+ . ++.++||||||+++|+|++|..||......+....+........
T Consensus 190 ~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------- 242 (287)
T 2wei_A 190 IAPEVLRG-T-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD------------------------- 242 (287)
T ss_dssp CCHHHHTT-C-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------------------
T ss_pred cChHHhcC-C-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------
Confidence 99998863 3 79999999999999999999999988776665554443211110
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
......+++.+.++|++||+.||.+|||++++|+||||++...
T Consensus 243 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 243 -LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp -SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred -chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 0112356889999999999999999999999999999987643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=325.01 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=198.5
Q ss_pred CCcceEEEEEec---CCCcEEEEEEcccccc---chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDK---KSGEFVAVKKLKKKIF---SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~---~~~~~v~vK~~~~~~~---~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|+||+||+|++. .+++.||+|+++.... ........+|+.++..+.+||||+++++++......++||||+.++
T Consensus 65 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 144 (355)
T 1vzo_A 65 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 144 (355)
T ss_dssp TTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred CCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCC
Confidence 899999999984 4799999999876432 1233445678899999877999999999999999999999999876
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCcccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTT 151 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~ 151 (282)
.+..++... ..+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++....... ......++
T Consensus 145 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt 223 (355)
T 1vzo_A 145 ELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 223 (355)
T ss_dssp BHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSC
T ss_pred CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccC
Confidence 565555544 36999999999999999999999999999999999999975 799999999987653221 22345789
Q ss_pred ccccCchhhhcc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 152 RWYRAPEVLLLS-EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 152 ~~~~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
+.|+|||.+.+. ..++.++|||||||++|+|++|..||...........+.......
T Consensus 224 ~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------------- 281 (355)
T 1vzo_A 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---------------------- 281 (355)
T ss_dssp CTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC----------------------
T ss_pred cCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc----------------------
Confidence 999999999753 346899999999999999999999997654332222222211000
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
....+..++..+.+||++||+.||.+|| |++++++||||+++.+
T Consensus 282 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 282 ----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred ----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 0123346788999999999999999999 9999999999998653
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=316.61 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=182.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.++.+|+.||+|++..............|+..+.+..+||||+++++++..++..++||||+.+++.+.+.
T Consensus 33 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~ 112 (327)
T 3aln_A 33 GAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYK 112 (327)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHH
T ss_pred CCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCCChHHHHH
Confidence 89999999999999999999999876544555666777776666667999999999999999999999999997766554
Q ss_pred H---hcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccccccc
Q 044127 81 E---RAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 155 (282)
Q Consensus 81 ~---~~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 155 (282)
. .....+++..+..++.|++.||.+||+. |++|+||||+||+++. +.+||+|||++.............+++.|+
T Consensus 113 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~ 192 (327)
T 3aln_A 113 YVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYM 192 (327)
T ss_dssp HHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----------------
T ss_pred HHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCcccc
Confidence 3 2245799999999999999999999999 9999999999999985 899999999998776555445557899999
Q ss_pred Cchhhh---ccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 156 APEVLL---LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 156 aPE~~~---~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|||.+. .+..++.++||||||+++|+|++|..||.......... ..... ....
T Consensus 193 aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~------------------~~~~ 248 (327)
T 3aln_A 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL------TQVVK------------------GDPP 248 (327)
T ss_dssp -------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCC------------------SCCC
T ss_pred CceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH------HHHhc------------------CCCC
Confidence 999983 23447899999999999999999999997643211100 00000 0000
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.........+++.+.+||++||+.||.+|||++++++||||.+..
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 001112245789999999999999999999999999999997643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=318.73 Aligned_cols=249 Identities=30% Similarity=0.456 Sum_probs=195.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-------hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-------LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-------~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||.||+|++..+++.||+|++...... .....+.+|+.++.++ +||||+++++++..+. .++||||+.+
T Consensus 21 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~lv~e~~~~ 98 (322)
T 2ycf_A 21 GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEG 98 (322)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESSS-EEEEEECCTT
T ss_pred CCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCCc-eEEEEecCCC
Confidence 89999999999999999999998754321 1223467899999999 5999999999987665 8999999987
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C---cEEEeecCcccccCCCCCCCCcc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G---VIKIGDLGMVKEIDSSLPCTDYV 149 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~---~~~l~df~~~~~~~~~~~~~~~~ 149 (282)
+.+...+... ..+++..++.++.||+.||.+||++|++|+||||+||+++. + .++|+|||++.............
T Consensus 99 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 177 (322)
T 2ycf_A 99 GELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC 177 (322)
T ss_dssp EETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHH
T ss_pred CcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccccccccccc
Confidence 5555555443 47999999999999999999999999999999999999974 2 49999999998765543333456
Q ss_pred ccccccCchhhh--ccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 150 TTRWYRAPEVLL--LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 150 ~~~~~~aPE~~~--~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
+++.|+|||.+. ....++.++|||||||++|+|++|..||...................
T Consensus 178 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------- 238 (322)
T 2ycf_A 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN------------------- 238 (322)
T ss_dssp SCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC-------------------
T ss_pred CCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc-------------------
Confidence 899999999984 24457899999999999999999999998765443333222211100
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
..+......++.+.+||++||+.||.+|||++++|+||||++..
T Consensus 239 ------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 239 ------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp ------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred ------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 01122345789999999999999999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=315.58 Aligned_cols=247 Identities=23% Similarity=0.445 Sum_probs=195.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc------CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE------HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~------~~~~~lv~e~~~~~ 74 (282)
|+||.||+|++..+++.|++|++.... .....+.+|+..++++.+||||+++++++.. ....++||||+.++
T Consensus 35 G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 112 (326)
T 2x7f_A 35 GTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAG 112 (326)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTE
T ss_pred CCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCC
Confidence 789999999999999999999987543 3345667899999999779999999999875 46899999999875
Q ss_pred HHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCcccc
Q 044127 75 LLKLMKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTT 151 (282)
Q Consensus 75 ~l~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~ 151 (282)
.+..++.. .+..+++..++.++.||+.||.+||++|++|+||+|+||+++. +.++|+|||++....... ......++
T Consensus 113 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 192 (326)
T 2x7f_A 113 SVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192 (326)
T ss_dssp EHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CC
T ss_pred cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCC
Confidence 55555543 3357999999999999999999999999999999999999984 799999999988664332 22345789
Q ss_pred ccccCchhhhc----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 152 RWYRAPEVLLL----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 152 ~~~~aPE~~~~----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
+.|+|||.+.. ...++.++|||||||++|+|++|..||...........+..... +
T Consensus 193 ~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------------------- 252 (326)
T 2x7f_A 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-P------------------- 252 (326)
T ss_dssp GGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-------------------
T ss_pred ccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-c-------------------
Confidence 99999999862 34478999999999999999999999987766555443322110 0
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
......++..+.+||++||..||.+|||++++++||||++..
T Consensus 253 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 253 --------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp --------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred --------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 011345688999999999999999999999999999998764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=324.43 Aligned_cols=273 Identities=27% Similarity=0.433 Sum_probs=204.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhC----------CCCCeeeeccccccCC----cEEE
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN----------NHPNIVKLRNLVKEHE----DVFI 66 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~----------~hp~i~~~~~~~~~~~----~~~l 66 (282)
|+||+||+|++..+++.||+|++.... .......+|+..++++. .||||+++++++...+ ..++
T Consensus 30 G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 107 (373)
T 1q8y_A 30 GHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVM 107 (373)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEE
Confidence 899999999999999999999987542 23445567888777764 2899999999987544 7899
Q ss_pred EEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeeeC-------CcEEEeecCcccc
Q 044127 67 VFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVSK-------GVIKIGDLGMVKE 138 (282)
Q Consensus 67 v~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~~-------~~~~l~df~~~~~ 138 (282)
+||++++++.+.+.......+++..+..++.||+.||.+||++ |++|+||||+||+++. +.++|+|||++..
T Consensus 108 v~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~ 187 (373)
T 1q8y_A 108 VFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187 (373)
T ss_dssp EECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEE
T ss_pred EEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccc
Confidence 9999977777777665555799999999999999999999998 9999999999999952 3799999999987
Q ss_pred cCCCCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCC------ChHHHHHHHHHhCCCCCCC
Q 044127 139 IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKN------SADQIYKICQVIGSPTEDS 212 (282)
Q Consensus 139 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 212 (282)
..... ....+++.|+|||++.+.. ++.++|||||||++|+|++|..||.... ..+....+....+.++...
T Consensus 188 ~~~~~--~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 264 (373)
T 1q8y_A 188 YDEHY--TNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 264 (373)
T ss_dssp TTBCC--CSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHH
T ss_pred cCCCC--CCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHH
Confidence 65433 4557899999999998554 8999999999999999999999998654 3455666666666554322
Q ss_pred ccccccccccCCc-----cccCCCCC-------cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 213 WPLGIQLASNLDW-----KFPQMGGV-------NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 213 ~~~~~~~~~~~~~-----~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
+.........++. ........ .....+...++.+.+||.+||+.||.+|||++++|+||||++...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 265 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp HHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred HhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 2111100000000 00000000 001123345678999999999999999999999999999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=329.78 Aligned_cols=238 Identities=18% Similarity=0.237 Sum_probs=184.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhC--CCCCeeeec-------cccccCC-------
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMN--NHPNIVKLR-------NLVKEHE------- 62 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~--~hp~i~~~~-------~~~~~~~------- 62 (282)
|+||+||+|+++.+|+.||||++..... ......+.+|+.++..+. +||||++++ ++++..+
T Consensus 84 G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~ 163 (377)
T 3byv_A 84 EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 163 (377)
T ss_dssp ETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC
T ss_pred CCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCcccccc
Confidence 7999999999999999999999975422 234456678885555443 699999998 4444432
Q ss_pred ----------cEEEEEecCCccHHHHHHHhcCCCCC-------HHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-
Q 044127 63 ----------DVFIVFEYMESDLLKLMKERAGQNFS-------EDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS- 124 (282)
Q Consensus 63 ----------~~~lv~e~~~~~~l~~~~~~~~~~l~-------~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~- 124 (282)
..+++|||++|++.+.+.... .++ +..+..++.||+.||+|||++|++|+||||+||+++
T Consensus 164 ~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~ 241 (377)
T 3byv_A 164 RLDERDMWVLSRFFLYPRMQSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ 241 (377)
T ss_dssp ------CEEESEEEEEECCSEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred ccCCCceEEEEEEEEEeccCCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 388999999887776665432 244 488889999999999999999999999999999998
Q ss_pred CCcEEEeecCcccccCCCCCCCCccccccccCchhhhcc----------ccCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 044127 125 KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS----------EIYGPEVDMWAMGAIMFEMLSFRILFPGKNS 194 (282)
Q Consensus 125 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~ 194 (282)
++.+||+|||++...+.. .....| +.|+|||.+.+. ..++.++|||||||++|+|++|..||.....
T Consensus 242 ~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~ 318 (377)
T 3byv_A 242 RGGVFLTGFEHLVRDGAR--VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318 (377)
T ss_dssp TCCEEECCGGGCEETTCE--EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred CCCEEEEechhheecCCc--ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccccc
Confidence 489999999999865432 234566 899999999865 2589999999999999999999999965432
Q ss_pred hHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccc
Q 044127 195 ADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274 (282)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 274 (282)
...... .......+++.+.+||.+||+.||.+|||+.++++||||+
T Consensus 319 ~~~~~~----------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 364 (377)
T 3byv_A 319 LGGSEW----------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364 (377)
T ss_dssp -CCSGG----------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred ccchhh----------------------------------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence 211100 0011246789999999999999999999999999999998
Q ss_pred ccc
Q 044127 275 SCH 277 (282)
Q Consensus 275 ~~~ 277 (282)
++.
T Consensus 365 ~~~ 367 (377)
T 3byv_A 365 QLR 367 (377)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=324.93 Aligned_cols=254 Identities=17% Similarity=0.185 Sum_probs=180.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhC-CCCCeeeecc-------ccccC---------
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMN-NHPNIVKLRN-------LVKEH--------- 61 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~-~hp~i~~~~~-------~~~~~--------- 61 (282)
|+||+||+|++..+++.||+|++...... .....+.+|+..+..+. +||||++++. ++..+
T Consensus 73 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~ 152 (371)
T 3q60_A 73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLS 152 (371)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCS
T ss_pred CCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeecc
Confidence 89999999999999999999999876532 23344456655444443 5999887553 33222
Q ss_pred --------CcEEEEEecCCccHHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C
Q 044127 62 --------EDVFIVFEYMESDLLKLMKERAGQNFSEDEV------RNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G 126 (282)
Q Consensus 62 --------~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~------~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~ 126 (282)
...++|||||++++.+.+.... ..++...+ ..++.||+.||+|||++|++|+||||+||+++. +
T Consensus 153 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 231 (371)
T 3q60_A 153 PGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG 231 (371)
T ss_dssp CC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTS
T ss_pred CCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCC
Confidence 3489999999977776665542 34566666 678899999999999999999999999999985 7
Q ss_pred cEEEeecCcccccCCCCCCCCccccccccCchhhhcc-ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHh
Q 044127 127 VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS-EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVI 205 (282)
Q Consensus 127 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~ 205 (282)
.+||+|||++...+... ....+++.|+|||.+.+. ..++.++|||||||++|+|++|..||.........
T Consensus 232 ~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~------- 302 (371)
T 3q60_A 232 RLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG------- 302 (371)
T ss_dssp CEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT-------
T ss_pred CEEEEecceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc-------
Confidence 99999999998765432 245667999999999741 45899999999999999999999999876432100
Q ss_pred CCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 206 GSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
.+. ..... ..............+++.+.+||.+||+.||++|||++++|+||||+++..
T Consensus 303 ------~~~-------~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 303 ------SWK-------RPSLR-VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp ------CCC-------BCCTT-SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred ------chh-------hhhhh-hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 000 00000 000000011123467999999999999999999999999999999998654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=319.43 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=172.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc----CCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE----HEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|+++.+++.||+|++.... ....|+....+..+||||+++++++.. ....++||||+.++.+
T Consensus 40 G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L 113 (336)
T 3fhr_A 40 GVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL 113 (336)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEH
T ss_pred CCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCH
Confidence 899999999999999999999986531 223345555555579999999999875 5568999999987555
Q ss_pred HHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCCCCCcccc
Q 044127 77 KLMKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 77 ~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
..++.. .+..+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++....... .....++
T Consensus 114 ~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~t 192 (336)
T 3fhr_A 114 FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYT 192 (336)
T ss_dssp HHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------------
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc-cccCCCC
Confidence 555444 3457999999999999999999999999999999999999973 469999999998665332 2456779
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
+.|+|||.+.+. .++.++||||||+++|+|++|..||................... .
T Consensus 193 ~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------------------~ 249 (336)
T 3fhr_A 193 PYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG----------------------Q 249 (336)
T ss_dssp -----------C-HHHHHHHHHHHHHHHHHHHHSSCCC------------------------------------------
T ss_pred cCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc----------------------c
Confidence 999999998644 47899999999999999999999997665443322111110000 0
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
..........+++.+.+||++||+.||.+|||++++|+||||++....|
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 298 (336)
T 3fhr_A 250 YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence 0001112246789999999999999999999999999999999876554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=317.62 Aligned_cols=240 Identities=24% Similarity=0.396 Sum_probs=197.7
Q ss_pred CCcceEEEEEec-------CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDK-------KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~-------~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||+||+|++. .++..||+|+++..........+.+|+.+++++.+||||+++++++.+.+..++||||+.+
T Consensus 92 G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~ 171 (370)
T 2psq_A 92 GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 171 (370)
T ss_dssp CSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred CCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCC
Confidence 899999999875 3456799999987655555677889999999996799999999999999999999999987
Q ss_pred cHHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCccc
Q 044127 74 DLLKLMKERAG---------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVK 137 (282)
Q Consensus 74 ~~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~ 137 (282)
+.|..++.... ..+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++.
T Consensus 172 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 251 (370)
T 2psq_A 172 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251 (370)
T ss_dssp CBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCE
T ss_pred CCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCc
Confidence 66666655432 3589999999999999999999999999999999999997 4899999999998
Q ss_pred ccCCCC---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCc
Q 044127 138 EIDSSL---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 138 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (282)
...... ......+++.|+|||++.+. .++.++|||||||++|+|++ |..||......+....+.....
T Consensus 252 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------- 323 (370)
T 2psq_A 252 DINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR------- 323 (370)
T ss_dssp ETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-------
T ss_pred ccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-------
Confidence 664332 22334567889999999754 48999999999999999999 9999988776665544332111
Q ss_pred cccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+..++..+.++|.+||+.||.+|||+++++++
T Consensus 324 ----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 324 ----------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12334678899999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=318.14 Aligned_cols=241 Identities=24% Similarity=0.366 Sum_probs=198.0
Q ss_pred CCcceEEEEE-----ecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCC-cEEEEEecCCcc
Q 044127 1 GSYGDVFQAL-----DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE-DVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~-----~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-~~~lv~e~~~~~ 74 (282)
|+||.||+|+ +..+++.||+|+++..........+.+|+.++.++.+||||+++++++.+.+ ..+++||||.++
T Consensus 33 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g 112 (359)
T 3vhe_A 33 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 112 (359)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTE
T ss_pred CCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCC
Confidence 8999999998 5567799999999876555566778899999999988999999999987654 489999999986
Q ss_pred HHHHHHHhcCC-----------------------------------------------------------------CCCH
Q 044127 75 LLKLMKERAGQ-----------------------------------------------------------------NFSE 89 (282)
Q Consensus 75 ~l~~~~~~~~~-----------------------------------------------------------------~l~~ 89 (282)
++..++..... .+++
T Consensus 113 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 192 (359)
T 3vhe_A 113 NLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTL 192 (359)
T ss_dssp EHHHHHHTTTTSBCSCC------------------------------------------------------CTTTTCBCH
T ss_pred cHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCH
Confidence 66666554321 2899
Q ss_pred HHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCC---CCCCccccccccCchhhhcccc
Q 044127 90 DEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL---PCTDYVTTRWYRAPEVLLLSEI 165 (282)
Q Consensus 90 ~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~ 165 (282)
..++.++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++....... ......+++.|+|||++.+..
T Consensus 193 ~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~- 271 (359)
T 3vhe_A 193 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV- 271 (359)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCC-
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCC-
Confidence 99999999999999999999999999999999997 4899999999998653322 123456788899999998544
Q ss_pred CCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCCh
Q 044127 166 YGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASR 244 (282)
Q Consensus 166 ~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (282)
++.++||||||+++|+|++ |..||.+....+............ ..+...++
T Consensus 272 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~ 323 (359)
T 3vhe_A 272 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM----------------------------RAPDYTTP 323 (359)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC----------------------------CCCTTCCH
T ss_pred CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC----------------------------CCCCCCCH
Confidence 8999999999999999998 999998887666555544432211 22345788
Q ss_pred hhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 245 ESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 245 ~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
.+.++|.+||+.||.+|||++++++|
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHH
Confidence 99999999999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=317.04 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=195.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCc----EEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHED----VFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~----~~lv~e~~~~~ 74 (282)
|+||+||+|++..+++.||+|++....... ....+.+|+..+.++ +||||+++++++..... .++||||+.++
T Consensus 23 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~ 101 (311)
T 3ork_A 23 GGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGV 101 (311)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEEEEEEEEECCCEE
T ss_pred CCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCcccEEEEecCCCC
Confidence 899999999999999999999997654322 234566788888888 59999999999875543 49999999876
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC----CCCCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL----PCTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~----~~~~~~ 149 (282)
.+..++... ..+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++....... ......
T Consensus 102 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 180 (311)
T 3ork_A 102 TLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180 (311)
T ss_dssp EHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----------------
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccC
Confidence 666666554 36999999999999999999999999999999999999974 899999999998664332 122346
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
+++.|+|||.+.+. .++.++||||||+++|+|++|..||......+...........+
T Consensus 181 gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------------- 238 (311)
T 3ork_A 181 GTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--------------------- 238 (311)
T ss_dssp -CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---------------------
T ss_pred cCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC---------------------
Confidence 89999999999854 48999999999999999999999998887766655544421111
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
.......+++.+.++|.+||+.||.+||++.+++.|+|++....
T Consensus 239 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 239 -----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp -----HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred -----cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 11223467899999999999999999999999999999975443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=314.50 Aligned_cols=238 Identities=24% Similarity=0.357 Sum_probs=196.9
Q ss_pred CCcceEEEEEecCCCc---EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|++..+++ .||+|++...........+.+|+.++.++. ||||+++++++.+++..++||||+.++++.
T Consensus 60 G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 138 (325)
T 3kul_A 60 GDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138 (325)
T ss_dssp TTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGGCCEEEEECCTTCBHH
T ss_pred CCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCccEEEeeCCCCCcHH
Confidence 8999999999986554 599999987655556677889999999995 999999999999999999999999887777
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC----CCCccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP----CTDYVTTR 152 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~----~~~~~~~~ 152 (282)
.++......+++..+..++.||+.||.+||++|++|+||||+||+++. +.++|+|||++........ .....+++
T Consensus 139 ~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~ 218 (325)
T 3kul_A 139 TFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218 (325)
T ss_dssp HHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCG
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcc
Confidence 777655567999999999999999999999999999999999999985 7999999999987644321 12234566
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+......
T Consensus 219 ~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------------------ 273 (325)
T 3kul_A 219 RWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL------------------------ 273 (325)
T ss_dssp GGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC------------------------
T ss_pred cccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC------------------------
Confidence 899999997544 8999999999999999999 99999888777666555432111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+..+++.+.++|.+||+.||.+|||++++++
T Consensus 274 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 274 -----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 123467899999999999999999999999885
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=309.47 Aligned_cols=246 Identities=29% Similarity=0.438 Sum_probs=189.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc-------------CCcEEEE
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE-------------HEDVFIV 67 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-------------~~~~~lv 67 (282)
|+||+||+|++..+++.|++|++... ......+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 17 G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv 93 (303)
T 1zy4_A 17 GAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQ 93 (303)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC------CEEEEEEE
T ss_pred CCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcccccCCceEEE
Confidence 89999999999999999999998653 23455677899999888 49999999998743 4678999
Q ss_pred EecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC----
Q 044127 68 FEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---- 142 (282)
Q Consensus 68 ~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~---- 142 (282)
|||+.++.+..++...+..+++..++.++.||+.||.+||++|++|+||||+||+++. +.++|+|||.+......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 173 (303)
T 1zy4_A 94 MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173 (303)
T ss_dssp EECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-----
T ss_pred EecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchh
Confidence 9999876666666655567899999999999999999999999999999999999974 78999999998765422
Q ss_pred -----------CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCC
Q 044127 143 -----------LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTED 211 (282)
Q Consensus 143 -----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (282)
.......+++.|+|||.+.+...++.++|||||||++|+|++ ||......... ........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~---~~~~~~~~-- 245 (303)
T 1zy4_A 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI---LKKLRSVS-- 245 (303)
T ss_dssp --------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH---HHHHHSTT--
T ss_pred ccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH---HHhccccc--
Confidence 122345688999999999765568999999999999999998 44322211111 11111100
Q ss_pred CccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 212 SWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
. ......+...+..+.++|++||+.||.+|||++++++||||+...
T Consensus 246 -------------~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 246 -------------I-------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp -------------C-------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred -------------c-------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 0 001123445678899999999999999999999999999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=310.77 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=191.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|++ ++..||+|++....... ....+.+|+.+++++. ||||+++++++.+.+..++||||+.++++..+
T Consensus 48 G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 124 (309)
T 3p86_A 48 GSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRL 124 (309)
T ss_dssp CSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSTTCCEEEEECCTTCBHHHH
T ss_pred CCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCceEEEEecCCCCcHHHH
Confidence 89999999976 58889999987665433 3456788999999995 99999999999999999999999998666666
Q ss_pred HHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCcccccc
Q 044127 80 KERAG--QNFSEDEVRNLCFQVFQGLHYMHRQG--YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRW 153 (282)
Q Consensus 80 ~~~~~--~~l~~~~~~~i~~qi~~~l~~Lh~~~--~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~ 153 (282)
+...+ ..+++..+..++.||+.||.+||++| ++|+||||+||+++. +.++|+|||++....... ......+++.
T Consensus 125 l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~ 204 (309)
T 3p86_A 125 LHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPE 204 (309)
T ss_dssp HHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCT
T ss_pred HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCcc
Confidence 65432 13999999999999999999999999 999999999999985 699999999987554332 2345678999
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
|+|||.+.+.. ++.++||||||+++|+|++|..||......+....+......
T Consensus 205 y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~-------------------------- 257 (309)
T 3p86_A 205 WMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-------------------------- 257 (309)
T ss_dssp TSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC--------------------------
T ss_pred ccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC--------------------------
Confidence 99999998554 799999999999999999999999988766655544321111
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc--CcccccccCcc
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALE--HPFFRSCHFVP 280 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--~~~~~~~~~~~ 280 (282)
...+..+++.+.++|++||+.||.+|||++++++ .+++++....|
T Consensus 258 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 258 --LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred --CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 1234567899999999999999999999999987 57776654433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=318.48 Aligned_cols=242 Identities=23% Similarity=0.348 Sum_probs=196.9
Q ss_pred CCcceEEEEE-----ecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQAL-----DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~-----~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|+ +..+++.||+|++...........+.+|+.++.++ +||||+++++++.+....++|||||.++.
T Consensus 82 G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~g~ 160 (367)
T 3l9p_A 82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGD 160 (367)
T ss_dssp CSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTEE
T ss_pred CCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCEEEEEeCCCCC
Confidence 8999999999 45578899999997665556666788899999999 59999999999999999999999998755
Q ss_pred HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccC---CC
Q 044127 76 LKLMKERAG------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEID---SS 142 (282)
Q Consensus 76 l~~~~~~~~------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~---~~ 142 (282)
|..++.... ..+++..++.++.||+.||.|||++|++||||||+||+++. ..+||+|||++.... ..
T Consensus 161 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~ 240 (367)
T 3l9p_A 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240 (367)
T ss_dssp HHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSC
T ss_pred HHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccccccccccc
Confidence 555554432 35999999999999999999999999999999999999973 359999999987542 22
Q ss_pred CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 143 LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 143 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
.......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+.....
T Consensus 241 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~--------------- 304 (367)
T 3l9p_A 241 RKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--------------- 304 (367)
T ss_dssp TTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC---------------
T ss_pred ccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 2234456788999999997554 8999999999999999998 9999988776665554433211
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
...+..++..+.+||.+||+.||.+|||+++++++.++
T Consensus 305 --------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 305 --------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11234678899999999999999999999999988665
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=307.03 Aligned_cols=247 Identities=21% Similarity=0.361 Sum_probs=193.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCC-CCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNN-HPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|++. +++.||+|++...... .....+.+|+..+.++.+ ||||+++++++.+....+++||+.++++.+.
T Consensus 39 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~ 117 (313)
T 3cek_A 39 GGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSW 117 (313)
T ss_dssp CSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECCCSEEHHHH
T ss_pred CCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEecCCCcHHHH
Confidence 899999999986 4888999998765433 344567789999999974 7999999999999999999999766766666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccccCCCCC---CCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLP---CTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~ 155 (282)
+... ..+++..+..++.||+.||.+||++|++|+||||+||+++++.++|+|||++........ .....+++.|+
T Consensus 118 l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 195 (313)
T 3cek_A 118 LKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195 (313)
T ss_dssp HHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEECCCSSSCC--------------CCGGGC
T ss_pred HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEEeeccccccccCccccccccCCCCCCCcC
Confidence 5543 479999999999999999999999999999999999999999999999999987643322 23456899999
Q ss_pred Cchhhhcc----------ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc
Q 044127 156 APEVLLLS----------EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225 (282)
Q Consensus 156 aPE~~~~~----------~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
|||.+.+. ..++.++||||||+++|+|++|..||.......... ........
T Consensus 196 aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~---------------- 257 (313)
T 3cek_A 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL--HAIIDPNH---------------- 257 (313)
T ss_dssp CHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH--HHHHCTTS----------------
T ss_pred CHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH--HHHHhccc----------------
Confidence 99998641 347889999999999999999999997665433221 11111100
Q ss_pred cccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
....+...+..+.++|.+||+.||.+|||++++++||||+...
T Consensus 258 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 258 ---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp ---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred ---------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 0112334578899999999999999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=306.53 Aligned_cols=247 Identities=27% Similarity=0.462 Sum_probs=199.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeecccc--ccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLV--KEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~--~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|+++.+++.|++|++....... ....+.+|+..++++ +||||+++++++ ..+...++||||+.++.+.
T Consensus 17 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 95 (279)
T 2w5a_A 17 GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLA 95 (279)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHH
T ss_pred CCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEEEEEeCCCCCCHH
Confidence 899999999999999999999997654433 445677899999999 499999999987 4567899999999875555
Q ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-CCC
Q 044127 78 LMKERA---GQNFSEDEVRNLCFQVFQGLHYMHRQG-----YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-CTD 147 (282)
Q Consensus 78 ~~~~~~---~~~l~~~~~~~i~~qi~~~l~~Lh~~~-----~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-~~~ 147 (282)
.++... ...+++..++.++.||+.||.+||++| ++|+||+|+||+++. +.++|+|||.+........ ...
T Consensus 96 ~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (279)
T 2w5a_A 96 SVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT 175 (279)
T ss_dssp HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHH
T ss_pred HHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccc
Confidence 444332 235999999999999999999999999 999999999999985 7899999999876644321 123
Q ss_pred ccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 148 YVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 148 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
..+++.|+|||.+.+. .++.++||||||+++|+|++|..||......+....+.....
T Consensus 176 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~--------------------- 233 (279)
T 2w5a_A 176 FVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF--------------------- 233 (279)
T ss_dssp HHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---------------------
T ss_pred cCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc---------------------
Confidence 4678899999998754 478999999999999999999999988776555544433211
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...+..+++.+.++|.+||+.||.+|||++++++|+|+.+...
T Consensus 234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 234 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred --------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 1223467899999999999999999999999999999987654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=313.77 Aligned_cols=239 Identities=26% Similarity=0.469 Sum_probs=197.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-----HHHHHHHHHHHHHHhC-CCCCeeeeccccccCCcEEEEEecCC--
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-----DESRNLKEVKCLRKMN-NHPNIVKLRNLVKEHEDVFIVFEYME-- 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-----~~~~~~~e~~~l~~~~-~hp~i~~~~~~~~~~~~~~lv~e~~~-- 72 (282)
|+||+||+|++..+++.||+|++....... ....+..|+.+++++. .||||+++++++..++..++++|++.
T Consensus 54 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 133 (320)
T 3a99_A 54 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 133 (320)
T ss_dssp SSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSE
T ss_pred CCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCC
Confidence 899999999999999999999997654332 2244567889999987 37999999999999999999999997
Q ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-C-CcEEEeecCcccccCCCCCCCCccc
Q 044127 73 SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-K-GVIKIGDLGMVKEIDSSLPCTDYVT 150 (282)
Q Consensus 73 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~-~~~~l~df~~~~~~~~~~~~~~~~~ 150 (282)
+++.+.+... ..+++..++.++.||+.||.+||++|++|+||||+||+++ + +.++|+|||++...... ......+
T Consensus 134 ~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~g 210 (320)
T 3a99_A 134 QDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDG 210 (320)
T ss_dssp EEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCS
T ss_pred ccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-cccCCCC
Confidence 4555444443 4799999999999999999999999999999999999998 3 79999999998876543 2345678
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
++.|+|||.+.+....+.++||||||+++|+|++|..||.... .... ..
T Consensus 211 t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~--~~----------------------- 259 (320)
T 3a99_A 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--GQ----------------------- 259 (320)
T ss_dssp CGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--CC-----------------------
T ss_pred CccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhc--cc-----------------------
Confidence 9999999999866655788999999999999999999996531 1111 00
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
......+++.+.+||++||+.||.+|||++++++||||++...
T Consensus 260 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 260 -----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp -----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred -----ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 0123457899999999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=315.18 Aligned_cols=240 Identities=24% Similarity=0.391 Sum_probs=198.4
Q ss_pred CCcceEEEEEecCC-------CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKS-------GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||+||+|++..+ +..||+|++...........+.+|+.++.++.+||||+++++++.+.+..++||||+.+
T Consensus 80 G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~ 159 (382)
T 3tt0_A 80 GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 159 (382)
T ss_dssp CSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred CCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCC
Confidence 89999999997543 35799999987655556677889999999997799999999999999999999999987
Q ss_pred cHHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccc
Q 044127 74 DLLKLMKERAG---------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK 137 (282)
Q Consensus 74 ~~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~ 137 (282)
++|..++.... ..+++..++.++.||+.||.+||++|++|+||||+||++++ +.+||+|||++.
T Consensus 160 g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 239 (382)
T 3tt0_A 160 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239 (382)
T ss_dssp CBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCC
T ss_pred CcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCccc
Confidence 66666655432 35999999999999999999999999999999999999984 899999999998
Q ss_pred ccCCCC---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCc
Q 044127 138 EIDSSL---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 138 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (282)
...... ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||......+....+.....
T Consensus 240 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------- 311 (382)
T 3tt0_A 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR------- 311 (382)
T ss_dssp CSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-------
T ss_pred ccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 764432 22344567889999999854 48999999999999999999 9999988776655544332211
Q ss_pred cccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+..+++.+.++|++||+.||++|||+++++++
T Consensus 312 ----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 312 ----------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp ----------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12234678999999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=318.04 Aligned_cols=263 Identities=20% Similarity=0.341 Sum_probs=202.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH----------------HHHHHHHHHHHHHhCCCCCeeeeccccccCCcE
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD----------------ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDV 64 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~----------------~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 64 (282)
|+||.||+|++ +++.||+|++........ ...+.+|+.++.++. ||||+++++++.+.+..
T Consensus 42 G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~ 118 (348)
T 2pml_X 42 GKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-NEYCLTCEGIITNYDEV 118 (348)
T ss_dssp CSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-CTTBCCCSEEEESSSEE
T ss_pred CCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-CCCcceEEEEEeeCCeE
Confidence 89999999998 899999999876543221 166788999999995 99999999999999999
Q ss_pred EEEEecCCccHHHHH------HHh-cCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeC-CcEEEeecCc
Q 044127 65 FIVFEYMESDLLKLM------KER-AGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSK-GVIKIGDLGM 135 (282)
Q Consensus 65 ~lv~e~~~~~~l~~~------~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~-~~~~l~df~~ 135 (282)
++||||+.++.+..+ +.. ....+++..++.++.||+.||.+||+ .|++|+||+|+||+++. +.++|+|||.
T Consensus 119 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 198 (348)
T 2pml_X 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE 198 (348)
T ss_dssp EEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEecccc
Confidence 999999998666554 322 24579999999999999999999999 99999999999999974 7999999999
Q ss_pred ccccCCCCCCCCccccccccCchhhhccccCCC-cchhHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHHhCCCCCCCc
Q 044127 136 VKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGP-EVDMWAMGAIMFEMLSFRILFPGKNS-ADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~DiwslG~ll~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 213 (282)
+...... ......+++.|+|||.+.+...++. ++||||||+++|+|++|..||..... .+....+... ....+...
T Consensus 199 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~-~~~~~~~~ 276 (348)
T 2pml_X 199 SEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK-NIEYPLDR 276 (348)
T ss_dssp CEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC-CCCCCCSS
T ss_pred ccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc-CcCCccch
Confidence 9876443 3355678999999999986634555 99999999999999999999998777 4433333221 11000000
Q ss_pred cccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
..................+++.+.+||.+||+.||.+|||++++++||||++...
T Consensus 277 ----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 277 ----------NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp ----------SSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred ----------hhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 0000011111112233567999999999999999999999999999999998654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=308.84 Aligned_cols=239 Identities=21% Similarity=0.380 Sum_probs=193.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|.+..+++.||+|++.... ......+.+|+.++.++. ||||+++++++.+++..++||||+.++++..++
T Consensus 21 G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 98 (310)
T 3s95_A 21 GCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII 98 (310)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred CCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEEEEEecCCCcHHHHH
Confidence 899999999999999999999875432 345566788999999995 999999999999999999999999987777777
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC--------------
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC-------------- 145 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~-------------- 145 (282)
......+++..+..++.||+.||.|||++|++|+||||+||++++ +.++|+|||++.........
T Consensus 99 ~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (310)
T 3s95_A 99 KSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178 (310)
T ss_dssp HHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------------------
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccccccccccc
Confidence 776668999999999999999999999999999999999999985 78999999999866433221
Q ss_pred -CCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCC
Q 044127 146 -TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224 (282)
Q Consensus 146 -~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
....|++.|+|||.+.+. .++.++||||||+++|+|++|..||........... .
T Consensus 179 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~------------~----------- 234 (310)
T 3s95_A 179 RYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG------------L----------- 234 (310)
T ss_dssp -CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS------------B-----------
T ss_pred ccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh------------h-----------
Confidence 145789999999999754 489999999999999999999998865432111000 0
Q ss_pred ccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
. .........+..+++.+.+++.+||+.||.+|||++++++
T Consensus 235 -~---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 235 -N---VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp -C---HHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -h---hhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 0000001224567889999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=302.50 Aligned_cols=236 Identities=25% Similarity=0.438 Sum_probs=196.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++.. ++.||+|++...... ...+.+|+..++++. ||||+++++++.+.+..++||||+.++++..++
T Consensus 21 G~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 96 (269)
T 4hcu_A 21 GQFGLVHLGYWLN-KDKVAIKTIREGAMS--EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL 96 (269)
T ss_dssp CSSCEEEEEEETT-TEEEEEEEECTTSBC--HHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred CCccEEEEEEecC-CCeEEEEEecccccC--HHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEEEEEeCCCCcHHHHH
Confidence 8999999999874 777999999865433 345778999999995 999999999999999999999999987777777
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aP 157 (282)
......+++..++.++.|++.||.+||++|++|+||||+||+++. +.++|+|||++....... ......+++.|+||
T Consensus 97 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP 176 (269)
T 4hcu_A 97 RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 176 (269)
T ss_dssp HTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCH
T ss_pred HhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCH
Confidence 665567999999999999999999999999999999999999975 789999999987654321 22334567789999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.+.. ++.++||||||+++|+|++ |..||......+....+......
T Consensus 177 E~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------- 226 (269)
T 4hcu_A 177 EVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------------------------- 226 (269)
T ss_dssp HHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-----------------------------
T ss_pred HHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC-----------------------------
Confidence 9987544 8999999999999999999 99999987776666554332111
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++.+.+++.+||+.||.+|||+++++++
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1233568899999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=319.85 Aligned_cols=238 Identities=22% Similarity=0.387 Sum_probs=195.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+++.||+|+++..........+.+|+.+++++ +||||+++++++...+..++||||+.++.+..++
T Consensus 125 G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l 203 (377)
T 3cbl_A 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL 203 (377)
T ss_dssp ETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred CCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHH
Confidence 799999999999999999999997654444556778899999998 4999999999999999999999999866565555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---CCCccccccccC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~a 156 (282)
...+..+++..+..++.||+.||.|||++|++|+||||+||++++ +.+||+|||++........ .....++..|+|
T Consensus 204 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~a 283 (377)
T 3cbl_A 204 RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA 283 (377)
T ss_dssp HHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSC
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCC
Confidence 554457999999999999999999999999999999999999984 8999999999876433211 112235677999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+..+. ++.++|||||||++|||++ |..||......+....+.....
T Consensus 284 PE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------- 333 (377)
T 3cbl_A 284 PEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR----------------------------- 333 (377)
T ss_dssp HHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-----------------------------
T ss_pred HhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------------------------
Confidence 99997554 7999999999999999998 9999988766554443322111
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...++.+.++|.+||+.||.+|||++++++
T Consensus 334 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1123457889999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=306.11 Aligned_cols=241 Identities=24% Similarity=0.369 Sum_probs=198.9
Q ss_pred CCcceEEEEEe-----cCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALD-----KKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~-----~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|++ ..+++.||+|++...........+.+|+.++.++.+||||+++++++.+++..++||||+.++.
T Consensus 34 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 113 (313)
T 1t46_A 34 GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113 (313)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEE
T ss_pred cCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCC
Confidence 89999999984 4578899999998765445567788999999999679999999999999999999999998755
Q ss_pred HHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccc
Q 044127 76 LKLMKERAGQ-----------------NFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK 137 (282)
Q Consensus 76 l~~~~~~~~~-----------------~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~ 137 (282)
+..++..... .+++..++.++.||+.||.+||++|++|+||||+||+++. +.++|+|||++.
T Consensus 114 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 193 (313)
T 1t46_A 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193 (313)
T ss_dssp HHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGS
T ss_pred HHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccc
Confidence 5555554322 4899999999999999999999999999999999999985 799999999998
Q ss_pred ccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCc
Q 044127 138 EIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 138 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (282)
....... .....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...................
T Consensus 194 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----- 267 (313)
T 1t46_A 194 DIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM----- 267 (313)
T ss_dssp CTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC-----
T ss_pred cccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC-----
Confidence 7654432 2234567789999998754 48999999999999999999 999998887766665554432111
Q ss_pred cccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++.+.++|.+||+.||.+|||+++++++
T Consensus 268 -----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 268 -----------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 1123568899999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=310.77 Aligned_cols=241 Identities=24% Similarity=0.366 Sum_probs=194.1
Q ss_pred CCcceEEEEEec-----CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDK-----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|++. .++..||+|++...........+.+|+.++.++.+||||+++++++...+..++||||+.++.
T Consensus 56 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 135 (344)
T 1rjb_A 56 GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 135 (344)
T ss_dssp CSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred CCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCc
Confidence 899999999973 457789999998655445566778999999999679999999999999999999999998766
Q ss_pred HHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEee
Q 044127 76 LKLMKERAGQ----------------------NFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGD 132 (282)
Q Consensus 76 l~~~~~~~~~----------------------~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~d 132 (282)
+..++..... .+++..+..++.||+.||.+||++|++|+||||+||+++. +.++|+|
T Consensus 136 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~D 215 (344)
T 1rjb_A 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 215 (344)
T ss_dssp HHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECC
T ss_pred HHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCC
Confidence 6655554322 3799999999999999999999999999999999999985 7999999
Q ss_pred cCcccccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCC
Q 044127 133 LGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSP 208 (282)
Q Consensus 133 f~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~ 208 (282)
||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||..................+
T Consensus 216 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 294 (344)
T 1rjb_A 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM 294 (344)
T ss_dssp CGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC
T ss_pred CccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC
Confidence 999986643322 22345677899999987544 8999999999999999998 999998887666555544421111
Q ss_pred CCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 209 TEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++.+.++|.+||+.||.+|||+++++++
T Consensus 295 ----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 295 ----------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 1234568999999999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=304.70 Aligned_cols=244 Identities=23% Similarity=0.295 Sum_probs=191.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++...... .....+.+|+..+.++ +||||+++++++.+++..++||||+.++++..
T Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~ 100 (294)
T 4eqm_A 22 GGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSE 100 (294)
T ss_dssp ETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred CCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeCCeEEEEEeCCCCCCHHH
Confidence 79999999999999999999998654332 2345667899988888 49999999999999999999999998866666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~ 155 (282)
++... .++++..+..++.||+.||.+||++|++|+||||+||+++. +.++|+|||++....... ......+++.|+
T Consensus 101 ~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~ 179 (294)
T 4eqm_A 101 YIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179 (294)
T ss_dssp HHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSC
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCcccc
Confidence 66554 36999999999999999999999999999999999999974 799999999998664332 223456899999
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||.+.+.. ++.++||||||+++|+|++|..||.+....+........ ..+ ...
T Consensus 180 aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~---~~~----------------------~~~ 233 (294)
T 4eqm_A 180 SPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD---SVP----------------------NVT 233 (294)
T ss_dssp CHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS---CCC----------------------CHH
T ss_pred CHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc---cCC----------------------Ccc
Confidence 999998544 799999999999999999999999887765544333221 000 011
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 272 (282)
......+++.+.++|.+||+.||.+||+..+.+.+.|
T Consensus 234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 2344568999999999999999999995444444443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=309.19 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=180.2
Q ss_pred CCcceEEEEEecCCCc---EEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcE------EEEEec
Q 044127 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDV------FIVFEY 70 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~---~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~------~lv~e~ 70 (282)
|+||+||+|++..++. .||+|++..... ......+.+|+..++++ +||||+++++++...... +++|||
T Consensus 34 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~ 112 (323)
T 3qup_A 34 GEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPF 112 (323)
T ss_dssp ETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-------CEEEEEEC
T ss_pred cCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccccccCCCccEEEEEe
Confidence 8999999999887765 799999976542 34556778899999999 599999999998776554 999999
Q ss_pred CCccHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC
Q 044127 71 MESDLLKLMKERA-----GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP 144 (282)
Q Consensus 71 ~~~~~l~~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~ 144 (282)
+.++.+..++... ...+++..++.++.||+.||.|||++|++|+||||+||++++ +.++|+|||++........
T Consensus 113 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~ 192 (323)
T 3qup_A 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192 (323)
T ss_dssp CTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecccccccccccc
Confidence 9976665554322 125999999999999999999999999999999999999985 7999999999986543321
Q ss_pred ---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccc
Q 044127 145 ---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA 220 (282)
Q Consensus 145 ---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
.....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+.....
T Consensus 193 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-------------- 257 (323)
T 3qup_A 193 YRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR-------------- 257 (323)
T ss_dssp --------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--------------
T ss_pred ccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC--------------
Confidence 22345577899999987544 8999999999999999999 8999998877776655443211
Q ss_pred ccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCC-------HHHHhcCcccccccCcc
Q 044127 221 SNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPT-------AAEALEHPFFRSCHFVP 280 (282)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-------~~~ll~~~~~~~~~~~~ 280 (282)
...+...++.+.++|.+||+.||.+||| ++++++|+|+.+....|
T Consensus 258 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p 309 (323)
T 3qup_A 258 ---------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309 (323)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred ---------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 1223467889999999999999999999 78888999998765544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=304.93 Aligned_cols=239 Identities=21% Similarity=0.269 Sum_probs=193.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.||+|++.... ....+.+|+..+..+.+|++++.+++++.+....+++||+++++ +..++
T Consensus 21 G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~-L~~~l 96 (298)
T 1csn_A 21 GSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPS-LEDLL 96 (298)
T ss_dssp CSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCB-HHHHH
T ss_pred cCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEecCCC-HHHHH
Confidence 899999999999999999999986542 33456778999999988999999999999999999999999544 55555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C-----cEEEeecCcccccCCCCC--------CC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G-----VIKIGDLGMVKEIDSSLP--------CT 146 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~-----~~~l~df~~~~~~~~~~~--------~~ 146 (282)
...+.++++..+..++.||+.||.+||++|++|+||||+||+++. + .++|+|||++........ ..
T Consensus 97 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 176 (298)
T 1csn_A 97 DLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 176 (298)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCcc
Confidence 554557999999999999999999999999999999999999974 3 399999999987654322 24
Q ss_pred CccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHHHhCCCCCCCccccccccccC
Q 044127 147 DYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQ---IYKICQVIGSPTEDSWPLGIQLASNL 223 (282)
Q Consensus 147 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
...+++.|+|||.+.+.. ++.++||||||+++|+|++|..||........ ...+......
T Consensus 177 ~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------- 239 (298)
T 1csn_A 177 NLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS---------------- 239 (298)
T ss_dssp CCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH----------------
T ss_pred CCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC----------------
Confidence 557899999999987544 79999999999999999999999987543322 2222221110
Q ss_pred CccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.........+++.+.+++.+||+.||.+|||+++|++
T Consensus 240 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 240 ---------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ---------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ---------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 0112334467899999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=300.26 Aligned_cols=236 Identities=25% Similarity=0.395 Sum_probs=194.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|.+. ++..||+|++...... ...+.+|+..+.++. ||||+++++++.+....++||||+.++++..++
T Consensus 19 G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 94 (268)
T 3sxs_A 19 GQFGVVKLGKWK-GQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL 94 (268)
T ss_dssp ETTEEEEEEEET-TTEEEEEEEECBTTBC--HHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEEEEEECCTTCBHHHHH
T ss_pred CCCceEEEEEec-CceeEEEEEeccCCCc--HHHHHHHHHHHHhCC-CCCEeeEEEEEccCCceEEEEEccCCCcHHHHH
Confidence 799999999876 4677999999765433 345778999999995 999999999999999999999999877666666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aP 157 (282)
...+..+++..++.++.|++.||.+||++|++|+||||+||+++. +.++|+|||.+........ .....+++.|+||
T Consensus 95 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP 174 (268)
T 3sxs_A 95 RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAP 174 (268)
T ss_dssp HHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCH
T ss_pred HHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCH
Confidence 555557999999999999999999999999999999999999975 7999999999886644321 1233456779999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.+.. ++.++||||||+++|+|++ |..||......+...........
T Consensus 175 E~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------------------- 224 (268)
T 3sxs_A 175 EVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL----------------------------- 224 (268)
T ss_dssp HHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----------------------------
T ss_pred HHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC-----------------------------
Confidence 9987544 7999999999999999999 99999887766665544332111
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++.+.+++.+||+.||.+|||+++++++
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1223468899999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=300.46 Aligned_cols=238 Identities=25% Similarity=0.404 Sum_probs=185.6
Q ss_pred CCcceEEEEEecCC---CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKS---GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|++..+ +..|++|++...........+.+|+..++++ +||||+++++++.+ +..++||||+.++.+.
T Consensus 26 G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~lv~e~~~~~~L~ 103 (281)
T 1mp8_A 26 GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE-NPVWIIMELCTLGELR 103 (281)
T ss_dssp CSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS-SSCEEEEECCTTEEHH
T ss_pred cCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEcc-CccEEEEecCCCCCHH
Confidence 89999999998654 4579999987655445566778899999998 49999999999854 5688999999986676
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC--CCCccccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP--CTDYVTTRWY 154 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~ 154 (282)
.++......+++..+..++.|++.||.+||++|++|+||||+||+++ ++.++|+|||++........ .....+++.|
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y 183 (281)
T 1mp8_A 104 SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183 (281)
T ss_dssp HHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGG
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccc
Confidence 66666555799999999999999999999999999999999999998 58999999999987644322 2233456789
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
+|||.+.... ++.++||||||+++|+|++ |..||......+....+.....
T Consensus 184 ~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~--------------------------- 235 (281)
T 1mp8_A 184 MAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--------------------------- 235 (281)
T ss_dssp CCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---------------------------
T ss_pred cChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC---------------------------
Confidence 9999987444 7999999999999999996 8999998877766655433211
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+..+++.+.++|.+||+.||.+|||+++++++
T Consensus 236 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 236 --LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12334678999999999999999999999999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=309.74 Aligned_cols=238 Identities=26% Similarity=0.363 Sum_probs=195.3
Q ss_pred CCcceEEEEEec-----CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDK-----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|++. .+++.||+|+++..........+.+|+.++.++ +||||+++++++.+.+..++||||+.++.
T Consensus 58 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 136 (343)
T 1luf_A 58 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGD 136 (343)
T ss_dssp CSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred cCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEccCCceEEEEecCCCCc
Confidence 899999999987 355899999998765455566778899999999 59999999999999999999999999766
Q ss_pred HHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEe
Q 044127 76 LKLMKERA-----------------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIG 131 (282)
Q Consensus 76 l~~~~~~~-----------------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~ 131 (282)
+..++... ...+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+
T Consensus 137 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~ 216 (343)
T 1luf_A 137 LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216 (343)
T ss_dssp HHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred HHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEe
Confidence 66655542 146999999999999999999999999999999999999985 799999
Q ss_pred ecCcccccCCC---CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCC
Q 044127 132 DLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGS 207 (282)
Q Consensus 132 df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~ 207 (282)
|||++...... .......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.....
T Consensus 217 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~- 294 (343)
T 1luf_A 217 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI- 294 (343)
T ss_dssp CCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-
T ss_pred ecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCc-
Confidence 99998765322 2223456788899999988554 8999999999999999999 9999988776665544432110
Q ss_pred CCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 208 PTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+..+++.+.++|++||+.||.+|||+.++++
T Consensus 295 ----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 295 ----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp ----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1233467889999999999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=309.02 Aligned_cols=238 Identities=18% Similarity=0.237 Sum_probs=190.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.||+|++.... ....+..|+.+++++.+||||+++++++...+..++|||++++++ ..++
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L-~~~~ 95 (330)
T 2izr_A 20 GNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSL-EDLF 95 (330)
T ss_dssp -CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCCCBH-HHHH
T ss_pred cCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCCCCH-HHHH
Confidence 899999999999999999999986543 234567899999999779999999999999999999999995554 4445
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-Cc-----EEEeecCcccccCCCCC--------CC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GV-----IKIGDLGMVKEIDSSLP--------CT 146 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~-----~~l~df~~~~~~~~~~~--------~~ 146 (282)
...+..+++..+..++.||+.||.|||++|++|+||||+||+++. +. ++|+|||++........ ..
T Consensus 96 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~ 175 (330)
T 2izr_A 96 DLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175 (330)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred HHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccC
Confidence 544468999999999999999999999999999999999999975 44 99999999987644322 24
Q ss_pred CccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HHHHhCCCCCCCccccccccccC
Q 044127 147 DYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYK---ICQVIGSPTEDSWPLGIQLASNL 223 (282)
Q Consensus 147 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
...||+.|+|||.+.+.. ++.++|||||||++|+|++|..||......+.... +........
T Consensus 176 ~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-------------- 240 (330)
T 2izr_A 176 SLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-------------- 240 (330)
T ss_dssp CCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC--------------
T ss_pred CcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC--------------
Confidence 567899999999998544 79999999999999999999999988654433322 211110000
Q ss_pred CccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
........+ .+.+++..||+.||.+||++++|++
T Consensus 241 -----------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 -----------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp -----------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -----------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 011122344 8999999999999999999988875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=313.54 Aligned_cols=238 Identities=22% Similarity=0.362 Sum_probs=186.1
Q ss_pred CCcceEEEEEec---CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDK---KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~---~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|+++ .++..||+|+++..........+.+|+.++.++ +||||+++++++.+.+..++||||+.++.+.
T Consensus 56 G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~ 134 (373)
T 2qol_A 56 GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLD 134 (373)
T ss_dssp CSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred CCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCceEEEEeCCCCCcHH
Confidence 899999999877 457789999998765445566788999999999 5999999999999999999999999877777
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC----CCCccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP----CTDYVTTR 152 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~----~~~~~~~~ 152 (282)
.++...+..+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++........ .....++.
T Consensus 135 ~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~ 214 (373)
T 2qol_A 135 SFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214 (373)
T ss_dssp HHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------------C
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCC
Confidence 777766667999999999999999999999999999999999999985 7999999999986643321 11223466
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+......
T Consensus 215 ~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~------------------------ 269 (373)
T 2qol_A 215 RWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL------------------------ 269 (373)
T ss_dssp TTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC------------------------
T ss_pred CccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------------------
Confidence 799999997544 8999999999999999998 99999887766655444322111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...+..+.+++.+||+.||.+||+++++++
T Consensus 270 -----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 270 -----PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -----CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 112356889999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=320.23 Aligned_cols=263 Identities=21% Similarity=0.327 Sum_probs=198.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCC--cEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE--DVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++...........+.+|+.+++++. ||||+++++++.... ..++|||||.++++..
T Consensus 20 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~ 98 (396)
T 4eut_A 20 GATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYT 98 (396)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEEEEECCCTTEEHHH
T ss_pred CCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCCeeEEEEecCCCCCHHH
Confidence 8999999999999999999999987655555566778999999995 999999999987654 7899999998766666
Q ss_pred HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceee----eC-CcEEEeecCcccccCCCCCCCCcccc
Q 044127 79 MKERAG--QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV----SK-GVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 79 ~~~~~~--~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili----~~-~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
++.... ..+++..++.++.||+.||.|||++|++|+||||+||++ +. +.+||+|||++.............++
T Consensus 99 ~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt 178 (396)
T 4eut_A 99 VLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGT 178 (396)
T ss_dssp HTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSC
T ss_pred HHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCC
Confidence 655432 239999999999999999999999999999999999998 33 46999999999877665555567899
Q ss_pred ccccCchhhhcc-------ccCCCcchhHHHHHHHHHHHhCCCCCCCCC----ChHHHHHHHHHhCCCCCCCcccccccc
Q 044127 152 RWYRAPEVLLLS-------EIYGPEVDMWAMGAIMFEMLSFRILFPGKN----SADQIYKICQVIGSPTEDSWPLGIQLA 220 (282)
Q Consensus 152 ~~~~aPE~~~~~-------~~~~~~~DiwslG~ll~~l~~g~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
+.|+|||.+.+. ..++.++|||||||++|+|++|..||.... ..+....+.. ......+..... .
T Consensus 179 ~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~-~ 254 (396)
T 4eut_A 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT---GKPSGAISGVQK-A 254 (396)
T ss_dssp CTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH---SCCTTCCEEEEC-S
T ss_pred ccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc---CCCcccchhhee-c
Confidence 999999998641 346889999999999999999999997533 2333333333 222211111111 1
Q ss_pred ccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 221 SNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+.+.. .......++..++..+.++|++||+.||++|||++++++
T Consensus 255 ~~~~~~~~~-~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 255 ENGPIDWSG-DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp TTCCEEEES-SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred cCCCcccCc-cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 111111110 011112334456778999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=302.72 Aligned_cols=235 Identities=15% Similarity=0.231 Sum_probs=190.4
Q ss_pred CCcceEEEEEecCCC-------cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSG-------EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~-------~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||+||+|++..++ ..|++|++.... ......+.+|+..+.++. ||||+++++++.+++..++||||+.+
T Consensus 19 G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~ 96 (289)
T 4fvq_A 19 GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLS-HKHLVLNYGVCVCGDENILVQEFVKF 96 (289)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSC-CTTBCCEEEEECCTTCCEEEEECCTT
T ss_pred CCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEeCCCCEEEEECCCC
Confidence 799999999998877 479999986543 334456788999999995 99999999999999999999999997
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-Cc--------EEEeecCcccccCCCCC
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GV--------IKIGDLGMVKEIDSSLP 144 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~--------~~l~df~~~~~~~~~~~ 144 (282)
+++..++...+..+++..+..++.||+.||.|||++|++|+||||+||+++. +. ++|+|||.+......
T Consensus 97 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-- 174 (289)
T 4fvq_A 97 GSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-- 174 (289)
T ss_dssp CBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH--
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc--
Confidence 6666666665556999999999999999999999999999999999999974 33 999999998654332
Q ss_pred CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCC
Q 044127 145 CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLD 224 (282)
Q Consensus 145 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
....+++.|+|||.+.+...++.++||||||+++|+|++|..|+................
T Consensus 175 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~------------------- 234 (289)
T 4fvq_A 175 -DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR------------------- 234 (289)
T ss_dssp -HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-------------------
T ss_pred -cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc-------------------
Confidence 334678889999999865668999999999999999999655554444443333332211
Q ss_pred ccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 225 WKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+...++.+.++|++||+.||.+|||+++++++
T Consensus 235 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 -----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp -----------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred -----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11233457889999999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=309.03 Aligned_cols=239 Identities=25% Similarity=0.392 Sum_probs=189.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-----HHHHHHHHHHHHHHhC---CCCCeeeeccccccCCcEEEEEec-C
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-----DESRNLKEVKCLRKMN---NHPNIVKLRNLVKEHEDVFIVFEY-M 71 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-----~~~~~~~e~~~l~~~~---~hp~i~~~~~~~~~~~~~~lv~e~-~ 71 (282)
|+||.||+|++..+++.||+|++....... ......+|+..+.++. +||||+++++++...+..++++|+ +
T Consensus 42 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 121 (312)
T 2iwi_A 42 GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPL 121 (312)
T ss_dssp ETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCS
T ss_pred CCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecC
Confidence 789999999999999999999997654321 2334456888888874 599999999999999999999999 6
Q ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee--CCcEEEeecCcccccCCCCCCCCcc
Q 044127 72 ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYV 149 (282)
Q Consensus 72 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~--~~~~~l~df~~~~~~~~~~~~~~~~ 149 (282)
.++.+..++... ..+++..++.++.||+.||.+||++|++|+||||+||+++ ++.++|+|||++...... ......
T Consensus 122 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~-~~~~~~ 199 (312)
T 2iwi_A 122 PAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE-PYTDFD 199 (312)
T ss_dssp SEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS-CBCCCC
T ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC-cccccC
Confidence 665555555543 3699999999999999999999999999999999999998 478999999998876543 234567
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++..|+|||.+.+....+.++||||||+++|+|++|..||.... .....
T Consensus 200 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~------------------------- 248 (312)
T 2iwi_A 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA------------------------- 248 (312)
T ss_dssp SCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT-------------------------
T ss_pred CcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh-------------------------
Confidence 89999999998766544568999999999999999999996531 11110
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
....+..++..+.++|++||+.||++|||++++++||||++..
T Consensus 249 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 249 -----ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred -----ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 0112346788999999999999999999999999999998753
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=309.59 Aligned_cols=240 Identities=25% Similarity=0.378 Sum_probs=192.0
Q ss_pred CCcceEEEEEecCCCcEE--EEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFV--AVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v--~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|++..++..+ ++|.+...........+.+|+.++.++.+||||+++++++.+.+..++||||+.++.+..
T Consensus 36 G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 115 (327)
T 1fvr_A 36 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115 (327)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred CCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHH
Confidence 789999999999888865 999887654445566778899999999679999999999999999999999998755655
Q ss_pred HHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC
Q 044127 79 MKERA---------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 142 (282)
Q Consensus 79 ~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~ 142 (282)
++... ...+++..++.++.||+.||.+||++|++|+||||+||+++. +.++|+|||++......
T Consensus 116 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~ 195 (327)
T 1fvr_A 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 195 (327)
T ss_dssp HHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE
T ss_pred HHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc
Confidence 55443 246999999999999999999999999999999999999985 79999999998765444
Q ss_pred CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 143 LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 143 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
.......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+....
T Consensus 196 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~---------------- 258 (327)
T 1fvr_A 196 VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---------------- 258 (327)
T ss_dssp CCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC----------------
T ss_pred ccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC----------------
Confidence 434455667889999998744 47999999999999999998 999998876655444322110
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
....+..+++.+.++|.+||+.||.+|||+++++++
T Consensus 259 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 259 -------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp -------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011234568899999999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=304.05 Aligned_cols=239 Identities=23% Similarity=0.376 Sum_probs=196.0
Q ss_pred CCcceEEEEEec-----CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDK-----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|.+. .++..||+|++...........+.+|+.+++++ +||||+++++++.+.+..++||||+.++.
T Consensus 34 G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 112 (314)
T 2ivs_A 34 GEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGS 112 (314)
T ss_dssp CSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred cCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecCCceEEEEeecCCCC
Confidence 899999999873 456889999998765455566778899999999 59999999999999999999999999766
Q ss_pred HHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEe
Q 044127 76 LKLMKERAG-----------------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIG 131 (282)
Q Consensus 76 l~~~~~~~~-----------------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~ 131 (282)
+..++.... ..+++..++.++.||+.||.|||++|++|+||||+||++++ +.++|+
T Consensus 113 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~ 192 (314)
T 2ivs_A 113 LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192 (314)
T ss_dssp HHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEEC
T ss_pred HHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEc
Confidence 666655432 23899999999999999999999999999999999999985 789999
Q ss_pred ecCcccccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCC
Q 044127 132 DLGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGS 207 (282)
Q Consensus 132 df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~ 207 (282)
|||++........ .....+++.|+|||.+.+. .++.++||||||+++|+|++ |..||...........+.....
T Consensus 193 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~- 270 (314)
T 2ivs_A 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR- 270 (314)
T ss_dssp CCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-
T ss_pred cccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc-
Confidence 9999886643322 2334567889999999754 48999999999999999999 9999988776665544322110
Q ss_pred CCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 208 PTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+..+++.+.++|.+||+.||.+|||+++++++
T Consensus 271 ----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 271 ----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp ----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12234678999999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=305.28 Aligned_cols=240 Identities=25% Similarity=0.368 Sum_probs=196.6
Q ss_pred CCcceEEEEEecCCCc-----EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGE-----FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~-----~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|.+..+++ .|++|++...........+.+|+.++.++.+||||+++++++.+.+..++||||+.++.
T Consensus 57 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 136 (333)
T 2i1m_A 57 GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136 (333)
T ss_dssp CSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEE
T ss_pred CCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCc
Confidence 8999999999877654 79999998765455566788999999999669999999999999999999999998755
Q ss_pred HHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC
Q 044127 76 LKLMKERA-------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS 141 (282)
Q Consensus 76 l~~~~~~~-------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~ 141 (282)
+..++... ...+++..+..++.||+.||.+||++|++|+||||+||++++ +.++|+|||++.....
T Consensus 137 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 216 (333)
T 2i1m_A 137 LLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216 (333)
T ss_dssp HHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGG
T ss_pred HHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECcccccccccc
Confidence 55444321 246899999999999999999999999999999999999985 7899999999986543
Q ss_pred CCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccc
Q 044127 142 SLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGI 217 (282)
Q Consensus 142 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (282)
... .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...................
T Consensus 217 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------- 286 (333)
T 2i1m_A 217 DSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM--------- 286 (333)
T ss_dssp CTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCC---------
T ss_pred ccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCC---------
Confidence 322 22345677899999987544 8999999999999999998 899998877766665554432111
Q ss_pred cccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 218 QLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...++.+.++|.+||+.||.+|||++++++
T Consensus 287 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 287 -------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 122346889999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=303.78 Aligned_cols=241 Identities=24% Similarity=0.365 Sum_probs=196.6
Q ss_pred CCcceEEEEEe-----cCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC-CcEEEEEecCCcc
Q 044127 1 GSYGDVFQALD-----KKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH-EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~-----~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-~~~~lv~e~~~~~ 74 (282)
|+||+||+|++ ..+++.||+|++...........+.+|+.++.++.+||||+++++++... ...+++|||+.++
T Consensus 38 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~ 117 (316)
T 2xir_A 38 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117 (316)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTE
T ss_pred CCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCC
Confidence 89999999984 45678999999987655555667889999999997799999999998765 4589999999976
Q ss_pred HHHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccc
Q 044127 75 LLKLMKERAGQ---------------NFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKE 138 (282)
Q Consensus 75 ~l~~~~~~~~~---------------~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~ 138 (282)
.+..++..... .+++..+..++.||+.||.+||++|++|+||||+||+++ ++.++|+|||++..
T Consensus 118 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 197 (316)
T 2xir_A 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197 (316)
T ss_dssp EHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred cHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccc
Confidence 66666665432 289999999999999999999999999999999999997 47999999999986
Q ss_pred cCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCcc
Q 044127 139 IDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWP 214 (282)
Q Consensus 139 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (282)
...... .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+............
T Consensus 198 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------ 270 (316)
T 2xir_A 198 IYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------ 270 (316)
T ss_dssp TTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC------
T ss_pred cccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccC------
Confidence 643322 12345678899999997544 8999999999999999998 999998877655554443322111
Q ss_pred ccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 215 LGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++.+.++|.+||+.||.+|||++++++|
T Consensus 271 ----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 271 ----------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1233568899999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=306.89 Aligned_cols=238 Identities=20% Similarity=0.321 Sum_probs=185.5
Q ss_pred CCcceEEEEEecCCCcE----EEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEF----VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~----v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|++..+++. |++|.+...........+.+|+.++.++. ||||+++++++.++. .+++++++.++.+
T Consensus 26 G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~~v~e~~~~g~L 103 (327)
T 3poz_A 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCL 103 (327)
T ss_dssp ETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS-EEEEEECCTTCBH
T ss_pred CCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC-eEEEEEecCCCcH
Confidence 89999999998877765 57887765544445567788999999995 999999999998764 7788999886666
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC---CCccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC---TDYVTTR 152 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~---~~~~~~~ 152 (282)
..++......+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++......... ....+++
T Consensus 104 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 183 (327)
T 3poz_A 104 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183 (327)
T ss_dssp HHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCG
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccc
Confidence 6566555567999999999999999999999999999999999999985 89999999999866443322 2334577
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+......
T Consensus 184 ~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~------------------------ 238 (327)
T 3poz_A 184 KWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------------------------ 238 (327)
T ss_dssp GGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------------------------
T ss_pred cccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC------------------------
Confidence 899999998544 8999999999999999999 99999887766654443322111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 239 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1234568899999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=304.58 Aligned_cols=240 Identities=24% Similarity=0.387 Sum_probs=196.0
Q ss_pred CCcceEEEEEec-------CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDK-------KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~-------~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||+||+|++. .++..||+|++...........+.+|+.++.++.+||||+++++++.+.+..++||||+.+
T Consensus 46 G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 125 (334)
T 2pvf_A 46 GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 125 (334)
T ss_dssp CSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTT
T ss_pred cCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCC
Confidence 899999999875 4577899999987655555667889999999997799999999999999999999999987
Q ss_pred cHHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCccc
Q 044127 74 DLLKLMKERAG---------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVK 137 (282)
Q Consensus 74 ~~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~ 137 (282)
+.+..++.... ..+++..++.++.||+.||.+||++|++|+||||+||+++ ++.++|+|||++.
T Consensus 126 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 205 (334)
T 2pvf_A 126 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205 (334)
T ss_dssp CBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccc
Confidence 66666655432 2489999999999999999999999999999999999997 4899999999998
Q ss_pred ccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCc
Q 044127 138 EIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 138 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (282)
....... .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.....
T Consensus 206 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~------- 277 (334)
T 2pvf_A 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR------- 277 (334)
T ss_dssp ECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC-------
T ss_pred cccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCC-------
Confidence 6654321 23345678899999987544 7999999999999999999 9999988776655544433211
Q ss_pred cccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+..++..+.++|.+||+.||.+|||+++++++
T Consensus 278 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 278 ----------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11234678899999999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=299.30 Aligned_cols=238 Identities=24% Similarity=0.350 Sum_probs=197.1
Q ss_pred CCcceEEEEEec--CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDK--KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.+. .++..||+|++...........+.+|+.++.++ +||||+++++++ ..+..++|||++.++++..
T Consensus 21 G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~ 98 (287)
T 1u59_A 21 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK 98 (287)
T ss_dssp CTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSSEEEEEECCTTEEHHH
T ss_pred cCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHH
Confidence 899999999854 468889999998765445566778899999999 599999999999 4557999999999877777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC----CCCcccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP----CTDYVTTRW 153 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~----~~~~~~~~~ 153 (282)
++......+++..+..++.||+.||.+||+.|++|+||+|+||+++ ++.++|+|||++........ .....+++.
T Consensus 99 ~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 178 (287)
T 1u59_A 99 FLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178 (287)
T ss_dssp HHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGG
T ss_pred HHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccccccccc
Confidence 7765556799999999999999999999999999999999999997 48999999999987643322 123345788
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.....
T Consensus 179 y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~-------------------------- 231 (287)
T 1u59_A 179 WYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-------------------------- 231 (287)
T ss_dssp GCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC--------------------------
T ss_pred ccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc--------------------------
Confidence 99999987444 7999999999999999998 9999988877665554433110
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+..+++.+.++|.+||+.||.+|||+++++++
T Consensus 232 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 232 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12344678999999999999999999999999976
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=299.94 Aligned_cols=236 Identities=24% Similarity=0.406 Sum_probs=193.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|.+. ++..||+|++...... ...+.+|+.++.++. ||||+++++++.+.+..++||||+.++.+..++
T Consensus 35 G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 110 (283)
T 3gen_A 35 GQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 110 (283)
T ss_dssp --CEEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEECCCTTCBHHHHH
T ss_pred CCCceEEEEEEc-CCCeEEEEEecCCCCC--HHHHHHHHHHHhcCC-CCCEeeEEEEEecCCCeEEEEeccCCCcHHHHH
Confidence 899999999876 5778999999865433 355778999999995 999999999999999999999999876666666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aP 157 (282)
......+++..++.++.|++.||.+||++|++|+||||+||++++ +.++|+|||++....... ......+++.|+||
T Consensus 111 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP 190 (283)
T 3gen_A 111 REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 190 (283)
T ss_dssp HCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCH
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCH
Confidence 554457999999999999999999999999999999999999985 799999999987653321 12334557789999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.+.. ++.++||||||+++|+|++ |..||......+....+......
T Consensus 191 E~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------- 240 (283)
T 3gen_A 191 EVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL----------------------------- 240 (283)
T ss_dssp HHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----------------------------
T ss_pred HHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC-----------------------------
Confidence 9998554 7999999999999999998 99999988776666555432211
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++.+.++|.+||+.||.+|||++++++|
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1223568899999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=296.59 Aligned_cols=238 Identities=22% Similarity=0.331 Sum_probs=193.0
Q ss_pred CCcceEEEEEecC---CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKK---SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|++.. ++..|++|++...........+.+|+..++++. ||||+++++++.++ ..+++||++.++.+.
T Consensus 23 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~ 100 (281)
T 3cc6_A 23 GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEEE-PTWIIMELYPYGELG 100 (281)
T ss_dssp CSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECSS-SCEEEEECCTTCBHH
T ss_pred cCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCC-CCCcceEEEEEcCC-CCEEEEecCCCCCHH
Confidence 8999999998654 345699999987655556677888999999995 99999999998765 568999999977777
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC--CCCccccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP--CTDYVTTRWY 154 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~ 154 (282)
.++...+..+++..+..++.||+.||.+||++|++|+||||+||+++ ++.++|+|||.+........ .....+++.|
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y 180 (281)
T 3cc6_A 101 HYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180 (281)
T ss_dssp HHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGG
T ss_pred HHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcce
Confidence 66666556799999999999999999999999999999999999997 48999999999887644321 2334567789
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+......
T Consensus 181 ~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~-------------------------- 233 (281)
T 3cc6_A 181 MSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL-------------------------- 233 (281)
T ss_dssp CCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC--------------------------
T ss_pred eCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC--------------------------
Confidence 9999987444 7999999999999999998 99999877776665544432111
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++.+.++|.+||+.||.+|||+++++++
T Consensus 234 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 ---PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 1223568899999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=307.13 Aligned_cols=238 Identities=18% Similarity=0.273 Sum_probs=189.2
Q ss_pred CCcceEEEEEecCCCcE----EEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEF----VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~----v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|++..+++. |++|.+...........+.+|+..+.++ +||||+++++++.+ +..++||||+.++.+
T Consensus 24 G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L 101 (325)
T 3kex_A 24 GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPG-SSLQLVTQYLPLGSL 101 (325)
T ss_dssp CSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECB-SSEEEEEECCTTCBS
T ss_pred cCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC-CccEEEEEeCCCCCH
Confidence 89999999999888776 6777765443333344566788888888 59999999999864 568899999986655
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC---CCCCccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---PCTDYVTTR 152 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~---~~~~~~~~~ 152 (282)
..++......+++..+..++.||+.||.|||++|++|+||||+||+++. +.++|+|||++....... ......++.
T Consensus 102 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~ 181 (325)
T 3kex_A 102 LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181 (325)
T ss_dssp HHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCT
T ss_pred HHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcc
Confidence 5555544457999999999999999999999999999999999999974 899999999998764332 223446677
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.....
T Consensus 182 ~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~------------------------- 235 (325)
T 3kex_A 182 KWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER------------------------- 235 (325)
T ss_dssp TTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-------------------------
T ss_pred cccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-------------------------
Confidence 899999997554 8999999999999999999 9999998776665554433211
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+...+..+.+++.+||+.||.+|||+++++++
T Consensus 236 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 ----LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ----CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ----CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11223467789999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=303.21 Aligned_cols=239 Identities=21% Similarity=0.354 Sum_probs=190.0
Q ss_pred CCcceEEEEEecCCC----cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSG----EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~----~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|.+..++ ..||+|++...........+.+|+.++.++. ||||+++++++.+.+..++||||+.++++
T Consensus 55 G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 133 (333)
T 1mqb_A 55 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENGAL 133 (333)
T ss_dssp CSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred CCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCCcEEEEeCCCCCcH
Confidence 899999999987553 4599999986654455667788999999994 99999999999999999999999998777
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC----CCCcccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP----CTDYVTT 151 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~----~~~~~~~ 151 (282)
..++...+..+++..+..++.||+.||.+||++|++|+||||+||+++. +.++|+|||++........ .....++
T Consensus 134 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 213 (333)
T 1mqb_A 134 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213 (333)
T ss_dssp HHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCC
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCcc
Confidence 7777665567999999999999999999999999999999999999985 7999999999987643221 1223456
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
+.|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+......
T Consensus 214 ~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~----------------------- 269 (333)
T 1mqb_A 214 IRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL----------------------- 269 (333)
T ss_dssp GGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-----------------------
T ss_pred ccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC-----------------------
Confidence 789999998744 48999999999999999999 99999887766555444332111
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++.+.++|.+||+.||.+||++.+++++
T Consensus 270 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 ------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1223568899999999999999999999998863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=296.13 Aligned_cols=238 Identities=21% Similarity=0.266 Sum_probs=190.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHH------HHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE------SRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~------~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|+||+||+|++..+++.||+|++......... ..+.+|+.+++++ +||||+++++++.+.. +++|||+.++
T Consensus 30 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~--~lv~e~~~~~ 106 (287)
T 4f0f_A 30 GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNPP--RMVMEFVPCG 106 (287)
T ss_dssp CSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTTT--EEEEECCTTC
T ss_pred CCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCCC--eEEEEecCCC
Confidence 89999999999999999999998764432211 4567899999999 4999999999997765 6999999865
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeeC-Cc-----EEEeecCcccccCCCCCCC
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG--YFHRDLKPSNLLVSK-GV-----IKIGDLGMVKEIDSSLPCT 146 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~--~~H~dl~p~nili~~-~~-----~~l~df~~~~~~~~~~~~~ 146 (282)
.+...+......+++..+..++.|++.||.+||++| ++|+||||+||+++. +. ++|+|||++...... ..
T Consensus 107 ~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~ 184 (287)
T 4f0f_A 107 DLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VS 184 (287)
T ss_dssp BHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC--EE
T ss_pred CHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc--cc
Confidence 554444444457999999999999999999999999 999999999999974 33 999999998755443 34
Q ss_pred CccccccccCchhhhc-cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc
Q 044127 147 DYVTTRWYRAPEVLLL-SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225 (282)
Q Consensus 147 ~~~~~~~~~aPE~~~~-~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
...+++.|+|||.+.. ...++.++||||||+++|+|++|..||...................
T Consensus 185 ~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 247 (287)
T 4f0f_A 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL----------------- 247 (287)
T ss_dssp CCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC-----------------
T ss_pred ccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC-----------------
Confidence 5678999999999842 3446889999999999999999999998766554422211111111
Q ss_pred cccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+..+++.+.++|.+||+.||.+|||++++++
T Consensus 248 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 ---------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11234567899999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=327.73 Aligned_cols=268 Identities=26% Similarity=0.384 Sum_probs=202.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc------CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE------HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~------~~~~~lv~e~~~~~ 74 (282)
|+||+||+|.+..+|+.||+|++...........+.+|+.++.++ +||||+++++++.. ++..++|||||.++
T Consensus 25 G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~gg 103 (676)
T 3qa8_A 25 GGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGG 103 (676)
T ss_dssp CSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSC
T ss_pred CCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCCeEEEEEEeCCCC
Confidence 899999999999999999999998765455566778899999999 59999999998765 67889999999876
Q ss_pred HHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C---cEEEeecCcccccCCCCCCCCc
Q 044127 75 LLKLMKERAG--QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G---VIKIGDLGMVKEIDSSLPCTDY 148 (282)
Q Consensus 75 ~l~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~---~~~l~df~~~~~~~~~~~~~~~ 148 (282)
.+..++...+ ..+++..++.++.||+.||.|||+.|++|+||||+||+++. + .++|+|||.+............
T Consensus 104 sL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~ 183 (676)
T 3qa8_A 104 DLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183 (676)
T ss_dssp BHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCC
T ss_pred CHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccc
Confidence 6666666533 25999999999999999999999999999999999999984 2 4999999999987766666677
Q ss_pred cccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 149 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
.+++.|+|||.+.+. .++.++||||||+++|+|++|..||............ ............... .....+.
T Consensus 184 ~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~~~~l--~g~~~~~ 257 (676)
T 3qa8_A 184 VGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVVYDDL--TGAVKFS 257 (676)
T ss_dssp CSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCSCCCC--SSSCCCC
T ss_pred cCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhhhhhh--ccccccc
Confidence 899999999998744 4899999999999999999999999765432211000 000000000000000 0000111
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
............+++.+.++|.+||..||.+|||++++++||||+..
T Consensus 258 -~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 258 -SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp -SSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred -cccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 01111233455578899999999999999999999999999999764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=305.62 Aligned_cols=247 Identities=22% Similarity=0.379 Sum_probs=199.5
Q ss_pred CCcceEEEEEec-----CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDK-----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|++. .+++.|++|++...........+.+|+.+++.+. ||||+++++++.+.+..++||||+.++.
T Consensus 36 G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 114 (322)
T 1p4o_A 36 GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQGQPTLVIMELMTRGD 114 (322)
T ss_dssp CSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred CCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEccCCccEEEEEeCCCCc
Confidence 899999999877 4678899999987655555667788999999884 9999999999999999999999998755
Q ss_pred HHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--
Q 044127 76 LKLMKERAG---------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-- 143 (282)
Q Consensus 76 l~~~~~~~~---------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-- 143 (282)
+..++.... ..+++..+..++.||+.||.+||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 115 L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~ 194 (322)
T 1p4o_A 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194 (322)
T ss_dssp HHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE
T ss_pred HHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCcccccccccccc
Confidence 555544321 35799999999999999999999999999999999999985 799999999987653322
Q ss_pred -CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 144 -PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 144 -~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+....
T Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---------------- 257 (322)
T 1p4o_A 195 RKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG---------------- 257 (322)
T ss_dssp EGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC----------------
T ss_pred ccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC----------------
Confidence 112345678899999987544 7999999999999999999 889998876655554433211
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC------cccccccC
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH------PFFRSCHF 278 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~------~~~~~~~~ 278 (282)
....+...++.+.++|.+||+.||.+|||+.+++++ ++|+++.+
T Consensus 258 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~ 307 (322)
T 1p4o_A 258 -------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 307 (322)
T ss_dssp -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCS
T ss_pred -------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccc
Confidence 012234678999999999999999999999999975 77766543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=305.07 Aligned_cols=242 Identities=23% Similarity=0.354 Sum_probs=193.8
Q ss_pred CCcceEEEEE-----ecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQAL-----DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~-----~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|+ +..++..||+|++...........+.+|+.++.++ +||||+++++++.+....++||||+.++.
T Consensus 41 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 119 (327)
T 2yfx_A 41 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGD 119 (327)
T ss_dssp -CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTEE
T ss_pred CCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCCCCcEEEEecCCCCc
Confidence 8999999998 55678899999997655455666788899999999 59999999999999999999999997666
Q ss_pred HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCC--
Q 044127 76 LKLMKERAG------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSL-- 143 (282)
Q Consensus 76 l~~~~~~~~------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~-- 143 (282)
+..++.... ..+++..++.++.||+.||.+||++|++|+||||+||+++. ..++|+|||++.......
T Consensus 120 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~ 199 (327)
T 2yfx_A 120 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199 (327)
T ss_dssp HHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC----
T ss_pred HHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccccccccccccc
Confidence 666555432 34999999999999999999999999999999999999972 469999999987543221
Q ss_pred -CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 144 -PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 144 -~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.....
T Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--------------- 263 (327)
T 2yfx_A 200 RKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--------------- 263 (327)
T ss_dssp --CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC---------------
T ss_pred ccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC---------------
Confidence 223446688899999987544 8999999999999999998 8999988766555444332111
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
...+..+++.+.++|.+||+.||.+|||+++++++.|+
T Consensus 264 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 264 --------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 11234678899999999999999999999999998775
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=296.42 Aligned_cols=235 Identities=25% Similarity=0.435 Sum_probs=182.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch---HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL---DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~---~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|.+. ++.||+|++....... ....+.+|+..++.+. ||||+++++++.+++..++||||+.++++.
T Consensus 18 G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (271)
T 3dtc_A 18 GGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLCLVMEFARGGPLN 94 (271)
T ss_dssp ETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--CEEEEECCTTEEHH
T ss_pred CCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCceEEEEEcCCCCCHH
Confidence 799999999875 8899999987653322 2345677889888885 999999999999999999999999987777
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccCCCCCceeee---------CCcEEEeecCcccccCCCCCC
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG---YFHRDLKPSNLLVS---------KGVIKIGDLGMVKEIDSSLPC 145 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~---~~H~dl~p~nili~---------~~~~~l~df~~~~~~~~~~~~ 145 (282)
.+... ..+++..++.++.|++.||.+||++| ++|+||||+||+++ ++.++|+|||.+........
T Consensus 95 ~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~- 171 (271)
T 3dtc_A 95 RVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK- 171 (271)
T ss_dssp HHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----------
T ss_pred HHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc-
Confidence 77654 57999999999999999999999999 88999999999996 46799999999986654332
Q ss_pred CCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc
Q 044127 146 TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225 (282)
Q Consensus 146 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.................
T Consensus 172 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------- 231 (271)
T 3dtc_A 172 MSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL------------------- 231 (271)
T ss_dssp ----CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC-------------------
T ss_pred cCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC-------------------
Confidence 3557899999999987544 89999999999999999999999988766555443322110
Q ss_pred cccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
....+...++.+.+++.+||+.||.+|||+++++++
T Consensus 232 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 232 ---------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 112345678999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=296.41 Aligned_cols=236 Identities=25% Similarity=0.427 Sum_probs=195.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|.+..++..|++|++... ......+.+|+..++++. ||||+++++++.+....++|||++.++.+..++
T Consensus 24 G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 100 (288)
T 3kfa_A 24 GQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100 (288)
T ss_dssp GTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred CCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHH
Confidence 89999999999999999999998754 334566788999999995 999999999999999999999999965555554
Q ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCccccccccC
Q 044127 81 ER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~a 156 (282)
.. ....+++..+..++.||+.||.+||++|++|+||||+||+++. +.++|+|||.+........ .....+++.|+|
T Consensus 101 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~a 180 (288)
T 3kfa_A 101 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180 (288)
T ss_dssp HHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCC
T ss_pred HhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCC
Confidence 43 4456999999999999999999999999999999999999975 7899999999987654321 223355778999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+.+.. ++.++||||||+++|+|++ |..||...........+.....
T Consensus 181 PE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~----------------------------- 230 (288)
T 3kfa_A 181 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----------------------------- 230 (288)
T ss_dssp HHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-----------------------------
T ss_pred hhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC-----------------------------
Confidence 99997554 7999999999999999999 9999988776665554433211
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+..+++.+.+++.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 1223467899999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=315.60 Aligned_cols=244 Identities=26% Similarity=0.356 Sum_probs=183.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||. ....+++.||||++..... ....+|+.+++.+.+||||+++++++.+....++|||+|++++.+.+.
T Consensus 35 G~~G~V~~-~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~ 109 (432)
T 3p23_A 35 GAEGTIVY-RGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVE 109 (432)
T ss_dssp CGGGCEEE-EEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHH
T ss_pred CcCEEEEE-EEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCCHHHHHH
Confidence 89999663 3356789999999865432 234568999998867999999999999999999999999987776665
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----C--cEEEeecCcccccCCC----CCCCCccc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----G--VIKIGDLGMVKEIDSS----LPCTDYVT 150 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~--~~~l~df~~~~~~~~~----~~~~~~~~ 150 (282)
.. ...+.+..+..++.||+.||.|||++|++|+||||+||+++. + .++|+|||++...... .......|
T Consensus 110 ~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~g 188 (432)
T 3p23_A 110 QK-DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188 (432)
T ss_dssp SS-SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCS
T ss_pred hc-CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCC
Confidence 44 335666677899999999999999999999999999999952 2 5889999999876533 22234678
Q ss_pred cccccCchhhhc--cccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 151 TRWYRAPEVLLL--SEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 151 ~~~~~aPE~~~~--~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
|+.|+|||++.+ ...++.++|||||||++|+|++ |..||........... ........
T Consensus 189 t~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~----~~~~~~~~--------------- 249 (432)
T 3p23_A 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL----LGACSLDC--------------- 249 (432)
T ss_dssp CTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH----TTCCCCTT---------------
T ss_pred CcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH----hccCCccc---------------
Confidence 999999999864 2346789999999999999999 8889865544332211 11110000
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.......+..+.+||.+||+.||.+|||++++++||||.+..
T Consensus 250 --------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 250 --------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp --------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred --------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 001112355688999999999999999999999999998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=313.37 Aligned_cols=246 Identities=30% Similarity=0.391 Sum_probs=182.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||.+ ...+|+.||||++.... .....+|+.++.++.+||||+++++++.+++..++|||+|++++.+.+.
T Consensus 26 G~~g~V~~~-~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~ 100 (434)
T 2rio_A 26 GSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVE 100 (434)
T ss_dssp CSTTCEEEE-EESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHHHHHH
T ss_pred CCCeEEEEE-EEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHHHHHh
Confidence 899999875 35679999999986532 2345679999988867999999999999999999999999986665554
Q ss_pred HhcCCC-----CCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--------------CcEEEeecCcccccCC
Q 044127 81 ERAGQN-----FSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--------------GVIKIGDLGMVKEIDS 141 (282)
Q Consensus 81 ~~~~~~-----l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--------------~~~~l~df~~~~~~~~ 141 (282)
...... .++..++.++.||+.||.|||++|++|+||||+||+++. ..++|+|||++.....
T Consensus 101 ~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~ 180 (434)
T 2rio_A 101 SKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180 (434)
T ss_dssp TC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC
T ss_pred ccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCC
Confidence 321110 133346789999999999999999999999999999963 3799999999987654
Q ss_pred CCC-----CCCccccccccCchhhhc------cccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCC
Q 044127 142 SLP-----CTDYVTTRWYRAPEVLLL------SEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPT 209 (282)
Q Consensus 142 ~~~-----~~~~~~~~~~~aPE~~~~------~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~ 209 (282)
... .....+++.|+|||++.+ ...++.++|||||||++|+|++ |..||....... ..+........
T Consensus 181 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~ 258 (434)
T 2rio_A 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLD 258 (434)
T ss_dssp --------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCC
T ss_pred CCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcc
Confidence 321 234578999999999864 2457899999999999999999 899997655443 22222111100
Q ss_pred CCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 210 EDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.. . ......+++.+.++|.+||+.||.+|||+.++++||||.+.
T Consensus 259 ~~-------------------~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 259 EM-------------------K----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp CC-------------------T----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred cc-------------------c----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 00 0 00011345789999999999999999999999999999753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=299.84 Aligned_cols=253 Identities=21% Similarity=0.367 Sum_probs=186.0
Q ss_pred CCcceEEEEE----ecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc--CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQAL----DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE--HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~----~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~~~~ 74 (282)
|+||+||+|+ +..+++.||+|++.... ......+.+|+.++.++. ||||+++++++.. ....++||||+.++
T Consensus 21 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 98 (295)
T 3ugc_A 21 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98 (295)
T ss_dssp CSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHHHHTSCEEEEECCTTC
T ss_pred cCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCCceEEEEEeCCCC
Confidence 8999999998 56789999999987542 334456778999999995 9999999998754 45689999999876
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC----CCCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP----CTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~----~~~~~ 149 (282)
++..++......+++..+..++.||+.||.+||+.|++|+||||+||+++ ++.++|+|||++........ .....
T Consensus 99 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 178 (295)
T 3ugc_A 99 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178 (295)
T ss_dssp BHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTT
T ss_pred CHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCC
Confidence 66666665555699999999999999999999999999999999999998 48999999999987643321 22345
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++..|+|||.+.+.. ++.++||||||+++|+|++|..|+...... .....+........... ....
T Consensus 179 ~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-~~~~------- 244 (295)
T 3ugc_A 179 SPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQMIVFH-LIEL------- 244 (295)
T ss_dssp CGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTHHHHHH-HHHH-------
T ss_pred CccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccchhHHH-HHHH-------
Confidence 667799999998554 899999999999999999999988653211 01111110000000000 0000
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.........+..+++.+.++|++||+.||.+|||++++++
T Consensus 245 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000011234567899999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=292.84 Aligned_cols=236 Identities=25% Similarity=0.425 Sum_probs=194.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|.+. +++.|++|++...... ...+.+|+..+.++. ||||+++++++.+.+..+++||++.++++..++
T Consensus 19 G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 94 (267)
T 3t9t_A 19 GQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL 94 (267)
T ss_dssp ETTEEEEEEEET-TTEEEEEEEECTTTBC--HHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEEEECCCTTCBHHHHH
T ss_pred CCceeEEEEEec-CCCeEEEEEccccCCC--HHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHH
Confidence 789999999986 5778999999875433 356778999999994 999999999999999999999999876666666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aP 157 (282)
......+++..+..++.|++.||.+||++|++|+||+|+||++++ +.++|+|||++....... ......+++.|+||
T Consensus 95 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aP 174 (267)
T 3t9t_A 95 RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 174 (267)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCH
T ss_pred hhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccCh
Confidence 665557999999999999999999999999999999999999974 789999999987653321 12334567789999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.+.. ++.++||||||+++|+|++ |..||......+....+..... .
T Consensus 175 E~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~-----------------------------~ 224 (267)
T 3t9t_A 175 EVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-----------------------------L 224 (267)
T ss_dssp HHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------------------------C
T ss_pred hhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-----------------------------C
Confidence 9987544 7999999999999999999 8999988776665554433211 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++.+.+++.+||+.||.+|||+++++++
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1223568899999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=296.69 Aligned_cols=239 Identities=21% Similarity=0.280 Sum_probs=184.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.|++|++....... ....+.+|+..+.++ +||||+++++++..++..+++|||+.++.+..
T Consensus 45 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 123 (309)
T 2h34_A 45 GGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAA 123 (309)
T ss_dssp CSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCCCEEHHH
T ss_pred CCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEEEEEEecCCCCHHH
Confidence 899999999999999999999997654332 235567899988888 59999999999999999999999999766666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCC--CCCCcccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL--PCTDYVTTRWYR 155 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~ 155 (282)
++... ..+++..+..++.||+.||.+||++|++|+||+|+||+++ ++.++|+|||++....... ......+++.|+
T Consensus 124 ~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~ 202 (309)
T 2h34_A 124 MLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYM 202 (309)
T ss_dssp HHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGC
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCcc
Confidence 55554 3699999999999999999999999999999999999997 4899999999987654332 223457889999
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||.+.+. .++.++||||||+++|+|++|..||........ ...... . ....
T Consensus 203 aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~--~------------------------~~~~ 254 (309)
T 2h34_A 203 APERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQ--A------------------------IPRP 254 (309)
T ss_dssp CGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHS--C------------------------CCCG
T ss_pred CHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhcc--C------------------------CCCc
Confidence 99998744 479999999999999999999999987654322 221111 0 0111
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCC-CHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRP-TAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~~ll~ 269 (282)
......+++.+.++|.+||+.||.+|| |++++++
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 233457789999999999999999999 8888774
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=303.19 Aligned_cols=237 Identities=27% Similarity=0.382 Sum_probs=175.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccc--------ccCCcEEEEEecCC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV--------KEHEDVFIVFEYME 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~--------~~~~~~~lv~e~~~ 72 (282)
|+||+||+|++..+++.||+|++.... ......+.+|+..+.++.+||||+++++++ ......+++|||+.
T Consensus 39 G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~ 117 (337)
T 3ll6_A 39 GGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117 (337)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS
T ss_pred CCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC
Confidence 899999999999999999999985542 344556788999999997799999999987 44556899999999
Q ss_pred ccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC---
Q 044127 73 SDLLKLMKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQG--YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC--- 145 (282)
Q Consensus 73 ~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~--~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~--- 145 (282)
|++.+.+... ....+++..++.++.||+.||.|||+.| ++|+||||+||++++ +.++|+|||++.........
T Consensus 118 g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 197 (337)
T 3ll6_A 118 GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197 (337)
T ss_dssp EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-----
T ss_pred CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCccccc
Confidence 9888776552 2346999999999999999999999999 999999999999985 79999999999876543221
Q ss_pred ----------CCccccccccCchhhh--ccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCc
Q 044127 146 ----------TDYVTTRWYRAPEVLL--LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 146 ----------~~~~~~~~~~aPE~~~--~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (282)
....+++.|+|||++. ....++.++||||||+++|+|++|..||............ .
T Consensus 198 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~----~------- 266 (337)
T 3ll6_A 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK----Y------- 266 (337)
T ss_dssp --------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------C-------
T ss_pred ccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc----c-------
Confidence 1345889999999983 2444788999999999999999999999764433221110 0
Q ss_pred cccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
........+..+.+||++||+.||.+|||+++++++
T Consensus 267 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 267 ---------------------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp ---------------------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ---------------------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 001123457789999999999999999999999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=301.54 Aligned_cols=237 Identities=20% Similarity=0.328 Sum_probs=186.1
Q ss_pred CCcceEEEEEecCCCcEE----EEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFV----AVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v----~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|++..+++.+ ++|.+...........+.+|+.++.++. ||||+++++++..+. .+++++++.++.+
T Consensus 26 G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~-~~~v~~~~~~g~L 103 (327)
T 3lzb_A 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCL 103 (327)
T ss_dssp CSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS-EEEEECCCSSCBH
T ss_pred CCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC-ceEEEEecCCCcH
Confidence 899999999998887755 6666655444455667788999999985 999999999998765 7788999886656
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---CCCccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTTR 152 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~---~~~~~~~~ 152 (282)
..++......+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++........ .....+++
T Consensus 104 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~ 183 (327)
T 3lzb_A 104 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183 (327)
T ss_dssp HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCG
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccc
Confidence 5555555567999999999999999999999999999999999999975 8999999999987643322 22334577
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+......
T Consensus 184 ~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------------------ 238 (327)
T 3lzb_A 184 KWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------------------------ 238 (327)
T ss_dssp GGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC------------------------
T ss_pred cccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC------------------------
Confidence 899999998544 8999999999999999999 99999888776655544332111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...+..+.++|++||+.||.+|||++++++
T Consensus 239 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 239 -----PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 123456889999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=297.73 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=189.0
Q ss_pred CCcceEEEEE----ecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCcc
Q 044127 1 GSYGDVFQAL----DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~----~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~ 74 (282)
|+||.||+|+ +..+++.||+|++...........+.+|+.+++++. ||||+++++++... ...+++|||+.++
T Consensus 32 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 110 (302)
T 4e5w_A 32 GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSG 110 (302)
T ss_dssp CSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC---CCEEEEEECCTTC
T ss_pred CCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCceEEEEEEeCCCC
Confidence 8999999998 567899999999986654445567788999999995 99999999998766 6789999999886
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC----CCCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP----CTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~----~~~~~ 149 (282)
++..++......+++..++.++.|++.||.+||++|++|+||||+||+++ ++.++|+|||++........ .....
T Consensus 111 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 190 (302)
T 4e5w_A 111 SLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190 (302)
T ss_dssp BHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTT
T ss_pred cHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCC
Confidence 66666655556799999999999999999999999999999999999997 58999999999987654432 23456
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++..|+|||.+.+.. ++.++||||||+++|+|++|..|+.... ............. ..... ... .
T Consensus 191 ~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~-~~~~~-~~~-------~ 255 (302)
T 4e5w_A 191 SPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQ-MTVTR-LVN-------T 255 (302)
T ss_dssp CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGG-GHHHH-HHH-------H
T ss_pred CCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccc-cCHHH-HHH-------H
Confidence 778899999997554 7899999999999999999998864321 1111111110000 00000 000 0
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.........+..+++.+.++|.+||+.||.+|||++++++
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0000011234567899999999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=315.79 Aligned_cols=236 Identities=24% Similarity=0.425 Sum_probs=195.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.++..||+|+++... .....+.+|+.+++++. ||||+++++++......++||||+.++.|..++
T Consensus 231 G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l 307 (495)
T 1opk_A 231 GQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307 (495)
T ss_dssp GTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred CCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcC-CCCEeeEEEEEecCCcEEEEEEccCCCCHHHHH
Confidence 899999999999999999999997653 23566788999999995 999999999999999999999999865555554
Q ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccC
Q 044127 81 ER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~a 156 (282)
.. ....+++..+..++.||+.||.|||++|++|+||||+||++++ +.+||+|||++....... ......++..|+|
T Consensus 308 ~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~a 387 (495)
T 1opk_A 308 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 387 (495)
T ss_dssp HHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCC
T ss_pred HhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeC
Confidence 43 4456999999999999999999999999999999999999975 799999999998764322 1123345678999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||++.... ++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 388 PE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------------- 437 (495)
T 1opk_A 388 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----------------------------- 437 (495)
T ss_dssp HHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-----------------------------
T ss_pred HhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------------------------
Confidence 99997544 8999999999999999999 8999988776665544322111
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+..+++.+.+||.+||+.||.+|||+++|++
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 1223467899999999999999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=295.79 Aligned_cols=230 Identities=27% Similarity=0.400 Sum_probs=177.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc----CCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE----HEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~~~lv~e~~~~~~l 76 (282)
|+||.||+|.+..+++.||+|++... ....+|+..+.+..+||||+++++++.. ....++||||+.++.+
T Consensus 29 G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L 102 (299)
T 3m2w_A 29 GINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 102 (299)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBH
T ss_pred CCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcH
Confidence 79999999999999999999998642 3455688888777789999999999876 6789999999987445
Q ss_pred HHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee----CCcEEEeecCcccccCCCCCCCCcccc
Q 044127 77 KLMK-ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 77 ~~~~-~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~----~~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
..++ ...+..+++..++.++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++....
T Consensus 103 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----------- 171 (299)
T 3m2w_A 103 FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----------- 171 (299)
T ss_dssp HHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-----------
Confidence 4444 44345799999999999999999999999999999999999997 4689999999875432
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
+..++.++|||||||++|+|++|..||............ ........
T Consensus 172 -----------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~----------------------~~~~~~~~ 218 (299)
T 3m2w_A 172 -----------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------------------KTRIRMGQ 218 (299)
T ss_dssp -----------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS----------------------CCSSCTTC
T ss_pred -----------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH----------------------HHHHhhcc
Confidence 123688999999999999999999999765433211100 00000000
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
..........+++.+.+||.+||+.||.+|||++++++||||++....|
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 0011112246789999999999999999999999999999998876544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=293.81 Aligned_cols=239 Identities=21% Similarity=0.257 Sum_probs=186.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.||+|++..... ...+.+|+.++..+.+++++..+..+.......+++|||+++++.+ ++
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~-~~ 95 (296)
T 3uzp_A 20 GSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED-LF 95 (296)
T ss_dssp ETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHH-HH
T ss_pred CCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEecCCCHHH-HH
Confidence 7899999999999999999999865432 2356789999999974444555555556778889999999555554 44
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee----CCcEEEeecCcccccCCCCC--------CCCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSSLP--------CTDY 148 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~----~~~~~l~df~~~~~~~~~~~--------~~~~ 148 (282)
......+++..+..++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++........ ....
T Consensus 96 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 175 (296)
T 3uzp_A 96 NFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175 (296)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCC
T ss_pred HhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccc
Confidence 44445799999999999999999999999999999999999993 47899999999987654332 2455
Q ss_pred cccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHHhCCCCCCCccccccccccCCc
Q 044127 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS---ADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225 (282)
Q Consensus 149 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
.+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||..... ......+.......
T Consensus 176 ~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------------- 237 (296)
T 3uzp_A 176 TGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST----------------- 237 (296)
T ss_dssp CSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----------------
T ss_pred ccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-----------------
Confidence 7899999999988554 89999999999999999999999986433 22222222211000
Q ss_pred cccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
........+++.+.+++.+||+.||.+|||++++++
T Consensus 238 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 238 --------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp --------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred --------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 011233467899999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=294.51 Aligned_cols=238 Identities=20% Similarity=0.308 Sum_probs=190.3
Q ss_pred CCcceEEEEEecCCCc---EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcE-EEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDV-FIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~-~lv~e~~~~~~l 76 (282)
|+||+||+|.+..++. .|++|++...........+.+|+.+++++ +||||+++++++.+.+.. +++||++.++.+
T Consensus 32 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L 110 (298)
T 3pls_A 32 GHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGLPHVLLPYMCHGDL 110 (298)
T ss_dssp ETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEEECCCTTCBH
T ss_pred CCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCCcEEEEecccCCCH
Confidence 8999999999765544 79999987655455567778899999999 499999999999766554 999999987666
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-----CCCCCCccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-----SLPCTDYVT 150 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-----~~~~~~~~~ 150 (282)
..++......+++..+..++.|++.||.+||++|++|+||||+||++++ +.++|+|||++..... ........+
T Consensus 111 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 190 (298)
T 3pls_A 111 LQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190 (298)
T ss_dssp HHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTC
T ss_pred HHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCC
Confidence 6666655567999999999999999999999999999999999999986 6999999999975532 122234567
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCC-CCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRIL-FPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++.|+|||.+.+.. ++.++||||||+++|+|++|..| |...+..+....+.....
T Consensus 191 ~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~----------------------- 246 (298)
T 3pls_A 191 PVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR----------------------- 246 (298)
T ss_dssp GGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC-----------------------
T ss_pred CccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC-----------------------
Confidence 88899999997444 79999999999999999996554 555554444433322111
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...++.+.+++.+||+.||.+|||++++++
T Consensus 247 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 247 ------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1123456889999999999999999999999885
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=297.15 Aligned_cols=239 Identities=22% Similarity=0.266 Sum_probs=185.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+++.||+|++.... ....+..|..++..+.+++++..+..++......+++||++++++.+ ++
T Consensus 20 G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~-~~ 95 (296)
T 4hgt_A 20 GSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED-LF 95 (296)
T ss_dssp CSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHH-HH
T ss_pred CCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEccCCCHHH-HH
Confidence 899999999999999999999865532 23456778999999974555555555567788899999999555554 44
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceee---e-CCcEEEeecCcccccCCCCC--------CCCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLV---S-KGVIKIGDLGMVKEIDSSLP--------CTDY 148 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili---~-~~~~~l~df~~~~~~~~~~~--------~~~~ 148 (282)
......+++..+..++.||+.||.|||++|++|+||||+||++ + ++.++|+|||++........ ....
T Consensus 96 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~ 175 (296)
T 4hgt_A 96 NFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175 (296)
T ss_dssp HHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCC
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCccccc
Confidence 4444579999999999999999999999999999999999999 3 47899999999987654322 2355
Q ss_pred cccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHHhCCCCCCCccccccccccCCc
Q 044127 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSA---DQIYKICQVIGSPTEDSWPLGIQLASNLDW 225 (282)
Q Consensus 149 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
.+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...... .............
T Consensus 176 ~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------------- 237 (296)
T 4hgt_A 176 TGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST----------------- 237 (296)
T ss_dssp CSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----------------
T ss_pred CCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-----------------
Confidence 7899999999988554 899999999999999999999999865432 2222221111000
Q ss_pred cccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
........+++.+.++|.+||+.||++|||++++++
T Consensus 238 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 --------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp --------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred --------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 111233467899999999999999999999999885
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=294.63 Aligned_cols=238 Identities=20% Similarity=0.321 Sum_probs=190.7
Q ss_pred CCcceEEEEEecCC---CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccc-cccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKS---GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL-VKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~-~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|++..+ +..+++|.+...........+.+|+..++++. ||||++++++ +..++..+++|||+.++.+
T Consensus 36 G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L 114 (298)
T 3f66_A 36 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL 114 (298)
T ss_dssp ETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSCCEEEEECCTTCBH
T ss_pred cCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCCceEEEEeCCCCCCH
Confidence 89999999987543 34689999876554555667788999999995 9999999998 4566788999999998777
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-----CCCCccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-----PCTDYVT 150 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-----~~~~~~~ 150 (282)
..++......+++..+..++.|++.||.+||++|++|+||||+||++++ +.++|+|||.+....... ......+
T Consensus 115 ~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~ 194 (298)
T 3f66_A 115 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 194 (298)
T ss_dssp HHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCB
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCC
Confidence 7777665567999999999999999999999999999999999999985 799999999998653321 2234456
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+...........
T Consensus 195 ~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------- 251 (298)
T 3f66_A 195 PVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---------------------- 251 (298)
T ss_dssp CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC----------------------
T ss_pred CccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC----------------------
Confidence 78899999997544 8999999999999999999 56677776666655544332111
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...++.+.+++.+||+.||.+|||++++++
T Consensus 252 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 -------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 123356889999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=293.11 Aligned_cols=240 Identities=24% Similarity=0.368 Sum_probs=183.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|++.. .|++|+++...... ....+.+|+..++++. ||||++++++. .....++||||+.++++...
T Consensus 35 G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~ 109 (289)
T 3og7_A 35 GSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHH 109 (289)
T ss_dssp CSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CSSSCEEEEECCCEEEHHHH
T ss_pred CCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cCCccEEEEEecCCCcHHHH
Confidence 8999999997653 49999987654333 3456778999998885 99999999965 45568999999998777776
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC---CCCCCCcccccccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS---SLPCTDYVTTRWYR 155 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~ 155 (282)
+......+++..+..++.||+.||.+||++|++|+||||+||+++. +.++|+|||++..... ........+++.|+
T Consensus 110 l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 189 (289)
T 3og7_A 110 LHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189 (289)
T ss_dssp HTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTC
T ss_pred HhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCcccc
Confidence 6655567999999999999999999999999999999999999985 7999999999875543 22223457899999
Q ss_pred Cchhhh--ccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 156 APEVLL--LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 156 aPE~~~--~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
|||.+. ....++.++||||||+++|+|++|..||......+.............
T Consensus 190 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------ 245 (289)
T 3og7_A 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP------------------------ 245 (289)
T ss_dssp CHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC------------------------
T ss_pred CchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc------------------------
Confidence 999985 234478899999999999999999999998877776666554322111
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
........+++.+.+||.+||+.||.+|||++++++
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 112234467899999999999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=293.10 Aligned_cols=236 Identities=23% Similarity=0.356 Sum_probs=188.4
Q ss_pred CCcceEEEEE--ecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQAL--DKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~--~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|. ...+++.|++|++....... ....+.+|+.++..+ +||||+++++++ ..+..++|||++.++.+.
T Consensus 28 G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~ 105 (291)
T 1xbb_A 28 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAESWMLVMEMAELGPLN 105 (291)
T ss_dssp CSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSSEEEEEECCTTEEHH
T ss_pred ccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCCcEEEEEeCCCCCHH
Confidence 8999999994 45678899999997654332 355677899999999 599999999999 556789999999976666
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCC----CCccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC----TDYVTTR 152 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~----~~~~~~~ 152 (282)
.++... ..+++..+..++.||+.||.+||++|++|+||||+||+++ ++.++|+|||++......... ....+++
T Consensus 106 ~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 184 (291)
T 1xbb_A 106 KYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184 (291)
T ss_dssp HHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCG
T ss_pred HHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCc
Confidence 666654 4699999999999999999999999999999999999997 588999999999876443221 2234567
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+....
T Consensus 185 ~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------------------- 237 (291)
T 1xbb_A 185 KWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-------------------------- 237 (291)
T ss_dssp GGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------------------------
T ss_pred eeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence 899999997544 7899999999999999999 999998876655444332211
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+..+++.+.++|++||+.||.+|||+.++++
T Consensus 238 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 ---RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01223467899999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=305.58 Aligned_cols=239 Identities=19% Similarity=0.314 Sum_probs=185.2
Q ss_pred CCcceEEEEEecCC---CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccc-ccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKS---GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV-KEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|++..+ +..|++|.+...........+.+|+.+++++ +||||+++++++ ..++..++||||+.++.+
T Consensus 100 G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L 178 (373)
T 3c1x_A 100 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 178 (373)
T ss_dssp CSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSCCEEEEECCTTCBH
T ss_pred CCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCCeEEEEECCCCCCH
Confidence 89999999987643 3468999987655456667788999999998 499999999985 455688999999998777
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-----CCCCccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-----PCTDYVT 150 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-----~~~~~~~ 150 (282)
..++...+..+++..+..++.||+.||.|||++|++|+||||+||++++ +.+||+|||++....... ......+
T Consensus 179 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~ 258 (373)
T 3c1x_A 179 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258 (373)
T ss_dssp HHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------C
T ss_pred HHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCC
Confidence 7777666567999999999999999999999999999999999999985 799999999997653321 1123456
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+.....
T Consensus 259 ~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~----------------------- 314 (373)
T 3c1x_A 259 PVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR----------------------- 314 (373)
T ss_dssp CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-----------------------
T ss_pred cccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 77899999997544 8999999999999999999 6778877766655544332211
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+...++.+.++|.+||+.||.+|||+++++++
T Consensus 315 ------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 315 ------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01234568899999999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=290.25 Aligned_cols=232 Identities=28% Similarity=0.437 Sum_probs=189.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc----------------CCcE
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE----------------HEDV 64 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----------------~~~~ 64 (282)
|+||.||+|++..+++.|++|++.... ....+|+.++.++. ||||+++++++.. ....
T Consensus 22 G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (284)
T 2a19_B 22 GGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCL 95 (284)
T ss_dssp SSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC---------CCEEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCC-CCCEEEEeeeEeccccCcccccccccccCcceE
Confidence 899999999999999999999987542 34567899999995 9999999998754 4568
Q ss_pred EEEEecCCccHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC
Q 044127 65 FIVFEYMESDLLKLMK-ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 142 (282)
Q Consensus 65 ~lv~e~~~~~~l~~~~-~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~ 142 (282)
+++|||+.++.+..++ ...+..+++..++.++.||+.||.+||++|++|+||||+||++++ +.++|+|||++......
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 96 FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175 (284)
T ss_dssp EEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCC
T ss_pred EEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheecccc
Confidence 9999999975555544 444457999999999999999999999999999999999999975 79999999999887665
Q ss_pred CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccccc
Q 044127 143 LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN 222 (282)
Q Consensus 143 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (282)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|..|+... .........
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~--------------- 233 (284)
T 2a19_B 176 GKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFET------SKFFTDLRD--------------- 233 (284)
T ss_dssp SCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHT---------------
T ss_pred ccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhc---------------
Confidence 555667789999999999754 4799999999999999999998887421 111111100
Q ss_pred CCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 223 LDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
...+..++..+.++|.+||+.||.+|||+.+++++.+.
T Consensus 234 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 234 -------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp -------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 01223568899999999999999999999999998765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=309.33 Aligned_cols=231 Identities=25% Similarity=0.421 Sum_probs=187.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC-CcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH-EDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|.+. ++.||||+++... ....+.+|+.+++++. ||||+++++++.+. ...++|||||.++.|..+
T Consensus 204 G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~ 277 (450)
T 1k9a_A 204 GEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 277 (450)
T ss_dssp CSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTSCEEEEEECCTTCBHHHH
T ss_pred cCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCCceEEEEEecCCCcHHHH
Confidence 899999999875 7799999997643 4456788999999995 99999999997654 479999999987555555
Q ss_pred HHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 80 KERAG-QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~-~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+...+ ..+++..+..++.||+.||.|||++|++|+||||+||++++ +.+||+|||++....... ....++..|+||
T Consensus 278 l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aP 355 (450)
T 1k9a_A 278 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAP 355 (450)
T ss_dssp HHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------CCCTTTSCH
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--cCCCCCcceeCH
Confidence 44433 34799999999999999999999999999999999999984 799999999988654332 233567889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|++.+.. ++.++||||||+++|||++ |..||......+....+..... .
T Consensus 356 E~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-----------------------------~ 405 (450)
T 1k9a_A 356 EALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----------------------------M 405 (450)
T ss_dssp HHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-----------------------------C
T ss_pred HHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------------------------C
Confidence 9998544 8999999999999999998 9999988777666655433211 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+..+++.+.++|++||+.||.+|||+.++++
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 233467899999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=304.42 Aligned_cols=253 Identities=24% Similarity=0.262 Sum_probs=182.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCC----cEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE----DVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----~~~lv~e~~~~~~l 76 (282)
|+||+||+|++. ++.||+|++.... ........|+..+.++ +||||+++++++.... .+++|||||.++++
T Consensus 35 G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L 109 (322)
T 3soc_A 35 GRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL 109 (322)
T ss_dssp STTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred cCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEEEEEecCCCCCH
Confidence 899999999775 7899999987542 3344455688878788 4999999999987643 47999999988666
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc----------CccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ----------GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP- 144 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~----------~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~- 144 (282)
..++.. ..+++..++.++.||+.||.|||+. |++|+||||+||+++. +.+||+|||++........
T Consensus 110 ~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~ 187 (322)
T 3soc_A 110 SDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187 (322)
T ss_dssp HHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCC
T ss_pred HHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCc
Confidence 666665 3699999999999999999999999 9999999999999985 7999999999976543322
Q ss_pred --CCCccccccccCchhhhcc----ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccc
Q 044127 145 --CTDYVTTRWYRAPEVLLLS----EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQ 218 (282)
Q Consensus 145 --~~~~~~~~~~~aPE~~~~~----~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (282)
.....+++.|+|||.+.+. ..++.++|||||||++|+|++|..||.+................+.......
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 264 (322)
T 3soc_A 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQE--- 264 (322)
T ss_dssp CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHH---
T ss_pred cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhh---
Confidence 2345789999999998753 3356788999999999999999999976543211110000000000000000
Q ss_pred ccccCCccccCCCCCcccc--cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 219 LASNLDWKFPQMGGVNLRE--LSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..........+.. .....++.+.+||.+||+.||.+|||++++++
T Consensus 265 ------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 265 ------VVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp ------HHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------hhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000000000000 01122455999999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=318.74 Aligned_cols=237 Identities=23% Similarity=0.351 Sum_probs=193.6
Q ss_pred CCcceEEEEEec--CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDK--KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.++ .++..||||+++..........+.+|+.++.++ +||||+++++++.. +..++|||||.++.+..
T Consensus 347 G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~ 424 (613)
T 2ozo_A 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHK 424 (613)
T ss_dssp CSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSEEEEEECCTTCBHHH
T ss_pred CCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCeEEEEEeCCCCcHHH
Confidence 899999999876 356679999998765455667788999999999 59999999999876 56999999999877777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCC----CCcccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPC----TDYVTTRW 153 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~----~~~~~~~~ 153 (282)
++......+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++......... ....+++.
T Consensus 425 ~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 504 (613)
T 2ozo_A 425 FLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504 (613)
T ss_dssp HHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCT
T ss_pred HHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccc
Confidence 7665556799999999999999999999999999999999999998 479999999999876433211 12234578
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|+|||++.... ++.++|||||||++|||++ |..||......+....+.....
T Consensus 505 y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-------------------------- 557 (613)
T 2ozo_A 505 WYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-------------------------- 557 (613)
T ss_dssp TSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC--------------------------
T ss_pred eeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--------------------------
Confidence 99999997544 8999999999999999998 9999999888776655433211
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+..+++.+.++|.+||+.||.+||+++++++
T Consensus 558 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 558 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1233467899999999999999999999999853
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=304.02 Aligned_cols=247 Identities=17% Similarity=0.146 Sum_probs=180.0
Q ss_pred CCcceEEEEEecCC-----CcEEEEEEccccccchH-H---------HHHHHHHHHHHHhCCCCCeeeeccccccC----
Q 044127 1 GSYGDVFQALDKKS-----GEFVAVKKLKKKIFSLD-E---------SRNLKEVKCLRKMNNHPNIVKLRNLVKEH---- 61 (282)
Q Consensus 1 G~~g~Vy~~~~~~~-----~~~v~vK~~~~~~~~~~-~---------~~~~~e~~~l~~~~~hp~i~~~~~~~~~~---- 61 (282)
|+||+||+|.+..+ ++.||+|++........ . .....|+..+..+ +||||+++++++...
T Consensus 46 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~ 124 (364)
T 3op5_A 46 GGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGVPKYWGSGLHDKNGK 124 (364)
T ss_dssp C-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCSCCEEEEEEEEETTE
T ss_pred CCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCCCeEEeeeeeccCCc
Confidence 89999999998765 57899999865431100 0 1112233334444 499999999998654
Q ss_pred CcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee---CCcEEEeecCcccc
Q 044127 62 EDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKE 138 (282)
Q Consensus 62 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~---~~~~~l~df~~~~~ 138 (282)
...++||||+ |+++..++...+..+++..+..++.||+.||.|||++|++|+||||+||+++ ++.++|+|||++..
T Consensus 125 ~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~ 203 (364)
T 3op5_A 125 SYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203 (364)
T ss_dssp EEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEE
T ss_pred ceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCccee
Confidence 5689999999 5556666665556799999999999999999999999999999999999997 37899999999976
Q ss_pred cCCCCC--------CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCC
Q 044127 139 IDSSLP--------CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTE 210 (282)
Q Consensus 139 ~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (282)
...... .....+|+.|+|||.+.+.. ++.++|||||||++|+|++|..||.....................
T Consensus 204 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 282 (364)
T 3op5_A 204 YCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENI 282 (364)
T ss_dssp SSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCH
T ss_pred cccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhH
Confidence 532211 13345899999999997554 899999999999999999999999864433333222111100000
Q ss_pred CCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 211 DSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+ .+.. -.....++.+.+++..||+.||.+||++++|++
T Consensus 283 ~~~---------~~~~----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 283 ASL---------MDKC----------FPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHH---------HHHH----------SCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHH---------HHHh----------cccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 000 0000 011467899999999999999999999998875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=289.36 Aligned_cols=234 Identities=15% Similarity=0.230 Sum_probs=189.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|++. ++.||+|++...... .....+.+|+..+.++ +||||+++++++.+. ...+++|||+.++.+.
T Consensus 21 G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~ 97 (271)
T 3kmu_A 21 NHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLY 97 (271)
T ss_dssp ETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCEEEEECCTTCBHH
T ss_pred CCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeEeeecccCCCcHH
Confidence 799999999875 888999999865433 3345677888888888 599999999999876 7889999999976666
Q ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccccc
Q 044127 78 LMKERAG-QNFSEDEVRNLCFQVFQGLHYMHRQG--YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRW 153 (282)
Q Consensus 78 ~~~~~~~-~~l~~~~~~~i~~qi~~~l~~Lh~~~--~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~ 153 (282)
.++.... ..+++..+..++.||+.||.|||++| ++|+||||+||++++ +.++++||+++..... ....+++.
T Consensus 98 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~----~~~~~t~~ 173 (271)
T 3kmu_A 98 NVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPA 173 (271)
T ss_dssp HHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----TTCBSCGG
T ss_pred HHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc----cCccCCcc
Confidence 5555433 35999999999999999999999999 999999999999985 6899998887654332 34567899
Q ss_pred ccCchhhhcccc--CCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 154 YRAPEVLLLSEI--YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 154 ~~aPE~~~~~~~--~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
|+|||.+.+... .+.++||||||+++|+|++|..||......+...........
T Consensus 174 y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------------------ 229 (271)
T 3kmu_A 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR------------------------ 229 (271)
T ss_dssp GSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC------------------------
T ss_pred ccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC------------------------
Confidence 999999975432 233799999999999999999999887776665554432111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+..+++.+.++|.+||+.||.+|||++++++
T Consensus 230 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 ----PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1234567899999999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=298.96 Aligned_cols=253 Identities=21% Similarity=0.325 Sum_probs=190.2
Q ss_pred CCcceEEEEE----ecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc--cCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQAL----DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK--EHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~----~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~~~~ 74 (282)
|+||+||+|+ +..+++.|++|++.... ......+.+|+.+++++ +||||+++++++. +....++||||+.++
T Consensus 34 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 111 (327)
T 3lxl_A 34 GNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111 (327)
T ss_dssp ETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSCEEEEEEECCTTC
T ss_pred CCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCceEEEEEeecCCC
Confidence 7999999998 56789999999987643 33445678899999999 5999999999875 556799999999876
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCC----CCCCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL----PCTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~----~~~~~~ 149 (282)
++..++......+++..++.++.||+.||.+||++|++|+||||+||+++ ++.++|+|||++....... ......
T Consensus 112 ~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 191 (327)
T 3lxl_A 112 CLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191 (327)
T ss_dssp BHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCC
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCC
Confidence 66666655445699999999999999999999999999999999999997 5899999999998764433 223345
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.......... ..... ..+........
T Consensus 192 ~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-----~~~~~--~~~~~~~~~~~------- 256 (327)
T 3lxl_A 192 SPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-----MGCER--DVPALSRLLEL------- 256 (327)
T ss_dssp SCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-----CC------CCHHHHHHHH-------
T ss_pred ccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-----ccccc--ccccHHHHHHH-------
Confidence 778899999987544 7999999999999999999999986543221100 00000 00000000000
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
.........+..+++.+.++|++||+.||.+|||+++++++
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000112345778999999999999999999999999653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=301.35 Aligned_cols=250 Identities=22% Similarity=0.343 Sum_probs=190.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++. +++.||+|++.... ......+.+|+..+..+. ||||+++++++.+.+..++||||+.++.+..++
T Consensus 50 G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 126 (321)
T 2qkw_B 50 GVFGKVYKGVLR-DGAKVALKRRTPES-SQGIEEFETEIETLSFCR-HPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126 (321)
T ss_dssp CSSSEEEEEECT-TCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTTCCEEEEECCTTCBTGGGS
T ss_pred CCCeeEEEEEEC-CCCEEEEEEecccC-hHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHH
Confidence 899999999965 68899999987653 334556778999888884 999999999999999999999999876666555
Q ss_pred HhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC---CCCCCcccccc
Q 044127 81 ERAG---QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRW 153 (282)
Q Consensus 81 ~~~~---~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~---~~~~~~~~~~~ 153 (282)
.... ..+++..+..++.||+.||.+||++|++|+||||+||++++ +.++|+|||++...... .......+++.
T Consensus 127 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 206 (321)
T 2qkw_B 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206 (321)
T ss_dssp SSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETT
T ss_pred hccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCcc
Confidence 4322 35899999999999999999999999999999999999985 79999999998764322 22234468999
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH---HHHhCCCCCCCccccccccccCCccccCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKI---CQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
|+|||.+.+.. ++.++||||||+++|+|++|+.||....+.+..... ........ ......
T Consensus 207 y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~-- 270 (321)
T 2qkw_B 207 YIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ-------------LEQIVD-- 270 (321)
T ss_dssp TCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC-------------CCSSSS--
T ss_pred ccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc-------------HHHhcC--
Confidence 99999987554 899999999999999999999999765443221110 00000000 000000
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...........+..+.+++.+||+.||++|||+++++++
T Consensus 271 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 271 -PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp -SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000112233456779999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=300.07 Aligned_cols=253 Identities=20% Similarity=0.281 Sum_probs=187.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++. +++.||+|++...........+.+|+.++..+. ||||+++++++......++||||+.++++..++
T Consensus 41 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 118 (326)
T 3uim_A 41 GGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANGSVASCL 118 (326)
T ss_dssp CSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCC-CTTBCCCCEEECCSSCCEEEEECCTTCBHHHHH
T ss_pred CCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhcc-CCCccceEEEEecCCceEEEEEeccCCCHHHHH
Confidence 899999999854 588999999987654444446778999888885 999999999999999999999999986666666
Q ss_pred HhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCcccc
Q 044127 81 ERAG---QNFSEDEVRNLCFQVFQGLHYMHRQ---GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTT 151 (282)
Q Consensus 81 ~~~~---~~l~~~~~~~i~~qi~~~l~~Lh~~---~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~ 151 (282)
.... ..+++..+..++.|++.||.+||+. |++|+||||+||++++ +.++|+|||++........ .....++
T Consensus 119 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt 198 (326)
T 3uim_A 119 RERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198 (326)
T ss_dssp HCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSC
T ss_pred HhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCC
Confidence 5432 3499999999999999999999999 9999999999999986 6999999999986643322 2344589
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCC----CChHHHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGK----NSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
+.|+|||.+.+.. ++.++||||||+++|+|++|..||... ............. ...... ....
T Consensus 199 ~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~----------~~~~ 265 (326)
T 3uim_A 199 IGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL--LKEKKL----------EALV 265 (326)
T ss_dssp GGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT--TSSCCS----------TTSS
T ss_pred cCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH--hhchhh----------hhhc
Confidence 9999999987554 799999999999999999999999521 1111111111100 000000 0000
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCc
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHP 271 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~ 271 (282)
............+..+.+++.+||+.||.+|||++++++|-
T Consensus 266 ---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 266 ---DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp ---CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred ---ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 00000112233457899999999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=290.17 Aligned_cols=240 Identities=27% Similarity=0.432 Sum_probs=179.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||.||+|.+..+|+.||+|++..... ......+.+|+..++++. ||||+++++++...+..+++|||+.++.+..
T Consensus 43 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 121 (310)
T 2wqm_A 43 GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAGDLSR 121 (310)
T ss_dssp C--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEECCCSCBHHH
T ss_pred CCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcEEEEEecCCCCCHHH
Confidence 8999999999999999999999875332 234456778999999994 9999999999999999999999999866655
Q ss_pred HHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCC-CCCCcccccc
Q 044127 79 MKER---AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL-PCTDYVTTRW 153 (282)
Q Consensus 79 ~~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~ 153 (282)
++.. ....+++..++.++.||+.||.+||++|++|+||+|+||+++ ++.++|+|||++....... ......+++.
T Consensus 122 ~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 201 (310)
T 2wqm_A 122 MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 201 (310)
T ss_dssp HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------------------CCS
T ss_pred HHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCee
Confidence 5442 345699999999999999999999999999999999999998 4899999999987654332 2234568899
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSAD-QIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|+|||.+.+. .++.++||||||+++|+|++|..||....... ...........+
T Consensus 202 y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------ 256 (310)
T 2wqm_A 202 YMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP------------------------ 256 (310)
T ss_dssp SCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC------------------------
T ss_pred EeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC------------------------
Confidence 9999998754 47999999999999999999999997654321 111111111000
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.......++.+.++|.+||..||.+|||++++++
T Consensus 257 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 257 ---PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp ---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0112356889999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=292.60 Aligned_cols=239 Identities=21% Similarity=0.311 Sum_probs=183.4
Q ss_pred CCcceEEEEEecC---CCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCC-----cEEEEEecC
Q 044127 1 GSYGDVFQALDKK---SGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE-----DVFIVFEYM 71 (282)
Q Consensus 1 G~~g~Vy~~~~~~---~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-----~~~lv~e~~ 71 (282)
|+||+||+|.+.. ++..||+|++...... .....+.+|+..+.++. ||||+++++++.+.. ..+++|||+
T Consensus 45 G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~v~e~~ 123 (313)
T 3brb_A 45 GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFM 123 (313)
T ss_dssp -CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC-------CEEEEEECC
T ss_pred cCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeeccccCCcccEEEEecc
Confidence 8999999998765 5668999999865433 33456778999999995 999999999987654 459999999
Q ss_pred CccHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--
Q 044127 72 ESDLLKLMKER-----AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-- 143 (282)
Q Consensus 72 ~~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-- 143 (282)
.++.+..++.. ....+++..++.++.||+.||.+||++|++|+||||+||++++ +.++|+|||++.......
T Consensus 124 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~ 203 (313)
T 3brb_A 124 KYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY 203 (313)
T ss_dssp TTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC---------
T ss_pred cCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceeccccccc
Confidence 97666655532 2356999999999999999999999999999999999999985 799999999987654321
Q ss_pred -CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 144 -PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 144 -~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
......+++.|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+.....
T Consensus 204 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------- 267 (313)
T 3brb_A 204 RQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR--------------- 267 (313)
T ss_dssp -------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------------
T ss_pred CcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC---------------
Confidence 12334567789999999744 48999999999999999999 8899988877666655433211
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+..+++.+.++|.+||..||.+|||+++++++
T Consensus 268 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 --------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp --------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11234578899999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=308.47 Aligned_cols=242 Identities=20% Similarity=0.263 Sum_probs=191.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||.||+|++..+++.||||++.... ....+..|..++..+.+++++..+..++......++||||+++++.+. +
T Consensus 18 G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~g~sL~~l-l 93 (483)
T 3sv0_A 18 GSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDL-F 93 (483)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEETTC---SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHH-H
T ss_pred CCCEEEEEEEECCCCcEEEEEEecccc---ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECCCCCHHHH-H
Confidence 899999999999999999999876543 234567899999999877888888777888889999999995555554 4
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee----CCcEEEeecCcccccCCCCCC--------CCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSSLPC--------TDY 148 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~----~~~~~l~df~~~~~~~~~~~~--------~~~ 148 (282)
......+++..++.|+.||+.||.|||++||+|+||||+||+++ ++.+||+|||++......... ...
T Consensus 94 ~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 173 (483)
T 3sv0_A 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173 (483)
T ss_dssp HHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCC
T ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccccccccccc
Confidence 44445799999999999999999999999999999999999993 478999999999876543321 256
Q ss_pred cccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 149 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
.+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...........+.......
T Consensus 174 ~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-------------------- 232 (483)
T 3sv0_A 174 TGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-------------------- 232 (483)
T ss_dssp CSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH--------------------
T ss_pred CCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc--------------------
Confidence 7899999999998554 8999999999999999999999998765533322221111000
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.......+...+++++.+||..||+.||.+||++++|++
T Consensus 233 --~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 233 --VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp --HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 000111223467899999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=307.31 Aligned_cols=234 Identities=25% Similarity=0.442 Sum_probs=190.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|.+.. +..||||+++... .....+.+|+.+++++. ||||+++++++. .+..++||||+.++.+..++
T Consensus 199 G~fg~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l 273 (454)
T 1qcf_A 199 GQFGEVWMATYNK-HTKVAVKTMKPGS--MSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFL 273 (454)
T ss_dssp CSSEEEEEEEETT-TEEEEEEEECTTS--BCHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHH
T ss_pred CCceEEEEEEECC-ccEEEEEEecCCC--ccHHHHHHHHHHHhhCC-CCCEeeEEEEEe-CCccEEEEeecCCCcHHHHH
Confidence 8999999998864 6789999997653 33567788999999995 999999999987 55789999999865555444
Q ss_pred H-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccC
Q 044127 81 E-RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~-~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~a 156 (282)
. ..+..+++..+..++.||+.||.|||++|++|+||||+||+++. +.+||+|||++....... ......++..|+|
T Consensus 274 ~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~a 353 (454)
T 1qcf_A 274 KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 353 (454)
T ss_dssp HSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSC
T ss_pred HhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccC
Confidence 4 33346899999999999999999999999999999999999985 799999999998654321 1123345678999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||++.... ++.++||||||+++|||++ |..||.+....+....+......+
T Consensus 354 PE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------------------------- 405 (454)
T 1qcf_A 354 PEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP--------------------------- 405 (454)
T ss_dssp HHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC---------------------------
T ss_pred HHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---------------------------
Confidence 99997544 8999999999999999999 999999887776666554432211
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.+..+++.+.++|.+||+.||.+|||+++|++
T Consensus 406 --~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 23456899999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=307.16 Aligned_cols=240 Identities=25% Similarity=0.437 Sum_probs=189.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|.+.. +..||+|+++.... ....+.+|+.+++++. ||||+++++++.+ +..++||||+.++.+..++
T Consensus 195 G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l 269 (452)
T 1fmk_A 195 GCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 269 (452)
T ss_dssp CSSCEEEEEEETT-TEEEEEEECCTTSS--CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEEECCCTTCBHHHHH
T ss_pred CCCeEEEEEEECC-CceEEEEEeccCCC--CHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-CceEEEehhhcCCCHHHHH
Confidence 8999999999875 45699999986542 2456788999999995 9999999999876 6789999999875555544
Q ss_pred H-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccC
Q 044127 81 E-RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~-~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~a 156 (282)
. ..+..+++..+..++.||+.||.|||++|++|+||||+||++++ +.+||+|||++....... ......++..|+|
T Consensus 270 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~a 349 (452)
T 1fmk_A 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349 (452)
T ss_dssp SHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSC
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccC
Confidence 3 33456999999999999999999999999999999999999985 799999999998654322 1223445678999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+..+. ++.++||||||+++|+|++ |..||.+....+....+......
T Consensus 350 PE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------------------------- 400 (452)
T 1fmk_A 350 PEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------------------------- 400 (452)
T ss_dssp HHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------------------------
T ss_pred HhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------------------
Confidence 99998554 8999999999999999999 89999888776665554332111
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc--Cccccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE--HPFFRS 275 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--~~~~~~ 275 (282)
..+..+++.+.++|.+||+.||++|||++++++ ..++++
T Consensus 401 -~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 401 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 123467889999999999999999999999986 355543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=287.03 Aligned_cols=231 Identities=29% Similarity=0.451 Sum_probs=178.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++. ++.|++|++... .....+.+|+..+.++. ||||+++++++.+ ..++||||+.++++..++
T Consensus 19 G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l 90 (307)
T 2eva_A 19 GAFGVVCKAKWR--AKDVAIKQIESE---SERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCLVMEYAEGGSLYNVL 90 (307)
T ss_dssp CSSSEEEEEEET--TEEEEEEECSST---THHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TTEEEEECCTTCBHHHHH
T ss_pred CCCceEEEEEEC--CeeEEEEEecCh---hHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHH
Confidence 899999999765 788999998643 34566788999999994 9999999999875 478999999876666666
Q ss_pred HhcCC--CCCHHHHHHHHHHHHHHHHHHHH---cCccccCCCCCceeeeC-Cc-EEEeecCcccccCCCCCCCCcccccc
Q 044127 81 ERAGQ--NFSEDEVRNLCFQVFQGLHYMHR---QGYFHRDLKPSNLLVSK-GV-IKIGDLGMVKEIDSSLPCTDYVTTRW 153 (282)
Q Consensus 81 ~~~~~--~l~~~~~~~i~~qi~~~l~~Lh~---~~~~H~dl~p~nili~~-~~-~~l~df~~~~~~~~~~~~~~~~~~~~ 153 (282)
..... .++...+..++.||++||.|||+ +|++|+||||+||++++ +. +||+|||++....... ....+++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~ 168 (307)
T 2eva_A 91 HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--TNNKGSAA 168 (307)
T ss_dssp HCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------CCTT
T ss_pred hccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--ccCCCCCc
Confidence 54332 47899999999999999999999 89999999999999975 44 8999999987654432 34568999
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
|+|||.+.+. .++.++||||||+++|+|++|..||................+.
T Consensus 169 y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------- 221 (307)
T 2eva_A 169 WMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-------------------------- 221 (307)
T ss_dssp SSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC--------------------------
T ss_pred eEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC--------------------------
Confidence 9999998754 4899999999999999999999999865443322111111110
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
.......+++.+.++|.+||+.||.+|||++++++
T Consensus 222 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 222 -RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp -CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01223467889999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=315.04 Aligned_cols=236 Identities=23% Similarity=0.351 Sum_probs=190.3
Q ss_pred CCcceEEEEEe--cCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALD--KKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~--~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|.+ +.+++.||||+++...... ....+.+|+.++.++. ||||+++++++.. +..++|||||.++.+.
T Consensus 380 G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~ 457 (635)
T 4fl3_A 380 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEMAELGPLN 457 (635)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEEEEEECCTTEEHH
T ss_pred CCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEEEEEEccCCCCHH
Confidence 89999999954 4567899999998654332 3467789999999995 9999999999865 4588999999977676
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC----CCCccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP----CTDYVTTR 152 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~----~~~~~~~~ 152 (282)
.++... ..+++..+..++.||+.||+|||++|++|+||||+||++++ +.+||+|||++........ .....+++
T Consensus 458 ~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~ 536 (635)
T 4fl3_A 458 KYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 536 (635)
T ss_dssp HHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CG
T ss_pred HHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCce
Confidence 666554 47999999999999999999999999999999999999975 7899999999986643321 22334567
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||++.... ++.++|||||||++|||++ |..||.+....+....+.....
T Consensus 537 ~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------------------------- 590 (635)
T 4fl3_A 537 KWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------------------------- 590 (635)
T ss_dssp GGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------------------------
T ss_pred eeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------------------------
Confidence 899999997544 8999999999999999998 9999998877665554433211
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+..+++.+.++|..||+.||.+|||+++|++
T Consensus 591 ----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 591 ----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1223467899999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=297.15 Aligned_cols=241 Identities=13% Similarity=0.127 Sum_probs=182.6
Q ss_pred CCcceEEEEEecCC--------CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeee---------------eccc
Q 044127 1 GSYGDVFQALDKKS--------GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVK---------------LRNL 57 (282)
Q Consensus 1 G~~g~Vy~~~~~~~--------~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~---------------~~~~ 57 (282)
|+||+||+|++..+ ++.||+|++... ..+.+|+..+.++. ||||++ ++++
T Consensus 53 G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~i~~~~~~ 125 (352)
T 2jii_A 53 DNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAA-KPLQVNKWKKLYSTPLLAIPTCMGF 125 (352)
T ss_dssp ETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHC-CHHHHHHHHHHTTCTTCSCCCCCEE
T ss_pred CCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhc-ccchhhhhhhhccCCccCccchhhc
Confidence 78999999999874 889999998654 35677899999995 999887 4444
Q ss_pred ccc-CCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCC---cEEEeec
Q 044127 58 VKE-HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG---VIKIGDL 133 (282)
Q Consensus 58 ~~~-~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~---~~~l~df 133 (282)
+.. +...++||||+++++.+.+....+..+++..+..++.||+.||.|||++|++|+||||+||+++.+ .++|+||
T Consensus 126 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Df 205 (352)
T 2jii_A 126 GVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGY 205 (352)
T ss_dssp EEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCG
T ss_pred cccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecC
Confidence 443 678999999995555555444323579999999999999999999999999999999999999864 8999999
Q ss_pred CcccccCCCC--------CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHH
Q 044127 134 GMVKEIDSSL--------PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKN-SADQIYKICQV 204 (282)
Q Consensus 134 ~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~-~~~~~~~~~~~ 204 (282)
|++....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.... ...........
T Consensus 206 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 284 (352)
T 2jii_A 206 GFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQK 284 (352)
T ss_dssp GGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHH
T ss_pred cceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHh
Confidence 9997654321 113347899999999987544 8999999999999999999999998765 33333333322
Q ss_pred hCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 205 IGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
......... ........+++.+.++|++||+.||.+|||++++++
T Consensus 285 ~~~~~~~~~--------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 285 FVDKPGPFV--------------------GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHSCCCEE--------------------CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccCChhhhh--------------------hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 111110000 000112356899999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=291.56 Aligned_cols=250 Identities=21% Similarity=0.304 Sum_probs=190.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc---chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF---SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~---~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|.+ +++.|++|++..... ......+.+|+.+++++. ||||+++++++.+.+..+++|||+.++.+.
T Consensus 42 G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 118 (307)
T 2nru_A 42 GGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLVYVYMPNGSLL 118 (307)
T ss_dssp CSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred CCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEEEEecCCCcHH
Confidence 89999999976 588999999875431 233556778999999995 999999999999999999999999865555
Q ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---CCCcccc
Q 044127 78 LMKER--AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTT 151 (282)
Q Consensus 78 ~~~~~--~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~---~~~~~~~ 151 (282)
.++.. ....+++..++.++.||+.||.+||++|++|+||||+||++++ +.++|+|||++........ .....++
T Consensus 119 ~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~ 198 (307)
T 2nru_A 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGT 198 (307)
T ss_dssp HHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSC
T ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCC
Confidence 55442 2346999999999999999999999999999999999999985 7999999999876543221 2345689
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
+.|+|||.+.+ . ++.++||||||+++|+|++|..||...........+.......... . ....
T Consensus 199 ~~y~aPE~~~~-~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~--------------~~~~ 261 (307)
T 2nru_A 199 TAYMAPEALRG-E-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT-I--------------EDYI 261 (307)
T ss_dssp GGGCCHHHHTT-E-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC-H--------------HHHS
T ss_pred cCcCChHHhcC-C-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh-h--------------hhhc
Confidence 99999998863 3 7899999999999999999999998765544333332222111100 0 0000
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
.......+...++.+.+++.+||+.||.+|||+++++++
T Consensus 262 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 262 DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 001112223446779999999999999999999999863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=297.11 Aligned_cols=245 Identities=16% Similarity=0.153 Sum_probs=180.8
Q ss_pred CCcceEEEEEecC---CCcEEEEEEccccccch----------HHHHHHHHHHHHHHhCCCCCeeeecccccc----CCc
Q 044127 1 GSYGDVFQALDKK---SGEFVAVKKLKKKIFSL----------DESRNLKEVKCLRKMNNHPNIVKLRNLVKE----HED 63 (282)
Q Consensus 1 G~~g~Vy~~~~~~---~~~~v~vK~~~~~~~~~----------~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~ 63 (282)
|+||+||+|++.. ++..+|+|+........ ....+.+|+..+..+ +||||+++++++.. ...
T Consensus 48 G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~~~~~~~~~~~~~ 126 (345)
T 2v62_A 48 GGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFYGSGLTEFKGRSY 126 (345)
T ss_dssp ----CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEEEEEEEESSSCEE
T ss_pred cCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceeecccccccCCCcE
Confidence 8999999999987 78899999987653211 011244566667777 59999999999876 788
Q ss_pred EEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C--cEEEeecCcccccC
Q 044127 64 VFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G--VIKIGDLGMVKEID 140 (282)
Q Consensus 64 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~--~~~l~df~~~~~~~ 140 (282)
.++||||+ ++.+..++...+ .+++..++.++.||+.||.|||++|++|+||||+||+++. + .++|+|||++....
T Consensus 127 ~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~ 204 (345)
T 2v62_A 127 RFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204 (345)
T ss_dssp EEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESS
T ss_pred EEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecc
Confidence 99999999 555555555443 7999999999999999999999999999999999999984 4 89999999997653
Q ss_pred CCC--------CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHHhCCCCCC
Q 044127 141 SSL--------PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKN-SADQIYKICQVIGSPTED 211 (282)
Q Consensus 141 ~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~ 211 (282)
... ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||.... ................+.
T Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 283 (345)
T 2v62_A 205 PNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQ 283 (345)
T ss_dssp GGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTH
T ss_pred cccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccH
Confidence 221 11345789999999998854 48999999999999999999999996532 222222222211111000
Q ss_pred CccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 212 SWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
... .......+++.+.++|.+||..||.+|||++++++
T Consensus 284 ~~~--------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 284 SVL--------------------KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHH--------------------HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHH--------------------hhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 000 00001257889999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=288.52 Aligned_cols=238 Identities=23% Similarity=0.353 Sum_probs=181.9
Q ss_pred CCcceEEEEEecC-CCc--EEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKK-SGE--FVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~-~~~--~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|++.. +++ .|++|+++.... ......+.+|+..+.++. ||||+++++++..+. .++++|++.++.
T Consensus 29 G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~v~e~~~~~~ 106 (291)
T 1u46_A 29 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP-MKMVTELAPLGS 106 (291)
T ss_dssp ---CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS-CEEEEECCTTCB
T ss_pred CCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC-ceeeEecccCCC
Confidence 7899999998643 333 689999876532 234566788999999995 999999999998765 889999998655
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC----CCCccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP----CTDYVT 150 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~----~~~~~~ 150 (282)
+..++......+++..+..++.||+.||.+||++|++|+||||+||+++ ++.++|+|||++........ .....+
T Consensus 107 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 186 (291)
T 1u46_A 107 LLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186 (291)
T ss_dssp HHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----C
T ss_pred HHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCC
Confidence 5554444335699999999999999999999999999999999999997 58999999999887654322 123456
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
+..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+......
T Consensus 187 ~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------- 243 (291)
T 1u46_A 187 PFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---------------------- 243 (291)
T ss_dssp CGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC----------------------
T ss_pred CceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC----------------------
Confidence 77899999987544 7899999999999999999 99999888766655544321100
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+..+++.+.++|.+||..||.+|||++++++
T Consensus 244 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 244 ------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1123467899999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=294.18 Aligned_cols=240 Identities=25% Similarity=0.399 Sum_probs=183.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc----cCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK----EHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~----~~~~~~lv~e~~~~~~l 76 (282)
|+||.||+|++..+++.||+|++.... ......+.+|+.+++.+ +||||+++++++. .....++||||+.++.+
T Consensus 40 G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L 117 (317)
T 2buj_A 40 GGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL 117 (317)
T ss_dssp --CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBH
T ss_pred CCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcH
Confidence 899999999999999999999986532 33455677899999888 5999999999986 34578999999998555
Q ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC-------
Q 044127 77 KLMKER---AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC------- 145 (282)
Q Consensus 77 ~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~------- 145 (282)
..++.. .+..+++..++.++.||+.||.+||++|++|+||||+||+++. +.++|+|||.+.........
T Consensus 118 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 197 (317)
T 2buj_A 118 WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197 (317)
T ss_dssp HHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHH
T ss_pred HHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccc
Confidence 554443 3457999999999999999999999999999999999999974 89999999987754321110
Q ss_pred ---CCccccccccCchhhhccc--cCCCcchhHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHHhCCCCCCCccccccc
Q 044127 146 ---TDYVTTRWYRAPEVLLLSE--IYGPEVDMWAMGAIMFEMLSFRILFPGKNS-ADQIYKICQVIGSPTEDSWPLGIQL 219 (282)
Q Consensus 146 ---~~~~~~~~~~aPE~~~~~~--~~~~~~DiwslG~ll~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (282)
....+++.|+|||.+.... .++.++||||||+++|+|++|..||..... .+........ . .
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~-~----------- 264 (317)
T 2buj_A 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-Q-L----------- 264 (317)
T ss_dssp HHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C-------------
T ss_pred cccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-c-C-----------
Confidence 1234588899999986432 368899999999999999999999853110 0001111110 0 0
Q ss_pred cccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 220 ASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
........++.+.++|.+||+.||.+|||+++++++
T Consensus 265 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 ---------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 001123568899999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=286.31 Aligned_cols=231 Identities=25% Similarity=0.413 Sum_probs=178.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc-cCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK-EHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|.+. |+.|++|++.... ....+.+|+..+.++. ||||+++++++. ..+..+++|||+.++.+..+
T Consensus 32 G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 105 (278)
T 1byg_A 32 GEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 105 (278)
T ss_dssp CSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEEEECCCTTEEHHHH
T ss_pred CCCceEEEEEEc--CCEEEEEEecchh---HHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCceEEEEecCCCCCHHHH
Confidence 899999999764 8899999997543 4456778999999885 999999999864 44578999999987555444
Q ss_pred HHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 80 KERA-GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~-~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+... ...+++..+..++.|++.||.+||++|++|+||||+||+++ ++.++|+|||++....... ....+++.|+||
T Consensus 106 l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~y~aP 183 (278)
T 1byg_A 106 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAP 183 (278)
T ss_dssp HHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCH
T ss_pred HHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--cCCCccccccCH
Confidence 4432 22489999999999999999999999999999999999998 4799999999987654432 334667889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.+.. ++.++||||||+++|+|++ |..||......+....+.... ..
T Consensus 184 E~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~ 233 (278)
T 1byg_A 184 EALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-----------------------------KM 233 (278)
T ss_dssp HHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC-----------------------------CC
T ss_pred HHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----------------------------CC
Confidence 9987544 7999999999999999998 999998877665554432210 01
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...++.+.++|.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 233467899999999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=285.77 Aligned_cols=234 Identities=24% Similarity=0.423 Sum_probs=188.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|.+. ++..|++|++..... ....+.+|+..++++ +||||+++++++.+ +..+++|||+.++.+..++
T Consensus 24 G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l 98 (279)
T 1qpc_A 24 GQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 98 (279)
T ss_dssp ETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHT
T ss_pred CCCeEEEEEEEc-CCcEEEEEEecCCcc--cHHHHHHHHHHHHhC-CCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHH
Confidence 799999999876 467899999876532 345677899999999 49999999999875 4588999999866565554
Q ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccC
Q 044127 81 ER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~a 156 (282)
.. .+..+++..+..++.|++.||.+||++|++|+||||+||++++ +.++|+|||.+....... ......++..|+|
T Consensus 99 ~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~a 178 (279)
T 1qpc_A 99 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178 (279)
T ss_dssp TSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSC
T ss_pred hcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccC
Confidence 43 2236999999999999999999999999999999999999985 799999999998764332 1223455778999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+.+.. ++.++||||||+++|+|++ |..||......+....+.....
T Consensus 179 PE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------- 228 (279)
T 1qpc_A 179 PEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------------------------- 228 (279)
T ss_dssp HHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------------------------
T ss_pred hhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC-----------------------------
Confidence 99987444 7999999999999999999 8999988776665544432111
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...++.+.+++.+||..||++|||++++++
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1123467899999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=294.67 Aligned_cols=237 Identities=18% Similarity=0.263 Sum_probs=187.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|.+.. .+++|++....... ....+.+|+..+.++ +||||+++++++.+....+++|||+.++.+..+
T Consensus 44 G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~ 119 (319)
T 2y4i_B 44 GRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHLAIITSLCKGRTLYSV 119 (319)
T ss_dssp SSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCEEEECBCCCSEEHHHH
T ss_pred CCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCceEEEeecccCCcHHHH
Confidence 8999999998764 48999987643322 234456688888888 499999999999999999999999998777777
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccccCC------CCCCCCcccccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDS------SLPCTDYVTTRW 153 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~~~~------~~~~~~~~~~~~ 153 (282)
+...+..+++..+..++.||+.||.+||++|++|+||||+||+++++.++|+|||++..... ........+++.
T Consensus 120 l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~ 199 (319)
T 2y4i_B 120 VRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199 (319)
T ss_dssp TTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEECCCSCCC----------CCSCBCCSGGGG
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEEeecCCccccccccccccccccccCCCccc
Confidence 77655679999999999999999999999999999999999999999999999999775432 122233468899
Q ss_pred ccCchhhhc--------cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc
Q 044127 154 YRAPEVLLL--------SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225 (282)
Q Consensus 154 ~~aPE~~~~--------~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
|+|||.+.. ...++.++||||||+++|+|++|..||...........+......
T Consensus 200 y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 261 (319)
T 2y4i_B 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP------------------ 261 (319)
T ss_dssp TSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC------------------
T ss_pred ccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC------------------
Confidence 999999864 234688999999999999999999999887766555443321110
Q ss_pred cccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
......++..+.+++.+||..||.+|||++++++
T Consensus 262 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 262 ----------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp ----------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred ----------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112256889999999999999999999999985
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=293.43 Aligned_cols=240 Identities=23% Similarity=0.377 Sum_probs=188.7
Q ss_pred CCcceEEEEE----ecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc--CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQAL----DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE--HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~----~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~~~~ 74 (282)
|+||+||++. +..+++.||+|++...........+.+|+.+++++. ||||+++++++.+ ....++||||+.++
T Consensus 42 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 120 (318)
T 3lxp_A 42 GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLG 120 (318)
T ss_dssp CSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTTTEEEEEECCCTTC
T ss_pred CCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC-CcchhhEEEEEecCCCceEEEEEecccCC
Confidence 8999998775 445789999999987654455667789999999995 9999999999976 46789999999987
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC----CCCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP----CTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~----~~~~~ 149 (282)
.+..++... .+++..++.++.||+.||.+||+.|++|+||||+||++++ +.++|+|||++........ .....
T Consensus 121 ~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 198 (318)
T 3lxp_A 121 SLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198 (318)
T ss_dssp BHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CC
T ss_pred cHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCC
Confidence 777666653 5999999999999999999999999999999999999985 7899999999987654322 23445
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHH-----------HHHHHHHhCCCCCCCcccccc
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQ-----------IYKICQVIGSPTEDSWPLGIQ 218 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~ 218 (282)
++..|+|||.+.+.. ++.++||||||+++|+|++|..||........ ..........
T Consensus 199 ~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 266 (318)
T 3lxp_A 199 SPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER----------- 266 (318)
T ss_dssp CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT-----------
T ss_pred CCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc-----------
Confidence 777899999997544 78999999999999999999999865322110 0011111000
Q ss_pred ccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 219 LASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
......+..++..+.+||++||+.||.+|||++++++
T Consensus 267 --------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 267 --------------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp --------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0012234567899999999999999999999999984
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=288.86 Aligned_cols=253 Identities=22% Similarity=0.374 Sum_probs=188.9
Q ss_pred CCcceEEEEE----ecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccC--CcEEEEEecCCcc
Q 044127 1 GSYGDVFQAL----DKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEH--EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~----~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--~~~~lv~e~~~~~ 74 (282)
|+||.||+|+ +..+++.||+|++.... ......+.+|+.+++++. ||||+++++++... ...++|||++.++
T Consensus 52 G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 129 (326)
T 2w1i_A 52 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129 (326)
T ss_dssp CSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC----CCEEEECCCTTC
T ss_pred CCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEecCCCceEEEEECCCCC
Confidence 8999999998 46689999999987642 445566788999999994 99999999987654 3789999999886
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC----CCCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP----CTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~----~~~~~ 149 (282)
++..++......+++..+..++.||+.||.+||++|++|+||||+||+++ ++.++|+|||++........ .....
T Consensus 130 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 209 (326)
T 2w1i_A 130 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209 (326)
T ss_dssp BHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCS
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCC
Confidence 67666666555799999999999999999999999999999999999998 58999999999987654322 22345
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++..|+|||.+.+.. ++.++||||||+++|+|++|..||..... . .....+.......... ......
T Consensus 210 ~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~--~---~~~~~~~~~~~~~~~~-~~~~~~------ 276 (326)
T 2w1i_A 210 SPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--E---FMRMIGNDKQGQMIVF-HLIELL------ 276 (326)
T ss_dssp CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHH--H---HHHHHCTTCCTHHHHH-HHHHHH------
T ss_pred CceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHH--H---HHHhhccccchhhhHH-HHHHHh------
Confidence 677799999987544 78999999999999999999998864311 0 1111111100000000 000000
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
........+..+++.+.++|++||+.||.+|||+.++++
T Consensus 277 -~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 277 -KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp -HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000001234567899999999999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=308.80 Aligned_cols=239 Identities=15% Similarity=0.172 Sum_probs=179.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeee---------------------ccc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKL---------------------RNL 57 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~---------------------~~~ 57 (282)
|+||+||+|++..+|+.||||++....... ....+.+|+..+..+.++++.... ..+
T Consensus 89 G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (413)
T 3dzo_A 89 EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 168 (413)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-------
T ss_pred CCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccc
Confidence 899999999999999999999987433222 234566787777777522322111 111
Q ss_pred ccc-----CCcEEEEEecCCccHHHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C
Q 044127 58 VKE-----HEDVFIVFEYMESDLLKLMKE-----RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G 126 (282)
Q Consensus 58 ~~~-----~~~~~lv~e~~~~~~l~~~~~-----~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~ 126 (282)
+.. ....+++|+.+.+++.+.+.. ..+..+++..+..++.||+.||.|||++|++||||||+||+++. +
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~ 248 (413)
T 3dzo_A 169 RLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 248 (413)
T ss_dssp --------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred cCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCC
Confidence 111 235788999888877765531 12345788899999999999999999999999999999999985 7
Q ss_pred cEEEeecCcccccCCCCCCCCccccccccCchhhh---------ccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHH
Q 044127 127 VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL---------LSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQ 197 (282)
Q Consensus 127 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~---------~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~ 197 (282)
.+||+|||++...+.. .....| +.|+|||.+. ....++.++|||||||++|+|++|+.||........
T Consensus 249 ~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~ 325 (413)
T 3dzo_A 249 GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325 (413)
T ss_dssp CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC
T ss_pred eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 8999999998876544 244566 8999999984 334478899999999999999999999976543221
Q ss_pred HHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 198 IYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
... . ......+++.+.+||.+||+.||.+|||+.++++||||+++
T Consensus 326 ~~~-------------------------~---------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 326 SEW-------------------------I---------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp SGG-------------------------G---------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHH-------------------------H---------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 100 0 01123568999999999999999999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=290.15 Aligned_cols=239 Identities=26% Similarity=0.327 Sum_probs=178.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHh-CCCCCeeeeccccc----cCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKM-NNHPNIVKLRNLVK----EHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~-~~hp~i~~~~~~~~----~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|++ +++.||+|++... .......|..++... .+||||+++++++. .....++||||+.++.
T Consensus 19 G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~ 92 (301)
T 3q4u_A 19 GRYGEVWRGSW--QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGS 92 (301)
T ss_dssp CSSEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCB
T ss_pred CCCcEEEEEEE--CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCC
Confidence 89999999976 5889999998653 233445566666553 36999999999854 3456899999999866
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMH--------RQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP-- 144 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh--------~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~-- 144 (282)
+..++.. ..+++..+..++.||+.||.||| +.|++|+||||+||+++. +.+||+|||++........
T Consensus 93 L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 170 (301)
T 3q4u_A 93 LYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL 170 (301)
T ss_dssp HHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEE
T ss_pred HHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccc
Confidence 6666654 47999999999999999999999 999999999999999984 7999999999876543322
Q ss_pred ---CCCccccccccCchhhhccc-----cCCCcchhHHHHHHHHHHHhC----------CCCCCCCCCh----HHHHHHH
Q 044127 145 ---CTDYVTTRWYRAPEVLLLSE-----IYGPEVDMWAMGAIMFEMLSF----------RILFPGKNSA----DQIYKIC 202 (282)
Q Consensus 145 ---~~~~~~~~~~~aPE~~~~~~-----~~~~~~DiwslG~ll~~l~~g----------~~~~~~~~~~----~~~~~~~ 202 (282)
.....+++.|+|||.+.+.. .++.++|||||||++|+|++| ..||...... .......
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~ 250 (301)
T 3q4u_A 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV 250 (301)
T ss_dssp ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH
T ss_pred cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHH
Confidence 12347899999999997542 244789999999999999999 7787553322 2221111
Q ss_pred HHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 203 QVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..... .. ...........++.+.+++.+||+.||.+|||++++++
T Consensus 251 ~~~~~--~~--------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 251 CVDQQ--RP--------------------NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTSCC--CC--------------------CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred hccCC--CC--------------------CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 10000 00 00001112235678999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=306.97 Aligned_cols=240 Identities=25% Similarity=0.436 Sum_probs=192.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|.+.. +..||||+++.... ....+.+|+.+++++. ||||+++++++.+ +..++||||+.++.|..++
T Consensus 278 G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l 352 (535)
T 2h8h_A 278 GCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 352 (535)
T ss_dssp CSSEEEEEEEETT-TEEEEEEEECTTSS--CHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEEECCCTTEEHHHHH
T ss_pred CCCeEEEEEEECC-CceEEEEEeCCCCC--CHHHHHHHHHHHHhCC-CCCEeeEEEEEee-ccceEeeehhcCCcHHHHH
Confidence 8999999999875 45699999976542 3456788999999995 9999999999876 6789999999875555444
Q ss_pred H-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccC
Q 044127 81 E-RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~-~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~a 156 (282)
. ..+..+++..+..++.||+.||.|||++|++|+||||+||++++ +.+||+|||++....... ......++..|+|
T Consensus 353 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~a 432 (535)
T 2h8h_A 353 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 432 (535)
T ss_dssp SHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSC
T ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccC
Confidence 3 33456999999999999999999999999999999999999975 799999999997654321 1123345678999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||++.... ++.++|||||||++|||++ |..||.+....+....+......
T Consensus 433 PE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------------------------- 483 (535)
T 2h8h_A 433 PEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------------------------- 483 (535)
T ss_dssp HHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC----------------------------
T ss_pred HHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------------------
Confidence 99998554 8999999999999999999 89999887766665554332111
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC--ccccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEH--PFFRS 275 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~--~~~~~ 275 (282)
..+..+++.+.+||.+||+.||++|||+++|++. .+|..
T Consensus 484 -~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 1234678899999999999999999999999863 45543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=309.29 Aligned_cols=237 Identities=25% Similarity=0.400 Sum_probs=192.9
Q ss_pred CCcceEEEEEecCC---CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKS---GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|.+..+ +..|++|+............+.+|+.++.++ +||||+++++++.+ +..++||||+.++.+.
T Consensus 401 G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~ 478 (656)
T 2j0j_A 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE-NPVWIIMELCTLGELR 478 (656)
T ss_dssp CSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEECCTTCBHH
T ss_pred CCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec-CceEEEEEcCCCCcHH
Confidence 89999999998653 4679999987655445556778899999999 49999999999865 5689999999977777
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC--CCCccccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP--CTDYVTTRWY 154 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~ 154 (282)
.++...+..+++..+..++.||+.||.|||++|++|+||||+||+++ ++.+||+|||++........ .....+++.|
T Consensus 479 ~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y 558 (656)
T 2j0j_A 479 SFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558 (656)
T ss_dssp HHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGG
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcce
Confidence 77666555799999999999999999999999999999999999998 58999999999987644322 1233456789
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
+|||.+.+. .++.++||||||+++|+|++ |..||.+....+....+......
T Consensus 559 ~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~-------------------------- 611 (656)
T 2j0j_A 559 MAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-------------------------- 611 (656)
T ss_dssp CCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC--------------------------
T ss_pred eCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--------------------------
Confidence 999999754 48999999999999999997 89999988777766655442111
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+..+++.+.++|.+||+.||.+|||++++++
T Consensus 612 ---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 123467899999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=292.97 Aligned_cols=230 Identities=13% Similarity=0.143 Sum_probs=176.7
Q ss_pred CCcceEEEE-----EecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhC--CCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQA-----LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN--NHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~-----~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~--~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||+||+| .+..+++.||+|++.... ...+..|...+..+. .|+||+.+++++...+..++|||||.+
T Consensus 76 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 151 (365)
T 3e7e_A 76 GAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSY 151 (365)
T ss_dssp CSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCS
T ss_pred cCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCC
Confidence 899999999 467789999999987542 334555666666664 289999999999999999999999987
Q ss_pred cHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC------------CcEEEeecCccc
Q 044127 74 DLLKLMKER----AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK------------GVIKIGDLGMVK 137 (282)
Q Consensus 74 ~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~------------~~~~l~df~~~~ 137 (282)
+.|..++.. ....+++..++.++.||+.||+|||++|++||||||+||+++. +.+||+|||++.
T Consensus 152 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~ 231 (365)
T 3e7e_A 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231 (365)
T ss_dssp CBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCE
T ss_pred CcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhh
Confidence 666555543 2457999999999999999999999999999999999999965 689999999996
Q ss_pred ccC---CCCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcc
Q 044127 138 EID---SSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP 214 (282)
Q Consensus 138 ~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (282)
... .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... +.
T Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~----------------~~ 294 (365)
T 3e7e_A 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----------------CK 294 (365)
T ss_dssp EGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----------------EE
T ss_pred hhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc----------------ee
Confidence 543 233334567899999999998555 8999999999999999999999985432210 00
Q ss_pred ccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 215 LGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+. ....++.+.+++..||+.+|.+|++..+.+.
T Consensus 295 --------~~~~~~----------~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 295 --------PEGLFR----------RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp --------ECSCCT----------TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred --------echhcc----------ccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 000000 0123677899999999999999976544443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=286.89 Aligned_cols=263 Identities=24% Similarity=0.219 Sum_probs=173.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHH-hCCCCCeeeecccc-----ccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRK-MNNHPNIVKLRNLV-----KEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~-~~~hp~i~~~~~~~-----~~~~~~~lv~e~~~~~ 74 (282)
|+||+||+|++ +++.||+|++.... ......|..+... ..+||||+++++.+ ......++|||||.++
T Consensus 24 G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g 97 (336)
T 3g2f_A 24 GRYGAVYKGSL--DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNG 97 (336)
T ss_dssp CSSEEEEEEEE--TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTC
T ss_pred CCCeEEEEEEE--CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCC
Confidence 89999999965 68999999986542 2222233333221 23699999998743 3445689999999876
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---------CccccCCCCCceeeeC-CcEEEeecCcccccCCC--
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ---------GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-- 142 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~---------~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-- 142 (282)
.|..++... ..++..+..++.||+.||.|||+. |++|+||||+||+++. +.+||+|||++......
T Consensus 98 ~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~ 175 (336)
T 3g2f_A 98 SLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175 (336)
T ss_dssp BHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSC
T ss_pred cHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccc
Confidence 666666653 569999999999999999999999 9999999999999985 79999999999765432
Q ss_pred -------CCCCCccccccccCchhhhcc------ccCCCcchhHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHHhCCC
Q 044127 143 -------LPCTDYVTTRWYRAPEVLLLS------EIYGPEVDMWAMGAIMFEMLSFRILFPGKNS-ADQIYKICQVIGSP 208 (282)
Q Consensus 143 -------~~~~~~~~~~~~~aPE~~~~~------~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~ 208 (282)
.......+++.|+|||.+.+. ..++.++|||||||++|+|++|..||..... .+.........+..
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3g2f_A 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNH 255 (336)
T ss_dssp C---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSS
T ss_pred cCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCC
Confidence 112245689999999998752 3456789999999999999999776643221 11000000000000
Q ss_pred CCCCccccccccccCCccccCCCCCcccc---cCCCCChhhHHHHHHHhCCCCCCCCCHHHHh------cCcccccccCc
Q 044127 209 TEDSWPLGIQLASNLDWKFPQMGGVNLRE---LSPSASRESISLISRLCSWNPHMRPTAAEAL------EHPFFRSCHFV 279 (282)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll------~~~~~~~~~~~ 279 (282)
... ...... ..........+. .....++.+.+||.+||+.||.+|||+++++ .++|-++-..-
T Consensus 256 ~~~--~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~~~ 327 (336)
T 3g2f_A 256 PTF--EDMQVL------VSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327 (336)
T ss_dssp CCH--HHHHHH------HTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-----
T ss_pred chH--HHHHhh------hcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcccCC
Confidence 000 000000 000000000000 0112345799999999999999999999994 46777765443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=287.39 Aligned_cols=239 Identities=26% Similarity=0.346 Sum_probs=174.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHh-CCCCCeeeeccccccC----CcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKM-NNHPNIVKLRNLVKEH----EDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~-~~hp~i~~~~~~~~~~----~~~~lv~e~~~~~~ 75 (282)
|+||.||+|++. ++.||+|++.... ......|..++... .+||||+++++++... ...++||||+.++.
T Consensus 48 G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~ 121 (337)
T 3mdy_A 48 GRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS 121 (337)
T ss_dssp ETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCB
T ss_pred CCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCc
Confidence 799999999875 8899999986432 23334455544443 2699999999998766 68999999998866
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc--------CccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC-
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ--------GYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC- 145 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~--------~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~- 145 (282)
+..++.. ..+++..++.++.|++.||.|||+. |++|+||||+||+++. +.+||+|||++.........
T Consensus 122 L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 199 (337)
T 3mdy_A 122 LYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199 (337)
T ss_dssp HHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred HHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccc
Confidence 6666655 3699999999999999999999999 9999999999999974 79999999999765433221
Q ss_pred ----CCccccccccCchhhhccccCCC------cchhHHHHHHHHHHHhC----------CCCCCCCCChH----HHHHH
Q 044127 146 ----TDYVTTRWYRAPEVLLLSEIYGP------EVDMWAMGAIMFEMLSF----------RILFPGKNSAD----QIYKI 201 (282)
Q Consensus 146 ----~~~~~~~~~~aPE~~~~~~~~~~------~~DiwslG~ll~~l~~g----------~~~~~~~~~~~----~~~~~ 201 (282)
....+++.|+|||.+.+.. ... ++|||||||++|+|++| ..||....... .....
T Consensus 200 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 278 (337)
T 3mdy_A 200 DIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278 (337)
T ss_dssp ---CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH
T ss_pred cCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHH
Confidence 2457899999999987544 344 38999999999999999 56665432211 11111
Q ss_pred HHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 202 CQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
... ... .... .........++.+.++|.+||+.||.+|||+++++++
T Consensus 279 ~~~-~~~-~~~~--------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 279 VCI-KKL-RPSF--------------------PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HTT-SCC-CCCC--------------------CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred Hhh-hcc-Cccc--------------------cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 110 000 0000 0000112346779999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=283.01 Aligned_cols=242 Identities=26% Similarity=0.332 Sum_probs=181.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHh-CCCCCeeeeccccccCC----cEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKM-NNHPNIVKLRNLVKEHE----DVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~-~~hp~i~~~~~~~~~~~----~~~lv~e~~~~~~ 75 (282)
|+||+||+|++ +++.||+|++... ......+|..++... .+||||+++++++.... ..++||||+.++.
T Consensus 53 G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~ 126 (342)
T 1b6c_B 53 GRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGS 126 (342)
T ss_dssp ETTEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCB
T ss_pred CCCcEEEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCc
Confidence 78999999987 4899999998653 234556788877773 36999999999987765 8999999999866
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC---
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMH--------RQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--- 143 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh--------~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--- 143 (282)
+..++.. ..+++..++.++.||+.||.+|| +.|++|+||||+||+++. +.++|+|||++.......
T Consensus 127 L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 204 (342)
T 1b6c_B 127 LFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204 (342)
T ss_dssp HHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEE
T ss_pred HHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecccccccc
Confidence 6666655 36999999999999999999999 899999999999999974 799999999997665433
Q ss_pred --CCCCccccccccCchhhhcccc-----CCCcchhHHHHHHHHHHHhC----------CCCCCCCCChH-HHHHHHHHh
Q 044127 144 --PCTDYVTTRWYRAPEVLLLSEI-----YGPEVDMWAMGAIMFEMLSF----------RILFPGKNSAD-QIYKICQVI 205 (282)
Q Consensus 144 --~~~~~~~~~~~~aPE~~~~~~~-----~~~~~DiwslG~ll~~l~~g----------~~~~~~~~~~~-~~~~~~~~~ 205 (282)
......+++.|+|||.+.+... ++.++||||||+++|+|++| ..||......+ ....+....
T Consensus 205 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 284 (342)
T 1b6c_B 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 284 (342)
T ss_dssp EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH
T ss_pred ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHH
Confidence 2244578999999999875421 23689999999999999999 67876543211 111111111
Q ss_pred CC-CCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 206 GS-PTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 206 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
.. ......+ ........++.+.++|.+||+.||++|||+++++++
T Consensus 285 ~~~~~~~~~~--------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 285 CEQKLRPNIP--------------------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTSCCCCCCC--------------------GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCc--------------------ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 00 0000000 000112345679999999999999999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=314.56 Aligned_cols=229 Identities=24% Similarity=0.354 Sum_probs=186.2
Q ss_pred CCcceEEEEEecC-CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc-----EEEEEecCCcc
Q 044127 1 GSYGDVFQALDKK-SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHED-----VFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~-----~~lv~e~~~~~ 74 (282)
|+||+||+|.+.. +++.|++|++...........+.+|+..+.++. ||||+++++++...+. .|+||||+.|+
T Consensus 91 G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~ 169 (681)
T 2pzi_A 91 GGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQ 169 (681)
T ss_dssp ETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEECTTSCEEEEEEEECCCCE
T ss_pred CCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecCCCCCceeEEEEEeCCCC
Confidence 7999999999976 789999999876543444556778999998885 9999999999987655 79999999987
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccccCCCCCCCCccccccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPCTDYVTTRWY 154 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 154 (282)
++...... .+++..+..++.||+.||.|||++||+|+||||+||+++++.+||+|||++...... ....||+.|
T Consensus 170 ~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl~DFG~a~~~~~~---~~~~gt~~y 243 (681)
T 2pzi_A 170 SLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKLIDLGAVSRINSF---GYLYGTPGF 243 (681)
T ss_dssp ECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEECCCTTCEETTCC---SCCCCCTTT
T ss_pred cHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEEEecccchhcccC---CccCCCccc
Confidence 77665543 799999999999999999999999999999999999999999999999999876543 456789999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||.+.++ .+.++|||||||++|+|++|..||........ + ..
T Consensus 244 ~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~--~~---------------------- 287 (681)
T 2pzi_A 244 QAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------P--ED---------------------- 287 (681)
T ss_dssp SCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------C--TT----------------------
T ss_pred cCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccccc----------c--cc----------------------
Confidence 999998743 38899999999999999999888764211000 0 00
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 274 (282)
......++.+.++|.+||+.||.+||+..+.+.|+|+.
T Consensus 288 --~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 288 --DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp --CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00012357899999999999999999998888888874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=291.77 Aligned_cols=235 Identities=16% Similarity=0.167 Sum_probs=175.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-------chHHHHHHHHHHHHHHhC--------C-----------------C
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-------SLDESRNLKEVKCLRKMN--------N-----------------H 48 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-------~~~~~~~~~e~~~l~~~~--------~-----------------h 48 (282)
|+||+||+|++ +|+.||+|++..... ......+.+|+.+++.+. . |
T Consensus 31 G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~h 108 (336)
T 2vuw_A 31 GVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYP 108 (336)
T ss_dssp ETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCC
T ss_pred cCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCc
Confidence 79999999987 689999999986532 122356677888888775 2 4
Q ss_pred CCeeeecccccc-------------CCcEEEEEecCCcc-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCccc
Q 044127 49 PNIVKLRNLVKE-------------HEDVFIVFEYMESD-LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMH-RQGYFH 113 (282)
Q Consensus 49 p~i~~~~~~~~~-------------~~~~~lv~e~~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh-~~~~~H 113 (282)
|||+++++++.+ .+..|+|||||.++ +++.+.. ..+++..++.++.||+.||.||| ++|++|
T Consensus 109 p~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH 185 (336)
T 2vuw_A 109 PLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLRFEH 185 (336)
T ss_dssp HHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHCCBC
T ss_pred HHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCCEeE
Confidence 555555555554 78899999999754 6666543 46899999999999999999999 999999
Q ss_pred cCCCCCceeeeC-C--------------------cEEEeecCcccccCCCCCCCCccccccccCchhhhccccCCCcchh
Q 044127 114 RDLKPSNLLVSK-G--------------------VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172 (282)
Q Consensus 114 ~dl~p~nili~~-~--------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di 172 (282)
|||||+||+++. + .+||+|||++...... ...||+.|+|||++.+.. +.++||
T Consensus 186 rDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~--~~~~Di 259 (336)
T 2vuw_A 186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG--DYQFDI 259 (336)
T ss_dssp SCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCS--SHHHHH
T ss_pred CCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCC--ccceeh
Confidence 999999999985 4 8999999999876542 457899999999997443 889999
Q ss_pred HHHHHH-HHHHHhCCCCCCCCCChH-HHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHH
Q 044127 173 WAMGAI-MFEMLSFRILFPGKNSAD-QIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLI 250 (282)
Q Consensus 173 wslG~l-l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 250 (282)
||||++ .+++++|..||....... ....+....... .......+..+++++++||
T Consensus 260 wsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 260 YRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK-----------------------TKCNTPAMKQIKRKIQEFH 316 (336)
T ss_dssp HHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS-----------------------SCCCSHHHHHHHHHHHHHH
T ss_pred hhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC-----------------------cccchhhhhhcCHHHHHHH
Confidence 998776 777888988884321111 111111110000 0011112234688999999
Q ss_pred HHHhCCCCCCCCCHHHHh-cCcccc
Q 044127 251 SRLCSWNPHMRPTAAEAL-EHPFFR 274 (282)
Q Consensus 251 ~~~l~~dp~~Rps~~~ll-~~~~~~ 274 (282)
++||+.| |++|+| +||||+
T Consensus 317 ~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 317 RTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHHhccC-----CHHHHHhcCCCcC
Confidence 9999977 999999 999996
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=268.62 Aligned_cols=214 Identities=15% Similarity=0.146 Sum_probs=170.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|++..+++.||+|++...... .....+.+|+..+.++ +||||+++++++.+++..|+||||+.|+++..
T Consensus 42 G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~ 120 (286)
T 3uqc_A 42 VPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQE 120 (286)
T ss_dssp STTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCCEEEHHH
T ss_pred cCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcEEEEEEecCCCCHHH
Confidence 89999999999999999999999876443 2335677888888888 59999999999999999999999999877777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++.. ......+..++.||+.||.|||++|++|+||||+||++++ +.++|++++. ++
T Consensus 121 ~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~-------------------~~- 177 (286)
T 3uqc_A 121 VADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT-------------------MP- 177 (286)
T ss_dssp HHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-------------------CT-
T ss_pred HHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-------------------cC-
Confidence 7654 2467788999999999999999999999999999999985 7888885432 22
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
.++.++|||||||++|+|++|..||.+.+..+.... ..............
T Consensus 178 -------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~ 227 (286)
T 3uqc_A 178 -------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----------------------AERDTAGQPIEPAD 227 (286)
T ss_dssp -------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-----------------------CCBCTTSCBCCHHH
T ss_pred -------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-----------------------HHHHhccCCCChhh
Confidence 268899999999999999999999987643221100 00000111112234
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
....+++.+.++|.+||+.||.+| |++++++
T Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred cccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 456789999999999999999999 9999986
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=259.78 Aligned_cols=182 Identities=14% Similarity=0.104 Sum_probs=131.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc---------chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF---------SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYM 71 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~---------~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 71 (282)
|+.|.+..+++...|+.|++|++..... ......+.+|+.+++++.+|+||+++++++++++..||||||+
T Consensus 245 ~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv 324 (569)
T 4azs_A 245 GAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKL 324 (569)
T ss_dssp -------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECC
T ss_pred CCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecC
Confidence 4556677777777899999999875421 1234567889999999988999999999999999999999999
Q ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCC-CCCCCcc
Q 044127 72 ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSS-LPCTDYV 149 (282)
Q Consensus 72 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~-~~~~~~~ 149 (282)
+|+.|..++...+ ++++. +|+.||++||+|+|++||+||||||+|||++ ++.+||+|||+|...... ......+
T Consensus 325 ~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~v 400 (569)
T 4azs_A 325 PGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLV 400 (569)
T ss_dssp CSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHH
T ss_pred CCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCce
Confidence 9988888887654 67765 4789999999999999999999999999998 489999999999876443 2334568
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRIL 188 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~ 188 (282)
||+.|+|||.+.+. ...++|+||+|++++++.++..+
T Consensus 401 GTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 401 QSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred echhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence 99999999998743 57789999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-28 Score=209.85 Aligned_cols=176 Identities=19% Similarity=0.208 Sum_probs=137.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-h------HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-L------DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~------~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||+||+|. ..+..+++|+....... . ....+.+|+.+++++. ||||+.+..+....+..++|||||.+
T Consensus 347 G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lVmE~~~g 423 (540)
T 3en9_A 347 GAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKRIMMSYING 423 (540)
T ss_dssp -CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTEEEEECCCS
T ss_pred CCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccEEEEECCCC
Confidence 8999999994 44778899986443221 1 1234678999999995 99999555555566677999999987
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccccCCCCCC--------
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSLPC-------- 145 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~~~~~~~~-------- 145 (282)
+.|..++.. +..++.||++||.|||++|++|+||||+||++++ .+||+|||++.........
T Consensus 424 gsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-~~kL~DFGla~~~~~~~~~~~~~~~~~ 493 (540)
T 3en9_A 424 KLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-DLYIIDFGLGKISNLDEDKAVDLIVFK 493 (540)
T ss_dssp EEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-SEEECCCTTCEECCCHHHHHHHHHHHH
T ss_pred CCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-eEEEEECccCEECCCccccccchhhhh
Confidence 666655543 5689999999999999999999999999999999 9999999999877543211
Q ss_pred CCccccccccCchhhhcc-ccCCCcchhHHHHHHHHHHHhCCCCC
Q 044127 146 TDYVTTRWYRAPEVLLLS-EIYGPEVDMWAMGAIMFEMLSFRILF 189 (282)
Q Consensus 146 ~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~ll~~l~~g~~~~ 189 (282)
....+|+.|+|||++... ..++..+|+||..+-..+-+.++.+|
T Consensus 494 ~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 494 KAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 245789999999999741 33678889999998888877766554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6e-24 Score=169.90 Aligned_cols=135 Identities=21% Similarity=0.179 Sum_probs=104.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-----------------hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-----------------LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHED 63 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-----------------~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~ 63 (282)
|+||.||+|.+ .+|+.||+|+++..... .....+.+|+.++.++. | +++.+.+.. +.
T Consensus 101 G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~---~~v~~~~~~-~~ 174 (282)
T 1zar_A 101 GKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G---LAVPKVYAW-EG 174 (282)
T ss_dssp CSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T---SSSCCEEEE-ET
T ss_pred CCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C---CCcCeEEec-cc
Confidence 89999999999 78999999998643221 13455778999999996 4 555554444 45
Q ss_pred EEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccccCCCC
Q 044127 64 VFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSL 143 (282)
Q Consensus 64 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~~~~~~ 143 (282)
.++||||+.|+.+..+ .......++.||+.||.+||+.|++|+||||+||+++++.++|+|||++...
T Consensus 175 ~~lvmE~~~g~~L~~l--------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~~~~vkl~DFG~a~~~---- 242 (282)
T 1zar_A 175 NAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEV---- 242 (282)
T ss_dssp TEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTTCEET----
T ss_pred eEEEEEecCCCcHHHc--------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEECCcEEEEECCCCeEC----
Confidence 6999999987655442 1233557999999999999999999999999999999889999999998643
Q ss_pred CCCCccccccccCchhhh
Q 044127 144 PCTDYVTTRWYRAPEVLL 161 (282)
Q Consensus 144 ~~~~~~~~~~~~aPE~~~ 161 (282)
..+.|||.+.
T Consensus 243 --------~~~~a~e~l~ 252 (282)
T 1zar_A 243 --------GEEGWREILE 252 (282)
T ss_dssp --------TSTTHHHHHH
T ss_pred --------CCCCHHHHHH
Confidence 2357888774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=6.8e-21 Score=150.46 Aligned_cols=129 Identities=17% Similarity=0.203 Sum_probs=96.7
Q ss_pred CCcceEEEEEecCCCcE--EEEEEccccccc-----------------------hHHHHHHHHHHHHHHhCCCCCe--ee
Q 044127 1 GSYGDVFQALDKKSGEF--VAVKKLKKKIFS-----------------------LDESRNLKEVKCLRKMNNHPNI--VK 53 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~--v~vK~~~~~~~~-----------------------~~~~~~~~e~~~l~~~~~hp~i--~~ 53 (282)
|+||.||+|.+..+|+. ||||+++..... .......+|...+.++. |+++ +.
T Consensus 58 G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~ 136 (258)
T 1zth_A 58 GKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK-EAGVSVPQ 136 (258)
T ss_dssp CSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH-HTTCCCCC
T ss_pred cceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH-hCCCCCCe
Confidence 89999999998778999 999987543211 01124567888888885 6653 33
Q ss_pred eccccccCCcEEEEEecCCc-----cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HcCccccCCCCCceeeeCCc
Q 044127 54 LRNLVKEHEDVFIVFEYMES-----DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMH-RQGYFHRDLKPSNLLVSKGV 127 (282)
Q Consensus 54 ~~~~~~~~~~~~lv~e~~~~-----~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh-~~~~~H~dl~p~nili~~~~ 127 (282)
+++. ...++||||+++ ..+...... .++..+..++.||+.||.+|| +.|++|+||||+||++++ .
T Consensus 137 ~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~-~ 207 (258)
T 1zth_A 137 PYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID-K 207 (258)
T ss_dssp EEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS-S
T ss_pred EEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC-c
Confidence 3332 356899999953 134433221 345677899999999999999 999999999999999999 9
Q ss_pred EEEeecCccccc
Q 044127 128 IKIGDLGMVKEI 139 (282)
Q Consensus 128 ~~l~df~~~~~~ 139 (282)
++|+|||++...
T Consensus 208 ~~liDFG~a~~~ 219 (258)
T 1zth_A 208 VYFIDMGQAVTL 219 (258)
T ss_dssp EEECCCTTCEET
T ss_pred EEEEECcccccC
Confidence 999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=4.9e-18 Score=139.44 Aligned_cols=130 Identities=15% Similarity=0.218 Sum_probs=85.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-------------hHHH--------HHHHHHHHHHHhCCCCCeeeeccccc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-------------LDES--------RNLKEVKCLRKMNNHPNIVKLRNLVK 59 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-------------~~~~--------~~~~e~~~l~~~~~hp~i~~~~~~~~ 59 (282)
|++|.||+|.+. +|+.||||+++..... .... ...+|...+.++. +.++ .....+.
T Consensus 106 Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~gv-~vp~p~~ 182 (397)
T 4gyi_A 106 GKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EEGF-PVPEPIA 182 (397)
T ss_dssp CSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HTTC-SCCCEEE
T ss_pred CCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hcCC-CCCeeee
Confidence 899999999875 5999999987643211 0000 1123444444442 2222 1111111
Q ss_pred cCCcEEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCC-----------cE
Q 044127 60 EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKG-----------VI 128 (282)
Q Consensus 60 ~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~-----------~~ 128 (282)
. ...++||||++|..+..+ ........++.||+.+|.+||+.|++||||||.|||++++ .+
T Consensus 183 ~-~~~~LVME~i~G~~L~~l-------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~ 254 (397)
T 4gyi_A 183 Q-SRHTIVMSLVDALPMRQV-------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTP 254 (397)
T ss_dssp E-ETTEEEEECCSCEEGGGC-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEE
T ss_pred c-cCceEEEEecCCccHhhh-------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccce
Confidence 1 123799999998665322 1223456788999999999999999999999999999753 38
Q ss_pred EEeecCcccccCC
Q 044127 129 KIGDLGMVKEIDS 141 (282)
Q Consensus 129 ~l~df~~~~~~~~ 141 (282)
.++||+.+.....
T Consensus 255 ~iID~~Q~V~~~h 267 (397)
T 4gyi_A 255 IIIXFPQMVSMDH 267 (397)
T ss_dssp EECCCTTCEETTS
T ss_pred EEEEeCCcccCCC
Confidence 9999998765443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=4.6e-13 Score=105.85 Aligned_cols=128 Identities=16% Similarity=0.132 Sum_probs=98.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+.+.||++... +..+++|+...... .....+.+|...++.+..+..+.+++++....+..|+|||+++|..+....
T Consensus 25 ~s~~~v~~~~~~--~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~ 101 (263)
T 3tm0_A 25 MSPAKVYKLVGE--NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CSSSEEEEEECS--SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHC
T ss_pred CCCCeEEEEECC--CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhcc
Confidence 345779999643 67899999865321 223457789999998876778888999988888999999999997765431
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------------
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHR---------------------------------------------------- 108 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~---------------------------------------------------- 108 (282)
. +......++.+++++|..||+
T Consensus 102 ~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 175 (263)
T 3tm0_A 102 E------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp C------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHH
T ss_pred C------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHH
Confidence 1 122345778899999999998
Q ss_pred -------cCccccCCCCCceeeeCCcE-EEeecCccc
Q 044127 109 -------QGYFHRDLKPSNLLVSKGVI-KIGDLGMVK 137 (282)
Q Consensus 109 -------~~~~H~dl~p~nili~~~~~-~l~df~~~~ 137 (282)
..++|+|++|.||+++++.+ .++||+.+.
T Consensus 176 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 44899999999999988765 599998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.31 E-value=5.7e-12 Score=99.38 Aligned_cols=123 Identities=15% Similarity=0.117 Sum_probs=88.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCC-eeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPN-IVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~-i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|..+.||++.. .+|..+++|+.... .......|...++.+..+.- +.+++++...++..++|||+++|..+.
T Consensus 31 g~~~~v~~~~~-~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 31 CSDAAVFRLSA-QGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp TSSCEEEEEEC-TTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred CCCceEEEEec-CCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 34589999964 45778999997543 22345678888888865522 566888887778899999999987663
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC-------------------------------------------------
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQG------------------------------------------------- 110 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~------------------------------------------------- 110 (282)
.. ..+. ..++.+++..|..||+..
T Consensus 104 ~~----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (264)
T 1nd4_A 104 SS----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKA 176 (264)
T ss_dssp TS----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHH
T ss_pred cC----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHH
Confidence 11 1222 256677777777777643
Q ss_pred ---------ccccCCCCCceeeeCCcE-EEeecCccc
Q 044127 111 ---------YFHRDLKPSNLLVSKGVI-KIGDLGMVK 137 (282)
Q Consensus 111 ---------~~H~dl~p~nili~~~~~-~l~df~~~~ 137 (282)
++|+|++|.||+++++.+ .++||+.+.
T Consensus 177 ~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 177 RMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 999999999999998765 599999753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.23 E-value=4.4e-11 Score=98.86 Aligned_cols=133 Identities=15% Similarity=0.232 Sum_probs=95.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEcc--ccccchHHHHHHHHHHHHHHhCC-CCCeeeeccccccC---CcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLK--KKIFSLDESRNLKEVKCLRKMNN-HPNIVKLRNLVKEH---EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~--~~~~~~~~~~~~~e~~~l~~~~~-hp~i~~~~~~~~~~---~~~~lv~e~~~~~ 74 (282)
|.++.||++... +..+++|+.. ..........+.+|...++.+.. +..+.+++.++.+. +..++|||+++|.
T Consensus 49 G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~ 126 (359)
T 3dxp_A 49 GQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGR 126 (359)
T ss_dssp -CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCB
T ss_pred cccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCe
Confidence 567889999654 4678899886 43322334566778888888863 34577788877665 4589999999986
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHR---------------------------------------------- 108 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~---------------------------------------------- 108 (282)
.+.. ..-..++......++.+++.+|..||+
T Consensus 127 ~l~~---~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (359)
T 3dxp_A 127 VLWD---QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDW 203 (359)
T ss_dssp CCCC---TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHH
T ss_pred ecCC---CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHH
Confidence 5522 111247888999999999999999997
Q ss_pred ------------cCccccCCCCCceeeeCC---cEEEeecCcccc
Q 044127 109 ------------QGYFHRDLKPSNLLVSKG---VIKIGDLGMVKE 138 (282)
Q Consensus 109 ------------~~~~H~dl~p~nili~~~---~~~l~df~~~~~ 138 (282)
..++|+|++|.||+++.+ .+.++||+.+..
T Consensus 204 l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 204 LPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp GGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 358999999999999853 368999998763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.11 E-value=1.7e-10 Score=93.03 Aligned_cols=178 Identities=15% Similarity=0.131 Sum_probs=112.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCC--eeeeccccccCC---cEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPN--IVKLRNLVKEHE---DVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~--i~~~~~~~~~~~---~~~lv~e~~~~~~ 75 (282)
|..+.||.+. ..+++|+.... .......+|...++.+..+.. +..++....... ..|+||++++|..
T Consensus 31 G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~ 102 (304)
T 3sg8_A 31 GNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVP 102 (304)
T ss_dssp CSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEE
T ss_pred CCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeE
Confidence 5556777762 45889986532 334566778888888754433 334444433332 4588999999866
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc----------------------------------------------
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ---------------------------------------------- 109 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~---------------------------------------------- 109 (282)
+..... ..++..+...++.+++..+..||+.
T Consensus 103 l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 179 (304)
T 3sg8_A 103 LTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD 179 (304)
T ss_dssp CCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred CCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence 543222 2578888889999999999999861
Q ss_pred ------------CccccCCCCCceeeeC--C-cEEEeecCcccccCCCCCCCCccccccccCchhhhc--ccc-------
Q 044127 110 ------------GYFHRDLKPSNLLVSK--G-VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL--SEI------- 165 (282)
Q Consensus 110 ------------~~~H~dl~p~nili~~--~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~------- 165 (282)
.++|+|++|.||++++ + .+.++||+.+...+.............-.+|+.... ...
T Consensus 180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~ 259 (304)
T 3sg8_A 180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPT 259 (304)
T ss_dssp HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHH
T ss_pred HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHH
Confidence 2699999999999987 4 478999998765432111100000000023332210 000
Q ss_pred ----CCCcchhHHHHHHHHHHHhCCCCC
Q 044127 166 ----YGPEVDMWAMGAIMFEMLSFRILF 189 (282)
Q Consensus 166 ----~~~~~DiwslG~ll~~l~~g~~~~ 189 (282)
.....+.|++|.++|.+.+|..+|
T Consensus 260 ~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 260 VLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 112258999999999999987765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=2e-08 Score=79.47 Aligned_cols=124 Identities=16% Similarity=0.183 Sum_probs=90.7
Q ss_pred eEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHHHhcC
Q 044127 5 DVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMKERAG 84 (282)
Q Consensus 5 ~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 84 (282)
.||+......+..+++|+.... ....+..|...++.+..+-.+.+++++..+.+..++|||++.|..+.......
T Consensus 40 ~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~- 114 (272)
T 4gkh_A 40 TIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY- 114 (272)
T ss_dssp EEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC-
T ss_pred eEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC-
Confidence 6899887777778999986532 34556678888888865555778888888888999999999987665543321
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------------------------
Q 044127 85 QNFSEDEVRNLCFQVFQGLHYMHRQ------------------------------------------------------- 109 (282)
Q Consensus 85 ~~l~~~~~~~i~~qi~~~l~~Lh~~------------------------------------------------------- 109 (282)
......+..+++..|..||+.
T Consensus 115 ----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 190 (272)
T 4gkh_A 115 ----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFS 190 (272)
T ss_dssp ----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCC
T ss_pred ----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhccccc
Confidence 223345566666777777641
Q ss_pred ---CccccCCCCCceeeeCCc-EEEeecCccc
Q 044127 110 ---GYFHRDLKPSNLLVSKGV-IKIGDLGMVK 137 (282)
Q Consensus 110 ---~~~H~dl~p~nili~~~~-~~l~df~~~~ 137 (282)
.++|+|+.+.||+++++. +-|+||+.+.
T Consensus 191 ~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 191 PDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 168999999999999865 4599999754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=1.2e-07 Score=76.32 Aligned_cols=127 Identities=17% Similarity=0.155 Sum_probs=85.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCC--Ceeeeccccc-cCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHP--NIVKLRNLVK-EHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp--~i~~~~~~~~-~~~~~~lv~e~~~~~~l~ 77 (282)
|....||.+ +..+++|+... ......+..|...+..+..+- .+..++.+.. ..+..+++||++.|..+.
T Consensus 30 G~~n~v~~v-----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~ 101 (306)
T 3tdw_A 30 GFRNYAILV-----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILG 101 (306)
T ss_dssp CSSEEEEEE-----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECH
T ss_pred CcceeEEEE-----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECc
Confidence 444578877 45688998532 233456678999999887542 2445555542 456688999999986665
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc------------------------------------------------
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQ------------------------------------------------ 109 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~------------------------------------------------ 109 (282)
...- ..++......+..+++..|..||+.
T Consensus 102 ~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 178 (306)
T 3tdw_A 102 EDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS 178 (306)
T ss_dssp HHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred hhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence 4221 1355666666666666666666642
Q ss_pred ------------CccccCCCCCceeeeC----CcE-EEeecCcccc
Q 044127 110 ------------GYFHRDLKPSNLLVSK----GVI-KIGDLGMVKE 138 (282)
Q Consensus 110 ------------~~~H~dl~p~nili~~----~~~-~l~df~~~~~ 138 (282)
.++|+|++|.||++++ +.+ .++||+.+..
T Consensus 179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2489999999999986 554 8999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=4.1e-07 Score=74.85 Aligned_cols=74 Identities=9% Similarity=0.126 Sum_probs=45.1
Q ss_pred CCcceEEEEEec--C----CCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCC--CCeeeeccccccC---CcEEEE
Q 044127 1 GSYGDVFQALDK--K----SGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNH--PNIVKLRNLVKEH---EDVFIV 67 (282)
Q Consensus 1 G~~g~Vy~~~~~--~----~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~h--p~i~~~~~~~~~~---~~~~lv 67 (282)
|..+.+|.+... . ++..+++|+...... .........|...++.+..+ -.+.+++.+..+. +..++|
T Consensus 32 G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v 111 (357)
T 3ats_A 32 GMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFL 111 (357)
T ss_dssp SSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEE
T ss_pred CccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEE
Confidence 445678887643 0 156789998754320 10123455677777776543 2456666665544 457899
Q ss_pred EecCCcc
Q 044127 68 FEYMESD 74 (282)
Q Consensus 68 ~e~~~~~ 74 (282)
||+++|.
T Consensus 112 ~e~l~G~ 118 (357)
T 3ats_A 112 MDYVEGV 118 (357)
T ss_dssp EECCCCB
T ss_pred EEecCCC
Confidence 9999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=1.8e-06 Score=72.14 Aligned_cols=71 Identities=20% Similarity=0.263 Sum_probs=41.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc------chHHHHHHHHHHHHHHhCCC-CC-eeeeccccccCCcEEEEEecCC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF------SLDESRNLKEVKCLRKMNNH-PN-IVKLRNLVKEHEDVFIVFEYME 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~------~~~~~~~~~e~~~l~~~~~h-p~-i~~~~~~~~~~~~~~lv~e~~~ 72 (282)
|..+.||++....+++.+++|....... .........|...+..+... |. +..++.+ +....++|||+++
T Consensus 41 G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~ 118 (397)
T 2olc_A 41 GNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLS 118 (397)
T ss_dssp SSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCT
T ss_pred CceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCC
Confidence 5678999997666678899997643211 01123345677777776432 33 3345443 3345689999997
Q ss_pred c
Q 044127 73 S 73 (282)
Q Consensus 73 ~ 73 (282)
+
T Consensus 119 g 119 (397)
T 2olc_A 119 H 119 (397)
T ss_dssp T
T ss_pred C
Confidence 6
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.13 E-value=1.2e-05 Score=64.51 Aligned_cols=28 Identities=21% Similarity=0.018 Sum_probs=25.1
Q ss_pred ccccCCCCCceeeeCCcEEEeecCcccc
Q 044127 111 YFHRDLKPSNLLVSKGVIKIGDLGMVKE 138 (282)
Q Consensus 111 ~~H~dl~p~nili~~~~~~l~df~~~~~ 138 (282)
++|+|+.+.||+.+++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFLDTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEEECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEEECCCCEEEEecccccC
Confidence 8999999999997778899999997754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.12 E-value=3.9e-05 Score=57.33 Aligned_cols=99 Identities=15% Similarity=0.169 Sum_probs=61.0
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCccccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
+|..++...+.+++++++|.++.|.+.+|..+-. +.-...=+.|..|++. +|.|.+.+ ..+ .....
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s-----------~~~~~ 101 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AAD-----------DAGEP 101 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-ccc-----------ccccc
Confidence 4566666667899999999999999999887632 1212233445777776 46766663 111 01223
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRI 187 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~ 187 (282)
.+.|||... ...+.+.=|+|||+++|.-+--..
T Consensus 102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -----CCSS--SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCC
Confidence 467888653 234677889999999999887433
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.08 E-value=8.3e-05 Score=60.50 Aligned_cols=29 Identities=28% Similarity=0.335 Sum_probs=25.4
Q ss_pred cCccccCCCCCceeee-CCcEEEeecCccc
Q 044127 109 QGYFHRDLKPSNLLVS-KGVIKIGDLGMVK 137 (282)
Q Consensus 109 ~~~~H~dl~p~nili~-~~~~~l~df~~~~ 137 (282)
..++|+|+.+.||+++ ++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 4699999999999996 5789999999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.93 E-value=4.4e-05 Score=64.21 Aligned_cols=31 Identities=19% Similarity=0.272 Sum_probs=26.8
Q ss_pred HcCccccCCCCCceeeeCCcEEEeecCcccc
Q 044127 108 RQGYFHRDLKPSNLLVSKGVIKIGDLGMVKE 138 (282)
Q Consensus 108 ~~~~~H~dl~p~nili~~~~~~l~df~~~~~ 138 (282)
...++|||++|.||+++++.+.++||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDSTQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSCEEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCCCEEEeCccccc
Confidence 3569999999999999876699999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.87 E-value=9.3e-05 Score=59.43 Aligned_cols=68 Identities=16% Similarity=0.186 Sum_probs=49.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCC--CCeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNH--PNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~h--p~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|....+|++.. ++..+++|+.... ....+..|...++.+... ..+++++.+....+..++|||+++|.
T Consensus 47 G~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 47 GEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp SSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred ccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 56678999864 4667889987543 244556787777777533 55777777777778899999999864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00052 Score=56.64 Aligned_cols=131 Identities=12% Similarity=0.075 Sum_probs=77.9
Q ss_pred CCcceEEEEEecC-------CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKK-------SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|-...+|++.... +++.|++|+.... ........+|..+++.+..+.-..++++.+.+ .+|+||+.|
T Consensus 61 G~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G 134 (379)
T 3feg_A 61 GLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPS 134 (379)
T ss_dssp ---CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSE
T ss_pred cccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecC
Confidence 3345789887642 3578999997432 12334555788888877644444666666654 289999987
Q ss_pred cHHH-----------HH----HHhc------CCCC--CHHHHHHHHHHHHH-------------------HHHHHH----
Q 044127 74 DLLK-----------LM----KERA------GQNF--SEDEVRNLCFQVFQ-------------------GLHYMH---- 107 (282)
Q Consensus 74 ~~l~-----------~~----~~~~------~~~l--~~~~~~~i~~qi~~-------------------~l~~Lh---- 107 (282)
..+. .+ .+-+ ++.. -..++.++..++.. .+..|.
T Consensus 135 ~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~ 214 (379)
T 3feg_A 135 RPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLE 214 (379)
T ss_dssp EECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHH
T ss_pred ccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHh
Confidence 3321 11 1111 1111 13566666655432 233333
Q ss_pred Hc----CccccCCCCCceeeeC-----CcEEEeecCccc
Q 044127 108 RQ----GYFHRDLKPSNLLVSK-----GVIKIGDLGMVK 137 (282)
Q Consensus 108 ~~----~~~H~dl~p~nili~~-----~~~~l~df~~~~ 137 (282)
.. .++|+|+.+.||++++ +.+.++||..+.
T Consensus 215 ~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 215 STPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp TSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 3899999999999975 489999999865
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00021 Score=58.88 Aligned_cols=28 Identities=18% Similarity=0.402 Sum_probs=24.5
Q ss_pred CccccCCCCCceeeeCCcEEEeecCccc
Q 044127 110 GYFHRDLKPSNLLVSKGVIKIGDLGMVK 137 (282)
Q Consensus 110 ~~~H~dl~p~nili~~~~~~l~df~~~~ 137 (282)
.++|+|+.+.||+++++.+.++||+.+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKCLRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-CEEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCcEEEEEecCCC
Confidence 4899999999999988789999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0031 Score=53.03 Aligned_cols=66 Identities=17% Similarity=0.070 Sum_probs=41.4
Q ss_pred CCcceEEEEEecC-------CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKK-------SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|....+|++.... ++..+++|+..... . ......|...+..+..+.-..++++.+.+ .+|+||++|
T Consensus 84 G~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G 156 (429)
T 1nw1_A 84 GMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPS 156 (429)
T ss_dssp CTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCE
T ss_pred CcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCC
Confidence 3456799997542 25689999984321 1 13344688887777544334566666543 388999876
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0043 Score=52.57 Aligned_cols=66 Identities=12% Similarity=0.010 Sum_probs=41.7
Q ss_pred CcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 2 SYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 2 ~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
-...+|++.....+..+++|+..... ........|...+..+..+.-..++++.+.+ .+|+||++|
T Consensus 120 ~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 120 ITNILIKVKDMSKQAKYLIRLYGPKT--DEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp -CEEEEEEEETTTTEEEEEEEECC-C--CSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred eEeEEEEEEECCCCceEEEEECCCCh--hhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 34678998765445789999875431 1122235688888888654434667776642 359999876
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0024 Score=50.51 Aligned_cols=67 Identities=12% Similarity=0.107 Sum_probs=42.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCC--CeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHP--NIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp--~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|..+.||++.. .+|+.|++|+..... ......+..|...++.+.... .+.++++. +..+++||++.+
T Consensus 26 G~~~~vyrv~l-~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~ 94 (288)
T 3f7w_A 26 SHRWHLYRVEL-ADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDE 94 (288)
T ss_dssp ETTEEEEEEEE-TTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCC
T ss_pred CCCeEEEEEEE-CCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecc
Confidence 45678999974 568899999875432 222334567888888875332 23444443 224788999864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0038 Score=50.32 Aligned_cols=27 Identities=22% Similarity=0.158 Sum_probs=24.1
Q ss_pred CccccCCCCCceeeeCCcEEEeecCccc
Q 044127 110 GYFHRDLKPSNLLVSKGVIKIGDLGMVK 137 (282)
Q Consensus 110 ~~~H~dl~p~nili~~~~~~l~df~~~~ 137 (282)
.++|||+++.||++++ .+.++||+.+.
T Consensus 196 ~l~HgD~~~~Nil~~~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 196 LRLHGDCHAGNILWRD-GPMFVDLDDAR 222 (328)
T ss_dssp EECCSSCSGGGEEESS-SEEECCCTTCC
T ss_pred eeeeCCCCcccEeEcC-CCEEEECCCCC
Confidence 4899999999999985 89999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0022 Score=51.56 Aligned_cols=28 Identities=21% Similarity=0.262 Sum_probs=24.4
Q ss_pred CccccCCCCCceeeeCCcE-EEeecCccc
Q 044127 110 GYFHRDLKPSNLLVSKGVI-KIGDLGMVK 137 (282)
Q Consensus 110 ~~~H~dl~p~nili~~~~~-~l~df~~~~ 137 (282)
+++|+|+.+.||+++++.+ .++||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 5899999999999998765 799999764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0014 Score=53.11 Aligned_cols=30 Identities=27% Similarity=0.315 Sum_probs=25.8
Q ss_pred cCccccCCCCCceeeeC-----CcEEEeecCcccc
Q 044127 109 QGYFHRDLKPSNLLVSK-----GVIKIGDLGMVKE 138 (282)
Q Consensus 109 ~~~~H~dl~p~nili~~-----~~~~l~df~~~~~ 138 (282)
..++|||+.+.||+++. +.+.++||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 35999999999999975 5799999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0031 Score=52.79 Aligned_cols=68 Identities=10% Similarity=0.040 Sum_probs=41.1
Q ss_pred CCcceEEEEEecCC-------CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKS-------GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~-------~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|-...+|++..... ++.|++++..... ....+..+|...++.+..+.-..++++.+. .+.|++|+.|
T Consensus 81 G~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~efI~G 154 (424)
T 3mes_A 81 GLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEFIDG 154 (424)
T ss_dssp CSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEECCCS
T ss_pred CcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEEeCC
Confidence 34457888876421 5779999975432 222334567777777654433455555432 2789999987
Q ss_pred c
Q 044127 74 D 74 (282)
Q Consensus 74 ~ 74 (282)
.
T Consensus 155 ~ 155 (424)
T 3mes_A 155 E 155 (424)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.048 Score=44.21 Aligned_cols=29 Identities=28% Similarity=0.236 Sum_probs=25.4
Q ss_pred CccccCCCCCceeeeC-CcEEEeecCcccc
Q 044127 110 GYFHRDLKPSNLLVSK-GVIKIGDLGMVKE 138 (282)
Q Consensus 110 ~~~H~dl~p~nili~~-~~~~l~df~~~~~ 138 (282)
.++|+|+.+.||++++ +.+.++||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4899999999999985 6899999987664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.74 E-value=0.026 Score=46.93 Aligned_cols=28 Identities=21% Similarity=0.332 Sum_probs=23.9
Q ss_pred ccccCCCCCceeee-------CCcEEEeecCcccc
Q 044127 111 YFHRDLKPSNLLVS-------KGVIKIGDLGMVKE 138 (282)
Q Consensus 111 ~~H~dl~p~nili~-------~~~~~l~df~~~~~ 138 (282)
++|+|+.+.||++. ++.+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 68999999999993 25799999998763
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.79 E-value=2.4 Score=31.67 Aligned_cols=81 Identities=11% Similarity=0.048 Sum_probs=58.0
Q ss_pred CCCCeeeeccccccCCcEEEEEecCC-ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHHcCccccCCCCCceeee
Q 044127 47 NHPNIVKLRNLVKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLH-YMHRQGYFHRDLKPSNLLVS 124 (282)
Q Consensus 47 ~hp~i~~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~-~Lh~~~~~H~dl~p~nili~ 124 (282)
.||++ -..+-.+++.+.+.++.-. +..+..+ . .++....++++.+|+.... ++ ..-+|--+.|+|++++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-~----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-R----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-H----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-H----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 48888 3344466677777777763 4444433 2 5789999999988887655 33 3456778999999999
Q ss_pred -CCcEEEeecCcc
Q 044127 125 -KGVIKIGDLGMV 136 (282)
Q Consensus 125 -~~~~~l~df~~~ 136 (282)
++.+++.-.|.-
T Consensus 119 ~~~~p~i~hRGi~ 131 (219)
T 4ano_A 119 RALEPFFLHVGVK 131 (219)
T ss_dssp TTCCEEESCCEET
T ss_pred CCCcEEEEEcCCc
Confidence 579999988863
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 282 | ||||
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-74 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-70 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-70 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-70 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-68 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-67 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-67 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-67 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-66 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-66 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-65 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-64 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-64 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-64 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-64 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-63 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-63 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 9e-63 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-62 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-59 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-59 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-57 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-54 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-54 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-51 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-46 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-45 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-44 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 2e-74
Identities = 97/283 (34%), Positives = 156/283 (55%), Gaps = 10/283 (3%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDES----RNLKEVKCLRKMNNHPNIVKLRN 56
G + V++A DK + + VA+KK+K S + L+E+K L++++ HPNI+ L +
Sbjct: 9 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLD 67
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
++ +VF++ME+DL ++K+ + ++ QGL Y+H+ HRDL
Sbjct: 68 AFGHKSNISLVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 126
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
KP+NLL+ GV+K+ D G+ K S T V TRWYRAPE+L + +YG VDMWA
Sbjct: 127 KPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWA 186
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G I+ E+L PG + DQ+ +I + +G+PTE+ WP L + F G+
Sbjct: 187 VGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV--TFKSFPGIP 244
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
L + +A + + LI L +NP R TA +AL+ +F +
Sbjct: 245 LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 2e-72
Identities = 98/280 (35%), Positives = 161/280 (57%), Gaps = 5/280 (1%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
G+YG V++A +K +GE VA+KK++ + ++E+ L+++N HPNIVKL +++
Sbjct: 13 GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIH 71
Query: 60 EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+++VFE++ DL K M A +++ FQ+ QGL + H HRDLKP
Sbjct: 72 TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 131
Query: 120 NLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
NLL++ G IK+ D G+ + + T V T WYRAPE+LL + Y VD+W++G
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 191
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
I EM++ R LFPG + DQ+++I + +G+P E WP G+ + FP+ + +
Sbjct: 192 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP-GVTSMPDYKPSFPKWARQDFSK 250
Query: 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+ P + SL+S++ ++P+ R +A AL HPFF+
Sbjct: 251 VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 1e-70
Identities = 74/292 (25%), Positives = 126/292 (43%), Gaps = 20/292 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ G VF+ K SG +A K + +I ++ ++E++ L + N P IV
Sbjct: 17 GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS 75
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMH-RQGYFHRDLKPS 119
++ I E+M+ L + ++AG+ E + + V +GL Y+ + HRD+KPS
Sbjct: 76 DGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 120 NLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAI 178
N+LV S+G IK+ D G+ ++ S+ +V TR Y +PE L Y + D+W+MG
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPER-LQGTHYSVQSDIWSMGLS 192
Query: 179 MFEMLSFRILFPGKNSA-DQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
+ EM R P ++ ++ CQV G E + + + E
Sbjct: 193 LVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFE 252
Query: 238 L-------------SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276
L S S E +++ NP R + + H F +
Sbjct: 253 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 1e-70
Identities = 91/288 (31%), Positives = 154/288 (53%), Gaps = 19/288 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+G V+QA SGE VA+KK+ + D+ +E++ +RK++ H NIV+LR
Sbjct: 31 GSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLD-HCNIVRLRYFFYS 84
Query: 61 HED------VFIVFEYMESDLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYF 112
+ + +V +Y+ + ++ + RA Q V+ +Q+F+ L Y+H G
Sbjct: 85 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 144
Query: 113 HRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
HRD+KP NLL+ V+K+ D G K++ P Y+ +R+YRAPE++ + Y +
Sbjct: 145 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSI 204
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
D+W+ G ++ E+L + +FPG + DQ+ +I +V+G+PT + + ++KFPQ+
Sbjct: 205 DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR--EMNPNYTEFKFPQI 262
Query: 231 GGVNLREL-SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
++ P E+I+L SRL + P R T EA H FF
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 3e-70
Identities = 101/288 (35%), Positives = 159/288 (55%), Gaps = 15/288 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG V A D + VA+KK+ R L+E+K L + H NI+ + ++++
Sbjct: 19 GAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRA 77
Query: 61 -----HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+DV++V M +DL KL+K Q+ S D + +Q+ +GL Y+H HRD
Sbjct: 78 PTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRD 134
Query: 116 LKPSNLLVSK-GVIKIGDLGMVKEIDSSLP----CTDYVTTRWYRAPEVLLLSEIYGPEV 170
LKPSNLL++ +KI D G+ + D T+YV TRWYRAPE++L S+ Y +
Sbjct: 135 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 194
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQL-ASNLDWKFPQ 229
D+W++G I+ EMLS R +FPGK+ DQ+ I ++GSP+++ I L A N P
Sbjct: 195 DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 254
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
V L P+A +++ L+ ++ ++NPH R +AL HP+ +
Sbjct: 255 KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 8e-68
Identities = 93/285 (32%), Positives = 147/285 (51%), Gaps = 14/285 (4%)
Query: 1 GSYGDVFQALDKKS-GEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMN--NHPNIVKLRN 56
G+YG VF+A D K+ G FVA+K+++ + + ++EV LR + HPN+V+L +
Sbjct: 18 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77
Query: 57 LVKEHED-----VFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
+ + +VFE+++ DL + + + ++++ FQ+ +GL ++H
Sbjct: 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRV 137
Query: 112 FHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
HRDLKP N+LV S G IK+ D G+ + + T V T WYRAPEV LL Y V
Sbjct: 138 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV-LLQSSYATPV 196
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
D+W++G I EM + LF G + DQ+ KI VIG P E+ WP + L F
Sbjct: 197 DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP---RQAFHSK 253
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
+ + L+ + ++NP R +A AL HP+F+
Sbjct: 254 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-67
Identities = 104/286 (36%), Positives = 162/286 (56%), Gaps = 15/286 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G+YG V A+D ++G VA+KKL + S L R +E++ L+ M H N++ L ++
Sbjct: 29 GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFT 87
Query: 60 EHE------DVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
E D ++V +M +DL KLMK + ED ++ L +Q+ +GL Y+H G H
Sbjct: 88 PDETLDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIH 144
Query: 114 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
RDLKP NL V++ +KI D G+ ++ DS + T YV TRWYRAPEV+L Y VD+
Sbjct: 145 RDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTRWYRAPEVILNWMRYTQTVDI 202
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP-LGIQLASNLDWKFPQMG 231
W++G IM EM++ + LF G + DQ+ +I +V G+P + L A N P++
Sbjct: 203 WSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 262
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+ + +AS +++L+ ++ + R TA EAL HP+F S H
Sbjct: 263 KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 210 bits (536), Expect = 3e-67
Identities = 63/277 (22%), Positives = 115/277 (41%), Gaps = 32/277 (11%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V + ++ +G A K + D+ KE++ + + HP +V L + ++
Sbjct: 37 GAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLR-HPTLVNLHDAFED 94
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ +++E+M L SEDE QV +GL +MH Y H DLKP N
Sbjct: 95 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 154
Query: 121 LLVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
++ + +K+ D G+ +D T + APEV + G DMW++G
Sbjct: 155 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV-AEGKPVGYYTDMWSVGV 213
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
+ + +LS F G+N + + + + + ++
Sbjct: 214 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF------------------------ 249
Query: 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
S + I +L +P+ R T +ALEHP+
Sbjct: 250 --SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 210 bits (536), Expect = 4e-67
Identities = 64/280 (22%), Positives = 118/280 (42%), Gaps = 32/280 (11%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V + ++K +G K + + LD+ E+ + +++ HP ++ L + ++
Sbjct: 40 GAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLH-HPKLINLHDAFED 97
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ ++ E++ L SE EV N Q +GL +MH H D+KP N
Sbjct: 98 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 157
Query: 121 LLVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
++ +KI D G+ +++ T + APE+ + E G DMWA+G
Sbjct: 158 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI-VDREPVGFYTDMWAIGV 216
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
+ + +LS F G++ + + + + ED++
Sbjct: 217 LGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF------------------------ 252
Query: 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
S S E+ I L P R T +ALEHP+ + H
Sbjct: 253 --SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 206 bits (526), Expect = 2e-66
Identities = 77/289 (26%), Positives = 119/289 (41%), Gaps = 43/289 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--------LKEVKCLRKMNNHPNIV 52
G V + + K + + AVK + + LKEV LRK++ HPNI+
Sbjct: 14 GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73
Query: 53 KLRNLVKEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
+L++ + + F+VF+ M+ +L + E+ SE E R + + + + +H+
Sbjct: 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNI 131
Query: 112 FHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEI----- 165
HRDLKP N+L+ IK+ D G ++D + T Y APE++ S
Sbjct: 132 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPG 191
Query: 166 YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225
YG EVDMW+ G IM+ +L+ F + + I W
Sbjct: 192 YGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW------------ 239
Query: 226 KFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
S L+SR P R TA EAL HPFF+
Sbjct: 240 --------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 3e-66
Identities = 88/292 (30%), Positives = 146/292 (50%), Gaps = 19/292 (6%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G++G+VF+A +K+G+ VA+KK+ L+E+K L+ + H N+V L + +
Sbjct: 21 GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICR 79
Query: 60 EHE--------DVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
+++VF++ E DL L+ F+ E++ + + GL+Y+HR
Sbjct: 80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKI 138
Query: 112 FHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-----PCTDYVTTRWYRAPEVLLLSEI 165
HRD+K +N+L+++ GV+K+ D G+ + + T+ V T WYR PE+LL
Sbjct: 139 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERD 198
Query: 166 YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP--LGIQLASNL 223
YGP +D+W G IM EM + + G Q+ I Q+ GS T + WP +L L
Sbjct: 199 YGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL 258
Query: 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
+ Q V R + ++ LI +L +P R + +AL H FF S
Sbjct: 259 ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 7e-66
Identities = 62/280 (22%), Positives = 115/280 (41%), Gaps = 35/280 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++G V++A +K++ A K + K + + E+ L + HPNIVKL +
Sbjct: 23 GAFGKVYKAQNKETSVLAAAKVIDTKSEE-ELEDYMVEIDILASCD-HPNIVKLLDAFYY 80
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+++I+ E+ + + + +E +++ +C Q L+Y+H HRDLK N
Sbjct: 81 ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGN 140
Query: 121 LLV-SKGVIKIGDLGMVKEIDSSLPCTD-YVTTRWYRAPEVLLL----SEIYGPEVDMWA 174
+L G IK+ D G+ + ++ D ++ T ++ APEV++ Y + D+W+
Sbjct: 141 ILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 200
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G + EM N + KI + P + P
Sbjct: 201 LGITLIEMAEIEPPHHELNPMRVLLKIAK--SEPPTLAQP-------------------- 238
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
S + + N R T ++ L+HPF
Sbjct: 239 -----SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 5e-65
Identities = 75/290 (25%), Positives = 119/290 (41%), Gaps = 38/290 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKL----RN 56
G G V Q +K++ E A+K L+ + +EV+ + + P+IV++ N
Sbjct: 23 GINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYEN 76
Query: 57 LVKEHEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
L + + IV E ++ +L +++R Q F+E E + + + + Y+H HRD
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 136
Query: 116 LKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
+KP NLL + ++K+ D G KE S T T +Y APEV L E Y D
Sbjct: 137 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV-LGPEKYDKSCD 195
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231
MW++G IM+ +L F + + I ++FP
Sbjct: 196 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG---------------QYEFP--- 237
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVPR 281
S E LI L P R T E + HP+ VP+
Sbjct: 238 ----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 283
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 202 bits (514), Expect = 1e-64
Identities = 87/277 (31%), Positives = 150/277 (54%), Gaps = 7/277 (2%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKK-KIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK 59
G+YG V++A + GE A+KK++ K S ++E+ L+++ H NIVKL +++
Sbjct: 13 GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIH 70
Query: 60 EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP- 118
+ + +VFE+++ DL KL+ G ++ Q+ G+ Y H + HRDLKP
Sbjct: 71 TKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQ 129
Query: 119 SNLLVSKGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
+ L+ +G +KI D G+ + + T + T WYRAP+VL+ S+ Y +D+W++G
Sbjct: 130 NLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC 189
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
I EM++ LFPG + ADQ+ +I +++G+P +WP + D F +
Sbjct: 190 IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP-NVTELPKYDPNFTVYEPLPWES 248
Query: 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
I L+S++ +P+ R TA +ALEH +F+
Sbjct: 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 202 bits (514), Expect = 4e-64
Identities = 70/289 (24%), Positives = 142/289 (49%), Gaps = 22/289 (7%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G Y +VF+A++ + E V VK LK + + +E+K L + PNI+ L ++VK+
Sbjct: 46 GKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKD 101
Query: 61 HED--VFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+VFE++ +D +L Q ++ ++R +++ + L Y H G HRD+K
Sbjct: 102 PVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVK 156
Query: 118 PSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
P N+++ +++ D G+ + V +R+++ PE+L+ ++Y +DMW++
Sbjct: 157 PHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSL 216
Query: 176 GAIMFEMLSFRI-LFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK-------F 227
G ++ M+ + F G ++ DQ+ +I +V+G+ + + + +
Sbjct: 217 GCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSR 276
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276
+ E S E++ + +L ++ R TA EA+EHP+F +
Sbjct: 277 KRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 5e-64
Identities = 71/278 (25%), Positives = 117/278 (42%), Gaps = 37/278 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
G +G+V+ A +K+S +A+K L K + +EV+ + HPNI++L
Sbjct: 17 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYF 75
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ V+++ EY + ++ F E ++ L Y H + HRD+KP
Sbjct: 76 HDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKP 134
Query: 119 SNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
NLL+ S G +KI D G SS T T Y PE+ + ++ +VD+W++G
Sbjct: 135 ENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEM-IEGRMHDEKVDLWSLGV 192
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
+ +E L + F + +I +V ++ FP
Sbjct: 193 LCYEFLVGKPPFEANTYQETYKRISRV-------------------EFTFP--------- 224
Query: 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
+ + LISRL NP RP E LEHP+ +
Sbjct: 225 --DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (511), Expect = 8e-64
Identities = 71/282 (25%), Positives = 117/282 (41%), Gaps = 38/282 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V+ A D ++ E VA+KK+ +E +KEV+ L+K+ HPN ++ R
Sbjct: 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCY 84
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
++V EY L++ + E E+ + QGL Y+H HRD+K
Sbjct: 85 LREHTAWLVMEYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKA 143
Query: 119 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLS--EIYGPEVDMWAM 175
N+L+S+ G++K+GD G + P +V T ++ APEV+L Y +VD+W++
Sbjct: 144 GNILLSEPGLVKLGDFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G E+ + N+ +Y I Q +
Sbjct: 201 GITCIELAERKPPLFNMNAMSALYHIAQ----------------------------NESP 232
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
S S + + P RPT+ L+H F
Sbjct: 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (506), Expect = 3e-63
Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 35/279 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G++ +V A DK++ + VA+K + KK E E+ L K+ HPNIV L ++ +
Sbjct: 20 GAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYES 78
Query: 61 HEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
++++ + + +L + E+ ++E + L FQV + Y+H G HRDLKP
Sbjct: 79 GGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPE 136
Query: 120 NLLVS----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
NLL I I D G+ K D + T Y APEV L + Y VD W++
Sbjct: 137 NLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV-LAQKPYSKAVDCWSI 195
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G I + +L F +N A +I + W
Sbjct: 196 GVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW---------------------- 233
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
S + I L +P R T +AL+HP+
Sbjct: 234 ----DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 5e-63
Identities = 62/282 (21%), Positives = 121/282 (42%), Gaps = 34/282 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+ G V+ A+D +G+ VA++++ + + + E+ +R+ +PNIV +
Sbjct: 31 GASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENK-NPNIVNYLDSYLV 88
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+++++V EY+ L + E ++ +C + Q L ++H HRD+K N
Sbjct: 89 GDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 146
Query: 121 LLV-SKGVIKIGDLGMVKEID-SSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAI 178
+L+ G +K+ D G +I + V T ++ APEV+ + YGP+VD+W++G +
Sbjct: 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIM 205
Query: 179 MFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238
EM+ + +N +Y I G+P +
Sbjct: 206 AIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNP------------------------- 239
Query: 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280
S ++R + R +A E L+H F + +
Sbjct: 240 -EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 9e-63
Identities = 61/278 (21%), Positives = 115/278 (41%), Gaps = 35/278 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G V + ++ S + K +K K D+ KE+ L H NI+ L +
Sbjct: 16 GEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIAR-HRNILHLHESFES 72
Query: 61 HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E++ ++FE++ D+ + + +E E+ + QV + L ++H H D++P
Sbjct: 73 MEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPE 131
Query: 120 NLLVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N++ IKI + G +++ T Y APEV ++ DMW++G
Sbjct: 132 NIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV-HQHDVVSTATDMWSLG 190
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+++ +LS F + + I I + E+++
Sbjct: 191 TLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF----------------------- 227
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
S E++ + RL R TA+EAL+HP+ +
Sbjct: 228 ---KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 3e-62
Identities = 100/286 (34%), Positives = 158/286 (55%), Gaps = 15/286 (5%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
G+YG V A D K+G VAVKKL + S+ ++ +E++ L+ M H N++ L ++
Sbjct: 29 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFT 87
Query: 60 ------EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFH 113
E DV++V M +DL ++K Q ++D V+ L +Q+ +GL Y+H H
Sbjct: 88 PARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIH 144
Query: 114 RDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
RDLKPSNL V++ +KI D G+ + D T YV TRWYRAPE++L Y VD+
Sbjct: 145 RDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDI 202
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP-LGIQLASNLDWKFPQMG 231
W++G IM E+L+ R LFPG + DQ+ I +++G+P + + + A N QM
Sbjct: 203 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMP 262
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+N + A+ ++ L+ ++ + R TAA+AL H +F H
Sbjct: 263 KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 5e-62
Identities = 87/281 (30%), Positives = 152/281 (54%), Gaps = 7/281 (2%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNLVK 59
G+YG VF+A ++++ E VA+K+++ + L+E+ L+++ H NIV+L +++
Sbjct: 13 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLH 71
Query: 60 EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ + +VFE+ + DL K G + V++ FQ+ +GL + H + HRDLKP
Sbjct: 72 SDKKLTLVFEFCDQDLKKYFDSCNGDLD-PEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQ 130
Query: 120 NLLV-SKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
NLL+ G +K+ + G+ + + C + V T WYR P+VL +++Y +DMW+ G
Sbjct: 131 NLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC 190
Query: 178 IMFEMLSFRI-LFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
I E+ + LFPG + DQ+ +I +++G+PTE+ WP +L + +L
Sbjct: 191 IFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP-ATTSLV 249
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+ P + L+ L NP R +A EAL+HP+F
Sbjct: 250 NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-61
Identities = 59/278 (21%), Positives = 107/278 (38%), Gaps = 33/278 (11%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G+YG+V A+++ + E VAVK + K KE+ + +N H N+VK +E
Sbjct: 16 GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRRE 74
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
++ EY + E + + Q+ G+ Y+H G HRD+KP N
Sbjct: 75 GNIQYLFLEYCSGGE-LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPEN 133
Query: 121 LLV-SKGVIKIGDLGMVKEI---DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
LL+ + +KI D G+ + T Y APE+L E + VD+W+ G
Sbjct: 134 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 193
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
++ ML+ + + + + Q Y + +
Sbjct: 194 IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP------------------------- 228
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
++L+ ++ NP R T + + ++
Sbjct: 229 --WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 4e-60
Identities = 74/283 (26%), Positives = 119/283 (42%), Gaps = 41/283 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKL----R 55
GS+ V++ LD ++ VA +L+ + + E + K E + L+ + HPNIV+
Sbjct: 20 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWE 78
Query: 56 NLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY--FH 113
+ VK + + +V E M S LK +R +R+ C Q+ +GL ++H + H
Sbjct: 79 STVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTPPIIH 137
Query: 114 RDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
RDLK N+ ++ G +KIGDLG+ +S + T + APE+ E Y VD
Sbjct: 138 RDLKCDNIFITGPTGSVKIGDLGLATLKRASF-AKAVIGTPEFMAPEM--YEEKYDESVD 194
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231
++A G M EM + + +A QIY+
Sbjct: 195 VYAFGMCMLEMATSEYPYSECQNAAQIYRRV---------------------------TS 227
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
GV A E +I N R + + L H FF+
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-59
Identities = 69/285 (24%), Positives = 125/285 (43%), Gaps = 44/285 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLVK 59
GSYG + K G+ + K+L + E + L EV LR++ HPNIV+ + +
Sbjct: 15 GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRII 73
Query: 60 EHED--VFIVFEYME-SDLLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGY--- 111
+ + ++IV EY E DL ++ + + Q E+ V + Q+ L HR+
Sbjct: 74 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 133
Query: 112 --FHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPC-TDYVTTRWYRAPEVLLLSEIYG 167
HRDLKP+N+ + K +K+GD G+ + ++ +V T +Y +PE + Y
Sbjct: 134 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN-RMSYN 192
Query: 168 PEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227
+ D+W++G +++E+ + F + + KI +
Sbjct: 193 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------------------------ 228
Query: 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPF 272
R + S E +I+R+ + + RP+ E LE+P
Sbjct: 229 -----GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 5e-59
Identities = 66/285 (23%), Positives = 118/285 (41%), Gaps = 39/285 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDES-----RNLKEVKCLRKMNNHPNIVKLR 55
G + V + +K +G A K +KK+ +EV L+++ HPN++ L
Sbjct: 21 GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLH 79
Query: 56 NLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
+ + DV ++ E + L ++ +E+E Q+ G++Y+H H D
Sbjct: 80 EVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFD 138
Query: 116 LKPSNLLVS-----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
LKP N+++ K IKI D G+ +ID + T + APE++ E G E
Sbjct: 139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-YEPLGLEA 197
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
DMW++G I + +LS F G + + + V ++ +
Sbjct: 198 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS---------------- 241
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
+ S + I RL +P R T ++L+HP+ +
Sbjct: 242 ----------NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-58
Identities = 88/296 (29%), Positives = 151/296 (51%), Gaps = 24/296 (8%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKL------ 54
G+ G V A D VA+KKL + + ++ L K NH NI+ L
Sbjct: 28 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87
Query: 55 RNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ ++E +DV++V E M+++L ++++ + + L +Q+ G+ ++H G HR
Sbjct: 88 QKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHR 143
Query: 115 DLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMW 173
DLKPSN++V S +KI D G+ + +S T YV TR+YRAPEV +L Y VD+W
Sbjct: 144 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV-ILGMGYKENVDIW 202
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
++G IM EM+ +ILFPG++ DQ K+ + +G+P + N P+ G+
Sbjct: 203 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL 262
Query: 234 NLRELSPSA------------SRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277
+L P + + ++ L+S++ +P R + +AL+HP+ +
Sbjct: 263 TFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-57
Identities = 67/290 (23%), Positives = 114/290 (39%), Gaps = 45/290 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
GS+ V A + + A+K L+K+ + +E + +++ HP VKL
Sbjct: 19 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTF 77
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
++ E ++ Y ++ L + G F E R ++ L Y+H +G HRDLKP
Sbjct: 78 QDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHGKGIIHRDLKP 136
Query: 119 SNLLV-SKGVIKIGDLGMVKEI---DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
N+L+ I+I D G K + +V T Y +PE+L + D+WA
Sbjct: 137 ENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT-EKSACKSSDLWA 195
Query: 175 MGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234
+G I++++++ F N KI L++ FP+
Sbjct: 196 LGCIIYQLVAGLPPFRAGNEYLIFQKII-------------------KLEYDFPE----- 231
Query: 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEA------LEHPFFRSCHF 278
+ P A L+ +L + R E HPFF S +
Sbjct: 232 --KFFPKA----RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-55
Identities = 57/283 (20%), Positives = 106/283 (37%), Gaps = 45/283 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-----LDESRNLKEVKCLRKMN-NHPNIVKL 54
G +G V+ + VA+K ++K S + +R EV L+K++ +++L
Sbjct: 15 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 74
Query: 55 RNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ + + ++ E E E+ R+ +QV + + + H G HR
Sbjct: 75 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHR 134
Query: 115 DLKPSNLLV--SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
D+K N+L+ ++G +K+ D G + + TD+ TR Y PE + +G +
Sbjct: 135 DIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAV 193
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
W++G ++++M+ I F + F
Sbjct: 194 WSLGILLYDMVCGDIPFEHDEEIIR-------------------------GQVFFR---- 224
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275
S E LI + P RPT E HP+ +
Sbjct: 225 -------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-54
Identities = 76/284 (26%), Positives = 123/284 (43%), Gaps = 39/284 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDES--RNLKEVKCLRKMNNHPNIVKLRNLV 58
GS+G VF A KK+ +F A+K LKK + +D+ + E + L HP + +
Sbjct: 13 GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72
Query: 59 KEHEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ E++F V EY+ DL+ ++ F ++ GL ++H +G +RDLK
Sbjct: 73 QTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLK 130
Query: 118 PSNLLVSK-GVIKIGDLGMVKEI-DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
N+L+ K G IKI D GM KE + T Y APE+LL + Y VD W+
Sbjct: 131 LDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILL-GQKYNHSVDWWSF 189
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G +++EML + F G++ + + I +P W
Sbjct: 190 GVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRW---------------------- 225
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAA-EALEHPFFRSCHF 278
+E+ L+ +L P R + +HP FR ++
Sbjct: 226 ------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 178 bits (451), Expect = 3e-54
Identities = 68/285 (23%), Positives = 113/285 (39%), Gaps = 39/285 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDES----RNLKEVKCLRKMNNHPNIVKLRN 56
G +G+V+ +G+ A+K L KK + + N + + L + P IV +
Sbjct: 15 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ + + + M L + G E ++R ++ GL +MH + +RDL
Sbjct: 75 AFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYAAEIILGLEHMHNRFVVYRDL 133
Query: 117 KPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAM 175
KP+N+L+ + G ++I DLG+ + P V T Y APEVL Y D +++
Sbjct: 134 KPANILLDEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGVAYDSSADWFSL 192
Query: 176 GAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
G ++F++L F + D+ +
Sbjct: 193 GCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--------------------------- 225
Query: 236 RELSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRS 275
EL S S E SL+ L + + R A E E PFFRS
Sbjct: 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (428), Expect = 8e-52
Identities = 59/277 (21%), Positives = 109/277 (39%), Gaps = 36/277 (12%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLK-EVKCLRKMNNHPNIVKLRNLVK 59
GS+G V++ VAVK L + + + K EV LRK H NI+
Sbjct: 19 GSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMG-YS 73
Query: 60 EHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+ IV ++ E L F ++ ++ Q QG+ Y+H + HRDLK +
Sbjct: 74 TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSN 133
Query: 120 NLLV-SKGVIKIGDLGMVK---EIDSSLPCTDYVTTRWYRAPEVLLLSE--IYGPEVDMW 173
N+ + +KIGD G+ S + + APEV+ + + Y + D++
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
Query: 174 AMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
A G +++E+++ ++ + N+ DQI + + P
Sbjct: 194 AFGIVLYELMTGQLPYSNINNRDQIIFMVGR-------------------GYLSP----- 229
Query: 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
+L ++ + + L++ RP + L
Sbjct: 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (429), Expect = 2e-51
Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 43/283 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V + +G + A+K LKK+I + E L + HP I+++
Sbjct: 15 GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTF 73
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
++ + +F++ +Y+E L + + Q F + +V L Y+H + +RDLKP
Sbjct: 74 QDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKP 132
Query: 119 SNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
N+L+ G IKI D G K + T Y APEV + ++ Y +D W+ G
Sbjct: 133 ENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEV-VSTKPYNKSIDWWSFGI 189
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
+++EML+ F N+ KI N + +FP
Sbjct: 190 LIYEMLAGYTPFYDSNTMKTYEKIL-------------------NAELRFP--------- 221
Query: 238 LSPSASRESISLISRLCSWNPHMR-----PTAAEALEHPFFRS 275
P + + L+SRL + + R + HP+F+
Sbjct: 222 --PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 167 bits (425), Expect = 2e-51
Identities = 51/285 (17%), Positives = 101/285 (35%), Gaps = 40/285 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLRNLV 58
G +V A D + VAVK L+ + +E + +N HP IV + +
Sbjct: 18 GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTG 76
Query: 59 KEHED----VFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ +IV EY++ L+ + G + + Q L++ H+ G HR
Sbjct: 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQNGIIHR 135
Query: 115 DLKPSNLLVSKG-----VIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPE 169
D+KP+N+++S + + +S + T Y +PE +
Sbjct: 136 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR-GDSVDAR 194
Query: 170 VDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
D++++G +++E+L+ F G + Y+ + P
Sbjct: 195 SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH---------------- 238
Query: 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274
S + +++ + + NP R A + R
Sbjct: 239 ----------EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 3e-49
Identities = 70/283 (24%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE--SRNLKEVKCLRKMNNHPNIVKLRNLV 58
G++G V +K +G + A+K L+K++ + + + E + L+ HP + L+
Sbjct: 16 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAF 74
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ H+ + V EY L R + F+E+ R ++ L Y+H + +RD+K
Sbjct: 75 QTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKL 133
Query: 119 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
NL++ K G IKI D G+ KE S +L YG VD W +G
Sbjct: 134 ENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 193
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
+M+EM+ R+ F ++ I + +FP
Sbjct: 194 VMYEMMCGRLPFYNQDHERLFELIL-------------------MEEIRFP--------- 225
Query: 238 LSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRS 275
+ S E+ SL++ L +P R A E +EH FF S
Sbjct: 226 --RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-49
Identities = 57/273 (20%), Positives = 103/273 (37%), Gaps = 40/273 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +GDV + G VAVK +K L E + ++ H N+V+L ++ E
Sbjct: 18 GEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLR-HSNLVQLLGVIVE 71
Query: 61 HED-VFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ ++IV EYM L+ ++ R D + V + + Y+ + HRDL
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 131
Query: 119 SNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
N+LVS+ V K+ D G+ KE S+ + APE L + + + D+W+ G
Sbjct: 132 RNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEA-LREKKFSTKSDVWSFGI 188
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
+++E+ SF + + + ++ P
Sbjct: 189 LLWEIYSFGRVPYPRIPLKDVVP-----------------RVEKGYKMDAP--------- 222
Query: 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
++ + MRP+ + E
Sbjct: 223 --DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-48
Identities = 58/273 (21%), Positives = 110/273 (40%), Gaps = 36/273 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G V + + VA+K +++ ++ E ++E + + K++ HP +V+L + E
Sbjct: 16 GQFGLVHLGYWL-NKDKVAIKTIREG--AMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLE 71
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+ +VFE+ME L F+ + + +C V +G+ Y+ HRDL N
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 131
Query: 121 LLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
LV VIK+ D GM + + D T + +PEV Y + D+W+ G
Sbjct: 132 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV-FSFSRYSSKSDVWSFGV 190
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
+M+E+ S + S ++ + +++ P++
Sbjct: 191 LMWEVFSEGKIPYENRSNSEVVE-----------------DISTGFRLYKPRL------- 226
Query: 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
AS +++ P RP + L
Sbjct: 227 ----ASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-47
Identities = 62/302 (20%), Positives = 117/302 (38%), Gaps = 61/302 (20%)
Query: 1 GSYGDVFQALDKKSGEF-----VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G V A + VAVK LK+K S + + E+K + ++ +H NIV L
Sbjct: 48 GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 107
Query: 56 NLVKEHEDVFIVFEYME-SDLLKLMKERAGQN---------------------FSEDEVR 93
++++FEY DLL ++ + + + +++
Sbjct: 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 167
Query: 94 NLCFQVFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI---DSSLPCTDYV 149
+QV +G+ ++ + HRDL N+LV V+KI D G+ ++I + + +
Sbjct: 168 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR 227
Query: 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSP 208
+ APE L IY + D+W+ G +++E+ S +PG YK+ Q
Sbjct: 228 LPVKWMAPES-LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ----- 281
Query: 209 TEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268
+ P A+ E ++ +++ RP+
Sbjct: 282 ------------NGFKMDQP-----------FYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 269 EH 270
Sbjct: 319 SF 320
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (399), Expect = 2e-47
Identities = 53/290 (18%), Positives = 97/290 (33%), Gaps = 42/290 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+GD++ D +GE VA+K K + E K + M I +R E
Sbjct: 18 GSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 74
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+ +V E + L L + FS V L Q+ + Y+H + + HRD+KP N
Sbjct: 75 GDYNVMVMELLGPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 133
Query: 121 LLVS----KGVIKIGDLGMVKEIDSS--------LPCTDYVTTRWYRAPEVLLLSEIYGP 168
L+ ++ I D G+ K+ + + T Y + L
Sbjct: 134 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT-HLGIEQSR 192
Query: 169 EVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228
D+ ++G ++ + + G +A + K ++
Sbjct: 193 RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-------------- 238
Query: 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAA---EALEHPFFRS 275
L E + ++ S +P + + + F R
Sbjct: 239 --------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 5e-47
Identities = 57/284 (20%), Positives = 105/284 (36%), Gaps = 43/284 (15%)
Query: 1 GSYGDVFQALDK--KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G++G V Q + + K VA+K LK+ D ++E + + +++ +P IV+L V
Sbjct: 20 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIG-V 77
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
+ E + +V E L + V L QV G+ Y+ + + HRDL
Sbjct: 78 CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAA 137
Query: 119 SNLLV-SKGVIKIGDLGMVKEIDSS----LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMW 173
N+L+ ++ KI D G+ K + + + + APE + + D+W
Sbjct: 138 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC-INFRKFSSRSDVW 196
Query: 174 AMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
+ G M+E LS+ + + + + I Q
Sbjct: 197 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ----------------------------- 227
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAE---ALEHPFF 273
E P E +L+S + RP + ++
Sbjct: 228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 7e-47
Identities = 62/282 (21%), Positives = 117/282 (41%), Gaps = 42/282 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V+ VAVK LK+ S+ L E ++++ H +V+L V
Sbjct: 24 GQFGEVWMGYYN-GHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQ-HQRLVRLYA-VVT 78
Query: 61 HEDVFIVFEYMESDLL-KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E ++I+ EYME+ L +K +G + +++ ++ Q+ +G+ ++ + Y HRDL+ +
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA 138
Query: 120 NLLV-SKGVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+LV KI D G+ + I+ + + APE + + + D+W+ G
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN-YGTFTIKSDVWSFG 197
Query: 177 AIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
++ E+++ RI +PG + + I + + D+ P
Sbjct: 198 ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP--------------------- 236
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE--HPFFRS 275
E L+ P RPT FF +
Sbjct: 237 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-46
Identities = 62/282 (21%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V+ + VA+K LK ++ L+E + ++K+ H +V+L V
Sbjct: 28 GCFGEVWMGTWNGTTR-VAIKTLKPG--TMSPEAFLQEAQVMKKLR-HEKLVQLYA-VVS 82
Query: 61 HEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
E ++IV EYM LL +K G+ ++ ++ Q+ G+ Y+ R Y HRDL+ +
Sbjct: 83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 142
Query: 120 NLLV-SKGVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N+LV V K+ D G+ + I+ + + APE L + + D+W+ G
Sbjct: 143 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFG 201
Query: 177 AIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235
++ E+ + R+ +PG + + + ++ + P
Sbjct: 202 ILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--------------------------- 234
Query: 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE--HPFFRS 275
P L+ + P RPT +F S
Sbjct: 235 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-46
Identities = 58/285 (20%), Positives = 108/285 (37%), Gaps = 45/285 (15%)
Query: 1 GSYGDVFQAL--DKKSGEFVAVKKLKKKIFSLDESRN-LKEVKCLRKMNNHPNIVKLRNL 57
G++G V + KK + VAVK LK + L E +++++ +P IV++
Sbjct: 18 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIG- 75
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ E E +V E E L ++ + + L QV G+ Y+ + HRDL
Sbjct: 76 ICEAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNFVHRDLA 134
Query: 118 PSN-LLVSKGVIKIGDLGMVKEIDSSLPC----TDYVTTRWYRAPEVLLLSEIYGPEVDM 172
N LLV++ KI D G+ K + + T + APE + + + D+
Sbjct: 135 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC-INYYKFSSKSDV 193
Query: 173 WAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231
W+ G +M+E S+ + + G ++ + +
Sbjct: 194 WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---------------------------- 225
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAE---ALEHPFF 273
RE L++ +++ RP A L + ++
Sbjct: 226 -GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (389), Expect = 7e-46
Identities = 48/283 (16%), Positives = 91/283 (32%), Gaps = 41/283 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
GS+G +F+ + + + VA+K ++ D + E + + + I + +E
Sbjct: 16 GSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 72
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+V + + L L+ G+ FS V Q+ + +H + +RD+KP N
Sbjct: 73 GLHNVLVIDLLGPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDN 131
Query: 121 LLVSK------GVIKIGDLGMVKEIDSSL--------PCTDYVTTRWYRAPEVLLLSEIY 166
L+ + +I + D GMVK + + T Y + L
Sbjct: 132 FLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT-HLGREQ 190
Query: 167 GPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226
D+ A+G + L + + G +A K ++
Sbjct: 191 SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-------------- 236
Query: 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269
LREL E + + P
Sbjct: 237 --------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (389), Expect = 7e-46
Identities = 57/280 (20%), Positives = 104/280 (37%), Gaps = 40/280 (14%)
Query: 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +G+V K G+ FVA+K LK L E + + + HPN++ L +
Sbjct: 37 GEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGV 95
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
V + V I+ E+ME+ L + F+ ++ + + G+ Y+ Y HRDL
Sbjct: 96 VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLA 155
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLL-----LSEIYGPEVD 171
N+LV S V K+ D G+ + ++ Y + + P + D
Sbjct: 156 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASD 215
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
+W+ G +M+E++S+ + + D I I Q D++ P
Sbjct: 216 VWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ--------------------DYRLPP- 254
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
L+ + + RP + +
Sbjct: 255 --------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-45
Identities = 58/293 (19%), Positives = 104/293 (35%), Gaps = 42/293 (14%)
Query: 1 GSYGDVFQA---LDKKSGEFVAVKKLKKKIFSLDES---RNLKEVKCLRKMNNHPNIVKL 54
G+YG VF +G+ A+K LKK E + L + P +V L
Sbjct: 35 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 94
Query: 55 RNLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHR 114
+ + ++ +Y+ L + F+E EV+ ++ L ++H+ G +R
Sbjct: 95 HYAFQTETKLHLILDYINGGELF-THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 153
Query: 115 DLKPSNLLVSK-GVIKIGDLGM---VKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
D+K N+L+ G + + D G+ ++ T + V + V
Sbjct: 154 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 213
Query: 171 DMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
D W++G +M+E+L+ F + +I + I
Sbjct: 214 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----------------- 256
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278
S + LI RL +P R A E EH FF+ ++
Sbjct: 257 ---------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-45
Identities = 54/274 (19%), Positives = 106/274 (38%), Gaps = 38/274 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G V + VA+K +K+ S+ E ++E K + ++ H +V+L + +
Sbjct: 15 GQFGVVKYGKWR-GQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTK 70
Query: 61 HEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSN 120
+FI+ EYM + L F ++ +C V + + Y+ + + HRDL N
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 130
Query: 121 LLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
LV +GV+K+ D G+ + + D + PEVL+ + + D+WA G
Sbjct: 131 CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM-YSKFSSKSDIWAFGV 189
Query: 178 IMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+M+E+ S ++ + +++ I Q +
Sbjct: 190 LMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS---------------------- 227
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
+ +++ RPT L +
Sbjct: 228 -------EKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (389), Expect = 3e-45
Identities = 70/313 (22%), Positives = 128/313 (40%), Gaps = 43/313 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G + V+ A D + VA+K ++ + E+K L+++N + K ++
Sbjct: 24 GHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVN-DADNTKEDSMGAN 80
Query: 61 H---------------EDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHY 105
H V +VFE + +LL L+K+ + V+ + Q+ GL Y
Sbjct: 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 140
Query: 106 MH-RQGYFHRDLKPSNLLVSK-----GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEV 159
MH R G H D+KP N+L+ +I+I + T+ + TR YR+PEV
Sbjct: 141 MHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEV 200
Query: 160 LLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS------ADQIYKICQVIGSPTEDSW 213
LL + +G D+W+ ++FE+++ LF D I +I +++G
Sbjct: 201 LLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLL 259
Query: 214 PLG------------IQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMR 261
G ++ S L + + + S ++E +S + +P R
Sbjct: 260 RNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319
Query: 262 PTAAEALEHPFFR 274
A + HP+ +
Sbjct: 320 ADAGGLVNHPWLK 332
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-45
Identities = 59/288 (20%), Positives = 114/288 (39%), Gaps = 47/288 (16%)
Query: 1 GSYGDVFQALDKKSGEF--VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLV 58
G++G V +A KK G A+K++K+ D E++ L K+ +HPNI+ L
Sbjct: 21 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80
Query: 59 KEHEDVFIVFEYME-SDLLKLMKER--------------AGQNFSEDEVRNLCFQVFQGL 103
+ +++ EY +LL +++ S ++ + V +G+
Sbjct: 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 140
Query: 104 HYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLL 162
Y+ ++ + HRDL N+LV V KI D G+ + + + T + A E L
Sbjct: 141 DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN- 199
Query: 163 SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASN 222
+Y D+W+ G +++E++S + ++Y+ +L
Sbjct: 200 YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE-----------------KLPQG 242
Query: 223 LDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
+ P + E L+ + P+ RP+ A+ L
Sbjct: 243 YRLEKP-----------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (382), Expect = 7e-45
Identities = 62/273 (22%), Positives = 118/273 (43%), Gaps = 36/273 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G YG+V++ + KK VAVK LK+ +++ LKE ++++ HPN+V+L +
Sbjct: 28 GQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTR 84
Query: 61 HEDVFIVFEYME-SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPS 119
+I+ E+M +LL ++E Q S + + Q+ + Y+ ++ + HRDL
Sbjct: 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 144
Query: 120 NLLV-SKGVIKIGDLGMVKEI--DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMG 176
N LV ++K+ D G+ + + D+ + APE L + + D+WA G
Sbjct: 145 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES-LAYNKFSIKSDVWAFG 203
Query: 177 AIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236
+++E+ ++ + Q+Y++ L + + P
Sbjct: 204 VLLWEIATYGMSPYPGIDLSQVYEL-----------------LEKDYRMERP-------- 238
Query: 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALE 269
+ L+ WNP RP+ AE +
Sbjct: 239 ---EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-44
Identities = 53/280 (18%), Positives = 108/280 (38%), Gaps = 40/280 (14%)
Query: 1 GSYGDVFQALDKKS---GEFVAVKKLKKKIFSLDESRN--LKEVKCLRKMNNHPNIVKLR 55
GS+G V + VAVK LK + S E+ + ++EV + ++ H N+++L
Sbjct: 19 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLY 77
Query: 56 NLVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRD 115
V + +V E L + +F + QV +G+ Y+ + + HRD
Sbjct: 78 G-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRD 136
Query: 116 LKPSNLLVS-KGVIKIGDLGMVKEI---DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
L NLL++ + ++KIGD G+++ + D ++ + L + + D
Sbjct: 137 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASD 196
Query: 172 MWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230
W G ++EM ++ + + G N + ++KI +
Sbjct: 197 TWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL---------------------- 234
Query: 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
++ +++ + + P RPT +
Sbjct: 235 ------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (383), Expect = 2e-44
Identities = 69/286 (24%), Positives = 114/286 (39%), Gaps = 43/286 (15%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDE--SRNLKEVKCLRKMNNHPNIVKLRNLV 58
GS+G V K+SG A+K L K+ + L E + L+ +N P +VKL
Sbjct: 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSF 110
Query: 59 KEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKP 118
K++ ++++V EY+ + R G+ FSE R Q+ Y+H +RDLKP
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKP 169
Query: 119 SNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGA 177
NLL+ +G I++ D G K + T APE+ +LS+ Y VD WA+G
Sbjct: 170 ENLLIDQQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEI-ILSKGYNKAVDWWALGV 226
Query: 178 IMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237
+++EM + F KI +FP
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSG-------------------KVRFP--------- 258
Query: 238 LSPSASRESISLISRLCSWNP-----HMRPTAAEALEHPFFRSCHF 278
S + L+ L + +++ + H +F + +
Sbjct: 259 --SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 9e-44
Identities = 54/278 (19%), Positives = 104/278 (37%), Gaps = 39/278 (14%)
Query: 1 GSYGDVFQALDKKSGEF----VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G++G V++ L GE VA+K+L++ L E + ++ +P++ +L
Sbjct: 20 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLG 78
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
+ V ++ + M L N + N C Q+ +G++Y+ + HRDL
Sbjct: 79 -ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 137
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEI---DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDM 172
N+LV + +KI D G+ K + + + A E +L IY + D+
Sbjct: 138 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES-ILHRIYTHQSDV 196
Query: 173 WAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232
W+ G ++E+++F A +I I L P
Sbjct: 197 WSYGVTVWELMTFGSKPYDGIPASEISSI-----------------LEKGERLPQP---- 235
Query: 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
P + + ++ + + RP E +
Sbjct: 236 -------PICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-43
Identities = 59/296 (19%), Positives = 111/296 (37%), Gaps = 56/296 (18%)
Query: 1 GSYGDVFQA-----LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G V +A + + VAVK LK + + E+K L + NH NIV L
Sbjct: 34 GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93
Query: 56 NLVKEHEDVFIVFEYME-SDLLKLMKERAGQN----------------FSEDEVRNLCFQ 98
++ EY DLL ++ + +++ + +Q
Sbjct: 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQ 153
Query: 99 VFQGLHYMHRQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEI---DSSLPCTDYVTTRWY 154
V +G+ ++ + HRDL N+L+ + KI D G+ ++I + + + +
Sbjct: 154 VAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKW 213
Query: 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSW 213
APE + + +Y E D+W+ G ++E+ S +PG + YK+
Sbjct: 214 MAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM------------ 260
Query: 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269
+ P A E ++ +P RPT + ++
Sbjct: 261 -----IKEGFRMLSP-----------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-42
Identities = 59/277 (21%), Positives = 107/277 (38%), Gaps = 39/277 (14%)
Query: 1 GSYGDVFQALDKK---SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +GDV Q + VA+K K + L+E +R+ + HP+IVKL +
Sbjct: 18 GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGV 76
Query: 58 VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLK 117
+ E+ V+I+ E L+ + + + +Q+ L Y+ + + HRD+
Sbjct: 77 ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 135
Query: 118 PSNLLV-SKGVIKIGDLGMVKEIDSS--LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWA 174
N+LV S +K+GD G+ + ++ S + + APE + + D+W
Sbjct: 136 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN-FRRFTSASDVWM 194
Query: 175 MGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233
G M+E+L F G + D I +I
Sbjct: 195 FGVCMWEILMHGVKPFQGVKNNDVIGRIENG----------------------------- 225
Query: 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
+ P+ SL+++ +++P RP E
Sbjct: 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-42
Identities = 55/278 (19%), Positives = 108/278 (38%), Gaps = 39/278 (14%)
Query: 1 GSYGDVFQALDKKSGE----FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRN 56
G +G+V++ + K S VA+K LK L E + + + H NI++L
Sbjct: 18 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEG 76
Query: 57 LVKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
++ +++ + I+ EYME+ L FS ++ + + G+ Y+ Y HRDL
Sbjct: 77 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDL 136
Query: 117 KPSNLLV-SKGVIKIGDLGMVKEI----DSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVD 171
N+LV S V K+ D G+ + + +++ + + APE + + D
Sbjct: 137 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS-YRKFTSASD 195
Query: 172 MWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231
+W+ G +M+E++++ + S ++ K I P+
Sbjct: 196 VWSFGIVMWEVMTYGERPYWELSNHEVMKA---INDGFRLPTPMDC-------------- 238
Query: 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269
L+ + RP A+ +
Sbjct: 239 -----------PSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-41
Identities = 53/282 (18%), Positives = 106/282 (37%), Gaps = 44/282 (15%)
Query: 1 GSYGDVFQALDKKS---GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNL 57
G +G V+ + AVK L + + S+ L E ++ + HPN++ L +
Sbjct: 38 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGI 96
Query: 58 VKEHED-VFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDL 116
E +V YM+ L+ N + ++ QV +G+ ++ + + HRDL
Sbjct: 97 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDL 156
Query: 117 KPSNLLVSKG-VIKIGDLGMVK-----EIDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEV 170
N ++ + +K+ D G+ + E DS T + A E L ++ + +
Sbjct: 157 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES-LQTQKFTTKS 215
Query: 171 DMWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229
D+W+ G +++E+++ +P N+ D + Q
Sbjct: 216 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-------------------------- 249
Query: 230 MGGVNLRELSPS-ASRESISLISRLCSWNPHMRPTAAEALEH 270
R L P ++ + MRP+ +E +
Sbjct: 250 ----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-40
Identities = 66/293 (22%), Positives = 103/293 (35%), Gaps = 40/293 (13%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE 60
G +G+V++ K GE VAVK + E+ + H NI+ +
Sbjct: 14 GRFGEVWRG--KWRGEEVAVKIFSSR--EERSWFREAEIYQTVMLR-HENILGFIAADNK 68
Query: 61 ----HEDVFIVFEYMES-DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMH-------- 107
+++V +Y E L + + + + L GL ++H
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 108 RQGYFHRDLKPSNLLV-SKGVIKIGDLGMVKEIDS-----SLPCTDYVTTRWYRAPEVLL 161
+ HRDLK N+LV G I DLG+ DS + V T+ Y APEVL
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 162 LSEI-----YGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLG 216
S D++AMG + +E+ R G + Q+ V P+ +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 217 IQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269
+ L P R S A R ++ N R TA +
Sbjct: 245 V-CEQKLRPNIPN------RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 2e-40
Identities = 66/302 (21%), Positives = 116/302 (38%), Gaps = 64/302 (21%)
Query: 1 GSYGDVFQA-----LDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G VFQA L + VAVK LK++ + ++ +E + + + +PNIVKL
Sbjct: 24 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLL 82
Query: 56 NLVKEHEDVFIVFEYME-SDLLKLMKERAGQN----------------------FSEDEV 92
+ + + ++FEYM DL + ++ + S E
Sbjct: 83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ 142
Query: 93 RNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDY 148
+ QV G+ Y+ + + HRDL N LV + V+KI D G+ + I S+ +
Sbjct: 143 LCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGND 202
Query: 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRIL-FPGKNSADQIYKICQVIGS 207
+ PE + Y E D+WA G +++E+ S+ + + G + IY +
Sbjct: 203 AIPIRWMPPES-IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD---- 257
Query: 208 PTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEA 267
N+ + E +L+ S P RP+
Sbjct: 258 -------------------------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292
Query: 268 LE 269
Sbjct: 293 HR 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 5e-40
Identities = 56/296 (18%), Positives = 113/296 (38%), Gaps = 55/296 (18%)
Query: 1 GSYGDVFQALDKKSGE-------FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVK 53
G++G V A + VAVK LK D S + E++ ++ + H NI+
Sbjct: 24 GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 83
Query: 54 LRNLVKEHEDVFIVFEYME-SDLLKLMKER--------------AGQNFSEDEVRNLCFQ 98
L + ++++ EY +L + ++ R + S ++ + +Q
Sbjct: 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 143
Query: 99 VFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCT---DYVTTRWY 154
V +G+ Y+ + HRDL N+LV+ V+KI D G+ ++I + +
Sbjct: 144 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 203
Query: 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWP 214
APE L IY + D+W+ G +++E+ + ++++K+ +
Sbjct: 204 MAPEA-LFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM------ 256
Query: 215 LGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
+ + + E ++ P RPT + +E
Sbjct: 257 ----------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-39
Identities = 54/303 (17%), Positives = 114/303 (37%), Gaps = 56/303 (18%)
Query: 1 GSYGDVFQALDK-----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
GS+G V++ + K + VA+K + + + L E +++ N ++V+L
Sbjct: 31 GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLL 89
Query: 56 NLVKEHEDVFIVFEYMESDLL---------KLMKERAGQNFSEDEVRNLCFQVFQGLHYM 106
+V + + ++ E M L + S ++ + ++ G+ Y+
Sbjct: 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 149
Query: 107 HRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI---DSSLPCTDYVTTRWYRAPEVLLL 162
+ + HRDL N +V++ +KIGD GM ++I D + + +PE L
Sbjct: 150 NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES-LK 208
Query: 163 SEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221
++ D+W+ G +++E+ + + G ++ + + +
Sbjct: 209 DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------------------ 250
Query: 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE------HPFFRS 275
L + + L+ +NP MRP+ E + P FR
Sbjct: 251 -----------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
Query: 276 CHF 278
F
Sbjct: 300 VSF 302
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 6e-38
Identities = 58/296 (19%), Positives = 112/296 (37%), Gaps = 55/296 (18%)
Query: 1 GSYGDVFQALDKK-----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLR 55
G++G V +A + VAVK LK+ + + E+K L + +H N+V L
Sbjct: 24 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83
Query: 56 NLVKEHED-VFIVFEYMESDLLK---------------LMKERAGQNFSEDEVRNLCFQV 99
+ + ++ E+ + L ++ + + + FQV
Sbjct: 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 143
Query: 100 FQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEI---DSSLPCTDYVTTRWYR 155
+G+ ++ + HRDL N+L+S+ V+KI D G+ ++I + D +
Sbjct: 144 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 203
Query: 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRIL-FPGKNSADQIYKICQVIGSPTEDSWP 214
APE + +Y + D+W+ G +++E+ S +PG ++ +
Sbjct: 204 APET-IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------------- 249
Query: 215 LGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270
L + P + E + P RPT +E +EH
Sbjct: 250 ----LKEGTRMRAP-----------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.4 bits (208), Expect = 2e-20
Identities = 32/195 (16%), Positives = 58/195 (29%), Gaps = 28/195 (14%)
Query: 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN--------NHPNIV 52
G VF +K VK K S + + ++ L +
Sbjct: 11 GKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ 69
Query: 53 KLRNL-VKEHEDVFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGY 111
KL+ L V + ME L+ + + + + + + + +G
Sbjct: 70 KLQGLAVPKVYAWEGNAVLME-----LIDAKELYRVRVENPDEVLDMILEEVAKFYHRGI 124
Query: 112 FHRDLKPSNLLVSKGVIKIGDLGMVKEIDSS-----LPCTDYVTTRWYRAPEVLLLSEIY 166
H DL N+LVS+ I I D E+ L ++ Y
Sbjct: 125 VHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT--------Y 176
Query: 167 GPEVDMWAMGAIMFE 181
E D+ + + +
Sbjct: 177 RTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 282 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.78 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.22 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.13 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.37 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.62 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-61 Score=385.61 Aligned_cols=246 Identities=25% Similarity=0.464 Sum_probs=210.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+|+.||+|++...... ....+.+|+.+++++. ||||+++++++.+++..|+|||||.|+++..+.
T Consensus 31 G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~ 108 (293)
T d1yhwa1 31 GASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV 108 (293)
T ss_dssp SSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred CcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEEEEEEecCCCcHHHHh
Confidence 89999999999999999999998765432 3456788999999995 999999999999999999999999987777776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCC-CCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE 158 (282)
.. ..+++..++.++.||+.||.|||++|++||||||+||+++ ++.+||+|||++..... ........||+.|+|||
T Consensus 109 ~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE 186 (293)
T d1yhwa1 109 TE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186 (293)
T ss_dssp HH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHH
T ss_pred hc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChh
Confidence 65 3699999999999999999999999999999999999997 47999999999987643 33345667999999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccccc
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLREL 238 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
++.+. .++.++|||||||++|+|++|..||.+.+..+....+..... +. ...
T Consensus 187 ~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~--------------------------~~~ 238 (293)
T d1yhwa1 187 VVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE--------------------------LQN 238 (293)
T ss_dssp HHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC--------------------------CSS
T ss_pred hhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CC--------------------------CCC
Confidence 99854 489999999999999999999999998877776666554321 11 012
Q ss_pred CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 239 SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
+..+++.+++||.+||+.||++|||++|+|+||||+....
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~ 278 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCC
Confidence 3457899999999999999999999999999999986543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-62 Score=387.29 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=202.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+|+.||+|+++..........+.+|+.+++++. ||||+++++++.+++..|+|||||.++.|..++
T Consensus 16 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l 94 (271)
T d1nvra_ 16 GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRI 94 (271)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEECCTTEEGGGGS
T ss_pred CcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeEEEEeccCCCcHHHHH
Confidence 8999999999999999999999977654445566788999999994 999999999999999999999999976665555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC---CCCCCccccccccC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~a 156 (282)
... ..+++..++.++.||++||+|||++||+||||||+||++++ +.+||+|||+|...... .......||+.|+|
T Consensus 95 ~~~-~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~A 173 (271)
T d1nvra_ 95 EPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173 (271)
T ss_dssp BTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSC
T ss_pred hcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccC
Confidence 443 47999999999999999999999999999999999999975 89999999999865322 22345689999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+...++.++|||||||++|+|++|+.||................... .
T Consensus 174 PE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---------------------------~ 226 (271)
T d1nvra_ 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------------------L 226 (271)
T ss_dssp THHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------------------------S
T ss_pred HhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------------------------C
Confidence 9999866655788999999999999999999998766544443332211110 0
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.....+++.+.+||++||+.||++|||++|+|+||||+...
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 267 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence 11235688999999999999999999999999999998643
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-61 Score=381.22 Aligned_cols=242 Identities=29% Similarity=0.452 Sum_probs=206.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+++.||+|++...... .....+.+|+.+++++ +||||+++++++.+++..|+|||||+++.+..
T Consensus 17 G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~ 95 (263)
T d2j4za1 17 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTVYR 95 (263)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHH
T ss_pred CCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEEEeecCCCcHHH
Confidence 89999999999999999999998754322 2345567899999999 59999999999999999999999999766666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
++... ..+++..++.++.||++||+|||++|++||||||+||++++ +.+||+|||++....... .....||+.|+||
T Consensus 96 ~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~AP 173 (263)
T d2j4za1 96 ELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPP 173 (263)
T ss_dssp HHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-CEETTEEGGGCCH
T ss_pred HHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-ccccCCCCcccCH
Confidence 66554 36999999999999999999999999999999999999985 799999999998765443 3456899999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.... ..
T Consensus 174 E~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~------------------------------~~ 222 (263)
T d2j4za1 174 EMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------------------------FT 222 (263)
T ss_dssp HHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC------------------------------CC
T ss_pred HHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------------------------CC
Confidence 999854 48999999999999999999999998877666665543311 12
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.+..+++++++||.+||+.||++|||++|+|+||||++-
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 234678999999999999999999999999999999753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-61 Score=387.80 Aligned_cols=274 Identities=35% Similarity=0.655 Sum_probs=229.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH----HHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD----ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~----~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|+++.+|+.||||+++....... ...+.+|+.+++++. ||||+++++++.+++..|+|||||.++++
T Consensus 9 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE~~~~~~~ 87 (299)
T d1ua2a_ 9 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFMETDLE 87 (299)
T ss_dssp ETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEECCSEEHH
T ss_pred CcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhhhhcchHH
Confidence 8999999999999999999999976543322 245678999999994 99999999999999999999999999988
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC-CCCCCccccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS-LPCTDYVTTRWY 154 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~-~~~~~~~~~~~~ 154 (282)
..+.... ..+++..+..++.||+.||+|||++|++||||||+||+++. +.+||+|||.+...... .......+|+.|
T Consensus 88 ~~~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y 166 (299)
T d1ua2a_ 88 VIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWY 166 (299)
T ss_dssp HHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTT
T ss_pred hhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhh
Confidence 7766543 57999999999999999999999999999999999999985 89999999999876443 233456789999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||++.....++.++|||||||++|+|++|..||.+....+.+..+....+.+....++............ ......
T Consensus 167 ~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 244 (299)
T d1ua2a_ 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK--SFPGIP 244 (299)
T ss_dssp CCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC--CCCCCC
T ss_pred ccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc--cCCCCC
Confidence 999999867778999999999999999999999999999999999999999998888777655444333222 223333
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
........++++.+||++||+.||++|||++|+|+||||++...
T Consensus 245 ~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 245 LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288 (299)
T ss_dssp HHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred hHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence 44556678999999999999999999999999999999997653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-61 Score=387.40 Aligned_cols=248 Identities=29% Similarity=0.425 Sum_probs=192.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+++.||||++...........+.+|+.+++++ +||||+++++++.+++..|+|||||+|+.|..++
T Consensus 20 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l 98 (307)
T d1a06a_ 20 GAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 98 (307)
T ss_dssp GGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred ccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhh
Confidence 899999999999999999999998765555555677899999999 5999999999999999999999999976665555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee----CCcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS----KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~----~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
... ..+++..+..++.||+.||+|||++|++||||||+||++. ++.+||+|||++.............||+.|+|
T Consensus 99 ~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~A 177 (307)
T d1a06a_ 99 VEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 177 (307)
T ss_dssp HTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSC
T ss_pred hcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccC
Confidence 543 4799999999999999999999999999999999999994 47899999999987766655566789999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+. .++.++|||||||++|+|++|..||.+....+....+......+. .
T Consensus 178 PE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~ 230 (307)
T d1a06a_ 178 PEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD--------------------------S 230 (307)
T ss_dssp HHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC--------------------------T
T ss_pred cHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC--------------------------C
Confidence 9999854 489999999999999999999999998877766665544221111 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.....+++.+.+||.+||+.||++|||++|+++||||++..
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 23346789999999999999999999999999999998643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-61 Score=383.27 Aligned_cols=247 Identities=24% Similarity=0.422 Sum_probs=209.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+++.||+|+++... ......+.+|+.+++++. ||||+++++++.+++..++|||||.++++..++
T Consensus 23 G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~ 100 (288)
T d2jfla1 23 GAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 100 (288)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTEEHHHHH
T ss_pred CCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHH
Confidence 899999999999999999999987643 344567789999999995 999999999999999999999999987777776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCC-CCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSS-LPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~aPE 158 (282)
...+.++++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++...... .......||+.|+|||
T Consensus 101 ~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE 180 (288)
T d2jfla1 101 LELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180 (288)
T ss_dssp HHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHH
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHH
Confidence 65556799999999999999999999999999999999999998 589999999998754322 1123567899999999
Q ss_pred hhhc----cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 159 VLLL----SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 159 ~~~~----~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
++.. ...++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 181 ~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~--------------------------- 233 (288)
T d2jfla1 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP--------------------------- 233 (288)
T ss_dssp HHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC---------------------------
T ss_pred HHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC---------------------------
Confidence 9852 345789999999999999999999999998888877766553110
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
....+..+++++++||++||+.||++|||++|+|+||||+.-
T Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 011234578999999999999999999999999999999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-59 Score=378.61 Aligned_cols=276 Identities=36% Similarity=0.685 Sum_probs=231.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|+++.+|+.||+|+++...... ....+.+|+.+++++ +||||+++++++.+++..|+|||||.++++...
T Consensus 13 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~ 91 (298)
T d1gz8a_ 13 GTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFM 91 (298)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHH
T ss_pred CcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEEEeecCCchhhhh
Confidence 899999999999999999999997654332 245678899999988 599999999999999999999999999988888
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aP 157 (282)
.......+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||.+..... ........+++.|+||
T Consensus 92 ~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~ap 171 (298)
T d1gz8a_ 92 DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171 (298)
T ss_dssp HHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCH
T ss_pred hhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeeh
Confidence 7776678999999999999999999999999999999999999974 7999999999987643 2334456899999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+......+.++|||||||++|+|++|+.||.+.+..+....+....+.+....++....... ....+..........
T Consensus 172 E~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 250 (298)
T d1gz8a_ 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD-YKPSFPKWARQDFSK 250 (298)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT-CCTTSCCCCCCCHHH
T ss_pred hhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc-cccccccccccchhh
Confidence 9988777678999999999999999999999999999999999999888887777664333222 222223333333444
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....+++++.+||++||+.||++|||++|+|+||||+++..
T Consensus 251 ~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 251 VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 55678899999999999999999999999999999998754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-60 Score=373.62 Aligned_cols=242 Identities=28% Similarity=0.438 Sum_probs=201.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeecccccc----CCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKE----HEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|+++.++..||+|++....... ....+.+|+.+++++. ||||+++++++.+ +..+|+|||||++++
T Consensus 20 G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~ 98 (270)
T d1t4ha_ 20 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGT 98 (270)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEEEEEECCCSCB
T ss_pred CcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEEEEEeCCCCCc
Confidence 899999999999999999999987765443 3456678999999995 9999999999854 456899999999877
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccCCCCCceeee--CCcEEEeecCcccccCCCCCCCCcccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQG--YFHRDLKPSNLLVS--KGVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~--~~H~dl~p~nili~--~~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
|..++... ..+++..+..++.||++||+|||+++ |+||||||+||+++ ++.+||+|||++...... ......||
T Consensus 99 L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT 176 (270)
T d1t4ha_ 99 LKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGT 176 (270)
T ss_dssp HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSS
T ss_pred HHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-ccCCcccC
Confidence 76666554 47999999999999999999999999 99999999999996 379999999999765433 23456899
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
+.|+|||++. +. ++.++|||||||++|+|++|+.||........+.+......
T Consensus 177 ~~Y~aPE~~~-~~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~------------------------- 229 (270)
T d1t4ha_ 177 PEFMAPEMYE-EK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV------------------------- 229 (270)
T ss_dssp CCCCCGGGGG-TC-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-------------------------
T ss_pred ccccCHHHhC-CC-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCC-------------------------
Confidence 9999999886 33 89999999999999999999999987766665544332110
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFR 274 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 274 (282)
.....+...++++.+||.+||+.||++|||++|+|+||||+
T Consensus 230 --~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 230 --KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp --CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred --CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 11123345788999999999999999999999999999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.1e-60 Score=388.32 Aligned_cols=249 Identities=25% Similarity=0.405 Sum_probs=213.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+|+.||||++.... ......+.+|+.+++++. ||||+++++++.+++..|+|||||.|+.|..++
T Consensus 37 G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l 114 (350)
T d1koaa2 37 GAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 114 (350)
T ss_dssp ETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHH
T ss_pred CcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHH
Confidence 899999999999999999999987653 234556778999999995 999999999999999999999999976666655
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee---CCcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
......+++..+..++.||+.||.|||++|++||||||+||+++ ++.+||+|||++.............||+.|+||
T Consensus 115 ~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aP 194 (350)
T d1koaa2 115 ADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194 (350)
T ss_dssp TCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCH
T ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCH
Confidence 44445799999999999999999999999999999999999995 368999999999988776666677899999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+. .++.++|||||||++|+|++|..||.+.+..+....+......... .
T Consensus 195 Ev~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--------------------------~ 247 (350)
T d1koaa2 195 EVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD--------------------------S 247 (350)
T ss_dssp HHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC--------------------------G
T ss_pred HHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--------------------------c
Confidence 999854 4799999999999999999999999988877777776553322211 1
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....+++.+++||.+||+.||++|||++|+|+||||++...
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 22357899999999999999999999999999999987654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-59 Score=379.08 Aligned_cols=243 Identities=28% Similarity=0.461 Sum_probs=208.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||||++....... ....+.+|+.+++++. ||||+++++++.+++..|+|||||.++++..
T Consensus 26 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~ 104 (309)
T d1u5ra_ 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDL 104 (309)
T ss_dssp CSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCSEEHHHH
T ss_pred CCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEEEEEEecCCCchHH
Confidence 899999999999999999999987654332 3346788999999995 9999999999999999999999999998877
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+.... .++++..++.++.||++||.|||++||+||||||+||++++ +.+||+|||++...... ....||+.|+||
T Consensus 105 ~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~AP 180 (309)
T d1u5ra_ 105 LEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAP 180 (309)
T ss_dssp HHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCH
T ss_pred HHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---CccccCccccCH
Confidence 66554 47999999999999999999999999999999999999985 79999999999876543 456899999999
Q ss_pred hhhhc--cccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 158 EVLLL--SEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 158 E~~~~--~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|++.+ ...++.++|||||||++|+|++|..||.+....+....+.......
T Consensus 181 E~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------------------- 233 (309)
T d1u5ra_ 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------------------------- 233 (309)
T ss_dssp HHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------------------------
T ss_pred HHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC---------------------------
Confidence 99864 2347899999999999999999999999888777766655422111
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
..+..+++.+.+||++||+.||.+|||++++|+||||+..
T Consensus 234 -~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 234 -LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp -CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 1123568999999999999999999999999999999753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.2e-60 Score=388.51 Aligned_cols=247 Identities=24% Similarity=0.407 Sum_probs=213.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+|+.||+|+++... ......+.+|+.+++++ +||||++++++|.+++.+|+|||||+|+.|....
T Consensus 40 G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~ 117 (352)
T d1koba_ 40 GAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI 117 (352)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHT
T ss_pred CCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHH
Confidence 899999999999999999999987653 23445667899999998 5999999999999999999999999977666555
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee---CCcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS---KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
...+.++++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.............+++.|+||
T Consensus 118 ~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aP 197 (352)
T d1koba_ 118 AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 197 (352)
T ss_dssp TCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCH
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCH
Confidence 55555799999999999999999999999999999999999996 378999999999988776666677899999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+......+. ..
T Consensus 198 E~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~ 250 (352)
T d1koba_ 198 EIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD--------------------------ED 250 (352)
T ss_dssp HHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC--------------------------SS
T ss_pred HHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------------------cc
Confidence 998754 489999999999999999999999998888777776655322221 12
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
....+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 334678999999999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-60 Score=378.17 Aligned_cols=245 Identities=25% Similarity=0.401 Sum_probs=204.6
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||||++..... ......+.+|+.+++++ +||||+++++++.+++..|+|||||.|+.+..
T Consensus 19 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~ 97 (288)
T d1uu3a_ 19 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97 (288)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEEECCCTTEEHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEEEEccCCCCHHH
Confidence 8999999999999999999999876432 22335577899999999 59999999999999999999999999766655
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC---CCCCCccccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWY 154 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~---~~~~~~~~~~~~ 154 (282)
++... +.+++..++.++.|++.||+|||++|++||||||+||++++ +.+||+|||++...... .......||+.|
T Consensus 98 ~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y 176 (288)
T d1uu3a_ 98 YIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176 (288)
T ss_dssp HHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGG
T ss_pred hhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccc
Confidence 55544 47999999999999999999999999999999999999985 79999999999876432 223456799999
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCc
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVN 234 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 177 ~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~----------------------------- 226 (288)
T d1uu3a_ 177 VSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE----------------------------- 226 (288)
T ss_dssp CCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-----------------------------
T ss_pred cCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC-----------------------------
Confidence 9999998554 8999999999999999999999999887766665554311
Q ss_pred ccccCCCCChhhHHHHHHHhCCCCCCCCCHHH------HhcCcccccccC
Q 044127 235 LRELSPSASRESISLISRLCSWNPHMRPTAAE------ALEHPFFRSCHF 278 (282)
Q Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~------ll~~~~~~~~~~ 278 (282)
..++..+++++++||++||+.||++|||++| +++||||+++.+
T Consensus 227 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 227 -YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp -CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 1233467899999999999999999999988 578999998864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.9e-59 Score=369.38 Aligned_cols=249 Identities=30% Similarity=0.385 Sum_probs=211.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--------HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--------DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYME 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--------~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 72 (282)
|+||+||+|+++.+|+.||||+++...... ....+.+|+.+++++..||||+++++++.+++..|+|||||.
T Consensus 14 G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~ 93 (277)
T d1phka_ 14 GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMK 93 (277)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred CcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCC
Confidence 899999999999999999999987654221 223567899999999779999999999999999999999998
Q ss_pred ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccc
Q 044127 73 SDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 73 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
++.|..++... .++++..++.++.||++||+|||++|++||||||+||++++ +.+||+|||++...+.........||
T Consensus 94 ~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt 172 (277)
T d1phka_ 94 KGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT 172 (277)
T ss_dssp TCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSC
T ss_pred CchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeecc
Confidence 76666555554 37999999999999999999999999999999999999984 79999999999988766666677899
Q ss_pred ccccCchhhhcc-----ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcc
Q 044127 152 RWYRAPEVLLLS-----EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWK 226 (282)
Q Consensus 152 ~~~~aPE~~~~~-----~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
+.|.|||.+.+. ..++.++||||+||++|+|++|+.||.+.+..+....+......+..
T Consensus 173 ~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------------- 236 (277)
T d1phka_ 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS---------------- 236 (277)
T ss_dssp GGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----------------
T ss_pred CCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC----------------
Confidence 999999998632 34688999999999999999999999988877776666553221111
Q ss_pred ccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 227 FPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.....+++++++||++||+.||++|||++|+|+||||++.
T Consensus 237 ----------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 237 ----------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp ----------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ----------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 1223678999999999999999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-60 Score=384.45 Aligned_cols=273 Identities=26% Similarity=0.383 Sum_probs=203.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+|+.||+|+++..........+.+|+.+++++ +||||++++++|.+++..|+|||||.|++|..++
T Consensus 17 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l 95 (322)
T d1s9ja_ 17 GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 95 (322)
T ss_dssp CSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHH
T ss_pred CCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHH
Confidence 899999999999999999999998765455566788999999998 5999999999999999999999999987777666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHc-CccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCccccccccCch
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQ-GYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAPE 158 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~-~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE 158 (282)
.+.+ .+++..++.++.||+.||.|||++ ||+||||||+||+++ ++.+||+|||+|....... .....||+.|+|||
T Consensus 96 ~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~~~~~GT~~Y~APE 173 (322)
T d1s9ja_ 96 KKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPE 173 (322)
T ss_dssp HHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-C---CCSSCCCCHH
T ss_pred hhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-cccccCCccccCch
Confidence 6553 699999999999999999999975 999999999999997 4899999999998664322 24568999999999
Q ss_pred hhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHH-hCCCCCC----CccccccccccCCcccc-----
Q 044127 159 VLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQV-IGSPTED----SWPLGIQLASNLDWKFP----- 228 (282)
Q Consensus 159 ~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~----- 228 (282)
++.+. .++.++||||+||++|||++|+.||.+.+..+........ .+..... ..+.........+....
T Consensus 174 vl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (322)
T d1s9ja_ 174 RLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFE 252 (322)
T ss_dssp HHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHH
T ss_pred HHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHH
Confidence 99854 4899999999999999999999999876654432211111 1110000 00000000000000000
Q ss_pred ---CCCCCccccc-CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 229 ---QMGGVNLREL-SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 229 ---~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.......+.. ....+.++++||.+||+.||.+|||++|+|+||||++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 253 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp HHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred HHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 0000000111 123578999999999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-59 Score=377.23 Aligned_cols=249 Identities=26% Similarity=0.407 Sum_probs=210.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-----HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-----DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-----~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|+++.+|+.||||++++..... ....+.+|+.+++++. ||||+++++++.+++..|+|||||.|+.
T Consensus 21 G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv~E~~~gg~ 99 (293)
T d1jksa_ 21 GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGE 99 (293)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred CCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEEcCCCcc
Confidence 899999999999999999999987654322 2456788999999995 9999999999999999999999999766
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-C----cEEEeecCcccccCCCCCCCCccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-G----VIKIGDLGMVKEIDSSLPCTDYVT 150 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~----~~~l~df~~~~~~~~~~~~~~~~~ 150 (282)
|..++... ..+++..++.++.||+.||+|||+.|++||||||+||+++. + .+|++|||++.............+
T Consensus 100 L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~ 178 (293)
T d1jksa_ 100 LFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 178 (293)
T ss_dssp HHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCC
T ss_pred ccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCC
Confidence 66666554 37999999999999999999999999999999999999974 2 599999999988776666667789
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 179 t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~---------------------- 235 (293)
T d1jksa_ 179 TPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF---------------------- 235 (293)
T ss_dssp CGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC----------------------
T ss_pred CCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC----------------------
Confidence 9999999999854 48999999999999999999999999887777666554321111
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
....+...++.+++||++||+.||++|||++|+|+||||++..+
T Consensus 236 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 236 ----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp ----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred ----CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 11233467899999999999999999999999999999987554
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-58 Score=376.78 Aligned_cols=244 Identities=30% Similarity=0.490 Sum_probs=209.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||+|++++... ........+|+.+++++. ||||+++++++.+++.+|+|||||.|+.+..
T Consensus 16 G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~ 94 (337)
T d1o6la_ 16 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANGGELFF 94 (337)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEEEEECCTTCBHHH
T ss_pred CcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeeccccccccceeccCCCchhh
Confidence 8999999999999999999999986532 223456788999999985 9999999999999999999999999877766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~a 156 (282)
++...+ .+++..++.++.||+.||+|||++|++||||||+||+++. +.+||+|||+|..... .......+||+.|+|
T Consensus 95 ~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~a 173 (337)
T d1o6la_ 95 HLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173 (337)
T ss_dssp HHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCC
T ss_pred hhhccc-CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhh
Confidence 666553 7999999999999999999999999999999999999985 8999999999987643 334456789999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+.. ++.++|||||||++|||++|+.||.+.+..+....+.... .
T Consensus 174 PE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~------------------------------~ 222 (337)
T d1o6la_ 174 PEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE------------------------------I 222 (337)
T ss_dssp GGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------------------------C
T ss_pred hhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC------------------------------C
Confidence 99998554 8999999999999999999999999888766665544421 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCccccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCH 277 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~ 277 (282)
..+..+++++++||++||+.||.+|++ ++++++||||+++.
T Consensus 223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 234567999999999999999999994 89999999998864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-59 Score=371.11 Aligned_cols=242 Identities=27% Similarity=0.461 Sum_probs=192.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeecccccc--CCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKE--HEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|+++.+|+.||+|++......+ ....+.+|+.+++++ +||||+++++++.+ ++.+|+|||||++++|.
T Consensus 15 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~ 93 (269)
T d2java1 15 GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLA 93 (269)
T ss_dssp CSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEEEEECCTTEEHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHH
Confidence 899999999999999999999987765443 345567899999888 59999999998854 56789999999976666
Q ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC-----ccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCC
Q 044127 78 LMKER---AGQNFSEDEVRNLCFQVFQGLHYMHRQG-----YFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTD 147 (282)
Q Consensus 78 ~~~~~---~~~~l~~~~~~~i~~qi~~~l~~Lh~~~-----~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~ 147 (282)
.++.. .+..+++..++.++.||+.||.|||++| |+||||||+||+++. +.+||+|||++....... ....
T Consensus 94 ~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 173 (269)
T d2java1 94 SVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173 (269)
T ss_dssp HHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---------
T ss_pred HHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCcccc
Confidence 55542 2457999999999999999999999976 999999999999984 899999999998765433 2345
Q ss_pred ccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccc
Q 044127 148 YVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKF 227 (282)
Q Consensus 148 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
..||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 174 ~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~--------------------- 231 (269)
T d2java1 174 FVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF--------------------- 231 (269)
T ss_dssp --CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---------------------
T ss_pred CCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence 68899999999997544 89999999999999999999999998877766665544211
Q ss_pred cCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccc
Q 044127 228 PQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFF 273 (282)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~ 273 (282)
...+..+++++.+||++||+.||.+|||++|+|+|||+
T Consensus 232 --------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 12344678999999999999999999999999999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.1e-59 Score=375.03 Aligned_cols=243 Identities=28% Similarity=0.463 Sum_probs=210.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||||+++.... ......+.+|+.+++++ +||||+++++++.+++..|+|||||.|+++..
T Consensus 15 G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~ 93 (316)
T d1fota_ 15 GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 93 (316)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeEeeecCCccccc
Confidence 8999999999999999999999976532 22345667899999888 59999999999999999999999999887777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+.... ..+++..++.++.||+.||+|||++||+||||||+||+++. +.+||+|||++....... ....||+.|+||
T Consensus 94 ~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~--~~~~Gt~~Y~AP 170 (316)
T d1fota_ 94 LLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAP 170 (316)
T ss_dssp HHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--CCCCSCTTTCCH
T ss_pred ccccc-ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc--ccccCcccccCH
Confidence 76665 46899999999999999999999999999999999999985 899999999998876543 457899999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+. .++.++|||||||++|+|++|+.||.+.+..+....+..... .
T Consensus 171 E~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------------------------~ 219 (316)
T d1fota_ 171 EVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL------------------------------R 219 (316)
T ss_dssp HHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC------------------------------C
T ss_pred HHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC------------------------------C
Confidence 998744 489999999999999999999999998887777766654211 2
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 238 LSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
.+..+++++.++|++||+.||.+|+ |++++++||||+++.+
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 2346789999999999999999996 9999999999998753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-58 Score=373.85 Aligned_cols=273 Identities=34% Similarity=0.645 Sum_probs=227.5
Q ss_pred CCcceEEEEEecCC-CcEEEEEEccccccch-HHHHHHHHHHHHHHhC--CCCCeeeeccccc-----cCCcEEEEEecC
Q 044127 1 GSYGDVFQALDKKS-GEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMN--NHPNIVKLRNLVK-----EHEDVFIVFEYM 71 (282)
Q Consensus 1 G~~g~Vy~~~~~~~-~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~--~hp~i~~~~~~~~-----~~~~~~lv~e~~ 71 (282)
|+||+||+|++..+ ++.||||+++...... ......+|+.+++.+. +||||+++++++. .....+++||+|
T Consensus 18 G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~ 97 (305)
T d1blxa_ 18 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 97 (305)
T ss_dssp ETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECC
T ss_pred ccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEec
Confidence 89999999999765 6679999987654332 2334566777776653 6999999999984 345789999999
Q ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccc
Q 044127 72 ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVT 150 (282)
Q Consensus 72 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~ 150 (282)
.++++..........+++..++.++.||+.||+|||++||+||||||+|||+++ +.+|++|||.+.............|
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~g 177 (305)
T d1blxa_ 98 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 177 (305)
T ss_dssp SCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCC
T ss_pred cCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCccc
Confidence 999888777777678999999999999999999999999999999999999985 8999999999887665555667889
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
|+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+....+.+....++........ .+...
T Consensus 178 T~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~ 253 (305)
T d1blxa_ 178 TLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ---AFHSK 253 (305)
T ss_dssp CCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGG---GSCCC
T ss_pred ChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhh---hhccc
Confidence 9999999999854 4899999999999999999999999999999999999999988877766543333222 12223
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
............++.+.+||++||+.||++|||++|+|+||||+++.
T Consensus 254 ~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 254 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 33344556678899999999999999999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.1e-58 Score=376.86 Aligned_cols=249 Identities=28% Similarity=0.401 Sum_probs=202.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch--HHHHHHHHHHHHHHhC--CCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL--DESRNLKEVKCLRKMN--NHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~--~~~~~~~e~~~l~~~~--~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|+++.+|+.||||++....... ......+|...+..+. +||||+++++++.+++..|+|||||.|+.|
T Consensus 15 G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L 94 (364)
T d1omwa3 15 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL 94 (364)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcH
Confidence 899999999999999999999987543221 1223344443333332 599999999999999999999999997766
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccccccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYR 155 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 155 (282)
..++... ..+++..++.++.||+.||.|||++|++||||||+|||++. +.+||+|||+|....... .....||+.|+
T Consensus 95 ~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~ 172 (364)
T d1omwa3 95 HYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYM 172 (364)
T ss_dssp HHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-CCSCCSCGGGC
T ss_pred HHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCc-ccccccccccc
Confidence 6666554 46999999999999999999999999999999999999985 899999999998776543 34568999999
Q ss_pred CchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 156 APEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 156 aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
|||++..+..++.++|||||||++|+|++|..||......+.......... ..
T Consensus 173 APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~---------------------------~~ 225 (364)
T d1omwa3 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------------------------MA 225 (364)
T ss_dssp CHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS---------------------------CC
T ss_pred hhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc---------------------------CC
Confidence 999997666689999999999999999999999987665544332211111 11
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCC-----HHHHhcCcccccccC
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPT-----AAEALEHPFFRSCHF 278 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps-----~~~ll~~~~~~~~~~ 278 (282)
...+..+++++++||.+||+.||.+||| ++++++||||+++.+
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 1234568999999999999999999999 799999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-59 Score=377.14 Aligned_cols=246 Identities=24% Similarity=0.364 Sum_probs=211.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+|+.||+|+++.. ......+.+|+.+++++. ||||+++++++++++.+|+|||||.|+.|..++
T Consensus 16 G~fg~Vy~~~~~~~~~~~AiK~i~~~--~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i 92 (321)
T d1tkia_ 16 GEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIAR-HRNILHLHESFESMEELVMIFEFISGLDIFERI 92 (321)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEEEEEECCCCCCBHHHHH
T ss_pred CCCeEEEEEEECCCCcEEEEEEEcCC--cccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEEEEecCCCCcHHHHH
Confidence 89999999999999999999999765 334456778999999985 999999999999999999999999986666666
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC---CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK---GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
...+..+++.+++.++.||+.||.|||++|++||||||+||+++. ..++++|||++.............+++.|+||
T Consensus 93 ~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ap 172 (321)
T d1tkia_ 93 NTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172 (321)
T ss_dssp TSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCH
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccc
Confidence 655557999999999999999999999999999999999999974 47999999999887665555667889999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+. .++.++|||||||++|+|++|..||...+..+....+......+. ..
T Consensus 173 e~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~~ 225 (321)
T d1tkia_ 173 EVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD--------------------------EE 225 (321)
T ss_dssp HHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--------------------------HH
T ss_pred hhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------------------hh
Confidence 998754 489999999999999999999999999888887777665322211 12
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
....+++++++||++||+.||++|||++|+|+||||++-
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 234578999999999999999999999999999999753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.8e-58 Score=366.07 Aligned_cols=271 Identities=32% Similarity=0.628 Sum_probs=227.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|+++ +|+.||||+++...... ....+.+|+.+++++. ||||+++++.+.+++..++++|++.++++..+
T Consensus 13 G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~ 90 (286)
T d1ob3a_ 13 GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLL 90 (286)
T ss_dssp ETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEEEECCSEEHHHHH
T ss_pred CCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEEEEeehhhhHHHH
Confidence 899999999986 68999999997654322 2456778999999995 99999999999999999999999999999888
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-CCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aP 157 (282)
.... +.+++..+..++.||+.||+|||+.||+||||||+||+++. +.+|++|||.+....... ......+++.|+||
T Consensus 91 ~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~p 169 (286)
T d1ob3a_ 91 DVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169 (286)
T ss_dssp HTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCH
T ss_pred Hhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhH
Confidence 7654 57999999999999999999999999999999999999974 899999999998764432 23445688999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|.+.+...++.++|||||||++|+|++|+.||.+.+..+...++....+.+....++........ ..............
T Consensus 170 E~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 248 (286)
T d1ob3a_ 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY-DPNFTVYEPLPWES 248 (286)
T ss_dssp HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC-CTTCCCCCCCCGGG
T ss_pred HHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc-ccccccccCcchhh
Confidence 99987777899999999999999999999999999999999999999999888877755444332 23333334444556
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccc
Q 044127 238 LSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRS 275 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 275 (282)
.....++.+++||++||+.||++|||++|+|+||||++
T Consensus 249 ~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 67788999999999999999999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-58 Score=371.45 Aligned_cols=245 Identities=30% Similarity=0.486 Sum_probs=207.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||||+++++.. .........|...+.+..+||||+++++++.+++..|+|||||.++.+..
T Consensus 13 G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~ 92 (320)
T d1xjda_ 13 GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMY 92 (320)
T ss_dssp CSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHH
T ss_pred CCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHH
Confidence 8999999999999999999999976532 23344566777777765579999999999999999999999999866766
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC-CCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS-SLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~a 156 (282)
++... ..+++..++.++.||+.||+|||++|++||||||+||++++ +.+||+|||++..... ........||+.|+|
T Consensus 93 ~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~a 171 (320)
T d1xjda_ 93 HIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIA 171 (320)
T ss_dssp HHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCC
T ss_pred Hhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCC
Confidence 66654 36999999999999999999999999999999999999986 8999999999986643 333345689999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+... .+
T Consensus 172 PE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~---------------------------- 220 (320)
T d1xjda_ 172 PEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP---------------------------- 220 (320)
T ss_dssp HHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC----------------------------
T ss_pred HHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC----------------------------
Confidence 99998554 899999999999999999999999988777666655431 11
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHH-HHhcCccccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAA-EALEHPFFRSCH 277 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~ll~~~~~~~~~ 277 (282)
..+..+++.+.+||++||+.||++|||+. ++++||||+++.
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 23346789999999999999999999995 899999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-58 Score=374.61 Aligned_cols=243 Identities=28% Similarity=0.414 Sum_probs=208.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||||+++..... .....+.+|+.+++++ +||||+++++++.+....++|||++.++.+..
T Consensus 52 G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~ 130 (350)
T d1rdqe_ 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130 (350)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTTCBHHH
T ss_pred CcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccccccccccccccccchhh
Confidence 89999999999999999999998754322 2334567899999888 59999999999999999999999999766666
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
.+...+ .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....... ....||+.|+||
T Consensus 131 ~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~Gt~~Y~AP 207 (350)
T d1rdqe_ 131 HLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--WTLCGTPEALAP 207 (350)
T ss_dssp HHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--CCCEECGGGCCH
T ss_pred hHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--ccccCccccCCH
Confidence 555543 799999999999999999999999999999999999997 5899999999998876443 457899999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLRE 237 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
|++.+. .++.++|||||||++|+|++|..||.+.+.......+..... .
T Consensus 208 E~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------------------------~ 256 (350)
T d1rdqe_ 208 EIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------------------------------R 256 (350)
T ss_dssp HHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------------------------C
T ss_pred HHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC------------------------------C
Confidence 999854 489999999999999999999999998877766666544211 2
Q ss_pred cCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 238 LSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
.+..+++++.+||++||+.||.+|+ |++++++||||+++.+
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 2346789999999999999999995 9999999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-58 Score=373.89 Aligned_cols=251 Identities=28% Similarity=0.410 Sum_probs=200.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc----CCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE----HEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|+++.+++.||||+++.. ....+|+.++.++.+||||++++++|++ ...+|+|||||.|+.|
T Consensus 23 G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L 96 (335)
T d2ozaa1 23 GINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 96 (335)
T ss_dssp CSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEH
T ss_pred ccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcH
Confidence 89999999999999999999998642 3455788888777789999999999865 4678999999987555
Q ss_pred HHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCCCCCcccc
Q 044127 77 KLMKER-AGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 77 ~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
..++.. .+..+++.+++.++.||+.||+|||++|++||||||+||++++ +.+||+|||++.............||
T Consensus 97 ~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt 176 (335)
T d2ozaa1 97 FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176 (335)
T ss_dssp HHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCC
T ss_pred HHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccccCC
Confidence 555544 3457999999999999999999999999999999999999974 57999999999887766666778899
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+........ ..+
T Consensus 177 ~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~---------------~~~---- 236 (335)
T d2ozaa1 177 PYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ---------------YEF---- 236 (335)
T ss_dssp CSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS---------------SSC----
T ss_pred cccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC---------------CCC----
Confidence 999999998754 489999999999999999999999987766554443322211100 000
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccCcc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHFVP 280 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 280 (282)
.......+++++.+||++||+.||++|||++|+++||||++....|
T Consensus 237 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 282 (335)
T d2ozaa1 237 ---PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282 (335)
T ss_dssp ---CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSC
T ss_pred ---CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCC
Confidence 0111224688999999999999999999999999999997655443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=367.65 Aligned_cols=269 Identities=33% Similarity=0.588 Sum_probs=219.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc------cCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK------EHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~------~~~~~~lv~e~~~~~ 74 (282)
|+||+||+|+++.+|+.||||++..... ...+|+.+++++ +||||++++++|. +..++++|||||+++
T Consensus 31 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~ 104 (350)
T d1q5ka_ 31 GSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET 104 (350)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE
T ss_pred CcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEEeccCCc
Confidence 8999999999999999999999876432 223689999998 5999999999983 334689999999998
Q ss_pred HHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCCCCCccc
Q 044127 75 LLKLMKE--RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVT 150 (282)
Q Consensus 75 ~l~~~~~--~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~~~~~~~ 150 (282)
++..+.. .....+++..++.++.||+.||+|||++||+||||||+||+++. ..+||+|||++.............+
T Consensus 105 ~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~g 184 (350)
T d1q5ka_ 105 VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184 (350)
T ss_dssp HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCS
T ss_pred cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccc
Confidence 7766543 33457999999999999999999999999999999999999984 3899999999988766666677889
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
++.|+|||.+.+...++.++||||+||++|||++|..||...+..+.+..+.+..+.+....+...... .....+...
T Consensus 185 t~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~--~~~~~~~~~ 262 (350)
T d1q5ka_ 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN--YTEFKFPQI 262 (350)
T ss_dssp CTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-----CCCCCCC
T ss_pred cccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc--hhhcccccc
Confidence 999999999886667899999999999999999999999999999999999888887765544322211 111222221
Q ss_pred CCCc-ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 231 GGVN-LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 231 ~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.... ........++++.+||.+||+.||.+|||++|+|+||||+++.
T Consensus 263 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred ccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 1111 1223446789999999999999999999999999999998763
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-56 Score=366.52 Aligned_cols=271 Identities=36% Similarity=0.631 Sum_probs=218.4
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeeccccccCC------cEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE------DVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~------~~~lv~e~~~~ 73 (282)
|+||+||+|+++.+|+.||||+++....... .....+|+.+++++ +||||++++++|...+ .+|+|||||+.
T Consensus 29 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~ 107 (346)
T d1cm8a_ 29 GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT 107 (346)
T ss_dssp ----CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCEEEEECCSE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccccceEEEEEecccc
Confidence 8999999999999999999999986544433 45667899999999 5999999999987554 57999999966
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
.+.. +... ..+++..++.++.||+.||.|||++||+||||||+||+++. +.++++|||++...+... ....+++
T Consensus 108 ~l~~-~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~--~~~~~t~ 182 (346)
T d1cm8a_ 108 DLGK-LMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--TGYVVTR 182 (346)
T ss_dssp EHHH-HHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC--CSSCSCG
T ss_pred cHHH-HHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCcc--ccccccc
Confidence 5544 4444 47999999999999999999999999999999999999984 899999999998776543 5678899
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCcccccccc-ccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLA-SNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (282)
.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+.......+.+....+....... ...........
T Consensus 183 ~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (346)
T d1cm8a_ 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 262 (346)
T ss_dssp GGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCC
T ss_pred cccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCccc
Confidence 99999999876668999999999999999999999999999888888888887776654332111111 01111223334
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
...........++.+.+||++||+.||++|||++|+|+||||++..
T Consensus 263 ~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 263 KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred ccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 4445566678899999999999999999999999999999998764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-57 Score=359.59 Aligned_cols=240 Identities=24% Similarity=0.410 Sum_probs=198.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-----HHHHHHHHHHHHHHhC-CCCCeeeeccccccCCcEEEEEecCCc-
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-----DESRNLKEVKCLRKMN-NHPNIVKLRNLVKEHEDVFIVFEYMES- 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-----~~~~~~~e~~~l~~~~-~hp~i~~~~~~~~~~~~~~lv~e~~~~- 73 (282)
|+||+||+|+++.+|+.||||++....... ....+.+|+.+++++. .||||+++++++.+++..++|||++.+
T Consensus 15 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~ 94 (273)
T d1xwsa_ 15 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV 94 (273)
T ss_dssp ETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCc
Confidence 899999999999999999999987654321 2233567999999886 489999999999999999999999974
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-C-CcEEEeecCcccccCCCCCCCCcccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-K-GVIKIGDLGMVKEIDSSLPCTDYVTT 151 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~-~~~~l~df~~~~~~~~~~~~~~~~~~ 151 (282)
+++..++... ..+++..++.++.||+.||+|||++|++||||||+||+++ + +.+||+|||++...... ......||
T Consensus 95 ~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT 172 (273)
T d1xwsa_ 95 QDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGT 172 (273)
T ss_dssp EEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSC
T ss_pred chHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc-cccccccC
Confidence 4444444433 4799999999999999999999999999999999999997 3 68999999999865443 33456899
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
+.|+|||.+.+...++.++|||||||++|+|++|+.||...+ .+... .
T Consensus 173 ~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~------------------------ 220 (273)
T d1xwsa_ 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--Q------------------------ 220 (273)
T ss_dssp GGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--C------------------------
T ss_pred CCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--c------------------------
Confidence 999999999866656788999999999999999999997531 11110 0
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...+..+++++++||++||+.||++|||++|+|+||||+++..
T Consensus 221 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 221 ----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263 (273)
T ss_dssp ----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred ----cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence 1123467899999999999999999999999999999998753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-55 Score=350.87 Aligned_cols=274 Identities=31% Similarity=0.610 Sum_probs=229.2
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|+++.+++.||||+++..... .....+.+|+.+++.+ +||||+++++++.+....+++++++.++++..+
T Consensus 13 G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~ 91 (292)
T d1unla_ 13 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF 91 (292)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCSEEHHHHH
T ss_pred CcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEEeeeccccccccc
Confidence 89999999999999999999999765443 3456678899999888 599999999999999999999999999998887
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCC-CCCCccccccccCc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSL-PCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aP 157 (282)
.... +.+++..++.++.|++.||+|||++||+||||||+||+++ ++.+|++|||.+....... ......+++.|.||
T Consensus 92 ~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~p 170 (292)
T d1unla_ 92 DSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170 (292)
T ss_dssp HHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCH
T ss_pred cccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhh
Confidence 7654 5799999999999999999999999999999999999998 5899999999998765433 33445677889999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhCCCCC-CCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSFRILF-PGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.....++.++|||||||++|+|++|+.|| .+.+..+....+....+.+....++............... ......
T Consensus 171 e~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 249 (292)
T d1unla_ 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP-ATTSLV 249 (292)
T ss_dssp HHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCC-TTCCCT
T ss_pred hHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccccc-ccchhh
Confidence 99887766899999999999999999998875 5666677777888888888877777665554443333222 223344
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
......++.+.+||++||+.||.+|||++|+|+||||++..
T Consensus 250 ~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 250 NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred hccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 56667899999999999999999999999999999998754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=356.04 Aligned_cols=274 Identities=30% Similarity=0.545 Sum_probs=213.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeecccccc--------CCcEEEEEecC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKE--------HEDVFIVFEYM 71 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--------~~~~~lv~e~~ 71 (282)
|+||+||+|+++.+|+.||||++....... ....+.+|+.+++++. |||++++++++.. +...+++||+|
T Consensus 21 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~ 99 (318)
T d3blha1 21 GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFC 99 (318)
T ss_dssp CSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC----------CEEEEEECC
T ss_pred CcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc-CCCccceEeeeecccccccccCceEEEEEecc
Confidence 899999999999999999999987654432 3455678999999995 9999999998744 45689999999
Q ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCC-----CCC
Q 044127 72 ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSS-----LPC 145 (282)
Q Consensus 72 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~-----~~~ 145 (282)
.++++....... ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.++++|||++...... ...
T Consensus 100 ~~~~~~~~~~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 178 (318)
T d3blha1 100 EHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178 (318)
T ss_dssp CEEHHHHHTCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCC
T ss_pred CCCccchhhhcc-cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccc
Confidence 999887655543 5799999999999999999999999999999999999997 489999999999765422 222
Q ss_pred CCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCc
Q 044127 146 TDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDW 225 (282)
Q Consensus 146 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.........+....+.+.+..+............
T Consensus 179 ~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T d3blha1 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKL 258 (318)
T ss_dssp CSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC------
T ss_pred cceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhh
Confidence 34578999999999987767899999999999999999999999999998988888888888776655433222221111
Q ss_pred cccCCCCCccccc--CCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 226 KFPQMGGVNLREL--SPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 226 ~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
............. ....++.+++||.+||+.||++|||++|+|+||||++-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 259 ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp -CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 1111111111000 11246788999999999999999999999999999963
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-55 Score=352.35 Aligned_cols=239 Identities=23% Similarity=0.368 Sum_probs=190.6
Q ss_pred CCcceEEEEEecCCCc---EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKSGE---FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~---~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|+++.+++ .||+|.+...........+.+|+.+++++ +||||+++++++.+++..++|||||.++++.
T Consensus 37 G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~ 115 (299)
T d1jpaa_ 37 GEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSLD 115 (299)
T ss_dssp CSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCTTEEHH
T ss_pred CCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEecCCCcce
Confidence 8999999999887665 58899887665555666788999999999 5999999999999999999999999988888
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCC------CCccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPC------TDYVT 150 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~------~~~~~ 150 (282)
.+.......+++.++..++.||++||.|||++|++||||||+||+++. +.+||+|||++......... ....+
T Consensus 116 ~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~ 195 (299)
T d1jpaa_ 116 SFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195 (299)
T ss_dssp HHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------
T ss_pred eeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccC
Confidence 777766667999999999999999999999999999999999999985 79999999999866433221 22356
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
++.|+|||.+..+ .++.++|||||||++|||+| |..||.+....+....+......
T Consensus 196 t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---------------------- 252 (299)
T d1jpaa_ 196 PIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL---------------------- 252 (299)
T ss_dssp CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC----------------------
T ss_pred CccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------------------
Confidence 8899999998855 48999999999999999998 89999888777666554432111
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+..+++.+.+|+.+||+.||++|||+++|+++
T Consensus 253 -------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 253 -------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1234678999999999999999999999998875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=350.30 Aligned_cols=242 Identities=22% Similarity=0.348 Sum_probs=201.1
Q ss_pred CCcceEEEEEecC--CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKK--SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~--~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|.++. ++..||||+++..........+.+|+.++.++ +||||+++++++..+ ..++|||||++++|..
T Consensus 20 G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~ 97 (285)
T d1u59a_ 20 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHK 97 (285)
T ss_dssp CTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SEEEEEECCTTEEHHH
T ss_pred ccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeeccC-eEEEEEEeCCCCcHHH
Confidence 8999999998764 45579999998765555567788999999999 499999999998754 6899999999877777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC----CCCcccccc
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP----CTDYVTTRW 153 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~----~~~~~~~~~ 153 (282)
++......+++..+..++.||++||.|||++|++||||||+||+++ ++.+||+|||++........ .....+|+.
T Consensus 98 ~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~ 177 (285)
T d1u59a_ 98 FLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177 (285)
T ss_dssp HHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGG
T ss_pred HhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCcc
Confidence 7665556799999999999999999999999999999999999997 58999999999987644322 234467889
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
|+|||++..+. ++.++|||||||++|||+| |..||......+....+....+
T Consensus 178 y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-------------------------- 230 (285)
T d1u59a_ 178 WYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-------------------------- 230 (285)
T ss_dssp GCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC--------------------------
T ss_pred ccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------------------
Confidence 99999997554 8999999999999999998 8999998887766655433211
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHH---hcCcccc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEA---LEHPFFR 274 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l---l~~~~~~ 274 (282)
...+..+++++.+||.+||+.||++|||+.++ |+|+|++
T Consensus 231 ---~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 12345678999999999999999999999888 5778774
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-55 Score=348.77 Aligned_cols=237 Identities=25% Similarity=0.442 Sum_probs=196.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH-HH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK-LM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~-~~ 79 (282)
|+||+||+|+++.+++.||||+++.+. .....+.+|+.+++++. ||||+++++++.+++..+++||||.++++. .+
T Consensus 28 G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l 104 (287)
T d1opja_ 28 GQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 104 (287)
T ss_dssp TTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred CCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCC-CCCEecCCccEeeCCeeEEEeecccCcchHHHh
Confidence 899999999999999999999997654 33456789999999995 999999999999999999999999865554 44
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCccccccccC
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~a 156 (282)
.......+++..+..++.||++||+|||++|++||||||+|||+++ +.+||+|||++........ .....+++.|+|
T Consensus 105 ~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~a 184 (287)
T d1opja_ 105 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184 (287)
T ss_dssp HHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCC
T ss_pred hhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccC
Confidence 4444567999999999999999999999999999999999999975 7999999999987644322 223457888999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
||++.++. ++.++|||||||++|||++|..||.................. .
T Consensus 185 PE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~----------------------------~ 235 (287)
T d1opja_ 185 PESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR----------------------------M 235 (287)
T ss_dssp HHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC----------------------------C
T ss_pred hHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC----------------------------C
Confidence 99998554 899999999999999999987776655555555444432111 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+..+++.+.+||++||+.||++|||++++++
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 234567899999999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-54 Score=353.78 Aligned_cols=270 Identities=25% Similarity=0.463 Sum_probs=208.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc--cCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK--EHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|+.||||+++.. ....+.+|+.++..+.+||||+++++++. .....++|||||.++++..
T Consensus 46 G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~ 121 (328)
T d3bqca1 46 GKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 121 (328)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGG
T ss_pred CcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHH
Confidence 89999999999999999999998653 23456789999999978999999999986 4467999999999877654
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC--CcEEEeecCcccccCCCCCCCCccccccccC
Q 044127 79 MKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK--GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRA 156 (282)
Q Consensus 79 ~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~a 156 (282)
+. +.+++..++.++.||+.||.|||++||+||||||+|||++. +.++|+|||++.............+|+.|+|
T Consensus 122 ~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~a 197 (328)
T d3bqca1 122 LY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 197 (328)
T ss_dssp TT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCC
T ss_pred Hh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccC
Confidence 32 46999999999999999999999999999999999999974 4699999999988776666677889999999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCCh-HHHHHHHHHhCCCCCCCcccccccccc--CCccccCC---
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSA-DQIYKICQVIGSPTEDSWPLGIQLASN--LDWKFPQM--- 230 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--- 230 (282)
||.+.+...++.++||||+||++|++++|..||...... +....+....+.+....+......... ........
T Consensus 198 PE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (328)
T d3bqca1 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRK 277 (328)
T ss_dssp HHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCC
T ss_pred cccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhccccccc
Confidence 999987777899999999999999999999999766543 333334333332211111000000000 00000000
Q ss_pred --CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 231 --GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 231 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...........+++++.+||++||+.||++|||++|+|+||||+++.+
T Consensus 278 ~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 278 RWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred chhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 001111223457889999999999999999999999999999999865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-55 Score=355.71 Aligned_cols=241 Identities=24% Similarity=0.368 Sum_probs=197.2
Q ss_pred CCcceEEEEEecCCCc-----EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGE-----FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~-----~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|++..+++ .||+|.+...........+.+|+.++.++.+||||+++++++.+.+..++|||||.++.
T Consensus 48 G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~ 127 (325)
T d1rjba_ 48 GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 127 (325)
T ss_dssp CSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred CCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCc
Confidence 8999999999876543 69999987665555666788999999999779999999999999999999999999766
Q ss_pred HHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEee
Q 044127 76 LKLMKERAG----------------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGD 132 (282)
Q Consensus 76 l~~~~~~~~----------------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~d 132 (282)
+..++.... ..+++..+..++.||++||+|||++||+||||||+||+++. +.+||+|
T Consensus 128 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~D 207 (325)
T d1rjba_ 128 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 207 (325)
T ss_dssp HHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECC
T ss_pred HHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEee
Confidence 666654321 24899999999999999999999999999999999999985 7999999
Q ss_pred cCcccccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCC
Q 044127 133 LGMVKEIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSP 208 (282)
Q Consensus 133 f~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~ 208 (282)
||+|........ .....+|+.|+|||++.++. ++.++|||||||++|||++ |..||.+.+....+..++.....+
T Consensus 208 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~ 286 (325)
T d1rjba_ 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM 286 (325)
T ss_dssp CGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC
T ss_pred ccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 999986644332 23456799999999998554 8999999999999999997 899999887777766665532111
Q ss_pred CCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 209 TEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
+.+...++.+++||.+||+.||++|||++||++|
T Consensus 287 ----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 287 ----------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2344678999999999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=356.46 Aligned_cols=273 Identities=36% Similarity=0.646 Sum_probs=212.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCC-----cEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE-----DVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-----~~~lv~e~~~~~~ 75 (282)
|+||+||+|+++.+|+.||||+++..........+.+|+.+++++ +||||+++++++.... ..+++++.+++++
T Consensus 19 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L 97 (345)
T d1pmea_ 19 GAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADL 97 (345)
T ss_dssp --CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEH
T ss_pred ccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccceEEEEEeecCCch
Confidence 899999999999999999999997655444556778999999999 5999999999986543 4667766666666
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC----CCCCCccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS----LPCTDYVT 150 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~----~~~~~~~~ 150 (282)
.+.+ .. ..+++..++.++.||+.||+|||++||+||||||+||++++ +.+||+|||++...... .......+
T Consensus 98 ~~~l-~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~g 174 (345)
T d1pmea_ 98 YKLL-KT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174 (345)
T ss_dssp HHHH-HH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCS
T ss_pred hhhh-hc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccc
Confidence 5554 44 36999999999999999999999999999999999999985 89999999998765322 22345678
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc-cCCccccC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS-NLDWKFPQ 229 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 229 (282)
++.|+|||++.....++.++||||+||++|+|++|..||.+....+...........+............. ........
T Consensus 175 t~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (345)
T d1pmea_ 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 254 (345)
T ss_dssp CGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCC
T ss_pred cceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCc
Confidence 99999999987677689999999999999999999999999888877777776666554332211111000 01111222
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
.............++++++||.+||+.||.+|||++|+|+||||++..
T Consensus 255 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 255 KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp CCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred cCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 233334455667889999999999999999999999999999998653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=344.76 Aligned_cols=241 Identities=23% Similarity=0.325 Sum_probs=195.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccccc-chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIF-SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||+||+|+.. ..||||+++.... ......+.+|+.++.++ +||||+++++++.+ +..++|||||++++|..+
T Consensus 19 G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~ 93 (276)
T d1uwha_ 19 GSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHH 93 (276)
T ss_dssp CSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEEEECCCEEEHHHH
T ss_pred CCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec-cEEEEEEecCCCCCHHHH
Confidence 899999999754 3599999976543 33456678899999999 59999999998755 468999999998777776
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC---CCCCCcccccccc
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS---LPCTDYVTTRWYR 155 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~ 155 (282)
+...+..+++..+..++.||++||+|||++||+||||||+||++++ +.+||+|||++...... .......||+.|+
T Consensus 94 l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 173 (276)
T d1uwha_ 94 LHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173 (276)
T ss_dssp HHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGC
T ss_pred HhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccC
Confidence 6655567999999999999999999999999999999999999985 79999999999766432 2234567899999
Q ss_pred Cchhhhcc--ccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 156 APEVLLLS--EIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 156 aPE~~~~~--~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
|||++... ..++.++|||||||++|||++|+.||.+................. .
T Consensus 174 APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~------------------------p 229 (276)
T d1uwha_ 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS------------------------P 229 (276)
T ss_dssp CHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC------------------------C
T ss_pred CHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC------------------------C
Confidence 99998643 347889999999999999999999999888777766555432211 1
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
.....+..+++.+.+||.+||+.||++|||+++++++
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 2234456789999999999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-55 Score=343.90 Aligned_cols=236 Identities=25% Similarity=0.433 Sum_probs=187.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++ +++.||||+++.... ....+.+|+..++++. ||||+++++++.+++..++|||||.++++..++
T Consensus 16 G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l 91 (263)
T d1sm2a_ 16 GQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL 91 (263)
T ss_dssp CSSCCEEEEEET-TTEEEEEEECCSSSS--CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred CCCeEEEEEEEC-CCCEEEEEEECCCcC--cHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEEEEecCCCcHHHHh
Confidence 899999999976 467899999976543 3456789999999995 999999999999999999999999987777776
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC--CCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP--CTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aP 157 (282)
......+++..+..++.||+.||.|||+++++||||||+||++++ +.+||+|||++........ .....+|+.|+||
T Consensus 92 ~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aP 171 (263)
T d1sm2a_ 92 RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171 (263)
T ss_dssp HTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCH
T ss_pred hccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCCh
Confidence 665567999999999999999999999999999999999999985 7999999999986643322 2345688999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|++.+.. ++.++|||||||++|||+++ ..||...+..+....+......
T Consensus 172 E~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~----------------------------- 221 (263)
T d1sm2a_ 172 EVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------------------------- 221 (263)
T ss_dssp HHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-----------------------------
T ss_pred HHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-----------------------------
Confidence 9998555 89999999999999999995 5556655555555544442211
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++++.+|+.+||+.||++|||+++++++
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1234568899999999999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-55 Score=341.91 Aligned_cols=236 Identities=23% Similarity=0.404 Sum_probs=199.7
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++ ++..||||+++.... ....+.+|+..+.++. ||||+++++++.+++..++||||+.++++..+.
T Consensus 15 G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~ 90 (258)
T d1k2pa_ 15 GQFGVVKYGKWR-GQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 90 (258)
T ss_dssp ETTEEEEEEEET-TTEEEEEEEEESSSS--CHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEEEECCTTEEHHHHH
T ss_pred CCCeEEEEEEEC-CCCEEEEEEECcCcC--CHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEEEEccCCCcHHHhh
Confidence 899999999985 688899999987543 3456889999999994 999999999999999999999999876666665
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRAP 157 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aP 157 (282)
......+++..+++++.||++||.|||++|++|+||||+||++++ +.+||+|||++....... ......+++.|+||
T Consensus 91 ~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aP 170 (258)
T d1k2pa_ 91 REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170 (258)
T ss_dssp HSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCH
T ss_pred hccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCc
Confidence 554557999999999999999999999999999999999999986 799999999997654322 23346788999999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.+.. ++.++|||||||++|||+| |+.||...+..+....+....+.
T Consensus 171 E~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~----------------------------- 220 (258)
T d1k2pa_ 171 EVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL----------------------------- 220 (258)
T ss_dssp HHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----------------------------
T ss_pred HHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-----------------------------
Confidence 9998555 8999999999999999998 89999988877766655442211
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++.+.+||++||+.||++|||++++++|
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 2234568899999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=355.48 Aligned_cols=270 Identities=32% Similarity=0.550 Sum_probs=204.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchH-HHHHHHHHHHHHHhCCCCCeeeeccccc------cCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLD-ESRNLKEVKCLRKMNNHPNIVKLRNLVK------EHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~-~~~~~~e~~~l~~~~~hp~i~~~~~~~~------~~~~~~lv~e~~~~ 73 (282)
|+||+||+|+++.+|+.||||++........ ...+.+|+.+++++ +||||++++++|. ....+|+|||||.+
T Consensus 28 G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~ 106 (355)
T d2b1pa1 28 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 106 (355)
T ss_dssp C--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE
T ss_pred CcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCceeEEEEeccch
Confidence 8999999999999999999999987654433 34567899999998 5999999999985 34688999999999
Q ss_pred cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCCCCCccccc
Q 044127 74 DLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLPCTDYVTTR 152 (282)
Q Consensus 74 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~~~~~~~~~ 152 (282)
++++.+. ..+++..++.++.||+.||.|||++|++|+||||+||+++ ++.++++|||++.............+|+
T Consensus 107 ~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~ 182 (355)
T d2b1pa1 107 NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 182 (355)
T ss_dssp EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------------CC
T ss_pred HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccccccccccccc
Confidence 9887653 3699999999999999999999999999999999999998 5789999999988877766667778999
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGG 232 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+......+.+..+...................
T Consensus 183 ~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (355)
T d2b1pa1 183 YYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG 261 (355)
T ss_dssp TTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCC
T ss_pred cccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccc
Confidence 99999999854 58999999999999999999999999998888888888877776555443222211110000000000
Q ss_pred Cc------------ccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccc
Q 044127 233 VN------------LRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSC 276 (282)
Q Consensus 233 ~~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 276 (282)
.. ........++++.+||++||+.||++|||++|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 262 LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp CCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred cccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 00 001112246778999999999999999999999999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=343.57 Aligned_cols=241 Identities=22% Similarity=0.354 Sum_probs=192.8
Q ss_pred CCcceEEEEEec--CCCcEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDK--KSGEFVAVKKLKKKIFS-LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~--~~~~~v~vK~~~~~~~~-~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|.+. .+++.||||+++..... .....+.+|+.+++++ +||||+++++++..+ ..++|||||+++++.
T Consensus 18 G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~ 95 (277)
T d1xbba_ 18 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE-SWMLVMEMAELGPLN 95 (277)
T ss_dssp CSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESS-SEEEEEECCTTEEHH
T ss_pred CCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEeccC-CEEEEEEcCCCCcHH
Confidence 899999999864 45678999998765433 3345688999999999 599999999998654 578999999987777
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC----CCCccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP----CTDYVTTR 152 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~----~~~~~~~~ 152 (282)
.++... ..+++..+..++.||+.||+|||++|++||||||+||+++. +.+|++|||++........ .....+|+
T Consensus 96 ~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~ 174 (277)
T d1xbba_ 96 KYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174 (277)
T ss_dssp HHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCG
T ss_pred HHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCc
Confidence 766654 46999999999999999999999999999999999999974 8999999999986543322 22346789
Q ss_pred cccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 153 WYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 153 ~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
.|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+....+....+
T Consensus 175 ~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~------------------------- 228 (277)
T d1xbba_ 175 KWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------------------------- 228 (277)
T ss_dssp GGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------------------------
T ss_pred eecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC-------------------------
Confidence 999999998554 8999999999999999998 8999998776665544432111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh---cCcccc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEAL---EHPFFR 274 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll---~~~~~~ 274 (282)
...+..+++++.+||.+||+.||++|||+++|+ +|+|+.
T Consensus 229 ----~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 229 ----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 123456789999999999999999999999984 565543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=338.90 Aligned_cols=239 Identities=22% Similarity=0.348 Sum_probs=188.9
Q ss_pred CCcceEEEEEecCCC----cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSG----EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~----~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|.++.++ ..||||++...........+.+|+.++.++. ||||+++++++.+.+..+++||||.++++
T Consensus 18 G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~~~~v~e~~~~~~l 96 (283)
T d1mqba_ 18 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENGAL 96 (283)
T ss_dssp CSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred CCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCceEEEEEecccCcc
Confidence 899999999987654 4699999977655556667889999999995 99999999999999999999999998777
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC----CCCCcccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL----PCTDYVTT 151 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~----~~~~~~~~ 151 (282)
..........+++..+..++.||+.||+|||+++++||||||+|||++. +.+||+|||++....... ......+|
T Consensus 97 ~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt 176 (283)
T d1mqba_ 97 DKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176 (283)
T ss_dssp HHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCC
T ss_pred hhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCC
Confidence 7766666668999999999999999999999999999999999999985 799999999998654322 22334678
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMG 231 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
+.|+|||.+.++ .++.++|||||||++|||++|..|+............+.....
T Consensus 177 ~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------------------------ 231 (283)
T d1mqba_ 177 IRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR------------------------ 231 (283)
T ss_dssp GGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------------------------
T ss_pred ccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC------------------------
Confidence 899999999855 4899999999999999999976665544444444333321111
Q ss_pred CCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 232 GVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 232 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+...+..+.+||.+||+.||++|||+++|++
T Consensus 232 ----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 ----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1233457889999999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=341.45 Aligned_cols=240 Identities=24% Similarity=0.435 Sum_probs=192.8
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHH-
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLM- 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~- 79 (282)
|+||+||+|+++ ++..||||+++.... ....+.+|+.++.++ +||||+++++++.+ +..++|||||.++++..+
T Consensus 24 G~fg~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~ 98 (272)
T d1qpca_ 24 GQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 98 (272)
T ss_dssp ETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHT
T ss_pred CCCcEEEEEEEC-CCCEEEEEEEccCcC--CHHHHHHHHHHHHhC-CCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHH
Confidence 899999999976 577899999976543 345688999999999 59999999998765 467899999997666543
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccC
Q 044127 80 KERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRA 156 (282)
Q Consensus 80 ~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~a 156 (282)
....+.++++..+..++.||++||.|||+++++||||||+||++++ +.+||+|||++....... ......+++.|+|
T Consensus 99 ~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~A 178 (272)
T d1qpca_ 99 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178 (272)
T ss_dssp TSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSC
T ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccC
Confidence 3333346999999999999999999999999999999999999985 799999999998764432 2234578889999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCC-CCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRIL-FPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||++..+. ++.++|||||||++|||+||..| +......+....+.....
T Consensus 179 PE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~----------------------------- 228 (272)
T d1qpca_ 179 PEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------------------------- 228 (272)
T ss_dssp HHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------------------------
T ss_pred hHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------------------------
Confidence 99998554 89999999999999999996555 555444444443322111
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc--Cccccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE--HPFFRS 275 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--~~~~~~ 275 (282)
...+..+++.+.+|+++||+.||++|||+++|++ ++||++
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 1223467899999999999999999999999998 788875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-54 Score=353.25 Aligned_cols=272 Identities=34% Similarity=0.577 Sum_probs=210.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccch-HHHHHHHHHHHHHHhCCCCCeeeeccccccC-----CcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSL-DESRNLKEVKCLRKMNNHPNIVKLRNLVKEH-----EDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~ 74 (282)
|+||+||+|+++.+|+.||||+++...... ....+.+|+.+++++. |||++++++++... ...+++++++.|+
T Consensus 29 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg 107 (348)
T d2gfsa1 29 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 107 (348)
T ss_dssp GTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSTTTCCCCEEEEECCSE
T ss_pred CCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeccccccCceEEEEEeecCC
Confidence 899999999999999999999998665443 3446678999999995 99999999987532 2334444555555
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCcccccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRW 153 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~ 153 (282)
.|..++.. +++++..++.++.||+.||+|||++|++||||||+||+++. +.++++|||.+....... ....+++.
T Consensus 108 ~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~--~~~~g~~~ 183 (348)
T d2gfsa1 108 DLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--TGYVATRW 183 (348)
T ss_dssp EHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGGG--SSSCHHHH
T ss_pred chhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCccc--cccccccc
Confidence 55555544 47999999999999999999999999999999999999974 899999999987654433 55678999
Q ss_pred ccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc-cCCccccCCCC
Q 044127 154 YRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS-NLDWKFPQMGG 232 (282)
Q Consensus 154 ~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 232 (282)
|+|||.+.+...++.++|||||||++|+|++|..||.+.+.......+....+.+............. ...........
T Consensus 184 y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (348)
T d2gfsa1 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 263 (348)
T ss_dssp TSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCC
T ss_pred ccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCC
Confidence 99999988777689999999999999999999999999988888888888777655433221111100 01111122223
Q ss_pred CcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCccccccc
Q 044127 233 VNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCH 277 (282)
Q Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 277 (282)
..........++.+++||++||+.||.+|||++|+|+||||++..
T Consensus 264 ~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred cchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 333444567899999999999999999999999999999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-53 Score=340.61 Aligned_cols=244 Identities=24% Similarity=0.342 Sum_probs=192.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc--hHHHHHHHHHHHHHHhCCCCCeeeeccccccCC----cEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS--LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE----DVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----~~~lv~e~~~~~ 74 (282)
|+||+||+|+++.+|+.||||+++..... .....+.+|+.+++++ +||||+++++++...+ ..|+|||||.|+
T Consensus 18 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~ 96 (277)
T d1o6ya_ 18 GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGV 96 (277)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCCEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCceEEEEEECCCCC
Confidence 89999999999999999999999765433 2344678899999888 5999999999986543 489999999987
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC----CCCCCcc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS----LPCTDYV 149 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~----~~~~~~~ 149 (282)
.+..+.... .++++.++..++.||+.||+|||++|++||||||+||+++. +.++++|||.+...... .......
T Consensus 97 ~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 175 (277)
T d1o6ya_ 97 TLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175 (277)
T ss_dssp EHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-------------
T ss_pred Eehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccccccccccccc
Confidence 777666554 37999999999999999999999999999999999999974 89999999987654322 2234557
Q ss_pred ccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 150 TTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 150 ~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+...........+
T Consensus 176 Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~--------------------- 233 (277)
T d1o6ya_ 176 GTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--------------------- 233 (277)
T ss_dssp ---TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---------------------
T ss_pred CcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC---------------------
Confidence 89999999998754 48999999999999999999999999888777766655421111
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCC-CHHHHhcCcccc
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRP-TAAEALEHPFFR 274 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-s~~~ll~~~~~~ 274 (282)
.......+++.+.+||++||+.||.+|| |++++ .|+|.+
T Consensus 234 -----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r 273 (277)
T d1o6ya_ 234 -----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLVR 273 (277)
T ss_dssp -----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred -----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence 1223456899999999999999999999 55554 566654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=345.59 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=205.3
Q ss_pred CCcceEEEEEe---cCCCcEEEEEEccccccc---hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALD---KKSGEFVAVKKLKKKIFS---LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~---~~~~~~v~vK~~~~~~~~---~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
|+||+||+|++ +.+|+.||||+++..... .....+.+|+.+++++.+||||+++++++.+....+++|||+.++
T Consensus 35 G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~ 114 (322)
T d1vzoa_ 35 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 114 (322)
T ss_dssp TTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred CCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeeccccc
Confidence 89999999987 447899999998765322 234556789999999986799999999999999999999999977
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCC--CCCCCCcccc
Q 044127 75 LLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDS--SLPCTDYVTT 151 (282)
Q Consensus 75 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~--~~~~~~~~~~ 151 (282)
.+..++...+ .+++..+..++.||+.||+|||++|++||||||+||+++. +.++|+|||++..... ........++
T Consensus 115 ~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~ 193 (322)
T d1vzoa_ 115 ELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193 (322)
T ss_dssp BHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSC
T ss_pred HHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccc
Confidence 6666665553 6899999999999999999999999999999999999985 8999999999876533 2223456789
Q ss_pred ccccCchhhhccc-cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 152 RWYRAPEVLLLSE-IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 152 ~~~~aPE~~~~~~-~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
+.|+|||.+.... .++.++|||||||++|+|++|..||......+....+........
T Consensus 194 ~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~--------------------- 252 (322)
T d1vzoa_ 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--------------------- 252 (322)
T ss_dssp CTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC---------------------
T ss_pred cccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC---------------------
Confidence 9999999997543 468899999999999999999999988776665555444321111
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCC-----CHHHHhcCcccccccC
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRP-----TAAEALEHPFFRSCHF 278 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp-----s~~~ll~~~~~~~~~~ 278 (282)
...+...++++.+||.+||+.||.+|| |++|+++||||+++.+
T Consensus 253 -----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 253 -----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred -----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 123456799999999999999999999 5899999999998763
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-53 Score=335.59 Aligned_cols=238 Identities=25% Similarity=0.407 Sum_probs=189.1
Q ss_pred CCcceEEEEEecCC---CcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHH
Q 044127 1 GSYGDVFQALDKKS---GEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLK 77 (282)
Q Consensus 1 G~~g~Vy~~~~~~~---~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 77 (282)
|+||+||+|++..+ +..||+|.++..........+.+|+.+++++ +||||+++++++.+ +..++|||||.++.+.
T Consensus 18 G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~-~~~~iv~E~~~~g~l~ 95 (273)
T d1mp8a_ 18 GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE-NPVWIIMELCTLGELR 95 (273)
T ss_dssp CSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS-SSCEEEEECCTTEEHH
T ss_pred CCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec-CeEEEEEEeccCCcHH
Confidence 89999999998754 3568999987655455566788999999999 59999999999965 5789999999977776
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccc
Q 044127 78 LMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWY 154 (282)
Q Consensus 78 ~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~ 154 (282)
.+.......+++..+..++.||++||.|||+++++||||||+||++++ +.+||+|||++....... ......+|+.|
T Consensus 96 ~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y 175 (273)
T d1mp8a_ 96 SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175 (273)
T ss_dssp HHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGG
T ss_pred hhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCccc
Confidence 666555567999999999999999999999999999999999999975 899999999998764322 22345678899
Q ss_pred cCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCC
Q 044127 155 RAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGV 233 (282)
Q Consensus 155 ~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
+|||++.... ++.++|||||||++|||++ |..||...+..+....+.....
T Consensus 176 ~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~--------------------------- 227 (273)
T d1mp8a_ 176 MAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--------------------------- 227 (273)
T ss_dssp CCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---------------------------
T ss_pred chhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------------------
Confidence 9999998554 8999999999999999998 8999998888777766544211
Q ss_pred cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 234 NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+..+++.+.+||.+||+.||++|||+++|+++
T Consensus 228 --~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 --LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 12345678999999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-53 Score=334.70 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=188.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+ ..||||+++.... ....+.+|+.++.++ +||||+++++++.+ +..++|||||.++++..+.
T Consensus 28 G~fg~Vy~~~~~~~-~~vAiK~l~~~~~--~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~ 102 (285)
T d1fmka3 28 GCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 102 (285)
T ss_dssp CSSCEEEEEEETTT-EEEEEEECCTTSS--CHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHH
T ss_pred CCCeEEEEEEECCC-CEEEEEEECcccC--CHHHHHHHHHHHHhc-ccCCEeEEEEEEec-CCeEEEEEecCCCchhhhh
Confidence 89999999998765 5699999976543 345688999999999 49999999999865 4578999999976555444
Q ss_pred -HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC--CCCCccccccccC
Q 044127 81 -ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL--PCTDYVTTRWYRA 156 (282)
Q Consensus 81 -~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~a 156 (282)
......+++.++..++.||+.||+|||++|++||||||+||++++ +.+||+|||++....... ......+++.|+|
T Consensus 103 ~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 182 (285)
T d1fmka3 103 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182 (285)
T ss_dssp SHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSC
T ss_pred hhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccC
Confidence 333356999999999999999999999999999999999999985 799999999998664322 2234568899999
Q ss_pred chhhhccccCCCcchhHHHHHHHHHHHhCCCCCCC-CCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCcc
Q 044127 157 PEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPG-KNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNL 235 (282)
Q Consensus 157 PE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
||.+..+. ++.++|||||||++|||++|..|+.. ....+....+.....
T Consensus 183 PE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~----------------------------- 232 (285)
T d1fmka3 183 PEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------------------------- 232 (285)
T ss_dssp HHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------------------------
T ss_pred hHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------------------------
Confidence 99998555 79999999999999999997665544 444444433322111
Q ss_pred cccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc--Ccccccc
Q 044127 236 RELSPSASRESISLISRLCSWNPHMRPTAAEALE--HPFFRSC 276 (282)
Q Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--~~~~~~~ 276 (282)
...+..+++.+.+||.+||+.||++|||+++|++ ++||++.
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1234467899999999999999999999999988 8899664
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-52 Score=333.70 Aligned_cols=241 Identities=23% Similarity=0.366 Sum_probs=188.4
Q ss_pred CCcceEEEEEecC-----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc-CCcEEEEEecCCcc
Q 044127 1 GSYGDVFQALDKK-----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE-HEDVFIVFEYMESD 74 (282)
Q Consensus 1 G~~g~Vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~~~ 74 (282)
|+||+||+|++.. +++.||+|+++..........+..|...+.++.+||||+.+++++.+ +..++++||||+++
T Consensus 24 G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g 103 (299)
T d1ywna1 24 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 103 (299)
T ss_dssp CSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTC
T ss_pred cCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCC
Confidence 8999999999754 45789999998766566667788899999999889999999998654 55789999999977
Q ss_pred HHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccc
Q 044127 75 LLKLMKERA---------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKE 138 (282)
Q Consensus 75 ~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~ 138 (282)
.+..++... ...+++..+..++.||++||+|||++|++||||||+||++++ +.+||+|||++..
T Consensus 104 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~ 183 (299)
T d1ywna1 104 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 183 (299)
T ss_dssp BHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------
T ss_pred cHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhh
Confidence 666665432 235899999999999999999999999999999999999985 8999999999976
Q ss_pred cCCCC---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHhCCCCCCCcc
Q 044127 139 IDSSL---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWP 214 (282)
Q Consensus 139 ~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (282)
..... ......||+.|+|||++.++. ++.++|||||||++|||++| ..||......+.+.........+
T Consensus 184 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~------ 256 (299)
T d1ywna1 184 IYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------ 256 (299)
T ss_dssp CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC------
T ss_pred ccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC------
Confidence 53322 223457899999999998544 89999999999999999987 56788777666655544432111
Q ss_pred ccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 215 LGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+...++++.++|.+||+.||++|||++++++|
T Consensus 257 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 257 ----------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2344678999999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=336.39 Aligned_cols=237 Identities=21% Similarity=0.356 Sum_probs=187.2
Q ss_pred CCcceEEEEEecCCCc----EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCC-ccH
Q 044127 1 GSYGDVFQALDKKSGE----FVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYME-SDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~-~~~ 75 (282)
|+||+||+|++..+|+ +||+|.++..........+.+|+.++.++ +||||+++++++.++. .+++++++. +++
T Consensus 20 G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l 97 (317)
T d1xkka_ 20 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCL 97 (317)
T ss_dssp CSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESSS-EEEEEECCTTCBH
T ss_pred CCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC-eeEEEEeccCCcc
Confidence 8999999999988776 58888876654445566788999999999 5999999999998764 566677776 555
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC---CCCcccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP---CTDYVTT 151 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~---~~~~~~~ 151 (282)
++.+.. ....+++..+..++.||+.||+|||++|++||||||+||+++. +.+||+|||++........ .....+|
T Consensus 98 ~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 176 (317)
T d1xkka_ 98 LDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176 (317)
T ss_dssp HHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CC
T ss_pred cccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccC
Confidence 555444 4467999999999999999999999999999999999999985 7999999999987643322 2334678
Q ss_pred ccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 152 RWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 152 ~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
+.|+|||.+.++. ++.++|||||||++|||+| |..||.+.+..+....+....+.
T Consensus 177 ~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~----------------------- 232 (317)
T d1xkka_ 177 IKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----------------------- 232 (317)
T ss_dssp TTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-----------------------
T ss_pred ccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----------------------
Confidence 9999999998554 8999999999999999998 78899887776665554442211
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
..+..+++.+.+|+.+||+.||.+|||+.++++|
T Consensus 233 ------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1234578899999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=331.61 Aligned_cols=239 Identities=24% Similarity=0.399 Sum_probs=194.6
Q ss_pred CCcceEEEEEecCCC-------cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCc
Q 044127 1 GSYGDVFQALDKKSG-------EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMES 73 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~-------~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~ 73 (282)
|+||+||+|++..++ ..||||+++..........+.+|...+.++.+||||+++++++.+++..++|||||.+
T Consensus 24 G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~ 103 (299)
T d1fgka_ 24 GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 103 (299)
T ss_dssp ----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred cCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCC
Confidence 899999999876654 4799999988766666778889999999997899999999999999999999999997
Q ss_pred cHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccc
Q 044127 74 DLLKLMKERA---------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK 137 (282)
Q Consensus 74 ~~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~ 137 (282)
+.+..++... ...+++.++..++.||+.||+|||+.+++||||||+||+++. +.+||+|||.+.
T Consensus 104 g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~ 183 (299)
T d1fgka_ 104 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 183 (299)
T ss_dssp CBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCC
T ss_pred CcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhc
Confidence 7666665433 235899999999999999999999999999999999999985 799999999998
Q ss_pred ccCCCC---CCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCc
Q 044127 138 EIDSSL---PCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 138 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (282)
...... ......+++.|+|||.+.++ .++.++||||||+++|||++ |..||......+....+... ..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~-~~------ 255 (299)
T d1fgka_ 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HR------ 255 (299)
T ss_dssp CGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CC------
T ss_pred cccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC-CC------
Confidence 664332 23446788999999999855 48999999999999999998 68888776665544333221 11
Q ss_pred cccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+..+++.+.+||.+||+.||++|||++||++
T Consensus 256 ----------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 256 ----------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp ----------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 1234467899999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-52 Score=336.10 Aligned_cols=240 Identities=25% Similarity=0.381 Sum_probs=194.0
Q ss_pred CCcceEEEEEecCCCcE--EEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHH
Q 044127 1 GSYGDVFQALDKKSGEF--VAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKL 78 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~--v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 78 (282)
|+||+||+|+++.+|.. ||||.++..........+.+|+.++.++.+||||+++++++.+++..++|||||.++.+..
T Consensus 21 G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~ 100 (309)
T d1fvra_ 21 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 100 (309)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred CCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHH
Confidence 89999999999988774 6777776554455566788999999998679999999999999999999999999777766
Q ss_pred HHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCC
Q 044127 79 MKERA---------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSS 142 (282)
Q Consensus 79 ~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~ 142 (282)
++... ...+++..+..++.||+.||.|||+++++||||||+|||++. +.+||+|||++......
T Consensus 101 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~ 180 (309)
T d1fvra_ 101 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180 (309)
T ss_dssp HHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE
T ss_pred HHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccccccccc
Confidence 65432 356999999999999999999999999999999999999985 79999999999876655
Q ss_pred CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCC-CCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 143 LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFR-ILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 143 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
.......++..|+|||.+.++. ++.++|||||||++|||++|. .||.+.+..+....+.+..+
T Consensus 181 ~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~--------------- 244 (309)
T d1fvra_ 181 VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--------------- 244 (309)
T ss_dssp CCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC---------------
T ss_pred ccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---------------
Confidence 5555667899999999998554 899999999999999999975 56777665555544322111
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+..+++++.+||++||+.||++|||+++|+++
T Consensus 245 --------------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 --------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp --------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 12345678999999999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-51 Score=328.29 Aligned_cols=240 Identities=24% Similarity=0.360 Sum_probs=200.2
Q ss_pred CCcceEEEEEec-----CCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDK-----KSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||.||+|++. .+++.||||+++..........+.+|+.++.++.+||||+++++++.++...+++||||+++.
T Consensus 34 G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~ 113 (311)
T d1t46a_ 34 GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113 (311)
T ss_dssp CSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEE
T ss_pred cCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCC
Confidence 899999999863 467789999998766556666788999999999889999999999999999999999999777
Q ss_pred HHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCccc
Q 044127 76 LKLMKERAG-----------------QNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVK 137 (282)
Q Consensus 76 l~~~~~~~~-----------------~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~ 137 (282)
+..++.... ..+++..+..++.||+.||+|||+++++||||||+||+++. +.++++|||.+.
T Consensus 114 l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~ 193 (311)
T d1t46a_ 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193 (311)
T ss_dssp HHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGS
T ss_pred HHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchhe
Confidence 766654422 25899999999999999999999999999999999999985 899999999998
Q ss_pred ccCCCCC---CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCc
Q 044127 138 EIDSSLP---CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSW 213 (282)
Q Consensus 138 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (282)
....... .....+++.|+|||.+.++. ++.++|||||||++|||++ |..||......+.+.++......+
T Consensus 194 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~----- 267 (311)
T d1t46a_ 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM----- 267 (311)
T ss_dssp CTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC-----
T ss_pred eccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----
Confidence 7654322 23457899999999998544 8999999999999999998 566677777767666665532221
Q ss_pred cccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 214 PLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
..+...++.+.+||.+||+.||++|||+++|++
T Consensus 268 -----------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 268 -----------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 123456899999999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=325.48 Aligned_cols=237 Identities=23% Similarity=0.342 Sum_probs=183.3
Q ss_pred CCcceEEEEEecCC-C--cEEEEEEcccccc--chHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKKS-G--EFVAVKKLKKKIF--SLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~~-~--~~v~vK~~~~~~~--~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|++..+ + ..||||+++.... ......+.+|+.+++++ +||||+++++++.++ ..++|||||.++.
T Consensus 19 G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~~-~~~lv~e~~~~~~ 96 (273)
T d1u46a_ 19 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP-PMKMVTELAPLGS 96 (273)
T ss_dssp ---CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS-SCEEEEECCTTCB
T ss_pred CCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeec-chheeeeeecCcc
Confidence 89999999986533 2 3689999876543 23345778999999999 599999999999764 6789999998655
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee-CCcEEEeecCcccccCCCCC----CCCccc
Q 044127 76 LKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS-KGVIKIGDLGMVKEIDSSLP----CTDYVT 150 (282)
Q Consensus 76 l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~-~~~~~l~df~~~~~~~~~~~----~~~~~~ 150 (282)
+..........+++..+..++.||+.||.|||++|++||||||+||+++ ++.+||+|||++........ .....+
T Consensus 97 l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~ 176 (273)
T d1u46a_ 97 LLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176 (273)
T ss_dssp HHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----C
T ss_pred hhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCcccc
Confidence 4444433335799999999999999999999999999999999999997 47999999999997654432 123456
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQ 229 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
+..|+|||.+.+. .++.++|||||||++|||++ |..||.+.+..+....+......
T Consensus 177 ~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~---------------------- 233 (273)
T d1u46a_ 177 PFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER---------------------- 233 (273)
T ss_dssp CGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC----------------------
T ss_pred CcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC----------------------
Confidence 7889999999854 48999999999999999998 89999988877776655432111
Q ss_pred CCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh
Q 044127 230 MGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268 (282)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 268 (282)
.+.+..+++.+.+||++||+.||++|||+++|+
T Consensus 234 ------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 234 ------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 123456789999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=323.73 Aligned_cols=232 Identities=25% Similarity=0.424 Sum_probs=183.1
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccc-cCCcEEEEEecCCccHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVK-EHEDVFIVFEYMESDLLKLM 79 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-~~~~~~lv~e~~~~~~l~~~ 79 (282)
|+||.||+|+++ |..||||+++.+ .....+.+|+.+++++ +||||+++++++. .++.+++||||+.++++..+
T Consensus 18 G~fg~Vy~~~~~--~~~vAvK~i~~~---~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~ 91 (262)
T d1byga_ 18 GEFGDVMLGDYR--GNKVAVKCIKND---ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 91 (262)
T ss_dssp CSSCEEEEEEET--TEEEEEEECCCC---C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTEEHHHH
T ss_pred CCCeEEEEEEEC--CeEEEEEEECcH---HHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHH
Confidence 899999999874 778999999764 3445678899999999 5999999999874 45678999999987666555
Q ss_pred HH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCCCCCccccccccCc
Q 044127 80 KE-RAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLPCTDYVTTRWYRAP 157 (282)
Q Consensus 80 ~~-~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aP 157 (282)
+. .....+++..+..|+.||+.||.|||+++++|+||||+||+++. +.++++|||.+....... ....+++.|+||
T Consensus 92 l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--~~~~~~~~y~aP 169 (262)
T d1byga_ 92 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAP 169 (262)
T ss_dssp HHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCH
T ss_pred HHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC--ccccccccCCCh
Confidence 43 32235899999999999999999999999999999999999984 899999999998765433 445678899999
Q ss_pred hhhhccccCCCcchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCCCCCccc
Q 044127 158 EVLLLSEIYGPEVDMWAMGAIMFEMLS-FRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQMGGVNLR 236 (282)
Q Consensus 158 E~~~~~~~~~~~~DiwslG~ll~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
|.+.++. ++.++|||||||++|||++ |..||...+..+....+.+... .
T Consensus 170 E~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~-----------------------------~ 219 (262)
T d1byga_ 170 EALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----------------------------M 219 (262)
T ss_dssp HHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-----------------------------C
T ss_pred HHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----------------------------C
Confidence 9998554 8999999999999999998 6888888777776655432111 1
Q ss_pred ccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 237 ELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
+.+...++.+.+||++||+.||.+|||+.+++++
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 3345678999999999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-51 Score=327.74 Aligned_cols=240 Identities=18% Similarity=0.267 Sum_probs=191.4
Q ss_pred CCcceEEEEEecCCC---cEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeecccccc-CCcEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSG---EFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKE-HEDVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~---~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~~~~l 76 (282)
|+||+||+|++..++ ..||||+++..........+.+|+.++.++. ||||+++++++.+ ++..++|||||+++++
T Consensus 38 G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l 116 (311)
T d1r0pa_ 38 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDL 116 (311)
T ss_dssp ETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEEEEECCTTCBH
T ss_pred cCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEEEEEEeecCch
Confidence 899999999986543 3689999876554555677899999999995 9999999999754 5689999999998888
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCC-----CCCCccc
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL-----PCTDYVT 150 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~-----~~~~~~~ 150 (282)
..+.......+++..+..++.|++.||.|||+.+++||||||+||++++ +.+||+|||++....... ......+
T Consensus 117 ~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~g 196 (311)
T d1r0pa_ 117 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196 (311)
T ss_dssp HHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSC
T ss_pred hhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccc
Confidence 8877766667889999999999999999999999999999999999986 799999999998654322 1223467
Q ss_pred cccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCccccCC
Q 044127 151 TRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFPQM 230 (282)
Q Consensus 151 ~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
++.|+|||.+..+. ++.++||||||+++|||++|+.||............+.....
T Consensus 197 t~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~----------------------- 252 (311)
T d1r0pa_ 197 PVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR----------------------- 252 (311)
T ss_dssp CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC-----------------------
T ss_pred cccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 89999999988554 899999999999999999988877654433322222211111
Q ss_pred CCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcC
Q 044127 231 GGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALEH 270 (282)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 270 (282)
...+...++.+.+||.+||+.||++|||++||+++
T Consensus 253 -----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 253 -----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11234568899999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-51 Score=327.31 Aligned_cols=238 Identities=26% Similarity=0.376 Sum_probs=195.0
Q ss_pred CCcceEEEEEecC-----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKK-----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|+++. +++.||||+++..........+.+|+.+++++ +||||+++++++.+....+++||++.++.
T Consensus 24 G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~~v~e~~~~g~ 102 (301)
T d1lufa_ 24 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGD 102 (301)
T ss_dssp CSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred CCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeeccCCceEEEEEecCCCc
Confidence 8999999998753 56789999998765555567789999999999 59999999999999999999999998766
Q ss_pred HHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEe
Q 044127 76 LKLMKERA-----------------------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIG 131 (282)
Q Consensus 76 l~~~~~~~-----------------------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~ 131 (282)
+..++... ...+++..+..++.||+.||+|||+++++||||||+||+++. +.+||+
T Consensus 103 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~ 182 (301)
T d1lufa_ 103 LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 182 (301)
T ss_dssp HHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred HHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEc
Confidence 66555432 124899999999999999999999999999999999999985 789999
Q ss_pred ecCcccccCCC---CCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCC-CCCCCCCChHHHHHHHHHhCC
Q 044127 132 DLGMVKEIDSS---LPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFR-ILFPGKNSADQIYKICQVIGS 207 (282)
Q Consensus 132 df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~-~~~~~~~~~~~~~~~~~~~~~ 207 (282)
|||++...... .......+++.|+|||.+.+.. ++.++|||||||++|||++|. .||...+..+....+.....
T Consensus 183 DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~- 260 (301)
T d1lufa_ 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI- 260 (301)
T ss_dssp CCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-
T ss_pred cchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCC-
Confidence 99998755322 2223457888999999998544 899999999999999999985 57887777766655433211
Q ss_pred CCCCCccccccccccCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 208 PTEDSWPLGIQLASNLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
...+..+++++.+||++||+.||++|||+.+|++
T Consensus 261 ----------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 261 ----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp ----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1234577899999999999999999999999964
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=327.00 Aligned_cols=248 Identities=21% Similarity=0.360 Sum_probs=203.0
Q ss_pred CCcceEEEEEecC-----CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccH
Q 044127 1 GSYGDVFQALDKK-----SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 1 G~~g~Vy~~~~~~-----~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
|+||+||+|.+.. ++..||||+++..........+.+|+.++.++. ||||+++++++..++..++|||||.+++
T Consensus 31 G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~g~ 109 (308)
T d1p4oa_ 31 GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQGQPTLVIMELMTRGD 109 (308)
T ss_dssp CSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred CCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecCCceeEEEeecCCCC
Confidence 8999999998753 357899999987655555667889999999995 9999999999999999999999999766
Q ss_pred HHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC-CcEEEeecCcccccCCCCC-
Q 044127 76 LKLMKERA---------GQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSLP- 144 (282)
Q Consensus 76 l~~~~~~~---------~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~~- 144 (282)
+..++... -..++...+..++.|+++||.|||+++++||||||+||++++ +.+||+|||++........
T Consensus 110 l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~ 189 (308)
T d1p4oa_ 110 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189 (308)
T ss_dssp HHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE
T ss_pred HHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcce
Confidence 65554321 124789999999999999999999999999999999999986 6899999999986643222
Q ss_pred --CCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhC-CCCCCCCCChHHHHHHHHHhCCCCCCCccccccccc
Q 044127 145 --CTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSF-RILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLAS 221 (282)
Q Consensus 145 --~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
.....+++.|+|||.+.++. ++.++||||||+++|||++| ..||.+.+..+....+.+...
T Consensus 190 ~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~--------------- 253 (308)
T d1p4oa_ 190 RKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL--------------- 253 (308)
T ss_dssp EGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC---------------
T ss_pred eeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC---------------
Confidence 23446889999999998554 78999999999999999998 577877776666655543211
Q ss_pred cCCccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc------CcccccccCc
Q 044127 222 NLDWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEALE------HPFFRSCHFV 279 (282)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~------~~~~~~~~~~ 279 (282)
...+..+++.+.++|.+||+.||++|||+++|++ +|+|++..+.
T Consensus 254 --------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~~~ 303 (308)
T d1p4oa_ 254 --------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY 303 (308)
T ss_dssp --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred --------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCCCC
Confidence 1234567899999999999999999999999997 8888876553
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-50 Score=321.37 Aligned_cols=248 Identities=22% Similarity=0.273 Sum_probs=193.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|++..+|+.||||++.... ....+..|..+++.+.+|++|+.+.+++.+++..++|||++++++...+.
T Consensus 18 G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~ 94 (299)
T d1ckia_ 18 GSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN 94 (299)
T ss_dssp CSSSEEEEEEETTTTEEEEEEEEESCT---TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHH
T ss_pred CCCcEEEEEEECCCCCEEEEEEEchhc---cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCCchhhhhh
Confidence 899999999999999999999876543 23456779999999976666777777788888999999999988877665
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeC----CcEEEeecCcccccCCCCC--------CCCc
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSK----GVIKIGDLGMVKEIDSSLP--------CTDY 148 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~----~~~~l~df~~~~~~~~~~~--------~~~~ 148 (282)
.. ...+++..+..++.|++.||+|||++||+||||||+||+++. ..++++|||+|........ ....
T Consensus 95 ~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~ 173 (299)
T d1ckia_ 95 FC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173 (299)
T ss_dssp HT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSC
T ss_pred hc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCc
Confidence 54 357999999999999999999999999999999999999852 4799999999987643321 2345
Q ss_pred cccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHHhCCCCCCCccccccccccCCcccc
Q 044127 149 VTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYKICQVIGSPTEDSWPLGIQLASNLDWKFP 228 (282)
Q Consensus 149 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
.||+.|+|||.+.+.. ++.++|||||||++|||++|..||......+............
T Consensus 174 ~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-------------------- 232 (299)
T d1ckia_ 174 TGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-------------------- 232 (299)
T ss_dssp CCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH--------------------
T ss_pred CCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc--------------------
Confidence 7899999999998554 8999999999999999999999998776655444332211100
Q ss_pred CCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHH---HHhcCccccc
Q 044127 229 QMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAA---EALEHPFFRS 275 (282)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~---~ll~~~~~~~ 275 (282)
...........+++++.+||+.||+.||++||+++ ++|+|+|.+.
T Consensus 233 --~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 233 --MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp --HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 00111234457899999999999999999999987 4567776543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.1e-48 Score=311.79 Aligned_cols=238 Identities=21% Similarity=0.261 Sum_probs=193.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMK 80 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 80 (282)
|+||+||+|+++.+|+.||||+++... ....+.+|+..+..+.+|+|++.+++++.++...++|||++++++.+.+.
T Consensus 16 G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~~~l~~~~~ 92 (293)
T d1csna_ 16 GSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD 92 (293)
T ss_dssp CSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHH
T ss_pred CCCeEEEEEEECCCCCEEEEEEEcccc---CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecCCCHHHHHH
Confidence 899999999999999999999886542 23445678888889987899999999999999999999999887776554
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeee------CCcEEEeecCcccccCCCC--------CCC
Q 044127 81 ERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVS------KGVIKIGDLGMVKEIDSSL--------PCT 146 (282)
Q Consensus 81 ~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~------~~~~~l~df~~~~~~~~~~--------~~~ 146 (282)
..+..++...+..++.|++.||++||++|++||||||+||+++ ++.++|+|||++....... ...
T Consensus 93 -~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~ 171 (293)
T d1csna_ 93 -LCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171 (293)
T ss_dssp -HTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred -hhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccC
Confidence 4445799999999999999999999999999999999999996 3679999999998654321 223
Q ss_pred CccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HHHHhCCCCCCCccccccccccC
Q 044127 147 DYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQIYK---ICQVIGSPTEDSWPLGIQLASNL 223 (282)
Q Consensus 147 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
...||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+......... +.....
T Consensus 172 ~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~----------------- 233 (293)
T d1csna_ 172 NLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ----------------- 233 (293)
T ss_dssp CCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-----------------
T ss_pred ceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-----------------
Confidence 45799999999999854 489999999999999999999999987655433322 221110
Q ss_pred CccccCCCCCcccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHh
Q 044127 224 DWKFPQMGGVNLRELSPSASRESISLISRLCSWNPHMRPTAAEAL 268 (282)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 268 (282)
.....++...+|+++.+++..|+..+|++||+.+.+.
T Consensus 234 --------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 234 --------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp --------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred --------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 0112234456789999999999999999999877664
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-47 Score=316.20 Aligned_cols=273 Identities=26% Similarity=0.422 Sum_probs=195.5
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhC----------CCCCeeeeccccccC--CcEEEEE
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMN----------NHPNIVKLRNLVKEH--EDVFIVF 68 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~----------~hp~i~~~~~~~~~~--~~~~lv~ 68 (282)
|+||+||+|+++.+|+.||||+++.+.. ......+|+.+++.+. .||||+++++++... ...++++
T Consensus 24 G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~ 101 (362)
T d1q8ya_ 24 GHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVM 101 (362)
T ss_dssp CSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEE
T ss_pred CCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeee
Confidence 8999999999999999999999976532 2334556777766653 368899999887543 3445555
Q ss_pred ecC--CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccCCCCCceeeeC-C------cEEEeecCcccc
Q 044127 69 EYM--ESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHR-QGYFHRDLKPSNLLVSK-G------VIKIGDLGMVKE 138 (282)
Q Consensus 69 e~~--~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~-~~~~H~dl~p~nili~~-~------~~~l~df~~~~~ 138 (282)
.++ .+.............+++..++.++.||+.||.+||+ .||+||||||+||+++. + .++++|||.+..
T Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~ 181 (362)
T d1q8ya_ 102 VFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181 (362)
T ss_dssp EECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEE
T ss_pred eecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccc
Confidence 544 4555555555555689999999999999999999998 88999999999999973 2 599999999876
Q ss_pred cCCCCCCCCccccccccCchhhhccccCCCcchhHHHHHHHHHHHhCCCCCCCCCC------hHHHHHHHHHhCCCCCCC
Q 044127 139 IDSSLPCTDYVTTRWYRAPEVLLLSEIYGPEVDMWAMGAIMFEMLSFRILFPGKNS------ADQIYKICQVIGSPTEDS 212 (282)
Q Consensus 139 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~ll~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 212 (282)
..... ....+++.|+|||++.... ++.++|+||+||++++|++|+.||..... .+........++.+....
T Consensus 182 ~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~ 258 (362)
T d1q8ya_ 182 YDEHY--TNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYL 258 (362)
T ss_dssp TTBCC--CSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHH
T ss_pred ccccc--ccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHH
Confidence 54433 5668999999999998555 79999999999999999999999975432 344455555555543332
Q ss_pred ccccccccccCCc-----cccCCCCC-------cccccCCCCChhhHHHHHHHhCCCCCCCCCHHHHhcCcccccccC
Q 044127 213 WPLGIQLASNLDW-----KFPQMGGV-------NLRELSPSASRESISLISRLCSWNPHMRPTAAEALEHPFFRSCHF 278 (282)
Q Consensus 213 ~~~~~~~~~~~~~-----~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 278 (282)
...........+. ........ .........++.+.+||.+||..||.+|||++|+|+||||+++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 259 LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 336 (362)
T ss_dssp HHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred hhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCC
Confidence 2111111111100 00000000 011223345778999999999999999999999999999997643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=306.96 Aligned_cols=241 Identities=26% Similarity=0.271 Sum_probs=172.9
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCC----cEEEEEecCCccHH
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHE----DVFIVFEYMESDLL 76 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----~~~lv~e~~~~~~l 76 (282)
|+||+||+|++ +|+.||||+++.+. ........|+..+.++ +||||+++++++.+.+ .+++|||||.+++|
T Consensus 14 G~fg~Vy~~~~--~g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L 88 (303)
T d1vjya_ 14 GRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL 88 (303)
T ss_dssp CSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred CCCeEEEEEEE--CCEEEEEEEECccc--hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEEEecccCCCH
Confidence 89999999975 58899999986542 2222222344444455 5999999999986543 68999999998777
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------cCccccCCCCCceeeeC-CcEEEeecCcccccCCCC----
Q 044127 77 KLMKERAGQNFSEDEVRNLCFQVFQGLHYMHR--------QGYFHRDLKPSNLLVSK-GVIKIGDLGMVKEIDSSL---- 143 (282)
Q Consensus 77 ~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~--------~~~~H~dl~p~nili~~-~~~~l~df~~~~~~~~~~---- 143 (282)
..++.. .++++..+..++.|++.||.|||+ +||+||||||+||++++ +.+||+|||++.......
T Consensus 89 ~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~ 166 (303)
T d1vjya_ 89 FDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 166 (303)
T ss_dssp HHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEC
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCccee
Confidence 777766 369999999999999999999996 58999999999999975 799999999988664332
Q ss_pred -CCCCccccccccCchhhhccc-----cCCCcchhHHHHHHHHHHHhCCCCCCCCCChHH-----------HHHHHHHhC
Q 044127 144 -PCTDYVTTRWYRAPEVLLLSE-----IYGPEVDMWAMGAIMFEMLSFRILFPGKNSADQ-----------IYKICQVIG 206 (282)
Q Consensus 144 -~~~~~~~~~~~~aPE~~~~~~-----~~~~~~DiwslG~ll~~l~~g~~~~~~~~~~~~-----------~~~~~~~~~ 206 (282)
......||+.|+|||.+.+.. .++.++|||||||++|||+||..||........ .........
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (303)
T d1vjya_ 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246 (303)
T ss_dssp C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT
T ss_pred ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHh
Confidence 223467899999999986432 246789999999999999999888754322110 000000000
Q ss_pred CCCCCCccccccccccCCccccCCCCCcccc--cCCCCChhhHHHHHHHhCCCCCCCCCHHHHhc
Q 044127 207 SPTEDSWPLGIQLASNLDWKFPQMGGVNLRE--LSPSASRESISLISRLCSWNPHMRPTAAEALE 269 (282)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 269 (282)
. ... .+.++. ........+.+|+.+||+.||++|||+.||++
T Consensus 247 ~-----------------~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 247 E-----------------QKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp T-----------------SCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred c-----------------ccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0 000 000000 01122356889999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.6e-25 Score=167.23 Aligned_cols=155 Identities=20% Similarity=0.148 Sum_probs=112.0
Q ss_pred CCcceEEEEEecCCCcEEEEEEccccccc-----------------hHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKKIFS-----------------LDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHED 63 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~~~~-----------------~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~ 63 (282)
|+||+||+|++. +|+.||||+++..... ........|...+.++. |++++..+++..
T Consensus 11 G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~~~~~~---- 84 (191)
T d1zara2 11 GKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKVYAWEG---- 84 (191)
T ss_dssp CSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCEEEEET----
T ss_pred CcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceEEEecC----
Confidence 899999999875 6899999987532211 01122345677777774 888888776532
Q ss_pred EEEEEecCCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCccccCCCCCceeeeCCcEEEeecCcccccCCCC
Q 044127 64 VFIVFEYMESDLLKLMKERAGQNFSEDEVRNLCFQVFQGLHYMHRQGYFHRDLKPSNLLVSKGVIKIGDLGMVKEIDSSL 143 (282)
Q Consensus 64 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~l~~Lh~~~~~H~dl~p~nili~~~~~~l~df~~~~~~~~~~ 143 (282)
.+++||++++.... .++...+..++.|++.++++||++|++|+||||+||+++++.++|+|||.|...+.+.
T Consensus 85 ~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~liDFG~a~~~~~~~ 156 (191)
T d1zara2 85 NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWIIDFPQSVEVGEEG 156 (191)
T ss_dssp TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEECCCTTCEETTSTT
T ss_pred CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEEECCCcccCCCCC
Confidence 37999999975432 3566667889999999999999999999999999999999999999999987654332
Q ss_pred CCCCccccccccC------chhhhccccCCCcchhHHHHHH
Q 044127 144 PCTDYVTTRWYRA------PEVLLLSEIYGPEVDMWAMGAI 178 (282)
Q Consensus 144 ~~~~~~~~~~~~a------PE~~~~~~~~~~~~DiwslG~l 178 (282)
. ..|+. .+.+ .+.++.++|+||+.--
T Consensus 157 ~-------~~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 157 W-------REILERDVRNIITYF--SRTYRTEKDINSAIDR 188 (191)
T ss_dssp H-------HHHHHHHHHHHHHHH--HHHHCCCCCHHHHHHH
T ss_pred c-------HHHHHHHHHHHHHHH--cCCCCCcccHHHHHHH
Confidence 1 11111 1122 2347899999997643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.78 E-value=2.5e-08 Score=76.54 Aligned_cols=125 Identities=15% Similarity=0.139 Sum_probs=82.5
Q ss_pred ceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCccHHHHHHHhc
Q 044127 4 GDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESDLLKLMKERA 83 (282)
Q Consensus 4 g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~ 83 (282)
+.||++. .++..+++|....... .......+|...+..+..+--+.+++.+..+++..++||++..|..+......
T Consensus 28 ~~v~rv~--~~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~- 103 (263)
T d1j7la_ 28 AKVYKLV--GENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED- 103 (263)
T ss_dssp SEEEEEE--CSSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT-
T ss_pred CcEEEEE--eCCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc-
Confidence 5799884 4566678888765432 22334566888887776554467777777888889999999998665432211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------------------
Q 044127 84 GQNFSEDEVRNLCFQVFQGLHYMHR------------------------------------------------------- 108 (282)
Q Consensus 84 ~~~l~~~~~~~i~~qi~~~l~~Lh~------------------------------------------------------- 108 (282)
......++.+++..+..||+
T Consensus 104 -----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 178 (263)
T d1j7la_ 104 -----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEK 178 (263)
T ss_dssp -----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSC
T ss_pred -----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcC
Confidence 11122234444444444443
Q ss_pred ----cCccccCCCCCceeeeCCcE-EEeecCccc
Q 044127 109 ----QGYFHRDLKPSNLLVSKGVI-KIGDLGMVK 137 (282)
Q Consensus 109 ----~~~~H~dl~p~nili~~~~~-~l~df~~~~ 137 (282)
..++|+|+.|.||+++++.+ .++||+.+.
T Consensus 179 ~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 179 PEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 12789999999999998775 599999754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.22 E-value=1.9e-06 Score=69.85 Aligned_cols=71 Identities=20% Similarity=0.271 Sum_probs=39.3
Q ss_pred CCcceEEEEEecCCCcEEEEEEcccc------ccchHHHHHHHHHHHHHHhCCC-C-CeeeeccccccCCcEEEEEecCC
Q 044127 1 GSYGDVFQALDKKSGEFVAVKKLKKK------IFSLDESRNLKEVKCLRKMNNH-P-NIVKLRNLVKEHEDVFIVFEYME 72 (282)
Q Consensus 1 G~~g~Vy~~~~~~~~~~v~vK~~~~~------~~~~~~~~~~~e~~~l~~~~~h-p-~i~~~~~~~~~~~~~~lv~e~~~ 72 (282)
|....||++....+++.+++|..... ...........|...+..+..+ | .+++++.+ ++...+++||+++
T Consensus 37 G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE~L~ 114 (392)
T d2pula1 37 GNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLS 114 (392)
T ss_dssp SSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCT
T ss_pred CceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEeccC
Confidence 44568999988777888999964321 1111122234577777665433 3 34445443 3445679999997
Q ss_pred c
Q 044127 73 S 73 (282)
Q Consensus 73 ~ 73 (282)
+
T Consensus 115 ~ 115 (392)
T d2pula1 115 H 115 (392)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.13 E-value=5e-06 Score=62.97 Aligned_cols=67 Identities=12% Similarity=0.066 Sum_probs=44.1
Q ss_pred ceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCC-CCeeeeccccccCCcEEEEEecCCccH
Q 044127 4 GDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNH-PNIVKLRNLVKEHEDVFIVFEYMESDL 75 (282)
Q Consensus 4 g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~h-p~i~~~~~~~~~~~~~~lv~e~~~~~~ 75 (282)
+.||++... ++..+++|...... ......|...++.+..+ -.+.+++.+..+++..+++|++++|..
T Consensus 25 ~~v~r~~~~-~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 25 AAVFRLSAQ-GRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CEEEEEECT-TSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred CeEEEEEeC-CCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 578988743 46668889765432 22344566666655432 225667777778888999999998743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.44 E-value=0.00017 Score=58.16 Aligned_cols=65 Identities=15% Similarity=0.035 Sum_probs=42.3
Q ss_pred cceEEEEEecC-------CCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcEEEEEecCCcc
Q 044127 3 YGDVFQALDKK-------SGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHPNIVKLRNLVKEHEDVFIVFEYMESD 74 (282)
Q Consensus 3 ~g~Vy~~~~~~-------~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 74 (282)
.-.+|++.... ..+.|+++++... .......+|..+++.+..+.-..++++++.+ ++|+||+.|.
T Consensus 55 tN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~ 126 (395)
T d1nw1a_ 55 SNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSR 126 (395)
T ss_dssp TEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEE
T ss_pred ccceEEEEeCCCCccccCCCCcEEEEecCCc---chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccc
Confidence 34789887543 2456778876532 2233456788888877655445677777754 5889998873
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.37 E-value=0.00097 Score=51.97 Aligned_cols=67 Identities=18% Similarity=0.209 Sum_probs=39.7
Q ss_pred ceEEEEEecCCCcEEEEEEccccccchHHHHHHHHHHHHHHhCCCC-Ceeeecc-----ccccCCcEEEEEecCCc
Q 044127 4 GDVFQALDKKSGEFVAVKKLKKKIFSLDESRNLKEVKCLRKMNNHP-NIVKLRN-----LVKEHEDVFIVFEYMES 73 (282)
Q Consensus 4 g~Vy~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~e~~~l~~~~~hp-~i~~~~~-----~~~~~~~~~lv~e~~~~ 73 (282)
..||++.. .+|..|++|+...... +..++..|...+..+..+. .++.... .+...+..+.+++++.|
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 36999974 4688899999865432 2344555666666654211 1111111 12345678899999876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.62 E-value=0.0059 Score=47.00 Aligned_cols=29 Identities=21% Similarity=0.198 Sum_probs=25.1
Q ss_pred cCccccCCCCCceeeeCCc-EEEeecCccc
Q 044127 109 QGYFHRDLKPSNLLVSKGV-IKIGDLGMVK 137 (282)
Q Consensus 109 ~~~~H~dl~p~nili~~~~-~~l~df~~~~ 137 (282)
.|++|+|+.++||+++++. .-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 3699999999999999865 4899999865
|